{
    "pages": [
        {
            "index": 0,
            "markdown": "- incidental finding\n$\\sqrt{ }$ cisterna magna $\\geq 10 \\mathrm{~mm}$ (on midsagittal image)\n$\\sqrt{ }$ free communication with $4^{\\text {th }}$ ventricle + cervical subarachnoid space (confirmed with CSF flow study)\nPertinent negatives:\n$\\sqrt{ }$ intact vermis + normal $4^{\\text {th }}$ ventricle\n$\\sqrt{ }$ absence of hydrocephalus\n$\\sqrt{ }$ occasionally enlarged posterior fossa\n$D D x$ : (1) Blake pouch cyst (hydrocephalus)\n(2) Isolated inferior vermian hypoplasia\n\n\n# MELANOCYTOMA \n\n$=$ benign lesion arising from resident melanocytic cells found within leptomeninges\nAge: any; $5^{\\text {th }}$ decade (majority); $\\mathrm{F}>\\mathrm{M}$\nPath: darkly pigmented mass\nHisto: tight cellular nests / whorls $\\pm$ abundant melanin pigment within cytoplasm: NO mitotic activity, NO nuclear pleomorphism, NO hyperchromaticity; S-100 + melan-A + HMB-45 positivity (similar to melanoma)\n\n- myelopathy, radiculopathy\n- seizures, hydrocephalus, cranial nerve deficits\n\nLocation: posterior fossa, Meckel cave, spinal canal (cervical + thoracic spine)\n$\\sqrt{ }$ avidly enhancing iso- to hyperattenuating mass\n$\\sqrt{ }$ indolent growth pattern\n$\\sqrt{ }$ typically iso- to hypointense on T2WI $\\pm$ T1 hyperintensity $\\leftarrow$ melanin\n$R x$ : surgical resection (in up to $22 \\%$ recurrence within 3 years)\n$D D x$ : melanoma\n\n## MENINGIOMA\n\nIncidence: most common extraaxial tumor: 15-18\\% of intracranial tumors in adults; 1-2\\% of primary brain tumors in children; $33 \\%$ of all incidental intracranial neoplasms\nOrigin: derived from meningothelial cells concentrated in arachnoid villi (= \"arachnoid cap cells\"), which penetrate the dura (villi are numerous in large dural sinuses, in smaller veins, along root sleeves of exiting cranial + spinal nerves, choroid plexus)\nHistologic classification:\n$>$ benign behavior pattern\n(a) fibroblastic (fibrous) type $=$ interwoven bands of spindle cells + collagen + reticulin fibers\n(b) transitional (mixed) type\n$=$ features of meningothelial + fibroblastic forms\n> aggressive imaging appearance\n(c) meningothelial (syncytial) type $=$ forming a syncytium of closely packed cells with indistinct borders\n(d) angioblastic (malignant) type\n$=$ probably hemangiopericytoma / hemangioblastoma arising from vascular pericytes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 1,
            "markdown": "Peak age: 45 (range, 35-70) years; rare $<20$ years (in children $>50 \\%$ malignant); $\\mathrm{M}+\\mathrm{F}=1 \\div 2$ to $1 \\div 4$\n\nIn pediatric age group:\nNO gender predilection\nHigher risk of sarcomatous change\nConsider association with neurofibromatosis type 2\nAssociated with: NF2 (multiple meningiomas, occurrence in childhood), basal cell nevus syndrome\n$\\diamond 10 \\%$ of patients with multiple meningiomas have type 2 neurofibromatosis!\n$\\diamond$ Most common radiation-induced CNS tumor with latency period of 19-35 years varying with dosage!\nTypes:\n(1) Globular meningioma (most common):\ncompact rounded mass with invagination of brain; flat at base; contact to falx / tentorium / basal dura / convexity dura\n(2) Meningioma en plaque:\npronounced hyperostosis of adjacent bone, particularly along base of skull; difficult to distinguish hyperostosis from tumor cloaking the inner table (DDx: Paget disease, chronic osteomyelitis, fibrous dysplasia, metastasis)\n(3) Multicentric meningioma ( $2-9 \\%$ ):\n$16 \\%$ in autopsy series; tendency to localize to a single hemicranium; present clinically at earlier age; global / mixed; CSF seeding is exceptional; in $50 \\%$ associated with neurofibromatosis type 2\nLocation:\nA. Supratentorial $(90 \\%)$\n(a) convexity = lateral hemisphere (20-34\\%)\n(b) parasagittal $=$ medial hemisphere (18-22\\%):\nfalcine meningioma ( $5 \\%$ ) below superior sagittal sinus, usually extending to both hemispheres\n(c) sphenoid ridge + middle cranial fossa (17-25\\%)\n(d) frontobasal at olfactory groove ( $10 \\%$ )\nB. Infratentorial $(9-15 \\%)$\n(a) cerebellar convexity (5\\%)\n(b) tentorium cerebelli ( $2-4 \\%$ )\n(c) cerebellopontine angle ( $2-4 \\%$ )\n(d) clivus $(<1 \\%)$\nC. Spine $(12 \\%)$\n\nAtypical location:\n(a) cerebellopontine angle $(<5 \\%)$\n(b) optic nerve sheath $(<2 \\%)$\n(c) intraventricular ( $0.5-3.7 \\%$ ): $80 \\%$ in atrium ( $\\mathrm{L}>\\mathrm{R}$ ), $15 \\%$ in $3^{\\text {rd }}, 5 \\%$ in $4^{\\text {th }}$ ventricle $\\leftarrow$ infolding of meningeal tissue during formation of choroid plexus\n$\\diamond$ Most common trigonal intraventricular mass in adulthood!\n(d) ectopic = extradural $(<1 \\%)$ : intradiploic space, outer table of skull, scalp, paranasal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 2,
            "markdown": "sinus, parotid gland, parapharyngeal space, mediastinum, lung, adrenal gland Plain film:\n$\\checkmark$ hyperostosis at site close to / within bone (exostosis, enostosis, sclerosis):\n$\\diamond$ Hyperostosis does NOT indicate tumor infiltration!\n$\\checkmark$ blistering at paranasal sinuses (ethmoid, sphenoid) $\\pm$ sclerosis (= pneumosinus dilatans)\n$\\checkmark$ enlarged meningeal grooves (if location in vault)\n$\\checkmark$ enlarged foramen spinosum\n$\\checkmark$ calcification (= psammoma bodies)\nCT:\n$\\checkmark$ sharply demarcated well-circumscribed slowly growing mass\n$\\checkmark$ hyperdense $(70-75 \\% \\leftarrow$ highly cellular nature or psammomatous calcifications) / isodense lesion on NECT\n$\\checkmark$ calcifications ( $15-20-25 \\%$ ) in circular / radial pattern (DDx: osteoma)\n$\\checkmark$ \"cortical buckling\" of underlying brain\n$\\checkmark$ \"intraosseous meningioma\" = permeation of bone with intra- and extracerebral soft-tissue component (DDx: fibrous dysplasia)\n$\\checkmark$ hyperostosis of adjacent bone (18\\%)\n$\\checkmark$ intense uniform enhancement on $\\mathrm{CECT} \\leftarrow$ absence of blood-brain barrier:\n$\\checkmark$ \"dural tail\" = wide attachment to adjacent dura mater\n$\\checkmark$ minimal peritumoral edema (in up to $75 \\%$ ):\n$\\diamond$ NO correlation between tumor size + amount of edema (DDx: intraaxial lesion)\n$\\checkmark$ cystic component: major in $2 \\%$, minor in $15 \\%$\nMR ( $100 \\%$ detection rate with gadolinium DTPA):\n$\\checkmark$ hypo- to isointense on T1WI + iso- to hyperintense on T2WI (intensity depends on amount of cellularity versus collagen elements):\n$\\checkmark$ tends to follow cortical signal intensity\n$\\checkmark$ homogeneous / heterogeneous texture ( $\\leftarrow$ tumor vascularity, cystic changes, calcifications)\n$\\checkmark$ arcuate bowing of white matter + cortical effacement\n$\\checkmark$ tumor-brain interface $\\leftarrow$ low-intensity vessels + high-intensity cerebrospinal cleft on T2WI\n$\\checkmark$ contrast enhancement for 3-60 min on T1WI as high as $148 \\%$ above enhancement of brain parenchyma\n$\\checkmark$ \"dural tail\" sign (in $60-72 \\%$ )\n$\\checkmark$ encasement + narrowing of vessels\n$\\checkmark$ elevated alanine peak ( 1.5 ppm ) + glutamate-glutamic acid peak (2.1-2.5 ppm)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 3,
            "markdown": "| Differences between Meningioma and Schwannoma |  |  |\n| :-- | :--: | :--: |\n|  | Meningioma | Schwannoma |\n| Angle with dura | obtuse | acute |\n| Dural tail | frequent | rare |\n| Calcification | $20 \\%$ | rare |\n| Cystic/necrotic | rare | $10 \\%$ |\n| IAC involvement | rare | $80 \\%$ |\n| NECT | hyperdense | isodense |\n| Enhancement | uniform | $32 \\%$ nonuniform |\n\nAngio:\n$\\sqrt{ }$ \"mother-in-law\" phenomenon (contrast material shows up early and stays late into venous phase)\n$\\sqrt{ }$ \"sunburst\" / \"spoke-wheel\" pattern of tumor vascularity with hypervascular cloudlike stain\n$\\sqrt{ }$ early draining vein (rare: perhaps in angioblastic meningioma)\n$\\sqrt{ }$ en plaque meningioma is poorly vascularized\nVascular supply:\nA. External carotid artery (almost always):\n\n1. vault: middle meningeal artery\n2. sphenoid plane + tuberculum: recurrent meningeal branch of ophthalmic a.\n3. tentorium: meningeal branch of meningohypophyseal trunk of ICA\n4. clivus + posterior fossa: vertebral artery / ascending pharyngeal artery\n5. falx: partly middle meningeal artery + others\nB. Internal carotid artery (rare):\n6. intraventricular: choroidal vessels\n$C x:$ local invasion of venous sinuses\n\n# Atypical Meningioma (15\\%) \n\n1. Low attenuation area of necrosis, old hemorrhage, cyst formation, fat (DDx: malignant glioma, metastasis)\n(a) Cystic meningioma ( $2-4 \\%$ )\n\nFrequency: $55-65 \\%$ in $1^{\\text {st }}$ year of life; $10 \\%$ in children\nType $=$ intratumoral central / eccentric cyst (ischemic necrosis, microcystic\nI degeneration, breakdown of hemorrhagic products); often associated with meningothelial / microcystic / atypical / malignant histologic subtypes\nType $=$ extratumoral intraparenchymal cyst (arachnoid cyst / reactive gliosis /\nII liquefactive necrosis of adjacent brain)\nType $=$ trapped CSF (DDx: cystic / necrotic glioma)\nIII\n(b) Lipoblastic / xanthomatous meningioma (5\\%) lipid-laden meningothelial cells (in $10-90 \\%$ ) with metaplasia of meningothelial cells into mature adipocytes\n2. Heterogeneous / ring enhancement $\\leftarrow$ bland tumor infarction / necrosis in aggressive histologic variants / true cyst formation from benign fluid accumulation\n3. \"En plaque\" morphology",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 4,
            "markdown": "4. \"Comma shape\" = combination of semilunar component bounded by dural interface + spherical component growing beyond dural margin\n5. Sarcomatous transformation with spread over hemisphere + invasion of cerebral parenchyma (leptomeningeal supply)\n6. M eningeal hemangiopericytoma\n$\\checkmark$ multilobulated contour\n$\\checkmark$ narrow dural base / \"mushroom\" shape\n$\\checkmark$ large intratumoral vascular signals\n$\\checkmark$ bone erosion\n$\\checkmark$ prominent peritumoral edema\n$\\checkmark$ multiple irregular feeding vessels on angiogram\n\n# Sphenoid Wing Meningioma \n\n1. Hyperostotic meningioma en plaque\n\n- slowly progressive unilateral painless exophthalmos\n- numbness in distribution of cranial nerve $\\mathrm{V}_{1}+\\mathrm{V}_{2}$\n- headaches, seizures\n\n2. Meningioma arising from middle third of sphenoid ridge\n\n- headaches, seizures\n$\\checkmark$ compression of regional frontal + temporal lobes\n\n3. Meningioma arising from clinoid process\n$\\checkmark$ encasement of carotid + middle cerebral arteries\n$\\checkmark$ compression of optic nerve + chiasm\n4. Meningioma of planum sphenoidale\n$\\checkmark$ subfrontal growth + posterior growth into sella turcica and clivus\n$\\checkmark$ hyperostotic blistering of planum sphenoidale\n\n## Suprasellar Meningioma\n\nIncidence: $10 \\%$ of all intracranial meningiomas\nOrigin: from arachnoid + dura along tuberculum sellae / clinoids / diaphragma sellae / cavernous sinus with secondary extension into sella; NOT from within pituitary fossa\n\n- hypothalamic / pituitary dysfunction (rare)\n$\\checkmark$ irregular hyperostosis = blistering adjacent to sinus (HALLMARK of meningiomas at planum sphenoidale / tuberculum sellae)\n$\\checkmark$ pneumatosis sphenoidale = increased pneumatization of sphenoid in area of anterior clinoids + dorsum sellae (DDx: normal variant)\n$\\checkmark$ broad base of attachment\n$\\checkmark$ intense homogeneous enhancement (may be impossible to differentiate from supraclinoid carotid aneurysm on CT)\n$\\checkmark$ blood supply: posterior ethmoidal branches of ophthalmic artery, branches of meningohypophyseal trunk\nMR:\n$\\checkmark$ large mass isointense to gray matter on T1WI + T2WI\n$\\checkmark$ hyperintense flattened pituitary gland within floor of sella",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 5,
            "markdown": "V marked homogeneous enhancement on T1WI\n$D D x$ : metastasis, glioma, lymphoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 6,
            "markdown": "# MENINGITIS \n\n$=$ infection of the pia mater + arachnoid + adjacent CSF\n\n1. Pachymeningitis: infection of dura mater\n2. Leptomeningitis: infection of pia matter / arachnoid (most common) + CSF\n\n- headaches, stiff neck, confusion, disorientation\n- positive CSF lab analysis\n\nROLE of CT and MR:\n(1) to exclude parenchymal abscess, ventriculitis, localized empyema\n(2) to evaluate paranasal sinuses / temporal bone as source of infection\n(3) to monitor complications: hydrocephalus, subdural effusion, infarction\n\n## Chemical / Aseptic Meningitis\n\n$=$ rare complication of dermoid / epidermoid cyst $\\leftarrow$ cyst rupture into subarachnoid space MR:\n$\\checkmark$ T1-hyperintense speckles in cortical sulci\n$\\checkmark$ fat-fluid level in ventricles\n\n## Purulent / Bacterial / Acute Septic Meningitis\n\nCause: otitis media / sinusitis\nOrganism:\n(a) adults: Neisseria meningitidis, Diplococcus pneumoniae, Haemophilus influenzae, Meningococcus, Staphylococcus aureus\n(b) children: group B Streptococcus ( $86 \\%$ ), S pneumonia (= Pneumococcus in 58\\%), Escherichia coli, Citrobacter\nIncidence: 4100 cases annually in USA\n\n- fever, headache, seizures, altered consciousness, neck stiffness\n\nNeuroimaging most useful to:\n> exclude herniation before lumbar puncture\n$>$ to detect complications\nCross-sectional imaging is neither sensitive nor specific for detection of meningitis.\nNECT:\n$\\sqrt{ }$ often normal / falsely negative due to subtlety of findings\n$\\sqrt{ }$ sulcal effacement\n$\\sqrt{ }$ slightly increased density in subarachnoid space $\\leftarrow$ increased vascularity, esp. in children\n$\\sqrt{ }$ small ventricles $\\leftarrow$ diffuse cerebral edema\nCECT:\n$\\sqrt{ }$ marked curvilinear meningeal enhancement over cerebrum (frontal + parietal lobes) and interhemispheric + sylvian fissures\n$\\sqrt{ }$ obliteration of basal cisterns with enhancement (common)\nMR (most sensitive modality):\n$\\sqrt{ }$ no abnormality (in most cases)\n$\\sqrt{ }$ $\\pm$ hyperintense obliterated basal cisterns on FLAIR $\\leftarrow$ increased protein content (NOT",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 7,
            "markdown": "specific for meningitis)\n$\\sqrt{ }$ abnormal hyperintensity in cerebral sulci on DWI (NOT specific for meningitis) $\\leftarrow$ pyogenic (bacterial) $>>$ lymphocytic (viral) / aseptic meningitis\nCEMR (postcontrast FLAIR + delayed T1WI):\n$\\sqrt{ }$ abnormal enhancement of pia mater + subarachnoid space (leptomeninges) $\\leftarrow$ inflammatory breakdown of blood-brain barrier (in only 50\\%):\n$\\sqrt{ }$ thin linear enhancement in cerebral sulci $=$ typical for acute pyogenic (bacterial) + lymphocytic (viral) meningitis\n$\\sqrt{ }$ thick nodular enhancement in basal cisterns = typical of granulomatous / carcinomatous meningitis\n$\\sqrt{ }$ leptomeningeal enhancement (in chronic infection)\n$D x:$ CSF analysis\n$C x:$\n(1) Cerebritis (parenchymal) / subdural infection, especially with streptococcus / staphylococcus\n(2) Ventriculitis $\\leftarrow$ retrograde spread\n(3) Brain atrophy\n(4) Brain infarction $\\leftarrow$ arteritis, venous thrombosis ( $5-15 \\%$ of adults, in up to $30 \\%$ of neonates)\n(5) Subdural effusion [sterile subdural effusion $\\leftarrow \\mathrm{H}$. influenzae meningitis (in children) may turn into subdural empyema]\n(6) Hydrocephalus $\\leftarrow$ cellular debris blocking foramen of Monro, aqueduct, $4^{\\text {th }}$ ventricular outlet / intraventricular septa / arachnoid adhesions\n(7) Cranial nerve dysfunction\n\nPrognosis:\n$\\diamond$ Cerebral infarction + edema predict poor outcome\n$\\diamond$ Enlargement of ventricles + subarachnoid spaces + subdural effusions have no predictive value\nMortality: $10 \\%$ for H. influenza + meningococcus, $30 \\%$ for Pneumococcus ( $5^{\\text {th }}$ commonest cause of death in children between 1 and 4 years of age)\n$D D x$ : meningeal carcinomatosis\n\n# Granulomatous Meningitis \n\nHisto: thick exudate, perivascular inflammation, granulation tissue + reactive fibrosis\n(1) Tuberculous meningitis = basilar meningitis\npart of generalized miliary tuberculosis / primary tuberculous infection\n(2) Sarcoidosis (in 5\\% of sarcoidosis cases)\n\nHisto: granulomatous infiltration of leptomeninges\n$\\sqrt{ }$ nodular pattern (DDx from bacterial causes)\n$\\sqrt{ }$ thick meningeal plaques over convexities (mimicking meningioma)\n$\\sqrt{ }$ marked enhancement\n$\\sqrt{ }$ may be associated with single / multiple intracerebral mass(es)\n$C x$ : cranial nerve palsy, hypothalamic-pituitary dysfunction, chronic meningitis\n(3) Fungal meningitis: coccidioidomycosis (endemic), blastomycosis, mucormycosis (diabetics), nocardiosis, actinomycosis, aspergillosis (under chronic corticosteroid",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 8,
            "markdown": "therapy)\n(a) yeast $=$ unicellular eukaryotic microorganism that reproduce by asymmetric fission:\n> Cryptococcosis\n$>$ Candidiasis\n(b) mold = multicellular filaments (hyphae) that can form into macroscopic networks (mycelia); too large for meningeal microcirculation and more likely cause invasive parenchymal CNS disease in immunocompromised patients\n> Aspergillus\n> Mucormycosis\n(c) dimorphic fungus $=$ dimorphic fungus that grows as mold (yeast) at room (body) temperature; resides in soil in endemic regions and releases conidia (spores) into the air (unicellular eukaryotes at body temperature $\\rightarrow$ initially misidentified as protozoa)\n> Blastomycosis\n> Coccidioidomycosis\n$>$ Histoplasmosis\nFungal CNS diseases are usually opportunistic infections from hematogenous dissemination in susceptible hosts at extremes of age or with immunodeficiency.\n\n- acute life-threatening process / chronic indolent disease\n\nMay be associated with: cerebritis, abscess formation\n$\\checkmark$ hydrocephalus\nCT:\n$\\checkmark$ obliteration of basal cisterns, sylvian fissure, suprasellar cistern (isodense cisterns $\\leftarrow$ filling with debris)\n$\\checkmark$ intense contrast enhancement of gyri + involved subarachnoid spaces\n$\\checkmark$ calcification of meninges\n$\\checkmark$ decreased attenuation of white matter\nMR:\n$\\checkmark$ high-signal intensity of basilar cisterns on T2WI\n$\\checkmark$ enhancement with gadopentetate dimeglumine\nCx: (1) Hydrocephalus $\\leftarrow$ obliteration of basal cisterns, blocking of CSF flow + blocking of CSF absorption\n(2) Infarction $\\leftarrow$ arteritis\n\n# MESIAL TEMPORAL SCLEROSIS \n\nCause: long-standing temporal lobe epilepsy\nHisto: marked neuronal loss + astrogliosis in hippocampal subfields CA1 + CA3 + CA4\nMechanism for excitotoxicity-induced neuronal death:\nseizures $\\rightarrow$ excessive neuronal depolarization $\\rightarrow$ overproduction of excitory amino acid neurotransmitters $\\rightarrow$ excessive activation of N-methyl-D-aspartate receptors $\\rightarrow$ unregulated entry of $\\mathrm{Ca} 2+\\rightarrow$ neuronal swelling with cytotoxic edema\nLocation: uni- / bilateral; symmetric / asymmetric\n$\\checkmark$ hippocampal atrophy + loss of internal architecture\n$\\checkmark$ increased signal intensity on T2WI\n$\\checkmark$ dilatation of temporal horn",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 9,
            "markdown": "Associated limbic system findings:\n$\\sqrt{ }$ ipsilateral atrophy of fornix (55\\%)\n$\\sqrt{ }$ ipsilateral atrophy of mamillary body (26\\%)\nAssociated extrahippocampal abnormalities:\n$\\sqrt{ }$ increased SI of anterior temporal lobe cortex (38\\%)\n$\\sqrt{ }$ cerebral hemiatrophy ( $1 \\%$ )\n$R x:$ amygdalohippocampectomy\n\n# METACHROMATIC LEUKODYSTROPHY \n\n$=\\mathrm{MLD}=$ most common hereditary (autosomal recessive) leukodystrophy (dysmyelinating disorder)\nCause: deficiency of arylsulfatase A resulting in severe deficiency of myelin lipid sulfatide within macrophages + Schwann cells\nAge of presentation: before age $3(2 / 3)$, in adolescence ( $1 / 3$ )\nA. LATE INFANTILE FORM\n\nAge: $2^{\\text {nd }}$ year of life\n\n- gait disorder + strabismus, impairment of speech\n- spasticity + tremor, intellectual deterioration\n\nPrognosis: death within 4 years of onset\nB. JUVENILE FORM\n\nAge: 5-7 years\nC. ADULT FORM\n\n- organic mental syndrome\n- progressive corticospinal, corticobulbar, cerebellar, extrapyramidal signs\n$\\sqrt{ }$ progressive loss of hemispheric brain tissue\nCT:\n$\\sqrt{ }$ symmetric low density of white matter adjacent to ventricles (esp. centrum ovale and frontal horns)\n$\\sqrt{ }$ progressive atrophy\n$\\sqrt{ }$ no contrast enhancement\nMR:\n$\\sqrt{ }$ progressive symmetrical areas of hypointensity on T1WI\n$\\sqrt{ }$ hyperintensity on T2WI (increased water)\n$\\sqrt{ }$ early sparing of internal capsule + subcortical U-fibers\nPrognosis: death within several years\n\n\n## METASTASIS TO BRAIN\n\nIncidence: $14-37 \\%$ of all intracranial tumors\n$\\diamond$ Most common intracranial neoplasm!\n$\\diamond$ Most common infratentorial mass in adulthood\nMetastatic primary:\nSix tumors account for $95 \\%$ of all brain metastases:\n\n1. Bronchial carcinoma (47\\%): rarely squamous cell ca.\n2. Breast carcinoma ( $17 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 10,
            "markdown": "3. GI-tract tumors (15\\%): colon, rectum\n4. Hypernephroma ( $10 \\%$ )\n5. Melanoma ( $8 \\%$ )\n6. Choriocarcinoma\n\nIn childhood:\n\n1. Leukemia / lymphoma\n2. Neuroblastoma\n$\\diamond$ Brain metastases from sarcomas are exceptionally rare!\nLocation:\n(a) corticomedullary junction of brain (most characteristic)\n(b) subarachnoid space $=$ carcinomatous meningitis\n(c) subependymal spread (frequent in breast carcinoma)\n(d) skull $(5 \\%)$\nN.B.: CORTICAL METASTASES\n$\\checkmark$ minimal / no edema\n$\\checkmark$ may not be identified on T2WI\n$\\checkmark$ contrast-enhancement essential for detection\nPresentation:\n> multiple lesions $(2 / 3)$, single lesion $(1 / 3)$\n> cerebral hemispheres ( $57 \\%$ ), cerebellum (29\\%), brainstem (32\\%)\n> nodular deposits to dura (common)\n$\\checkmark$ usually well-defined round masses:\n$\\checkmark$ multiple lesions of different sizes + locations\n$\\checkmark$ surrounding edema usually exceeds tumor volume\n$\\diamond$ Employ contrast enhancement to disclose additional lesions!\nCT:\n$\\checkmark$ hypodense on NECT (unless hemorrhagic / hypercellular)\n$\\checkmark$ solid enhancement in small tumors / ringlike enhancement in large tumors\nMR (combination of T2WI + contrast-enhanced T1WI offer greatest sensitivity):\n$\\checkmark$ hypointense on T1WI\n$\\checkmark$ hypointense mass relative to edema / variable intensity on T2WI $\\leftarrow$ hemorrhage, necrosis, cyst formation:\n$\\checkmark$ hypointensity more pronounced in melanoma + mucinous adenocarcinoma $\\leftarrow$ paramagnetic effect\n$\\checkmark$ homogeneous / ring / nodular mixed enhancement after Gd-DTPA; often more than one metastatic focus identified in region of colliding edema\n$\\checkmark$ asymmetric enhancement of dura with dural spread\n$\\checkmark$ leptomeningeal enhancement (eg, in metastatic ependymoma)\n$D D x$ : glioma (indistinct border, less well defined, lesser amount of vasogenic edema); multifocal inflammatory lesions\n\n# Carcinomatous Meningitis (8-15\\%) \n\n$=$ Meningeal Carcinomatosis\n$=$ metastatic involvement of leptomeninges\nSource:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 11,
            "markdown": "A. Primary CNS tumor: medulloblastoma, glioblastoma, pineal tumors\nB. Secondary tumor: carcinoma of breast + lung, melanoma, NHL, leukemia\n\nHisto: adenocarcinoma ( $75 \\%$ )\nSpread:\n(a) hematogenous dissemination (most common)\n(b) contiguous perineural spread\n(c) lymphatic spread\n(d) shedding of tumor cells from parenchymal metastases\n\nAssociated with: concurrent brain parenchymal metastases (in 20\\%)\n$\\diamond$ Simultaneous occurrence of symptoms localized to more than one area!\n\n- headaches ( $50 \\%$ ), seizures ( $15 \\%$ ), cauda equina syndrome\n- cranial nerve deficits ( $40 \\%$ ): visual disturbances, diplopia, hearing loss, facial numbness\n- mental status changes: lethargy + confusion (20\\%)\n- progressive asymmetric weakness of extremities\n\nDx: harvest of malignant cells $\\leftarrow$ lumbar puncture positive in $45-55 \\%$ (1 $1^{\\text {st }}$ puncture), $80 \\%$ (after several taps)\nN.B.: Perform MRI prior to lumbar puncture\n$\\diamond$ Lumbar puncture contraindicated if intracranial pressure increased!\nLocation: basal cisterns, lumbar spine (areas of CSF stasis)\n$\\sqrt{ }$ communicating hydrocephalus $\\leftarrow$ tumor interferes with CSF reabsorption in pacchionian granulations near vertex\n$\\checkmark$ ischemic changes $\\leftarrow$ vasculitis (rare)\nCEMR (abnormalities in up to $2 / 3$ ):\n$\\sqrt{ }$ linear / nodular enhancement of sulci, cisternal spaces, ventricles with associated effacement\n$\\checkmark$ diffuse / asymmetric nodular enhancement\n$\\checkmark$ hydrocephalus\n$\\checkmark$ cranial nerve enhancement\n\n# Patterns: \n\n1. Dural Meningeal Carcinomatosis\n» rarely associated with positive cytology\n$\\sqrt{ }$ short discontinuous thin sections of enhancement localized / diffuse curvilinear underneath inner table in expected position of dura\n2. Leptomeningeal Carcinomatosis\n» frequently associated with positive cytology\n$\\sqrt{ }$ thin rim of subarachnoid enhancement following convolutions of gyri \"coating the surface of the brain\"\n$\\checkmark$ discrete leptomeningeal nodules\n$\\checkmark$ invasion of underlying brain $\\rightarrow$ mass effect + edema\n$D D x$ : bacterial / fungal meningitis, postoperative changes (fibrosis), previous subarachnoid hemorrhage, idiopathic cranial pachymeningitis, vasculitis, extramedullary hematopoiesis, primary leptomeningeal gliomatosis, amyloidosis, glioneural heterotopia, Castleman disease, Gaucher disease\n\n## Dural Metastasis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 12,
            "markdown": "Origin: most common: breast, lung, prostate others: melanoma, lymphoma, RCC, gastric cancer\n$\\sqrt{ }$ often solitary linear dural thickening / nodular lesion: focal / diffuse involvement\n$\\sqrt{ } \\pm$ dural tail\n$\\sqrt{ }$ avid enhancement $\\leftarrow$ lack of blood-brain barrier:\n$\\sqrt{ }$ dural enhancement adjacent to osseous involvement $\\leftarrow$ dural invasion / reactive dural response\n$\\diamond$ The lower the T2 signal the more hypercellular the lesion!\nDural metastases are frequently solitary, potentially leading to a misdiagnosis of meningioma and delay in care.\n\n# Hemorrhagic Metastases to Brain (in 3-4\\%) \n\n1. Malignant melanoma\n2. Breast cancer\n3. Choriocarcinoma\n4. Oat cell carcinoma of lung\n5. Renal cell carcinoma\n6. Thyroid carcinoma\n$\\sqrt{ }$ hyperdense without contrast\n$\\sqrt{ }$ hypervascular with contrast\nmnemonic: MR CT BB\nMelanoma\nRenal cell carcinoma\nChoriocarcinoma\nThyroid carcinoma\nBronchogenic carcinoma\nBreast carcinoma\n\n## Cystic Metastasis to Brain\n\n1. Squamous cell carcinoma of lung\n2. Adenocarcinoma of lung\n\nDDx: benign cyst, abscess\n\n## Calcified Metastasis to Brain\n\n1. Mucin-producing neoplasm: GI, breast\n2. Cartilage- / bone-forming sarcoma\n3. Effective radio- and chemotherapy\n\n## Malignant Melanoma Metastatic to Brain\n\nPrevalence: $39 \\%$ at autopsy\nLocation: cerebrum > cerebellum; usually multiple lesions\n\n- variable degree of pigmentation\n$\\sqrt{ }$ tendency for hemorrhage\n\n1. Melanotic pattern (in $24-54 \\%$ )\n$\\sqrt{ }$ paramagnetic property of melanin $\\rightarrow$ T1-shortening effect:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 13,
            "markdown": "$\\checkmark$ hyperintense relative to cortex on T1WI\n$\\checkmark$ iso- / hypointense relative to cortex on T2WI\nCause: free radicals in melanin + blood products\n$\\diamond$ NO clear consensus on contribution of paramagnetic effect of blood products versus melanin!\n2. Amelanotic pattern (38\\%)\n$\\diamond$ Pattern similar to other brain neoplasm\n$\\checkmark$ hypo- / isointense on T1WI\n$\\checkmark$ hyper- / isointense on T2WI\n3. Other patterns\n$\\checkmark$ isointense on T1WI\n$\\checkmark$ hyperintense on T2WI\nPrognosis: median survival of 113 days after discovery\n$D D x$ : primary malignant melanoma of CNS ( $1 \\%$ of all melanoma cases; solitary lesion; leptomeningeal / choroid plexus location)\n\n# MICROCEPHALY \n\n$=$ clinical syndrome characterized by a head circumference below the normal range\nIncidence: $1.6 \\div 1,000$ or $1 \\div 6,200$ to $1 \\div 8,500$ births\nEtiology:\n(1) Undiagnosed intrauterine infection (toxoplasmosis, rubella, CMV, herpes, syphilis), toxic agents, drugs, hypoxia, irradiation, maternal phenylketonuria\n(2) Premature craniosynostosis\n(3) Chromosomal abnormalities (trisomies 13, 18, 21)\n(4) Meckel-Gruber syndrome\n\nOften associated with:\nmicroencephaly, macrogyria, pachygyria, atrophy of basal ganglia, decrease in dendritic arborization, holoprosencephaly\n$\\sqrt{ } \\mathrm{AC} \\div \\mathrm{HC}$ discrepancy\n$\\sqrt{ }$ head circumference $<3$ SD below the mean\n$\\checkmark$ apelike sloping of forehead\n$\\checkmark$ dilatation of lateral ventricles\n$\\checkmark$ poor growth of fetal cranium\n$\\checkmark$ intracranial contents may not be visible (rare)\nPrognosis: normal to severe mental retardation (depending on degree of microcephaly)\n\n## MINERALIZING MICROANGIOPATHY\n\n$=$ RADIATION-INDUCED LEUKOENCEPHALOPATHY\n$=$ sequelae of radiotherapy combined with methotrexate therapy for leukemia\nIncidence: in $25-30 \\%$ after $>9$ months after treatment\nAge: childhood\nCause: deposition of calcium within small vessels of previously irradiated brain parenchyma\n\n- $85 \\%$ without neurologic deficits\n\nCT:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 14,
            "markdown": "$\\sqrt{ }$ thin reticular / serrated linear / punctate calcifications near corticomedullary junction, especially in basal ganglia + frontal and posterior parietal lobes\n$\\sqrt{ }$ symmetric low-attenuation process in white matter near corticomedullary area\nMR:\n$\\sqrt{ }$ confluent diffuse periventricular distribution spreading peripherally with an irregular scalloped edge\n\n# Diffuse White Matter Injury \n\n$=$ radiation-induced demyelination of periventricular white matter\nCause: whole-brain irradiation\n\n- subclinical\n\n\n## Diffuse Necrotizing Leukoencephalopathy\n\nCause: intrathecal methotrexate $\\pm$ whole brain irradiation\n\n- rapidly deteriorating clinical course\n$\\sqrt{ }$ confluent pattern with scalloped margins in periventricular white matter extending out to subcortical U-fibers\n\n\n## MOYAMOYA DISEASE\n\n[moyamoya, Japanese = puff of smoke]\n$=$ uncommon occlusive cerebral arteritis classically involving supraclinoid internal carotid arteries with relative sparing of the posterior fossa in early stages\nEtiology: unknown; NO underlying cause identified\nAge: bimodal distribution in $1^{\\text {st }}$ decade $+4^{\\text {th }}$ decade of life\nPath: development of extensive tiny basal perforator and transdural collateral vessels (moyamoya vessels)\nHisto: endothelial hyperplasia + fibrosis without associated inflammatory reaction\n\n- headaches, behavioral disturbances\n$\\sqrt{ }$ bilateral stenosis / occlusion of supraclinoid portion of ICA extending to proximal portions of MCA + ACA\n$\\sqrt{ }$ large network of moyamoya vessels in basal ganglia + upper brainstem fed by basilar a. + ACA + MCA (dilatation of lenticulostriate + thalamoperforating arteries)\n$\\sqrt{ }$ anastomoses between dural meningeal + leptomeningeal aa.\nMR:\n$\\sqrt{ }$ tiny flow voids commonly arising from basal cisterns extending into basal ganglia / thalamus\n$\\sqrt{ }$ microbleeds (in 15-44\\%)\n$\\sqrt{ }$ ischemia and infarction\n$\\sqrt{ }$ NO nidus / dilated vessels\n$\\sqrt{ }$ \"ivy\" sign = curvilinear high signal intensities along cortical sulci + brain surface = sulcal hyperintensity on FLAIR $\\leftarrow$ leptomeningeal collateral vessels\n$\\sqrt{ }$ marked leptomeningeal enhancement along cortical sulci\n$\\diamond$ Angio needed for planning of revascularization procedure\nCx: in children: transient ischemic hemiparetic attacks, cerebral infarction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 15,
            "markdown": "in $1 / 2$ of adults: intracranial hemorrhage\n\n# Moyamoya Syndrome \n\n$=$ underlying cause for moyamoya image identified\nEtiology: neurocutaneous syndromes (eg, neurofibromatosis), atherosclerosis, sickle cell anemia, periarteritis nodosa, coarctation of aorta, Down syndrome, Marfan syndrome, head trauma, tuberculosis, oral contraceptives, bacterial meningitis\n\n## MULTIPLE SCLEROSIS\n\n$=$ most frequent form of chronic inflammatory demyelinating disease of unknown etiology, which reduces the lipid content and brain volume; characterized by a relapsing + remitting course\nPrevalence: $6 \\div 10,000$ (higher frequency in cooler climates; increased incidence with positive family history)\nCause: ? viral / autoimmune mechanism\nPeak age: $25-30$ (range, $20-50$ ) years; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 3$\nHisto:\n(a) acute stage: perivenular inflammation (at junctions of pial veins) with\n> hypercellularity (= infiltration of lipid-laden macrophages + lymphocytes)\n> well-demarcated demyelination (destruction of oligodendroglia with loss of myelin sheath)\n> reactive astrocytosis (= gliosis), initially with preservation of axons (= denuded axons) $\\rightarrow$ scar (= white matter plaque)\n(b) chronic stage: plaques advance to fibrillary gliosis with reduction in inflammatory component\nClinical forms: (a) relapsing remitting\n(b) relapsing progressive\n(c) chronic progressive\n\n- waxing and waning course with\n- numbness, dysesthesia, burning sensations\n- signs of brain neoplasm: headaches, seizures, dizziness, nausea, weakness, altered mental status, ataxia, diplopia\n- optic neuritis = retrobulbar pain, central loss of vision, afferent pupillary defect (Marcus Gunn pupil)\n- trigeminal neuralgia ( $1-2 \\%$ )\n- Schumacher criteria:\n(1) CNS dysfunction\n(2) Involvement of two / more parts of CNS\n(3) Predominant white matter involvement\n(4) $\\geq 2$ episodes lasting $>24 \\mathrm{hr}$ less than 1 month apart\n(5) Slow stepwise progression of signs + symptoms\n(6) At onset $10-50$ years of age\n- Rudick red flags (suggests diagnosis other than MS):\n(1) No eye findings\n(2) No clinical remission",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 16,
            "markdown": "(3) Totally local disease\n(4) No sensory findings\n(5) No bladder involvement\n(6) No CSF abnormality\n@ Brain\nLocation:\nsubependymal periventricular location (along lateral aspects of atria + occipital horns), corpus callosum, internal capsule, centrum semiovale, corona radiata, optic nerves, chiasm, optic tract, brainstem (ventrolateral aspect of pons at $5^{\\text {th }}$ nerve root entry), cerebellar peduncles (CLASSIC), cerebellum; rather symmetric involvement of cerebral hemispheres; subcortical $U$ fibers NOT spared\n$\\diamond 10 \\%$ of MS lesions occur in gray matter!\n$\\diamond$ Number + extent of plaques correlate with duration of disease + degree of cognitive impairment\n$\\checkmark$ lesion size of 1-25 (majority between 5 and 10) mm :\n$\\checkmark$ large lesions may masquerade as brain tumors\n$\\checkmark$ mass effect / edema in active lesions (infrequent)\n$\\checkmark$ ovoid lesions ( $86 \\%$ ) oriented with their long axis perpendicular to ventricular walls $\\leftarrow$ perivenous demyelination (pathologically described as \"Dawson fingers\")\n$\\checkmark$ chronic plaques do not enhance $\\leftarrow$ intact blood-brain barrier\n$\\checkmark$ diffuse cerebral atrophy ( $21-45-78 \\%$ ) in chronic MS: enlarged ventricles, prominent sulci\n$\\checkmark$ lesion enhancement $\\leftarrow$ breakdown of blood-brain barrier in demyelinating process (irrespective of clinical symptoms):\n$\\checkmark$ peripheral enhancement of lesion\n$\\checkmark$ occasionally central enhancement\nCT:\n$\\checkmark$ normal CT scan (18\\%)\n$\\checkmark$ periventricular (near atria) multifocal nonconfluent lesions with distinct margins (lesion location does NOT always correlate well with symptoms)\n(a) NECT: isodense / lucent\n(b) CECT: transient enhancement during acute stage (active demyelination) for about 2 weeks; may require double dose of contrast; ultimately disappearance / permanent scar\nMR (modality of choice; 95-99\\% specific):\n$\\checkmark$ well-marginated discrete foci of varying size with high signal intensity on T2WI + proton density images ( $=$ loss of hydrophobic myelin produces increase in water content); hypointense on T1WI\n$\\checkmark$ abnormally bright signal of the optic nerve + variable swelling (optic neuritis) with loss of \"doughnut\" sign of the normal optic nerve complex\n$\\checkmark$ Gd-DTPA enhancement of lesions on T1WI (up to 8 weeks following acute demyelination with breakdown of blood-brain barrier)\n$\\checkmark$ characteristically as a solid lesion / incomplete ring\n$\\checkmark$ lesions on undersurface of corpus callosum (CHARACTERISTIC on sagittal images)\n@ Spinal cord (in up to $80 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 17,
            "markdown": "$\\diamond$ Most common demyelinating process of spinal cord!\n$\\diamond$ In $12-33 \\%$ without coexistent intracranial plaques!\n\n- number + extent of plaques correlate with degree of disability\n\nLocation: predilection for cervical cord\nSite: eccentric involvement of dorsal + lateral elements abutting subarachnoid space\n$\\sqrt{ }$ atrophic plaques oriented along spinal cord axis\n$\\sqrt{ }$ length of plaque usually less than 2 vertebral body segments + width less than half of cross section\n$\\sqrt{ }$ acute tumefactive MS = cord swelling with enhancement\n$\\sqrt{ }$ cord atrophy in chronic MS\n$D D x$ : (1) Acute transverse myelitis\n(2) Cord tumor (follow-up after 6 weeks without decrease in size of lesion)\n(3) Trauma\n(4) Infarct\n(3) Postviral syndromes\n$R x$ : steroids (incite rapid decrease in size of lesions with loss of enhancement)\n$D D x$ :\n(1) Acute disseminated encephalomyelitis (ADEM), subacute sclerosing panencephalitis (lesions of similar age)\n(2) Lyme encephalopathy (skin rash)\n(3) Susac syndrome (encephalopathy + branch retinal artery occlusion + hearing loss)\n(4) Small vessel ischemia (patients $>50$ years of age, lesions $<5 \\mathrm{~mm}$, NOT infratentorial)\n(5) Enlarged type II Virchow-Robin spaces\n(6) AIDS, CNS vasculitis, migraine, radiation injury, lymphoma, sarcoidosis, tuberculosis, systemic lupus erythematosus, cysticercosis, metastases, multifocal glioma, neurofibromatosis, contusions\n\n# NEONATAL INTRACRANIAL HEMORRHAGE \n\n## Germinal Matrix Bleed\n\n$=$ GERMINAL MATRIX-RELATED HEMORRHAGE\nRisk factors:\n(1) Prematurity\n(2) Low birth weight\n(3) $\\operatorname{Sex}\\left(\\mathrm{M} \\div \\mathrm{F}=2 \\div 1\\right)$\n(4) Multiple gestations\n(5) Trauma at delivery\n(6) Prolonged labor\n(7) Hyperosmolarity\n(8) Hypocoagulation\n(9) Pneumothorax\n(10) Patent ductus arteriosus\n\nEtiology: hypoxia with loss of autoregulation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 18,
            "markdown": "Pathogenesis: rupture of friable vascular bed due to\n(1) Fluctuating cerebral blood flow in preterm infants with respiratory distress\n(2) Increase in cerebral blood flow with\n(a) systemic hypertension (pneumothorax, REM sleep, handling, tracheal suctioning, ligation of PDA, seizures, instillation of mydriatics)\n(b) rapid volume expansion (blood, colloid, hyperosmolar glucose / sodium bicarbonate)\n(c) hypercarbia (RDS, asphyxia)\n(3) Increase in cerebral venous pressure with labor and delivery, asphyxia (= impairment in exchange of oxygen and carbon dioxide), respiratory disturbances\n(4) Decrease in cerebral blood flow with systemic hypotension followed by reperfusion\n(5) Platelet and coagulation disturbance\n\nIncidence: in premature neonates $<32$ weeks of age; in $43 \\%$ of infants $<1,500 \\mathrm{~g}$ (in $65 \\%$ of $500-700 \\mathrm{~g}$ infants, in $25 \\%$ of $701-1,500 \\mathrm{~g}$ infants); in up to $50 \\%$ without prenatal care, in $5-10 \\%$ with prenatal care\nTime of onset: usually during first 24 hours of life; $36 \\%$ on $1^{\\text {st }}$ day, $32 \\%$ on $2^{\\text {nd }}$ day, $18 \\%$ on $3^{\\text {rd }}$ day of life; by $6^{\\text {th }}$ day $91 \\%$ of all intracranial bleeds have occurred\nLocation: region of caudate nucleus and thalamostriate groove ( $=$ caudothalamic notch) remains metabolically active the longest; in $80-90 \\%$ in infants $<28$ weeks of MA\nGRADES (Papile classification):\nI : subependymal hemorrhage confined to germinal matrix (GMH) on one / both sides\nII : subependymal hemorrhage ruptured into nondilated ventricle (IVH)\nIII : intraventricular hemorrhage (IVH) with ventricular enlargement: (a) mild, (b) moderate, (c) severe\nIV : extension of germinal matrix hemorrhage into brain parenchyma (intraparenchymal hemorrhage $=\\mathrm{IPH}$ )\nUS ( $100 \\%$ sensitivity $+91 \\%$ specificity for lesions $>5 \\mathrm{~mm} ; 27 \\%$ sensitivity $+88 \\%$ specificity for lesions $\\leq 5 \\mathrm{~mm}$ ):\n\n1. Germinal matrix hemorrhage (grade I)\n$\\sqrt{ }$ well-defined ovoid area of increased echogenicity ( $=$ fibrin mesh within clot) inferolateral to floor of frontal horn $\\pm$ body of lateral ventricle\n$\\sqrt{ }$ bulbous enlargement of caudothalamic groove anterior to termination of choroid plexus\n$D D x$ : choroid plexus (attached to inferomedial aspect of ventricular floor, tapers toward caudothalamic groove, NEVER anterior to foramen of Monro)\n$\\sqrt{ }$ resolving bleed develops central sonolucency\n$\\sqrt{ }$ outcome: (1) complete involution (2) thin echogenic scar (3) subependymal cyst\n2. Mild intraventricular hemorrhage (grade II)\n$\\sqrt{ }$ echogenic material filling a portion of lateral ventricles (acute phase) becoming sonolucent in a few weeks\n$\\sqrt{ }$ clot may gravitate into occipital horns\n$\\sqrt{ }$ vertical band of echogenicity between thalami on coronal scans (blood in $3^{\\text {rd }}$ ventricle)\n$\\sqrt{ }$ irregular bulky choroid plexus (clot layered on surface of choroid plexus)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 19,
            "markdown": "$\\sqrt{ }$ temporarily increased echogenicity of ventricular wall (= subependymal white halo between 7 days and 6 weeks after hemorrhagic event)\n3. Extensive intraventricular hemorrhage (grade III)\n$\\sqrt{ }$ intraventricular cast of blood distending lateral ventricles\n$\\sqrt{ } \\pm$ extension of hemorrhage into basal cisterns, cavum septi pellucidi\n$\\sqrt{ }$ hemorrhage becomes progressively less echogenic\n$\\sqrt{ }$ temporarily thickened echogenic walls of ventricles (\"ventriculitis\")\n4. Intraparenchymal hemorrhage (grade IV)\n\nFrequency: $5-8 \\%$\nCause: (a) extension of hemorrhage originating from germinal matrix (unusual)\n(b) separate hemorrhage within infarcted periventricular tissue (frequent)\n$=$ periventricular venous infarction $\\leftarrow$ thrombosis of medullary veins draining periventricular brain\nLocation: on side of largest amount of IVH, commonly lateral to frontal horns / in parietal lobe, rare in occipital lobe + thalamus\n$\\sqrt{ }$ unilateral triangular hemorrhage\n$\\sqrt{ }$ homogeneous highly echogenic intraparenchymal mass with irregular margins\n$\\sqrt{ }$ central hypoechogenicity (liquefying hematoma after 10-14 days)\n$\\sqrt{ }$ retracted clot settles to dependent position (3-4 weeks)\n$\\sqrt{ }$ complete resolution by $8-10$ weeks results in anechoic area (= porencephalic cyst)\nSerial scans: recommended in 5-10-day intervals\nCT:\n$\\sqrt{ }$ hyperdense bleed only visible up to 7 days before it becomes isodense\n$D D x$ : subdural hemorrhage, cerebral parenchymal hemorrhage, posterior fossa lesion\nMR (gradient-echo, susceptibility-weighted sequences):\n$\\sqrt{ }$ highest sensitivity for detecting small hemorrhages\n$\\sqrt{ }$ useful for depicting periventricular venous infarction in grade 4 germinal matrix hemorrhages\n$C x$ :\n(1) Posthemorrhagic hydrocephalus ( $30-70 \\%$ )\n$\\diamond$ Severity of hydrocephalus directly proportional to size of original hemorrhage!\nCause:\n(a) temporary blockage of arachnoid villi by particulate blood clot (within days), often transient with partial / total resolution\n(b) obliterative fibrosing arachnoiditis often in cisterna magna (within weeks); frequently leads to permanent progressive ventricular dilatation ( $50 \\%$ )\n$\\sqrt{ }$ thickened echogenic ventricular walls\nTime of onset: by 14 days (in $80 \\%$ )\n\n- delayed clinical signs because of compressible premature brain parenchyma\n$\\sqrt{ }$ ventricular dilatation, particularly affecting the occipital horns (amount of\ncompressible immature white matter is larger posteriorly)\n$D D x$ : ventriculomegaly $\\leftarrow$ periventricular cerebral atrophy (occurring slowly over several weeks)\n(2) Cyst formation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 20,
            "markdown": "(a) cavitation of hemorrhage\n(b) unilocular subependymal cyst\n(c) unilocular porencephalic cyst\n(3) Mental retardation, cerebral palsy\n(4) Death in $25 \\%$\n$\\diamond$ IVH is the most common cause of neonatal death!\nPrognosis:\n(1) Grade I + II: good with normal developmental scores (12-18\\% risk of handicap)\n(2) Grade III + IV: $54 \\%$ mortality; $30-40 \\%$ risk of handicap (spastic diplegia, spastic quadriparesis, intellectual retardation)\n\n# Choroid Plexus Hemorrhage \n\naffects primarily full-term infants\nCause: birth trauma, asphyxia, apnea, seizures\n$\\checkmark$ echogenicity of choroid plexus same as hemorrhage\n$\\checkmark$ nodularity of choroid plexus\n$\\checkmark$ enlargement of choroid plexus $>12 \\mathrm{~mm}$ in AP diameter\n$\\checkmark$ left-right asymmetry $>5 \\mathrm{~mm}$\n$\\checkmark$ intraventricular hemorrhage without subependymal hemorrhage\n$C x$ : intraventricular hemorrhage ( $25 \\%$ )\n\n## Intracerebellar Hemorrhage\n\n## Cause:\n\n(a) full-term infant: traumatic delivery, intermittent positive pressure ventilation, coagulopathy\n(b) premature infant (in 25\\%): subependymal germinal matrix hemorrhage in external granule cell layer and subependymal layer of roof of $4^{\\text {th }}$ ventricle up to 30 weeks GA\nIncidence: $16-21 \\%$ of autopsies\n$\\checkmark$ echogenicity of vermis same as hemorrhage\n$\\checkmark$ echogenic mass in less echogenic cerebellar hemisphere (coronal scan most useful)\n$\\checkmark$ nonvisualization / deformity of $4^{\\text {th }}$ ventricle\n$\\checkmark$ asymmetry in thickness of paratentorial echogenicity is a sign of subarachnoid hemorrhage\nPrognosis: poor + frequently fatal\n\n## Intraventricular Hemorrhage\n\nEtiology:\n(a) germinal matrix hemorrhage ruptures through ependymal lining at multiple sites\n(b) bleeding from choroid plexus\n\n## Route of hemorrhage:\n\nblood dissipates throughout ventricular system + aqueduct of Sylvius, passes through foramina of $4^{\\text {th }}$ ventricle, collects in basilar cistern of posterior fossa\n\n- seizures, dystonia, obtundation, intractable acidosis\n- bulging anterior fontanel, drop in hematocrit, bloody / proteinaceous CSF\n$\\checkmark$ IVH usually clears within 7-14 days\nCx: (1) Intracerebral hemorrhage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 21,
            "markdown": "# (2) Hydrocephalus \n\n## Periventricular Leukoencephalopathy\n\n## Periventricular Leukomalacia\n\n$=$ WHITE MATTER INJURY OF PREMATURITY\n$=$ PVL $=$ perinatal hypoxic-ischemic encephalopathy\n$=$ PRINCIPAL ischemic lesion of the premature infant characterized by areas of focal coagulation necrosis of deep white matter (= cystic variant) / more diffuse injury to premyelinating oligodendrocytes ( $=$ noncystic variant)\nCause: toxic injury to premyelinating oligodendrocytes $\\leftarrow$ cerebral ischemia $\\pm$ reperfusion\nLocation: peritrigonal area of lateral ventricles and foramen of Monro ( $=$ watershed zones in periventricular white matter) involving particularly the centrum semiovale (anterior and lateral to frontal horns + body), optic (occipital horn), and acoustic (temporal horn) radiations\n\n## Vascular supply:\n\n(a) ventriculopetal branches penetrating cerebrum from pial surface derived from MCA $\\pm \\mathrm{PCA} \\pm \\mathrm{ACA}$\n(b) ventriculofugal branches extending from ventricular surface derived from choroidal $\\pm$ striate arteries\nIncidence: $7-22 \\%$ at autopsy (in $88 \\%$ of infants between 900 and $2,200 \\mathrm{~g}$ surviving beyond 6 days); in $34 \\%$ of infants $<1,500 \\mathrm{~g}$; in $59 \\%$ of infants surviving longer than 1 week on assisted ventilation; MOST FREQUENTLY in infants born $<32$ weeks GA\n$\\diamond$ Only $28 \\%$ detected by cranial sonography!\nHisto: edema, white matter necrosis, evolution of cysts + cavities / diminished myelin; nonhemorrhagic+hemorrhagic PVL $=3 \\div 1$\nRisk factors: hypotension, hypocarbia, infection, prematurity, asphyxia, sepsis, patent ductus arteriosus, multiple gestation, respiratory distress, maternal hemorrhage\n\n## Pathogenesis:\n\nimmature autoregulation of periventricular vessels $\\leftarrow$ deficient muscularis of arterioles limits vasodilation in response to hypoxemia + hypercapnia + hypotension of perinatal asphyxia (hypoxic-ischemic encephalopathy); ischemia reperfusion injury of white matter $\\rightarrow$ free radicals $\\rightarrow$ destruction of progenitor cells of oligodendrocyte with impaired myelination\n\n- \"cerebral palsy\" (in $6.5 \\%$ of infants $<1,800 \\mathrm{~g}$ ):\n- spastic diplegia $(81 \\%)>$ quadriparesis (necrosis of descending fibers from motor cortex)\n- choreoathetosis, ataxia, $\\pm$ mental retardation\n- severe visual / hearing impairment, convulsive disorders\n\nUS ( $50 \\%$ sensitivity $+87 \\%$ specificity):\nEarly changes (2 days to 2 weeks after insult)\n$\\sqrt{ }$ increased periventricular echogenicity (PVE) (DDx: echogenic periventricular halo / blush of fiber tracts in normal neonates, white matter gliosis, cortical infarction extending into deep white matter)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 22,
            "markdown": "$\\sqrt{ }$ bilateral often asymmetric zones, occasionally extending to cortex\n$\\sqrt{ }$ infrequently accompanied by IVH\nLate changes (1-3-6 weeks after development of echodensities):\n$\\sqrt{ }$ periventricular cystic PVL = cystic degeneration of ischemic areas (= multiple small NEVER septated periventricular cysts in relationship to lateral ventricles; the larger the echodensities, the sooner the cyst formation)\n$\\sqrt{ }$ brain atrophy $\\leftarrow$ thinning of periventricular white matter always at trigones, occasionally involving centrum semiovale\n$\\sqrt{ }$ ventriculomegaly (after disappearance of cysts) with irregular outline of body + trigone of lateral ventricles\n$\\sqrt{ }$ deep prominent sulci abutting ventricles with little / no interposed white matter (DDx: schizencephaly)\n$\\sqrt{ }$ enlarged interhemispheric fissure\nCT (not sensitive in early phase):\n$\\sqrt{ }$ periventricular hypodensity (DDx: immature brain with increased water + incomplete myelination)\nMR (NOT sensitive in early phase):\n$\\sqrt{ }$ hypointense areas on T1WI\n$\\sqrt{ }$ hyperintense periventricular signals on T2WI in peritrigonal region $\\leftarrow$ delay in maturation / injury\n$D D x$ : normal (SI subject to interpretation)\n$\\sqrt{ }$ thinning of posterior body + splenium of corpus callosum (= degeneration of transcallosal fibers)\nPrognosis: major neurologic problem / death in up to $62 \\%$; PVL localized to frontal lobes shows relative normal development; PVL in parieto-occipital location $>10 \\mathrm{~mm}$ in size $\\rightarrow$ cerebral palsy in close to $100 \\%$\n$D D x$ : tissue damage from ventriculitis (sequelae of meningitis), metabolic disorders, in utero ischemia (eg, maternal cocaine abuse)\n\n# Periventricular Hemorrhagic Infarction \n\n$=$ CYSTIC PERIVENTRICULAR LEUKOMALACIA\n$=$ leukoencephalopathy resulting from pre- / perinatal hypoxic-ischemic event\nIncidence: in $15-25 \\%$ of infants with IVH\nPathogenesis:\n(a) germinal matrix hemorrhage with intraventricular blood clot (in $80 \\%$ )\n(b) ischemic periventricular leukomalacia $\\rightarrow$ obstruction of terminal veins with sequence of venous congestion $\\rightarrow$ thrombosis $\\rightarrow$ infarction\nHisto: perivascular hemorrhage of medullary veins near ventricular angle\nAssociated with: the most severe cases of intraventricular hemorrhage\nAge: peak occurrence on $4^{\\text {th }}$ postnatal day\n\n- spastic hemiparesis (affecting lower + upper extremities equally) / asymmetric quadriparesis (in $86 \\%$ of survivors)\nLocation: lateral to external angle of lateral ventricle on side of the more marked IVH: $67 \\%$ unilateral; $33 \\%$ bilateral but asymmetric\nStages: vascular congestion $\\rightarrow$ coagulative necrosis $\\rightarrow$ cavitation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 23,
            "markdown": "US:\nEarly changes (hours to days after major IVH):\n$\\checkmark$ unilateral / asymmetric bilateral triangular \"fan-shaped\" echodensities\n$\\checkmark$ extension from frontal to parietooccipital regions / localized (particularly in anterior portion of lesion)\nLate changes:\n$\\checkmark$ single large cyst $=$ porencephaly\n$\\checkmark$ bumpy ventricle / false accessory ventricle\nMR:\n$\\checkmark$ increased signal intensity in periventricular white matter on T2WI + FLAIR\n$\\checkmark$ marked loss of periventricular white matter (predominantly in periatrial region)\n$\\checkmark$ adjacent compensatory focal ventricular enlargement\n$\\checkmark$ secondary thinning of corpus callosum\n$\\checkmark$ relative sparing of overlying cortical mantle\n$\\checkmark$ surrounded by gliosis easily depicted on FLAIR\nPrognosis: $59 \\%$ overall mortality with echodensities $>1 \\mathrm{~cm}$; in $64 \\%$ major intellectual deficits\nDDx: enlarged Virchow-Robin spaces\n\n# Encephalomalacia \n\n$=$ more extensive brain damage than PVL; may include all of white matter in subcortex + cortex\nAssociated with:\n(1) Neonatal asphyxia\n(2) Vasospasm\n(3) Inflammation of CNS\n\nUS:\n$\\checkmark$ small ventricles ( $\\leftarrow$ edema) with diffuse damage\n$\\checkmark$ increased parenchymal echogenicity making it difficult to define normal structures\n$\\checkmark$ decreased vascular pulsations\n$\\checkmark$ transcranial Doppler:\n(a) group I (good prognosis)\n$\\checkmark$ normal flow profile, normal velocities, normal resistive index\n(b) group II (guarded prognosis)\n$\\checkmark$ increase in peak-systolic + end-diastolic flow velocities + decreased resistive index\n(c) group III (unfavorable prognosis)\n$\\checkmark$ reduced diastolic flow + decreased peak systolic and diastolic velocities + increased resistive index\n$\\checkmark$ ventricular enlargement + atrophy\n$\\checkmark$ extensive multicystic encephalomalacia with cysts often not communicating\n\n## NEUROCUTANEOUS MELANOSIS\n\n$=$ rare sporadic congenital syndrome characterized by large multiple melanocytic nevi (in 5$15 \\%)+$ melanotic lesions of CNS (in $40-60 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 24,
            "markdown": "Age: first 2 years of life (most); $2^{\\text {nd }} / 3^{\\text {rd }}$ decade (less common); $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nCause: abnormal migration of melanocyte precursors, abnormal expression of melaninproducing genes within leptomeningeal cells, rapid proliferation of melanin-producing leptomeningeal cells\nHisto: abnormal abundance of melanotic cells (which are normally found in basilar leptomeninges) with concomitant infiltration of perivascular spaces\n\n- increased intracranial pressure\n- seizures, ataxia, cranial nerve VI + VII palsies\n$\\checkmark$ high attenuation of melanin pigments on CT scan\n$\\checkmark$ hyperintense on T1WI, hypointense on T2WI ( $\\leftarrow$ paramagnetic effect of oxygen-free radicals in melanin)\n$\\checkmark$ leptomeningeal melanosis $=$ foci of abnormally thickened leptomeninges\nLocation: inferior surface of cerebellum; inferior surface of frontal, temporal, occipital lobes; ventral aspect of pons; cerebral peduncles; upper cervical spinal cord\n$\\checkmark$ parenchymal melanosis (less common)\nLocation: cerebellum, anterior temporal lobes (esp. amygdala)\n$\\checkmark$ frankly hemorrhagic necrotic invasive mass with transformation into malignant melanoma\n$\\checkmark$ hydrocephalus\n$\\checkmark$ posterior fossa cyst\n$\\checkmark$ cerebellar hypoplasia\n$\\checkmark$ Dandy-Walker malformation\n$\\checkmark$ syringomyelia\n$\\checkmark$ intraspinal arachnoid cyst\n$\\checkmark$ intraspinal lipoma\nPrognosis: rapid deterioration + death within 3 years of diagnosis $\\leftarrow$ development of malignant melanoma / complication of hydrocephalus\n\n\n# NEUROGLIAL CYST \n\n$=$ GLIOEPENDYMAL CYST $=$ NEUROEPITHELIAL CYST\n$=$ rare benign epithelium-lined lesion\nIncidence: $<1 \\%$ of all intracranial cysts\nCause: sequestration of developing neural tube elements during embryogenesis\nHisto: rounded smooth unilocular cyst lined by ependymal (columnar epithelium) / choroid plexus cells (low cuboidal epithelium) with CSF-like content\nLocation: anywhere (typically in frontal lobe); intraparenchymal > extraparenchymal\nSize: up to several cm in diameter\n\n- typically asymptomatic; symptomatic if CSF flow obstructed\n$\\checkmark$ spherical / ovoid lesion of CSF signal intensity:\n$\\checkmark$ hyperintense to CSF on T2WI with proteinaceous content\n$\\checkmark$ smooth rounded borders\n$\\checkmark$ NO enhancement, NO adjacent edema, NO soft-tissue mass, NO gliosis\n$D D x$ : choroid plexus cyst (commonly abnormal DWI); arachnoid cyst (typically extraaxial); enlarged Virchow-Robin space (no differentiating feature on imaging, typically multiple + clustered around basal ganglia); porencephalic cyst (communication with lateral",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 25,
            "markdown": "ventricle, surrounding gliosis); epidermoid cyst; infectious cyst of neurocysticercosis (< 1 cm , partially enhancing)\n\n# NEUROFIBROMATOSIS \n\n$=$ autosomal dominant inherited disorder, probably of neural crest origin affecting all 3 germ cell layers, capable of involving any organ system\nPath: frequently combination of\n(1) pure neurofibromas ( $=$ tumor of nerve sheath with involvement of nerve, nerve fibers run through mass)\n(a) localized neurofibroma (most common, $90 \\%$ )\n(b) diffuse neurofibroma mostly solitary + not associated with NF1\n(c) plexiform neurofibroma (PATHOGNOMONIC of NF1)\n$\\diamond$ Often precedes development of cutaneous neurofibromas!\n(2) neurilemmomas ( $=$ nerve fibers diverge and course over the surface of the tumor mass)\nHisto: proliferation of fibroblasts + Schwann cells\n$\\diamond$ More frequent involvement of deep large nerves (sciatic nerve, brachial plexus) in NF1 in contradistinction to isolated neurofibromas without NF1!\n\n## Peripheral Neurofibromatosis ( $90 \\%$ )\n\n$=$ NEUROFIBROMATOSIS TYPE $1=$ NF1 $=$ VON RECKLINGHAUSEN DISEASE\n[Friedrich von Recklinghausen (1833-1910), pathologist in Königsberg, Würzburg and Strasbourg]\n$=$ fully penetrant autosomal-dominant disorder with variable expressivity characterized by dysplasia of mesodermal + neuroectodermal tissue with potential for diffuse systemic involvement\nGenetics: NF1 gene $=$ tumor suppressor gene localized in the pericentromeric region of chromosome $\\mathbf{1 7}$ produces neurofibromin that functions as a negative regulator of Ras signaling proteins; $50 \\%$ represent new spontaneous mutations mnemonic: 'von Recklinghausen' has 17 letters\nIncidence: $1 \\div 3,000 ; \\mathrm{M} \\div \\mathrm{F}=1 \\div 1$; all races\n$\\diamond$ One of the most common genetic diseases and phakomatoses!\nPredisposing factor: advanced paternal age $>35$ years (2-fold increase in new mutations)\nDiagnostic clinical criteria (at least two must be present):\n(1) $\\geq 6$ \"coast-of-California\" café-au-lait spots\n$>5 \\mathrm{~mm}$ in diameter in prepubertal individuals\n$>15 \\mathrm{~mm}$ in diameter in postpubertal individuals\n(2) $\\geq 2$ neurofibromas of any type $/ \\geq 1$ plexiform neurofibroma\n(3) Intertriginous freckling (Crowe sign) in axilla / inguina\n(4) Optic pathway glioma\n(5) $\\geq 2$ Lisch nodules $=$ pigmented iris hamartomas\n(6) Characteristic skeletal lesion\n> sphenoid bone dysplasia\n> dysplasia + thinning of long bone cortex",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 26,
            "markdown": "(7) $1^{\\text {st }}$-degree relative (parent, sibling, child) with NF1\n\nCLASSIC TRIAD:\n(1) Cutaneous lesions\n(2) Skeletal deformity\n$\\diamond$ Musculoskeletal abnormalities predominate in NF1!\n(3) Mental deficiency\n\nMay be associated with:\n(1) MEA IIb (pheochromocytoma + medullary carcinoma of thyroid + multiple neuromas)\n(2) CHD ( 10 fold increase): pulmonary valve stenosis, ASD, VSD, IHSS\n\nCx: malignant transformation to malignant neurofibroma + malignant schwannoma (2-5$29 \\%$ ), glioma, xanthomatous leukemia\nRapid episodes of growth of neurofibromas:\npuberty, pregnancy, malignancy\n\n# CNS Manifestations of NF1 \n\n@ Intracranial\n\n1. Optic pathway glioma\n2. Cerebral glioma astrocytomas of tectum, brainstem, gliomatosis cerebri (= unusual confluence of astrocytomas)\n3. Hydrocephalus obstruction usually at aqueduct of Sylvius\n\nCause: benign aqueductal stenosis, glioma of tectum / tegmentum of mesencephalon\n4. Vascular dysplasia\n$=$ occlusion / stenosis of distal internal carotid artery, proximal middle / anterior cerebral artery\n$\\sqrt{ }$ moyamoya phenomenon $(60-70 \\%)$\n5. Neurofibroma of cranial nerves III-XII (most commonly V + VIII)\n$\\diamond 30 \\%$ of patients with solitary neurofibromas have NF1\n$\\diamond$ Virtually all patients with multiple neurofibromas have NF1\n6. Craniofacial plexiform neurofibroma\n$=$ locally aggressive congenital lesion composed of tortuous cords of Schwann cells, neurons and collagen with progression along nerve of origin (usually small unidentified nerves)\nLocation: commonly orbital apex, superior orbital fissure\n$\\diamond$ Plexiform neurofibromas are PATHOGNOMONIC for NF1\n7. CNS hamartoma (up to $75-90 \\%$ )\n$=$ probably dysmyelinating lesion (may resolve)\nLocation: pons, basal ganglia (most commonly in globus pallidus), thalamus, cerebellar white matter\n$\\sqrt{ }$ multiple foci of isointensity on T1WI + hyperintensity on T2WI without mass effect ( $=$ \"unidentified bright objects\")\n8. Vacuolar / spongiotic myelinopathy (in $66 \\%$ )\n\nLocation: basal ganglia (esp. in globus pallidus), cerebellum, internal capsule, brainstem\n$\\sqrt{ }$ nonenhancing hyperintense foci on T2WI",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 27,
            "markdown": "# Spinal cord \n\n1. Cord neurofibroma\n$\\sqrt{ }$ smooth round / tubular masses of varying sizes at nearly every level throughout spinal canal\n$\\sqrt{ }$ spinal cord displaced to contralateral side\n$\\sqrt{ }$ enlargement of neural foramen $\\leftarrow$ \"dumbbell\" neurofibroma of spinal nerves (in $30 \\%)$\n$\\sqrt{ }$ smooth fusiform / spherical mass:\n$\\sqrt{ }$ hypoattenuating mass $(20-30 \\mathrm{HU})$ in up to $73 \\% \\leftarrow$ cystic degeneration, xanthomatous features, confluent areas of hypocellularity, lipid-rich Schwann cells\n$\\sqrt{ }$ areas of higher attenuation $\\leftarrow$ densely cellular components / collagen-rich regions\n$\\sqrt{ }$ slightly hyperintense to muscle on T1WI, hyper-intense periphery + hypointense core on T2WI\n$\\sqrt{ }$ hypoechoic heterogeneous well-circumscribed cylindrical lesion with variable through transmission\n2. Paraspinal / presacral plexiform neurofibroma\n$=$ regional enlargement of nerve root trunk (plexus / multiple fascicles of medium to large nerve); exclusive to NF1\n\nLocalized and plexiform neurofibromas of the paraspinal and sacral region are the most common abdominal neoplasm in NF1.\nLocation: retroperitoneal along lumbosacral plexus adjacent to psoas muscle at single / multiple vertebral body levels\nForm: ropelike = involving non-branching nerves; \"bag of worms\" = in branching nerves\n$\\sqrt{ }$ heterogeneous echotexture with variable through transmission\n$\\sqrt{ }$ smooth round / tubular symmetric / asymmetric paraspinal masses within / adjacent to psoas m.:\n$\\sqrt{ }$ homogeneously hypoattenuating $(20-25 \\mathrm{HU})$ in up to $73 \\% \\leftarrow$ myxoid + mucinous stroma\n$\\sqrt{ }$ focal areas of higher attenuation $\\leftarrow$ excessive collagen\n$\\sqrt{ }$ homo- / heterogeneous enhancement to $30-50 \\mathrm{HU}$ on CECT in $50 \\%$\n$\\sqrt{ }$ enlargement of adjacent neural foramen in $30 \\%$\n$C x$ : malignant degeneration\n3. Lateral / anterior intrathoracic meningocele\n$=$ diverticula of thecal sac extending through widened neural foramina / defects in vertebra\nCause: dysplasia of meninges focally stretched by CSF pulsations $\\leftarrow$ pressure differences between thoracic + subarachnoid space superimposed on osseous vertebral defect\n$\\sqrt{ }$ erosion of bony elements with marked posterior scalloping\n$\\sqrt{ }$ widening of neural foramina $\\leftarrow$ protrusion of spinal meninges\n$D D x$ : mediastinal / lung abscess",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 28,
            "markdown": "Skeletal Manifestations of NF1 (in 25-40\\%)\n\n- skeletal dysplasias + pseudarthroses\n\nAge: during first year of life\n@ Orbit\n$\\sqrt{ }$ Harlequin appearance to orbit $=$ sphenoid wing dysplasia $=$ partial absence of greater and lesser wing of sphenoid bone + orbital plate of frontal bone $\\leftarrow$ failure of development of membranous bone\n$\\checkmark$ hypoplasia + elevation of lesser wing of sphenoid\n$\\checkmark$ defect in sphenoid bone $\\pm$ extension of middle cranial fossa structures into orbit\n$\\checkmark$ concentric enlargement of optic foramen $\\leftarrow$ optic glioma\n$\\checkmark$ enlargement of orbital margins + superior orbital fissure $\\leftarrow$ plexiform neurofibroma of peripheral and sympathetic nerves within orbit / optic nerve glioma\n$\\checkmark$ sclerosis in the vicinity of optic foramen $\\leftarrow$ optic nerve sheath meningioma\n$\\checkmark$ deformity + decreased size of ipsilateral ethmoid and maxillary sinuses\n@ Skull\n$\\checkmark$ macrocranium + macroencephaly\n$\\checkmark$ left-sided calvarial defect adjacent to lambdoid suture = parietal mastoid (rare)\n@ Spine\n\n- dwarfism caused by scoliosis\n$\\checkmark$ sharply angled focal kyphoscoliosis ( $50 \\%$ ) in lower thoracic + lumbar spine; kyphosis predominates over scoliosis; incidence increases with age\nCause: abnormal development of vertebral bodies\n$\\checkmark$ hypoplasia of pedicles + transverse + spinous processes\n$\\checkmark$ posterior scalloping of vertebral bodies $\\leftarrow$ dural ectasia $\\leftarrow$ weakened meninges allowing transmission of normal CSF pulsations\n$\\checkmark$ dumbbell-shaped enlargement of neural foramina\n@ Appendicular skeleton\n$\\checkmark$ anterolateral bowing of lower half of tibia (most common) / fibula (frequent) / upper extremity (uncommon) secondary to deossification $\\rightarrow$ thinning $\\rightarrow$ pathologic fracture\n$\\checkmark$ pseudarthrosis / nonunion after bowing fracture in 1 st year of life\nLocation: tibia, fibula\n$\\checkmark$ atrophic thinned / absent fibula\n$\\checkmark$ periosteal dysplasia = traumatic subperiosteal hemorrhage with abnormally easy stripping of periosteum from bone\n$\\checkmark$ subendosteal sclerosis\n$\\checkmark$ bone erosion from periosteal / soft-tissue neurofibroma\n$\\checkmark$ intramedullary longitudinal streaks of increased density\n$\\checkmark$ multiple nonossifying fibromas / fibroxanthomas\n$\\checkmark$ single / multiple cystic lesions within bone $\\leftarrow$ deossification / nonossifying fibroma\n$\\checkmark$ focal gigantism = unilateral overgrowth of a limb bone $\\leftarrow$ overgrowth of ossification center\nSite: marked enlargement of a digit in a hand / foot\n\n# Pulmonary Manifestations of NF1 \n\n@ Lung",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 29,
            "markdown": "- exertional dyspnea\n$\\sqrt{ }$ intrathoracic lateral + anterior meningoceles\n$\\sqrt{ }$ peripheral pulmonary nodule $=$ pedunculated intercostal neurofibroma\n$\\sqrt{ }$ progressive pulmonary interstitial fibrosis with lower lung field predominance (in up to $20 \\%$ )\n$\\sqrt{ }$ large thin-walled bullae with asymmetric upper lobe predominance\n@ Mediastinum\n$\\diamond$ Neurogenic tumors account for $9 \\%$ of primary mediastinal masses in adults $+30 \\%$ in children\n$\\checkmark$ mediastinal mass:\n$\\checkmark$ well-marginated smooth round / elliptic mass\n$\\checkmark$ extensive fusiform / infiltrating mass\n$\\checkmark$ paravertebral neurofibroma\n@ Chest wall\n$\\checkmark$ numerous small well-defined subcutaneous neurofibromas\n$\\checkmark$ twisted \"ribbonlike\" ribs in upper thoracic segments $\\leftarrow$ bone dysplasia / multiple neurofibromas of intercostal nerves:\n$\\checkmark$ localized cortical notches / depression of inferior margins of ribs (DDx: aortic coarctation)\n$\\checkmark$ chest wall mass invading / eroding / destroying adjacent rib\n\n\n# Abdominal Tumors in NF1 \n\nA. NEUROGENIC TUMORS IN NF1\n\n1. Neurofibroma\n2. Plexiform neurofibroma\n3. Malignant peripheral nerve sheath tumor\n4. Ganglioneuroma\n5. Ganglioneuromatosis\nB. NEUROENDOCRINE TUMORS IN NF1\n6. Periampullary carcinoid\n7. Pheochromocytoma in adults\n\nLocation: solitary + unilateral (84\\%); bilateral (10\\%); extraadrenal (6\\%)\n3. Paraganglioma\nC. OTHER TUMORS ASSOCIATED WITH NF1\n\n1. GIST\n2. Embryonal tumor\n3. Adenocarcinoma\n4. Parathyroid adenoma\n\n- hyperparathyroidism\n\n\n## Vascular Lesions in NF1\n\n$=$ Schwann cell proliferation within vessel wall\nAge: common in childhood\n\n1. Cranial artery stenosis\n2. Renal artery stenosis: very proximal, funnel-shaped",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 30,
            "markdown": "$\\diamond$ Renal artery stenosis in NF1 is one of the most common causes of hypertension in childhood!\n3. Renal artery aneurysm\n4. Thoracic / abdominal aortic coarctation\n\n# GI Tract Manifestations in NF1 (10-25\\%) \n\nNeurofibromas appear as well-defined masses but frequently infiltrate into adjacent fat, muscle, or viscera $\\rightarrow$ local recurrence after resection is common.\n\n1. Neurofibroma\n\n- most clinically occult\n- intestinal bleeding (hematemesis, melena, hematochezia) with mucosal involvement\n- obstruction with nausea, vomiting, abdominal distension (intussusception, volvulus, simulating Hirschsprung disease with plexiform neurofibromas of colon)\nLocation: jejunum > stomach > ileum > duodenum\nSite: myenteric $>$ mesenteric / subserosal plexus\nAssociated with: increased prevalence of carcinoid tumors + GI stromal tumors\n(a) single / solitary neurofibroma, neuroma, ganglioneuroma, schwannoma\n$\\checkmark$ subserosal / submucosal filling defect (\"mucosal ganglioneurofibromatosis\")\n$\\checkmark$ displacement of intestine\n$\\checkmark$ external mass effect on serosal surface\n$\\checkmark$ infiltrating submucosal / mucosal polypoid masses\n$\\checkmark$ lobular mural thickening of soft-tissue attenuation with variable amount of luminal narrowing $\\leftarrow$ infiltration through intestinal wall\n(b) mesenteric plexiform neurofibroma\n\nLocation: common in perirectal space\nSite: from root of mesentery to wall of intestine\n$\\checkmark$ mass effect on adjacent barium-filled loops\n$\\checkmark$ multiple eccentric polypoid filling defects involving mesenteric side of small bowel\n$\\checkmark$ mesenteric fat trapped within entangled network (15-30 HU)\nCHARACTERISTIC\n$\\checkmark$ multiple leiomyomas $\\pm$ mucosal ulcers\nCx: intussusception\n2. Malignant peripheral nerve sheath tumor\n$\\diamond$ Most common malignant abdominal tumor in NF1\n3. Ganglioneuroma\n4. Carcinoid\n\n- more common in NF1 than in general population\n\nLocation: near ampulla of Vater\nHisto: psammomatous somatostatinoma\n5. Gastrointestinal stromal tumor\n\n## Genitourinary Manifestations of NF1 (rare)\n\n1. Renal artery stenosis\n$\\checkmark$ plexiform neurofibroma with vascular narrowing",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 31,
            "markdown": "2. Urinary bladder neurofibroma\n\nOrigin: vesicoprostatic (male) / urethrovaginal neural plexus (female)\n\n- symptoms of urinary tract obstruction: frequency, urgency, incontinence, hematuria, abdominal pain\n$\\sqrt{ }$ solitary hypoechoic bladder wall mass\n$\\sqrt{ }$ diffuse bladder wall thickening; mass may surround uterus, vagina, sigmoid colon\n$\\checkmark$ scalloped contour of urinary bladder\nCx: hydronephrosis\n\n\n# Ocular Manifestations in NF1 (6\\%) \n\n- pulsatile exophthalmos / unilateral proptosis (herniation of subarachnoid space + temporal lobe into orbit)\n- buphthalmos\n\n1. Plexiform neurofibroma (most common)\n2. Lisch nodules\n= PATHOGNOMONIC asymptomatic melanocytic iris hamartomas $<2 \\mathrm{~mm}$ in size\n\n- yellow / brown pigmented nodular elevations projecting from surface of iris; mostly bilateral\n- asymptomatic\n\nAge: 5-10 years; $>20$ years of age in $>90 \\%$\n3. Optic glioma (in $12 \\%$ of patients, in $4 \\%$ bilateral)\n\nAge: $75 \\%$ in $1^{\\text {st }}$ decade\n$\\sqrt{ }$ extension into optic chiasm (up to $25 \\%$ ), optic tracts, optic radiation\n$\\sqrt{ }$ increased intensity on T2WI if chiasm and visual pathway involved\n4. Perioptic meningioma\n5. Choroidal hamartoma: in $50 \\%$ of patients\n\n## Skin Manifestations in NF1\n\n1. Café-au-lait spots\n$=\\tan /$ light brown pigmented often ovoid cutaneous macules + patches with irregular borders\n$\\geq 6$ in number $>$\n5 mm in greatest diameter prior to puberty\n$>15 \\mathrm{~mm}$ in postpubertal individuals\n\n- randomly distributed\n- \"coast of California\" type (= smooth outline)\n\nDDx: \"coast-of-Maine\" spots of McCune-Albright syndrome (with more jagged borders)\nAge: usually present at birth, increase in number over first 1-2 years of life\n$\\diamond$ One of the earliest manifestations of NF1\nHisto: increased melanin pigment in basal epidermal layer\n$D D x$ : tuberous sclerosis, fibrous dysplasia\nExtent: often parallels disease severity\n2. Intertriginous freckling (= Crowe sign)\n$=$ pigmented cutaneous macules $<5 \\mathrm{~mm}$ in size",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 32,
            "markdown": "Age: $3-5$ years\nLocation: intertriginous skin of axilla (in 66\\%), groin, submammary fold, neck\n3. Dermal (cutaneous) neurofibroma\n\nHisto: benign mixture of Schwann cells + fibroblasts + perineural cells + mast cells\nAge: begins to appear around early childhood / puberty subsequent to detection of café-au-lait spots\n(a) localized $=$ fibroma molluscum $=$ string of pearls along peripheral nerve\n\n- firm well-circumscribed movable tumor\n- soft compressible fleshy nodule of cutis\n- firm rubbery nodule of subcutis\n\nCx: NO malignant degeneration!\n(b) plexiform neurofibroma $=$ multilobulated tortuous entanglement / interdigitating network of tumor along a nerve and its branches\n$\\diamond$ Exclusively seen in NF1 (in 30\\%)\nAge: noticeable by $4-5$ years\n\n- soft gritty often hyperpigmented tumor feeling like a \"bag of worms / braided ropes\"\n- may become very large hanging in a pendulous fashion associated with massive disfiguring enlargement of an extremity ( $=$ elephantiasis ne uromatosa)\n$\\sqrt{ } \\pm$ osseous hypertrophy $\\leftarrow$ chronic hyperemia\nCx: may transform to malignant peripheral nerve sheath tumor (MPNST $=$ neurofibrosarcoma) in $10 \\%$ !\nDx: new onset of pain / neurologic deficit / rapid growth associated with preexisting plexiform neurofibroma $\\rightarrow$ FDG-PET\n(c) diffuse neurofibroma\n\nLocation: most common in subcutaneous tissue\n\n# Neurofibromatosis with Bilateral Acoustic Neuromas \n\n$=$ NEUROFIBROMATOSIS TYPE $2=$ NF $2=$ CENTRAL NEUROFIBROMATOSIS\n$=$ rare autosomal dominant syndrome characterized by propensity for developing multiple schwannomas, meningiomas, and gliomas of ependymal derivation mnemonic: MISME\n\nMultiple Inherited Schwannomas\nMeningiomas\nEpendymomas\nIncidence: $1 \\div 50,000$ births\nEtiology: deletion on the long arm of chromosome 22; in $50 \\%$ new spontaneous mutation mnemonic: Neurofibromatosis 2 is located on chromosome 22!\nSymptomatic age: during $2^{\\text {nd }} / 3^{\\text {rd }}$ decade of life\nDiagnostic criteria:\n(1) bilateral $8^{\\text {th }}$ cranial nerve masses\n(2) first-degree relative with unilateral $8^{\\text {th }}$ nerve mass, neurofibroma, meningioma, glioma (spinal ependymoma), schwannoma, juvenile posterior subcapsular lenticular opacity\n\n- NO Lisch nodules, skeletal dysplasia, optic pathway glioma, vascular dysplasia, learning disability\n- café-au-lait spots $(<50 \\%)$ : pale and $<5$ in number",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 33,
            "markdown": "- cutaneous neurofibroma: minimal in size + number / absent\n@ Intracranial\n\n1. Bilateral acoustic schwannomas (SINE QUA NON)\n\nSite: superior / inferior division of vestibular nerve\n$\\sqrt{ }$ usually asymmetric in size\n2. Schwannoma of other cranial nerves\n\nFrequency: trigeminal nerve $>$ facial nerve\n$\\diamond$ Nerves without Schwann cells are excluded: olfactory nerve, optic nerve\n3. Multiple meningiomas: intraventricular in choroid plexus of trigone, parasagittal, sphenoid ridge, olfactory groove, along intracranial nerves\n4. Meningiomatosis = dura studded with innumerable small meningiomas\n5. Glioma of ependymal derivation\n@ Spinal\n\n- symptoms of cord compression\nA. Extramedullary\n\n1. Multiple paraspinal neurofibromas\n2. Meningioma of spinal cord (esp. in thoracic region)\nB. Intramedullary\n3. Spinal cord ependymomas\n\n# NEUROMA \n\n$=$ ambiguous term and misnomer (really a schwannoma rather than a tumor of actual nerve tissue)!\nPrevalence: $8 \\%$ of all intracranial tumors\nAge: $20-50$ years\n\n- slow growth; not painful\n\n\n## Vestibular Schwannoma\n\n$=$ ACOUSTIC NEUROMA $=$ ACOUSTIC SCHWANNOMA\n$=$ NEURILEMMOMA\n[Theodor Ambrose Hubert Schwann (1810-1882), German anatomist and physiologist, professor of physiology and comparative anatomy in Louvain and at the State University of Liège, Belgium]\n$\\diamond$ Most common neoplasm of internal auditory canal / cerebellopontine angle!\nPrevalence: $6-10 \\%$ of all intracranial tumors; $85 \\%$ of all intracranial neuromas; $60-90 \\%$ of all cerebellopontine angle tumors\nAge: (a) sporadic tumor: $35-60$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 2$\n(b) type 2 neurofibromatosis: $2^{\\text {nd }}$ decade\n\n## Histo:\n\nencapsulated neoplasm composed of proliferating fusiform Schwann cells with\n(a) highly cellular dense regions (Antoni A) with reticulin + collagen, and\n(b) loose areas with widely separated cells (Antoni B) in a reticulated myxoid matrix; common degenerative changes with cyst formation, vascular features, lipid-laden foam cells\nMay be associated with: central neurofibromatosis (NF2)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 34,
            "markdown": "$\\diamond$ Solitary intracranial schwannoma is associated with type 2 neurofibromatosis in 5-25\\%!\n$\\diamond$ Bilateral acoustic schwannomas allow a presumptive diagnosis of type 2 neurofibromatosis!\n\n- long history of slowly progressive unilateral sensorineural hearing loss mostly for highfrequency sounds (in $95 \\%$ )\n- tinnitus, pain; diminished corneal reflex\n- unsteadiness, vertigo, ataxia, dizziness ( $<10 \\%$ )\n\nDoubling time: 2 years\nLocation:\n(a) arises from within internal auditory canal (IAC) in $80 \\%$ / cochlea\n(b) may arise in cerebellopontine angle cistern at opening of IAC (= porus acusticus) with intracanalicular extension in $5 \\%$\nSite: (a) in $85 \\%$ from the vestibular portion of $8^{\\text {th }}$ nerve (around vestibular ganglion of Scarpa / at the glial-Schwann cell junction) posterior to cochlear portion [Antonio Scarpa (1752-1832), professor of anatomy at the Università di Pavia, Lombardia, Italy]\n(b) in $15 \\%$ from the cochlear portion\n$\\checkmark$ round mass centered on long axis of porus acusticus forming acute angles with dural surface of petrous bone\n$\\checkmark$ funnel-shaped component extending into IAC\n$\\checkmark$ IAC enlargement / erosion ( $70-90 \\%$ )\n$\\checkmark$ widening / obliteration of ipsilateral cerebellopontine angle cistern\n$\\checkmark$ shift / asymmetry of $4^{\\text {th }}$ ventricle with hydrocephalus\n$\\checkmark$ degenerative changes (cystic areas and hemorrhage) with tumors $>2-3 \\mathrm{~cm}$\nPlain film:\n$\\checkmark$ flaring porus acusticus\n$\\checkmark$ erosion of IAC: a difference in canal heights of $>2 \\mathrm{~mm}$ is abnormal + indicates a schwannoma in $93 \\%$\nCT:\n$\\checkmark$ small isodense / large hypodense solid tumor\n$\\checkmark$ cyst formation in tumor ( $=$ central necrosis in $15 \\%$ of large tumors) / coexistent extramural arachnoid cyst adjacent to tumor\n$\\checkmark$ usually uniformly dense tumor enhancement with small tumors ( $50 \\%$ may be missed without CECT) / ring enhancement with large tumors\n$\\checkmark$ NO calcification\n$\\checkmark$ intrathecal contrast / carbon dioxide insufflation (for tumors $<5 \\mathrm{~mm}$ )\nMR (most sensitive test with Gd-DTPA enhancement):\n$\\checkmark$ iso- / slightly hypointense relative to gray matter on T1WI\n$\\checkmark$ intensely enhancing homogeneous mass / ringlike enhancement (if cystic) after Gd-DTPA\n$\\checkmark$ hyperintense on T2WI relative to gray matter (DDx: meningioma remains hypo- / isointense)\nAngio:\n$\\checkmark$ elevation + posterior displacement of anterior inferior cerebellar artery (AICA) on basal view\n$\\checkmark$ elevation of the superior cerebellar artery (large tumors)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 35,
            "markdown": "$\\sqrt{ }$ displacement of basilar artery anteriorly / posteriorly and to contralateral side\n$\\sqrt{ }$ compression / posterior and lateral displacement of petrosal vein\n$\\sqrt{ }$ posterior displacement of choroid point of PICA\n$\\sqrt{ }$ vascular supply frequently from ECA branches\n$\\sqrt{ }$ rarely hypervascular tumor with tumor blush\n$D D x$ : ossifying hemangioma (bony spiculations)\n\n# Trigeminal Schwannoma \n\n$=$ TRIGEMINAL NEUROMA\nIncidence: $2-5 \\%$ of intracranial neuromas, $0.26 \\%$ of all brain tumors\nOrigin: arising from gasserian ganglion within Meckel cave at the most anteromedial portion of the petrous pyramid / trigeminal nerve root\n[Johann Lorentz Gasser (1723-1765), Austrian anatomist at the Universität Wien, Österreich]\nAge: $\\quad 35-60$ years; $\\mathrm{M}+\\mathrm{F}=1 \\div 2$\n\n- symptoms of location in middle cranial fossa:\n- facial paresthesia / hypesthesia\n- exophthalmos, ophthalmoplegia\n- symptoms of location in posterior cranial fossa:\n- facial nerve palsy\n- hearing impairment, tinnitus\n- ataxia, nystagmus\n\nLocation: (in any segment of trigeminal nerve)\n(a) middle cranial fossa $(46 \\%)=$ gasserian ganglion\n(b) posterior cranial fossa ( $29 \\%$ )\n(c) in both fossae ( $25 \\%$ )\n(d) pterygoid fossa / paranasal sinuses ( $10 \\%$ )\n$\\sqrt{ }$ erosion of petrous tip\n$\\sqrt{ }$ enlargement of contiguous fissures, foramina, canals\n$\\sqrt{ }$ dumbbell / saddle-shaped mass (extension into middle cranial fossa + through tentorial incisura into posterior fossa)\n$\\sqrt{ }$ isodense mass with dense inhomogeneous enhancement $\\leftarrow$ tumor necrosis + cyst formation\n$\\sqrt{ }$ distortion of ipsilateral quadrigeminal cistern\n$\\sqrt{ }$ displacement + cutoff of posterior $3^{\\text {rd }}$ ventricle\n$\\sqrt{ }$ anterior displacement of temporal horn\n$\\sqrt{ }$ angiographically avascular / hypervascular mass\n\n## NEUROSYPHILIS\n\n$=$ consequence of hematogenous dissemination\nRisk of progression: 3\\% if treated with penicillin; accelerated in cell-mediated immunodeficiency (HIV, AIDS)\nTypes:\n(1) Meningeal neurosyphilis\n\nLatency period: $<2$ years\n$\\sqrt{ }$ thick nodular meninges + gummas (similar to tuberculosis / sarcoidosis)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 36,
            "markdown": "# (2) Vascular neurosyphilis \n\nLatency period: 5-7 years\n$\\sqrt{ }$ alternating arterial stenoses + dilatations $\\leftarrow$ large-vessel arteritis\n$\\sqrt{ }$ parenchymal edema $\\leftarrow$ perivascular extension of subarachnoid infection / from rare deposition of cerebral gummas\nCx: large- / small-vessel infarctions\n(3) General paresis\n\nLatency period: 10-20 years\n(4) Tabes dorsalis\n\nLatency period: 15-20 years\n\n## OLIGODENDROGLIOMA\n\n$=$ uncommon form of slowly growing glioma presenting with large size at time of diagnosis\nIncidence: $0.3 \\div 100,000$ annually; $3^{\\text {rd }}$ most common glioma; $2-5 \\%$ of all primary brain tumors; $5-25 \\%$ of all glial neoplasms; $<1 \\%$ of pediatric CNS neoplasms\nPath: (a) well-differentiated oligodendroglioma\n(b) anaplastic oligodendroglioma ( $20-54 \\%$ )\n(c) \"mixed glioma\" containing neoplastic astrocytes ( $9 \\%$ )\n\nHisto: monotonous \"fried-egg\" appearance = uniformly rounded hyperchromatic nuclei surrounded by perinuclear halo of clear cytoplasm; \"chicken-wire\" pattern = delicate branching network of capillaries; little mitotic activity\nGenetics: deletion of alleles at chromosome loci 19q (50-80\\%) and 1p (40-92\\%) in welldifferentiated tumors\nMedian age: 35-45 years; $\\mathrm{M}+\\mathrm{F}=2 \\div 1$; adult + child $=8 \\div 1,6 \\%$ in childhood ( $2^{\\text {nd }}$ peak at 6-12 years)\n$\\diamond$ Older age is associated with more aggressive tumor behavior!\n\n- long clinical presentation $>5$ years\n- seizures ( $35-85 \\%$ ), headache, mental status change\n- paralysis ( $50 \\%$ ), visual loss ( $49 \\%$ ), papilledema ( $47 \\%$ )\n$\\diamond$ Worse prognosis with neurologic deficit!\n- ataxia (39\\%), abnormal reflexes (37\\%), meningismus (10\\%)\n\nLocation:\n(a) supratentorial: frontal lobe (50-65\\%); temporal lobe (47\\%); parietal lobe (7-20\\%); occipital lobe $(1-4 \\%)$\n(b) infratentorial: cerebellum (3\\%); brainstem \\& spinal cord (1\\%)\n(c) others: leptomeninges (\"oligodendrogliomatosis\"); cerebellopontine angle; cerebral ventricles $(3-8 \\%)=$ \"subependymal oligodendroglioma\"; retina, optic n .\nSite: mostly involving cortical gray matter and subcortical white matter; occasionally through corpus callosum as \"butterfly glioma\"\n$\\checkmark$ round / oval usually sharply marginated mass\n$\\checkmark$ large nodular clumps of calcifications (in $45 \\%$ on plain film; in $20-91 \\%$ on CT)\nCT:\n$\\checkmark$ hypodense ( $60 \\%$ ) / isodense ( $23 \\%$ ) / hyperdense ( $6 \\%$ ) mass\n$\\diamond$ May NOT AT ALL be detectable by CT!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 37,
            "markdown": "$\\sqrt{ }$ cystic degeneration (frequent)\n$\\sqrt{ }$ hemorrhage (uncommon)\n$\\sqrt{ } \\pm$ erosion of inner table of skull (exophytic growth)\nCECT:\n$\\sqrt{ }$ may be adherent to dura (mimicking meningiomas)\n$\\sqrt{ }$ surrounding vasogenic edema (in $50 \\%$ of low-grade, in $80 \\%$ of high-grade tumors)\n$\\sqrt{ }$ subtle ill-defined enhancement ( $15-20 \\%$ ) associated with high-grade tumor\nMR:\n$\\sqrt{ }$ well-circumscribed tumor of heterogeneous intensity:\n$\\sqrt{ }$ hypo- / isointense compared to gray matter on T1WI\n$\\sqrt{ }$ hyperintense compared to gray matter on T2WI\n$\\sqrt{ }$ hyperintense signal on DWI + low ADC values in solid tumor portion of high-grade tumors $\\leftarrow$ restricted water diffusion + lowered extracellular hyaluronic acid\n$\\sqrt{ }$ little edema / mass effect (common)\n$\\sqrt{ }$ solid / mixed moderate peripheral enhancement:\n> moderate to strong for high-grade glioma\n> minimal / none for low-grade glioma\nN.B.: lack of enhancement does not equal low-grade\n$\\sqrt{ }$ calcification may not be detected\nSPECT $\\left({ }^{201} \\mathrm{Tl}\\right) \\&$ PET ( ${ }^{11} \\mathrm{C}$-L-methylmethionine):\n$\\sqrt{ }$ metabolic rate correlates with histologic grade\n$\\sqrt{ }$ detects hypermetabolic regions within tumor\nPrognosticators of malignant behavior:\n> increasing age of patient\n> mass effect, cyst formation, necrosis\n> moderate to strong enhancement $\\leftarrow$ disruption of blood-brain barrier\nhowever: up to $25 \\%$ of high-grade gliomas show faint / no enhancement\n> $\\downarrow$ ADC values in non-enhancing solid tumor portion of high-grade tumor\n$>\\uparrow$ rCBV on perfusion MRI in solid portions + peritumoral region $\\leftarrow$ tumor neoangiogenesis\n$C x$ : leptomeningeal seeding via CSF ( $1-15 \\%$ )\n$R x$ : gross total resection; PCV chemotherapy (procarbazine, lomustine, vincristine); irradiation reserved for chemotherapy failure\nPrognosis: $46 \\% 10$-year survival rate with low-grade; $20 \\% 10$-year survival rate with highgrade; 3-17 years median postop survival\n$D D x$ : (1) Astrocytoma (no large calcifications)\n(2) Ganglioglioma (in temporal lobes + deep cerebral tissues\n(3) Ependymoma (enhancing tumor, often with internal bleeding producing fluid levels)\n(4) Glioblastoma (infiltrating, enhancing, edema, NO calcifications)\n(5) Central neurocytoma\n\n# OSMOTIC DEMYELINATION SYNDROME \n\n$=$ CENTRAL PONTINE MYELINOLYSIS $=$ OSMOTIC MYELINOLYSIS\nPredisposed: chronic alcoholic with liver failure ( $60-70 \\%$ ); malnourished patient; chronically debilitated transplant recipient (liver transplantation with cyclosporine use);",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 38,
            "markdown": "prolonged use of diuretics; extensive burns\nEtiology: unknown; comatose patient receiving rapid correction / overcorrection of severe hyponatremia $>12 \\mathrm{mmol} / \\mathrm{L} / \\mathrm{d}$ (following prolonged IV fluid administration)\nPathophysiology:\nrapid correction of sodium $\\rightarrow$ release of myelinotoxic compounds by gray matter components\n$\\rightarrow$ destruction of myelin sheaths of oligodendrocytes (osmotic myelinolysis with\nintramyelinitic splitting, vacuolization, rupture of myelin sheath); preservation of neurons +\naxons\nHisto: abundant foamy histiocytes without lymphocytes / neutrophils; luxol fast blue staining demarcates demyelination; neurofilament staining shows preserved neuronal axons\nAge: middle age; $\\mathrm{M}>\\mathrm{F}$\n\n- spastic quadriplegia + pseudobulbar palsy (= head and neck weakness, dysphagia, dysarthria)\n- encephalopathy with seizures + acute mental status change\n- progression to pseudocoma (locked-in syndrome) in 3-5 days\n- serial measurements of serum sodium\n\nLocation: (a) isolated pons lesion (most commonly)\n(b) combined type $=$ central pons + extrapontine areas: globus pallidus, putamen, thalamus, cerebellar white matter, lateral geniculate body, caudate nucleus, subcortical cerebral white matter, corona radiata, hippocampi\ntypically spared: ventrolateral pons; pontine portion of corticospinal tract\nCT:\n$\\sqrt{ }$ diminished attenuation in central basilar region of pons without mass effect\n$\\sqrt{ }$ hypoattenuated areas in basal ganglia + thalamus\nMR (positive 1-2 weeks post-onset of symptoms):\n$\\sqrt{ }$ single central symmetric midline pons lesion:\n$\\sqrt{ }$ hyperintense symmetric trident-shaped / round (coronal scan) + bat-wing configuration (sagittal scan) on T2WI + FLAIR\n$\\sqrt{ }$ hypointense / (less commonly) isointense on T1WI\n$\\sqrt{ }$ sparing of ventrolateral pons + pontine portions of corticospinal tracts\n$\\sqrt{ }$ bilateral symmetric well-demarcated lesions in basal ganglia $\\pm$ other extrapontine sites\n$\\sqrt{ } \\pm$ restricted diffusion ( 24 hours after onset of symptoms)\n$\\sqrt{ }$ no enhancement of lesions\nPrognosis: 5-10\\% survival rate beyond 6 months; significant neurologic sequelae (in most)\n$D D x$ : hypoxia, Leigh disease, Wilson disease\n\n# PARAGONIMIASIS OF BRAIN \n\n$=$ Oriental lung fluke (Paragonimus westermani) producing arachnoiditis, parenchymal granulomas, encapsulated abscesses\n$\\sqrt{ }$ isodense / inhomogeneous masses surrounded by edema\n$\\sqrt{ }$ ring enhancement\n\n## PELIZAEUS-MERZBACHER DISEASE[\n\nFriedrich Christoph Pelizaeus (1851-1942), neurologist and balneologist in Nassau, Ilmenau, Kreischa and Bad Oeynhausen, Germany]",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 39,
            "markdown": "[Ludwig Merzbacher (1875-1942), neuropathologist and psychiatrist in Freiburg, Heidelberg and at the University of Tübingen, Germany and chief physician at German Hospital in Buenos Aires, Argentina]\n$=$ rare X-linked sudanophilic leukodystrophy ( 5 types with different times of onset, rate of progression, genetic transmission)\nAge: neonatal period\n\n- bizarre pendular nystagmus + head shaking; cerebellar ataxia\n- slow psychomotor development\n\nCT:\n$\\checkmark$ hypodense white matter\n$\\checkmark$ progressive white matter atrophy\nMR:\n$\\checkmark$ lack of myelination (appearance of newborn brain retained)\n$\\checkmark$ hyperintense internal capsule, optic radiations, proximal corona radiata on T1WI\n$\\checkmark$ near complete absence of hypointensity in supratentorial region on T2WI\n$\\checkmark$ mild / moderate prominence of cortical sulci\nPrognosis: death in adolescence / early adulthood\n\n# PERSISTENT EMBRYONIC INFUNDIBULAR RECESS \n\n$=$ rare congenital malformation of neurohypophysis\n\n- abnormal pituitary function\n$\\sqrt{ }$ unusual expansion of anterior aspect of $3^{\\text {rd }}$ ventricle into sella with loss of normal contours of recesses\n$\\checkmark$ empty sella $=$ expansion of sella + thinning of pituitary\n\n\n## PICK DISEASE\n\n[Arnold Pick (1851-1924), professor of psychiatry and neurology at the German University in Prague]\n$=$ FRONTOTEMPORAL DEMENTIA\n$=$ rare form of presenile dementia similar to Alzheimer disease; may be inherited with autosomal dominant mode; $\\mathrm{M}<\\mathrm{F}$\n\n- social impairment + disinhibitive and impulsive behavior\n$\\checkmark$ focal cortical atrophy of anterior frontal + anterior temporal lobes\n$\\checkmark$ dilatation of frontal + temporal horns of lateral ventricle\nPET:\n$\\checkmark$ hypometabolism in frontal + anterior temporal lobes + anterior cingulate gyrus\n$\\checkmark$ temporal lobe involvement extends to anterior aspects (NOT in Alzheimer disease)\n$\\checkmark$ frontal-predominant form = sparing of temporal lobes\n\n\n## PINEAL CYST\n\n$=$ small nonneoplastic cyst of pineal gland\nIncidence: $25-40 \\%$ on autopsy; $4-23 \\%$ on imaging\nAge: any, predominantly 40-49 years; $\\mathrm{M}<\\mathrm{F}$\nOrigin:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 40,
            "markdown": "(a) developmental = persistence of ependymal-lined pineal diverticulum\n(b) degenerative = glial-lined secondary cavitation within area of gliosis\n\nPath: uni- / multilocular cyst; inner layer = gliotic tissue, middle layer = pineal parenchymal tissue, outer layer = connective tissue; proteinaceous / hemorrhagic cyst fluid\n\n- rarely cause of hydrocephalus ( $\\leftarrow$ compression / occlusion of aqueduct) with headache / visual change\n- NEVER associated with Parinaud syndrome\n\nSize: $2-15 \\mathrm{~mm}$, remaining stable over time; may be symptomatic if $>15 \\mathrm{~mm}$\n$\\sqrt{ }$ round / oval thin-walled well-circumscribed cyst\n$\\sqrt{ } \\pm$ calcification\nCT:\n$\\sqrt{ }$ normal-sized gland ( $80 \\%$ ), slightly $>1 \\mathrm{~cm}$ in $20 \\%$, can be $>2 \\mathrm{~cm}$ in size\n$\\sqrt{ }$ isodense to CSF in surrounding cistern (infrequently noted)\nMR:\n$\\sqrt{ }$ isointense to CSF on T1WI; may have higher signal intensity than CSF $\\leftarrow$ high protein content\n$\\sqrt{ }$ slightly hyperintense to CSF on T2WI $\\leftarrow$ phase coherence in cyst but not in moving CSF\n$\\sqrt{ }$ signal not completely suppressed on FLAIR $\\leftarrow$ proteinaceous content\n$\\sqrt{ }$ typically incomplete enhancement of cyst wall $\\leftarrow$ fragmentation of pineal parenchyma as cyst enlarges\n$\\sqrt{ }$ appearance of a solid mass on delayed contrast images (contrast may diffuse from enhanced rim of residual pineal tissue into fluid center $\\leftarrow \\mathrm{NO}$ blood-brain barrier)\n$\\sqrt{ }$ slight impression on superior colliculi (sagittal image)\nPrognosis: lack of growth over 9 years (in 75\\%); rarely \"pineal apoplexy\" = intracystic hemorrhage\nFollow-up: for cysts $\\geq 10 \\mathrm{~mm}$\n$D D x$ : cystic tumors (astrocytoma, pineocytoma, pineoblastoma)\n\n# PINEAL TERATOCARCINOMA \n\n$=$ highly malignant variant of germ cell tumors\nTypes:\n\n1. Choriocarcinoma\n2. Embryonal cell carcinoma\n3. Endodermal sinus tumor\n\nHisto: arising from primitive germ cells, frequently containing more than one cell type\nAge: $<20$ years; males\n\n- Parinaud syndrome\n- tumor markers elevated in serum + CSF\n$\\sqrt{ }$ intratumoral hemorrhage (esp. choriocarcinoma)\n$\\sqrt{ }$ invasion of adjacent structures\n$\\sqrt{ }$ intense homogeneous contrast enhancement\n$C x$ : seeding via CSF\n\n\n## PINEAL CELL TUMORS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 41,
            "markdown": "$=$ TUMORS OF PINEAL PARENCHYMAL ORIGIN\nIncidence: $<0.2 \\%$ of intracranial neoplasms\nHisto: neuroepithelial neoplasm arising from pineocytes / their precursors\n$\\sqrt{ }$ similar imaging appearance\n$\\sqrt{ }$ peripheral displacement of preexisting normal pineal calcification (= \"exploded pineal calcification pattern\")\n\n# Pineoblastoma (40\\%) \n\n$=$ highly malignant tumor derived from primitive pineal parenchymal cells\nHisto: unencapsulated highly cellular primitive embryonal neoplasm composed of diffuse sheets of small round cells with scant cytoplasm (similar to medulloblastoma, neuroblastoma, retinoblastoma) $\\pm$\n(a) Homer-Wright rosettes (neuroblastic differentiation), or\n(b) Flexner-Wintersteiner rosettes (retinoblastic differentiation)\n\nAge: any age, most common in first 2 decades; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n$\\sqrt{ }$ usually large lobulated mass\n$\\sqrt{ }$ obstructive hydrocephalus in almost $100 \\%$\nCT:\n$\\sqrt{ }$ poorly marginated iso- / typically hyperdense mass\n$\\sqrt{ }$ may contain dense tumor calcifications\n$\\sqrt{ }$ intense homogeneous contrast enhancement\nMR:\n$\\sqrt{ }$ heterogeneous with solid portion iso- / moderately T1 hypointense on T1WI + iso- / mildly T2 hyperintense\n$\\sqrt{ }$ reduced perfusion $\\leftarrow$ increased cellularity\n$\\sqrt{ }$ dense heterogeneous Gd-DTPA enhancement\nCx: hemorrhage, necrosis, spread\nSpread:\n(1) direct extension posteriorly with invasion of cerebellar vermis + anteriorly into $3^{\\text {rd }}$ ventricle\n(2) CSF dissemination (frequent) along meninges / via ventricles as most common cause of death\nN.B.: common CSF dissemination $\\rightarrow$ image the entire craniospinal axis!\n\nPrognosis: 58\\% 5-year survival after resection\n\n## Pineal Tumor of Intermediate Differentiation (20\\%)\n\nAge: any with peak in early adulthood; $\\mathrm{M}<\\mathrm{F}$\nHisto: diffuse sheets of uniform cells + formation of small rosettes; low to moderate levels of mitotic activity + nuclear atypia\nPrognosis: 39-74\\% 5-year survival after resection\n\n## Pineocytoma (14-60\\%)\n\n$=$ rare slow-growing unencapsulated tumor\nHisto: low-grade small uniform mature pineal parenchymal cells with lobular architecture +",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 42,
            "markdown": "pineocytomatous rosettes\nMean age: 38 years; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\nSize: $\\quad<3 \\mathrm{~cm}$\nCT:\n$\\sqrt{ }$ well-marginated slightly hyperdense / isodense mass\n$\\sqrt{ }$ dense focal tumor calcifications possible\n$\\sqrt{ }$ well-defined marked homogeneous enhancement\nMR:\n$\\sqrt{ }$ well-circumscribed hypointense / isointense mass on T1WI + hyperintense on T2WI\n$\\sqrt{ }$ avid homogeneous / internal nodular Gd-DTPA enhancement\nCx: cystic changes: rare CSF dissemination\nPrognosis: 86-100\\% 5-year survival after resection\n$D D x$ : pineal cyst (NO trabeculations, NO enhancement)\nTrilateral Retinoblastoma (rare variant in 1.5-5\\%)\n$=$ uni- / bilateral ocular retinoblastomas + midline small cell tumor\n(a) most frequently in the region of the pineal gland (= neuroectodermal pineal tumor $=$ pineoblastoma)\n(b) suprasellar region\n\nFrequency: $6 \\%$ of patients with bilateral disease\n\n- usually family history\n$\\diamond$ Usually diagnosed 21 (range, 6-141) months after discovery of ocular tumor\n$\\sqrt{ }$ enhancing midline pineal mass\n$\\sqrt{ }$ isoattenuating relative to gray matter on CT\n$\\sqrt{ }$ isointense relative to gray matter on T1WI\nCx: intracranial / intraspinal leptomeningeal dissemination\nPrognosis: mean survival up to 19 months\n\n\n# PITUITARY ADENOMA \n\n$=$ benign slow-growing neoplasm arising from adenohypophysis (= anterior lobe); most common tumor of adenohypophysis\nPrevalence: $5-10-18 \\%$ of all intracranial neoplasms; $<3 \\%$ of patients have underlying MEN 1\n\n- pituitary hyperfunction / hypofunction / visual field defect\n\nPlain film (UNRELIABLE):\n$\\sqrt{ }$ enlargement of sella + sloping of sella floor\n$\\sqrt{ }$ erosion of anterior + posterior clinoid processes\n$\\sqrt{ }$ erosion of dorsum sellae\n$\\sqrt{ }$ calcification in $<10 \\%$\n$\\sqrt{ }$ may present with mass in nasopharynx\nNECT:\n$\\sqrt{ }$ upward convexity of gland\n$\\sqrt{ }$ increased height $>10 \\mathrm{~mm}$\n$\\sqrt{ }$ deviation of pituitary stalk (nonspecific + unreliable)\n$\\sqrt{ }$ erosion of floor of sella with adenoma $>5 \\mathrm{~mm}$\n$\\sqrt{ }$ gland asymmetry",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 43,
            "markdown": "CECT (thin section $\\mathrm{SAG}+$ COR with dynamic bolus injection):\n$\\sqrt{ }$ focal hypodensity (most specific for adenoma) before + after IV contrast administration\n$\\sqrt{ }$ \"pituitary tuft\" sign = displacement / compression of visualized capillary bed (sinusoids of mid-anterior lobe) of pituitary by adenoma\nMR (thin-section SAG + COR with small field of view):\n$\\diamond$ Highest sensitivity on coronal nonenhanced T1WI (70\\%) + 3-D FLASH sequence (69\\%) + combination of both $(90 \\%)$\n$\\diamond 1 / 3$ of lesions are missed with enhancement\n$\\diamond 1 / 3$ of lesions are missed without enhancement\n$\\sqrt{ }$ focus of low signal intensity on T1WI\n$\\sqrt{ }$ focus of high-signal intensity on T2WI\n$\\sqrt{ }$ focal hypointensity within normally enhancing gland\n$D D x:$ simple pituitary cyst ( $=$ Rathke cleft cyst)\n\n# Functioning Pituitary Adenoma \n\n$\\diamond$ Adenoma may secrete multiple hormones!\n\n1. PROLACTINOMA ( $30 \\%$ )\n$=$ most common of pituitary adenomas; $\\sim 50 \\%$ of all cranial tumors at autopsy; $\\mathrm{M}<<\\mathrm{F}$\n\n- prolactin levels do not closely correlate with tumor size\n$\\diamond$ Any mass compressing hypothalamus / pituitary stalk diminishes the tonic inhibitory effect of dopaminergic factors, which originate there $\\rightarrow$ hyperprolactinemia\nFemale:\nAge: 15-44 years (during childbearing age)\n- infertility, amenorrhea, galactorrhea\n- elevated prolactin levels (normal $<20 \\mathrm{ng} / \\mathrm{mL}$ )\n$\\diamond>75 \\%$ of patients with serum prolactin levels $>200 \\mathrm{ng} / \\mathrm{mL}$ will show a pituitary tumor!\nMale:\n- headache, visual disturbance\n- impotence + decreased libido\n$\\sqrt{ }$ characteristic lateral location / anteriorly / inferiorly; variable in size\nRx: bromocriptine\n\n2. CORTICOTROPHIC ADENOMA (14\\%)\n\nFunction: ACTH-secreting tumor\nAge: 30-40 years; $\\mathrm{M}+\\mathrm{F}=1 \\div 3$\n\n- Cushing disease\n$\\sqrt{ }$ central location; posterior lobe; usually $<5 \\mathrm{~mm}$ in size\n$\\sqrt{ }$ blood sampling of inferior petrosal sinuses ( $95 \\%$ diagnostic accuracy compared with $65 \\%$ for MR)\nRx: (1) suppression by high doses of dexamethasone of $8 \\mathrm{mg} / \\mathrm{d}$\n(2) surgical resection difficult because ACTH adenomas usually require resection of an apparently normal gland (tumor small + usually not on surface of gland)\n\n3. SOMATOTROPHIC ADENOMA (14\\%)\n\n- gigantism, acromegaly, elevated $\\mathrm{GH}>10 \\mathrm{ng} / \\mathrm{mL}$, NO rise in GH after administration of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 44,
            "markdown": "glucose / TRH\nHisto: (a) densely granulated type\n(b) sparsely granulated type: more aggressive\n$\\sqrt{ }$ hypodense region, may be less well-defined, variable size\n4. GONADOTROPHIC CELL ADENOMA (7\\%)\nsecretes follicle-stimulating hormone (FSH) / luteinizing hormone (LH)\n$\\sqrt{ }$ slow-growing often extending beyond sella\n5. THYROTROPHIC CELL ADENOMA ( $<1 \\%$ )\nsecretes thyroid-stimulating hormone (TSH)\n$\\sqrt{ }$ often large + invasive pituitary adenoma\n6. PLURIHORMONAL PITUITARY ADENOMA ( $>5 \\%$ )\n\n# Nonfunctioning Pituitary Adenoma \n\n1. NULL CELL ADENOMA\n$=$ hormonally inactive pituitary tumor with no histologic / immunologic / ultrastructural markers to indicate its cellular derivation\nPrevalence: $17 \\%$ of all pituitary tumors\nAge: older patient\n$\\sqrt{ }$ slow-growing\n2. ONCOCYTOMA\n\nPrevalence: $10 \\%$ of all pituitary tumors\n\n- clinically + morphologically similar to null cell adenoma\n\n\n## Pituitary Macroadenoma\n\n$=$ tumor $>10 \\mathrm{~mm}$ in size\nIncidence: $10 \\%(=70-80 \\%$ of pituitary adenomas)\nAge: $\\quad 25-60$ years; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n\n- symptoms of mass effect: hypopituitarism, bitemporal hemianopia (with superior extension), pituitary apoplexy, hydrocephalus, cranial nerve involvement III, IV, VI\n- usually endocrinologically inactive\n\nExtension into: suprasellar cistern / cavernous sinus / sphenoid sinus + nasopharynx (up to $67 \\%$ invasive)\n$\\checkmark$ occasionally tumor hemorrhage\n$\\checkmark$ lucent areas $\\leftarrow$ cysts / focal necrosis\n$\\checkmark$ invasion of cavernous sinus $\\rightarrow$ encasement of carotid artery (SUREST sign)\nCT:\n$\\checkmark$ tumor isodense to brain tissue\n$\\checkmark$ erosion of bone (eg, floor of sella)\n$\\checkmark$ calcifications infrequent\nMR: (allows differentiation from aneurysm)\n$\\checkmark$ homogeneous enhancement\nCx:\n(1) Obstructive hydrocephalus (at foramen of Monro)\n(2) Encasement of carotid artery\n(3) Pituitary apoplexy (rare)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 45,
            "markdown": "$D D x:$\n(1) Metastasis (more bone destruction, rapid growth)\n(2) Pituitary abscess\n\n# Pituitary Microadenoma \n\n$=$ very small adenoma $<10 \\mathrm{~mm}$ in size\n\n- usually become clinically apparent by hormone production ( $20-30 \\%$ of all pituitary adenomas)\n$\\diamond$ Prolactin elevation ( $>25 \\mathrm{ng} / \\mathrm{mL}$ in females)\n$4-8 \\times$ normal: adenoma demonstrated in $71 \\%$\n$>8 \\times$ normal: adenoma demonstrated in $100 \\%$\n- incidentaloma $=$ nonfunctioning microadenoma / pituitary cyst\n$\\sqrt{ }$ NO imaging features to distinguish between different types of adenomas\nMR:\n$\\sqrt{ }$ small nonenhancing mass of hypointensity on pre- and postcontrast T1WI\n$\\checkmark$ occasionally isointense on precontrast images + hyperintense on postcontrast images\n$\\checkmark$ enhancement on delayed images\n$\\checkmark$ focal bulge on surface of gland\n$\\checkmark$ focal depression of sellar floor\n$\\checkmark$ deviation of pituitary stalk\n\n\n## PITUITARY APOPLEXY\n\n$=$ rare clinical syndrome of acute hemorrhagic / ischemic transformation of normal / tumorous adenohypophysis\nCause: massive hemorrhage into pituitary adenoma (especially in patients on bromocriptine for pituitary adenoma) / dramatic necrosis / sudden infarction of pituitary gland\nSheehan $\\quad=$ necrosis of anterior pituitary gland $\\leftarrow$ postpartum infarct $\\leftarrow$ hemorrhagic syndrome shock of complicated delivery\n$\\diamond$ Only $25 \\%$ of patients with intratumoral hemorrhage will present with apoplexy!\n\n- severe headache, stiff neck, nausea, vomiting, hypertension\n- sudden visual-field defect, ophthalmoplegia\n- obtundation (frequent)\n- hypopituitarism (eg, secondary hypothyroidism)\n$\\diamond$ Area of destruction must be $>70 \\%$ to produce pituitary insufficiency!\n$\\sqrt{ }$ enlargement of pituitary gland\nNECT:\n$\\sqrt{ }$ increased density $\\pm$ fluid level\nMR:\n$\\diamond 20 \\%$ of all pituitary adenomas show evidence of hemorrhage by MR!\n$\\sqrt{ }$ mass lesion of heterogeneous signal intensity:\n$\\sqrt{ }$ sellar enlargement ( $=$ macroadenoma)\n$\\checkmark$ high signal on DWI (in acute stage) $\\leftarrow$ restricted diffusion\n$\\checkmark$ predominant T1 hyperintensity + predominant T2 hypointensity $\\leftarrow$ hemoglobin\n$\\sqrt{ }$ intermediate SI on T1WI + T2WI $\\leftarrow$ deoxyhemoglobin",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 46,
            "markdown": "$\\sqrt{ }$ intratumoral fluid-debris level $\\leftarrow$ sedimentation of blood products (at later stage)\n$D D x$ : Rathke cleft cyst (NO hemorrhage, NO fluid-fluid level)\n$\\checkmark$ mucosal thickening of sphenoid sinus $\\leftarrow$ venous engorgement of acute stage\n\n# PONTINE TEGMENTAL CAP DYSPLASIA \n\n$=$ sporadic malformation with unknown genotype\n\n- hearing loss, facial paralysis, trigeminal anesthesia\n- difficulty in swallowing\n$\\checkmark$ flattened ventral pons\n$\\checkmark$ vaulted pontine tegmentum (\"cap\")\n$\\checkmark$ partial absence of middle cerebellar peduncles\n$\\checkmark$ vermian hypoplasia\n$\\checkmark$ molar tooth-like aspect of pontomesencephalic junction\n$\\checkmark$ absent inferior olivary prominence\n\n\n## PORENCEPHALY\n\n$=$ focal cavity as a result of localized brain destruction\nA. AGENETIC PORENCEPHALY\n$=$ SCHIZENCEPHALY $=$ TRUE PORENCEPHALY\nB. ENCEPHALOCLASTIC PORENCEPHALY\n\nTime of injury: during first half of gestation\nHisto: necrotic tissue completely reabsorbed without surrounding glial reaction (= liquefaction necrosis)\nMR:\n$\\checkmark$ smooth-walled cavity filled with CSF on all pulse sequences (= porencephalic cyst)\n$\\checkmark$ lined by white matter\nC. ENCEPHALOMALACIA\n$=$ PSEUDOPORENCEPHALY $=$ ACQUIRED PORENCEPHALY\n$=$ end result of destructive process with replacement by CSF\nPrevalence: $2.5 \\%$ of children with perinatal brain injury\nCause: intraparenchymal hemorrhage, infection, surgery\nTime of injury: after end of $2^{\\text {nd }}$ trimester / postnatally (brain has developed capacity for glial response)\nLocation: parasagittal watershed areas with sparing of periventricular region + ventricular wall\nCT:\n$\\checkmark$ hypodense regions\nMR:\n$\\checkmark$ hypointense on T1WI + hyperintense on T2WI\n$\\checkmark$ surrounding hyperintense rim on T2WI ( $=$ gliosis)\n$\\checkmark$ glial septa coursing through cavity identified on T1WI + proton density images\nUS:\n$\\checkmark$ damaged area hyperechoic (during first days to weeks) following initial hemorrhagic event\n$\\checkmark$ subsequent conversion to area with anechoic center and echogenic border $\\leftarrow$ clot retraction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 47,
            "markdown": "$\\sqrt{ }$ ultimately completely anechoic cystic area $\\leftarrow$ CSF:\n$\\sqrt{ }$ septations in cavity well visualized\n$\\sqrt{ } \\pm$ discrete wall calcifications\n\n# POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME \n\n$=($ PRES $)=$ REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME $=$ HYPERTENSIVE ENCEPHALOPATHY\n$=$ heterogeneous collection of disorders associated with a breakdown in cerebral autoregulatory perfusion mechanisms\n$\\diamond$ Emergency condition as patient may proceed to cerebral infarction and death if untreated!\nCause: acute rise in systemic blood pressure, preeclampsia or eclampsia, hemolytic uremic syndrome, cryoglobulinemia, SLE, following immunosuppressive treatment with cyclosporine A, cisplatin, tacrolimus (= Tsukuba macrolide immunosuppressan $=$ FK506)\n\nPathophysiology: vasogenic edema related to sparse sympathetic innervation in posterior circulation\n\n- headache, nausea, vomiting, visual changes\n- decreased alertness, seizures\n\nLocation: white matter of posterior half of brain\n$\\sqrt{ }$ hypodense white matter on NECT\n$\\sqrt{ }$ lesion hypointense on T1WI + hyperintense on T2WI $\\leftarrow$ vasogenic edema (= fluid extravasation into interstitium)\n$\\sqrt{ }$ lesion hypo- to isointense on DWI + hyperintense on ADC map (due to a net effect of elevated diffusion coefficient from vasogenic edema + T2 shine-through effect)\n$\\sqrt{ }$ NO contrast enhancement\nCx: infarction (lesions develop high DWI signal + normal ADC signal)\n$R x$ : rapid control of blood pressure / withdrawal of offending drug\n\n## PRIMARY ANGIITIS OF CNS\n\n$=$ PACNS $=$ idiopathic inflammatory disease of medium-sized to small arteries affecting CNS / peripheral nervous system WITHOUT evidence of generalized inflammation\nAge: $5-6^{\\text {th }}$ decade\n\n- acute / subacute confusion, hallucinations, headache\n- paresis, cranial neuropathy, loss of consciousness\n- elevated inflammatory markers: $\\uparrow$ ESR\n- CSF analysis: $\\uparrow$ opening pressure, $\\uparrow$ protein level\n\nLocation: spinal cord abnormalities (5\\%)\n$\\diamond$ Nonspecific CT and MR imaging findings!\nCT:\n$\\sqrt{ }$ areas of low attenuation $\\leftarrow$ suggestive of ischemic events\nMR:\n$\\sqrt{ }$ discrete / diffuse supra- and infratentorial lesions involving deep + superficial white matter\n$\\sqrt{ } \\pm$ vessel irregularities\n$\\sqrt{ } \\pm$ areas of infarct + hemorrhage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 48,
            "markdown": "$\\sqrt{ }$ lesion enhancement in $90 \\%$\nDSA (supports diagnosis in spite of negative biopsies):\n$\\sqrt{ }$ focal / multifocal segmental narrowing / occlusion / irregularities in both hemispheres\n$\\sqrt{ }$ collateral vessel formation\n$\\sqrt{ }$ prolonged circulation time\n$\\sqrt{ }$ microaneurysm (unusual)\nSubsets:\n\n1. Hemorrhagic form (11-12\\%)\n\nCause: hemorrhagic transformation of recent infarction / focal necrosis of intracerebral blood vessel\n$\\sqrt{ }$ intracerebral $>$ subarachnoid hemorrhage\n2. Pseudotumoral form (15\\%)\n$\\sqrt{ }$ nonspecific mass lesions characterized by central necrosis, surrounding edema, infiltration of adjacent structures, mass effect, variable contrast enhancement N.B.: often misinterpreted as malignant neoplasms\n3. Rapidly progressive primary vasculitis of CNS\n$\\sqrt{ }$ numerous bilateral lesions of large cerebral vessels\n$\\sqrt{ }$ several bilateral cerebral infarctions\nPrognosis: poor, often fatal\n4. Angiography-negative, biopsy-positive PACNS\n\nSite: small arteries / arterioles\n\n- cognitive dysfunction, $\\uparrow$ CSF protein\n$\\sqrt{ }$ meningeal / parenchymal enhancing lesions at MR\nPrognosis: good with favorable response to treatment\n\n5. Childhood PACNS\n\nSite: unilateral, proximal, multifocal, supratentorial involving gray + white matter with preference for basal ganglia / lateral lenticulostriate vasculature; frequently terminal segment of ICA and proximal segments of ACA + MCA\n$D x$ : leptomeningeal + brain parenchymal biopsies\n$R x$ : high-dose steroids, cytotoxic agents\n\n# PRIMITIVE NEUROECTODERMAL TUMOR \n\n$=$ PNET $=$ PRIMARY CEREBRAL NEUROBLASTOMA\n$=$ group of very undifferentiated tumors arising from germinal matrix cells of primitive neural tube $=$ rare presentation of neuroblastoma\nIncidence: $<5 \\%$ of supratentorial neoplasms in children, $30 \\%$ of posterior fossa tumors\nAge: mainly in children $<5$ years of age/ early adolescence; $\\mathrm{M}+\\mathrm{F}=1+1$\nPath: most undifferentiated form of malignant small cell neoplasms grouped with Ewing sarcoma, Askin tumor\nHisto: highly cellular tumor composed of $>90-95 \\%$ undifferentiated cells (histologically similar to medulloblastoma, pineoblastoma, peripheral neuroblastoma)\n\n- signs of increased intracranial pressure / seizures\n\nLocation:\n(a) supratentorial: deep cerebral white matter (most commonly in frontal lobe), pineal gland,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 49,
            "markdown": "in thalamic + suprasellar territories (least frequently)\n(b) posterior fossa (= medulloblastoma)\n(c) outside CNS: chest wall, paraspinal region, kidney\n$\\sqrt{ }$ large (hemispheric) heterogeneous mass with tendency for central necrosis ( $65 \\%$ ), cyst formation, hemorrhage $(10 \\%)$\n$\\checkmark$ intratumoral coarse dense calcifications ( $71 \\%$ )\n$\\checkmark$ thin rim of edema\n$\\checkmark$ mild / moderate enhancement of solid tumor portion\nCT:\n$\\checkmark$ large hypodense / mixed-density mass with well-defined margins\n$\\checkmark$ solid tumor portions hyperdense $\\leftarrow$ high nuclear to cytoplasmic ratio\nMR:\n$\\checkmark$ mildly hypointense on T1WI + hyperintense on T2WI\n$\\checkmark$ remarkably inhomogeneous due to cyst formation + necrosis\n$\\checkmark$ areas of signal dropout due to calcifications\n$\\checkmark$ hyperintense areas on T1WI + variable intensity (usually intermediate) on T2WI due to hemorrhage\n$\\checkmark$ inhomogeneously moderately enhancing mass with tumor nodules + ringlike areas surrounding central necrosis after Gd-DTPA\n$C x$ : meningeal + subarachnoid seeding ( $15-40 \\%$ )\n$D D x$ : Neuroblastoma usually NOT metastatic to brain!\n\n# Primitive Neuroectodermal Soft-tissue Tumor \n\n$\\checkmark$ tumor of low to intermediate attenuation\n$\\checkmark$ NO evidence of calcification\n$\\checkmark$ low to intermediate signal intensity on T1WI + high signal intensity on T2WI\n$\\checkmark$ often peripheral low-SI vascular channels $\\leftarrow$ high-flow\n$\\checkmark$ areas of hemorrhage (common)\n$\\checkmark$ well-defined tumor margins with pseudocapsule / infiltrative appearance\n\n## PROGRESSIVE MULTIFOCAL LEUKO-ENCEPHALOPATHY\n\n$=$ rapidly progressive fatal demyelinating disease in patients with impaired immune system (chronic lymphocytic leukemia, lymphoma, Hodgkin disease, carcinomatosis, AIDS, tuberculosis, sarcoidosis, organ transplant)\nPrevalence: $4 \\%$ of AIDS patients\nEtiology: reactivation of ubiquitous JC papovavirus\nPathophysiology: destruction of oligodendrogliocytes leading to areas of demyelination + edema\nHisto: intranuclear inclusion bodies within swollen oligodendrocytes (viral particles in nuclei); lysis of oligodendrocytes $\\rightarrow$ demyelination; absence of significant perivenous inflammation\n\n- progressive neurologic deficits, dementia, ataxia, spasticity\n- speech, motor and visual disturbances; normal CSF fluid\n\nLocation: frontoparietal $>$ temporo-occipital cerebral hemispheres; white matter tracts in cerebellum, brainstem, deep gray matter; ? predilection for parieto-occipital region",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 50,
            "markdown": "Site: subcortical white matter spreading centrally into brainstem, deep gray matter\n$\\sqrt{ }$ bilateral white matter lesions ( $92 \\%$ ); confluent ( $94 \\%$ ); discrete ( $67 \\%$ ) in periventricular region + centrum semiovale + subcortical white matter\n$\\sqrt{ }$ gray matter lesions in thalamus + basal ganglia (from involvement of traversing white matter tracts)\n$\\checkmark$ sparing of cortical gray matter\n$\\checkmark$ mild cortical atrophy (up to $69 \\%$ )\n$\\checkmark$ ventricular dilatation $(50 \\%)$\n$\\checkmark$ NO contrast enhancement\nCT:\n$\\checkmark$ multicentric confluent white matter lesions of low attenuation with scalloped borders along cortex\n$\\checkmark$ NO mass effect, NO edema\nMR:\n$\\checkmark$ hypointense lesions on T1WI\n$\\checkmark$ patchy hyperintense lesions of white matter away from ependyma in asymmetric distribution on T2 + FLAIR\n$\\checkmark$ NO enhancement\nPrognosis: death usually within 6 months\nDDx in early stages: primary CNS lymphoma\n\n# RATHKE CLEFT CYST \n\n[Martin Heinrich Rathke (1793-1860), professor of physiology and pathology at the University of Dorpat (Tartu), Estonia and professor of zoology and anatomy in Königsberg, Germany]\n$=$ usually asymptomatic benign cystic sellar lesion\nHisto: lined with single layer of epithelial cells; CSF / mucopolysaccharide content\n\n- often asymptomatic\n- hypopituitarism, visual disturbance, headache (in older patients)\n\nLocation: commonly midline at junction of anterior + posterior pituitary lobes anterior to infundibular stalk; intra- and suprasellar ( $71 \\%$ ); purely suprasellar (rare)\n$\\checkmark$ may contain thick mucinous material\n$\\checkmark$ no contrast enhancement\n$\\checkmark$ calcifications rare\nMR:\n$\\checkmark$ round well-demarcated lesion\n$\\checkmark$ variable SI ranging from hypo- to hyperintense on T1WI $\\leftarrow$ dependent on biochemical content:\n$\\checkmark$ homogeneously high T1 SI $(50 \\%) \\leftarrow$ high protein content\n$\\checkmark$ low T2 intensity $(30 \\%) \\leftarrow$ low intracystic water content\n$\\checkmark$ simple / complex cyst content $\\pm$ fluid-fluid level\n$\\checkmark$ NO central enhancement / hemorrhagic component\n$\\checkmark$ small intracystic nodules of lower T2 + higher T1 SI $(75 \\%) \\leftarrow$ proteinaceous concretions\n$\\checkmark$ wall enhancement due to squamous metaplasia / displaced rim of pituitary tissue\n$D D x$ : craniopharyngioma, macroadenoma (hemorrhagic fluid-debris level)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 51,
            "markdown": "# REYE SYNDROME \n\n[Ralph Douglas Kenneth Reye (1912-1977), director of pathology of the Royal Alexandra Hospital for Children in Sydney, Australia]\n$=$ hepatitis + encephalitis following viral upper respiratory tract infection with history of large doses of aspirin ingestion\nAge: in children + young adults\n\n- obtundation rapidly progressing to coma\n$\\sqrt{ }$ initially (within $2-3$ days) small ventricles\n$\\sqrt{ }$ later progressive enlargement of lateral ventricles + sulci\n$\\sqrt{ }$ markedly diminished attenuation of white matter\nMortality: $15-85 \\%$ (from white matter edema + demyelination)\n$D x:$ liver biopsy\n\n\n## RHOMBENCEPHALOSYNAPSIS\n\n$=$ characterized by absence of vermis + continuity of cerebellar hemispheres, dentate nuclei, superior cerebellar peduncles\nAssociated with: Gómez-López-Hernández syndrome (parietal alopecia, trigeminal anesthesia, craniofacial dysmorphic signs); VACTERL\n\n- truncal $\\pm$ limb ataxia, delayed motor development\n- abnormal eye movements\n$\\sqrt{ }$ agenesis or hypogenesis of vermis\n$\\sqrt{ }$ keyhole-shaped fourth ventricle $\\leftarrow$ horseshoe-shaped arch across midline $\\leftarrow$ fusion (continuity) of cerebellar hemispheres + superior cerebellar peduncles + dentate nuclei $\\sqrt{ }$ abnormal transverse orientation of cerebellar foliae\nPrognosis: varying between severe impairment and normalcy\n\n\n## ROSAI-DORFMAN DISEASE\n\n$=$ rare benign histiocytosis\nEtiology: reaction to infectious agents / autoimmune process\nHisto: polymorphous infiltrate of lymphoplasmacytic cells and histiocytes of varying size embedded in fibrous stroma; S-100 + CD68 positive; CD1a negativity excludes Langerhans histiocytosis; CHARACTERISTIC emperipolesis (= phagocytosis of lymphocytes) in $70 \\%$\n[em, Greek = inside, peri = around, polemai = wander about]\nA. EXTRACRANIAL\n\nAge: primarily in children + young adults; $\\mathrm{M}>\\mathrm{F}$\n\n- painless bilateral cervical adenopathy + involvement of nasal cavity, bone, orbit\nB. INTRACRANIAL ( $40 \\%$ )\n\nAge: $4^{\\text {th }}-5^{\\text {th }}$ decades; $\\mathrm{M} \\div \\mathrm{F}=3 \\div 1$\nLocation: cerebral convexities, parasagittal, petroclival, suprasellar regions\n\n- headache, visual change, seizures, numbness, paraplegia\n$\\sqrt{ }$ well-circumscribed dural-based iso to- hyperattenuating single / multiple masses\n$\\sqrt{ }$ isointense on T1WI + iso- to hypointense on T2WI:\n$\\sqrt{ }$ central low SI on T2WI $\\leftarrow$ release of free radicals by inflammatory macrophages",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 52,
            "markdown": "$\\sqrt{ }$ marked enhancement + dural tail (common)\n$\\sqrt{ }$ edema within adjacent brain parenchyma (frequent)\n$D D x$ : meningioma (iso- to hyperintense on T2WI)\n\n# SCHISTOSOMIASIS OF CNS \n\nTransmission: embolic distribution of ova through venous shunts / anomalous migration of adult worms\nCause: granuloma formation\n\n## Cerebral Schistosomiasis\n\nOrganism: primarily S. japonicum\n\n- fever, focal neurologic deficits, seizures\n\nLocation: cerebellum, cerebral hemispheres, thalamus, dura\nCT:\n$\\sqrt{ }$ single / multiple variably enhancing hyperattenuated lesions $\\pm$ surrounding hypoattenuated edema $\\leftarrow$ focal granulomatous reaction\n$\\sqrt{ }$ nodular / ring / patchy enhancement\nMR:\n$\\sqrt{ }$ bilateral symmetric T1 hyperintensities of globus pallidus + substantia nigra $\\leftarrow$ manganese deposition related to portosystemic shunt\n$\\sqrt{ }$ \"arborized\" T1-enhancement pattern with central linear enhancement (? specific)\n\n## Spinal Schistosomiasis\n\nOrganism: primarily S. mansoni + hematobium\n\n- acute / subacute transverse myelitis (common): back pain, urinary retention, motor + sensory disturbances\nLocation: distal thoracic spinal cord, cauda equina $\\leftarrow$ presumably via vertebral venous (Batson) plexus\nMR:\n$\\sqrt{ }$ T2 hyperintensity $\\leftarrow$ granulomatous involvement\n$\\sqrt{ }$ \"arborized\" T1-enhancement pattern\nCx: (1) spinal cord compression (by focal granuloma)\n(2) anterior spinal artery syndrome (rare)\n\n\n## SCHIZENCEPHALY\n\n$=$ AGENETIC PORENCEPHALY $=$ TRUE PORENCEPHALY\n$=$ \"split brain\"\n$=$ rare CNS malformation consisting of a full-thickness CSF-filled parenchymal cleft lined by gray matter extending from subarachnoid space to subependyma of lateral ventricles\nFrequency: $1 \\div 1,650$\nCause: ? vascular ischemia of portion of germinal matrix / genetic mutation $\\rightarrow$ segmental developmental failure of neuronal cell migration to form cerebral cortex; NOT porencephaly\nTime of injury: 30-60 days of gestation\nOften associated with: polymicrogyria, microcephaly, gray matter heterotopia, septooptic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 53,
            "markdown": "# dysplasia \n\n## Types:\n\n(1) Closed-lip schiz encephaly (type 1) = gray matter-lined lips in contact with each other (may be missed in imaging planes parallel to the plane of cleft)\n$\\sqrt{ }$ walls appose one another obliterating CSF space\n(2) Open-lip schiz encephaly (type 2) = separated lips\n$\\checkmark$ CSF-cleft from wall of lateral ventricle to pial surface\n\n- seizure disorder\n- motor + mental deficiencies correlate with extent of defect:\n- mild / moderate developmental motor delay\n- range of normal mentation to severe mental retardation\n- blindness possible (optic nerve hypoplasia in 33\\%)\n\nLocation: most commonly near pre- and postcentral gyri (sylvian fissure); uni- / (mostly) bilateral; in middle cerebral artery distribution\n$\\checkmark$ cleft from ependyma of lateral ventricle to pial surface of cortex:\n$\\checkmark$ cleft lined by gray matter (PATHOGNOMONIC)\n$\\checkmark$ full-thickness cleft through hemisphere with irregular margins\n$\\checkmark$ asymmetrical dilatation of lateral ventricles with midline shift\n$\\checkmark$ wide separation of lateral ventricles + squaring of frontal lobes\n$\\checkmark$ ventricle wall may be tented pointing to defect\n$\\checkmark$ absence of cavum septi pellucidi $(66 \\%)$\n$\\checkmark$ absence / focal thinning of corpus callosum\n$\\checkmark$ cleft lined by polymicrogyria ( $66 \\%$ ) + heterotopias (common)\n$\\checkmark$ abnormal gyral pattern adjacent to cleft = \"gyri dive into cleft\"\n$\\checkmark$ polymicrogyria / pachygyria adjacent / remote to cleft\n$\\checkmark$ bilateral often symmetric intracranial cysts, usually around sylvian fissure\nPrognosis: severe intellectual impairment, spastic tetraplegia, blindness\n$D D x$ : (1) Pseudoporencephaly = acquired porencephaly = local parenchymal destruction $\\leftarrow$ vascular / infectious / traumatic insult (almost always unilateral, lined by gliotic white matter on MRI)\n(2) Arachnoid cyst\n(3) Cystic tumor\n\n## SEPTOOPTIC DYSPLASIA\n\n$=$ DE MORSIER SYNDROME\n[Georges de Morsier (1894-1982), professor of neurology and director of the neurological clinic of the university of Geneva, Switzerland]\n$=$ rare anterior midline anomaly with\n(1) Hypoplasia of optic nerves\n(2) Hypoplasia / absence of septum pellucidum\n$\\diamond$ Often considered a mild form of lobar holoprosencephaly\nCause: insult between $5-7^{\\text {th }}$ week of GA; $\\mathrm{M}+\\mathrm{F}=1 \\div 3$\nAssociated with: schizencephaly (50\\%)\n\n- hypothalamic hypopituitarism ( $66 \\%$ ):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 54,
            "markdown": "diabetes insipidus (in $50 \\%$ ), growth retardation ( $\\leftarrow$ deficient secretion of growth hormone + thyroid stimulating hormone)\n\n- diminished visual acuity (hypoplasia of optic discs), nystagmus, occasionally hypotelorism; seizures, hypotonia\n$\\checkmark$ small optic canals\n$\\checkmark$ hypoplasia of optic nerves + chiasm + infundibulum\n$\\checkmark$ dilatation of chiasmatic + suprasellar cisterns\n$\\checkmark$ fused dilated boxlike frontal horns squared off dorsally + pointing inferiorly\n$\\checkmark$ bulbous dilatation of anterior recess of $3^{\\text {rd }}$ ventricle\n$\\checkmark$ hypoplastic / absent septum pellucidum\n$\\checkmark$ thin corpus callosum\n\n\n# STURGE-WEBER-DIMITRI SYNDROME \n\n$=$ ENCEPHALOTRIGEMINAL ANGIOMATOSIS $=$ MENINGOFACIAL ANGIOMATOSIS\n[William Allen Sturge (1850-1919), physician and pathologist to the Royal Free Hospital in\nLondon, England\nFrederick Parkes Weber (1863-1962, dermatologist and honorary physician to the German\nHospital, Queen Square, London, England\nVincente Dimitri (1885-1955), Austrian dermatologist in Argentina]\n$=$ vascular malformation with capillary venous angiomas in distribution of trigeminal nerve with ipsilateral leptomeningeal malformation + atrophy + calcification of subjacent cerebral cortex, malformation of choroid of eye, and face\nCause: persistence of transitory primordial sinusoidal plexus stage of vessel development; usually sporadic\n\n- seizures ( $80 \\%$ ) in $1^{\\text {st }}$ year of life: usually focal involving the side of the body contralateral to nevus flammeus\n- mental deficiency ( $>50 \\%$ ); homonymous hemianopia\n- increasing crossed hemiparesis (35-65\\%)\n- hemiatrophy of body contralateral to facial nevus $\\leftarrow$ hemiparesis\n@ FACIAL MANIFESTATION\n- congenital facial port-wine stain (nevus flammeus) = telangiectasia of trigeminal region; usually $1^{\\text {st }} \\pm 2^{\\text {nd }}$ division of $5^{\\text {th }}$ nerve and usually unilateral\n> $\\mathrm{V}_{1}$ associated with occipital lobe angiomatosis\n$>\\mathrm{V}_{2}$ associated with parietal lobe angiomatosis\n$>\\mathrm{V}_{3}$ associated with frontal lobe angiomatosis\n@ CNS MANIFESTATION\n$\\checkmark$ leptomeningeal venous angiomas confined to pia mater\nLocation: parietal $>$ occipital $>$ frontal lobes\n$\\checkmark$ cortical hemiatrophy beneath meningeal angioma $\\leftarrow$ anoxia (steal)\n$\\checkmark$ \"tram track\" gyriform cortical calcifications $>2$ years of age; in layers 2-3 (-4-5) of opposing gyri underlying pial angiomatosis; bilateral in up to $20 \\%$\nLocation: temporoparieto-occipital area, occasionally frontal, rare in posterior fossa\n$\\checkmark$ subjacent white matter hypodense on CT\n$\\checkmark$ slight prolongation of T1 + T2 relaxation times (gliosis)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 55,
            "markdown": "$\\sqrt{ }$ choroid plexus enlargement ipsilateral to angiomatosis\n$\\sqrt{ }$ ipsilateral thickening of skull + orbit $\\leftarrow$ bone apposition as result of subdural hematoma\n$\\leftarrow$ brain atrophy\n$\\sqrt{ }$ elevation of sphenoid wing + petrous ridge\n$\\sqrt{ }$ enlarged ipsilateral paranasal sinuses + mastoid air cells\n$\\sqrt{ }$ thickened calvarium (= widening of diploic space)\nAngio:\n$\\sqrt{ }$ capillary blush\n$\\sqrt{ }$ abnormally large veins in subependymal + periventricular regions\n$\\sqrt{ }$ abnormal deep medullary veins draining into internal cerebral vein (= venous shunt)\n$\\sqrt{ }$ failure to opacify superficial cortical veins in calcified region $\\leftarrow$ markedly slow blood\nflow / thrombosis of dysgenetic superficial veins\n@ ORBITAL MANIFESTATION (30\\%)\nSite: ipsilateral to nevus flammeus\n\n- congenital glaucoma (30\\%)\n$\\sqrt{ }$ choroidal hemangioma ( $71 \\%$ )\n$\\sqrt{ }$ dilatation and tortuosity of conjunctival + episcleral + iris + retinal vessels\n$\\sqrt{ }$ buphthalmos\nCx: retinal detachment\n@ VISCERAL MANIFESTATION\n$\\sqrt{ }$ localized / diffuse angiomatous malformation\nLocation: intestine, kidneys, spleen, ovaries, thyroid, pancreas, lungs\n$D D x$ : Klippel-Trénaunay syndrome, Wyburn-Mason syndrome\n\n\n# SUBARACHNOID HEMORRHAGE \n\n$=$ blood between pia + arachnoid membrane\nCause:\nA. Spontaneous\n(1) Ruptured aneurysm (72\\%)\n(2) AV malformation ( $10 \\%$ )\n(3) Hypertensive hemorrhage\n(4) Hemorrhage from tumor\n(5) Embolic hemorrhagic infarction\n(6) Blood dyscrasia, anticoagulation therapy\n(7) Eclampsia\n(8) Intracranial infection\n(9) Spinal vascular malformation\n(10) Cryptogenic in 6\\% (negative 4-vessel angiography; seldom recurrent)\nB. Trauma (common)\nconcomitant to cerebral contusion\n(1) Injury to leptomeningeal vessels at vertex\n(2) Rupture of major intracerebral vessels (less common)\n\nLocation:\n(a) focal, overlying site of contusion / subdural hematoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 56,
            "markdown": "(b) interhemispheric fissure, paralleling falx cerebri\n(c) spread diffusely throughout subarachnoid space (rare in trauma): convexity sulci $>$ basal cisterns\nPathophysiology: irritation of meninges by blood and extra fluid volume increases intracranial pressure $\\rightarrow$ vasospasm in $2-41 \\%$\n\n- acute severe headache (\"worst in life\"), vomiting\n- altered state of consciousness: drowsiness, sleepiness, stupor, restlessness, agitation, coma\n- spectrophotometric analysis of CSF obtained by lumbar puncture\n\nNECT ( $60-90 \\%$ accuracy of detection depending on time of scan; sensitivity depends on amount of blood; accuracy high within 4-5 days of onset, $90 \\%$ sensitive within $1^{\\text {st }}$ day):\n$\\sqrt{ }$ increased density in basal cisterns, superior cerebellar cistern, sylvian fissure, cortical sulci, intraventricular\n$\\sqrt{ }$ along interhemispheric fissure $=$ on lateral aspect irregular dentate pattern due to extension into paramedian sulci with rapid clearing after several days\n$\\sqrt{ }$ \"cortical vein\" sign = visualization of cortical veins passing through extraaxial fluid collection\nMR (relatively insensitive within first 48 hours):\n$\\sqrt{ }$ hyperintense sulci and cisterns on FLAIR and T2* (more sensitive than CT for small amounts of blood)\n$\\sqrt{ }$ \"dirty\" CSF isointense to brain on T1WI + T2WI\n$\\sqrt{ }$ low signal intensity on brain surfaces in recurrent subarachnoid hemorrhages (hemosiderin deposition)\nPrognosis: clinical course depends on amount of subarachnoid blood\nCx:\n(1) Acute obstructive hydrocephalus (in $<1$ week) $\\leftarrow$ intraventricular hemorrhage / ependymitis obstructing aqueduct of Sylvius or outlet of $4^{\\text {th }}$ ventricle\n(2) Delayed communicating hydrocephalus (after 1 week) $\\leftarrow$ fibroblastic proliferation in subarachnoid space and arachnoid villi interferes with CSF resorption\n(3) Cerebral vasospasm + infarction (develops after 72 hours, at maximum between 5-17 days, amount of blood is a prognostic parameter)\n(4) Transtentorial herniation (cerebral hematoma, hydrocephalus, infarction, brain edema)\n\n# SUBDURAL HEMATOMA OF BRAIN \n\n= accumulation of blood in potential space between pia-arachnoid membrane (leptomeninges) + dura mater (= \"epiarachnoid space\")\nIncidence: in 5\\% of head trauma patients; in $15 \\%$ of closed head injuries; in $65 \\%$ of head injuries with prolonged interruption of consciousness\nAge: accident-prone middle age; also in infants + elderly (large subarachnoid space with freedom to move in brain atrophy)\nCause: severe trauma, hemorrhagic diathesis\nSource of blood:\n(1) pial cortical arteries + veins: direct trauma $=$ penetrating injury\n(2) large contusions: direct / indirect trauma = \"pulped brain\"; occasionally in blood clotting disorder / during anticoagulation therapy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 57,
            "markdown": "(3) torn bridging cortical veins (indirect force) $\\leftarrow$ sudden de-/acceleration; also with forceful coughing / sneezing / vomiting in elderly\nElderly predisposed: longer bridging veins in brain atrophy\n$\\diamond$ NO consistent relationship to skull fractures!\nPathogenesis:\ndifferential movement of brain and adherent cortical veins with respect to skull + attached dural sinuses $\\rightarrow$ tear of \"bridging veins\" (= subdural veins which connect cerebral cortex to dural sinuses + travel through subarachnoid and subdural space)\nLocation: hematoma freely extending across suture lines, limited only by interhemispheric fissure and tentorium\n\n- nonspecific headaches, nonlocalizing signs; low-voltage EEG\n- lethargy, confusion; usually negative lumbar puncture\n\nCT:\n$\\sqrt{ }$ hyperdense $65-90 \\mathrm{HU}(<1$ week $) /$ isodense $20-40 \\mathrm{HU}(1-2$ weeks $) /$ hypodense $0-22 \\mathrm{HU}$ (3-4 weeks)\nFalse-negative CT scan:\nhigh-convexity location, beam-hardening artifact, volume averaging with high density of calvarium obscuring flat \"en plaque\" hematoma, too narrow window setting, isodense hematoma due to delay in imaging 10-20 days post injury / low hemoglobin content of blood / lack of clotting, dilution by CSF from associated arachnoid tear\n$\\diamond 38 \\%$ of small subdural hematomas are missed!\nAids in detection of acute subdural hematoma:\n$\\sqrt{ }$ perceived \"thickening\" of ipsilateral portion of skull (hematoma of similar pixel brightness as bone)\n$\\sqrt{ }$ \"subdural window\" setting = window level of $40 \\mathrm{HU}+$ window width of 400 HU\n$\\sqrt{ }$ effacement of adjacent sulci\n$\\sqrt{ }$ sulci not traceable to brain surface\n$\\sqrt{ }$ ipsilateral ventricular compression / distortion\n$\\sqrt{ }$ displacement of gray-white matter interface away from ipsilateral inner table\n$\\sqrt{ }$ midline shift (often greater than width of subdural hematoma due to underlying brain contusion)\n$\\sqrt{ }$ contrast enhancement of cortex but not of subdural hematoma\nAids in detection of bilateral subdural hematomas:\n$\\sqrt{ }$ \"parentheses\" ventricles\n$\\sqrt{ }$ ventricles too small for patient's age\nUS (neonate):\n$\\sqrt{ }$ linear / elliptical space between cranial vault + brain\n$\\sqrt{ }$ flattened gyri + prominent sulci\n$\\sqrt{ } \\pm$ distortion of ventricles, extension into interhemispheric space\nLimitations:\n(a) convexity hematoma may be obscured by pie-shaped display + loss of near-field resolution\n$\\diamond$ Use contralateral transtemporal approach!\n(b) small loculations may be missed",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 58,
            "markdown": "Prognosis: poor (due to association with other lesions)\n$D D x$ : (1) Arachnoid cyst (extension into sylvian fissure)\n(2) Subarachnoid hemorrhage (extension into sulci)\n\n# Acute Subdural Hematoma \n\nCause: usually follows severe trauma, manifests within hours after injury\nTime frame: $<7$ days old\nAssociated with: underlying brain injury ( $50 \\%$ ) with worse long-term prognosis than epidural hematoma, skull fracture ( $1 \\%$ )\nLocation:\n(a) over cerebral convexity, frequent extension into interhemispheric fissure, along tentorial margins, beneath temporal + occipital lobes; NO crossing of midline\n(b) bilateral in $15-25 \\%$ of adults (common in elderly) and in $80-85 \\%$ of infants\n$\\checkmark$ extraaxial peripheral crescentic / convex fluid collection between skull and cerebral hemisphere usually with:\n$\\checkmark$ concave inner margin $\\leftarrow$ hematoma minimally pressing into brain substance\n$\\checkmark$ convex outer margin $\\leftarrow$ following normal contour of cranial vault\n$\\checkmark$ hyperdense collection of $65-100 \\mathrm{HU}$\n$\\diamond$ Hematoma hypodense if hematocrit $<29 \\%$ !\n$\\checkmark$ \"swirl\" sign = mixture of clotted and unclotted blood\n$\\checkmark$ occasionally with blood-fluid level\n$\\checkmark$ after surgical evacuation $\\rightarrow$ underlying parenchymal injury becomes more obvious\n$\\checkmark$ after healing $\\rightarrow$ ventricular + sulcal enlargement\n$C x$ : Arteriovenous fistula $\\leftarrow$ meningeal artery + vein caught in fracture line\nPrognosis: may progress to subacute + chronic stage / may disappear spontaneously\n$R x$ : evacuation, but with poor response $\\leftarrow$ high uncontrollable intracranial pressure from associated injuries\nMortality: $35-50 \\%$ (higher number due to associated brain injury, mass effect, old age, bilateral lesions, rapid rate of hematoma accumulation, surgical evacuation $>4$ hours)\n\n## Interhemispheric Subdural Hematoma\n\nMost common acute finding in child abuse $\\leftarrow$ whiplash forces on large head + weak neck muscles\n$\\checkmark$ predominance for posterior portion of interhemispheric fissure\n$\\checkmark$ crescentic shape with flat medial border\n$\\checkmark$ unilateral increased attenuation with extension along course of tentorium\n$\\checkmark$ anterior extension to level of genu of corpus callosum\n\n## Subdural Hemorrhage in Newborn\n\nCause: mechanical trauma during delivery (excessive vertical molding of head)\n\n1. Posterior fossa hemorrhage\n(a) tentorial laceration with rupture of vein of Galen / straight sinus / transverse sinus\n(b) occipital osteodiastasis = separation of squamous portion from exoccipital portion of occipital bone",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 59,
            "markdown": "$\\sqrt{ }$ high-density \"thickening\" of affected tentorial leaf extending down posterior to cerebellar hemisphere (better seen on coronal view)\n$\\sqrt{ }$ mildly echogenic subtentorial collection\n$C x$ : death from compression of brainstem $\\rightarrow$ acute hydrocephalus\n2. Supratentorial hemorrhage\n(a) laceration of falx near junction with tentorium $\\leftarrow$ rupture of inferior sagittal sinus (less common than tentorial laceration)\n$\\checkmark$ hematoma over corpus callosum in inferior aspect of interhemispheric fissure\n(b) convexity hematoma $\\leftarrow$ rupture of superficial cortical veins\n$\\checkmark$ usually unilateral subdural convexity hematoma accompanied by subarachnoid blood\n$\\checkmark$ underlying cerebral contusion\n$\\checkmark$ sonographic visualization of convexities difficult\n\n# Subacute Subdural Hematoma \n\nTime frame: 7-22 days\nCT:\n$\\sqrt{ }$ isodense hematoma of $25-45 \\mathrm{HU}$ (during $1^{\\text {st }}-3^{\\text {rd }}$ week), may be recognizable by mass effect:\n$\\checkmark$ effacement of cortical sulci\n$\\checkmark$ deviation of lateral ventricle\n$\\checkmark$ midline shift\n$\\checkmark$ white matter buckling\n$\\checkmark$ displacement of gray-white matter junction\n$\\checkmark$ contrast enhancement of inner membrane\nAid in Dx: contrast enhancement defines cortical-subdural interface\nMR (modality of choice in subacute stage):\n$\\checkmark$ high sensitivity for Met-Hb on T1WI (superior to CT during isodense phase concerning small subdural hematomas + for hematomas oriented in the CT scan plane, eg, tentorial subdural hematoma):\n$\\checkmark$ hyperintense on T1WI\n\n## Chronic Subdural Hematoma\n\nTime frame: $>22$ days old\nCause: mild unremembered head trauma?\nPathogenesis: vessel fragility accounts for repeated episodes of rebleeding (in 10-30\\%) following minor injuries that tear a fragile capillary bed within neomembrane surrounding subdural hematoma\nPredisposing factors:\nalcoholism, increased age, epilepsy, coagulopathy, prior placement of ventricular shunt\n$\\diamond>75 \\%$ occur in patients $>50$ years of age!\nHisto: hematoma enclosed by thick + vascular membrane, which forms after 3-6 weeks\n\n- history of antecedent trauma often absent ( $25-48 \\%$ )\n- ill-defined neurologic signs + symptoms: cognitive deficit, behavioral abnormality,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 60,
            "markdown": "nonspecific headache\n\n- progressive neurologic deficit; low-voltage EEG, normal CSF\n$\\sqrt{ }$ often biconvex lenticular $=$ medially concave configuration, esp. after compartmentalization\n$\\leftarrow$ formation of fibrous septa\n$\\sqrt{ }$ low-density lesion of $0-25 \\mathrm{HU}$ (= intermediate attenuation between CSF + brain):\n$\\sqrt{ }$ different attenuations within different compartments\n$\\sqrt{ }$ sometimes as low as CSF\n$\\sqrt{ }$ high-density components of collection (after common rebleeding)\n$\\sqrt{ }$ fluid-sediment levels (= sedimented fresh blood with proteinaceous fluid layered above)\n$\\sqrt{ }$ displacement / absence of sulci, displacement of ventricles and parenchyma\n$\\sqrt{ }$ No midline shift if bilateral ( $25 \\%$ )\n$\\sqrt{ }$ absent \"cortical vein\" sign = cortical veins seen along periphery of fluid collection without passing through it ( $1-4$ weeks after injury)\n$D D x$ : Acute epidural hematoma (similar biconvex shape)\n\n\n# SUBDURAL HYGROMA \n\n$=$ TRAUMATIC SUBDURALEFFUSION\n$=$ localized CSF-fluid collection within subdural space\nCause: (a) minor trauma results in separation of dura and arachnoid; proliferation of dural border cell layer results in neomembrane with hyperpermeable capillaries + efflux of serous fluid into subdural space\n(b) traumatic tear in arachnoid with secondary ball valve mechanism\n\nAge: most often in elderly + young children\nTime of onset: 6-30 days following trauma\n\n- asymptomatic in majority; headaches, drowsiness\n- decreased level of consciousness, confusion\n$\\sqrt{ }$ radiolucent crescent-shaped collection (as in acute subdural hematoma) of CSF density\n$\\sqrt{ }$ NO evidence of blood products (DDx to subdural hematoma)\nMR:\n$\\sqrt{ }$ isointense to CSF / hyperintense to CSF on T1WI ( $\\leftarrow$ increased protein content)\nPrognosis: often spontaneous resorption; may develop into a chronic subdural hematoma\n$D D x$ : (1) Enlarged subarachnoid space\n(2) Subdural empyema\n(3) Chronic subdural hematoma\n(4) Brain atrophy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 61,
            "markdown": "# SUBEPENDYMAL CYST \n\nEtiology:\n\n1. Acquired posthemorrhagic subependymal cyst:\n> hemorrhage\n> hypoxic-ischemic damage\nSite: caudothalamic notch\n\n- frequently in preterm infant\n$\\sqrt{ }$ tear-shaped, $2-11 \\mathrm{~mm}$ in size\n\n2. Congenital subependymal cyst $\\leftarrow$ germinolysis\n> neurotropic infection: CMV, rubella\n> metabolic disorders (esp. Zellweger syndrome)\n> chromosomal abnormalities\n> maternal cocaine consumption\n> idiopathic in otherwise healthy newborn\nHisto: cystic cavity with pseudocapsule of aggregates of germinal cells + glial tissue; NO epithelium; macrophage-like cells within fluid $\\leftarrow$ vascular origin\n\n## TERATOMA OF CNS\n\nIncidence: $0.5 \\%$ of primary intracranial neoplasms; $2 \\%$ of intracranial tumors before age 15\nHisto: mostly benign; occasionally containing highly malignant primitive elements\nLocation: pineal + parapineal region $>$ floor of $3^{\\text {rd }}$ ventricle $>$ posterior fossa $>$ spine (associated with spina bifida)\n$\\checkmark$ heterogeneous midline lesion, occasionally homogeneous soft-tissue mass (DDx: astrocytoma)\n$\\checkmark$ contains fat + calcium\n$\\checkmark$ hydrocephalus (common)\n\n## Pineal Teratoma\n\n$=$ benign tumor containing one / all three germ cell layers (pineal region most common site of teratomas)\nIncidence: $15 \\%$ of all pineal masses; $2^{\\text {nd }}$ most common tumor in pineal region\nAge: $\\quad<20$ years; $\\mathrm{M}+\\mathrm{F}=2 \\div 1$ to $8 \\div 1$\n\n- Parinaud syndrome; hypothalamic symptoms\n- headache, somnolence (related to hydrocephalus)\n\nHisto: (a) mature teratoma = fully differentiated tissue\n> ectoderm: skin + skin appendages\n> mesoderm: cartilage, bone, fat, smooth muscle, skeletal muscle\n> endoderm: respiratory + enteric epithelium\n(b) immature teratoma = complex mixture of fetal-type tissues from all 3 germ layers + mature tissue elements\n(c) teratoma with malignant transformation of mature tissues\n\nLocation: pineal, parapineal, suprasellar, $3^{\\text {rd }}$ ventricle\n$\\checkmark$ well-defined rounded / irregular lobulated extremely heterogeneous multiloculated mass of fat, cartilage, hair, linear / nodular calcifications + cysts",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 62,
            "markdown": "$\\diamond$ Fat is absent in all other pineal tumors!\n$\\checkmark$ may show heterogeneous / rimlike contrast enhancement (limited to solid-tissue areas)\nAngio:\n$\\checkmark$ elevation of internal cerebral vein\n$\\checkmark$ posterior displacement of precentral vein\nCT:\n$\\checkmark$ heterogeneous mass with fat, calcification, cystic + solid areas\nMR:\n$\\checkmark$ variegated appearance on all pulse sequences:\n$\\checkmark$ hyperintense areas of fat on T1WI with chemical shift artifact\n$\\checkmark$ variable signal intensity on T1WI due to calcifications\n$\\checkmark$ iso- to hypointense soft-tissue component\n$\\checkmark$ enhancement of soft-tissue component\n$C x$ : chemical meningitis with spontaneous rupture\n\n# TOXOPLASMOSIS OF BRAIN \n\nOrganism: obligate intracellular protozoan parasite Toxoplasma gondii, can live in any cell except for nonnucleated RBCs; reservoirs in feces of house cat (felines are definite host)\nInfection: ingestion of undercooked meat (eg, pork, free-range chicken) containing cysts or sporulated oocysts / transplacental transmission of trophozoites; acquired through blood transfusion + organ transplantation\n$\\diamond$ Disease remains dormant for as long as normal host immunity is maintained!\nForms: (1) Cyst (bradyzoite)\n(2) Trophozoite\n(3) Oocyst: uniquely found in intestinal mucosa of cat; outside cat it can survive for $>$ I year in warm moist soil\nHosts: birds, mammals, reptiles, cockroach, flea\nGeographic exposure: France ( $75-90 \\%$ ) > Central America > urban USA (17-35\\%)\n$\\diamond 500$ million persons infected with T. gondii worldwide!\nSeropositivity: up to $20 \\%$ of urban adults in USA; up to $90 \\%$ of European adults\nTransmission:\n(a) fecal-oral: fruits, vegetables, poorly cooked meat; children especially susceptible via house cat / litter box\n(b) hematogenous: blood transfusion\n\nSpread: hematogenous\nHisto: inflammatory solid / cystic granulomas ( $\\leftarrow$ glial mesenchymal reaction) surrounded by edema and microinfarcts ( $\\leftarrow$ vasculitis)\nAffected tissue:\n@ Gray + white matter of brain\n$\\diamond$ Most common cause of focal CNS infection mass effect in patients with AIDS!\n@ Retina: most common retinal infection in AIDS\n@ Alveolar lining cells (4\\%):\nmimics Pneumocystis carinii pneumonia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 63,
            "markdown": "@ Heart (rare):\ncardiac tamponade / biventricular failure\n@ Skeletal muscle\n\n- asymptomatic; lymphadenopathy; malaise, fever\n\nToxoplasmosis is the most common opportunistic infection affecting the CNS in patients with AIDS!\nA. AIDS INFECTION $=$ toxoplasmic encephalitis\n$=$ reactivation of a chronic latent infection in $>95 \\%$\n$\\diamond$ Most common cerebral mass lesion in AIDS!\n$\\diamond 2-3$ times more frequent than lymphoma!\nIncidence: $3-20-40 \\%$ of AIDS patients; $20-70 \\%$ of normal adult population is seropositive for antibodies\nPath: well-localized indolent granulomatous process / diffuse necrotizing encephalitis\n\n- fever, headaches, confusion, seizures (15-25\\%)\n- focal neurologic deficit of subacute onset (50-89\\%)\n- pseudotumor cerebri syndrome\n\nLocation: (a) basal ganglia (75\\%)\n(b) subcortical at gray-white matter junction scattered throughout brain parenchyma\n(c) NO involvement of corpus callosum / leptomeninges\n\nCT:\n$\\sqrt{ }$ multifocal abscesses with a predilection for basal ganglia:\n$\\sqrt{ }$ multiple / solitary (up to $39 \\%$ ) lesions $<2 \\mathrm{~cm}$ with nodular / thin-walled (common) ring enhancement\n$\\sqrt{ }$ surrounding white matter edema\n$\\sqrt{ }$ double-dose delayed CT scans with higher detection rate for multiple lesions (64$72 \\%)$\n$\\sqrt{ } \\pm$ hemorrhage and calcifications after therapy\nMR:\n$\\sqrt{ }$ multiple hypo- to isointense lesions on T2WI\n$\\sqrt{ }$ T1 hyperintense lesion + hypointensity on GRE $\\leftarrow$ hemorrhage\n$\\sqrt{ }$ prominent associated mass effect\n$\\sqrt{ }$ marked edema\n$\\sqrt{ }$ increased diffusivity related to underlying acellular core on DWI (opposite to pyogenic + fungal abscess)\n$\\sqrt{ }$ nodular / ring enhancement\n$\\sqrt{ }$ poorly defined peripheral enhancement $=$ poor host response\n$\\sqrt{ }$ HIGHLY SUGGESTIVE \"eccentric target\" sign ( $30 \\%$ ) = small enhancing nodule along lesion margin\n$\\sqrt{ }$ diffuse cerebral volume loss ( $30 \\%$ )\nMR spectroscopy:\n$\\sqrt{ }$ lipid breakdown products without elevated choline levels\n$D x$ : improvement on antitoxoplasma therapy within 2-3 weeks / biopsy\nDDx: CNS lymphoma (single lesion, hyperattenuation, T2 hypointensity, restricted",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 64,
            "markdown": "diffusion, periventricular location)\n$\\diamond$ Multiple lesions suggest toxoplasmosis!\nB. INTRAUTERINE INFECTION\n$=$ devastating effects on fetal brain because maternal antibodies passed to child will be limited by blood-brain barrier\nTime of fetal infection: chances of transplacental transmission greater in late pregnancy\nScreening: impractical due to high false-positive rate\n\n- Toxoplasma gondii found in ventricular fluid\n- microcephaly, mental retardation, seizures; chorioretinitis\n$\\sqrt{ }$ thickened vault, sutures apposed / overlapping\n$\\sqrt{ }$ hydrocephalus $\\rightarrow$ return to normal / persistent large head\n$\\sqrt{ }$ intracerebral calcifications in posterior aspect of brain\n$\\sqrt{ }$ multiple irregular nodular / cystlike / curvilinear calcifications in periventricular area + thalamus + basal ganglia + choroid plexus (= necrotic foci); bilateral; 1-20 mm in size; increasing in number + size (usually not developed by time of birth)\nOB-US (as early as 20 weeks MA):\n$\\sqrt{ }$ sonographic findings in only $36 \\%$\n$\\sqrt{ }$ evolving symmetric ventriculomegaly\n$\\sqrt{ }$ intracranial periventricular + hepatic densities\n$\\sqrt{ }$ increased thickness of placenta\n$\\sqrt{ }$ ascites\n$\\diamond$ Microcephaly is NOT a feature of toxoplasmosis!\n$D x$ : elevated toxospecific IgM levels in fetal blood\n$D x$ : demonstration of elongated teardrop-shaped trophozoites in histologic sections of tissue\n$R x$ : empiric therapy (pyrimethamine + sulfadiazine for 3 weeks)\n\n\n# TUBERCULOSIS OF CNS \n\n$=$ slowly dividing facultative intracellular pathogen\nPrevalence: $5 \\%$ ( $15 \\%$ with immunodeficiency)\nWorldwide: 1.7 million deaths per year; latent infection in 2 billion persons $\\rightarrow 10 \\%$ lifetime risk for active symptomatic tuberculosis\nTransmission: through respiratory droplets $\\rightarrow$ active infection usually begins as Ghon focus\n\n## Cranial Tuberculous Meningitis\n\n$\\diamond$ Most common cause of chronic meningitis!\nPathophysiology:\nrupture of initial subependymal / subpial tubercle (Rich focus) into subarachnoid space (after earlier hematogenous dissemination) into CSF $\\rightarrow$ thick gelatinous inflammatory exudate settles at base of brain along cisterns + sylvian fissure + along traversing blood vessels\nPredisposed: in AIDS patients + infants + small children (part of generalized miliary tuberculosis / primary tuberculous infection)\nLocation: basal cisterns (around M1 segment of MCA and sylvian fissure) $>$ sulci $>$ cerebral convexities, interhemispheric fissure\n$\\sqrt{ }$ characteristic thick / nodular enhancement in basal cisterns",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 65,
            "markdown": "$D D x$ : (1) other granulomatous disease: fungus, sarcoid\n(2) neoplastic disease: carcinoma, lymphoma\n\nCT:\n$\\sqrt{ }$ iso- / hyperattenuating meninges relative to basal cisterns\n$\\sqrt{ }$ often homogeneous contrast enhancement of meninges\nMR:\n$\\sqrt{ }$ normal at unenhanced SE (in early stage)\n$\\sqrt{ }$ distention of affected subarachnoid spaces with mild shortening of T1 + T2 relaxation times compared with CSF\nCEMR:\n$\\sqrt{ }$ abnormal meningeal enhancement on gadolinium-enhanced T1WI (corresponds to gelatinous exudate)\n$\\sqrt{ }$ abnormal enhancement of choroid plexus + ependymal lining (rare)\n$C x$ : (1) Communicating hydrocephalus (most common) $\\leftarrow$ blockage of basal cisterns by inflammatory exudate\n(2) Obstructive hydrocephalus (rare) $\\leftarrow$ mass effect of tuberculoma causing obstruction of CSF flow\n(3) Ischemic infarction ( $20-41 \\%$ ) in basal ganglia and internal capsule $\\leftarrow$ vasospasm of penetrating vessels / vascular compression / occlusive panarteritis (mostly in MCA distribution)\n(4) Cranial neuropathy (17-70\\%): CN2, CN3, CN4, CN7 $\\leftarrow$ extension of cisternal inflammation along traversing cranial nerves\n(5) Pachymeningitis (rare) $\\leftarrow$ seeding to bone / dura\n\nDDx: infection (nontuberculous bacteria, virus, fungus, parasite), inflammatory disease (rheumatoid disease, sarcoidosis), neoplasia (meningiomatosis, CSF-seeding neoplasm)\n\n# Parenchymal Tuberculosis \n\n## Tuberculoma of Brain 70\\%\n\n$=$ tuberculous granuloma formation within cerebrum as most common parenchymal form of tuberculosis\nIncidence: $0.15 \\%$ of intracranial masses in Western countries; $30 \\%$ in underdeveloped countries\nAge: infant, small child, young adult\nAssociated with: tuberculous meningitis in $50 \\%$\n\n- history of previous extracranial TB (in 60\\%)\n\nLocation: more common in posterior fossa (62\\%), cerebellar hemispheres (frontal + parietal lobes)\n$\\sqrt{ }$ solitary lesion; may be multiloculated\nProgression: noncaseating $\\rightarrow$ caseating $\\rightarrow$ solid $\\rightarrow$ liquid center\nNECT:\n$\\sqrt{ }$ hypo- / iso- (72\\%) / hyperdense round / lobulated lesion of $0.5-4 \\mathrm{~cm}$ in diameter with mass effect $(93 \\%)$\n$\\sqrt{ }$ moderate surrounding edema ( $72 \\%$ ) less marked than in pyogenic abscess",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 66,
            "markdown": "$\\sqrt{ }$ central calcification $(29 \\%)$\nCECT:\n$\\sqrt{ }$ homogeneously enhancing parenchymal tuberculoma\n$\\sqrt{ }$ homogeneous blush in tuberculoma en plaque along dural plane (6\\%) (DDx: meningioma en plaque)\n$\\sqrt{ }$ ring blush (nearly all) with smooth / slightly shaggy margins + thick irregular wall around an isodense center (DDx: pyogenic abscess less thick + more regular)\n$\\sqrt{ }$ \"target\" sign $(1 / 2)=$ central calcification in isodense lesion with ring-blush HIGHLY SUGGESTIVE (DDx: giant aneurysm)\nMR:\n$\\sqrt{ }$ single / multiple well-defined T2 hypointensities\n$\\sqrt{ }$ solid / ringlike enhancement\n$\\sqrt{ }$ varying central T2 hyperintensity depending on extent of liquefaction / caseation\n$\\sqrt{ }$ \"target\" sign = small focal area of calcification / enhancement in center of ringenhancing mass\nMR spectroscopy:\n$\\sqrt{ }$ lipid level peaks at $0.9 \\mathrm{ppm}, 1.3 \\mathrm{ppm}, 2.0 \\mathrm{ppm}, 2.8 \\mathrm{ppm}$\n$\\sqrt{ }$ NO amino acid resonance at 0.9 ppm\n$D D x$ : other CNS infection (esp. toxoplasmosis, cysticercosis, fungus), lymphoma, atypical meningioma, radiation necrosis\n\n# Tuberculous Abscess of Brain (rare) \n\nHisto: numerous tubercle bacilli in the absence of tubercular granulomatous formation\n\n- early rapid clinical deterioration favors abscess\n$\\sqrt{ }$ hypointense lesion core on T1WI\n$\\sqrt{ }$ hyperintense lesion core on T2WI\n$\\sqrt{ }$ peripheral hypointense rim (= capsule)\n\n\n## Miliary Tuberculosis of CNS 30-60\\%\n\nUsually associated with: tuberculous meningitis\n$\\sqrt{ }$ multiple tiny $<2 \\mathrm{~mm}$ T2-hyperintense foci with homogeneous enhancement\n\n## Spinal Tuberculous Meningitis\n\nMR:\n$\\sqrt{ }$ cerebrospinal fluid loculations with cord compression\n$\\sqrt{ }$ obliteration of spinal subarachnoid space:\n$\\sqrt{ }$ loss of outline of spinal cord in cervicothoracic spine\n$\\sqrt{ }$ matting of nerve roots in lumbar region\n$\\sqrt{ }$ nodular thick linear intradural enhancement of meninges\n$C x$ : syringomyelia, syringobulbia\n\n## Tuberculous Vasculitis\n\n= infectious vasculitis of small and medium-sized cerebral aa. in subarachnoid space\nLocation: lenticulostriate arteries, posterior cerebral branches, thalamoperforating arteries\n$C x$ : small infarctions in basal ganglia and deep white matter (in up to $41 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 67,
            "markdown": "# TUBEROUS SCLEROSIS \n\n$=$ TSC $=$ BOURNEVILLE EPIPLOIA\n[Désiré-Magloire Bourneville (1840-1909), French neurologist at Salpêtrière, Bicêtre, Hôpital Saint-Louis, Pitié]\n= autosomal-dominant neuroectodermal disorder characterized by multifocal systemic hamartomas + malformations that may affect CNS, eye, kidney, lung, liver, skin, heart with a spectrum of phenotypic expressions\nCLASSIC TRIAD (of Vogt, 1908) in only 29\\% of patients:\n(1) Facial angiofibromas\n(2) Epileptic seizures\n(3) Mental retardation\nmnemonic: zits, fits, nitwits\nPrevalence: $1 \\div 6,000$ to $1 \\div 150,000$ live births\n\n- family history of TSC in $25-50 \\%$\n\nCause: autosomal-dominant germ line mutation inhibiting cell proliferation with low penetrance (frequent skips in generations); sporadic mutations in 50-60-80\\%\nGenetics: gene mutations of\n(a) TSC1 on chromosome $9 q 34 \\rightarrow$ protein hamartin\n(b) TSC2 on chromosome $16 \\mathrm{p} 13 \\rightarrow$ protein tuberin\n\nDx: A. Major features\n(1) Cortical / subcortical tubers\n(2) Subependymal giant cell astrocytoma\n(3) Cardiac rhabdomyoma\n(4) Facial angiofibroma\n(5) Retinal hamartoma\n(6) Renal angiomyolipoma\n(7) Shagreen patches\n(8) Ash-leaf spots\n(9) Lymphangioleiomyomatosis\nB. Minor features\n(1) Gingival fibroma\n(2) Dental pits\n(3) Hamartomatous rectal polyps\n(4) Renal cysts\n(5) Cerebral white matter migration lines\n(6) Confetti skin lesions\n(7) Bone cysts\n\nA diagnosis is definite with 2 major / 1 major +2 minor features!\nPrognosis: $30 \\%$ dead by age 5; $75 \\%$ dead by age 20\nRx: antiepileptic medication; ketogenic diet\n@ CNS INVOLVEMENT ( $>95 \\%$ )\n\n- intractable myoclonic seizures ( $75-80 \\%$ ): often first and most common sign of tuberous sclerosis with onset at $1^{\\text {st }}-2^{\\text {nd }}$ year, decreasing in frequency with age\n- mental retardation (50-82\\%): moderate to severe cognitive deficits ( $2 / 3$ ), mild to",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 68,
            "markdown": "moderate ( $1 / 4$ ); progressive; observed in adulthood; common if onset of seizures before age 5 years\n\n- autism, behavioral + sleep + psychiatric disorders\n\n1. Subependymal hamartomas\n\nLocation: along ventricular surface of caudate nucleus, on lamina of sulcus thalamostriatus immediately posterior to foramen of Monro (most often), along frontal + temporal horns or $3^{\\mathrm{rd}}+4^{\\mathrm{th}}$ ventricle (less commonly)\n$\\sqrt{ }$ multiple subependymal nodules of $1-12 \\mathrm{~mm}$ :\n$\\sqrt{ }$ \"candle drippings\" appearance\n$\\sqrt{ }$ periventricular calcification with increasing age (in up to $88 \\%$ )\nMR:\n$\\sqrt{ }$ subependymal nodules protruding into adjacent ventricle isointense with white matter\n$\\sqrt{ }$ iso- to hyperintense on T1WI + hyper- and hypointense on T2WI relative to gray and white matter\n$\\sqrt{ }$ minimal contrast enhancement (in up to $56 \\%$ )\n2. Giant cell astrocytoma (in $15-20 \\%$ )\n= SUBEPENDYMAL GIANT CELL TUMOR (SGCT)\nIncidence: $5-15 \\% ; \\mathrm{M}+\\mathrm{F}=1 \\div 1$\nMean age: 11 years (range, birth to $5^{\\text {th }}$ decade); typically $<20$ years\nOrigin: ? subependymal nodule\nHisto: low-grade astrocytoma (WHO grade I lesion) with large cells resembling astrocytes / ganglion cells with abundant cytoplasm\nImmunohisto: markers for both glial + neuronal proteins\nLocation: in the region of foramen of Monro; uncommonly in other locations\n$\\sqrt{ }$ well-circumscribed solid intraventricular neoplasm\n$\\sqrt{ }$ typically $>13 \\mathrm{~mm}$ in diameter with interval growth\n$\\sqrt{ } \\pm$ variable degrees of calcification $\\pm$ cystic changes\n$\\sqrt{ }$ uniform avid enhancement\n$\\sqrt{ }$ frequent extension into frontal horn / body of lateral ventricle\n$\\sqrt{ }$ occasionally hemorrhagic\nCT:\n$\\sqrt{ }$ hypo- / isodense well-demarcated round mass\nMR:\n$\\sqrt{ }$ hypo- to isointense to gray matter on T1WI\n$\\sqrt{ }$ iso- to hyperintense to gray matter on T2WI\nPrognosis: tendency to enlarge + growth into ventricles $\\rightarrow$ obstruction at foramen of Monro $\\rightarrow$ progressive obstructive hydrocephalus\nCx: degeneration into higher grade astrocytoma\nSurveillance: imaging every 2 (3) years with TSC2 (TSC1) mutation; once identified follow-up imaging at yearly intervals\n\nSubependymal GCT is considered PATHOGNOMONIC for TS (rare without manifestations of TS, then likely representing somatic mosaicism of the TS gene)\n3. Cortical / subcortical tubers (in 56\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 69,
            "markdown": "$=$ CORTICAL / SUBCORTICAL HAMARTOMAS\nHisto: clusters of atypical glial cells surrounded by giant cells with frequent calcifications (if $>2$ years of age)\nFrequency: multiple ( $75 \\%$ ); bilateral ( $30 \\%$ )\n$\\sqrt{ }$ large misshapen broadened gyri with central hypodense regions $\\leftarrow$ abnormal myelination\n$\\sqrt{ }$ masslike / curvilinear calcification of cortical tubers (in $15 \\%<1$ year of age, in $50 \\%$ by age 10)\nMR:\n$\\sqrt{ }$ relaxation time similar to white matter (if uncalcified)\n$\\sqrt{ }$ multiple nodules hyperintense on T2WI / FLAIR + iso- to hypointense on T1WI $\\leftarrow$ fibrillary gliosis / demyelination\n$\\sqrt{ }$ enhancement extremely rare\n4. Heterotopic gray matter islands in white matter\n\nHisto: grouping of bizarre and gigantic neuronal cells associated with gliosis + areas of demyelination\nFrequency: in up to $93 \\%$\nLocation: along lines of neuronal migration\n$\\sqrt{ }$ straight / curvilinear bands extending radially from ventricular wall\n$\\sqrt{ }$ wedge-shaped lesion with apex at ventricular wall\n$\\sqrt{ }$ conglomerate masses\n$\\sqrt{ }$ calcification of all / part of nodule\n$\\sqrt{ }$ may show contrast enhancement\nCT:\n$\\sqrt{ }$ hypodense well-defined regions within cerebral white matter\nMR:\n$\\sqrt{ }$ iso- to hypointense region on T1WI + well-defined hyperintense area on T2WI relative to normal white matter\nDDx of CNS lesions:\n(1) Intrauterine CMV / Toxoplasma infection (smaller lesions, brain atrophy, microcephaly)\n(2) Basal ganglia calcification in hypoparathyroidism / Fahr disease (different location)\n(3) Sturge-Weber, calcified AVM (diffuse atrophy, not focal)\n(4) Heterotopic gray matter (along medial ventricular wall, isodense, associated with agenesis of corpus callosum, Chiari malformation)\n(5) Focal cortical dysplasia\n(6) Subependymal heterotopia\n@ SKIN INVOLVEMENT ( $90 \\%$ )\n\n- Facial angiofibroma (former misnomer: adenoma sebaceum) in 80-90\\%\n\nPath: small hamartomas from neural elements with blood vessel hyperplasia $=$ angiofibromas\nAge: first discovered at age $1-5$ years; family history in $30 \\%$\n\n- wartlike nodules of red-brown / red color averaging 4 mm in size with tendency to enlarge + increase in number over time\nLocation: CHARACTERISTIC bimalar distribution (\"butterfly rash\"); initially",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 70,
            "markdown": "nasolabial folds, eventually covering nose + middle of cheeks\n\n- Ungual fibroma $=$ Koenen tumor $(15-50 \\%)$\n\nAge: develop in adolescent / adult\nLocation: sub- / periungual region of toes\n$\\sqrt{ }$ erosion of distal tuft\n\n- Shagreen rough skin patches $(80 \\%)$\n$=$ \"pigskin\" = \"peau d'orange\"\nHisto: connective tissue nevus (collagenoma) = patches of fibrous hyperplasia\n- irregularly shaped skin-colored / brown soft plaque\n\nAge: early childhood\nLocation: posterior trunk / buttocks + intertriginous\n\n- Ash leaf patches = hypomelanotic / hypopigmented macules shaped like ash / spearmint leaf\n- may be visible only under ultraviolet light\n\nAge: typically present at birth, persist throughout life\nLocation: trunk, lower extremity\n\n- \"Thumbprint\" / \"confetti\" macules\n- Café-au-lait spots\n\nIncidence: similar to that in general population\n$D D x$ : neurofibromatosis type 1, fibrous dysplasia\n\n- Fibrous forehead plaques\n@ OCULAR INVOLVEMENT (50\\%)\n- Phakoma $(>5 \\%)=$ whitish disk-shaped retinal hamartoma\n$=$ astrocytic proliferation in / near optic disc, plaques often multiple + usually in both eyes\n$\\sqrt{ }$ small calcifications in region of optic nerve head\n$\\sqrt{ }$ optic nerve glioma\n@ RENAL INVOLVEMENT ( $70-90 \\%)$\n- usually asymptomatic; flank pain, hematuria, hypertension\n- renal failure in severe cases $(5 \\%) \\leftarrow$ mass effect of cysts and angiomyolipomas\n$\\diamond 75 \\%$ of patients die from complications of renal failure by age 20\n\n1. Angiomyolipoma ( $55-89 \\%$ ): usually multiple\n\nCx: spontaneous retroperitoneal hemorrhage (subcapsular / perinephric) $\\rightarrow$ shock\n2. Multiple cysts of varying size in cortex + medulla mimicking adult polycystic kidney disease $(15 \\%)$\nPath: cysts lined by columnar epithelium with foci of hyperplasia projecting into cyst lumen\n$\\checkmark$ polycystic involvement in infants\n3. Renal cell carcinoma / Malignant epithelioid form of angiomyolipoma (1-3\\%), bilateral in $40 \\%$;\nAverage age: 28 years ( $=25$ years younger than for RCC in general population)\n$\\checkmark$ rapid growth + presence of calcifications\nRecommendation:\nUS evaluation every $2-3$ years before puberty + yearly thereafter to identify growing lesions",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 71,
            "markdown": "@ LUNG INVOLVEMENT (1-4\\%)\nAge: $3^{\\text {rd }}-5^{\\text {th }}$ decade; in women\n\n- progressive respiratory insufficiency\n$\\sqrt{ }$ interstitial fibrosis in lower lung fields + miliary nodular pattern may progress to honeycomb lung (lymphangioleiomyomatosis $=$ smooth muscle proliferation around blood vessels)\n$\\sqrt{ }$ multiple bilateral small cysts in lung parenchyma on CT (26-39\\%)\n$\\sqrt{ }$ repeated episodes of spontaneous pneumothorax ( $50 \\%$ )\n$\\sqrt{ }$ chylothorax\n$\\sqrt{ }$ cor pulmonale\n@ HEART INVOLVEMENT in children\nPrevalence: decreases with increasing age $\\leftarrow$ spontaneous tumor regression + better survival of patients without cardiac tumor\n- congenital cardiomyopathy; typically clinically silent\n$\\sqrt{ }$ circumscribed / diffuse subendocardial rhabdomyoma (in 5-30\\%) of ventricle (70\\%) / atrium $(30 \\%)$\n$\\sqrt{ }$ aortic aneurysm\n@ BONE INVOLVEMENT\n$\\sqrt{ }$ bone cysts with undulating periosteal reaction in distal phalanges (most common), metacarpals, metatarsals of hand (DDx: sarcoidosis, neurofibromatosis)\n$\\sqrt{ }$ \"bone islands\":\n$\\sqrt{ }$ dense sclerotic calvarial patches ( $45 \\%$ )\nLocation: frontal and parietal diploe + internal table; pelvic brim, vertebral neural arch, long bones\n$\\sqrt{ }$ bone thickening:\n$\\sqrt{ }$ thickening of diploe $\\leftarrow$ long-term phenytoin therapy\n$\\sqrt{ }$ expansion + sclerosis of rib (may be isolated)\n$\\sqrt{ }$ periosteal thickening of long bones\n$\\sqrt{ }$ dysplasia of sphenoid body (DDx: NF1 with dysplasia of sphenoid wing)\n@ OTHER VISCERAL INVOLVEMENT\n\n1. Adenomas + lipomyomas of liver\n2. Adenomas of pancreas\n3. Tumors of spleen\n@ VASCULAR INVOLVEMENT (rare)\n$\\sqrt{ }$ thoracic + abdominal arterial aneurysms\nPath: vascular dysplasia with intimal + medial abnormalities of large muscular + musculoelastic arteries\nPrognosis: $75 \\%$ mortality by 20 years\n\n# UNILATERAL MEGALENCEPHALY \n\n$=$ hamartomatous overgrowth of all / part of a cerebral hemisphere with neuronal migration defects\n\n- intractable seizure disorder at early age, hemiplegia\n- developmental delay",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 72,
            "markdown": "$\\sqrt{ }$ moderate / marked enlargement of one hemisphere\n$\\sqrt{ }$ ipsilateral ventriculomegaly proportionate to enlargement of affected hemisphere\n$\\sqrt{ }$ straightened frontal horn of ipsilateral ventricle pointing anterolaterally\n$\\sqrt{ }$ neuronal migration defects:\n$\\sqrt{ }$ polymicrogyria\n$\\sqrt{ }$ pachygyria\n$\\sqrt{ }$ heterotopia of gray matter\n$\\sqrt{ }$ white matter gliosis (low density in white matter on CT, prolonged T1 + T2 relaxation times on MR)\n$R x:$ partial / complete hemispheric resection\n\n# VEIN OF GALEN MALFORMATION / ANEURYSM \n\n$=$ central embryonic AVM of quadrigeminal plate cistern directly drains into a secondarily enlarged ectatic vein of Galen (aneurysm is a misnomer)\nPrevalence: $<1 \\%$ of all vascular brain malformations\nCause: arteriovenous fistula between primitive choroidal vessels and embryonic median\nprosencephalic vein of Markowski; fistula prevents involution of this embryonic vein + leads to development of the vein of Galen\nAnatomical types:\nType $=$ AV fistula fed by enlarged arterial branches $\\rightarrow$ dilatation of vein of Galen + straight\n1 sinus + torcular herophili\nType $=$ angiomatous malformation involving basal ganglia + thalami $\\pm$ midbrain draining\n2 into vein of Galen\nType $=$ transitional AVM with both features\n3\nFeeding vessels:\n(a) posterior cerebral artery, posterior choroidal artery ( $90 \\%$ )\n(b) anterior cerebral artery + anterior choroidal artery\n(c) middle cerebral artery + lenticulostriate + thalamic perforating arteries (least common)\n\nAge at presentation: detectable in utero $>30$ weeks GA; $\\mathrm{M} \\pm \\mathrm{F}=2 \\pm 1$\n(a) neonatal pattern ( $0-1$ month)\n\n- high-output cardiac failure ( $36 \\%$ ) $\\leftarrow$ massive shunting\n- cranial bruit\n(b) infantile pattern ( $1-12$ months)\n- macrocrania from obstructive hydrocephalus; seizures\n(c) adult pattern ( $>1$ year)\n- headaches $\\pm$ intracranial hemorrhage $\\pm$ hydrocephalus\n- focal neurologic deficits ( $5 \\%$ ) $\\leftarrow$ steal of blood from surrounding structures\n$\\diamond$ Rarely diagnosed $>3$ years of age\nAssociated with: anomalous dural sinuses + sinus stenosis\nMay be associated with: porencephaly, nonimmune hydrops\nLocation: midline posterior to $3^{\\text {rd }}$ ventricle\nTypes:\n(1) Choroidal type",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 73,
            "markdown": "$\\checkmark$ multiple prominent choroidal + pericallosal and thalamostriate feeder arteries\n$\\checkmark$ drainage into anterior aspect of intensely enhancing aneurysmal median prosencephalic vein of Markowski\n(2) Mural type\n$\\checkmark$ few prominent posterior choroidal / collicular feeder arteries\n$\\checkmark$ arteries fistulize with lateral walls of an intensely enhancing median prosencephalic vein of Markowski\n$\\rightarrow$ both types drain via persistent falcine sinus into superior sagittal sinus\n$\\checkmark$ prominent serpiginous network of feeding arteries in basal ganglia, thalami, midbrain + nidus\n+ draining veins\nNECT:\n$\\checkmark$ round well-circumscribed homogeneous slightly hyperdense mass posterior to indented $3^{\\text {rd }}$ ventricular outlet\n$\\checkmark$ hyperdense intracerebral hematoma $\\leftarrow$ ruptured AVM\n$\\checkmark$ focal hypodense zones $\\leftarrow$ ischemic changes\n$\\checkmark$ rim calcification $(14 \\%)$\nCECT:\n$\\checkmark$ marked homogeneous enhancement of serpentine structures + vein of Galen + dilated straight + transverse sinus + torcular herophili\nUS / OB-US:\n$\\checkmark$ anechoic tubular midline structure superior to cerebellum\n$\\checkmark$ cardiac enlargement $\\leftarrow$ high-output heart failure\n$\\checkmark$ dilated veins of head + neck\n$\\checkmark$ hydrocephalus with dilatation of lateral $+3^{\\text {rd }}$ ventricle (in $37 \\%$ ) $\\leftarrow$ aqueductal obstruction / posthemorrhagic impairment of CSF absorption\n$\\checkmark$ brain infarction / leukomalacia $\\leftarrow$ steal phenomenon with hypoperfusion\nDoppler US:\n$\\checkmark$ median tubular cystic space with high-velocity turbulent flow\n$\\checkmark$ variable thrombus + feeding vessels\n$\\checkmark$ tortuous network of dilated arteries\nMR:\n$\\checkmark$ areas of signal void\nAngio:\nnecessary to define vascular anatomy for surgical / endovascular intervention\n$C x$ : subarachnoid hemorrhage\n$R x$ : ligation, excision, embolization of vessels from transtorcular / transarterial approach\nPrognosis: $56 \\%$ (91\\%) overall (neonatal) mortality: death from cardiac + multisystem failure if untreated\n$D D x$ : (1) Aneurysmal dilatation of vein of Galen (= thalamic arteriovenous malformation of brain with deep venous drainage into secondarily dilated vein of Galen)\n(2) Dural AV fistula\n(3) Giant developmental venous anomaly\n(4) Pineal tumor\n(5) Arachnoid / colloid / porencephalic cyst",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 74,
            "markdown": "# VENTRICULITIS \n\n$=$ EPENDYMITIS $=$ PYOCEPHALUS\n$=$ inflammation of ependymal lining of one / more ventricles\nCause: (1) rupture of periventricular abscess (thinner capsule wall medially)\n(2) retrograde spread of infection from basal cisterns\n\nCECT (necessary for diagnosis):\n$\\checkmark$ thin uniform enhancement of involved ependymal lining\n$\\checkmark$ often associated with intraventricular inflammatory exudate + septations\nMR:\n$\\checkmark$ intraventricular pus shows restricted diffusion on DWI\n$D D x$ : intraventricular blood (history!)\n$C x$ : obstructive hydrocephalus $\\leftarrow$ occlusion at foramen of Monro / aqueduct\n$D D x$ : ependymal metastases, lymphoma, infiltrating glioma\n\n## Ependymitis Granularis\n\n$=$ symmetric focal areas of hyperintensity on T2WI in normal individuals\nHisto: patchy loss of ependyma with paucity of hydrophobic myelin (astrocytic gliosis), which allows migration of fluid out of the ventricle into interstitium\nLocation: anterior + lateral to frontal horns\n$\\checkmark$ punctate / up to 1 cm in diameter\n$\\checkmark$ grossly triangular in shape\n\n## Pyogenic Ventriculitis\n\n$=$ frequent complication of meningitis in infants (uncommon in adults)\nRisk factors: craniotomy, diabetes (predisposes to staphylococcus and enterobacter infections)\n$\\checkmark$ intraventricular debris $\\pm$ restricted diffusion\n$\\checkmark$ periventricular edema $\\pm$ enhancement\n$\\checkmark$ ventricular dilatation\n\n## VENTRICULOPERITONEAL SHUNT MALFUNCTION\n\n$\\diamond$ The peritoneum is an efficient site of fluid absorption\nComponents: ventriculostomy catheter, pressure-sensitive valve + reservoir, barium-integrated silicone peritoneal catheter\n\n- symptoms of increased intracranial pressure: seizures, headache, nausea, vomiting, lethargy, irritability\n- persistent bulging of anterior fontanel\n- excessive rate of head growth\n- slowed refill of shunt reservoir; abdominal pain, fever\n\n\n## Mechanical Shunt Failure\n\nCause: occlusion of catheter by choroid plexus / glial tissue, discontinuity of tubes\n$\\checkmark$ sutural diastasis + increased size of cranial cavity\n$\\checkmark$ increasing ventricular size:\n$\\checkmark$ interval increase since last exam",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 75,
            "markdown": "$\\sqrt{ }$ enlargement of temporal horns (earliest finding)\n$\\sqrt{ }$ preferential enlargement of temporal horns in infants\nN.B.: (1) no enlargement with scarring of ventricular walls\n(2) marked ventricular dilatation does not necessarily indicate shunt malfunction\n$\\sqrt{ }$ shuntogram (by scintigram / contrast radiography) determines site of obstruction\n$\\sqrt{ }$ brain edema tracking along shunt + within interstices of centrum semiovale (with partial obstruction)\n$\\sqrt{ }$ formation of white matter cyst surrounding ventricular catheter\n\n# Obstruction of VP Shunt \n\nLocation: ventricular end $>$ peritoneal end\nCause: plugging of the catheter by brain parenchyma / choroid plexus / proteinaceous material / tumor cells; adhesions within peritoneum\nNUC: ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-albumin colloid injected into shunt tubing proximal to reservoir:\n$\\sqrt{ }$ no uptake within ventricles + normal peritoneal activity (= proximal obstruction)\nContrast study (injection of nonionic contrast material into shunt reservoir):\n$\\sqrt{ }$ collection of contrast material at peritoneal end of shunt without spillage (= distal obstruction)\n\n## Disconnection \\& Breaks of VP Shunt\n\nLocation: connection of tubing to reservoir, at Y-connectors, areas of great mobility (neck)\n$D D x:$ pseudo-disconnection $\\leftarrow$ radiolucent tube components\n\n## Migration of VP Shunt\n\nA. Proximal catheter: into soft tissues of neck / unusual locations within CNS\nB. Distal catheter: peritoneal cavity, thorax, abdominal wall, scrotum, perforation into GI tract\n\n## Leakage of VP Shunt\n\n$=$ CSF escape without complete break / disconnection\n\n- palpable cystic mass\n$\\sqrt{ }$ contrast verifies leak site\n\n\n## CSF Pseudocyst of VP Shunt\n\n$\\sqrt{ }$ shunt tubing coiled in an abdominal soft-tissue mass\nUS / CT:\n$\\sqrt{ }$ cyst surrounding catheter tip\n$C x$ : bowel obstruction\n\n## Infection of VP Shunt\n\nIncidence: $1-5-38 \\%$\nTime of onset: within 2 months of shunt placement\n\n- intermittent low-grade fever\n- anemia, dehydration, hepatosplenomegaly\n- stiff neck; swelling + redness over shunting tract; peritonitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 76,
            "markdown": "$\\sqrt{ }$ ventriculitis (= enlarged ventricles with irregular enhancing ventricular wall $\\pm$ septations)\n$\\sqrt{ }$ meningitis (= enhancement of cerebral cortical sulci)\n\n# Abdominal Complications of VP Shunt \n\n1. Ascites\n2. Pseudocyst formation\n3. Perforation of viscus / abdominal wall\n4. Intestinal obstruction\n5. Metastases to peritoneum: germinoma, medulloblastoma, astrocytoma, glioblastoma\n\n## Subdural Hematoma / Hygroma of VP Shunt\n\nCause: precipitous drainage of markedly enlarged ventricles\nAge: usually seen in children $>3$ years of age with relatively fixed head size\nPrognosis: small hematomas resolve on their own\n\n## Granulomatous Lesion of VP Shunt\n\n$=$ rare granulomatous reaction adjacent to shunt tube within / near ventricle\n$\\sqrt{ }$ irregular contrast-enhancing mass along course of shunt tube\n\n## Slit Ventricle Syndrome (0.9-3.3\\%)\n\n$=$ proximal shunt failure from ventricular collapse\nCause: overdrainage of CSF, intermittent shunt obstruction, decreased intracranial compliance, periventricular fibrosis, intracranial hypotension\nIncidence: $0.9-3.3 \\%$\n\n- intermittent / chronic headaches, vomiting, malaise\n- slowed refill of shunt reservoir\n$\\sqrt{ }$ small / slitlike ventricles\n\n\n## VISCERAL LARVA MIGRANS OF BRAIN\n\nOrganism: roundworm nematode (Toxocara canis)\n$\\sqrt{ }$ small calcific nodules, especially in basal ganglia + periventricular location\n$D D x$ : tuberous sclerosis\n\n## VON HIPPEL-LINDAU DISEASE\n\n$=\\mathrm{vHL}=$ RETINOCEREBELLAR ANGIOMATOSIS\n[Eugen von Hippel (1867-1939)], professor of ophthalmology in Heidelberg, Halle and Göttingen, Germany\nArvid Vilhelm Lindau (1892-1958), chair of general pathology, bacteriology and general health science in Lund, Sweden\n$=$ autosomal dominant inherited neurocutaneous dysplasia complex grouped under hereditary phakomatosis (although the skin is not affected)\nPrevalence: $1 \\div 31,000-1 \\div 53,000$ births\nGenetics: mutation of VHL tumor suppressor gene located on chromosome 3p25-p26 with 80$100 \\%$ high penetrance + variable delayed expressivity (ie, different subset of 40 types of lesions in 14 different organs); in $20 \\%$ familial",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 77,
            "markdown": "Effect: propensity to develop multiple clear cell neoplasms like retinal and CNS hemangioblastoma, clear cell renal cell carcinoma, pheochromocytoma, pancreatic serous cystadenoma, pancreatic endocrine tumor (PET)\nAge at onset: $2^{\\text {nd }}-3^{\\text {rd }}$ decade; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\nDiagnostic criteria:\n$\\diamond$ Hemangioblastoma $=$ almost always disease-defining tumor\n(a) $>1$ hemangioblastoma of CNS\n(b) 1 hemangioblastoma + visceral manifestation\n(c) 1 manifestation + known family history\n\nSubclassification (NIH):\nType I = renal + pancreatic cysts, high risk for renal cell carcinoma, NO pheochromocytoma\nType $\\quad=$ pheochromocytoma, pancreatic islet cell tumor (typically without cysts)\nIIA\nType $\\quad=$ pheochromocytoma + renal + pancreatic disease\nIIB\n@ CNS MANIFESTATION\nAge at presentation: 25-35 years\n\n- signs of increased intracranial pressure: headache, vomiting\n- vision changes: reactive retinal inflammation with exudate + hemorrhage, retinal detachment, glaucoma, cataract, uveitis, decreasing visual acuity, eye pain\n- cerebellar symptoms: vertigo, dysdiadochokinesia, dysmetria, Romberg sign\n- spinal cord symptoms (uncommon): loss of sensation, impaired proprioception\n\n1. Retinal angiomatosis $=$ von Hippel tumor ( $>50 \\%$ ) earliest manifestation of disease; multiple in up to $66 \\%$, bilateral in up to $50 \\%$\nHisto: hemangioblastoma of retina\n$D x$ : indirect ophthalmoscopy + fluorescein angiography\n$\\sqrt{ }$ small tumors rarely detected by imaging studies\n$\\sqrt{ }$ globe distortion\n$\\sqrt{ }$ thick calcified retinal density (calcified angioma-induced hematoma)\nUS:\n$\\sqrt{ }$ small hyperechoic biconvex homogeneous solid noncalcified masses, usually in temporal retina\n$\\sqrt{ }$ NO choroidal excavation\n$C x$ : (1) repeated vitreous hemorrhage (frequent)\n(2) exudative retinal detachment posteriorly\n2. Hemangioblastoma of $\\mathrm{CNS}=$ Lindau tumor ( $40 \\%$ )\n$=$ benign nonglial neoplasm as the most commonly recognized manifestation of vHL disease\nAge: $15-40$ years\nSite: cerebellum ( $65 \\%$ ), brainstem ( $20 \\%$ ), spinal cord ( $15 \\%$ ); multiple lesions in 10 $15 \\%$ (may be metachronous)\n$\\diamond 4-20 \\%$ of single hemangioblastomas occur in von Hippel-Lindau disease!\nCT:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 78,
            "markdown": "$\\sqrt{ }$ large cystic lesion with $3-15-\\mathrm{mm}$ mural nodule ( $75 \\%$ )\n$\\sqrt{ }$ solid enhancing lesion ( $10 \\%$ )\n$\\sqrt{ }$ enhancing lesion with multiple cystic areas ( $15 \\%$ )\n$\\sqrt{ }$ intense tumor blush / blushing mural nodule\n$\\sqrt{ }$ NO calcifications (DDx: cystic astrocytoma calcifies in 25\\%)\nMR (modality of choice):\n$\\sqrt{ }$ hypointense cystic component on T1WI (slightly hyperintense to CSF $\\leftarrow$ protein content); hyperintense on T2WI\n$\\sqrt{ }$ small tubular areas of flow void within mural nodule (= enlarged feeding + draining vessels); intense contrast enhancement of mural nodule\n$\\sqrt{ }$ slightly hypointense solid lesion on T1WI; hyperintense on T2WI; intense contrast enhancement\nAngio:\n$\\sqrt{ }$ intense staining of mural nodule (\"mother-in-law phenomenon\" = tumor blush \"comes early and stays late\", very dense)\n$\\sqrt{ }$ presence of feeding vessels\nPrognosis: most frequent cause of morbidity and mortality; frequent recurrence after incomplete resection\n@ LABYRINTH\n\n1. Endolymphatic sac neoplasm\n$=$ aggressive adenomatous tumor with mixed histologic features\n\n- sensorineural hearing loss\n\nLocation: retrolabyrinthine temporal bone\nSite: endolymphatic sac\n$\\sqrt{ }$ aggressive lytic lesion containing intratumoral osseous spicules + areas of hemorrhage\n$\\sqrt{ }$ heterogeneous enhancement with hyperintense areas on T1WI + T2WI (due to hemorrhage)\n@ HEART\n\n1. Rhabdomyoma\n@ KIDNEYS\n\n- polycythemia $\\leftarrow$ elevated erythropoietin level (in $15 \\%$ with hemangioblastoma, in $10 \\%$ with renal cell ca.)\n\n1. Cortical renal cysts $(59-63 \\%)$\nmultiple + bilateral (may be confused with adult polycystic kidney disease); simple appearing cysts often contain small foci of renal cell carcinoma\n2. Renal cell carcinoma ( $24-45 \\%$ )\n\nAge: $20-50$ years\n$\\sqrt{ }$ multicentric in $87 \\%$, bilateral in $10-75$ \\%; many arise from cyst wall\n$\\sqrt{ }$ sensitivity: $35 \\%$ for angiography, $37 \\%$ for US, $45 \\%$ for CT $\\leftarrow$ inability to reliably distinguish between cystic RCC, cancer within cyst, atypical cyst\n$\\sqrt{ } 50 \\%$ metastatic at time of discovery\nPrognosis: slower growing with higher 10-year survival rate than RCC without vHL; RCC is cause of death in $30-50 \\%$ as the $2^{\\text {nd }}$ most frequent cause of mortality!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 79,
            "markdown": "Screening and management strategy:\nfollow solid lesion every 6-12 month until the largest lesion is $3 \\mathrm{~cm} \\rightarrow$ nephronsparing surgery\n3. Renal adenoma\n4. Renal hemangioma\n@ ADRENAL pheochromocytoma ( $0-60 \\%$ ) bilateral in up to $40 \\%$; confined to certain families\n@ epididymis\n\n1. Cystadenoma of epididymis\n@ PANCREAS\n2. Microcystic serous pancreatic adenoma (12-56\\%)\n3. Microcystic serous pancreatic carcinoma (rare)\n4. Pancreatic endocrine tumor (PET in 5-17\\%)\n\nMean age: 38 years (slightly younger than sporadic PET)\n$\\diamond$ multiple mostly nonfunctioning PETs ( $30 \\%$ ) with clear cell change ( $60 \\%$ )\nPrognosis: metastases in $1.4 \\%$ with $>3 \\mathrm{~cm}$ tumor\n4. Pancreatic hemangioblastoma\n5. Pancreatic cysts (in $50-91 \\%$ )\n\nIncidence: in up to $72 \\%$ (autopsies)\nLocation: pancreatic body + tail\n$\\checkmark$ usually multiple multilocular cysts (spectrum from single cyst to cystic replacement of gland)\n$\\checkmark \\pm$ peripheral calcifications\n$\\diamond$ Pancreatic cysts may be only manifestation for years\n$\\diamond$ Pancreatic cysts in a patient with a family history of von Hippel-Lindau disease are DIAGNOSTIC!\n@ LIVER\n\n1. Liver hemangioma\n2. Adenoma\n@ OTHERS\n3. Paraganglioma\n4. Cysts in virtually any organ: liver, spleen, adrenal, epididymis, omentum, mesentery, lung, bone\nMULTIPLE ORGAN NEOPLASMS\n@ Kidney : renal cell carcinoma (up to 40\\%), renal angioma (up to 45\\%)\n@ Liver : adenoma, angioma\n@ Pancreas : cystadenoma / adenocarcinoma\n@ Epididymis : adenoma\n@ Adrenal gland : pheochromocytoma\nMULTIPLE ORGAN CYSTS\n(1) Kidney (usually multiple cortical cysts in $75-100 \\%$ at early age, most common abdominal manifestation)\n(2) Pancreas (in $9-72 \\%$ often numerous cysts; second most common affected abdominal organ)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 80,
            "markdown": "(3) Others: liver, spleen, omentum, mesentery, epididymis, adrenals, lung, bone\n\n# WERNICKE ENCEPHALOPATHY \n\n[Karl Wernicke (1848-1905), professor of neurology and psychiatry in Breslau and Halle, Germany]\n$\\diamond$ MEDICALEMERGENCY!\nCause: vitamin B1 (thiamine) deficiency\nPredisposed:\nmalnutrition $\\leftarrow$ chronic alcoholism, GI neoplasm, hematologic neoplasm, chronic dialysis, bowel obstruction, hyperemesis gravidarum, prolonged parenteral Rx\n\n- classic triad of\n- altered consciousness\n- ocular dysfunction (= ophthalmoplegia)\n- ataxia\n- anterograde amnesia\n\nAffected areas: medial thalami, periaqueductal gray matter, mamillary bodies, tectal plate MR:\n$\\checkmark$ symmetric T2 prolongation\n$\\checkmark$ petechial hemorrhage\n$\\checkmark$ diffusion restriction\n$\\checkmark$ contrast enhancement\n$R x:$ IV replacement of thiamine\n\n## WILSON DISEASE\n\n$=$ HEPATOLENTICULAR DEGENERATION\n[Samuel Alexander Kinnier Wilson (1878-1937), professor of neurology at King's College Hospital, London and founding editor of the Journal of Neurology and Psychopathology]\n$=$ autosomal recessive disorder with increased intestinal resorption of copper $\\rightarrow$ excessive copper retention (= copper toxicosis) with deposition and cell damage in liver + brain\nPrevalence: $1 \\div 33,000-200,000 ; 1 \\div 90$ persons is a heterozygous carrier\nCause: alteration of chromosome 13 resulting in inability of liver to excrete copper into bile; hypothetically due to\n(a) lysosomal defect in hepatocytes, or\n(b) deficiency of biliary copper-binding proteins, or\n(c) persistence of fetal mode of copper metabolism, or\n(d) hepatic synthesis of high-affinity copper-binding proteins\n\nAge of onset: 7-50 years; hepatic manifestations predominate in children; neuropsychiatric manifestations predominate in adolescents + adults\n\n- $\\downarrow$ levels of serum copper; $\\uparrow$ urinary copper excretion\n- $\\Downarrow$ levels of ceruloplasmin (= copper transport protein)\n- $\\uparrow$ copper concentration in serum ceruloplasmin (BEST SCREENING TEST)\n- $\\downarrow$ incorporation of orally administered radiolabeled copper into newly synthesized ceruloplasmin\nStages:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 81,
            "markdown": "1 Asymptomatic copper accumulation in hepatocytic cytosol\n2 Redistribution of copper into hepatic lysosomes + circulation from saturated hepatocytic cytosol\n(a) gradual redistribution is asymptomatic\n(b) rapid redistribution causes fulminant hepatic failure / acute intravascular hemolysis\n\n3 Cirrhosis, neurologic, ophthalmologic, renal dysfunction: may be reversible with therapy $R x$ : life-long pharmacologic therapy with chelation agents (penicillamine / trientine / zinc); liver transplantation\n@ CNS\n$=$ excessive copper deposition in brain\nLocation: commonly in lenticular nucleus ( $=$ lenslike configuration of putamen + globus pallidus)\nperhaps also in:\ncaudate nucleus, ventrolateral aspect of thalamus, cortical and subcortical region, mesencephalon, pons, vermis, dentate nucleus\n\n- Kayser-Fleischer ring ( $=$ green pigmentation surrounding limbus corneae) is DIAGNOSTIC\n- dysarthria, dysphagia, dystonia\n- tremors, ataxia, Parkinsonian symptoms\n- intellectual impairment, emotional disturbance\n$\\sqrt{ }$ diffusion restriction (in early stages)\n$\\sqrt{ }$ cerebral white matter atrophy\n$\\sqrt{ }$ areas of CT hypodensities + T2 prolongation\n@ Liver\n- jaundice / portal hypertension (with liver cirrhosis)\n\nHisto: macrovesicular fat deposition in hepatocytes, glycogen degeneration of hepatocyte nuclei, Kupffer cell hypertrophy\nin children:\n$\\sqrt{ }$ normal hepatic attenuation (fatty infiltration + copper deposition cancel each other out)\n$\\sqrt{ }$ normal T1 relaxation time (in spite of paramagnetic effects of copper)\n$C x$ : acute fulminant hepatitis, macronodular cirrhosis\n@ Skeletal manifestations (in $\\%$ )\n\n- pain, stiffness, gelling of joints (in $75 \\%$ )\n\nLocation: shoulder (frequent), knee, hip, wrist, $2^{\\text {nd }}-4^{\\text {th }}$ MCP joints\n$\\sqrt{ }$ subarticular cysts\n$\\sqrt{ }$ premature osteoarthritis (narrowing of joint space + osteophyte formation)\n$\\sqrt{ }$ osteochondritis dissecans\n$\\sqrt{ }$ chondrocalcinosis\n$\\sqrt{ }$ premature osteoarthrosis of spine, prominent Schmorl nodes, wedging of vertebrae, irregularities of vertebral plates\n$\\sqrt{ }$ generalized deossification may produce pathologic fractures\n$C x$ : rickets + osteomalacia ( $\\leftarrow$ renal tubular dysfunction) in minority of patients\n\n# ZELLWEGER SYNDROME",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 82,
            "markdown": "[Hans Ulrich Zellweger (1909-1990), Swiss-American pediatrician at American University in Beirut, Lebanon and University of Iowa]\n$=$ CEREBROHEPATORENAL SYNDROME\n$=$ autosomal recessive peroxisomal disorder with disturbed myelination in oligodendrocytes during neonatal + infantile period\nPath: $\\uparrow$ very long-chain fatty acids in plasma and fibroblasts\nAssociated with:\n@ CNS: cortical dysplasia, hypomyelination\n@ Bile ducts: intrahepatic biliary dysgenesis\n@ Kidney: polycystic renal disease\n\n- poor feeding + failure to thrive, muscular hypotonia\n- hepatomegaly + prolonged jaundice\n- craniofacial dysmorphism, abnormal vision (typical)\n- seizures, mental retardation\n\nMR:\n$\\checkmark$ hypomyelination\n$\\checkmark$ diffuse microgyria + regions of pachygyria, lissencephaly\n$\\checkmark$ subependymal germinolytic cysts in caudothalamic groove\nMR spectroscopy:\n$\\sqrt{ } \\uparrow$ lipid levels $+\\downarrow \\mathrm{N}$-acetylaspartate levels\n$\\checkmark$ renal cortical cysts\nPrognosis: death within $1^{\\text {st }}$ year of life",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 83,
            "markdown": "# ORBIT \n\n## DIFFERENTIAL DIAGNOSIS OF ORBITAL AND OCULAR DISORDERS\n\n## OPHTHALMOPLEGIA\n\nLesions of\n\n1. Oculomotor nerve (CN III)\ninnervates medial rectus, superior rectus, inferior rectus, inferior oblique muscle, pupilloconstrictor, levator palpebrae\n2. Trochlear nerve (CN IV)\ninnervates superior oblique muscle\n3. Abducens nerve (CN VI)\ninnervates lateral rectus muscle\n\n## ANOPIA\n\n[numbers refer to drawing]\nA. MONOCULAR DEFECTS\n$1=$ monocular blindness (optic nerve lesion in fracture of optic canal, amaurosis fugax)\nB. BILATERAL heteronymous DEFECTS\n$2=$ bitemporal hemianopia (chiasmatic lesion)\nC. BILATERAL HOMONYMOUS DEFECTS\n$3=$ homonymous hemianopia\n$4=$ upper right-sided quadrantanopia\n$5=$ central hemianoptic scotoma\n$3,4,5=$ most common type of hemianopia (CVA, brain tumor)\n\n## Monocular Blindness In Adulthood\n\n1. Optic neuritis\n2. Vascular ischemia\n(a) Amaurosis fugax = cholesterol emboli from ICA occluding central retinal artery and its branches\n(b) Occult cerebrovascular malformation affecting the optic nerve\n3. Temporal arteritis\n4. Malignant optic glioma of adulthood\n\n## ORBIT\n\n## Spectrum of Orbital Disorders\n\nA. INFLAMMATORY DISEASE",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 84,
            "markdown": "1. Tissue-specific inflammation:\norbital cellulitis, optic neuritis, scleritis, myositis, Graves disease\n2. Panophthalmitis\n3. Pseudotumor of orbit\nB. CYSTIC DISEASE\n4. Dermoid cyst\n5. Mucocele\n6. Retroocular cyst (developmental)\nC. VASCULAR LESIONS\n(a) arterial and arteriovenous lesion\n7. Ophthalmic artery aneurysm\n8. Arteriovenous fistula (rare) eg, Wyburn-Mason syndrome\n9. Carotid-cavernous fistula\n(b) capillary lesion\n10. Capillary hemangioma / benign hemangioendotheliloma\n(c) venous vascular malformation\n11. Cavernous hemangioma\n12. Orbital varix\n(d) venous lymphatic malformation\n13. Capillary lymphangioma\n14. Cavernous lymphangioma\n15. Cystic lymphangioma\nD. TUMORS\n16. Rhabdomyosarcoma\n17. Optic nerve glioma\n18. Meningioma\n19. Lymphoma\n20. Metastasis\n21. Hemangiopericytoma\n\n# Intraconal lesion \n\nmnemonic: Mel Met Rita Mending Hems On Poor Charlie's Grave\nMelanoma\nMetastasis\nRetinoblastoma\nMeningioma\nHemangioma\nOptic glioma\nPseudotumor\nCellulitis\nGrave disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 85,
            "markdown": "![img-0.jpeg](img-0.jpeg)\n\n# Intraconal Lesion with Optic Nerve Involvement \n\n1. Optic nerve glioma\n2. Optic nerve sheath meningioma ( $10 \\%$ of orbital neoplasm)\n3. Optic neuritis\n4. Inflammatory pseudotumor (may surround optic nerve)\n5. Sarcoidosis\n6. Intraorbital lymphoma (may surround optic nerve, older patient)\n7. Elevated intracranial pressure\n$\\rightarrow$ distension of optic sheath\n$\\sqrt{ }$ bilateral tortuous enlarged optic nerve-sheath complex\n\n## OPIC NERVE TRAM-TRACK SIGN\n\n1. Optic nerve sheath meningioma\n2. Orbital pseudotumor\n3. Perioptic neuritis\n4. Perioptic hemorrhage\n5. Sarcoidosis\n6. Lymphoma / leukemia\n7. Metastasis\n8. Erdheim-Chester disease $=$ systemic xanthogranulomatosis\n\n## Intraconal Lesion without Optic Nerve Involvement\n\n1. Cavernous hemangioma\n2. Orbital varix\n3. Carotid-cavernous fistula\n4. Arteriovenous malformation\nleast common of orbital vascular malformations (congenital, idiopathic, traumatic)\n$\\sqrt{ }$ irregularly shaped intensely enhancing mass of enlarged vessels\n$\\sqrt{ }$ associated with dilated superior / inferior ophthalmic v .\n5. Hematoma",
            "images": [
                {
                    "id": "img-0.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 191,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 772,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 86,
            "markdown": "6. Lymphangioma\n7. Neurilemmoma\n$\\sqrt{ }$ commonly adjacent to superior orbital fissure, inferior to optic nerve\n$\\sqrt{ }$ local bone erosion\n8. Rhabdomyosarcoma (mostly extraconal)\n\n# Extraconal lesion \n\n## Extraconal-intraorbital Lesion\n\nA. BENIGN TUMOR\n\n1. Dermoid cyst\n2. Teratoma\n$<1 \\%$ of all pediatric orbital tumors\n$\\sqrt{ } \\pm$ areas of fat, cartilage, bone\n$\\sqrt{ }$ expansion of bony orbit $\\pm$ bone defect\n3. Capillary hemangioma\n4. Lymphangioma\n5. Plexiform neurofibroma\n6. Inflammatory orbital pseudotumor\n7. Histiocytosis X\nlesion usually arises from bone\nB. MALIGNANT TUMOR\n8. Lymphoma / leukemia\n9. Metastasis\n10. Rhabdomyosarcoma\nmnemonic: MOLD\nMetastasis\nOthers (rhabdomyosarcoma, lymphangioma, sinus lesion)\nLymphoma, Lacrimal gland tumor\nDermoid\n\n## Extraconal-extraorbital Lesion\n\nA. FROM SINUS\nmaxillary / sphenoid sinuses are rare locations of origin\n\n1. Tumor:\nsquamous cell carcinoma ( $80 \\%$ ), lymphoma, adenocarcinoma, adenoid cystic carcinoma\n2. Mucocele\n3. Paranasal sinusitis:\n$\\diamond$ Most common cause of orbital infection!\nOrigin: from ethmoid sinuses (in children), from frontal sinus (in adolescence)\n$\\sqrt{ }$ preseptal / orbital edema / cellulitis\n$\\sqrt{ }$ subperiosteal / orbital abscess\n$\\sqrt{ }$ mucormycosis (in diabetics) destroys bone and extends into cavernous sinus\nCx: (1) Epidural abscess",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 87,
            "markdown": "(2) Subdural empyema\n(3) Cavernous sinus thrombosis\n(4) Meningitis\n(5) Cerebritis\n(6) Brain abscess\nB. FROM SKIN\n\n1. Orbital cellulitis\nC. FROM LACRIMAL GLAND\n$\\sqrt{ }$ mass arising from superolateral aspect of orbit\n\n# Dilatation of Superior Ophthalmic Vein \n\n1. Carotid-cavernous sinus fistula\n2. Cavernous sinus thrombosis\n3. Venous varix\n4. Graves disease\n5. Normal variant\n\n## ORBITAL MASS\n\n## Orbital Mass in Adults\n\n(a) vasculogenic orbital mass\n1. Cavernous malformation\n2. Hemangiopericytoma\n(b) lymphoproliferative orbital lesion\n\n1. Typical / atypical lymphoid hyperplasia\n2. Lymphoma of orbit\n(c) lacrimal gland lesion ( $5-14 \\%$ of biopsied orbital masses)\n> epithelial (largely neoplastic) lesion ( $40-50 \\%$ )\n3. Pleomorphic adenoma\n4. Adenoid cystic carcinoma\n> nonepithelial lesion\n5. Dacryoadenitis\n6. Lacrimal gland lymphoma\n(d) optic nerve \\& meningeal lesions\n7. Optic pathway glioma\n8. Optic nerve sheath meningioma\n(e) peripheral nerve sheath lesions\n9. Schwannoma (rare)\n10. Neurofibroma\n11. Malignant peripheral nerve sheath tumor\n(f) Primary orbital melanoma\n(g) Metastasis to orbit\n\n## Orbital Mass in Childhood",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 88,
            "markdown": "1. Dermoid cyst $46 \\%$\n2. Inflammatory lesion $16 \\%$\n3. Dermolipoma $7 \\%$\n4. Capillary hemangioma $4 \\%$\n5. Rhabdomyosarcoma $4 \\%$\n6. Leukemia / lymphoma $2 \\%$\n7. Optic nerve glioma $2 \\%$\n8. Lymphangioma $2 \\%$\n9. Cavernous hemangioma $1 \\%$\nmnemonic: LO VISHON\nLeukemia, Lymphoma\nOptic nerve glioma\nVascular malformation: hemangioma, lymphangioma\nInflammation\nSarcoma: ie, rhabdomyosarcoma\nHistiocytosis\nOrbital pseudotumor, Osteoma\nNeuroblastoma\n\n# Osseous Orbital Lesion in Children \n\n(a) development of the osseous orbit\n\n1. Dermoid inclusion cyst\n2. Epidermoid inclusion cyst\n(b) primary bone lesions\n3. Fibrous dysplasia\n4. Juvenile ossifying fibroma\n5. Cementifying fibroma\n6. Langerhans cell histiocytosis\n(c) malignant tumors involving multiple sites\n7. Granulocytic sarcoma\n8. Hematogenous metastasis: neuroblastoma (most common primary tumor to involve orbit)\n(d) primary malignant bone tumor\n9. Osteosarcoma\n\n## Nonosseous Lesion of Extraocular Orbit in Children\n\n1. Rhabdomyosarcoma\n2. Infantile hemangioma\n3. Lymphangioma\n4. Infantile fibromatosis\n\n## Primary Malignant Orbital Tumors\n\n1. Retinoblastoma $86.0 \\%$\n2. Rhabdomyosarcoma $8.1 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 89,
            "markdown": "3. Uveal melanoma $2.3 \\%$\n4. Sarcoma $1.7 \\%$\n\n# Pediatric Orbital Tumors \n\n1. Retinoblastoma\n2. Medulloepithelioma\n3. Optic nerve glioma\n\n## Secondary Malignant Orbital Tumors\n\n1. Leukemia $36.7 \\%$\n2. Sarcoma $14.3 \\%$\n3. Hodgkin lymphoma $11.0 \\%$\n4. Neuroblastoma $9.2 \\%$\n5. Wilms tumor $6.7 \\%$\n6. Non-Hodgkin lymphoma $5.6 \\%$\n7. Histiocytosis $3.9 \\%$\n8. Medulloblastoma $3.5 \\%$\n\n## Orbital Cystic Lesion\n\n1. Abscess\n2. Intraorbital hematoma\n3. Dermoid cyst\n4. Lacrimal cyst\n5. Lymphangioma\n6. Hydatid cyst\n\n## Orbital Vascular Tumors\n\n1. Orbital varix\n2. Arteriovenous malformation\n3. Carotid-cavernous fistula\n4. Hemangioma: capillary / cavernous\n5. Blood cyst\n6. Arterial malformation\n7. Glomus tumor\n8. Hemangiopericytoma\n\n## Mass in Superolateral Quadrant of Orbit\n\n1. Lacrimal gland tumor\n2. Dermoid cyst\n3. Metastasis (breast, prostate, lung)\n4. Lymphoma\n5. Leukemic infiltration of lacrimal gland\n6. Sarcoidosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 90,
            "markdown": "7. Wegener granulomatosis\n8. Pseudotumor\n9. Frontal sinus mucocele\n\n# Granulomatous Orbital Apex Mass \n\n$\\sqrt{ }$ avidly enhancing orbital soft-tissue mass with involvement of extraocular muscles + lacrimal glands\n\n1. Granulomatosis with polyangiitis\n2. Sarcoidosis\n\n## Extraocular Muscle Enlargement\n\nA. ENDOCRINE\n\n1. Graves disease $(50 \\%)$\n2. Acromegaly\nB. INFLAMMATION\n3. Myositis\n\n- rapid onset of proptosis, erythema of lids, conjunctival injection\n\nLocation: single muscle (in adults); multiple muscles (in children)\n$\\sqrt{ }$ enlarged extraocular muscle\n$\\sqrt{ }$ positive response to steroids\n2. Orbital cellulitis\n3. Sjögren disease, Wegener granulomatosis, lethal midline granuloma, SLE\n4. Sarcoidosis\n5. Foreign-body reaction\nC. TUMOR\n6. Pseudotumor\n7. Rhabdomyosarcoma\n8. Metastasis, lymphoma, leukemia\nD. VASCULAR\n9. Spontaneous / traumatic hematoma\n10. Arteriovenous malformation\n11. Carotid-cavernous sinus fistula\n\n## GLOBE\n\n## Spectrum of Ocular Disorders\n\nA. CONGENITAL\n\n1. Persistent fetal vasculature\n2. Coats disease\n3. Coloboma\n4. Congenital cataract\nB. VITREORETINAL\n5. Vitreous hemorrhage\n6. Retinal detachment\n7. Choroidal detachment",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 91,
            "markdown": "4. Endophthalmitis\n5. Retinoschisis\n6. Retrolental fibroplasia\nC. TUMOR\n7. Retinoblastoma\n8. Choroidal hemangioma\n9. Retinal angiomatosis\n10. Melanocytoma\n11. Choroidal osteoma\nD. TRAUMA\n\n# Microphthalmia \n\n$=$ congenital underdevelopment / acquired diminution of globe\nA. BILATERAL with cataract\n\n1. Congenital rubella\n2. Persistent hyperplastic vitreous\n3. Retinopathy of prematurity\n4. Retinal folds\n5. Lowe syndrome\n$\\sqrt{ }$ small globe + small orbit\nB. UNILATERAL\n6. Trauma / surgery / radiation therapy\n7. Inflammation with disorganization of eye (phthisis bulbi)\n$\\sqrt{ }$ shrunken calcified globe + normal orbit\n\n## Macrophthalmia\n\n$=$ enlargement of globe\nA. WITHOUT INTRAOCULAR MASS\n(a) generalized enlargement\n\n1. Axial myopia (most common cause)\n$\\checkmark$ enlargement of globe in AP direction\n$\\checkmark \\pm$ thinning of sclera\n2. Buphthalmos\n3. Juvenile glaucoma\n4. Connective tissue disorder:\n\nMarfan syndrome, Ehlers-Danlos syndrome, Weill-Marchesani syndrome (congenital mesodermal dysmorphodystrophy), homocystinuria\n$\\sqrt{ }$ \"wavy\" contour of sclera\n(b) focal enlargement\n\n1. Staphyloma\n2. Apparent enlargement due to contralateral microphthalmia\nB. WITH INTRAOCULAR MASS\n(rare cause for enlargement)\n(a) with calcifications:\n3. Retinoblastoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 92,
            "markdown": "(b) without calcifications:\n\n1. Melanoma\n2. Metastasis\n\n# Posterior Wall Mass \n\nOrigin: vascular uvea\n\n1. Melanoma\n2. Metastasis\n3. Melanocytic nevus\n4. Choroidal hemangioma\n5. Hemangioblastoma\n6. Pseudomass: subretinal hematoma, granuloma\n\n## Deformity of Globe Contour\n\n1. Open-globe injury\n2. Posttraumatic orbital hematoma\n3. Coloboma\n4. Staphyloma\n\n## Orbital Calcifications\n\n## Extraocular Calcifications\n\n1. Trochlear calcifications\n$=$ aging-related normal variant / young diabetic patient\nLocation: superomedial orbit\n\n## Intraocular Calcifications\n\n1. Retinoblastoma ( $>50 \\%$ of all cases)\n2. Astrocytic hamartoma\n3. Choroidal osteoma\n4. Optic drusen\n5. Scleral calcifications\n(a) in systemic hypercalcemic states (HPT, sarcoidosis, hypervitaminosis D, in chronic renal disease)\n(b) in elderly: scleral plaques at insertion of extraocular muscles, esp. medial + lateral rectus mm.\n6. Retrolental fibroplasia\n7. Phthisis bulbi\n\nCause: trauma or infection / inflammation\n$\\sqrt{ }$ small contracted / shrunken calcified / ossified disorganized nonfunctioning globe\n7. Calcified cataract\nmnemonic: NMR CT\nNeurofibromatosis\nMelanoma (hyperdense melanin)\nRetinoblastoma\nChoroidal osteoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 93,
            "markdown": "Tuberous sclerosis\n\n# Posttherapeutic Orbital Changes \n\n1. Lens implant\n2. Scleral band / buckle\n$\\sqrt{ }$ radiopaque / radiolucent device at midglobe level\n3. Intraocular silicone oil injection\n$\\sqrt{ }$ silicone $>100 \\mathrm{HU}$ (DDx: blood $<90 \\mathrm{HU}$ )\n$\\sqrt{ }$ silicone-related chemical shift artifact\n4. Pneumatic retinopexy\n$\\sqrt{ }$ gas within globe\n5. Globe prosthesis\n\n## Noncalcified Ocular Lesion\n\n1. Melanoma\n2. Metastasis\n3. Choroidal hemangioma\n4. Vitreous lymphoma\n$\\sqrt{ }$ diffuse ill-defined soft-tissue density\n5. Developmental anomalies\n(a) Primary glaucoma $=$ enlargement of eye $\\leftarrow$ narrowing of Schlemm canal\n(b) Coloboma\n(c) Staphyloma\n\n## Vitreous Hemorrhage\n\nCause: trauma, surgical intervention, arterial hypertension, retinal detachment, ocular tumor, Coats disease\n\n- visual loss frequent\n\nUS:\n$\\sqrt{ }$ numerous irregular, poorly defined low-intensity echoes\n$\\sqrt{ }$ echogenic material moving freely within vitreous chamber during eye movement\n$\\sqrt{ }$ voluminous hyperechoic fibrin clots not fixed to optic nerve (DDx to retinal detachment)\nPrognosis: complete absorption / development of vitreous membranes (repetitive episodes)\n$C x$ : retinal detachment $\\leftarrow$ vitreous traction $\\leftarrow$ fibrovascular ingrowth following hemorrhage\n\n## Dense Vitreous in Pediatric Age Group\n\n1. Retinoblastoma\n2. Persistent fetal vasculature\n3. Coats disease\n4. Norrie disease\n5. Retrolental fibroplasia\n6. Sclerosing endophthalmitis\n\n## Echoes within Normal Anechoic Vitreous\n\n1. Vitreous degeneration",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 94,
            "markdown": "$\\sqrt{ }$ usually bilateral small freely moving low-level echoes within vitreous\n2. Asteroid hyalosis\n3. Vitreous hemorrhage\n4. Vitritis\n$\\sqrt{ }$ low- / medium-level echoes throughout vitreous\n$\\sqrt{ }$ membranes appear with progressive organization\n\n# Leukokoria \n\n$=$ abnormal white / pinkish / yellowish pupillary light reflex [leuko, Greek = white; kore, Greek = pupil]\nAlthough leukokoria is suspicious for retinoblastoma, other disease processes may also cause leukokoria.\nA. TUMOR\n\n1. Retinoblastoma $47-58 \\%$\n2. Retinal astrocytic hamartoma (3\\%)\n\nAssociated with: tuberous sclerosis + von Recklinghausen disease\n3. Medulloepithelioma (rare)\nB. DEVELOPMENTAL\n\n1. Persistent fetal vasculature $19-28 \\%$\n2. Coats disease $4-16 \\%$\n3. Retrolental fibroplasia (3-5\\%)\n4. Coloboma of choroid / optic disc ( $11 \\%$ )\nC. INFECTION\n5. Uveitis\n6. Larval endophthalmitis / granulomatosis $7-16 \\%$\nD. DEGENERATIVE\n7. Posterior cataract (13\\%)\nE. TRAUMA\n8. Retinopathy of prematurity $5-13 \\%$\n9. Organized vitreous hemorrhage\n10. Long-standing retinal detachment\n\n## Leukokoria in Normal-sized Eye\n\nA. CALCIFIED MASS\n\n1. Retinoblastoma\n2. Retinal astrocytoma\nB. NONCALCIFIED MASS\n3. Toxocara endophthalmitis\n4. Coats disease\n\n## Leukokoria with Microphthalmia\n\nA. UNILATERAL\n\n1. Persistent fetal vasculature\nB. BILATERAL\n2. Retinopathy of prematurity",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 95,
            "markdown": "2. Bilateral persistent hyperplastic primary vitreous\n\n# OPTIC NERVE \n\n## Optic Nerve Enlargement\n\nA. TUMOR:\n\n1. Optic pathway glioma\n2. Optic nerve sheath meningioma\n3. Infiltration by leukemia / lymphoma\nB. FLUID:\n4. Perineural hematoma\n5. Papilledema of intracranial hypertension\n6. Patulous subarachnoid space\nC. INFLAMMATION:\n7. Optic neuritis\n8. Sarcoidosis\n$\\sqrt{ }$ fusiform thickening of optic nerve-sheath complex\n$=$ lens-shaped thickening\n(a) with central lucency: meningioma\n(b) without central lucency: optic nerve glioma\n$\\sqrt{ }$ excrescentic thickening of optic nerve-sheath complex\n$=$ single / multiple nodules along nerve-sheath complex usually due to tumor\n$\\checkmark$ tubular enlargement of optic nerve-sheath complex\n$=$ uniform enlargement of nerve-sheath complex\n(a) with central lucency: subarachnoid process (metastases, perineuritis, meningioma, perineural hemorrhage)\n(b) without central lucency: papilledema, leukemia, lymphoma, sarcoid, optic nerve glioma\n\n## LACRIMAL GLAND\n\n## Lacrimal Gland Lesion\n\nA. INFLAMMATION\n\n1. Dacryoadenitis\n2. Mikulicz disease\n3. Sjögren syndrome\n4. Sarcoidosis\n5. Pseudotumor of orbit\n6. IgG4-related disease\nB. TUMOR\n(a) benign: granuloma, cyst, benign mixed tumor (= pleomorphic adenoma)\n(b) malignant: malignant mixed tumor (= pleomorphic adenocarcinoma), adenoid cystic carcinoma, lymphoma, metastasis (rare)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 96,
            "markdown": "# Lacrimal Gland Enlargement \n\nmnemonic: MELD\nMetastasis\nEpithelial tumor\nLymphoid tumor\nDermoid\n\n## Bilateral Lacrimal Gland Masses\n\nmnemonic: LACS\nLymphoma\nAnd\nCollagen-vascular disease\nSarcoidosis\n\n## Lacrimal Sac Lesion\n\nA. INFLAMMATION\n\n1. Sarcoidosis\n2. Wegener granulomatosis\nB. BENIGN LESION\n3. Mucoceles\n4. Epidermoid cysts\nC. MALIGNANCY\n5. Squamous cell carcinoma\n6. Lymphoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 97,
            "markdown": "# ANATOMY OF ORBIT \n\n## ORBIT\n\n[orbita, Latin = wheel track, course, path]; [oculus, Latin = eye]\n$=$ four-sided pyramidal space formed by 7 bones\nFloor: maxilla, zygoma, palatine\nRoof: orbital plate of frontal bone, lesser wing of sphenoid\nMedial wall: ethmoid, lacrimal bone\nDivision:\nA. Globe / ocular compartment\nB. Muscle cone\n$=5$ extraocular muscles (except inferior oblique m.) separating intra- from extraconal spaces\n$\\sqrt{ }$ converges at orbital apex to form tendinous ring ( $=$ annulus of Zinn)\n[Johann Gottfried Zinn (1727-1759), German anatomist and botanist, member of the Berlin Academy]\nAnnulus of Zinn contains\n\n1. Optic nerve\n2. Oculomotor nerve (superior + inferior divisions)\n3. Abducens nerve\n4. Nasociliary branch of ophthalmic nerve\n5. Ophthalmic artery\nC. Intraconal space\nD. Extraconal space\n\n## Normal Orbit Measurements\n\n6 extraocular muscles\nmedial rectus muscle $\\quad 4.1 \\pm 0.5 \\mathrm{~mm}$\ninferior rectus muscle $\\quad 4.9 \\pm 0.8 \\mathrm{~mm}$\nsuperior rectus muscle $\\quad 3.8 \\pm 0.7 \\mathrm{~mm}$\nlateral rectus muscle $\\quad 2.9 \\pm 0.6 \\mathrm{~mm}$\nsuperior oblique muscle $2.4 \\pm 0.4 \\mathrm{~mm}$\ninferior oblique muscle\nSuperior ophthalmic vein\naxial CT $\\quad 1.8 \\pm 0.5 \\mathrm{~mm}$\ncoronal CT $2.7 \\pm 1.0 \\mathrm{~mm}$\nOptic nerve sheath\nretrobulbar $5.5 \\pm 0.8 \\mathrm{~mm}$\nwaist $\\quad 4.2 \\pm 0.6 \\mathrm{~mm}$\nGlobe position",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 98,
            "markdown": "behind interzygomatic line $9.9 \\pm 1.7 \\mathrm{~mm}$\n\n# Orbital Compartments \n\nthe orbital septum + globe divide orbit into\nA. ANTERIOR COMPARTMENT\nlids, lacrimal apparatus, anterior soft tissues\n![img-1.jpeg](img-1.jpeg)",
            "images": [
                {
                    "id": "img-1.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 459,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1218,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 99,
            "markdown": "![img-2.jpeg](img-2.jpeg)\n\n# Orbital Spaces \n\nglobe:\noptic nerve-sheath complex:\nintraconal space:\nconus:\nextraconal space:\nsubdivided into anterior + posterior segments by lens\noptic nerve surrounded by meningeal sheath as extension from cerebral meninges\norbital fat, ophthalmic a., superior ophthalmic v., nerves I, III, IV, $\\mathrm{V}_{1}$, VI incomplete fenestrated musculofascial system extending from bony orbit to anterior third of globe, consists of extraocular muscles + interconnecting fascia\nbetween muscle cone + bony orbit containing fat, lacrimal gland, lacrimal sac, portion of superior ophthalmic v.\n\n## B. POSTERIOR COMPARTMENT\n\n$=$ RETROBULBAR SPACE $=$ cone consisting of extraorbital muscles + envelope of fascia divides retrobulbar space into\n(a) intraconal space\n(b) extraconal space\n\n## GLOBE\n\nOcular globe diameter: $22-25 \\mathrm{~mm}$\nWall: composed of 3 layers:\n(a) fibrous outermost layer\n\nFunction: maintaining shape + pressure of globe\n\n1. Sclera $=$ collagenous tissue layer continuous anteriorly with cornea posteriorly with dura mater\n2. Cornea",
            "images": [
                {
                    "id": "img-2.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 189,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 957,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 100,
            "markdown": "(b) Uvea $=$ pigmented vascular middle layer\n[uvea, Latin = grape]\n3. Iris\n4. Ciliary body (anteriorly)\n5. Choroid (posteriorly) = most vascular structure of globe Attachment: tethered to sclera by arteries + veins\n$\\diamond$ Most frequent site of intraocular metastases!\n(c) innermost sensory layer\n5. Retina $=$ light-sensitive (sensory) inner layer Attachment: firm at anterior margin (= ora serrata) and posteriorly at optic disc\n![img-3.jpeg](img-3.jpeg)\n$\\sqrt{ }$ various layers of globe are NOT discernable at imaging, especially CT\n$\\checkmark$ sclera may be separated from choroid at high-res MRI\n$\\checkmark$ individually visualized in ocular (choroidal / retinal) detachments\nContents: (a) anterior segment containing\n\n1. Aqueous humor subdivided by iris into:\n> anterior chamber\n> canal of Schlemm (see below)\n> posterior chamber\n(b) posterior segment containing\n2. Vitreous humor\n\nPotential ocular spaces:\n(a) between retina + choroid $\\rightarrow$ retinal detachment\n(b) suprachoroidal space between choroid + sclera $\\rightarrow$ choroidal detachment\n(c) between vitreous + posterior hyaloid membrane $\\rightarrow$ hyaloid detachment\n\n# Canal of Schlemm \n\n[Friedrich Schlemm (1795-1858), German anatomist, sentenced for grave robbing, eventually",
            "images": [
                {
                    "id": "img-3.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 624,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1278,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 101,
            "markdown": "professor at the University of Berlin]\n= SCLERAL VENOUS SINUS [misnomer - not a blood vessel]\n$=$ circular ringlike endothelium-lined tube lymphatic tube resembling a lymphatic vessel\nLocation: adjacent to outer angle of anterior chamber in pectinatum iridis ( $=$ periphery of cornea) between cornea + iris\nFunction: collects aqueous humor from anterior chamber and delivers it into the venous system\n\n# OPTIC NERVE SHEATH \n\n$=$ extension of dura mater\nContent:\n\n1. Optic nerve\n2. Ophthalmic artery\n3. Small veins\n\n## OPTIC NERVE (CN II)\n\nHisto: CN II is an extension of brain = retinal ganglion cell axons myelinated by oligodendrocytes + enveloped within meninges\nSegments:\nA. Retinal segment leaves ocular globe through lamina cribrosa sclerae\nB. Orbital segment travels in center of fat-filled orbit $\\sqrt{ }$ surrounded by dural sheath containing CSF\nC. Canalicular segment lies in optic canal below ophthalmic artery; frequently overlooked on radiologic images\nD. Cisternal segment in suprasellar cistern leading to optic chiasm\n$\\checkmark$ anterior cerebral a. passes over superior aspect of nerve\n\n## OCULOMOTOR NERVE (CN III)\n\nExit: from brainstem anteriorly between posterior cerebral (PCA) + superior cerebellar arteries\nSegments:\n(1) cisternal segment courses through prepontine cistern\n(2) cavernous sinus segment along cephalad portion of the lateral dural wall\n(3) orbital segment through the superior orbital fissure\n(4) division into superior + inferior branches\n\n## Function:\n\n(a) motor fibers to\n> levator palpebrae muscle\n> all extraocular muscles except lateral rectus and superior oblique mm .\n(b) parasympathetic fibers to\n> internal eye muscles (pupillary sphincter and ciliary muscles) $\\rightarrow$ constriction of pupil via Edinger-Westphal nucleus\nLocation: periphery of CN III $\\rightarrow$ subject to compression by extrinsic masses\nDisturbed function:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 102,
            "markdown": "(1) \"pupil-sparing\" oculomotor palsy = loss of motor function in extraocular muscles with relative sparing of pupillary parasympathetic innervation $\\leftarrow$ compromised blood flow to central microvessels\n(2) compression by posterior communicating artery aneurysm $\\leftarrow$ close association with posterior cerebral (PCA) + superior cerebellar arteries\n(3) compression during transtentorial uncal herniation $\\leftarrow$ course over petroclinoid ligament\n\nNuclei:\n(1) Edinger-Westphal nucleus\nlocated dorsally in periaqueductal gray matter\n(2) Number of smaller nuclei arranged in an anterior and posterior group\n\n# TROCHLEAR NERVE (CN IV) \n\nFunction: pure motor nerve $\\rightarrow$ innervates superior oblique $m$.\nNucleus: paramedian midbrain $\\rightarrow$ fascicles course postero-inferiorly around cerebral aqueduct $\\rightarrow$ decussation\n![img-4.jpeg](img-4.jpeg)\n$\\diamond$ Each superior oblique muscle is innervated by the contralateral cranial nerve IV nucleus!\nExit: dorsal midbrain\n$\\diamond$ The only cranial nerve to exit the dorsal brainstem!\nSegments:\n(1) Cisternal segment courses through ambient cistern traveling inferolateral to cranial nerve III between superior cerebellar and posterior cerebral arteries\n(2) Cavernous sinus segment within dural investment inferior to CN III\n(3) Orbital segment passes through superior orbital fissure above annulus of Zinn\n\n## ABDUCENS NERVE (CN VI)",
            "images": [
                {
                    "id": "img-4.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 840,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1489,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 103,
            "markdown": "Function: pure motor nerve for the lateral rectus muscle\nNucleus: located in pontine tegmentum near midline surrounded by a loop of the facial nerve (CN VII) causing a bulge in the floor of the $4^{\\text {th }}$ ventricle (= facial colliculus)\nSegments:\n(1) Cisternal portion exits brainstem near midline through a space between pons and pyramid of medulla oblongata\n(2) Prepontine portion the nerve courses anteriorly within prepontine cistern + penetrates dura mater to enter Dorello canal\n(3) Cavernous sinus portion the only nerve that travels within venous sinusoids of cavernous sinus inferolateral to cavernous ICA\n$\\diamond$ Cranial nerves III, IV, $\\mathrm{V}_{1}, \\mathrm{~V}_{2}$ all lie within lateral dural wall of cavernous sinus!\nExit: enters orbit through superior orbital fissure\n\n# ORBITAL CONNECTIONS \n\n## Superior Orbital Fissure\n\nBoundaries (Gray's Anatomy):\n> medial : sphenoid body\n> above : lesser wing of sphenoid = optic strut\n> below : greater wing of sphenoid\n> lateral : small segment of frontal bone\nContents:\n(a) nerves: III oculomotor nerve\n\nIV trochlear nerve\n$\\mathrm{V}_{1}$ ophthalmic branch of trigeminal n .:\n(a) lacrimal nerve\n(b) frontal nerve\n\nVI abducens nerve\nsympathetic filaments of ICA plexus\n(b) veins: superior + inferior ophthalmic vein\n(c) arteries: 1. meningeal branch of lacrimal artery\n2. orbital branch of middle meningeal artery\n\n## Inferior Orbital Fissure\n\nLocation: between floor + lateral wall of orbit; connects with pterygopalatine + infratemporal fossa\nContents:\n(a) nerves: infraorbital + zygomatic nerves branches from pterygopalatine ganglion\n(b) veins: connection between inferior orbital vein + pterygoid plexus\n\n## Optic Canal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 104,
            "markdown": "completely formed by lesser wing of sphenoid\nContents:\n(a) nerve: optic nerve (I) sympathetic fibers\n(b) vessel: ophthalmic artery\n\n# Infraorbital Canal \n\n## Contents:\n\n(a) nerve: maxillary branch of trigeminal nerve\n(b) vessel: infraorbital artery \\& vein\n![img-5.jpeg](img-5.jpeg)",
            "images": [
                {
                    "id": "img-5.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 600,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1287,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 105,
            "markdown": "![img-6.jpeg](img-6.jpeg)",
            "images": [
                {
                    "id": "img-6.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1526,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 106,
            "markdown": "# ORBITAL AND OCULAR DISORDERS \n\n## ADENOID CYSTIC CARCINOMA\n\n$=$ most common malignancy of lacrimal gland\nFrequency: $29 \\%$ of all lacrimal epithelial neoplasms; $\\sim 5 \\%$ of all primary orbital neoplasms $\\diamond 2^{\\text {nd }}$ most common lacrimal epithelial lesion\nAge: $4^{\\text {th }}$ decade of life\nHisto: nonencapsulated bland-appearing epithelial cells arranged in nests / chords forming a characteristic cribriform (swiss cheese-like) pattern\n\n- pain (common presentation = indicative of malignancy)\n- proptosis (may be minimal due to infiltrative pattern)\n$\\checkmark$ irregular borders with distortion of globe + orbital contents (with more advanced disease)\n$\\sqrt{ } \\pm$ bone erosion + calcifications\n$\\sqrt{ }$ perineural invasion (lacrimal branch of ophthalmic nerve)\nPrognosis: poor; 20\\% 10-year-survival rate\n\n\n## ASTEROID HYALOSIS\n\n$=$ degenerative orbital condition with small white opacities of hydroxyl apatite ( $=$ calcium + phosphate / phospholipid deposits) attached to vitreous collagenous framework\nFrequently associated with: hyperlipidemia, hypertension, diabetes mellitus\n\n- small white vitreous opacities visible under direct illumination\n$\\sqrt{ }$ small hyperechoic refringent mobile echoes (usually unilateral) $\\leftarrow$ calcified deposits\n\n\n## BUPHTHALMOS\n\n$=$ HYDROPHTHALMOS $=$ MEGOPHTHALMOS\n$=$ diffuse enlargement of eye in children $\\leftarrow$ increased intraocular pressure\nCause:\n\n1. Congenital / infantile glaucoma\n2. Neurofibromatosis type 1: obstruction of canal of Schlemm by membranes / masses composed of aberrant mesodermal tissue\n3. Sturge-Weber-Dimitri syndrome\n4. Lowe (cerebrohepatorenal) syndrome\n5. Ocular mesodermal dysplasia (eg, Axenfeld or Rieger anomalies)\n6. Homocystinuria\n7. Aniridia\n8. Acquired glaucoma (rare)\n\nPathophysiology:\nobstruction of canal of Schlemm located between cornea + iris $\\rightarrow$ decreased resorption of aqueous humor ( $=$ anterior chamber fluid) $\\rightarrow$ scleral distension\n$\\sqrt{ }$ uniformly enlarged globe without mass of round / oval / bizarre shape\n$R x$ : goniotomy (increases the angle of anterior chamber); trabeculotomy (lysis of adhesions)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 107,
            "markdown": "# CHOROIDAL DETACHMENT \n\n$=$ serous fluid / blood accumulation in potential suprachoroidal space separating choroid from sclera with sparing of optic disc due to anchoring effect of short posterior ciliary arteries and veins and nerves\nPotential suprachoroidal space: extends from ora serrata to optic disc\nCause: trauma (accidental perforation), inflammation (uveitis), surgical intervention, spontaneous\nPathomechanism: ocular hypotonia $\\rightarrow$ decreased pressure in suprachoroidal space $\\rightarrow$ accumulation of serous / hemorrhagic transudate\nUS:\n$\\sqrt{ } 2$ convex lines projecting into the eye from periphery of globe + advancing to ciliary body with posterior fixation outside the optic disc ( $=$ macula) creating an obtuse angle\n$\\sqrt{ }$ minimal / no choroidal membrane mobility during eye movement\n\n## CHOROIDAL HEMANGIOMA\n\n$=$ congenital vascular hamartoma\nMean age: 31 (range, 7-58) years (most common benign tumor in adults); $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\nMay be associated with: Sturge-Weber syndrome\nClassification: capillary / cavernous / mixed\nLocation: posterior to equator, temporal to optic disc ( $70 \\%$ )\n\n- smoothly elevated slightly dome-shaped reddish-orange choroidal mass\n$\\sqrt{ }$ lenticular mass of 7.5 (range, $3-11$ ) mm\n$\\sqrt{ }$ intense enhancement similar to choroid\n$\\sqrt{ }$ focal thickening of posterior wall of globe\nCT:\n$\\sqrt{ }$ ill-defined mass with intense enhancement\nMR:\n$\\sqrt{ }$ hyperintense to vitreus on T1WI (rule)\n$\\sqrt{ }$ isointense to vitreus on T2WI (rule)\nUS:\n$\\sqrt{ }$ hyperechoic homogeneous mass\n$D D x$ : uveal melanoma (choroidal excavation)\n$C x$ : retinal detachment (frequent)\n$R x$ : usually none; photocoagulation with retinal detachment\n\n\n## CHOROIDAL OSTEOMA\n\n$=$ rare juxtapapillary tumor of mature bone\nAge: young woman\nLocation: may be bilateral\n$\\sqrt{ }$ small flat very dense curvilinear mass aligned with choroidal margin of globe\n$D D x$ : calcified choroidal angioma\n\n## CMV-INDUCED RETINITIS\n\nFrequency: in $1 / 3$ of AIDS patents NOT on HAART (highly active antiretroviral therapy)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 108,
            "markdown": "Location: unilateral $\\rightarrow$ bilateral\n$\\sqrt{ }$ uveal enhancement\n$\\sqrt{ }$ retinal detachment\n$\\sqrt{ }$ calcifications of retina\n$C x$ : blindness $\\leftarrow$ retinal detachment within 3-6 months (in $33 \\%$ prior to HAART)\n\n# COATS DISEASE \n\n$=$ RETINAL TELANGIECTASIA $=$ PSEUDOGLIOMA\n$=$ congenital nonhereditary primary vascular malformation of the retina characterized by retinal telangiectasia ( $=$ multiple abnormal telangiectatic retinal vessels with aneurysm formation) and retinal exudation\nPathogenesis:\nbreakdown of blood-retina barrier at level of endothelial cells $\\rightarrow$ leakage of\nlipoproteinaceous exudate of cholesterol crystals into retina + subretinal space $\\rightarrow$ detachment of retina $\\rightarrow$ progressive obliteration of vitreous space\nPeak age: 6-8 years (range, 5 month - 75 years); $\\mathrm{M}+\\mathrm{F}=2+1$\n\n- $\\pm$ leukokoria (if retina massively detached $=16 \\%$ of leukokoria cases)\n- strabismus, secondary glaucoma, loss of vision\n- cholesterol crystals at funduscopy\n\nLocation: unilateral in $83-95 \\%$\nAssociated with: retinal detachment, slight microphthalmia\n$\\sqrt{ }$ NO focal mass, NO calcification, NO enhancement of subretinal space (HALLMARK)\n$\\sqrt{ }$ normal-sized / slightly smaller globe\nUS:\n$\\sqrt{ }$ clumpy particulate echoes in subretinal space $\\leftarrow$ cholesterol crystals suspended in fluid\n$\\sqrt{ }$ vitreous + subretinal hemorrhage (frequent)\nCT:\n$\\sqrt{ }$ unilateral dense vitreus $\\leftarrow$ proteinaceous subretinal exudate\n$\\sqrt{ }$ linear V-shaped enhancement at anterior margin of subretinal exudate $\\leftarrow$ thickened retina composed of telangiectatic and aneurysmal vessels\nMR:\n$\\sqrt{ }$ subretinal exudate hyperintense on T1WI + T2WI $\\leftarrow$ mixture of protein + lipid\n$\\sqrt{ }$ heterogeneous hypointensity on T2WI (with hemorrhage + fibrosis)\n$\\sqrt{ }$ mild to moderate linear enhancement of retina at ora serrata and of detached retinal leaves\n$C x$ : cataract, painful glaucoma, phthisis bulbi\n$R x$ : photocoagulation / cryo- / laser ablation to obliterate telangiectasias (in early stages); enucleation\n$D D x$ : (1) Persistent hyperplastic primary vitreus (thick tubular retrolental mass)\n(2) Retinopathy of prematurity\n(3) Unilateral diffuse infiltrating noncalcifying retinoblastoma ( $<3$ years of age, no microphthalmia)\n\n## COLOBOMA\n\n$=$ COLOBOMA OF CHOROID $=$ OPTIC DISC COLOBOMA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 109,
            "markdown": "$[$ koloboun, Greek $=$ to mutilate $]$\n$=$ incomplete closure of embryonic choroidal fissure affecting eyelid / lens / iris / choroid / retina / macula ( $=$ gap in choroidal layer of globe between retina and sclera)\nGenetics: autosomal dominant trait with variable penetrance ( $30 \\%$ ) and expression\nTime of insult: $6^{\\text {th }}$ week of GA\nMay be associated with: encephalocele, agenesis of corpus callosum\nLocation: in $50-60 \\%$ bilateral\n\n- leukokoria $\\leftarrow$ exposed underlying sclera\n$\\checkmark$ cystic outpouching (= herniation) of vitreus at site of optic nerve attachment\n$\\checkmark$ scleral bulge on T2WI\n$\\checkmark$ small globe\nUS:\n$\\checkmark$ defect in optic disc + retroocular cyst\n$D D x$ : microphthalmos with cyst (= duplication cyst); axial (high) myopia\n\n\n# CATARACT \n\n$=$ opacification of lens\nEtiology: congenital, age-related, infection, trauma\n\n## Congenital Cataract\n\nLocation: frequently bilateral\n\n- leukokoria = white reflection with opaque lens\n\nUS:\n$\\checkmark$ increased thickness of lens\n$\\checkmark$ intralenticular echoes\n$\\checkmark$ echogenicity of posterior / both walls\n\n## DACRYOADENITIS\n\n$=$ infection of lacrimal gland\nOrganism: staphylococci (most common), mumps, infectious mononucleosis, influenza\n$\\checkmark$ homogeneous enlargement of lacrimal gland\n$\\checkmark \\pm$ compression of globe\n\n## DACRYOCYSTITIS\n\n$=$ inflammation / infection with dilatation of lacrimal sac\nCause:\n(a) obstruction of nasolacrimal duct $\\leftarrow$ duct stenosis / dacryolith\n(b) sarcoidosis, Wegener granulomatosis, benign lesions (eg, mucocele and epidermoid cyst), and malignant lesions (including squamous cell carcinoma and lymphoma)\nLocation: medial (internal / inner) canthus\n\n- acute onset of pain, conjunctivitis\n- medial canthus mass, lid swelling\n- mucopurulent discharge from puncta\n- conjunctivitis concurrent preseptal cellulitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 110,
            "markdown": "$\\sqrt{ }$ well-circumscribed round fluid collection along inner canthus\n$\\sqrt{ }$ peripheral enhancement\n$\\sqrt{ }$ adjacent inflammation + soft-tissue thickening\n$C x$ : periorbital / orbital cellulitis\n\n# DACRYOCYSTOCELE \n\n$\\diamond 2^{\\text {nd }}$ most common cause of neonatal nasal obstruction (after choanal atresia)\nCause: congenital obstruction of nasolacrimal duct (imperforate Hasner membrane distally, reason for proximal obstruction unknown)\nLocation: inferomedial canthus of neonates\n\n- tense blue-gray mass at medial canthus / in nasal cavity\n\nCT / MR:\n$\\checkmark$ homogeneous well-defined mass of fluid attenuation extending into nasal cavity along course of nasolacrimal duct $=$ nasolacrimal duct dilatation\n$\\checkmark$ enhancement of thin wall\n$\\checkmark$ superior displacement of inferior turbinate bone\n$\\checkmark$ contralateral shift of nasal septum\n$C x$ : dacryocystitis, periorbital cellulitis\n$R x$ : duct massage, duct probing with irrigation, prophylactic antibiotics, endoscopic resection, marsupialization\n$\\diamond$ Prompt treatment to prevent secondary infection!\n\n## INCLUSION CYST OF ORBIT\n\n$=$ congenital unilocular closed sac containing derivatives of single germ layer (monodermal)\nEtiology: failure of surface ectoderm to separate completely from underlying developing neural tube; usually arises in fetal cleavage planes (sutures)\nPrevalence: $5 \\%$ of all orbital masses\n$\\diamond$ Most common benign developmental orbital tumor in childhood ( $45 \\%$ of all masses)\nAge: $1^{\\text {st }}$ decade; $<1 / 4$ diagnosed at birth\nLocation: in anterior extraconal orbit in close relation to frontozygomatic suture $=$ upper temporal (outer) quadrant / lacrimal fossa ( $60-80 \\%$ ) or frontoethmoidal suture $=$ upper nasal quadrant $(25 \\%)$\nSite: overwhelmingly superficial in lateral $1 / 3$ of eyebrow\n\n- slow progression of painless lesion\n- proptosis (for deeper lesion in older child / adult)\n\nPrognosis: slow enlargement over years / decades secondary to accumulation of debris\n$D D x$ : cephalocele (tracts leading to midline anterior cranial fossa, no lipid)\n\n## Dermoid Cyst of Orbit\n\n$=$ DERMOID INCLUSION CYST\nHisto: thick vascularized capsule composed of stratified squamous epithelium identical to epidermis + additional ectodermal features like hair follicles / sebaceous glands containing oily secretions + proteinaceous keratin debris",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 111,
            "markdown": "$\\sqrt{ }$ thick surrounding capsule $\\pm$ enhancement\n$\\sqrt{ } \\pm$ expansion / erosion of bony orbit:\n$\\sqrt{ }$ periosteal and intradiploic remodeling of bone\n$\\sqrt{ }$ reactive sclerotic margin / shell of dense bone\nUS:\n$\\sqrt{ }$ encapsulated heterogeneous mass with variable cystic component\nCT:\n$\\sqrt{ }$ encapsulated well-circumscribed unilocular cystic mass:\n$\\sqrt{ } \\pm$ fat-density of -60 to -90 HU\n$\\sqrt{ } \\pm$ high-attenuation foci in wall $\\leftarrow$ calcification\nMR:\n$\\sqrt{ }$ high signal intensity on T1WI + T2WI $\\leftarrow$ lipids of sebum\n$\\sqrt{ } \\downarrow$ SI of lipid on fat-suppressed images\n\n# Epidermoid Inclusion Cyst \n\nPath: white \"pearly\" tumor consisting of dry waxy / flaky keratin $\\leftarrow$ desquamated inner lining of squamous cells\nHisto: exclusively squamous epithelium\n$\\sqrt{ }$ water / CSF density $\\leftarrow$ high proteinaceous content\nMR:\n$\\sqrt{ }$ high SI on T2WI\n$\\sqrt{ }$ internal signal NOT suppressed on FLAIR\n$\\sqrt{ } \\uparrow$ signal intensity on DWI $+\\downarrow$ ADC map\n\n## ENDOPHTHALMITIS\n\n## Infectious Endophthalmitis\n\nOrganism: bacteria (rare in childhood, trauma, idiopathic), fungi, parasites\nCause:\n(a) exogenous endophthalmitis: most commonly related to eye injury / surgery\n(b) endogenous endophthalmitis: hematogenous spread from distant source of infection\n\nUS:\n$\\sqrt{ }$ medium- to high-intensity echoes dispersed throughout vitreus (DDx: vitreous hemorrhage echoes are more mobile)\nCT:\n$\\sqrt{ }$ increased attenuation of vitreus\n$\\sqrt{ }$ uveal-scleral thickening\n$\\sqrt{ }$ decreased attenuation of lens\n\n## Sclerosing Endophthalmitis\n\n$=$ TOXOCARA CANIS ENDOPHTHALMITIS $=$ OCULAR LARVA MIGRANS $=$ NEMATODE ENDOPHTHALMITIS\n$=$ granulomatous uveitis resulting in subretinal exudate, retinal detachment, organized vitreus Age: $2-6-12$ years\nMode of infection: playing in soil contaminated by viable infective eggs from dog / cat",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 112,
            "markdown": "excrement (common in playgrounds)\nOrganism: helminthic nematode Toxocara canis / Toxocara cati causes visceral / ocular larva migrans ( 0.5 mm long, $20 \\mu \\mathrm{~m}$ wide); endemic throughout world; especially common in southeastern USA\nLife cycle:\negg hatches into larva within intestines of definite host (dog) $\\rightarrow$ develops into adult worm; alternatively dog may eat infective-stage larvae from intestines / viscera of other animals; in noncanine host (human) larvae will not develop into adult worm, but burrow through intestinal wall and migrate to liver, lung, and other tissue including brain + eye (= visceral larva migrans)\nAccidental host: human\nPathophysiology: migration through human tissue produces a severe eosinophilic reaction that becomes granulomatous; spreads hematogenously to temporal choroid\nPath: retina elevated + distorted + partially replaced by an inflammatory mass containing abundant dense scar tissue; subjacent choroid infiltrated with chronic inflammatory cells including eosinophils; proteinaceous subretinal exudate\nAge: $\\quad 5-10$ years\n\n- strabismus, red \"hot\" eye, pain\n$\\sqrt{ }$ unilateral visual impairment, photophobia\n- anterior chamber flare cells, keratic precipitates\n- vitreous synechia; peripheral blood eosinophilia\n- vitreitis = accumulation of cellular debris in vitreus\n- leukokoria ( $16 \\%$ of cases of childhood leukokoria)\n- fever, hepatomegaly, pneumonitis, convulsions\n\nLocation: usually unilateral\n$\\sqrt{ }$ eye of normal size\n$\\sqrt{ }$ no calcifications\nUS:\n$\\sqrt{ }$ hyperechoic mass in peripheral fundus / vitreus\n$\\sqrt{ } \\pm$ calcifications\nCT:\n$\\sqrt{ }$ intravitreal mass\n$\\sqrt{ }$ focal uveoscleral thickening (granulomatous reaction around larva) with contrast enhancement\n$\\sqrt{ }$ increased density of vitreous cavity\nMR:\n$\\sqrt{ }$ granuloma isointense to vitreus on T1WI\n$\\sqrt{ }$ mass usually hyperintense relative to vitreus on first-echo T2WI\n$\\sqrt{ }$ mass may be isointense on second-echo T2WI compared to surrounding vitreus\n$\\sqrt{ }$ granuloma may be of low SI $\\leftarrow$ dense fibrosis\n$\\sqrt{ }$ moderate to marked enhancement\n$C x$ : secondary retinal detachment ( $\\leftarrow$ subretinal fluid / vitreoretinal traction), cataract\n$R x$ : antithelminthic albendazole $\\pm$ vitrectomy\nDx: (1) Enzyme-linked immunosorbent assay (ELISA) on blood serum (less reliable) / vitreous aspirate",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 113,
            "markdown": "(2) Histologic identification of organism (larvae difficult to detect within inflammatory reaction)\n$D D x$ : retinoblastoma (calcifications); fascioliasis, ascariasis, ancylostomiasis, angiostrongylosis\n\n# GRAVES OPHTHALMOPATHY \n\n$=$ THYROID OPHTHALMOPATHY $=$ ENDOCRINE EXOPHTHALMOS\n$=$ autoimmune disease unrelated to thyroid function with an increase in orbital pressure producing ischemia, edema, fibrosis of muscles\nEtiology: produced by long-acting thyroid-stimulating factor (LATS); probably immunologic cross-reactivity against antigens shared by thyroid + orbital tissue\nAge: adulthood; $5 \\%$ younger than 15 years; $\\mathrm{M}+\\mathrm{F}=1 \\div 4$\nHisto: deposition of hygroscopic mucopolysaccharides + glycoprotein (early) + collagen (late); infiltration by mast cells and lymphocytes, edema, muscle fiber necrosis, lipomatosis, fatty degeneration\nTime of onset: signs + symptoms usually develop within 5 years after the onset of hyperthyroidism\n\n- proptosis\n$\\diamond$ Most common cause of uni- / bilateral exophthalmos in adults!\n- lid lag = upper eyelid retraction\n- periorbital swelling, chemosis (= conjunctival swelling), conjunctivitis; progressive optic neuropathy $(5 \\%)$\n- ophthalmoplegia $=$ restricted ocular motility (correlates with increase in mean muscle diameters)\n- hyperthyroidism; euthyroidism (in 10-15\\%); severity of orbital involvement unrelated to degree of thyroid dysfunction\nStaging (Werner's modified classification):\nStage I : eyelid retraction without symptoms\nStage II : eyelid retraction with symptoms\nStage III : proptosis $>22 \\mathrm{~mm}$ without diplopia\nStage IV : proptosis $>22 \\mathrm{~mm}$ with diplopia\nStage V : corneal ulceration\nStage VI : loss of sight\nLocation:\nbilateral in $70-85 \\%$; single muscle in $10 \\%$; asymmetrical involvement in $10-30 \\%$; all muscles equally affected with similar proportional enlargements; superior muscle group most commonly when only single muscle involved [FORMER notion: inferior $>$ medial $>$ superior rectus muscle + levator palpebrae $>$ lateral rectus muscle]\nmnemonic: I'M SLow\nInferior\nMedial\nSuperior\nLateral\n$\\sqrt{ }$ eyelid edema",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 114,
            "markdown": "$\\sqrt{ }$ proptosis $=$ globe protrusion $>21 \\mathrm{~mm}$ anterior to interzygomatic line on axial scans at level of lens\n$\\sqrt{ }$ \"Coke-bottle\" sign = swelling of muscles maximally in midportion (relative sparing of tendinous insertion at globe)\n$\\sqrt{ }$ slight uveal-scleral thickening\n$\\sqrt{ }$ tenting of posterior globe\n$\\sqrt{ }$ apical crowding $=$ orbital apex involved late $\\rightarrow$ pressure on optic nerve\n$\\sqrt{ }$ dilatation of superior ophthalmic vein $\\leftarrow$ compromised orbital venous drainage at orbital apex $\\leftarrow$ enlarged extraocular muscles\n$\\sqrt{ }$ increase in diameter of retrobulbar optic nerve sheath $\\leftarrow$ dural distension $\\leftarrow$ accumulation of CSF in subarachnoid space $\\leftarrow$ optic neuropathy\n$\\sqrt{ }$ stretching of optic nerve\n$\\sqrt{ }$ increased orbital fat:\n$\\sqrt{ }$ increased density of orbital fat (late)\n$\\sqrt{ }$ intracranial fat herniation through superior ophthalmic fissure (best correlation with compressive neuropathy)\n$\\sqrt{ }$ enlargement of lacrimal gland with anterior displacement\nMR:\n$\\sqrt{ }$ high SI in enlarged eye muscles on T2WI (edema in acute inflammation)\nPrognosis: in $90 \\%$ spontaneous resolution within 3-36 months; in $10 \\%$ decrease in visual acuity (corneal ulceration / optic neuropathy)\n$R x$ : short- and long-term steroid therapy, cyclosporine, radiation, surgical decompression, correction of eyelid position\n$D D x$ : pseudotumor (usually includes tendon of eye muscles)\n\n# HEMANGIOMA OF ORBIT \n\n$\\diamond$ Most common benign orbital tumor in adults!\nLocation: 83-94\\% retrobulbar (intraconal)\n$\\sqrt{ }$ sharply demarcated oval mass in superior-temporal portion of conus ( $2 / 3$ ) often sparing orbital apex\n$\\sqrt{ }$ displacement (NOT involvement) of optic nerve\n$\\sqrt{ }$ expansion of bony orbit\n$\\sqrt{ }$ uniform / inhomogeneous (when thrombosed) enhancement\n$\\sqrt{ }$ small calcifications (phleboliths)\n$\\sqrt{ }$ puddling of contrast material on angiography\nUS:\n$\\sqrt{ }$ well-defined encapsulated mass of intermediate echogenicity\n$\\sqrt{ }$ absent / poor predominantly venous flow\n\n## Capillary Hemangioma of Orbit\n\n$=$ INFANTILE HEMANGIOMA $=$ BENIGN HEMANGIOENDOTHELIOMA\n$\\diamond$ Most common tumor of infancy ( $60 \\%$ in head \\& neck)!\nFrequency: most common vascular tumor of orbit in children; $3 \\%$ of all pediatric orbital masses; $17 \\%$ of vasculogenic orbital lesions\nAge: first 2 weeks of life; $95 \\%$ at $<6$ months of age; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 3$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 115,
            "markdown": "Path: nonencapsulated infiltrative mass consisting of multiple lobules separated by vascular fibrous septa\nHisto: proliferation (lasting up to 10 months) of endothelial cells with multiple vessels of capillary size; involutional phase with progressive peripheral replacement by fibrofatty tissue $\\rightarrow$ atrophy of mass\nMay be associated with: PHACES syndrome\n\n- appears shortly after birth + rapidly increases in size for 6-12 months + then gradually involutes over $7-10$ years\n- proptosis, chemosis (= edema) of eyelid + conjunctiva exaggerated by crying for deep lesion\n- associated with cutaneous red to bluish angiomas ( $90 \\%$ ); NO familial / hereditary association\nLocation: anterior part of orbit (red discoloration of skin - most frequently eyelid), subcutaneous (bluish discoloration of skin); occasionally posterior; multiple hemangiomas in $20 \\%$\nSite: entirely extraconal / substantial extraconal component\n$\\sqrt{ }$ displacement of globe (= proptosis)\n$\\checkmark$ lobulated irregularly marginated heterogeneous mass (suggesting malignant cause)\n$\\checkmark$ intense enhancement equal to / greater than orbital muscle\n$\\checkmark$ often transspatial $\\rightarrow$ may extend intracranially through optic canal / superior orbital fissure\n$\\checkmark$ activity in radionuclide flow studies\nUS:\n$\\checkmark$ smoothly contoured heterogeneous mass of variable (usually hyperechoic) echogenicity\n$\\checkmark$ abundant intralesional flow decreasing with age:\n$\\checkmark$ high density of vessels ( $>5$ vessels per $\\mathrm{cm}^{2}$ )\n$\\checkmark$ increased arterial and venous flow velocity (Doppler shift $>2 \\mathrm{kHz}$ )\n$\\checkmark$ arterial flow of low resistance\nCT:\n$\\checkmark$ fairly homogeneous mostly extraconal mass:\n$\\checkmark$ isoattenuating relative to muscle\n$\\checkmark$ hyperattenuating relative to brain $\\leftarrow$ blood in vessels\n$\\checkmark$ scalloping / expansion of bony orbit\n$\\checkmark$ invasion of bone (extremely rare)\n$\\checkmark$ calcifications (rare)\n$\\checkmark$ prompt marked uniform persistent enhancement\n$\\checkmark$ shrinkage of mass with decrease in vascularity and progressive replacement by fat (during involution)\nMR:\n$\\checkmark$ lobulated mass with thin hypointense septa\n$\\checkmark$ usually iso- to hyperintense to muscle on T1WI\n$\\checkmark$ moderately hyperintense on T2WI\n$\\checkmark$ intra- and perilesional flow voids (distinguishing feature)\n$\\checkmark$ intense uniform enhancement (during proliferative phase)\n$\\checkmark$ increased SI on T1WI + T2WI $\\leftarrow$ fibrofatty deposition during involutional phase\nAngio (reserved for embolotherapy):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 116,
            "markdown": "$\\sqrt{ }$ hypervascular mass with prolonged capillary stain and large feeding and draining vessels\n$C x$ : profuse hemorrhage, thrombosis, calcification, corneal ulceration, optic nerve compression, amblyopia (\"lazy eye\"), visual axis occlusion, bone remodeling, $\\pm$ visceral hemangiomas $\\rightarrow$ severe consumptive thrombocytopenic coagulopathy (Kasabach-Merritt syndrome)\n$R x$ : observation; topical / systemic oral / intralesional corticosteroids; interferon; laser; surgery\nPrognosis: often increase in size for 6-10 months followed by spontaneous involution within $1-2$ years\n$D D x$ : (1) Rhabdomyosarcoma (older age, may contain flow voids)\n(2) Vascular malformations\n(3) Infantile fibromatosis\n(4) Infantile fibrosarcoma\n\n# Cavernous Hemangioma of Orbit \n\n$=$ CAVERNOUS MALFORMATION\n$=$ congenital vascular anomaly (1) present at birth (2) without spontaneous involution (3) slow growth over time\nFrequency: low; 12-15\\% of all orbital masses; 1-2\\% of childhood orbital masses Cavernous hemangioma is the most common benign orbital mass in adults!\nMean age: 45 (range, 18-72) years; $\\mathrm{M}+\\mathrm{F}=2 \\div 3$\nHisto: large dilated venous channels with flattened endothelial cells surrounded by fibrous pseudocapsule\n\n- slowly progressive painless unilateral proptosis (most common presenting sign)\n- visual field deficit $(50 \\%) \\leftarrow$ mass effect on optic nerve\n- acute-onset proptosis (occasionally) $\\leftarrow$ abrupt orbital enlargement $\\leftarrow$ cytokine + hormonal stimulation at puberty / during pregnancy\n- recurrent episodes of diminished visual acuity (optic nerve compression)\n- pain, eyelid swelling, diplopia, palpable lump (less common)\n\nLocation: lateral aspect of retrobulbar intraconal space; conal + extraconal cavernous malformation (rare)\nCT:\n$\\sqrt{ }$ well-circumscribed round / ovoid solitary homogeneously hyperattenuating mass\n$\\sqrt{ }$ displacement of adjacent structures (extraconal muscles, optic nerve) without invasion\n$\\sqrt{ } \\pm$ phleboliths (extremely rare)\n$\\sqrt{ } \\pm$ bone remodeling with expansion of orbital walls\n$\\sqrt{ } \\pm$ intracranial extension through superior orbital fissure (5-10\\%)\nCECT:\n$\\sqrt{ }$ poor enhancement during early arterial phase $\\leftarrow$ scant arterial supply\n$\\sqrt{ }$ progressive filling from periphery to center (complete filling within 30 minutes) during delayed phase\nMR:\n$\\sqrt{ }$ mass isointense to muscle on T1WI\n$\\sqrt{ }$ uniformly hyperintense to muscle on T2WI",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 117,
            "markdown": "$\\sqrt{ }$ internal septa in larger lesions\n$\\sqrt{ }$ NO flow voids\n$\\sqrt{ }$ progressive accumulation of contrast (late phase dynamic images / or delayed images after 1 hour!)\nUS:\n$\\sqrt{ }$ well-defined borders (pseudocapsule)\n$\\sqrt{ }$ honeycomb-like structure\nPrognosis: no involution\n$R x$ : conservative; surgical excision in cases of severe proptosis / optic nerve compression\n$D D x$ : other vascular lesions (arterial phase enhancement) like capillary hemangioma (pediatric diagnosis), hemangiopericytoma, arteriovenous malformation\n\n# PHACES Syndrome \n\n$=$ acronymic syndrome composed of\n(1) Posterior fossa brain malformation (Dandy-Walker malformation, ventricular dilatation, ipsilateral cerebellar hypoplasia, cerebellar vermian hypoplasia, cortical dysgenesis)\n(2) Hemangiomas of face + neck: (segmental / plaquelike $>5 \\mathrm{~cm}$ in diameter)\n(3) Arterial anomalies related to ipsilateral intracranial circulation (persistent trigeminal artery, agenesis of internal carotid / vertebral artery)\n(4) Cardiac anomalies / Coarctation of aorta (aortic aneurysm, aortic dissection, ASD, VSD)\n(5) Eye abnormalities (cataract, coloboma, optic nerve hypoplasia, glaucoma)\n(6) Sternal / ventral developmental anomalies\n\nIncidence: $>150$ cases\n\n- endocrine abnormalities\n$\\sqrt{ }$ occasionally absence / defect of sternum / supraumbilical raphe (= fibrous band / cleft in midline above umbilicus)\n\n\n## HEMANGIOPERICYTOMA OF ORBIT\n\n$=$ rare orbital neoplasm derived from pericytes ( $=$ contractile support cells surrounding small vessels) with cell lineage identical to solitary fibrous tumors\nFrequency: $1 \\%$ of all orbital masses\nMean age: 41 years; $\\mathrm{M}=\\mathrm{F}$\n\n- proptosis, palpable mass (common)\n- pain, diplopia, decreased visual acuity (less common)\n\nPath: slow growing mass, may recur / metastasize (15\\%)\nHisto: dense hypercellular tumor with spindle-shaped cells + \"staghorn\" vascular branching pattern, relatively bland to frankly malignant\nSpread: lung\nLocation: extraconal (commonly adjacent to paranasal sinuses)\n$\\sqrt{ }$ lobulated well circumscribed mass\n$\\sqrt{ } \\pm$ infiltrative border + bone erosion ( $=$ aggressive lesion)\n$\\sqrt{ }$ calcification (rare)\nCECT:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 118,
            "markdown": "$\\sqrt{ }$ marked enhancement during arterial + early venous phase with rapid washout MR:\n$\\sqrt{ }$ isointense relative to gray matter on T1WI + T2WI\n$D D x$ : cavernous malformation\n\n# INFANTILE FIBROMATOSIS OF ORBIT \n\n$=$ rare nonmetastasizing locally invasive fibrous proliferation with tendency to recur after surgical resection\nAge: congenital $(54 \\%),<2$ years of age (in $89 \\%$ )\nClinical forms:\n(1) solitary: $\\mathrm{M}>\\mathrm{F}$\n(2) multicentric (= congenital generalized fibromatosis): $\\mathrm{F}>$ M\nLocation: head \\& neck $>$ trunk $>$ lower extremity $>$ upper extremity\nSite: skin, subcutaneous tissue, deeper structures including visceral organs; combination of all\nMean size: 3.5 (range, $0.5-7.0) \\mathrm{cm}$\n\n- painless swelling / lump + skin discoloration $\\leftarrow$ vascularity\n- proptosis\n\nX-ray:\n$\\sqrt{ }$ nonspecific expansion of orbit\nUS:\n$\\sqrt{ }$ round well-circumscribed mass of heterogeneous texture\n$\\sqrt{ } \\pm$ target appearance $\\leftarrow$ central necrosis / hemorrhage\nCT:\n$\\sqrt{ } \\pm$ orbital bone erosion $\\pm$ small foci of calcifications\n$\\sqrt{ }$ enhancing mass hyperattenuating to muscle\nMR:\n$\\sqrt{ }$ multilobulated / infiltrative margins\n$\\sqrt{ }$ low to intermediate SI relative to muscle on T1WI + (frequently) foci of hyperintensity\n$\\sqrt{ }$ heterogeneous predominantly hyperintense SI on T2WI:\n$\\sqrt{ }$ T2 hyperintensity $\\leftarrow$ high cellularity + myxoid change\n$\\sqrt{ }$ T2 hypointensity $\\leftarrow$ high collagen content\n$\\sqrt{ }$ target appearance $\\leftarrow$ central hemorrhage / necrosis / cystic / myxoid change\n$\\sqrt{ }$ intense diffuse / peripheral enhancement\nPrognosis: spontaneous resolution (common); 7\\% recurrence rate after surgical resection\nMortality: $15 \\%$ overall; $75 \\%$ with visceral involvement\nRx: conservative; surgical resection for local complications\nDDx of solitary disease:\n(1) Rhabdomyosarcoma (occurs in older age group)\n(2) Hemangioma (flow voids at tumor periphery)\n\n## INFECTION OF ORBIT\n\nCause: bacterial infection extending from paranasal sinuses (especially ethmoid + frontal sinuses), face, eyelid, nose, teeth, lacrimal sac through thin lamina papyracea + valveless facial veins into orbit",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 119,
            "markdown": "Organism: staphylococci, streptococci, pneumococci\n\n- lid edema, ocular pain, ophthalmoplegia; fever, elevated WBC\n\nLocation: preseptal = periorbital soft tissue; subperiosteal; peripheral = extraconal fat; extraocular muscles; central = intraconal fat; optic nerve complex; globe; lacrimal gland\n$C x$ : epidural abscess, subdural empyema, cavernous sinus thrombosis, cerebral abscess, osteomyelitis\n\n# Abscess of Orbit \n\n$=$ abscess of intraconal space\nCause: penetrating orbital injury, ocular surgery, metastatic process\n\n- marked proptosis, chemosis, ophthalmoplegia\n- impaired visual acuity\n\nMR:\n$\\sqrt{ }$ hyperintensity on T1WI + T2WI\n$R x$ : surgical drainage for intraconal abscess\n\n## Subperiosteal Orbital Abscess\n\nCause: sinusitis, orbital inflammation\nLocation: along medial wall of orbit between lamina papyracea and medial rectus muscle\n$\\checkmark$ subperiosteal spindle-shaped fluid collection\n$\\checkmark$ displacement of thickened periosteal membrane + increased enhancement\n$\\checkmark$ displacement of adjacent fat + extraocular muscles\n$C x$ : orbital abscess (extension to intraconal space)\n\n## Pott Puffy Tumor\n\n$=$ frontal osteomyelitis with subperiosteal abscess formation beneath galea aponeurotica\nCause: frontal sinusitis + periorbital cellulitis $\\rightarrow$ thrombophlebitis of valveless emissary veins $\\rightarrow$ frontal osteomyelitis\n\n- enlarging broad swollen bump of doughy consistency in the region above brow\n$\\checkmark$ osseous destruction of frontal bone\n$\\checkmark$ frontal subgaleal fluid collection\n$C x$ : epidural / subdural empyema; parenchymal cerebral abscess; meningitis; cavernous sinus thrombosis; thrombophlebitis; venous brain infarct\n\n\n## Orbital / Postseptal Cellulitis\n\n$=$ acute bacterial postseptal infection\nOrbital septum $=$ thin sheet of fibrous tissue originating in the orbital periosteum + inserting in palpebral tissues along tarsal plates; acts as barrier against spread of periorbital infection into posterior compartment of orbit\nCT: $\\sqrt{ }$ thin band paralleling superior orbital rim deep to facial musculature\nClassification: intraconal, extraconal, subperiosteal\nSource: paranasal sinusitis (most commonly) spreading via perivascular pathway\n\n- limitation of eye movement $\\pm$ proptosis\n- visual acuity usually maintained",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 120,
            "markdown": "- fever\n\nLocation: mostly confined to extraconal space\n$\\sqrt{ }$ proptosis\n$\\sqrt{ }$ scleral thickening\n$\\sqrt{ }$ enlargement + displacement of extraocular muscles (frequently medial rectus muscle $\\leftarrow$ ethmoid sinusitis)\n$\\sqrt{ }$ increased attenuation of retroorbital fat + obliteration of fat planes\n$\\sqrt{ }$ opacification of ethmoid + maxillary sinuses (extension through thin lamina papyracea into orbit)\nMR (enhanced fat-suppressed images most sensitive):\n$\\sqrt{ }$ hypointense on T1WI + hyperintense on T2WI\nUS:\n$\\sqrt{ }$ diffuse hypoechoic area invading retrobulbar fat\n$R x:$ IV antibiotics + corticosteroids\n$C x$ : subperiosteal / intraconal abscess; thrombosis of superior ophthalmic vein / cavernous sinus; bacterial meningitis; epididural / subdural abscess; brain abscess; loss of vision\n$D D x$ : edema, orbital pseudotumor, orbital myositis, intra- and extraorbital neoplasm (chloroma, leukemic infiltrate)\n\n# Preseptal / Periorbital Cellulitis \n\n$=$ preseptal infection limited to soft tissues anterior to orbital septum\nPeriorbital (preseptal) + orbital (postseptal) cellulitis are differentiated by location with respect to the orbital septum.\nSource of infection: face, teeth, ocular adnexa, local trauma\n\n- swelling + erythema of eyelid, chemosis\n- limitation of eye movement (in severe cases) without proptosis\n$\\sqrt{ }$ thickening of eyelids + septum\n$\\sqrt{ }$ diffuse swelling of anterior orbital tissues with increased density + obliteration of fat planes\n$R x$ : oral antibiotics in outpatient setting\n\n\n## Edema of Orbit\n\nLocation: usually confined to preseptal structures (eyelid, face); involvement of orbital structures (rare)\n$\\sqrt{ }$ swelling of eyelids / face\n$\\sqrt{ }$ increased attenuation of orbital fat + obliteration of fat planes\n$\\sqrt{ }$ displacement + enlargement of extraocular muscles\nMR:\n$\\sqrt{ }$ hyperintensity on T2WI\n\n## LYMPHANGIOMA OF ORBIT\n\n$=$ VENOUS-LYMPHATIC MALFORMATION\n= NO-FLOW / LOW-FLOW VASCULAR MALFORMATION\n= LYMPHATICOVENOUS MALFORMATION",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 121,
            "markdown": "Prevalence: $\\quad 3.5 \\div 100,000 ; 1-2 \\%$ of orbital childhood masses; $4-8 \\%$ of expanding pediatric orbital lesions; $25 \\%$ of vasculogenic orbital lesions\nOrigin: arises from a pluripotent venous anlage as a malformation (NOT neoplasm of proliferating cells!)\nPath: unencapsulated diffuse multicompartmental lesion often with intra- and extraconal components insinuating between normal orbital structures\nHisto: dilated lymphatics, dysplastic venous vessels, smooth muscle, areas of hemorrhage\n(a) simple / capillary lymphangioma\n= lymphatic channels of normal capillary size\n(b) cavernous lymphangioma (most common)\n$=$ dilated microscopic channels\n(c) cystic hygroma\n$=$ macroscopic multilocular cystic mass\nMay be associated with: intracranial vascular anomalies ( $70 \\%$ ): developmental venous anomalies ( $61 \\%$ ), AVM, cerebral cavernous malformation, sinus pericranii\nAge: $1^{\\text {st }}$ decade or later (mean age of 6 years); $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1 ; 43 \\%$ before age of 6 years; $60 \\%$ before age of 16 years\n\n- proptosis:\n- slowly progressive proptosis with restriction of eye movement, optic nerve compression, vertical displacement of globe\n- sudden proptosis from intratumoral hemorrhage\n$=$ CARDINAL FEATURE; often occurring spontaneously / after minor trauma / during upper respiratory infection\n- worsening proptosis from intralesional proliferation of lymphocytes during viral infection with subsequent resolution\n- associated with lesions on lid, conjunctiva, cheek:\n- eyelid fullness from birth\n- purple discoloration of skin, usually in superomedial orbit\n- vesicles in conjunctiva, facial skin, oral mucosa\n- restricted ocular motility $(50 \\%)$\n- growth with patient's growth $\\pm$ accelerated growth in response to hormonal changes (during puberty / pregnancy)\nLocation: unilateral; usually medial to optic nerve with intra- and extraconal component, crossing anatomic boundaries (conal fascia / orbital septum)\nSite: superficial (conjunctiva + eyelid) in anterior orbit ( $79 \\%$ ); deeper orbit ( $67 \\%$ ); pre- and postseptal orbit $(73 \\%)$\n$\\checkmark$ poorly defined infiltrating multilobulated heterogeneous lesion\n$\\checkmark$ single / multiple cystlike areas with rim enhancement (after hemorrhage):\n$\\checkmark$ solid-appearing microcystic component\n$\\checkmark$ macrocystic component $=$ cysts of $1-2 \\mathrm{~cm}$ in size\n$\\checkmark$ blood cyst = \"chocolate cyst\" associated with multiple recurrences\n$\\checkmark$ variably mild patchy low-flow enhancement ( $=$ venous channels) / ring enhancement (after hemorrhage)\n$\\checkmark$ rarely contains phleboliths (DDx: hemangioma, orbital varix)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 122,
            "markdown": "US:\n$\\checkmark$ heterogeneous echotexture with ill-defined borders:\n$\\checkmark$ area of predominantly cystic low-level internal echoes with infiltrative borders\n$\\checkmark$ hyperechoic intracystic clot\nCT:\n$\\checkmark$ poorly marginated lesion insinuating itself between normal structures:\n$\\checkmark$ well visualized $\\leftarrow$ inherent contrast between malformation + orbital fat\n$\\checkmark$ venous / solid components slightly hyperattenuating relative to brain tissue\n$\\checkmark$ macrocystic lymphatic components similar in attenuation to vitreous of globe\n$\\checkmark$ mild to moderate expansion / remodeling / hyperostotic / lytic lesion of bony orbit\n$\\checkmark \\pm$ widening of superior / inferior orbital fissure\n$\\checkmark$ frequent thickening of upper eyelid\nMR (modality of choice):\n$\\checkmark$ iso- to slightly hyperintense relative to brain on T1WI + very hyperintense relative to brain on T2WI:\n$\\checkmark$ T1WI for lymphatic / proteinaceous fluid\n$\\checkmark$ fat-suppressed T1WI for blood / blood products\n$\\checkmark$ fat-suppressed T2WI for nonhemorrhagic fluid\n$\\checkmark$ fluid-fluid levels of hemorrhages of various ages / T2 shading in multiple cysts (almost PATHOGNOMONIC)\n$\\checkmark$ NO enlarged feeding vessels / flow voids\nPrognosis: no involution; aggressive behavior with continued enlargement (in 64\\%) + recurrence after treatment; eventually loss of vision (in 40\\%); progression slows with termination of body growth\n$R x$ : observation; intralesional injection with sclerosing agents (tetradecyl sulfate or OK-432) / steroids; surgery in case of optic nerve compression + for relieve of pain and for cosmetic improvement\n$D D x$ : orbital varix (affected by postural changes, communication with systemic circulation)\n\n# LYMPHOMA OF ORBIT \n\nUsually presents without evidence of systemic disease; subsequent development of systemic disease frequent\nFrequency: in $8 \\%$ of leukemia; in 3-4\\% of lymphoma; 67-90\\% of orbital lymphoproliferative tumors; $24 \\%$ of all space-occupying orbital tumors in patients $>60$ years of age\nAge: 50 years on average\nType: usually non-Hodgkin B-cell lymphoma; Burkitt lymphoma with orbit as primary manifestation; Hodgkin disease rare\n\n- palpable mass, mildly restricted ocular motility\n- painless swelling of eyelid (pain is uncommon)\n- proptosis (late in course of disease)\n$\\diamond 3^{\\text {rd }}$ most common cause of proptosis (after orbital pseudotumor + cavernous hemangioma)\nLocation: extraconal (especially lacrimal gland, anterior extraconal space, retrobulbar) $>$ intraconal $>$ optic nerve-sheath complex; unilateral ( $76 \\%$ )\n$\\diamond$ The lacrimal gland is a common site for leukemic infiltrates + lymphoma (40\\%)!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 123,
            "markdown": "# Growth types: \n\n(a) well-defined high-density mass (most commonly about lacrimal gland)\n$\\checkmark$ smooth circumscribed mass $(50 \\%)$\n(b) diffuse infiltration (tends to involve entire intraconal region)\n$\\checkmark$ diffuse ill-defined lesion $(50 \\%)$\n$\\checkmark$ tendency to mold to orbital structures (globe, optic nerve, orbital wall $\\rightarrow \\pm$ bone remodeling\n$\\checkmark$ slight to moderate uniform enhancement\n$\\checkmark$ osseous erosion (rare)\n$\\checkmark$ isointense relative to muscle on T1WI\n$\\checkmark$ hyperintense relative to orbital fat on T2WI\nUS:\n$\\checkmark$ solitary / multiple hypoechoic homogeneous masses with infiltrative borders\n$D D x$ : pseudotumor (infiltration / thickening of ocular muscles, mass commonly T2-isointense relative to orbital fat, high ADC values, acute onset of pain)\n\n## MEDULLOEPITHELIOMA\n\n$=$ DIKTYOMA $=$ TERATONEUROMA $[$ diktyon, Greek $=$ net $]$\n$=$ rare embryonal malignant (most) / benign intraocular neoplasm\nOrigin: primitive medullary epithelium in ciliary body\nHisto: folded cords + sheets resembling a fisherman's net (diktyomatous pattern) surrounding fluid collections predominantly composed of hyaluronic acid; heteroplastic components of hyaline cartilage, rhabdomyoblasts, neuroglia, sarcomatous elements (a) teratoid (30$50 \\%$ ) (b) nonteratoid ( $50-70 \\%$ )\nMean age: 5 years; $\\mathrm{M}=\\mathrm{F}$\n\n- poor vision $\\leftarrow$ lens subluxation, lens notching, glaucoma, cataract formation, retinal detachment\n- pain; leukokoria; mass of iris / ciliary body\n- exophthalmos, buphthalmos. strabismus, ptosis\n\nLocation: ciliary body (common); optic nerve head / retina (rare); usually unilateral\n$\\checkmark$ dystrophic calcifications (in hyaline cartilage component) in $30 \\%$\nUS:\n$\\checkmark$ echogenic irregularly shaped /ovoid mass\nCT:\n$\\checkmark$ dense irregular mass\n$\\checkmark$ moderate to marked enhancement\nMR:\n$\\checkmark$ slightly to moderately hyperintense to vitreus on T1WI\n$\\checkmark$ hypointense on T2WI\n$\\checkmark$ marked homogeneous enhancement / heterogeneous ( $\\leftarrow$ cystic components)\nPrognosis: local recurrence common; metastases rare\n\n## METASTASIS TO ORBIT\n\nPrevalence: $1-13 \\%$ of orbital tumors\nOrigin: source known in only in $50 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 124,
            "markdown": "adults: carcinoma of breast + lung\nchildren: neuroblastoma $>$ Ewing sarcoma, leukemia, Wilms tumor\nFrequency of metastases to orbit:\nbreast cancer ( $48-53 \\%$ of orbital metastases) $>$ prostate carcinoma $>$ cutaneous melanoma $>$ lung cancer\n\n- proptosis, motility disturbance, pain, diplopia, $\\downarrow$ vision\n- paradoxical enophthalmos ( $10 \\%$ of orbital lesions)\n$=$ posterior globe retraction $\\leftarrow$ infiltrative + fibrotic contraction of orbital fat $\\leftarrow$ scirrhous breast cancer (most common) / scirrhous gastrointestinal carcinoma\nLocation: $12 \\%$ intraorbital, $86 \\%$ intraocular; bilateral in $1 / 3$\nPreferential site by type of metastasis:\n> breast cancer $\\rightarrow$ orbital fat + muscle\n> prostate cancer $\\rightarrow$ bone\n$>$ melanoma $\\rightarrow$ muscle\n$\\sqrt{ }$ diffuse enhancement of retrobulbar fat with abnormally heterogeneous hypointensity on T1WI $+\\mathrm{T} 2 \\mathrm{WI} \\leftarrow$ fibrotic infiltration\n$D D x$ : thyroid ophthalmopathy (bilateral, sparing tendinous insertions); orbital pseudotumor (typically painful involving tendinous insertion); sarcoidosis\n\n\n# Choroidal Metastasis \n\n[choroid $=$ posterior portion of uvea]\n$\\diamond$ Most common ocular malignancy in adults!\nOrigin: lung $>$ breast, hypervascular + hematologic malignancy\nLocation: posterior half of globe near macula (access via short posterior ciliary arteries); extension along plane of choroid (in $1 / 3$ bilateral + in $1 / 3$ multiple)\n\n- often asymptomatic (unless fovea involved)\n- visual loss $\\leftarrow$ retinal detachment\n$\\checkmark$ small areas of broad-based flat thickening + increased density\n$\\checkmark$ subretinal fluid $=$ retinal detachment\n$\\checkmark$ mild posterior choroidal thickening\nUS:\n$\\checkmark$ often multiple hyperechoic posterior wall masses: usually flat / discoid + with an irregular surface\n$\\checkmark$ higher flow than melanoma at Doppler\nMR:\n$\\checkmark$ iso- to hyperintense on T1WI, hyperintense on T2WI\n$\\checkmark$ heterogeneous enhancement\n$\\checkmark$ may be T1 hyperintense + T2 hypointense $\\leftarrow$ high level of protein / hemoglobin degradation products $\\leftarrow$ metastasis from mucin-producing adenocarcinoma / hemorrhagic metastasis\n\n\n## NORRIE DISEASE\n\n$=$ RETINAL DYSPLASIA\n$=$ X-linked recessive disease: ? inherited form of persistent hyperplastic primary vitreus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 125,
            "markdown": "- seizures, mental retardation (50\\%)\n- hearing loss, deafness by age $4(30 \\%)$\n- bilateral leukokoria + microphthalmia\n- cataract, blindness $\\leftarrow$ absence of retinal ganglion cells\n$\\sqrt{ }$ microphthalmia\n$\\sqrt{ }$ dense vitreus with blood-fluid level\n$\\sqrt{ }$ cone-shaped central retinal detachment\n$\\sqrt{ }$ calcifications\n\n\n# OCULAR TRAUMA \n\nFrequency: 3\\% of all visits to Emergency Department in USA\nCause: blunt trauma ( $97 \\%$ )\nMechanism: motor vehicle accident, sport-related accident, industrial accident, fall, violent trauma\nAssociated with: facial fractures (up to 11\\%), head injury (84\\%)\n\n- clinical evaluation: testing of visual acuity, slit-lamp evaluation of cornea + anterior segment, intraocular pressure measurement, funduscopy\nUS (used if ocular media opaque due to vitreous hemorrhage / hyphema / traumatic cataract):\n$\\diamond$ Dynamic imaging improves visualization of the entire eye and depicts movement of vitreous echoes / lines.\n$\\sqrt{ }$ may depict hyphema, lens dislocations, globe rupture, intraocular foreign body, vitreous + retinal hemorrhage\nContraindications for ocular US:\nsuspected traumatic globe rupture / recent surgery to prevent extrusion of ocular contents\nCT (modality of choice):\n$\\sqrt{ }$ especially useful for foreign body\nMR:\n$\\sqrt{ }$ CONTRAINDICATED with metallic foreign bodies\n$\\sqrt{ }$ usually reserved for subtle open-globe injury / organic foreign body\n\n\n## Anterior Chamber Injury\n\n1. Corneal laceration\n\nCause: usually penetrating trauma\n$\\sqrt{ }$ decreased anterior-posterior dimension of anterior chamber compared to a normal globe on CT\nCave: anterior subluxation of lens may mimick a decreased anterior chamber volume $C x$ : globe rupture with complete penetration of cornea\n2. Traumatic hyphema\n\nCause: disruption of blood vessels in iris / ciliary body\n\n- blood-fluid level in anterior chamber\n$\\sqrt{ }$ increased attenuation in anterior chamber on CT\nCave: US NOT RECOMMENDED $\\rightarrow$ excessive pressure\n\n\n## Lens Dislocation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 126,
            "markdown": "Cause:\n(1) Blunt trauma to eye ( $>50 \\%$ of all lens dislocations)\n(2) Spontaneous (and often bilateral)\nassociated with connective tissue: Marfan syndrome, Ehlers-Danlos syndrome, homocystinuria\nPathomechanism: deformation of globe in anteroposterior direction $\\rightarrow$ compensatory expansion equatorially $\\rightarrow$ stretching + tearing of zonular attachments $\\rightarrow$ dislocation of lens\nLocation of lens: posterior (common) / anterior (unusual)\nTypes:\n(a) partial luxation = one margin of lens maintains its normal position behind iris\n$\\checkmark$ posteriorly angled position of lens\n(b) complete luxation\n$\\sqrt{ }$ lens in dependent portion of vitreous humor\nIn trauma associated with: echogenic lens (= traumatic cataract) + vitreous hemorrhage\n\n# Traumatic Cataract \n\nPathophysiology: disruption of lens capsule $\\rightarrow$ edema within lens $\\rightarrow$ cataract\n$\\sqrt{ }$ hypoattenuating lens compared with nonaffected lens (in acute phase)\n$\\checkmark$ hyperattenuating / calcified lens (= mature cataract)\n\n## Open-Globe Injury = Ruptured Globe\n\n$=$ disruption of scleral integrity by blunt trauma / penetrating injury\nSite: behind insertion of intraocular muscles (= thinnest portion of sclera)\n\n- enlarged anterior chamber\n\nUS: CONTRAINDICATED in suspected globe rupture\nCT (56-75\\% sensitive):\n$\\sqrt{ }$ direct signs of globe injury:\n$\\checkmark$ change in globe contour (DDx: coloboma, staphyloma, posttraumatic orbital hematoma)\n$\\checkmark$ \"flat tire\" sign = loss of volume\n$\\checkmark$ scleral discontinuity with prolapse of vitreus\n$\\checkmark$ indirect signs of globe injury:\n$\\checkmark$ deep anterior chamber $=$ mild posterior movement of lens (in spite of intact zonular fibers)\nMechanism: rupture in posterior segment $\\rightarrow$ decrease in pressure + volume $\\rightarrow$ allows lens to sink posteriorly\n$\\checkmark$ decreased anterior chamber depth = decreased volume in anterior segment $\\leftarrow$ severe corneal laceration\nOne indirect imaging finding of open-globe injuries is alteration of the anterior chamber depth.\n$\\checkmark$ intraocular air (DDx: injected perfluoropropane gas for treatment of retinal detachment)\n$\\checkmark$ intraocular foreign body (DDx: metal buckle of scleral band for treatment of retinal detachment)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 127,
            "markdown": "$\\diamond$ Consider MRI when a clinically suspected open-globe injury is not identified at CT!\n$C x$ : blindness\nNontraumatic mimics:\ncoloboma, staphyloma, congenital glaucoma, elongated globe from myopia, phthisis bulbi\nAltered globe contour:\nmass effect from orbital mass / hematoma\n\n# Ocular Detachments / Posterior Segment Injury \n\n1. Traumatic retinal detachment\n$=$ separation of retina from choroid\nMechanism: traumatic retinal tear $\\rightarrow$ accumulation of vitreous fluid + blood between retina and choroid $\\rightarrow$ detachment of retina\n(a) Total retinal detachment\n$\\checkmark$ characteristic V-shaped appearance with apex at optic disc\n$\\checkmark$ retina remains bound down at ora serrata\n(b) Focal retinal detachment\n$\\checkmark$ elevated immobile line close to sclera at periphery of globe\nRetinal detachments may have a characteristic V-shaped appearance with the apex at the optic disc !\n2. Vitreous detachment\n$=$ separation of vitreous from retina\n$\\checkmark$ thin undulated mobile line moving away from posterior aspect of globe during eye motion\n3. Traumatic choroidal detachment\n$=$ separation of choroid from sclera by fluid accumulation in potential suprachoroidal space\nMechanism: traumatic injury $\\rightarrow$ decreased pressure in posterior segment + suprachoroidal space $\\rightarrow$ accumulation of fluid / blood $\\rightarrow$ detachment of choroidal layer\nSite: from vortex vein to ora serrata\n$\\checkmark$ biconvex / lentiform fluid accumulation\n$\\checkmark$ lentiform / biconvex shape with sparing of posterior portion of globe\n$D D x$ : high-attenuation silicone oil injected between vitreus and retina for treatment of retinal detachment\nChoroidal detachments have a lentiform / biconvex shape and spare the posterior portion of the globe !\n\n## Intraocular Hemorrhage\n\n1. Vitreous hemorrhage ( $53 \\%$ )\n\nMechanism: disruption of retinal blood vessels $\\rightarrow$ hemorrhage into vitreous humor of posterior segment\n\n- \"black rain\" / decreased visual acuity (frequent)\n\nUS:\n$\\checkmark$ normal / slightly increased vitreous echogenicity (= mild acute bleeding)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 128,
            "markdown": "$\\sqrt{ }$ poorly defined low-level echoes / hypoechoic clots within vitreous (= abundant hemorrhage)\n$\\sqrt{ }$ echogenic material moving freely within vitreous chamber during eye movement CAVE: Severe vitreous hemorrhage may obscure other ocular findings!\nCT:\n$\\sqrt{ }$ hyperattenuating fluid in posterior segment\n$C x$ : retinal detachment $\\leftarrow$ vitreous traction $\\leftarrow$ fibrovascular ingrowth following hemorrhage\nPrognosis: resolution may occur within 2-8 weeks\n$R x$ : vitrectomy\n2. Retrohyaloid hemorrhage $(2 \\%)$\n$\\sqrt{ }$ echogenic material remaining behind detached vitreous capsule during eye movement\n3. Hematoma in retroocular space\n\n# Intraocular Foreign Body \n\nIncidence: penetrating eye injury in $3.1 \\div 100,000$ per year\n$\\diamond$ Intraorbital foreign bodies are present in $10-17 \\%$ of all ocular injuries + in $41 \\%$ of open-globe injuries!\nCause: violent trauma, motor vehicle accident, recreational accident, work-related industrial accident\nLocation: anywhere (commonly in posterior segment)\nType: (a) inorganic: metal, glass, plastic\n(b) organic: wood $\\rightarrow$ may cause a severe infection\n\nRadiography ( $40-90 \\%$ sensitive, depending on type of material)\nUS ( $95 \\%$ sensitive for intraocular $+50 \\%$ for intraorbital foreign body):\n$\\sqrt{ }$ echogenic spot\n$D D x$ : intraocular air may mimic a foreign body\nCT (up to $100 \\%$ sensitive):\n$\\sqrt{ }$ metallic fragments $<1 \\mathrm{~mm}$ can be demonstrated\n$\\sqrt{ }$ glass foreign body: (detection depends on location, size + type of glass)\n$\\sqrt{ } 96 \\%$ of $>1.5-\\mathrm{mm}$ glass foreign bodies\n$\\sqrt{ } 48 \\%$ of $0.5-\\mathrm{mm}$ glass foreign bodies\n$\\sqrt{ }$ wood splinter:\n$\\sqrt{ }$ Wood is initially of low attenuation similar to air\n$\\sqrt{ }$ geometric margins\n$\\sqrt{ }$ increase in density after $1-5$ days\nMR:\nN.B.: Failure to detect a metallic foreign body before performing MR may result in blindness!\n$\\sqrt{ }$ more sensitive than CT in depicting organic material\n$C x$ : siderosis (if metallic), endophthalmitis, retinal toxicity, vision loss\n$D D x$ : optic drusen; scleral plaques (calcifications along insertions of medial + lateral rectus mm. in elderly); calcified cataract; material for treatment of retinal detachment (scleral bands, silicon oil, gas)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 129,
            "markdown": "# OPTIC DRUSEN \n\n[druse, German = geode]\n$=$ accretions of hyaline material on / near surface of optic disc; often familial\nAge: patient with macular degeneration; also in young patient\n\n- usually asymptomatic\n- headache, visual field defects\n- pseudopapilledema\n\nLocation: at junction of retina + optic nerve; bilateral in $75 \\%$\nUS:\n$\\checkmark$ hyperechoic lesions at papilla + acoustic shadowing\nCT:\n$\\checkmark$ hyperattenuating small flat / round calcification\nCx: atrophy of optic nerve\n\n## OPTIC PATHWAY GLIOMA\n\n$=$ JUVENILE PILOCYTIC ASTROCYTOMA = OPTIC NERVE GLIOMA\n$=$ isolated to single prechiasmatic optic nerve anywhere along optic tract $\\pm$ extension to other optic nerve, chiasm, optic tract\n$\\diamond$ Most common > cause of optic nerve enlargement\n> primary tumor of optic nerve\n> intraconal tumor of childhood\n> CNS neoplasm in NF1\nFrequency: $1 \\%$ of all intracranial tumors; $4 \\%$ of orbital masses; $80 \\%$ of primary tumors of optic nerve\nPath: optic nerve is embryologically part of hypothalamus and develops gliomas instead of schwannomas\n(a) perineural spread $=$ fusiform enlargement of optic nerve: boundary between tumor and nerve often indistinguishable, overlying dura stretched but intact\n(b) subarachnoid spread = tumor predominantly involves subarachnoid space surrounding a relatively spared nerve: infiltration through pia mater but contained by dura\nHisto: proliferation of well-differentiated astrocytes\n$=$ low-grade glial neoplasm with cystic components\n(a) in children (most common): juvenile pilocytic astrocytoma = grade 1 WHO with spindle-shaped astrocytes having hairlike (pilocytic) processes $\\pm$ eosinophilic degenerative cell processes (Rosenthal fibers)\n(b) in adults: glioblastoma\n\nMean age: 4-5 years; $1^{\\text {st }}$ decade (75\\%); rare in adults without NF1 (GBM); M+F = 1+2 to 2+3\nAssociated with: neurofibromatosis type 1 (NF1) in 10-33-50\\% ( $\\pm$ bilateral optic gliomas)\n$\\diamond 15-21 \\%$ of children with NF1 have (often bilateral) optic nerve gliomas\n$\\diamond 10 \\%$ of all optic nerve gliomas are associated with neurofibromatosis\n\n- decreased visual acuity / visual-field deficit\n- optic disc edema, pallor, atrophy (axonal damage)\n- abnormal pupillary reflex; relative afferent pupillary defect",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 130,
            "markdown": "- axial proptosis with larger masses (less common)\n- vision loss, strabismus\n- spasmus nutans (= high-frequency nystagmus of low amplitude associated with head nodding movement)\n- precocious puberty with accelerated growth (in 39\\% of only NF1 patients) $\\leftarrow$ involvement of optic chiasm + hypothalamus\nLocation: any part of optic pathway (intraorbital optic nerve in 25-48\\%); unilateral (most common); bilateral / multifocal (PATHOGNOMONIC for NF1); involvement of chiasma (more common in sporadic cases without NF1)\nExtension to: intracanalicular + retrocanalicular optic nerve; lateral geniculate body and optic radiation (rare)\n$\\checkmark$ tubular / fusiform / excrescentic well-circumscribed homogeneous enlargement of optic nerve-sheath complex:\n$\\checkmark$ CHARACTERISTIC kinking / buckling of nerve\n$\\checkmark$ posterior extension to involve chiasm + hypothalamus in $25-60 \\%$ (indicates nonresectability)\n$\\checkmark$ ipsilateral optic canal enlargement $(90 \\%)>3 \\mathrm{~mm} / 1 \\mathrm{~mm}$ difference compared with contralateral side\nCT:\n$\\checkmark$ iso- to slightly hypodense compared to normal optic nerve\n$\\checkmark$ variable contrast enhancement (less intense than meningioma)\n$\\checkmark$ calcifications (rare)\nUS:\n$\\checkmark$ well-defined homogeneous mass of medium echogenicity inseparable from optic nerve\nMR: more sensitive than CT in detecting intracanalicular + intracranial extent\n$\\checkmark$ fusiform enlargement of nerve (without NF1):\n$\\checkmark$ effacement of surrounding subarachnoid space\n$\\checkmark$ tortuous / kinked / buckled diffusely enlarged optic nerve (NF1 patient):\n$\\checkmark$ tumor in subarachnoid space surrounds normal-sized optic nerve\n$\\checkmark$ lesion isointense to muscle on T1WI\n$\\checkmark$ lesion heterogeneously hyperintense on T2WI\n$\\checkmark$ rim of T2-hyperintensity at tumor periphery (mimicking expanded subarachnoid space) = arachnoidal gliomatosis $\\leftarrow$ leptomeningeal infiltration + proliferation\n$\\checkmark \\pm$ cystic spaces\n$\\checkmark$ calcifications (rare)\n$\\checkmark$ nerve indistinguishable from tumor (DDx to meningioma)\n$\\checkmark$ variable enhancement (in 50\\%):\n$\\checkmark$ additional intracranial findings:\n$\\checkmark$ other gliomas\n$\\checkmark$ macrocephaly\n$\\checkmark$ hydrocephalus $\\leftarrow$ aqueductal stenosis (almost exclusive to patients without NF1)\n$\\checkmark$ neurofibromatosis spots (= foci of T2 prolongation due to myelin vacuolization)\n$C x$ : precocious puberty $\\leftarrow$ hypothalamic impingement\nPrognosis: slow growth / stability over time; 87-97\\% 5-year survival\n$R x$ : conservative management; chemotherapy (for young patients), radiation therapy (for patients $>5$ years of age)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 131,
            "markdown": "$D D x$ : optic nerve sheath meningioma (middle age, hyperattenuating mass, plaquelike calcifications, hypointense on T2WI, intense enhancement, no intracranial extension along optic pathway)\n\n# Malignant Optic Glioma of Adulthood \n\nPrevalence: extremely rare; 30 cases in this century\nMean age: $6^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=1.3 \\div 1.0$\nHisto: anaplastic astrocytoma / glioblastoma multiforme\n\n- rapidly progressive monocular visual loss culminating in monocular blindness within a few weeks\n- with retrograde tumor extension: contralateral temporal hemianopia, polyuria, polydipsia\n$\\sqrt{ }$ focal / diffuse enlargement of optic nerve\n$\\sqrt{ }$ hypo- to isointense on T1WI + hyperintense on T2WI\n$\\sqrt{ }$ obliteration of subarachnoid space around affected portion of nerve\n$\\sqrt{ }$ diffuse intense enhancement of optic nerve\n$\\sqrt{ }$ thickening + abnormal enhancement of optic nerve sheath\nTumor extension: optic chiasm, hypothalamus, basal ganglia, brain stem, medial temporal lobes, leptomeninges, ependyma\nPrognosis: $<1$-year survival despite aggressive therapy\n$D D x$ : (1) Optic neuritis (demyelinating plaques elsewhere)\n(2) Perioptic meningioma (hypointense on T2WI, stippled calcifications, hyperostosis)\n(3) Sarcoidosis, lymphoma, orbital pseudotumor (moderately / markedly hypointense on T2WI)\n\n\n## OPTIC NERVE SHEATH MENINGIOMA\n\n$=$ PERIOPTIC MENINGIOMA\nFrequency: $2 \\%$ of space-occupying orbital masses; $<2 \\%$ of intracranial meningiomas $\\diamond 2^{\\text {nd }}$ most common optic nerve tumor!\nMean age: 49 years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 4$; slightly more aggressive in children\nOccasionally associated with:\nneurofibromatosis type 2 (usually in teenagers)\nOrigin: meningothelial cells in arachnoid sheath of optic nerve in orbit / middle cranial fossa\nHisto: syncytial growth pattern composed of meningioma cells with indistinct cytoplasmic margins $\\pm$ multiple ringlike psammoma bodies ( $=$ round calcifications)\n\n- classic clinical triad of retinal examination:\n(1) Painless slowly progressive loss of visual acuity over months\n(2) Optic nerve atrophy $\\rightarrow$ progressive loss of vision\n(3) Optociliary shunt vessels $=$ dilated connections between ciliary circulation + central retinal vessels $\\leftarrow$ long-term compression of central retinal vein\n- proptosis\n\nLocation:\n(a) orbit = intraoptic nerve sheath meningioma\n(b) in optic canal $=$ intracanalicular meningioma\n(c) intracranial opening of optic canal = foraminal meningioma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 132,
            "markdown": "(d) middle cranial fossa\n$\\sqrt{ }$ tubular (most common) / fusiform / eccentric (excrescentic) thickening of optic nerve\n$\\sqrt{ }$ calcifications in $20-50 \\%$ (HIGHLY SUGGESTIVE)\n$\\sqrt{ }$ sphenoid bone hyperostosis\nUS:\n$\\checkmark$ hypoechoic tumor with irregular border\nCECT: enhancement is the rule\n$\\checkmark$ tumor enhancement around nonenhancing optic n.:\n$\\sqrt{ }$ \"tram-track\" configuration on axial CECT = enhancing tumor on either side of spared optic nerve\n$\\checkmark$ ringlike / doughnut configuration on coronal CECT\n$\\checkmark$ linear high-attenuation area parallel to optic nerve (= tumor spread along subarachnoid space)\n$\\checkmark$ bone remodeling $\\pm$ enlargement of optic canal\n$\\checkmark$ minimal extension into optic canal (not uncommon)\nMR (most valuable in determining extent of disease):\n$\\checkmark$ hypointense to fat on T1WI\n$\\checkmark$ iso- to slightly hyperintense relative to optic nerve on T2WI\n$\\checkmark$ \"tram-track\" sign = intensely enhancing extrinsic soft-tissue mass surrounding optic nerve on fat-suppressed T1WI\n$R x:$ surgical intervention to prevent disease dissemination to contralateral eye if disease spreads to optic chiasm\n\n# OPTIC NEURITIS \n\n$=$ nerve involvement by inflammation, degeneration, demyelination\nEtiology:\n(1) Multiple sclerosis (involves optic nerve in $1 / 3$ )\n(2) Inflammation $\\leftarrow$ ocular infection\n(3) Degeneration: toxic, metabolic, nutritional\n(4) Ischemia\n(5) Meningitis / encephalitis (= viral infection)\n(6) Systemic lupus erythematosus\n(7) Radiation therapy\n$\\diamond 45-80 \\%$ of patients develop multiple sclerosis within 15 years of their first episode of optic neuritis!\n\n- ipsilateral ocular pain on eye movement\n- sudden onset of unilateral loss of vision over several hours to several days\n\nCT:\n$\\checkmark$ normal / mildly enlarged optic nerve + chiasm\n$\\checkmark$ may show enhancement\nMR:\n$\\checkmark$ mild enlargement + enhancement of optic nerve best demonstrated on axial T1WI\n$\\checkmark$ hyperintense optic nerve on T2WI\nPrognosis: spontaneous improvement of visual acuity within 1-2 weeks",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 133,
            "markdown": "# Perioptic Neuritis \n\nEtiology: demyelination from\n(1) Multiple sclerosis\n(2) Infection: measles, mumps, syphilis\n(3) Sarcoidosis\n$\\sqrt{ }$ leptomeningeal enhancement obscures lucent optic nerve\n\n## ORBITAL SCHWANNOMA\n\n$=$ slowly progressive benign tumor\nLocation: branches of trigeminal ( CN V ) nerve (most common) $>$ oculomotor $>$ trochlear $>$ abducens $>$ para-sympathetic $>$ sympathetic fibers $>$ ciliary ganglia\nSite: extraconal superior orbit often abutting orbital apertures $\\leftarrow$ origin from supratrochlear and supraorbital nn. of frontal branch of ophthalmic n.\n$\\sqrt{ }$ cone-shaped tumor $\\leftarrow$ involvement of orbital apex\n$\\sqrt{ }$ dumbbell shape $\\leftarrow$ involvement of superior orbital fissure\nMR:\n$\\sqrt{ }$ well-circumscribed mass:\n$\\sqrt{ }$ uniformly T1-isointense $\\pm$ variations\n$\\sqrt{ }$ T2-hyperintense heterogeneous pattern $\\leftarrow$ mixture of solid and cystic components\n$\\sqrt{ }$ typically heterogeneous uptake of contrast medium\n$D D x$ : cavernous malformation (homogeneous pattern, progressive enhancement)\n\n## PERSISTENT FETAL VASCULATURE\n\n$=$ PERSISTENT HYPERPLASTIC PRIMARY VITREUS\n$=$ rare congenital nonhereditary condition with persistence + hyperplasia of fibrovascular system derived from embryonic primary vitreus + its hyaloid arterial supply $\\leftarrow$ arrest of normal regression\nEmbryology:\n\n## > Hyaloid artery\n\n$=$ important source of intraocular nutrition until $8^{\\text {th }}$ month of gestation; arises from dorsal ophthalmic artery at $3^{\\text {rd }}$ week of gestation; grows anteriorly with branches supplying vitreus + posterior aspect of lens\n> Primary vitreous humor\n[vitreus, Latin = glass; humor, Latin = body fluid]\n$=$ fibrillar ectodermal meshwork + mesodermal tissue consisting of embryonic hyaloid vascular system; appears during $1^{\\text {st }}$ month of life in posterior ocular chamber between lens + retina; involutes by $6^{\\text {th }}$ month of gestation\n\n## > Secondary / adult vitreous humor\n\nbegins to form during $3^{\\text {rd }}$ gestational month; watery mass of loose collagen fibers + hyaluronic acid gradually replaces primary vitreus, which is reduced to a small S-shaped remnant (hyaloid canal $=$ Cloquet canal) and serves as lymph channel\nPathogenesis: breakdown in posterior capsule $\\rightarrow$ invasion of lens $\\rightarrow$ absorption of lens $\\rightarrow$ cataract formation + glaucoma; hemorrhage from fibrovascular tissue (common) $\\rightarrow$ folding of retina with detachment $(30-56 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 134,
            "markdown": "May be associated with: any severe ocular malformation / optic dysplasia / trisomy 13\nAge: noticed at birth / within first few weeks of life\n\n- unilateral leukokoria ( $2^{\\text {nd }}$ most common cause)\n$\\diamond 19-28 \\%$ of leukokoria cases\n- seizures, mental deficiency, hearing loss\n- $\\pm$ cataract, strabismus, painful glaucoma, hyphema, uveitis\n- ophthalmoscopy: S-shaped tubular mass extending between posterior surface of lens + region of optic nerve head; lens opacity may preclude diagnosis\nLocation: unilateral\n$\\diamond$ Bilaterality is a feature of a congenital syndrome (Norrie disease, Warburg disease)!\n$\\checkmark$ microphthalmia $=$ small hypoplastic globe $(61-92 \\%)$ :\n$\\checkmark$ normal-sized globe $(13 \\%)$\n$\\checkmark$ buphthalmos (in up to $26 \\%$ )\n$\\checkmark$ retinal detachment $\\leftarrow$ vitreoretinal traction in $30 \\%$\nUS:\n$\\checkmark$ hyperechoic band extending from posterior pole of globe to posterior surface of lens (= embryonic rest of primary vitreus)\n$\\checkmark$ central anechoic line (= persistent hyaloid artery) with positive Doppler signals\n$\\checkmark$ hyperechoic band extending from papilla to ora serrata (= retinal detachment)\n$\\checkmark$ heterogeneous increased echogenicity of vitreus $\\leftarrow$ hemorrhage\nCT:\n$\\checkmark$ enhancing cone-shaped central retrolental density extending from lens through vitreous body to back of orbit, just lateral to optic nerve (= primary vitreus)\n$\\checkmark$ linear band / septum extending to posterior pole\n$\\checkmark$ small optic nerve\n$\\checkmark$ abnormally small lucent rounded lens $\\leftarrow$ absorption / swelling\n$\\checkmark$ hyperdense vitreus (from previous hemorrhage)\n$\\checkmark$ fluid-fluid levels from breakdown of recurrent hemorrhage in subhyaloid (between vitreus + retina) / subretinal space (between sensory + pigment epithelium)\n$\\diamond$ Blood does NOT layer in extremely viscous vitreous humor\n$\\checkmark$ enhancement of vascular retrolental mass\n$\\checkmark$ NO calcifications\nMR:\n$\\checkmark$ hyperintense vitreous body on T1WI + T2WI from chronic blood degradation products (methemoglobin) / proteinaceous fluid\n$\\checkmark$ hypo- to isointense thin triangular band with base near optic disc and apex at posterior surface of lens\n$\\checkmark$ marked enhancement of fibrovascular mass within vitreus\n$\\checkmark$ lens abnormalities\n$\\checkmark$ elongated ciliary process\n$\\checkmark$ anterior tenting retina\nCx: (1) Glaucoma, cataract from recurrent spontaneous intravitreal hemorrhage (due to friable vessels)\n(2) Proliferation of embryonic tissue",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 135,
            "markdown": "(3) Retinal detachment from organizing hemorrhage / traction\n(4) Hydrops / atrophy of globe + resorption of lens\n(5) Phthisis bulbi (scarred shrunken eye)\n\nRx: preservation of globe for cosmetic reasons; enucleation for retinal hemorrhage + glaucoma only\n\n# PHTHISIS BULBI \n\n[phthinein, Greek = to waste away]\n$=$ \"wood eye\" = shrunken nonfunctioning + usually calcified eye\nCause: trauma, angiomatosis, intrauterine environmental conditions, infection, genetic disorders, retrolental fibroplasia (retinopathy of prematurity)\nUS:\n$\\sqrt{ }$ shrunken eye\n$\\sqrt{ }$ usually calcified wall\n$\\sqrt{ } \\pm$ hyperechoic fibrous tracts within vitreous + resultant retinal detachment\n\n## PLEOMORPHIC ADENOMA OF ORBIT\n\n$=$ BENIGN MIXED TUMOR\nFrequency: $57 \\%$ of epithelial lesions in lacrimal gland\n$\\diamond$ Most common benign neoplasm of lacrimal gland\nAge: $4^{\\text {th }}$ to $5^{\\text {th }}$ decade of life\n\n- proptosis (= commonly downward displacement of globe)\n- rarely painful slow-growing tumor\n\nHisto: fibrous pseudocapsule with epithelial cells that may form nests / tubules resembling ducts; myxoid / mucinous background stroma with spindle-shaped cells $\\pm$ cartilage or bone\nLocation: superotemporal orbit\n$\\sqrt{ }$ well-circumscribed usually homogeneously enhancing mass\n$\\sqrt{ }$ larger lesion heterogeneous $\\leftarrow$ cystic degeneration, hemorrhage, serous / mucous collections, necrosis\n$\\sqrt{ }$ smooth concavity of lacrimal fossa $\\leftarrow$ bone remodeling\n$\\sqrt{ }$ T1-hypointense + T2-hyperintense mass\n$D D x$ : lacrimal gland malignancy (infiltrative borders, nodularity, bone erosion)\n\n## PRIMARY ORBITAL MELANOMA\n\n$=$ UVEAL MELANOMA $=$ Choroidal Melanoma\nMost common primary intraocular neoplasm in adult Caucasian\nPrevalence: $5-7 \\div 1,000,000$\nMean age: 56 (range, $50-70$ ) years; in $65 \\%>50$ years of age; Whites+African Americans $=$ $8 \\div 1$ to $15 \\div 1$\nPredisposed: exposure to sunlight, fair skin complexion, light eye color, preexisting melanocytic nevi\nAt risk: Caucasian, light-colored iris, ocular melanocytosis\nPath: mushroom-shaped tumor with broad choroidal base / flat mass / crescentic mass; range",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 136,
            "markdown": "from amelanotic to heavily pigmented lesion\nHisto: (a) spindle containing varying amounts of spindle-B cells\n(b) epithelioid cells with abundant cytoplasm, clear cellular borders, enlarged ovoid nuclei\nMetastases to: globe, optic nerve; liver ( $90 \\%$ ), lung ( $24 \\%$ ), bone ( $16 \\%$ ), kidney, brain, subcutis\n\n- asymptomatic (most frequently) detected on routine eye exam\n- pain (uncommon), floaters, astigmatism\n- visual loss $\\leftarrow$ vitreous hemorrhage\n- visual field (campimetric) defect\n- photopsia (perceived flashes of light) $\\leftarrow$ retinal detachment\n- glaucoma (with iris location)\n- accommodation impairment (with ciliary body location)\n\nLocation: choroid ( $85-93 \\%$ ) > ciliary body ( $4-9 \\%$ ) > iris ( $3-6 \\%$ ); almost always unilateral\n$\\sqrt{ }$ initially flat growth profile, later becoming elevated, erupting through Bruch membrane (= innermost layer of choroid) into a CHARACTERISTIC mushroom shape\n$\\sqrt{ }$ episcleral spread after infiltration of underlying sclera\n$\\sqrt{ }$ moderate to strong contrast enhancement\nUS ( $95 \\%$ diagnostic accuracy):\n$\\sqrt{ }$ low-to-medium internal reflectivity spikes on tumor surface + vascular oscillations (Amode US)\n$\\sqrt{ }$ domed lobulated mushroom-shaped mass / round hyperechoic solid mass / small flat lesion\n$\\sqrt{ }$ well-defined solid mass with smooth surface (unless hemorrhagic / necrotic)\n$\\sqrt{ }$ NO calcification\n$\\sqrt{ }$ choroidal excavation beneath a small posterior wall mass with retinal bowing $\\leftarrow$ local invasion (TYPICAL)\nCT:\n$\\sqrt{ }$ nonspecific ill-defined hyperdense thickening of wall of globe with inward bulge\n$\\sqrt{ }$ diffuse moderate enhancement\n$\\sqrt{ }$ calcifications may appear after therapy\n$\\sqrt{ }$ diffuse moderate enhancement $\\leftarrow$ abnormal / absent blood-ocular barrier\n$\\sqrt{ }$ restricted diffusion + low apparent diffusion coefficient\nMR (superior to CT, mainly used for extraocular extension):\n(a) melanotic melanoma $(75 \\%)=\\mathrm{T} 1+\\mathrm{T} 2$ shortening effect of paramagnetic stable free radicals with unpaired electrons in melanin pigment\n$\\sqrt{ }$ paramagnetic effect of melanin $\\rightarrow$ intrinsic T1 + T2 shortening: $\\uparrow$ T1 signal intensity +\n$\\downarrow$ T2 signal intensity\n(b) amelanotic / slightly melanotic melanoma (25\\%)\n$\\sqrt{ }$ iso- to hypointense on T1WI\n$\\sqrt{ }$ hyperintense lesion on T2WI\n$D x$ : indirect ophthalmoscopy, clinical history, transillumination, sequential US evaluation\n$C x$ : retinal detachment and extrascleral spread\n$R x$ : plaque brachytherapy, external beam radiation, transpupillary thermotherapy, surgical enucleation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 137,
            "markdown": "N.B.: small nonprogressive melanoma $<3 \\mathrm{~mm}$ thick can be followed every 3-6 months by US\nPrognosis: 5-year survival rate for (a) small $<3 \\mathrm{~mm}$ thick choroidal melanoma $85 \\%$, (b) medium $3-10 \\mathrm{~mm}$ thick choroidal melanoma $68 \\%$, (c) large $>10 \\mathrm{~mm}$ thick choroidal melanoma $47 \\%$; mean survival of $2-7$ months for metastatic disease\n$D D x$ : (1) Choroidal metastasis (frequently bilateral + multiple, usually broad-based flat lesion, iso- to hyperintense on T1WI, hyperintense on T2WI, heterogeneous enhancement)\n(2) Choroidal hemangioma (typically hypointense on T1WI + extremely hyperintense on T2WI, appreciable enhancement, high internal reflectivity at A-mode US)\n(3) Vitreous hemorrhage / clot (typically hyperintense on T1WI + extremely hypointense on T2WI greater than for melanoma $\\leftarrow$ intracellular methemoglobin, no enhancement)\n(4) Retinal detachment (similar to vitreous hemorrhage, pathognomonic V shape)\n(5) Melanocytic nevus (common small flat lesion, difficult to detect at MRI, no flow at Doppler, pigmented tumor at direct examination)\n(6) Orbital melanocytoma $=$ subtype of nevus (enhancing hyperintense lesion on T1WI + extremely hypointense on T2WI, indistinguishable from uveal melanoma at MRI)\n(7) Retinoblastoma (younger patient, calcifications at CT, high internal reflectivity at Amode US, heterogeneously enhancing T1 hypointense + T2 hyperintense lesion)\n(8) Retinal hamartoma = hemangioblastoma (in tuberous sclerosis, heterogeneously enhancing T1 hypointense + T2 hyperintense lesion)\n(9) Osteoma (same SI characteristics as uveal melanoma, bone attenuation at CT)\n\n# PSEUDOTUMOR OF ORBIT \n\n$=$ INFLAMMATORY MYOFIBROBLASTIC TUMOR $=$ IDIOPATHIC ORBITAL INFLAMMATORY SYNDROME\n$=$ idiopathic nongranulomatous inflammatory process affecting all intraorbital soft tissues Etiology:\n(a) cause not apparent at time of study: bacterial, viral, foreign body\n(b) systemic disease presently not apparent: part of in IgG4-related disease, sarcoidosis, collagen, endocrine\n(c) idiopathic: probably abnormal immune response\n\nFrequency: $6 \\%$ of all orbital lesions\n$\\diamond 2^{\\text {nd }}$ most common cause of exophthalmos ( $25 \\%$ of all unilateral exophthalmos)\n$\\diamond 3^{\\text {rd }}$ most common primary tumor of the orbit\nAge: young to middle-aged; $\\mathrm{M}=\\mathrm{F}$\nHisto: myofibroblastic spindle cells with an inflammatory infiltrate of plasma cells + lymphocytes + eosinophils\nMay be associated with:\nWegener granulomatosis, sarcoidosis, fibrosing mediastinitis, retroperitoneal fibrosis, thyroiditis, cholangitis, vasculitis, lymphoma\n\n- sudden acute onset of unilateral eye pain\n- ophthalmoplegia (= impaired ocular movement) + diplopia\n- decreased visual acuity, proptosis; eyelid swelling, chemosis\n\nLocation: retrobulbar fat ( $76 \\%$ ), commonly superior + medial extraocular muscle (57\\%), optic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 138,
            "markdown": "nerve ( $38 \\%$ ), uveal-scleral area ( $33 \\%$ ), lacrimal gland ( $5 \\%$ ), thyroid gland, skull base; usually unilateral\nSubcategories: often coexistence\n(1) Myositic type (most common) affects extraocular muscles\n$\\checkmark$ enlargement of one / more extraocular muscles with ill-defined margins close to insertion on globe\n$\\checkmark$ typically at muscles + tendon insertions (DDx to Graves disease with muscle involvement only)\n(2) Dacryoadenitis-related form affects lacrimal glands\n(3) Neuritis-associated form affects optic nerve sheath\n(4) Apical form affects orbital apex\n(5) Episcleral form affects anterior orbit with sclera and preseptal soft tissues\n(6) Diffuse form affects entire orbit\n$\\checkmark$ inflammatory stranding of retrobulbar fat (may involve anterior compartment)\n$\\checkmark$ SPECIFIC uveoscleral thickening ( $1 / 4$ ) with enhancement (sclera near Tenon capsule)\n$\\checkmark$ orbital muscle thickening $\\leftarrow$ myositis\n$\\checkmark$ enhancement of optic nerve sheath\n$\\checkmark$ enlarged inflamed lacrimal gland\n$\\checkmark$ proptosis\n$\\checkmark$ bone destruction and intracranial extension (rare)\nMR:\n$\\checkmark$ lesion isointense to fat on T2WI\nPrognosis:\n(1) Remitting / chronic + progressive course (= intermediate malignant potential)\n(2) Rapid dramatic + lasting response to steroid therapy\n\nCx: Tolosa-Hunt syndrome ( $=$ involvement of cavernous sinus by pseudotumor)\n$D D x$ : (1) Lymphoma (may be confused with lymphoma clinically, radiographically, pathologically)\n(2) Thyroid ophthalmopathy (tapering of distal muscles, painless proptosis)\n(3) Radiation therapy\n\n# RETINAL ASTROCYTOMA \n\n$=$ RETINAL ASTROCYTIC HAMARTOMA\n$=$ low-grade benign neoplasm / hamartoma arising from the nerve fiber layer of retina / optic nerve\nEtiology: tuberous sclerosis (53\\%); neurofibromatosis type 1 (14\\%); sporadic (33\\%)\n$\\diamond 50 \\%$ of patients with tuberous sclerosis develop astrocytic hamartomas (bilateral in $1 / 4)$ !\nPath: usually multiple + bilateral in tuberous sclerosis;\n(1) small flat noncalcified semitranslucent lesion in posterior / peripheral retina\n(2) \"mulberry\" lesion = raised white tumor in posterior retina with fine nodularity containing calcifications + cystic fluid accumulations\nHisto: spindle-shaped fibrous astrocytes with small oval nuclei\nAge: congenital",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 139,
            "markdown": "- leukokoria (3\\% of all childhood cases of leukokoria)\n- asymptomatic, progressive loss of vision\n\nLocation: retina near optic disc; bilateral in $25 \\%$\n$\\sqrt{ }$ retinal mass $\\pm$ enhancement $\\pm$ calcifications\n$\\sqrt{ }$ typically unilateral (DDx to drusen)\n$C x$ : (1) Central retinal vein occlusion + secondary hemorrhage\n(2) Neovascular glaucoma\n(3) Extensive tumor necrosis\n$R x$ : not necessary\n$D D x$ : retinoblastoma\n\n# RETINAL DETACHMENT \n\n$=$ separation of the sensory retina from retinal pigment epithelium $(\\mathrm{RPE})=$ deep retinal layer adjacent to choroid\n$\\diamond$ MEDICALEMERGENCY!\nCause: inflammation, neoplasm, trauma\nPathophysiology: formed vitreous gel liquefies with age, eventually separates from retina Mechanism:\n(a) rhegmatogenous / retinal tearing (most common) $=$ tear in retina $\\rightarrow$ accumulation of liquefied vitreus in subretinal space $\\rightarrow$ separation of retina from underlying RPE [rhegma, Greek = discontinuity, break]\nPredisposed: diabetic retinopathy, trauma, high myopia, congenital cataract, surgery, congenital glaucoma, sickle cell disease, leukemia, systemic lupus erythematosus, metastases\n(b) tractional: pulling / tugging by vitreous membranes /fibrovascular tissue (scar)\n(c) exudative: = blood / fluid / tumor within subretinal space\n$\\sqrt{ }$ CHARACTERISTIC V-shape (= total detachment)\n$\\sqrt{ }$ in one quadrant only (= partial detachment)\n$\\sqrt{ }$ thick folded retina with loss of mobility (long-standing detachment)\n$\\sqrt{ }$ subretinal space normal / occupied by blood / inflammation / tumor (depending on cause)\nMR:\n$\\sqrt{ }$ differentiation of serous vs. proteinaceous vs. hemorrhagic fluid\nUS:\n$\\sqrt{ }$ curvilinear line of high echogenicity fixed at optic disc (= papilla) + extending to ora serrata forming an acute angle of V shape with apex at optic disc\n$\\sqrt{ }$ floating echogenic line fixed at papilla extending to ora serrata (if acute)\n$\\sqrt{ }$ thick folded fixed echogenic line (if chronic)\n$\\sqrt{ } \\pm$ anechoic retinal cysts\n$\\sqrt{ }$ fluid $=$ anechoic; blood $=$ anechoic / hypoechoic with low-level echoes; neoplasm $=$ solid heterogeneous hypoechogenicity\n$C x$ : vision loss (if macula involved)\n$R x$ : scleral buckle, pneumatic retinopexy, laser therapy, cryotherapy, vitrectomy\n$D D x$ : proliferative vitreous membranes (lines / irregularities), choroidal detachment (point of fixation not at papilla)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 140,
            "markdown": "DDx of partial detachment: diabetes, macular lesion, retinal ischemia\nN.B.: Examine subretinal space and vitreous for blood / exudative fluid / tumor since determination of cause is usually not possible at ophthalmoscopy.\n\n# RETINOBLASTOMA \n\n$=$ NEUROEPITHELIOMA OF RETINA\n$=$ rare aggressive malignant congenital intraocular tumor\nPrevalence: $1 \\div 18,000$ children $<5$ years old in USA; $1 \\div 17,000-1 \\div 24,000$ live births $\\diamond$ Most common intraocular childhood malignancy\nFrequency: $1 \\%$ of all pediatric malignancies; $11 \\%$ of all cancers in $1^{\\text {st }}$ year of life; in $80 \\%$ diagnosed $<3$ years of age; in $95 \\%<5$ years of age\nOrigin: primitive photoreceptor cells of immature retina (included in primitive neuroectodermal tumor group)\nCause: biallelic mutation (= loss of function of both alleles) in primitive neuroepithelial cells located on long arm of chromosome 13 (13q14) $\\rightarrow$ inactivation of retinoblastoma tumor suppressor gene Rb 1\nMen age: at presentation 18 (range for bilateral tumors 7-16, range for unilateral tumors 2429) months; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$; no race predilection\n\nLocation: bilateral in $20-34 \\%$\nClassification:\n(A) SPORADIC NONHERITABLE FORM (60\\%)\n\nClinical DDx to nonheritable form:\n$\\diamond$ Tumor typically solitary\n$\\diamond$ Age of onset usually $>2$ years\n(1) Sporadic postzygotic somatic mutation (subsequent generations unaffected)\n\nMean age at presentation: 23 months\n(2) Chromosomal anomaly\n$=$ monosomy 13 / deletions of 13 q\nAssociated with: microcephaly, ear changes, facial dysmorphism, mental retardation, finger + toe abnormalities, malformation of genitalia\n(B) HERITABLE FORM (40\\%)\n$=$ autosomal dominant transmission to offspring with $90-95 \\%$ penetrance\nGenetics: mutation of tumor suppressor gene RB1 located on long arm of chromosome 13 $(13 q 14)$\nClinical DDx to nonheritable form:\n$\\diamond$ Tumors bilateral in $2 / 3$ and multifocal\n$\\diamond$ Age at presentation usually $<2$ years\n$\\checkmark$ multiple tumors in $60-75 \\%$\n(1) Heritable sporadic form ( $20-25 \\%$ )\n= sporadic germline mutation ( $50 \\%$ chance to occur in subsequent generations)\nMean age at presentation: 12 months\n$\\checkmark$ bilateral retinoblastomas in $66 \\%$\n(2) Familial retinoblastoma ( $10-30 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 141,
            "markdown": "$=$ autosomal dominant with $95 \\%$ penetrance\nMean age at presentation: 8 months\n$\\sqrt{ }$ usually $3-5$ ocular tumors per eye\nRisk of secondary nonocular malignancy ( $8 \\%$ ):\nosteo-, chondro-, fibrosarcoma, malignant fibrous histiocytoma, melanoma, carcinoma ( $20 \\%$ risk within 10 years, $>90 \\%$ by 30 years of age); high risk within field of external-beam radiation ( $30 \\%$ )\n\nLocation: head, skin, bone, brain\n\n# Trilateral retinoblastoma \n\n## Quadrilateral retinoblastoma\n\n$=$ trilateral retinoblastoma $+4^{\\text {th }}$ focus in suprasellar cistern\n$\\sqrt{ }$ enhancing midline suprasellar mass\nPath: (1) Endophytic form = centripetal tumor invasion $\\rightarrow$ floating islands of tumor within semiliquid vitreus $\\pm$ anterior chamber\n(2) Exophytic form = growth toward sclera into subretinal space $\\rightarrow$ retinal detachment + invasion of vascular choroid $\\rightarrow$ hematogenous spread\n(3) Mixture of endo- and exophytic growth (common)\n(4) Diffuse infiltrating form = thin en-plaque lesion extending along retina (in 1-2\\%) $\\rightarrow$ cells discharged into vitreus $\\rightarrow$ seeding of anterior chamber mimicking an inflammatory process ( $=$ pseudohypopyon)\n(5) Necrotic retinoblastoma with orbital cellulitis\n(6) Complete spontaneous regression (rare) $\\rightarrow$ phthisis bulbi ( $=$ shrunken nonfunctioning globe)\nHisto:\n$\\sqrt{ }$ primitive neuroepithelial neoplastic cells tend to outgrow blood supply $\\rightarrow$ necrosis $\\rightarrow$ foci of calcifications\n(a) Flexner-Wintersteiner rosettes (in 50\\%)\n$=$ neuronal cells line up around an empty central zone filled with polysaccharides ( $=$ photoreceptor differentiation)\n$\\diamond$ Very specific for retinoblastomas!\n(b) Homer-Wright rosettes\n$=$ neuronal cells line up around a central area containing a cobweb of filaments (also found in other primitive neuroectodermal tumors) = neuronal differentiation\n(c) \"fleurettes\"\n$=$ flowerlike groupings of tumor cells that form photoreceptor elements (specific for retinal differentiation)\n\n- \"cat's eye\" = leukokoria (white pupillary reflex) in 56-72\\%\n$\\diamond$ About $50 \\%$ of all childhood leukokoria cases are caused by retinoblastoma!\n- strabismus $=$ crossed eyes $=$ lack of binocular vision (22-24\\%)\n- proptosis (less common)\n- decreased visual acuity, heterochromia iridis, anisokoria\n- spontaneous hyphema, periocular inflammation\n- iris neovascularization",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 142,
            "markdown": "- ocular pain $\\leftarrow$ secondary angle-closure glaucoma\n\nLocation: posterolateral wall of globe (most commonly); $60 \\%$ unilateral; $40 \\%$ bilateral + frequently synchronous ( $90 \\%$ bilateral in inherited forms)\n$\\sqrt{ }$ normal ocular size\n$\\sqrt{ }$ presence of calcifications\n$\\diamond$ Lack of calcifications OFTEN INDICATIVE of another disease!\nUS:\n$\\checkmark$ irregular heterogeneous hyperechoic solid intraocular mass\n$\\checkmark$ cystic areas of tumor necrosis\n$\\checkmark$ secondary retinal detachment (common)\n\n| Staging of Retinoblastoma |  |  |  |\n| :--: | :--: | :--: | :--: |\n| International Classification for Intraocular Retinoblastoma (2006) |  |  |  |\n| Group | Description |  | Features |\n|  |  |  | $<3 \\mathrm{~mm}$ in diameter, $>3 \\mathrm{~mm}$ from fovea, $>1.5 \\mathrm{~mm}$ from optic disc; confined to retina (no vitreous seeding) |\n| A | small |  | macular / juxtapapillary location without dissemination; subretinal fluid extends $<3 \\mathrm{~mm}$ from tumor |\n| B | large |  | vitreous / subretinal seeding $<3 \\mathrm{~mm}$ from tumor |\n| D |  | diffuse | massive tumor + diffuse / greasy vitreous seeding / fine subretinal seeds; avascular plaques / exophytic disease |\n| E |  |  | nonvascular glaucoma / intraocular or corneal hemorrhage / tumor contacting lens or in anterior segment / diffuse infiltrating tumor |\n| F | extrascleral |  | extrascleral spread to optic nerve / orbit / brain; distant metastases |\n\n$\\checkmark$ focal fine calcifications with acoustic shadowing (in 75\\%)\n$\\checkmark$ echogenic foci of vitreous hemorrhage (frequent)\nCT (primary modality in leukokoria):\n$\\checkmark$ solid smoothly marginated lobulated retrolental hyperdense mass of endophytic type (DDx to exophytic type: retinal detachment)\n$\\checkmark$ partial punctate / nodular calcification (50-75-95\\%)\n$\\diamond$ Retinoblastoma is the most common cause of orbital calcifications!\n$\\checkmark$ dense vitreus (common)\n$\\checkmark$ extraocular extension (in 25\\%): optic nerve enlargement, abnormal soft tissue in orbit, intracranial extension\n$\\checkmark$ contrast enhancement (27\\%)\n$\\checkmark \\pm$ macrophthalmia\nRisk: cataract formation\nMR:\nAdvantage: assessment of extension into optic pathway + subarachnoid space + vitreous",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 143,
            "markdown": "seeding; follow-up without radiation exposure\n$\\sqrt{ }$ mass with SI similar to gray matter:\n$\\sqrt{ }$ mildly hyperintense on T1WI relative to vitreus\n$\\sqrt{ }$ distinctly T2 hypointense (similar to uveal melanoma)\n$\\sqrt{ }$ hyperintense on DWI (= reduced diffusion) with high tumor cellularity\n$\\sqrt{ }$ heterogeneous intensity in the presence of calcifications\n$\\sqrt{ }$ calcifications of low / high signal intensity with various pulse sequences $\\leftarrow$ dependent on proton content (susceptibility imaging for DDx to hemorrhage!)\n$\\diamond$ Even large calcifications may be missed on MR!\n$\\sqrt{ }$ subretinal exudate usually hyperintense on T1WI + T2WI (proteinaceous fluid) = retinal detachment\n$\\sqrt{ }$ assessment for 1-2 mm small vitreous seeds on high resolution T2WI 3-dimensional fast spin echo sequences\n$\\sqrt{ }$ vitreous hemorrhage ( $=$ high SI on T1WI + low SI on T2WI) may obscure tumor\n$\\sqrt{ }$ discontinuity within dark band of sclera $=$ trans-scleral spread\n$\\sqrt{ }$ tumor within orbital fat on enhanced fat-suppressed T1WI = extrascleral spread\nCEMR:\n$\\sqrt{ }$ moderate to marked enhancement\n$\\sqrt{ }$ thinning with focal $\\downarrow$ in enhancement OR thickening with focal $\\uparrow$ in choroidal enhancement (= choroidal invasion)\n$\\sqrt{ }$ thickening of enhancing choroidoretinal complex = prelaminar invasion\n$\\sqrt{ }$ focal enhancement $\\pm$ focal thickening of optic nerve (DDx: reactive gliosis)\n$\\sqrt{ }$ leptomeningeal enhancement $=$ dissemination into CSF\nCx: (1) Metastases to: meninges (via subarachnoid space), bone marrow, lung, liver, lymph nodes\n$\\diamond$ Optic nerve involvement through optic disc = port for dissemination into subarachnoid space!\n$\\diamond$ No risk of metastases without penetration of lamina cribrosa!\n(2) Radiation-induced sarcomas develop in $15-20 \\%$\n\nPrognosis: spontaneous regression in $1 \\%$\n$\\sqrt{ }$ calcifications $=$ favorable prognostic sign\n$\\sqrt{ }$ contrast enhancement $=$ poor prognostic sign\nMortality:\n(a) choroidal invasion: $65 \\%$ significant, $24 \\%$ slight\n(b) optic nerve invasion through optic disc:\n$<10 \\%$ not invaded\n$15 \\%$ through lamina cribrosa\n$44 \\%$ significantly posterior to lamina cribrosa\n(c) margin of resection not free of tumor: $>65 \\%$\n\nRx: cryoablation, laser photocoagulation, chemothermotherapy, brachytherapy, plaque radiation therapy; chemoreduction and surgery; enucleation\nSurvival: $90-95 \\%$ due to earlier detection\n$D D x$ : Pseudoretinoblastomas (in order of decreasing frequency)\n(1) Persistent fetal vasculature (no calcifications, microphthalmia, vertical septum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 144,
            "markdown": "between optic disc + posterior lens)\n(2) Coats disease (subretinal exudation, no calcification, slightly older age group, no enhancement of subretinal space)\n(3) Toxocara endophthalmitis (no calcification, usually $>5$ years of age, contact with dogs, serology)\n(4) Retrolental fibroplasia (microphthalmia, bilateral, low birth weight, periventricular leukomalacia)\n(5) Giant drusen = nodular type of retinal astrocytic hamartoma (confined to sensory retina / optic disc, often lack hemorrhage / necrosis, may be associated with tuberous sclerosis / NF1)\n(6) Norrie disease (retinal dysplasia)\n(7) Coloboma of choroid / optic disc coloboma\n(8) Retinoma = retinocytoma (benign variant)\n\n# RETROLENTAL FIBROPLASIA \n\n$=$ RETINOPATHY OF PREMATURITY\n$=$ bilateral often asymmetric postnatal fibrovascular organization of vitreous humor, which usually leads to retinal detachment\nPathophysiology:\nretinal vascularization occurs in $4^{\\text {th }}-9^{\\text {th }}$ months of fetal life progressing from papilla to periphery; vascularization is incomplete in premature neonates, especially in temporal sectors\nPredisposed: premature infants with respiratory distress syndrome requiring prolonged oxygen therapy\nSeverity directly related to:\n(1) Degree of prematurity\n(2) Birth weight\n(3) Amount of oxygen used in therapy\n\n- leukokoria in severe cases (traction retinal detachment, usually bilateral + temporal) [3-5\\% of all childhood leukokoria cases]\n- Ophthalmoscopic stages:\n$1^{\\text {st }}$ stage $=$ arteriolar narrowing of most immature vessels at the border of the vascular-avascular retina $\\leftarrow$ spasm as a reaction to hyperoxygenation\n$2^{\\text {nd }}$ stage $=$ dilatation + elongation + tortuosity of retinal vessels (after oxygen withdrawal)\n$3^{\\text {rd }}$ stage $=$ retinal neovascularization with growth into vitreus $\\rightarrow$ vitreous hemorrhage\n$4^{\\text {th }}$ stage $=$ fibrosis $\\rightarrow$ retraction of fibrovascular tissue $\\rightarrow$ retinal detachment\n$\\sqrt{ }$ bilateral microphthalmia $\\pm$ retinal detachment\nUS:\n$\\sqrt{ }$ hyperechoic tracts extending from temporal side of periphery of retina to vitreus behind lens\nCT:\n$\\sqrt{ }$ dense vitreus bilaterally (neovascular ingrowth)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 145,
            "markdown": "$\\sqrt{ } \\pm$ dystrophic calcifications in choroid + lens (late stage)\nMR:\n$\\sqrt{ }$ hyperintense vitreus on T1WI + T2WI $\\leftarrow$ chronic subretinal hemorrhage\n$\\sqrt{ }$ hypointense retrolental mass $\\leftarrow$ apposition of detached leaves of retina displaced from retinal pigment layer\nPrognosis:\n(1) spontaneous regression of vitreous neovascularization (85-95\\%) $\\pm$ retinal detachment\n(2) progression to cicatricial stage characterized by formation of dense membrane of graywhite vascularized tissue in retrolental vitreus + retinal detachment + microphthalmia\n$D D x$ : Retinoblastoma (calcifications in eye of normal size)\n\n# STAPHYLOMA \n\n$=$ sacculation of posterior pole of globe (or berrylike protrusion of cornea)\nPrevalence: increasing with size of globe\nCause: axial myopia (temporal side of optic disc / anteriorly / along equator), trauma, scleritis, necrotizing infection\n$\\sqrt{ }$ increase of anteroposterior ocular axis $>25 \\mathrm{~mm}$\n$\\sqrt{ }$ focal bulge + thinning of sclera of posterior pole\n$C x$ : advanced chorioretinal degeneration ( $77 \\%$ ), choroid retraction from optic disc, posterior vitreous detachment, choroidal hemorrhage, retinal detachment, cataract, glaucoma\n\n## SUPERIOR OPHTHALMIC VEIN THROMBOSIS\n\nCause: paranasal sinusitis\n\n- orbital pain, headache, visual disturbance, cranial nerve palsy\n- periorbital edema, chemosis, proptosis\n$\\sqrt{ }$ filling defect in superior ophthalmic vein\n$\\sqrt{ }$ enlargement of both superior ophthalmic veins + cavernous sinus\n$\\sqrt{ }$ periorbital edema\n$\\sqrt{ }$ engorgement of extraocular muscles\n$\\sqrt{ }$ exophthalmos\n$C x$ : vision loss, thrombosis of cavernous sinus, sepsis\n$R x$ : anticoagulation + antibiotics\n\n\n## TOLOSA-HUNT SYNDROME\n\n[Eduardo Tolosa (1900-1981), Spanish neurosurgeon]\n[William Edward Hunt (1921-1999), neurosurgeon at Ohio State University]\n$=$ rare disorder characterized by painful ophthalmoplegia $\\leftarrow$ cavernous sinus inflammation responsive to steroid therapy\nCause: inflammation of cavernous sinus and orbital apex\nPath: lymphofibroblastic lesion (similar to orbital pseudotumor)\nAge: $5^{\\text {th }}$ decade\n\n- acute onset of severe retro- / periorbital pain\n- ophthalmoplegia $\\pm$ exophthalmos\n- diplopia, ptosis, pupillary + variable extraocular muscle dysfunction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 146,
            "markdown": "- visual loss with optic nerve involvement\n- fever, chronic fatigue, vertigo, arthralgia\n\nLocation: unilateral, bilateral (5\\%)\nCT:\n$\\checkmark$ inflammatory soft-tissue density around orbital apex\n$\\checkmark$ asymmetric enlargement of cavernous sinus\n$\\checkmark$ abnormal nodular enhancement in prepontine cistern\nMR (thin-section contrast-enhanced MRI + fat suppression):\n$\\checkmark$ loss of SI of orbital fat\n$\\checkmark$ enlargement of the cavernous sinus with convex outer margin\n$\\checkmark$ abnormal soft tissue in cavernous sinus:\n$\\checkmark$ isointense to gray matter on T1WI\n$\\checkmark$ hypo- to isointense to gray matter on T2WI $\\leftarrow$ fibrous tissue\n$\\checkmark$ homogeneous enhancement\n$\\checkmark$ extension of lesion into orbital apex through superior orbital fissure with involvement of extraocular muscles\n$\\checkmark$ narrowing of cavernous segment of ICA (in 50\\%)\n$\\checkmark$ enhancement of dura, trigeminal n., facial n. (uncommon)\nAngio:\n$\\checkmark$ narrowing of carotid siphon\n$\\checkmark$ occlusion of superior ophthalmic vein\n$\\checkmark$ nonvisualization of cavernous sinus\nRx: corticosteroids, immunosuppressive agents (methotrexate, azathioprine)\n$D x:$ findings reversible with steroid use\n$D D x$ : perineural tumor spread, fungal infection, schwannoma, meningioma (no resolution with steroids), lymphoma (systemic symptoms), sarcoidosis (systemic symptoms)\n\n# VARIX OF ORBIT \n\n$\\diamond$ Most common cause of spontaneous orbital hemorrhage!\nEtiology:\n(a) congenital: weakness in postcapillary venous wall\n(b) acquired: intraorbital / intracranial AVM\n$\\diamond$ Orbital veins are valveless!\nFrequency: uncommon\nAge: $2^{\\text {nd }}-3^{\\text {rd }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nMay be associated with: contiguous / noncontiguous intracranial venous anomalies\n\n- stress proptosis $=$ dramatic protrusion of eye with straining (coughing, forward bending, breath holding, Valsalva)\n- frequent blindness\n$\\checkmark$ involvement of superior / inferior orbital vein; phleboliths rare\n$\\checkmark$ may produce bony erosion without sclerotic reaction\n$\\checkmark$ well-defined markedly enhancing mass\n$\\checkmark$ enlargement of mass during Valsalva maneuver / jugular vein compression\nCT:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 147,
            "markdown": "$\\sqrt{ }$ normal / only mild enlargement of veins in supine position (repeat scan during Valsalva maneuver / in prone position / with neck tourniquet)\n$\\sqrt{ }$ smoothly contoured clublike / triangular tangled mass of vessels\n$\\sqrt{ }$ intense contrast enhancement\nUS:\n$\\sqrt{ }$ anechoic tubular / oval structure $\\pm$ thrombus\n$\\sqrt{ }$ venous flow increasing / reversing with Valsalva\nMR:\n$\\sqrt{ }$ flow void (rapid flow) / flow-related enhancement (slow flow)\nCx: 1. Hemorrhage\n2. Spontaneous thrombosis (with rapid painful\nproptosis)\n\n# WARBURG DISEASE \n\n= autosomal recessive syndrome characterized by\n(1) Bilateral persistent hyperplastic primary vitreous\n(2) Hydrocephalus, lissencephaly\n(3) Mental retardation\n\n- bilateral leukokoria + microphthalmia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 148,
            "markdown": "# EAR, NOSE AND THROAT \n\n## DIFFERENTIAL DIAGNOSIS OF EAR, NOSE, AND THROAT DISORDERS\n\n## FACE\n\n## Facial Swelling in Childhood\n\nA. ACUTE SWELLING with inflammation (most common)\n\n1. Lymphadenitis of neck and face\n\nCause: upper-airway viral (common) / bacterial infection (S. aureus, group A streptococci)\n\n- erythema in upper neck, submandibular, parotid region\n\nCx: abscess (CECT!)\n2. Sinusitis\n\n- swelling around malar / brow region\n\nCx: preorbital / preseptal cellulitis\n3. Odontogenic infection\n\n- jaw swelling, trismus $\\leftarrow$ masticator space phlegmon\nB. NONPROGRESSIVE SWELLING\n(a) congenital midfacial mass\n- broad nasal bridge, glabellar swelling, hypertelorism\n\n1. Frontoethmoidal cephalocele\n2. Nasal glioma\n3. Nasal dermoid / epidermoid cyst\n(b) developmental\n4. Dacryocystocele\n5. Orbital dermoid\n6. First branchial cleft cyst\nC. SLOWLY PROGRESSIVE SWELLING\n(a) underlying mass\n7. Neurofibroma\n8. Lymphangioma\n9. Hemangioma\n10. Plunging ranula\n(a) osseous disease\n11. Craniofacial fibrous dysplasia\nD. RAPIDLY PROGRESSIVE SWELLING\n12. Rhabdomyosarcoma\n13. Langerhans cell histiocytosis\n14. Ewing sarcoma of mandible",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 149,
            "markdown": "4. Osteogenic sarcoma\n5. Metastatic neuroblastoma\n\n# Facial Nerve Paralysis \n\nA. INTRACRANIAL SEGMENT\n(a) intraaxial brainstem glioma, metastasis, multiple sclerosis, cerebrovascular accident, hemorrhage\n\n- cranial nerve VI also involved\n(b) extraaxial CPA tumor (acoustic neuroma, meningioma, epidermoid), CPA\ninflammation (sarcoidosis, basilar meningitis), vertebrobasilar dolichoectasia, AVM, aneurysm\n- cranial nerve VIII also involved\nB. INTRATEMPORAL SEGMENT\nfracture, cholesteatoma, paraganglioma, hemangioma, facial nerve schwannoma, metastasis, Bell palsy, otitis media\n- loss of lacrimation, hyperacusis, loss of taste\nC. EXTRACRANIAL PAROTID SEGMENT\nforceps delivery, penetrating facial trauma, parotid surgery, parotid malignancy, malignant otitis externa\n- preservation of lacrimation, stapedius reflex, taste\n\n\n## Bell Palsy\n\n$=$ facial nerve paralysis without identifiable cause\nCause: ? viral inflammation (herpes simplex virus)\n\n- rapid onset of facial nerve paralysis progressing over a few hours to up to 3 weeks\n$\\sqrt{ }$ enhancement of canalicular, labyrinthine, geniculate portion of facial $n$.\nPrognosis: spontaneous improvement (in 80\\%); persistent Bell palsy (in 5\\% caused by neurinoma)\nN.B.: if symptoms persist for $>3$ weeks $\\rightarrow$ MRI\n\n\n## EAR\n\n## Hearing deficit\n\nA. CONDUCTIVE HEARING LOSS\n\n- decrease in air conduction via EAC, tympanic membrane, ossicular chain, oval window (sound via headphones)\n- normal bone conduction (sound via bone oscillator)\n(a) congenital (uncommon):\n\n1. EAC atresia / stenosis\n2. Malformed ossicles\n3. Absence of oval window\n(b) trauma: incudostapedial / malleoincudal subluxation; incus dislocation; stapes dislocation; stapes / malleus fracture\n(c) destruction of ossicular chain:\n4. Otitis media",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 150,
            "markdown": "(d) restriction of ossicular chain: fenestral otosclerosis\n$\\diamond$ CT is the modality of choice!\nB. SENSORINEURAL HEARING LOSS (most common)\n\n- elevated conduction thresholds for bone + air\n(a) sensory / cochlear SNHL = damage to cochlea / organ of Corti (less common)\n> bony labyrinth\n» demineralization:\n\n1. Otosclerosis (otospongiosis)\n2. osteogenesis imperfecta\n3. Paget disease, syphilis\n» congenital deformity:\n4. Cochlear dys- / aplasia\n5. Michel anomaly\n6. Mondini dysplasia\n7. Enlarged vestibular aqueduct syndrome\n8. X-linked sensorineural hearing loss\n» traumatic lesion:\n9. Transverse fracture\n10. Perilymphatic fistula, cochlear concussion\n» destructive lesion: inflammation, neoplasm\n$\\diamond$ High-resolution CT is the modality of choice!\n> membranous labyrinth\n» enhancement: labyrinthitis, Cogan syndrome (early phase of autoimmune interstitial keratitis), intralabyrinthine schwannoma, site of postinflammatory perilymphatic fistula\n» obliteration: labyrinthitis ossificans, Cogan syndrome (late phase)\n» hemorrhage: trauma, labyrinthitis, coagulopathy, tumor fistulization\n» Ménière disease (vertigo + fluctuating sensory sensorineural hearing loss)\n$\\diamond$ Thin-section MR is the modality of choice!\n(b) neural / retrocochlear SNHL (more common)\n$=$ abnormalities of neurons of spiral ganglion + central auditory pathways\n> IAC / cerebellopontine angle\n(1) Neoplastic lesion: vestibular / trigeminal schwannoma (acoustic neuroma in $1 \\%$ ), meningioma, arachnoid cyst, epidermoid cyst, leptomeningeal carcinomatosis, lymphoma, lipoma, hemangioma\n(2) Nonneoplastic lesion: sarcoidosis, meningitis, vascular loop, siderosis\n> intraaxial auditory pathway\n(brainstem, thalamus, temporal lobe)\n(1) Ischemic lesion\n(2) Neoplastic lesion\n(3) Traumatic lesion\n(4) Demyelinating lesion\n$\\diamond \\mathrm{MR}$ is the modality of choice!\n\n# Pulsatile tinnitus $\\pm$ Vascular Tympanic Membrane",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 151,
            "markdown": "$=$ perception of a rhythmic cardiac synchronous sound of ringing / buzzing / roaring\nA. NO ABNORMALITY (20\\%)\nB. CONGENITAL VASCULAR VARIANTS (21\\%)\n\n1. Aberrant ICA\n2. Dehiscent jugular bulb\n3. High-riding nondehiscent jugular bulb (= jugular megabulb)\n$\\sqrt{ }$ high jugular bulb with diverticulum projecting cephalad into petrous temporal bone\nC. ACQUIRED VASCULAR LESIONS (25\\%)\n4. Dural AVM\n5. Extracranial arteriovenous fistula\n6. High-grade stenotic vascular lesion:\ncarotid artery atherosclerosis, fibromuscular dysplasia, carotid artery dissection\n7. Aneurysm involving horizontal segment of petrous ICA\nD. TEMPORAL BONE TUMORS (31\\%)\n8. Paraganglioma (27\\%):\nglomus tympanicum, glomus jugulare\n9. Meningioma\n10. Hemangioma\nE. MISCELLANEOUS\n11. Cholesterol granuloma\n\n# External Ear Masses \n\nA. CONGENITAL\n\n1. Atresia\nB. INFLAMMATORY\n2. Malignant external otitis\n3. Keratosis obturans\n4. Cholesteatoma\nC. BENIGN TUMOR\n5. Exostosis $=$ surfer's ear\n\nCause: irritation by cold water\n$\\checkmark$ bony mass projecting into EAC; often multiple + bilateral\n2. Osteoma\n$\\checkmark$ may invade adjacent bone\n$\\checkmark$ single in EAC / mastoid\n3. Ceruminoma\nfrom apocrine + sebaceous glands; bone erosion mimics malignancy\nD. MALIGNANT TUMOR\n\n1. Squamous cell carcinoma\n\n- often long history of chronic suppurative otitis media = \"malignant otitis\"\n\n2. Basal cell carcinoma\n3. Melanoma, adenocarcinoma, adenoid cystic carcinoma\n4. Metastases\n(a) hematogenous: breast, prostate, lung, kidney, thyroid\n(b) direct spread: skin, parotid, nasopharynx, brain, meninges",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 152,
            "markdown": "(c) systemic: leukemia, lymphoma, myeloma\n5. Histiocytosis X: in $15 \\%$ of patients\n\n# Middle Ear Masses \n\nA. CONGENITAL\n\n1. Aberrant internal carotid artery\n2. Dehiscent jugular bulb\nB. INFLAMMATORY\n3. Cholesteatoma\n4. Cholesterol granuloma\n5. Granulation tissue\n$\\checkmark$ linear strands partially opacifying middle ear cavity without bony erosion\nC. BENIGN TUMOR\n6. Adenomatous tumor (mixed pattern type)\n$\\checkmark$ intense enhancement\n$\\checkmark$ no osseous destruction\n7. Glomus tumor (multiple in $10 \\% ; 8 \\%$ malignant)\n(a) glomus tympanicum: at cochlear promontory\n$\\checkmark$ seldom erodes bone\n(b) glomus jugulare: at jugular foramen\n$\\checkmark$ invasion of middle ear from below\n$\\checkmark$ destruction of bony roof of jugular fossa + bony spur separating vein from carotid artery\n8. Facial nerve schwannoma\n9. Ossifying hemangioma\n10. Choristoma $=$ ectopic mature salivary tissue\n11. Endolymphatic sac tumor\n12. Meningioma\nD. MALIGNANT TUMOR\n13. Squamous cell carcinoma\n14. Metastasis\n15. Rhabdomyosarcoma\n\nLocation: orbit $>$ nasopharynx $>$ ear\n4. Adenocarcinoma (rare), adenoid cystic carcinoma\n\n## Mass on Promontory\n\n[promontory = bone over basal turn of cochlea]\n\n1. Glomus tympanicum\n2. Congenital cholesteatoma\n3. Aberrant carotid artery\n4. Persistent stapedial artery\n\n## Inner Ear Masses\n\nA. CONGENITAL\n\n1. Congenital / primary cholesteatoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 153,
            "markdown": "$=$ epidermoid tumor (3rd most common CPA tumor)\nB. INFLAMMATION\n\n1. Cholesterol granuloma\n2. Petrous apex mucocele\nC. TUMOR\n3. Glomus jugulare tumor\n4. Hemangioma, fibro-osseous lesion\n5. Metastasis\n6. Facial nerve neurinoma\n7. Large CPA tumors: acoustic neuroma, meningioma ( $2^{\\text {nd }}$ most common CPA tumor)\n\n# TEMPORAL BONE \n\n## Congenital Malformation of Temporal Bone\n\n- congenital hearing deficit\n\nDevelopmental malformations affecting the EAC + middle ear may cause conductive hearing loss.\nThose affecting the membranous + bony labyrinth may result in sensorineural hearing loss (SN HL).\nCause: (a) nongenetic\n(b) genetic\n> isolated\n> associated with:\n(1) CHARGE syndrome (= Coloboma, Heart defect, Atresia of nasal choanae, Retardation of growth $\\pm$ development, Genital $\\pm$ urinary abnormalities, Ear abnormalities and deafness)\n(2) Klippel-Feil syndrome\n(3) Trisomy 21\n(4) Goldenhar syndrome\n(5) Crouzon syndrome\n\nLocation: external ear, middle ear, inner ear\n\n1. Congenital atresia of EAC\n2. Otic capsule dysplasia\n3. Large vestibular aqueduct syndrome\n\n## Vascular Abnormalities of Temporal Bone\n\n1. Aberrant internal carotid artery (rare)\n2. High-riding jugular bulb\n3. Persistence of stapedial artery\n\n## Inflammatory Temporal Bone Lesion\n\nThe most common inflammatory condition affecting the temporal bone is acute otitis media.\n(a) External auditory canal\n\n1. EAC cholesteatoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 154,
            "markdown": "2. Keratosis obturans\n3. Malignant otitis externa\n@ Middle ear\n4. Acute otitis media\n5. Chronic otitis media\n6. Cholesterol granuloma\n7. Cholesteatoma\n@ Inner ear\n8. Labyrinthitis\n\n# Tumor of Temporal Bone \n\nA. CEREBELLOPONTINE ANGLE + IAC\n\n1. Vestibular schwannoma (most common)\nB. MIDDLE EAR\n$\\diamond$ First exclude a vascular structure!\n(a) Vascular structure\n2. Persistent stapedial artery\n3. Lateral / aberrant carotid artery\n4. Dehiscent jugular bulb\n(b) benign neoplasm\n\nParaganglioma (glomus tumor / chemodectoma) is the $2^{\\text {nd }}$ most common tumor to involve the temporal bone and most common tumor of the middle ear.\n\n1. Paraganglioma\n2. Facial nerve schwannoma\n3. Geniculate hemangioma\n4. Salivary choristoma\n5. Meningioma\n6. Middle ear adenoma\n(c) malignant neoplasm (rare)\n7. Carcinoma\n8. Metastasis\n9. Perineural spread along facial $n$.\nC. EAC AND MASTOID\n(a) malignant neoplasm (common)\n10. Squamous cell carcinoma\n11. Others: basal cell carcinoma, melanoma, lymphoma, myeloma, metastasis, chondro-, osteosarcoma\n(b) benign process\n12. Langerhans cell histiocytosis\n13. Tuberculosis\n14. Wegener granulomatosis\n15. Malignant otitis media\n16. Radiation necrosis\nD. PETROUS APEX",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 155,
            "markdown": "(a) primary neoplasm\n\n1. Chondrosarcoma: most common primary malignancy\n2. Endolymphatic sac tumor\n\n| Petrous Apex Lesions |  |\n| :--: | :--: |\n| Type | Imaging Characteristics |\n| Developmental |  |\n| Cholesterol granuloma (most common) | $\\checkmark$ hyperintense on T1 + T2WI <br> - long Hx of otitis media <br> $\\checkmark$ restricted diffusion at DWI <br> $\\checkmark$ CSF signal intensity |\n| Cholesteatoma (4-9\\%) |  |\n| Cephalocele (rare) |  |\n| Mucocele (uncommon) |  |\n| Inflammatory |  |\n| $\\begin{aligned} & \\text { Petrous apicitis, } \\\\ & \\text { osteomyelitis, } \\\\ & \\text { inflammatory } \\\\ & \\text { pseudotumor, Wegener } \\\\ & \\text { granulomatosis } \\end{aligned}$ |  |\n| Benign tumor |  |\n| Meningioma, schwannoma, paraganglioma |  |\n| Chondroma, chondroblastoma | $\\checkmark$ chondroid matrix calcification |\n| Myxoma, osteoblastoma, giant cell tumor |  |\n| Malignant tumor |  |\n| Chondrosarcoma | $\\checkmark$ chondroid matrix calcification |\n| Chordoma | $\\checkmark$ honeycomb enhancement |\n| Endolymphatic sac tumor | $\\checkmark$ hemorrhage, bone destruction |\n| Metastasis, plasmacytoma, lymphoma, nasopharyngeal ca., rhabdomyosarcoma, LCH |  |\n| Vascular |  |\n| Petrous carotid aneurysm |  |\n| Intraosseous dural AV fistula | $\\checkmark$ multiple intraosseous flow voids |\n| Osseous dysplasia |  |\n| Fibrous dysplasia | $\\checkmark$ ground-glass matrix <br> calcification |\n| Paget disease |  |\n| Pseudolesion |  |\n| asymmetric marrow pseudofracture effusion | $\\checkmark$ fat signal with all sequences <br> $\\checkmark$ through superior semicircular canal |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 156,
            "markdown": "(b) secondary involvement by regional tumor:\ntrigeminal schwannoma, jugular paraganglioma, nasopharyngeal carcinoma\n\n# Dumbbell Mass Spanning Petrous Apex \n\n1. Large trigeminal schwannoma\n2. Meningioma\n3. Epidermoid cyst\n\n## Enhancing Lesion in Internal Auditory Canal\n\nA. NEOPLASTIC\n\n1. Acoustic schwannoma\n2. Ossifying hemangioma\n3. Lymphoma\n4. Metastasis\nB. NONNEOPLASTIC\n5. Sarcoidosis\n6. Meningitis\n7. Postmeningitic / postcraniotomy fibrosis\n8. Vascular loop of anterior inferior cerebellar artery\n9. Syphilis\n\n## Demineralization of Temporal Bone\n\n1. Otosclerosis $=$ otospongiosis\n2. Paget disease $=$ osteoporosis circumscripta\n\n- sensorineural / mixed hearing loss (cochlear involvement / stapes fixation in oval window)\n$\\sqrt{ }$ usually lytic changes beginning in petrous pyramid + progressing laterally; otic capsule last to be affected\n$\\sqrt{ }$ calvarial changes $\\pm$ basilar impression\n\n3. Fibrous dysplasia monostotic with temporal bone involvement\n\nCause: inability to form mature lamellar bone owing to disordered osteoblastic activity\n\n- painless mastoid swelling\n- conductive hearing loss $\\leftarrow$ narrowing of EAC / middle ear\n$\\sqrt{ }$ homogeneously dense thickened structurally weak bone (fibro-osseous tissue less dense than calvarial bone)\n$\\sqrt{ }$ bone expansion with preserved cortex $\\rightarrow$ osseous narrowing of vascular channels + neuroforamina\n$\\sqrt{ }$ lytic lesions (less frequent)\n$\\sqrt{ }$ sparing of membranous labyrinth, facial nerve canal, IAC is the rule\n\n4. Osteogenesis imperfecta\n$\\sqrt{ }$ changes similar to otosclerosis\nvan der Hoeve-de Kleyn syndrome\n$=$ osteogenesis imperfecta + hearing loss + blue sclerae in patients in late $2^{\\text {nd }} /$ early $3^{\\text {rd }}$ decade\n5. Otosyphilis: labyrinthitis + gummatous lesion of internal auditory canal + inflammatory",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 157,
            "markdown": "resorptive osteitis\n$\\sqrt{ }$ moth-eaten permeative osteolysis of temporal bone\n6. Metastasis\n\n# Mastoid Abnormality in Child \n\n1. Acute otitis media\n2. Langerhans cell histiocytosis\n3. Rhabdomyosarcoma\n4. Metastatic disease: most commonly neuroblastoma\n\n## SINUSES\n\n## Opacification of Maxillary Sinus\n\nA. WITHOUT BONE DESTRUCTION\n\n1. Sinus aplasia / hypoplasia\n\nAge: NOT routinely visualized at birth, by age 6 antral floor at level of middle turbinate, by age 15 of adult size\nLocation: uni- / bilateral\n$\\sqrt{ }$ depression of orbital floor with enlargement of orbit\n$\\sqrt{ }$ lateral displacement of lateral wall of nasal fossa with large turbinate\n2. Maxillary dentigerous cyst\nusually containing a tooth / crown; without tooth = primordial dentigerous cyst\n3. Ameloblastoma\n4. Acute sinusitis\n$\\sqrt{ }$ air-fluid level\nB. WITH BONE DESTRUCTION\n\n1. Maxillary sinus tumor\n2. Infection: aspergillosis, mucormycosis, TB, syphilis\n3. Wegener granulomatosis; lethal midline granuloma\n4. Blowout fracture\n\n## Paranasal Sinus Masses\n\n1. Mucocele\n\nCause: obstruction of a paranasal sinus\n$\\sqrt{ } \\pm$ bone remodeling / sinus expansion\n2. Mucus retention cyst\n\nCause: obstruction of small seromucinous gland\nLocation: commonly in floor of maxilla\n$\\sqrt{ }$ smoothly marginated soft-tissue mass\n3. Sinonasal polyp\n4. Antrochoanal polyp\n5. Inverting papilloma\n6. Sinusitis\n7. Carcinoma\n8. Rhabdomyosarcoma (of adulthood)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 158,
            "markdown": "Site: ethmoid sinuses\nPrognosis: poor (due to frequent intracranial extension)\n\n# Sinonasal Granulomatous Disease \n\n$\\sqrt{ }$ sinus mucosal thickening\n$\\sqrt{ }$ osseous + cartilaginous erosion (through cribriform plate)\n$\\sqrt{ }$ nasal septal perforation\n$\\sqrt{ }$ intraorbital extension\nA. Chronic irritants\n\n1. Beryllium\n2. Chromate salts\nB. Infection\n3. Tuberculosis\n4. Actinomycosis\n5. Rhinoscleroma\n6. Yaws\n7. Blastomycosis\n8. Leprosy\n9. Rhinosporidiosis\n10. Syphilis\n11. Leishmaniasis\n12. Glanders\nC. Autoimmune disease\n13. Wegener granulomatosis\n14. Churg-Strauss syndrome\nD. Lymphoma-like lesions\n15. Midline granuloma\nE. Unclassified\n16. Sarcoidosis\n\n## Hyperdense Sinus Secretions\n\n1. Inspissated secretions\n2. Mycotic (fungal) sinusitis\n3. Hemorrhage into sinus\n4. Chronic sinusitis infected with bacteria (in particular in very long-standing disease / cystic fibrosis)\n\n## Opacified Sinus \\& Expansion / Destruction\n\nmnemonic: PLUMP FACIES\nPlasmacytoma\nLymphoma\nUnknown etiology: Wegener granulomatosis\nMucocele\nPolyp\nFibrous dysplasia, Fibroma (ossifying)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 159,
            "markdown": "Aneurysmal bone cyst, Angiofibroma\nCancer\nInverting papilloma\nEsthesioneuroblastoma\nSarcoma: ie, rhabdomyosarcoma\n\n# Frontal Soft-tissue Swelling \n\n1. Pott puffy tumor\n2. Dermoid and epidermoid cyst\n3. Cephalocele\n4. Cephalhematoma\n5. Mucocele\n6. Destructive lesion: Langerhans cell histiocytosis, metastasis\n\n## NOSE\n\n## Nasal Vault Masses\n\nA. BENIGN\n\n1. Sinonasal polyp\n2. Inverted papilloma\n3. Hemangioma\n\n- history of epistaxis\n\n4. Pyogenic granuloma\n$\\checkmark$ pedunculated lobular mass\n5. Granuloma gravidarum\n$=$ nasal hemangioma of pregnancy\n6. Hemangiopericytoma\n7. Juvenile nasopharyngeal angiofibroma\n$\\checkmark$ arises in superior nasopharynx with extension into nose via posterior choana\nB. MALIGNANT\n8. Squamous cell carcinoma (most common primary)\n\nPredisposed: nickel workers\n2. Adenocarcinoma, mucoepidermoid carcinoma, adenoid cystic carcinoma\n3. Rhabdomyosarcoma: head and neck most frequent site\n4. Lymphoma, chloroma\n5. Melanoma\n6. Metastasis\n\n## Mass in Nasopharynx\n\nmnemonic: NASALPIPE\nNasopharyngeal carcinoma\nAngiofibroma (juvenile)\nSpine / skull fracture\nAdenoids\nLymphoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 160,
            "markdown": "Polyp\nInfection\nPlasmacytoma\nExtension of neoplasm (sphenoid / ethmoid sinus ca.)\n\n# Congenital Midline Nasal Mass \n\n$=$ result of faulty regression of embryologic dural diverticulum through foramen cecum + fonticulus frontalis ( $=$ nasofrontal fontanel) from the prenasal space\nFrequency: $1 \\div 20,000$ to $1 \\div 40,000$ births\n\n1. Teratoma, dermoid, epidermoid\n2. Nasal glioma = nasal cerebral heterotopia\n3. Sincipital encephalocele\n4. Hemangioma / lymphangioma\n5. Dacryocystocele\n6. Dacryocystitis\n\n## Nasal Septal Perforation / Destruction\n\nNasal septal perforation due to granulomatous pressure erosions and cartilage destruction is most commonly seen in granulomatosis with polyangitis (formerly Wegener granulomatosis), sarcoidosis and relapsing polychondritis.\nA. AUTOIMMUNE DISEASE\n\n1. Wegener granulomatosis\n2. Relapsing polychondritis\nB. IDIOPATHIC\n3. Sarcoidosis\n4. Reparative giant cell granuloma\nC. INFECTION\n5. Syphilis\n6. Leprosy\nD. TOXIC EXPOSURE\n7. Cocaine abuse\nE. TRAUMA\n8. Rhinotillexomania ( $=$ chronic nose picking)\n9. Surgery\nF. MALIGNANCY\n10. Lymphoma\n\n## ORAL CAVITY\n\n## Infections of Oral Cavity\n\n1. Periodontal disease\n2. Ludwig angina\n3. Descending necrotizing mediastinitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 161,
            "markdown": "# Cystic Lesion in Floor of Mouth \n\nA. CYSTIC LESION\n\n1. Ranula\n2. Dermoid / epidermoid\nB. INFLAMMATION / INFECTION\n3. Ludwig angina\n4. Dental infection: premolar / $1^{\\text {st }}$ molar\n5. Penetrating trauma\n6. Obstructing submandibular calculus\n7. IV drug use\nC. SUBMANDIBULAR DUCT OBSTRUCTION\nD. VASCULAR MALFORMATION\n8. High-flow AVM\n9. Low-flow hemangioma / venous malformation / lymphangioma\nE. NEOPLASM\n(a) benign: lipoma, pleomorphic adenoma of sublingual / minor salivary gland, neural sheath tumors\n(b) malignant: SCC, salivary gland tumor\nF. PSEUDOTUMOR: compensatory hypertrophy of sublingual gland, ectopic submandibular salivary gland, ectopic thyroid tissue\n\n## Primary Lesion at Root of Tongue\n\nA. CONGENITAL (75\\%)\n(a) nonvascular\n\n1. Thyroglossal duct cyst $(70 \\%)$\n2. Dermoid / epidermoid cyst\n3. Foregut duplication cyst $(7 \\%)$\n4. Lingual thyroid\n5. Lipoma $(0.1-5 \\%)$\n6. Capillary hemangioma\n(b) vascular\n7. Lymphatic malformation\n8. Venous malformation\n9. Venolymphatic malformation\n10. Arteriovenous malformation\nB. INFECTIOUS (rare)\n11. Abscess\nC. NEOPLASTIC\n(a) benign (rare)\n12. Rhabdomyoma\n13. Leiomyoma\n14. Schwannoma\n15. Neurofibroma, plexiform neurofibroma\n(b) malignant (rare)\n$\\diamond$ More aggressive than cancers of oral tongue",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 162,
            "markdown": "1. Rhabdomyosarcoma (5\\% of oral rhabdomyosa.)\n2. Alveolar soft part sarcoma\n\n# PHARYNX \n\n## Pharyngeal Abnormalities\n\nA. NONMALIGNANT\n(a) congenital\n\n1. Branchial arch anomaly\n2. Laryngeal cleft\n3. Laryngeal cyst\n4. Tracheoesophageal fistula\n(b) acquired\n5. Foreign body ingestion\n6. Perforation\n7. Laryngocele\n8. Zenker diverticulum\n9. Killian-Jamieson diverticulum\n(c) infection / inflammation:\n10. Epiglottitis, pharyngitis\n11. Granulomatous disease: tuberculosis, sarcoidosis\n12. Amyloidosis\n13. Irradiation\nB. MALIGNANT\n$\\diamond$ Squamous cell carcinoma in $90 \\%$ !\n@ Oropharynx\nLocation: tonsils ( $75-80 \\%$ ) > tongue base $>$ valleculae $>$ pharyngeal wall cancer\n@ Larynx\nLocation: glottic $>$ supraglottic $>$ subglottic cancer\n@ Hypopharynx\nLocation: piriform sinus $>$ postcricoid $>$ posterior pharyngeal wall cancer\n\n## Parapharyngeal Space Mass\n\nA. BENIGN\n\n1. Asymmetric pterygoid venous plexus\n$\\checkmark$ racemose, enhancing area along medial border of lateral pterygoid muscle\n2. Abscess\n\nOrigin: pharyngitis (most common), dental infection, parotid calculus disease, penetrating trauma\n3. Atypical second branchial cleft cyst\n$\\checkmark$ exits pharynx at level of tonsillar fossa\n4. Third branchial arch anomaly\n$\\checkmark$ exits pharynx at piriform sinus\n5. Pleomorphic adenoma of ectopic salivary tissue / of deep lobe of parotid gland (common)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 163,
            "markdown": "6. Schwannoma, neurofibroma\n\nOrigin: usually from cranial nerve X\n$\\checkmark$ carotid artery pushed anteriorly\n7. Paraganglioma\n$\\checkmark$ posterior to carotid artery\n$\\checkmark$ extremely vascular (numerous flow voids)\n8. Lipoma\nB. MALIGNANT\n\n1. Squamous cell carcinoma\n$\\checkmark$ direct extension from pharyngeal mucosal space\n$\\checkmark$ vertical extension to skull base / hyoid bone\n2. Salivary gland malignancy\n\n# Pharyngeal Mucosal Space Mass \n\n1. Asymmetric fossa of Rosenmüller\n$=$ lateral pharyngeal recess $=$ asymmetry in amount of lymphoid tissue\n2. Tonsillar / peritonsillar abscess\n\n- sore throat, fever, painful swallowing\n\n3. Postinflammatory retention cyst\n$\\sqrt{1-2-\\mathrm{cm}}$ well-circumscribed cystic mass\n4. Postinflammatory calcification\n\n- remote history of severe pharyngitis\n$\\checkmark$ multiple clumps of calcification\n\n5. Benign mixed tumor\n\n- pedunculated mass arising from minor salivary glands\n$\\checkmark$ oval / round well-circumscribed mass protruding into airway\n\n6. Squamous cell carcinoma\n$\\checkmark$ infiltrating mass with epicenter medial to + invading parapharyngeal space\n$\\checkmark$ middle-ear fluid (eustachian tube malfunction)\n$\\checkmark$ cervical adenopathy\n7. Non-Hodgkin lymphoma\n8. Minor salivary gland malignancy\n9. Thornwaldt cyst\n$\\diamond$ Most common congenital head and neck cyst in a child!\n\n## PET in Squamous Cell Carcinoma of Head and Neck\n\n(1) Mucosal primary not identified (in 1-5\\%): 25-35\\% sensitive\n(2) Staging: detection of contralateral nodal involvement\n(3) Restaging ( $88-100 \\%$ sensitive, $75-100 \\%$ specific): more sensitive and specific than CT / MR\n\n## Masticator Space Mass\n\nA BENIGN\n\n1. Asymmetric accessory parotid gland\n\nFrequency: $21 \\%$ of general population",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 164,
            "markdown": "Location: usually on surface of masseter muscle $\\checkmark$ prominent salivary gland tissue\n2. Benign masseteric hypertrophy\n\nCause: bruxism (= nocturnal gnashing of teeth)\n$\\checkmark$ homogeneous enlargement of one / both masseters\n3. Odontogenic abscess / mandibular cysts\n\n- bad dentition + trismus\n\n4. Lymphangioma, hemangioma\nB. MALIGNANT\n5. Sarcoma (chondro-, osteo-, soft-tissue sarcoma, especially rhabdomyosarcoma in children)\n$\\checkmark$ infiltrating mass with mandibular destruction\n6. Malignant schwannoma\n$\\checkmark$ tubular mass along cranial nerve $\\mathrm{V}_{3}$\n7. Non-Hodgkin lymphoma\n8. Infiltrating squamous cell carcinoma\n$\\checkmark$ extending from pharyngeal mucosa\n9. Salivary gland malignancy: mucoepidermoid carcinoma, adenoid cystic carcinoma\n$\\checkmark$ extending from parotid gland\nN.B.: (1) check course of $\\mathrm{V}_{3}$ to foramen ovale for skull base extension to Meckel cave area + cavernous sinus\n(2) check for extension to pterygopalatine fossa + infraorbital fissure into orbit\n\n# Carotid Space Mass \n\nA. VASCULAR LESION\n\n1. Ectatic common / internal carotid artery\n2. Carotid artery aneurysm / pseudoaneurysm\n3. Asymmetric internal jugular vein\n4. Jugular vein thrombosis, Lemierre syndrome\nB. BENIGN TUMOR\n5. Paraganglioma: carotid body tumor + glomus jugulare + glomus vagale\n6. Schwannoma\n$\\checkmark$ displacement of carotid artery anteromedially + internal jugular vein posteriorly $\\checkmark$ well-encapsulated mass\n7. Neurofibroma of cranial nerves IX, X, XI\n8. Branchial cleft cyst\nC. MALIGNANT TUMOR\n9. Nodal metastasis from squamous cell carcinoma to interior jugular chain (common) $\\checkmark$ encasement of carotid artery = inoperable\n10. Non-Hodgkin lymphoma\n\n## Carotid Artery Aneurysm\n\n$=$ aneurysm of extracranial carotid artery\n\n1. Trauma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 165,
            "markdown": "2. Infection (mycotic aneurysm)\n3. Congenital (very rare): manifestation of connective tissue disorder (Ehlers-Danlos, Marfan, Kawasaki, Maffucci syndrome)\n\n# Retropharyngeal Space Mass \n\nA. INFECTION\n\nOrganism: S. aureus, Haemophilus parainfluenzae, b-hemolytic Streptococcus\n\n1. Reactive lymphadenopathy\n$\\sqrt{ }$ nodes $>10 \\mathrm{~mm}$ in diameter\n2. Suppurative lymphadenitis (common in childhood)\n$\\sqrt{ }$ cystic change with peripheral enhancement\n3. Retropharyngeal cellulitis\n$\\checkmark$ retropharyngeal edema\n4. Retropharyngeal abscess\nB. BENIGN TUMOR\n5. Hemangioma\n6. Lipoma\nC. MALIGNANT TUMOR\n7. Metastasis to retropharyngeal nodes\n\nSource: nasopharyngeal squamous cell carcinoma, melanoma, thyroid carcinoma\nN.B.: sentinel node of Rouvière (= lateral retro pharyngeal node) = early sign of nasopharyngeal cancer before primary mass becomes obvious\n2. Non-Hodgkin lymphoma\n3. Direct invasion by squamous cell carcinoma\n\n## Prevertebral Space Mass\n\nA. PSEUDOTUMOR\n\n1. Anterior disk herniation\n2. Vertebral body osteophyte\nB. INFLAMMATION\n3. Vertebral body osteomyelitis\n4. Abscess\n$\\sqrt{ }$ extension from retropharyngeal space / osteomyelitis / diskitis / epidural abscess\nC. TUMOR\n5. Chordoma\n6. Vertebral body metastasis: lung, breast, prostate, non-Hodgkin lymphoma, myeloma\n$\\diamond$ Metastases to prevertebral space = inoperable\n\n## LARYNX\n\n## Vocal Cord Paralysis\n\n$\\diamond$ Follow anatomic course of laryngeal nerve\nA. INTRACRANIAL CAUSES\n$\\checkmark$ outward bowing of ipsilateral oropharynx\n$\\checkmark$ atrophic thinning of pharyngeal constrictor muscle",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 166,
            "markdown": "$\\sqrt{ }$ uvular deviation away from side of causative lesion\n\n1. Birth injury\n2. Arnold-Chiari malformation\n3. Intracranial tumor\n4. Medullary infarct\nB. MEDIASTINAL CAUSES\n(a) neoplastic: bronchogenic ca., lymphoma, esophageal ca., thyroid ca., neurogenic tumor (paraganglioma, schwannoma), thymic malignancy, nodal metastasis (breast, lung, esophagus), retrosternal goiter\n(b) inflammatory: sarcoidosis, silicosis, fibrosing mediastinitis\n(c) infectious: TB, histoplasmosis, coccidioidomycosis, bacterial abscess, mycotic aortic aneurysm\n(d) infiltrative: amyloidosis\n(e) vascular / cardiac: vascular ring, aortic dissection / pseudoaneurysm, left atrial enlargement, CHD, pulmonary artery enlargement, pulmonary embolism\n(f) traumatic / surgical procedure: median sternotomy (CABG, valve repair), ligation of PDA, mediastinoscopy, radical esophagectomy, left pneumonectomy / left upper lobectomy, carotid endarterectomy, thyroidectomy, anterior cervical spine fusion, central venous line placement, endotracheal intubation, deceleration injury\nC. PARALYTIC PERIPHERAL NEUROPATHY\n5. Radioactive iodine ablation treatment\n6. External beam radiation effect\n7. Chemotherapy (vinca alkaloids)\n8. Jugular vein thrombosis\n\n# Fluoroscopy \n\n$\\sqrt{ }$ fixed vocal cords\nCT (true axial):\n$\\sqrt{ }$ ipsilateral dilatation of piriform sinus\n$\\sqrt{ }$ ipsilateral dilatation of laryngeal ventricle\n$\\sqrt{ }$ medial rotation + thickening of aryepiglottic fold\n$\\sqrt{ }$ anteromedial displacement of ipsilateral arytenoid cartilage + medial displacement of posterior vocal cord margin\n$\\sqrt{ }$ \"sail\" sign = medialization of posterior vocal cord margin + air distention of ipsilateral laryngeal ventricle\nCT (oblique axial):\n$\\sqrt{ }$ mushroom-like appearance = \"stem\" between posterior vocal cords + \"head\" tilted toward side of paralysis\nPET/CT:\n$\\sqrt{ }$ asymmetric increased uptake in normal cord\n\n## Mimics of Vocal Cord Paralysis\n\n1. Tilted patient positioning (oblique imaging)\n$\\sqrt{ }$ subglottic air seen anterior to obliquely imaged vocal cord $\\neq$ dilated laryngeal ventricle\n2. Invasion of aryepiglottic cartilage by squamous cell carcinoma of larynx / piriform sinus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 167,
            "markdown": "$\\checkmark$ immobilization of vocal cords\n$\\checkmark$ apparent medialization of cord by thickening from enhancing tumor\n$\\checkmark$ obliteration of normal fat planes\n$\\checkmark$ sclerosis of adjacent cartilage\n$\\checkmark$ regional lymphadenopathy\n3. Arytenoid cartilage dislocation / subluxation\n$\\checkmark$ poorly defined cricoarytenoid joint\n$\\checkmark$ disparity in height of vocal cords (coronal CT)\n4. Injection laryngoplasty\n$\\checkmark$ \"medialization\" of paralyzed cord (to improve glottis closure + competence)\n\n# Epiglottic Enlargement \n\nA. NORMAL VARIANT\n\n1. Prominent normal epiglottis\n2. Omega epiglottis\nB. INFLAMMATION\n3. Acute / chronic epiglottitis\n4. Angioneurotic edema\n5. Stevens-Johnson syndrome\n6. Caustic ingestion\n7. Radiation therapy\nC. MASSES\n8. Epiglottic cyst\n9. Aryepiglottic cyst\n10. Foreign body\n\n## Aryepiglottic Cyst\n\n1. Retention cyst\n2. Lymphangioma\n3. Cystic hygroma\n4. Thyroglossal cyst\n\n- may be symptomatic at birth\n$\\checkmark$ well-defined mass in aryepiglottic fold\n\n\n## Laryngeal Neoplasms\n\nA. SQUAMOUS CELL CARCINOMA (95-98\\%)\n\nLocation: glottic $>$ supraglottic $>>$ subglottic\n\n- endoscopically visible due to mucosal involvement\nB. NON-SQUAMOUS CELL NEOPLASMS (2-5\\%)\nmalignant + benign $=1 \\div 1$\n(a) vasoformative tumor $33 \\%$\n\nBENIGN\n\n1. Hemangioma\n2. Lymphangioma\n3. Angiofibroma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 168,
            "markdown": "4. Angiomatosis\n5. Granuloma pyogenicum\n6. Arteriovenous fistula\n7. Phlebectasia, telangiectasia\n\nMALIGNANT\n\n1. Angiosarcoma (Kaposi sarcoma)\n\nLocation: epiglottis (most frequent)\n$\\sqrt{ }$ intensely enhancing mass\n2. Hemangiopericytoma\n(b) chondrogenic tumor $20 \\%$\n\n1. Chondroma\n2. Chondrosarcoma\n3. Osteosarcoma\n(c) hematopoietic tumor $12 \\%$\n4. Hodgkin / NHL / leukemia\n5. Plasmacytoma\n6. Pseudolymphoma\n(d) salivary gland tumor $10 \\%$\n7. Pleomorphic adenoma\n8. Adenoid cystic carcinoma\n9. Mucoepidermoid carcinoma\n10. Adenocarcinoma\n(e) fatty-tissue tumor $7 \\%$\n11. Lipoma\n12. Liposarcoma\n(f) metastasis $7 \\%$\nskin (melanoma) $>$ kidney $>$ breast $>$ lung $>$ prostate $>$ colon $>$ stomach $>$ ovary\n(g) neurogenic tumor $5 \\%$\n(h) myogenic tumor $2 \\%$\n(i) fibrohistiocytic tumor $2 \\%$\n\n# AIRWAYS \n\n## Inspiratory Stridor in Children\n\n1. Croup\n2. Congenital subglottic stenosis\n3. Subglottic hemangioma\n4. Airway foreign body\n5. Esophageal foreign body\n6. Epiglottitis\n\n## Airway Obstruction in Childhood\n\nPredisposing anatomy compared to adult:\n(1) Narrower nasopharynx\n(2) Shorter trachea",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 169,
            "markdown": "(3) Larynx location more anterosuperiorly at level of C3-C4\n(4) Cricoid cartilage $=$ narrowest part\n(5) Conus elasticus (located 1 cm below glottis): very susceptible to edema\n(6) Vocal cords more anteriorly angled\n(7) Epiglottis broader and longer\n(8) Tongue larger\n(9) Intercostal and diaphragmatic muscles weaker\n\nIn acute upper airway obstruction obtain lateral and frontal soft-tissue radiographs of the neck in upright position. If unstable, a single upright soft-tissue lateral radiograph is usually sufficiently diagnostic.\nIn acute lower airway obstruction $\\rightarrow$ upright frontal CXR during inspiration with depiction of $>6$ anterior ribs at mid-hemidiaphragmatic level + lateral neck radiograph and also expiratory CXR with possible foreign body aspiration.\n\n# Nasopharyngeal Narrowing \n\n(a) choanal atresia, choanal stenosis, encephalocele\n\nCongenital:\n(b) adenoidal enlargement ( $=$ pharyngeal tonsils narrow pharynx), polyps\n\nInflammatory:\n(c) juvenile angiofibroma, rhabdomyosarcoma, teratoma, neuroblastoma,\n\nNeoplastic: lymphoepithelioma\n(d) Traumatic: foreign body, hematoma, rhinolith\n\n## Oropharyngeal Narrowing\n\n(a) Congenital: glossoptosis + micrognathia (Pierre Robin, Goldenhar, Treacher Collins syndrome), macroglossia (cretinism, Beckwith-Wiedemann syndrome)\n(b) Inflammatory: abscess, tonsillar hypertrophy (if tonsils occupy $>50 \\%$ of oropharynx)\n(c) Neoplastic: $\\quad$ lingular tumor / cyst\n(d) Traumatic: hematoma, foreign body\n\n## Retropharyngeal Narrowing\n\n$=$ potential space (normally $<3 / 4$ of AP diameter of adjacent cervical spine in infants $/<3$ mm in older children)\n(a) Congenital: branchial cleft cyst, ectopic thyroid\n(b) Inflammatory: retropharyngeal abscess\n(c) Neoplastic: cystic hygroma (originating in posterior cervical triangle with extension toward midline + into mediastinum), neuroblastoma, neurofibromatosis, hemangioma\n(d) Traumatic: hematoma, foreign body\n(e) Metabolic: hypothyroidism\n\nDDx: \"pseudothickening\" $\\leftarrow$ flexed position (exacerbates respiratory distress), young age, during expiration",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 170,
            "markdown": "# Vallecular Narrowing \n\n$=$ valleys on each side of glossoepiglottic folds between base of tongue + epiglottis\n(a) Congenital: congenital cyst, ectopic thyroid, thyroglossal cyst\n(b) Inflammatory: abscess\n(c) Neoplastic: teratoma\n(d) Traumatic: foreign body, hematoma\n\n## Supraglottic Narrowing\n\n$=$ area between epiglottis and true vocal cords\n(a) Congenital: aryepiglottic fold cyst\n(b) Inflammatory: acute bacterial epiglottitis, angioneurotic edema\n(c) Neoplastic: retention cyst, cystic hygroma, neurofibroma\n(d) Traumatic: foreign body, hematoma, radiation, caustic ingestion\n(e) Idiopathic: laryngomalacia\n\n## Glottic Narrowing\n\n$=$ area of true vocal cords\n(a) Congenital: laryngeal atresia, laryngeal stenosis, laryngeal web (anterior commissure)\n(b) Neoplastic: laryngeal papillomatosis\n(c) Neurogenic: vocal cord paralysis (most common)\n(d) Traumatic: foreign body, hematoma\n\n## Subglottic Narrowing\n\n$=$ short segment between undersurface of true vocal cords and inferior margin of cricoid cartilage $=$ narrowest portion of child's airway\n(a) Congenital: congenital subglottic stenosis\n(b) Inflammatory: croup, Wegener granulomatosis\n(c) Neoplastic: hemangioma, papillomatosis\n(d) Traumatic: acquired stenosis $\\leftarrow$ prolonged endotracheal intubation in $5 \\%$\n(e) Idiopathic: mucocele $=$ mucous retention cyst (rare complication of prolonged endotracheal intubation)\n\n## Most Common Tracheal / Laryngeal Mass in Childhood\n\n(a) endoluminal\n\n1. Recurrent respiratory papillomatosis\n2. Laryngocele\n3. Subglottic hemangioma\n(b) extraluminal (compressing airway)\n4. Bronchogenic cyst\n5. Lymphadenopathy\n6. Neuroblastoma\n\n## Epiglottic and Aryepiglottic Fold Thickening",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 171,
            "markdown": "1. Epiglottitis\n2. Ingestion of caustic substance / foreign body\n3. Angioedema\n4. Hemorrhage\n5. Epiglottic cyst\n6. Postirradiation edema and fibrosis\n\n# NECK \n\n## Torticollis\n\n$=$ \"wry neck\" = congenital / acquired deformity characterized by rotational deformity of the cervical spine\n\n## Congenital Torticollis\n\nA. MUSCULAR\n\n1. Congenital muscular torticollis\n(a) fibromatosis colli\n(b) muscular torticollis = muscular tightness\n(c) postural torticollis\n2. Absence of sternocleidomastoid muscle (SCM)\nB. SKELETAL\n3. Occipitoatlantal fusion\n4. Klippel-Feil syndrome\n5. Achondroplasia\n6. Osteogenesis imperfecta\n7. Down syndrome\nC. CUTANEOUS\n8. Pterygium colli\nD. NEUROLOGIC\n9. Syringomyelia\n10. Ocular abnormalities: strabismus, nystagmus\n\n## Acquired Torticollis\n\nA. TRAUMATIC\n\n1. Atlantoaxial rotary fixation\n2. Occipital condyle fracture\n3. Unilateral facet dislocation\n4. Muscle spasm\n5. Spinal hematoma\nB. INFECTIOUS / INFLAMMATORY $\\rightarrow$ SCM SPASM\n6. Upper respiratory infection\n7. Otitis media, mastoiditis\n8. Cervical adenitis\n9. Retropharyngeal abscess\n10. Osteomyelitis, diskitis, epidural abscess, meningitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 172,
            "markdown": "6. Juvenile idiopathic arthritis\nC. NEOPLASTIC\n> CNS tumor: posterior fossa, brainstem, spinal cord\n> Bone tumor:\n7. Eosinophilic granuloma\n8. Osteochondroma\n9. Osteoid osteoma\n10. Metastasis to skull base / spine\n(d) miscellaneous (eg, Langerhans cell histiocytosis)\n\n# Solid Neck Mass \n\n## Soft-tissue Tumors of Head \\& Neck\n\n$=$ group of mesenchymal tumors with widely varied biologic behaviors [benign (76\\%), intermediate ( $13 \\%$ ), malignant ( $11 \\%$ )]\nLocation: head \\& neck (27\\%)\nAge: in 1st year of life (50\\%),; during 1st decade (71\\%)\n$\\diamond 12 \\%$ of soft tissue tumors in children + adolescents\n(a) benign\n\n1. Fibromatosis colli\n2. Infantile myofibromatosis / myofibroma\n3. Nodular fasciitis\n4. Giant cell angiofibroma\n5. Myositis ossificans\n(b) intermediate malignant potential\n6. Desmoid-type fibromatosis\n7. Solitary fibrous tumor\n8. Hemangiopericytoma\n9. Inflammatory myofibroblastic tumor\n(b) malignant\n10. Extraskeletal fibrosarcoma\n\nFeatures of malignancy:\nMalignant soft tissue tumors usually have lower ADC values than benign tumors. ADC value correlates with tumor cellularity in soft tissue sarcomas.\n(a) size\n$\\sqrt{ }$ large volume with $>5 \\mathrm{~cm}$ in diameter\n(b) internal texture\n$\\sqrt{ }$ intratumoral hemorrhage + necrosis\n$\\sqrt{ }$ heterogeneous texture\n$\\sqrt{ }$ high T2 signal intensity\n(c) margin\n$\\sqrt{ }$ poorly defined margin\n$\\sqrt{ }$ broad interface with underlying fascia\n$\\sqrt{ }$ extracompartmental extension",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 173,
            "markdown": "(d) vascularity\n$\\sqrt{ }$ marked primarily peripheral enhancement\n(e) interaction with surroundings\n$\\sqrt{ }$ invasion of bone + neurovascular structures\nDemographics of soft-tissue tumors of head \\& neck:\n, Child: Infantile hemangioma, lymphangioma, lipoblastoma, fibromatosis colli, myofibroma, rhabdomyosarcoma\n, Adolescent: Hibernoma, desmoid-type fibromatosis, synovial sarcoma, Ewing sarcoma\n, Older adult: Liposarcoma, malignant fibrous histiocytoma\nRadiation-induced sarcoma of head \\& neck:,\n\n1. Fibrosarcoma $41.5 \\%$\n2. Osteosarcoma $22.6 \\%$\n3. Malignant fibrous histiocytoma $13.2 \\%$\n\nA mass at a previously irradiated site and average latency period of 9 (range, 3-26) years raises concern for radiation-induced sarcoma.\n\n# Solid Neck Mass in Neonate \n\n1. Cystic hygroma\n2. Hemangioma\n3. Neuroblastoma\n4. Teratoma\n5. Fibromatosis colli\n\n## Solid Neck Mass in Childhood\n\n1. Lymphadenopathy\n2. Fibromatosis colli\n3. Aggressive fibromatosis\n4. Malignancy: neuroblastoma (most common), lymphoma, embryonal rhabdomyosarcoma\n5. Teratoma\n6. Hemangioma\n7. Cervicothoracic lipoblastomatosis\n8. Lipoma\n9. Thyroid mass / lingual thyroid\n10. Parathyroid adenoma\n11. Ectopic thymus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 174,
            "markdown": "| Soft-tissue Tumors of Neck (WHO Classification 2002) |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| Histology | Benign | Intermediate locally aggressive | Intermediate rarely metastasizing | Malignant |\n| Adipocytic | Lipoma, lipoblastoma, hibernoma, lipomatosis | Atypical lipomatous tumor, well-differentiated liposarcoma | ... | Liposarcoma |\n| Fibroblastic / myofibroblastic | Fibromatosis colli, myofibroma, giant cell angiofibroma | Desmoid-type fibromatosis | Solitary fibrous tumor, hemangiopericytoma, inflammatory myofibroblastic tumor (inflammatory pseudotumor) | Fibrosarcoma |\n| So-called fibrohistiocytic | Benign fibrous histiocytoma, diffuse-type giant cell tumor (PVNS) | ... | Giant cell tumor of soft tissues | Malignant fibrous histiocytoma (undifferentiated pleomorphic sarcoma) |\n| Skeletal muscle | Rhabdomyoma | ... | ... | Rhabdomyosarcoma |\n| Smooth muscle | Leiomyoma, angioleiomyoma | ... | ... | Leiomyosarcoma |\n| Vascular | Hemangioma, lymphangioma | Kaposiform hemangioendothelioma | Kaposi sarcoma | Angiosarcoma |\n| Perivascular | Glomus tumor, myopericytoma | ... | ... | Malignant glomus tumor |\n| Chondro-osseous | Soft tissue sarcoma | ... | ... | Mesenchymal chondrosarcoma, extraskeletal osteosarcoma |\n| Uncertain differentiation | Myxoma | ... | Ossifying fibromyxoid tumor | Synovial sarcoma, alveolar soft part sarcoma, primitive neuroectodermal tumor, Ewing sarcoma |\n\n# Pediatric Neck Lesions \n\n@ Superficial\n\n1. Teratoma\n@ Visceral\n2. Retropharyngeal cellulitis\n3. GI duplication cyst\n4. Thyroglossal duct cyst\n5. Goiter\n6. Laryngocele\n7. Lymphadenopathy\n@ Prevertebral space\n8. Descending necrotizing mediastinitis\n@ Carotid space\n9. Lemierre syndrome\n@ Parotid space\n10. Acute parotitis\n11. HIV parotitis\n@ Submandibular space\n12. $2^{\\text {nd }}$ branchial cyst\n13. Thyroglossal duct cyst\n@ Masticator space\n14. Venous malformation\n@ Parapharyngeal space",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 175,
            "markdown": "1. Rhabdomyosarcoma\n@ Posterior cervical space\n2. Lymphatic malformation\n@ Perivertebral space\n3. Cervical sporadic Burkitt lymphoma\n4. Cervical neuroblastoma\n5. Cervical dermal sinus\n@ Sternocleidomastoid muscle space\n6. Fibromatosis colli\n@ Multiple spaces\n7. Cervical lymphadenitis\n\n# Congenital Cystic Lesions of Neck \n\nIt is critical to identify common congenital lesions like branchial cleft + thyroglossal duct cysts, and to recognize their complications (eg, superinfection)\n\n1. Thyroglossal duct cyst\n\n- vertical movement with protrusion of tongue\n\nLocation: anterior cervical triangle close to midline between foramen cecum + thyroid isthmus\n2. Lateral ectopic thyroid tissue\n$\\sqrt{ }$ NO thyroid tissue in normal location\n$\\sqrt{ }$ thin fibrous band attaching it to an orthotopic gland\n3. Lymphangioma / cystic hygroma\n\nLocation: mostly in posterior cervical triangle, occasionally in floor of mouth / tongue\n$\\sqrt{ }$ transspatial extent containing locules\nAge: congenital lesion detected by age 2 years\n4. Branchial cleft anomalies\n\n- often noted during upper respiratory infection\n(a) $2^{\\text {nd }}$ branchial cleft cyst\n\nLocation: near mandibular angle along anterior surface of sternocleidomastoid muscle, lateral to carotid sheath structures, posterior to submandibular gland\n\n- painless fluctuating mass often appearing after an upper respiratory infection\n$\\sqrt{ }$ round mass displacing sternocleidomastoid muscle posterolaterally\n$\\sqrt{ }$ PATHOGNOMONIC beak insinuating itself between ICA + ECA\n(b) branchial cleft fistula\n\nLocation: apex of piriform sinus to thyroid\n5. Cervical dermoid / epidermoid cyst\n\nLocation: base of tongue, anterior portion of neck, floor of mouth\n$\\sqrt{ }$ fat content / diffusion restriction\n6. Cervical thymic cyst $=$ persistent thymopharyngeal duct\n\nLocation: mostly on left side of neck\n7. Cervical bronchogenic cyst\n\nCause: anomalous foregut development",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 176,
            "markdown": "Histo: columnar ciliated pseudostratified epithelial lining\n$\\mathrm{M} \\div \\mathrm{F}=3 \\div 1$\n\n- draining sinus in suprasternal notch / supraclavicular area\n$\\sqrt{ }$ cyst up to 6 cm in diameter\n$\\sqrt{ }$ indentation of trachea\n\n8. Parathyroid cyst\n\nAge: $30-50$ years\n\n- hormonally inactive\n$\\sqrt{ }$ noncolloidal cyst near lower pole of thyroid gland\n\n9. Obstructed laryngocele\n\nLocation: lateral aspect of superior paralaryngeal space connecting to larynx $\\leftarrow$ originating from saccule / appendix of laryngeal ventricle\n$\\sqrt{ }$ well-defined smooth mass / saccular cyst\n10. Lingual abscess\n$=$ infected lingual thyroglossal duct cyst / dermoid cyst / ranula / secondary to instrumentation or tongue piercing\n\n# Midline Neck Mass \n\n1. Thyroglossal duct cyst\n2. Epidermoid / dermoid cyst\n3. Lymph node\n4. Abscess",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 177,
            "markdown": "| Pediatric Lesions compared to Neck Compartments |  |\n| :--: | :--: |\n| Space | Differential Diagnosis |\n| Superficial fascia | teratoma, vascular malformation, cellulitis, plexiform neurofibroma, keloid, scar, SQ fat fibrosis |\n| Visceral space | all 3: cellulitis, abscess, extension of goiter |\n| Retropharyngeal space | lateral and medial retropharyngeal lymphadenopathy, extension of pharyngeal tumor |\n| Retrovisceral - | esophageal duplication |\n| Pretracheal - | thyroglossal cyst, laryngocele, lymphadenopathy, spondylodiskitis |\n| Danger space | cellulitis, abscess |\n| Carotid space | Internal jugular / retromandibular vein thrombosis or phlebitis, lymphadenopathy, paraganglioma |\n| Submandibular / sublingual space | thyroglossal / branchial cyst, venous / lymphatic malformation, dermoid cyst, ranula, sublingual gland disease, lymphadenopathy, facial vein disease |\n| Masticator space | venous / lymphatic malformation, cellulitis, abscess, rhabdomyosarcoma |\n| Parapharyngeal space | cellulitis, abscess, rhabdomyosarcoma, paraganglioma |\n| Perivertebral space | cervical dermal sinus, meningocele, rhabdomyosarcoma, lymphoma extension |\n| Posterior cervical - | lymphatic malformation, lymphadenopathy |\n\n# Air-containing Masses of Neck \n\n1. Laryngocele\n2. Tracheal diverticulum arising from anterior wall of trachea close to thyroid\n3. Zenker diverticulum\n4. Lateral pharyngeal diverticulum located in tonsillar fossa / vallecula / pyriform fossa\n\n## Fat-containing Masses of Neck\n\n1. Dermoid cyst\n2. Lipoblastoma\n3. Liposarcoma\n$\\diamond 4 \\%$ of all liposarcomas\n\n- extremely rare $<10$ years of age\n\nLocation: neck (28\\%), larynx (20\\%), pharynx (18\\%)\n\n## Lymph node enlargement of neck\n\n$\\diamond$ Most common neck mass in children!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 178,
            "markdown": "# A. NORMAL LYMPH NODES \n\n$\\sqrt{ }$ few small oval hypoechoic masses\n$\\sqrt{ } \\pm$ central linear echogenicity ( $=$ invaginating hilar fat)\n$\\sqrt{ }$ larger in transverse than anteroposterior dimension\nB. CERVICAL ADENITIS\n\nLocation: posterior cervical triangle\n\n1. Cat scratch disease\n\nOrganism: Bartonella henselae\nMode of transfer: cat bite / lick / scratch (bacteria present in cat saliva may be transferred to paws)\n\n- common cause of enlarged lymph nodes in children\n\n2. Tuberculous lymphadenitis\nC. NEOPLASTIC LYMPH NODES\n\n- firm, nonmobile, painless\n\nCause: Castleman disease, lymphoma (Hodgkin disease, NHL), leukemia, metastasis\n$\\sqrt{ }$ increased anteroposterior diameter\n$\\sqrt{ }$ prominent calcifications suggestive of medullary thyroid cancer\n$\\sqrt{ }$ axial diameter of $>15$ in jugulodigastric region $/>11 \\mathrm{~mm}$ elsewhere (in squamous cell carcinoma)\nUS:\n$\\sqrt{ }$ loss of hilar echogenicity\n$\\sqrt{ }$ peripheral / mixed hypervascularity on Doppler\n$\\sqrt{ } \\pm$ intranodal cystic change\nCT:\n$\\sqrt{ }$ irregular peripheral (marginal) enhancement\n$\\sqrt{ }$ central necrosis (regardless of size)\n$\\sqrt{ }$ fuzzy borders as sign of extracapsular extension\n$\\sqrt{ }$ ill-defined borders + loss of fat plane between node and adjacent structures (muscle, vasculature, bone) $\\leftarrow$ extracapsular spread\n\n## Low-density Nodes with Peripheral Enhancement\n\n1. Suppurative adenitis\n2. Tuberculosis\n3. Metastatic malignancy\n4. Lymphoma\n5. Inflammatory conditions\n\n## Lymph Node Metastasis by Location\n\n@ SUPRACLAVICULAR\nhead \\& neck, lung, breast, esophagus\n@ INTERNAL JUGULAR\nsupraglottic larynx, esophagus, thyroid\n@ MIDJUGULAR\ntongue, pharynx, supraglottic larynx\n@ JUGULODIGASTRIC",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 179,
            "markdown": "nasopharynx, oropharynx, tonsils, parotid gland, supraglottic larynx\n@ SUBMANDIBULAR\nskin, submandibular gland, base of tongue\n@ POSTERIOR TRIANGLE\nnasopharynx, base of tongue\n@ LATERAL PHARYNGEAL\nnasopharynx, oropharynx\n\n# Tonsillar Enlargement \n\n1. Tonsillitis\n2. Lymphoid hyperplasia\n3. Mononucleosis\n4. Tonsillar neoplasm: squamous cell carcinoma, lymphoma)\n5. Angioedema\n6. Mucositis $\\leftarrow$ Kawasaki disease\n\n## SALIVARY GLANDS\n\n## Multiple Small Hypoechoic Areas in Salivary Gland\n\n1. Sialadenitis: chronic / acute\n2. Granulomatous disease: sarcoidosis\n3. Sjögren syndrome\n4. Disseminated lymphoma\n5. Metastases: hematogenous (uncommon)\n6. Benign lymphoepithelial lesions: HIV\n\n## Anechoic Cystic Areas in Salivary Gland at US\n\nA. BENIGN LESION\n\n1. Pleomorphic adenoma\n2. Basal cell adenoma\n3. Abscess\n4. Benign lymphoepithelial lesions\n5. Warthin tumor\nB. MALIGNANT LESION\n6. Mucoepidermoid carcinoma\n7. Acinic cell carcinoma\n8. Necrotic metastatic node\n\n## Inflammatory Disease of Salivary Glands\n\n1. Acute inflammation\n\nOrganism: viral (mumps, CMV); bacterial (S. aureus)\n$\\sqrt{ }$ hypoechoic enlargement of gland\n$\\sqrt{ }$ multiple small oval hypoechoic areas\n$\\sqrt{ }$ enlarged lymph nodes with increased blood flow\n2. Abscess",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 180,
            "markdown": "3. Chronic sialadenitis\n4. Sialolithiasis\n5. Sjögren syndrome\n\n# Parotid Gland Enlargement \n\nA. LOCALIZED INFLAMMATION / INFECTION\n\n1. Chronic recurrent sialadenitis\n2. Sialosis\n3. Sarcoidosis\n4. Tuberculosis\n5. Cat-scratch fever\n6. Syphilis\n7. Parotid abscess $\\leftarrow$ acute bacterial (suppurative) sialadenitis\n8. Reactive adenopathy\n9. Parotitis\nB. SYSTEMIC AUTOIMMUNE RELATED DISEASE\n10. Sjögren disease\n11. Mikulicz disease\nC. NEOPLASM (incidence in \\%)\n(a) benign parotid tumor\n12. Pleomorphic / monomorphic adenoma $59 \\%$\n13. Cystadenolymphoma (= Warthin tumor) $7 \\%$\n14. Benign lymphoepithelial lesions\n15. Lipoma\n16. Facial nerve neurofibroma\n17. Oncocytoma\n18. Parotid hemangioma\n19. Angiolipoma\n(b) primary malignant parotid tumor\n20. Mucoepidermoid carcinoma $8 \\%$\n21. Adenoid cystic carcinoma (= cylindroma) $3 \\%$\n22. Malignant mixed tumor\n23. Adenocarcinoma\n24. Acinic cell carcinoma $3.5 \\%$\n25. Rhabdomyosarcoma\n(c) metastatic parotid tumor\n$\\diamond$ Parotid gland undergoes late encapsulation, which leads to incorporation of lymph nodes!\n26. Squamous cell carcinoma $2 \\%$\n27. Melanoma of periauricular region\n28. Non-Hodgkin lymphoma\n29. Thyroid carcinoma\nD. LYMPHOPROLIFERATIVE DISORDER\n30. Lymphoma / leukemia\n31. Primary non-Hodgkin lymphoma (MALToma)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 181,
            "markdown": "# E. CONGENITAL \n\n1. First branchial cleft cyst\n\n## Bilateral Enlargement of Salivary Glands\n\n1. Viral infection (mumps)\n2. Acute phase of Sjögren syndrome\n3. Mikulicz disease\n4. Sarcoidosis\n5. Lymphoma\n\n## Salivary Gland Neoplasm\n\nFrequency: 90-95\\% occur in parotid gland, $5 \\%$ in submandibular + sublingual glands; only $1 \\%$ of all pediatric tumors!\n$\\diamond$ Most salivary gland neoplasms are benign ( $70 \\%-80 \\%$ ) and found in parotid glands (80$90 \\%$ !!\n$\\diamond$ The smaller the salivary gland the higher the rate of malignancy: parotid ( $20-25 \\%$ ) < submandibular $(40-50 \\%)<$ sublingual + minor salivary glands in tongue / floor of mouth / retromolar region $(50-81 \\%)$\n$\\diamond$ Spread to regional lymph nodes is infrequent!\n\n## Benign Salivary Gland Neoplasm\n\n1. Pleomorphic adenoma ( $80 \\%$ )\n2. Warthin tumor $(5 \\%-10 \\%)$\n\nOthers: oncocytoma, basal cell adenoma, hemangioma, lipoma, neurinoma, schwannoma\n\n## Malignant Salivary Gland Neoplasm\n\n1. Mucoepidermoid carcinoma\n2. Adenoid cystic carcinoma\n3. Acinic cell carcinoma\n4. Carcinoma ex-pleomorphic adenoma\n\nOthers: squamous cell carcinoma, adenocarcinoma\n\n## Solitary Lesion of Parotid Gland\n\n1. Pleomorphic adenoma ( $80 \\%$ )\n2. Warthin tumor\n3. Mucoepidermoid carcinoma\n\n## Multiple Lesions of Parotid Gland\n\n1. Warthin tumor\n2. Metastases to lymph nodes: squamous cell carcinoma of skin, malignant melanoma, nonHodgkin lymphoma\n3. Benign lymphoepithelial lesions (HIV)\n\n## THYROID\n\n## Congenital Dyshormonogenesis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 182,
            "markdown": "1. Trapping defect\n$=$ defective cellular uptake of iodine into thyroid, salivary glands, gastric mucosa\n$\\diamond$ High doses of inorganic iodine facilitate diffusion into thyroid permitting a normal rate of thyroid hormone synthesis\n$\\diamond$ Normal ratio of iodine concentration for gastric juice+plasma $=20 \\div 1$\n$\\checkmark$ nearly entire dose of administered radioiodine is excreted within 24 hours\n2. Organification defect\n$=$ deficient peroxidase activity, which catalyzes the oxidation of iodide by $\\mathrm{H}_{2} \\mathrm{O}_{2}$ to form monoiodotyrosine (MIT) / diiodotyrosine (DIT)\n\n- $\\uparrow$ serum TSH; $\\downarrow$ serum $\\mathrm{T}_{4}$\n- diffuse symmetric thyromegaly\n$\\checkmark$ high thyroidal uptake of radioiodine / pertechnetate\n$\\checkmark$ rapid ${ }^{131} \\mathrm{I}$ turnover\n$\\checkmark$ positive perchlorate washout test\nPendred syndrome $=$ autosomal recessive trait of deficient peroxidase regeneration characterized by hypothyroidism + goiter + nerve deafness\n\n3. Deiodinase (dehalogenase) defect\n$=$ deficient deiodination of MIT / DIT to release iodide, which is reutilized to synthesize thyroid hormone production\n\n- hypothyroidism; \"intrinsic\" iodine deficiency goiter\n- identification of MIT + DIT in serum + urine following administration of ${ }^{131} \\mathrm{I}$\n$\\checkmark$ high thyroidal ${ }^{131}$ I uptake\n$\\checkmark$ rapid intrathyroidal turnover of ${ }^{131} \\mathrm{I}$\n\n4. Thyroxin-binding globulin (TBG) deficiency\n\n- abnormal $\\mathrm{T}_{4}$ transport\n- low bound serum $\\mathrm{T}_{4}$ concentration\n- euthyroid\n\n5. End-organ resistance to thyroid hormone\n\n- high serum $\\mathrm{T}_{4}$\n- euthyroid / hypothyroid; growth retardation\n$\\checkmark$ goiter\n$\\checkmark$ stippled epiphyses\n\n\n# Thyrotoxicosis \n\n$=$ clinical syndrome of increased systemic metabolism\n\n- elevated free $\\mathrm{T}_{4}$, elevated free $\\mathrm{T}_{3}$, or both\n\nCause:\n(a) increased thyroid function\n\n1. Graves disease\n2. Marine-Lenhart syndrome\n$=$ nodular Graves $=$ Graves disease coexistent in multinodular goiter\n3. Toxic autonomous nodule\n4. Toxic multinodular goiter\n(b) thyroid inflammation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 183,
            "markdown": "1. Subacute thyroiditis\n2. Painless / silent thyroiditis\n3. Postpartum thyroiditis\n(c) iodine-induced hyperthyroidism\n(d) hyperthyroidism of extrathyroidal origin\n4. Factitious hyperthyroidism\n5. Ectopic thyroid hormone production: metastatic thyroid cancer, toxic struma ovarii\n6. Thyrotropin-induced hyperthyroidism (pituitary adenoma)\n\n# Hyperthyroidism \n\n$=$ excessive thyroid hormone activity\n\n- tachycardia, weight loss, muscle weakness, anxiety, decreased temperature tolerance\n\n\n## Radioiodine Therapy for Hyperthyroidism\n\nDose:\n(a) empiric: $\\quad 15-30 \\mathrm{mCi}$\n(b) calculation $(\\mathrm{Y}): 80-160 \\mu \\mathrm{Ci} /$ gram\n\nCalculation:\nDose $[\\mathrm{mCi}]=$ (gland weight [gram] $\\mathrm{x} \\mathrm{Y}[\\mu \\mathrm{Ci} /$ gram $]$ ) divided by 24 -hour uptake\n\n## Hyperthyroidism with High Radioiodine Uptake\n\n(a) stimulation of thyrotropin receptor by specific immunoglobulin\n\n1. Graves disease\n(b) autonomous production of thyroid hormone\n2. Toxic adenoma\n3. Toxic multinodular goiter\n(c) thyroid stimulation by endogenous hormones\n4. Trophoblastic disease\n$=$ hydatidiform mole / choriocarcinoma / testicular trophoblastic carcinoma\n\n- stimulation of thyroid by hCG\n\n5. TSH-mediated hyperthyroidism\n\n## Hyperthyroidism with Low Radioiodine Uptake\n\n1. Iodine-induced hyperthyroidism $=$ Jod-Basedow\n\nMechanism of low thyroid uptake:\nlarge serum concentration of exogenous non-radioactive iodine dilutes radioiodine tracer\nSources of iodine:\n\n1. Foods: seaweed, sushi, Japanese cuisine, Portuguese stew\n2. Health food supplement: Kelp tablets\n3. Radiographic contrast agent: renografin, Gastrografin ${ }^{\\circledR}$\n4. Topical antiseptic: povidone iodine, iodoform gauze\n5. Medication: amiodarone, Entero-Vioform ${ }^{\\circledR}$, COMBID ${ }^{\\circledR}$, iodine-containing expectorants\n6. Iodine solutions: KI, Lugol's solution, saturated solution of potassium iodide",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 184,
            "markdown": "Wolff-Chaikoff effect $=$ continued organification of iodine is inhibited once intrathyroidal iodide stores reach a critical level\nEscape from the Wolff-Chaikoff effect = intrathyroidal level of iodide decreases despite persistent high serum iodine levels $\\rightarrow$ iodide organification and thyroid hormone synthesis resume\nDuration: weeks - months\n\n# Hyperthyroidism with Radioiodine Uptake $<1 \\%$ \n\n1. Subacute thyroiditis\n2. Ectopic hyperthyroidism\n$=$ extrathyroidal source of thyroid hormone\n(a) Thyrotoxicosis factitia / medicamentosa\n$=$ factitious surreptitious (stealthy) self-administration of thyroid hormones (eg, hamburger thyroiditis $\\leftarrow$ bovine thyroid in hamburger meat)\n(b) Struma ovarii\n$=$ monodermal ovarian teratoma containing thyroid tissue\nFrequency: up to $3 \\%$ of all teratomas (malignant teratoma in $24 \\%$ of cases)\nPeak age: 50 years\n\n- hyperthyroidism in $5 \\%$\n$\\checkmark$ multilocular cystic ovarian mass with solid components\nMR:\n$\\checkmark$ multiple intracystic areas with low SI on T2WI + intermediate SI on T1WI\nNUC:\n$\\checkmark$ higher uptake than thyroid gland\n$D D x$ : thyroid cancer metastatic to the ovary\nPrognosis: $>95 \\%$ benign; malignant transformation to papillary / follicular thyroid cancer (rare)\n(c) Metastatic functional thyroid cancer (very rare, 25 cases)\n- mild $\\mathrm{T}_{3}$ toxicosis\n\n\n## Hypothyroidism\n\nA. PRIMARY HYPOTHYROIDISM (most common)\n$=$ thyroid's inability to produce sufficient thyroid hormone\n\n- TSH $>10 \\mathrm{mU} / \\mathrm{L}+\\mathrm{FT}_{4}$ below reference range\n\n1. Agenesis of thyroid\n2. Congenital dyshormonogenesis\n3. Chronic thyroiditis\n4. Previous radioiodine therapy\n5. Ectopic thyroid $(1 \\div 4,000)$\nB. SECONDARY HYPOTHYROIDISM\n$=$ failure of anterior pituitary to release sufficient quantities of TSH\n\n- low to mildly elevated TSH + low $\\mathrm{FT}_{4}$\n\n1. Sheehan syndrome\n2. Head trauma\n3. Pituitary tumor (primary / secondary)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 185,
            "markdown": "4. Aneurysm\n5. Surgery\nC. TERTIARY / HYPOTHALAMIC HYPOTHYROIDISM\n$=$ failure of hypothalamus to produce sufficient amounts of TRH\n\n# Prominent Pyramidal Lobe \n\n$=$ distal remnant of thyroid descent tract\n\n1. Normal variant: present in $10 \\%$\n2. Hyperthyroidism\n3. Thyroiditis\n4. S/P thyroid surgery\n$D D x$ : esophageal activity from salivary excretion (disappears after glass of water)\n\n## Thyroid Calcifications\n\n(a) microcalcifications = psammoma bodies\n$\\sqrt{ }$ punctate hyperechoic foci without acoustic shadowing\n(b) large coarse calcifications = tissue necrosis\n$\\sqrt{ }$ spicules / fragmented plates / granular deposit within fibrous septa with posterior acoustic shadowing\n$\\diamond$ Common in multinodular goiter + medullary cancer\n$\\diamond$ Associated with $75 \\%$ malignancy rate in solitary nodule\n(c) peripheral calcifications\n$\\checkmark$ alignment along periphery of lesion\n$\\diamond$ Common in multinodular goiter $\\pm$ malignancy\n\n## Psammoma Bodies\n\n$=10-100 \\mu \\mathrm{~m}$ round crystalline calcific deposits\nFrequency: in 29-59\\% of all primary thyroid cancers\n$\\diamond$ Most specific feature of thyroid malignancy ( $86-95 \\%$ specific, $59 \\%$ sensitive, $84 \\%$ accurate, $42-94 \\%$ PPV)\n\n1. Papillary carcinoma $61 \\%$\n2. Follicular carcinoma $26 \\%$\n3. Undifferentiated carcinoma $13 \\%$\n4. Follicular adenoma\n5. Hashimoto thyroiditis\n\n## Cystic Areas in Thyroid\n\n$\\diamond 15-25 \\%$ of all thyroid nodules!\n$\\diamond$ Cystic component in 13-26\\% of all thyroid malignancies!\nA. Anechoic fluid + smooth regular wall:\n\n1. Colloid accumulation in goiter\n$=$ colloid-filled dilated macrofollicle\n2. Simple cyst (extremely uncommon)\nB. Solid particles + irregular outline:\n3. Hemorrhagic colloid nodule",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 186,
            "markdown": "2. Hemorrhagic adenoma ( $30 \\%$ )\n3. Necrotic papillary cancer ( $15 \\%$ )\n4. Liquefaction necrosis in adenoma / goiter\n5. Abscess\n6. Cystic parathyroid tumor\n\n- bloody fluid = benign / malignant lesion\n- clear amber fluid = benign lesion\n\nAspiration: cystic lesions often yield insufficient number of cells\n\n# Thyroid Nodule \n\nFrequency: (increasing with age)\n(a) $4-8 \\%$ by palpation ( $>2 \\mathrm{~cm}$ in $2 \\%, 1-2 \\mathrm{~cm}$ in $5 \\%,<1 \\mathrm{~cm}$ in $1 \\%$ ); $\\mathrm{M}+\\mathrm{F}=1 \\div 4$\n\n- $16 \\%$ have no corresponding nodule on US\n- $15 \\%$ have an additional nonpalpable nodule $>1 \\mathrm{~cm}$\n(b) $10-41 \\%$ by thyroid US if clinically normal: multiple in $38 \\%$, solitary in $12 \\%$ (occult small cancers found in $4 \\%$ )\n(c) incidental nodule in $9 \\%$ by CT and MR\n(d) incidental nodule in $2 \\%-3 \\%$ by PET\n\nBOTH benign + malignant nodules show increased uptake ( $=14-40 \\%$ risk for malignancy) $\\rightarrow$ evaluate further with US + FNAB\n(e) $50 \\%$ by autopsy\nA. THYROID ADENOMA (most common)\n\n1. Adenomatous nodule ( $42-77 \\%$ )\n2. Follicular adenoma ( $15-40 \\%$ )\n3. Ectopic parathyroid adenoma\nB. INFLAMMATION / HEMORRHAGE\n4. Thyroiditis: chronic lymphocytic (Hashimoto)\n5. Inflammatory lymph node in subacute + chronic thyroiditis\n6. Hemorrhage / hematoma: frequently associated with adenomas\n7. Abscess\nC. MALIGNANCY ( $5-7 \\%$ of all thyroid nodules)\n$\\diamond$ Higher risk of malignancy if\n> patient $<15-20$ and $>45-60$ years of age\n> patient is male\n> Hx of radiation therapy to neck / upper chest\n> family Hx of thyroid cancer / MEN syndrome\n> new nodule in long-standing goiter\n> nodule firm / fixed to adjacent structures\n> growth rapid\n> vocal cord paralyzed\n> regional lymph nodes enlarged\n8. Thyroid carcinoma\n(a) papillary carcinoma ( $70 \\%$ )\n(b) follicular carcinoma ( $15 \\%$ )\n> Hürthle cell carcinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 187,
            "markdown": "> Poorly differentiated carcinoma\n(c) medullary carcinoma (5-10\\%)\n(d) anaplastic / undifferentiated carcinoma (5\\%)\n(e) primary thyroid lymphoma (5\\%)\n2. Nonthyroidal neoplasm\n(a) Metastasis: from breast, lung, kidney, malignant melanoma\n(b) Lymphoma (uncommon):\n(usually) NHL as secondary involvement in generalized lymphoma / primary lymphoma in Hashimoto thyroiditis\n3. Hürthle cell carcinoma\n$\\checkmark$ very thin hypoechoic halo\n4. Carcinoma in situ\n$\\checkmark$ echogenic area inside a goiter nodule\n\n# Role of Fine-needle Aspiration Biopsy (FNAB): \n\n$\\diamond$ FNAB as initial test leads to a better selection of patients for surgery than any other test!\n$\\diamond$ Large-needle biopsy has more complications with no increase in diagnostic yield\nDiagnostic adequacy:\n$>6$ follicular cell groups each containing $10-15$ cells derived from at least 2 aspirates of the nodule\nDiagnostic accuracy (70-97\\%):\n(a) $60-70 \\%$ benign (with US guidance up to $0.6 \\%$ false negative rate due to sampling error)\nDx: benign follicular nodule / thyroiditis\nRecommendation: clinical follow-up\nRisk of malignancy: $0-3 \\%$\n(b) $10 \\%$ positive specimens ( $3-6 \\%$ false-positive rate often due to Hashimoto thyroiditis)\n(c) $10-20 \\%$ indeterminate (follicular neoplasm, Hürthle cell neoplasm, cellular atypia / findings suggestive but not diagnostic of malignancy)\n$\\diamond$ FNA cannot distinguish between benign and malignant follicular lesions!\nNondiagnostic material: in up to $20 \\%$\ntoo few follicular cells, too much blood, cyst fluid only, excessive air drying\nNondiagnostic rate: $9-30 \\%$ for palpation; $4-17 \\%$ for US\n\n## Technique of Fine-Needle Aspiration Biopsy\n\nNeedles: 27-gauge, 18- / 20-gauge core biopsy\nTarget: solid / central vascular component of nodule\n6 passes for each nodule:\n> 3 passes with capillary technique without suction\n> 3 passes with aspiration technique $=$ continuous $0.5-1-\\mathrm{mL}$ suction applied to attached $10-\\mathrm{mL}$ syringe\n\n- each pass consists of $\\sim 50$ vigorous controlled excursions of the needle through nodule for a 20 -second period\nIf repeat biopsy inadequate: Use FNAB + core biopsy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 188,
            "markdown": "Indeterminate result: repeat biopsy after 3 months\n\n# Role of Imaging: \n\n$\\diamond$ Imaging cannot reliably distinguish malignant from benign nodules!\nRadionuclide scanning (limited role):\n$\\diamond$ Useful in suppressed TSH / indeterminate cytology\n$\\diamond$ Hyperfunctioning nodule is almost always benign!\nUS:\n$\\diamond$ Best method to determine volume of nodule\n$\\diamond$ Useful during follow-up to distinguish nodular growth from intranodular hemorrhage\n$\\diamond$ US-guidance recommended for\n> nodules that are difficult to palpate\n> predominantly cystic nodule\n> nondiagnostic cytology from palpation-guided FNAB\n> growing nodule with prior benign cytology\n$\\diamond$ US-follow-up recommended to ensure stability\n> initially at $12+24$ months\n> subsequently at 3-5-year intervals\n\n## Discordant Thyroid Nodule\n\n$=$ nodule \"warm\" on ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate scan + \"cold\" on ${ }^{123} \\mathrm{I}$ scan, which indicates ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ trapping but no organification\nCause:\n\n1. Malignancy: follicular / papillary carcinoma\n$\\diamond<5 \\%$ of thyroid carcinomas manifest as discordant nodules\n2. Benign lesion: follicular adenoma / adenomatous hyperplasia (autonomous nontoxic nodules have accelerated iodine turnover + discharge radioiodine as hormone within 24 hr )\n$R x$ : thyroid fine-needle aspiration biopsy\n\n## Hot / Hyperfunctioning Thyroid Nodule\n\nFrequency: $5-8 \\%$\n\n1. Adenoma\n(a) Autonomous adenoma $=$ TSH-independent\n\n- euthyroid ( $80 \\%$ ), thyrotoxicosis ( $20 \\%$ )\n$\\sqrt{ }$ partial / total suppression of remainder of gland\n(b) Adenomatous hyperplasia $=$ TSH-dependent $\\leftarrow$ defective thyroid hormone production\n\n2. Thyroid carcinoma (extremely rare)\n$\\checkmark$ discordant uptake\nN.B.: (1) Any hot nodule on ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ scan must be imaged with ${ }^{123} \\mathrm{I}$ to differentiate between autonomous and cancerous lesion\n(2) A hot hyperfunctioning ( $=$ low TSH level) nodule is rarely malignant $\\rightarrow$ further evaluation with US / FNAB NOT NECESSARY\n\n## Increased Thyroid Uptake of Radiotracer",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 189,
            "markdown": "mnemonic: THRILLEr\nThyroiditis (early Hashimoto)\nHyperthyroidism (diffuse / nodular)\nRebound after withdrawal of antithyroid medication\nIodine starvation\nLow serum albumin\nLithium therapy\nEnzyme defect\n\n# Cold / Hypofunctioning Thyroid Nodule \n\nA. BENIGN TUMOR\n\n1. Nonfunctioning adenoma\n2. Cyst (11-20\\%)\n3. Involutional nodule\n4. Parathyroid tumor\nB. INFLAMMATORY MASS\n5. Focal thyroiditis\n6. Granuloma\n7. Abscess\nC. MALIGNANT TUMOR (10-23\\%)\n8. Carcinoma\n9. Lymphoma\n10. Metastasis\n\nUS features of cold nodule:\n$\\checkmark$ hypoechoic ( $71 \\%$ ), isoechoic ( $22 \\%$ ), hyperechoic ( $3 \\%$ )\n$\\checkmark$ mixed echogenicity ( $4 \\%$ )\n$\\checkmark$ cystic (rarely malignant)\nmnemonic: CATCH LAMP\nColloid cyst\nAdenoma (most common)\nThyroiditis\nCarcinoma\nHematoma\nLymphoma, Lymph node\nAbscess\nMetastasis (kidney, breast)\nParathyroid\nProbability of a cold nodule to represent thyroid cancer:\n(a) $5-25 \\%$ for solitary cold nodule\n(b) $1-6 \\%$ for multiple nodules (DDx: multinodular goiter)\n(c) $4 \\%$ for palpable cold nodule in Graves disease\n(d) with history of neck irradiation in childhood\n> $31 \\%$ for solitary nodule (found in $70 \\%$ of irradiations)\n$>37 \\%$ for multiple nodules (found in $25 \\%$ of irradiations)\n$>20 \\%$ with normal thyroid scan (found in $5 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 190,
            "markdown": "$\\diamond$ Solitary cold nodule by scintigraphy $\\rightarrow$ multinodular by US in $20-25 \\%$ !\n\n# Thyroid Uptake Measurements \n\nAgents: ${ }^{123} \\mathrm{I} /{ }^{131} \\mathrm{I}$ (easier to use), ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate (requires calibration)\nMethod:\n» orally administered isotope of iodine is absorbed from upper GI tract\n» tracer mixes with intravascular iodine pool\n» iodine is cleared by thyroid in competition with kidneys\n» uptake parallels thyroidal clearance of plasma inorganic iodide\n» all measurements are taken for 3 minutes at 4 and 24 hours (measurements at both 4 and 24 hours prevent missing the occasional rapid-turnover hyperthyroid patient returning to normal by 24 hours)\nRadioactive Iodine Uptake (RAIU):\nRAIU = Thyroid Counts* / Capsule Counts*\n\n*     * background corrected (thigh) + decay corrected\n*     * decay corrected\n\nInterpretation:\n(a) normal: $\\quad<25 \\%$ at 4 hours, $<35 \\%$ at 24 hours\n(b) increased: in Graves disease\n(c) decreased: in subacute thyroiditis\nN.B.: Uptake values do not diagnose hyperthyroidism, which is done with laboratory values $\\left(\\mathrm{T}_{4}, \\mathrm{~T}_{3}, \\mathrm{TSH}\\right)$ and clinical history\n\n## Decreased / No Thyroid Uptake of Radiotracer\n\nA. BLOCKED TRAPPING FUNCTION\n\n1. Iodine load (most common) $=$ dilution of tracer within iodine flooded pool Source of flooding:\n$\\diamond$ Suppression usually lasts for at least 4 weeks!\n$\\diamond$ A low-iodine diet for 3-10 days may be prescribed\n2. Exogenous thyroid hormone (replacement therapy) $\\rightarrow$ suppresses TSH release\nB. BLOCKED ORGANIFICATION\n3. Antithyroid medication (propylthiouracil [PTU] / methimazole)\n4. Goitrogenic substances\n$\\sqrt{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ uptake not inhibited\nC. DIFFUSE PARENCHYMAL DESTRUCTION\n5. Subacute thyroiditis\n6. Postpartum thyroiditis\n7. Chronic lymphocytic thyroiditis\nD. HYPOTHYROIDISM\n8. Congenital hypothyroidism\n9. Surgical / radioiodine ablation\n10. Thyroid ectopia (struma ovarii, intrathoracic goiter)\nmnemonic: H MITTE\nHypothyroidism (congenital)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 191,
            "markdown": "Medications: PTU, perchlorate, Cytomel ${ }^{\\circledR}$, Synthroid ${ }^{\\circledR}$, Lugol solution\nIodine overload (eg, after IVP)\nThyroid ablation (surgery, radioiodine)\nThyroiditis (subacute / chronic)\nEctopic thyroid hormone production\n\n# Thyroxin-binding Globulin Dysfunction \n\nA. ELEVATION OF TBG\n\n1. Pregnancy\n2. Estrogen administration\n3. Genetic trait\nB. REDUCTION IN TBG\n4. Androgens\n5. Anabolic steroids\n6. Glucocorticoids\n7. Nephrotic syndrome\n8. Chronic hepatic disease\nC. INHIBITION OF $\\mathrm{T}_{4}$ BINDING TO TBG: salicylates\n\n## Ultrasound Characterization of Thyroid Nodules\n\nUltrasound Features of Malignancy\n$\\checkmark$ microcalcifications = psammoma bodies\n$\\checkmark$ extension beyond thyroid margin\n$\\checkmark$ cervical lymph node metastasis (in 19\\%)\n$\\checkmark$ taller-than-wide shape in transverse plane\n$\\checkmark$ marked hypoechogenicity relative to thyroid parenchyma\nless specific:\n$\\checkmark$ irregular / microlobulated / ill-defined margin\n$\\checkmark$ solid composition\n$\\checkmark$ increased central vascularity\n\n## Ultrasound Features of Benignity\n\n$\\checkmark$ nodule surrounded by uniform halo\n$\\checkmark$ predominantly cystic composition\n$\\checkmark$ avascularity\n$\\checkmark$ enlarged thyroid with multiple nodules\n\n## Thyroid Nodule with Halo\n\n$=$ hypoechoic rim around a thyroid nodule\nCause: pseudocapsule of fibrous connective tissue + compressed thyroid parenchyma + chronic inflammatory infiltrate",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 192,
            "markdown": "| Cancer Risk of Thyroid Nodule by Ultrasound |  |  |\n| :-- | :-- | :-- |\n| US Finding | Low Risk | Increased Risk |\n| Echogenicity | hyperechoic | hypoechoic |\n| Calcification | coarse + large | microcalcifications |\n| Vascularity | in periphery | central |\n| Internal texture | spongiform |  |\n| Margin |  | irregular $\\pm$ vascular |\n| Edge definition | well-defined | incomplete halo |\n| Shape | taller than wide | wider than tall |\n| Growth | none | enlarging |\n\n(a) complete uniform halo\nhighly suggestive of benignity ( $95 \\%$ specific);\nBUT in $10-24 \\%$ of papillary carcinomas\n(b) incomplete / absent halo\nin $>50 \\%$ of all benign nodules\n\n# Thyroid Nodule with Ill-defined Border \n\n$=>50 \\%$ of margin not clearly demarcated with irregular jagged edges (= absence of pseudocapsule)\n$\\diamond$ suggests malignancy ( $7-97 \\%$ sensitive)\n$\\diamond$ Unreliable sign unless frank invasion beyond capsule\n\n## Shape of Thyroid Nodule\n\n$\\diamond$ A nodule that is taller than wide suggests malignancy ( $93 \\%$ specific)\n\n## Vascularity of Thyroid Nodule\n\n$\\sqrt{ }$ marked intrinsic hypervascularity = flow in central part of nodule greater than in surrounding parenchyma\n$\\diamond$ in $69-74 \\%$ of all thyroid malignancies\n$\\diamond>50 \\%$ hypervascular nodules are benign\n$\\checkmark$ perinodular flow $=$ vascularity in $>25 \\%$ of circumference\n$\\diamond$ characteristic of benign nodules\n$\\diamond$ in $22 \\%$ of all thyroid malignancies\n$\\checkmark$ avascularity\n$\\diamond$ malignancy unlikely\n$\\diamond$ All malignant papillary carcinomas show some vascularity\n\n## Echogenicity of Thyroid Nodule\n\n$\\sqrt{ }$ hypoechoic solid nodule less than thyroid parenchyma ( $87 \\%$ sensitive $+15-27 \\%$ specific for carcinoma / lymphoma)\n$\\diamond$ in $55 \\%$ of benign nodules\n$\\checkmark$ hypoechogenicity less than infrahyoid / strap muscles ( $12 \\%$ sensitive $+94 \\%$ specific for malignancy)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 193,
            "markdown": "# Cystic Thyroid Nodule \n\n$=$ hemorrhagic / cystic degeneration\nFeatures associated with cancer:\n\n1. $>50 \\%$ solid tissue component\n2. Eccentricity of cystic space\n3. Microcalcifications\n\n## Growth of Thyroid Nodule\n\n$=2 \\mathrm{~mm} / 10 \\%$ increase (if $>20 \\mathrm{~mm}$ ) in 2 dimensions\n$\\diamond 40 \\%$ of benign nodules grow at least $15 \\%$ by volume over 5 years\n\n## Size of Thyroid Nodule\n\nPapillary carcinomas $<1 \\mathrm{~cm}$ are usually nonaggressive\nFollicular carcinomas $<2 \\mathrm{~cm}$ are usually nonaggressive\n$\\diamond$ Papillary microcarcinoma ( $<1 \\mathrm{~cm}$ ) are incidentally detected in $10 \\%$ of surgical specimens for benign disease + in $12 \\%$ at autopsies\n$\\diamond$ The rate of metastases + invasion is the same for lesions of $8-10 \\mathrm{~mm}$ as for lesions of $11-15 \\mathrm{~mm}$\n\n## Likely Benign Thyroid Nodule\n\n1. Entirely cystic nodule\n2. Predominantly cystic nodule $<2 \\mathrm{~cm}$, its solid part without flow / calcifications\n3. Honeycomb / spongiform nodule $<2 \\mathrm{~cm}$\n4. Pseudonodule of autoimmune thyroiditis\n5. Mixed nodule with functioning solid component",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 194,
            "markdown": "# ANATOMY AND FUNCTION OF NECK ORGANS \n\n## PARANASAL SINUSES\n\nMucus production of $1 \\mathrm{~L} / \\mathrm{d}$ (Liter/day); mucus blanket turns over every 20-30 minutes; irritants are propelled toward nasopharynx at a rate of $1 \\mathrm{~cm} /$ minute\n\n## Maxillary Sinus\n\nSize: $\\quad 6-8 \\mathrm{~cm}$ at birth\nWalls: roof = floor of orbit; posterior wall abuts pterygopalatine fossa\nExtension: $4-5 \\mathrm{~mm}$ below level of nasal cavity by age 12\nOstium: maxillary ostium + infundibulum enter middle meatus within posterior aspect of hiatus semilunaris; additional ostia may be present\nPlain film: present at birth; visible at 4-5 months; completely developed by 15 years of age\nVariations: sinus hypoplasia in $9 \\%$; aplasia in $0.4 \\%$\n\n## Ethmoid Sinuses\n\nSize: adult size by age 12; 3-18 air cells per side\nWalls: roof = floor of anterior cranial fossa; lateral wall = lamina papyracea\nPlain film: very small at birth; visible at 1 year of age; completely developed by puberty\n(a) anteromedial ethmoid air cells\n\n2-8 cells with a total area of $24 \\times 23 \\times 11 \\mathrm{~mm}$\nOstia: opening into anterior aspect of hiatus semilunaris of middle meatus (anterior group), opening into ethmoid bulla (middle group)\n\n## Agger nasi cell\n\n[agger, Latin = mound, heap]\n$=$ anteriormost ethmoid air cell in front of the attachment of middle turbinate to cribriform plate near the lacrimal duct = intranasal portion of frontal process of maxilla\nFrequency: $78-99 \\%$\nLocation: anterior, lateral + inferior to frontoethmoidal recess = on lateral nasal wall at leading edge of middle turbinate\nPrevalence: present in $>90 \\%$\n\n## Ethmoidal bulla\n\n$=$ ethmoidal air cell above + posterior to infundibulum + hiatus semilunaris, located outside the lamina papyracea at the lateral wall of the middle meatus\n\n## Haller cells",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 195,
            "markdown": "![img-7.jpeg](img-7.jpeg)\n$=$ INFRAORBITAL ETHMOIDAL AIR CELL = MAXILLOETHMOIDAL / ORBITOMAXILLARY CELL\n$=$ anterior ethmoid air cells inferolateral to ethmoidal bulla, on lateral wall of infundibulum, along inferior margin of orbit / roof of maxillary sinus, protruding into maxillary sinus\nPrevalence: $2-10-45 \\%$\nSignificance: may narrow ipsilateral ostiomeatal complex if large $\\rightarrow$ obstruction of ipsilateral maxillary antrum\n(b) posterior ethmoid air cells\n\n1-8 cells, larger cells, total area smaller than that of anteromedial group\nLocation: behind the basal (= ground) lamella of the middle turbinate\nOstium: into superior meatus / supreme meatus, ultimately draining into sphenoethmoidal recess of nasal cavity\n\n# Onodi cell \n\n$=$ most posterior ethmoid air cell pneumatized into sphenoid bone $\\pm$ surrounding the optic canal\nLocation: superolateral to sphenoid sinus\n\n## Frontal Sinus\n\nSize: $\\quad 28 \\times 24 \\times 20 \\mathrm{~mm}$ in adults, rapid growth until late teens\nWalls: posterior wall = anterior cranial fossa; inferior wall = anterior portion of roof of orbit\nOstium: into frontal recess of middle meatus via frontoethmoidal recess (= nasofrontal duct) Outflow tract: frontal infundibulum + frontal ostium + frontal recess",
            "images": [
                {
                    "id": "img-7.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 189,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 976,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 196,
            "markdown": "Plain film: visible at age 6 years\nVariations: sinus aplasia in up to $4 \\%$ (in $90 \\%$ with Down syndrome)\n\n# Frontal Recess $=$ Frontoethmoidal Recess \n\nWalls: agger nasi cell anteriorly; lamina papyracea laterally; middle turbinate medially; ethmoid cell with bulla lamella posteriorly\n\n## Frontal Recess Cells (20-33\\%)\n\n$=$ pneumatization of frontal recess by various anterior ethmoid cells\nRelevance: obstruction of frontal sinus outflow\n![img-8.jpeg](img-8.jpeg)\n(a) anterior group\n> Type 1 frontal cell (in up to $37 \\%$ )\n$=$ single anterior ethmoid cell within frontal recess above agger nasi cell\n> Type 2 frontal cell (in up to $19 \\%$ )\n$=$ tier of $>2$ anterior ethmoid cells above agger nasi cell\n> Type 3 frontal cell (in up to $7 \\%$ )\n$=$ single massive cell above agger nasi pneumatizing into frontal sinus\n> Type 4 frontal cell ( $2 \\%$ )\n$=$ isolated air cell along anterior wall of frontal sinus not abutting the agger nasi cell\n(b) posterior group\n\n1. Supraorbital ethmoid cell (in up to $15 \\%$ )\n$=$ pneumatized orbital plate of frontal bone posterior to frontal recess mimicking septated frontal sinus = anterior ethmoid air cell extending from frontal recess superiorly + laterally over orbit",
            "images": [
                {
                    "id": "img-8.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 611,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1388,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 197,
            "markdown": "2. Frontal bullar cell\n$=$ pneumatized anterior skull base atop ethmoid bulla with extension into frontal sinus as part of posterior boundary of frontal recess + sinus\n3. Suprabullar cell\n$=$ atop ethmoid bulla but below level of frontal sinus ostium without extension into frontal sinus as part of posterior boundary of frontal recess\n4. Interfrontal sinus septal cell\n$=$ pneumatized interfrontal sinus septum; may extend into crista galli\n\n# Sphenoid Sinus \n\nSize: $20 \\times 23 \\times 17 \\mathrm{~mm}$ in adults, small evagination of sphenoethmoidal recess at birth, invasion of sphenoid bone begins at age 5 years; aerated extensions into pterygoid plates $(44 \\%)+$ into clinoid processes $(13 \\%)$\nWalls: roof = floor of sella turcica; anterior wall shared with ethmoid sinuses; posterior wall $=$ clivus; inferior wall $=$ roof of nasopharynx\nOstium: 10 mm above sinus floor into sphenoethmoidal recess posterior to superior meatus at level of sphenopalatine foramen\nPlain film: appears by 3 years of age; continues to grow posteriorly + inferiorly into the sella until adulthood\n\n## OSTIOMEATAL UNIT\n\n$=$ area of superomedial maxillary sinus + middle meatus as the common mucociliary drainage pathway of frontal maxillary, and anterior + middle ethmoid air cells into the nose\nCoronal CT: visualized on two or three 3-mm-thick sections\n![img-9.jpeg](img-9.jpeg)\n\n## Components:\n\n## Infundibulum\n\n$=$ flattened conelike passage between inferomedial border of orbit / ethmoid bulla (laterally) + uncinate process (medially) + maxillary sinus (inferiorly) + hiatus",
            "images": [
                {
                    "id": "img-9.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 1183,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1808,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 198,
            "markdown": "semiłunaris (superiorly)\n\n# Uncinate process \n\n$=$ key bony structure in lateral nasal wall below hiatus semilunaris in middle meatus defines hiatus semilunaris together with adjacent ethmoid bulla\nAttachment: skull base / middle turbinate / lamina papyracea / agger nasi\n$\\sqrt{ }$ pneumatized in $<2.5 \\%$ of patients\n\n## Ethmoid bulla\n\n$\\sqrt{ }$ located in cephalad recess of middle meatus\n\n## Hiatus semilunaris\n\n$=$ final segment for drainage of maxillary sinus; located just inferior to ethmoid bulla in middle meatus\nOstia:\n(1) Multiple ostia from anterior ethmoid air cells (at its anterior aspect)\n(2) Maxillary ostium infundibulum (at its posterior aspect)\n\nAnatomic variations predisposing to ostiomeatal narrowing:\n\n1. Concha bullosa $(4-15 \\%)=$ aerated / pneumatized middle turbinate\n2. Intralamellar cell $=$ air cell within vertical portion of middle turbinate\n3. Oversized ethmoid bulla\n4. Haller cell\n5. Uncinate process bulla\n6. Bowed nasal septum\n7. Paradoxical middle turbinate $=$ convexity of turbinate directed toward lateral nasal wall $(10-26 \\%)$\n8. Deviation of uncinate process\n$\\diamond$ These conditions are not disease states per se!\n\n## FACIAL BUTTRESSES\n\n$=$ areas of relatively increased bone density that support functional units of the face (muscles, eyes, dental occlusion, airways)\n> sufficient bone thickness to accommodate metal screw fixation\n$>$ linked directly / through another buttress to cranium / skull base\n(a) horizontal buttresses\n\n- responsible for facial height\n(1) Upper transverse maxillary buttress: temporal squamosa $\\rightarrow$ zygomatic arch $\\rightarrow$ inferior orbital rim $\\rightarrow$ nasofrontal junction\nPosterior extension: orbital floor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 199,
            "markdown": "![img-10.jpeg](img-10.jpeg)\n(2) Lower transverse maxillary buttress: maxilla above alveolar ridge\n\nPosterior extension: hard palate\n(3) Upper transverse mandibular\n(4) Lower transverse mandibular\n(b) vertical buttresses\n\n- responsible for facial profile and width\n(1) Medial maxillary buttress: anterior nasal spine $\\rightarrow$ rim of piriform aperture $\\rightarrow$ frontal process of maxilla $\\rightarrow$ nasofrontal junction $\\rightarrow$ frontal bone",
            "images": [
                {
                    "id": "img-10.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1647,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 200,
            "markdown": "Posterior projection: medial orbital wall\nAnterior projection: lateral nasal wall\n(2) Lateral maxillary buttress: above posterior maxillary molar $\\rightarrow$ zygomaticomaxillary suture $\\rightarrow$ body of zygoma $\\rightarrow$ lateral orbital rim $\\rightarrow$ zygomaticofrontal suture $\\rightarrow$ frontal bone\nPosterior projection: lateral orbital wall, lateral wall of maxillary sinus\n(3) Posterior maxillary buttress: pterygomaxillary junction\n(4) Posterior vertical buttress\n\n# BRANCHIAL CLEFT DEVELOPMENT \n\nBranchial apparatus: branchial arches, pharyngeal pouches, branchial grooves, branchial membranes\n> 6 paired branchial arches are responsible for formation of lower face + neck; recognizable by $4^{\\text {th }}$ week GA\n> each branchial arch contains a central core of cartilage + muscle, a blood vessel, and a nerve\n> 5 ectodermal \"clefts\" / grooves on outer aspect of neck +5 endodermal pharyngeal pouches separate the 6 arches with a closing membrane located at the interface between pouches and clefts\nFormation: during $4^{\\text {th }}-6^{\\text {th }}$ week of embryonic development\n\n## 1st Branchial Arch = maxillomandibular arch\n\n(a) large ventral / mandibular prominence\nforms: mandible, incus, malleus, muscles of mastication\n(b) small dorsal / maxillary prominence\nforms: maxilla, zygoma, squamous portion of temporal bone, cheek, portions of external ear\nnerve: mandibular division of trigeminal nerve $\\left(\\mathrm{CN}_{3}\\right)$\npouch forms: mastoid air cells + eustachian tube\ncleft forms: external auditory canal + tympanic cavity\n\n## 2nd Branchial Arch = hyoid arch\n\nnerve: facial nerve (CN VII)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 201,
            "markdown": "![img-11.jpeg](img-11.jpeg)\narch forms: thyroid gland, stapes, portions of external ear, muscles of facial expression pouch forms: palatine tonsil + tonsillar fossa\n$\\rightarrow$ cleft involutes completely by $9^{\\text {th }}$ fetal week; $2^{\\text {nd }}$ arch overgrows $2^{\\text {nd }}+3^{\\text {rd }}+4^{\\text {th }}$ clefts to form cervical sinus, which creates a tract that runs from the supraclavicular area just lateral to carotid sheath, turns medially at mandibular angle between external + internal carotid artery, and terminates in tonsillar fossa\n\n# 3rd Branchial Arch \n\nsinks into retrohyoid depression\nnerve: glossopharyngeal nerve (CN IX)\narch forms: glossoepiglottic fold, superior constrictor m., internal carotid a., parts of hyoid bone\npouch forms:\n(a) thymus gland, which descends into mediastinum by $9^{\\text {th }}$ fetal week\n(b) inferior parathyroid glands passing down with the thymus\n\n## 4th Branchial Arch\n\nsinks into retrohyoid depression\nnerve: superior laryngeal branch of vagus nerve (CN X)\narch epiglottis + aryepiglottic folds, thyroid cartilage, cricothyroid m., left component of\nforms: aortic arch, right component of right proximal subclavian a.\npouch superior parathyroid glands, apex of piriform fossa",
            "images": [
                {
                    "id": "img-11.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1097,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 202,
            "markdown": "forms:\ncleft ultimobranchial body, which provides parafollicular (\"C\") cells of thyroid forms:\n\n# $5^{\\text {th }}+6^{\\text {th }}$ Branchial Arches \n\ncannot be recognized externally\nnerve: recurrent laryngeal branch of vagus nerve (CN X)\n\n## TONGUE\n\n$=$ complex of muscle groups + fibrous scaffolding\nA. FIBROUS SCAFFOLDING\n\n1. Hyoglossal membrane\nanchors inferior posterior edge of tongue to hyoid bone\n2. Midline lingual septum\ninserts into hyoglossal membrane + extends superiorly along midline of tongue dividing\ntongue into halves + providing attachments for transverse intrinsic muscles\nB. INTRINSIC MUSCLES (named for their orientation):\n\nFunction: wide range of motion for mobile tongue\n$>$ vertical + transverse\n$>$ inferior + superior longitudinal\nC. EXTRINSIC MUSCLES\n\nFunction: raising + lowering of tongue, forward + backward motion\n\n1. Genioglossus m .\n\nOrigin: symphysis menti on back of mandible\nInsertion: dorsum of tongue (interdigitating with intrinsic tongue muscles); hyoid bone (few inferolateral fibers)\n2. Geniohyoid $m$.\n\nOrigin: symphysis menti on back of mandible\nInsertion: hyoid bone\n3. Hyoglossus m .\n\nOrigin: hyoid bone\nInsertion: lateral aspect of tongue\n4. Styloglossus m .\n5. Palatoglossus m .\n\nAnatomic subdivision:\n(A) Mobile tongue (part of oral cavity)\n$=$ frenulum to circumvallate papillae\n\") \"Root of tongue\"\n$=$ region deep to mobile tongue + anterior to base of tongue\nParts: (1) Lingual septum\n(2) Genioglossus-geniohyoid complex\n$=$ both genioglossus m. + geniohyoid m.\nBorders:\n(a) anterior: mandible",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 203,
            "markdown": "(b) lateral: sublingual space\n(c) inferior: U-shaped mylohyoid m. underneath geniohyoid m.\n(c) superior: indistinct $\\leftarrow$ genioglossus m . fans out and blends with intrinsic tongue muscles\n(B) Base of tongue (part of oropharynx)\n$=$ posterior to circumvallate papillae\n\n# ORAL CAVITY \n\n$=$ most ventral portion of aerodigestive tract\nBorders:\n(a) inferior: circumvallate papillae\n(b) superior: soft palate\n(c) lateral: anterior tonsillar pillars\n\n## Anatomic subdivisions:\n\nlips; floor of mouth; oral tongue (= anterior $2 / 3$ of tongue); buccal mucosa; upper + lower gingiva; hard palate; retromolar trigone\nSites of squamous cell carcinoma: lower lip $>$ oral tongue $>$ floor of mouth (in $75 \\%$ )\n\n## Floor of Mouth\n\n$=$ horizontally aligned U -shaped space situated in the part of the oral cavity that lies beneath the tongue between mucosal surface and mylohyoid muscle sling\nAnatomic components:\n\n1. Squamous epithelium of mucosal surface\n2. Mylohyoid muscle sling (paired)\n[mylai, Greek = molar (mill) teeth]\nseparates floor of mouth from $\\mathrm{R}+\\mathrm{L}$ submandibular spaces and midline submental space\nOrigin: inner surface of mandible from symphysis menti to last molar posteriorly\nInsertion: fibrous median raphe (medially), posterior aspect of hyoid bone (midline); free edge (posterolaterally) allowing communication between sublingual + submandibular space\n\n- palpable lump $\\leftarrow$ herniated sublingual salivary gland mylohyoid defect into adjacent submandibular space\n$\\sqrt{ }$ boutonniere $=$ defect in mylohyoid $\\mathrm{m} .(77 \\%$ of CTs)\n\n3. Sublingual space\n$=$ located on both sides of tongue, superomedial to mylohyoid m. and lateral to midline geniohyoid-genioglossus muscle complex\nContent:\n> lingual artery (medial to hyoglossus m.)\n> lingual vein + main submandibular duct (lateral to hyoglossus m.) coursing between hyoglossus + mylohyoid mm.\n$\\sqrt{ }$ higher T1 + T2 signal $\\leftarrow$ higher fat + connective tissue content\n4. Submandibular space\n5. Submental space",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 204,
            "markdown": "Content: salivary glands (see below); nerves (lingual n. = branch of mandibular division of trigeminal nerve with input from chorda tympani branch of facial n.), distal portions of hypoglossal n . and glossopharyngeal n .\n\n# Salivary Glands at Floor of Mouth \n\n1. Sublingual glands\n\nExcretion via:\n(a) Rivinus ducts $=$ numerous small ducts that open at mucosa of floor of mouth\n(b) Bartholin duct = formation of a common duct from joining of several of more anterior ducts typically emptying into main submandibular duct\n2. Deep portion of submandibular glands\n\nExcretion via: Wharton duct = main submandibular duct coursing anteriorly through sublingual space from deep aspect of submandibular gland\nOrifice: sublingual papilla on ipsilateral side of frenulum, anterior to sublingual gland\n3. Subepithelial minor salivary glands\n\n## PHARYNX\n\nBarium Pharyngography:\nPatient maneuvers:\n(a) modified Valsalva maneuver = patient puffs out cheeks as if blowing a trumpet\n(b) phonation = patient phonating letter $\\mathrm{E} \\rightarrow$ widening of oropharynx + deepening of valleculae with forward movement of tongue\nTechnique: videofluoroscopic recording\n> patient standing in upright position\n> initial swallow with high-density barium assessing for aspiration, leak, stricture, obstruction, delayed emptying on lateral view\n> second swallow to coat oro- and hypopharynx in LAT + AP projection during maneuvers\n> solid-column evaluation for inferior hypopharynx\nThe pharynx is divided into oropharynx and hypopharynx by the pharyngoepiglottic fold, which is not seen at barium pharyngography. Instead the base of the free margin of the epiglottis / hyoid bone are used as a proxy landmark.\n\n## Normal variants:\n\n1. Lateral protrusion of superior $1 / 3$ of lateral hypopharyngeal wall",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 205,
            "markdown": "![img-12.jpeg](img-12.jpeg)\n\nCause: weakening of thyrohyoid membrane in elderly / glassblower / trumpet player\n$\\checkmark$ symmetric bilateral outward bulge of superior aspect of lateral wall of piriform sinus, more pronounced during modified Valsalva maneuver\n2. Mild asymmetry of vallecular pouches due to lymphoid tissue\n\nStructural abnormalities of the pharynx are diagnosed by a change in the normal coated surfaces / an alteration in density.\n\n# Oropharynx \n\nconsists of\n(a) oropharyngeal mucosa (pharyngeal wall between nasopharynx + pharyngoepiglottic fold)\n(b) soft palate\n(c) palatine tonsils\n(d) base of tongue (= posterior $1 / 3$ of tongue)\n\nBorders:\n(a) superior: soft palate and Passavant ridge (= ridge of pharyngeal muscle that opposes the soft palate when soft palate is elevated)\n[Philippas G. Passavant, German surgeon, 1815-1893]",
            "images": [
                {
                    "id": "img-12.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1232,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 206,
            "markdown": "(b) anterior: plane formed by the posterior border of soft palate, anterior tonsillar pillars, circumvallate papillae\n(c) posterior: posterior pharyngeal wall\n(d) inferior: valleculae\n$[$ valles, Latin $=$ valley $\\rightarrow$ vallecula $=$ little valley $]$\n(e) lateral: tonsillar region consisting of anterior tonsillar pillar (= palatoglossus m.) + palatine / faucial tonsil + posterior tonsillar pillar (= palatopharyngeus muscle)\nAnatomic subdivisions: base of tongue; tonsils\nTonsillar complex: tonsillar fossa + tonsillar pillars\nBarium Pharyngography:\n$\\sqrt{ }$ valleculae $=$ paired symmetric structures divided by median glossoepiglottic fold posteroinferior to tongue base\n$\\sqrt{ }$ free margin of epiglottis projects posterior + superior to valleculae\n$\\sqrt{ }$ cornua of hyoid project on end with change in position during swallowing\n$\\sqrt{ }$ slightly nodular surface of base of tongue superior to valleculae\n$\\sqrt{ }$ aryepiglottic fold covers posterior surface of arytenoid cartilage\n\n# Hypopharynx \n\n$=$ LARYNGOPHARYNX\n$=$ compartment of aerodigestive tract posterior to supraglottic larynx bridging oropharynx above + esophagus below\nOrigin: derived from $4^{\\text {th }}$ branchial arch (= buccopharyngeal bud) $\\rightarrow$ rich lymphatic drainage directed cranially to upper deep jugular chain (levels II + III)\nSuperior boundary: valleculae at level of hyoid bone\nInferior boundary: lower edge of cricopharyngeus $\\mathrm{m} .=$ lower edge of cricoid cartilage\n\n1. Piriform sinus [pirum, Latin = pear; forma, Latin = shape $\\rightarrow$ pear-shaped]\n= two symmetric lateral stalactites of air hanging from hypopharynx behind larynx\n> inferior wall: level of cricoarytenoid joint\n> anteromedial wall: lateral wall of aryepiglottic fold\n> lateral wall: abuts posterior ala of thyroid cartilage\n> posterior wall: most lateral aspect of posterior hypopharyngeal wall\n2. Postcricoid area $=$ pharyngoesophageal junction extends from level of arytenoid cartilages to inferior border of cricoid cartilage\n> anterior wall of hypopharynx = posterior wall of lower larynx = \"party wall\"",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 207,
            "markdown": "![img-13.jpeg](img-13.jpeg)\n3. Posterior hypopharyngeal wall extends from level of valleculae to cricoarytenoid joints Barium Pharyngography:\n$\\sqrt{ }$ lateral walls of piriform sinuses $=$ lateral margins of hypopharynx\n$\\sqrt{ }$ \"postcricoid line\" = coated mucosal surface $\\leftarrow$ larynx pressing on anterior wall of hypopharynx\n$\\sqrt{ }$ barium coating of inner anterior surface of laryngeal vestibule $\\pm$ laryngeal ventricle $\\leftarrow$ laryngeal penetration + aspiration\n\n# LARYNX \n\nVertical length: 44 mm (males), 36 mm (females), at $4^{\\text {th }}-6^{\\text {th }}$ cervical vertebrae (from tip of epiglottis to lower end of cricoid cartilage)\nFunction: (1) Protection against aspiration\n(2) Phonation\n\nLymphatic drainage:\n(a) supraglottis: rich drainage directed cranially to upper deep jugular chain (levels II + III)\n(b) glottis + subglottis: sparse drainage directed inferiorly to lower deep jugular + paratracheal nodes (levels IV + VI)\n\n## Supraglottis\n\nextends from tip of epiglottis to laryngeal ventricle\nderived from $4^{\\text {th }}$ branchial arch (= buccopharyngeal bud)\n\n1. Vestibule $=$ airspace within supraglottic larynx\n2. Epiglottis\n$=$ leaf-shaped cartilage that functions as a lid to endolarynx\n(a) petiole $=$ stem of epiglottis\n(b) thyroepiglottic ligament $=$ connects petiole to thyroid cartilage inferiorly\n(c) hyoepiglottic ligament $=$ connects epiglottis to hyoid bone anteriorly, covered by a mucosal fold between the valleculae (glossoepiglottic fold)\n(d) \"free margin\" = superior portion of epiglottis\n3. False vocal cords\n$=$ ventricular folds $=$ inferior continuation of aryepiglottic folds $=$ mucosal surface of ventricular ligaments; forming superior border of laryngeal ventricle",
            "images": [
                {
                    "id": "img-13.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 189,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 668,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 208,
            "markdown": "4. Arytenoid cartilages\n5. Aryepiglottic folds\n$=$ mucosal reflections between cephalad portion (= arytenoid processes) of arytenoid cartilage + inferolateral margin of epiglottis\n$\\sqrt{ }$ soft-tissue folds forming border between lateral piriform sinuses + central laryngeal lumen\n6. Laryngeal ventricle of Morgagni\n$=$ slitlike fusiform cavity between true + false cords\nBoundary: crescentic edge of false cords superiorly + straight margin of true cords inferiorly\n$\\sqrt{ }$ generally not visible on axial scans\n7. Laryngeal saccule of Hilton = laryngeal appendix\n$=$ small conical mucosa-lined blind ( pouchdiverticulum) arising from anterosuperior third of laryngeal ventricle\nBoundary: superiorly between ventricular fold (= false vocal cord) and aryepiglottic fold medially + inner surface of thyroid cartilage laterally\nFunction: lubrication of vocal folds\n$\\sqrt{ }$ relatively large in infancy\n$\\sqrt{ }$ usually involutes by $6^{\\text {th }}$ year of life\n8. Preepiglottic space\n\nBoundary: hypoepiglottic lig. (superiorly), thyrohyoid membrane (anteriorly), thyroepiglottic lig. (inferiorly), epiglottis (posteriorly)\n9. Paraglottic (paralaryngeal) space\n\nBoundary: quadrangular membrane + medial piriform sinus wall (superiorly), conus elasticus (inferiorly), thyroid cartilage (laterally)\n$\\sqrt{ }$ low-density tissue between true + false cords\n$\\sqrt{ }$ contiguous with preepiglottic space anterosuperiorly + aryepiglottic folds superiorly\n\n# Glottis \n\nBoundary: from laryngeal ventricles to imaginary plane 1 cm below laryngeal ventricles\nOrigin: $5^{\\text {th }}$ branchial arch (= tracheobronchial bud)\n\n1. True vocal cords\n$=$ extend from vocal process of arytenoid cartilage to anterior commissure\n$\\sqrt{ }$ vocal cords adduct during phonation of \"E\" / breath holding",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 209,
            "markdown": "![img-14.jpeg](img-14.jpeg)",
            "images": [
                {
                    "id": "img-14.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 187,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1940,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 210,
            "markdown": "![img-15.jpeg](img-15.jpeg)",
            "images": [
                {
                    "id": "img-15.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 191,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1920,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 211,
            "markdown": "![img-16.jpeg](img-16.jpeg)\n2. Anterior commissure\n$=$ midline laryngeal mucosa covering anterior portions of the true vocal cords where they abut the laryngeal surface of the thyroid cartilage\n$\\sqrt{ }<1 \\mathrm{~mm}$ soft tissue behind thyroid cartilage (during abduction of vocal cords with quiet breathing)",
            "images": [
                {
                    "id": "img-16.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 189,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1762,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 212,
            "markdown": "3. Posterior commissure\n$=$ midline laryngeal mucosal surface between attachment of true vocal cords and the arytenoid cartilages\n\n# Subglottis \n\nextends from undersurface of true vocal cords to inferior edge of cricoid cartilage\nderived from $6^{\\text {th }}$ branchial arch (= tracheobronchial bud)\n\n1. Conus elasticus\n$=$ fibroelastic membrane extending from cricoid cartilage to medial margin of true vocal cords; forming lateral wall of subglottis\n\n## FASCIAE OF THE NECK\n\n$=$ well-defined sheets of fat + fibrous tissue that circumscribe several compartments / spaces\nA. Superficial cervical fascia\nB. Deep cervical fascia\n(a) superficial layer\n(b) middle layer\n(c) deep layer\n\n## DEEP SPACES OF SUPRAHYOID HEAD \\& NECK\n\n## Masticator Space\n\n$=$ lateral to parapharyngeal space\nFascia: superficial layer of deep cervical fascia encloses muscles of mastication\nContents:\n, muscles of mastication (medial + lateral pterygoid muscles, masseter, temporalis muscle)\n, ramus + body of mandible\n, cranial nerve $\\mathrm{V}_{3}$\n\n## Pharyngeal Mucosal Space\n\n## Components:\n\n, Waldeyer ring = adenoids, faucial + lingual tonsils + submucosal lymphatics\n[Heinrich Wilhelm Gottfried Waldeyer-Hartz (1836-1921), professor of pathology in Breslau, Strasbourg and Berlin]\n> superior + middle constrictor muscles\n, salpingopharyngeal muscle\n> levator palatini muscle underneath torus tubarius\n> torus tubarius = prominent ridge between orifice of eustachian tube anteroinferiorly + fossa of Rosenmüller posterosuperiorly\n, pharyngeal recess = fossa of Rosenmüller\n[Johann Christian Rosenmüller (1771-1820), professor of anatomy and surgery at University of Leipzig]\nContents: squamous mucosa, lymphoid tissue, minor salivary glands",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 213,
            "markdown": "# Parapharyngeal Space \n\n$=$ triangular-shaped centrally located space; major vertical highway extending from skull base to hyoid\n![img-17.jpeg](img-17.jpeg)\n\n## Fascial borders:\n\nmedial = middle layer of deep cervical fascia\nlateral = superficial layer of deep cervical fascia\nposterior = carotid sheath",
            "images": [
                {
                    "id": "img-17.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 343,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1768,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 214,
            "markdown": "# Contents: \n\n$>$ fat\n> internal maxillary artery\n> ascending pharyngeal artery\n> pharyngeal venous plexus\n> branches of cranial nerve V3\nVectors: if parapharyngeal fat is effaced\nanteriorly $=$ lesion in masticator space\nmedially $=$ lesion in pharyngeal mucosal space\nlaterally $=$ lesion in parotid space\nposteriorly $=$ lesion in carotid space\n\n## Retropharyngeal Space\n\n$=$ potential space posterior to pharyngeal mucosal space + anterior to prevertebral space; major vertical highway from skull base to T4\nFascial borders:\nmid + deep layers of cervical fascia; alar fascia laterally\nContents:\n$>$ fat\n> medial + lateral retropharyngeal nodes\n\n## Prevertebral Space\n\n$=$ major highway from skull base to T4; posterior to retropharyngeal space\nFascial borders:\n(a) anterior compartment of deep cervical fascia:\nfrom one transverse process to the other anteriorly in front of longus colli muscle\n(b) posterior compartment of deep cervical fascia:\nfrom transverse process posteriorly to spinous process\nContents:\n> prevertebral muscles (longus colli)\n> scalene muscles\n> vertebral artery + vein\n> brachial plexus\n> phrenic nerve\n\n## Carotid Space\n\nCarotid fascia extends from skull base to aortic arch\nContents:\n(a) below hyoid bone:\n> common carotid artery\n> internal jugular vein\n> cranial nerve X (= vagus nerve)\n> cervical sympathetic plexus\n(b) at level of nasopharynx:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 215,
            "markdown": "> internal carotid artery\n> internal jugular vein\n> cranial nerves IX-XII\n> internal jugular chain of nodes\n\n# Parotid Space \n\n## Contents:\n\n> parotid gland with Stensen duct\n> intraparotid lymph nodes\n> external carotid + internal maxillary arteries\n> retromandibular vein\n> facial nerve\n\n## Submandibular Space\n\n## Contents:\n\n> submandibular gland with Wharton duct\n> facial artery + vein\n> cranial nerve XII\n\n## TEMPORAL BONE\n\nA. SQUAMOUS PORTION\n$=$ lateral wall of middle cranial fossa + floor of temporal fossa\nB. MASTOID PORTION\n\n1. Mastoid antrum\n[mastos, Greek = woman's breast; eidos, Greek = form / shape]; [oeides, Greek = like; mastoeides, Greek = resembling a nipple]\n[antron, Greek / antrum, Latin = cave]\n2. Aditus ad antrum\nconnects epitympanum (= attic) of middle ear cavity to mastoid antrum\n[ad + ire, Latin = to go to; aditus, Latin = entrance]\n[tympanum, Latin / tympanon, Greek = drum]\n3. Körner septum\n$=$ small bony projection extending inferiorly from roof of mastoid antrum as part of petrosquamosal suture between lateral + medial mastoid air cells posteriorly from epitympanum\nC. PETROUS PORTION = inner ear\n4. Tegmen tympani\n[tegmina, Latin $(\\mathrm{pl})=$ covering structure or roof]\n$=$ roof of tympanic cavity\n5. Arcuate eminence\n$=$ prominence of bone over superior semicircular canal\n6. Internal auditory canal (IAC)\n7. Vestibular aqueduct\n8. Cochlear aqueduct\n9. Otic capsule $=$ densest portion of temporal bone that surrounds osseous labyrinth",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 216,
            "markdown": "7. Petrous apex\n$=$ separated from clivus by petrooccipital fissure + foramen lacerum\nD. TYMPANIC PORTION\n8. External auditory canal (EAC)\nE. STYLOID PORTION\n\n# TEMPOROMANDIBULAR JOINT \n\n## Components:\n\n1. Meniscus $=$ articular disk\n$=$ biconcave fibrocartilaginous structure that divides the synovial TMJ into superior + inferior compartments\nLocation: between mandibular condyle and temporal bone component of TMJ\nShape: round / oval\n(a) thin center (= intermediate zone)\n(b) thicker periphery (= bands of disk)\n\nFunction: interposition of thinnest part between condyle and temporal bone prevents articular damage (in closed- or open-mouth position)\n(a) hyperintense anterior band of disk attached to\n> superior attachment of capsule\n> inferior attachment of capsule\n$\\sqrt{ }$ lies immediately in front of condyle + junction of bilaminar zone\n$\\sqrt{ }$ may form bulge (? normal variant)\n(b) hyperintense intermediate zone\n$\\sqrt{ }$ lies at superior part of the condyle\n(c) mildly hyperintense posterior band of disk formed by\n> superior retrodiskal layer\n> inferior retrodiskal layer\n$\\sqrt{ }$ best depicted in open-mouth position\n2. Retrodiskal tissue $=$ bilaminar zone composed of\n(a) retrodiskal layers\n(b) vasculonervous structures\n$\\sqrt{ }$ best depicted in open-mouth position\nMuscles:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 217,
            "markdown": "![img-18.jpeg](img-18.jpeg)\n\n1. Lateral pterygoid $m$.\n(a) superior lateral pterygoid m.\n(a) inferior lateral pterygoid m.\n2. Digastric muscle\n\nMotion:\n\n1. Rotation around horizontal axis through condylar heads\n2. Translation $=$ condyle + meniscus move together anteriorly to lie beneath articular eminence\n$\\rightarrow$ central part of disk interposed between condyle and articular tubercle\nClosed-mouth position:\n$\\sqrt{ }$ thick posterior band of meniscus lies immediately above condyle near 12 o'clock position\n$\\checkmark$ junction of posterior band + bilaminar zone should fall within $10^{\\circ}$ of vertical\nOpen-mouth position:\n$\\checkmark$ best depiction of posterior band + retrodiskal tissue\n$\\checkmark$ anterior band lies immediately in front of condyle + junction of bilaminar zone\n$\\checkmark$ condyle may lie beneath anterior band of meniscus when mouth is fully opened\n$\\checkmark$ disk lies at superior part of condyle\n$\\checkmark$ anterior band may be seen as a bulge\n\n# EXTERNAL (OUTER) EAR \n\nOrigin: $1^{\\text {st }}$ branchial cleft and $1^{\\text {st }}+2^{\\text {nd }}$ branchial arches during $6^{\\text {th }}-12^{\\text {th }}$ weeks of intrauterine life\nA. Auricle",
            "images": [
                {
                    "id": "img-18.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1042,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 218,
            "markdown": "B. External auditory canal (EAC)\n\nOrigin: meatal plate (= solid core of epithelium) that migrates toward $1^{\\text {st }}$ pharyngeal pouch and hollows out during $2^{\\text {nd }}-7^{\\text {th }}$ months of intrauterine life\nWall of lateral $1 / 3$ : fibrocartilage\nWall of medial $2 / 3$ : tympanic portion of temporal bone\nAnterior wall: posterior aspect of glenoid fossa\nPosterior wall: anterior margin of mastoid\nMedial border: tympanic membrane,\n\n# MIDDLE EAR / TYMPANIC CAVITY \n\n$=$ air-filled cavity within petrous portion of temporal bone containing ossicular chain\nBorders:\n$>$ anterior wall $=$ carotid wall\n$>$ posterior wall $=$ mastoid wall including from lateral to medial\n(a) facial nerve recess for descending facial nerve\n(b) pyramidal eminence overlying stapedius muscle (inserting onto head of stapes)\n(c) sinus tympani (clinically blind spot)\n(d) round window niche\n> superior wall $=$ tegmen tympani (= thin bony plate separating dura of middle cranial fossa from middle ear)\n> inferior wall $=$ jugular wall\n> lateral wall $=$ tympanic membrane\n> medial wall $=$ labyrinthine wall\nA. EPITYMPANUM (= attic)\n$=$ tympanic cavity superior to level of tympanic membrane above a line drawn between the inferior tip of drum spur ( $=$ scutum) + tympanic portion of facial nerve\n[scutum, Latin $=$ shield; tympanum, Latin $=$ semicircular area enclosed by the arch above the horizontal portion of a portal]\nContents: malleus head, body + short process of incus, Prussak space (= superior recess between incus + lateral wall of epitympanum)\nCommunication: with mastoid via aditus ad antrum\nB. MESOTYMPANUM (= tympanic cavity proper)\n$=$ tympanic cavity at level of tympanic membrane between inferior tip of scutum + line drawn parallel to inferior aspect of bony EAC\nContents: manubrium of malleus, long process of incus, stapes, tensor tympani muscle (innervated by $\\mathrm{V}_{3}$ ), stapedius muscle (innervated by VII)\nC. HYPOTYMPANUM\n$=$ shallow trough in floor of middle ear inferior to tympanic membrane\nContents: opening of eustachian tube\nMedial margin: ICA\nD. TYMPANIC MEMBRANE (eardrum)\n$=$ thin cone-shaped membrane separating external from middle ear\nOrigin: ectoderm from 1st branchial groove; mesoderm and endoderm from 1st branchial",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 219,
            "markdown": "pouch\n$\\sqrt{ }$ may be faintly discerned on CT\nDiameter: 10 mm\nFunction: transmission of sound from air to malleus\nAttachment: superiorly at scutum (=sharp bony projection); inferiorly at tympanic annulus Regions:\n(a) pars flaccida (= Shrapnell membrane)\n$=$ small triangular fragile 2-layered membrane in upper region loosely attached to petrous bone\nLocation: above malleolar folds; forms superior $1 / 8$ of drum circumference\nRelationship: chorda tympani crosses on inner surface\n(b) pars tensa\n$=$ larger robust tightly attached region consisting of 3 layers ( skin + fibrous tissue + mucosa)\nE. TYMPANIC CAVITY \\& EUSTACHIAN TUBE\n\nOrigin: from 1st pharyngeal pouch during 10-30 weeks EGA\n\n# Wall Ridges of Tympanic Cavity \n\non medial \\& posterior wall of tympanic cavity produced by:\n» MEDIAL WALL:\n(1) Anterior limb of lateral semicircular canal\n$\\checkmark$ wall prominence posteriorly + superiorly\n(2) Bony canal for facial nerve\n$\\checkmark$ wall prominence inferior and anterior to (1)\n(3) Terminus of septum canalis musculotubarii\n$=$ landmark for geniculate ganglion\n$\\checkmark$ wall prominence anterior to (2)\n(4) Oval window\n$\\checkmark$ inferior to (3)\n(5) Basal turn of cochlea\n$\\checkmark$ convexity inferior + slightly anterior to (4)\n$=$ rounded promontory\n» POSTERIOR WALL:\n(6) Sinus tympani\n$=$ landmark for ampulla of posterior semicircular canal\n$\\checkmark$ recess on posterior wall\n(7) Facial nerve recess\n$=$ important surgical landmark when tympanic cavity is entered via mastoid approach\n$\\checkmark$ recess on posterior wall lateral to (6)\n(8) Pyramidal eminence\n$=$ protrusion that gives rise to stapedius muscle\n$\\checkmark$ situated between sinus tympani + facial nerve recess\n\n## Embryology of Stapedial Artery (complex \\& simplified)\n\n> $2^{\\text {nd }}$ aortic arch becomes hyoid artery and persists as caroticotympanic branch of the ICA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 220,
            "markdown": "![img-19.jpeg](img-19.jpeg)",
            "images": [
                {
                    "id": "img-19.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1335,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 221,
            "markdown": "![img-20.jpeg](img-20.jpeg)\n![img-21.jpeg](img-21.jpeg)\n\nMost Anterior Scan through Cochlea \"snake eyes\" = two facial n. segments\n![img-22.jpeg](img-22.jpeg)\n\nScan through Oval Window\n![img-23.jpeg](img-23.jpeg)\n\nPosterior Scan through Round Window\n\nCoronal CT Scan of Normal Right Ear",
            "images": [
                {
                    "id": "img-20.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 189,
                    "bottom_right_x": 1339,
                    "bottom_right_y": 1346,
                    "image_base64": null
                },
                {
                    "id": "img-21.jpeg",
                    "top_left_x": 188,
                    "top_left_y": 1364,
                    "bottom_right_x": 625,
                    "bottom_right_y": 1700,
                    "image_base64": null
                },
                {
                    "id": "img-22.jpeg",
                    "top_left_x": 639,
                    "top_left_y": 1368,
                    "bottom_right_x": 1057,
                    "bottom_right_y": 1698,
                    "image_base64": null
                },
                {
                    "id": "img-23.jpeg",
                    "top_left_x": 1055,
                    "top_left_y": 1368,
                    "bottom_right_x": 1507,
                    "bottom_right_y": 1698,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 222,
            "markdown": "![img-24.jpeg](img-24.jpeg)\n> stapedial artery arises from hyoid artery near its origin from the proximal ICA ( $3^{\\text {rd }}$ arch) at $4-5$ weeks of fetal life following regression of $1^{\\text {st }}+2^{\\text {nd }}$ aortic arches\n» stapedial artery extends cranially to pass through obturator foramen of stapes and branches into\n(a) upper supraorbital branch with its posterior division that becomes middle meningeal artery\n(b) lower maxillofacial branch forms an anastomosis with ventral pharyngeal artery (precursor of external carotid artery) and exits through foramen spinosum\n> as ventral pharyngeal artery supplies flow to middle meningeal artery, stapedial artery regresses leaving a small caroticotympanic artery\n\n# OSSICULAR CHAIN \n\n[malleus, Latin = hammer; manubrium, Latin = handle $\\leftarrow$ manus = hand; incus, Latin = anvil; stapia, Latin = stand; pes, Latin = foot; stapes, Latin = stirrup; umbo, Latin = boss at center of a circular shield]\nOrigin: from $1^{\\text {st }}+2^{\\text {nd }}$ branchial arches\nFunction: transmits + amplifies vibrations incident on tympanic membrane across middle ear cavity $\\rightarrow$ deflection of oval window (area of tympanic membrane is 30 x greater than that of oval window)\n\n## A. Malleus\n\nLocation: anterolateral to incus and stapes\nAttachment: manubrium to tympanic membrane\nArticulation: diarthrodial incudomalleal joint between facet on posterior surface of head of malleus and body of incus\n$\\sqrt{ }$ \"ice cream cone\" configuration on axial CT\n\n## Components:\n\n> head: articulating facet on posterior surface\n> neck: at inferior aspect of club-shaped head; provides attachment for tensor tympani m .\n> manubrium: long process that lies further inferiorly; tip attaches to tympanic membrane at umbo\n> anterior + lateral processes: small bony spicules that project from upper portion of manubrium; provide attachment for anterior + lateral malleal ligaments that support malleus within middle ear cavity",
            "images": [
                {
                    "id": "img-24.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 191,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 618,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 223,
            "markdown": "$\\sqrt{ }$ lateral process with ligament may be visible on CT\nB. Incus\nshaped like a premolar tooth\nArticulation:\n(1) facet on anterior surface of body of incus $\\rightarrow$ head of malleus\n(2) lenticular process of incus $\\rightarrow$ head of stapes\n\nComponents:\n> body\n> short process: directed posterolaterally\n> long process: directed inferiorly parallel to manubrium;\ntip of long process bends medially to end in lenticular process (rounded projection) articulating with stapes\n> lenticular process: for articulation with head of stapes\nC. Stapes\nmost medial ossicle resembling a stirrup\nAttachment: footplate to oval window of vestibule (= incudostapedial joint)\nArticulation: with lenticular process of incus\nComponents:\n> head / capitellum\n> neck: provides insertion for stapedius muscle at its posterior aspect\n> anterior + posterior crus\n![img-25.jpeg](img-25.jpeg)\n> footplate: attached to margins of oval window by annular ligament\nD. Suspensory ligaments\n\n1. Superior malleal\n2. Lateral malleal\n3. Posterior malleal\n4. Posterior incudal\n$\\sqrt{ }$ sometimes visible on CT as thin linear structures (most commonly lateral malleal lig.)",
            "images": [
                {
                    "id": "img-25.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 1067,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1685,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 224,
            "markdown": "# INNER EAR \n\n## A. OSSEOUS LABYRINTH\n\nencloses membranous labyrinth = otic capsule\n$\\diamond$ Densest bone in entire body\nEmbryology: develops from mesenchyme around membranous labyrinth between 4-8 weeks EGA $\\rightarrow$ continued growth between $8-16$ weeks EGA $\\rightarrow$ ossification by $24^{\\text {th }}$ week EGA\nLocation: petrous portion of temporal bone\n\n1. Cochlea\n[kokhlias, Greek; probably related to konkhe = conch]\n[modiolus, diminutive of modius, Latin = hub of a wheel]\n$=$ spiral-shaped structure with $21 / 2-23 / 4$ turns encircling central bony axis (= modiolus) like conical snail shell\n> basal first turn opens into round window posteriorly\n> lateral aspect of basal turn bulges into middle ear cavity forming cochlear promontory\n> nerve of Jacobson = tympanic branch of glossopharyngeal n. (CN IX) courses over promontory\nDivision by interscalar septum:\n(a) scala vestibuli (upper compartment)\n(b) scala tympani (lower compartment)\n![img-26.jpeg](img-26.jpeg)\n(c) scala media / cochlear duct contains organ of Corti (sensory organ of hearing) helicotrema $=$ open communication between scala vestibuli + tympani at cochlear apex\n[scala, Latin = stair, slope]\n[helix, Greek = coil and trema, Greek = hole]\n2. Vestibule",
            "images": [
                {
                    "id": "img-26.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 1029,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1694,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 225,
            "markdown": "$=$ central and most capacious ovoid part of bony labyrinth posterior to cochlea\n> continuous anteriorly with cochlea\n> continuous posteriorly with semicircular canals\n> separated from middle ear by oval window\nSubunits: (not separately visualized)\n(a) utricle [utriculus, Latin = little bag]\n\nLocation: in elliptical recess superiorly and posteriorly on medial wall of vestibule\n(b) saccule [diminutive of saccus, Latin = bag]\n\nLocation: in spherical recess inferiorly + anteriorly\nFunction: both involved with balance\n3. Semicircular canals (SCC)\n$=3$ canals oriented orthogonal to each other\n> each canal has a dilatation at one end (= ampulla)\n> common crus $\\leftarrow$ junction of posterior end of superior SCC + upper end of posterior SCC\nFunction: detection of angular acceleration\n(a) lateral / horizontal (external) SSC\n\n- detects rotation in transverse plane around vertical axis (ie, left-right movement of head)\nLocation: lateral\nArch direction: horizontal backward\n$\\sqrt{ }$ juts into epitympanum\n(b) superior / anterior SCC\n- detects rotation in sagittal plane around lateral axis (ie, nodding of head)\n\nLocation: anteromedial\nArch direction: superiorly\n$\\sqrt{ }$ vertical orientation transverse to long axis of petrous part of temporal bone\n$\\sqrt{ }$ forms convexity of arcuate eminence\n(c) posterior SCC\n\n- detects rotation in coronal plane around anterior-posterior axis (ie, head touching shoulder)\nLocation: posteromedial\nArch direction: superiorly\n$\\sqrt{ }$ nearly parallel to posterior surface of petrous bone\n\n4. Cochlear aqueduct\n$=$ thin osseous canal containing $8-\\mathrm{mm}$-long perilymphatic duct\nSize: $\\leq 0.1-0.2 \\mathrm{~mm}$\nCourse: from basal turn of cochlea (anterior to round window) to lateral border of jugular foramen paralleling IAC inferiorly",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 226,
            "markdown": "![img-27.jpeg](img-27.jpeg)\n\nFunction: regulates CSF + perilymphatic fluid pressure\n5. Vestibular aqueduct\n$=$ curvilinear duct connected to utricle + saccule\nSize: $\\leq 1 \\mathrm{~mm}$ at midpoint; $\\leq 2 \\mathrm{~mm}$ at operculum\nContent: endolymphatic duct and sac\nCourse: from vestibule to endolymphatic sac\nFunction: equilibration of endolymphatic fluid pressure\nLocation: along posteroinferior surface of petrous bone to the medial wall of vestibule in a course parallel + posterior to posterior SCC\n6. Internal auditory canal (IAC)\ntraverses petrous portion of temporal bone; extends from labyrinth to cerebellopontine angle\nContent:\n(a) $7^{\\text {th }}$ (facial) CN (anterosuperior quadrant)\n(b) $8^{\\text {th }}$ (vestibulocochlear) CN\n> superior vestibular branch (posterosuperior)\nInnervation: utricle, superior + lateral SCC\n> inferior vestibular branch (posteroinferior)\nInnervation: saccule, posterior SCC\n> cochlear branch (anteroinferior quadrant)\nInnervation: cochlea\nBorders:\n(a) medial opening = porus acusticus internus\n(b) lateral opening abutting labyrinth = fundus; separated from inner ear by lamina\ncribrosa (= perforated vertical plate of bone) allowing passage of facial +\nvestibulocochlear nerves\n> crista falciformis (= falciform crest)\n$=$ horizontal bony septum dividing IAC into superior and inferior compartments\n» superoposteriorly: superior vestibular n.\n» inferoposteriorly: inferior vestibular n.\n> \"Bill's bar\" = vertical crest divides superior compartment into anterior + posterior areas",
            "images": [
                {
                    "id": "img-27.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 690,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 227,
            "markdown": "» anterosuperiorly: facial n. (CN VII)\n» anteroinferiorly: cochlear n.\nmnemonic: \"Seven Up Coke Down\"\n\n# B. PERILYMPH \n\n$=$ fluid within space between osseous + membranous labyrinth\nOsseous openings:\n![img-28.jpeg](img-28.jpeg)\n\n## Internal Auditory Canal\n\nPosterior wall of IAC is removed; cross sections through IAC are displayed above; $\\mathrm{A}=$ anterior ( 7 UP), $\\mathrm{P}=$ posterior, $\\mathrm{I}=$ inferior",
            "images": [
                {
                    "id": "img-28.jpeg",
                    "top_left_x": 357,
                    "top_left_y": 462,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1423,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 228,
            "markdown": "![img-29.jpeg](img-29.jpeg)\n(a) oval window: compresses perilymph in scala vestibuli via stapes excursions\n(b) round window: pressure-relief diaphragm that bulges outward with each pressure wave in scala tympani\nC. MEMBRANOUS LABYRINTH\n\nOrigin: arises from neuroectoderm in $4^{\\text {th }}$ week EGA\nEmbryology: otic placode (neuroectoderm) invaginates $\\rightarrow$ otic pit $\\rightarrow$ otic vesicle\n(otocyst); otocyst divides into superior (dorsal pars) + inferior (ventral pars) pouches = precursors to utricle, semicircular canals, cochlear duct, saccule\n$\\sqrt{ }$ filled with endolymph\n\n1. Cochlear duct\n2. Utricle\n3. Saccule\n4. Semicircular ducts\n5. Endolymphatic duct\n\nCourse: from posterior aspect of vestibule toward posterior cranial fossa\n6. Endolymphatic sac\n\nLocation: posterior margin of petrous ridge\nD. ENDOLYMPH\n$=$ fluid within membranous labyrinth\n\n# SALIVARY GLANDS \n\nUS:\n$\\sqrt{ }$ homogeneous texture varying from markedly hyperechoic to slightly hyperechoic (compared to adjacent muscles)\n\n## Parotid Gland\n\nEmbryology:\nglandular component arises from ingrowth of local proliferation of oral epithelium, which",
            "images": [
                {
                    "id": "img-29.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 776,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 229,
            "markdown": "creates ducts by $10^{\\text {th }}$ week GA; secretions begin by $18^{\\text {th }}$ week GA\n$\\diamond$ Epithelial buds branch around divisions of facial nerve thus incorporating it into parotid parenchyma\n$\\diamond$ The only salivary gland that becomes encapsulated after development of the lymphatic system resulting in intraglandular lymph nodes and lymph vessels\nLocation: mainly in upper + lower poles of parotid\nFeatures of normal intraparotid lymph nodes:\n$\\sqrt{ }$ short axis-to-long axis ratio $>0.5$ (in $60 \\%$ )\n$\\sqrt{ }$ short axis diameter $<5-6 \\mathrm{~mm}$\n$\\checkmark$ hyperechoic hilum\nLocation: retromandibular fossa; wraps around mandibular angle (within parotid space)\nAnatomic divisions:\n(a) superficial lobe $=$ main bulk of gland superficial and posterior to masseter muscle; separated by invisible facial nerve / (in its place) retromandibular vein\n(b) deep lobe $=$ small extension of gland deep to angle of mandible\n(c) accessory lobe $(20 \\%)=$ superficial and lateral to masseter muscle + anterior to superficial lobe along course of Stenon duct draining directly into parotid duct\nDrainage route: Stensen / Stenon duct\n\n# Stensen / Stenon Duct \n\n[Stensen, Niels aka Steensen, Latin: Nicolaus Stenonius, Italian: Stenone, French : Stenon (1638-1686), Danish anatomist, natural scientist, theologist in Holland, France, Italy and Germany]\n$=$ main excretory duct of parotid gland\nLength: $3-5 \\mathrm{~cm}$\nCourse: lies on masseter muscle about 1 cm below zygomatic arch $\\rightarrow$ crosses buccal muscle\nOrifice: parotid papilla above upper $2^{\\text {nd }}$ molar tooth\n$\\checkmark$ normal duct sonographically not visible\n\n## Submandibular Gland\n\nLocation: in posterior part of submandibular triangle (created by anterior + posterior bellies of the digastric muscle and body of the mandible)\n$\\checkmark$ may be connected to parotid / sublingual glands by glandular processes\nDrainage route:\n$5-\\mathrm{cm}$ long submandibular duct (Wharton duct) forms at hilum superiorly; runs forward between mylohyoid m., hyoglossus m. and genioglossus m.; bends around margin of mylohyoid muscle; exits through orifice (= sublingual caruncle) along medial aspect of sublingual gland\n[Thomas Wharton (1614-1673), English anatomist, in 1956 published \"Adenographia\", a description of the glands of the entire body, associated with St. Thomas's Hospital, London]\n$\\checkmark$ duct sonographically not visible\nRelationship to adjacent vessels:\n> tortuous facial artery may cross through parenchyma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 230,
            "markdown": "> facial vein runs along anterosuperior part of gland\n> $\\pm$ branch vein connecting to retromandibular v . in posterior portion\n> lingual artery and vein medial to gland\n\n# Sublingual Gland \n\nLocation: between geniohyoid m., intrinsic muscles of tongue, hyoglossal m. (medially) + mylohyoid m.; medial to mandible\nDrainage route: 8-20 excretory ducts with orifices on either side of frenulum; some form major sublingual duct of Bartholin connecting to submandibular duct\n![img-30.jpeg](img-30.jpeg)",
            "images": [
                {
                    "id": "img-30.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 580,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1306,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 231,
            "markdown": "![img-31.jpeg](img-31.jpeg)",
            "images": [
                {
                    "id": "img-31.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 193,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1166,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 232,
            "markdown": "![img-32.jpeg](img-32.jpeg)\n\nAnatomy of Left Recurrent Laryngeal Nerve at level of aortic arch\n\n| Thyroid Hormones |  |  |\n| :--: | :--: | :--: |\n| Thyroxin | $\\mathrm{T}_{4}$ | $4.5-12.0 \\mu \\mathrm{~g} / \\mathrm{dL}$ |\n| Triiodothyronine | $\\mathrm{T}_{3}$ | $90-200 \\mathrm{ng} / \\mathrm{dL}$ |\n| Thyroid stimulating hormone | TSH | $0.4-4.5 \\mu \\mathrm{IU} / \\mathrm{mL}$ |\n| Free $\\mathrm{T}_{4}\\left(0.03 \\%\\right.$ of $\\left.\\mathrm{T}_{4}\\right)$ | $\\mathrm{FT}_{4}$ | $0.7-1.6 \\mathrm{ng} / \\mathrm{dL}$ |\n| Free $\\mathrm{T}_{3}\\left(0.4 \\%\\right.$ of $\\left.\\mathrm{T}_{3}\\right)$ | $\\mathrm{FT}_{3}$ | $230-420 \\mathrm{ng} / \\mathrm{L}$ |\n| Thyroxin-binding globulin | TBG | binds $70 \\%$ of $\\mathrm{T}_{4}$ <br> binds $38 \\%$ of $\\mathrm{T}_{3}$ |\n| Thyroxin-binding prealbumin | TBPA | binds $10 \\%$ of $\\mathrm{T}_{4}$ <br> binds $27 \\%$ of $\\mathrm{T}_{3}$ |\n| Albumin |  | binds $20 \\%$ of $\\mathrm{T}_{4}$ <br> binds $35 \\%$ of $\\mathrm{T}_{3}$ |\n| Radioiodine uptake | RAIU | $8-35 \\%$ @ 24 hr |",
            "images": [
                {
                    "id": "img-32.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 193,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1062,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 233,
            "markdown": "![img-33.jpeg](img-33.jpeg)\n\n# RECURRENT LARYNGEAL NERVE (RLN) \n\nnot directly visualized on CT\nOrigin: nucleus ambiguus in medulla of brainstem within vagus n .\nCourse:\ncrosses lateral in cerebellomedullary cistern $\\rightarrow$ exits skull base via pars vascularis of jugular foramen (located within dural sheath shared by spinal accessory n. [CN XI]) $\\rightarrow$ superior ganglion within jugular foramen $\\rightarrow$ inferior ganglion immediately below jugular foramen $\\rightarrow$ exit point of pharyngeal branches (containing sensory fibers of glossopharyngeal n. [CN IX]) + superior laryngeal n. $\\rightarrow$ descends within carotid sheath posterolateral to internal carotid a. + posteromedial to jugular v.\n(a) RT RLN:\n\nExit: from vagus n. anterior to subclavian a.\ncourses posteriorly beneath the subclavian a. at level of brachiocephalic bifurcation $\\rightarrow$ right tracheoesophageal groove over surface of apical parietal pleura\nLength to cricothyroid joint: $5-6 \\mathrm{~cm}$\n(b) LT RLN:\n\nExit: from vagus at level of aortic arch\ncourses posteromedial beneath aortic arch through aorticopulmonary window + posterior to ligamentum arteriosum $\\rightarrow$ ascends vertically to reach left tracheoesophageal groove\nLength to cricothyroid joint: 12 cm\nInnervation by superior laryngeal nerve:\nmotor fibers to cricothyroid + superior pharyngeal constrictor mm .\nInnervation by recurrent laryngeal nerve:\nintrinsic laryngeal mm. (posterior cricoarytenoid m. = main vocal cord abductor)\n\n## THYROID GLAND",
            "images": [
                {
                    "id": "img-33.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 895,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 234,
            "markdown": "Normal size: $4.0-4.8 \\mathrm{~cm}(\\mathrm{~L}) \\times 1.0-1.8 \\mathrm{~cm}(\\mathrm{~W}) \\times 0.8-1.6(\\mathrm{H}) \\mathrm{cm}$\nVolume: $\\mathrm{L} \\times \\mathrm{W} \\times \\mathrm{H} \\times \\pi / 6$\nNormal weight: $10-25 \\mathrm{~g}$\nPhysiology: hypothalamic TRH $\\rightarrow$ anterior pituitary $\\mathrm{TSH} \\rightarrow \\mathrm{T}_{4}$ (= main hormone produced by thyroid); $\\mathrm{T}_{3}$ mainly produced by peripheral conversion of $\\mathrm{T}_{4} ; \\mathrm{T}_{3}$ and $\\mathrm{T}_{4}$ are largely protein-bound in plasma to (mainly) TBG; only the unbound free portion $\\left(\\mathrm{FT}_{3}, \\mathrm{FT}_{4}\\right)$ is active $\\rightarrow$ increased cell metabolism by binding to nuclear receptors\n$\\sqrt{ }$ intense homogeneous enhancement\nCT:\n$\\sqrt{ }$ homogeneous mildly hyperattenuating relative to surrounding neck musculature with an average attenuation of $80-100$ (range, $70-120$ ) HU\nMR:\n$\\sqrt{ }$ slightly hyperintense on T1WI + iso- to slightly hyperintense on T2WI relative to the neck musculature\nNUC ( ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ pertechnetate / ${ }^{123} \\mathrm{I} /{ }^{131} \\mathrm{I}$ ):\n$\\sqrt{ }$ symmetric uniform uptake in both lobes\nN.B.: intravenous contrast medium impairs thyroid uptake of radioactive iodine for 4-8 weeks\n\n# Embryogenesis of Thyroid \n\nOrigin: derived from median thyroid anlage $=$ endodermal thickening between $1^{\\text {st }}+2^{\\text {nd }}$ pharyngeal arches $\\rightarrow$ forming small pit at $24^{\\text {th }}$ day GA $=$ thyroid bud $\\rightarrow$ elongates into bilobate diverticulum $\\rightarrow$ descends caudally while in contact with aortic primordium $\\rightarrow$ reaches final location by 7 weeks GA\nCells: (a) thyroid follicular cells $\\leftarrow$ median thyroid anlage\n(b) parafollicular cells ( C cells) $\\leftarrow$ arise laterally from $4^{\\text {th }}$ pharyngeal pouch $\\leftarrow$ lateral thyroid anlagen (= ultimobranchial bodies) merge with products of median anlage after descent into infrahyoid portion of neck $\\rightarrow$ dispersion of parafollicular cells throughout thyroid gland\n\n## Ectopic Thyroid Tissue\n\nLocation: (a) base of the tongue $(90 \\%)$;\n(b) infrahyoid portion of neck $(<10 \\%)$;\n(c) lateral to midline = superficial to strap muscle (rare)\n(d) beyond usual path of migration: mediastinum, heart, adrenal, bowel, ovary\n\nMean age at presentation: 40.5 years\n$\\sqrt{ }$ absence of orthotopic thyroid tissue (in $70-80 \\%$ )\nNUC ( ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate, ${ }^{123} \\mathrm{I},{ }^{131} \\mathrm{I}$ ):\n$\\sqrt{ }$ thyroid tissue identified in usual thyroid bed / at ectopic sites\nN.B.: normal thyroid gland may trap majority of radionuclide making identification of small ectopic rests difficult!\nCT:\n$\\sqrt{ }$ mildly increased attenuation of $70 \\mathrm{HU} \\pm 10$ relative to adjacent muscle $\\leftarrow$ intrinsic iodine content",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 235,
            "markdown": "$\\sqrt{ }$ well-circumscribed homogeneous avidly enhancing mass\n$\\sqrt{ }$ islands of low attenuation within ectopic thyroid tissue $=$ clue to diagnosis of ectopic thyroid tissue\nMR:\n$\\sqrt{ }$ isointense to mildly hyperintense relative to musculature on T1WI\n$\\sqrt{ }$ mildly hyperintense with variable enhancement on T2WI\n![img-34.jpeg](img-34.jpeg)\n\n# Embryogenesis of Thyroglossal Duct \n\n$=$ small temporary channel along which thyroid primordium descends in midline of neck to its final position $\\rightarrow$ forms in $3^{\\text {rd }}$ week $\\mathrm{GA} \\rightarrow$ usually involutes by $8^{\\text {th }}-10^{\\text {th }}$ week of fetal life prior to definite formation of thyroid\nOrigin: foramen cecum at base of tongue (= vertex of sulcus terminalis linguae formed by circumvallate papillae)\nCourse: passes from foramen cecum anterior to primordial hyoid bone $\\rightarrow$ makes a recurrent loop through / posterior to precursor of hyoid bone $\\rightarrow$ finally descends to infrahyoid portion of neck anterior to thyrohyoid membrane + thyroid cartilage + trachea + strap muscles\nInferior end: becomes pyramidal lobe of thyroid\n\n## Biosynthesis of Thyroid Hormone\n\n(1) Uptake of iodide by thyrocytes\n\nNIS (natrium-iodide symporter) gene:\n) located on chromosome 9p12-13.2 $\\rightarrow$ intrinsic thyrocyte-based plasma membrane glycoprotein NIS\nSodium iodide symporter (NIS):\ndriven by $\\mathrm{Na}+/ \\mathrm{K}+$ ATPase cotransports two $\\mathrm{Na}+$ and one I- into follicular cell raising cytoplasmic iodine concentration to $20-40$ times that of plasma (iodide trapping)\nBiodistribution of NIS expression:\nthyroid, salivary gland (ductal cell), gastric mucosa (parietal + mucus cells), lactating",
            "images": [
                {
                    "id": "img-34.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 464,
                    "bottom_right_x": 1319,
                    "bottom_right_y": 1060,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 236,
            "markdown": "mammary gland (nonlactating breast in 6\\%), lacrimal gland, choroid plexus, ciliary body, skin, placenta, thymus [lower levels in prostate, ovary, adrenal gland, lung, heart, colon, orbital fibroblasts, nasopharyngeal mucosa]\n(2) Efflux into follicular lumen\n(3) Organification onto thyroglobulin thyroid peroxidase $\\rightarrow$ oxidisation of two I- to nonreactive I2 and very reactive $10 \\rightarrow$ iodinates tyrosyl residue of thyroglobulin within colloid\nThyroglobulin\nproduced in endoplasmic reticulum of follicular cell $\\rightarrow$ secreted into colloid of thyroid follicle by exocytosis\n\n# PARATHYROID GLANDS \n\nEmbryology: parathyroid glands develop by 6 weeks GA + migrate into neck at 8 weeks\nSize: $6 \\times 3-4 \\times 1-2 \\mathrm{~mm}=29.5 \\pm 17.8$ (range, $25-65$ ) mg\nHisto: gland composed of chief cells (secretion of parathyroid hormone), oxyphil cells (packed with mitochondria of unknown function), transitional oxyphil cells mixed with adipose tissue\nA. SUPERIOR PARATHYROID GLANDS\n\nEmbryology: derived from $4^{\\text {th }}$ pharyngeal pouches, descending together with thyroid gland in close relationship to its posterolateral lobes\nEutopic location:\nposterior to superior / middle third of thyroid gland in tracheoesophageal groove on dorsal surface of thyroid / intracapsular ( $>90 \\%$ ); posterior to inferior thyroid artery + recurrent laryngeal n .\n$\\diamond$ Fairly constant position due to minimal descent\nEctopic location:\n> above upper pole of thyroid lobe $(<1 \\%)$\n> posterior to pharynx / esophagus, on either side of neck or superior mediastinum ( $1 \\%-$ $4 \\%)$\n> intrathyroidal $(<3 \\%)$\nB. INFERIOR PARATHYROID GLANDS\n\nEmbryology: derived from $3^{\\text {rd }}$ pharyngeal (branchial) pouches migrating caudally with thymus\nEutopic location:\nanterior / lateral / posterior to inferior third of thyroid (61\\%); anterior to inferior thyroid artery + recurrent laryngeal nerve\n$\\diamond$ More variable position $\\leftarrow$ descent over greater distance\nEctopic location:\n> in neck, inferior to lower pole of thyroid lobe: either in thyrothymic ligament / associated with cervical portion of thymus ( $26 \\%$ )\n> on / adjacent to the posterior aspect of the middle third of the thyroid lobe (7\\%)\n> in anterior mediastinum ( $4 \\%-5 \\%$ ): within thymus / at posterior aspect of thymic capsule / in contact with great vessels\n> along the carotid sheath $(<1 \\%-2 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 237,
            "markdown": "> intrathyroidal $(<3 \\%)$\nC. SUPERNUMERARY PARATHYROID GLANDS\n$5^{\\text {th }} / 6^{\\text {th }}$ gland may occupy an ectopic site\n$\\diamond$ Up to 12 parathyroids may be present!\nD. ABSENCE OF 1 PARATHYROID GLAND\n\nSurgical success rates for finding parathyroid glands:\n$>95 \\%$ for initial cervical exploration\n$>60 \\%$ for repeat surgical exploration\nCause for failure: overlooking an adenoma, multiple abnormal glands, diffuse hyperplasia\nLocalization technique:\nUS ( $75 \\%$ sensitivity), thallium-technetium subtraction scintigraphy, MR ( $88 \\%$ sensitivity)\n\n# LYMPH NODES OF THE NECK \n\nImaging of normal lymph nodes:\nShape: oval similar to a lima bean\nCT:\n$\\sqrt{ }$ iso- or hypoattenuating to muscle\nMR:\n$\\sqrt{ }$ low to intermediate signal intensity on T1WI\n$\\sqrt{ }$ intermediate to high signal intensity on T2WI\nUS:\n$\\sqrt{ }$ hypoechoic in comparison with muscle\n$\\sqrt{ }$ ovoid shape with echogenic fatty hilum\nReactive lymph nodes:\nOrganism:\n(a) bacterium\n$\\sqrt{ }$ greater enlargement + inflammation of surrounding tissue\n$C x$ : progression to suppurative adenopathy\n(b) virus (CMV, infectious mononucleosis, HIV)\n$\\sqrt{ }$ diffuse enlargement + little surrounding inflammation\n(c) inflammatory cause: sarcoidosis\n(d) idiopathic:\n\nKimura, Kawasaki, Kikuchi-Fujimoto disease\n\n- signs of local or systemic infection\n- painful mobile nodes at physical examination\n$\\sqrt{ }$ normal to slightly enlarged in size\n$\\sqrt{ } \\pm$ enhancement $\\leftarrow$ increased vascularity\nA. CENTRAL COMPARTMENT\n$=$ between right and left carotid arteries\n\n1. Delphian (prelaryngeal) / pretracheal\n[The Delphic Oracle in the Greek world was consulted before all major undertakings.\nAn enlarged Delphian node is ominously evidence of metastatic thyroid cancer.]\n= level VI node (not routinely excised during radical neck dissection)\nInvolvement with: thyroid carcinoma, squamous cell carcinoma, laryngeal cancer",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 238,
            "markdown": "2. Paratracheal: alongside recurrent laryngeal nerve\n3. Thymic / perithymic: within fatty tissue in the lower anterior part of neck\nB. LATERAL COMPARTMENT\n4. Internal jugular\n> jugulodigastric node: $<15 \\mathrm{~mm}$ maximal longitudinal diameter, $<10 \\mathrm{~mm}$ axial diameter\n> retropharyngeal: $<8 \\mathrm{~mm}$ maximal longitudinal, $<10 \\mathrm{~mm}$ axial diameter\n> others: $<10 \\mathrm{~mm}$ maximal longitudinal diameter, $<10 \\mathrm{~mm}$ axial diameter\n5. Spinal accessory: posterior triangle\n6. Transverse cervical: supraclavicular\n![img-35.jpeg](img-35.jpeg)\n\nEssential anatomic landmarks:\njugular fossa of skull base, bottom of hyoid body, bottom of cricoid arch, top of manubrium, back edge of submandibular gland, back edge of sternocleidomastoid m., lateral posterior edge of anterior scalene m., anterior edge of trapezius m., internal + common carotid a., internal jugular v., clavicle, medial margin of anterior belly of digastric m., mylohyoid m.",
            "images": [
                {
                    "id": "img-35.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 620,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1731,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 239,
            "markdown": "I above hyoid + below mylohyoid m. + anterior to posterior edge of submandibular gland (submandibular nodes); IA = between medial edge of anterior bellies of both digastric mm. (submental nodes)\nII skull base at jugular fossa + lower body of hyoid bone + anterior to posterior edge of sternocleidomastoid m. + posterior to posterior edge of submandibular gland; IIA = anterior to internal jugular vein (upper internal jugular nodes); IIB = posterior to internal jugular v. (upper spinal accessory nodes); retropharyngeal node = level II node medial to internal carotid a.; jugulodigastric node = where posterior belly of digastric muscle crosses internal jugular vein\nIII lower body of hyoid + lower margin of cricoid arch + posterior edge of sternocleidomastoid m. (midjugular nodes)\nIV lower margin of cricoid + clavicle + posterior edge of sternocleidomastoid m. + posterolateral edge of anterior scalene m. + medial aspect of common carotid a. (jugular nodes)\nV behind posterior edge of sternocleidomastoid m.\nVI lower body of hyoid + top of manubrium + between common carotid aa. (visceral nodes)\nVII top of manubrium to innominate v. + between common carotid aa. (superior mediastinal nodes)\nSupraclavicular nodes = level IV \\& VB nodes; Internal jugular nodes of Rouvière = level II or III or IV nodes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 240,
            "markdown": "# EAR, NOSE, AND THROAT DISORDERS \n\n## ABERRANT INTERNAL CAROTID ARTERY\n\n$=$ collateral pathway $=$ anastomosis of enlarged inferior tympanic artery with enlarged caroticotympanic artery ( $=$ remnant of embryonic hyoid artery) $\\leftarrow$ involution of normal cervical portion (1st embryonic segment) of ICA\n\n- vascular tympanic membrane, sensation of fullness in ear\n- pulsatile tinnitus, hearing loss, vertigo\n$\\sqrt{ }$ tubular soft-tissue density entering middle ear cavity posterolateral to cochlea $\\rightarrow$ crossing mesotympanum along cochlear promontory $\\rightarrow$ exiting anteromedial to become horizontal portion of carotid canal\n$\\sqrt{ }$ protrusion into middle ear without bony margin\nCave: catastrophic hemorrhage from tympanotomy / biopsy\n$D D x$ : neoplastic process (eg, paraganglioma); inflammation (eg, effusive otitis media)\n\n\n## ADENOID CYSTIC CARCINOMA\n\n$=$ CYLINDROMA\nFrequency: $4-15 \\%$ of salivary gland cancers; $1-3 \\%$ of all head \\& neck malignancies\nHisto: (a) cribriform subtype, grade 1\n(b) tubular subtype, grade 2\n(c) solid / basaloid subtype, grade 3\n$\\diamond$ Perineural invasion is typical!\nAge: $3^{\\text {rd }}-9^{\\text {th }}$ decade; maximum between 40 and 70 years; $\\mathrm{M}=\\mathrm{F}$\n\n- slowly growing with pain $\\leftarrow$ tendency to infiltrate nerves\n\nLocation:\n$\\diamond$ Most often found in minor salivary glands\n@ Minor salivary glands (most common; 25-31\\% of malignant neoplasms occur in minor salivary glands)\n$\\diamond$ Most common tumor of the minor salivary glands!\n\n- nasal obstruction + swelling\n\nSite: oral cavity $>$ pharynx $>$ nose $>$ paranasal sinuses $>$ trachea $>$ larynx\n@ Submandibular gland ( $15 \\%$ of tumors affecting this gland)\n@ Parotid gland ( $2-6 \\%$ of tumors in this gland; arises from peripheral parotid ducts with propensity for perineural spread along facial nerve)\n\n- hard mass + facial nerve pain / paralysis\n$\\checkmark$ infiltrating parotid mass\n@ Trachea\nMR:\n$\\checkmark$ hypo- to hyperintense (high signal corresponds to low cellularity with a better prognosis) on T2WI",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 241,
            "markdown": "$\\sqrt{ }$ adenoid cystic carcinomas have the highest relative incidence of perineural invasion (up to 56\\%)\nMetastases to: lung, cervical lymph nodes, bone, liver, brain\nPrognosis: slow growing but relentless malignant course with repeat recurrences; the greater the cellularity, the worse the prognosis (requires entire tumor); 60-69\\% 5-year survival rate; $40 \\% 10$-year survival rate\n$R x$ : repeat surgical excision + radiation therapy\n\n# Laryngeal Adenoid Cystic Carcinoma \n\n$0.25-1 \\%$ of all malignant laryngeal tumors\nHisto: uniform small basaloid cells with large deeply staining ovoid nuclei arranged in anastomosing cords or islands\n\n- coughing attacks, wheezing, hemoptysis\n- CHARACTERISTIC paralysis of recurrent laryngeal nerve $\\leftarrow$ propensity to invade nerves\n- absent history of cigarette smoking\n\nLocation: subglottis at junction with trachea ( $80 \\%$ )\n$\\checkmark$ extensive submucosal tumor spread of entire larynx\n$\\checkmark$ invasion of cricoid cartilage, thyroid + esophagus\n$\\checkmark$ regional neck nodes hardly ever involved\n\n## ANGIOFIBROMA\n\n## Giant Cell Angiofibroma\n\n$=$ benign tumor with rapid growth mimicking malignancy / with slow growth over many years\nMean age: 45 years\nHisto: pseudovascularized spaces within stromal matrix\nLocation: orbital region / eyelid (most common); buccal mucosa, submandibular region, parapharyngeal space\n$\\sqrt{ }$ NO osseous erosion\nCT:\n$\\sqrt{ }$ circumscribed enhancing mass\nMR:\n$\\sqrt{ }$ usually hyperintense relative to muscle on T2WI\n$\\sqrt{ }$ isointense relative to muscle on unenhanced T1WI\n$\\sqrt{ }$ heterogeneous mass with stippled areas of low signal intensity / signal void $\\leftarrow$ multiple pseudovascular spaces\n$\\sqrt{ }$ intense enhancement\n\n## Juvenile Angiofibroma\n\n$=$ most common benign nasopharyngeal tumor, can grow to enormous size and locally invade vital structures\nFrequency: $0.5 \\%$ of all head and neck neoplasms\nMean age: 15 years; almost exclusively in males\n\n- recurrent + severe epistaxis (59\\%)\n- nasal speech $\\leftarrow$ nasal obstruction ( $91 \\%$ )\n- facial deformity (less common)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 242,
            "markdown": "Location: nasopharynx / posterior nares; center of mass within sphenopalatine foramen\nExtension: posterolateral wall of nasal cavity; via pterygopalatine fossa into retroantral region / orbit / middle cranial fossa; laterally into infratemporal fossa\nVascular supply: primarily by ipsilateral internal maxillary / ascending pharyngeal / palatine artery\n$\\checkmark$ widening of pterygopalatine fossa ( $90 \\%$ ) with anterior bowing of posterior antral wall\n$\\checkmark$ osseous erosion of nasal cavity, hard palate, pterygoid plates\n$\\checkmark$ invasion of sphenoid sinus ( $2 / 3$ ) from tumor erosion through floor of sinus\n$\\checkmark$ widening of inferior + superior orbital fissures $\\rightarrow$ spread into orbit via inferior orbital fissure + into middle cranial fossa via superior orbital fissure\n$\\checkmark$ highly vascular nasopharyngeal mass\nCECT:\n$\\checkmark$ avid enhancement of mass (only enhances on CT scan immediately after bolus injection)\nMR (best for tumor extension into skull base / intracranially):\n$\\checkmark$ low to intermediate SI on T1WI with discrete punctate areas of hypointensity $\\leftarrow$ highly vascular stroma\n$\\checkmark$ heterogeneous intermediate SI on T2WI\n$\\checkmark$ avid enhancement with flow voids\nAngio (to define vascular supply):\n$\\checkmark$ may involve branches of contralateral ICA + ECA\nNOTE: Biopsy contraindicated!\n\n# ANGIOLIPOMA OF PAROTID GLAND \n\n$=$ benign nodular lesion similar to ordinary lipomas except for associated angiomatous proliferation\nAge: rare before puberty\nCT:\n$\\checkmark$ circumscribed (more common) / infiltrating mass\n$\\checkmark$ marked enhancement around fatty components\n$D D x$ : hemangioma with fatty degeneration\n\n## APICAL PETROSITIS\n\n$=$ PETROUS APICITIS $=$ PETROSITIS\n$=$ infectious process caused by medial extension of acute otitis media into pneumatized petrous air cells\nFrequency: chronic $>$ acute apicitis\nEtiology: spread from middle ear + mastoid infection; requires presence of air cells in petrous apices (which is normally found in $9-30 \\%$ of population)\nOrganism: Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus\n\n- Gradenigo syndrome $=$ classic triad of\n- deep facial (retroorbital) pain in distribution of cranial nerve $\\mathrm{V}_{1}$ (trigeminal pain) $\\leftarrow$ focal meningitis over petrous apex with irritation of gasserian ganglion in Meckel cavity\n- diplopia $\\leftarrow 6^{\\text {th }}$ nerve palsy\n- ipsilateral otorrhea $\\leftarrow$ otitis media",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 243,
            "markdown": "[Giuseppe Conte Gradenigo (1859-1926), Italian otolaryngologist in Wien, Torino and Napoli]\n$\\sqrt{ }$ opacification of aerated petrous apex + air-fluid levels\n$\\sqrt{ }$ osseous erosion\n$\\sqrt{ }$ fluid in ipsilateral middle ear + mastoid\nMR:\n$\\sqrt{ }$ hyperintense signal on T2WI + hypointense on T1WI\n$\\sqrt{ }$ avidly enhancing mass in pneumatized petrous apex\n$\\sqrt{ }$ enhancing meninges $\\leftarrow$ adjacent meningeal inflammation\n$C x$ : meningitis; epidural / brain abscess (ring enhancement, restricted DWI); venous sinus thrombosis; cranial nerve palsy (abducens, trigeminal, vagus nn.)\nMortality: up to 20\\% (prior to antibiotic era)\n$R x$ : intravenous antibiotics, myringotomy, surgery\n$D D x$ : petrous apex osteomyelitis (nonpneumatized petrous apex, septal + cortical destruction, predisposing diabetes mellitus); neoplastic disease (rhabdomyosarcoma, metastasis); epidermoid tumor\n\n# BENIGN LYMPHOEPITHELIAL LESIONS \n\n$=$ BLL $=$ HIV-ASSOCIATED LYMPHOEPITHELIAL CYSTS\n$=$ painless idiopathic swelling of one / both parotid glands characterized by chronic progression in the absence of retroviral therapy\nPrevalence: 5\\% of HIV population\nCause: serves as index lesion for diagnosis of HIV infection without AIDS; NOT an AIDS defining illness\nPathogenesis: cystic dilatation of terminal salivary ducts\nAge: $6^{\\text {th }}$ decade; $\\mathrm{M}+\\mathrm{F}=2 \\div 3$ to $4 \\div 5$\nHisto: polyclonal CD8+ lymphoid hypertrophy $\\rightarrow$ obstruction + dilatation of intraglandular ducts\nLocation: one / both (20\\%) parotid glands\nUS:\n$\\sqrt{ }$ cystic lesions with multiple small septations + small mural nodules (in 40\\%)\n$\\sqrt{ } \\pm$ vascular pedicle entering the cystic region\n$\\sqrt{ }$ moderately vascular ( $79 \\%$ ), hypervascular ( $14 \\%$ ), avascular ( $7 \\%$ ) on color Doppler\nCT:\n$\\sqrt{ }$ numerous (rarely isolated single) mixed cystic + solid lesions\n$\\sqrt{ }$ reactive cervical lymphadenopathy\n$\\sqrt{ }$ tonsillar hypertrophy\nCECT:\n$\\sqrt{ }$ rimlike enhancement around cystic parotid lesions\n$\\sqrt{ }$ heterogeneous enhancement of solid parotid lesions\n$C x$ : transformation into B-cell lymphoma (rare)\n$D D x$ : acute phase of Sjögren syndrome (lesions predominantly solid, of decreased echogenicity, smaller, more numerous), sarcoidosis, lymphoma, viral infection (mumps), Warthin tumor (frequently multicentric or bilateral, internal cystic elements, no cervical",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 244,
            "markdown": "# adenopathy) \n\n## BRANCHIAL CLEFT ANOMALIES\n\n$=$ BRANCHIAL CLEFT CYST\n$=$ failure of involution of branchial cleft\nFrequency: $2^{\\text {nd }}$ most common congenital lesion of head \\& neck after thyroglossal duct cyst!\n\n- neck mass / cyst; respiratory compromise, dysphagia (if large)\n\nBarium pharyngography:\n$\\sqrt{ }$ performed for localization of a fistulous tract in $2^{\\text {nd }}+3^{\\text {rd }}$ arch anomalies\n$C x$ : high incidence of infection\n\n## First Branchial Cleft Cyst (5-8\\%)\n\n$=$ PAROTID LYMPHOEPITHELIAL CYST\nFrequency: $5-8 \\%$ of all branchial cleft anomalies (rare)\nAge: middle-aged women\n\n- enlarging mass near lower pole of parotid gland\n- recurrent parotid abscesses near ear / angle of mandible\n- otorrhea (if cyst drains into EAC) $\\pm$ facial nerve palsy\n\nSpectrum: branchial cyst (68\\%) / sinus (16\\%) / fistula (16\\%)\nLocation: from submandibular triangle (posterior / inferior to angle of mandible) near branches of facial nerve within parotid gland to preauricular region extending anterior / posterior to pinna to junction of cartilaginous + bony external auditory canal\nPathologic classification (Work):\nType 1 duplication anomaly of membranous EAC; derived from ectoderm + lined with squamous epithelium; no skin appendages\nSite: postauricular region = course parallel to EAC; medial to concha of ear\nType 2 parotid cyst containing ectoderm and mesoderm involving EAC + pinna; skin appendages (hair follicles, sweat and sebaceous glands)\n\n- otorrhea without otitis media\n$\\sqrt{ }$ cystic mass within parotid or immediate periparotid region (superficial to / deep to parotid gland)\n$\\sqrt{ }$ may extend into adjacent fat-containing parapharyngeal space $\\pm$ connection to EAC\n$D D x$ : inflammatory parotid cyst, benign cystic parotid tumor, necrotic metastatic lymphadenopathy\n\n\n## Second Branchial Cleft Cyst (95\\%)\n\n$=$ incomplete obliteration of $2^{\\text {nd }}$ branchial cleft tract (cervical sinus of His) resulting in sinus tract / fistula / cyst $(75 \\%)$\nFrequency: $95 \\%$ of all branchial cleft anomalies\n$\\diamond$ Most common branchial cleft abnormality!\nAge: $\\quad 10-40$ years; $\\mathrm{M}=\\mathrm{F}$\nClassification (Bailey):\nType along anterior surface of sternocleidomastoid muscle, just deep to platysma I",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 245,
            "markdown": "Type along anterior surface of sternocleidomastoid muscle, lateral to carotid space, II posterior to submandibular gland adhering to the great vessels (most common)\nType extension medially between bifurcation of external and internal carotid arteries to III lateral pharyngeal wall\nType within pharyngeal mucosal space\nIV\nPath: $1-10-\\mathrm{cm}$ large thin-walled cyst, lined by stratified squamous epithelium overlying lymphoid tissue, filled with turbid yellowish fluid $\\pm$ cholesterol crystals\n\n- skin openings with sinus / fistula\n- painless fluctuant mass at mandibular angle\n- history of multiple parotid abscesses unresponsive to drainage + antibiotics\n- otorrhea (if connected to external auditory canal)\n\n\n# Location: \n\nanywhere along a line from the oropharyngeal tonsillar fossa to supraclavicular region of neck; CLASSICALLY at anteromedial border of sternocleidomastoid muscle + lateral to carotid space + at posterior margin of submandibular gland; may be in parapharyngeal space (after extension through stylomandibular tunnel + middle constrictor muscle)\nInternal opening: oropharyngeal tonsillar fossa\n$\\sqrt{ }$ oval / round cyst near mandibular angle\n$\\sqrt{ }$ displacement of sternocleidomastoid muscle posteriorly, carotid artery + jugular vein posteromedially, submandibular gland anteriorly\n$\\sqrt{ }$ cyst may enlarge after upper respiratory tract infection / injury\nUS:\n$\\sqrt{ }$ well-marginated thin-walled ovoid compressible hypoechoic mass:\n$\\sqrt{ }$ occasionally fine internal echoes = internal debris (due to hemorrhage / infection) obscuring its cystic nature\n$\\sqrt{ }$ lack of internal flow\nCT / MR:\n$\\sqrt{ }$ \"beak\" sign = curved rim of tissue pointing medially between internal + external carotid arteries (PATHOGNOMONIC)\n$\\sqrt{ }$ slight enhancement of capsule\n$D D x$ : necrotic neural tumor, cervical abscess, submandibular gland cyst, cystic lymphangioma, necrotic metastatic / inflammatory lymphadenopathy\n\n## Atypical Second Branchial Cleft Cyst\n\nAge: child / young adult\n\n- protruding parotid gland\n- bulging posterolateral pharyngeal wall\n$\\sqrt{ }$ cystic mass projecting from deep margin of faucial tonsil toward skull base\n\n\n## Third Branchial Fistula / Cyst\n\n$=$ above superior laryngeal nerve\nFrequency: extremely rare\nInternal opening: piriform sinus anterior to fold formed by internal laryngeal nerve\nCourse: fistula pierces thyrohyoid membrane; passes anterior to vagus nerve + above",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 246,
            "markdown": "hypoglossal nerve + below glossopharyngeal nerve; between internal + external carotid arteries; caudolateral / posterolateral to proximal ICA + CCA\nExternal opening: at base of neck anterior to sternocleidomastoid muscle\n$\\sqrt{ }$ unilocular cystic mass within posterior cervical space\n\n# Fourth Branchial Fistula \n\n$=$ below superior laryngeal nerve\nFrequency: extremely rare $(\\mathrm{R}>\\mathrm{L})$\nInternal opening: apex of piriform sinus\nCourse: between cricoid + thyroid cartilage, below cricothyroid muscle, caudal course between trachea + carotid vessels, deep to clavicle into mediastinum, looping forward below aorta (left side) / right subclavian artery (right side), ascending along ventral surface of common carotid artery, passing over hypoglossal nerve\nExternal opening: at base of neck anterior to sternocleido-mastoid m. + anteroinferior to subclavian a.\n\n- recurrent episodes of \"suppurative thyroiditis\" / neck abscesses\n\nSite: $\\quad 90 \\%$ on left side\n\n## CALCIFIC LONGUS COLLI TENDINITIS\n\n$=$ ACUTE CALCIFIC RETROPHARYNGEAL TENDINITIS\n$=$ calcification anterior to $\\mathrm{C} 1-\\mathrm{C} 2 \\leftarrow$ deposition of calcium hydroxyapatite\nLocation: near insertion of longus colli tendon in close proximity to anterior arch of C1 Site: superior oblique tendon fibers of the longus colli muscle\n\n- recent history of upper respiratory infection / minor trauma to head or neck, acute to subacute onset of neck pain and stiffness\n- dysphagia, odynophagia\n- low-grade fever, mildly elevated WBC count\n$\\checkmark$ prevertebral / retropharyngeal soft-tissue swelling\n$\\checkmark$ amorphous calcification anterior to $\\mathrm{C} 1-\\mathrm{C} 2$ (CT most sensitive)\n$\\checkmark$ fluid originating in prevertebral space $\\pm$ extension to retropharyngeal space:\n$\\checkmark$ retropharyngeal space smoothly expanded in all directions from C1 tapering inferiorly to C5-6\n$\\checkmark$ effusions may involve both lateral atlantoaxial joints\n$\\checkmark$ no rimlike enhancement\n$R x:$ antiinflammatory medication\n$D D x$ : retropharyngeal abscess (similar clinical manifestation, enhancing wall), suppurative retropharyngeal lymphadenitis (low-attenuation centers), traumatic injury, infectious spondylitis\n\n\n## CAROTID ARTERY STENOSIS\n\nHigh-grade ICA stenosis is associated with increased risk for TIA, stroke, carotid occlusion, embolism arising from thrombi forming at site of narrowing\nIncreased risk for stroke:\n(a) significant ICA stenosis $\\rightarrow$ compromised blood flow:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 247,
            "markdown": "$\\diamond$ Reduction of blood flow occurs at $50-60 \\%$ diameter stenosis $/ 75 \\%$ area stenosis\n$\\diamond 2 \\%$ risk of stroke with nonsignificant stenosis\n$\\diamond 16 \\%$ incidence of stroke with significant stenosis\n$\\diamond 2 \\%$ incidence of subsequent stroke following endarterectomy\n(b) intraplaque hemorrhage $\\rightarrow$ embolic stroke\n\n# Histo: \n\nArteriosclerosis $=$ generic term for all structural changes resulting in hardening of the arterial wall\n\n1. Diffuse intimal thickening\n$=$ growth of intima $\\leftarrow$ migration of medial smooth muscle cells into subendothelial space through fenestrations in internal elastic lamella associated with increasing amounts of collagen, elastic fibers, glycosaminoglycans\nAge: beginning at birth slowly progressing to adult life\n2. Atherosclerosis\n$=$ intimal pool of necrotic, proteinaceous + fatty substances within hardened arterial wall\nLocation: large + medium-sized elastic and muscular arteries\n(a) fatty streak = superficial yellow-gray flat intimal lesion characterized by focal accumulation of subendothelial smooth muscle cells + lipid deposits\n(b) fibrous plaque $=$ whitish protruding lesion consisting of central core of lipid + cell debris surrounded by smooth muscle cells, collagen, elastic fibers, proteoglycans; fibrous cap separates lipid core ( $=$ atheroma) from vessel lumen\n(c) complicated lesion = fibrous plaque with degenerative changes such as calcification, plaque hemorrhage, intimal ulceration / rupture, mural thrombosis\nPlaque hemorrhage $=$ vascularized plaque may cause ulceration, thrombosis + embolism, and luminal narrowing\n$\\diamond$ In $93 \\%$ of symptomatic patients\n$\\diamond$ In $27 \\%$ of asymptomatic patients\nPlaque ulceration exposes thrombogenic subendothelial collagen + lipid-rich material $\\diamond$ Frequent in plaques occupying $>85 \\%$ of lumen\n$\\diamond 12.5 \\%$ stroke incidence per year\n3. Mönckeberg sclerosis $=$ medial calcification\n4. Hypertensive arteriosclerosis\n\nTemporal course of carotid artery stenosis:\n\n1. Stable stenosis $(68 \\%)$\n2. Progressive stenosis to $>50 \\%$ diameter reduction ( $25 \\%$ )\n\nAngiography:\n@ Extracranial\n$\\sqrt{ }$ smooth asymmetrical excrescence encroaching upon vessel lumen\n$\\sqrt{ }$ crater / niche $=$ ulceration\n$\\sqrt{ }$ mound within base of crater $=$ mural thrombus\n$\\sqrt{ }$ Holman \"carotid slim\" sign = diffuse narrowing of entire contrasted ICA distal to high-grade stenosis $\\leftarrow$ decrease in perfusion pressure\n$\\sqrt{ }$ occlusion of ICA\n@ Intracranial\n$\\sqrt{ }$ carotid siphon stenosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 248,
            "markdown": "$\\sqrt{ }$ retrograde flow in ophthalmic artery filled via ECA\n$\\sqrt{ }$ small vessel occlusion\n$\\sqrt{ }$ focal areas of slow flow\n$\\sqrt{ }$ early draining vein $=$ reactive hyperemia $=$ \"luxury perfusion\" $\\leftarrow$ shunting between arterioles + venules surrounding an area of ischemia\n$\\sqrt{ }$ ICA-MCA slow flow $=$ delayed arrival + washout of ICA-MCA distribution in comparison to ECA\nCarotid endarterectomy:\nBenefit: $17 \\%$ reduction of ipsilateral stroke at 2 years in patients with $>70 \\%$ carotid stenosis (NASCET $=$ North American Symptomatic Carotid Endarterectomy Trial)\nRisk: $1 \\%$ mortality; $2 \\%$ risk of intraoperative neurologic deficit\n\n| Predilection Sites of Arterial Stenosis |  |  |\n| :-- | :--: | :--: |\n|  | Incidence of Lesions |  |\n|  | Stenosis | Occlusion |\n| Right ICA origin | $33.8 \\%$ | $8.6 \\%$ |\n| Left ICA origin | $34.1 \\%$ | $8.7 \\%$ |\n| Right vertebral artery origin | $18.4 \\%$ | $4.8 \\%$ |\n| Left vertebral artery origin | $22.3 \\%$ | $2.2 \\%$ |\n| Right carotid siphon | $6.7 \\%$ | $9.0 \\%$ |\n| Left carotid siphon | $6.6 \\%$ | $9.2 \\%$ |\n| Basilar artery | $7.7 \\%$ | $0.8 \\%$ |\n| Right MCA | $3.5 \\%$ | $2.2 \\%$ |\n| Left MCA | $4.1 \\%$ | $2.1 \\%$ |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 249,
            "markdown": "![img-36.jpeg](img-36.jpeg)\n\n# Carotid Duplex Ultrasound \n\nIndications for carotid duplex US:\n(1) Screening for suspected extracranial carotid disease\n(a) high-grade flow-limiting stenosis\n(b) low-grade stenosis with hemorrhage\n(2) Nonhemispheric neurologic symptomatology\n(3) History of transient ischemic attack / stroke\n(4) Asymptomatic carotid bruit\n(5) Retinal cholesterol embolus\n(6) Preoperative evaluation before major cardiovascular surgery\n(7) Intraoperative monitoring of vascular patency during endarterectomy\n(8) Sequential evaluation after endarterectomy\n(9) Monitoring of known plaque during medical treatment\n\n## Grading of Internal Carotid Stenosis\n\n$=$ severity of stenosis is primarily graded as a ratio of lumen diameter narrowing NOT reduction in cross sectional area",
            "images": [
                {
                    "id": "img-36.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 189,
                    "bottom_right_x": 1339,
                    "bottom_right_y": 1047,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 250,
            "markdown": "| Decrease in Luminal Diameter vs. Cross-sectional Area |  |\n| :--: | :--: |\n| Decrease in <br> Lumen Diameter | Decrease in <br> Cross-sectional Area |\n| $20 \\%$ | $36 \\%$ |\n| $40 \\%$ | $64 \\%$ |\n| $60 \\%$ | $84 \\%$ |\n| $80 \\%$ | $96 \\%$ |\n\nLimitations of assessment by US:\n\n1. Calcification $>1 \\mathrm{~cm}$ in length obscures vessel lumen\n$\\diamond$ A jet associated with a stenosis of $>70 \\%$ usually travels at least 1 cm downstream allowing conclusion about degree of obscured stenosis!\n2. Contralateral high-grade stenosis\n$=$ ipsilateral ICA functions as collateral $\\rightarrow$ increased blood flow velocities\n$\\diamond$ Use velocity ratios to compensate for this effect!\n3. Tortuosity of artery\n4. Increased depth of artery\n5. \"High\" bifurcation $\\rightarrow$ possibly obscured by mandible\n![img-37.jpeg](img-37.jpeg)\n\nAccuracy of duplex scans (compared to arteriography) for ICA lesions:",
            "images": [
                {
                    "id": "img-37.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 946,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1920,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 251,
            "markdown": "$91-94 \\%$ sensitivity, $85-99 \\%$ specificity, $90-95 \\%$ accuracy for $>50 \\%$ ICA diameter stenosis\nA. NORMAL ( $0 \\%$ diameter reduction)\n$\\sqrt{ }$ no evidence of plaque\n$\\sqrt{ }$ peak systolic velocity (PSV) $<125 \\mathrm{~cm} / \\mathrm{sec}$\n$\\sqrt{ }$ no spectral broadening (= clear window under systole)\nB. MINIMAL DISEASE ( $0-15 \\%$ diameter reduction)\n$\\sqrt{ }$ minimal amount of plaque\n$\\sqrt{ }$ PSV $<125 \\mathrm{~cm} / \\mathrm{sec}$\n$\\sqrt{ }$ minimal spectral broadening in deceleration phase of systole\nC. MODERATE DISEASE ( $16-49 \\%$ diameter reduction)\n$\\sqrt{ }$ moderate amount of plaque\n$\\sqrt{ }$ peak systole $<125 \\mathrm{~cm} / \\mathrm{sec}$\n$\\sqrt{ }$ end-diastolic velocity (EDV) $<40 \\mathrm{~cm} / \\mathrm{sec}$\n$\\sqrt{ }$ poststenotic spectral broadening throughout systole\nD. SEVERE DISEASE = hemodynamically SIGNIFICANT LESION\n(a) $50-69 \\%$ stenosis\n$\\sqrt{ }$ PSV $125-230 \\mathrm{~cm} / \\mathrm{sec}$\n$\\sqrt{ }$ EDV $40-100 \\mathrm{~cm} / \\mathrm{sec}$\n(b) $>70 \\%$ stenosis ( $\\rightarrow$ benefit of endarterectomy documented in NASCET study)\n$\\sqrt{ }$ peak systole $>230 \\mathrm{~cm} / \\mathrm{sec}$\n$\\sqrt{ }$ end diastole $>100 \\mathrm{~cm} / \\mathrm{sec}$\n$\\sqrt{ }$ peak systolic velocity ratio of ICA+CCA $>4.0$\nE. CRITICAL STENOSIS ( $>95 \\%$ diameter reduction)\n$\\sqrt{ }$ PSV + EDV return to normal range / flow undetectable\n$\\sqrt{ }$ \"string\" sign on color Doppler with slow-flow sensitivity setting\nF. OCCLUSION\n$\\sqrt{ }$ NO signal in ICA on longitudinal / transverse images (color sensitivity + velocity scale must be set low enough to clearly discern flow signals within internal jugular vein)\n$\\sqrt{ }$ absence of diastolic flow / diastolic flow reversal in CCA (= high impedance flow)\n$\\sqrt{ }$ increased diastolic flow in ECA (if ECA assumes the role of primary supplier of blood to brain)\n$\\sqrt{ }$ increase in peak systolic velocities in contralateral ICA $\\leftarrow$ collateral flow\n\n# Common Carotid Waveform Analysis \n\nA. DISTAL OBSTRUCTION\n$\\sqrt{ }$ high-pulsatility waveform\n$\\diamond$ Pulsatility changes occur only with $>80 \\%$ stenosis\n$\\sqrt{ }$ reduced amplitude\nB. PROXIMAL OBSTRUCTION\n$\\sqrt{ }$ low-amplitude damped waveform\n\n## Hemodynamic Variations of Carotid Stenosis\n\nA. MORPHOLOGY OF STENOSIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 252,
            "markdown": "1. Degree of stenosis: velocities increase up to a luminal diameter of $1.0-1.5 \\mathrm{~mm}$\n2. Length of stenosis: peak velocities decrease with length of stenosis\n$\\sqrt{ }$ use the same angle + beam steering direction when following a patient for disease progression\n\n# B. PHYSIOLOGIC VARIABILITY \n\n$\\diamond$ A range of velocities may be encountered with a given degree of stenosis!\n$\\diamond \\mathrm{ICA}+\\mathrm{CCA}$ ratio obviates effects of physiologic variability!\n$\\diamond$ Compare left with right waveforms to avoid errors!\n$\\diamond$ Measure volume flow (more sensitive because of contralateral compensatory flow increase)\nCause:\n\n1. Cardiac output\n2. Pulse rate\n3. Flow velocity: $\\uparrow$ with obstruction in collateral vessels, $\\downarrow$ with proximal obstruction in same vessel\n4. Normal helical nature of blood flow with many different velocity vectors + nonaxial blood flow NOT detectable by color Duplex imaging\n5. Peripheral resistance\n6. Arterial compliance\n7. Hypertension\n8. Blood viscosity\n\n| Doppler Spectrum Analysis <br> (Consensus Conference of Society of Radiologists in Ultrasound 2002) |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| Diameter Stenosis <br> $(\\%)$ | ICA Peak Systolic Velocity <br> (cm/sec) | ICA/CCA Peak Systolic <br> Velocity Ratio | ICA End-Diastolic Velocity <br> (cm/sec) | Plaque |\n| Normal | $<125$ | $<2.0$ | $<40$ | none |\n| $<50$ | $<125$ | $<2.0$ | $<40$ | $<50 \\%$ diameter reduction |\n| $50-69$ | $125-230$ | $2.0-4.0$ | $40-100$ | $\\geq 50 \\%$ diameter reduction |\n| $>70$ | $>230$ | $>4.0$ | $>100$ | $\\geq 50 \\%$ diameter reduction |\n| Critical stenosis | low / undetectable | variable | variable | massive, detectable lumen |\n| Occlusion | undetectable | not applicable | undetectable | no detectable lumen |\n\n## Carotid Plaque\n\n1. Asymptomatic patients with diffuse atherosclerotic disease:\n\nPrevalence of $>50 \\%$ stenosis: $18-20 \\%$\n2. Symptomatic patients with stroke, TIA, amaurosis fugax $\\leftarrow$ emboli from atheromas at carotid bifurcation\nPrevalence of $>50 \\%$ stenosis: $14 \\%$\n\n## Formation Theory of Carotid Plaque\n\n1. Stagnant eddy that rotates at outer vessel margin (away from and opposite to flow divider $=$ area of flow separation + low shear stress) $\\rightarrow$ net influx of fluid into subendothelial tissue with progressive deposition of lipids + smooth muscle cell proliferation\n2. Increased likelihood of intraplaque hemorrhage $\\leftarrow$ vascularization of plaque with fragile vessels derived from vasa vasorum / from lumen) + fissuring at a critical size $\\diamond$ As the degree of stenosis increases, it is more likely that plaques become denser +",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 253,
            "markdown": "more heterogeneous demonstrating an irregular luminal surface!\n\n# Density of Carotid Plaque \n\n1. Hypoechoic = low-echogenicity plaque\n$=$ fibrofatty plaque / hemorrhage\n$\\sqrt{ }$ echogenicity less than sternocleidomastoid muscle\n$\\sqrt{ }$ flow void / flow disturbance on color Duplex\n2. Isoechoic plaque\n$=$ smooth muscle cell proliferation / laminar thrombus\n$\\sqrt{ }$ echogenicity equal to sternocleidomastoid muscle + lower than adventitia\n3. Hyperechoic = moderately echogenic (fibrous) plaque\n$\\sqrt{ }$ echogenicity higher than sternocleidomastoid muscle + similar to adventitia\n4. Calcification $=$ strongly echogenic plaque\n$\\sqrt{ }$ acoustic shadow impairs visualization of intima\n\n## Texture of Carotid Plaque\n\n1. Homogeneous (stable) plaque\n\nHisto: deposition of fatty streaks + fibrous tissue; rarely shows intraplaque hemorrhage / ulcerations\n$\\sqrt{ }$ homogeneous uniform echo pattern with smooth surface (acoustic impedance similar to blood)\n2. Heterogeneous (unstable) plaque\n$=$ mixture of high, medium, and low-level echoes with smooth / irregular surface; may fissure / tear resulting in intraplaque hemorrhage / ulceration + thrombus formation $\\rightarrow$ embolus / increasing stenosis\nB-mode ultrasound has $90-94 \\%$ sensitivity, $75-88 \\%$ specificity, $90 \\%$ accuracy for intraplaque hemorrhage!\nMRI depicts intraplaque hemorrhage (methemoglobin) on T1 fat-suppressed SPGR / FLASH sequence\nHisto: lipid-laden macrophages, monocytes, leukocytes, necrotic debris, cholesterol crystals, calcifications\n$\\sqrt{ }$ anechoic areas within plaque ( $=$ hemorrhage / lipid deposition / focal plaque degeneration)\n$\\sqrt{ }$ heterogeneous complex echo pattern\n\n| Plaque Texture vs. Prognosis |  |  |\n| :-- | :--: | :--: |\n| Consequences | Homogeneous | Heterogeneous |\n| Neurologic deficit | $4 \\%$ | $27 \\%$ |\n| Ipsilateral infarction by CT | $12 \\%$ | $24 \\%$ |\n| Ipsilateral symptoms | $22 \\%$ | $50 \\%$ |\n| Progressive stenosis | $18 \\%$ | $77 \\%$ |\n\n## Surface Characteristics of Carotid Plaque\n\n$\\diamond$ US unreliable due to poor visualization of intima\n4 Categories: > smooth",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 254,
            "markdown": "```\n) mildly irregular\n> markedly irregular\n    > ulcerated\n1. Intimal thickening\n    Histo: fatty streaks\n    \\(\\sqrt{ }\\) wavy / irregular line paralleling vessel wall extending \\(>1 \\mathrm{~mm}\\) into vessel lumen\n2. Ulcerated plaque\n    Accuracy: \\(60 \\%\\) sensitive, \\(60-70 \\%\\) specific\n    \\(\\diamond\\) The presence of intraplaque hemorrhage is much more common than normally\n        appreciated (neither arteriography nor US has proved reliable)!\n    \\(\\sqrt{ }\\) isolated crater of \\(>2 \\mathrm{~mm}\\) within surface of plaque demonstrated on transverse +\n        longitudinal images\n    \\(\\sqrt{ }$ reversed flow vortices extending into plaque crater demonstrated by color Doppler\n    \\(\\sqrt{ }\\) proximal + distal undercutting of plaque\n    \\(\\sqrt{ }$ anechoic area within plaque extending to surface\n```\n\n\n# Errors In Duplex Ultrasound \n\n1. Error in proper localization of stenosis (6\\%)\n\nCause: ECA stenosis placed into ICA / carotid bifurcation or vice versa\n2. Mistaking patent ECA branches for carotid bifurcation (4\\%)\n\nCause: complete occlusion of ICA not recognized\n$\\sqrt{ }$ disparity in position of bifurcation between left and right\n$\\sqrt{ }$ no difference in waveform pulsatility\n$\\sqrt{ }$ high-resistance waveform in CCA\n3. Interpreter error in estimating severity of stenosis (2.5\\%):\n» usually overestimation, rarely underestimation\n$\\sqrt{ }$ absence of one / more components for diagnosis which are\n(a) significant elevation of peak velocity\n(b) poststenotic turbulence\n(c) extension of high velocity into diastole\n4. Superimposition of ECA + ICA (2\\%)\n\nCause: strict coronal orientation of ECA + ICA\n$\\sqrt{ }$ superimposition can be avoided by rotation of patient's head to opposite side\n5. Severe stenosis mistaken for occlusion\n$\\sqrt{ }$ minimal flow not detectable\n$\\sqrt{ }$ angiogram necessary with delayed images\n6. Weak signals misinterpreted as occlusion\n7. Normal / weak signals in severe stenosis\n\nCause: severe stenosis causes a decrease in blood flow and peak velocity $\\rightarrow$ return to normal velocity levels\n$\\sqrt{ }$ high resistivity in CCA\n8. Point of maximum frequency shift not identified\n\nCause: extremely small lumen / short segment of stenosis\n$\\sqrt{ }$ unexplained (poststenotic) coarse turbulence",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 255,
            "markdown": "$\\checkmark$ collateral flow in ipsilateral ECA\n$\\checkmark$ abnormal CCA resistivity\n9. Stenosis obscured by plaque / strong Doppler shift in overlying vessel\n10. Inaccessible stenosis\n$\\checkmark$ abnormal CCA resistivity\n$\\checkmark$ abnormal oculoplethysmography\n11. Unreliable velocity measurements\n(a) higher velocities: HTN, severe bradycardia, obstructive contralateral carotid disease, anemia, hyperthyroidism\n(b) lower velocities: arrhythmia, aortic valvular lesion, CHF, severe cardiomyopathy, proximal obstructive carotid lesion (\"tandem lesion\"), > 95\\% ICA stenosis\n(c) aliasing = high velocities are displayed in reversed direction below zero baseline due to Doppler frequency exceeding half the pulse repetition frequency\nRemedy: shift zero baseline; increase pulse repetition frequency; increase Doppler angle; decrease transducer frequency; use continuous-wave Doppler probe\n(d) misalignment of Doppler \"Angle Correct\" cursor\n$=$ cursor not aligned with blood stream line introducing a wrong Doppler angle\n$\\diamond$ Doppler angle larger than actual angle means velocity measurement are higher than actual velocity!\n\n| Error in Doppler \"Angle Correct Cursor\" Alignment <br> at an Actual Velocity of $50 \\mathrm{~cm} / \\mathrm{sec}$ |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Actual <br> Angle | Erroneous <br> Angle | Estimated <br> Velocity | Percent <br> Error |\n| $0^{\\circ}$ | $5^{\\circ}$ | $50.2 \\mathrm{~cm} / \\mathrm{sec}$ | $0.4 \\%$ |\n| $20^{\\circ}$ | $25^{\\circ}$ | $51.8 \\mathrm{~cm} / \\mathrm{sec}$ | $3.6 \\%$ |\n| $40^{\\circ}$ | $45^{\\circ}$ | $54.2 \\mathrm{~cm} / \\mathrm{sec}$ | $8.4 \\%$ |\n| $60^{\\circ}$ | $65^{\\circ}$ | $59.2 \\mathrm{~cm} / \\mathrm{sec}$ | $18.3 \\%$ |\n| $80^{\\circ}$ | $85^{\\circ}$ | $99.6 \\mathrm{~cm} / \\mathrm{sec}$ | $99.0 \\%$ |\n\n# CHOANAL ATRESIA \n\n$\\diamond$ Most common cause of neonatal nasal obstruction!\nFrequency: $1 \\div 5,000$ to $1 \\div 8,000$ neonates; $\\mathrm{M}<\\mathrm{F}$\nEtiology: failure of perforation of buccopharyngeal + oronasal membrane, which normally perforates by $7^{\\text {th }}$ week EGA\nAssociated anomalies (in 50-75\\%):\nacrophalyngosyndactyly, amniotic band syndrome, malrotation of bowel, Crouzon syndrome, fetal alcohol syndrome, DiGeorge syndrome, Treacher-Collins syndrome, chromosome 18 / 12 anomalies, polydactyly, coloboma, facial cleft, CHD, tracheoesophageal fistula, craniosynostosis\nLocation: bilateral+unilateral atresia $=3 \\div 2$ to $2 \\div 1$\n\n- respiratory distress in bilateral choanal atresia (relieved by crying in neonates who are obligatory nasal breathers during first 2-6 months)\n- nasal stuffiness, rhinorrhea, infection in unilateral choanal atresia\n\nTypes:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 256,
            "markdown": "# A. OSSEOUS / BONY SEPTATION (85-90\\%) \n\nCause: incomplete canalization of choanae\n$\\sqrt{ }$ fusion of hard palate + vomer + ventral clivus with nasopharyngeal atresia\nB. MEMBRANOUS SEPTATION ( $10-15 \\%$ )\n\nCause: incomplete resorption of epithelial plugs\nC. OSSEOMEMBRANOUS\n\nCT (preceded by vigorous suctioning + administration of topical decongestant):\n$\\sqrt{ }$ narrowing of choanal orifice to a width of $<3.4-3.7 \\mathrm{~mm}$ (in children $<2$ years of age)\n$\\sqrt{ }$ inward bowing of posterior maxilla\n$\\checkmark$ deviation / bowing of nasal septum\n$\\checkmark$ fusion / thickening of vomer\n$\\checkmark$ bone / soft-tissue septum extending across posterior choanae\n$D x$ : nasal catheter cannot be advanced to beyond 32 mm\n$C x$ : bilateral choanal atresia is LIFE-THREATENING\n$R x$ : endoscopic perforation, choanal reconstruction\n\n## CHOLESTEATOMA\n\n$=$ KERATOMA $=$ EPIDERMOID\n$=$ epithelium-lined sac characterized by accumulation of desquamated keratin epithelium $\\rightarrow$ bone destruction by pressure + increase in osteoclastic activity\nLocation: middle ear cavity, other pneumatized portions of temporal bone\nHisto: (a) acellular keratin debris $=$ content of sac\n(b) matrix = biologically active sac lining consisting of\n> inner layer of keratinizing squamous epithelium\n> outer layer of subepithelial connective tissue (= perimatrix) producing proteolytic enzymes $\\rightarrow$ bone resorption\n$\\sqrt{ }$ NO enhancement\n\n- pearly white lesion diagnosed otoscopically in $95 \\%$\n\nCx: (1) Infection $\\rightarrow$ malodorous discharge\n(2) Erosion of ossicular chain, scutum, mastoid bone, Körner septum\n\nDDx of soft-tissue attenuation:\n(1) Fluid attenuation of chronic otitis media\n(2) Inflammation / infection ( NO restricted diffusion)\n\n## Primary Cholesteatoma (2\\%)\n\n$=$ CONGENITAL CHOLESTEATOMA $=$ EPIDERMOID CYST\n$=$ derived from aberrant embryonic ectodermal rests in temporal bone (commonly petrous apex) / epidural space / meninges\n\n- conductive hearing loss (hypoacusis) in child with NO history of otorrhea, membrane perforation, otologic procedure\n- cholesteatoma seen through intact tympanic membrane (usually difficult due to stenosis of EAC)\nAssociated with: dysplasia / atresia / stenosis of EAC /middle ear cavity\nLocation:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 257,
            "markdown": "(a) epitympanum (commonly in anterior superior quadrant of middle ear cavity just above opening of eustachian tube)\n(b) petrous pyramid: internal auditory canal first involved\n(c) meninges: scooped out appearance of petrous ridge\n(d) cerebellopontine angle: erosion of porus, shortening of posterior canal wall\n(e) jugular fossa: erosion of posteroinferior aspect of petrous pyramid\n$C x$ : facial palsy, mastoiditis, intracranial disease\n\n# Secondary Cholesteatoma ( $98 \\%$ ) \n\n$=$ INFLAMMATORY CHOLESTEATOMA $=$ ACQUIRED EPIDERMOID\nPathophysiology:\n(a) invagination theory = eustachian tube dysfunction $\\rightarrow$ vacuum phenomenon in middle ear cavity $\\rightarrow$ formation of posterosuperior retraction pocket in pars flaccida $\\rightarrow$ repeated episodes of ear inflammation (= chronic otitis media)\n(b) epithelial invasion theory = marginal perforation of eardrum $\\rightarrow$ ingrowth of keratinizing stratified squamous epithelium\nLocation: middle ear cavity\nAge: usually $>40$ years\n\n- chronic foul-smelling otorrhea\n- facial paralysis $\\leftarrow$ compression of nerve VII at geniculate ganglion\n- conductive hearing loss $\\leftarrow$ compromise of CN VIII in internal auditory canal / involvement of cochlea or labyrinth\n- severe vertigo (labyrinthine fistula)\n\n\n## Type:\n\n1. Pars flaccida cholesteatoma ( $80 \\%$ )\n$=$ PRIMARY ACQUIRED CHOLESTEATOMA\n$=$ Attic cholesteatoma\nSite: centered in Prussak space (pars flaccida invaginates toward Prussak space)\n$\\sqrt{ }$ rounded expansile lobulated lesion\n$\\sqrt{ }$ increasing width of attic\n$\\sqrt{ }$ initially destruction of lateral wall of attic, particularly erosion of drum spur (scutum)\n$\\sqrt{ }$ medial displacement + erosion of auditory ossicles\n$\\sqrt{ }$ extension superiorly into attic + mastoid air cells through aditus ad antrum\n$\\sqrt{ }$ destruction of Körner septum\n2. Pars tensa cholesteatoma ( $20 \\%$ )\n$=$ SECONDARY ACQUIRED CHOLESTEATOMA\nSite: centered in sinus tympani / facial recess\n$\\sqrt{ }$ lateral displacement of auditory ossicles\n$\\sqrt{ }$ erosion of ossicular chain: first affecting long process of incus\nCT:\n$\\sqrt{ }$ nondependent homogeneous mass\n$\\sqrt{ }$ perforation of tympanic membrane posterosuperiorly (= pars flaccida)\n$\\sqrt{ }$ poorly pneumatized mastoid (frequent association)\n$\\sqrt{ }$ erosion of tegmen tympani (with more extensive cholesteatoma) $\\rightarrow$ extradural mass $\\pm$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 258,
            "markdown": "formation of meningoencephalocele\n$\\sqrt{ }$ destruction of labyrinthine capsule (less common) involving the lateral semicircular canal first $\\rightarrow$ labyrinthine / perilymphatic fistula\n$\\sqrt{ }$ erosion of bony facial canal in its tympanic / mastoid pars\nMR (adjunct to CT ONLY if doubt in diagnosis):\n$\\sqrt{ }$ iso- / hypointense relative to cortex on T1WI\nCAVE: occasional T1-hyperintensity similar to \"white\" epidermoid cyst $\\leftarrow$ high protein content\n$\\sqrt{ }$ mildly hyperintense lesion on T2WI + FLAIR\n$\\sqrt{ }$ restricted diffusion (highly hyperintense) on DWI $\\leftarrow$ high keratin content\n$F N$ : mural / evacuated cholesteatoma, lesion $<2-3 \\mathrm{~mm}$\nFP: residual hemorrhage after recent surgery; silastic sheet; bone pâté; cerumen in EAC; cholesterol granuloma; artifact $\\leftarrow$ dental brace; middle ear / mastoid abscess\n$\\sqrt{ }$ relatively hypointense ADC map (DDx: cholesterol granuloma very hyperintense)\n$\\sqrt{ }$ NO delayed enhancement 45-60 min after Gd-DTPA (DDx: cholesterol granuloma enhances $\\leftarrow$ inflammatory / granulation / scar tissue)\nCx: (1) Intratemporal: ossicular destruction; facial nerve paralysis (1\\%); labyrinthine fistula; automastoidectomy; complete hearing loss\n(2) Intracranial: meningitis; cerebritis; subdural / epidural empyema; temporal lobe abscess; sigmoid sinus thrombosis; CSF rhinorrhea\n$R x$ : canal-wall-down / canal-wall-up tympanoplasty with recurrence rates of $7 \\%$ and $20 \\%$, respectively\n$D D x$ : chronic otitis media; granulation tissue (= cholesterol granuloma); brain herniation through tegmen defect; neoplasm (rhabdomyosarcoma, squamous cell carcinoma)\n\n# Cholesteatoma of External Auditory Canal \n\nIncidence: $0.1-0.5 \\%$\nCause: spontaneous (most), prior trauma, surgery, radiation\nPath: local invasion of EAC by squamous epithelial lining into underlying bone $\\rightarrow$ periostitis, canal wall erosion\nAge: older age group\n\n- chronic dull pain, otorrhea\n\nCT:\n$\\sqrt{ }$ focal soft-tissue within EAC (typically inferior wall)\n$\\sqrt{ }$ canal wall erosion into underlying bone\n$D D x$ : carcinoma, otitis externa\n\n## CHOLESTEROL GRANULOMA\n\n$=$ CHOLESTEROL CYST\n$=$ acquired benign chronic inflammatory mass in petrous bone\n$\\diamond$ Most common lesion arising in petrous apex!\nPathophysiology:\nmucosal edema $\\rightarrow$ exposure of bone marrow $\\rightarrow$ hemorrhage + obstruction $\\rightarrow$ breakdown of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 259,
            "markdown": "erythrocytes + tissue $\\rightarrow$ release of cholesterol $\\rightarrow$ foreign body giant cell reaction (= chronic granuloma) $\\rightarrow$ cyst formation + bone expansion\nHisto: cholesterol crystals surrounded by foreign-body giant cells; embedded in fibrous connective tissue with varying proportions of hemosiderin-laden macrophages, chronic inflammatory cells and blood vessels; brownish cyst fluid contains cholesterol crystals + blood (= \"chocolate cyst\" = \"blue-domed cyst\")\nLocation: in pneumatized petrous apex; (occasionally in)mastoid segment, middle ear, orbitofrontal region\n\n- blue (vascular) tympanic membrane without pulsatile tinnitus\n- hemotympanum; conductive hearing loss, headache\n- long-standing history of otitis media\n$\\checkmark$ bone gaps $\\leftarrow$ bone remodeling\n$\\checkmark$ ossicles remain intact\n$\\checkmark$ NO enhancement\nCT:\n$\\checkmark$ expansile homogeneous middle ear lesion with smooth well-defined / imperceptible bone margins\n$\\checkmark$ nonenhancing mass\nMR:\n$\\checkmark$ hyperintense signal on T1WI $\\leftarrow$ methemoglobin\n$\\checkmark$ heterogeneously hyperintense signal on T2WI $\\leftarrow$ cholesterol crystals + methemoglobin from repeated hemorrhage\n$\\checkmark$ remains hyperintense with fat-suppression\n$\\checkmark \\pm$ hypointense rim on T2WI $\\leftarrow$ hemosiderin deposition / preserved rim of bone\n$D D x$ : (1) Asymmetric petrous apex pneumatization (hyperintense fatty marrow on T1WI, hypointense with fat suppression)\n(2) Petrous apex effusion (no expansion / destruction of petrous air cells)\n(3) Cholesteatoma (isointense to brain on T1WI)\n$R x$ : conservative Rx for asymptomatic lesion; surgical drainage / cyst resection for large symptomatic lesion\n$\\diamond$ Loss of T1-hyperintensity after successful drainage!\n\n\n# CHRONIC SIALADENITIS \n\n- often painful intermittent swelling of gland\n$\\checkmark$ normal-sized / small hypoechoic heterogeneous texture\n$\\checkmark$ multiple small round / oval hypoechoic areas\n\n\n## Chronic Sclerosing Sialadenitis\n\n$=$ KÜTTNER TUMOR $=$ IgG4-RELATED SIALADENITIS\n[Hermann Küttner (1870-1932), German surgeon in Breslau]\n$=$ non-neoplastic uni / bilateral hard swelling of submandibular gland considered part of IgG4-related disease\nHisto: markedly fibrous sclerotic lesion containing IgG4-positive plasma cells\n$\\checkmark$ diffuse / focal swelling of both submandibular glands",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 260,
            "markdown": "US:\n$\\sqrt{ }$ multiple small hypoechoic foci scattered on a heterogeneous background of salivary tissue\nCT:\n$\\sqrt{ }$ homogeneous attenuation\nMR:\n$\\sqrt{ }$ low to intermediate SI on T2WI\n$\\sqrt{ }$ intermediate SI on T1WI + homogeneous enhancement\n$D D x$ : lymphoma, acute Sjögren syndrome\n\n# Granulomatous Sialadenitis \n\nOrganism: TB, actinomycosis\n$\\sqrt{ }$ single / multiple hypoechoic areas in enlarged / normal-sized gland of diffusely low echogenicity\n$\\sqrt{ } \\pm$ increased blood flow\n\n## COGAN SYNDROME\n\n$=$ AUTOIMMUNE INTERSTITIAL KERATITIS\n$=$ rare autoimmune multisystem disease characterized by nonsyphilitic interstitial keratitis + audiovestibular dysfunction + vascular inflammation\nAge: young white adult\n\n- eye redness. photophobia, eye pain (from interstitial keratitis)\n- audiovestibular manifestations (similar to Ménière syndrome)\n- nerve deafness\n@ Cardiovascular ( $10-15 \\% \\%$ )\nHisto: prominent lymphocytic infiltration of aortic wall, destruction of media elastica, fibrosis, aneurysm formation, neovascularization\n$\\sqrt{ }$ aortitis $\\rightarrow$ aortic insufficiency\n$\\sqrt{ }$ necrotizing vasculitis $\\rightarrow$ coronary / iliac / renal artery stenosis\n@ CNS (29\\%)\n- psychosis, headache, convulsion, stroke, coma\n$\\sqrt{ }$ ischemic change or infarction, meningoencephalitis, cerebral venous sinus thrombosis, cranial neuropathy\nMR:\n$\\sqrt{ }$ membranous labyrinthine obliteration / narrowing\n$\\sqrt{ }$ enhancement of membranous labyrinth\n\n\n## CONGENITAL ATRESIA OF EAC\n\n$=$ failure of EAC to fully develop\nPrevalence: $\\sim 1 \\div 10,000$\nOften associated with: abnormalities of pinna\nClassification: osseous / membranous / mixed\nLocation: unilateral > bilateral\nImaging assessment:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 261,
            "markdown": "(1) Size + pneumatization of middle ear\n(2) Abnormalities of ossicles\n(3) Location of mastoid segment of facial nerve (often displaced anteriorly)\n\n# CROUP \n\n$=$ ACUTE LARYNGOTRACHEOBRONCHITIS $=$ ACUTE VIRAL SPASMODIC LARYNGITIS\n$=$ lower respiratory tract infection\n$\\diamond$ Most common cause of airway obstruction in young children!\nOrganism: parainfluenza, respiratory syncytial virus\nSeason: fall and winter months\nAge: $>6$ months of age; peak incidence $2-3$ years\n\n- prodromal symptoms of viral infection\n- \"brassy / barking\" cough $\\rightarrow$ worse at night and while crying\n- inspiratory difficulty with stridor, fever, hoarse cry\n$\\sqrt{ }$ thickening of vocal cords\n$\\sqrt{ }$ distension of cervical trachea on expiration\nAP radiograph (most helpful image):\n$\\sqrt{ }$ \"steeple\" / subglottic \"inverted V\" sign = symmetrical funnel-shaped narrowing $1-1.5 \\mathrm{~cm}$ below lower margins of pyriform sinuses ( $=$ loss of lateral convexities / normal \"shouldering\" of air column)\nCause: subglottic mucosal edema affecting most severely the conus elasticus + external restriction by cricoid\n$\\sqrt{ }$ accentuated on expiration\n$\\sqrt{ }$ paradoxical inspiratory collapse $\\rightarrow$ less pronounced during expiration\nLAT radiograph:\n$\\sqrt{ }$ NORMAL epiglottis + aryepiglottic folds ( $\\rightarrow$ NO epiglottitis)\n$\\sqrt{ }$ subglottic narrowing + increased density of subglottic region\n$\\sqrt{ }$ narrow + indistinct subglottic trachea\n$\\sqrt{ }$ inspiratory ballooning of hypopharynx ( $=$ nonspecific sign of any acute upper airway obstruction)\n$D D x$ : normal at end of inspiratory phase in a crying child\nWith clinically suspected croup imaging is performed to determine if another cause of inspiratory stridor is present.\nViral croup is unlikely to occur in children $>3$ years of age. With radiographic findings of croup outside this age range, consider membranous croup and foreign-body aspiration.\nPrognosis: usually self-limiting\nRx: supportive\n\n\n## DERMOID / EPIDERMOID OF HEAD AND NECK\n\n$=$ benign congenital or acquired (eg, posttraumatic) inclusions of dermal elements at site of embryonic $1^{\\text {st }}+2^{\\text {nd }}$ branchial arches\n$\\diamond$ Dermoids of the head and neck comprise $7 \\%$ of all dermoids\nDefinition:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 262,
            "markdown": "Teratoma $=$ neoplasm whose tissue is foreign to the part of the body from which the tumor arises\n\n# Teratoid cyst \n\nOrigin: ectoderm + mesoderm + endoderm\nHisto: inclusion cyst lined by squamous / respiratory epithelium containing derivatives of ectoderm + endoderm + mesoderm (skin appendages, nervous / GI / respiratory tissue)\n\n## Dermoid cyst\n\nOrigin: ONLY ectoderm = epidermis + dermal substructure of subcutaneous tissue + skin appendages ( $=$ annexa consisting of hair follicles, sebaceous glands, sweat glands)\nHisto: inclusion cyst lined by a thick keratinizing squamous epithelium containing a variable number of skin appendages $\\pm$ dystrophic calcifications; lumen filled with keratin + sebaceous material + hair (occasionally)\nPath: cheesy tumor, fat content often collects in globules\n$\\sqrt{ }$ greater signal heterogeneity $\\leftarrow$ combination of solid and cystic elements\n$\\sqrt{ }$ intralesional fat $=$ DISTINGUISHING feature:\n$\\sqrt{ }$ \"sack-of-marbles appearance\" = globules of coalesced fat (nearly PATHOGNOMONIC)\n\n## Epidermoid cyst\n\nOrigin: ONLY epithelial elements WITHOUT skin appendages\nHisto: inclusion cyst lined by thin simple squamous epithelium $\\pm$ calcifications (rarely); lumen filled with debris of keratin and some cholesterol\nPath: \"pearly tumor\" = shiny smooth waxy character\n$\\sqrt{ }$ usually lacks observable solid components\n$\\sqrt{ } \\pm$ CHARACTERISTIC restriction at DWI (= high diffusion + moderately low apparent diffusion coefficient)\nMean age: 30 years (range, $5-50$ years); $\\mathrm{M} \\div \\mathrm{F}=3 \\div 1$\nLocation:\n(1) Periorbital ( $50 \\%$ ): lateral eyebrow (most common)\n(2) Oral cavity ( $25 \\%$ ): floor of mouth ( $12 \\%$ ), root of tongue\n(3) Nasal cavity ( $13 \\%$ )\n(4) Submental: neck\n$\\sqrt{ }$ well-circumscribed lesions of high T2 signal\n$\\sqrt{ } \\mathrm{NO} /$ only rim enhancement\n\n## Nasal Dermoid\n\n$=$ dermal inclusion in cranium through patent suture\nAge: infants (most common)\nAssociated with: craniofacial malformation (in 41\\%)\nLocation: anywhere between glabella (= depressed space between eyebrows above nose) and columella (= fleshy external part of nasal septum); lower third of bridge of nose (most commonly)\n\n- nasal pit (skin dimple) / fistula / fluctuant swelling\n- hair protruding from cyst / sinus tract $(<50 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 263,
            "markdown": "$\\sqrt{ }$ bone defect in cranium (= dermal sinus)\nMR:\n$\\sqrt{ }$ variable nonspecific appearance of sinus $\\pm$ cyst\n$C x$ : infection with abscess in nasal septum\n$D D x$ : normal fat in crista galli / nasal septum\n\n# Cervical Dermoid / Epidermoid Cyst \n\nAge: $2^{\\text {nd }}-3^{\\text {rd }}$ decades; $\\mathrm{M}=\\mathrm{F}$\n\n- slowly growing soft mobile mass in the suprahyoid midline (no movement with tongue protrusion!)\nSite: (a) sublingual space (superior to mylohyoid muscle) = intraoral surgical approach (more frequent)\nType: frequently epidermoid cyst\n(b) submandibular (inferior to mylohyoid muscle) = external surgical approach Type: frequently dermoid cyst\nSize: few mm - up to 12 cm\n$\\sqrt{ }$ thin-walled unilocular mass\nCT:\n$\\sqrt{ }$ homogeneous fluid material of $0-18 \\mathrm{HU}$\n$\\sqrt{ }$ heterogeneous mass $\\leftarrow$ various germinal components\n$\\sqrt{ }$ fluid-fluid level $\\leftarrow$ supernatant lipid\n$\\sqrt{ }$ rim enhancement frequent\nMR:\n$\\sqrt{ }$ hypointense / hyperintense (sebaceous fluid) / isointense relative to muscle on T1WI\n$\\sqrt{ }$ hyperintense on T2WI + internally heterogeneous\nPrognosis: malignant degeneration into squamous cell carcinoma in 5\\%\n$D D x$ : ranula\n\n\n## DISSECTION OF CERVICOCEPHALIC ARTERIES\n\n$=$ CRANIOCERVICAL ARTERIAL DISSECTION\n$=$ hematoma within media splitting off vessel wall $\\rightarrow$ false lumen within media\nIncidence: $5 \\div 100,000$ per year; responsible for $5-20 \\%$ of strokes in young and middle-aged adult\nEtiology:\nA. SPONTANEOUS\n(1) trivial trauma (frequent): nonrecalled minor trauma like coughing, vomiting, sports (bowling, tennis, archery)\n(2) primary arteriopathy (rare): fibromuscular dysplasia (in 15\\%), Marfan syndrome, Ehlers-Danlos syndrome type IV, autosomal dominant polycystic kidney disease, osteogenesis imperfecta type I, cystic medial necrosis, collagen vascular disease, homocystinuria\nIndirect evidence of arteriopathy:\nintracranial aneurysm, widened aortic root, arterial redundancy\nAssociated with: hypertension (36\\%), smoking (47\\%), migraine (11\\%)\nB. TRAUMATIC (rare)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 264,
            "markdown": "severe blunt head and neck trauma / penetrating trauma (automobile accident, boxing, accidental hanging, diagnostic carotid compression, chiropractic cervical manipulation)\n\n| Arteriographic Injury Grading |  |\n| :--: | :--: |\n| Grade | Type of Lesion |\n| I | $\\checkmark$ irregularity of vessel wall <br> $\\checkmark$ dissecting intramural hematoma with $<25 \\%$ stenosis |\n| II | $\\checkmark$ intraluminal thrombus / raised intimal flap <br> $\\checkmark$ small arteriovenous fistula <br> $\\checkmark$ dissection / intramural hematoma $\\geq 25 \\%$ stenosis |\n| III | $\\checkmark$ pseudoaneurysm |\n| IV | $\\checkmark$ occlusion |\n| $\\checkmark$ | $\\checkmark$ transection <br> $\\checkmark$ hemodynamically significant AV fistula |\n\nPathophysiology:\nprimary intramural hematoma / penetration of blood into arterial wall via primary intimal tear $\\rightarrow$ dissection usually extends cranially (same direction as blood stream) $\\rightarrow$ narrowing of vessel lumen + enlargement of external diameter $\\rightarrow$ pseudoaneurysm $=$ dissecting aneurysm (with extension of hematoma into adventitia) $\\rightarrow$ nidus for distal thromboembolism\nLocation: cervical ICA (68\\%), vertebral artery (27\\%), both ICA + vertebral artery (5\\%); multiple simultaneous dissections (28\\%)\nSite: (a) subintimal dissection = close to intima\n(b) subadventitial dissection = close to adventitia\n$\\checkmark$ arterial narrowing / occlusion\n$\\checkmark$ intimal flap\n$\\checkmark$ pseudoaneurysm\n$\\checkmark$ embolic distal branch occlusion of intracranial artery\nUS (low sensitivity due to location, $50 \\%$ accuracy):\n$\\checkmark$ wall hematoma $=$ thickened hypoechoic vessel wall\n(DDx: intraluminal thrombus)\n$\\checkmark$ echogenic intimal flap floating in lumen (rarely depicted)\n$\\checkmark$ echogenic thrombus\nColor Doppler ( $71-95 \\%$ sensitive):\n$\\checkmark$ separation of 2 lumina with different Doppler signals\n$\\checkmark$ dampened / high-resistance Doppler waveform\nDDx of increased ICA flow:\nICA redundancy, fibromuscular dysplasia, vasospasm, brain AVM, carotid cavernous sinus fistula, persistent trigeminal artery, anemia, hyperthyroidism\n$D D x$ of decreased ICA flow:\nipsilateral severe stenosis / occlusion of carotid siphon or intracranial ICA or M1 segment NECT:\n$\\checkmark$ crescent-shaped hyperattenuating acute wall hematoma\nCECT ( $50-100 \\%$ sensitive, $67-100 \\%$ specific):\n$\\checkmark$ target picture $=$ narrow eccentric lumen surrounded by crescent-shaped mural thickening +",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 265,
            "markdown": "peripheral thin annular enhancement (enhancing vasa vasorum)\n$\\sqrt{ }$ increase in external diameter\n$\\sqrt{ }$ intramural hematoma becomes isoattenuating to muscle with correct window settings (DDx: atherosclerotic plaque, thrombus)\n$\\sqrt{ }$ intimal flap\n$\\sqrt{ }$ dissecting aneurysm\n$\\sqrt{ }$ arterial occlusion\nMR (50-100\\% sensitive, 58-99\\% specific):\n$\\sqrt{ }$ cross-sectional T1WI imaging $\\pm$ fat saturation:\n$\\sqrt{ }$ increase in external diameter of artery\n$\\sqrt{ }$ narrowing of lumen\n$\\sqrt{ }$ intramural hematoma:\n$\\sqrt{ }$ isointense to surrounding structures during early / chronic stage\n$\\sqrt{ }$ crescent-shaped hyperintense hematoma around eccentric flow void between 7 days and 2 months\n$\\sqrt{ }$ iso- to hyperintense on T2WI around flow void of artery\n3-D TOF MR angiography:\n$\\sqrt{ }$ pseudoenlargement of lumen in subacute dissection = flow-simulating intramural hematoma\n$D D x$ : pseudodissection (= high SI of turbulent flow in aneurysmal dilatation)\n$R x$ : best therapy not clear; anticoagulation (primary treatment) in absence of subarachnoid hemorrhage / dissecting aneurysm; surgery; endovascular stent placement\n\n# Carotid Artery Dissection \n\n$\\diamond$ Twice as common as vertebral artery dissection!\nFrequency: 2-5-20\\% of strokes in persons aged 40-60 years\nAge: 18-76 years ( $66 \\%$ between 35 and 50 years)\n\n- unremitting unilateral anterior headache ( $47-86 \\%$ ), neck pain ( $25 \\%$ ), facial pain\n- TIA / stroke (49-82\\%), amaurosis fugax (12\\%):\n- completed stroke usually during first 7 days after onset of symptoms, may occur up to 1 month later\n- oculosympathetic paresis = Horner syndrome (52\\%)\n- cranial nerve palsy, bruit (48\\%), pulsatile tinnitus\n\nLocation: cervical ICA usually at level of C1-2 (60\\%) within a few cm of carotid bifurcation $>$ supraclinoid segment of ICA; bilateral carotid dissections (15\\%)\nLength: a few centimeters\nAngiography / DSA (gold standard):\n$\\sqrt{ }$ \"string\" sign = long tapered usually eccentric irregular luminal stenosis beginning distal to carotid bulb + extending to base of skull $(76 \\%)$\n$\\sqrt{ }$ \"string and pearl\" sign = focal narrowing + distal site of dilatation\n$\\sqrt{ }$ abrupt luminal reconstitution at level of bony carotid canal ( $42 \\%$ )\n$\\sqrt{ }$ fingerlike / saccular aneurysm ( $40 \\%$ ), often in upper cervical / subcranial region\n$\\sqrt{ }$ intimal flap (29\\%)\n$\\sqrt{ }$ double-barrel lumen similar to aortic dissection (rare)\n$\\sqrt{ }$ slow ICA-MCA flow",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 266,
            "markdown": "$\\sqrt{ }$ tapered \"flamelike\" / \"radish taillike\" occlusion (17\\%) that spares the carotid bulb\nCx: (1) Thromboemboli due to stenosis\n(2) Subarachnoid hemorrhage (with intracranial location)\n(3) Secondary aneurysm\n\nPrognosis: complete / excellent recovery (8\\%) with normalization in a few months; worsening in $10 \\%$\n$D D x$ :\n(1) Fibromuscular dysplasia (\"string of beads\" sign, young woman, adjacent to C1-2, bilateral in $65 \\%$ )\n(2) Dysgenesis of ICA (hypoplastic / absent carotid canal)\n(3) Atherosclerosis (carotid bifurcation + bulb)\n(4) Radiation treatment (circumferential wall thickening in radiation field)\n(5) Takayasu arteritis (long-segment wall thickening of aorta + side branches on both sides, young woman, common in Asia + Mexico)\n(6) Giant cell (temporal) arteritis (extradural carotid siphon most severely affected, $>50$ years of age)\n(7) Behçet disease\n\n# Vertebral Artery Dissection \n\n$=$ hemorrhage into wall of vertebral artery\nPrevalence: unknown; up to $15 \\%$ of strokes in young adults\n\n- headache: occipital ( $>50 \\%$ ), frontal ( $20 \\%$ ), orbital ( $20 \\%$ )\n- neck pain ( $30 \\%$ ), ischemia of posterior circulation (57-84\\%)\n- ischemia of cervical spinal cord, cervical root impairment\n\nLocation: in pars transversaria at level of $\\mathrm{C} 1 / 2=\\mathrm{V}_{2}(35 \\%)$; atlas loop $=\\mathrm{V}_{3}(34 \\%)$; bilateral vertebral artery dissections (5\\%); site of direct trauma\nCT:\n$\\sqrt{ }$ subarachnoid hemorrhage $\\leftarrow$ rupture of adventitia\nMR (modality of choice):\n$\\sqrt{ }$ decreased arterial lumen\n$\\sqrt{ }$ diminished flow void\n$\\sqrt{ }$ periarterial rim SI changes with time (hemoglobin)\nAngio:\n$\\sqrt{ }$ tapering of artery / intimal flap / complete occlusion\nCx: stroke (in up to $95 \\%$ ) after hours / weeks\nPrognosis: full recovery with some residual deficit ( $88 \\%$ ); recurrence within 4-6 weeks involving multiple cervical arteries in sequence\n\n## EPIGLOTTITIS\n\n$=$ ACUTE BACTERIAL EPIGLOTTITIS=SUPRAGLOTTITIS\n$=$ life-threatening infection characterized by edema of supraglottic structures ( $=$ epiglottis + aryepiglottic folds)\n[glottis, Greek = mouth of windpipe $\\leftrightarrow$ glotta / glossa $=$ tongue]\nCause:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 267,
            "markdown": "(a) infectious\n\nOrganism: Haemophilus influenzae type B, Pneumococcus, Streptococcus group A\n$\\diamond$ Less prevalent since introduction of vaccine against H. influenzae!\n(b) noninfectious: angioedema, trauma, ingestion of caustic agent, anaphylaxis\n\nPeak age: formerly 6 (range, 1-5) years; now more prevalent among adults + children of $>15$ years\n\n- toxic appearance, high fever, posturing with neck extension\n- abrupt onset of inspiratory stridor + respiratory distress\n- sore throat, drooling, severe dysphagia\n\nLocation: purely supraglottic lesion; associated subglottic edema in 25\\%\nLateral radiograph (preferred modality, frontal view irrelevant):\n$\\diamond$ Radiograph should be taken in erect position only!\n$\\checkmark$ \"thumb\" sign = bulbous thickening of epiglottis\n$\\checkmark$ thickening of aryepiglottic folds\n$\\checkmark$ circumferential narrowing of subglottic portion of trachea during inspiration\n$\\checkmark \\pm$ supraglottitis $=$ additional swelling of supraglottic larynx\n$\\checkmark$ ballooning of hypopharynx + pyriform sinuses\n$\\checkmark$ cervical kyphosis\nCT (NOT recommended in acute setting):\n$\\checkmark$ enlarged edematous epiglottis with mucosal enhancement\n$\\checkmark$ edema of entire supraglottic larynx + tongue base + tonsils\n$\\checkmark$ phlegmonous collection in adjacent soft tissues\nCx: necrotizing epiglottitis, deep neck abscess (4-25\\%)\nPrognosis: in children mortal danger of suffocation $\\leftarrow$ hazard of complete airway closure; patient needs to be accompanied by physician experienced in endotracheal intubation\n$R x$ : broad-spectrum antibiotics, steroids, direct laryngoscopy, emergent intubation (in children) may be required\n\n# EXTERNAL AUDITORY CANAL DYSPLASIA \n\nFrequency: $1 \\div 10,000$ births; family history in $14 \\%$\nEtiology:\n(a) isolated\n(b) Trisomy 13, 18, 21\n(c) Turner syndrome\n(d) maternal rubella\n(e) craniofacial dysostosis\n(f) mandibulofacial dysostosis\n\nSpectrum:\n\n1. Stenosis of EAC\n2. Fibrous atresia of EAC\n3. Bony atresia (in position of tympanic membrane)\n4. Decreased pneumatization of mastoid (mastoid cells begin to form in $7^{\\text {th }}$ fetal month)\n5. Decreased size / absence of tympanic cavity\n6. Ossicular changes (rotation, fusion, absence)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 268,
            "markdown": "7. Ectopic facial nerve $=$ anteriorly displaced vertical (mastoid) portion of facial nerve canal\n8. Decrease in number of cochlear turns / absence of cochlea\n9. Dilatation of lateral semicircular canal\n\nLocation: bilateral in $29 \\% ; \\mathrm{M} \\div \\mathrm{F}=6 \\div 4$\n\n- pinna deformity; stenotic / absent auditory canal\n\nCx: congenital cholesteatoma (infrequent)\n\n# EXTRACARDIAC RHABDOMYOMA \n\n$=$ benign tumor consisting of immature striated muscle cells\nLocation: $70 \\%-90 \\%$ in head \\& neck\n\n1. Adult rhabdomyoma\n\nAge: $5^{\\text {th }}$ decade; $\\mathrm{M}>\\mathrm{F}$\nLocation: larynx, pharynx, oral cavity\nSize: large $\\leftarrow$ slow rate of growth\n2. Fetal rhabdomyoma\n\nMedian age: 4 years; $\\mathrm{M}>\\mathrm{F}$\nLocation: subcutaneous tissue with a particular predilection for postauricular region\n$\\sqrt{ }$ signal intensity similar to muscle on T1WI and T2WI\n$\\checkmark$ usually enhancement after contrast administration\n\n## EXTRAMEDULLARY PLASMACYTOMA\n\n$=$ EXTRAOSSEOUS PLASMACYTOMA\nUncommon form of plasmacytoma (3-4\\%); questionable if precursor to multiple myeloma\nAge: $40-60$ years; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\nLocation: air passages ( $50 \\%$ ) predominantly in upper nose and oral cavity; larynx; conjunctiva $(37 \\%)$; lymph nodes $(3 \\%)$; perirenal\n\n- usually not associated with increased immunoglobulin titer or amyloid deposition\n$\\sqrt{ }$ mass of one to several cm in size with well-defined lobulated border\nClassification:\nA. OSSEOUS\n\n1. Medullary plasmacytoma\n2. Multiple myeloma:\n(a) scattered involvement of bone\n(b) myelomatosis of bone\nB. EXTRAOSSEOUS\n3. Extramedullary plasmacytoma\n\nDx: requires exclusion of multiple myeloma by:\n> bone marrow biopsy with normal results\n> normal plasma electrophoresis\n> negative skeletal survey\n> negative bone marrow imaging with MR\nPrognosis: relatively benign course (dissemination may be found months / years later or not at all); better than solitary bone plasmacytoma; progression to multiple myeloma in 50\\%\n$D D x$ :",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 269,
            "markdown": "(1) MULTIPLE MYELOMA\n$=$ malignant course with soft-tissue involvement in $50-73 \\%$ :\n(a) microscopic infiltration\n(b) enlargement of organs\n(c) formation of tumor mass $(1 / 3)$\n\n- usually associated with protein abnormalities\n- may have amyloid deposition\n\nAge incidence: $50-85$ years\n$\\diamond$ Extramedullary plasmacytoma tends to occur late in the course of multiple myeloma $\\rightarrow$ indicates a poor prognosis ( $0-6 \\% 5$-year survival)\n\n# FIBROMATOSIS COLLI \n\n$=$ PSEUDOTUMOR OF INFANCY $=$ STERNOCLEIDOMASTOID TUMOR OF INFANCY $=$ CONGENITAL MUSCULAR TORTICOLLIS\n$=$ rare form of benign self-limiting benign fibrous mass within sternocleidomastoid muscle associated with torticollis in neonates and infants\nPrevalence: $0.4 \\%$ of live births\nCause: in $>60-90 \\%$ associated with birth trauma during difficult breech / forceps delivery; positive family history $(11 \\%)$\nPath: compartment syndrome with pressure necrosis + secondary fibrosis of sternocleidomastoid m .\nHisto: myoblasts + fibroblasts + myofibroblasts in various stages of differentiation Associated congenital abnormalities:\ndevelopmental hip dysplasia, rib anomalies, talipes equinovarus (clubfoot), thoracic scoliosis, metatarsus adductus, mental retardation, seizure disorder\nAssociated skeletal abnormalities:\nipsilateral lateral mandibular asymmetry, cervicothoracic scoliosis, facial deformity, ipsilateral mastoid process hypertrophy, ipsilateral elevation of clavicle / shoulder\nAge: $2^{\\text {nd }}$ to $4^{\\text {th }}$ week of life; $\\mathrm{M}>\\mathrm{F}$\n\n- unilateral firm soft-tissue mass in mid to lower $1 / 3$ of sternocleidomastoid muscle; typically unaffected at birth; enlarging neck mass over the course of $2-6$ weeks\n- torticollis ( $14-30 \\%$ ) tilting toward lesion $\\leftarrow$ muscle contraction\n\nLocation: lower $1 / 3$ of sternocleidomastoid muscle affecting sternal + clavicular heads of the muscle; usually unilateral $(\\mathrm{R}>\\mathrm{L})$\nAverage size: $1-3 \\mathrm{~cm}$\n$\\sqrt{ }$ focal / diffuse enlargement of sternocleidomastoid muscle\n$\\sqrt{ }$ NO extramuscular extension / associated soft tissue abnormality\n$\\sqrt{ }$ mild mass effect on surrounding structures\nX-ray (NOT indicated):\n$\\sqrt{ }$ normal in $98 \\%$\n$\\sqrt{ }$ lytic lesion in clavicular head at insertion of sternocleidomastoid muscle\nUS:\n$\\sqrt{ }$ unilateral diffuse fusiform homogeneous expansion of sternocleidomastoid muscle\n$\\sqrt{ }$ well- / ill-defined focal mass within muscle:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 270,
            "markdown": "$\\checkmark$ homogeneous echotexture ( $51 \\%$ )\n$\\checkmark$ hypo- to iso- to hyperechoic depending on duration\n$\\checkmark$ mass moves synchronously with muscle at real-time\nMR:\nIndication: atypical sonographic features, NO resolution within 12 months\n$\\checkmark$ isointense lesion to normal muscle on T1WI\n$\\checkmark$ hyperintense lesion relative to normal muscle on T2WI\n$\\checkmark$ subtle patchy and linear areas of decreased signal intensity\n$\\checkmark$ heterogeneous enhancement\nCT:\n$\\checkmark$ focal / diffuse homogeneous enlargement isoattenuating to other muscle\nPrognosis: gradual spontaneous regression over 2-3 months; spontaneous resolution during next $4-8$ months in $90 \\%$ with / without treatment\nRx: (1) Muscle stretching exercise\n(2) Surgery in $10 \\%$\n\nDDx: (1) Neuroblastoma (heterogeneous solid mass with calcifications)\n(2) Rhabdomyosarcoma\n(3) Lymphoma (well-defined round /oval masses along cervical lymph node chain)\n(4) Cystic hygroma (anechoic region with septations)\n(5) Branchial cleft cyst\n(6) Hematoma\n\n# EXTRASKELETAL FIBROSARCOMA \n\n$=$ malignant tumor of fibroblasts of classic herringbone-like architecture\nPrevalence: $1-3 \\%$ of sarcomas in adults; $11-12 \\%$ of sarcomas in infants\nMay be associated with: prior irradiation of head \\& neck\nAge: $40-70$ years; $\\mathrm{M} \\div \\mathrm{F}=3 \\div 2$\n\n- painful / painless enlarging mass\n\nSubtypes: storiform-pleomorphic (50-60\\%), myxoid (25\\%), giant cell (5-10\\%), inflammatory $(5 \\%)$\nLocation: sinonasal cavity, larynx, neck\nMR:\n$\\checkmark$ heterogeneous mass of predominantly low signal intensity with variable enhancement on T1WI\n$\\checkmark$ heterogeneous high signal intensity on T2WI\nPrognosis: infantile extraskeletal fibrosarcoma better than adult fibrosarcoma\n\n## GENICULATE HEMANGIOMA\n\n$=$ venous malformation in region of facial nerve\nSite: geniculate ganglion $>\\mathrm{IAC}>$ posterior genu\nCT:\n$\\checkmark$ expansile honeycomb appearance\n$\\checkmark$ intratumoral bone spicules",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 271,
            "markdown": "$\\sqrt{ }$ bone forming / growth among bone trabeculae (= ossifying hemangioma)\nMRI:\n$\\sqrt{ }$ mass of heterogeneous signal intensity\n$\\sqrt{ }$ avid enhancement\n$D D x$ : meningioma with intraosseous involvement\n\n# GLOMUS TUMOR \n\n$\\diamond$ Distinct from head \\& neck paragangliomas!\n$=$ composed of cells closely resembling modified smooth muscle cells of glomus bodies of dermis\nPrevalence: $<2 \\%$ of all soft tissue tumors\nLocation: distal extremities, head \\& neck (15-30\\%)\n\n## Sinonasal Glomus Tumor (5\\%)\n\n$=$ GLOMANGIOPERICYTOMA $=$ SINONASAL-TYPE HEMANGIOPERICYTOMA\nOrigin: modified perivascular glomuslike myoid cells in nasal cavity + paranasal sinuses\nPath: well-delineated unencapsulated cellular tumors\nHisto: closely packed cells (= high cellularity) forming short fascicles, sometimes exhibiting storiform / whorled / palisaded patterns with multiple interspersed vascular channels of staghorn configuration; NO hemorrhage, NO necrosis\nPeak age: $7^{\\text {th }}$ decade; $\\mathrm{M}=\\mathrm{F}$\n\n- nasal obstruction / congestion, epistaxis\n- difficulty breathing, sinusitis, headache\n\nSite: nasal cavity\nCT:\n$\\sqrt{ }$ soft tissue mass with strong enhancement\n$\\sqrt{ }$ extension into orbits + intracranial compartment and destruction of adjacent bone (if large)\nMR:\n$\\sqrt{ }$ tumor isointense relative to muscle on T1WI\n$\\sqrt{ }$ hypo- to isointense relative to muscle on T2WI\n$\\sqrt{ }$ variable degrees of (usually marked) enhancement\nPrognosis: low tendency for metastasis (5\\%)\n\n## GOITER\n\n[gutteria, Latin = throat]\nDefinition: visible enlargement of thyroid gland\nVolume definition: $>18 \\mathrm{~mL}$ for women; $>25 \\mathrm{~mL}$ for men\nClinical classification:\nClass I: palpable but not visible in normal posture of head\nClass II: palpable and easily visible\nClass III: very large + retrosternal with compression marks",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 272,
            "markdown": "# Adenomatous Goiter \n\n$=$ MULTINODULAR GOITER\nUS: ( $89 \\%$ sensitive, $84 \\%$ specific, $73 \\%$ positive predictive value, $94 \\%$ negative predictive value)\n$\\sqrt{ }$ increased size + asymmetry of gland\n$\\sqrt{ }$ multiple $1-4-\\mathrm{cm}$ solid nodules\n$\\sqrt{ }$ areas of hemorrhage + necrosis\n$\\sqrt{ }$ coarse calcifications may occur within adenoma $\\leftarrow$ hemorrhage + necrosis\n$C x:$ compression of trachea\n\n## Diffuse Goiter\n\nUS:\n$\\sqrt{ }$ increase in glandular size, R lobe $>$ L lobe\n$\\sqrt{ }$ NO focal textural changes\n$\\sqrt{ }$ calcifications not associated with nodules\n\n## lodine-deficiency Goiter\n\nNot a significant problem in USA because of supplemental iodine in food\nEtiology: chronic TSH stimulation\n\n- low serum T4\n$\\sqrt{ }$ high ${ }^{131}$ I uptake\n\n\n## Jod-Basedow Phenomenon (2\\%)\n\n$=$ development of thyrotoxicosis ( $=$ excessive amounts of $\\mathrm{T}_{4}$ synthesized + released) if normal dietary intake is resumed / iodinated contrast medium administered\nFrequency: most common in individuals with long-standing multinodular goiter Age: $>50$ years\n$\\sqrt{ }$ multinodular goiter with in- / decreased uptake (depending on iodine pool)\n\n## Toxic Nodular Goiter\n\n$=$ PLUMMER DISEASE\n$=$ autonomous function of one / more thyroid adenomas\nPeak age: $4^{\\text {th }}-5^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 3$\n\n- elevated $\\mathrm{T}_{4}$, suppressed TSH\n$\\sqrt{ }$ nodular thyroid with hot nodule + suppression of remainder of gland\n$\\sqrt{ }$ stimulation scan will disclose normal uptake in remainder of gland\n$\\sqrt{ } \\sim 80 \\%$ increased radioiodine uptake by 24 hours\nRx: (1) ${ }^{131} \\mathrm{I}$ treatment with empirical dose of $25-29 \\mathrm{mCi} \\rightarrow$ hypothyroidism in $5-30 \\%$\n(2) Surgery $\\rightarrow$ hypothyroidism in $11 \\%$\n(3) Percutaneous ethanol injection $\\rightarrow$ hypothyroidism in $<1 \\%, \\rightarrow$ transient damage of recurrent laryngeal nerve in $4 \\%$\n\n\n## Intrathoracic Goiter\n\n$=$ extension of cervical thyroid tissue / ectopic thyroid tissue (rare) into mediastinum\nFrequency: $5 \\%$ of resected mediastinal masses; most common cause of mediastinal masses;",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 273,
            "markdown": "$2 \\%$ of all goiters\n\n- mostly asymptomatic\n- symptoms of tracheal + esophageal + recurrent laryngeal nerve compression\n\nLocation:\n(a) retrosternal ( $80 \\%$ ) in front of trachea\n(b) posterior descending $(20 \\%)=$ behind trachea but in front of esophagus, caudal extent limited by arch of azygos vein, exclusively on right side of trachea\n$\\sqrt{ }$ continuity with cervical thyroid / lack of continuity (with narrow fibrous / vascular pedicle)\n$\\checkmark$ frequent focal calcifications\nCT:\n$\\checkmark$ mass of high $\\mathrm{HU}+$ well-defined margins\n$\\checkmark$ inhomogeneous texture with low-density areas (= degenerative cystic areas)\n$\\checkmark$ marked + prolonged enhancement\n\n# GRAVES DISEASE \n\n$=$ DIFFUSE TOXIC GOITER\n$=$ autoimmune disorder antibodies binding to TSH receptors (LATS) with inhibitory + stimulatory effects producing hyperplasia + hypertrophy of thyroid gland\nPrevalence: $5 \\div 10,000$; most common form of hyperthyroidism ( $60-80 \\%$ )\nPeak age: $3^{\\text {rd }}-4^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 7$\n\n- $\\uparrow \\mathrm{T}_{3}$ and $\\mathrm{T}_{4}, \\downarrow$ TSH production\n- elevated levels of thyroid-peroxidase antibodies ( $75 \\%$ )\n- positive thyroid stimulating immunoglobulins\n- ophthalmopathy $(50 \\%)=$ periorbital edema, lid retraction, ophthalmoplegia, proptosis, malignant exophthalmos\n- dermopathy = pretibial myxedema (5\\%)\n- acropachy = bulbous swelling of hands + feet (rare)\n$\\checkmark$ diffuse thyroid enlargement\n$\\checkmark$ gland may be normal in size in early stage\n$\\checkmark$ uniformly increased uptake\n$\\checkmark$ incidental nodules superimposed on preexisting adenomatous goiter (5\\%)\nUS: (identical to diffuse goiter)\n$\\checkmark$ global enlargement of 2-3 times the normal size\n$\\checkmark$ normal / diffusely hypoechoic pattern\n$\\checkmark$ \"thyroid inferno\" = diffuse hyperemia on color Doppler\nRx: ${ }^{131}$ I treatments (for adults):\nDose: $80-120 \\mu \\mathrm{Ci} / \\mathrm{g}$ of gland with $100 \\%$ uptake (taking into account estimated weight of gland + measured radioactive iodine uptake for 24 hours)\nCx: $10-30 \\%$ develop hypothyroidism within $1^{\\text {st }}$ year $+3 \\%$ per year rate thereafter\n\n\n## HYPOPHARYNGEAL CARCINOMA\n\nHisto: squamous cell carcinoma (95\\%)\nMetastases: common (50-75\\%) due to rich lymphatic drainage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 274,
            "markdown": "May be associated with:\nPlummer-Vinson syndrome ( $=$ atrophic mucosa of tongue, achlorhydria, sideropenic anemia) affecting women in $90 \\%$\n\n- sore throat, intolerance to hot / cold liquids (early signs)\n- dysphagia, weight loss (late signs)\n- cervical adenopathy (in $50 \\%$ at presentation)\n\nStage:\nT1 tumor limited to one subsite of hypopharynx $\\leq 2 \\mathrm{~cm}$\nT2 tumor involves $>1$ subsite / adjacent site without fixation of hemilarynx measuring 2-4 cm\nT3 same as T2 with fixation of hemilarynx $>4 \\mathrm{~cm}$ in size\nT4 invasion of thyroid / cricoid cartilage / hyoid bone / esophagus / strap muscles / SQ fat\n\n# Pyriform Sinus Carcinoma (60\\%) \n\n- may escape clinical detection if located at inferior tip = often cause of \"cervical adenopathy with unknown primary\" (next to primaries in lingual + faucial tonsils and nasopharynx)\n$\\checkmark$ invasion of posterior ala of thyroid cartilage, cricothyroid space, soft tissue of neck in T4 lesion\nPrognosis: poor $\\leftarrow$ early soft-tissue invasion\n\n\n## Postcricoid Carcinoma (25\\%)\n\n$\\checkmark$ difficult assessment due to varying thickness of inferior constrictor + prevertebral muscles\nPrognosis: $25 \\%$ 5-year survival (worst prognosis)\n\n## Posterior Pharyngeal Wall Carcinoma (15\\%)\n\n$\\checkmark$ invasion of retropharyngeal space with extension into oro- and nasopharynx\n$\\checkmark$ retropharyngeal adenopathy\n\n| Staging of Cervical Nodes in SCC of Head \\& Neck |  |\n| :--: | :--: |\n| N Stage | Definition |\n| Nx | cannot assess regional lymph nodes |\n| N0 | no regional lymph node metastasis |\n| N1 | single ipsilateral node $\\leq 3 \\mathrm{~cm}$ |\n| N2a | single ipsilateral node $3-6 \\mathrm{~cm}$ |\n| N2b | multiple ipsilateral nodes, each $\\leq 6 \\mathrm{~cm}$ |\n| N2c | bi- / contralateral nodes, each $\\leq 6 \\mathrm{~cm}$ |\n| N3 | any nodal mass $>6 \\mathrm{~cm}$ |\n\n## IMMUNOGLOBULIN IGG4-RELATED DISEASE\n\n$=$ IGG4-RELATED SCLEROSING DISEASE (ISD) $=$ HYPER-IGG4 DISEASE $=$ MULTIFOCAL FIBROSCLEROSIS\n$=$ systemic disease with multiorgan involvement and elevated IgG4 levels\nMajor diagnostic criteria:\n(1) Diffuse / localized swelling / masses in $\\geq 1$ organ",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 275,
            "markdown": "(2) Elevated serum IgG4 concentrations $\\geq 135 \\mathrm{mg} / \\mathrm{dL}$\n(3) Marked lymphoplasmacytic infiltration + storiform fibrosis with organ infiltration by IgG4-positive plasma cells\nMultiorgan involvement in IgG4-related disease make whole-body CT, MRI, and PET important diagnostic tools.\nHisto: diffuse lymphoplasmacytic infiltration (by T-lymphocytes and plasma cells staining positive for $\\operatorname{IgG} 4$ ) + irregular fibrosis + occasional eosinophilic infiltration + obliterative phlebitis\nHead and neck are commonly involved in IgG4-related disease, most commonly salivary glands, lacrimal glands, orbits, thyroid gland, lymph nodes, sinonasal cavities, pituitary stalk.\n@ Orbit: fibrotic orbital pseudotumor\n@ Salivary gland\n\n1. Mikulicz disease\n2. Sclerosing sialadenitis (Küttner tumor)\n@ Lacrimal gland\n3. Inflammatory pseudotumor (IPT)\n\nLocation: mostly bilateral symmetric; unilateral lacrimal gland lesions may occur CT:\n$\\sqrt{ }$ intermediate soft-tissue attenuation\nMR:\n$\\sqrt{ }$ low Tl signal intensity (= isointense to muscle)\n$\\sqrt{ }$ homogeneous low to intermediate SI on $\\mathrm{T} 2 \\mathrm{WI} \\leftarrow$ increased cellularity + fibrosis\n2. Lymphoid hyperplasia\n@ Thyroid\n\n1. Hashimoto thryoiditis\n2. Riedel fibrosing thyroiditis\n@ Pituitary gland: hypophysitis\n@ Lung: interstitial pneumonia\n@ Mediastinum: mediastinal fibrosis\n@ Abdomen\n3. Autoimmune pancreatitis (most commonly affected organ)\n4. Sclerosing cholangitis\n5. Sclerosing cholecystitis\n6. Sclerosing mesenteritis\n7. Retroperitoneal fibrosis (RPF)\n8. Prostatitis\n\n# INVERTED PAPILLOMA \n\n$=$ INVERTING PAPILLOMA $=$ ENDOPHYTIC PAPILLOMA\n=SQUAMOUS CELL PAPILLOMA = TRANSITIONAL CELL PAPILLOMA $=$ CYLINDRICAL EPITHELIOMA\n$=$ SCHNEIDERIAN PAPILLOMA\nFrequency: 4\\% of all nasal neoplasms; most common of epithelial papillomas; commonly",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 276,
            "markdown": "occurring after nasal surgery\nCause: unknown; association with human papillomavirus-11\nAge: $40-60$ years; $\\mathrm{M} \\div \\mathrm{F}=3-5 \\div 1$\nPath: vascular mass with prominent mucous cyst inclusions interspersed throughout epithelium\nHisto: hyperplastic epithelium inverts into underlying stroma rather than in an exophytic direction; high intracellular glycogen content\n$\\diamond$ Squamous cell carcinoma coexistent in 5.5-27\\%\nLocation: uniquely unilateral (bilateral in $<5 \\%$ )\n(a) most often arising from the lateral nasal wall with extension into ethmoid / maxillary sinuses, at junction of antrum + ethmoid sinuses\n(b) paranasal sinus (most frequently maxillary antrum)\n(c) nasal septum $(5.5-18 \\%)$\n\n- unilateral nasal obstruction, epistaxis, postnasal drip, recurrent sinusitis, sinus headache\n- distinctive absence of allergic history\n$\\checkmark$ commonly involves antrum + ethmoid sinus\n$\\checkmark$ widening of infundibulum / outflow tract of antrum\n$\\checkmark$ destruction of medial antral wall / lamina papyracea of orbit, anterior cranial fossa (pressure necrosis) in up to $30 \\%$\n$\\checkmark$ septum may be bowed to opposite side (NO invasion)\n$\\checkmark$ homogeneous enhancement\nMR:\n$\\checkmark$ may have intermediate to low intensity on T2WI (DDx: squamous cell carcinoma, olfactory neuroblastoma, melanoma, small cell carcinoma)\nCx: (1) Cellular atypia / squamous cell carcinoma (10\\%)\n(2) Recurrence rate of $15-78 \\%$\n\nRx: complete surgical extirpation (lateral rhinotomy with en bloc excision of lateral nasal wall)\n\n# KERATOSIS OBTURANS \n\n$=$ expansile accumulation of keratin debris within EAC\nAge: younger patient $<40$ years\n\n- severe pain, conductive hearing loss, (rarely) otorrhea\n\nAssociated with: chronic sinusitis, bronchiectasis\nLocation: usually bilateral process\n$\\checkmark$ diffuse widening of EAC by epidermal plug\n$\\checkmark \\pm$ smooth scalloping of surrounding bone\n$D D x$ : EAC cholesteatoma (periostitis, bone erosion)\n\n## LABYRINTHITIS\n\n## Acute Labyrinthitis\n\nCause: viral infection (mumps, measles) $>$ bacterial infection $>$ syphilis, autoimmune disease, toxins\n\n- sudden hearing loss, vertigo, tinnitus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 277,
            "markdown": "MR:\n$\\sqrt{ }$ faint diffuse enhancement of labyrinth on T1WI (HALLMARK)\n\n# Tympanogenic Labyrinthitis \n\nCause: agent enters through oval / round window in middle ear infection\n\n## Meningogenic Labyrinthitis\n\nCause: agent propagates along IAC / cochlear aqueduct in meningitis\nLocation: often bilateral\n\n## Fibrous Labyrinthitis\n\n$=$ cochlear obstruction\n\n## Ramsay-Hunt Syndrome\n\n$=$ HERPES ZOSTER OTICUS\nCause: reactivation of varicella zoster virus latent in geniculate ganglion\nPredisposition: immunocompromised, systemic disease, aging\n\n- burning pain in ear, facial paralysis, hearing loss, vertigo\n- mucosal vesicles of external auditory canal 1-4 days later\n$\\sqrt{ }$ enhancement of $7^{\\text {th }}+8^{\\text {th }}$ nerve, labyrinth $\\pm$ pontine nucleus\n\n\n## Labyrinthitis Ossificans\n\n$=$ LABYRINTHITIS OBLITERANS $=$ SCLEROSING LABYRINTHITIS $=$ CALCIFIC / OSSIFYING COCHLEITIS\nCause: suppurative infection (tympanogenic, meningogenic, hematogenic) in $90 \\%$, trauma, surgery, tumor, severe otosclerosis\n$\\diamond$ Meningitis is the most likely etiology!\nPathophysiology: progressive fibrosis + ossification of granulation tissue within labyrinth\n\n- bi- / unilateral profound deafness\n$\\sqrt{ }$ loss of normal fluid signal within labyrinth on T2WI (early in course of disease)\n$\\sqrt{ }$ inner ear structures filled with bone: most common region of cochlear ossification = scala tympani of basal turn\n\n\n## LARYNGEAL CARCINOMA\n\nFrequency: 98\\% of all malignant laryngeal tumors; 1\\% of all cancers; 89,081 cases in USA (2013)\n\nAge: $5^{\\text {th }} / 6^{\\text {th }}$ decade of life; $\\mathrm{M}>\\mathrm{F}$\nRisk factors: tobacco, alcohol, airborne irritants\n$\\diamond$ High risk to develop $2^{\\text {nd }}$ primary malignancy of lung + upper aerodigestive tract (in $8 \\%$ )\nHisto: squamous cell carcinoma ( $95 \\%$ )\nNegative prognostic factors:\n$\\sqrt{ }$ nodal involvement\n$\\sqrt{ }$ invasion of cricoid / thyroid cartilage:\n$\\sqrt{ }$ tumor within fatty medullary cavity\n$\\sqrt{ }$ tumor on outer extralaryngeal side of thyroid cartilage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 278,
            "markdown": "$\\diamond$ Assessment made difficult by natural asymmetric ossification of thyroid cartilage!\nN.B.: Reactive periostitis may lead to sclerosis of cartilage\n$\\checkmark$ invasion of pre- and paraepiglottic fat (clinically not detectable!)\n$\\checkmark$ fixation of carotid artery\n$\\checkmark$ extranodal spread\nSuggestive of lymph node metastasis:\n$\\checkmark$ uptake on PET-CT (50-94\\% sensitive, $82-100 \\%$ specific depending on lymph node size)\n$\\checkmark$ enlarged lymph node:\n(a) $>15 \\mathrm{~mm}$ in cross section for level I / II nodes\n(b) $>8 \\mathrm{~mm}$ in cross section for retropharyngeal node\n(c) $>10 \\mathrm{~mm}$ in greatest dimension for all other node levels\n$\\checkmark$ round lymph node with loss of reniform shape\n$\\checkmark$ necrotic lymph node (= central low attenuation)\n$\\checkmark$ amorphous node with spiculated / indistinct border suggests extracapsular spread\n$\\checkmark$ proximity to laryngeal mass\n$\\checkmark$ cluster of $>3$ lymph nodes $6-15 \\mathrm{~mm}$ in size\nDistant metastasis (in 5-15\\%): lung > bone > abdomen\nPrognosis: $64 \\%$-year survival (2013)\n$R x$ : conservative laryngectomy (partial laryngectomy preserving speech + control of aspiration)\n\n# Supraglottic Carcinoma (20-30\\%) \n\nMetastases: early to lymph nodes of deep cervical chain (levels II + III), in 25-55\\% at time of presentation\n\n- symptomatic late in course of disease (often T3 / T4)\n\nStage:\nT1 tumor confined to one supraglottic subsite\nT2 involvement of adjacent supraglottic subsite / glottis without cord fixation\nT3 tumor limited to larynx with cord fixation or extension to postcricoid area / medial wall of pyriform sinus / preepiglottic space\nT4 extension beyond larynx with involvement of oropharynx (base of tongue) / prevertebral space / encasement of carotid a. / thyroid cartilage\nA. ANTERIOR COMPARTMENT\n\n1. Epiglottic carcinoma\n$\\checkmark$ circumferential relatively symmetric growth\n$\\checkmark$ extension into preepiglottic space $\\pm$ base of tongue $\\pm$ paraglottic space\nPrognosis: better than for tumors of posterolateral compartment\nB. POSTEROLATERAL COMPARTMENT\n2. Aryepiglottic fold (marginal supraglottic) carcinoma\n$\\checkmark$ exophytic growth from medial surface of aryepiglottic fold\n$\\checkmark$ growth into fixed portion of epiglottis + paraglottic (= paralaryngeal) space\n3. False vocal cord / laryngeal ventricle carcinoma\n$\\checkmark$ submucosal spread into paraglottic space\n$\\checkmark \\pm$ destruction of thyroid cartilage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 279,
            "markdown": "$\\sqrt{ } \\pm$ involvement of true vocal cords\nPrognosis: poorer than for cancer of anterior compartment\n\n# Glottic Carcinoma (50-60\\%) \n\n- early detection due to hoarseness\n\nMetastases: uncommon $(<10 \\%) \\leftarrow$ sparse lymphatic drainage to lower deep jugular chain (levels IV + VI)\nStage:\nT1 tumor confined to vocal cord with normal mobility\nT1a tumor limited to one vocal cord\nT1b tumor involving both vocal cords\nT2 supra- / subglottic extension + impaired mobility\nT3 fixation of true vocal cord $\\pm$ invasion of paraglottic space $\\pm$ inner cortex of thyroid cartilage\nT4 destruction of thyroid cartilage / extension outside larynx\nPatterns of tumor invasion:\n(1) Anterior extension into anterior commissure\n$\\sqrt{ }>1 \\mathrm{~mm}$ thickness of anterior commissure\n$\\sqrt{ }$ invasion of contralateral vocal cord via anterior commissure\n$\\sqrt{ }$ FDG uptake in opposite cord at PET\n(2) Posterior extension to arytenoid cartilage, posterior commissure, cricoarytenoid joint\n(3) Subglottic extension\n$\\sqrt{ }$ tumor $>5 \\mathrm{~mm}$ inferior to level of vocal cords\n(4) Deep lateral extension into paralaryngeal space\n\nPrognosis: T1 carcinoma rarely metastasizes ( $0-2 \\%$ ) due to absence of lymphatics within true vocal cords\n\n## Subglottic Carcinoma (5\\%)\n\n- late detection due to minimal symptomatology (stridor)\n\nStage:\nT1 confined to subglottis\nT2 extension to vocal cords $\\pm$ impaired mobility\nT3 tumor confined to larynx + cord fixation\nT4 cartilage destruction / extension beyond larynx\n$\\sqrt{ }$ any tissue seen on airway side of cricoid cartilage\nPrognosis: poor due to early metastases to cervical lymph nodes (in $25 \\%$ at presentation)\n\n## LARYNGEAL CHONDROSARCOMA\n\n$\\diamond$ The most common sarcoma of the larynx\nAge: $50-70$ years; $\\mathrm{M}>>\\mathrm{F}$\n\n- lobulated submucosal mass\n\nLocation: posterior lamina of cricoid cartilage (50-70\\%), thyroid cartilage (20-35\\%)\n$\\sqrt{ }$ coarse / stippled intratumoral calcifications",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 280,
            "markdown": "$\\sqrt{ } \\pm$ locally invasive\nMR:\n$\\sqrt{ }$ very high SI of tumor matrix on T2WI (= hyaline cartilage)\n$R x$ : function-preserving laryngeal resection (local recurrence may be seen 10 years or more)\n$D D x$ : benign chondroma\n\n# LARYNGEAL CLEFT \n\n$=$ rare sagittal communication between trachea + esophagus $\\leftarrow$ lack of separation between laryngotracheal and pharyngoesophageal systems\nCause: failure of fusion of posterior cricoid lamina\nClassification: based on downward extent of cleft (ranging from submucosal interarytenoid cleft to a cleft that extends into thoracic trachea)\n\n- swallowing difficulty, stridor, recurrent pneumonia, weak cry\n- clinical suspicion of TE fistula\n\nAssociated with other congenital anomalies:\n(1) CHARGE syndrome\n(2) VACTERL (VATER) association; esophageal atresia; imperforate anus\n$\\sqrt{ }$ simultaneous barium opacification of esophagus + trachea\n$D x$ : endoscopic visualization\n\n## LARYNGEAL CYST\n\n$=$ rare benign pharyngeal cyst of vallecula / vocal cord / epiglottis\nAge: any; most common in $6^{\\text {th }}$ decade\n\n- dysphonia, airway obstruction, foreign body sensation in throat\n\nClassification: ductal and saccular types\nA. Ductal cyst (more common)\n\nCause: submucosal gland duct obstruction\nInvolvement of: valleculae, vocal cords, epiglottis\nB. Saccular cyst\n\nCause: mucus retention within laryngeal saccule from obstruction / loss of patency of saccular orifice\n$\\sqrt{ }$ smoothly hemispheric mass $\\pm$ distortion of coated surfaces of pharyngeal / laryngeal supraglottic anatomy\n$D D x$ : laryngocele, branchial cleft cyst, oncocytic papillary cystadenoma\n\n## LARYNGEAL HEMANGIOMA\n\nHisto: cavernous / capillary type\n\n- dark bluish red / pale red compressible swelling on endoscopy\n$\\sqrt{ }$ strong contrast enhancement\nCT:\n$\\sqrt{ }$ phleboliths (PATHOGNOMONIC for cavernous type)\nMR:\n$\\sqrt{ }$ very high signal intensity on T2WI\n$D D x$ : paraganglioma, hypervascular metastasis (renal adenocarcinoma)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 281,
            "markdown": "# Infantile Laryngeal Hemangioma (10\\%) \n\n$=$ SUBGLOTTIC HEMANGIOMA\n$\\diamond$ Most common subglottic soft-tissue mass causing upper respiratory tract obstruction in neonates\nAge: $\\quad<6$ months; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 2$\n\n- crouplike symptoms (dyspnea, stridor) in neonatal period\n- hemangiomas elsewhere (skin, mucosal membranes) in 50\\%\n\nLocation: subglottic region\nNeck X-ray:\n$\\checkmark$ posterolateral subglottic airway narrowing (AP view)\n$\\checkmark$ eccentric thickening of subglottic portion of trachea (AP view)\n$\\checkmark$ subtle endoluminal mass arising from posterior wall below true cords (LAT view)\nN.B.: CECT required to depict full extent\n\nRx: tracheostomy (waiting for spontaneous regression)\n\n## Adult Laryngeal Hemangioma\n\nLocation: supraglottic region (isolated); associated with extensive cervicofacial angiodysplasia\n$\\mathrm{M}>\\mathrm{F}$\nRx: laser excision, cryotherapy, selective embolization\n\n## LARYNGEAL PAPILLOMATOSIS\n\n$=$ RECURRENT RESPIRATORY PAPILLOMATOSIS\n$\\diamond$ Squamous papilloma is the most common benign tumor of the larynx!\nEtiology: human papilloma virus serotypes $6 \\div 11$ (papova virus causing genital condyloma acuminatum)\nHisto: core of vascular connective tissue covered by stratified squamous epithelium\nAge of onset: 1-54 years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$; bimodal distribution\n(a) $<10$ years (diffuse involvement) = juvenile laryngotracheal papillomatosis\n\nCause: transmission from mother to child via birth canal\n(b) $21-50$ years (usually single papilloma)\n\n- signs of upper respiratory tract obstruction:\n- progressive hoarseness / aphonia, asthmalike symptoms\n- repeated episodes of respiratory distress, inspiratory stridor\n- cough, hemoptysis, recurrent pneumonia\n\nLocation: (a) uvula, palate\n(b) vocal cord\n(c) subglottic extension ( $50-70 \\%$ )\n(d) pulmonary involvement ( $1-6 \\%$ ): lower lobe and posterior part of lung\n$\\checkmark$ thickened lumpy cords\n$\\checkmark$ bronchiectasis\n$C x$ :\n(1) Tracheobronchial papillomatosis (2-5\\%)\n\nCause: tracheostomy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 282,
            "markdown": "Location: lower lobe + posterior predilection\n$\\sqrt{ }$ solid pulmonary nodules in mid + posterior lung fields\n$\\sqrt{ } 2-3 \\mathrm{~cm}$ large thin-walled cavity with $2-4 \\mathrm{~mm}$ thick nodular wall (foci of squamous papillomas enlarge centrifugally, undergo central necrosis, cavitate)\n$\\sqrt{ }$ peripheral atelectasis + obstructive pneumonitis\nHRCT:\n$\\sqrt{ }$ tree-in-bud opacities\n(2) Pulmonary papillomatosis\nfrom aerial dissemination (bronchoscopy, laryngoscopy, tracheal intubation) 10 years after initial diagnosis\n$\\sqrt{ }$ irregularities of tracheal / bronchial walls\n$\\sqrt{ }$ noncalcified granulomata progressing to cavitation\n(3) Malignant transformation into invasive squamous cell carcinoma\n\nRx: $\\mathrm{CO}_{2}$ laser resection / surgical excision\n\n# LARYNGEAL PLASMACYTOMA \n\nAge: $50-70$ years; $\\mathrm{M}>>\\mathrm{F}$\nHisto: large sheets of uniform cells indistinguishable from normal plasma cells; marked amyloid deposition (20\\%)\n\n- pedunculated / slightly prominent mass that bleeds easily\n\nLocation: epiglottis, true and false vocal cords\nCT:\n$\\sqrt{ }$ large smoothly marginated homogeneous mass\n$\\sqrt{ }$ no significant contrast enhancement\n\n## LARYNGOCELE\n\n$=$ dilated appendix / saccular cyst of the laryngeal ventricle that contains air $\\leftarrow$ maintaining communication with laryngeal lumen + extending beyond superior border of thyroid cartilage\nPrevalence: $1 \\div 2,500,000$\nAge: middle-aged men\nPathogenesis: chronic increase in intraglottic pressure\nCause: excessive coughing, shouting, playing wind instrument, blowing glass, obstruction of appendicular ostium ( $=$ secondary laryngocele) by chronic granulomatous disease / laryngeal neoplasm ( $15 \\%$ )\nN.B.: Almost $50 \\%$ of laryngoceles detected with plain radiography contain a laryngeal carcinoma!\n\nHisto: lined by pseudostratified columnar ciliated epithelium + mixture of submucosal serous and mucous glands\nTypes: based on relationship to thyrohyoid membrane\n(a) internal $(40 \\%)=$ in parapharyngeal space confined within thyrohyoid membrane\n$\\sqrt{ }$ confined within larynx between false vocal cord and medial surface of thyrohyoid membrane\n(b) external $(26 \\%)=$ protrusion through thyrohyoid membrane at the point of insertion of the neurovascular bundle (superior laryngeal nerve + vessels) presenting as lateral neck mass near hyoid bone with normal size inside the membrane",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 283,
            "markdown": "$\\checkmark$ extension upward and laterally\n(c) mixed $(44 \\%)=$ internal + external dilatation of saccule on both sides of thyrohyoid membrane\n\n- visible in $10 \\%$ of adults during phonation\n- hoarseness / dysphagia / stridor (internal laryngocele)\n- compressible anterior neck mass just below angle of mandible (external laryngocele)\n- Bryce sign = gurgling / hissing sound on compression\n\nSite: unilateral ( $80 \\%$ ), bilateral ( $20 \\%$ )\n$\\checkmark$ sharply defined round / oval radiolucent area within paralaryngeal soft tissues:\n$\\checkmark$ increase in size during Valsalva maneuver\n$\\checkmark$ decrease in size during compression\n$\\checkmark$ cystic mass that can be followed to level of ventricle\n$\\checkmark$ may be filled with fluid / contain air-fluid level\n$\\checkmark$ DIAGNOSTIC $=$ connection between air sac + airway\nCx: infection (laryngopyocele) in $8-10 \\%$, formation of mucocele\n$D D x$ : (1) Laryngeal cyst (lined by squamous epithelium)\n(2) Lateral pharyngeal diverticulum (fills with barium)\n\n# LARYNGOMALACIA \n\n$=$ immaturity of cartilage;\nmost common cause of stridor in neonate + young infant\n\n- only cause of stridor to get worse at rest\n$\\checkmark$ hypercollapsible larynx during inspiration (supraglottic portion only)\n$\\checkmark$ backward bent of epiglottis + anterior kink of aryepiglottic folds during inspiration\nPrognosis: transient (disappears by age 1 year)\n\n\n## LEMIERRE SYNDROME\n\n$=$ SEPTIC JUGULAR VEIN THROMBOPHLEBITIS $=$ POSTANGINAL SEPSIS $=$ NECROBACILLOSIS\n$=$ uncommon potentially life-threatening complication of acute oropharyngeal infection (pharyngotonsillitis)\nAge: adolescent, teenager, young adult $>$ infant, child\nOrganism: anaerobic Fusobacterium necrophorum ( $81 \\%$, part of the normal oropharyngeal flora), other Fusobacterium species ( $11 \\%$ ), other gram-negative organisms ( $8 \\%$ )\n\n- acute pharyngitis followed by fever 3-10 days later\n- pain and swelling over the sternocleidomastoid muscle\n- hoarseness, dysphagia $\\leftarrow$ cranial nerve involvement\n- septicemia with rigors, malaise, trismus\n\nUS / CT:\n$\\checkmark$ internal jugular venous thrombosis\n$\\checkmark$ edema of the surrounding soft tissues + wall of jugular vein\nCT of chest:\n$\\checkmark$ patchy consolidation $=$ bronchopneumonia\n$\\checkmark$ septic pulmonary emboli:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 284,
            "markdown": "$\\sqrt{ }$ multiple peripheral round / wedge-shaped opacities\n$\\sqrt{ }$ \"feeding vessel\" sign = vessel leading into nodule\n$\\sqrt{ }$ peripheral enhancement with central areas of reduced attenuation $=$ cavitation\n$\\sqrt{ }$ pleural effusion $\\rightarrow$ empyema\nCx: systemic dissemination of infection: pleuropulmonary septic emboli (97\\%), septic arthritis ( $15 \\%$ ), hepatic and splenic abscesses, osteomyelitis, meningitis, epidural abscess, diffuse encephalopathy\n$R x$ : prolonged IV antibiotics with anaerobic activity, anticoagulation\n\n# LINGUAL THYROID \n\n$=$ solid embryonic rest of thyroid tissue, which remains ectopic along the tract of thyroglossal duct\nFrequency: in $10 \\%$ of autopsies (within tongue $<3 \\mathrm{~mm}$ ); $\\mathrm{M}<<\\mathrm{F}$\n\n- may be the only functioning thyroid tissue (in $70-80 \\%$ )\nN.B.: resection of ectopic thyroid will render patient athyroid\n- asymptomatic (usually), may enlarge causing dysphagia / dyspnea\n\nLocation: midline dorsum of tongue near foramen cecum ( $90 \\%$ ), thyroglossal duct, trachea; $\\pm$ multifocal\nCT:\n$\\sqrt{ }$ small hyperattenuating focus relative to muscle $\\leftarrow$ iodine content + moderate contrast enhancement\nMR:\n$\\sqrt{ }$ solid avidly enhancing lesion mildly T1 hyper- / isointense relative to muscle\nNUC:\n$\\sqrt{ }$ SPECIFIC high uptake of ${ }^{123} \\mathrm{I}$ and ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$\nCx: in 3\\% malignant (papillary carcinoma) / goitrous transformation\n\n## LIPOMATOSIS\n\n$=$ condition caused by diffuse overgrowth of mature adipocytes\nAge: children $<2$ years of age; may affect adults\nTypes:\n(1) Infiltrating congenital lipomatosis of the face\n$=$ infiltrative nonencapsulated accumulations of mature fat cells\n\n- lesion growth $\\rightarrow$ facial asymmetry, parotid involvement, osseous hypertrophy, macroglossia\nMay be associated with: cutaneous capillary blush and mucosal neuromas\n(2) Encephalocraniocutaneous lipomatosis\n$=$ infiltrative lipomatous process\nLocation: commonly temporofrontal area unilaterally, cerebral + leptomeningeal tissue, skull; occasionally eye and heart\nMay be associated with: cerebral malformations and calcifications\n(3) Madelung disease\n\n\n## LUDWIG ANGINA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 285,
            "markdown": "[Wilhelm Friedrich von Ludwig, 1790-1865, German surgeon and obstetrician in Tübingen] [angina $=$ ankhon, Greek $=$ strangling]\n$=$ serious potentially life-threatening necrotizing infection of floor of mouth rapidly involving both submandibular spaces\nCause: odontogenic / gum infection ( $90 \\%$ ) surrounding a partially erupted tooth (= pericoronitis) usually of $2^{\\text {nd }} / 3^{\\text {rd }}$ mandibular molar; frenulum piercing\nPredisposing factors: poor dental hygiene, dental extraction from lower jaw a few days prior, compromised immune status, diabetes, IV drug abuse\nSpread: by direct extension of infection = tooth apices of $2^{\\text {nd }} / 3^{\\text {rd }}$ molar of jaw extend inferiorly to mandibular insertion of mylohyoid muscle $\\rightarrow$ fascial planes of neck $\\rightarrow$ mediastinitis $\\rightarrow$ airway compromise\nOrganism: Streptococcus, Actinomyces israelii, Pseudomonas aeruginosa\nAge: usually in young adults\nLocation: bilateral sublingual and submandibular spaces\n\n- swelling of the submandibular (and sublingual) spaces\n- brawny (firm hard) painful edema $\\pm$ crepitation of submandibular tissue $\\rightarrow$ elevation of tongue\n- malaise, fever, laryngeal edema, stridor, difficulty breathing\n- displacement of tongue $\\rightarrow$ drooling, dysphagia, difficulty swallowing or speaking\n\nImaging: (1) Assessment of airway patency\n(2) Presence of gas-forming organism\n(3) Location of underlying dental infection\n$\\sqrt{ }$ underlying dental disease\n$\\sqrt{ }$ local skin thickening, muscle enlargement\n$\\sqrt{ }$ increased attenuation of subcutaneous fat\n$\\sqrt{ }$ loss of fat planes within submandibular space\n$\\sqrt{ }$ soft tissue emphysema\n$\\sqrt{ }$ ill-defined abscesses in submandibular / sublingual spaces\nCT:\n$\\sqrt{ }$ inflammatory change with small cystic spaces $=$ serosanguinous accumulation in floor of mouth\n$\\sqrt{ } \\pm$ extension deep into submandibular + parapharyngeal spaces + pharynx $\\rightarrow$ airway narrowing / obstruction\n$\\sqrt{ }$ well-defined fluid collection with rimlike enhancement\n$C x$ : mandibular osteomyelitis, spread of infection into deep fascial spaces of neck, thrombophlebitis of IJV (Lemierre syndrome)\nMortality: up to $10 \\%$\n$R x$ : IV antibiotics, aggressive drainage, surgical airway creation\n\n# LYMPHANGIOMA \n\n$=$ congenital lymphatic malformation\nFrequency: $5.6 \\%$ of all benign tumors of infancy + childhood\nAge: present at birth in $50-65 \\%$, in $80-90 \\%$ evident by age 2 (time of greatest lymphatic growth); $\\mathrm{M}=\\mathrm{F}$\nLymphatic development:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 286,
            "markdown": "endothelial buds from veins in jugular region form confluent plexuses, which develop into rapidly enlarging bilateral juguloaxillary lymph sacs ( 7.5 weeks GA); these fused lymph sacs extend craniad and dorsolateral with extensive outgrowth of lymph vessels in all directions; connection with internal jugular vein at level of confluence + external jugular vein persists on left side\n\n# Pathogenesis: \n\n(1) Early sequestration of embryonic lymphatic tissue with failure to join central lymphatic channels\n(2) Congenital obstruction of lymphatic drainage $\\leftarrow$ abnormal budding of lymph vessels (= loss of connection / noncommunication of primordial jugular lymphatic sac with jugular vein)\nClassification (based on size of lymphatic spaces):\n(1) Cystic lymphangioma = cystic hygroma (see below)\n(2) Cavernous lymphangioma\n$=$ mildly dilated cavernous lymphatic spaces with cysts of intermediate size\nLocation: tongue, floor of mouth, salivary glands\n$\\sqrt{ }$ penetration of contiguous structures\n$\\sqrt{ }$ same signal intensities as cystic lymphangioma + fibrous stromal component of low intensity on T1WI + T2WI\n(3) Capillary / simple lymphangioma (least common)\n$=$ capillary-sized lymphatic channels\nLocation: epidermis + dermis of proximal limbs\n(4) Vasculolymphatic malformation\ncomposed of lymphatic + vascular elements, eg, lymphangiohemangioma\nHisto: endothelial-lined lymphatic channels containing serous / milky fluid + separated by connective tissue stroma\n\n- asymptomatic (in majority) soft / semifirm mass\n- rapid increase in size (from infection / hemorrhage)\n- $\\pm$ dyspnea / dysphagia with encroachment upon trachea, pharynx, esophagus\n\nLocation: anywhere in developing lymphatic system; mostly in posterior cervical triangle, occasionally in floor of mouth / tongue\n(a) posterior triangle of neck ( $75 \\%$ ), with extension into mediastinum in $3-10 \\%$\n\n- visible at birth in $65 \\%$\n- clinically apparent by end of $2^{\\text {nd }}$ decade in $90 \\%$\n(b) anterior mediastinum $(<1 \\%)$\n(c) axilla ( $20 \\%$ ), chest wall, groin\n(d) retroperitoneum ( $1 \\%$ ), abdominal organs, bone\n$\\sqrt{ }$ multilocular thin-walled cysts separated by fibrous tissue\n$\\sqrt{ }$ well-marginated small lesions / ill-defined infiltrative large lesions with transspatial growth pattern\nCx: infection, airway compromise, chylothorax, chylopericardium\nPrognosis: spontaneous regression (10-15\\%)\n$R x$ : surgical excision (treatment of choice but difficult since mass does not follow tissue planes) with recurrence rate of up to $15 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 287,
            "markdown": "# Cystic Hygroma \n\n$=$ CYSTIC LYMPHANGIOMA\n$=$ single / multiloculated fluid-filled cavities on either side of fetal neck + head (localized form) $\\pm$ trunk (generalized form) as the most common form of lymphangioma developing within loose connective tissue\nFrequency: $1 \\div 6,000$ pregnancies\nPath: multiple enormously dilated cystic lymphatic channels; variation in size between a few mm to $>10 \\mathrm{~cm}$ in diameter containing chylous fluid; separated by minimal intervening stroma; may invade adjacent soft tissues / muscle and surround vessels\nHisto: cystic spaces lined by endothelial cells + supporting connective tissue stroma Associated with:\n(a) chromosomal abnormalities in $60-80 \\%$ (in particular when detected in $2^{\\text {nd }}$ trimester)\n(1) Turner syndrome ( 45 XO , mosaic) in $40-80 \\%$\n(2) Trisomies $13,18,21,13 \\mathrm{q}, 18 \\mathrm{p}, 22$\n(3) Noonan syndrome\n(4) Distichiasis (= second row of hair behind eyelash) -lymphedema syndrome [stichos, Greek = row]\n(5) Familial pterygium colli\n(6) Roberts, Cumming, Cowchock syndrome\n(7) Achondrogenesis type II\n(8) Lethal pterygium syndrome\n(b) exposure to teratogens\n(1) Fetal alcohol syndrome\n(2) Aminopterin\n(3) Trimethadione\n\n## Types:\n\n(1) Cystic hygroma with abnormal peripheral lymphatic system\n$\\checkmark$ lymphangioma in posterior compartment of neck\n$\\checkmark$ septations (indicate high probability for aneuploidy, development of hydrops, and perinatal death)\n(2) Diffuse lymphangiectasia\n$\\checkmark$ lymphangioma of chest + extremities\n$\\checkmark$ peripheral lymphedema + nonimmune hydrops\n(3) Isolated cystic hygroma\n(a) axillary lymph sac malformation\n$\\checkmark$ lymphangioma restricted to axilla\n(b) jugular lymph sac malformation\n$\\checkmark$ lymphangioma restricted to lateral neck\n(c) internal thoracic + paratracheal lymph sac malformation\n$\\checkmark$ lymphangioma within mediastinum\n(d) combined lymph sac malformation\n(e) thoracic duct malformation\n$\\checkmark$ thoracic duct cyst\n\n- AF-AFP / MS-AFP may be elevated\n\nLocation: neck (frequently posterior cervical space) and lower portions of face (75-80\\%);",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 288,
            "markdown": "mediastinum ( $3-10 \\%$, in $1 / 2$ extension from neck); axilla ( $20 \\%$ ); chest wall ( $14 \\%$ ); face $(10 \\%)$; retroperitoneum (kidneys); abdominal viscera (colon, spleen, liver); groin; scrotum; skeleton\nUS:\n$\\sqrt{ }$ thin-walled fluid-filled structure with multiple septa of variable thickness + solid cyst wall components\n$\\sqrt{ }$ fluid-fluid level with layering hemorrhagic component\n$\\sqrt{ }$ isolated nuchal cysts\n$\\sqrt{ }$ webbed neck (= pterygium colli) following later communication with jugular veins\n$\\sqrt{ }$ nonimmune hydrops ( $43 \\%$ )\n$\\sqrt{ }$ progressive peripheral edema\n$\\sqrt{ }$ fetal ascites\n$\\sqrt{ }$ oligo- / polyhydramnios / normal amount of fluid\n$\\sqrt{ }$ bradycardia\nCT:\n$\\sqrt{ }$ poorly circumscribed multiloculated masses\n$\\sqrt{ }$ homogeneous attenuation of fluid values / higher (after infection)\nMR (allows the best differentiation between lymphatic malformations and surrounding soft tissues):\n$\\sqrt{ }$ low signal intensity on T1WI\n$\\sqrt{ }$ high SI lesion with low-SI septations of variable thickness on T2WI\n$\\sqrt{ }$ may be hyperintense on T1WI $\\leftarrow$ clotted blood / high chylous lipid content / high protein content\n$\\sqrt{ } \\pm$ fluid-fluid level (if hemorrhage present)\n$D D x$ : hemangioma (different location, feeding vessels, contrast enhancement)\n$C x$ : (1) Compression of airways / esophagus\n(2) Slow growth / sudden enlargement (hemorrhage, inflammation)\n\nPrognosis:\n(1) Intrauterine demise (33\\%)\n(2) Mortality of $100 \\%$ with hydrops\n(3) Spontaneous regression ( $10-15 \\%$ )\n$\\diamond$ Favorable prognosis for localized lesions of anterior neck and axilla\n$\\diamond$ Only $2-3 \\%$ of fetuses with posterior cystic hygroma become healthy living children!\n$D D x$ : twin sac of blighted ovum; cervical meningocele; encephalocele; cystic teratoma; nuchal edema; branchial cleft cyst; vascular malformation; lipoma; abscess\n\n# Pseudocystic Hygroma \n\n$=$ PSEUDOMEMBRANE\n$=$ anechoic space bordered by specular reflection on posterior aspect of fetal neck during $1^{\\text {st }}$ trimester\nCause: ? developing integument\n$\\sqrt{ }$ NO prominent posterior bulge / internal septations\n\n## MADELUNG DISEASE\n\n$=$ BENIGN SYMMETRICAL LIPOMATOSIS $=$ MULTIPLE SYMMETRIC LIPOMATOSIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 289,
            "markdown": "$=$ rare benign condition characterized by symmetric proliferation of adipose tissue\nLocation: head, neck, shoulders (periscapular), upper chest; NO involvement of anterior mediastinal / cardiophrenic / paraspinal areas\nAge: $25-60$ years; white men\nMay be associated with:\nhistory of alcohol abuse, dyslipidemia, diabetes mellitus, hyperthyroidism, liver disease, hypertension, hyperuricemia, renal tubular acidosis, macrocytic anemia, polyneuropathy\n$C x$ : respiratory compromise $\\leftarrow$ tracheal compression at neck\n$D D x$ : obesity (different fat distribution)\n\n# MALIGNANT EXTERNAL OTITIS \n\n$=$ NECROTIZING EXTERNAL OTITIS\n$=$ severe bacterial infection of the soft tissues + bones at base of skull\nOrganism: almost always Pseudomonas aeruginosa\nAge: elderly\nPredisposed: diabetes mellitus / immunocompromised\n\n- unrelenting severe otalgia, headache\n- purulent otorrhea unresponsive to topical antibiotics\n- $\\pm$ malfunction of nerves VII, IX, X, XI $\\leftarrow$ skull base osteomyelitis; granulation tissue within external auditory canal\nLocation: at bone-cartilage junction of EAC\nSpread of infection:\nvia fissures of Santorini ( $=2-3$ vertical fissures in cartilaginous portion of EAC anteroinferiorly) $\\rightarrow$\n(a) inferiorly into soft tissues inferior to temporal bone, parotid space, nasopharyngeal masticator space\n(b) posteriorly into mastoid\n(c) anteriorly into temporomandibular joint\n(d) medially into petrous apex of skull base\n$\\sqrt{ }$ osseous erosion of external auditory canal\nCT:\n$\\sqrt{ }$ soft-tissue density in external auditory canal ( $100 \\%$ )\n$\\sqrt{ }$ fluid in middle ear / mastoid air cells ( $89 \\%$ )\n$\\sqrt{ }$ disease around eustachian tube ( $64 \\%$ )\n$\\sqrt{ }$ obliteration of fat planes beneath temporal bone ( $64 \\%$ )\n$\\sqrt{ }$ involvement of parapharyngeal space ( $54 \\%$ )\n$\\sqrt{ }$ masticator space disease ( $27 \\%$ )\n$\\sqrt{ }$ mass effect in nasopharynx ( $54 \\%$ )\n$\\sqrt{ }$ bone erosion of clivus ( $9 \\%$ )\n$\\sqrt{ }$ intracranial extension ( $9 \\%$ )\nMR (method of choice for soft-tissue complications):\n$\\sqrt{ }$ abnormal signal intensity + obliteration of fat within stylomastoid foramen\n$C x$ : bone destruction; skull base osteomyelitis (clivus, jugular foramen); abscess of epidural space + brain parenchyma + prevertebral space",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 290,
            "markdown": "Prognosis: $20 \\%$ recurrence rate; high mortality rate\n$D D x$ : nasopharyngeal carcinoma (with obstruction of eustachian tube and secondary otomastoiditis); nonnecrotizing external otitis (no osseous erosion); cholesteatoma of EAC; squamous cell carcinoma of EAC\n\n# MIKULICZ DISEASE \n\n$=$ painless bilateral symmetric swelling of lacrimal and salivary glands (parotid ( $80 \\%$ ), submandibular, sublingual)\n[Jan Mikulicz-Radecki (1850-1905), Polish-Austrian surgeon at universities in Kraków, Königsberg and Wrocław]\nAge: $6^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 3$ to $4 \\div 5$\nHisto: \"epimyoepithelial islands\" = marked lymphoplasmacytic infiltration surrounding epithelial nests, excess hyaline basement membrane material, acinar atrophy and destruction\nOften associated with: IgG4-related disease, Sjögren syndrome\n$\\sqrt{ }$ homogeneous attenuation + enhancement of involved glands\nCT:\n$\\checkmark$ intermediate soft-tissue attenuation\nMR:\n$\\sqrt{ }$ low signal intensity (= isointense to muscle) on T1WI\n$\\checkmark$ homogeneous low to intermediate SI on T2WI $\\leftarrow$ increased cellularity + fibrosis\n$D D x$ : viral infection (mumps), acute phase of Sjögren syndrome, sarcoidosis, lymphoma, leukemia\n\n## MUCOCELE\n\n$=$ end stage of a chronically obstructed sinus\nFrequency: increased incidence in cystic fibrosis\n$\\diamond$ Most common lesion to cause expansion of paranasal sinus!\nEtiology: chronic obstruction of paranasal sinus ostium\nPath: expanded sinus cyst lined by mucosa + filled with accumulated secretions and desquamations\nAge: usually adulthood\n\n- history of chronic nasal polyposis + pansinusitis\n- commonly present with unilateral proptosis\n- $\\downarrow$ visual acuity, visual field defect, intractable headaches\n- palpable mass in superomedial aspect of orbit (frontal mucocele)\n\nLocation:\nmnemonic: fems\nfrontal $(60 \\%)>$ ethmoid $(30 \\%)>$ maxillary $(10 \\%)>$ sphenoid (rare)\n$\\checkmark$ expanded airless sinus filled with homogeneous mucoid material\nN.B.: Presence of air in an affected sinus effectively rules out a mucocele!\n$\\checkmark$ sinus cavity expansion (DDx: never in sinusitis)\n$\\checkmark$ bone demineralization + remodeling at late stage but NO bone destruction (impossible DDx",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 291,
            "markdown": "from neoplasm)\n$\\sqrt{ }$ surrounding zone of bone sclerosis / calcification at edges of mucocele (from chronic infection)\n$\\sqrt{ }$ macroscopic calcification in $5 \\%$ (especially with superimposed fungal infection)\n$\\sqrt{ }$ uniform enhancement of thin rim\nUS:\n$\\sqrt{ }$ homogeneous hypoechoic mass\nMR:\n$\\sqrt{ }$ expansive well-delineated mass with homogeneously hyperintense T1 and T2 signal:\n$\\sqrt{ }$ signal intensity varies with state of hydration, protein content, hemorrhage, air content, calcification, fibrosis\n$\\sqrt{ }$ hypointense on T1WI + signal void on T2WI $\\leftarrow$ inspissated debris + fungus\n$\\sqrt{ }$ NO enhancement / peripheral enhancement pattern (DDx from solid enhancement pattern of neoplasms)\nCx: (1) Protrusion into orbit displacing medial rectus muscle laterally\n(2) Expansion into subarachnoid space $\\rightarrow$ CSF leak\n(3) Mucopyocele = superimposed infection (rare)\nRx: followed (if asymptomatic); surgical drainage (if symptomatic)\n$D D x$ : paranasal sinus carcinoma, mucus retention cyst, Aspergillus infection (enlargement of medial rectus muscle + optic nerve, focal / diffuse areas of increased attenuation), chronic infection, inverting papilloma\n\n# MUCOEPIDERMOID CARCINOMA \n\nPath: arises from intercalated ducts of seromucinous glands\nHisto: composed of a mixture of 3 cells: mucin-secreting cells + squamous cells + mucous cells; arranged in cords / sheets / cystic configuration\nAge: $30-50$ years\nPrognosis: variable (well-encapsulated low-grade to infiltrating highly aggressive malignancy)\nRx: complete surgical removal\n\n## Parotid Mucoepidermoid Carcinoma\n\n$\\diamond$ Most common malignant lesion of parotid gland\n$\\diamond$ In children: up to $35 \\%$ of all salivary gland tumors are malignant ( $60 \\%$ are mucoepidermoid carcinomas)\n\n- rock-hard mass; facial nerve paralysis\n- pain / itching along course of facial nerve\n\nCT:\n$\\sqrt{ }$ may contain cystic low-attenuating areas\n$\\sqrt{ }$ focal calcifications (rare)\n(a) low-grade lesion:\n$\\sqrt{ }$ well-circumscribed parotid mass\n$\\sqrt{ }$ hypo- to isointense on T1WI\n$\\sqrt{ }$ hyperintense on T2WI\nRx: wide local excision",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 292,
            "markdown": "(b) high-grade lesion:\n$\\sqrt{ }$ infiltrating poorly marginated, more solid, relatively homogeneous lesion with few cystic areas\n$R x$ : wide block excision + radical neck dissection\n\n# Laryngeal Mucoepidermoid Carcinoma \n\nPrevalence: $\\sim 100$ cases\n$\\mathrm{M} \\div \\mathrm{F}=6 \\div 1$\nLocation: epiglottis (most common)\n\n## MUCOUS RETENTION CYST\n\n$=$ obstructed submucosal mucinous gland\n$\\sqrt{ }$ partially surrounded by air\n$D D x$ : indistinguishable from polyps, mucocele (NEVER surrounded by air)\n\n## NASAL GLIOMA\n\nmisnomer (no neoplastic features) $=$ NASAL CEREBRAL HETEROTOPIA\n$=$ rare congenital mass composed of dysplastic sequestered neurogenic tissue (= distal part of a cephalocele in extracranial location) that has become isolated from the subarachnoid space (= disrupted central connection); analogous to nasoethmoidal encephalocele\nAge: usually identified at birth\nLocation: (a) extranasal ( $60 \\%$ )\nSite: paramedian at bridge of nose external to nasal passage\n(b) intranasal $(30 \\%)$\n\nSite: within nasal passage medial to middle turbinate\n(c) combination of intra- and extranasal ( $10 \\%$ )\n\nSite: root of nose; unilateral right > left side\n\n- smooth firm noncompressible mass, covered by skin\n- no change in size during crying\n$\\sqrt{ }$ no growth / very little growth / growth similar to brain\n$\\sqrt{ }$ attached to middle turbinate bone / nasal septum\n$\\sqrt{ }$ foramen cecum may be deeper than normal\n$\\sqrt{ } \\pm$ small and bifid crista galli (intracranial extension likely)\n$\\sqrt{ }$ soft-tissue mass of glabella\n$\\sqrt{ }$ attached to brain by stalk of tissue (in $1-15-30 \\%$ )\n$\\diamond$ NO communication with subarachnoid space by fluid-filled tract as in encephalocele\nMR (method of choice):\n$\\sqrt{ }$ iso- / hypointense relative to normal gray matter on T1WI\n$\\sqrt{ }$ hyperintense on T2WI (as a result of gliosis)\n$\\sqrt{ }$ contrast enhancement may depict tract to frontobasal region\n$D D x$ : encephalocele (communicates with subarachnoid space)\n\n\n## ODONTOGENIC INFECTION\n\nSpread:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 293,
            "markdown": "(1) dental caries $\\rightarrow$ bacteria enter tooth and spread to apex (root) $\\rightarrow$ apical periodontitis, granuloma, abscess, radicular cyst formation\n(2) bacterial overgrowth + inflammation in space between tooth and gum $\\rightarrow$ destruction of periodontal ligaments $\\rightarrow$ erosion of bone\n\n# Odontogenic Abscess \n\n- fever, tooth pain, facial swelling, dysphagia, trismus\n- possibly dyspnea\n\nCT:\n$\\checkmark$ periodontal lucency with focal cortical break / fistula\n$\\checkmark$ extraosseous fluid collection with rimlike enhancement\n$C x$ : spread of infection into deep spaces of neck and orbit, airway compromise, internal jugular vein thrombosis, intracranial extension of infection\n\n## OLFACTORY NEUROBLASTOMA\n\n$=$ very malignant tumor arising from olfactory mucosa\nTypes:\n\n1. Esthesioneuroepithelioma\n2. Esthesioneurocytoma\n3. Esthesioneuroblastoma\n$\\sqrt{ }$ mass in superior nasal cavity with extension into ethmoid + maxillary sinuses\n$C x$ : distant metastases in $20 \\%$\n\n## Esthesioneuroblastoma\n\n$=$ OLFACTORY NEUROBLASTOMA\nOrigin: olfactory epithelium\nAge peaks: young men $+50-60$ years\n\n- hyposmia, anosmia, nasal congestion, epistaxis, facial pain\n- headache, personality change (with frontal lobe involvement)\n- exophthalmos, ophthalmoplegia, visual loss\n\nLocation: centered on cribriform plate\n$\\checkmark$ erosion of cribriform plate and nasal septum\nMR:\n$\\checkmark$ tumor hypointense to brain on T1WI\n$\\checkmark$ tumor iso- or hyperintense to brain on T2WI\n$\\checkmark$ cysts along the superior tumor margin within anterior cranial fossa (CHARACTERISTIC)\n\n## OTIC CAPSULE DYSPLASIA\n\n## Single-cavity Cochlea\n\n$=$ cochlear cavity malformation\n$=$ saccular defect / cavity in otic capsule in the position normally occupied by cochlea without recognizable modiolus, osseous spiral lamina, interscalar septum\n\n- profound hearing loss discovered in early childhood",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 294,
            "markdown": "May be associated with: recurrent bacterial meningitis, perilymphatic fistula of oval window\n$\\sqrt{ }$ cystic cochlea (= developed basal turn, middle + apical turn occupy common nondeveloped space)\nType: (a) incomplete partition type I\n$=$ cystic cochleovestibular malformation\n$=$ complete lack of partitioning of cochlea\n$\\sqrt{ }$ cystic structure at CT\n(b) incomplete partition type II (see below)\n$=$ classic Mondini malformation\n\n# Insufficient Cochlear Turns \n\n$=$ normal basilar turn + varying degrees of hypoplasia of middle and apical turns\n\n## Mondini Malformation\n\nCause: in utero insult at 7 weeks GA\nFrequency: $2^{\\text {nd }}$ most common imaging finding in children with sensorineural hearing loss\n\n- some high-frequency hearing preserved; vertigo\n- otorrhea, rhinorrhea, recurrent meningitis (perilymphatic fistula caused by absence / defect of stapes footplate)\n$\\sqrt{ }$ cochlea contains $11 / 2$ turns:\n$\\sqrt{ }$ normal basal turn\n$\\sqrt{ }$ cystic-appearing dilated apical portion\n$\\sqrt{ }$ absence of cochlear apex\nMay be associated with: deformity of vestibule + semicircular canals + vestibular aqueduct\n\n\n## Labyrinthine Aplasia\n\n$=$ Michel aplasia $=$ Michel anomaly $=$ agenesis of osseous + membranous labyrinth (rare)\nCause: arrested development at 4 weeks GA\n\n- total sensorineural hearing loss\n$\\sqrt{ }$ region of otic capsule normally occupied by cochlea is replaced by dense labyrinthine + pneumatized bone\n$\\sqrt{ }$ flat medial wall of middle ear (= undeveloped horizontal semicircular canal)\n$\\sqrt{ }$ hypoplasia of internal auditory canal\n$\\sqrt{ }$ dysplasia of vestibule $=$ marked enlargement into region of lateral + superior semicircular canals\n$D D x$ : labyrinthitis obliterans (no loss of lateral convexity of medial wall of middle ear)\n\n\n## Anomalies of Membranous Labyrinth\n\nScheibe dysplasia $=$ abnormal cochlea + saccule\nAlexander dysplasia $=$ dysplasia of basal turn\n$\\sqrt{ }$ normal CT findings\n\n## Small Internal Auditory Canal\n\n$=$ decrease in the diameter of IAC $\\leftarrow$ hypoplasia / aplasia of cochlear nerve (portion of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 295,
            "markdown": "cranial nerve VIII)\n\n- total sensorineural hearing loss\n$\\sqrt{ }$ hypoplastic anteroinferior quadrant of IAC\n\n\n# Large Vestibule \n\nAssociated with: underdeveloped lateral semicircular canal\n\n- sensorineural hearing loss (most common cause)\n$\\sqrt{ }$ lateral semicircular canal smaller\n$\\sqrt{ }$ vestibule extends further into lateral + superior aspects of otic capsule\n\n\n## Large Vestibular Aqueduct\n\n$=$ ENLARGED VESTIBULAR AQUEDUCT SYNDROME\nAge: manifests around 3 years\nFrequency: most common imaging abnormality detected in children with sensorineural hearing loss (SNHL)\nMay be associated with: other inner ear abnormalities\n\n- unilateral congenital deafness (commonly missed)\n$\\diamond$ in $12 \\%$ of children with congenital SNHL\n- vertigo, tinnitus (in $50 \\%$ )\n\nLocation: bilateral in $50-66 \\%$\n$\\sqrt{ }$ vestibular aqueduct $>1.4-2 \\mathrm{~mm}$ in diameter (measured at halfway point between posterior petrous bone + common crus at level of vestibule)\n$\\sqrt{ }$ vestibular aqueduct larger than normal semicircular canals\n$\\sqrt{ }$ CLASSIC funnel-shaped deformity of dilated vestibular aqueduct $\\leftarrow$ enlarged endolymphatic sac housed within dorsal vestibular aqueduct\n\n## OTITIS MEDIA\n\nCx: (1) Otomastoiditis\n(2) Development of acquired middle ear cholesteatoma\n\n## Acute Otitis Media\n\n$\\diamond$ Most common infection of the temporal bone!\n$\\diamond$ Most common infection in first 5 years of life!\nCause: viral upper respiratory infection with disruption of the mucosal barrier $\\rightarrow$ bacteria in nose and nasopharynx spread to middle ear\nAge: infants + young children $>$ adults\nOrganism: Streptococcus species, Haemophilus influenzae\n\n- fever, otalgia, otorrhea; red bulging tympanic membrane\n$\\sqrt{ }$ partial / total fluid-attenuation opacification of middle ear $\\pm$ fluid level\n$\\sqrt{ }$ opacification of mastoid air cells\n\n\n## Chronic Otitis Media\n\n$=$ CHRONIC OTOMASTOIDITIS\n$=$ long-term damage to middle ear\nCause: long-standing eustachian tube dysfunction, perforation of tympanic membrane",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 296,
            "markdown": "Sequelae:\n$\\checkmark$ middle ear effusion\n$\\checkmark$ granulation tissue (no displacement / destruction)\n$\\checkmark$ cholesterol granuloma\n$\\checkmark$ cholesteatoma\n\n# OTOMASTOIDITIS \n\n$=$ serious complication of acute otitis media in children\nAnatomy: tympanic cavity communicates with mastoid air cells via the tympanic antrum (subject to viral and bacterial invasion by way of eustachian tube)\nAge: young children\nOrganism: Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus\n\n- retroauricular swelling + erythema, protrusion of auricle\n- history of recent otitis media\n\nTemporal bone CT ( $87 \\%-100 \\%$ sensitive):\n$\\checkmark$ increased attenuation of the middle ear cavity (= middle ear effusion)\n$\\checkmark$ increased attenuation of the mastoid cells\n$\\checkmark \\pm$ fluid levels\nIntratemporal Cx:\n(1) Coalescent mastoiditis $=$ empyema of mastoid\n\nPathomechanism: suppuration under pressure $\\rightarrow$ local acidosis + ischemia $\\rightarrow$ osseous decalcification + osteoclasis of pneumatic cell walls\n$\\checkmark$ loss of internal bone septa of the mastoid air cells $\\leftarrow$ erosion of mastoid septa / cortex with periosteal reaction\n$\\checkmark$ fluid or soft-tissue opacification of mastoid air cells\n$\\checkmark$ subperiosteal abscess located postauricular / in external auditory canal / along zygomatic bone\nRx: myringotomy, mastoidectomy\n(2) Petrositis $=$ petrous apicitis\n(3) Labyrinthitis\n\n- vertigo, nystagmus\n$\\checkmark$ abnormal labyrinthine enhancement\n(4) Facial nerve paralysis\n(5) Hearing loss\n\nCervical Cx:\n(1) Carotid artery involvement: arteritis, occlusion, pseudoaneurysm, rupture\n(2) Bezold abscess = inflammatory collection that may spread along plane of sternocleidomastoid muscle to lower neck\nLocation: inferior to mastoid tip + medial to insertion of posterior belly of digastric muscle\n$\\checkmark$ erosion of mastoid tip\n$\\checkmark$ adjacent involvement of posterior digastric muscle insertion\nCx: mediastinitis $\\leftarrow$ extension of infection inferiorly along fascial planes\nIntracranial Cx:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 297,
            "markdown": "(1) Meningitis\n(2) Epidural abscess\n> perisinus abscess = erosion of the cortical plate overlying the sigmoid sinus\n(3) Dural sinus / Sigmoid sinus thrombophlebitis\n\nCause: erosion of sigmoid plate / thrombophlebitic spread via emissary veins\nLocation: (commonly) sigmoid + transverse sinus\n\n- headache, otalgia, papilledema, fever\n$\\sqrt{ }$ sinus of low attenuation on NECT and CECT\n$\\sqrt{ }$ absence of normal flow void on spin-echo MR\n$\\sqrt{ }$ no flow-related enhancement on gradient-echo MR\n$\\sqrt{ }$ occlusion on MRV\n$D D x$ : aberrant arachnoid granulation\n(4) Subdural empyema\n\nRoute: communication through intact bone and dura with vessels in subarachnoid space + brain parenchyma\nLocation: along posterior interhemispheric fissure; tentorium cerebelli\n\n- meningismus, focal neurologic deficits, focal seizures\n$\\sqrt{ }$ widening of extracerebral space\n$\\sqrt{ }$ compression of adjacent sulci\n$R x$ : prompt neurosurgical drainage\n(5) Intraparenchymal brain abscess and empyema\n\n\n# OTOSCLEROSIS \n\n$=$ OTOSPONGIOSIS\n$=$ replacement of dense otic capsule by highly vascular spongy bone in active phase\n(otosclerosis = misnomer!) with restoration of density during reparative sclerotic phase\nEtiology: unknown; frequently hereditary\nAge: adolescent / young adult Caucasian; $\\mathrm{M}+\\mathrm{F}=1+2$\nHisto: otosclerosis limited to endochondral layer\n$D D x$ : Paget disease, osteogenesis imperfecta, syphilis\n\n## Stapedial = Fenestral Otosclerosis (80-90\\%)\n\nLocation: lateral wall of bony labyrinth, including oval and round windows, promontory, facial nerve canal\nSite: anterior oval window margin (= fissula ante fenestrum); bilateral in $85 \\%$\n\n- tinnitus early in course ( $5 / 8$ )\n- progressive conductive hearing loss (stapes fixation in oval window)\n$\\sqrt{ }$ oval window too wide (lytic phase)\n$\\sqrt{ }$ new bone formation on anterior oval window margin $\\pm$ posterior oval window margin $\\pm$ round window\n$\\sqrt{ }$ complete plugging of oval window = obliterative otosclerosis (in 2\\%)\n\nCochlear = Retrofenestral Otosclerosis (10-20\\%)\nLocation: otic capsule\nInvariably associated with: fenestral otosclerosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 298,
            "markdown": "- progressive sensorineural hearing loss (involvement of otic capsule / cytotoxic enzyme diffusion into fluid of membranous labyrinth)\n- Schwartze sign = reddish hue behind tympanic membrane when promontory involved\n$\\checkmark$ \"double ring / double lucent\" = lucent halo around cochlea (may appear as $3^{\\text {rd }}$ turn to cochlea) in early phase\n$\\checkmark$ bony proliferation in reparative sclerotic phase difficult to diagnose because of same density as cochlea",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 299,
            "markdown": "# PAPILLARY ENDOLYMPHATIC SAC TUMOR \n\n$=$ HEFFNER TUMOR\n$=$ locally invasive papillary cystadenomatous tumor of temporal bone\nOrigin: epithelial lining of endolymphatic sac\nAssociated with: von Hippel-Lindau disease (in 7\\%), which may have bilateral papillary endolymphatic sac neoplasms\n\n- hearing loss, facial nerve palsy, vestibular dysfunction\n\nLocation: along posterior petrous apex (retrolabyrinthine petrous bone) typically involving vestibular aqueduct\nCT:\n$\\checkmark$ moth-eaten lytic appearance of invaded bone surrounded by thin shell of reactive bone:\n$\\checkmark$ solid + cystic components\n$\\checkmark$ intratumoral calcifications = \"bone sequestra\" from destruction of petrous bone\n$\\checkmark$ may be hypervascular (supplied by branches of external carotid artery)\nMR:\n$\\checkmark$ speckled pattern of hyperintensity on T1WI (mimicking glomus tumor)\n$\\checkmark$ commonly contains blood products (hyperintense on T1WI + hypointense on T2WI)\n$\\checkmark$ areas of low SI may represent hemosiderin\n$\\checkmark$ heterogeneous enhancement\n$D D x$ : paraganglioma, cystic and papillary adenocarcinoma, chondroid lesions (benign chondroma, low-grade chondrosarcoma, chondromyxoid fibroma), cholesterol granuloma, metastatic disease\n\n## PARAGANGLIOMA\n\n$=$ NONCHROMAFFIN PARAGANGLIOMA $=$ GLOMUS TUMOR (describes the rich arborization of blood vessels and nerves) $=$ CHEMODECTOMA (reflective of chemoreceptor tissue of origin) $=$ GLOMERULOCYTOMA $=$ ENDOTHELIOMA $=$ PERITHELIOMA $=$ SYMPATHOBLASTOMA $=$ FIBROANGIOMA $=$ SYMPATHETIC NEVI\n$=$ rare neuroendocrine tumor arising from paraganglionic tissue found between base of skull and floor of pelvis; belongs to amine-precursor-uptake decarboxylation (APUD) system characterized by cytoplasmic vesicles containing catecholamines\nParaganglion $=$ collection of tissue of the extraadrenal neuroendocrine system, frequently located near nerves and vessels with special chemoreceptor function\nOrigin: arises from nonchromaffin paraganglion cells of neuroectodermal origin (= neural crest cells found in adrenal medulla + parasympathetic ganglia + chemoreceptors); differs from adrenal medulla only in its nonchromaffin feature\n\n## Terminology of Neuroendocrine System:\n\n(a) Adrenal paraganglioma arising from adrenal medulla $=$ pheochromocytoma\n(b) Extraadrenal pheochromocytoma\n$=$ pheochromocytoma arising from organs of Zuckerkandl\n(c) Paraganglioma $(10 \\%)$\n$=$ pheochromocytoma arising in other extraadrenal locations like retroperitoneum, bladder, GI tract",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 300,
            "markdown": "1. Aorticosympathetic paraganglioma associated with sympathetic chain + retroperitoneal ganglia\n2. Parasympathetic paraganglioma including branchiomeric chemodectoma, vagal + visceral autonomic paraganglioma\nClassification of extraadrenal paragangliomas (Glenner):\nA. BRANCHIOMERIC DISTRIBUTION\n3. Associated with great vessels of chest + neck including carotid body, glomus jugulare, glomus tympanicum\nB. PARASYMPATHETIC DISTRIBUTION\n4. Associated with vagal nerve\n5. Associated with aorticosympathetic chain in thoracolumbar region from aortic arch to urinary bladder, including organ of Zuckerkandl at origin of inferior mesenteric artery\n6. Associated with visceral organs\n\nHisto: acidophil-epithelioid cells in contact with endothelial cells of a vessel; storage of catecholamines (usually nonfunctioning); histologically similar to pheochromocytoma\nPeak age: $5^{\\text {th }}-6^{\\text {th }}$ decade (range, 6 months to 80 years); $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n\n- tumor may secrete catecholamine in $40 \\%$ (= functional paraganglioma); proportion of hormonally active tumors high for pheochromocytomas, intermediate for aorticosympathetic paragangliomas, low for parasympathetic paragangliomas\n- paroxysmal / permanent hypertension $\\leftarrow$ secretion of vasopressor amines responsible for:\n> pain in head (headache)\n> pallor\n> perspiration (excessive sweating)\n> palpitations\n- elevated urinary metanephrine / vanillylmandelic acid\n- pheochromocytomas secrete norepinephrine + epinephrine, extraadrenal paragangliomas secrete only norepinephrine, some paragangliomas produce dopamine\n- determination of free norepinephrine most sensitive with gas chromatography / high-pressure liquid chromatography (HPLC) performed on 24-hour urine specimens\n\nLocation of functioning paragangliomas:\n(a) adrenal medulla ( $>80 \\%$ )\n(b) extraadrenal intraabdominal ( $8-16 \\%$ )\n(c) extraadrenal in head \\& neck ( $2-4 \\%$ )\n\nFour primary sites in head \\& neck:\n\n1. Carotid body\n2. Jugular foramen\n3. Path of vagus nerve\n4. Middle ear\n\nLess common sites in head \\& neck:\nsella turcica, pineal gland, cavernous sinus, larynx (laryngeal branches of vagus nerve), orbit (ciliary ganglion of the eye), thyroid gland, nasopharynx, mandible, soft palate, face, cheek\n(d) spinal paraganglioma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 301,
            "markdown": "(e) multiple paragangliomas, particularly in hereditary disorders (multiple endocrine neoplasia syndromes (MEN 2a and 2b) + neuroectodermal disorders of neurofibromatosis type 1, von Hippel-Lindau syndrome):\nsynchronous multicentricity in 3-26\\%:\n> autosomal dominant in $25-35 \\%$\n$>$ nonhereditary in $<5 \\%$\n$\\sqrt{ }$ highly vascular tumor with intense early blush that persists into late arterial + venous phases\n$\\sqrt{ }$ well-circumscribed iso- to hyperintense mass on T2WI\n$\\sqrt{ }$ flow voids $\\leftarrow$ multiple small serpentine + arborizing vessels\n$\\sqrt{ }$ frequent hemorrhage with \"cap\" sign (= hypointense rim)\nCx: malignant transformation in $2-10 \\%$\n\n# Carotid Body Tumor \n\n## Embryology:\n\nderived from mesoderm of $3^{\\text {rd }}$ branchial arch + neural crest ectoderm cells, which differentiate into sympathogonia ( $=$ forerunner of paraganglionic cells)\n$\\diamond$ Chemodectoma is misnomer (NOT derived from chemoreceptor cells)!\nHisto: nests of epithelioid cells (\"Zellballen\") with granular eosinophilic cytoplasm separated by trabeculated vascularized connective tissue\n$\\diamond$ Chromaffin-positive granules (= catecholamines) may be present\nFunction of carotid body:\n$5 \\times 3 \\times 2 \\mathrm{~mm}$ carotid body regulates pulmonary ventilation through afferent input by way of glossopharyngeal nerve to the medullary reticular formation\nChemoreceptor: detects changes in arterial partial pressures of $\\mathrm{O}_{2}+\\mathrm{CO}_{2}+\\mathrm{pH}$\nStimulus: hypoxia $>$ hypercapnia $>$ acidosis\nEffect: increase in respiratory rate + tidal volume; increase in sympathetic tone (heart rate, blood pressure, vasoconstriction, elevated catecholamines)\n\n- painless pulsatile firm neck mass below the angle of the jaw, laterally mobile but vertically fixed\nLocation: within / outside adventitial layer of CCA at level of carotid bifurcation, commonly along posteromedial wall; bilateral in $5 \\%$ with sporadic occurrence, in $32 \\%$ with autosomal dominant transmission\n$\\sqrt{ }$ enhancing oval mass with splaying of ICA + ECA above CCA bifurcation\n$\\sqrt{ }$ no narrowing of ICA / ECA caliber\nExtension: inferiorly to lower cranial nerves + pharynx; superiorly to skull base + intracranial cavity\nGrowth rate: about 5 mm per year\nCx: malignant transformation in $6 \\%$ with metastases to regional lymph nodes, brachial plexus, cerebellum, lung, bone, pancreas, thyroid, kidney, breast\n\n\n## Jugulotympanic Paraganglioma\n\n$=$ large glomus tumor with 2 components in the middle ear + jugular foramen\nAge: $\\quad 4^{\\text {th }}-6^{\\text {th }}$ decade; $\\mathrm{M}+\\mathrm{F}=1+4$\nLocation: margin of jugular foramen\nNUC:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 302,
            "markdown": "$\\sqrt{ }^{\\text {111 }}$ In-octreotide (higher sensitivity)\n$\\sqrt{ }^{\\text {123 }}$ I-metaiodobenzylguanidine (lower sensitivity)\n$R x$ : embolization of larger tumor prior to surgery\n\n# Glomus Tympanicum Tumor \n\nMost common tumor in middle ear\n\n- hearing loss, pulsatile tinnitus\n- reddish purple mass behind tympanic membrane\n\nOrigin: nerve of Jacobson = jugulotympanic paraganglia cells along tympanic branch of glossopharyngeal $n$.\nLocation: tympanic plexus on cochlear promontory of middle ear\nCT (bone algorithm preferred):\n$\\checkmark$ globular soft-tissue mass abutting promontory\n$\\checkmark$ intense enhancement\n$\\checkmark$ usually small at presentation (but with early involvement of ossicles)\n$\\checkmark$ erosion + displacement of ossicles\n$\\checkmark$ inferior wall of middle ear cavity intact\nAngio:\n$\\checkmark$ difficult to visualize because of small size\n\n## Glomus Jugulare Tumor\n\n$\\diamond$ Most common tumor in jugular fossa with intracranial extension\nOrigin: adventitia of jugular vein arising from paraganglia cells along nerves of Jacobson / Arnold\n\n- tinnitus, hearing loss; vascular tympanic membrane\n\nLocation: at dome of jugular bulb\n$\\sqrt{ }$ soft-tissue mass in jugular bulb region / hypotympanum / middle ear space\n$\\sqrt{ }$ intense enhancement\n$\\sqrt{ }$ destruction of posteroinferior petrous pyramid + corticojugular spine of jugular foramen\n$\\sqrt{ }$ destruction of ossicles (usually incus), otic capsule, posteromedial surface of petrous bone\nMR:\n$\\sqrt{ }$ \"salt and pepper\" appearance on T1WI + T2WI $\\leftarrow$ multiple small serpentine + arborizing tumor vessels in large tumor\n$\\checkmark$ intense enhancement in small tumor\nAngio: (film entire neck for concurrent glomus tumors!)\n$\\checkmark$ enlarge feeding arteries + rapidly draining veins:\n$\\checkmark$ arteriovenous shunting\n$\\checkmark$ hypervascular mass with persistent homogeneous reticular stain\n$\\checkmark$ invasion / occlusion of jugular bulb by thrombus / tumor\n$\\checkmark$ supplied by tympanic branch of ascending pharyngeal artery, meningeal branch of occipital artery, posterior auricular artery via stylomastoid branch, internal carotid artery, internal maxillary artery\n$C x$ : malignant transformation with metastases to regional lymph nodes (in 2-4\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 303,
            "markdown": "# Glomus Vagale Tumor \n\n$=$ PARAGANGLIA OF VAGUS NERVE $=$ VAGAL BODY TUMOR\nHisto: dispersed within perineurium / below nerve sheath / between nerve fiber fascicles; not organized into a compact mass\nLocation:\n(1) within inferior ganglion (= ganglion nodosum), inferior to base of skull close to jugular foramen (most common location)\n(2) within superior ganglion (= ganglion jugulare) within base of skull at level of jugular bulb\n(3) elsewhere along course of vagus nerve\n\n## Inferior Nodose Paraganglion\n\n$\\checkmark$ spindle-shaped mass\n$\\checkmark$ compression of internal jugular vein\n$\\checkmark$ displacement of carotid vessels anteromedially\n$\\checkmark$ displacement of lateral pharyngeal wall medially\n$\\checkmark$ minimal destruction of skull base\n\n## Superior Jugular Paraganglion\n\n$\\checkmark$ dumbbell-shaped mass\n$\\checkmark$ may encase / displace ICA\nLocation in temporal bone:\n(1) dome of jugular bulb = intravagal paraganglia inferior to jugular foramen\n(2) mucosa of cochlear promontory related to tympanic branch of glossopharyngeal nerve (Jacobson nerve)\n(3) auricular branch of vagus nerve (Arnold nerve)\n\n## Extension:\n\n(a) superiorly into posterior cranial fossa $\\pm$ compression of brainstem\n(b) inferiorly into infratemporal / parapharyngeal space ( $5 / 8$ )\n(c) medially to involve arch of atlas\n(d) laterally into middle ear structures\n(e) posteriorly into mastoid air cells\n\n- slow growing + asymptomatic\n$\\sqrt{ }$ spherical / ovoid / spindle-shaped mass with sharp interfacing margins and homogeneous enhancement\n$\\checkmark$ highly vascular mass + neovascularity + intense tumor blush\n$C x$ : malignant transformation + metastases in $15 \\%$ to regional lymph nodes + lung (for other paragangliomas in $10 \\%$ )\n\n\n## PARANASAL SINUS CARCINOMA\n\nLocation: maxillary sinus ( $80 \\%$ ), nasal cavity ( $10 \\%$ ), ethmoid sinus ( $5-6 \\%$ ), frontal + sphenoid sinus (rare)\n\n## Maxillary Sinus Carcinoma (80\\%)\n\nHisto: squamous cell carcinoma ( $80 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 304,
            "markdown": "Age: $\\quad>40$ years in $95 \\% ; \\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\n\n- asymmetry of face, tumor in oral / nasal cavity\n$\\checkmark$ bone destruction (in $90 \\%$ ) predominates over expansion\n$\\checkmark$ nodal metastases in $10-18 \\%$\n\n\n# Nasopharyngeal Carcinoma (10\\%) \n\nFrequency: $0.25-0.5 \\%$ of all malignant tumors in whites; $\\mathrm{M}>\\mathrm{F}$\nPredisposed: Chinese population\nHisto: squamous cell carcinoma ( $>85 \\%$ ), nonkeratinizing carcinoma, undifferentiated carcinoma\nMean age: 40 years\n\n- asymptomatic for a long time; unilateral nasal obstruction\n- history of chronic sinusitis / nasal polyps (15\\%)\n\nLocation: turbinates ( $50 \\%$ ) > septum $>$ vestibule $>$ posterior choanae $>$ floor\nExtension:\n(a) lateral + superior: through sinus of Morgagni ( $=$ natural defect in superior portion of lateral nasopharyngeal wall) into cartilaginous portion of eustachian tube + levator veli palatini muscle\n$\\pm$ masticator space and pre- and poststyloid parapharyngeal spaces\n$\\pm$ involvement of levator + tensor veli palatini muscle, $3^{\\text {rd }}$ division of nerve $V$, petroclinoid fissure\n$\\pm$ foramen lacerum of skull base encasing ICA\n$\\pm$ cavernous sinus (along ICA / mandibular nerve / direct skull base invasion)\n(b) anterior: posterior nasal cavity + pterygopalatine fossa\n(c) inferior ( $1 / 2$ ): submucosal spread along lateral pharyngeal wall + anterior and posterior tonsillar pillars\n$\\checkmark$ polypoid or papillary $(2 / 3)$\n$\\checkmark$ bone invasion $(1 / 2)$\nMR:\n$\\checkmark$ asymmetric thickening of nasopharyngeal mucosa\n$\\checkmark$ homogeneous intermediate SI similar to that of adjacent mucosa on T2WI\n$\\checkmark$ moderate contrast enhancement less than that of normal mucosa on T1WI\n$\\checkmark$ focal homogeneous enhancing mass\n\n## Ethmoid Sinus Carcinoma (5-6\\%)\n\nHisto: squamous cell carcinoma ( $>90 \\%$ ), sarcoma, adenocarcinoma, adenoid cystic carcinoma; frequently secondarily involved from maxillary sinus carcinoma\n\n- nasal obstruction, bloody discharge\n- anosmia, broadening of nose\n\n\n## PARATHYROID ADENOMA\n\nLocation: posterior to thyroid gland; ectopic in 5-15\\%\nUS ( $82 \\%$ sensitive):\n$\\diamond$ Often used after localization with ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-MIBI scintigraphy\n$\\checkmark$ well-defined oval hypoechoic mass",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 305,
            "markdown": "$\\sqrt{ }$ multilobulated mass $\\pm$ echogenic areas (in large adenoma)\nCT:\nIndication: ectopic mediastinal adenoma (detected in 50\\%)\nMR:\n$\\sqrt{ }$ hypointense on T1WI, hyperintense on T2WI + STIR\nNUC ( ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-MIBI):\n$\\sqrt{ }$ increased radiotracer uptake\n\n# PAROTID HEMANGIOMA \n\nFrequency: $90 \\%$ of parotid gland tumors during $1^{\\text {st }}$ year of life; $\\mathrm{M}<\\mathrm{F}$\nHisto: capillary type $>>$ cavernous type (in older children)\n\n- soft-tissue mass developing shortly after birth with progressive growth peaking at age 1-2 years\n- gradual spontaneous regression usually complete by adolescence\n\nUS:\n$\\checkmark$ hypoechoic mass relative to parotid tissue\n$\\checkmark$ variable degree of abnormal flow\nCT:\n$\\checkmark$ occasionally phleboliths\n$\\checkmark$ well-defined mass with uniform intense enhancement\nMR:\n$\\checkmark$ low to intermediate signal intensity on short TR\n$\\checkmark$ bright signal intensity on long TR\n$\\checkmark$ flow voids due to prominent vasculature\n$R x$ : surgery, sclerotherapy, laser ablation (therapy only with large size + encroachment on adjacent structures due to spontaneous regression)\n\n## PENDRED SYNDROME\n\n[Vaughan Pendred (1869-1946), English general practitioner]\n$=$ autosomal recessive disorder of chromosome 7 characterized by dyshormonogenic goiter associated with sensory-neural deafness\nCause: deficient protein that functions as a membrane-bound chloride-iodine transporter\n\n- slowly progressive + fluctuating / profound hearing loss\n- prelingual deafness ( $=$ hearing loss prior to the age at which speech is acquired)\n- vestibular symptoms\n- euthyroid / variable degrees of hypothyroidism\n- positive perchlorate discharge test ( $=10-80 \\%$ of iodine taken up by thyroid is discharged by perchlorate $\\leftarrow$ organification defect)\n$\\checkmark$ multinodular goiter\n$\\checkmark$ absence of interscalar septum of modiolus (= central bony spiral of cochlea) in 20-75\\%; bilateral in $80 \\%$\n$\\checkmark$ enlargement of vestibular duct in $80-100 \\%$\n\n\n## PERIODONTAL DISEASE",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 306,
            "markdown": "- facial swelling, pain, dysphagia, dysphonia\n\nLocation:\n(a) submandibular space: roots of $2^{\\mathrm{nd}} / 3^{\\mathrm{rd}}$ molar tooth reach inferior to mylohyoid muscle\n(b) sublingual space: roots of teeth anterior to $2^{\\mathrm{nd}} / 3^{\\mathrm{rd}}$ molar remain above mylohyoid muscle CT:\n$\\sqrt{ }$ rimlike enhancement of fluid collection (abscess), cellulitis, myositis\n$\\sqrt{ }$ cortical dehiscence commonly on lingual aspect of mandible\n$\\checkmark$ permeative bone changes, osseous destruction, periosteal reaction\n$C x$ : descending necrotizing mediastinitis\n$R x$ : tooth extraction, abscess drainage, IV antibiotics\n\n# PERITONSILLAR ABSCESS \n\n$=$ complication of untreated / incompletely treated tonsillitis\n$\\diamond$ Most commonly encountered deep neck infection among adolescents + young adults!\nPrevalence: $1 / 3$ of all soft-tissue abscesses of head \\& neck\nOrganism: $\\beta$-hemolytic Streptococcus, Staphylococcus aureus, pneumococcus, Haemophilus influenzae\n\n- severe unilateral sore throat, dysphagia, otalgia, trismus\n- tender cervical lymphadenopathy\n- pharyngotonsillar exudate, fever\n\nImaging: (1) Diagnosis uncertain\n(2) Limited clinical examination (severe trismus)\n(3) Suspected infection of deep neck space\n(4) Failed response to therapy\n\nLocation: between tonsillar capsule and pillar\nCECT ( $75 \\%$ specific, $99 \\%$ sensitive):\n$\\checkmark$ tonsillar enlargement: $\\sqrt{ }$ \"kissing tonsils\" = medial apposition of enlarged tonsils\n$\\checkmark$ mass effect on oropharynx\n$\\checkmark$ linear striated enhancement of palatine tonsil + posterior pharyngeal soft tissue\n$\\checkmark$ central liquefaction + surrounding rimlike enhancement\n$\\diamond$ Commonly FP due to phlegmon!\nSite: peritonsillar abscess typically along superior tonsillar pole (= potential space between tonsillar capsule + superior constrictor muscle)\n$\\checkmark$ true tonsillar abscess (rare)\n$C x$ : extension of infection into parapharyngeal + masticator + submandibular space\n$R x$ : needle aspiration, surgical drainage\n$D D x$ : tonsillitis; phlegmonous infection; necrotic retropharyngeal lymph node\n\n## PERSISTENCE OF STAPEDIAL ARTERY\n\n$=$ rare congenital vascular anomaly due to failure of regression of the embryonic stapedial artery that connects branches of the future external carotid artery to internal carotid artery\nPrevalence: $\\quad 1 \\div 5,000$\nMay be associated aberrant ICA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 307,
            "markdown": "with:\nOrigin:\nCourse:\n\n- pulsatile tinnitus\n- conductive hearing loss $\\leftarrow$ ankylosis of stapes\n- sensorineural hearing loss $\\leftarrow$ erosion of otic capsule (rare)\n$\\checkmark$ enlarged / separate tympanic segment of facial nerve canal\n$\\checkmark$ abnormal linear soft-tissue density crossing over cochlear promontory\n$\\checkmark$ absent / hypoplastic ipsilateral foramen spinosum\n$\\checkmark$ absence of normal origin of middle meningeal artery\n\n\n# PHARYNGEAL ABSCESS \n\nEtiology: spread of infection from tonsils / pharynx\nAge: children $>$ adults\n\n- trismus (most common presenting symptom) from involvement of pterygoid muscle, sore throat, low-grade fever\n$\\checkmark$ isodense / low-density mass with unsharp margins\n$\\checkmark$ rim enhancement\n$C x$ : mycotic aneurysm of carotid artery (within 10 days)\n\n\n## PINDBORG TUMOR\n\n[Jens Pindborg (1921-1995), Danish oral pathologist in Copenhagen]\n$=$ CALCIFYING EPITHELIAL ODONTOGENIC TUMOR\nFrequency: $0.17-1.8 \\%$ of all odontogenic tumors\nAge: $20-60$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nHisto: epithelial cells in a fibrous stroma\nAssociated with: crown of impacted tooth\nLocation: premolar / molar region of mandible ( $3 / 4$ ), maxilla ( $1 / 4$ )\n$\\checkmark$ perichondral lucencies\n$\\checkmark$ radiolucent with scattered calcified components\nCT:\n$\\checkmark$ diffuse highly attenuated foci = intralesional calcifications\nMR:\n$\\checkmark$ predominantly low signal intensity on T1WI\n$\\checkmark$ high signal intensity on T2WI\n$\\checkmark$ heterogeneous contrast enhancement\n\n## PLEOMORPHIC ADENOMA\n\n$=$ BENIGN MIXED TUMOR OF PAROTIS\nFrequency: $80 \\%$ of all benign parotid tumors; $3^{\\text {rd }}$ most common tumor in pediatric parotid gland (after hemangioma + lymphangioma)\nHisto: mixture of epithelial + myoepithelial cells\nAge: usually $>50$ (range, $30-70$ ) years; $\\mathrm{M}<\\mathrm{F}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 308,
            "markdown": "- slow-growing asymptomatic hard painless lump in cheek\n\nLocation: usually solitary + unilateral\nmnemonic: $80 \\%$ in parotid gland\n$80 \\%$ in superficial lobe\n$80 \\%$ benign\n$\\checkmark$ lobulated round / oval sharply marginated mass\n$\\checkmark$ rarely dystrophic calcifications\n$\\checkmark$ variable, usually mild contrast enhancement\nUS:\n$\\checkmark$ hypo- to isoechoic well-defined lobulated mass\n$\\checkmark$ posterior acoustic enhancement\n$\\checkmark$ homogeneous well-defined tumor (if small)\n$\\checkmark$ less well-defined with low-density center if large (mucoid matrix, hemorrhage, necrosis)\n$\\checkmark \\pm$ hyperechogenic shadowing foci of calcifications\n$\\checkmark$ often poor / absent / occasionally abundant vascularity\nMR:\n$\\checkmark$ hypointense on T1WI + hyperintense mass on T2WI\n$\\checkmark$ hyperintense areas in center (mucoid matrix)\n$C x$ : malignant transformation after decades ( $=$ carcinoma ex pleomorphic adenoma, typically after $10-15$ years); usually multifocal recurrence after inadequate surgery\n$R x$ : facial nerve-sparing partial parotidectomy\n\n# RANULA \n\n$=$ mucus retention cyst / mucocele $\\leftarrow$ obstruction of sublingual / adjacent minor salivary gland Classification:\n(a) confined to sublingual space; occasionally in submandibular space $\\leftarrow$ herniation\nsimple: through mylohyoid defect / arising from ectopic sublingual gland\n(b) extends to below mylohyoid muscle into submandibular space\ndiving:\nCause: trauma / inflammation of salivary gland\nOrigin: sublingual gland / minor salivary gland\n\n- swelling in floor of mouth\n\nUS:\n$\\checkmark$ simple cystic (anechoic) lesion deep to mylohyoid muscle\n$\\checkmark \\pm$ fine internal echoes $\\leftarrow$ debris\nMR:\n$\\checkmark$ lesion of high SI in sublingual space on T2WI\n$\\checkmark \\pm$ abnormally high SI on T1WI $\\leftarrow$ high protein content\n\n## Plunging / Diving Ranula\n\n$=$ pseudocyst ( $=$ no epithelial lining) in submandibular space\nCause: ruptured sublingual gland retention cyst\n\n- gradually enlarging painless mass in submental / submandibular triangle\n\nLocation: posterior extension into submental / submandibular space with narrow tail to",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 309,
            "markdown": "floor of mouth\nSize: $\\quad<6 \\mathrm{~cm}$ in largest diameter\n$\\sqrt{ }$ continuous cystic mass of comet-tail shape:\n$\\sqrt{ }$ head of the comet $=$ submandibular space component\n$\\sqrt{ }$ tail of the comet $=$ component pointing toward sublingual space\n$\\sqrt{ }$ constriction at myohyoid muscle\n\n# RETROPHARYNGEAL ABSCESS / HEMORRHAGE \n\n$=$ PREVERTEBRAL ABSCESS\n$=$ spread of infection within retropharyngeal space\n$\\diamond$ In neck $2^{\\text {nd }}$ most common location after peritonsillar abscess\nEtiology: tonsillitis, suppurative lymphadenitis, pharyngitis, otitis media, infection of oral cavity, dental infection, sinusitis, penetrating trauma of pharynx / esophagus, diskitis, osteomyelitis\nOrganism: Staphylococcus aureus, H influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Bacteroides melaninogenicus, typically mixed polymicrobial flora\nPath: cellulitis $>$ abscess\nAge: usually 2-4 (range, 1-6) years (atrophy of nodes with age)\n\n- history of upper respiratory tract infection\n- fever, sore throat, neck stiffness, dysphagia, cough, sepsis\n\nLateral neck radiograph:\n$\\sqrt{ }$ thickness of retropharyngeal space $>3 / 4$ of AP diameter of vertebral body:\n$\\sqrt{ }$ may contain locules of gas / gas-fluid levels\n$\\sqrt{ }$ reversal of cervical lordosis\n$\\sqrt{ }$ anterior bowing / displacement of airway\nN.B.: look carefully for possible ingested foreign body\n\nDDx: \"pseudothickening\" (common in pediatric patients) $\\leftarrow$ neck flexion / incomplete inspiration\nUS:\n$\\sqrt{ }$ hypoechoic areas + adenopathy\nCECT (obligatory with concern for abscess):\n$\\sqrt{ }$ hypoattenuating ovoid fluid collection\n$\\sqrt{ }$ loss of normal bow-tie shape of retropharyngeal space\n$\\sqrt{ }$ complete irregular circumferential rimlike enhancement (HALLMARK)\n$D D x:$ partial / NO enhancement $=$ phlegmon\n$C x$ : (1) Inferior extension through anatomic \"danger space\" into mediastinum\nN.B.: ensure that at least part of mediastinum is imaged to exclude descending mediastinitis\n(2) Direct extension to spine / epidural or carotid space\n(3) Compromised airway\n(4) UV thrombosis $=$ Lemierre syndrome\n(5) Narrowing of ICA\n(6) Pseudoaneurysm of ICA\n\nRx: aggressive treatment with IV antibiotics, airway management, surgical drainage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 310,
            "markdown": "$D D x$ : retropharyngeal space edema; suppurative retropharyngeal lymph node\nThe differentiation of retropharyngeal abscess from retropharyngeal edema or cellulitis is critical but difficult in the absence of rimlike enhancement.\n\n# RHINOCEREBRAL MUCORMYCOSIS \n\n$=$ paranasal sinus / orbital infection caused by nonseptated fungi Rhizopus arrhizus and\nRhizopus oryzae\nSpread: fungus first involves nasal cavity, then extends into maxillary / ethmoid sinuses / orbits / intracranially along ophthalmic artery / cribriform plate (frontal sinuses are spared)\nPredisposed:\n(1) Poorly controlled diabetes mellitus\n(2) Chronic renal failure\n(3) Cirrhosis\n(4) Malnutrition\n(5) Cancer\n(6) Prolonged antibiotic therapy\n(7) Steroid therapy\n(8) Cytotoxic drug therapy\n(9) AIDS\n(10) Extensive burns\n\n- black crusting of nasal mucosa (in diabetics)\n- small ischemic areas (invasion of arterioles + small arteries)\n$\\sqrt{ }$ propensity for vascular invasion by fungal hyphae $\\leftarrow$ production of elastase\nCx: cerebral infarction, hemorrhage, mycotic aneurysm\n$\\checkmark$ nodular thickening involving nasal septum + turbinates\n$\\checkmark$ mucoperiosteal thickening + clouding of ethmoids\n$\\checkmark$ focal areas of bone destruction\nCx: (1) Blindness\n(2) Cranial nerve palsy\n(3) Hemiparesis\n\nPrognosis: high mortality rate\n\n## SIALADENITIS\n\nOrganism: S. aureus\nLocation: submandibular gland, parotid gland\nSite: typically unilateral\n\n## Acute Submandibular Sialadenitis\n\n- \"salivary colic\" = painful swelling exacerbated by eating US:\n$\\checkmark$ may depict ductal obstruction + calculi as small as 3 mm\nCT:\n$\\checkmark$ enlargement of submandibular gland\n$\\checkmark$ ductal dilatation $\\leftarrow$ obstructive calculus / stenosis:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 311,
            "markdown": "$\\sqrt{ }$ calculus in submandibular duct $(80-90 \\%)$ / parotid duct $(10-20 \\%)=$ radiographically visible in $80-90 \\%$\n$\\sqrt{ }$ cellulitis + myositis in sublingual + submandibular space\nSialography:\n$\\sqrt{ }$ may demonstrate cause of ductal stricture $\\leftarrow$ calculus, recurrent infection, autoimmune disease, trauma (rare)\n\n# Chronic Recurrent Sialadenitis \n\nA. PAROTID GLAND\n\n- painful periodic unilateral enlargement of parotid gland\n- milky discharge may be expressed\n\nSialography:\n$\\sqrt{ }$ Stensen duct irregularly enlarged / sausage-shaped\n$\\sqrt{ }$ pruning of distal parotid ducts\n$\\sqrt{ } \\pm$ calculi\nCT:\n$\\sqrt{ }$ diffusely enlarged dense gland\n$\\sqrt{ }$ dilated Stensen duct $\\pm$ calculi\nCx: Mucocele\nB. SUBMANDIBULAR GLAND\n\n- firm painless submandibular gland\n$\\sqrt{ }$ unilateral atrophy + fatty infiltration\n\n\n## Acute Parotitis\n\nCause: bacterial, viral, calculus-induced\n\n- toxic appearance, high fever, tenderness\n- sudden onset of pain, swelling, tenderness\n\n\n## Acute Suppurative Parotitis\n\n- purulent material expressed from Stenson duct\n\nOrganism: S. aureus ( $>50 \\%$ ), anaerobic bacteria\nAt risk: elderly, debilitated, intubated + dehydrated patient\nCT:\n$\\sqrt{ }$ diffusely enlarged + enhancing parotid gland\n$\\sqrt{ }$ ill-defined margins\n$\\sqrt{ }$ intraparotid hypoattenuating abscess\n\n## HIV Parotitis\n\nHisto: benign lymphoepithelial lesion consisting of an intranodal cyst lined with epithelial cells\nUS:\n$\\sqrt{ }$ multiple hypoechoic / anechoic areas without posterior acoustic enhancement (70\\%)\n$\\sqrt{ }$ anechoic cysts $(30 \\%)$\nCT / MR:\n$\\sqrt{ }$ bilateral parotid gland enlargement with intraglandular cystic + solid masses\n$\\sqrt{ }$ cervical lymphadenopathy + enlarged adenoids typically associated",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 312,
            "markdown": "Prognosis: parotid involvement is associated with a better prognosis in HIV-positive children!\n\n# Viral Parotitis \n\n- self-limiting condition with prodromal symptoms\n\nPeak age: 5-9 years\nOrganism: paramyxovirus (mumps) > influenzavirus, parainfluenzavirus, coxsackievirus, cytomegalovirus, adenovirus\nSite: bilateral in $75 \\%$\nAssociated with: systemic viral illness $\\pm$ involvement of submandibular and sublingual glands\n\n## Calculus-induced Parotitis\n\nSite: typically unilateral\nX-ray: viclaculus radiolucent in $90 \\%$\nCT: vmajority of calculi visible\n\n## SIALOLITHIASIS\n\n- recurrent swelling of salivary gland during eating\n- palpable stone in floor of mouth = in distal part of submandibular (Wharton) duct\n\nLocation: submandibular gland ( $60-90 \\%$ ), parotid gland ( $10-20 \\%$ ); may be multiple\nX-ray:\n$\\checkmark$ stones radiopaque (in only $20 \\%$ )\nSialography (digital / MR)\nUS:\n$\\checkmark$ strongly hyperechoic line + distal acoustic shadowing\n$\\checkmark$ dilated excretory ducts\nCx: partial / total mechanical obstruction of salivary duct, bacterial infection, loss of glandular function\n\n## SIALOSIS\n\n$=$ usually bilateral nontender noninflammatory recurrent enlargement of parotid gland\nCause: cirrhosis, alcoholism, diabetes, malnutrition, hormonal insufficiency (ovarian / pancreatic / thyroid), drugs (sulfisoxazole, phenylbutazone), radiation therapy\nHisto: serous acinar hypertrophy + fatty replacement of gland\nSialography:\n$\\checkmark$ sparse peripheral ducts\nCT:\n$\\checkmark$ enlarged / normal-sized gland\n$\\checkmark$ diffusely dense gland in end stage\nUS:\n$\\checkmark$ enlarged hyperechoic salivary gland\n$\\checkmark$ NO focal lesion / increased blood flow",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 313,
            "markdown": "# SINONASAL POLYPOSIS \n\n$=$ benign sinonasal mucosal lesions\nFrequency: in $25 \\%$ of patients with allergic rhinitis; in $15 \\%$ of patients with asthma\n$\\diamond$ Most frequent complication of sinusitis!\nPathogenesis: expansion of fluid in deep lamina propria of sinonasal mucosa\nCause: infectious rhinosinusitis; allergic fungal rhinitis (atopic hypersensitivity); cystic fibrosis (child); asthma; Kartagener syndrome; nickel exposure; aspirin intolerance; nonneoplastic hyperplasia of inflamed mucous membranes\nLocation: commonly maxillary antrum\n$\\sqrt{ }$ multiple homogeneous soft-tissue masses with smooth convex borders within nasal cavity enlarging sinus ostium\n$\\checkmark$ remodeling / expansion of sinus with enlargement\n$\\diamond$ Most common expansile lesion in nasal cavity!\n$\\checkmark$ thinning of bony trabeculae $\\pm$ erosive changes at anterior skull base\n$\\checkmark$ usually peripheral / occasionally solid heterogeneous enhancement\n$D D x$ : neoplasm, mucocele, mucus retention cyst\nPrognosis: $75 \\%$ surgical failure rate\n\n## Antrochoanal Polyp\n\n$=$ benign antral polyp, which widens the sinus ostium and extends into nasal cavity; $5 \\%$ of all nasal polyps\nAge: teenagers + young adults\n$\\checkmark$ antral clouding\n$\\checkmark$ ipsilateral nasal mass\n$\\checkmark$ smooth mass enlarging the sinus ostium\n$\\checkmark$ NO sinus expansion\n\n## Angiomatous Polyp\n\n$=$ derivative of choanal polyp (following ischemia of polyp with secondary neovascularity along its surface)\n$D D x$ : juvenile angiofibroma (involvement of pterygopalatine fossa)\n\n## SINONASAL PSEUDOTUMOR\n\nLocation: nasal cavity, nasopharynx, skull base, temporal bone, maxillary sinus, larynx, trachea, thyroid gland, salivary gland\n$\\checkmark$ more aggressive appearance than orbital pseudotumors:\n$\\checkmark$ osseous erosion, remodeling, sclerosis (common)\n$\\checkmark \\pm$ perineural spread along maxillary, mandibular, hypoglossal nn.\n$C x$ : internal carotid occlusion\nPrognosis: good after complete resection\n$R x$ : less responsive to steroid therapy than orbital pseudotumors\n\n## SINUSITIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 314,
            "markdown": "# Incidence: \n\nmost common paranasal sinus problem; most common chronic disease diagnosed in USA ( $31,000,000$ persons per year); complicating common colds in $0.5 \\%$ (3-4 colds per year in adults, 6-8 colds per year in children)\n\n## Pathogenesis:\n\nviral infection $\\rightarrow$ mucosal congestion $\\rightarrow$ apposition of mucosal surfaces $\\rightarrow$ retention of secretions $\\rightarrow$ bacterial superinfection\n(1) Obstruction of major ostia\n(a) middle meatus draining frontal, maxillary, anterior ethmoid sinus\n(b) sphenoethmoidal recess draining posterior ethmoid sphenoid sinus\n(2) Ineffective mucociliary clearing $\\leftarrow$ contact of two mucosal surfaces\n\nPredisposing anatomic variants:\n(1) Greater degree of nasal septal deviation\n(2) Horizontally oriented uncinate process NOT concha bullosa, paradoxical turbinate, Haller cells, uncinate pneumatization\n\n## Location:\n\n(1) Infundibular pattern (26\\%)\n$=$ isolated obstruction of inferior infundibulum just above the maxillary sinus ostium\n$\\sqrt{ }$ limited maxillary sinus disease\n(2) Ostiomeatal unit pattern (25\\%)\n$\\sqrt{ }$ middle meatus opacification\n(3) Sphenoethmoidal recess obstruction (6\\%)\n$\\checkmark$ sphenoid / posterior ethmoid sinus inflammation\n(4) Sinonasal polyposis pattern\n$\\checkmark$ enlargement of ostia, thinning of adjacent bone\n$\\checkmark$ air-fluid levels\nPlain films (Waters, Caldwell, lateral, submental vertex views):\n\n1. Acute sinusitis\n$D x:$ rests on clinical rather than radiologic findings!\n\n- \"cold\" symptoms (cough), fever, purulent nasal discharge\n$\\checkmark$ mucosal thickening + enhancement\n$\\checkmark$ air-fluid level $\\leftarrow$ retention of secretions $\\leftarrow$ ostial dysfunction $\\leftarrow$ mucosal swelling\n$\\checkmark$ total sinus opacification\n$\\checkmark$ hyperintense secretions on T2WI ( $95 \\%$ water content $+5 \\%$ proteinaceous macromolecules)\n$D D x:$ mucus retention cyst\n\n2. Chronic sinusitis\n$\\checkmark$ mucosal swelling $>5 \\mathrm{~mm}$ thick on Waters view ( $99 \\%$ sensitive, $46 \\%$ specific in maxillary sinus)\n$\\checkmark$ bone remodeling + sclerosis $\\leftarrow$ osteitis\n$\\checkmark$ polyposis\n$\\checkmark$ hyperattenuating lesion on NECT $\\leftarrow$ inspissated secretions / fungal disease\n$\\checkmark$ hypointense secretions on T1WI + T2WI $\\leftarrow$ inspissated material with chronic obstruction (DDx: air)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 315,
            "markdown": "CT and MR lack specificity to diagnose acute sinusitis.\nEither modality may be used to identify complications.\nCT:\nmapping bony anatomy for surgical planning\nMR:\n$\\sqrt{ }$ sinus thickening with high SI on T2WI + low SI on T1WI\n$\\sqrt{ }$ near solid secretions with $>28 \\%$ protein concentration are hypointense on both T1WI + T2WI simulating air\n$\\sqrt{ }$ rim gadolinium enhancement (DDx to neoplasms, which enhance centrally)\nCx: (1) Mucous retention cyst (10\\%)\n(2) Mucocele\n(3) Orbital extension through neurovascular foramina, dehiscences, or thin bones: orbital cellulitis\n(4) Pott puffy tumor\n(5) Septic thrombophlebitis\n(6) Intracranial extension: meningitis, epidural abscess, subdural empyema, venous sinus thrombosis, cerebral abscess\n$R x$ : functional endoscopic sinus surgery (amputation of uncinate process; enlargement of infundibulum + maxillary ostium; creation of common channel for anterior ethmoid air cells; complete / partial ethmoidectomy\n\n# Bacterial Sinusitis \n\nOrganism:\n(a) acute phase: Streptococcus pneumoniae + Haemophilus influenzae ( $>50 \\%$ ), betahemolytic streptococcus, Moraxella catarrhalis\n(b) chronic phase: staphylococcus, streptococcus, corynebacteria, Bacteroides, fusobacteria\n$\\checkmark$ solitary antral disease (obstruction of sinus ostium)\n$\\checkmark$ uniform enhancement\n\n## Mycotic = Fungal Sinusitis\n\nOrganism: Aspergillus fumigatus, mucormycosis, bipolaris, Drechslera, Curvularia, Candida\n$\\checkmark$ polypoid lesion / fungus ball (= extramucosal infection $\\leftarrow$ saprophytic growth on retained secretions, usually caused by Aspergillus)\n$\\checkmark$ infiltrating fungal sinusitis (in immune-competent host)\n$\\checkmark$ fulminant fungal sinusitis (aggressive infection in immune-compromised individual / diabetics)\nCT:\n$\\checkmark$ punctate calcifications (= calcium phosphate / calcium sulfonate deposition near mycelium)\nMR:\n$\\checkmark$ dark on T2WI $\\leftarrow$ high fungal mycelial iron, magnesium, manganese content from amino acid metabolism (DDx: inspissated secretions / polypoid disease)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 316,
            "markdown": "Dx: failure to respond to antibiotic therapy\n\n# Noninvasive Fungal Sinusitis \n\n## Fungal Mycetoma / Fungus Ball of Sinus\n\n$=$ uncommon manifestation as a tangled collection of fungal hyphae without allergic mucin\nOrganism: Aspergillus fumigatus, (rarely) Pseudallescheria boydii and Alternaria\nCause: deficient mucociliary clearance\nAge: older individual; $\\mathrm{M}<\\mathrm{F}$\n\n- asymptomatic\n- minimal symptoms: chronic pressure, nasal discharge, cacosmia [kakos, Greek = bad, osme $=$ smell $]$\n$\\sqrt{ }$ nonenhancing intraluminal mass (usually limited to one sinus)\nNECT:\n$\\checkmark$ hyperattenuating mass $\\leftarrow$ dense matted fungal hyphae\n$\\checkmark \\pm$ punctate calcifications\n$\\checkmark$ hypoattenuating mucosal lining $\\leftarrow$ inflammation\n$\\checkmark$ sclerotic thickened bony sinus walls\n$\\checkmark \\pm$ sinus expansion with focally thinned wall $\\leftarrow$ pressure necrosis\nMR:\n$\\checkmark$ hyperintense mucosal lining on T2WI\n$\\checkmark$ hypointense intraluminal mass on T1WI + T2WI $\\leftarrow$ absence of free water\n$\\checkmark$ areas of signal void on T2WI $\\leftarrow$ calcifications and paramagnetic metals (iron, magnesium, manganese)\nN.B.: NO invasion of sinus mucosa, blood vessels, bone\n\n\n## Allergic Fungal Sinusitis\n\n$\\diamond$ Most common form of fungal sinusitis characterized by presence of \"allergic mucin\" (= inspissated yellow-green / white-tan / gray / brown / black mucin of peanut butter consistency)\nPrevalence: $5-10 \\%$ of surgical patients with chronic hypertrophic sinus disease\nRegion: northern India, southern USA (warm humid climate)\nCause: IgE-mediated type I immediate hypersensitivity and type III delayed hypersensitivity reaction to inhaled fungal organisms (similar to allergic bronchopulmonary aspergillosis)\nOrganism: Bipolaris, Curvularia, Alternaria (dematiaceous pigmented fungi), Aspergillus, Fusarium (hyaline molds)\nHisto: eosinophils + Charcot-Leyden crystals\nAge: immunocompetent patient in $3^{\\text {rd }}$ decade\n\n- chronic headaches, nasal congestion, chronic sinusitis\n- history of sinus surgery\n\nOften associated with: atopy (allergic rhinitis, asthma)\nLocation: multiple / all sinuses (bilateral); nose\n$\\checkmark$ near-complete opacification\n$\\checkmark$ high concentration of various metals (iron, magnesium, manganese) concentrated by",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 317,
            "markdown": "fungal organisms + high protein concentration + low free-water content:\n$\\sqrt{ }$ hyperattenuating allergic mucin\n$\\sqrt{ }$ mixed low / intermediate / high SI on T1WI\n$\\sqrt{ }$ characteristic low SI / signal void on T2WI\n$\\sqrt{ }$ inflamed mucosal lining:\n$\\sqrt{ }$ hypointense on T1WI + hyperintense on T2WI\n$\\sqrt{ }$ enhancement after administration of gadolinium\n$\\sqrt{ }$ no central enhancement (DDx to neoplasm)\n$\\sqrt{ } \\pm$ expansion of sinus and smooth bone erosion\n$\\sqrt{ } \\pm$ intracranial and intraorbital extension\n\n# Invasive Fungal Sinusitis \n\nPredisposed: immunocompromised\nPathophysiology: vascular invasion $\\rightarrow$ rapid spread to maxillofacial soft tissues, orbit, pterygo-palatine fossa, anterior cranial fossa\nMR signs of invasion:\n$\\sqrt{ }$ obliteration of periantral fat $=$ subtle sign of invasion\n$\\sqrt{ }$ intraorbital invasion:\n$\\sqrt{ }$ inflammation of orbital fat + extraocular muscle $\\rightarrow$ proptosis\n$\\sqrt{ }$ intracranial invasion:\n$\\sqrt{ }$ leptomeningeal enhancement (initial stage)\n$\\sqrt{ }$ adjacent cerebritis, granuloma, cerebral abscess\n$C x$ : thrombosis of veins + cavernous sinus, meningitis, epidural + cerebral abscess, intraorbital extension, osteomyelitis, carotid artery invasion / occlusion / pseudoaneurysm $\\rightarrow$ fatal cerebral infarct and intracranial hemorrhage\n$D D x$ : malignant neoplasm\n\n## Acute Invasive Fungal Sinusitis\n\n$=$ INVASIVE FUNGAL RHINOSINUSITIS\n$=$ rapidly progressive most lethal form of sinusitis with hyphae within mucosa / submucosa / bone / blood vessels of paranasal sinuses\nPredisposed: immunocompromised, poorly controlled diabetes\nOrganism:\n(a) zygomycosis in diabetics with varied species: Rhizopus, Rhizomucor, Absidia, Mucor\n(b) neutropenia (= neutropenic sinusitis) with hematologic malignancy, systemic chemotherapy, systemic steroid Rx, bone marrow transplantation, organ transplantation, AIDS : Apergillus in $80 \\%$\nAssociated with: nasal infection ( $2 / 3$ in middle turbinate)\n\n- painless necrotic nasal septal ulcer (eschar), sinusitis\n\nCT:\n$\\sqrt{ }$ aggressive bone destruction of sinus walls on CT\n$\\sqrt{ }$ severe unilateral nasal cavity soft-tissue thickening (nonspecific)\nMortality: $50-80 \\%$ among neutropenic patients\nRx: aggressive surgical débridement, systemic antifungal medication",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 318,
            "markdown": "# CHRONIC Invasive FungAL Sinusitis \n\n$=$ persistent + recurrent disease $\\rightarrow$ invasion develops over months to years\nOrganism: Mucor, Rhizopus, Aspergillus, Bipolaris, Candida\n\n- chronic rhinosinusitis: paranasal sinus pain, fever, serosanguinous nasal discharge, epistaxis, nasal polyposis\nCT:\n$\\checkmark$ hyperattenuating soft-tissue collection\n$\\checkmark$ mottled lucencies / irregular bone destruction\n$\\checkmark$ sclerotic changes in osseous sinus walls (chronic)\nMR:\n$\\checkmark$ decreased signal intensity on T1WI + T2WI\n\n\n## Odontogenic Sinusitis\n\nIncidence: 5-38\\% of maxillary sinusitis\n\n- purulent nasal discharge, facial pressure, cheek and facial pain\n$\\diamond$ Infection decompressed through patent ostiomeatal unit!\n$\\diamond$ Sinus floor mucosal inflammation may manifest with toothache!\n$\\checkmark$ sinus mucosal thickening above a carious tooth\n$\\checkmark$ focal ballooning / dehiscence above a carious tooth\n$\\checkmark$ unerupted tooth in maxillary sinus\n$R x$ : root canal therapy, tooth extraction, antibiotics\n\n\n## SJÖGREN SYNDROME\n\n$=$ MYOEPITHELIAL SIALADENITIS\n$=$ chronic autoimmune multisystem disorder (= collagen-vascular disease) characterized by inflammation + destruction of exocrine glands (by T-lymphocytes, mainly CD4+ cells, and autoantibodies from hyperstimulated B cells) $\\rightarrow$ dryness of mucous membranes affecting\n(1) Salivary + lacrimal glands\n(2) Mucosa + submucosa of pharynx\n(3) Tracheobronchial tree\n(4) Reticuloendothelial system\n(5) Joints\n\nFrequency: $0.1 \\%$ of population; $3 \\%$ of older adults\nCause:\nA. PRIMARY SJöGREN SYNDROME\n$=$ autoimmune exocrinopathy in isolation\n(a) recurrent parotitis in children\n(b) Sicca syndrome $=$ Mikulicz disease $=$ xerophthalmia + xerostomia\nB. SECONDARY SJöGREN SYNDROME\nas a complication of other autoimmune disorders\nAssociated with:\n(a) connective tissue diseases\n\n1. Rheumatoid arthritis (55\\%)\n2. Systemic lupus erythematosus (2\\%)\n3. Progressive systemic sclerosis $(0.5 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 319,
            "markdown": "4. Psoriatic arthritis, primary biliary cirrhosis $(0.5 \\%)$\n5. Polymyositis\n(b) lymphoproliferative disorders\n6. Lymphocytic interstitial pneumonitis (LIP)\n7. Pseudolymphoma ( $25 \\%$ )\n8. Lymphoma ( $5 \\% ; 44 \\mathrm{x}$ increased risk): mostly B-cell lymphoma\n9. Waldenström macroglobulinemia\n\nMean age: 57 (range, $35-70$ ) years; $\\mathrm{M}+\\mathrm{F}=1 \\div 9$\nPath: benign lymphoepithelioma\nHisto: lymphocytic infiltrate associated ductal dilatation, acinar atrophy, interstitial fibrosis (= parotid destruction)\n\n- xerostomia (most common symptom) = atrophy of salivary + parotid glands $\\rightarrow$ diminished saliva production and dryness of mouth + lips\n- xerophthalmia $=$ dryness of eyes $=$ keratoconjunctivitis sicca $=$ desiccation of cornea + conjunctiva $\\leftarrow$ decreased lacrimation\n- xerorhinia $=$ dryness + crusting of nasal mucosa\n$C x$ : epistaxis, nasal septal perforation\n- decreased sweating, decreased vaginal secretions\n- swelling of parotid gland:\n> recurrent acute episodes with tenderness; usually unilateral\n> chronic glandular enlargement with superimposed acute attacks of painless progressive swelling\n- rheumatoid factor (positive in up to $95 \\%$ )\n- ANA (positive in up to $80 \\%$ ); mitochondrial antibodies (6\\%)\n\nLocation: lacrimal + salivary glands; mucous glands of conjunctivae, nasal cavity, pharynx, larynx, trachea, bronchi; extraglandular involvement in 5-10\\%\n@ Lung ( $9-75 \\%$ )\naffected by airway abnormalities, interstitial pneumonias, and lymphoproliferative disorders\n\n- chronic dry cough, recurrent bronchitis, dyspnea on exertion\n\nHistologic pattern of interstitial lung disease:\nLIP, NSIP, UIP, cryptogenic organizing pneumonia, follicular bronchiolitis, diffuse interstitial amyloidosis\n$\\sqrt{ }$ pulmonary fibrosis ( $10-14 \\%$, most common finding)\n$\\sqrt{ }$ reticulonodular pattern (3-33-52\\%) involving lower lobes (= lymphocytic interstitial pneumonitis)\n$\\checkmark$ patchy consolidation\n$\\checkmark$ inspissated mucus\n$\\checkmark$ atelectasis\n$\\checkmark$ recurrent pneumonia\n$\\checkmark$ bronchiectasis of both lower lobes\n$\\checkmark$ acute focal / lipoid pneumonia $\\leftarrow$ oils taken to combat dry mouth\n$\\checkmark \\pm$ pleural effusion (uncommon)\nHRCT (usually required for detection):\n$\\checkmark$ poorly defined centrilobular nodules + branching linear opacities $=$ tree-in-bud appearance",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 320,
            "markdown": "$\\checkmark$ bronchiectasis + bronchiolectasis\n$\\checkmark$ bronchial wall thickening $\\leftarrow$ bronchiolar inflammation\n$\\checkmark$ groundglass opacities + air trapping\n$\\checkmark$ thickening of interlobular septa\n$\\checkmark$ cysts $\\leftarrow$ bronchiolar obstruction $\\leftarrow$ follicular bronchiolitis (= lymphocytic wall infiltration)\n@ Mediastinum\n$\\checkmark$ lymph node enlargement\n$\\checkmark$ thymic lymphoid hyperplasia\n$\\checkmark$ multilocular thymic cyst\n$\\checkmark$ MALT lymphoma\n@ Parotid gland\nSialogram:\n$\\checkmark$ nonobstructive sialectasia (ducts + acini destroyed by lymphocytic infiltrates / infection)\nStage I : punctate contrast collection $<1 \\mathrm{~mm}$\nStage II : globular contrast collection $1-2 \\mathrm{~mm}$\nStage III : cavitary contrast collection $>2 \\mathrm{~mm}$\nStage IV : destruction of gland parenchyma\nUS:\n$\\checkmark$ enlarged heterogeneous gland with punctate areas of increased echogenicity (= mucusfilled ducts)\n$\\checkmark$ multiple small oval usually well-defined scattered hypo- / anechoic areas bilaterally ( $=$ sialectasis $\\leftarrow$ cystic dilatation of intraparotid ducts + glands)\n$\\checkmark$ increased parenchymal vascularity on color Doppler\nMR:\n$\\checkmark$ inhomogeneous \"honeycomb\" / \"salt and pepper\" appearance (= areas of low intensity between nodular parenchyma of high SI) on T2WI / Gd-enhanced T1WI\n@ CNS involvement (in $25-30 \\%$ )\n\n- trigeminal neuropathy, recurrent aseptic meningoencephalitis, cerebral parenchymatous lesions\nMR:\n$\\checkmark$ extensive uni- / multifocal white and gray matter lesions + infarctions + microbleeds\n$\\checkmark$ multiple arterial narrowings\nPrognosis: generally good (morbidity from decreased function of exocrine organs)\nCx: Sjögren syndrome-associated B-cell lymphoma (occurs in salivary glands + mucosaassociated lymphatic tissue in stomach + lung in a significant number of patients + follows an aggressive course)\n$D x$ : biopsy for fast-growing lesions $>2 \\mathrm{~cm}$\n\n\n# SUBGLOTTIC STENOSIS \n\n## A. CONGENITAL SUBGLOTTIC STENOSIS\n\n- crouplike symptoms, often self-limiting disease\n\nLocation: $1-2 \\mathrm{~cm}$ below vocal cords",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 321,
            "markdown": "$\\checkmark$ circumferential symmetrical narrowing of subglottic portion of trachea during inspiration $\\sqrt{ } \\mathrm{NO}$ change in degree of narrowing with expiration\nB. ACQUIRED SUBGLOTTIC STENOSIS\nfollowing prolonged endotracheal intubation (in 5\\%)\n\n# TERATOMA OF HEAD \\& NECK \n\n$=$ GERM CELL TUMOR OF NECK\nPrevalence: $1 \\div 20,000$ to $1 \\div 40,000$ live births; $5 \\%$ of newborn teratomas in lateral + anterior neck\n$\\diamond 80 \\%$ of mediastinal germ cell tumors are benign!\nOrigin: thyrocervical area / palate / nasopharynx\nSpectrum:\n\n1. Dermoid cyst (with skin appendages):\n\nSite: orbit, nasal region, at floor of the mouth\n2. Epidermoid cyst\n3. Teratoid cyst (with tissues from CNS, GI, respiratory system)\n\nOB-US:\n$\\checkmark$ polyhydramnios in $30 \\% \\leftarrow$ esophageal obstruction\n$\\checkmark$ large bulky complex cystic + solid mass in cervical region\n$\\checkmark$ calcifications (in $50 \\%$ )\nCT:\n$\\checkmark$ hypoattenuating thin-walled unilocular mass:\n$\\checkmark$ nodules frequent in dermoid cysts\n$\\checkmark$ heterogeneous contents in teratomas\nMR:\n$\\checkmark$ hypo- to isointense on T1WI + hyperintense on T2WI:\n$\\checkmark$ dermoid cysts may be hyperintense on T1WI $\\leftarrow$ lipid-containing areas\n$\\checkmark$ coronal imaging useful to depict relationship to mylohyoid muscle\n$C x$ : airway obstruction, compromised swallowing\n$R x$ : ex utero intrapartum treatment (EXIT) procedure\n$D D x$ : cystic hygroma (septated fluid-filled collection, posterior location), goiter, branchial cleft cyst, cervical meningo-cele, neuroblastoma of neck, hemangioma of neck\n\n## Cervical Teratoma\n\n$=$ usually benign; malignant transformation possible\nPrevalence: $5 \\%$ of teratomas in newborn\nLocation: anteriorly (thyroid gland) with extension to trapezius muscle (posteriorly), mastoid (superiorly), clavicle / mediastinum (inferiorly)\n$\\checkmark$ hyperextension of neck\n$\\checkmark$ solid + cystic structures within heterogeneous mass\n$\\checkmark$ calcifications (more frequent than cartilage / bone)\n$C x$ : malpresentation, dystocia\n\n## Teratoma of Mouth\n\n$=$ EPIGNATHUS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 322,
            "markdown": "Origin: hard / soft palate\n$\\sqrt{ }$ mass filling oral cavity + extending out through mouth\n$D D x$ : frontal encephalocele, myoblastoma\n\n# TEMPOROMANDIBULAR JOINT DYSFUNCTION \n\n$=$ internal derangement $=$ abnormal relationship of disk to condyle\nIncidence: affects up to $28 \\%$ of population\nCause: disk injury\n$\\sqrt{ }$ intrinsic disk lesion (change in shape + signal intensity):\n$\\sqrt{ }$ irregular biconvex / rounded disk $\\leftarrow$ thickening of posterior band + reduction in mass of anterior band and central thin area\n$\\sqrt{ }$ flattening of disk\n$\\sqrt{ }$ reduction in normal intermediate to high SI of disk\n$\\sqrt{ }$ disk displacement:\n$\\sqrt{ }$ anterior (in up to $34 \\%$ of asymptomatic volunteers), anterolateral, anteromedial, lateral, medial, posterior disk displacement\n$\\sqrt{ }$ anterior displacement of posterior band in front of condyle with abnormal stretching of bilaminar zone\n$\\sqrt{ }$ anterior displacement of meniscus without reduction at maximum mouth opening\n$\\sqrt{ }$ \"stuck disk\" = fixed position of disk relative to glenoid fossa and articular eminence during closed- and open-mouth positions\n$\\sqrt{ }$ \"locked jaw\" = posterior band displaced beyond 1 o'clock position\n$\\sqrt{ }$ joint effusion\n$\\sqrt{ }$ osteoarthritis: flattening, osteophytes, erosions, sclerosis\n\n## THYROGLOSSAL DUCT CYST\n\n$=$ failure of complete involution of embryonic thyroglossal duct\nFrequency: most common congenital neck mass ( $70 \\%$ of all congenital neck anomalies); $2^{\\text {nd }}$ most common benign neck mass after benign lymphadenopathy; $90 \\%$ of nonodontogenic congenital cysts\nHisto: cyst lined by stratified squamous epithelium / ciliated pseudostratified columnar epithelium $\\pm$ mucous glands; ectopic thyroid tissue in 5-62\\%\nAge: $<10$ years in $50 \\% ; 2^{\\text {nd }}$ peak at $20-30$ years; $\\mathrm{M}=\\mathrm{F}$\n\n- gradually enlarging painless midline neck mass\n- cyst moves vertically / upward during protrusion of tongue / swallowing $\\leftarrow$ close relationship of cyst to hyoid bone + foramen cecum ( $=$ most SPECIFIC physical finding)\n- $\\pm$ history of previous incision and drainage of an \"abscess\" in area of cyst\n\nLocation: suprahyoid (15-25\\%), at level of hyoid (15-50\\%), infrahyoid (20-65\\%)\nSite: midline ( $75 \\%$ ), paramedian within 2 cm of midline frequently on left ( $25 \\%$ )\nSize: $1.5-3.0$ (range, $0.5-6.0) \\mathrm{cm}$\n$\\sqrt{ }$ cyst with occasional septation within 2 cm of midline\n$\\sqrt{ }$ infrahyoid cyst embedded within / deep to strap muscle:\n$\\sqrt{ }$ infrahyoid strap muscles beaks over edge of cyst\n$\\sqrt{ }$ thin connecting stalk to midline",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 323,
            "markdown": "$\\sqrt{ }$ paramedian cyst with a tail that dives into hyoid bone\nUS:\n$\\sqrt{ }$ anechoic cyst ( $42 \\%$ ) in midline\n$\\sqrt{ }$ hypoechoic mass with fine to coarse internal echoes (= proteinaceous material) + increased through transmission\nScintigraphy:\n$\\sqrt{ }$ uptake in functional thyroid tissue of thyroglossal duct cyst\nCT:\n$\\sqrt{ }$ smooth well-circumscribed midline mass with thin wall\n$\\sqrt{ }$ homogeneous mucoid attenuation of $0-20 \\mathrm{HU} /$ occasionally higher $\\leftarrow$ increased protein content\n$\\sqrt{ }$ thin peripheral rim of enhancement\n$\\sqrt{ }$ tract of thyroid tissue between cystic mass + thyroid\nMR:\n$\\sqrt{ }$ cyst of low to intermediate SI on T1WI + high SI on T2WI\n$\\sqrt{ }$ NO restricted diffusion\n$\\sqrt{ }$ nonenhancing / enhancing very thin rim (unless inflamed)\n$\\sqrt{ }$ heterogeneous complex cyst with infection:\n$\\sqrt{ }$ thick irregular rim of enhancement\n$\\sqrt{ }$ variable SI of fluid $\\leftarrow$ infection / hemorrhage\n$\\sqrt{ }$ profuse surrounding soft-tissue edema\nCx: (1) Infection $\\rightarrow$ thick external wall $\\pm$ internal septa\n(2) Fistulous communication to the skin (15-33\\%)\n(3) Thyroid carcinoma ( $1-4 \\%$ ): in $80 \\%$ papillary ca.\n(4) Squamous cell carcinoma (even rarer)\n\nDx: close association with hyoid bone ( $60-80 \\%$ )\n$R x$ : Sistrunk procedure ( $=$ resection of central portion of hyoid bone + core of tissue following the expected course of entire thyroglossal duct to foramen cecum) with $2.6 \\%$ recurrence rate\n$D D x$ : (1) Ectopic thyroid (no thyroid tissue in normal location)\n(2) Obstructed laryngocele (well-defined smooth mass / saccular cyst in lateral aspect of superior paralaryngeal space connecting to larynx originating from saccule / appendix of laryngeal ventricle)\n(3) $2^{\\text {nd }}$ branchial cleft cyst (round mass near mandibular angle along anterior surface of sternocleidomastoid muscle / displacing muscle posterolaterally, lateral to carotid sheath structures (carotid artery + internal jugular vein), posterior to submandibular gland, PATHOGNOMONIC beak insinuating itself between ICA + ECA)\n(4) Thymic cyst $=$ persistent thymopharyngeal duct (mostly on left side of neck)\n(5) Lymphatic malformation (mostly in posterior cervical triangle, transspatial, containing locules, congenital lesion detected by age 2 years)\n(5) Lingual abscess ( $\\leftarrow$ infected lingual thyroglossal duct cyst / dermoid cyst / ranula / secondary to instrumentation or tongue piercing)\n\n# THYROID ADENOMA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 324,
            "markdown": "$\\sqrt{ }$ round / oval mass of low attenuation with enhancement\n\n# Adenomatous Nodule (42-77\\%) \n\n$=$ COLLOID NODULE $=$ ADENOMATOUS HYPERPLASIA\n$=$ DEGENERATIVE INVOLUTED NODULE\nCytology: abundant colloid + benign follicular cells with uniform slightly large nuclei, arranged in a honeycomb pattern (difficult DDx from follicular tumors)\n$\\sqrt{ }$ often multiple nodules by US / scintigraphy / surgery\n$\\checkmark$ mostly hypofunctioning, rarely hyperfunctioning\n$\\checkmark$ solid form = incompletely encapsulated, poorly demarcated nodules merging with surrounding tissue\n$\\checkmark$ cystic form (= colloid cyst) = anechoic areas in nodule $\\leftarrow$ hemorrhage / colloid degeneration\n$\\checkmark$ calcific deposits\n\n## Follicular Adenoma (15-40\\%)\n\n$=$ monoclonal tumor arising from follicular epithelium\nPath: single lesion with well-developed fibrous capsule\nHisto subtypes:\n(a) Simple colloid (macrofollicular) adenoma: most common form\n(b) Microfollicular (fetal) adenoma\n(c) Embryonal (trabecular) adenoma\n(d) Hürthle-cell (oxyphil / oncocytic) adenoma: large single polygonal cells with abundant granular cytoplasm + uniform eccentric nuclei + no colloid\n(e) Atypical adenoma\n(f) Adenoma with papillae\n(g) Signet-ring adenoma\n$\\diamond 5 \\%$ of microfollicular adenomas, $5 \\%$ of Hürthle-cell adenomas, $25 \\%$ of embryonal adenomas prove to be follicular cancers in carefully performed study!\nFunctional status:\n(1) Toxic adenoma\n(2) Toxic multinodular goiter = hyperfunctioning adenoma within multinodular goiter; usually occurs in nodule $>2.5 \\mathrm{~cm}$ in size\n(3) Nonfunctioning adenoma\n$\\checkmark$ mass with increased / decreased echogenicity\n$\\checkmark$ \"halo\" sign = complete hypoechoic ring with regular border surrounding isoechoic solid mass\nRx: surgical hemithyroidectomy ( $\\rightarrow 15-30 \\%$ risk of malignancy if diagnosed on FNAB)\n\n## THYROID CARCINOMA\n\nIncidence: 25,000 new cancers per year in USA (2005); clinically silent cancers in up to $35 \\%$ at autopsy / surgery (usually papillary carcinomas of $<1.0 \\mathrm{~cm}$ in size); $3.6 \\div 100,000$ (1973), $8.7 \\div 100,000$ (2002)\n\nAge: $<30$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 3$ to $1 \\div 2$\nRisk factors: age $<20$ years or $>60$ years; history of neck irradiation; family history of thyroid",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 325,
            "markdown": "cancer\n$\\diamond$ Lifetime risk of thyroid cancer $<1 \\%$ in USA\nTypes (in order of worsening prognosis):\npapillary $(50-80 \\%)>$ follicular $(10-20 \\%)>$ medullary $(6-10 \\%)>$ anaplastic\n\n- history of neck irradiation, rapid growth\n- stone-hard nodule:\n$\\diamond 5-7 \\%$ of all thyroid nodules are malignant!\n$\\checkmark$ hypoechoic / hypoattenuating mass\n$\\checkmark$ irregular ill-defined border without / disrupted halo\n$\\checkmark$ NO hemorrhage / liquefaction necrosis\n$\\checkmark$ ancillary findings:\n$\\checkmark$ lymphadenopathy (in 19\\%)\nFrequency: papillary carcinoma (in up to $40-90 \\%$ ) > medullary carcinoma (in up to $50 \\%)>$ follicular carcinoma (rare)\n$\\checkmark$ increased size with round bulging shape\n$\\checkmark$ replaced fatty hilum\n$\\checkmark$ heterogeneous echotexture\n$\\checkmark$ irregular margins\n$\\checkmark$ psammomatous calcifications\n$\\checkmark$ cystic change ( $70 \\%$ in metastatic papillary carcinoma)\n$\\checkmark$ color Doppler vascularity throughout instead of central hilar vessels only\n$\\checkmark$ destruction of adjacent structures\n$\\checkmark$ loss of fat planes\n$\\checkmark$ distant metastasis\nPET:\n$\\checkmark$ well-differentiated thyroid carcinomas are not FDG-avid\nMortality: 0.5 deaths $+100,000$ (unchanged over decades)\n\n\n# Radiation-induced Thyroid Cancer \n\nIncidence: increases with doses of thyroidal irradiation from $6.5-1,500 \\mathrm{rad}$ (higher doses are associated with hypothyroidism)\nPeak occurrence: 5-30 (up to 50) years post irradiation\nThyroid abnormalities in 20\\%:\n(a) in $14 \\%$ adenomatous hyperplasia, follicular adenoma, colloid nodules, thyroiditis\n(b) in $6 \\%$ thyroid cancer\n$\\diamond$ Nondetectable microscopic foci of cancer in $25 \\%$ of patients operated on for benign disease!\n$\\diamond$ In patients with multiple cold nodules frequency of cancer is $40 \\%$\n\n## Diagnostic Whole-body ${ }^{131}$ I Scintigram\n\nIndication: to detect metastases of thyroid carcinoma after total thyroidectomy; for skeletal metastases preferred over bone scan (that only detects $40 \\%$ )\n$\\diamond$ Metastases not detectable in presence of normal functioning thyroid tissue because uptake is much less in metastases\n$\\diamond 99 \\mathrm{mTc}$-pertechnetate is useless because of high background activity + lack of organification",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 326,
            "markdown": "$\\diamond$ False-negative ${ }^{131} \\mathrm{I}$ scan in $24 \\% \\leftarrow$ nonfunctioning metastases\nTechnique:\n» low iodine diet for 7 days = avoid iodized salt; milk and diary products; eggs; seafood; bread made with iodate dough conditioners; red food dyes; restaurant food; food containing iodized salt, sea salt, iodates, iodines, algin, alginates, agar agar\n» $\\mathrm{T}_{4}$ replacement therapy discontinued for 6 weeks\n» short-acting $\\mathrm{T}_{3}$ is administered for 4-6 weeks\n» $\\mathrm{T}_{3}$ replacement therapy discontinued $10-14$ days prior to whole-body scan\n» measurement of TSH level to confirm adequate elevation (TSH $>30-50 \\mathrm{mIU} / \\mathrm{mL}$; administration of exogenous TSH not desirable because of uneven stimulation)\n» oral administration of $1-5-10 \\mathrm{mCi}{ }^{131} \\mathrm{I}$\n» whole-body scan after 24-48-72 hours (low background activity) with high-energy collimator $+20 \\%$ energy window centered at 364 keV\nN.B.: posttherapy scan ( 1 week after therapeutic dose) identifies more lesions than diagnostic scan; CONTRAINDICATED during pregnancy!\n\n# Treatment for Follicular / Papillary Cancer \n\n(1) Surgery: total thyroidectomy + modified radical neck dissection\n(2) Postoperative radioiodine treatment with ${ }^{131}$ I if diagnostic scan positive (multiple treatments are usually necessary)\n$\\diamond$ Radioiodine therapy only appropriate for papillary / mixed / follicular thyroid carcinomas (NOT for medullary or anaplastic carcinomas)\n(a) Ablation of thyroid tissue remnants\n\nTime interval: 6 weeks after surgery\n\n- no thyroid hormone replacement for 3-4 weeks\n\nCalculated dose:\n$=\\{$ (thyroid weight $[\\mathrm{g}] \\times 80-120 \\mu \\mathrm{Ci} / \\mathrm{g}) \\pi \\%$ uptake of ${ }^{123} \\mathrm{I}$ by 24 hours $\\} \\times 100$\nEstimated dose: $30-100 \\mathrm{mCi}{ }^{131} \\mathrm{I}$ orally\n» rescan after 3-7 days\n$\\checkmark$ no change from pre-ablation: on suppression therapy\n$\\checkmark$ new foci (in up to $16 \\%$ ): consider therapy\n$\\checkmark$ decreased uptake: may be due to \"stunning\"\n(b) Treatment of metastases\n\nMiddle-of-the-road dose:\n» 100 mCi for residual neck activity\n» 150 mCi for regional lymph node metastases\n» 175 mCi for lung metastases\n» 200 mCi for bone metastases\nTumor dose:\n150 mCi of ${ }^{131}$ I with an uptake of $0.5 \\%$ per gram of tumor tissue and a biologic halflife of 4 days will produce $25,000 \\mathrm{rad}$ to tumor\n$\\diamond$ Rapid turnover rates may exist in some metastases (lower dose advisable)\n$\\diamond$ Treatment of large tumors incomplete (range of beta radiation is a few mm only)\nCx: radiation thyroiditis; radiation parotitis; GI symptoms (nausea, diarrhea); minimal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 327,
            "markdown": "bone marrow depression; leukemia (2\\%); anaplastic transformation (uncommon); lung fibrosis (with extensive pulmonary metastases and dose $>200 \\mathrm{mCi}$ )\n(3) Thyroid replacement therapy: exogenous thyroid hormone to suppress TSH stimulation of metastases\n(4) External radiation therapy for anaplastic carcinoma + metastases without iodine uptake FOLLOW-UP: thyroglobulin $>50 \\mathrm{ng} / \\mathrm{mL}$ indicates functioning metastases after complete ablation of thyroid tissue\n\n# Papillary Carcinoma of Thyroid (60-80\\%) \n\nPeak age: $5^{\\text {th }}$ decade; $\\mathrm{F}>\\mathrm{M}$\nHisto: unencapsulated well-differentiated tumor\n(a) purely papillary\n(b) mixed with follicular elements (more common, especially under age 40)\n\nMetastases:\n(1) Lymphogenic spread to regional lymph nodes ( $40 \\%$, in children almost $90 \\%$ )\n(2) Hematogenous spread to lung ( $4 \\%$ ), bone (rare)\n\n- carcinoma elaborates thyroglobulin\n\nNUC:\n$\\sqrt{ }$ tumor usually concentrates radioiodine (even some purely papillary tumors) $\\rightarrow{ }^{131} \\mathrm{I}$ whole-body scintigraphy to assess for recurrence after thyroidectomy / ablation US:\n$\\sqrt{ }$ psammoma bodies = punctate echogenic foci less than 1 mm in size WITHOUT acoustic shadowing\n$\\sqrt{ }$ tumor of decreased echogenicity\n$\\sqrt{ }$ purely solid / complex mass with areas of necrosis, hemorrhage, cystic degeneration X-ray:\n$\\sqrt{ }$ punctate / linear psammomatous calcifications at tumor periphery\n$R s$ : total thyroidectomy ( $\\leftarrow$ commonly multifocal); radioactive iodine ablation\nPrognosis: 90-95\\% 20-year survival; 60\\% 10-year survival for extrathyroidal cancer; worse prognosis with increasing age\n\n## Follicular Carcinoma of Thyroid (11-20\\%)\n\nPeak age: $5^{\\text {th }}$ decade; $\\mathrm{F}>\\mathrm{M}$\nPath: encapsulated well-differentiated tumor without papillary elements; in 25\\% multifocal\nHisto: follicular cells with capsular / vascular invasion; cytologically impossible to distinguish between well-differentiated follicular carcinoma + follicular adenoma (vascular invasion is the only criteria)\nEarly hematogenous spread to:\n(a) lung\n(b) bone ( $30 \\%$ ): almost always osteolytic lesion (more frequent than in papillary carcinoma)\n\n- carcinoma elaborates thyroglobulin\n$\\sqrt{ }$ psammoma bodies + stromal calcium deposits\nNUC:\n$\\sqrt{ }$ usually concentrates pertechnetate, but fails to accumulate ${ }^{123} \\mathrm{I}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 328,
            "markdown": "US:\n$\\sqrt{ }$ indistinguishable from benign follicular adenoma\nPrognosis: slow growing; 75\\% 20-year survival; 90\\% 10-year survival with slight / equivocal angioinvasion; $35 \\% 10$-year survival with moderate / marked angioinvasion\n$R x$ : total thyroidectomy (for invasive cancer); $\\pm$ subsequent radioactive iodine ablation; lobectomy + isthmusectomy (for minimally invasive cancer)\n\n# Anaplastic / Undifferentiated Carcinoma of Thyroid \n\nPrevalence: $2-15 \\%$\nAge: $\\quad 6-7^{\\text {th }}$ decade; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n$\\sqrt{ }$ intrathoracic extension in up to $50 \\%$\n$\\sqrt{ } \\pm$ invasion of carotid artery, internal jugular vein, larynx\nNUC:\n$\\sqrt{ }$ NO radioiodine uptake\nCT:\n$\\sqrt{ }$ mass with inhomogeneous attenuation\n$\\sqrt{ }$ areas of necrosis ( $74 \\%$ )\n$\\sqrt{ }$ calcifications ( $58 \\%$ )\n$\\sqrt{ }$ regional lymphadenopathy ( $74 \\%$ )\nPrognosis: 5\\% 5-year survival; average survival time of 6-12 months\n\n## Medullary Carcinoma of Thyroid (1-5-10\\%)\n\nsporadic ( $80 \\%$ ) / familial\nHisto: arises from parafollicular C-cells, associated with amyloid deposition in primary + metastatic sites\nHormone activity: calcitonin, VIP, somatostatin, CEA\nMean age: 60 years for sporadic variety;\nduring adolescence in MEN 2\nIn $20 \\%$ associated with:\n(1) MEN $2 \\mathrm{a}=$ pheochromocytoma + parathyroid hyperplasia (Sipple syndrome)\n(2) MEN $2 b=$ without parathyroid component\n\nMetastases: early spread to lymph nodes (50\\%), lung, liver, bone\n\n- elevated calcitonin (= primary tumor marker from tumor production) stimulated by pentagastrin + calcium infusion\n- elevated carcinoembryonic antigen (CEA)\n$\\sqrt{ }$ mass of $2-26 \\mathrm{~mm}$\n$\\sqrt{ }$ granular calcifications within fibrous stroma / amyloid masses (50\\%)\n$\\sqrt{ }$ local invasion (common)\n$\\sqrt{ }$ nodal spread to neck + mediastinum (in up to $50 \\%$ ) at time of presentation\n$\\sqrt{ }$ distant metastases to liver, lung, bone ( $15-25 \\%$ )\nNUC:\n$\\sqrt{ }$ NO uptake by radioiodine / pertechnetate\n$\\sqrt{ }$ frequently shows increased uptake of ${ }^{201} \\mathrm{Tl}$\n$\\sqrt{ }$ concentrates ${ }^{123} \\mathrm{I}$-MIBG, pentavalent ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DMSA, ${ }^{111} \\mathrm{In}$-pentetreotide ( $41 \\%$ sensitive)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 329,
            "markdown": "$\\sqrt{ }$ FDG-PET ( $96 \\%$ sensitive)\nCT:\n$\\sqrt{ }$ mass of low attenuation (no iodine concentration)\nPrognosis: 90\\% 10-year survival without nodal metastases; $42 \\% 10$-year survival with nodal metastases\n$R x$ : total thyroidectomy + modified radical neck dissection\n\n# THYROIDITIS \n\n## DeQuervain Thyroiditis\n\n$=$ SUBACUTE GRANULOMATOUS THYROIDITIS\n$=$ distinct clinical syndrome characterized by exquisite thyroid tenderness, goiter, and thyrotoxicosis\nEtiology: probably viral / postviral process (Coxsackie, mumps) frequently occurring in seasonal clusters\nHisto: infiltrate of neutrophils and lymphocytes + characteristic multinucleated giant cells\nPeak age: $2^{\\text {nd }}-5^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 5$\n\n- upper respiratory tract infection, fever, and systemic flulike symptoms precede onset of symptoms by $2-3$ weeks\n- tender gland with pain radiating to jaw / ear\n- firm tense mild thyroid gland enlargement\n- CHARACTERISTIC elevation of ESR $>50 \\mathrm{~mm} /$ hour\n- hyperthyroidism ( $50 \\%$ ) $\\leftarrow$ severe gland destruction\n- short-lived hypothyroidism ( $25 \\%$ ) $\\leftarrow$ hormone depletion\n\nUS:\n$\\sqrt{ }$ areas of hypoechogenicity\nNUC:\n$\\sqrt{ }$ abnormally low 24-hour radioiodine uptake with clinical and laboratory evidence of hyperthyroidism\n$\\sqrt{ }$ poor visualization of thyroid (initially)\n$\\sqrt{ }$ single / multiple hypofunctional areas (occasionally)\n$\\sqrt{ }$ increased uptake during phase of hypothyroidism (late event)\n$C x$ : permanent hypothyroidism (rare)\n$R x$ : treatment of pain with NSAID / prednisone\nPrognosis: usually full recovery\n\n## Hashimoto Thyroiditis\n\n$=$ CHRONIC LYMPHOCYTIC THYROIDITIS $=$ GOITROUS AUTOIMMUNE THYROIDITIS\nIncidence: $0.3-1.5 \\div 1,000$ population per year\nMost frequent cause of goitrous hypothyroidism in adults in the USA (iodine deficiency is the more common cause worldwide)\nEtiology: autoimmune process with marked familial predisposition (antibodies are typically present); functional organification defect\nHisto: diffuse lymphocytic infiltration; occasional germinal centers; small thyroid follicles",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 330,
            "markdown": "containing sparse colloid; fibrosis; Hürthle / Askanazy cells = large thyroid cells with pink cytoplasma (\"oxyphil change\")\nPeak age: $4-5^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 15$\n\n- firm rubbery possibly asymmetric lobular goiter\n- decreased thyroid reserve ( $=$ injection of TSH does not result in expected increase in radioiodine uptake / release of hormone from the gland)\n- $\\mathrm{FT}_{4}$ most typically normal / low\n- antithyroid peroxidase + antithyroglobulin antibodies\n\nClinical course:\n\n- gradual painless enlargement resulting in neck tightness\n- periods of mild thyrotoxicosis (4\\%) / subclinical to overt hypothyroidism (20\\%) at presentation\n- progression from euthyroidism to hypothyroidism\n- return to normal function over several years (in 25\\%)\n$\\sqrt{ }$ moderate enlargement of both lobes (usually $2-4 \\mathrm{x}$ normal volume) + prominent pyramidal lobe\nNUC:\n$\\sqrt{ }$ characteristically normal / elevated tracer uptake\n$\\sqrt{ }$ low tracer uptake with poor visualization (4\\%)\n$\\sqrt{ }$ positive perchlorate washout test\n$\\sqrt{ }$ patchy tracer distribution\n$\\sqrt{ }$ multiple ( $40 \\%$ ) / single cold defects ( $28 \\%$ ) / normal thyroid ( $8 \\%$ )\nUS:\n$\\sqrt{ }$ enlarged thyroid ( $77 \\%$ greater volume compared with normal size)\n$\\sqrt{ }$ initially heterogeneous nonspecific diffusely decreased echogenicity (in 18-77\\%)\n$\\sqrt{ }$ irregular surface with slight lobulation of contour\n$\\sqrt{ }$ marked hyperemia on color Doppler\n$\\sqrt{ }$ later densely echogenic (fibrosis) + acoustic shadowing\n$\\sqrt{ } \\pm$ satellite lymph nodes (Delphian node above isthmus)\nCx: hypothyroidism\nDx: (1) Diffuse firm bosselated goiter with pyramidal lobe enlargement\n(2) NO signs of thyrotoxicosis\n(3) Positivity for antibodies against thyroid microsomes / peroxidase / thyroglobulin\n(4) Lymphocytic infiltrates\n\nDDx (1) Atrophic chronic autoimmune thyroiditis (small gland)\n(2) Painless thyroiditis (transient disorder, painless goiter, hyperthyroidism / hypothyroidism)\n(3) Graves disease (diffuse goiter, hyperthyroidism, ophthalmopathy)\n\n# Painless / Silent Thyroiditis \n\n$=$ SUBACUTE LYMPHOCYTIC THYROIDITIS\nFrequency: up to $23 \\%$ of hyperthyroid patients in USA (many cases misdiagnosed as Graves disease)\nEtiology: autoimmune process frequently in postpartum period (postpartum thyroiditis) +",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 331,
            "markdown": "under cytokine / lithium therapy\nHisto: resembles chronic lymphocytic thyroiditis (Hashimoto) with paucity of lymphocyte germinal centers and fibrosis\n\n- clinical presentation similar to subacute thyroiditis + clinically indistinguishable from Graves disease\n- anti-thyroid peroxidase antibodies (in 60\\%)\n- small NOT painful / tender goiter (in 50-60\\%)\n- mild thyrotoxicosis lasting for a few months\n$\\sqrt{ } 24$-hour radioiodine uptake $<1 \\%$\nPrognosis: recovery of thyroid function (majority); persistent goiter (33\\%); permanent hypothyroidism (20\\%); recurrent episodes of subacute lymphocytic thyroiditis $(10 \\%)$\n\n\n# Acute Infectious / Suppurative Thyroiditis \n\n$=$ rare entity since the introduction of antibiotics\n\n- ill febrile usually euthyroid patient\n\nUS:\n$\\sqrt{ }$ focal / diffuse enlargement; possibly abscess\n$\\sqrt{ }$ decreased echogenicity\n\n## Subacute Thyroiditis\n\n$=$ inflammatory destruction of thyroid follicles with release of preformed hormone into the circulation\nClassification:\n\n1. Subacute granulomatous thyroiditis (de Quervain)\n2. Subacute lymphocytic thyroiditis\n(a) postpartum thyroiditis:\n$\\diamond$ Enable radioiodine uptake test by suspending breast-feeding for 1 week, during which time the radioiodine-contaminated breast milk should be pumped and discarded\n(b) cytokine-associated thyroiditis (interferon-alpha for chronic hepatitis B/C, interleukin-2 as adjunctive therapy for metastatic cancer and leukemia)\n(c) lithium-associated thyroiditis\n3. Subacute thyroiditis due to cellular injury\n$\\leftarrow$ amiodarone-induced thyroiditis\n4. Subacute thyroiditis due to trauma\n\nCause: palpation, parathyroid surgery, direct surgical trauma, thyroid biopsy, seatbelt injury\n5. Subacute thyroiditis due to radiation\n\nCause: radioiodine treatment, external beam radiation\nPhases:\n\n1. Hyperthyroid phase\n$=$ initial inflammatory stage $\\rightarrow$ leakage of $\\mathrm{T}_{4}$ and $\\mathrm{T}_{3}$ into the circulation $\\rightarrow$ suppression of pituitary TSH production $\\rightarrow$ virtually absent 24 -hour uptake\n\n- $\\mathrm{T}_{3} \\div \\mathrm{T}_{4}$ ratio $(\\mathrm{ng} / \\mathrm{dL}+\\mathrm{mg} / \\mathrm{dL})<20$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 332,
            "markdown": "$\\sqrt{ }$ virtually absent radioiodine uptake (usually $<1 \\%$ )\nDuration: several weeks - several months\n$\\sqrt{ }$ marked decrease in echogenicity (the lowest of all thyroid disorders)\n$\\sqrt{ }$ normal vascularity\n$R x$ : beta-adrenergic blocking agents; ipodate or iopanoic acid\n2. Hypothyroid phase\n$=$ inflammation subsides $\\rightarrow$ thyroid hormone levels decrease to euthyroid + into hypothyroid range\n$\\sqrt{ }$ normalization of 24 -hour radioiodine uptake\nDuration: 4 weeks -6 months\n$\\sqrt{ }$ regaining of isoechogenicity during recovery phase\n$\\sqrt{ } \\pm$ slightly increased vascularity\n$R x$ : levothyroxine dose adjusted to TSH level\nUS:\n$\\sqrt{ }$ discrete nodules $(50 \\%)$\n\n# Riedel Thyroiditis \n\n$=$ IgG4-RELATED THYROIDITIS\n$=$ rare chronic inflammatory process with extensive fibrosis\n\n- rock-hard painless mass involving thyroid parenchyma and surrounding tissues\n\nAssociated with: fibrosclerosis in other organs (in $1 / 3$ )\nUS:\n$\\sqrt{ }$ heterogeneously hypoechoic thyroid mass\nCT:\n$\\sqrt{ }$ focal / diffuse low-attenuation mass of thyroid\n$\\sqrt{ }$ minimal contrast enhancement relative to normal thyroid\nPET:\n$\\sqrt{ }$ avid uptake\n$R x$ : steroid therapy $\\rightarrow$ marked reduction of thyroid mass\n\n## TORNWALDT CYST\n\n$=$ midline congenital pouch / cyst lined by ectoderm within nasopharyngeal mucosal space [Gustav Ludwig Tornwaldt (1843-1910), physician in Danzig, Germany]\nOrigin: persistent focal adhesion between notochord + ectoderm extending to pharyngeal tubercle of occipital bone\nFrequency: $4 \\%$ of autopsies\n$\\diamond$ Most common congenital head and neck cyst in childhood!\nPeak age: $15-30$ years\n\n- asymptomatic incidental finding\n- persistent nasopharyngeal drainage\n- halitosis, foul taste in mouth\n\nLocation: posterior roof of nasopharynx\n$\\sqrt{ }$ smoothly marginated cystic mass of few mm to 3 cm in size\n$\\sqrt{ }$ low density, not enhancing\n$\\sqrt{ }$ NO bone erosion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 333,
            "markdown": "Cx: infection of cyst\n$D D x$ : Rathke pouch (occurs in craniopharyngeal canal located anteriorly + cephalad to Thornwaldt cyst)\n\n# TOXIC AUTONOMOUS NODULE \n\n$=$ PLUMMER DISEASE $=$ TOXIC ADENOMA\n$=$ hyperthyroidism caused by one / two hyperfunctioning nodules independent of normal pituitary-thyroid control mechanism\n$\\diamond$ All toxic nodules are autonomous;\nHOWEVER, not all autonomous nodules are toxic\nCause: gene mutation of TSH receptors of adenoma surface (not autoimmunity) result in continuous activation\nHisto: adenoma\n\n- excessive serum levels of thyroid hormone\n- suppressed TSH production, clinically hyperthyroid\n$\\sqrt{ }$ radioiodine uptake (RAIU) mildly to moderately elevated\n$\\sqrt{ }$ concentration of radiopharmaceutical to a far greater degree than surrounding extranodular thyroid tissue\n$D D x$ : Graves disease (RAIU significantly elevated)\n\n\n## TOXIC MULTINODULAR GOITER\n\n$=$ multinodular goiter associated with hyperthyroidism\nCause: several of nodules have gradually formed areas of hyperplasia that eventually grew into autonomously functioning nodules\nAge: elderly\n\n- mildly elevated thyroid levels, suppressed TSH\n$\\sqrt{ }$ RAIU normal / slightly elevated\n$\\sqrt{ }$ multiple \"hot\" nodules in thyroid with suppressed extranodular thyroid tissue\n$D D x$ : Graves disease (younger patient, milder degree of thyrotoxicosis)\n\n\n## TUBERCULOSIS OF HEAD \\& NECK\n\nFrequency: $15 \\%$ of extrapulmonary tuberculosis; initial presentation in $1.5 \\%$ of all new cases\nSite: (a) lymph nodes: multiple nodal chains\n(b) extranodal disease (rare): larynx $>$ temporal bone $>$ pharynx; sinonasal cavity, thyroid gland, skull base\n$\\sqrt{ }$ soft-tissue thickening + infiltration of preepiglottic + paraglottic spaces\n$D D x$ of low-density node: necrotic lymph node metastasis from squamous cell carcinoma\n$D D x$ of calcified node: metastatic thyroid cancer\n\n## Tuberculous Lymphadenitis = Scrofula\n\nOrganism: Mycobacterium scrofulaceum (in children), M. tuberculosis (in adults)\nPredisposed: HIV, AIDS\n\n- bilateral chronic painless lymphadenitis growing with time\n- \"cold abscess\" = no accompanying local color or warmth (overlying skin acquires a",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 334,
            "markdown": "violaceous color)\n$\\sqrt{ }$ initially homogeneous nodes, later with central necrosis:\n$\\checkmark$ multichambered centrally hypoattenuating mass\n$\\checkmark$ central T1-hypointensity and T2 -hyperintensity\n$\\checkmark$ thick enhancing peripheral rim\n$\\checkmark$ peripheral nodal calcifications (in late TB)\n\n# WARTHIN TUMOR \n\n$=$ PAPILLARY CYSTADENOMA LYMPHOMATOSUM = ADENOLYMPHOMA = CYSTADENOLYMPHOMA\nFrequency: $2^{\\text {nd }}$ most common benign tumor of parotid gland; $5 \\%-10 \\%$ of all benign salivary neoplasms: bilateral in $10 \\%$\nAge: $5-6^{\\text {th }}$ decade; $\\mathrm{M}>\\mathrm{F}$\nOrigin: from heterotopic salivary gland tissue within parotid lymph nodes (direct result of incorporation of lymphatic elements + heterotopic salivary gland ductal epithelium within intraparotid + periparotid nodes during embryonic development\nHisto: CHARACTERISTIC double layer of oncocytes (= epithelial cells) resting on a dense lymphoid stroma\n\n- slow-growing painless mass\n\nAssociated with: history of smoking\nLocation: usually solitary + unilateral; bilateral + multifocal ( $\\pm$ metachronous) in 10-60\\%\n$\\diamond$ Most common lesion to manifest as unilateral + multifocal masses\n$\\diamond$ Most common salivary neoplasm to manifest as multiple masses in one / both parotid glands\nSite: often in tail of parotid gland\n$\\checkmark$ well-circumscribed single / multiple cystic / solid lesion in parotid region usually $3-4 \\mathrm{~cm}$ in size\nMR:\n$\\checkmark$ hypointense compared with fat / surrounding parotid tissue on T2WI\nUS:\n$\\checkmark$ oval hypoechoic well-defined tumor\n$\\checkmark$ frequently multiple anechoic areas\n$\\checkmark$ increased vascularity\nNUC:\n$\\checkmark$ increased uptake with ${ }^{99 \\mathrm{~m}} \\mathrm{Tc},{ }^{201} \\mathrm{Tl}$, FDG\n$C x$ : sporadically malignant transformation of epithelial component\n$R x$ : surgical resection\n$D D x$ : lymphoma, inflammatory disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 335,
            "markdown": "# DIFFERENTIAL DIAGNOSIS OF CHEST DISORDERS \n\n## PULMONARY HEMORRHAGE\n\nA. WITHOUT RENAL DISEASE\n\n1. Bleeding diathesis: leukemia, hemophilia, disseminated intravascular coagulation (DIC)\n2. Pulmonary embolism, thromboembolism\n3. Blunt trauma: contusion\n4. Idiopathic pulmonary hemosiderosis\n5. Limited Wegener granulomatosis\n6. Drugs: amphotericin B, mitomycin, high-dose cyclophosphamide, cytarabine (ara-C), D-penicillamine, anticoagulants, lymphangiography\nB. WITH RENAL DISEASE\n(a) medium-sized vessel vasculitis\n7. Polyarteritis nodosa\n(b) ANCA-associated small-vessel vasculitis:\n8. Wegener granulomatosis\n9. Churg-Strauss syndrome\n(c) immune-complex small vessel vasculitis:\n10. Goodpasture syndrome $=$ antibasement membrane antibody disease with a linear pattern on tissue stains\n11. Henoch-Schönlein purpura\n12. Behçet disease\n(d) Collagen vascular disease:\n13. Systemic lupus erythematosus: granular pattern of immune complexes on tissue stains, noncaseating granulomas, malar rash\n14. Rheumatoid arthritis\n15. Seronegative juvenile rheumatoid arthritis\n(e) others\n16. Rapidly progressive glomerulonephritis $\\pm$ immune complexes\n17. Immunoglobulin A nephropathy\n18. Idiopathic pulmonary hemorrhage\n19. Idiopathic glomerulonephritis\nC. HEMORRHAGIC PNEUMONIA\n20. Bacteria: Legionnaires' disease\n21. Viruses: CMV, herpes, Rocky Mountain spotted fever, infectious mononucleosis\n22. Fungi: aspergillosis, mucormycosis\nD. BLEEDING METASTASIS, eg, choriocarcinoma\n\n- acute respiratory distress, hemoptysis (uncommon)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 336,
            "markdown": "CXR:\n$\\checkmark$ bilateral heterogeneous + homogeneous opacities\n$\\checkmark$ multifocal patchy segmental / lobar consolidation\nHRCT:\n$\\checkmark$ bilateral patchy / confluent ground-glass opacities / consolidation\n$\\checkmark$ ground-glass centrilobular nodules\n$\\checkmark$ may delineate underlying etiology (bronchiectasis, lung cancer, TB, pulmonary embolism)\nNUC:\n$\\checkmark$ typically matched defect on V/Q scan in bronchial artery bleeding\n\n# Hemoptysis \n\n$=$ bleeding from lower respiratory tract\n\n- frothy sputum, bright red blood, alkaline pH\n- massive hemoptysis = expectoration of greater than 300-600 mL of blood in 24 hours\n\nRisk: airway compromise\nSource:\n(a) bronchial artery ( $90-95 \\%$ )\n(b) pulmonary artery\n(c) nonbronchial systemic aa. (brachiocephalic, intercostal, inferior phrenic, gastric, celiac, internal mammary, subclavian aa. as contributing source in 41-88\\%)\nPathophysiology:\n(a) chronic thromboembolic disease / Takayasu arteritis $\\rightarrow$ \\& pulmonary arterial perfusion $\\rightarrow$ vasodilatation of bronchial-pulmonary arterial anastomotic connections $\\rightarrow$ rupture of thin-walled anastomoses under systemic blood pressure into alveolus / bronchus\n(b) chronic inflammation (eg, bronchiectasis and TB) / neoplasm $\\rightarrow$ release of angiogenic growth factors $\\rightarrow \\uparrow \\uparrow$ collateral vascular supply and neovascularization $\\rightarrow$ fragile + leaky new vessels prone to rupture into alveolus / bronchus\nEtiology:\n$\\diamond$ The 2 most common causes (in adults) are bronchial carcinoma + bronchiectasis and (in children) cystic fibrosis + CHD!\n$\\diamond$ Most clinically significant cases of hemoptysis are due to entities that increase bronchial + systemic pulmonary blood flow: bronchiectasis, lung cancer, chronic bronchitis, cavitary infection, cavitary sarcoidosis, bronchial artery malformation\nA. TUMOR\n\n1. Carcinoma (35\\%)\n2. Bronchial carcinoid\n3. Endobronchial metastasis\nB. BRONCHIAL WALL INJURY\n4. Foreign body erosion\n5. Bronchoscopy / biopsy\nC. VASCULAR\n6. COPD\n7. Pulmonary embolus with infarction\n$\\checkmark$ bronchial blood flow may increase by $300 \\%$ in the weeks following pulmonary artery embolization",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 337,
            "markdown": "3. Venous hypertension (most common): mitral stenosis\n4. Arteriovenous malformation\n5. Rupture of pulmonary artery aneurysm: TB, vasculitis, trauma, neoplasm, abscess, septic embolus, indwelling catheter\nD. INFECTION (pneumonia)\n6. Chronic bronchitis\n\nDieulafoy disease $=$ abnormally dilated submucosal vessels of pulmonary artery prone to hemorrhage\n[Paul Georges Dieulafoy (1839-1911), chief of medical services at the Hôtel-Dieu, Paris, France]\n2. Bronchiectasis, mouthful (15\\%)\n3. Tuberculosis (Rasmussen aneurysm)\n4. Aspergillosis\n5. Abscess\n6. Cystic fibrosis\nE. CRYPTOGENIC (3-10-42\\%)\n$\\diamond 6-10 \\%$ of patients who smoke present with unresectable lung cancer within subsequent 3 years!\nCT:\n$\\sqrt{ }$ cluster of avidly enhancing \"nodular\" bronchial arteries in posterior mediastinum below level of aortic arch paralleling bronchial anatomy\n$\\checkmark$ abnormal bronchial arteries show tortuosity, dilatation, hypervascularity, neovascularity, aneurysms, shunts\nN.B.: multidetector CT mapping prior to angiography reduces the rate of catheterization failures and the number of patients needing surgical intervention!\nAngio:\n$\\sqrt{ }$ vasodilated enlarged tortuous bronchial arteries $\\rightarrow$ bronchial-to-pulmonary-artery shunting, hypervascularity, parenchymal staining\nPrognosis: $50-100 \\%$ mortality rate of conservatively treated massive hemoptysis; death usually from asphyxiation rather than from exsanguination\n$R x$ : transcatheter particulate embolization of bronchial aa. using polyvinyl alcohol (PVA) + Gelfoam ${ }^{\\circledR}$ pledgets (effective in $70-95 \\%$; recurrent bleeding in $20-30 \\%$ )\nN.B.: identify arteria radicularis (= artery of Adamkiewicz) at T5-L2 (in 75\\% T9T12) to avoid postembolization transverse myelitis\n$D D x$ : hematemesis (containing food particles, dark blood, acid pH )\n\n# ASPIRATION \n\n$=$ intake of solid / liquid materials into the airways and lungs\nPredisposing factors:\n\n1. Alcoholism (most common in adults)\n2. General anesthesia, loss of consciousness\n3. Structural abnormalities of pharynx / esophagus (congenital / acquired tracheoesophageal + tracheopulmonary fistula), laryngectomy\n4. Neuromuscular disorders",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 338,
            "markdown": "5. Deglutition abnormalities\n\nSubstrate:\n(a) solids\n> foreign bodies\n$>$ lentils\n(b) liquids\n> gastric acid $=$ Mendelson syndrome\n> water $=$ near drowning\n> barium, water-soluble contrast material\n> liquid paraffin / petroleum = acute exogenous lipoid pneumonia / fire-eater pneumonia\n> mineral oil / cod liver oil = chronic exogenous lipoid pneumonia\n(c) contaminated substances from oropharynx / GI tract\n\n# Acute Lower Airway Obstruction in Childhood \n\nLocation: intrathoracic trachea + bronchi\n(a) infectious / inflammatory:\n\n- fever, cough, wheeze\n$><2$ years old:\n\n1. Bronchiolitis\n$\\checkmark$ bronchial wall thickening + hyperinflation\n$>>2$ years old:\n2. Lower respiratory tract inflammation\n$\\checkmark$ bronchial wall thickening\n3. Reactive airways disease\n$\\checkmark$ bronchial wall thickening + hyperinflation\n(b) others:\n4. Aspirated foreign body\n\n## PULMONARY DISEASE \\& CIGARETTE SMOKING\n\n1. Bronchogenic carcinoma\n2. Chronic bronchitis\n3. Centrilobular emphysema\n4. Panacinar emphysema with $\\alpha-1$ antitrypsin deficiency\n5. Smoking-related interstitial lung disease\n> Respiratory bronchiolitis ILD (RB-ILD)\n> Desquamative interstitial pneumonitis (DIP)\n> Pulmonary Langerhans cell histiocytosis (PLCH)\n> Idiopathic pulmonary fibrosis (IPF)\n\n## HYPERSENSITIVITY TO ORGANIC DUSTS\n\nA. TRACHEOBRONCHIAL HYPERSENSITIVITY\nlarge particles reaching the tracheobronchial mucosa (pollens, certain fungi, some animal / insect epithelial emanations)\n\n1. Extrinsic asthma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 339,
            "markdown": "2. Hypersensitivity aspergillosis\n3. Bronchocentric granulomatosis\n4. Byssinosis in cotton-wool workers\nB. ALVEOLAR HYPERSENSITIVITY\n$=$ HYPERSENSITIVITY PNEUMONITIS\n$=$ EXTRINSIC ALLERGIC ALVEOLITIS\nsmall particles of $<5 \\mu \\mathrm{~m}$ reaching alveoli\n\n# DRUG-INDUCED PULMONARY DAMAGE \n\nHistopathologic manifestations:\n(a) Diffuse alveolar damage:\nbleomycin, busulfan, carmustine, mitomycin, cyclophosphamide, melphalan, gold salts\n(b) Nonspecific interstitial pneumonia:\namiodarone, methotrexate, carmustine, chlorambucil\n(c) Bronchiolitis obliterans organizing pneumonia: gold salts, bleomycin, methotrexate, amiodarone, nitrofurantoin, penicillamine, sulfasalazine, cyclophosphamide\n(d) Eosinophilic pneumonia:\npenicillamine, sulfasalazine, nitrofurantoin, nonsteroidal anti-inflammatory drugs, paraaminosalicylic acid\n(e) Pulmonary hemorrhage:\nanticoagulants, amphotericin B, cytarabine (ara-C), penicillamine, cyclophosphamide\nA. CYTOTOXIC DRUGS (most important group)\n\n1. Cyclophosphamide\n\nUse: variety of malignancies, Wegener granulomatosis, glomerulonephritis\nToxicity: after 2 weeks - 13 years (mean, 3.5 years), no relationship to dose / duration of therapy\nPrognosis: good after discontinuation of therapy\n$\\checkmark$ diffuse alveolar damage (most common)\n$\\checkmark$ nonspecific interstitial pneumonia\n$\\checkmark$ BOOP (least common)\n2. Busulfan $=$ Myleran $^{\\circledR}$ (for CML)\n\nToxicity: dose-dependent, after 3-4 years on the drug in $1-10 \\%$\n$\\checkmark$ diffuse linear pattern (occasionally reticulonodular / nodular pattern)\n$\\checkmark$ partial / complete clearing after withdrawal of drug\n$D D x$ : Pneumocystis pneumonia, interstitial leukemic infiltrate\n3. Nitrosoureas $=$ carmustine (BCNU), lomustine (CCNU)\n\nUse: CNS glioma, lymphoma, myeloma\nToxicity: in $50 \\%$ after doses $>1500 \\mathrm{mg} / \\mathrm{m} 2$; sensitivity increased after radiation Rx\n$\\checkmark$ diffuse alveolar damage (most common)\n$\\checkmark$ nonspecific interstitial pneumonia:\n$\\checkmark$ linear / finely nodular opacities (following treatment of 2-3 years)\n$\\checkmark$ high incidence of pneumothorax\n4. Bleomycin\n\nUse: squamous cell carcinoma of neck / cervix / vagina, Hodgkin lymphoma,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 340,
            "markdown": "testicular carcinoma\nToxicity: at doses $>300 \\mathrm{mg}$ (in 3-6\\%); increased risk with age + radiation therapy + high oxygen concentrations\nPrognosis: death from respiratory failure within 3 months of onset of symptoms\n$\\sqrt{ }$ diffuse alveolar damage (most common)\n$\\sqrt{ }$ nonspecific interstitial pneumonia / BOOP:\n$\\sqrt{ }$ subpleural linear / nodular opacities ( $5-30 \\mathrm{~mm}$ ) in lower lung zones occurring after $1-3$ months following beginning of therapy\n$D D x$ : metastases\n5. Taxoid derivatives $=$ paclitaxel, docetaxel, gemcitabine, topotecan, vinorelbine\n\nUse: breast cancer, lung cancer, ovarian cancer\n$\\sqrt{ }$ interstitial pneumonitis\nB. NONCYTOTOXIC DRUGS\n\n1. Amiodarone\n$=$ triiodinated benzofuran\nUse: refractory ventricular tachyarrhythmia\nToxicity: in 5-10\\%; risk increased with daily dose $>400 \\mathrm{mg}+$ in elderly\nPrognosis: good after discontinuation of drug\n\n- pulmonary insufficiency after 1-12 months in $14-18 \\%$ on long-term therapy\n$\\checkmark$ nonspecific interstitial pneumonia (most common) + associated BOOP:\n$\\checkmark$ alveolar + interstitial infiltrates (chronic presentation)\n$\\checkmark$ focal homogeneous peripheral consolidation (acute presentation):\n$\\checkmark$ attenuation values of iodine $\\leftarrow$ incorporation of amiodarone into type II pneumocytes\n$\\checkmark$ pleural thickening (inflammation) adjacent to consolidation\n$\\checkmark$ associated high-attenuation of liver relative to spleen\n\n2. Gold salts\n\nUse: inflammatory arthritis\nToxicity: in $1 \\%$ within 2-6 months\n\n- mucocutaneous lesions (30\\%)\n$\\checkmark$ diffuse alveolar damage (common)\n$\\checkmark$ nonspecific interstitial pneumonia (common)\n$\\checkmark$ BOOP (less common)\n\n3. Methotrexate, procarbazine\n\nUse: lung cancer, breast cancer, head and neck epidermoid cancer, nonmetastatic osteosarcoma, advanced stage NHL, AML, recalcitrant psoriasis, severe rheumatoid arthritis, pemphigus\nToxicity: in 5-10\\%; not dose-related\nPrognosis: usually self-limited despite continuation of therapy\n\n- blood eosinophilia (common)\n$\\checkmark$ nonspecific interstitial pneumonia (most common)\n$\\checkmark$ BOOP (less frequent)\n$\\checkmark$ linear / reticulonodular process (time delay of 12 days to 5 years, usually early)\n$\\checkmark$ acinar filling pattern (later)\n$\\checkmark$ transient hilar adenopathy + pleural effusion (on occasion)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 341,
            "markdown": "$D D x$ : Pneumocystis pneumonia\n4. Nitrofurantoin (Macrodantin ${ }^{\\circledR}$ )\n\nUse: urinary tract infection\nToxicity: rare\n\n- positive for ANA + LE cells\n(a) acute disorder within 2 weeks of administration:\n- fever, dyspnea, cough\n- peripheral eosinophilia (more common)\n\nPrognosis: prompt resolution after withdrawal from drug\n$\\sqrt{ }$ diffuse bilateral predominantly basal heterogeneous opacities\n(b) chronic reaction with interstitial fibrosis (less common)\n\n- insidious onset of dyspnea + cough\n- may not be associated with peripheral eosinophilia\n$\\checkmark$ nonspecific interstitial pneumonia (common)\n$\\checkmark$ bilateral basilar interstitial opacities\nC. OTHERS\n\n1. Heroin, propoxyphene, methadone\n\nToxicity: overdose followed by pulmonary edema in 30-40\\%\n$\\checkmark$ bilateral widespread airspace consolidation\n$\\checkmark$ aspiration pneumonia in $50-75 \\%$\n2. Salicylates\n\n- asthma\n$\\checkmark$ pulmonary edema (with chronic ingestion)\n\n3. Intravenous contrast material\n$\\checkmark$ pulmonary edema\n\n# LYMPHOPROLIFERATIVE MALIGNANCIES \n\n$=$ subgroup of hematologic malignancies comprising 4 different types:\n\n1. Lymphoma (Non-Hodgkin Lymphoma)\n$>30$ subtypes of lymphoma\n2. Hodgkin disease\n3. Lymphocytic leukemias (acute or chronic)\n4. Plasma cell myeloma (multiple myeloma)\n\n## PULMONARY DISEASE AND OTHER ORGAN MANIFESTATIONS\n\n## Disorders with Hepatic \\& Pulmonary Manifestations\n\n1. Alpha-1-antitrypsin deficiency\n2. Cystic fibrosis\n3. Hereditary hemorrhagic telangiectasia\n4. Autoimmune disease: primary biliary cirrhosis, rheumatoid arthritis, Hashimoto thyroiditis, Sjögren syndrome, scleroderma, sarcoidosis\n5. Drugs with toxic effects on lung and liver: methotrexate, phenytoin, amiodarone\n\n## Pulmonary-Renal Syndromes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 342,
            "markdown": "1. Wegener granulomatosis $=$ granulomatosis with polyangiitis\n2. Goodpasture syndrome\n3. Systemic lupus erythematosus\n4. Mixed connective tissue disease\n5. Microscopic polyangiitis\n\n# PULMONARY EDEMA \n\n$=$ abnormal accumulation of fluid in the extravascular compartments of the lung\nPathophysiology (Starling equation):\ntranscapillary flow dependent on\n(1) Hydrostatic pressure\n(2) Oncotic (= colloid osmotic) pressure\n(3) Capillary permeability (the endothelial cells are relatively impermeable to protein but remain permeable to water and solutes; the tight intercellular junctions of alveolar epithelium remain nearly impermeable to water and solutes)\n$\\mathrm{Q}_{\\text {filt }}=\\mathrm{K}_{\\text {filt }}\\left(\\mathrm{HP}_{\\mathrm{iv}}-\\mathrm{HP}_{\\mathrm{ev}}\\right)-\\mathrm{t}\\left(\\mathrm{OP}_{\\mathrm{iv}}-\\mathrm{OP}_{\\mathrm{ev}}\\right)$\n$\\mathrm{Q}_{\\text {filt }}=$ amount of fluid filtered per unit area per unit time\n$\\mathrm{HP}_{\\mathrm{iv}}=$ intravascular hydrostatic pressure\n$\\mathrm{HP}_{\\mathrm{ev}}=$ extravascular hydrostatic pressure\n$\\mathrm{OP}_{\\mathrm{iv}}=$ intravascular oncotic pressure\n$\\mathrm{OP}_{\\mathrm{ev}}=$ extravascular oncotic pressure\n$\\mathrm{K}_{\\text {filt }}=$ conductance of capillary wall = water resistance of capillary endothelial cell junction\n$\\mathrm{t}=$ oncotic reflection coefficient $=$ permeability of capillary membrane to macromolecules\nCause: disturbed equilibrium of net flow $\\mathrm{F}_{\\text {net }}$ between fluid transudation / exudation $\\mathrm{Q}_{\\text {filt }}$ and lymphatic absorption $\\mathrm{Q}_{\\text {lymph }}$\n$\\mathrm{F}_{\\text {net }}=\\mathrm{Q}_{\\text {filt }}-\\mathrm{Q}_{\\text {lymph }}$\nA. INCREASED HYDROSTATIC PRESSURE\n(a) cardiogenic (most common)\n$=$ PULMONARY VENOUS HYPERTENSION\n\n1. Heart disease: left ventricular failure, mitral valve disease, left atrial myxoma\n2. Pulmonary venous disease: acute / chronic pulmonary embolism, primary venoocclusive disease, mediastinal fibrosis\n3. Pericardial disease: pericardial effusion, constrictive pericarditis (extremely rare)\n4. Drugs: antiarrhythmic drugs; drugs depressing myocardial contractility (betablocker)\n(b) noncardiogenic\n5. Renal failure\n6. Massive IV fluid overload\n7. Hyperosmolar fluid (eg, contrast medium)\n(c) neurogenic\n? sympathetic venoconstriction in cerebrovascular accident, head injury, CNS tumor,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 343,
            "markdown": "# postictal state \n\n## B. DECREASED COLLOID OSMOTIC PRESSURE\n\n1. Hypoproteinemia\n2. Transfusion of crystalloid fluid\n3. Rapid reexpansion of lung\nC. INCREASED CAPILLARY PERMEABILITY\n\nEndothelial injury from\n(a) physical trauma: parenchymal contusion, radiation therapy\n(b) aspiration injury:\n\n1. Mendelson syndrome (gastric contents)\n2. Near drowning in sea water / fresh water\n3. Aspiration of hypertonic contrast media\n(c) inhalation injury:\n4. Nitrogen dioxide $=$ silo-filler's disease\n5. Smoke (pulmonary edema may be delayed by $24-48$ hours)\n6. Sulfur dioxide, hydrocarbons, carbon monoxide, beryllium, cadmium, silica, dinitrogen tetroxide, oxygen, chlorine, phosgene, ammonia, organophosphates\n(d) injury via bloodstream\n7. Vessel occlusion: shock (trauma, sepsis, ARDS) or emboli (air, fat, amniotic fluid, thrombus)\n8. Circulating toxins: snake venom, paraquat\n9. Drugs: heroin, morphine, methadone, aspirin, phenylbutazone, nitrofurantoin, chlorothiazide\n10. Anaphylaxis: transfusion reaction, contrast medium reaction, penicillin\n11. Hypoxia: high altitude, acute large airway obstruction\nmnemonic: ABCDEFGHI - PRN\nAspiration\nBurns\nChemicals\nDrugs (heroin, nitrofurantoin, salicylates)\nExudative skin disorders\nFluid overload\nGram-negative shock\nHeart failure\nIntracranial condition\nPolyarteritis nodosa\nRenal disease\nNear drowning\nAtypical pulmonary edema = lung edema with an unusual radiologic appearance\nUnusual form of pulmonary edema $=$ lung edema from unusual causes\n\n## Increased Hydrostatic Pressure Edema\n\n- Pulmonary capillary wedge pressure (PCWP):\n$=$ reflects left atrial pressure and correlates well with radiologic features of $\\mathrm{CHF}+$ pulmonary venous HTN",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 344,
            "markdown": "$\\diamond$ In acute CHF radiologic features are delayed in onset and resolution\n$\\checkmark$ flow inversion = \"cephalization of pulmonary vessels\" is ONLY seen in longstanding left heart failure, NEVER in pulmonary edema of renal failure / overhydration / low oncotic pressure\nHRCT:\n$\\checkmark$ smooth interlobular septal + peribronchovascular thickening\n$\\checkmark$ ground-glass opacities in a perihilar / dependent distribution, which may progress to consolidation\n$\\checkmark$ centrilobular ground-glass nodules\n\n| Radiographic Signs in Pressure Edema |  |\n| :--: | :--: |\n| PCWP [mmHg] | Findings |\n| $5-12$ | normal |\n| $12-17$ | cephalization of pulmonary vessels (only in chronic conditions) |\n| $17-20$ | Kerley lines, subpleural effusions |\n| $>25$ | alveolar flooding edema |\n\n# Interstitial Pulmonary Edema \n\n$=1 \\mathrm{st}$ phase of pressure edema with increase in quantity of extracellular fluid\nCause: increase in mean transmural arterial pressure of $15-25 \\mathrm{mmHg}$\n$\\checkmark$ mild enlargement of peribronchovascular spaces\n$\\checkmark$ appearance of Kerley lines\n$\\checkmark$ subpleural effusions\n$\\checkmark$ early loss of definition of subsegmental + segmental vessels\n$\\checkmark$ progressive blurring of vessels $\\leftarrow$ central migration of edema at lobar + hilar levels\n$\\checkmark$ small peripheral vessels difficult to identify $\\leftarrow$ decrease in lung radiolucency\n$\\diamond$ Often marked dissociation between clinical signs + symptoms + roentgenographic evidence\n$\\diamond$ Nothing differentiates it from other interstitial lesions\n$\\diamond$ Does not necessarily develop before alveolar pulmonary edema\n$\\diamond$ NOT typical for bacterial pneumonia\n\n## Alveolar Flooding Edema\n\n$=2^{\\text {nd }}$ phase of pressure edema\nCause: increase in mean transmural arterial pressure of $>25 \\mathrm{mmHg} \\pm$ pressure-induced damage to alveolar epithelium\n$\\checkmark$ tiny nodular / acinar areas of increased opacity\n$\\checkmark$ frank consolidation\n\n## Bat-Wing Edema (in $<10 \\%$ )\n\n$=$ central nongravitational distribution of alveolar edema\nCause: rapidly developing severe cardiac failure (acute mitral insufficiency associated with papillary muscle rupture, massive MI, valve leaflet destruction by septic endocarditis) or renal failure",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 345,
            "markdown": "$\\sqrt{ }$ lung cortex spared from fluid (due to pumping effect of respiration / contractile property of alveolar septa / mucopolysaccharide-filled perivascular matrix)\n\n# Asymmetric Distribution of Pressure Edema \n\nCause: morphologic lung changes in COPD, hemodynamics, patient position\n$\\sqrt{ }$ lung apices spared (= lung emphysema in heavy smokers)\n$\\sqrt{ }$ upper + middle portions of lung spared (= end-stage TB, sarcoidosis, asbestosis)\n$\\sqrt{ }$ predominantly RUL involvement ( $=$ mitral regurgitation refluxes preferentially into right upper pulmonary vein)\n$\\sqrt{ }$ anteroposterior gradient on CT in recumbent position\n$\\sqrt{ }$ unilateral edema in lateral decubitus position\n\n## Pulmonary Edema with Acute Asthma\n\nCause: air trapping maintains a positive intraalveolar pressure and thus decreases hydrostatic pressure gradient\nPathogenesis: associated with severity of Müller maneuver\n$\\sqrt{ }$ heterogeneous edema $\\leftarrow$ nonuniform airway obstruction\n$\\sqrt{ }$ peribronchial cuffing\n$\\sqrt{ }$ ill-defined vessels\n$\\sqrt{ }$ enlarged ill-defined hila\n$\\sqrt{ }$ patency of narrowed airways maintained $\\leftarrow$ high negative pleural pressure in forced inspiration\n\n## Postobstructive Pulmonary Edema\n\nCause: following relief from an upper airway obstruction (impacted foreign body, laryngospasm, epiglottitis, strangulation)\nPathogenesis:\n(a) forced inspiration causes a high negative intrathoracic pressure (Müller maneuver) and increases venous return\n(b) obstruction creates high positive intrathoracic pressure that impairs development of edema\n$\\sqrt{ }$ septal lines, peribronchial cuffing\n$\\sqrt{ }$ central alveolar edema\n$\\sqrt{ }$ normal heart size\nPrognosis: resolution within 2-3 days\nEdema with Pulmonary Embolism (<10\\%)\nCause: occlusion of pulmonary arterial bed causes redirection of blood flow and hypertension in uninvolved areas\n$\\sqrt{ }$ areas of ground-glass attenuation\n$\\sqrt{ }$ sharply demarcated from areas of transparency distal to occluded arteries\n$\\sqrt{ }$ associated with dilated pulmonary arteries ( $70 \\%$ )\n\n## Edema \\& Pulmonary Venoocclusive Disease\n\nCause: organized thrombi in small veins causes an increase in peripheral resistance and hydrostatic pressure",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 346,
            "markdown": "- rapidly progressive dyspnea, orthopnea $\\pm$ hemoptysis\n- normal / low pulmonary capillary wedge pressure\n$\\sqrt{ }$ enlarged pulmonary arteries\n$\\sqrt{ }$ diffuse interstitial edema + numerous Kerley lines\n$\\sqrt{ }$ peribronchial cuffing\n$\\sqrt{ }$ dilated right ventricle\n\n\n# Permeability Edema \n\n## Heroin-induced Pulmonary Edema\n\nHx: overdose of opiates (almost exclusively with heroin, rarely with cocaine / \"crack\")\nFrequency: $15 \\%$ of cases of heroin overdose\nPathophysiology: depression of medullary respiratory center leading to hypoxia + acidosis\n$\\checkmark$ widespread patchy bilateral airspace consolidations\n$\\sqrt{ }$ ill-defined vessels + peribronchial cuffing\n$\\sqrt{ }$ markedly asymmetric gravity-dependent distribution of edema (motionless recumbent position for hours / days)\n$\\sqrt{ }$ resolution within 1 or 2 days in uncomplicated cases\n$C x$ :\n(1) Extensive crush injuries with associated muscle damage and ensuing renal insufficiency (from motionless recumbency)\n(2) Aspiration of gastric contents\n\nPrognosis: $10 \\%$ mortality rate\n\n## Edema following Administration of Cytokines\n\n(a) intravenous interleukin 2 (IL-2):\nenhances tumoricidal activity of natural killer cells in metastatic melanoma + RCC\n(b) intraarterial tumor necrosis factor:\nincreases production + release of IL-2\nFrequency: in $75 \\%$ of IL-2 therapy;\nin $20 \\%$ of tumor necrosis factor therapy;\nin $25 \\%$ of recombinant IL-2 therapy\nPathophysiology: permeability disruption of capillary endothelial cells\n\n- 12 mmHg increase in pulmonary capillary wedge pressure (= direct toxic effect on myocardium)\n$\\sqrt{ }$ pulmonary edema $1-5$ days after start of therapy:\n$\\sqrt{ }$ bilateral symmetric interstitial edema with thickened septal lines\n$\\sqrt{ }$ peribronchial cuffing $(75 \\%)$\n$\\sqrt{ }$ small pleural effusions ( $40 \\%$ )\n$\\sqrt{ }$ NO alveolar edema (unless associated cardiac insufficiency)\n\n\n## High-altitude Pulmonary Edema\n\nPredisposed: young males after rapid ascent to $>3,000 \\mathrm{~m}$\nCause: prolonged exposure to low partial oxygen atmospheric pressure\nPathophysiology: acute persistent hypoxia with endothelial leakage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 347,
            "markdown": "- prodromal acute mountain sickness\n- dyspnea at rest, cough with frothy pink sputum\n- neurologic disturbances $\\leftarrow$ brain edema\n- arterial oxygen levels as low as $38 \\%$\n$\\checkmark$ central interstitial pulmonary edema\n$\\checkmark$ peribronchial cuffing\n$\\checkmark$ ill-defined vessels\n$\\checkmark$ patchy airspace consolidation\n\n\n# Mixed Hydrostatic \\& Permeability Edema \n\n## Neurogenic Pulmonary Edema\n\nFrequency: in up to $50 \\%$ of severe brain trauma, stroke, subarachnoid hemorrhage, status epilepticus\nPathophysiology: modification in neurovegetative pathways causes sudden $\\uparrow$ in pressure in pulmonary venules with reduced venous outflow\n\n- dyspnea, tachypnea, cyanosis shortly after brain insult + rapid disappearance\n$\\checkmark$ bilateral inhomogeneous / homogeneous airspace consolidations, in $50 \\%$ affecting\npredominantly the apices, disappearing within 1-2 days\n$D x:$ by exclusion\n$D D x$ : fluid overload, postextubation edema\n\n\n## Reperfusion Pulmonary Edema\n\nFrequency: in up to $90-100 \\%$\nCause: pulmonary thrombendarterectomy for massive pulmonary embolism / for webs and segmental stenosis\nPathophysiology: rapid increase in blood flow + pressure\n\n- dyspnea, tachypnea, cough during the first 24-48 hours after reperfusion\n$\\checkmark$ pulmonary edema within 2 days after surgery:\n$\\checkmark$ heterogeneous airspace consolidation, predominantly in areas distal to recanalized vessels\n$\\checkmark$ random distribution in up to $50 \\%$\n\n\n## Reexpansion Pulmonary Edema\n\nCause: rapid reexpansion of a collapsed lung following evacuation of hydro-, hemo- or pneumothorax\nPathophysiology: prolonged local hypoxic event, abrupt restoration of blood flow, sudden marked increase in intrapleural pressure, diffuse alveolar damage\n\n- frank respiratory insufficiency: cough, dyspnea, tachypnea, tachycardia, frothy pink sputum; may be asymptomatic\n$\\checkmark$ pulmonary edema within reexpanded entire lung within 1 hour (in 64\\%)\n$\\checkmark$ increase in severity within 24-48 hours with slow resolution over next 5-7 days\nPrognosis: $20 \\%$ mortality\n\n\n## Pulmonary Edema due to Air Embolism\n\nCause: usually iatrogenic complication (neurosurgical procedure in sitting position,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 348,
            "markdown": "placement / manipulation of central venous line), rare in open / closed chest trauma\nPathophysiology: embolized air bubbles cause mechanical obstruction of pulmonary microvasculature\n\n- sudden onset of chest pain, tachypnea, dyspnea\n- hypotension\n$\\sqrt{ }$ air bubbles in right-sided cardiac chambers on echocardiography\n$\\sqrt{ }$ interstitial edema\n$\\sqrt{ }$ bilateral peripheral alveolar areas of increased opacity, predominantly at lung bases\n\n\n# Postpneumnectomy Pulmonary Edema \n\n$=$ life-threatening complication in early postoperative period after pneumonectomy (rare in lobectomy / lung reduction surgery)\nFrequency: $2.5-5 \\% ; \\mathrm{R}>\\mathrm{L}$ pneumonectomy\nRisk factors: excessive administration of fluid during surgery, transfusion of fresh frozen plasma, arrhythmia, marked postsurgical diuresis, low serum colloidal osmotic pressure\nPathophysiology: increased capillary hydrostatic pressure, altered capillary permeability\n\n- marked dyspnea during first $2-3$ postop days\n$\\sqrt{ }$ ARDS-like picture\nPrognosis: very high mortality rate\n\n\n## Pulmonary Edema after Lung Transplantation\n\nFrequency: in up to $97 \\%$ during first 3 days after surgery\nPathophysiology: tissue hypoxia, disruption of pulmonary lymphatic drainage, lung denervation\n$\\sqrt{ }$ progressive diffuse confluent areas of increased opacity, most pronounced on postop day 5\n$\\sqrt{ }$ return to normal 2 weeks after surgery\n\n## Unilateral Pulmonary Edema\n\nA. IPSILATERAL = on side of preexisting abnormality\n(a) filling of airways\n\n1. Unilateral aspiration / pulmonary lavage\n2. Drowned lung (bronchial obstruction)\n3. Pulmonary contusion\n(b) increased pulmonary venous pressure\n4. Unilateral venous obstruction\n5. Prolonged lateral decubitus position\n(c) pulmonary arterial overload\n6. Systemic artery-to-pulmonary artery shunt (Waterston, Blalock-Taussig, Pott procedure)\n7. Rapid thoracentesis (rapid reexpansion)\nB. CONTRALATERAL = opposite to side of abnormality\n(a) pulmonary arterial obstruction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 349,
            "markdown": "1. Congenital absence / hypoplasia of pulmonary a.\n2. Unilateral arterial obstruction\n3. Pulmonary thromboembolism\n(b) loss of lung parenchyma\n4. Swyer-James syndrome\n5. Unilateral emphysema\n6. Lobectomy\n7. Pleural disease\nC. RIGHT UPPER LOBE\n\nPATHOGNOMONIC for mitral valve regurgitation\n\n# Pulmonary Edema with Cardiomegaly \n\n1. Cardiogenic\n2. Uremic (cardiomegaly $\\leftarrow$ pericardial effusion / hypertension)\n\n## Pulmonary Edema without Cardiomegaly\n\nmnemonic: U DOPA\nUremia\nDrugs\nOverhydration\nPulmonary hemorrhage\nAcute myocardial infarction, Arrhythmia\n\n## Noncardiogenic Pulmonary Edema\n\nmnemonic: The alphabet\nARDS, Alveolar proteinosis, Aspiration, Anaphylaxis\nBleeding diathesis, Blood transfusion reaction\nCNS (increased pressure, trauma, surgery, CVA, cancer)\nDrowning (near), Drug reaction\nEmbolus (fat, thrombus)\nFluid overload, Foreign-body inhalation\nGlomerulonephritis, Goodpasture syndrome, Gastrografin ${ }^{\\circledR}$ aspiration\nHigh altitude, Heroin, Hypoproteinemia\nInhalation (SO2, smoke, CO, cadmium, silica)\n\nNarcotics, Nitrofurantoin\nOxygen toxicity\nPancreatitis\nRapid reexpansion of pneumothorax / removal of pleural effusion\n\nTransfusion\nUremia\n\n## PNEUMONIA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 350,
            "markdown": "\"Classic\" pneumonia pattern:\n\n1. Lobar distribution: Streptococcus pneumoniae\n2. Bulging fissure: Klebsiella\n3. Pulmonary edema: Viral / Pneumocystis pneumonia\n4. Pneumatocele: Staphylococcus\n5. Alveolar nodules: Varicella, bronchogenic spread of TB\n\nDistribution:\nA. SEGMENTAL / LOBAR\n> Normal host: S. pneumoniae, Mycoplasma, virus\n> Compromised host: S. pneumoniae\nB. BRONCHOPNEUMONIA\n> Normal host: Mycoplasma, virus, Streptococcus, Staphylococcus, S. pneumoniae\n> Compromised host: gram-negative, Streptococcus, Staphylococcus\n> Nosocomial: gram-negative, Pseudomonas, Klebsiella, Staphylococcus\n> Immunosuppressed: gram-negative, Staphylococcus, Nocardia, Legionella, Aspergillus, Phycomycetes\nC. EXTENSIVE BILATERAL PNEUMONIA\n> Normal host: virus (eg, influenza), Legionella\n> Compromised host: candidiasis, Pneumocystis, TB\nD. BILATERAL LOWER LOBE PNEUMONIA\n> Normal host: anaerobic (aspiration)\n> Compromised host: anaerobic (aspiration)\nE. PERIPHERAL PNEUMONIA\n> Noninfectious eosinophilic pneumonia\nTransmission:\nA. Community-acquired pneumonia\n\nOrganism: viruses, S. pneumoniae, Mycoplasma\nMortality: $10 \\%$\nB. Nosocomial pneumonia\n[nosos, Greek = disease; kamnein, Greek = to suffer; nosocomium, Latin = hospital]\n(a) gram-negative organism ( $>50 \\%$ ): Klebsiella pneumoniae, P. aeruginosa, E. coli, Enterobacter\n(b) gram-positive organism ( $10 \\%$ ): S. aureus, S. pneumoniae, H. influenzae\n\n# Complications: \n\n1. Empyema\n2. Pulmonary abscess\n3. Cavitary necrosis\n4. Pneumatocele\n5. Pneumothorax\n6. Pyopneumothorax\n7. Bronchopleural fistula\n\n## Bacterial Pneumonia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 351,
            "markdown": "# Lobar Pneumonia \n\n$=$ ALVEOLAR PNEUMONIA\n$=$ pathogens reach peripheral air space, incite exudation of watery edema into alveolar space, centrifugal spread via small airways, pores of Kohn + Lambert into adjacent lobules + segments\n$\\checkmark$ nonsegmental sublobar consolidation\n$\\checkmark$ round pneumonia (= uniform involvement of contiguous alveoli)\n(a) Streptococcus pneumoniae\n(b) Klebsiella pneumoniae (more aggressive); in immunocompromised + alcoholics\n(c) any pneumonia in children\n(d) atypical measles\n$\\checkmark$ expansion of lobe with bulging of fissures\n$\\checkmark$ lung necrosis with cavitation\n$\\checkmark$ lack of volume loss\n$D D x$ : aspiration; pulmonary embolus\n\n## Lobular Pneumonia\n\n$=$ BRONCHOPNEUMONIA\n$=$ combination of interstitial + alveolar disease (injury starts in airways, involves bronchovascular bundle, spills into alveoli, which may contain edema fluid, blood, leukocytes, hyaline membranes, organisms)\nOrganism:\n(a) Staphylococcus aureus, Pseudomonas pneumoniae: thrombosis of lobular artery branches with necrosis and cavitation\n(b) Streptococcus (pneumococcus), Klebsiella, Legionnaires' bacillus, Bacillus proteus, E. coli, anaerobes (Bacteroides + Clostridia), Nocardia, actinomycosis\n(c) Mycoplasma\n$\\checkmark$ small fluffy ill-defined acinar nodules, which enlarge with time\n$\\checkmark$ lobar + segmental densities with volume loss from airway obstruction $\\leftarrow$ bronchial narrowing + mucus plugging\n\n## Atypical Bacterial Pneumonia\n\n$=$ bacterial infection with radiographic appearance of viral pneumonia\nOrganism:\n(1) Mycoplasma\n(2) Pertussis\n(3) Chlamydia trachomatis\n\n## Gram-negative Pneumonia\n\nIn $50 \\%$ cause of nosocomial necrotizing pneumonias (including staphylococcal pneumonia)\nPredisposed: elderly, debilitated, diabetes, alcoholism, COPD, malignancy, bronchitis, gram-positive pneumonia, treatment with antibiotics, respirator therapy\nOrganism:\n\n1. Klebsiella\n2. Pseudomonas",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 352,
            "markdown": "3. E. coli\n4. Proteus\n5. Haemophilus\n6. Legionella\n$\\checkmark$ airspace consolidation (Klebsiella)\n$\\checkmark$ spongy appearance (Pseudomonas)\n$\\checkmark$ affecting dependent lobes (poor cough reflex without clearing of bronchial tree)\n$\\checkmark$ bilateral\n$\\checkmark$ cavitation common\nCx: (1) Exudate / empyema\n(2) Bronchopleural fistula\n\n# Mycotic Lung Infection \n\nA. IN HEALTHY SUBJECTS\n\n1. Histoplasmosis\n2. Coccidioidomycosis\n3. Blastomycosis\nB. OPPORTUNISTIC INFECTION\n4. Aspergillosis\n5. Mucormycosis (phycomycosis)\n6. Candidiasis\n\nGrowth: (a) mycelial form\n(b) yeast form (depending on environment)\n\nSource of contamination:\n(a) soil\n(b) growth in moist areas (apart from Coccidioides)\n(c) contaminated bird / bat excreta\n\n## Viral Lung Infection\n\n$=$ VIRAL PNEUMONIA $=$ BRONCHIOLITIS $=$ PERIBRONCHIAL PNEUMONIA $=$ INTERSTITIAL PNEUMONIA $=$ LOWER RESPIRATORY TRACT INFECTION\n[terms used in an attempt to differentiate from airspace pneumonia]\n$=$ infection of bronchi + peribronchial tissues\nOrganism:\n\n- The cause of infection cannot be reliably ascertained from its imaging appearance!\nA. RNA VIRUSES\n(a) Influenza A: more common during infancy, may lead to severe lower respiratory tract infection; mild URI in adults\n\n1. Avian flu (H5N1 subtype): 1997 Hong Kong; 60\\% fatality rate\n2. Swine influenza A (H1N1): 2009 in Mexico; pandemic; $1 \\%$ fatality rate\n(b) Parainfluenza 1-4: common cause of seasonal URI\n(c) RSV = respiratory syncytial virus: most frequent viral cause of lower respiratory tract infection in infants\n(d) Human metapneumovirus (HMPV): clinically indistinguishable from RSV\n(e) Rubeola (measles): highly contagious; 1-36\\% mortality; febrile illness before /",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 353,
            "markdown": "with onset of rash\n(f) Enterovirus, Coxsackie virus, ECHO virus: summertime URI\n(g) Human T-cell lymphotropic virus type 1 (HTLV-1): retrovirus associated with leukemia / lymphoma; transmission by sexual contact + blood transfusion + breast feeding\n(h) Hantavirus (hantavirus pulmonary syndrome): 1993 in southwestern USA\n(i) Coronavirus (SARS = severe acute respiratory syndrome): 2002 Guangdong Province / China; $10 \\%$ mortality rate\nB. DNA VIRUSES\n(a) Adenovirus: associated with Swyer-James-MacLeod syndrome in children\n(b) Herpes simplex virus: in immunocompromised\n(c) Varicella (chickenpox)-zoster virus: common in childhood; in 10\\% of adults; 2-5 days after rash\n(d) Cytomegalic inclusion virus: features suggestive of bronchopneumonia\n(e) Epstein-Barr virus\n\nPath: necrosis of ciliated epithelial cells, goblet cells, bronchial mucous glands with frequent involvement of peribronchial tissues + interlobular septa\nClinical syndromes:\n\n1. (Common) cold $=$ mild upper respiratory tract symptoms $\\leftarrow$ tonsillopharyngitis, pharyngitis, epiglottitis, sinusitis, otitis media, conjunctivitis\n\n- sore throat, runny nose, congestion, sneezing, cough\n- headache, fever (milder than for influenza)\n\nCause: $>200$ different viruses other than influenza; Most common: rhinovirus (30$80 \\%$ ), coronavirus ( $15 \\%$ ), influenza virus ( $10-15 \\%$ )\n2. Influenza\n\n- abrupt fever $>100^{\\circ} \\mathrm{F}\\left(38^{\\circ} \\mathrm{C}\\right)$, chills and sweats, headache, myalgias, malaise, fatigue, weakness\n- nasal congestion, sore throat, dry persistent cough\n\nCause: influenza virus types A, B, C constantly changing (= antigenic drift + shift)\n\n# Viral Pneumonia in Childhood \n\nPathophysiology:\ntracheitis, bronchitis, bronchiolitis with peribronchial infiltrates $\\rightarrow$ increased secretion of mucus + constriction of bronchi $\\rightarrow$ narrowing of airways $\\rightarrow$ increased resistance to air flow $\\rightarrow$ air trapping $\\rightarrow$ increase in residual volume; injury to alveolar cells with hyaline membranes; necrosis of alveolar walls with blood, edema, fibrin, macrophages within alveoli\nAge: most common cause of pneumonia in children $<5$ years of age; adults have usually acquired immunity\n\n- retractions, tachypnea, air hunger, respiratory distress\n\nDistribution: usually bilateral\nAccuracy of CXR: 92\\% NPV, 30\\% PPV\n$\\sqrt{ }$ hyperaeration + air trapping (best indicator!):\n$\\sqrt{ }$ depression of diaphragm on both views:\n(a) projects below anterior $6^{\\text {th }}$ rib",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 354,
            "markdown": "(b) projects below posterior $8^{\\text {th }} / 10^{\\text {th }} \\mathrm{rib}$ on lordotic view\n(c) loss of diaphragmatic dome on lateral view\n$\\sqrt{ }$ increase in transverse diameter of chest\n$\\sqrt{ }$ bowing of sternum upward + outward\n$\\sqrt{ }$ increased anteroposterior diameter on lateral view\n$\\sqrt{ }$ \"dirty chest\" = peribronchial cuffing + opacification:\n$\\sqrt{ }$ symmetric parahilar peribronchial linear densities $\\leftarrow$ patchy atelectasis\n$\\sqrt{ }$ bronchial wall thickening\n$\\sqrt{ }$ interstitial pattern\n$\\sqrt{ }$ segmental + subsegmental atelectasis with frequently changing distribution $\\leftarrow$ dislodgement of mucus plugs (common):\n$\\sqrt{ }$ wedge-shaped / triangular densities\n$\\sqrt{ }$ airspace pattern $(50 \\%) \\leftarrow$ hemorrhagic edema\n$\\sqrt{ }$ pleural effusion $(20 \\%)$\n$\\sqrt{ }$ hilar adenopathy $(3 \\%)$\n$\\sqrt{ }$ striking absence of pneumatoceles, lung abscess, pneumothorax\n$\\sqrt{ }$ radiographic resolution lags $2-3$ weeks behind clinical\nCx: (1) Bacterial superinfection (child becomes toxic after a week of sickness, peripheral consolidations + air bronchograms + pleural effusion)\n(2) Bronchiectasis\n(3) Unilateral hyperlucent lung, bronchiolitis obliterans\n$\\diamond$ Atypical measles pneumonia does NOT show the typical radiographic findings of viral pneumonias!\n\n# Viral Pneumonia in Adulthood \n\nClinical groups:\n(a) atypical pneumonia in healthy host\n(b) viral pneumonia in immunocompromised host\n\nRisk factors: very young \\& old age, malnutrition, immunologic disorders\nHisto:\n(a) diffuse alveolar damage (intraalveolar edema, fibrin, variable cellular infiltrate with hyaline membrane)\n(b) intraalveolar hemorrhage\n(c) interstitial (intrapulmonary / airway) inflammatory cell infiltration\n\nCXR:\n$\\sqrt{ }$ unilateral / patchy bilateral areas of consolidation\n$\\diamond$ Lobar consolidation is uncommon!\n$\\sqrt{ }$ nodular opacities\n$\\sqrt{ }$ bronchial wall thickening\n$\\sqrt{ }$ small pleural effusion\nCT:\n$\\sqrt{ }$ disturbances of parenchymal attenuation:\n$\\sqrt{ }$ patchy inhomogeneities $=$ mosaic attenuation ( $=$ bronchiolar inflammation $/$ cicatricial scarring $\\rightarrow$ bronchiolar obstruction $\\rightarrow$ alveolar hypoventilation):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 355,
            "markdown": "$\\sqrt{ }$ area of decreased attenuation persists during expiration $\\leftarrow$ air trapping\n$\\sqrt{ }$ lobular ground-glass opacities (= thickening of interstitium + partial filling of airspaces)\n$\\sqrt{ }$ pulmonary consolidation:\n$\\sqrt{ }$ patchy + poorly defined (bronchopneumonia)\n$\\sqrt{ }$ focal + well defined (lobar pneumonia)\n$\\sqrt{ }$ nodules $<10 \\mathrm{~mm}$\n$\\sqrt{ }$ centrilobular micronodules\n$\\sqrt{ }$ tree-in-bud of small airway disease\n$=$ dilated centrilobular bronchioles, their lumina impacted with mucus / fluid / pus\n$\\sqrt{ }$ widespread smooth interlobular septal thickening $\\pm$ crazy paving pattern\n$\\sqrt{ }$ bronchial $\\pm$ bronchiolar wall thickening\nCx: acute pneumonia with rapid progression to ARDS\n\n# Round Pneumonia \n\n$=$ NUMMULAR PNEUMONIA\n$=$ fairly spherical pneumonia caused by pyogenic organisms\nPathophysiology: in young children only few intraalveolar pores of Kohn +\nbronchoalveolar channels of Lambert have developed to allow collateral air drift\nOrganism: Haemophilus influenzae, Streptococcus, Pneumococcus\nAge: children $>>$ adults\n\n- cough, chest pain, fever of $\\geq 104^{\\circ} \\mathrm{F}\\left(40^{\\circ} \\mathrm{C}\\right)$\n\nLocation: always posterior, usually in lower lobes\n$\\sqrt{ }$ spherical infiltrate with slightly fluffy borders + air bronchogram\n$\\sqrt{ }$ triangular infiltrate abutting a pleural surface (usually seen on lateral view)\n$\\sqrt{ }$ rapid change in size and shape\n\n## Cavitating Pneumonia\n\n1. Staphylococcus aureus\n2. Haemophilus influenzae\n3. S. pneumoniae\nother gram-negative organisms (eg, Klebsiella)\n\n## Cavitating Opportunistic Infection\n\n$\\diamond$ Repeated infections in same patient are not necessarily due to same organism!\nA. FUNGAL INFECTIONS\n\n1. Aspergillosis\n2. Nocardiosis\n3. Mucormycosis (= phycomycosis)\nB. STAPHYLOCOCCAL ABSCESS\nC. TUBERCULOSIS (nummular form)\nD. SEPTIC EMBOLI\n4. Anaerobic organisms\n\nDDx: Metastatic disease in carcinoma / Hodgkin lymphoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 356,
            "markdown": "# Recurrent Pneumonia in Childhood \n\nA. IMMUNE PROBLEM\n\n1. Immune deficiency\n2. Chronic granulomatous disease of childhood (males)\n3. Alpha 1-antitrypsin deficiency\nB. ASPIRATION\n4. Gastroesophageal reflux\n5. H-type tracheoesophageal fistula\n6. Disorder of swallowing mechanism\n7. Esophageal obstruction, impacted esophageal foreign body\nC. UNDERLYING LUNG DISEASE\n8. Sequestration\n9. Bronchopulmonary dysplasia\n10. Cystic fibrosis\n11. Atopic asthma\n12. Bronchiolitis obliterans\n13. Sinusitis\n14. Bronchiectasis\n15. Ciliary dysmotility syndromes\n16. Pulmonary foreign body\n\n## NEONATAL LUNG DISEASE\n\n## Parenchymal Lung Disease on 1st Day of Life\n\n$\\diamond$ Radiographic findings overlap!\n\n1. Transient tachypnea of newborn\n2. Respiratory distress syndrome\n3. Neonatal pneumonia\n4. Meconium aspiration syndrome\n5. Prematurity with accelerated lung maturity (see below)\n\n## Air Leaks in Neonatal Chest\n\n$=$ intrathoracic extra-alveolar gas\n\n1. Pulmonary interstitial emphysema\n2. Pneumomediastinum\n3. Pneumothorax\n4. Gas below visceral pleura\n$\\sqrt{ }$ gas at lung base / against fissure\n5. Pneumopericardium\n6. Gas embolus to cardiac chambers / blood vessels\n\n## Mediastinal Shift \\& Abnormal Aeration in Neonate\n\nA. SHIFT TOWARD LUCENT LUNG\n\n1. Congenital diaphragmatic hernia\n2. Chylothorax",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 357,
            "markdown": "3. Cystic adenomatoid malformation\nB. SHIFT AWAY FROM LUCENT LUNG\n4. Congenital lobar emphysema\n5. Persistent localized pulmonary interstitial emphysema\n6. Obstruction of mainstem bronchus (by anomalous or dilated vessel / cardiac chamber)\n\n# Pulmonary Infiltrates in Neonate \n\nmnemonic: I HEAR\nInfection (pneumonia)\nHemorrhage\nEdema\nAspiration\nRespiratory distress syndrome\n\n## Reticulogranular Densities in Neonate\n\n1. Respiratory distress syndrome ( $90 \\%$ ): premature infant, inadequate surfactant\n2. Prematurity with Accelerated Lung Maturity (PALM)\n$=$ IMMATURE LUNG SYNDROME:\npremature infant with normal surfactant $\\leftarrow$ maternal steroid therapy / intrauterine stress\n$\\checkmark$ lung granularity ( $=$ almost clear chest)\n$\\checkmark$ small thymus (stress / steroids)\n3. Transient tachypnea of the newborn\n4. Neonatal group-B streptococcal pneumonia\n5. Idiopathic hypoglycemia\n6. Congestive heart failure\n7. Early pulmonary hemorrhage\n8. Infant of diabetic mother\n\n## CONGENITAL LUNG ABNORMALITIES\n\n$=$ SEQUESTRATION SPECTRUM\nA. BRONCHOPULMONARY (LUNG BUD) ANOMALY\n\n1. Lung agenesis-hypoplasia complex\n2. Congenital pulmonary airway malformation\n3. Congenital lobar overinflation / emphysema\n4. Bronchial atresia\n5. Bronchogenic cyst\nB. VASCULAR ANOMALY\n6. Absence of main pulmonary artery\n7. Pulmonary sling = Anomalous origin of left pulmonary a.\n8. Anomalous pulmonary venous drainage\n9. Pulmonary arterial / AV malformation\nC. COMBINED LUNG \\& VASCULAR ANOMALY\n10. Scimitar / hypogenetic lung / congenital pulmonary venolobar syndrome\n11. Bronchopulmonary sequestration\n12. Congenital pulmonary airway malformation $=$ cystic adenomatoid malformation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 358,
            "markdown": "# Hypogenetic Lung Syndrome \n\n$=$ collective name for congenital underdevelopment of one / more lobes of a lung separated into 3 forms:\n\n1. Pulmonary agenesis\n$=$ complete absence of a lobe + its bronchus\nCT:\n$\\sqrt{ }$ missing bronchus + lobe(s)\n2. Pulmonary aplasia\n$=$ rudimentary bronchus ending in blind pouch + absence of parenchyma + vessels\nIncidence: $1 \\div 10,000 ; \\mathrm{R} \\div \\mathrm{L}=1 \\div 1$\nCT:\n$\\checkmark$ absence of ipsilateral pulmonary artery\n$\\checkmark$ bronchus terminates in dilated blind pouch\n$\\checkmark$ absence of ipsilateral pulmonary tissue\n3. Pulmonary hypoplasia\n$=$ completely formed but congenitally small bronchus with rudimentary parenchyma + small vessels\nDevelopmental causes:\nresulting in intrauterine compression of chest\n(a) Idiopathic (rare)\n(b) Extrathoracic compression (= Potter syndrome)\n4. Oligohydramnios (renal agenesis, bilateral cystic renal disease, obstructive uropathy, premature rupture of membranes)\n5. Fetal ascites\n(c) Thoracic cage compression\n6. Thoracic bone dysplasia: Ellis-van Creveld, Jeune, thanatophoric dystrophy, severe achondroplasia\n7. Muscular disease\n(d) Intrathoracic compression\n8. Diaphragmatic defect\n9. Excess pleural fluid\n10. Large intrathoracic cyst / tumor\n\n## ABNORMAL LUNG PATTERN\n\n1. Mass\n$=$ any localized density not completely bordered by fissures / pleura\n2. Consolidative (alveolar) pattern\n$=$ commonly produced by filling of air spaces with fluid (transudate / exudate) / cells / other material, ALSO by alveolar collapse, airway obstruction, confluent interstitial thickening\nground glass $=$ hazy area of increased attenuation not obscuring bronchovascular structures\nconsolidation $=$ marked increase in attenuation with obliteration of underlying anatomic features",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 359,
            "markdown": "3. Interstitial pattern\n4. Vascular pattern\n(a) increased vessel size: CHF, pulmonary arterial hypertension, shunt vascularity, lymphangitic carcinomatosis\n(b) decreased vessel size: emphysema, thromboembolism\n5. Bronchial pattern\n$\\sqrt{ }$ wall thickening: bronchitis, asthma, bronchiectasis\n$\\sqrt{ }$ density without air bronchogram ( $=$ complete airway obstruction)\n$\\sqrt{ }$ lucency of air trapping (= partial airway obstruction with ball-valve mechanism)\n\n# ALVEOLAR (CONSOLIDATIVE) PATTERN \n\nClassic appearance of airspace consolidation:\nmnemonic: A2BC3\n$\\sqrt{ }$ Acinar rosettes: rounded poorly defined nodules of acinus size ( $6-10 \\mathrm{~mm}$ ), best seen at periphery of opacity\n$\\sqrt{ }$ Air alveologram / bronchogram\n$\\sqrt{ }$ Butterfly / bat-wing distribution: perihilar / bibasilar\n$\\sqrt{ }$ Coalescent / confluent cloudlike ill-defined opacities\n$\\sqrt{ }$ Consolidation in diffuse, perihilar / bibasilar, segmental / lobar, multifocal / lobular distribution\n$\\sqrt{ }$ Changes occur rapidly (labile / fleeting)\nHRCT:\n$\\sqrt{ }$ poorly marginated densities within primary lobule (up to 1 cm in size)\n$\\sqrt{ }$ rapid coalescence with neighboring lesions in segmental distribution\n$\\sqrt{ }$ predominantly central location with sparing of subpleural zones\n$\\sqrt{ }$ air bronchograms\n\n## Diffuse Airspace Disease\n\n$=$ alveoli filled with\nA. INFLAMMATORY EXUDATE = \"PUS\"\n\n1. Lobar pneumonia\n2. Bronchopneumonia: especially gram-negative organisms\n3. Unusual pneumonia\n(a) viral: extensive hemorrhagic edema especially in immunocompromised patient with hematologic malignancy + transplant\n(b) Pneumocystis\n(c) fungal: Aspergillus, Candida, Cryptococcus, Phycomycetes\n(d) tuberculosis\n4. Complication of pneumonia = lung abscess\nB. HEMORRHAGE = \"BLOOD\"\n5. Trauma: contusion\n6. Pulmonary embolism, thromboembolism\n7. Bleeding diathesis: leukemia, hemophilia, anticoagulants, DIC, immune thrombocytopenia (ITP)\n8. Vasculitis:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 360,
            "markdown": "Wegener granulomatosis, Goodpasture syndrome, SLE, mucormycosis, aspergillosis, Rocky Mountain spotted fever, infectious mononucleosis\n5. Idiopathic pulmonary hemosiderosis\n6. Bleeding metastasis: eg, choriocarcinoma\nC. TRANSUDATE = \"WATER\" = PULMONARY EDEMA / ARDS\n\n1. Cardiac edema\n2. Neurogenic edema\n3. Hypoproteinemia\n4. Fluid overload\n5. Renal failure\n6. Radiotherapy\n7. Shock\n8. Toxic inhalation\n9. Drug reaction\n10. Drowning\n11. Aspiration\n12. Adult respiratory distress syndrome\nD. SECRETIONS = \"PROTEIN\"\n13. Phospholipoprotein: Pulmonary alveolar proteinosis\n14. Mucus plugging\nE. \"CELLS\"\n(a) malignant: bronchioloalveolar cell carcinoma, lymphoma\n(b) T4 lymphocytes: sarcoidosis\n(c) Neutrophils: infection\n(d) Eosinophils: eosinophilic pneumonia\n(e) Plasma cells, mast cells: hypersensitivity pneumonitis\nF. INTERSTITIAL DISEASE\nsimulating airspace disease, eg, \"alveolar sarcoid\"\nmnemonic: AIRSPACED\nAspiration\nInhalation, Inflammatory\nRenal (uremia)\nSarcoidosis\nProteinosis (alveolar)\nAlveolar cell carcinoma\nCongestive (CHF)\nEmboli\nDrug reaction, Drowning\n\n# Air-space Opacification in Trauma \n\nA. ACUTE PHASE\n\n1. Pulmonary contusion\n2. Pulmonary laceration\n3. Aspiration pneumonia\n4. Atelectasis $\\leftarrow$ splinting / mucous plug",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 361,
            "markdown": "5. Pulmonary edema: cardiogenic / noncardiogenic\nB. SUBACUTE PHASE ( $>24$ hours) add\n6. Fat embolism\n7. Adult respiratory distress syndrome\n\n# Localized Airspace Disease \n\nmnemonic: 4P's \\& TAIL\nPneumonia\nPulmonary edema\nPulmonary contusion\nPulmonary interstitial edema\nTuberculosis\nAlveolar cell carcinoma\nInfant\nLymphoma\n\n## Acute Alveolar Infiltrate\n\nmnemonic: I 2 CHANGE FAST\nInfarct\nInfection\nContusion\nHemorrhage\nAspiration\nNear drowning\nGoodpasture syndrome\nEdema\nFungus\nAllergic sensitivity\nShock lung\nTuberculosis\n\n## Chronic Alveolar Infiltrate\n\nmnemonic: STALLAG\nSarcoidosis\nTuberculosis\nAlveolar cell carcinoma\nLymphoma\nLipoid pneumonia\nAlveolar proteinosis\nGoodpasture syndrome\n\n## CT Angiogram Sign\n\n$=$ homogeneous low attenuation of lung consolidation, which allows vessels to be clearly seen\n\n1. Lobar bronchioloalveolar cell carcinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 362,
            "markdown": "2. Lobar pneumonia\n3. Pulmonary lymphoma\n4. Extrinsic lipid pneumonia\n5. Pulmonary infarction\n6. Pulmonary edema\n\n# Migratory / Fleeting Pulmonary Opacities \n\n1. Simple pulmonary eosinophilia\n2. Pulmonary hemorrhage\n3. Pulmonary vasculitis\n4. Cryptogenic organizing pneumonia\n5. Recurrent aspiration / infection\n\n## INTERSTITIAL LUNG DISEASE\n\n$=$ thickening of lung interstices ( $=$ interlobular septa)\nA. MAJOR LYMPHATIC TRUNKS\n\n1. Lymphangitic carcinomatosis\n2. Congenital pulmonary lymphangiectasia\n3. Pulmonary edema\n4. Alveolar proteinosis\nB. PULMONARY VEINS ( $\\uparrow$ pulmonary venous pressure)\n5. Left ventricular failure\n6. Venous obstructive disease\nC. SUPPORTING CONNECTIVE TISSUE NETWORK\n7. Interstitial edema\n8. Chronic interstitial pneumonia\n9. Pneumoconioses\n10. Collagen-vascular disease\n11. Interstitial fibrosis\n12. Amyloid\n13. Tumor infiltration within connective tissue\n14. Desmoplastic reaction to tumor\n\nPath: stereotypical inflammatory response of alveolar wall to injury\n(a) acute phase: fluid + inflammatory cells exude into alveolar space, mononuclear cells accumulate in edematous alveolar wall\n(b) organizing phase: hyperplasia of type II pneumocytes attempt to regenerate alveolar epithelium, fibroblasts deposit collagen\n(c) chronic stage: dense collagenous fibrous tissue remodels normal pulmonary architecture\nCharacterizing criteria:\n(a) distribution:\n> vertical distribution: upper / lower lung zones\n> horizontal distribution : axial (core) / parenchymal (middle) / peripheral compartment\n(b) volume loss\n(c) time course",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 363,
            "markdown": "(d) interstitial lung pattern\n\n# Classification scheme: \n\nA. Interstitial pneumonia\n\n1. Usual interstitial pneumonia (UIP)\n2. Nonspecific interstitial pneumonia (NSIP)\n3. Acute interstitial pneumonia (AIP)\n4. Alveolar macrophage pneumonia (AMP) = desquamative interstitial pneumonia (DIP)\n5. Bronchiolitis obliterans organizing pneumonia\nB. Diffuse infiltrative disease with granulomas\n6. Sarcoidosis\n7. Hypersensitivity pneumonitis\nC. Lymphocytic interstitial pneumonia (LIP)\nD. Pneumoconiosis\nE. Interstitial lung disease with cysts\n8. Langerhans cell histiocytosis\n9. Lymphangioleiomyomatosis\nF. Interstitial lung disease with interlobular septal thickening\n10. Lymphangitic carcinomatosis\n11. Interstitial pulmonary edema\n12. Alveolar proteinosis\nG. Eosinophilic syndrome\nH. Pulmonary hemorrhage\nI. Vasculitis\n\n## Interstitial Lung Pattern on CXR\n\n1. LINEAR PATTERN\n(a) Kerley lines = septal lines = thickened connective septa\n\nPath: accumulation of fluid / tissue\n$\\sqrt{ }$ Kerley A lines $=$ relatively long fine linear shadows in upper lungs, deep within lung parenchyma radiating from hila\n$\\sqrt{ }$ Kerley B lines $=$ short horizontally oriented peripheral lines extending + perpendicular to pleura in costophrenic angles + retrosternal clear space\n(b) reticulations\n$=$ innumerable interlacing linear opacities suggesting a mesh / network\n$\\sqrt{ }$ Kerley C lines = fine \"spider web / lacelike\" polygonal opacities distributed primarily in a peripheral / subpleural location\nPath: pulmonary fibrosis (lower lobes), hypersensitivity pneumonitis (upper lobes)\n$\\sqrt{ }$ thick linear opacities in a central / perihilar distribution\nPath: (a) dilated thick-walled bronchi of bronchiectasis\n(b) cysts of lymphangioleiomyomatosis / tuberous sclerosis\n2. NODULAR / MILIARY PATTERN\n$=$ small well-defined innumerable uniform $3-5-\\mathrm{mm}$ nodules with even distribution\nPath: diffuse metastatic disease, infectious granulomatous disease (TB, fungal), noninfectious granulomatous disease (pneumoconioses, sarcoidosis, eosinophilic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 364,
            "markdown": "# granuloma) \n\n3. DESTRUCTIVE FORM $=$ honeycomb lung\n\n## Signs of Acute Interstitial Disease\n\n$\\sqrt{ }$ peribronchial cuffing $=$ thickened bronchial wall + peribronchial sheath (when viewed end on)\n$\\checkmark$ thickening of interlobular fissures\n$\\checkmark$ Kerley lines\n$\\checkmark$ perihilar haze $=$ blurring of hilar shadows\n$\\checkmark$ blurring of pulmonary vascular markings\n$\\checkmark$ increased density at lung bases\n$\\checkmark$ small pleural effusions\n\n## Signs of Chronic Interstitial Disease\n\n$\\diamond$ HRCT $\\sim 60 \\%$ more sensitive than CXR\n$\\checkmark$ irregular visceral pleural surface\n$\\checkmark$ reticulations:\n$\\checkmark$ fine reticulations\n$=$ early potentially reversible / minimal irreversible alveolar septal abnormality\n(1) Idiopathic pulmonary fibrosis (basilar predominance)\n$\\checkmark$ coarse reticulations\nin $75 \\%$ related to environmental disease, sarcoidosis, collagen-vascular disorders, chronic interstitial pneumonia\n$\\checkmark$ nodularity:\nin $90 \\%$ related to infectious / noninfectious granulomatous process, metastatic\nmalignancy, pneumoconioses, amyloidosis\n$\\checkmark$ linearity:\n(1) Cardiogenic / noncardiogenic interstitial pulmonary edema\n$\\checkmark$ symmetric linearity\n(2) Lymphangitic malignancy\n$\\checkmark$ asymmetric linearity\n(3) Diffuse bronchial wall disorders: cystic fibrosis, bronchiectasis, hypersensitivity asthma\n$\\checkmark$ honeycombing\n$=$ usually subpleural clustered cystic air spaces $<1 \\mathrm{~cm}$ in diameter with thick welldefined walls set off against a background of increased lung density (end-stage lung)\n\n## Distribution of Interstitial Disease\n\n## Perihilar Interstitial Lung Disease\n\n(a) acute rapidly changing\n\n1. Pulmonary edema\n2. Pneumocystis pneumonitis\n3. Early extrinsic allergic alveolitis\n(b) chronic slowly progressive\n4. Lymphangitic carcinomatosis:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 365,
            "markdown": "often unilateral, associated with adenopathy, pleural effusion\n\n# Peripheral Interstitial Lung Disease \n\n(a) acute rapidly changing\n\n1. Interstitial pulmonary edema with Kerley B lines (most common)\n2. Active fibrosing alveolitis\n(b) chronic slowly progressive\n3. Secondary pulmonary hemosiderosis\n\n## Upper Interstitial Lung Disease\n\n(a) chronic slowly progressive $\\pm$ volume loss\n\n1. Postprimary TB (common)\n2. Silicosis (common)\n(b) chronic slowly progressive with volume loss\n3. Sarcoidosis (common)\n4. Ankylosing spondylitis (rare)\n5. Sulfa drugs (rare)\n(c) chronic slowly progressive without volume loss\n6. Extrinsic allergic alveolitis\n7. Eosinophilic granuloma\n8. Aspiration pneumonia\n9. Postradiation pneumonitis\n10. Recurrent Pneumocystis carinii pneumonia (PCP) under aerosolized pentamidine prophylaxis\nmnemonic: SHIRT CAP\nSarcoidosis\nHistoplasmosis\nIdiopathic\nRadiation therapy\nTuberculosis (postprimary)\nChronic extrinsic alveolitis\nAnkylosing spondylitis\nProgressive massive fibrosis\n\n## Chronic Diffuse Infiltrative Lung Disease\n\n$=$ CHRONIC INTERSTITIAL LUNG DISEASE $=$ GENERALIZED INTERSTITIAL LUNG DISEASE\nPrevalence: up to $15 \\%$ of pulmonary conditions\nCause: $>200$ described disorders; in only $25-30 \\%$ known / established etiology; 15-20 diseases comprise $>90 \\%$ of cases\n\n- dyspnea (primary complaint)\n- dry basilar rales / crackles that fail to clear with coughing\n\nCXR:\n$\\diamond$ Difficult to characterize due to similar findings\n$\\diamond$ Differentiation into alveolar + interstitial disease is unreliable as \"interstitial disease\"",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 366,
            "markdown": "invariably involves alveoli + vice versa\n$\\sqrt{ } \\pm$ nonspecific abnormality\nmnemonic: HIDE FACTS\nHamman-Rich, Hemosiderosis\nInfection, Irradiation, Idiopathic\nDust, Drugs\nEosinophilic granuloma, Edema\nFungal, Farmer's lung\nAspiration (oil), Arthritis (rheumatoid, ankylosing spondylitis)\nCollagen vascular disease\nTumor, TB, Tuberous sclerosis\nSarcoidosis, Scleroderma\nZonal Predilection of Chronic Diffuse Parenchymal Lung Disease (DPLD)\nChronic DPLD of Upper Lung Zone\n$=$ zone with higher oxygen tension and pH , but less efficient lymphatic drainage\n(a) inhalational disease\n\n1. Silicosis\n2. Coal worker pneumoconiosis\n3. Extrinsic allergic alveolitis\n4. Aspiration pneumonia\n(b) granulomatous disease\n5. Sarcoidosis\n6. Langerhans cell histiocytosis (EG)\n7. Postprimary TB (common)\n(c) others\n8. Cystic fibrosis\n9. Ankylosing spondylitis\n10. Chronic interstitial pneumonia\n11. Sulfa drugs (rare)\n12. Radiation pneumonitis\n13. Recurrent Pneumocystis carinii pneumonia (PCP) under aerosolized pentamidine prophylaxis\nmnemonic: CASSET\nCystic fibrosis\nAnkylosing spondylitis\nSilicosis\nSarcoidosis\nEosinophilic granuloma\nTuberculosis, fungus\nChronic DPLD of Lower Lung Zone\nlower lung zone $=$ zone with greater ventilation, perfusion, and lymphatic drainage\n14. Idiopathic pulmonary fibrosis: usual interstitial pneumonia (common)\n15. Lymphangitic carcinomatosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 367,
            "markdown": "3. Collagen vascular disease: scleroderma (common)\n4. Asbestosis (posterior aspect of lung base)\n5. Lymphangioleiomyomatosis\n6. Chronic aspiration pneumonia with fibrosis (often regional + unilateral)\n\n# mnemonic: BAD LASS RIF \n\nBronchiectasis\nAspiration\nDermatomyositis\nLymphangitic spread\nAsbestosis\nSarcoidosis\nScleroderma\nRheumatoid arthritis\nIdiopathic pulmonary fibrosis\nFuradantin ${ }^{\\circledR}$\n\n## Compartmental Predilection of Chronic DPLD\n\nA. AXIAL / CORE COMPARTMENT\n$=$ peribronchial vascular bundles + lymphatics\n\n1. Sarcoidosis\n2. Lymphangitic carcinomatosis\n3. Lymphoma\n![img-38.jpeg](img-38.jpeg)\nB. MIDDLE / PARENCHYMAL COMPARTMENT\n$=$ formed by alveolar walls\n4. Sarcoidosis\n5. Lymphangitic carcinomatosis\n6. Chronic medications\n7. Neurofibromatosis\n8. Vasculitis\n9. Silicosis\nC. PERIPHERAL COMPARTMENT\n$=$ pleura with subpleural connective tissue, interlobular septa, pulmonary veins,",
            "images": [
                {
                    "id": "img-38.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 1095,
                    "bottom_right_x": 1506,
                    "bottom_right_y": 1551,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 368,
            "markdown": "lymphatics, walls of cortical alveoli\n\n1. Sarcoidosis\n2. Lymphangitic carcinomatosis\n3. Idiopathic pulmonary fibrosis\n4. Collagen vascular disease\n5. Rheumatoid arthritis\n\n# Lung Volumes in Chronic DPLD \n\n## Chronic DPLD with Normal Lung Volume\n\n1. Sarcoidosis\n2. Langerhans cell histiocytosis (in 66\\%)\n\nChronic DPLD with Increased Lung Volume\nmnemonic: ELECT\nEmphysema with interstitial lung disease\nLymphangioleiomyomatosis\nEosinophilic granuloma (Langerhans) in 33\\%\nCystic fibrosis\nTuberous sclerosis\nChronic DPLD with Reduced Lung Volume\ndue to fibrotic process\n\n1. Systemic lupus erythematosus\n2. Collagen vascular disease (eg, scleroderma, dermatomyositis, polymyositis)\n3. Idiopathic pulmonary fibrosis\n4. Chronic interstitial pneumonias\n5. Asbestosis\n\n## Pleural Disease in Chronic DPLD\n\n## Chronic DPLD with Pneumothorax\n\n1. Lymphangioleiomyomatosis\n2. Langerhans cell histiocytosis\n3. End-stage lung disease\n\n## Chronic DPLD with Pleural Effusion\n\n1. Lymphangioleiomyomatosis\n2. Rheumatoid arthritis\n3. Systemic lupus erythematosus\n4. Mixed connective tissue disorder\n5. Wegener granulomatosis\n6. Lymphangitic carcinomatosis\n7. Pulmonary edema\n\nChronic DPLD with Pleural Thickening\n\n1. Asbestosis\n2. Collagen vascular disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 369,
            "markdown": "# Lymphadenopathy in Chronic Diffuse Lung Disease \n\n1. Silicosis\n2. Sarcoidosis\n3. Lymphoma\n4. Lymphangitic carcinomatosis\n\n## Diffuse Fine Reticulations\n\n## Acute Diffuse Fine Reticulations\n\nA. ACUTE INTERSTITIAL EDEMA\n\n1. Congestive heart failure\n2. Fluid overload\n3. Uremia\n4. Hypersensitivity\nB. ACUTE INTERSTITIAL PNEUMONIA\n5. Viral pneumonia (Hantavirus, CMV)\n6. Mycoplasma pneumonia\n7. Pneumocystis carinii pneumonia\nmnemonic: HELP\nHypersensitivity\nEdema\nLymphoproliferative\nPneumonitis (viral)\n\n## Chronic Diffuse Fine Reticulations\n\nA. VENOUS OBSTRUCTION\n\n1. Atherosclerotic heart disease\n2. Mitral stenosis\n3. Left atrial myxoma\n4. Pulmonary venoocclusive disease\n5. Sclerosing mediastinitis\nB. LYMPHATIC OBSTRUCTION\n6. Lymphangiectasia (pediatric patient)\n7. Mediastinal mass (lymphoma)\n8. Lymphoma / leukemia\n9. Lymphangitic carcinomatosis:\npredominantly basilar distribution\n(a) bilateral (breast, stomach, colon, pancreas)\n(b) unilateral (lung tumor)\n10. Lymphocytic interstitial pneumonitis\nC. INHALATIONAL DISEASE\n11. Silicosis: small nodules + reticulations\n12. Asbestosis: basilar distribution, pleural thickening + calcifications\n13. Hard metals\n14. Allergic alveolitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 370,
            "markdown": "# D. GRANULOMATOUS DISEASE \n\nfrom a nodular to a reticular pattern if\n(a) nodules line up along bronchovascular bundles\n(b) interlobular septa show fibrotic changes\n\n1. Sarcoidosis:\n$\\sqrt{ }$ hilar + mediastinal adenopathy (may have disappeared)\n2. Eosinophilic granuloma: upper lobe distribution\nE. CONNECTIVE-TISSUE DISEASE\n$\\sqrt{ }$ reticulations in late stages\n3. Rheumatoid lung\n4. Scleroderma\n5. Systemic lupus erythematosus\nF. DRUG REACTIONS\nG. IDIOPATHIC\n6. Usual interstitial pneumonitis (UIP)\n7. Desquamative interstitial pneumonitis (DIP)\n8. Tuberous sclerosis: smooth muscle proliferation\n9. Lymphangiomyomatosis\n10. Idiopathic pulmonary hemosiderosis\n11. Alveolar proteinosis (late complication)\n12. Amyloidosis\n13. Interstitial calcification (chronic renal failure)\nmnemonic: LIFE lines\nLymphangitic spread\nInflammation / infection\nFibrosis\nEdema\n\n## Coarse Reticulations\n\n$=$ architectural destruction of interstitium = end-stage scarring of lung = interstitial pulmonary fibrosis $=$ honeycomb lung\n$\\sqrt{ }$ coarse reticular interstitial densities with intervening cystic spaces\n$\\sqrt{ }$ rounded radiolucencies $<1 \\mathrm{~cm}$ in areas of increased lung density\n$\\sqrt{ }$ small lung volume (decreased compliance)\nCx: (1) Intercurrent pneumothoraces\n(2) Bronchogenic carcinoma $=$ scar carcinoma\n\n## Cause:\n\nA. INHALATIONAL DISEASE\n(a) Pneumoconiosis\n\n1. Asbestosis: basilar distribution, shaggy heart, pleural thickening + calcifications\n2. Silicosis: upper lobe predominance $\\pm$ pleural thickening $\\pm$ hilar and mediastinal adenopathy\n3. Berylliosis\n(b) Chemical inhalation (late)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 371,
            "markdown": "1. Silo-filler's disease (nitrogen dioxide)\n2. Sulfur dioxide, chlorine, phosgene, cadmium\n(c) Extrinsic allergic alveolitis\n$\\leftarrow$ hypersensitivity to organic dusts\n(d) Oxygen toxicity\n$\\leftarrow$ sequelae of RDS therapy with oxygen\n(e) Chronic aspiration\neg, mineral oil: localized process in medial basal segments / middle lobe\nB. GRANULOMATOUS DISEASE\n3. Sarcoidosis\n4. Eosinophilic granuloma\nC. COLLAGEN-VASCULAR DISEASE\n5. Rheumatoid lung\n6. Scleroderma\n7. Ankylosing spondylitis: upper lobes\n8. SLE: rarely produces honeycombing\nD. IATROGENIC\n9. Drug hypersensitivity\n10. Radiotherapy\nE. IDIOPATHIC\n11. Usual interstitial pneumonitis (UIP)\n$\\checkmark$ honeycombing in $50 \\%$\n$\\checkmark$ severe volume loss in $45 \\%$\n12. Desquamative interstitial pneumonitis (DIP)\n$\\checkmark$ honeycombing in $12.5 \\%$\n$\\checkmark$ severe volume loss in $23 \\%$\n13. Lymphangiomyomatosis\n14. Tuberous sclerosis (rare)\n15. Neurofibromatosis (rare)\n16. Pulmonary capillary hemangiomatosis (rare)\n$D D x$ : bronchiectasis, cavitary metastases (rare)\n\n# Reticulations \\& Pleural Effusion \n\nA. ACUTE\n\n1. Edema\n2. Infection: viral, Mycoplasma (very rare)\nB. CHRONIC\n3. Congestive heart failure\n4. Lymphangitic carcinomatosis\n5. Lymphoma / leukemia\n6. SLE\n7. Rheumatoid disease\n8. Lymphangiectasia\n9. Lymphangiomyomatosis\n10. Asbestosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 372,
            "markdown": "# Reticulations \\& Hilar Adenopathy \n\n1. Sarcoidosis\n2. Silicosis\n3. Lymphoma / leukemia\n4. Lung primary: particularly oat cell carcinoma\n5. Metastases: lymphatic obstruction / spread\n6. Fungal disease\n7. Tuberculosis\n8. Viral pneumonia (rare combination)\n\n## End-stage Lung Disease\n\n$=$ evidence of honeycombing / cystic change / conglomerate fibrosis\nA. DISTRIBUTION\n\n1. Usual interstitial pneumonia\n$\\checkmark$ subpleural distribution + lower lobe predominance\n2. Asbestosis\n$\\checkmark$ subpleural distribution + lower lobe predominance + pleural thickening\n3. Sarcoidosis\n$\\checkmark$ subpleural honeycombing\n$\\checkmark$ central cystic bronchiectasis\n$\\checkmark$ conglomerate fibrosis\n$\\checkmark$ peribronchovascular distribution\n$\\checkmark$ upper lobe predominance\n4. Extrinsic allergic alveolitis\n$\\checkmark$ diffuse random distribution + patchy areas of ground-glass attenuation\nB. CYSTIC SPACES WITH WELL-DEFINED WALLS\n5. Langerhans cell histiocytosis\n$\\checkmark$ upper lobe predominance\n6. Lymphangioleiomyomatosis\n$\\checkmark$ no zonal predominance\nC. CONGLOMERATE FIBROTIC MASSES\n7. Sarcoidosis\n$\\checkmark$ peribronchovascular distribution\n8. Silicosis\n$\\checkmark$ bronchi splayed around masses\n9. Talcosis\n$\\checkmark$ areas of high attenuation (= talc deposits)\n\n## Honeycomb Lung\n\nmnemonic: SHIPS BOATS\nSarcoidosis\nHistiocytosis X = Langerhans cell histiocytosis\nIdiopathic (UIP)\nPneumoconiosis\nScleroderma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 373,
            "markdown": "Bleomycin, Busulfan\nOxygen toxicity\nArthritis (rheumatoid), Amyloidosis, Allergic alveolitis\nTuberous sclerosis, TB\nStorage disease (Gaucher)\n\n# Chronic Interstitial Disease Simulating Airspace Disease \n\nA. REPLACEMENT OF LUNG ARCHITECTURE BY AN INTERSTITIAL PROCESS\n(a) neoplastic: Hodgkin disease, histiocytic lymphoma\n(b) benign cellular infiltrate: lymphocytic interstitial pneumonia, pseudolymphoma\n(c) granulomatous disease: alveolar sarcoidosis\n(d) fibrosis\nB. EXUDATIVE PHASE OF INTERSTITIAL PNEUMONIA\n\n1. UIP\n2. Adult respiratory distress syndrome\n3. Radiation pneumonitis\n4. Drug reaction\n5. Reaction to noxious gases\nC. CELLULAR FILLING OF AIR SPACE\n6. Desquamative interstitial pneumonia\n7. Pneumocystis carinii pneumonia\n\n## Reticulonodular Lung Disease\n\nmnemonic: Please Don't Eat Stale Tuna Fish Sandwiches Every Morning\nPneumoconiosis\nDrugs\nEosinophilic granuloma\nSarcoidosis\nTuberculosis\nFungal disease\nSchistosomiasis\nExanthem (measles, chickenpox)\nMetastases (thyroid)\n\n## Reticulonodular Pattern \\& Lower Lobe Predominance\n\nmnemonic: CIA\nCollagen vascular disease\nIdiopathic\nAsbestosis\n\n## Nodular Lung Disease\n\n$=$ round moderately well marginated opacity $<3 \\mathrm{~cm}$ in maximum diameter\nA. GRANULOMATOUS LUNG DISEASE\n(a) infection: eg, tuberculosis\n(b) fungal disease: eg, histoplasmosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 374,
            "markdown": "(c) silicosis\n(d) vasculitis: eg, Wegener granulomatosis\nB. NEOPLASM\n(a) metastatic lung diseases: eg, thyroid cancer\n(b) lymphoma\n(c) bronchioloalveolar cell carcinoma\nC. OTHER DISEASE\n(a) drug-induced: methotrexate\n(b) nongranulomatous vasculitis\n(c) sarcoidosis\n\n# Macronodular Lung Disease \n\n$\\sqrt{ }$ nodules $>5 \\mathrm{~mm}$ in diameter\nmnemonic: GAMMA WARPS\nGranuloma (eosinophilic granuloma, fungus)\nAbscess\nMetastases\nMultiple myeloma\nAVM\nWegener granulomatosis\nAmyloidosis\nRheumatoid lung\nParasites (Echinococcus, paragonimiasis)\nSarcoidosis\n\n## Micronodular Lung Disease\n\n$=$ discrete $3-5-7-\\mathrm{mm}$ small round focal opacity of at least soft-tissue attenuation\n\n1. Granulomatous disease: miliary TB, histoplasmosis\n2. Hypersensitivity (organic dust)\n3. Pneumoconiosis (inorganic dust, thesaurosis = prolonged hair spray exposure)\n4. Sarcoidosis\n5. Metastases (thyroid, melanoma)\n6. Langerhans cell histiocytosis\n7. Chickenpox\n\nDiffuse Fine Nodular Disease \\& MILIARY Nodules\n$\\sqrt{ }$ very small $1-4-\\mathrm{mm}$ sharply defined nodules of interstitial disease\n(a) Inhalational disease\n\n1. Silicosis + coal worker's pneumoconiosis\n2. Berylliosis\n3. Siderosis\n4. Extrinsic allergic alveolitis (chronic phase)\n(b) Granulomatous disease\n5. Langerhans cell histiocytosis $=$ eosinophilic granuloma\n6. Sarcoidosis (with current / previous adenopathy)\n(c) Infectious disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 375,
            "markdown": "1. Bacteria: salmonella, nocardiosis\n2. TB\n3. Fungus: histoplasmosis, coccidioidomycosis, blastomycosis, aspergillosis (rare), cryptococcosis (rare)\n4. Virus: varicella (more common in adults), Mycoplasma pneumonia\n(d) Metastases:\nthyroid carcinoma, melanoma, adenocarcinoma of breast, stomach, colon, pancreas\n(e) Alveolar microlithiasis (rare)\n(f) Bronchiolitis obliterans\n(g) Gaucher disease\nmnemonic: TEMPEST\nTuberculosis + fungal disease\nEosinophilic granuloma\nMetastases (thyroid, lymphangitic carcinomatosis)\nPneumoconiosis, Parasites\nEmbolism of oily contrast\nSarcoidosis\nTuberous sclerosis\nFine Nodular Disease in Afebrile Patient\n5. Inhalational disease\n6. Eosinophilic granuloma\n7. Sarcoidosis\n8. Metastases\n9. Fungal infection (late stage)\n10. Miliary tuberculosis (rare)\n\nFine Nodular Disease in Febrile Patient\n\n1. Tuberculosis\n2. Fungal infection (early stage)\n3. Pneumocystis\n4. Viral pneumonia\n\n# DIFFUSE LUNG DISEASE ON HRCT \n\n## Patterns of Diffuse Lung Disease on HRCT\n\nmaximum resolution $=300 \\mu \\mathrm{~m}$\n\n1. Linear densities\n$=$ thickening of interlobular septa + bronchovascular interstitium\nCause: interstitial fluid / fibrosis / cellular infiltrates\n(a) intralobular septal thickening\n$=$ weblike network of fine lines in secondary pulmonary lobule\n(b) interlobular septal thickening\n$=$ fine linear opacities perpendicular to pleural surface / in a polygonal pattern in a more central location",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 376,
            "markdown": "$\\sqrt{ }$ smooth septal thickening: pulmonary edema, lymphangitic carcinomatosis\n$\\sqrt{ }$ beaded septa / septal nodules: lymphangitic carcinomatosis\n$\\sqrt{ }$ irregular septa imply fibrosis\n> distorted lobules: fibrosis\n> no architectural distortion of lobules: edema / infiltration\n\n# 2. Reticular densities \n\n$=$ clustered areas of septal thickening producing intricate network of crisscross lines in subpleural location\n(a) predominantly subpleural small reticular elements of $6-10 \\mathrm{~mm}$ in diameter with collection of small cystic airspaces with well-defined walls (\"honeycombing\") Associated with: interstitial fibrosis, lymphangio- leiomyomatosis, amyloidosis\n(b) fine diffusely distributed network of $2-3-\\mathrm{mm}$ basic elements Associated with: miliary TB, reactions to methotrexate\nDistribution:\n> lower lung zones in subpleural areas: idiopathic pulmonary fibrosis, collagen vascular disease, asbestosis\n> mid lung zone / all lung zones: chronic extrinsic allergic alveolitis\n$>$ mid + upper lung zones: sarcoidosis\n\n## 3. Nodules\n\n(a) interstitial nodules lymphangitic carcinomatosis, sarcoidosis, Langerhans cell histiocytosis, silicosis, coal worker pneumoconiosis, tuberculosis, hypersensitivity pneumonitis, metastatic tumor, amyloidosis\n$\\checkmark$ perihilar, peribronchovascular, centrilobular, interlobular septa, subpleural nodules\n(b) airspace nodules lobular pneumonia, transbronchial spread of TB, bronchiolitis obliterans organizing pneumonia (BOOP), pulmonary edema\n$\\checkmark$ ill-defined nodules, a few mm to 1 cm in size\n$\\checkmark$ peribronchiolar + centrilobular\nSize:\n> small ( $<5 \\mathrm{~mm}$ ): centrilobular location (separated by several mm from pleural surface, fissures, interlobular septa)\n> large ( $>5 \\mathrm{~mm}$ ): well / poorly defined occasionally surrounded by a halo of groundglass opacity\nDistribution:\n> along bronchoarterial bundles + interlobular septa + subpleural: sarcoidosis\n> upper zone: silicosis, coal-worker's pneumoconiosis\n> centrilobular: extrinsic allergic alveolitis\n$D D x$ : vessel on cross section\n\n## 4. Ground-glass attenuation\n\n$=$ hazy increase in lung opacity without obscuration of underlying vessels $\\leftarrow$ parenchymal abnormalities below spatial resolution of HRCT\n$\\diamond$ Often indicative of an acute, active, and potentially treatable process!\nHisto:\n(a) alveolar wall inflammation / thickening\n(b) partial filling of air-spaces",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 377,
            "markdown": "(c) combination of both\n\nCommon cause: \"water, blood, cells, no air\"\nA. Interstitial pulmonary edema $=$ increased capillary blood volume\n$\\checkmark$ perihilar + gravitational distribution\n$\\checkmark$ cardiomegaly and pleural effusion\nB. Diffuse inflammation / infection\n(a) alveolitis = minimal airspace filling as in\n\n1. Viral / mycoplasmal pneumonia\n2. Pneumocystis pneumonia in immunocompromised patient\n3. ARDS\n(b) early interstitial lung disease = minimal alveolar wall thickening (NSIP, DIP, RB-ILD, LIP)\nC. Hypersensitivity pneumonitis\n$\\checkmark$ centrilobular densities + air trapping\n\n- history of exposure to certain antigen\nD. Pulmonary alveolar hemorrhage\n- hemoptysis, anemia, coagulopathy, vasculitis\nE. Alveolar collapse\n\n1. Partial atelectasis = partial collapse of alveoli\n2. Normal during expiration\n\nDistribution:\n> peripheral in lower lung zones: DIP, UIP\n> mid + upper lung zones: sarcoidosis\n> \"crazy paving\" pattern\n> mosaic perfusion\n\n# 5. Consolidation \n\n$=$ homogeneous increase in pulmonary attenuation with obscuration of underlying vessels\n$\\sqrt{ } \\pm$ air-bronchogram\n$\\sqrt{ }$ sharp border at major fissure\n$\\sqrt{ }$ advancing margin of ground-glass opacity\n$\\sqrt{ }$ vessels visible only on enhanced CT\nCause:\n(a) any process filling airspaces with blood, fluid, inflammatory cells, tumor cells\n(b) alveolar collapse $=$ atelectasis\n> subpleural in mid + upper lung zones: chronic eosinophilic pneumonia\n> subpleural + peribronchial: BOOP\n> focal: bronchioloalveolar cell carcinoma, lymphoma\n> random: infectious pneumonia\n6. Cystic airspaces\n$=$ circumscribed round structure filled with air",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 378,
            "markdown": "![img-39.jpeg](img-39.jpeg)\n(a) with well-defined walls:\nlymphangioleiomyomatosis, pulmonary Langerhans-cell granulomatosis, DIP, LIP, honeycomb lung, cystic bronchiectasis\n(b) without well-defined walls:\ncentrilobular, panlobular (panacinar), paraseptal emphysema\nCause:\n(a) focally clustered: cystic bronchiectasis\n(b) subpleural location: honeycombing, Langerhans cell histiocytosis, lymphangioleiomyomatosis\n\n# Centrilobular Nodules \n\nA. Acute / chronic bronchiolar infection\n\n1. Bacterial infection\n2. Viral infection\n3. Fungal infection\nB. Inflammation\n4. Hypersensitivity pneumonia\n5. Respiratory bronchiolitis-interstitial lung disease",
            "images": [
                {
                    "id": "img-39.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1247,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 379,
            "markdown": "3. Bronchiolitis obliterans organizing pneumonia\n4. Bronchiolitis obliterans\n5. Sarcoidosis\n6. Asthma\n7. Autoimmune / immunodeficiency disease\nC. Pneumoconiosis\n\nPeribronchial / Peribronchiolar Nodules\n\n1. Metastatic calcifications\n2. Endobronchial spread of infection\n3. Hypersensitivity pneumonia\n4. Sarcoidosis\n5. Silicosis\n6. Langerhans cell histiocytosis\n7. Respiratory bronchiolitis\n\nCentrilobular Nodules Without Ground-Glass Opacities\n\n1. Endobronchial TB\n2. Chronic bronchiolitis\n3. Silicosis\n4. Langerhans cell histiocytosis\n\nCentrilobular Nodules with Ground-Glass Opacities\n\n1. Hypersensitivity pneumonia\n2. Bronchiolitis obliterans organizing pneumonia\n\n# Random Nodules \n\n1. Hematogenous metastases: thyroid, kidney, breast\n2. Miliary infection\n3. Langerhans cell histiocytosis\n4. Sarcoidosis\n5. Silicosis\n\nThickened Bronchovascular, Interlobular Septal \\& Pleural Interstitium\nA. Uni- / bilateral\n\n1. Lymphangitic tumor\n2. Lymphoma\nB. Bilateral\n3. Kaposi sarcoma\n4. Edema\n\nParenchymal Bands \\& Architectural Distortion\n\n1. Asbestos-related lung disease\n2. Atelectasis\n3. Tuberculosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 380,
            "markdown": "| Classification of Bronchiolar (Small Airways) Disorders |\n| :-- |\n| Primary bronchiolar disorders |\n| Constrictive bronchiolitis |\n| Acute bronchiolitis |\n| Diffuse panbronchiolitis |\n| Respiratory bronchiolitis |\n| Mineral dust airway disease |\n| Follicular bronchiolitis |\n| Interstitial lung disease + prominent bronchiolar involvement |\n| Hypersensitivity pneumonitis |\n| Respiratory bronchiolitis - interstitial lung disease |\n| Desquamative interstitial pneumonia |\n| Organizing pneumonia |\n| Bronchiolar involvement in large airway disease |\n| Chronic bronchitis |\n| Asthma |\n| Bronchiectasis |\n\n4. Sarcoidosis\n5. Diffuse pulmonary fibrosis\n\n# Smooth Thickening of Interstitium \n\n1. Lymphangitic tumor\n2. Edema\n3. Lymphoma\n4. Kaposi sarcoma\n5. Sarcoidosis (uncommon)\n\n## HRCT of Bronchiolitis\n\n[CT findings are nonspecific and must be interpreted in the appropriate clinical context] Cause:\n(a) infection via endobronchial spread (acute bronchiolitis):\n$\\diamond$ Most common cause of tree-in-bud appearance.\n> bacterial (most common)\n> mycobacterial: classic TB, M. avium-intracellulare\n> viral: acute infectious bronchiolitis in infants and young children due to RSV, adenovirus, mycoplasma\n> parasitic\n> fungal\n(b) inhalation of organic / inorganic antigens: hypersensitivity pneumonitis, mineral dust airways disease\n(c) immunologic deficiency or impaired host defense: cystic fibrosis, dyskinetic cilia syndrome",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 381,
            "markdown": "(d) cigarette smoking\n\n1. Respiratory bronchiolitis\n2. Respiratory bronchiolitis-interstitial lung disease\n(e) idiopathic\n3. Diffuse panbronchiolitis in Asians\n4. Follicular bronchiolitis ( $\\leftarrow$ lymphoid hyperplasia): rheumatoid arthritis, Sjögren syndrome\n5. Asthma\n6. Bronchiolitis obliterans $=$ constrictive bronchiolitis\n7. Cryptogenic organizing pneumonia $=$ bronchiolitis obliterans with organizing pneumonia $(\\mathrm{BOOP})=$ proliferative bronchiolitis\nA. DIRECT SIGNS\n$\\sqrt{ }$ ringlike tubular structures in lung periphery\nCause: wall thickening\n$\\sqrt{ }$ dilatation of bronchioles\n![img-40.jpeg](img-40.jpeg)\n\nCause: bronchiolectasis\n$\\sqrt{2}$ - to 4-mm nodules / branching linear structures in lung periphery\nCause: bronchiolar luminal impaction with pus, mucus, granulomas, inflammatory exudate, fibrosis",
            "images": [
                {
                    "id": "img-40.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 820,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1788,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 382,
            "markdown": "# B. INDIRECT SIGNS \n\n$\\sqrt{ }$ subsegmental atelectasis $=$ wedge-shaped area of ground-glass attenuation\n$\\sqrt{ }$ air trapping $=$ area of decreased attenuation from collateral air drift / ball-valve effect distal to occluded / stenotic airway more prominent on expiration:\n$D D x$ : physiologic air trapping with a few lucent secondary pulmonary lobules\n$\\sqrt{ }$ mosaic perfusion $=$ scattered areas of air trapping\n$\\sqrt{ }$ centrilobular emphysema $=$ destruction of small airways + surrounding parenchyma in the center of the pulmonary lobule\n$\\sqrt{ }$ centrilobular airspace nodule $=$ acinar nodule $=<1 \\mathrm{~cm}$ ill-defined nodule of groundglass attenuation (from inflammation within alveolar space) less prominent on expiration\nCause: extrinsic allergic alveolitis, sarcoidosis (perivenular nodules), pneumoconiosis (asbestosis, silicosis)\n$D D x$ : (1) Cystic lung disease (thin septum surrounds area of air attenuation, central vessel not present)\n(2) Panlobular emphysema (distortion of vascular + septal architecture, bullae)\n\n## Tree-in-bud Appearance\n\n$=$ peripheral (within 5 mm of pleural surface) small ( $2-4 \\mathrm{~mm}$ ) centrilobular well-defined soft-tissue nodules connected to linear branching opacity (single stalk) with more than one contiguous branching sites\n$\\diamond$ Direct sign of treatable exudative bronchiolitis!\nHisto: dilated centrilobular bronchioles $\\rightarrow$ lumina impacted with mucus / fluid / pus + peribronchiolar inflammation (analogous to \"gloved finger\" appearance)\n$\\sqrt{ }$ depiction of the normally invisible branching course of the intralobular bronchiole on HRCT\n$\\sqrt{ } \\pm$ air trapping $\\pm$ subsegmental consolidation\nA. AIRWAY INFECTION (most common)\n\n1. Bacterial: Mycobacterium tuberculosis (endobronchial spread of active TB), atypical mycobacteria (M avium- intracellulare complex, M fortuitum, M chelonei), Staphylococcus aureus, Haemophilus influenzae\n2. Viral: CMV, Respiratory syncytial virus\n3. Fungal: invasive aspergillosis (A fumigatus)\n4. Parasitic\nB. IMMUNOLOGIC DISORDER\n5. Allergic bronchopulmonary aspergillosis\n6. Congenital immunodeficiencies\nC. CONGENITAL DISORDER\n7. Cystic fibrosis\n8. Kartagener syndrome\n9. Yellow nail syndrome\nD. CONNECTIVE TISSUE DISORDER\n10. Rheumatoid lung\n11. Sjögren syndrome",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 383,
            "markdown": "# E. IDIOPATHIC DISORDER \n\n1. Bronchiolitis obliterans\n2. Panbronchiolitis\nF. NEOPLASM\n3. Primary pulmonary lymphoma\n4. Laryngotracheal papillomatosis\n5. Tumor embolism\nG. TUMOR EMBOLI\n6. Gastric cancer\n7. Breast cancer\n8. Ewing sarcoma\n9. Renal cancer\nH. ASPIRATION of irritant substance\n10. Aspiration pneumonitis\nI. INHALATION of toxic fumes + gases\n$=$ alveolocapillary damage $\\rightarrow$ pulmonary edema + bronchitis + bronchiolitis $\\pm$ complicated by atelectasis + pneumonia\n\n## Mosaic Attenuation / Perfusion\n\n$=\\mathrm{CT}$ imaging pattern consisting of a heterogeneous patchwork of normal and airattenuated segments\n\n| Mosaic Attenuation due to Ground-Glass Opacities |\n| :-- |\n| Acute causes |\n| Pulmonary edema |\n| Pulmonary hemorrhage |\n| Infection |\n| Pneumocystis pneumonia |\n| Cytomegalovirus pneumonia |\n| Herpes simplex pneumonia |\n| Diffuse alveolar damage |\n| Acute respiratory distress syndrome |\n| Acute interstitial pneumonia |\n| Acute eosinophilic pneumonia |\n| Subacute to chronic causes |\n| Organizing pneumonia |\n| Hypersensitivity pneumonitis |\n| Infection |\n| Pneumocystis pneumonia |\n| Diffuse alveolar damage (organizing + fibrotic changes) |\n| Nonspecific interstitial pneumonia |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 384,
            "markdown": "![img-41.jpeg](img-41.jpeg)\n$\\sqrt{ }$ hypoattenuated areas with small vessels in $94 \\% \\leftarrow$ diminished blood flow\n$\\checkmark$ hyperattenuated areas with normal / dilated arteries and enhancement in $77 \\% \\leftarrow$ increased perfusion\nThe best method to differentiate between causes of mosaic attenuation is to perform expiratory imaging $\\rightarrow$ thus allowing identification of areas trapping air.\nPathophysiology:\n(a) air trapping\n\nCause: any obstructive lung disease\n\n1. Chronic bronchitis / bronchiolitis obliterans\n2. Bronchiectasis\n3. Emphysema\n4. Asthma\n5. also: sarcoidosis, hypersensitivity pneumonia\n$\\checkmark$ attenuation differences are accentuated on expiratory HRCT\n$\\diamond$ Indirect sign of constrictive obliterative bronchiolitis without reversibility / improvement!\n(b) vascular obstruction\n\nCause:\n\n1. Chronic thromboembolic pulmonary hypertension (common)\n2. Pulmonary venoocclusive disease\n3. Idiopathic pulmonary hypertension\n$\\checkmark$ increase in lung attenuation in low- and high-attenuation areas on expiratory HRCT\n(c) diffuse ground-glass opacities\n\n# Focal Air-trapping on HRCT \n\n1. Asthma\n2. Bronchiolitis obliterans\n3. Bronchiectasis\n\n## Ground-glass Attenuation",
            "images": [
                {
                    "id": "img-41.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 191,
                    "bottom_right_x": 1322,
                    "bottom_right_y": 704,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 385,
            "markdown": "# Cause: \n\n(a) partial airspace filling\n(b) interstitial thickening with\n> inflammation\n> edema\n> fibrosis\n(c) neoplastic proliferation\n> bronchioloalveolar cell carcinoma\n> lymphoma\n\n1. Desquamative interstitial pneumonia\n2. Extrinsic allergic alveolitis\n3. Sarcoidosis\n4. Usual interstitial pneumonia\n5. Alveolar proteinosis\n6. Cryptogenic organizing pneumonia\n\n## Large Symmetric Regions of Ground-glass Opacities\n\nA. WATER\n\n1. Pulmonary edema\n2. Uremic lung\n3. Acute interstitial pneumonia\n4. Adult respiratory distress syndrome\nB. PROTEIN\n5. Alveolar proteinosis\n6. Nonspecific interstitial pneumonia\nC. RBCs\n7. Pulmonary hemorrhage\nD. WBCs\n8. Hypersensitivity pneumonia\n9. Acute / chronic eosinophilic pneumonia\n10. Desquamative interstitial pneumonia\n11. Churg-Strauss syndrome\n12. Atypical pneumonia (viral, pneumocystis, mycoplasma)\nE. TUMOR\n13. Bronchioloalveolar cell carcinoma\n\n## Nodular Ground-glass Opacity\n\nA. MALIGNANCY\n\n1. Atypical adenomatous hyperplasia (in $2.8 \\%$ of general population)\n2. Bronchioloalveolar cell carcinoma (in $5.2 \\%$ of non-small cell lung cancer population)\n3. Adenocarcinoma\n4. Lymphoma\nB. BENIGN CONDITION\n(a) idiopathic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 386,
            "markdown": "1. Focal interstitial fibrosis\n2. BOOP\n(b) infection\n3. Aspergillosis\n4. Cryptococcus\n(c) eosinophilic lung disease\n5. Simple eosinophilic pneumonia (Löffler syndrome)\n6. Idiopathic hypereosinophilic syndrome\n7. Collagen vascular disease\n8. Sarcoidosis\n9. Parasitic infection\n10. Drug reaction\n(d) hemorrhagic nodule\n11. Thoracic endometriosis\n12. Focal traumatic lung injury\n13. Wegener granulomatosis\n14. Henoch-Schönlein purpura\nC. TECHNICAL (false positive + false negative)\n15. Excessive noise due to low tube current\n16. Volume averaging\n\n# Ground-glass Opacities \\& Interlobular Septal Lines \n\nA. ACUTE / SUBACUTE\n\n1. Hypersensitivity pneumonia\n2. Pulmonary edema\n3. Diffuse alveolar hemorrhage\n4. Viral, pneumocystis, mycoplasmal pneumonia\nB. CHRONIC\n5. Hypersensitivity pneumonia\n6. Pulmonary alveolar proteinosis\n7. Usual interstitial pneumonia\n8. Bronchioloalveolar cell carcinoma\n\n## Ground-glass Opacity \\& Reticular Change\n\n1. Nonspecific interstitial pneumonia\n2. Desquamative interstitial pneumonia\n3. Acute interstitial pneumonia\n4. BOOP\n5. Chronic eosinophilic pneumonia\n6. Churg-Strauss syndrome\n\n## Reversed Halo / Atoll Sign\n\n$=$ focal area of ground-glass opacity surrounded by a complete / incomplete ring of denser consolidation initially thought to be specific for organizing pneumonia\nCause: (a) variety of infections\n(b) noninfectious granulomatous disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 387,
            "markdown": "(c) malignancy\n\n# Airspace Nodules \\& Ground-glass-opacity Halo \n\n(a) infection\n\n1. Invasive pulmonary aspergillosis\n2. Mucormycosis\n3. Candidiasis\n(b) noninfectious disease\n4. Wegener granulomatosis\n5. Bronchioloalveolar carcinoma\n6. Hemorrhagic tumors (primary, metastatic)\n7. Pulmonary lymphoma\n\n## Crazy-paving Pattern\n\n$=$ smooth thickening of interlobular septa + intralobular lines superimposed on a background of patchy ground-glass opacities in a geographic distribution\n\n1. Pulmonary alveolar proteinosis\n2. Pneumocystis carinii pneumonia\n3. Mucinous bronchioloalveolar cell carcinoma\n4. Sarcoidosis\n5. Nonspecific interstitial pneumonia\n6. Organizing pneumonia\n7. Exogenous lipoid pneumonia\n8. ARDS\n9. Pulmonary hemorrhage syndromes\n10. Bacterial pneumonia\n11. Acute eosinophilic pneumonia\n12. Cardiogenic edema\n\n## PULMONARY NODULE / MASS\n\n## Solitary Pulmonary Nodule (SPN) / Mass\n\nDefinition: any pulmonary / pleural sharply defined discrete nearly circular opacity\n\n$$\n\\begin{aligned}\n& 2-30 \\mathrm{~mm} \\text { in diameter }=\\text { nodule } \\\\\n& >30 \\mathrm{~mm} \\text { in diameter }=\\text { mass }(>90 \\% \\text { prevalence of malignancy })\n\\end{aligned}\n$$\n\nIncidence: 150,000 annually in USA on CXR\n(a) roentgenographic survey of low-risk population: $<5 \\%$ of nodules are cancerous\n(b) on surgical resection: $40 \\%$ malignant tumors (lung primaries + metastases), $40 \\%$ granulomas\nInternational Early Lung Cancer Action Project:\n(1) CT detection of nodules vs chest x-ray: $23 \\% \\div 7 \\%$\n(2) CT detection of malignancy vs chest x-ray: $2.7 \\% \\div 0.7 \\%$; stage I malignancy: $2.3 \\% \\div 0.4 \\%$ )\n(3) Cancers: $96 \\%$ resectable; $85 \\%$ stage I, $83 \\%$ not on CXR",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 388,
            "markdown": "# Controversy: \n\n» $80 \\%$ estimated 10-year survival rate $\\leftarrow$ high proportion of stage I lung cancer (National Lung Screening Trial, 2011)\n» NO mortality benefit from CT lung cancer screening (JAMA 2007)\nA. INFLAMMATION / INFECTION\n(a) inflammatory\n\n1. Granuloma (most common lung mass):\nsarcoidosis ( $1 / 2$ ), tuberculosis, berylliosis, leprosy, hypersensitivity pneumonitis, fungal disease (histoplasmosis, coccidioidomycosis, nocardiosis, cryptococcosis), gumma, atypical measles infection, Dirofilaria immitis (dog heartworm), talc, Crohn disease, primary biliary cirrhosis\n2. Fluid-filled cavity: abscess, hydatid cyst, bronchiectatic cyst, bronchocele\n3. Mass in preformed cavity: fungus ball, mucoid impaction\n4. Rounded atelectasis\n5. Inflammatory pseudotumor: fibroxanthoma, histiocytoma, plasma cell granuloma, sclerosing hemangioma\n6. Paraffinoma = lipoid granuloma\n7. Focal organizing pneumonia\n8. Round pneumonia\n(b) noninflammatory\n9. Rheumatoid arthritis\n10. Wegener granulomatosis\nB. MALIGNANT TUMORS $(<30 \\%)$\n$\\diamond$ A solitary pulmonary nodule is the initial radiographic finding in $20-30 \\%$ of patients with lung cancer!\n(a) Malignant primaries of lung:\n11. Bronchogenic carcinoma ( $66 \\%, 2^{\\text {nd }}$ most common mass)\n12. Primary pulmonary lymphoma\n13. Primary sarcoma of lung\n14. Plasmacytoma (primary / secondary)\n15. Clear cell carcinoma, carcinoid, giant cell carcinoma\n(b) Metastases ( $4^{\\text {th }}$ most common cause)\nin adults: kidney, colon, ovary, testes\nin children: Wilms tumor, osteogenic sarcoma, Ewing sarcoma, rhabdomyosarcoma\nC. BENIGN TUMORS\n(a) lung tissue : hamartoma ( $6 \\%, 3^{\\text {rd }}$ most common lung mass), chondroma\n(b) fat tissue : lipoma (usually pleural lesion)\n(c) fibrous tissue : fibroma\n(d) muscle tissue : leiomyoma\n(e) neural tissue : schwannoma, neurofibroma, paraganglioma\n(f) lymph tissue : intrapulmonary lymph node\n(g) deposits : amyloid, splenosis, endometrioma, extramedullary hematopoiesis\nD. VASCULAR\n16. Arteriovenous malformation (AVM), hemangioma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 389,
            "markdown": "2. Hematoma\n3. Organizing infarct\n4. Pulmonary venous varix\n5. Pseudoaneurysm of pulmonary artery\nE. DEVELOPMENTAL / CONGENITAL\n6. Bronchogenic cyst (fluid-filled)\n7. Pulmonary sequestration\n8. Bronchial atresia\nF. INHALATIONAL\n9. Silicosis (conglomerate mass)\n10. Mucoid impaction (allergic aspergillosis)\nG. MIMICKING DENSITIES (20\\%)\n(a) Pseudotumor\n11. Fluid in fissure\n12. Composite area of increased opacity\n(b) Mediastinal mass\n(c) Chest wall lesion\n13. Nipple\n14. Skin tumor: mole, neurofibroma, lipoma, keloid\n15. Bone island, rib osteochondroma\n16. Rib fracture / osteophyte\n17. Pleural plaque / mass (mesothelioma)\n(d) External object\n18. Electrocardiographic lead attachment\n19. Buttons, snaps\nmnemonic: Big Solitary Pulmonary Masses Commonly Appear Hopeless And Lonely\nBronchogenic carcinoma\nSolitary metastasis, Sequestration\nPseudotumor\nMesothelioma\nCyst (bronchogenic, neurenteric, echinococcal)\nAdenoma, Arteriovenous malformation\nHamartoma, Histoplasmosis\nAbscess, Actinomycosis\nLymphoma\nMorphologic Evaluation of Solitary Pulmonary Nodule\nA. SIZE\n$\\diamond$ The smaller the nodule the more likely it is benign!\n$\\sqrt{ }<3 \\mathrm{~mm}$ nodule: in $99.8 \\%$ benign\n$\\sqrt{ } 4-7 \\mathrm{~mm}$ nodule: in $99.1 \\%$ benign\n$\\sqrt{ } 8-20 \\mathrm{~mm}$ nodule: in $82 \\%$ benign\n$\\sqrt{ }>20 \\mathrm{~mm}$ nodule: in $50 \\%$ benign\n$\\sqrt{ }>30 \\mathrm{~mm}$ nodule: in $>93 \\%$ malignant\nB. MARGIN / EDGE",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 390,
            "markdown": "$\\sqrt{ }$ smooth well-defined margin $=$ likely benign\n$\\diamond$ Mostly benign, in $21 \\%$ malignant\n$\\sqrt{ }$ corona radiata $=$ irregular spiculated margin\n$\\diamond$ In $89 \\%$ malignant, in $10 \\%$ benign\n$\\checkmark$ pleural tag\n$\\diamond$ In $25 \\%$ malignant, in $9 \\%$ benign\n$\\checkmark$ \"halo\" sign (= nodule surrounded by ground-glass opacity)\n$\\diamond$ In neutropenic patient suggests aspergillosis\n$\\checkmark$ vessels feeding a smooth / lobulated nodule\n$\\diamond$ in arteriovenous malformation\nC. CONTOUR\n$\\checkmark$ sharply marginated nodule: benign in $79 \\%$\n$\\checkmark$ lobulated nodule: malignant in $58 \\%$\n\n| Probability of Malignancy for Indeterminate <br> Solitary Pulmonary Nodule |  |\n| :-- | :--: |\n| Characteristic / Feature | Likelihood Ratio |\n| spiculated margin | 5.54 |\n| size $>3 \\mathrm{~cm}$ | 5.23 |\n| $>70$ years of age | 4.16 |\n| malignant growth rate | 3.40 |\n| smoker | 2.27 |\n| upper lobe location | 1.22 |\n| size $<10 \\mathrm{~mm}$ | 0.52 |\n| smooth margin | 0.30 |\n| $30-39$ years of age | 0.24 |\n| never smoked | 0.19 |\n| $20-29$ years of age | 0.05 |\n| benign calcification | 0.01 |\n| benign growth rate | 0.01 |\n\n(a) organizing mass\n(b) tumor with multiple cell types growing at different rates (malignancy, hamartoma)\n$\\diamond$ A lobulated contour occurs in $25 \\%$ of benign nodules\n$\\checkmark$ vessel leading to mass: pulmonary varix, AVM\nD. SATELLITE LESION\n$=$ nodule(s) in association with larger peripheral nodule\n$>$ in $99 \\%$ due to inflammatory disease (often TB)\n$>$ in $1 \\%$ due to primary lung cancer\nE. LOCATION\n$\\checkmark$ attached nodule $=$ length of contact surface of nodule $>50 \\%$ of nodule diameter OR major part of nonspherical nodule attached to fissure / pleura / vessel\nHisto: scar, pleural plaque, post-infarction fibrosis, intrapulmonary lymph node",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 391,
            "markdown": "$\\diamond 1$-year follow-up is sufficient\n$\\sqrt{ }$ perifissural nodule $=$ oval / lentiform / triangular homo- generous nodule with smooth margins attached to fissure\nPrevalence: $20 \\%$ in lung cancer screening trial in heavy smokers\nPrognosis: $\\pm$ growth; almost uniformly benign\n$\\sqrt{ }$ purely intraparenchymal $=$ malignant\nF. ENHANCEMENT PATTERN\nG. INTERNAL ATTENUATION\nH. CALCIFICATION\n\n# INTERNAL ATTENUATION OF SPN \n\n$\\checkmark$ entirely solid nodule in $15 \\%$ malignant\n$\\checkmark$ nonsolid nodule of pure groundglass opacity in $34 \\%$ malignant\n$\\checkmark$ partially solid nodule in $40-50 \\%$ malignant\n$\\checkmark$ pseudocavitation (= small focal hypodense region) with air bronchogram suggests bronchioloalveolar cell carcinoma / lymphoma / resolving pneumonia\n$\\diamond$ Air bronchogram in nodules of $<2 \\mathrm{~cm}$ : in $65 \\%$ malignant, in $5 \\%$ benign\n$\\checkmark$ bubblelike areas of low attenuation: bronchiolo-alveolar cell carcinoma (in 50\\%)\n(a) CAVITATION\n$\\checkmark$ a thin $(\\leq 4 \\mathrm{~mm})$ smooth wall is benign in $94 \\%$\n$\\checkmark$ a thick $(>16 \\mathrm{~mm})$ irregular wall suggests malignancy\n(b) Intranodular fat ( -40 to -120 HU )\n$\\diamond$ Fat is a reliable indicator of a hamartoma!\n$\\checkmark$ fat density in up to $50 \\%$ of hamartomas\n\n## CALCIfICATION IN SOLITARY PULMONARY NODULE\n\nSensitivities of $H R C T>C T>C X R$ :\n$22-36 \\%$ of nodules considered noncalcified on CXR contain calcium on thinsection CT; HRCT is $10-20$ times more sensitive than CXR and detects more calcium by $24 \\%$ compared to standard CT\n$\\diamond 38-63 \\%$ of benign nodules are not calcified!\n$\\checkmark>200 \\mathrm{HU}$ at CT densitometry indicates calcification within a nodule ( $66 \\%$ sensitive, $98 \\%$ specific for benign disease)\n$\\checkmark$ diffuse amorphous, eccentric, stippled = malignant pattern\n$\\checkmark$ central, completely solid, laminated: granuloma of prior infection (TB / histoplasmosis)\n$\\checkmark$ popcornlike $=$ chondroid calcification in a hamartoma in $5-50 \\%$\n$\\checkmark$ peripheral calcification: granuloma, tumor\nCalcifying malignant lung tumors:\ncarcinoid (up to $33 \\%$ ), lung cancer (up to $6 \\%$ ), osteosarcoma, chondrosarcoma, metastatic mucinous adenocarcinoma\n\n## Enhancement Pattern of SPN\n\n( $98 \\%$ sensitive, $73 \\%$ specific, $75-85 \\%$ accurate)\n$\\checkmark$ nodule enhancement of $<15 \\mathrm{HU}$ suggests benign lesion\n$\\checkmark$ nodule enhancement of $>20 \\mathrm{HU}$ indicates malignancy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 392,
            "markdown": "# Growth Rate Assessment of Indeterminate SPN \n\n$=$ size comparison of nodule on current versus prior image\nGeneral recommendation for follow-up:\n3-month intervals for up to 1 year and 6-month intervals for another year\nBest method (quite imprecise):\nearly repeat HRCT (resolution in x and y planes of 0.3 mm ) in 1-4 weeks for nodules $>$ 5 mm measuring volume / area / diameter of nodule\nDoubling time ( $=$ time required to double in volume):\n(a) for most malignant nodules: $30-400$ days $=26 \\%$ increase in diameter\n$\\sim 30$ days: aggressive small cell cancer\n$\\sim 90$ days: squamous cell carcinoma\n$\\sim 120$ days: large cell carcinoma\n$\\sim 150$ days: aggressive adenocarcinoma\n$\\sim 1-80$ days: average adenocarcinoma\n(b) for benign nodules: $<30$ and $>400$ days\n$\\diamond$ Absence of growth over a 2-year period implies a doubling time of $>730$ days Disadvantage:\n(1) only $65 \\%$ positive predictive value\n> very slow growth: hamartoma, bronchial carcinoid, inflammatory pseudotumor, granuloma, low-grade adenoca., metastasis from renal cell carcinoma\n> very rapid growth: osteosarcoma, choriocarcinoma, testicular neoplasm, organizing infectious process, infarct (thromboembolism, Wegener granulomatosis)\n(2) unreliable growth perception in nodules $<10 \\mathrm{~mm}$ :\neg, a nodule with a doubling time of 6 months increases its diameter from 5 mm to only 6.25 mm remaining radiologically \"stable\"\nbetter: volumetric growth assessment\n(3) delay can worsen the prognosis\n$\\sqrt{ }$ decrease in size with time: benign lesion\n$\\diamond$ Bronchogenic carcinoma may show temporary decrease in size due to infarction necrosis - fibrosis - retraction sequence!\n\n## Clinical Assessment of Indeterminate SPN\n\n- by patient age (prevalence of cancer $<30$ years is low)\n- history of prior malignancy\n- presenting symptoms, smoking history\n\n\n## Management Strategies of Indeterminate SPN\n\nA. Bayesian Analysis\n$\\diamond$ Analysis of patient characteristics + selected radiologic features is superior to evaluation by experienced radiologist in stratification of benign from malignant nodules!\nLikelihood ratio $(\\mathrm{LR})=$ probability of malignancy\n$=\\mathrm{LR}$ of 1.0 means a $50 \\%$ chance of malignancy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 393,
            "markdown": "Odds of malignancy $\\left(\\mathrm{Odds}_{\\mathrm{ca}}\\right)=$ sum of LR of radiologic features or patient characteristics\nProbability of malignancy:\n\n$$\n\\mathrm{pCa}=\\mathrm{Odds}_{\\mathrm{ca}} /\\left(1+\\mathrm{Odds}_{\\mathrm{ca}}\\right)\n$$\n\nB. Decision Analysis\n$=$ cost-effective strategy for management decision determined by pCa\n$\\mathrm{pCa}<0.05$ observation\n$\\mathrm{pCa}>0.05$ and $<0.6$ biopsy\n$\\mathrm{pCa} \\geq 0.60$ immediate surgical resection\n\n# C. Contrast-enhanced thin-section CT \n\n$=$ degree of enhancement directly related to vascularity + likelihood of malignancy Technique:\n\n- $300 \\mathrm{mg} / \\mathrm{mL}$ iodine at $2 \\mathrm{~mL} / \\mathrm{sec}$ (total dose $420 \\mathrm{mg} / \\mathrm{kg}$ )\n- delay of 20 sec from onset of injection\n- contiguous sections through the nodule obtained at $1,2,3$, and 4 minute after onset of injection\n- scan of chest and upper abdomen obtained between 1 and 2 minute after onset of injection\n\n\n## D. ${ }^{18}$ F-FDG Positron Emission Tomography (PET)\n\nSize: $94 \\%$ sensitive $+83 \\%$ specific for nodules of $1-3 \\mathrm{~cm}$; NOT useful for nodules $<$ 8 mm\n$\\diamond$ Detectable size of metabolically active lesion: (4-)7 mm\n) benign nodule\n$\\sqrt{ }$ no uptake $=$ benign nodule ( $92-100 \\%$ sensitive, $52-100 \\%$ specific, $94 \\%$ accurate)\n$\\sqrt{ }$ SUV of $0.4-2.0$ indicates a benign lesion\n\n| Incidental Pulmonary Nodule Follow-up by CT for Persons $>35$ years <br> (Fleischner Society Recommendation) |  |  |\n| :--: | :--: | :--: |\n| Average Nodule Size* | Low-Risk Patient (Hx of minimal smoking; no malignancy) | High-Risk Patient (Hx of smoking \\& malignancy) |\n| $\\leq 4 \\mathrm{~mm}$ | no f/u needed | $\\mathrm{f} / \\mathrm{u} @ 12 \\mathrm{mo}$ |\n| $>4-6 \\mathrm{~mm}$ | $\\mathrm{f} / \\mathrm{u} @ 12 \\mathrm{mo}$ | $\\begin{aligned} & \\mathrm{f} / \\mathrm{u} @ 6-12 \\mathrm{mo} ; \\text { if } \\\\ & \\text { stable @ } 18-24 \\mathrm{mo} \\end{aligned}$ |\n| $>6-8 \\mathrm{~mm}$ | $\\begin{aligned} & \\mathrm{f} / \\mathrm{u} @ 6-12 \\mathrm{mo} ; \\text { if stable } \\\\ & @ 18-24 \\mathrm{mo} \\end{aligned}$ | $\\begin{aligned} & \\mathrm{f} / \\mathrm{u} @ 3-6 \\mathrm{mo} ; \\text { if stable } \\\\ & @ 9-12 \\mathrm{mo} \\text { and } \\\\ & @ 24 \\mathrm{mo} \\end{aligned}$ |\n| $>8 \\mathrm{~mm}$ | $\\begin{aligned} & \\mathrm{f} / \\mathrm{u} @ 3 \\mathrm{mo} ; \\text { if stable } \\\\ & @ 9 \\mathrm{mo} \\text { and } 24 \\mathrm{mo} \\end{aligned}$ | $\\begin{aligned} & \\mathrm{f} / \\mathrm{u} @ 3 \\mathrm{mo} ; \\text { if stable } \\\\ & @ 9 \\mathrm{mo} \\text { and } @ 24 \\mathrm{mo} \\end{aligned}$ |\n| * average of length + width |  |  |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 394,
            "markdown": "| Subsolid Pulmonary Nodule Follow-up by CT (Fleischner Society Recommendation) |  |\n| :--: | :--: |\n| Nodule Type | Management |\n| Solitary pure GGN |  |\n| $\\leq 5 \\mathrm{~mm}$ | NO $\\mathrm{f} / \\mathrm{u}$ needed |\n| $>5 \\mathrm{~mm}$ | $\\mathrm{f} / \\mathrm{u}$ @ 3 mo ; if persistent @ yearly intervals for 3 up to years |\n| Solitary part-solid GGN |  |\n| solid component $<5 \\mathrm{~mm}$ | $\\mathrm{f} / \\mathrm{u}$ @ 3 mo ; if persistent @ yearly intervals for up to 3 years |\n| solid component $\\geq 5 \\mathrm{~mm}$ | biopsy / resection |\n| Multiple subsolid nodules |  |\n| pure GGNs $\\leq 5 \\mathrm{~mm}$ | $\\mathrm{f} / \\mathrm{u}$ @ 2 and 4 years |\n| pure GGNs $>5 \\mathrm{~mm}$; | $\\mathrm{f} / \\mathrm{u}$ @ 3 mo ; if persistent @ |\n| NO dominant lesion | yearly intervals for up to 3 years |\n| part-solid GGNs $>5 \\mathrm{~mm}$; | $\\mathrm{f} / \\mathrm{u}$ @ 3 mo ; if persistent biopsy / |\n| WITH dominant lesion | resection |\n| GGN = ground-glass nodule; requires CT with contiguous 1-mm-thick sections; PET/CT for nodules only $>10 \\mathrm{~mm}$ |  |\n\n) inflammatory / infectious nodule\n$\\sqrt{ }$ low FDG uptake $=$ active TB, fungal infection (histoplasmosis), rheumatoid nodule, sarcoidosis, silicosis\n$\\sqrt{ }$ gradual washout of FDG after initial increase suggests benign inflammatory lesion\n) malignant nodule\n$\\sqrt{ }$ increased FDG uptake $=$ cancer $(94-97 \\%$ sensitive, $78-92 \\%$ specific, $92 \\%$ accurate)\n$\\sqrt{ }$ intensity greater than mediastinum / SUV (standardized uptake value) $>2.5$ indicates malignancy ( $95-100 \\%$ sensitive, $80-89 \\%$ specific, $92 \\%$ accurate for nodules $>15 \\mathrm{~mm}$ )\n$\\sqrt{ }$ continually increasing FDG uptake over time is indicative of malignancy\nFN: elevated serum glucose level $>250 \\mathrm{mg} / \\mathrm{dL}$, low-grade malignancy (bronchioloalveolar carcinoma in up to $57 \\%$ undetectable), carcinoid tumor, mucinous neoplasm; malignant lesion $<7 \\mathrm{~mm}$\nFP: sarcoidosis, active TB, fungal infection (histoplasmosis, aspergillosis, coccidioidomycosis), silicoanthracosis, lipoid pneumonia, rheumatoid nodule, Wegener, radiation pneumonitis\n\n# E. Transthoracic Needle Aspiration Biopsy \n\n$95-100 \\%$ sensitive for $10-15-\\mathrm{mm}$ malignancies;\n$50 \\%$ sensitive for $5-7-\\mathrm{mm}$ malignancies; improved with the addition of a core up to $91 \\%$ sensitive for establishing a benign diagnosis\nCx: pneumothorax (5-30\\%) with chest tube placement in 1-15\\%; self-limiting hemorrhage\nF. Bronchoscopy\n$10 \\%$ diagnostic yield for nodules $<20 \\mathrm{~mm}$;",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 395,
            "markdown": "$40-60 \\%$ diagnostic yield for nodules $20-40 \\mathrm{~mm}$\nCx: lower than transthoracic needle biopsy\n\n# Decision Algorithm for Solitary Pulmonary Nodule \n\nA. COMPARISON WITH OLD STUDY\n$\\sqrt{ }$ growth $\\rightarrow$ needle aspiration biopsy\n$\\sqrt{ }$ no growth $>2$ years $\\rightarrow$ no action\nB. COMPARISON NOT AVAILABLE\n$\\sqrt{ }$ benign calcification or fat $\\rightarrow$ no action\n$\\sqrt{ }$ nodule of any size $\\rightarrow$ further workup\n(a) immunocompromised / fever\n$\\rightarrow$ follow-up in 4-6-week intervals to resolution\n$\\rightarrow$ or intervention\n(b) history of malignancy\n$\\rightarrow$ follow-up at $3,6,12$ months\n$\\rightarrow$ if growth consider intervention\n(c) no history of malignancy $\\pm$ smoking\nmicronodule $<4 \\mathrm{~mm}$\n$\\rightarrow$ follow-up at 12 and 24 months for age $\\geq 35$\n$\\rightarrow$ follow-up at 12 months for age $18-35$\n$\\rightarrow$ if growth consider intervention\nnodule of $>4-8 \\mathrm{~mm}$\n$\\rightarrow$ follow-up at 3,9 and 24 months for age $\\geq 35$\n$\\rightarrow$ follow-up at 6,12 and 24 months for age $18-35$\n$\\rightarrow$ if growth consider intervention\nnodule of $>8 \\mathrm{~mm}$\n$\\rightarrow$ consider PET / intervention\nground-glass nodule\n$\\rightarrow$ longer follow-up for all ages\n$\\sqrt{ }$ if no growth then no intervention\n\n## CT Halo Sign\n\n$\\sqrt{ }$ central area of soft-tissue attenuation surrounded by a halo of ground-glass attenuation\nA. HEMORRHAGIC PULMONARY NODULE\n(a) hemorrhagic infarction (angioinvasion)\n\n1. Early invasive aspergillosis\n2. Mucormycosis\n3. Hematogenous candidiasis\n4. Coccidioidomycosis\n(b) necrotizing vasculitis\n5. Wegener granulomatosis\n(c) fragility of neovascular tissue\n6. Metastatic angiosarcoma\n7. Metastatic choriocarcinoma\n8. Metastatic osteosarcoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 396,
            "markdown": "4. Kaposi sarcoma\n(d) trauma\n5. Following lung biopsy\n6. Lung transplant\nB. LEPEDIC TUMOR GROWTH\n7. Bronchioloalveolar carcinoma\n8. Metastatic extrapulmonary adenocarcinoma\n9. Lymphoma\nC. OTHERS\n10. Eosinophilic pneumonia\n11. Bronchiolitis obliterans organizing pneumonia\n12. Tuberculoma associated with hemoptysis\n13. Mycobacterium avium complex\n14. Herpes simplex, CMV, varicella-zoster virus\n\n# Benign Lung Tumor \n\nA. CENTRAL LOCATION\n\n1. Bronchial polyp\n2. Bronchial papilloma\n3. Granular cell myoblastoma\nB. PERIPHERAL LOCATION\n4. Hamartoma\n5. Leiomyoma:\nbenign metastasizing leiomyoma, history of hysterectomy\n6. Amyloid tumor: not associated with amyloid of other organs / rheumatoid arthritis / myeloma\n7. Intrapulmonary lymph node\n8. Arteriovenous malformation\n9. Endometrioma, fibroma, neural tumor, chemodectoma\nC. CENTRAL / PERIPHERAL\n10. Lipoma: (a) subpleural, (b) endobronchial\nD. PSEUDOTUMOR\n11. Fibroxanthoma / xanthogranuloma\n12. Plasma cell granuloma\n13. Sclerosing hemangioma: middle-aged woman, RML / RLL (most commonly), may be multiple\n14. Pseudolymphoma\n15. Round atelectasis\n16. Pleural pseudotumor $=$ accumulation of pleural fluid within interlobar fissure\n\n## Lung Tumor in Childhood\n\n1. Metastatic (common)\n2. Blastoma\n3. Mucoepidermoid carcinoma\n4. Bronchogenic carcinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 397,
            "markdown": "5. Hemangiopericytoma\n6. Rhabdomyosarcoma\n\n# Solid Intrathoracic Neonatal Mass \n\n1. Type 3 / fluid-filled cystic adenomatoid malformation\n2. Sequestration\n3. Solid (high-grade) pleuropulmonary blastoma\n4. Bronchial atresia\n\n| Differential Diagnosis of Airspace Opacities |  |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: | :--: |\n| Disease | Presentation | Distribution | Adenopathy | Tree-in- <br> bud | Cavitation |  |\n| Wegener granulomatosis | most often acute | multifocal, bilateral perihilar + peribronchovascular |  | rare | rare | rare |\n| Bacterial pneumonia | acute | lobar + patchy |  | reactive | yes | rare |\n| Aspiration | most often acute | dependent, associated with bronchiectasis in lower lobes |  | reactive | yes | sometimes |\n| Organizing pneumonia | chronic | multifocal, peripheral, migratory, atoll sign |  | rare | no | no |\n| Rheumatoid arthritis | solitary / multiple | $5-7 \\mathrm{~mm}$ |  | usually peripherally | rare | waxing and waning; SQ nodules |\n| Adenocarcinoma | chronic | uni- / multifocal, ranging from ground-glass opacity to consolidation |  | yes | no | pseudocavitation |\n\n\n| Differential Diagnosis for Nodules and Masses |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: |\n| Disease | Number | Size | Distribution | Cavitation | Ancillary Findings |\n| Wegener granulomatosis | multiple | $5-100 \\mathrm{~mm}$ | usually bilateral, random (peribronchovascular, subpleural, angiocentric | in up to $50 \\%$ of lesions $>2 \\mathrm{~cm}$ | CT halo / atoll sign, radiating linear scarring, pleural tags |\n| Metastasis | multiple | variable | bilateral, random | uncommon; if present suggestive of squamous / sarcoma / TCC primary | lymphadenopathy |\n| Infection | variable | usually $<10 \\mathrm{~mm}$ | peripheral (septic emboli), miliary (TB, fungus) | rare | tree-in-bud opacities, consolidation, reactive lymphadenopathy |\n| Sarcoidosis | multiple | $2-10 \\mathrm{~mm}$ | perilymphatic | rare | architectural distortion, symmetric adenopathy |\n| Rheumatoid arthritis | solitary / multiple | $5-7 \\mathrm{~mm}$ | usually peripherally | rare | waxing and waning; subcutaneous nodules |\n\n## 5. Neuroblastoma\n\n## Large Pulmonary Mass\n\nmnemonic: CAT PIES\nCarcinoma (large cell, squamous cell, cannon ball metastasis\nAbscess\nToruloma (Cryptococcus)\nPseudotumor, Plasmacytoma\nInflammatory\nEchinococcal disease\nSarcoma, Sequestration\n\n## Cavitating Lung Nodule",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 398,
            "markdown": "# A. NEOPLASM \n\n(a) Lung primary:\n\n1. Squamous cell carcinoma ( $10 \\%$ )\n2. Adenocarcinoma ( $9.5 \\%$ )\n3. Bronchioloalveolar carcinoma (rare)\n4. Hodgkin disease (rare)\n(b) Metastases ( $4 \\%$ cavitate):\n5. Squamous cell carcinoma ( $2 / 3$ ):\nnasopharynx (males), cervix (females), esophagus\n6. Adenocarcinoma (colorectal)\n7. Sarcoma: Ewing sarcoma, osteo-, myxo-, angiosarcoma\n8. Melanoma\n9. Seminoma, teratocarcinoma\n10. Wilms tumor\nB. COLLAGEN-VASCULAR DISEASE\n11. Pulmonary angiitis + granulomatosis\n> Wegener granulomatosis + Wegener variant\n12. Rheumatoid nodules + Caplan syndrome\n13. SLE\n14. Periarteritis nodosa (rare)\nC. GRANULOMATOUS DISEASE\n15. Langerhans cell histiocytosis\n16. Sarcoidosis (rare)\nD. VASCULAR DISEASE\n17. Pulmonary embolus with infarction\n18. Septic emboli (Staphylococcus aureus)\nE. INFECTION\n19. Bacterial: pneumatoceles from staphylococcal / gram-negative pneumonia\n20. Mycobacterial: TB\n21. Fungal: nocardiosis, cryptococcosis, coccidioidomycosis (in 10\\%), aspergillosis\n22. Parasitic: echinococcosis (multiple in $20-30 \\%$ ), paragonimiasis\nF. TRAUMA\n23. Traumatic lung cyst (after hemorrhage)\n24. Hydrocarbon ingestion (lower lobes)\nG. BRONCHOPULMONARY DISEASE\n25. Infected bulla\n26. Cystic bronchiectasis\n27. Communicating bronchogenic cyst\nmnemonic: CAVITY\nCarcinoma (squamous cell), Cystic bronchiectasis\nAutoimmune disease (Wegener granulomatosis, rheumatoid lung)\nVascular (bland / septic emboli)\nInfection (abscess, fungal disease, TB, Echinococcus)\nTrauma\nYoung = congenital (sequestration, diaphragmatic hernia, bronchogenic cyst)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 399,
            "markdown": "mnemonic: WEIRD HOLES\nWegener's syndrome\nEmbolic (pulmonary, septic)\nInfection (anaerobes, pneumocystis, TB)\nRheumatoid (necrobiotic nodules)\nDevelopmental cysts (sequestration)\nHistiocytosis\nOncological\nLymphangioleiomyomatosis\nEnvironmental, occupational\nSarcoid\n\n# Pulmonary Mass with Air Bronchogram \n\n1. Bronchioloalveolar carcinoma\n2. Lymphoma\n3. Pseudolymphoma\n4. Kaposi sarcoma\n5. Blastomycosis\n\n## Air-crescent Sign\n\n$=$ air in a crescentic shape separating the outer wall of a nodule / mass from an inner sequestrum\nA. INFECTION\n\n1. Invasive pulmonary aspergillosis\n2. Noninvasive mycetoma\n3. Echinococcal lung cyst\n4. Tuberculoma\n5. Rasmussen aneurysm (most too small to be identified on CXR)\n6. Bacterial lung abscess $\\pm$ pulmonary gangrene\nB. CAVITATING NEOPLASM\n7. Primary / metastatic carcinoma / sarcoma\n8. Bronchial adenoma\n9. Cystic hamartoma\nC. TRAUMA\n10. Pulmonary hematoma\nD. THROMBOEMBOLISM\n\n## Shaggy Pulmonary Nodule\n\nmnemonic: Shaggy Sue Made Loving A Really Wild Fantasy Today\nSarcoidosis, alveolar type\nSeptic emboli\nMetastasis\nLymphoma, Lung primary, Lymphomatoid granulomatosis\nAlveolar cell carcinoma\nRheumatoid lung",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 400,
            "markdown": "Wegener granulomatosis\nFungus\nTuberculosis\n\n# Multiple Pulmonary Nodules and Masses \n\n$\\sqrt{ }$ homogeneous masses with sharp borders\n$\\sqrt{ }$ no air alveolo- / bronchogram\nA. TUMORS\n(a) malignant\n\n1. Metastases:\nfrom breast, kidney, GI tract, uterus, ovary, testes, malignant melanoma, sarcoma, Wilms tumor\n2. Lymphoma (rare)\n3. Multiple primary bronchogenic carcinomas (synchronous in $1 \\%$ of all lung cancers)\n(b) benign\n4. Hamartoma (rarely multiple)\n5. Benign metastasizing leiomyoma\n6. AV malformations\n7. Amyloidosis\nB. VASCULAR LESIONS\n8. Thromboemboli with organizing infarcts\n9. Septic emboli with organized infarcts\nC. COLLAGEN-VASCULAR DISEASE\n10. Wegener granulomatosis: vasculitis with organizing infarcts\n11. Wegener variants\n12. Rheumatoid nodules: tendency for periphery, occasionally cavitating\nD. INFLAMMATORY GRANULOMAS\n13. Fungal: coccidioidomycosis, histoplasmosis, cryptococcosis\n14. Bacterial: nocardiosis, tuberculosis\n15. Viral: atypical measles\n16. Parasites: hydatid cysts, paragonimiasis\n17. Sarcoidosis: large accumulation of interstitial granulomas\n18. Inflammatory pseudotumors: fibrous histiocytoma, plasma cell granuloma, hyalinizing pulmonary nodules, pseudolymphoma\nmnemonic: SLAM DA PIG\nSarcoidosis\nLymphoma\nAlveolar proteinosis\nMetastases\nDrugs\nAlveolar cell carcinoma\nPneumonias\nInfarcts\nGoodpasture syndrome",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 401,
            "markdown": "# Progressive Massive Fibrosis Pattern \n\n1. Sarcoidosis\n2. Tuberculosis\n3. Silicosis\n4. Berylliosis\n5. Talcosis\n\n## Multiple Cavitating Nodules / Masses\n\nA. PULMONARY VASCULITIS\n\n1. Wegener granulomatosis\n2. Necrotizing sarcoid granulomatosis\n3. Bronchocentric granulomatosis\nB. METASTATIC DISEASE\nparticularly squamous histologic type\nC. MULTIFOCAL INFECTION\n4. Pseudomonas\n5. Tuberculosis\n6. Septic abscesses\nD. MULTIPLE PULMONARY INFARCTS\nE. BRONCHIECTASIS\nF. NEOPLASMS\n7. Lymphoma\n8. Multicentric bronchioloalveolar carcinoma\nG. COLLAGEN-VASCULAR DISEASE\n9. Rheumatoid nodules\nH. GRANULOMATOUS DISEASE\n10. Cystic form of sarcoidosis\n11. Langerhans cell histiocytosis\n\n## Patchy Airspace Consolidations\n\n1. Pneumonia\n2. Sarcoidosis\n3. Tuberculosis\n4. Bronchiolitis obliterans organizing pneumonia\n\n## Small Pulmonary Nodules\n\nmnemonic: SMALT\nSarcoid\nMetastases (esp. thyroid)\nAlveolar cell carcinoma\nLymphoma, Leukemia\nTB\n\n## Pulmonary Nodules \\& Pneumothorax\n\n1. Osteosarcoma\n2. Wilms tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 402,
            "markdown": "# 3. Histiocytosis \n\n## Pleura-based Lung Nodule\n\n$\\checkmark$ ill-defined / sharply defined lesion mimicking a true pleural mass\n$\\checkmark$ associated linear densities in lung parenchyma\n\n1. Granuloma (fungus, tuberculosis)\n2. Inflammatory pseudotumor\n3. Metastasis\n4. Rheumatoid nodule\n5. Pancoast tumor\n6. Lymphoma\n7. Infarct: Hampton hump\n8. Atelectatic pseudotumor\n\n## Intrathoracic Mass of Low Attenuation\n\nA. CYSTS\n\n1. Bronchogenic / neurenteric / pericardial cyst\n2. Hydatid disease\nB. FATTY SUBSTRATE\n3. Hamartoma\n4. Lipoma\n5. Tuberculous lymph node\n6. Lymphadenopathy in Whipple disease\nC. NECROTIC MASSES\n7. Resolving hematoma\n8. Treated lymphoma\n9. Metastasis from ovary, stomach, testes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 403,
            "markdown": "# PNEUMOCONIOSIS \n\n$=$ tissue reaction to the presence of an accumulation of inhaled particulates (= dust) in lungs\nPath: 1. Fibrosis\n(a) focal / nodular $=$ silicosis\n(b) diffuse $=$ asbestosis\n\nCause: silicosis, coal worker pneumoconiosis, asbestosis, berylliosis, talcosis\n2. Nonfibrotic aggregates of particle-laden macrophages in inert dusts\n\nCause: siderosis (iron oxide), stannosis (tin oxide), and baritosis (barium)\nTypes:\n\n1. Silicosis\n2. Coal worker pneumoconiosis\n3. Berylliosis\n4. Talcosis\n5. Siderosis\n6. Carbon black pneumoconiosis\n7. Hard-metal pneumoconiosis\n8. Asbestos-related disease\n\n## Pneumoconiosis Categories\n\naccording to ILO (International Labour Office) useful for epidemiologic purposes\nA. TYPE OF OPACITIES\n\n1. Silicosis, coal worker's pneumoconiosis nodular (round) opacities: $\\mathrm{p}=<1.5 \\mathrm{~mm} ; \\mathrm{q}=1.5-3 \\mathrm{~mm} ; \\mathrm{r}=3-10 \\mathrm{~mm}$\n2. Asbestosis\nlinear (irregular) opacities: $\\mathrm{s}=$ fine; $\\mathrm{t}=$ medium; $\\mathrm{u}=$ coarse / blotchy\nB. PROFUSION / SEVERITY\n( $=$ concentration of small opacities in affected area) $0=$ normal; $1=$ slight; $2=$ moderate; 3\n$=$ advanced\nintermediate grading: $2 / 2=$ definitely moderate profusion\n$2 / 3=$ moderate possibly advanced profusion\nC. ZONAL DISTRIBUTION: upper / middle / lower\nD. PLEURAL THICKENING: diffuse / circumscribed\n\n## Pneumoconiosis with Mass\n\nAnthracosilicosis with:\n\n1. Granuloma (histoplasmosis, TB, sarcoidosis)\n2. Bronchogenic carcinoma (incidence same as in general population)\n3. Metastasis\n4. Progressive massive fibrosis\n5. Caplan syndrome (rheumatoid nodules)\n\n## PULMONARY CALCIFICATIONS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 404,
            "markdown": "# Multiple Pulmonary Calcifications \n\nA. INFECTION\n\n1. Histoplasmosis\n2. Tuberculosis\n3. Chickenpox pneumonia\nB. INHALATIONAL DISEASE\n4. Silicosis\nC. MISCELLANEOUS\n5. Hypercalcemia\n6. Mitral stenosis\n7. Alveolar microlithiasis\n\n## Calcified Pulmonary Nodules\n\nmnemonic: HAM TV Station\nHistoplasmosis, Hamartoma\nAmyloidosis, Alveolar microlithiasis\nMitral stenosis, Metastasis (thyroid, osteosarcoma, mucinous carcinoma)\nTuberculosis\nVaricella\nSilicosis\n$\\diamond$ Central / laminated / popcorn / diffuse calcifications are characteristic of benign solitary lung nodules!\n\n## DENSE LUNG LESIONS\n\n## Opacification of Hemithorax\n\nmnemonic: FAT CHANCE\nFibrothorax\nAdenomatoid malformation\nTrauma (ie, hematoma)\nCollapse, Cardiomegaly\nHernia\nAgenesis of lung\nNeoplasm (ie, mesothelioma)\nConsolidation\nEffusion\n\n## Atelectasis\n\nA. TUMOR\n\n1. Bronchogenic carcinoma ( $2 / 3$ of squamous cell carcinomas occur as an endobronchial mass with persistent or recurrent atelectasis / recurrent pneumonia)\n2. Bronchial carcinoid\n3. Metastasis: primary tumor of kidney, colon, rectum, breast, melanoma\n4. Lymphoma (usually as a late presentation)\n5. Lipoma, granular cell myoblastoma, amyloid tumor, fibroepithelial polyp",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 405,
            "markdown": "# B. INFLAMMATION \n\n1. Tuberculosis (endobronchial granuloma, broncholith, bronchial stenosis)\n2. Right middle lobe syndrome (chronic right middle lobe atelectasis)\n3. Sarcoidosis (endobronchial granuloma - rare)\nC. MUCUS PLUG\n4. Severe chest / abdominal pain (postoperative patient)\n5. Respiratory depressant drug (morphine; CNS illness)\n6. Chronic bronchitis / bronchiolitis obliterans\n7. Asthma\n8. Cystic fibrosis\n9. Bronchopneumonia (peribronchial inflammation)\nD. OTHER\n10. Large left atrium: mitral stenosis + LLL atelectasis\n11. Foreign body: food aspiration, endotracheal intubation\n12. Broncholithiasis\n13. Amyloidosis\n14. Wegener granulomatosis\n15. Bronchial transection\n\nSigns:\n$\\checkmark$ local increase in lung density\n$\\checkmark$ crowding of pulmonary vessels\n$\\checkmark$ bronchial rearrangement\n$\\checkmark$ displacement of fissures\n$\\checkmark$ displacement of hilum\n$\\checkmark$ mediastinal shift\n$\\checkmark$ elevation of hemidiaphragm\n$\\checkmark$ cardiac rotation\n$\\checkmark$ approximation of ribs\n$\\checkmark$ compensatory overinflation of normal lung\n\n## Obstructive Atelectasis\n\n## RESORPTIVE ATELECTASIS\n\nPathophysiology:\nsum of partial gas pressures in venous blood perfusing atelectatic region is less than atmospheric pressure, $\\rightarrow$ gradual resorption of air trapped distal to site of obstruction; continuing secretion into small airways leads to consolidation $\\rightarrow$ postobstructive pneumonitis / bacterial infection\nCause: bronchiolar obstruction by\n\n1. Tumor\n2. Stricture\n3. Foreign body\n4. Mucus plug\n5. Bronchial rupture\n\n- airless collapse within minutes to hours",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 406,
            "markdown": "MR:\n$\\sqrt{ }$ high signal intensity on T2WI in atelectatic area\n\n# Nonobstructive Atelectasis \n\nPathophysiology:\nbronchi less compliant than lung parenchyma $\\rightarrow$ bronchi + pathway between bronchial system + alveoli remain patent $\\rightarrow$ elimination of secretions continues with preservation of convective airflow to distal bronchioles\n\n- collapsed lung NOT completely airless (up to $40 \\%$ residual air)\n\nMR:\n$\\sqrt{ }$ low-signal intensity on T2WI in atelectatic area\n\n## Passive Atelectasis\n\n$=$ pleural space-occupying process\n\n1. Pneumothorax\n2. Hydrothorax / hemothorax\n3. Congenital diaphragmatic hernia\n4. Pleural masses: metastases, mesothelioma\n\n## Adhesive Atelectasis\n\n$=$ decrease in surfactant production\n\n1. Respiratory distress syndrome of the newborn (hyaline membrane disease)\n2. Pulmonary embolism: edema, hemorrhage, atelectasis\n3. Intravenous injection of hydrocarbon\n\n## Cicatrizing Atelectasis\n\n$=$ parenchymal fibrosis causing decreased lung volume\n\n1. Tuberculosis / histoplasmosis (upper lobes)\n2. Silicosis (upper lobes)\n3. Scleroderma (lower lobes)\n4. Radiation pneumonitis (nonanatomical distribution)\n5. Idiopathic pulmonary fibrosis\n\n## DisCOID ATELECTASIS\n\nmnemonic: EPIC\nEmbolus\nPneumonia\nInadequate inspiration\nCarcinoma, obstructing\n\n## Rounded Atelectasis\n\nCause: any type of pleural inflammatory reaction (asbestos as leading cause)\nPathomechanism:\nthickening of visceral pleura with progressive wrinkling + folding of subpleural lung\nLocation: posterobasal subpleural\n$\\sqrt{ }$ round / lentiform mass incompletely surrounded by lung\n$\\sqrt{ }$ increased attenuation in periphery of mass",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 407,
            "markdown": "$\\checkmark$ pleural thickening in vicinity of mass\n$\\checkmark$ curving of vessels + bronchi toward mass\n$\\checkmark$ air bronchogram within mass\n$\\checkmark$ lesion may be stable / enlarge\n\n# Left Upper Lobe Collapse \n\nPA view:\n$\\checkmark$ \"Luftsichel\" sign = sharply marginated paraaortic crescent of hyperlucency (= hyperexpanded superior segment of LLL extending toward lung apex + between aortic arch and atelectatic LUL)\n$\\checkmark$ hazy opacification of left hilum + cardiac border\n$\\checkmark$ elevation of left hilum\n$\\checkmark$ near horizontal course of left main bronchus\n$\\checkmark$ posterior + leftward rotation of heart\nLateral view:\n$\\checkmark$ retrosternal opacity\n$\\checkmark$ major fissure displaced anteriorly paralleling anterior chest wall\n$D D x$ : (1) Herniation of right lung across midline (leftward displacement of anterior junction line)\n(2) Medial pneumothorax\n\n## Multifocal III-defined Densities\n\n$=$ densities $5-30 \\mathrm{~mm}$ resulting in airspace filling\nA. INFECTION\n\n1. Bacterial bronchopneumonia\n2. Fungal pneumonia:\nhistoplasmosis, blastomycosis, actinomycosis, coccidioidomycosis, aspergillosis, cryptococcosis, mucormycosis, sporotrichosis\n3. Viral pneumonia\n4. Tuberculosis (primary infection)\n5. Rocky Mountain spotted fever\n6. Pneumocystis carinii\nB. GRANULOMATOUS DISEASE\n7. Sarcoidosis (alveolar form $\\leftarrow$ peribronchial granulomas)\n8. Eosinophilic granuloma\nC. VASCULAR\n(a) thromboembolic disease\n(b) septic emboli\n(c) vasculitis\n9. Wegener granulomatosis\n10. Wegener variants: limited Wegener, lymphomatoid granulomatosis\n11. Infectious vasculitis = invasion of pulmonary arteries: mucormycosis, invasive form of aspergillosis, Rocky Mountain spotted fever\n12. Goodpasture syndrome\n13. Scleroderma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 408,
            "markdown": "# D. NEOPLASTIC \n\n1. Bronchioloalveolar cell carcinoma\n$=$ only primary lung tumor to produce multifocal ill-defined densities with air bronchograms\n2. Alveolar type of lymphoma\n$=$ massive accumulation of tumor cells in interstitium with compression atelectasis + obstructive pneumonia\n3. Metastases\n(a) Choriocarcinoma: hemorrhage (however rare)\n(b) Vascular tumors: malignant hemangiomas\n4. Waldenström macroglobulinemia\n5. Angioblastic lymphadenopathy\n6. Mycosis fungoides\n7. Amyloid tumor\nE. IDIOPATHIC INTERSTITIAL DISEASE\n8. Lymphocytic interstitial pneumonitis (LIP)\n9. Desquamative interstitial pneumonitis (DIP)\n10. Pseudolymphoma $=$ localized form of LIP\n11. Usual interstitial pneumonitis (UIP)\nF. INHALATIONAL DISEASE\n12. Allergic alveolitis: acute stage (eg, farmer's lung)\n13. Silicosis\n14. Eosinophilic pneumonia\nG. DRUG REACTIONS\n\n## Diffuse Infiltrates in Immunocompromised Patient\n\nmnemonic: FOLD\nFailure (CHF)\nOpportunistic infection\nLymphangitic tumor spread\nDrug reaction\n\n## Segmental \\& Lobar Densities\n\nA. PNEUMONIA\n\n1. Lobar pneumonia\n2. Lobular pneumonia\n3. Acute interstitial pneumonia\n4. Aspiration pneumonia\n5. Primary tuberculosis\nB. PULMONARY EMBOLISM\n(rarely multiple / larger than subsegmental)\nC. NEOPLASM\n6. Obstructive pneumonia\n7. Bronchioloalveolar cell carcinoma\nD. ATELECTASIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 409,
            "markdown": "# Chronic Infiltrates \n\nChronic Infiltrates in Childhood<br>mnemonic: ABC'S<br>Asthma, Agammaglobulinemia, Aspiration<br>Bronchiectasis<br>Cystic fibrosis<br>Sequestration, intralobar\n\nChronic Multifocal Ill-defined Opacities\n\n1. Organizing pneumonia\n2. Granulomatous disease\n3. Allergic alveolitis\n4. Bronchioloalveolar cell carcinoma\n5. Lymphoma\n\nSubacute / Chronic Consolidation \\& Ground-glass Opacities\n\n1. BOOP\n2. Chronic eosinophilic pneumonia\n3. Churg-Strauss syndrome\n4. Desquamative interstitial pneumonia\n5. Nonspecific interstitial pneumonia\n6. Chronic hypersensitivity pneumonia\n7. Mycoplasma pneumonia\n8. Lymphoma\n9. Lipoid pneumonia\n\nChronic Diffuse Confluent Opacities\n\n1. Alveolar proteinosis\n2. Hemosiderosis\n3. Sarcoidosis\n\n## III-defined Opacities with Holes\n\nA. INFECTION\n\n1. Necrotizing pneumonias:\n\nStaphylococcus aureus, B-hemolytic streptococcus, Klebsiella pneumoniae, E. coli, Proteus, Pseudomonas, anaerobes\n2. Aspiration pneumonia:\nmixed gram-negative organisms\n3. Septic emboli\n4. Fungus:\nhistoplasmosis, blastomycosis, coccidioidomycosis, cryptococcosis\n5. Tuberculosis\nB. NEOPLASM\n\n1. Primary lung carcinoma\n2. Lymphoma (cavitates very rarely)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 410,
            "markdown": "# C. VASCULAR + COLLAGEN-VASCULAR DISEASE \n\n1. Emboli with infarction\n2. Wegener granulomatosis\n3. Necrobiotic rheumatoid nodules\nD. TRAUMA\n4. Contusion with pneumatoceles\n\n## Recurrent Fleeting Infiltrates\n\n1. Löffler disease\n2. Bronchopulmonary aspergillosis / bronchocentric granulomatosis\n3. Asthma\n4. Subacute bacterial endocarditis with pulmonary emboli\n\n## Tubular Density\n\nA. Mucoid impaction\nB. Vascular malformation\n\n1. Arteriovenous malformation\n2. Pulmonary varix\n\n## Mucoid Impaction\n\n$=$ BRONCHIAL MUCOCELE $=$ BRONCHOCELE\n$=\\mathrm{V}-/ \\mathrm{Y}$-shaped branching tubular opacities of dilated bronchi filled with inspissated mucus surrounded by aerated lung (collateral air drift circumvents obstructed bronchi)\n$\\sqrt{ }$ \"gloved finger / finger-in-glove\" sign\n$\\checkmark$ usually associated with bronchial dilatation\nCT:\n$\\checkmark$ bronchiectasis\n$\\checkmark$ low-attenuation mucus inspissated in bronchi\n$\\checkmark$ clear connection with central airway\nA. BRONCHIAL OBSTRUCTION\n(a) congenital\n\n1. Bronchial atresia\n2. Interlobar sequestration\n3. Intrapulmonary bronchogenic cyst\n(b) endobronchial tumor\n4. Endobronchial hamartoma\n5. Endobronchial lipoma\n6. Bronchogenic carcinoma / adenoma\n7. Carcinoid tumor\n8. Laryngeal papillomatosis\n9. Metastasis: breast, kidney, colon, rectum, uterus, skin\n(c) others\n10. Tuberculous stricture\n11. Broncholithiasis\n12. Foreign body aspiration",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 411,
            "markdown": "# B. WITHOUT BRONCHIAL OBSTRUCTION \n\n(a) congenital\n\n1. Cystic fibrosis\n(b) inflammatory / infectious\n2. Allergic bronchopulmonary aspergillosis: central perihilar + upper lobe bronchiectasis\n3. Asthma (most frequent cause): esp. during acute attack or convalescent phase\n4. Chronic bronchitis\n5. Fluid-filled bronchiectasis: history of childhood pneumonia; peripheral distribution\n\n## Perihilar \"Bat-wing\" Infiltrates\n\nmnemonic: Please, Please, Please, Study Light, Don't Get All Uptight\nPulmonary edema\nProteinosis\nPeriarteritis\nSarcoidosis\nLymphoma\nDrugs\nGoodpasture syndrome\nAlveolar cell carcinoma\nUremia\n\n## Peripheral \"Reverse Bat-wing\" Infiltrates\n\nmnemonic: REDS\nResolving pulmonary edema\nEosinophilic pneumonia\nDesquamative interstitial pneumonia\nSarcoidosis\n\n## LUCENT LUNG LESIONS\n\n## Pulmonary Oligemia\n\n## Generalized Oligemia\n\n$=$ reduction in pulmonary blood volume\n\n1. Aortic valve disease indicative of $\\Downarrow$ stroke volume + cardiac output $\\sqrt{ }$ LV enlargement\n2. Overpenetration of film = artifact\n3. Deep inspiration + Valsalva maneuver\n4. Positive pressure ventilation\n\n## Regional Oligemia\n\nA. DECREASE IN BLOOD VOLUME\n\n1. Pulmonary arterial hypoplasia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 412,
            "markdown": "2. Mitral valve disease\n3. Pulmonary embolism\n4. Flow inversion (= oligemic bases + hyperemic upper lobes in longstanding elevation of left heart pressure)\nB. INCREASE IN AIR SPACES\n5. Swyer-James syndrome\n6. Regional emphysema\n7. Valvular air trapping\n\n# Hyperlucent Lung \n\n## Bilateral Hyperlucent Lung\n\nA. FAULTY RADIOLOGIC TECHNIQUE\n\n1. Overpenetrated film\nB. DECREASED SOFT TISSUES\n2. Thin body habitus\n3. Bilateral mastectomy\nC. CARDIAC CAUSE of $\\downarrow$ pulmonary blood flow\n4. Right-to-left shunt:\n\nTetralogy of Fallot (small proximal pulmonary vessels), pseudotruncus, truncus type IV, Ebstein malformation, tricuspid atresia\n2. Eisenmenger physiology of left-to-right shunt:\n\nASD, VSD, PDA (dilated proximal pulmonary vessels)\nD. PULMONARY CAUSE of $\\downarrow$ pulmonary blood flow\n(a) decrease of vascular bed:\n\n1. Pulmonary embolism:\nbilaterality is rare; localized areas of hyperlucency (Westermark sign)\n(b) increase in air space:\n2. Air trapping (reversible changes):\nacute asthmatic attack, acute bronchiolitis (pediatric patient)\n3. Emphysema\n4. Bulla\n5. Bleb\n6. Interstitial emphysema\n\n## Unilateral Hyperlucent Lung\n\nA. FAULTY RADIOLOGIC TECHNIQUE\n\n1. Rotation of patient\nB. CHEST WALL DEFECT\n2. Mastectomy\n3. Absent pectoralis muscle (Poland syndrome)\nC. INCREASED PULMONARY AIR SPACE\nwith decreased pulmonary blood flow\n(a) large airway obstruction with air trapping\n@ Bronchial compression:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 413,
            "markdown": "1. Hilar mass (rare)\n2. Cardiomegaly compressing LLL bronchus\n@ Endobronchial obstruction with air trapping (collateral air drift):\n3. Foreign body\n4. Broncholith\n5. Bronchogenic carcinoma\n6. Carcinoid\n7. Bronchial mucocele\n(b) small airway obstruction\n8. Bronchiolitis obliterans\n9. Swyer-James / MacLeod syndrome\n10. Emphysema (particularly bullous emphysema)\n11. Emphysema + unilateral lung transplant\n(c) Pneumothorax (in supine patient)\nD. PULMONARY CAUSE of $\\downarrow$ pulmonary blood flow\n12. Pulmonary artery hypoplasia\n13. Pulmonary embolism\n14. Congenital lobar emphysema\n15. Compensatory overaeration\n\nUnilateral Hyperlucent Lung in Child\n(a) hyperattenuating contralateral hemithorax\n(b) pulmonary parenchyma\n\n1. Idiopathic bullous emphysema\n2. Bronchopulmonary dysplasia\n3. Pulmonary interstitial emphysema\n4. Pneumatocele\n(c) airway\n5. Aspiration of foreign body\n6. Swyer-James syndrome\n7. Congenital lobar overinflation\n8. Bronchial atresia\n9. Endobronchial mass (carcinoid)\n10. Extrinsic bronchial compression\n11. Accidental bronchial intubation\n(d) pulmonary vasculature\n12. (Unilateral) pulmonary agenesis\n13. Pulmonary hypoplasia\n14. Interruption of pulmonary artery\n15. Scimitar syndrome\n16. Unilateral pulmonary venous atresia\n17. Unilateral congenital pulmonary lymphangiectasia\n18. Unilateral massive central pulmonary embolism\n(e) pleural space\n19. Anterior pneumothorax",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 414,
            "markdown": "2. Contralateral layering pleural effusion\n3. Diaphragmatic hernia / rupture\n(f) chest wall\n4. Poland syndrome\n5. Scoliosis\n(g) technical\n6. Patient rotation ( $1 \\%$ of CXR)\n$\\sqrt{ }$ hyperlucent lung on side which patient rotates toward tube / away from film $\\leftarrow$ asymmetric absorption of x-ray beam by chest wall\n![img-42.jpeg](img-42.jpeg)\n7. Lateral decentering = positioning of x-ray tube lateral to patient's midline\n\n# Hyperinflation in Newborn \n\n$\\sqrt{ }$ level of inflation beyond $8^{\\text {th }}$ rib posteriorly\n$\\sqrt{ }$ depressed configuration of hemidiaphragms best judged on LAT view\n\n1. Fetal aspiration syndrome\n2. Neonatal pneumonia\n3. Pulmonary hemorrhage\n4. Congenital heart disease\n5. Transient tachypnea (mild)\n\n## Hyperinflation in Child\n\nmnemonic: BUMP FAD\nBronchiectasis / Bronchiolitis (viral) / Bronchopulmonary dysplasia\nUpper airway obstruction (vascular ring, laryngitis)\nMucoviscidosis (cystic fibrosis)\nPneumonia (esp. staph)\nForeign body inhalation / ingestion\nAsthma (reactive airway disease)\nDehydration (diarrhea, acidosis)\n\n## Localized Lucent Lung Defect\n\n## Lung Cavity\n\n= tissue necrosis with bronchial drainage",
            "images": [
                {
                    "id": "img-42.jpeg",
                    "top_left_x": 676,
                    "top_left_y": 583,
                    "bottom_right_x": 1023,
                    "bottom_right_y": 994,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 415,
            "markdown": "# A. INFECTION \n\n(a) bacterial pneumonia\n\n1. Pyogenic infection $=$ necrotizing pneumonia $=$ abscess: Staphylococcus, Klebsiella, E. coli, Pseudomonas, anaerobes, $\\beta$-hemolytic streptococcus, mixed gram-negative organisms\n2. Aspiration pneumonia $=$ gravitational pneumonia: mixed gram-negative organisms, anaerobes\n(b) granulomatous infection\n3. TB: cavitation indicates active infectious disease with risk for hematogenous / bronchogenic dissemination\n4. Fungus: coccidioidomycosis, nocardiosis (in immunocompromised), histoplasmosis, blastomycosis, mucormycosis, sporotrichosis, aspergillosis, cryptococcosis\n$\\sqrt{ }$ very thin-walled cavities less likely to follow the apical distribution of TB / histoplasmosis\n5. Sarcoidosis (stage IV, upper lobe predominance)\n6. Angioinvasion $\\rightarrow$ septic lung infarction followed by cavity formation: Aspergillus, Mucorales, Candida, torulosis, P. aeruginosa\n(c) parasitic infestation: hydatid disease\nB. NEOPLASM\n(a) primary lung tumor: $16 \\%$ of peripheral lung cancers (in particular squamous cell carcinoma ( $30 \\%$ ); also in bronchioloalveolar cell carcinoma\n(b) metastasis (usually multiple)\n7. Squamous cell carcinoma (in $2 / 3$ ): nasopharynx, esophagus, cervix\n8. Adenocarcinoma: lung, breast, GI\n9. Osteosarcoma (rare)\n10. Melanoma\n11. Lymphoma (rare): with adenopathy; cavities often $\\leftarrow$ opportunistic infection with nocardiosis + cryptococcosis\nC. VASCULAR OCCLUSION\n12. Infarct (thromboembolic, septic)\n13. Wegener granulomatosis\n14. Rheumatoid arthritis\nD. INHALATION\n15. Silicosis with coal worker's pneumoconiosis\n> complicating tuberculosis\n> ischemic necrosis of center of conglomerate mass (rare)\n\n## Mass within Cavity\n\n1. Mycetoma $=$ aspergilloma\n2. Tissue fragment within carcinoma\n3. Necrotic lung within abscess\n4. Disintegrating hydatid cyst\n5. Intracavitary blood clot",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 416,
            "markdown": "# Lung Cyst \n\n$=$ round circumscribed space surrounded by an epithelial / fibrous wall of uniform / varied thickness containing air / liquid / semisolid / solid material\nA. CONGENITAL CYST (rare)\n\n1. Bronchogenic cyst\n2. Intralobar sequestration: multicystic structure in lower lobes\n3. Congenital cystic adenomatoid malformation (CCAM) type I\n4. Congenital lobar emphysema\n5. Diaphragmatic hernia (congenital / traumatic)\n6. Bronchial atresia\nB. ACQUIRED CYST\n(a) centrilobular / bullous emphysema\n7. Bleb = cystic air collection within visceral pleura; mostly apical with narrow neck\n8. Bulla $=$ sharply demarcated dilated air space within lung parenchyma $>1 \\mathrm{~cm}$ in diameter with epithelialized wall $<1 \\mathrm{~mm}$ thick due to destruction of alveoli (= air cyst in localized / centrilobular / panlobular emphysema)\n\n- usually asymptomatic\n$\\sqrt{ }$ typically at lung apex\n$\\sqrt{ }$ slow progressive enlargement\n$C x$ :\n(1) Spontaneous pneumothorax\n(2) \"Vanishing lung\" = large area of localized emphysema causing atelectasis + dyspnea\n$R x:$ surgical resection if bulla $>1 / 3$ of hemithorax\n(b) pneumatocele\n\n1. Postinfectious pneumatocele\n2. Traumatic pneumatocele: lung hematoma / hydrocarbon inhalation\n(c) cystic bronchiectasis\n3. Cystic fibrosis (more obvious in upper lobes)\n4. Agammaglobulinemia (predisposed to recurrent bacterial infections)\n5. Recurrent bacterial pneumonias\n$\\sqrt{ }$ multiple thin-walled lucencies with air-fluid levels in lower lobes\n6. Childhood infection: tuberculosis, pertussis\n7. Allergic bronchopulmonary aspergillosis (in asthmatic patients)\n$\\sqrt{ }$ involvement of proximal perihilar bronchi\n8. Kartagener syndrome (ciliary dysmotility)\n(d) infection\n9. Hydatid disease\n(e) interstitial emphysema\n10. Pseudocyst\n\n## Large Cystic Neonatal Lung Lesion\n\n1. Type 1 / type 4 cystic adenomatoid malformation\n2. Bronchogenic cysts",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 417,
            "markdown": "3. Low-grade cystic pleuropulmonary blastoma\n4. Congenital diaphragmatic hernia\n5. Cavitary necrosis complicating pneumonia\n6. Congenital lobar overinflation\n7. Cystic lymphangioma\n\nSmall Cystic Neonatal Lung Lesion\n\n1. Type 2 cystic adenomatoid malformation\n2. Pneumonia\n3. Pulmonary sequestration\n4. Bronchial atresia\n\n# Multiple Lucent Lung Lesions \n\n## Multiple Lung Cavities\n\nA. INFECTION\n\n1. Bacteria: cavitating pneumonia, lung abscess\n2. Granulomatous infection: TB, sarcoidosis\n3. Fungal infection: coccidioidomycosis\n4. Parasitic infection: echinococcosis\n5. Protozoan infection: pneumocystosis\nB. NEOPLASM\nC. VASCULAR\n6. Thromboembolic + septic infarcts\n7. Wegener granulomatosis\n8. Rheumatoid arthritis\n9. Angioinvasive organism ( $\\rightarrow$ septic lung infarction followed by $\\rightarrow$ cavity formation): Aspergillus, Mucorales, Candida, torulosis, P. aeruginosa\n\n## Multiple Thin-walled Cavities\n\nmnemonic: BITCH\nBullae + pneumatoceles\nInfection (TB, cocci, staph)\nTumor (squamous cell carcinoma)\nCysts (traumatic, bronchogenic)\nHydrocarbon ingestion\n\n## Multiple Lung Cysts\n\nA. CONGENITAL\n\n1. Multiple bronchogenic cysts\n2. Intralobar sequestration:\nmulticystic structure in lower lobes\n3. Congenital cystic adenomatoid malformation (CCAM) type I\n4. Diaphragmatic hernia (congenital / traumatic)\nB. INFECTION\n5. Tuberculosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 418,
            "markdown": "2. Pneumocystis carinii pneumonia in AIDS\nC. VASCULAR-EMBOLIC\n3. Cavitating septic emboli\n$\\sqrt{ }$ often seen at end of feeding vessel\n4. Angioinvasive infection: invasive pulmonary aspergillosis, candida, P. aeruginosa\n5. Pulmonary vasculitis: Wegener granulomatosis\nD. DILATATION OF BRONCHI = cystic bronchiectasis\n$\\sqrt{ }$ bronchial wall thickening\n6. Cystic fibrosis (more obvious in upper lobes)\n7. Agammaglobulinemia (predisposed to recurrent bacterial infections)\n8. Recurrent bacterial pneumonias\n9. Tuberculosis\n10. Allergic bronchopulmonary aspergillosis (in asthmatic patients)\nE. DISRUPTION OF ELASTIC FIBER NETWORK\n11. Centrilobular emphysema\n$\\sqrt{ }$ imperceptible walls\n$\\checkmark$ chiefly in upper lung zones\n12. Panlobular emphysema\n$\\checkmark$ lobular architecture preserved with bronchovascular bundle in central position, areas of lung destruction without arcuate contour\n13. Paraseptal emphysema\n$\\checkmark$ cysts with walls arrayed in a single subpleural tier\n14. Lymphangioleiomyomatosis\n$\\checkmark$ randomly scattered cysts surrounded by normal lung\n$\\checkmark$ normal / increased lung volumes\n15. Tuberous sclerosis\n\n- skin abnormalities, mental retardation, epilepsy\n\n6. Air-block disease: adult respiratory distress syndrome, asthma, bronchiolitis, viral / bacterial pneumonia\nF. REMODELING OF LUNG ARCHITECTURE\n$=$ honeycombing of idiopathic pulmonary fibrosis (= fibrosing alveolitis)\n$\\sqrt{ } 3-10-\\mathrm{mm}$ small irregular thick-walled cystic air spaces usually of comparable diameter surrounded by abnormal + distorted lung parenchyma\n$\\checkmark$ predominantly peripheral + basilar distribution\n$\\checkmark$ bibasilar reticular opacities\n$\\checkmark$ progressive reduction in lung volumes\nG. MULTIFACTORIAL / UNKNOWN\n7. Langerhans cell histiocytosis\n$\\checkmark$ cysts with walls of variable thickness + irregular shape\n$\\checkmark$ in combination with nodules $\\pm$ cavitation\n$\\checkmark$ septal thickening\n$\\checkmark$ predilection for upper lung zones with relative sparing of lung bases\n8. Lymphocytic interstitial pneumonia\n$\\checkmark$ thickening of interlobular septa + bronchovascular bundles\n$\\checkmark$ enlarged mediastinal nodes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 419,
            "markdown": "3. Klippel-Trénaunay syndrome\n4. Juvenile tracheolaryngeal papillomatosis\n5. Neurofibromatosis\n$\\checkmark$ cystic air spaces predominantly apical\n6. Pneumatoceles\n\n# Cystlike Pulmonary Lesions \n\nmnemonic: C.C., I BAN WHIPS\nCoccidioidomycosis\nCystic adenomatoid malformation\nInfection\nBronchogenic cyst, Bronchiectasis\nAbscess\nNeoplasm\nWegener granulomatosis\nHydatid cyst, Histiocytosis X\nInfarction\nPneumatocele\nSequestration\n\n## PLEURA\n\n## Pneumothorax\n\n$=$ accumulation of air within pleural space\nPathophysiology: disruption of visceral pleura / trauma to parietal pleura\n\n- pleuritic back / shoulder pain, dyspnea (in $80-90 \\%$ )\n\nCause:\nmnemonic: THE CHEST SET\nTrauma\nHoneycomb lung, Hamman-Rich syndrome\nEmphysema, Esophageal rupture\nChronic obstructive pulmonary disease\nHyaline membrane disease\nEndometriosis\nSpontaneous, Scleroderma\nTuberous sclerosis\nSarcoma (osteo-), Sarcoidosis\nEosinophilic granuloma\nTuberculosis + fungus\nTypes:\n\n1. Closed pneumothorax $=$ intact thoracic cage\n2. Open pneumothorax = \"sucking\" chest wound\n3. Tension pneumothorax (clinical diagnosis)\n$=$ accumulation of air within pleural space $\\leftarrow$ free ingress + limited egress of air Pathophysiology:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 420,
            "markdown": "intrapleural pressure exceeds atmospheric pressure in lung during expiration (check-valve mechanism)\nFrequency: in 3-5\\% of patients with spontaneous pneumothorax, higher in barotrauma\n\n- compromised venous return\n$\\sqrt{ }$ hyperexpanded ipsilateral chest\n$\\sqrt{ }$ mediastinal shift to contralateral side\n$\\sqrt{ }$ contralateral displacement of anterior junction line\n$\\sqrt{ }$ \"deep sulcus\" sign = on frontal view larger lateral costodiaphragmatic recess than on opposite side\n$\\sqrt{ }$ flattening / inversion of ipsilateral hemidiaphragm\n$\\sqrt{ }$ total / subtotal collapse of ipsilateral lung\n$\\sqrt{ }$ collapse of SVC / IVC / right heart border $\\leftarrow$ decreased systemic venous return + decreased cardiac output\n$\\sqrt{ }$ sharp delineation of visceral pleural by dense pleural space\nN.B.: Medical emergency!\n\n4. Tension hydropneumothorax\n$\\sqrt{ }$ air-fluid level in pleural space on erect CXR\nPneumothorax size:\nAverage Interpleural Distance (AID) $=(\\mathrm{A}+\\mathrm{B}+\\mathrm{C}) \\div 3$ [in cm] converts to percentage of pneumothorax\n(see nomogram in drawing)\nCXR signs in upright position:\n$\\sqrt{ }$ white margin of visceral pleura separated from parietal pleura\n$D D x$ : skin fold, air trapped between soft tissues of chest wall, hair braid, overlying tubing / dressing / line, prior chest tube track\n$\\sqrt{ }$ absence of vascular markings beyond visceral pleural margin\nCXR signs in supine position:\n$\\diamond$ \"occult pneumothorax\" $=10-30-50 \\%$ of pneumothoraces go undetected on supine radiographs!\n5. Anteromedial pneumothorax (earliest location)\n$\\sqrt{ }$ outline of medial diaphragm under cardiac silhouette\n$\\sqrt{ }$ improved definition of mediastinal contours (SVC, azygos vein, left subclavian artery, anterior junction line, superior pulmonary vein, heart border, IVC, pericardial fat-pad)\n$\\sqrt{ }$ relative lucency of entire lung:\n$\\sqrt{ }$ \"large hyperlucent hemithorax\" sign (most common in neonates)\n$\\sqrt{ }$ depression of ipsilateral diaphragm\n$\\sqrt{ }$ band of air in minor fissure bounded by two visceral pleural lines",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 421,
            "markdown": "![img-43.jpeg](img-43.jpeg)\n$\\checkmark$ outline of anterior junction line (in bilateral pneumothoraces)\n$\\sqrt{ }$ \"figure 8\" / \"pseudomass\" = compression of malleable lobes of thymus (in bilateral pneumothoraces)\n2. Subpulmonic / anterolateral pneumothorax ( $2^{\\text {nd }}$ most common location)\n$\\sqrt{ }$ \"deep sulcus\" sign = lucency of abnormally deep lateral costophrenic angle extending toward hypochondrium (DDx: COPD)\n$\\checkmark$ hyperlucent upper abdominal quadrant / hypochondrial region\n$\\checkmark$ increased lucency of lung base = sharply outlined diaphragm / inferior surface of lung in spite of parenchymal disease / collapsed lower lobe\n$\\checkmark$ \"double-diaphragm\" sign = air outlining anterior costophrenic sulcus + aerated lung outlining diaphragmatic dome\n$\\checkmark$ visible lateral edge of right middle lobe $\\leftarrow$ medial retraction\n3. Apicolateral pneumothorax (least common location)\n$\\checkmark$ visualization of visceral pleural line\n$\\checkmark$ displacement of minor fissure from chest wall\n4. Posteromedial pneumothorax (in presence of lower lobe collapse)",
            "images": [
                {
                    "id": "img-43.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1339,
                    "bottom_right_y": 1331,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 422,
            "markdown": "$\\sqrt{ }$ lucent triangle with vertex at hilum\n$\\sqrt{ }$ V-shaped base delineating costovertebral sulcus\n5. Pneumothorax $\\rightarrow$ outlines pulmonary ligament\n\nPrognosis: resorption of pneumothorax occurs at a rate of $1.25 \\%$ per day (accelerated by increasing inspired oxygen concentrations)\n$R x: \\quad$ A pneumothorax $>35 \\%$ usually requires management with a chest tube!\n\n# Traumatic Pneumothorax \n\nA. PENETRATING TRAUMA\nB. BLUNT TRAUMA\n\nFrequency: $15-40 \\%$ of blunt chest trauma\nPathophysiology: ruptured alveoli (sudden increase in intrathoracic pressure), blunt crushing force, deceleration force\n\n1. Rib fracture\n2. Increased intrathoracic pressure against closed glottis: lung contusion / laceration\n3. Bronchial fracture\n$\\sqrt{ }$ \"fallen lung\" sign = hilum of lung below expected level within chest cavity\n$\\sqrt{ }$ persistent pneumothorax with functioning chest tube\n$\\sqrt{ }$ mediastinal pneumothorax\nC. IATROGENIC\ntracheostomy, central venous catheter, PEEP ventilator (3-16\\%), thoracic irradiation\n$R x$ : indication for chest tube placement dependent on symptoms + physiologic response\n\n## Spontaneous Pneumothorax\n\n1. Primary / idiopathic spontaneous pneumothorax ( $80 \\%$ )\n\nCause: rupture of subpleural blebs in lung apices\nAge: $20-40$ years; $\\mathrm{M}+\\mathrm{F}=8 \\div 1$; esp. in patients with tall asthenic stature; mostly in smokers\n\n- chest pain ( $69 \\%$ ), dyspnea\n\nPrognosis: recurrence in $30 \\%$ on same side, in $10 \\%$ on contralateral side\n$R x$ : simple aspiration (in $>50 \\%$ success) / tube thoracostomy (in $90 \\%$ effective)\n2. Secondary spontaneous pneumothorax ( $20 \\%$ ):\n(a) Air-trapping disease: spasmodic asthma, diffuse emphysema, Langerhans cell histiocytosis, lymph-angiomyomatosis, tuberous sclerosis, cystic fibrosis\n$\\diamond$ Chronic obstructive pulmonary disease is the most common predisposing disorder of secondary spontaneous pneumothorax.\n(b) Pulmonary infection: lung abscess, necrotizing pneumonia, hydatid disease, pertussis, acute bacterial pneumonia, Staphylococcus aureus, Pneumocystis carinii pneumonia\n(c) Granulomatous disease: tuberculosis, coccidioidomycosis, sarcoidosis, berylliosis\n(d) Malignancy: primary lung cancer, lung metastases (esp. osteosarcoma, pancreas, adrenal, Wilms tumor)\n(e) Connective tissue disorder: scleroderma, rheumatoid disease, Marfan syndrome, Ehlers-Danlos syndrome\n(f) Pneumoconiosis: silicosis, berylliosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 423,
            "markdown": "(g) Vascular disease: pulmonary infarction\n(h) Catamenial pneumothorax\n(i) Neonatal disease: meconium aspiration, respirator therapy for hyaline membrane disease\n(j) Cx of honeycomb lung: pulmonary fibrosis, cystic fibrosis, sarcoidosis, scleroderma, eosinophilic granuloma, interstitial pneumonitis, Langerhans cell histiocytosis, rheumatoid lung, idiopathic pulmonary hemosiderosis, pulmonary alveolar proteinosis, biliary cirrhosis\n\n# Pleural Effusion \n\nA. TRANSUDATE (protein level $=1.5-2.5 \\mathrm{~g} / \\mathrm{dL}$ )\n\nPathophysiology: systemic abnormality $\\rightarrow$ outpouring of low-protein fluid\n(a) $\\uparrow$ hydrostatic pressure\n\n1. Congestive heart failure (in $65 \\%$ ): bilateral ( $88 \\%$ ); right-sided ( $8 \\%$ ); left-sided ( $4 \\%$ ); least amount on left side $\\leftarrow$ stimulated lymphatic resorption $\\leftarrow$ cardiac movement\n2. Constrictive pericarditis (in $60 \\%$ )\n(b) $\\Downarrow$ colloid-oncotic pressure\n> decreased protein production\n3. Cirrhosis with ascites (in $6 \\%$ ): on right side (in $67 \\%$ )\n> protein loss / hypervolemia\n4. Nephrotic syndrome ( $21 \\%$ ), overhydration, glomerulonephritis ( $55 \\%$ ), peritoneal dialysis\n5. Hypothyroidism\n(c) Chylous effusion\n$\\diamond$ Most frequent cause of isolated pleural effusion in newborn $\\rightarrow 15-25 \\%$ mortality rate!\n\n- chylomicrons + lymphocytes in fluid\nB. EXUDATE\n\nPathophysiology: increased permeability of abnormal pleural capillaries with release of high-protein fluid into pleural space\nCriteria:\n\n- pleural fluid total protein $\\div$ serum total protein ratio of $>0.5$\n- pleural fluid $\\mathrm{LDH} \\div$ serum LDH ratio of $>0.6$\n$\\diamond$ Most frequent cause of isolated pleural effusion in newborn with $15-25 \\%$ mortality!\n- pleural fluid $\\mathrm{LDH}>\\frac{2}{3}$ of upper limit of normal for serum LDH (upper limit for LDH $\\sim 200 \\mathrm{IU})$\n- pleural fluid specific gravity $>1.016$\n- protein level $>3 \\mathrm{~g} / \\mathrm{dL}$\n$\\sqrt{ }$ effusion with septation / low-level echoes\n$\\sqrt{ }$ \"split pleura\" sign on CECT = thickened enhancing visceral + parietal pleura separated by fluid\n$\\sqrt{ }$ extrapleural fat thickening of $>2 \\mathrm{~mm}+$ increased attenuation (edema / inflammation)\nCause:\n(A) INFECTION",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 424,
            "markdown": "1. Empyema necessitatis = chronic empyema attempting to decompress through chest wall (in TB, nocardiosis, actinomycosis, aspergillosis, blastomycosis)\n2. Parapneumonic effusion (in $40 \\%$ )\n$=$ any effusion associated with pneumonia / lung abscess / bronchiectasis WITHOUT criteria for an empyema\n3. Tuberculosis (in $1 \\%$ ): high protein content ( $75 \\mathrm{~g} / \\mathrm{dL}$ ), lymphocytes $>70 \\%$, positive culture (only in $20-25 \\%$ )\n4. Fungi: Actinomyces, Nocardia\n5. Parasites: amebiasis ( $\\rightarrow$ liver abscess in $15-20 \\%$ ), Echinococcus\n6. Mycoplasma, rickettsia (in 20\\%)\n(B) MALIGNANT DISEASE (in 60\\%)\n\n- positive cytologic results\n\nPathogenesis:\n> pleural metastases $\\rightarrow \\uparrow$ pleural permeability\n> lymphatic obstruction $\\leftarrow$ pleural vessels, mediastinal nodes, thoracic duct disruption\n> bronchial obstruction $\\rightarrow$ loss of volume + resorptive surface\n> hypoproteinemia $\\leftarrow$ tumor cachexia\nCause: lung cancer (26-49\\%), breast cancer (8-24\\%), lymphoma (10-28\\% with chylothorax in $\\%$ ), ovarian cancer ( $10 \\%$ ), malignant mesothelioma containing hyaluronic acid $(5 \\%)$\nRx: sclerosing agents: doxycycline, bleomycin, talc\n(C) VASCULAR\n\nPulmonary emboli (in 15-30\\% of all embolic events):\n\n- often serosanguinous\n(D) ABDOMINAL DISEASE\n\n1. Pancreatitis / pancreatic pseudocyst / pancreaticopleural fistula (in $\\%$ ):\n$\\sqrt{ }$ usually left-sided pleural effusion\n\n- high amylase levels\n\n2. Boerhaave syndrome:\nleft-sided esophageal perforation\n3. Subphrenic abscess\n$\\checkmark$ pleural effusion ( $79 \\%$ )\n$\\checkmark$ elevation + restriction of diaphragmatic motion ( $95 \\%$ )\n$\\checkmark$ basilar platelike atelectasis / pneumonitis ( $79 \\%$ )\n4. Abdominal tumor with ascites\n5. Meigs-Salmon syndrome\n$=$ primary pelvic neoplasms (ovarian fibroma, thecoma, granulosa cell tumor, Brenner tumor, cystadenoma, adenocarcinoma, fibromyoma of uterus) cause pleural effusion in $2-3 \\%$; ascites + hydrothorax resolve with tumor removal\n6. Endometriosis\n7. Bile fistula\n(E) COLLAGEN-VASCULAR DISEASE\n8. Rheumatoid arthritis (in 3\\%):\nunilateral; $\\mathrm{R}>\\mathrm{L}$ (in $75 \\%$ ), recurrent alternating sides; pleural effusion relatively",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 425,
            "markdown": "unchanged in size for months; predominantly in men; LOW GLUCOSE content of $20-50 \\mathrm{mg} / \\mathrm{dL}$ (in $70-80 \\%$ ) without increase following IV infusion of glucose (DDx: TB, metastatic disease, parapneumonic effusion)\n2. SLE (in $15-74 \\%$ )\nmost common collagenosis to give pleural effusion, bilateral in $50 \\% ; \\mathrm{L}>\\mathrm{R}$\n$\\sqrt{ }$ ft size of cardiovascular silhouette (in $35-50 \\%$ )\n3. Wegener granulomatosis (in 50\\%)\n4. Sjögren syndrome\n5. Mixed connective tissue disease\n6. Periarteritis nodosa\n7. Postmyocardial infarct syndrome\n(F) TRAUMATIC\n\n- hemorrhagic, chylous\n\nCause: esophageal rupture, thoracic / abdominal surgery, intrapleural infusion $=$ \"infusothorax\" $(0.5 \\%)$, radiation pneumonitis\n(G) MISCELLANEOUS\n\n1. Sarcoidosis\n2. Uremic pleuritis (in $20 \\%$ of uremic patients)\n3. Drug-induced effusion\n\nCXR:\n$\\sqrt{ }$ first 300 mL not visualized on PA view (collect in subpulmonic region first, then spill into posterior costophrenic sinus)\n$\\sqrt{ }$ lateral decubitus views may detect as little as 25 mL\n$\\sqrt{ }$ hemidiaphragm + costophrenic sinuses obscured\n$\\sqrt{ }$ extension upward around posterior $>$ lateral $>$ anterior thoracic wall (mediastinal portion fixed by pulmonary ligament + hilum)\n$\\sqrt{ }$ meniscus-shaped semicircular upper surface with lowest point in midaxillary line\n$\\sqrt{ }$ associated collapse of ipsilateral lung\nMassive pleural effusion:\n$\\sqrt{ }$ enlargement of ipsilateral hemithorax\n$\\sqrt{ }$ displacement of mediastinum to contralateral side\n$\\sqrt{ }$ severe depression / flattening / inversion of ipsilateral hemidiaphragm\n$\\sqrt{ }$ visible air bronchogram\nSubpulmonic / subdiaphragmatic / infrapulmonary pleural effusion:\n$\\sqrt{ }$ peak of dome of pseudodiaphragm laterally positioned\n$\\sqrt{ }$ acutely angulated costophrenic angle\n$\\sqrt{ }$ increased distance between stomach bubble and lung\n$\\sqrt{ }$ blunted posterior costophrenic sulcus\n$\\sqrt{ }$ thin triangular paramediastinal opacity (mediastinal extension of pleural effusion)\n$\\sqrt{ }$ flattened pseudodiaphragmatic contour anterior to major fissure (on lateral CXR)\nCT:\n$\\sqrt{ }$ fluid outside diaphragm\n$\\sqrt{ }$ fluid elevating crus of diaphragm\n$\\sqrt{ }$ indistinct fluid-liver interface\n$\\sqrt{ }$ fluid posteromedial to liver (= bare area of liver)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 426,
            "markdown": "CAVE: \"central oval\" sign of ascites may be seen in subpulmonic effusion with inverted diaphragm\n\n# Unilateral Pleural Effusion \n\n$\\diamond$ The majority of massive unilateral pleural effusions are malignant (lymphoma, metastatic, primary lung cancer)!\n\n1. Neoplasm\n2. Infection: TB\n3. Collagen vascular disease\n4. Subdiaphragmatic disease\n5. Pulmonary emboli\n6. Trauma: fractured rib\n7. Chylothorax\n\n## Left-Sided Pleural Effusion\n\n1. Spontaneous rupture of esophagus\n2. Dissecting aneurysm of aorta\n3. Traumatic rupture of aorta distal to left subclavian a.\n4. Transection of distal thoracic duct\n5. Pancreatitis: left-sided (68\\%), right-sided (10\\%), bilateral (22\\%)\n6. Pancreatic + gastric neoplasm\n\n## Right-Sided Pleural Effusion\n\n1. Congestive heart failure\n2. Transection of proximal thoracic duct\n3. Pancreatitis\n\n## Pleural Effusion \\& Large Cardiac Silhouette\n\n1. Congestive heart failure (most common)\n$\\sqrt{ }$ cardiomegaly\n$\\sqrt{ }$ prominence of upper lobe vessels + constriction of lower lobe vessels\n$\\sqrt{ }$ prominent hilar vessels\n$\\sqrt{ }$ interstitial edema (fine reticular pattern, Kerley lines, perihilar haze, peribronchial thickening)\n$\\sqrt{ }$ alveolar edema (perihilar confluent ill-defined densities, air bronchogram)\n$\\sqrt{ }$ \"phantom tumor\" = fluid localized to interlobar pleural fissure (in $78 \\%$ in right horizontal fissure)\n2. Pulmonary embolus + right heart enlargement\n3. Myocarditis / pericarditis with pleuritis\n(a) viral infection\n(b) tuberculosis\n(c) rheumatic fever (poststreptococcal infection)\n4. Tumor: metastatic, mesothelioma\n5. Collagen-vascular disease\n(a) SLE (pleural + pericardial effusion)\n(b) rheumatoid arthritis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 427,
            "markdown": "# Pleural Effusion \\& Hilar Enlargement \n\n1. Pulmonary embolus\n2. Tumor: bronchogenic carcinoma, lymphoma, metastasis\n3. Tuberculosis\n4. Fungal infection (rare)\n5. Sarcoidosis (very rare)\n\n## Pleural Effusion \\& Subsegmental Atelectasis\n\n1. Postoperative (thoracotomy, splenectomy, renal surgery) $\\leftarrow$ thoracic splinting + mucous plugging of small airway\n2. Pulmonary embolus\n3. Abdominal mass\n4. Ascites\n5. Rib fractures\n\n## Pleural Effusion \\& Lobar Densities\n\n1. Pneumonia with empyema\n2. Pulmonary embolism\n3. Neoplasm: bronchogenic carcinoma $>$ lymphoma\n4. Tuberculosis\n\n## Hemothorax\n\n$=$ blood in pleural space\n\n- massive hemothorax $=$ blood exceeding $1 \\mathrm{~L}+$ clinical signs of shock and hypoperfusion\n$\\sqrt{ }$ rapidly enlarging pleural effusion of $35-70 \\mathrm{HU}$ attenuation\n$\\checkmark$ heterogeneous attenuation\n$\\checkmark$ hyperattenuating areas of debris\n$\\checkmark$ fluid-hematocrit level\nA. TRAUMA\n(a) thoracic injury\n\n1. Closed / penetrating injury to lung, chest wall, heart, great vessels\n2. Surgery\n3. Interventional procedures: thoracentesis, pleural biopsy, catheter placement\n(b) abdominal injury with diaphragmatic rupture: trauma to liver / spleen\nB. BLEEDING DIATHESIS\n4. Anticoagulant therapy\n5. Thrombocytopenia\n6. Factor deficiency\nC. VASCULAR\n7. Pulmonary infarct\n8. Arteriovenous malformation\n9. Aortic dissection\n10. Leaking atherosclerotic aneurysm\nD. MALIGNANCY\n11. Mesothelioma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 428,
            "markdown": "2. Lung cancer\n3. Metastasis\n4. Leukemia\nE. OTHER\n5. Catamenial hemorrhage\n6. Extramedullary hematopoiesis\n\n# Solitary Pleural Mass \n\nCXR:\n$\\sqrt{ }$ \"incomplete border\" sign (= mass density with partly invisible border)\n$\\sqrt{ }$ obtuse angle with chest wall\nCT:\n$\\sqrt{ }$ displacement of pulmonary vessels\n$\\sqrt{ }$ centered in pleural space\n$\\sqrt{ }$ NO involvement of chest wall\n$\\sqrt{ } \\pm$ outward displacement of extrapleural fat\n$D D x$ : (1) Chest wall mass (rib destruction reliable sign of chest wall mass)\n(2) Peripheral lung mass (centered within lung tissue, acute angle with chest wall, engulfs pulmonary vessels)\n\n## Malignant Pleural Tumor\n\n1. Metastasis (most common)\n\nOrigin: lung, breast, GI tract\n$\\sqrt{ }$ tumor nodule + pleural effusion\n2. Drop metastasis from thymoma / thymic carcinoma\n$\\sqrt{ }$ anterior mediastinal mass\n3. Mesothelioma\n\n## Benign Pleural Tumor\n\n1. Loculated pleural effusion (\"vanishing tumor\")\n2. Organized empyema\n3. Local benign mesothelioma\n4. Subpleural lipoma: may erode adjacent rib\n5. Mesothelial cyst\n6. Neural tumor: schwannoma, neurofibroma\n7. Solitary fibrous tumor of pleura (rare)\n8. Fibrin bodies\n$=3-4 \\mathrm{~cm}$ large tumorlike concentrations of fibrin forming in serofibrinous pleural effusions; usually near lung base\n9. Hematoma\n\n## Focal Tumorlike Condition of Pleura\n\n1. Pleural plaque\n2. Thoracic splenosis\n3. Catamenial pneumothorax\n4. Pleural pseudotumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 429,
            "markdown": "$=$ pleural fluid (frequently transudate) collected within lung fissure (most frequently minor fissure)\n5. Extrapleural hematoma\n$=$ injury to internal mammary / intercostal vessels without disruption of parietal pleura\n$\\diamond$ May expand rapidly causing respiratory / circulatory collapse\n$\\sqrt{ }$ \"extrapleural fat\" sign = inward displacement of extrapleural fat\n\n# Diffuse Tumorlike Condition of Pleura \n\n1. Diffuse pleural thickening\n$=$ inflammatory pleuritis fusing leaves of pleura\nCause: empyema, hemothorax, connective tissue disorder, asbestos exposure\n\n- $\\pm$ restrictive lung physiology\n$\\sqrt{ }$ ill-defined irregular thickening spanning multiple ribs\n$\\sqrt{ }$ costophrenic angle blunting\n$\\sqrt{ }$ often undergoing calcification\n\n2. Erdheim-Chester disease\n3. Diffuse pulmonary lymphangiomatosis\n\n## Multiple Pleural Densities\n\n$\\sqrt{ }$ diffuse pleural thickening with lobulated borders\n\n1. Loculated pleural effusion: infectious, hemorrhagic, neoplastic\n2. Pleural plaques\n3. Metastasis (most common cause)\n\nOrigin: lung ( $40 \\%$ ), breast ( $20 \\%$ ), lymphoma ( $10 \\%$ ), ovary, melanoma, uterus, GI tract, pancreas, sarcoma\n$\\diamond$ Metastatic adenocarcinoma histologically similar to malignant mesothelioma!\n4. Diffuse malignant mesothelioma:\nalmost always unilateral, associated with asbestos exposure\n5. Invasive thymoma (rare)\n$\\sqrt{ }$ contiguous spread, invasion of pleura, spreads around lung\n$\\sqrt{ }$ NO pleural effusion\n6. Thoracic splenosis\nmnemonic: Mary Tyler Moore Likes Lemon\nMetastases (especially adenocarcinoma)\nThymoma (malignant)\nMalignant mesothelioma\nLoculated pleural effusion\nLymphoma\n\n## Pleural Thickening\n\nA. TRAUMA\n\n1. Fibrothorax (most common cause)\n$=$ organizing effusion / hemothorax / pyothorax\n$\\sqrt{ }$ dense fibrous layer of $\\sim 2 \\mathrm{~cm}$ thickness; almost always on visceral pleura\n$\\sqrt{ }$ frequent calcifications on inner aspect of pleural peel",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 430,
            "markdown": "# B. INFECTION \n\n1. Chronic empyema: at bases; history of pneumonia; parenchymal scars\n2. Tuberculosis / histoplasmosis: lung apex; associated with apical cavity\n3. Aspergilloma: in preexisting cavity concomitant with pleural thickening\nC. COLLAGEN-VASCULAR DISEASE\n4. Rheumatoid arthritis: pleural effusion fails to resolve\nD. INHALATIONAL DISORDER\n5. Asbestos exposure: lower lateral chest wall; basilar interstitial disease ( $<25 \\%$ ); thickening of parietal pleura + typically sparing of visceral pleura\n6. Silicosis (advanced disease)\n7. Talcosis\nE. NEOPLASM\n8. Metastases: often nodular appearance; may be obscured by effusion\n9. Diffuse malignant mesothelioma\n10. Pancoast tumor\nF. OTHER\n11. Pleural hyaloserositis\n\nPath: hyaline sclerotic tissue = cartilagelike whitish sugar icing appearance (Zuckerguss) with occasional calcification\n2. Mimicked by extrathoracic musculature, $1^{\\text {st }}+2^{\\text {nd }}$ rib companion shadow, subpleural fat, focal scarring around old rib fractures\nmnemonic: TRINI\nTrauma (healed hemothorax)\nRheumatoid arthritis (collagen vascular disease)\nInhalation disease (asbestosis, talcosis)\nNeoplasm\nInfection\n\n## Circumferential Pleural Thickening\n\n1. Mesothelioma\n2. Adenocarcinoma\n3. Lymphoma\n4. Thymoma\n5. Asbestos-related benign pleural disease\n6. Infection\n\n## Apical Cap\n\n1. Inflammatory process: TB, healed empyema\n2. Postradiation fibrosis\n3. Neoplasm\n4. Vascular abnormality\n5. Mediastinal hemorrhage\n6. Mediastinal lipomatosis\n7. Peripheral upper lobe collapse",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 431,
            "markdown": "# Pleural Calcification \n\nA. INFECTION\n\n1. Healed empyema\n2. Tuberculosis (and therapy for TB: pneumothorax / oleothorax), histoplasmosis\nB. TRAUMA\n3. Healed hemothorax $=$ fibrothorax:\n\n- history of significant chest trauma\n$\\sqrt{ }$ irregular plaques of calcium usually in visceral pleura\n$\\sqrt{ }$ healed rib fracture\n\n2. Radiation therapy\nC. PNEUMOCONIOSIS\n3. Asbestos-related pleural disease (most common):\n$\\checkmark$ combination of basilar reticular interstitial disease $(<1 / 8)+$ pleural thickening\n$\\checkmark$ calcifications of parietal pleura frequently diagnostic (diaphragmatic surface of pleura, bilateral but asymmetric), visceral pleura typically spared\n4. Talcosis: similar to asbestos-related disease\n5. Bakelite\n6. Muscovite mica\nD. HYPERCALCEMIA\n7. Pancreatitis\n8. Secondary hyperparathyroidism of chronic renal failure / scleroderma\nE. MISCELLANEOUS\n9. Mineral oil aspiration\n10. Pulmonary infarction\n$\\checkmark$ FDG-avid pleural lesions at PET/CT with corresponding high attenuation at CT suggests pleurodesis, because $<10 \\%$ of pleural malignancies develop calcifications!\nmnemonic: TAFT\nTuberculosis\nAsbestosis\nFluid (effusion, empyema, hematoma)\nTalc\n\n## Chest Wall Tumor\n\nA. BONE TUMOR\n(a) malignant osseous chest wall tumor\n$\\diamond$ Primary bone tumors of the chest wall represent only $5-8 \\%$ of all skeletal masses!\n$\\diamond$ Sternal tumors are usually malignant!\n\n1. Metastasis\n2. Chondrosarcoma ( $33 \\%$ of primary rib tumors)\n3. Myeloma\n4. Ewing sarcoma\n(b) benign osseous chest wall tumor\n5. Fibrous dysplasia\n6. Enchondroma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 432,
            "markdown": "3. Osteochondroma ( $8 \\%$ of all rib tumors)\n4. Chondroblastoma\n5. ABC\n6. GCT\n7. Langerhans cell histiocytosis\nB. SOFT-TISSUE TUMOR\n(a) adipocytic tumor\n8. Lipoma\n9. Liposarcoma\n(b) vascular tumor\n10. Hemangioma\n11. Lymphangioma\n12. Angiosarcoma\n(c) fibroblastic-myofibroblastic tumor\n13. Elastofibroma\n14. Fibromatosis\n(d) fibrohistiocytic tumor\n15. Undifferentiated pleomorphic sarcoma\n(e) peripheral nerve sheath tumor (PNST)\n16. Schwannoma\n17. Neurofibroma\n18. Malignant PNST\n(f) cutaneous lesion\n19. Epidermal inclusion cyst\n20. Pilomatricoma\n21. Dermatofibrosarcoma protuberans (DFSP)\n\n# MEDIASTINUM \n\n## Conventional Radiographic Mediastinal Signs\n\nused in the interpretation of single frontal CXR\n\n1. \"Silhouette\" sign\n= obscured margin (ie, silhouette) of the normal air-soft tissue interface of a mediastinal structure (heart, aortic arch, hilum, azygoesophageal recess) / diaphragm\nCause: any intrathoracic opacity of the same density as the adjacent normal structure (eg, pneumonia, atelectasis, mass, fluid)\n2. \"Hilum overlay\" sign\n$=$ normal hilar structures project through a mass $\\rightarrow$ mass is not in contact with hilum but posterior / anterior to hilum\n3. \"Hilum convergence\" sign\n$=$ convergence of pulmonary arteries into the lateral border of a hilar density $\\rightarrow$ enlarged pulmonary artery\n$D D x:$ nodule / mass $\\rightarrow$ vessels course through opacity\n4. \"Cervicothoracic\" sign\n= uppermost border of anterior mediastinum ends at level of clavicles while middle",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 433,
            "markdown": "(higher) + posterior (highest) mediastinum project above clavicles\nUse: localizing a mediastinal mass\n$\\checkmark$ posterior superior mediastinal masses are sharply outlined by apical lung\n$\\checkmark$ anterior superior mediastinal masses extending into neck have unsharp borders\n\n# Acute Mediastinal Widening \n\n1. Rupture of aorta / brachiocephalic arteries\n2. Venous hemorrhage: traumatic / iatrogenic (malpositioning of central venous line)\n3. Congestive heart failure (venous dilatation)\n4. Rupture of esophagus\n5. Rupture of thoracic duct\n6. Atelectasis abutting the mediastinum\n7. Magnification + geometric distortion on supine radiograph (attempt at suspended full inspiration, no rotation, $10-15^{\\circ}$ caudal angulation of central beam)\n\n## Mediastinal Hematoma\n\n- dyspnea, dysphagia, dysphonia, chest pain\n- neck + chest wall ecchymosis, tachycardia\n$\\checkmark$ mediastinal widening\n$\\checkmark$ abnormal aortic contour\n$\\checkmark>5 \\mathrm{~mm}$ widening of right paratracheal stripe\n$\\checkmark$ deviation of nasogastric tube to right of T4 spinous process\nCT:\n$\\checkmark$ soft-tissue mass $>60 \\mathrm{HU}$\n$\\checkmark$ focal heterogeneous mass / ill-defined soft-tissue thickening with extension to cervical region\n$\\checkmark$ compression of trachea, main bronchi, great vessels\n\n\n## Mediastinal Shift\n\n$=$ displacement of heart, trachea, aorta, hilar vessels\n$\\diamond$ Expiration film, lateral decubitus film (expanded lung down), fluoroscopy helps to determine side of abnormality\nA. DECREASED LUNG VOLUME\n\n1. Atelectasis\n2. Postoperative (lobectomy, pneumothorax)\n3. Hypoplastic lung / lobe\n$\\checkmark$ small pulmonary artery + small hilum\n$\\checkmark$ decreased peripheral pulmonary vasculature\n$\\checkmark$ irregular reticular vascular pattern (bronchial origin) without converging on the hilum\n4. Bronchiolitis obliterans $=$ Swyer-James syndrome\nB. INCREASED LUNG VOLUME\n$=$ air trapping $=$ retention of excess gas in all / part of the lung, especially during expiration, as a result of\n(a) complete / partial airway obstruction, or",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 434,
            "markdown": "(b) local abnormalities in pulmonary compliance\n@ Major bronchus\n\n1. Foreign body obstructing main-stem bronchus (common in children) with ballvalve mechanism + collateral air drift $\\sqrt{ }$ contralateral mediastinal shift $\\rightarrow$ increasing with expiration\n@ Emphysema\n2. Bullous emphysema (localized form)\n$\\sqrt{ }$ large avascular areas with thin lines\n3. Congenital lobar emphysema: only in infants\n4. Interstitial emphysema\n\nCause: Cx of positive pressure ventilation therapy\n$\\sqrt{ }$ pattern of diffuse coarse lines\n@ Cysts / masses\n\n1. Bronchogenic cyst: with bronchial connection + check-valve mechanism\n2. Cystic adenomatoid malformation\n3. Large mass (pulmonary, mediastinal)\nC. PLEURAL SPACE ABNORMALITY\n4. Large unilateral pleural effusion:\n$\\sqrt{ }$ opaque hemithorax $\\leftarrow$ empyema, congestive heart failure, metastases\n5. Tension pneumothorax:\n\nNOT always complete collapse of lung\n3. Large diaphragmatic hernia:\nusually detected in neonatal period\n4. Large pleural mass\nD. Partial absence of pericardium / pectus excavatum\n$\\sqrt{ }$ shift of heart WITHOUT shift of trachea / aorta / mediastinal border\n\n# Pneumomediastinum \n\n$=$ free air around mediastinal structures\nFrequency: in $1 \\%$ of patients with pneumothorax\nSource of air:\nA. INTRATHORACIC\n\n1. Trachea, major bronchi: blunt chest trauma\n2. Esophagus\n3. Lung\n(a) narrowed / plugged airways (most common) = air trapping in small airways as in asthma\n(b) straining against closed glottis: vomiting, parturition, weight-lifting\n(c) blunt / penetrating chest trauma\n(d) alveolar rupture\n4. Pleural space\nB. EXTRATHORACIC\n5. Head and neck: sinus fracture, dental extraction\n6. Intra- and retroperitoneum: perforated hollow viscus\n\nPathophysiology:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 435,
            "markdown": "after alveolar rupture $\\rightarrow$ air tracks along bronchovascular sheath $\\rightarrow$ ruptures through fascial sheath at lung root into mediastinum + facial planes of the neck $\\rightarrow$ produces subcutaneous emphysema\n\n- chest pain, breathlessness, subcutaneous emphysema\n$\\diamond$ NOT a life-threatening condition!\n$\\checkmark$ subcutaneous emphysema\n$\\checkmark$ streaky lucencies of air in mediastinum (look at thoracic inlet on PA + retrosternal space on LAT film)\n$\\checkmark$ \"ring around artery\" sign = air surrounding intramediastinal segment of right pulmonary artery (LAT view)\n$\\checkmark$ \"tubular artery\" sign = air adjacent to major aortic branches, eg, left subclavian + left common carotid aa.\n$\\checkmark$ \"continuous diaphragm\" sign = air trapped posterior to pericardium produces lucency connecting both domes of hemidiaphragms (frontal view)\n$\\checkmark$ \"double bronchial wall\" sign = clear depiction of bronchial wall by air next to and within a bronchus\n$\\checkmark$ \"V\" sign of Naclerio / \"extrapleural\" sign = mediastinal air extends laterally between mediastinal pleura / lower thoracic aorta + diaphragm\n$\\checkmark$ \"spinnaker sail\" / \"thymic sail\" / \"angel wing\" sign in children = air outlining the thymus\n$\\checkmark$ air in azygoesophageal recess\n$\\checkmark$ air in pulmonary ligament $=$ triangular gas collection in low mid chest\n$D D x$ :\n(a) other air collections:\nmedial / subpulmonary pneumothorax (simulating \"extrapleural\" sign);\npneumoperitoneum (simulating \"extrapleural\" sign); pneumopericardium\n(b) mistaken normal anatomic structures:\nsuperior aspect of major fissure (on lordotic view); anterior junction line; Mach band effect\n\n\n# Spontaneous Pneumomediastinum \n\nAge: neonates $(0.05-1.00 \\%), 2^{\\text {nd }}-3^{\\text {rd }}$ decade\nCause:\n\n1. Rupture of marginally situated alveoli: sudden / prolonged rise in intraalveolar pressure $\\rightarrow$ subsequent dissection of air centrally along bronchovascular bundles to hila (interstitial emphysema) $\\rightarrow$ rupture into mediastinum:\n\nValsalva maneuver, status asthmaticus, aspiration pneumonia, hyaline membrane disease, measles, giant cell pneumonia, coughing, vomiting, strenuous exercise, parturition, diabetic acidosis, crack cocaine inhalation = free-basing (mixing solid cocaine salt with a solvent to render it \"smokeable\")\n2. Tumor erosion of trachea / esophagus\n3. Pneumoperitoneum / retropneumoperitoneum\n$=$ extension from peritoneal / retroperitoneal / deep fascial planes of the neck\n\n## Traumatic Pneumomediastinum (rare)\n\nCause:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 436,
            "markdown": "1. Pulmonary interstitial emphysema\n$=$ disruption of marginal alveoli with gas traveling toward mediastinum $\\leftarrow$ positive pressure ventilation\n2. Bronchial / tracheal rupture\n$\\sqrt{ }$ commonly associated with pneumothorax\n3. Esophageal rupture: diabetic acidosis, alcoholic, Boerhaave syndrome\n4. Iatrogenic - accidental:\nneck / chest / abdominal surgery, subclavian vein catheterization, mediastinoscopy, bronchoscopy, gastroscopy, rectosigmoidocolonoscopy, electrosurgery with intestinal gas explosion, positive pressure ventilation, intubation, barium enema\n\n# Tension Pneumomediastinum \n\n$\\diamond$ MEDICAL EMERGENCY!\nPathophysiology:\nincreased intramediastinal pressure $\\rightarrow$ compression of heart $\\rightarrow$ decreased venous return\n\n+ compression of tracheobronchial tree $\\rightarrow$ sudden profound cardiovascular + respiratory collapse\n- sudden development of severe hypoxia, hypotension, tachycardia, metabolic acidosis, high ventilation pressure\nCXR:\n$\\checkmark$ thin line outlining the borders of the heart (in 50\\%)\nCT (modality of choice):\n$\\checkmark$ substantial amount of mediastinal free air\n$\\checkmark$ flattening of anterior cardiac contour\n$\\checkmark$ uplifting of heart off the diaphragm\n$\\checkmark$ compression of right atrium\n$\\checkmark$ compression of mediastinal vessels\n$\\checkmark$ distension of IVC\n$\\checkmark$ flattening of main bronchi\n$R x$ : percutaneous needle aspiration / CT-guided catheter placement\n\n\n## Tension Pneumopericardium\n\n$\\diamond$ MEDICAL EMERGENCY!\n\n- chest pain, dyspnea, cyanosis, hypotension, tachycardia\n- \"mill wheel\" murmur, metallic sounds of high frequency, muffled heart sounds\n- ECG: elevated ST segment, low-voltage waveform\n\nCause:\n(a) traumatic: blunt / penetrating trauma; iatrogenic (eg, occurring during or after cardiac surgery); barotrauma from positive pressure ventilation\na) nontraumatic: pericarditis with gas-forming organism; direct extension of inflammation from adjacent structures; fistulous communication with air-containing structures (eg, stomach, esophagus, airway, lung); extension of pneumomediastinum into pericardial cavity\n$\\checkmark$ intrapericardial pressure $>265 \\mathrm{~mm} \\mathrm{H}_{2} \\mathrm{O}$\nCXR:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 437,
            "markdown": "$\\sqrt{ }$ \"halo\" sign = continuous rim of air outlining left and right heart borders\n$\\sqrt{ }$ \"small heart\" sign on frontal view = sudden marked decrease in size of cardiac silhouette\nCT:\n$\\sqrt{ }$ substantial amount of air in pericardial cavity\n$\\sqrt{ }$ compression + displacement of heart:\n$\\sqrt{ }$ collapse of heart chambers\n$\\sqrt{ }$ flattening of anterior heart border\n$\\sqrt{ }$ distention of inferior vena cava\n$C x:$ cardiac tamponade $\\rightarrow$ hemodynamic compromise\n$R x$ : immediate pericardial decompression $\\leftarrow$ needle pericardiocentesis / placement of pericardial drain\n\n# Mediastinal Fat \n\nA. MEDIASTINAL LIPOMATOSIS\nB. FAT HERNIATION\n$=$ omental fat herniating into chest\n\n1. Foramen of Morgagni\n$=$ sternocostal triangle mass, $\\mathrm{R} \\gg \\mathrm{L}$ side\n2. Foramen of Bochdalek\n$=$ lumbocostal triangle mass, almost always on left\n3. Paraesophageal hernia\n$=$ perigastric fat through phrenicoesophageal membrane\nCT:\n$\\sqrt{ }$ fat with fine linear densities (= omental vessels)\nC. LIPOMA\n$=$ un- / encapsulated fatty tissue with variable amount of fibrous septa\n$\\sqrt{ }$ smooth + sharply defined boundaries\n$D D x$ : liposarcoma, lipoblastoma (infancy), fat-containing teratoma, thymolipoma (inhomogeneous, higher CT numbers, poor demarcation, $\\pm$ invasion of surrounding structures)\nD. MULTIPLE SYMMETRIC LIPOMATOSIS\n\n## Low-attenuation Mediastinal Mass\n\nA. FLUID\n\n1. Foregut cyst\n2. Lymphocele\n3. Seroma\n4. Hematoma\n5. Abscess\n6. Hydatid disease\nB. LYMPH NODE\n7. Tuberculous lymph nodes\n8. Metastasis from thyroid / testicular tumor\n9. Lymphoma: treated / untreated",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 438,
            "markdown": "# C. PRIMARY NEOPLASM \n\n1. Neurogenic tumor\n2. Fat-containing neoplasm\n\n## Mediastinal Cyst\n\n$=21 \\%$ of all primary mediastinal tumors\n@ Anterior mediastinum\n\n1. Thymic cyst\n2. Dermoid cyst\n3. Parathyroid cyst (uncommon as mediastinal mass)\n@ Middle mediastinum\n4. Pericardial cyst\n5. Bronchogenic cyst\n@ Posterior mediastinum\n6. Esophageal duplication cyst\n7. Neurenteric cyst\n8. Thoracic duct cyst\n9. Transdiaphragmatic jejunal duplication\n10. Cystic hygroma\n11. Lateral thoracic meningocele\n12. Posttraumatic lymphocele\n$=$ contained pleural / mediastinal lymph collection\n\n- history of prolonged chylous chest tube drainage\n\nTime of onset: several months after injury\n8. Hydatid cyst\n\nLocation: paravertebral gutter\n$\\checkmark$ erosion of ribs + vertebrae\n\n## Frequency of Developmental Mediastinal Cyst\n\n1. Enterogenous cyst $=$ Foregut cyst $45 \\%$\n(a) bronchogenic cyst $(30 \\%)$\n(b) esophageal duplication cyst $(15 \\%)$\n(c) neurenteric cyst (least common)\n2. Pericardial cyst $30 \\%$\n3. Thymic cyst $10 \\%$\n4. Nonspecific mesothelial cyst $10 \\%$\n5. Cystic hygroma $5 \\%$\n\n## Mediastinal Mass\n\n(excluding hyperplastic thymus gland, granuloma, lymphoma, metastasis)\n\n1. Neurogenic tumor ( $28 \\%$ ): malignant in $16 \\%$\n2. Teratoid lesion (19\\%): malignant in $15 \\%$\n3. Enterogenous cyst $(16 \\%)$\n4. Thymoma (13\\%): malignant in $46 \\%$\n5. Pericardial cyst $(7 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 439,
            "markdown": "# A. BENIGN MEDIASTINAL MASS \n\n$\\diamond 66-75 \\%$ of all mediastinal tumors are benign (in all age groups)\n$\\diamond 88 \\%$ discovered incidentally on routine chest x-ray\nB. MALIGNANT MEDIASTINAL MASS\n$\\diamond 57-80 \\%$ of malignant tumors are symptomatic (pain, cough, shortness of breath)\n\n## Thoracic Inlet Lesion\n\n1. Thyroid mass\n$1-3 \\%$ of all thyroidectomies have a mediastinal component; $1 / 3$ of goiters are intrathoracic\nLocation: anterior ( $80 \\%$ ) / posterior ( $20 \\%$ ) mediastinum\n$\\sqrt{ }$ displacement of trachea posteriorly and laterally $\\leftarrow$ anterior goiter\n$\\checkmark$ displacement of trachea anteriorly and laterally + esophagus posteriorly $\\leftarrow$ posterior goiter\n$\\checkmark$ inhomogeneous density $\\leftarrow$ cystic spaces + high-density iodine contents of $>100 \\mathrm{HU}$\n$\\checkmark$ focal calcifications (common)\n$\\checkmark$ marked + prolonged contrast enhancement\n$\\checkmark$ connection to thyroid gland\n$\\checkmark$ vascular displacement + compression\nNUC (rarely helpful as thyroid tissue may be nonfunctioning):\n$\\sqrt{ } \\pm$ uptake on ${ }^{123} \\mathrm{I} /{ }^{131} \\mathrm{I}$ scan (pertechnetate is sufficient with modern gamma cameras, SPECT imaging may be helpful)\n2. Cystic hygroma\n$3-10 \\%$ involve mediastinum; childhood\n3. Lymphoma\n4. Other tumors: adenoma, carcinoma, ectopic thymoma\n\n## Mass in Raider Triangle\n\nRaider triangle ( $=$ retrotracheal triangle) on LAT CXR formed by posterior wall of trachea (anteriorly) + thoracic spine (posteriorly) + aortic arch (inferiorly) + thoracic inlet superiorly)\n[Louis Raider (1913-1999), professor of radiology in Mobile, AL at the University of South Alabama Medical Center]\n\n1. Aberrant right subclavian artery\n2. Aberrant left subclavian a. with right aortic arch\n3. Aneurysm\n4. Posterior descending goiter\n5. Enlarged lymph node\n6. Esophageal mass / duplication cyst\n\n## Anterior Mediastinal Mass\n\n$\\diamond$ Lymphoma is the most common anterior mediastinal mass in children + the $2^{\\text {nd }}$ most common in adults!\n$\\checkmark$ posterior junction line preserved\n$\\checkmark$ anterior junction line obliterated",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 440,
            "markdown": "$\\sqrt{ }$ \"hilum overlay\" sign present\n$\\sqrt{ }$ no interface with lung above level of clavicle\nmnemonic: 4 T's\nThymoma\nTeratoma\nThyroid tumor / goiter\nTerrible lymphoma\nA. SOLID THYMIC LESIONS\n\n1. Thymoma (benign, malignant): most common\n2. Normal thymus (neonate)\n3. Thymic hyperplasia (child)\n4. Thymic carcinoma\n5. Thymic carcinoid\n6. Thymolipoma\n7. Lymphoma\nB. SOLID TERATOID LESIONS $=$ germ cell tumors\n8. Teratoma\n9. Embryonal cell carcinoma\n10. Choriocarcinoma\n11. Seminoma\nC. THYROID / PARATHYROID\n12. Substernal thyroid / intrathoracic goiter ( $10 \\%$ of all mediastinal masses)\n13. Thyroid adenoma / carcinoma\n14. Ectopic parathyroid adenoma:\nectopia in $1-3 \\%$ ( $62-81 \\%$ in anterior mediastinum / thymus, $30 \\%$ within thyroid tissue, $8 \\%$ in posterior superior mediastinum)\nD. LYMPH NODES\n15. Lymphoma (Hodgkin, NHL): may arise in thymus, more common in young adults\n16. Metastasis\n17. Benign lymph node hyperplasia\n18. Angioblastic lymphadenopathy\n19. Mediastinal lymphadenitis: sarcoidosis / granulomatous infection\nE. CARDIOVASCULAR\n20. Tortuous brachiocephalic artery\n21. Aneurysm of ascending aorta\n22. Aneurysm of sinus of Valsalva\n23. Dilated SVC\n24. Cardiac tumor\n25. Epicardial fat-pad\n$\\sqrt{ }$ low-density mass obliterating cardiac silhouette\nF. CYSTS\n26. Cystic hygroma\n27. Bronchogenic cyst\n28. Extralobar sequestration",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 441,
            "markdown": "4. Thymic cysts / dermoid cysts\n5. Pericardial cyst: true cyst; pericardial diverticulum\n6. Pancreatic pseudocyst\nG. OTHERS\n7. Neural tumor: vagus, phrenic nerve\n8. Paraganglioma\n9. Hemangioma / lymphangioma\n10. Mesenchymal tumor: fibroma, lipoma\n11. Sternal tumors\n(a) metastasis from breast, bronchus, kidney, thyroid\n(b) malignant primary: chondrosarcoma, myeloma, lymphoma\n(c) benign primary: chondroma, aneurysmal bone cyst, giant cell tumor\n12. Primary lung / pleural tumor\n(invading mediastinum)\n13. Mediastinal lipomatosis:\n(a) Cushing disease\n(b) Corticosteroid therapy\n14. Morgagni hernia / localized eventration\n$\\checkmark$ presence of bowel gas\n15. Abscess\n\nFat-containing Mediastinal Mass\n\n1. Mature cystic teratoma\n2. Mediastinal lipoma\n3. Mediastinal lipomatosis\n4. Thymolipoma\n5. Liposarcoma\n\n# Prevascular Mediastinal Mass \n\n1. Lymphadenopathy\n2. Retrosternal goiter\n3. Thymic lesion\n4. Germ cell tumor\n\n## Precardiac Mass in Contact with Diaphragm\n\n1. Epicardial fat pad\n2. Diaphragmatic hump\n3. Morgagni hernia\n4. Pleuropericardial cyst\n5. Lymph node enlargement\n\n## Middle Mediastinal Mass\n\nmnemonic: HABIT5\nHernia, Hematoma\nAneurysm\nBronchogenic cyst / duplication cyst",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 442,
            "markdown": "Inflammation: sarcoidosis, histoplasmosis, coccidioidomycosis, primary TB in children Tumors - remember the 5 L's:\nLung, especially oat cell carcinoma\nLymphoma\nLeukemia\nLeiomyoma\nLymph node hyperplasia\nA. LYMPH NODES\n$\\diamond 90 \\%$ of middle mediastinal masses are malignant\n(a) neoplastic adenopathy\n\n1. Lymphoma: Hodgkin $\\div \\mathrm{NHL}=2 \\div 1$\n2. Leukemia (in $25 \\%$ ): lymphocytic $>$ granulocytic\n3. Metastasis: bronchus, lung, upper GI, prostate, kidney\n4. Angioimmunoblastic lymphadenopathy\n(b) inflammatory adenopathy\n5. Tuberculosis / histoplasmosis $\\rightarrow$ may lead to fibrosing mediastinitis\n6. Blastomycosis (rare) / coccidioidomycosis\n7. Sarcoidosis (predominant involvement of paratracheal nodes)\n8. Viral pneumonia (particularly measles + cat-scratch fever)\n9. Infectious mononucleosis / pertussis pneumonia\n10. Amyloidosis\n11. Plague / tularemia\n12. Drug reaction\n13. Giant lymph node hyperplasia $=$ Castleman dz.\n14. Connective tissue disease: rheumatoid, SLE\n15. Bacterial lung abscess\n(c) inhalational disease adenopathy\n16. Silicosis (eggshell calcification also in sarcoidosis + tuberculosis)\n17. Coal worker's pneumoconiosis\n18. Berylliosis\nB. FOREGUT CYST\n19. Bronchogenic / respiratory cyst (cartilage, respiratory epithelium)\n20. Enteric cyst = esophageal duplication cyst\n21. Extralobar sequestration (anomalous feeding vessel)\n22. Hiatal hernia\n23. Esophageal diverticula: Zenker, traction, epiphrenic\nC. PRIMARY TUMORS (infrequent)\n24. Carcinoma of trachea\n25. Bronchogenic carcinoma\n26. Esophageal tumor:\nleiomyoma, carcinoma, leiomyosarcoma\n27. Mesothelioma\n28. Granular cell myoblastoma of trachea (rare)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 443,
            "markdown": "D. VASCULAR LESIONS\n\n1. Aneurysm of transverse aorta\n2. Distended veins: SVC, azygos vein\n3. Hematoma\nE. VASCULAR VARIANTS\n4. Right aortic arch (in $0.5 \\%$ of general population)\n$\\sqrt{ }$ absence of aortic knuckle\n5. Left SVC (in $0.3 \\%$ of general population)\n6. Azygos continuation of IVC\n\n# SubCARINAL SPACE LESION \n\n1. Enlarged lymph nodes\n2. Bronchogenic cyst\n3. Pericardial effusion\n4. Enlarged left atrium\n5. Esophageal mass\n6. Aortic aneurysm\n\n## AorticOPOLMONARY WindOW Mass\n\n1. Adenopathy\n2. Aneurysm: traumatic aortic pseudoaneurysm, pulmonary artery aneurysm, ductus Botalli aneurysm, bronchial artery aneurysm\n3. Bronchogenic cyst\n4. Tumor of tracheobronchial tree\n5. Esophageal tumor\n6. Neurogenic tumor\n7. Mediastinal abscess\n\n## Widening of Paratracheal Space\n\nNormal width: $<5 \\mathrm{~mm}$\n\n1. Dilated tortuous vessels: brachiocephalic artery, SVC, azygos vein\n2. Enlarged lymph node\n3. Bronchogenic carcinoma\n4. Mediastinal lipomatosis\n5. Mediastinal hematoma\n6. Bronchogenic cyst\n\n## Retrocardiac Space of Holzknecht Lesion\n\n[Guido Holzknecht (1872-1931), pioneer in radiology and director of the X-ray laboratory at Vienna General Hospital in 1905, adjuvantly irradiated Sigmund Freud for an oral cavity squamous cell carcinoma unsuccessfully]\n\n1. Hiatal hernia\n2. Esophageal lesion\n3. Left ventricular aneurysm\n4. Pericardial cyst\n5. Bronchogenic cyst",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 444,
            "markdown": "6. Aortic aneurysm\n7. Vagal / phrenic nerve neurofibroma\n\n# Posterior Mediastinal Mass \n\nA. NEOPLASM\n> NEUROGENIC TUMOR (largest group): $30 \\%$ malignant\n(a) tumor of peripheral nerve origin\n\n- more common in adulthood\n$\\sqrt{ } 80 \\%$ appear as a round mass with sulcus\n$\\sqrt{ }$ lower attenuation than muscle (in $73 \\%$ )\n\n1. Schwannoma $=$ neurilemmoma ( $32 \\%$ )\n2. Neurofibroma ( $10 \\%$ ): contains Schwann cells + nerve cells, $3 \\mathrm{rd}+4^{\\text {th }}$ decade\n3. Malignant schwannoma\n(b) tumor of sympathetic ganglia origin\n\n- more common in childhood\n$\\sqrt{ } 80 \\%$ are elongated with tapered borders\n\n1. Ganglioneuroma ( $23-38 \\%$ ): second most common tumor of posterior mediastinum after neurofibroma\n2. Neuroblastoma ( $15 \\%$ ): highly malignant undifferentiated small round cell tumor originating in sympathetic ganglia, $<10$ years of age\n3. Ganglioneuroblastoma ( $14 \\%$ ): both features, spontaneous maturation possible\n(c) tumor of paraganglia origin (rare)\n4. Chemodectoma $=$ paraganglioma $(4 \\%)$\n5. Pheochromocytoma\n$\\sqrt{ }$ rib spreading, erosion, destruction\n$\\sqrt{ }$ enlargement of neural foramina (dumbbell lesion)\n$\\sqrt{ }$ scalloping of posterior aspect of vertebral body\n$\\sqrt{ }$ scoliosis\nCT:\n$\\sqrt{ }$ low-density soft-tissue mass (lipid contents)\n> SPINE TUMOR: metastasis (eg, bronchogenic carcinoma, multiple myeloma), ABC, chordoma, chondrosarcoma, Ewing sarcoma\n> LYMPHOMA\n> INVASIVE THYMOMA\n> MESENCHYMAL TUMOR: fibroma, lipoma, leiomyoma\n> HEMANGIOMA\n> LYMPHANGIOMA\n> THYROID TUMOR\nB. INFLAMMATION / INFECTION\n6. Infectious spondylitis: pyogenic, tuberculous, fungal\n$\\sqrt{ }$ destruction of endplates + disk space\n$\\sqrt{ }$ paravertebral soft-tissue mass\n7. Mediastinitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 445,
            "markdown": "5. Pancreatic pseudocyst\n6. Lymphoid hyperplasia\n7. Sarcoidosis (in $2 \\%$, typically asymptomatic patient)\nC. VASCULAR MASS\n8. Aneurysm of descending aorta (curvilinear calcification; elderly)\n9. Enlarged azygos + accessory hemiazygos vein\n10. Esophageal varices\n11. Congenital vascular anomalies:\naberrant subclavian artery, double aortic arch, pulmonary sling, interruption of IVC with azygos / hemiazygos continuation\nD. TRAUMA\n12. Aortic aneurysm / pseudoaneurysm\n13. Hematoma\n14. Loculated hemothorax\n15. Traumatic pseudomeningocele\nE. FOREGUT CYST\n$\\sqrt{ }$ cysts may demonstrate peripheral rimlike calcifications\n16. Bronchogenic cyst\n17. Enteric cyst\n18. Neurenteric cyst\n19. Extralobar sequestration\nF. FATTY MASS\n20. Bochdalek hernia\n21. Mediastinal lipomatosis\n22. Fat-containing tumors: lipoma, liposarcoma, teratoma (rare)\nG. OTHER\n23. Loculated pleural effusion\n24. Pancreatic pseudocyst\n25. Lateral meningocele: neurofibromatosis; enlarged neural foramen\n26. Extramedullary hematopoiesis:\nin chronic bone marrow deficiency; paraspinal area rich in RES-elements\n$\\checkmark$ splenomegaly; widening of ribs\n27. \"Pseudomass\" of the newborn\nmnemonic: BELLMAN\nBochdalek hernia\nExtramedullary hematopoiesis\nLymphadenopathy\nLymphangioma\nMeningocele (lateral)\nAneurysm\nNeurogenic tumor\nDeviation / Disruption of AzYgoesOPHAGEAL LINE\n28. Left atrial enlargement\n29. Subcarinal adenopathy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 446,
            "markdown": "3. Esophageal disease\n4. Bronchogenic cyst\n5. Hiatal hernia\n\n# Cardiophrenic-angle Mass \n\nA. LESION OF PERICARDIUM\n\n1. Pericardial cyst\n2. Intrapericardiac bronchogenic cyst\n3. Benign intrapericardiac neoplasm:\nteratoma, leiomyoma, hemangioma, lipoma\n4. Malignant neoplasm:\nmesothelioma, metastasis (lung, breast, lymphoma, melanoma)\nB. CARDIAC LESION\n5. Aneurysm\n6. Congenital absence of pericardium = pericardial defect\n$\\checkmark$ apparent elevation of cardiac apex\n$\\checkmark$ prominent pulmonary artery segment\n$\\checkmark$ lucency between aorta + main pulmonary artery caused by interposed lung\nC. OTHERS\n7. Mass of lung, pleura, diaphragm, abdomen\n8. Cardiophrenic angle varices\n\n## Right Cardiophrenic-Angle Mass\n\nA. HEART\n\n1. Aneurysm: cardiac ventricle, sinus of Valsalva\n2. Dilated right atrium\nB. PERI- / EPICARDIUM\n3. Epicardial fat-pad in obesity / lipoma (most common cause)\n$\\checkmark$ triangular opacity in cardiophrenic angle less dense than heart\n$\\checkmark$ increase in size under corticosteroid treatment\n4. Pericardial cyst\nC. DIAPHRAGM\n5. Diaphragmatic hernia of Morgagni\n6. Diaphragmatic lymph node (esp. in Hodgkin disease + breast cancer)\nD. ANTERIOR MEDIASTINAL MASS: thymolipoma\nE. PRIMARY LUNG MASS\nF. PARACARDIAC VARICES\nG. ENLARGED LYMPH NODE: lymphoma, metastasis (lung, breast, colon, ovary, melanoma)\n\n## FATTY CARDIOPHRENIC-ANGLE MASS\n\n1. Diaphragmatic hernia (congenital $>$ traumatic)\n2. Pericardial fat necrosis\n\n- acute pleuritic chest pain\n$\\checkmark$ encapsulated fatty lesion with inflammatory changes similar to epiploic appendagitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 447,
            "markdown": "$\\sqrt{ }$ local thickening of adjacent pericardium\nPrognosis: benign self-limiting course with spontaneous resolution / improvement\n3. Thymolipoma\n4. Teratoma\n5. Lipoma / liposarcoma (no diaphragmatic defect)\n\n# CYStic CARDIOPHRENIC-AngLE MASS \n\n1. Pericardial cyst\n2. Thymic tumor with predominantly cystic content\n3. Hydatid cyst\n\n## Solid Cardiophrenic-Angle Mass\n\n1. Lymphadenopathy: lymphoma $>$ metastasis (lung cancer, mesothelioma, several abdominal cancers)\n2. Malignant / benign thymic tumor (connection with superior mediastinum maintained)\n\n## Hypervascular Mediastinal Mass\n\n1. Paraganglioma\n2. Metastasis: typically renal cell carcinoma\n3. Castleman disease\n4. Hemangioma\n5. Sarcoma\n6. Tuberculosis\n7. Sarcoidosis\n\n## Popcorn-type Calcification\n\n1. Hamartoma (lung)\n2. Histoplasmosis (mediastinum)\n3. Sarcoidosis (mediastinum)\n\n## Hilar Mass\n\nA. LARGE PULMONARY ARTERIES\n$\\checkmark$ enlargement of main pulmonary artery\n$\\checkmark$ abrupt change in vessel caliber\n$\\checkmark$ enlarged pulmonary artery compared with bronchus (in same bronchovascular bundle)\n$\\checkmark$ cephalization\n$\\checkmark$ enlargement of right ventricle (RAO $45^{\\circ}$, LAO $60^{\\circ}$ )\nCause:\n\n1. Chronic obstructive disease: emphysema\n2. Chronic restrictive interstitial lung disease: idiopathic fibrosis, cystic fibrosis, rheumatoid arthritis, sarcoidosis\n3. Pulmonary embolic disease (acute massive / chronic)\n4. Idiopathic pulmonary hypertension\n5. Left-sided heart failure + mitral stenosis\n6. Congenital heart disease with left-to-right shunt\n(a) acyanotic: ASD, VSD, PDA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 448,
            "markdown": "(b) cyanotic (admixture lesions): transposition of great vessels, truncus arteriosus\n\n| Differential Diagnosis for Lymphadenopathy of Chest |  |\n| :--: | :--: |\n| Disease | Description |\n| Sarcoidosis / other granulomatous disease | $\\checkmark$ symmetric hilar + mediastinal involvement |\n| Primary lung cancer | $\\checkmark$ usually asymmetric involvement <br> $\\checkmark$ following course of lymphatic drainage |\n| Lymphoma | $\\checkmark$ bulky anterior and middle mediastinal mass |\n| Infection | $\\checkmark$ hypoattenuating (TB, mycobacterium avium complex) <br> $\\checkmark$ calcific (TB, fungal infection) |\n\n# B. DUPLICATION CYST \n\n## C. UNILATERAL HILAR ADENOPATHY\n\n(a) neoplastic\n\n1. Bronchogenic carcinoma (most common)\n2. Metastases (lack of mediastinal involvement exceptional)\n3. Lymphoma\n(b) inflammatory\n4. Tuberculosis (primary) in $80 \\%$\n5. Fungal infection: histoplasmosis, coccidioidomycosis, blastomycosis\n6. Viral infection: atypical measles\n7. Infectious mononucleosis\n8. Drug reaction\n9. Sarcoidosis (in $1-3 \\%$ )\n10. Bilateral lung abscess\nmnemonic: Fat Hila Suck\nFungus\nHodgkin disease\nSquamous / oat cell carcinoma\nD. BILATERAL HILAR ADENOPATHY\n$\\diamond$ Most common cause in the absence of specific symptoms / signs is sarcoidosis (in 75\\%)\n(a) neoplastic\n11. Lymphoma (in 50\\% Hodgkin disease)\n12. Metastasis\n13. Leukemia\n14. Primary bronchogenic carcinoma\n15. Plasmacytoma\n(b) inflammatory\n16. Sarcoidosis (in $70-90 \\%$ )\n17. Silicosis\n18. Langerhans cell histiocytosis\n19. Idiopathic pulmonary hemosiderosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 449,
            "markdown": "5. Chronic berylliosis\n(c) infectious\n6. Rubella, ECHO virus, varicella, mononucleosis\nmnemonic: Please Helen Lick My Popsicle Stick\nPrimary TB\nHistoplasmosis\nLymphoma\nMetastases\nPneumoconiosis\nSarcoidosis\n\n# Bilateral Hilar Lymphnode Enlargement \n\nin the absence of specific symptoms / signs\n\n1. Sarcoidosis $(75 \\%)$\n2. Fungal / mycobacterial infection\n3. Malignancy: lymphoma\n\n## Eggshell Calcification of Nodes\n\nA. PNEUMOCONIOSIS\n\n1. Silicosis (5\\%)\n2. Coal worker's pneumoconiosis (1.3-6\\%) not seen in: asbestosis, berylliosis, talcosis, baritosis\nB. SARCOIDOSIS (5\\%)\nC. FUNGAL + BACTERIAL INFECTION (rare)\n3. Tuberculosis\n4. Histoplasmosis\n5. Coccidioidomycosis\nD. FIBROSING MEDIASTINITIS\nE. LYMPHOMA FOLLOWING RADIATION THERAPY\n\n## Enlargement of Azygos Vein\n\nNormal azygos vein (on upright CXR): $\\leq 7 \\mathrm{~mm}$\n$\\sqrt{ }$ round / oval opacity at right tracheobronchial angle marks terminal portion of azygos vein\nA. COLLATERAL CIRCULATION\n\n1. Portal hypertension\n2. SVC obstruction / compression below azygos vein\n3. IVC obstruction / compression\n4. Interrupted IVC with azygos continuation\n5. Partial anomalous venous return (rare)\n6. Pregnancy\n7. Hepatic vein occlusion\nB. RIGHT ATRIAL HYPERTENSION\n8. Right-sided heart failure\n9. Tricuspid insufficiency\n10. Constrictive pericarditis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 450,
            "markdown": "4. Large pericardial effusion\n\n# Enlargement of Bronchial Artery \n\n$=>2 \\mathrm{~mm}$ in diameter\nN.B.: visualization of dilated bronchial arteries should initiate a search for thoracic problems\n\nCT / MR (best with multiplanar / 3-D volumetric images):\n$\\sqrt{ }$ undulating nodular / linear enhancing structures\n$\\sqrt{ }$ tortuous mediastinal course\nA. CONGENITAL PULMONARY ARTERY OBSTRUCTION / ANOMALIES\n\n1. Tetralogy of Fallot\n2. Proximal interruption of pulmonary artery\n3. Anomalous origin of LCA from pulmonary artery\nB. ACQUIRED PULMONARY ARTERY OBSTRUCTION\n(a) intrinsic\n4. Chronic thromboembolic disease\n5. Takayasu arteritis\n(b) extrinsic\n6. Fibrosing mediastinitis\nC. CHRONIC / ACUTE INFLAMMATION\n7. Bronchiectasis\n8. Infection: TB, nontuberculous mycobacterial infection, cystic fibrosis, chronic fungal infection\n9. Malignancy\nD. PULMONARY HYPERTENSION\n\n## THYMUS\n\n## Thymic Mass\n\n1. Thymoma\n2. Thymolipoma\n3. Thymic cyst\n4. Thymic carcinoid\n\n## Neoplasia in Thymus\n\n1. Epithelial thymic tumor: thymoma, thymic carcinoma\n2. Thymic lymphoma: Hodgkin disease, NHL\n3. Langerhans cell histiocytosis\n4. Thymolipoma\n5. Carcinoid tumor\n6. Germ cell tumor\n7. Sarcoma\n8. Metastasis\n\n## Diffuse Thymic Enlargement\n\nA. BENIGN",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 451,
            "markdown": "1. Thymic hyperplasia\n2. Intrathymic hemorrhage\n3. Hemangioma\n4. Lymphangioma\nB. MALIGNANT THYMIC INFILTRATION\n\n- presence of adenopathy elsewhere\n$\\checkmark$ no pleural implants\n\n1. Leukemia\n2. Hodgkin disease / non-Hodgkin lymphoma\n3. Langerhans cell histiocytosis\n\n# TRACHEA \\& BRONCHI \n\n## Malignant Central Airway Obstruction\n\n1. Primary lung cancer\n2. Lymphoma\n3. Metastatic mediastinal adenopathy\n4. Bronchial carcinoid\n5. Endobronchial metastasis\n6. Primary tracheal tumor: chondroma, adenoid cystic ca.\n\n## Tracheal Narrowing\n\nA. ANTERIOR COMPRESSION\n(a) congenital\n\n1. Congenital goiter\n2. Innominate artery syndrome\n\n- ablation of right radial pulse by rigid endoscopic pressure\n$\\checkmark$ posterior tracheal displacement\n$\\checkmark$ focal collapse of trachea at fluoroscopy\n$\\checkmark$ pulsatile indentation of anterior tracheal wall by innominate artery on MR\n$R x$ : surgical attachment of innominate artery to manubrium\n(b) inflammatory\n\n1. Cervical / mediastinal abscess\n(c) neoplastic\n2. Cervical / intrathoracic teratoma\n$\\checkmark$ amorphous calcifications + ossifications\n3. Thymoma\n4. Thyroid tumors\n5. Lymphoma\n(d) traumatic: hematoma\nB. POSTERIOR TRACHEAL COMPRESSION\n(a) congenital\n6. Vascular ring\n> complete: double aortic arch, right aortic arch\n> incomplete: anomalous right subclavian a.",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 452,
            "markdown": "$\\checkmark$ posterior indentation of esophagus + trachea\n2. Pulmonary sling\n$=$ anomalous left pulmonary artery arising from right pulmonary artery, passing between trachea + esophagus en route to left lung\n3. Bronchogenic cyst most commonly between esophagus + trachea at level of carina\n(a) inflammatory: abscess\n(b) neoplastic: neurofibroma\n(c) traumatic: esophageal foreign body, esophageal stricture, hematoma\nC. INTRINSIC TRACHEAL CAUSES\n(a) congenital:\n\n1. Congenital tracheal stenosis (generalized / segmental)\n$=$ complete cartilaginous ring (instead of horseshoe shape)\n2. Congenital tracheomalacia = immaturity of tracheal cartilage $=$ chondromalacia\n\n- expiratory stridor\n$\\checkmark$ tracheal collapse on expiration\n(b) neoplastic: papilloma, fibroma, hemangioma\n(c) traumatic: acquired stenosis (endotracheal + tracheostomy tubes), granuloma, acquired tracheomalacia (cartilage degeneration after inflammation, extrinsic pressure, bronchial neoplasia, tracheoesophageal fistula, foreign body)\n\n\n# Tracheal Wall Thickening \n\n1. Wegener granulomatosis\n$\\sqrt{ }$ involvement of posterior membrane\n2. Relapsing polychondritis\n$\\sqrt{ }$ thickening of cartilaginous trachea + tracheal wall\n3. Tracheobronchopathia osteochondroplastica\n$\\checkmark$ calcified / ossified nodules in cartilaginous trachea\n4. Amyloidosis\n$\\checkmark$ nodular concentric calcified / ossified wall thickening\n$\\checkmark$ no posterior sparing\n\n## Tracheal Tumor\n\n- asthma symptomatology, hoarseness, cough, hemoptysis\n- wheeze: inspiratory with extrathoracic lesion, expiratory with intrathoracic lesion\nA. PRIMARY MALIGNANT\n(a) from surface epithelium\n\n1. Squamous-cell carcinoma (commonest primary)\n$\\diamond 50 \\%$ of all malignant tracheal lesions\n2. Adenocarcinoma\n3. Neuroendocrine tumor $=$ carcinoid\n(b) from salivary gland\n4. Cylindroma $=$ adenoid cystic ca.\n5. Mucoepidermoid carcinoma\n(c) from mesenchyme\n6. Sarcoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 453,
            "markdown": "2. Lymphoma\n3. Plasmacytoma\nB. SECONDARY MALIGNANT\n(a) direct invasion: thyroid, lung, larynx, esophagus\n(b) hematogenous: malignant melanoma, breast cancer, renal cell carcinoma, colon cancer\nC. BENIGN TUMOR\n(a) from surface epithelium\n4. Squamous-cell papilloma\n5. Pleomorphic adenoma\n6. Oncocytoma\n7. Mucous gland adenoma\n(b) from mesenchyme\n8. Cartilaginous tumor (hamartoma)\n9. Leiomyoma\n10. Fibroma / lipoma\n11. Hemangioma\n12. Granular cell myoblastoma\n13. Neurogenic tumor\nD. INFLAMMATION\n14. Granulomatous disease:\n\nTB, sarcoidosis, Wegener granulomatosis\n2. Inflammatory myoblastic pseudotumor\n3. Amyloid tumor\n4. Pseudotumor: inspissated mucus, foreign body\n\n# Tracheobronchial Tumor \n\nFrequency: $<0.4 \\%$ of all body tumors\nA. PRIMARY MALIGNANT ( $90 \\%$ )\n(a) surface epithelium\n\n1. Squamous cell carcinoma (most common)\n2. Adenocarcinoma\n3. Neuroendocrine tumor: carcinoid, large / small cell carcinoma\n(b) salivary gland\n4. Adenoid cystic carcinoma ( $2^{\\text {nd }}$ most common)\n5. Mucoepidermoid carcinoma\n(c) mesenchyme\n6. Sarcoma\n7. Lymphoma\nB. SECONDARY MALIGNANT (uncommon)\n(a) directly invading: thyroid cancer, laryngeal cancer, lung cancer, esophageal cancer\n(b) hematogenous: melanoma, breast cancer, renal cell carcinoma, colon cancer\nC. BENIGN $(<10 \\%)$\n(a) surface epithelium: papilloma, papillomatosis, pleomorphic adenoma. oncocytoma\n(b) mesenchyme: hamartoma, leiomyoma, lipoma, fibroma, neurogenic tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 454,
            "markdown": "# Endobronchial Tumor \n\n1. Neuroendocrine tumor (typical / atypical carcinoid)\n2. Mucoepidermoid carcinoma\n3. Adenoid cystic carcinoma\n4. Hamartoma\n5. Leiomyoma\n6. Myoblastoma\n7. Mucous gland adenoma\n8. Squamous cell carcinoma\n\n## Bronchial Obstruction\n\n1. Foreign body: most commonly in young children\n2. Granulomatous disease: granuloma formation in bronchial wall / extrinsic compression by lymphadenopathy\n3. Broncholith\n4. Stenosis / atresia\n5. Neoplasm\n(a) Bronchogenic carcinoma\n(b) Adenoid cystic carcinoma\n(c) Mucoepidermoid tumor\n(d) Hamartoma\nmnemonic: MEATFACE\nMucus plug\nEndobronchial granulomatous disease\nAdenoma\nTuberculosis\nForeign body\nAmyloid, Atresia (bronchial)\nCancer (primary)\nEndobronchial metastasis\n\n## Bronchial Wall Thickening\n\n$\\diamond$ Apparent thickness of bronchial wall varies with lung window chosen on CT: a mean window that is too low can make the bronchial wall appear abnormal!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 455,
            "markdown": "| Differential Diagnosis of Airway Thickening |  |  |\n| :--: | :--: | :--: |\n| Disease | CT appearance | Differentiating Features |\n| Wegener granulomatosis | $\\checkmark$ circumferential tracheal wall thickening (mostly subglottic) | - history of sinus / renal disease <br> $\\checkmark$ subglottic tracheal narrowing <br> $\\checkmark$ involvement of posterior wall <br> $\\checkmark$ pulmonary cavitary nodules / pulmonary hemorrhage <br> $\\checkmark$ NO wall calcifications |\n| Relapsing polychondritis | $\\checkmark$ thickening of cartilaginous trachea + tracheal wall | - cartilaginous abnormalities of ears + nose <br> $\\checkmark$ sparing of posterior tracheal wall <br> $\\checkmark$ tracheal narrowing <br> $\\checkmark$ occasional wall calcifications |\n| Trachebronchopathia osteochondroplastica | $\\checkmark$ calcified / ossified nodules in cartilaginous trachea | $\\checkmark$ nodular calcified / ossified tracheal wall with wall thickening <br> $\\checkmark$ sparing of posterior tracheal membrane + superior trachea |\n| Amyloidosis | $\\checkmark$ calcified / ossified nodular concentric tracheal wall thickening | $\\checkmark$ possible involvement of larynx + upper trachea <br> $\\checkmark$ nodular concentric calcified / ossified tracheal wall with wall thickening <br> $\\checkmark$ NO sparing of posterior membrane of trachea |\n\n# Windowing: level at -250 to -700 HU , width at $>1000 \\mathrm{HU}$ \n\n## A. PERIBRONCHOVASCULAR\n\n1. Sarcoidosis\n2. Lymphangitic carcinomatosis\n3. Kaposi sarcoma\n4. Lymphoma\n5. Pulmonary edema\nB. BRONCHIAL WALL\n6. Airway disease\n7. Relapsing polychondritis\n8. Wegener granulomatosis\n9. Amyloidosis\n\n## C. MUCOSAL INFECTION\n\n1. Croup\n2. Tuberculosis\n3. Fungal disease\n4. Aspergillosis\n\n## Circumferential Tracheobronchial Wall Thickening\n\n1. Wegener granulomatosis\n2. Sarcoidosis\n3. Inflammatory bowel disease\n4. Post-intubation stenosis\n5. Amyloidosis\n6. Infection: Klebsiella rhinoscleromatis, fungal infection, TB\n\n## Signet-ring Sign\n\n$=$ cross section of usually thick-walled dilated ringlike bronchus + normal branch of pulmonary artery as adjacent round soft-tissue opacity\n\n1. Bronchiectasis\n2. Multifocal bronchioloalveolar carcinoma\n3. Metastatic adenocarcinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 456,
            "markdown": "# Broncholithiasis \n\nBroncholith = erosion of calcified peribronchial lymph node extruded into bronchial lumen $\\rightarrow$ bronchial obstruction\n\n1. Histoplasmosis\n2. Tuberculosis\n3. Cryptococcosis\n4. Actinomycosis\n5. Coccidioidomycosis\n$\\checkmark$ calcified lymph node within / adjacent to affected bronchus\n$\\checkmark$ bronchial obstruction $\\rightarrow$ atelectasis, mucoid impaction, bronchiectasis, air trapping, airspace disease (obstructive pneumonia)\n$\\checkmark$ absence of associated soft-tissue mass\n\n## Distribution of Bronchiectasis\n\nA. Bronchiectasis with upper / midlung predominance\n$=$ less effective lymphatic clearance in upper zones ( $\\leftarrow$ gravitational gradient of blood flow and lower respiratory excursions) may account for upper lobe predominance of certain inhalationaland perilymphatic-predominant diseases.\n\n1. Cystic fibrosis\n2. Sarcoidosis\n3. Silicosis and other pneumoconioses\n4. Allergic bronchopulmonary aspergillosis\n5. Tuberculosis\nB. Bronchiectasis with anterior predominance\n6. Atypical mycobacterial infection\n7. Acute respiratory distress syndrome\nC. Bronchiectasis with lower lung predominance\n8. Chronic aspiration\n9. Pulmonary fibrosis: UIP, NIP\n10. Primary ciliary dyskinesia = immotile cilia syndrome\n11. Immunodeficiency\n12. $\\alpha 1$-antitrypsin deficiency\nD. Bronchiectasis with central predominance\n13. Tracheobronchomegaly\n14. Williams-Campbell syndrome\nE. Focal bronchiectasis\n15. Endo- / peribronchial tumor\n16. Swyer-James syndrome\nF. Diffuse bronchiectasis\n17. Bronchiolitis obliterans\n\n## DIAPHRAGM\n\n## Bilateral Diaphragmatic Elevation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 457,
            "markdown": "A. Shallow inspiration (most frequent)\nB. Abdominal causes:\nobesity, pregnancy, ascites, large abdominal mass\nC. Pulmonary causes\n(1) Bilateral atelectasis\n(2) Restrictive pulmonary disease: SLE\nD. Neuromuscular disease\n(1) Myasthenia gravis\n(2) Amyotrophic lateral sclerosis\n\n# Unilateral Diaphragmatic Elevation \n\n1. Subpulmonic pleural effusion\n$\\sqrt{ }$ dome of pseudodiaphragm migrates toward the costophrenic angle and flattens\n2. Altered pulmonary volume\n(a) Atelectasis\n$\\checkmark$ associated pulmonary density\n(b) Postoperative lobectomy / pneumonectomy\n$\\checkmark$ rib defects, metallic sutures\n(c) Hypoplastic lung\n$\\checkmark$ small hemithorax (more often on the right), crowding of ribs, mediastinal shift, absent / small pulmonary artery, frequently associated with dextrocardia + anomalous pulmonary venous return\n3. Phrenic nerve paralysis\n(a) primary lung tumor\n(b) malignant mediastinal tumor\n(c) iatrogenic\n(d) idiopathic\n$\\sqrt{ }$ diagnosed fluoroscopically by paradoxic diaphragmatic motion (with patient asked to sniff in lateral projection)\n4. Abdominal disease\n(a) subphrenic abscess (history of surgery, accompanied by pleural effusion)\n(b) distended stomach / colon\n(c) interposition of colon\n(d) liver mass: tumor, echinococcal cyst, abscess\n5. Diaphragmatic hernia\n6. Eventration of diaphragm\n7. Traumatic rupture of diaphragm associated with rib fractures, pulmonary contusion, hemothorax\n8. Diaphragmatic tumor: mesothelioma, fibroma, lipoma, lymphoma, metastases\n\n## Diaphragmatic Paralysis\n\nA. PHRENIC NERVE INJURY\n\n1. Birth trauma\n2. Cardiac surgery\n3. Resection of thoracic tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 458,
            "markdown": "# B. INFECTION \n\n1. West Nile virus\n2. Lyme disease\nC. TUMOR\n3. Mediastinal tumor\n4. Neck tumor\n\n## Diaphragmatic Tumor in Children\n\nA. MALIGNANT ( $80 \\%$ )\n\n1. Rhabdomyosarcoma\n2. Undifferentiated sarcoma\n3. Germ cell tumor\n4. Ewing sarcoma\nB. BENIGN ( $20 \\%$ )\n5. Lymphangioma\n6. Hemangioma\n7. Lipoma\n8. Myofibroma\n9. Neurofibroma\n\n## Cystic Lesion of Diaphragm\n\n1. Mesothelial cyst\n\nLocation: between liver + posterolateral thoracic wall\n2. Bronchogenic cyst\n3. Cystic teratoma\n4. Pleuropulmonary blastoma\n5. Hydatid cyst\n\n## RetroCRURAL NEOPLASM\n\nA. NEUROGENIC TUMOR\n> ganglion cell tumor\n\n1. Neuroblastoma (most common)\n2. Ganglioneuroblastoma\n3. Ganglioneuroma\n> nerve / nerve sheath tumor\n4. Neurofibroma\n5. Neurilemmoma\n> tumor of paraganglia\n6. Paraganglioma\nB. MESENCHYMAL TUMOR\n> benign\n7. Lipoma, leiomyoma, lymphangioma\n8. Hemangiopericytoma, hemangioma\n> malignant\n9. Liposarcoma, leiomyosarcoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 459,
            "markdown": "2. Rhabdomyosarcoma, fibrosarcoma\n3. Malignant fibrous histiocytoma\nC. GERM CELL TUMOR\n4. Teratoma\n5. Seminomatous + nonseminomatous tumors\nD. LYMPHOID TUMOR\n$\\sqrt{ }$ enlarged $=$ lymph node $>6 \\mathrm{~mm}$ in diameter\n6. Lymphoma\n7. Extramedullary hematopoiesis\n\n# CHEST WALL \n\n## Chest Wall Lesions\n\n$\\sqrt{ }$ \"incomplete border\" sign $\\leftarrow$ obtuse angle\n$\\checkmark$ smooth tapering borders (tangential views)\n$\\checkmark$ tumor pedicle suggests a benign tumor\nA. EXTERNAL\n\n1. Cutaneous lesion: moles, neurofibroma\n2. Nipples\n3. Artifact\nB. NEOPLASTIC\nC. TRAUMATIC\n4. Hematoma\n5. Rib fracture\nD. INFECTIOUS\ncellulitis, pyomyositis, abscess, necrotizing fasciitis\n6. Actinomycosis (parenchymal infiltrate, pleural effusion, chest wall mass, rib destruction, cutaneous fistulas)\n7. Aspergillosis, nocardiosis, blastomycosis, tuberculosis (rare)\n8. Pyogenic: Staphylococcus, Klebsiella\nE. CHEST WALL INVASION\n9. Peripheral lung cancer (eg, Pancoast tumor)\n10. Recurrent breast cancer\n11. Lymphomatous nodes\n\n## Pancoast Syndrome\n\n[Henry Khunrath Pancoast (1875-1939), the first professor of radiology in the USA at the Hospital of the University of Pennsylvania in Philadelphia in 1912]\n$=$ superior sulcus tumor invading brachial plexus + sympathetic stellate ganglion CLINICAL TRIAD:\n\n1. Ipsilateral arm pain\n2. Muscle wasting of hand\n3. Horner syndrome = enophthalmos, ptosis, miosis, anhidrosis\n\nCause: lung cancer (most common), breast cancer, multiple myeloma, metastases, lymphoma, mesothelioma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 460,
            "markdown": "# Lung Disease with Chest Wall Extension \n\nA. INFECTIOUS\n\n1. Actinomycosis\n2. Nocardia\n3. Blastomycosis\n4. Tuberculosis\nB. MALIGNANT TUMOR\n5. Bronchogenic carcinoma\n6. Lymphoma\n7. Metastasis\n8. Mesothelioma\n9. Breast carcinoma\n10. Internal mammary node\nC. BENIGN TUMOR\n11. Capillary hemangioma of infancy\n12. Cavernous hemangioma\n13. Extrapleural lipoma\n14. Abscess\n15. Hematoma\n\n## Chest Wall Tumor\n\nLocation of primary tumors: ribs (95\\%) > sternum\nA. OSSEOUS TUMOR\n(a) secondary tumor\n\n1. Metastasis: most common type of skeletal tumor, particularly in older patients\n$\\checkmark$ absence of mineralization\n(b) primary malignant tumor\n\nFrequency: 5-8\\% of all skeletal masses\n\n1. Chondrosarcoma ( $33 \\%$ of primary rib tumors)\n$\\checkmark$ arc-and-ring / flocculent / stippled chondroid mineralization\n2. Myeloma\n$\\checkmark$ absence of mineralization\n3. Osteosarcoma\n$\\checkmark$ dense / cloudy / ivorylike osteoid mineralization greatest at center + least at periphery\n4. Parosteal osteosarcoma\n5. Ewing sarcoma\n(c) primary benign\n6. Fibrous dysplasia (in 30\\%)\n$\\checkmark$ amorphous mineralization\n7. Enchondroma\n$\\checkmark$ benign osteolytic lesion + chondroid calcification\n8. Osteochondroma\n$\\checkmark$ continuity of medullary cavity between lesion and affected bone\n9. Chondroblastoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 461,
            "markdown": "5. Aneurysmal bone cyst\n6. Giant cell tumor\nB. SOFT TISSUE TUMOR\n(a) adipocytic\n7. Lipoma (common):\n\nLocation: intrathoracic + subcutaneous\n$\\checkmark$ deep seated growing mass between ribs\n$\\checkmark$ mature fat tissue on CT + T1WI\n2. Liposarcoma ( $2^{\\text {nd }}$ most common soft-tissue malignancy)\n$\\checkmark$ prominent internal septa $>2 \\mathrm{~mm}$ in thickness\n$\\checkmark$ nodular nonadipose areas\n(b) vascular\n\n1. Hemangioma\n$\\checkmark$ high SI on T2WI $\\leftarrow$ vascular tissue\n$\\checkmark$ variable amounts of fat tissue on T1WI\n$\\checkmark$ phleboliths on CT\n2. Lymphangioma\n$\\checkmark$ commonly in neck + axilla\n$\\checkmark$ high SI greater than that of fat on T2WI\n3. Angiosarcoma\n\nAssociated with: postmastectomy lymphedema\n4. Hemangioendothelioma, hemangiopericytoma\n$\\checkmark$ usually deep seated\n5. Aneurysm, false aneurysm\n(c) fibroblastic-myofibroblastic\n\n1. Elastofibroma dorsi\n$\\checkmark$ fibrous mass located under serratus anterior / latissimus dorsi muscle\n2. Fibromatosis $=$ desmoid tumor\n(d) fibrohistiocytic\n3. Malignant fibrous histiocytoma $=$ undifferentiated pleomorphic sarcoma (most common soft-tissue malignancy)\n(e) peripheral nerve sheath tumor\n$\\checkmark$ \"target \"sign on T2WI (in 50-70\\% of neurofibromas, in 0-54\\% of schwannomas)\n$\\checkmark$ fascicular\" sign on T2WI (in $63 \\%$ of schwannomas and $25 \\%$ of neurofibromas)\n4. Schwannoma\n5. Neurofibroma (may erode ribs inferiorly with sclerotic bone reaction), neuroma, neuroblastoma\n6. Malignant PNST ( $5-10 \\%$ of all soft-tissue sarcomas)\n\nAssociated with: NF 2 (in 25-70\\%)\n(f) cutaneous lesions\n\n1. Epidermal cyst\n$\\checkmark$ NO high signal intensity on T2WI\n2. Pilomatricoma\n$\\checkmark$ calcified subdermal nodule + peritumoral edema\n3. Dermatofibrosarcoma protuberans",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 462,
            "markdown": "# Chest Wall Tumor in Children \n\n## Malignant Tumors of Chest Wall in Children\n\n$\\diamond$ More common than benign primary chest wall tumors!\n\n1. Ewing sarcoma of rib (most common)\n(a) older child: rib involvement in $7 \\%$, predominant involvement of pelvis + lower extremity\n(b) child $<10$ years: rib involvement in $30 \\%$\n\nDDx: osteomyelitis, unusual-appearing fracture, callus, direct spread of lung infection\n2. Rhabdomyosarcoma\nrelatively common in children + adolescents\n$\\sqrt{ }$ sclerosis / destruction / scalloping of cortex (local extension to contiguous bone)\n$\\sqrt{ }$ may calcify\nMetastases to: lung, occasionally lymph nodes\nPrognosis: infiltrative growth with high risk of local recurrence\n3. Metastasis\n(a) Neuroblastoma\n\n- $10 \\%$ present as chest wall mass\n$\\checkmark$ may calcify\n(b) Leukemia\n\n4. Askin tumor\n5. Chondro- / osteosarcoma (quite rare in pediatric patients)\n\n## Benign Tumors of Chest Wall in Children\n\nA. OSSEOUS\n\n1. Aneurysmal bone cyst\n2. Chondroblastoma\n3. Enchondroma\n4. Osteoblastoma\n5. Osteochondroma\n6. Osteoid osteoma\n\nOften associated with systemic syndrome: neurofibromatosis, histiocytosis, osteochondromatosis\n$\\checkmark$ cortical rib destruction + soft-tissue mass\nB. SOFT TISSUE\n\n1. Lipoma\n2. Hemangioma\n3. Lymphangioma\n4. Teratoma\n\n## BEDSIDE CHEST RADIOGRAPHY\n\nBenefit:\nUnexpected findings: in 37-43-65\\%\nChange in diagnostic approach / therapy: in $27 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 463,
            "markdown": "# Indications: \n\n## A. APPARATUS POSITION + COMPLICATIONS\n\n1. Malposition of tracheal tube ( $12 \\%$ )\n\n$\\sqrt{ }$ tip of tube $4-6 \\mathrm{~cm}$ above carina with neck in neutral position:\n$\\sqrt{ }$ migration by 2 cm inferiorly with flexion\n$\\sqrt{ }$ migration by 2 cm superiorly with extension\n$\\sqrt{ }$ tube diameter should be $1 / 2$ to $2 / 3$ of tracheal lumen\n$\\sqrt{ }$ diameter of inflated balloon should be less than diameter of trachea\n$C x$ :\n(a) Tracheal damage (stenosis / rupture) if ratio of cuff to tracheal lumen $>1.5$\n(2) Aspiration (in 8\\%)\n(3) Disloding of teeth / fillings\n2. Malposition of central venous line ( $9 \\%$ ) into internal jugular vein, azygos arch, internal mammary vein, congenital anomaly (eg, persistent left SVC), artery\n$C x$ : placement into branch vein / anomalous vein (eg, persistent left SVC), intraarterial placement, extravascular placement\nFDA Recommendation:\n(1) Tip of CVC within extrapericardial portion of SVC, 2 cm from cavoatrial junction $=85 \\%$ of distance from sternoclavicular junction to carina $=9 \\mathrm{~mm}$ above carina\n(2) Tip of tunneled hemodialysis catheter at junction of SVC and right atrium / in RA\n(3) Tip of nontunneled upper extremity catheter at superior cavoatrial junction $=4$ cm below carina\n\n- fibrin sheath occlusion is suspected when a well-positioned CVC fails to function normally (confirmed at conventional catheter venography)\n\n3. Malposition of nasogastric tube\n> esophageal malposition\n> bronchial intubation\n> esophageal perforation\n$\\sqrt{ }$ may not be on film if coiled in hypopharynx\n4. Swan-Ganz line (= balloon-directed line)\n\n- $25 \\%$ of catheters malpositioned on initial CXR\n$\\sqrt{ }$ tip should be in main / right / left pulmonary artery (NOT distal to proximal interlobar pulmonary a.)\n$C x$ : pulmonary infarction, pulmonary artery rupture, hemorrhage, cardiac perforation, pseudoaneurysm formation, malposition, intracardiac knot, arrhythmia\n\n5. Thoracostomy tube\n$\\sqrt{ }$ break in radiopaque material (= most proximal side hole should be intrathoracic)\n$\\sqrt{ }$ intrafissural placement makes tube ineffective\n6. Tracheostomy\n$\\diamond$ Position NOT affected by flexion / extension of neck!\n$\\sqrt{ }$ tube diameter should be $2 / 3$ of tracheal lumen\n$\\sqrt{ }$ tip should be at level of T3",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 464,
            "markdown": "7. Intraaortic balloon pump (IABP)\n\n- tip of pump should be just distal to left subclavian artery in proximal descending aorta $=1-2 \\mathrm{~cm}$ below top of aortic arch\n$\\sqrt{ }$ balloon inflates in diastole, deflates in systole\n\n8. Retained catheter / implantable cardioverter-defibrillator lead fragments\n9. Calcified fibrin sheath / calcified thrombus\nB. CARDIOPULMONARY DISEASE\n10. Atelectasis\n\n- most common CXR abnormality in ICU\n\nIncidence increased:\nafter general anesthesia, thoracic / upper abdominal surgery, pre-existing lung disease, smoking, obesity, elderly\nLocation: left lung base (most frequent)\n$\\sqrt{ }$ linear / platelike subsegmental\n$\\checkmark$ lobar / segmental:\n$\\checkmark$ air bronchogram present $=$ collapse of small airways $\\rightarrow$ bronchoscopy not beneficial\n$\\checkmark$ air bronchogram absent $=$ central mucoid impaction $\\rightarrow$ bronchoscopy therapeutic\n![img-44.jpeg](img-44.jpeg)\n$\\sqrt{ }$ patchy density mimicking pneumonia\n$\\checkmark$ rapid temporal change possible\n2. Pulmonary edema\n(a) cardiac (hydrostatic)\nincluding CHF, overhydration, renal failure\nN.B.: cephalization of vasculature NOT helpful in supine position\n$\\checkmark$ usually cardiomegaly (cardiothoracic ratio $\\geq 55 \\%$ )\n$\\checkmark$ enlarged vascular pedicle (mediastinal width at $\\mathrm{SVC} \\geq 70 \\mathrm{~mm}$ )\n$\\checkmark$ Kerley lines\n$\\checkmark$ pleural effusion frequent\n$\\checkmark$ central / diffuse lung opacity\n$\\checkmark$ rapid onset + resolution\nAccuracy of both CT ratio + vascular pedicle width: $70 \\%$ for pulmonary",
            "images": [
                {
                    "id": "img-44.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 941,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1432,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 465,
            "markdown": "wedge pressure $>18 \\mathrm{mmHg}$\n(b) noncardiac (permeability edema)\nincluding ARDS, sepsis, drug reaction, near drowning, smoke inhalation, neurogenic edema, aspiration, fat embolism\n$\\checkmark$ cardiomegaly rare\n$\\checkmark$ Kerley lines absent\n$\\checkmark$ pleural effusions unusual + small\n$\\checkmark$ decreased lung volumes frequent\n$\\checkmark$ diffuse / peripheral lung opacity\n$\\checkmark$ Patchy peripheral distribution in $58 \\%$ of permeability edema vs. in $13 \\%$ of hydrostatic edema\n$\\checkmark$ delayed onset + resolution\n$\\checkmark$ barotrauma common\n3. Pleural effusion (due to CHF)\n\nLocation: bilateral / right-sided\n$\\checkmark$ A solely left-sided effusion suggests a superimposed process / gravity!\n$\\checkmark$ homogeneous density over lower lung\n$\\checkmark$ fluid over apex / in fissures\n$\\checkmark$ intrafissural pseudotumor\n$\\checkmark$ not visible in $30 \\%$\n$D D x$ : atelectasis, empyema (loculated nonmobile effusion), postpericardiotomy syndrome (increasing effusion beyond $3^{\\text {rd }}$ postop. day)\n4. Alveolar disease $=$ pneumonia\n\n- in $10 \\%$ of ICU patients, in $60 \\%$ with ARDS\n- commonly related to aspiration\n$\\checkmark$ slowly progressing, often multifocal patchy areas of consolidation / poorly defined opacities\n$\\checkmark$ air bronchograms\n$\\checkmark$ cavitation (most specific finding)\nImpossible DDx: ARDS, lobar atelectasis\n\n5. Interstitial disease\n\nDDx: (a) interstitial pulmonary edema changes daily\n(b) pneumonia (CMV, pneumocystis)\n6. Barotrauma (in $4-15 \\%$ of ventilated patients)\n\nIncreased risk: underlying lung disease (ARDS, pneumonia), peak inspiratory pressure $>40 \\mathrm{~cm} \\mathrm{H}_{2} \\mathrm{O}$, use of PEEP, large tidal volume\n$\\checkmark$ pulmonary interstitial edema (initially)\n$\\checkmark$ anteromedial / subpulmonic location\n$\\checkmark$ tension pneumothorax (in $60-96 \\%$ ) with mediastinal shift masked by PEEP\n7. Aspiration\n\nIncreased risk: general anesthesia, depressed consciousness, neuromuscular disorder, esophageal disease, presence of NG / ET tube\nLocation: posterior aspect of upper lobes, superior segments + posterior basilar segments of lower lobes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 466,
            "markdown": "$\\checkmark$ focal / multifocal consolidation in dependent location with central predominance $\\checkmark$ aspiration pneumonitis (may progress over first day but clearing within a few days) $\\checkmark$ aspiration pneumonia (lack of clearing / progression)\n8. Thoracic bleeding\n9. Mediastinal disease\n\n# MEDICAL DEVICES ON CXR \n\n## Cardiac Devices\n\nCoronary Artery Bypass Grafting (CABG)\n$\\checkmark$ median sternotomy wires\n$\\checkmark$ vascular clips\n$\\checkmark$ anastomotic markers\n\n## Coronary Artery Stent\n\nwith self / balloon / thermally expandable stents\n\n## Cardiac Conduction Devices\n\n## Circulatory Assist Devices\n\n, Intraaortic Counterpulsation Balloon Pump (IACB) inflated with $\\mathrm{CO}_{2}$ during ventricular diastole to augment perfusion of coronary arteries\n, Ventricular Assist Device (VAD)\n\n## Heart Valve Replacement\n\n(a) mechanical: Starr-Edwards, Björk-Shiley, Medtronic Hall, St. Jude Medical, Sorin Bicarbon, CarboMedics\n(b) biologic: homograft (from human cadaver), xenograft from porcine aortic cusps, bovine pericardium, Carpentier-Edwards, Tissue Med, Hancock\n\n## Vascular Devices\n\n## Central Venous Pressure Catheter\n\n$=$ CVP $=$ CENTRAL CATHETER $=$ CENTRAL LINE\nTypes: Hickman, Broviac, Leonard, Hohn, Cordis Sheath, Swan-Ganz (= pulmonary artery catheter), Groshong\n\n## Implantable Access Devices\n\n$=$ SUBCUTANEOUS PORT\nTypes: Port-A-Cath, SlimPort, Dialock, LifeSite\n\n## Peripheral Inserted Central Catheter (PICC)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 467,
            "markdown": "![img-45.jpeg](img-45.jpeg)",
            "images": [
                {
                    "id": "img-45.jpeg",
                    "top_left_x": 0,
                    "top_left_y": 0,
                    "bottom_right_x": 1698,
                    "bottom_right_y": 2200,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 468,
            "markdown": "# ANATOMY AND FUNCTION OF LUNG",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 469,
            "markdown": "![img-46.jpeg](img-46.jpeg)\n\nORDER OF BRONCHOPULMONARY SEGMENTS OF RIGHT LUNG:\n\n# AIRWAYS \n\nThe carina is normally at the level of T4/T5.\n\n## Embryology of Airways \\& Maldevelopment\n\nfirst 5 weeks GA lung buds grow from ventral aspect of primitive foregut (from caudal end of laryngotracheal groove of primitive pharyngeal floor)\nabnormal: pulmonary agenesis\n5th week GA separation of trachea + esophagus\n5-16 weeks formation of tracheobronchial tree with bronchi, bronchioles, alveolar ducts, alveoli",
            "images": [
                {
                    "id": "img-46.jpeg",
                    "top_left_x": 190,
                    "top_left_y": 191,
                    "bottom_right_x": 1496,
                    "bottom_right_y": 1408,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 470,
            "markdown": "abnormal: bronchogenic cyst $\\leftarrow$ abnormal budding; pulmonary hypoplasia $\\leftarrow$ fewer than expected bronchi\n16-24 weeks dramatic increase in number + complexity of airspaces and blood vessels abnormal: small airways $\\leftarrow$ reduction in number and size of acini\n\n# Anomalous Bronchial Division \n\n## Branching anomalies:\n\n(a) displaced (replaced) bronchus\n$\\sqrt{ }$ bronchus with abnormal origin while normal bronchus ventilating corresponding parenchyma is absent\n(b) supernumerary (accessory) bronchus\n$\\sqrt{ }$ may end blindly in parenchyma of corresponding normal bronchus = congenital bronchial diverticulum\n$\\sqrt{ }$ may ventilate additional lung parenchyma, possibly delineated by an accessory fissure\nTracheal Bronchus (0.1-2.0\\%)\n$=$ bronchus of variable length arising from lower trachea\nFrequency: $0.1-1.3 \\%$ in adults; $1.5-2 \\%$ in childhood\nIn $78 \\%$ associated with:\n![img-47.jpeg](img-47.jpeg)\n\nDown syndrome; malformation of thoracic cage / foregut / lung; tracheal stenosis; other",
            "images": [
                {
                    "id": "img-47.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 963,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1905,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 471,
            "markdown": "tracheobronchial branching anomalies\nType: displaced in $75 \\%$; supernumerary in $25 \\% \\rightarrow$ ventilating intra- / extralobar tracheal lobe (NOT related to azygos lobe)\nLocation: almost invariably on right; bilateral (rare)\nSite: distal trachea $<2 \\mathrm{~cm}$ from carina\n\n- recurrent pneumonia, respiratory distress in childhood\n- almost invariably asymptomatic in adults\n$\\sqrt{ }$ blind-ending pouch (= congenital right tracheal diverticulum) / aeration of a portion or all of RUL\n$\\checkmark$ early origin of apicoposterior LUL bronchus (less common)\n$\\checkmark$ \"pig bronchus\" = entire RULB displaced on trachea\n\n\n# Right Preeparterial Bronchus \n\n$=$ any bronchus directed toward RUL that arises abnormally from RMB above level of right eparterial ULB\nFrequency: $0.9 \\%$\nType: $82 \\%$ displaced\n\n- mostly asymptomatic\n\nDDx: accessory cardiac bronchus\n\n## Right Posteparterial Bronchus\n\n$=$ any bronchus directed toward RUL that arises abnormally from right bronchial tree below level of right eparterial ULB\n\n## Left Eparterial Bronchus\n\n$=$ any bronchus directed toward LUL that arises from posterolateral / lateral wall of LMB above level where left pulmonary artery crosses LMB\n\n## Left Prehyparterial Bronchus\n\n$=$ anomalous bronchus directed toward LUL that arises from LMB between level of left pulmonary artery crossing and hyparterial LULB\n\n## Accessory Cardiac Bronchus (ACB)\n\n$=$ true supernumerary anomalous bronchus\nThe only bronchus originating from medial wall of either RMB or IMB (occasionally on left side)\n$\\mathrm{M} \\div \\mathrm{F}=2.8 \\div 1$\n$\\checkmark$ arises from medial wall of bronchus intermedius prior to origin of apical segmental RLL bronchus\n$\\checkmark$ caudal course toward pericardium\n$\\checkmark$ blind-ending pouch / ventilation of an accessory lobe\n\n## Bridging bronchus\n\n$=$ aberrant bronchus that partially / totally supplies the right lung but originates from LMB\n$\\checkmark$ carina at $\\mathrm{T} 4-\\mathrm{T} 5$\n$\\checkmark$ pseudocarina in the shape of an inverted T at T6-T7",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 472,
            "markdown": "# Paracardiac Bronchus \n\n$=$ normal bronchus arising from medial aspect of lower lobe\nPrevalence: $5 \\%$ of patients\n\n## Airway\n\n$=$ conducting branches for the transport of air; $\\sim 300,000$ branching airways from trachea to bronchiole with an average of 23 airway generations\nDefinition:\nbronchus $=$ cartilage in wall\n![img-48.jpeg](img-48.jpeg)\n\nLevel of Apical Segmental Bronchus\n![img-49.jpeg](img-49.jpeg)\n\nLevel of Right Middle Lobe Bronchus\n![img-50.jpeg](img-50.jpeg)\n\nLevel of Right Upper Lobe Bronchus\n![img-51.jpeg](img-51.jpeg)\n\nLevel of Left Superior Segmental Bronchus\n![img-52.jpeg](img-52.jpeg)\n\nLevel of Lower Lobe Bronchi\n\nCross-sectional Anatomy of Bronchovascular Divisions\n\nRight Lung\n\n| ant | $=$ anterior RUL | pb | $=$ | posterobasal RLL |\n| :-- | :-- | :-- | :-- | :-- |\n| ap | $=$ apical RUL | post | $=$ | posterior RUL |\n| BI | $=$ bronchus intermedius | RLL | $=$ | right lower lobe |\n| lat | $=$ lateral RML | RML | $=$ | right middle lobe |\n| mb | $=$ mediobasal RLL | RUL | $=$ | right upper lobe |\n| med $=$ | medial RML | s-RLL | $=$ | superior segment |\n| RUL-PA / LUL-PA | $=\\mathrm{R} / \\mathrm{L}$ upper lobe pulmonary artery |  |  |  |\n| RLL-PAs / LLL-PAs | $=\\mathrm{R} / \\mathrm{L}$ pulmonary artery |  |  |  |\n| RIPV / LIPV | $=\\mathrm{R} / \\mathrm{L}$ inferior pulmonary vein |  |  |  |\n| RPA | $=$ R pulmonary artery |  |  |  |\n\n\n| Left Lung |  |  |  |\n| :--: | :--: | :--: | :--: |\n| amb | $=$ | anteromediobasal <br> LLL | ap-p | apicoposterior <br> LUL |\n| lb | $=$ | laterobasal LLL | LLL | left lower lobe |\n| LMB | $=$ | left main bronchus | LUL | left upper lobe |\n| pb | $=$ | posterobasal LLL | s-LLL | superior segment |\n| ac | $=$ | azygoesophageal recess |  |  |\n\n\n| RIPA / LIPA | $=\\mathrm{R} / \\mathrm{L}$ inferior pulmonary artery |\n| :-- | :-- |\n| RLL-PAs / LLL-PAs | $=\\mathrm{R} / \\mathrm{L}$ lower lobe pulmonary arteries |\n| RSPV / LSPV | $=\\mathrm{R} / \\mathrm{L}$ superior pulmonary vein |",
            "images": [
                {
                    "id": "img-48.jpeg",
                    "top_left_x": 190,
                    "top_left_y": 580,
                    "bottom_right_x": 625,
                    "bottom_right_y": 908,
                    "image_base64": null
                },
                {
                    "id": "img-49.jpeg",
                    "top_left_x": 204,
                    "top_left_y": 957,
                    "bottom_right_x": 625,
                    "bottom_right_y": 1265,
                    "image_base64": null
                },
                {
                    "id": "img-50.jpeg",
                    "top_left_x": 654,
                    "top_left_y": 583,
                    "bottom_right_x": 1059,
                    "bottom_right_y": 908,
                    "image_base64": null
                },
                {
                    "id": "img-51.jpeg",
                    "top_left_x": 654,
                    "top_left_y": 957,
                    "bottom_right_x": 1059,
                    "bottom_right_y": 1265,
                    "image_base64": null
                },
                {
                    "id": "img-52.jpeg",
                    "top_left_x": 1072,
                    "top_left_y": 957,
                    "bottom_right_x": 1496,
                    "bottom_right_y": 1265,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 473,
            "markdown": "![img-53.jpeg](img-53.jpeg)",
            "images": [
                {
                    "id": "img-53.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1339,
                    "bottom_right_y": 1892,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 474,
            "markdown": "![img-54.jpeg](img-54.jpeg)\nbronchiole $=$ absence of cartilage (after 6-2 divisions of segmental bronchus)\n) membranous bronchiole = purely air conducting\nrespiratory bronchiole = contains alveoli in its wall\n) lobular bronchiole = supplies secondary pulmonary lobule; may branch into 3 or more terminal bronchioles\n) terminal bronchiole = last generation of purely conducting bronchioles without alveoli; each supplying one acinus\nsmall $\\quad=$ internal diameter $<2 \\mathrm{~mm}=$ small noncartilaginous membranous and airways $\\quad$ respiratory bronchioles; account for $25 \\%$ of airway resistance\nlarge $\\quad=$ diameter $>2 \\mathrm{~mm}$; account for $75 \\%$ of airway resistance\nairways\nHRCT of normal lung (window level -700 HU , window width $1,000-1,500$ ):\n$\\sqrt{ }-875 \\pm 18 \\mathrm{HU}$ at inspiration\n$\\sqrt{ }-620 \\pm 43 \\mathrm{HU}$ at expiration\n$\\sqrt{ } 8^{\\text {th }}$ order bronchi visible $=$ bronchi $>2 \\mathrm{~mm}$ in diameter\n$\\diamond$ Normal lobular bronchioles NOT visible!\n\n# Acinus \n\n$\\diamond$ Functionally most important subunit of lung!\n$=$ all parenchymal tissue distal to one terminal bronchiole comprising $2-5$ generations of respiratory bronchioles + alveolar ducts + alveolar sacs + alveoli\n\n- gas exchange\n$\\sqrt{ }$ radiologically NOT visible\nCells of Lung Parenchyma $75 \\%$ of all lung cells\n\n1. Air-blood barrier\n> epithelial cells $(25 \\%)=$ lining of air space\n> endothelial cells $(25 \\%)=$ lining of vessels\n> interstitial cells ( $35 \\%$ ), collagen fibres ( $15 \\%$ )\n2. Alveolar epithelium\n> lining cells (type I pneumocyte) $\\rightarrow$ tight junctions, no mitosis\n> secretory cells (type II pneumocyte) $\\rightarrow$ synthesis + storage + secretion of surfactant\n> brush cells\n\n## [Primary Pulmonary Lobule]",
            "images": [
                {
                    "id": "img-54.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 189,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 572,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 475,
            "markdown": "$=$ alveolar duct + its connected air spaces\n\n# Secondary Pulmonary Lobule \n\n$=$ REID LOBULE\n[Lynne McArthur Reid (1923-?), experimental pathologist and dean of Cardiothoracic Institute, London University, Harvard Medical School, pathologist-in-chief emeritus at Children's Hospital in Boston]\n$=$ smallest portion of lung surrounded by connective tissue septa; supplied by 3-5 terminal bronchioles\n$\\checkmark$ basic anatomic + functional pulmonary unit appearing as an irregular polyhedron containing $3-24$ acini\n$\\checkmark$ separated from each other by thin fibrous interlobular septa $(100 \\mu \\mathrm{~m})$\nSize: $\\quad 10-25 \\mathrm{~mm}$ in diameter\n\n- visible on surface of lung\n\nContents:\n> centrally = lobular core:\n» branches of terminal bronchioles with a 0.1 mm wall thickness = below the resolution of HRCT\n$\\checkmark$ pulmonary arterioles ( 1 mm )\n> peripherally (within interlobular septa):\n$\\checkmark$ pulmonary vein + lymph vessels\nHRCT:\n$\\checkmark$ barely visible fine lines of increased attenuation in contact with pleura (= interlobular septa); best developed in subpleural areas of\n> UL + ML: anterior + lateral + juxtamediastinal\n> LL: anterior + diaphragmatic regions\n$\\checkmark$ dotlike / linear / branching structures (= pulmonary arterioles)\nSite: near center of secondary pulmonary lobule; $3-5 \\mathrm{~mm}$ from pleura\n\n## Interstitial Anatomy\n\n1. Bronchovascular interstitium surrounding bronchovascular bundle\n2. Centrilobular interstitium\nsurrounds distal bronchiolovascular bundle\n$\\sqrt{ }$ line extending to the center of a lobule\n3. Interlobular septal interstitium\n$\\checkmark$ lines perpendicular to pleura surrounding a lobule\n4. Pleural interstitium",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 476,
            "markdown": "| Lung Interstitium |  |\n| :--: | :--: |\n| Division | Components |\n| Axial | bronchovascular sheaths, lymphatics |\n| Middle (parenchymal) | alveolar wall (interalveolar septum) |\n| Peripheral | pleura, subpleural connective tissue interlobular septa (enclosing pulmonary veins, lymphatics, walls of cortical alveoli) |\n\n# Lung Development \n\n) embryonic phase\nrespiratory diverticulum (= laryngotracheal bud) originates from ventral wall of primitive foregut\n$\\rightarrow$ elongation of lung bud $\\rightarrow$ lateral invagination of mesoderm $\\rightarrow$ tracheoesophageal septum\n$\\rightarrow$ bifurcation of laryngotracheal bud at 5-7 weeks EGA $\\rightarrow \\mathrm{R}+\\mathrm{L}$ mainstem bronchi\n$\\rightarrow$ mainstem bronchi branch further into lobar bronchi\n$\\rightarrow$ pulmonary arteries arise from $6^{\\text {th }}$ aortic arch\nTime: 26 days to 7 weeks EGA\n> pseudoglandular phase development of segmental + subsegmental bronchi, respiratory bronchioles + terminal bronchioles, alveolar ducts + alveoli\nTime: 7-16 weeks EGA\n> canalicular / acinar phase development of distal acinar units + canalization of further airspaces; airspaces are approximated by network of capillaries; type II alveolar cells capable of surfactant synthesis\nTime: 16-24 weeks EGA\n> saccular phase increase in number of terminal sacs + thinning of intervening interstitium + beginning of alveolar septation\nTime: 24-36 weeks EGA\n> alveolar phase development of true fully mature alveoli with progressive formation throughout first 2 years of life\nTime: 36 weeks EGA $-18^{\\text {th }}$ postnatal month\nmnemonic: Every Premature Child Takes Air\nEmbryonic phase\nPseudoglandular phase\nCanalicular phase\nTerminal sac phase\nAlveolar phase\n\n## Surfactant\n\n$=$ surface-active material essential for normal pulmonary function\nSubstrate: phospholipids (dipalmitoylphosphatidylcholine, phosphatidylglycerol), other lipids, cholesterol, lung-specific proteins\nProduction: type II pulmonary alveoli synthesize + transport + secrete lung surfactant; earliest production around $18^{\\text {th }}$ week of gestation (in amniotic fluid by $22^{\\text {nd }}$ week",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 477,
            "markdown": "of gestation)\nAction: increases lung compliance, stabilizes alveoli, enhances alveolar fluid clearance, reverses surface tension, protects against alveolar collapse during respiration, protects epithelial cell surface, reduces opening pressure + precapillary tone\n\n# PULMONARY CIRCULATION \n\n## Primary Pulmonary Circulation\n\n$\\Rightarrow$ supplies $99 \\%$ of blood flow to lungs pulmonary arteries travel along lobar + segmental bronchi down to subsegmental level matching caliber of airways\n(a) large elastic pulmonary arteries ( 500 to $>1,000 \\mu \\mathrm{~m}$ ) accompany lobar + segmental bronchi matching caliber of airways\n> main pulmonary artery / trunk: $\\leq 28 \\mathrm{~mm}$\n> right / left pulmonary artery\n> lobar pulmonary artery\n> segmental pulmonary artery\n(b) muscular arteries $(50-1,000 \\mu \\mathrm{~m})$ accompany subsegmental airways + terminal bronchioles\n$\\sqrt{ }$ provide active vasodilatation + constriction\n(c) arterioles $(15-150 \\mu \\mathrm{~m})$ accompany respiratory bronchioles + alveolar ducts\n(d) capillary network in alveolar walls\n(e) venules\n(f) pulmonary veins course through interlobular fibrous septa\n\nFunction: gas exchange\n\n## Bronchial Circulation\n\n$\\Rightarrow$ supplies $1 \\%$ of blood flow to lungs $=1 \\%$ of cardiac output\nPressure: systemic high-pressure system ( 6 x that of normal pulmonary circulation); bronchial arteries are resistant to arteriosclerosis\nOrigin:\n(a) orthotopic bronchial artery (64\\%): anteriorly from proximal to mid-descending thoracic aorta at level of left main bronchus between superior endplate of T5 and inferior endplate of T6\nAngio landmark: 1 cm above / below level of left main bronchus as it crosses descending thoracic aorta\n(b) at least one ectopic bronchial artery (36\\%):\n> from undersurface of aortic arch (15\\%)\n> distal descending thoracic aorta, subclavian artery, thyrocervical trunk, costocervical trunk, brachiocephalic trunk, internal mammary artery, pericardiophrenic a., inferior phrenic a., coronary a.\n(c) left bronchial artery: most commonly directly from aorta toward left side of esophagus\n(d) right bronchial artery: most commonly originating from another artery, typically intercostal artery toward right side of esophagus\nVariants of vascular anatomy (9 types):\n(1) 1 right bronchial a. arising posteromedially from a common InterCostal Bronchial",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 478,
            "markdown": "Artery Trunk (ICBAT) +2 left bronchial a. anteriorly (41\\%)\n(2) 1 bronchial artery on each side, the right bronchial artery originating from an ICBAT $(21 \\%)$\n(3) 2 bronchial aa. on each side, 1 right bronchial artery originating from an ICBAT (21\\%)\n(4) 1 right bronchial a. +1 right ICBAT +2 left bronchial arteries ( $10 \\%$ )\n\nCourse: behind trachea and main-stem bronchi; enter lung via hila; tortuous path along peribronchial sheath of mainstem airway to terminal bronchioles\nFunction:\n$\\Rightarrow$ nourishment for supporting structures\n> extra- and intrapulmonary airways\n> vasa vasorum of pulmonary arteries\n> nerves, pulmonary veins, lymph nodes within thorax\n$\\Rightarrow$ systemic blood supply to\n> trachea, bronchi, bronchial branches, visceral pleura\n> esophagus\nThe bronchial circulation + other collateral vessels (eg, intercostal, internal mammary, inferior phrenic aa.) respond to chronic pulmonary ischemia and $\\downarrow$ pulmonary blood flow $\\rightarrow$ vessel hypertrophy / enlargement $\\rightarrow$ maintenance of blood flow to affected lung + participation in gas exchange through systemic-pulmonary arterial anastomoses beyond the pulmonary artery obstruction.\n\n# Bronchial-to-Pulmonary Artery Anastomoses \n\n$=$ microvascular connections ( $=$ capillary communications) at level of alveoli and respiratory bronchioles\n$\\Rightarrow$ normal L-to-R shunt accounting for $5 \\%$ of cardiac output\n$\\sqrt{ }$ normal bronchial arteries NOT usually visible on thoracic angiography\n\n## LUNG FUNCTION\n\n## Lung Volumes \\& Capacities\n\n1. Tidal volume (TV)\n$=$ amount of gas moving in + out with each respiratory cycle",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 479,
            "markdown": "![img-55.jpeg](img-55.jpeg)\n2. Residual volume (RV)\n$=$ amount of gas remaining in lung after maximal expiration\n3. Total lung capacity (TLC)\n$=$ gas contained in lung at end of maximal inspiration\n4. Vital capacity (VC)\n$=$ amount of gas that can be expired after a maximal inspiration without force\n5. Functional residual capacity (FRC)\n$=$ volume of gas remaining in lungs at end of quiet expiration\n\n# Changes In Lung Volumes \n\nA. DECREASED VITAL CAPACITY:\n\n1. Reduction in functioning lung tissue due to\n(a) space-occupying process (eg, pneumonia, infarction)\n(b) surgical removal of lung tissue\n2. Process reducing overall volume of the lungs\n(eg, diffuse pulmonary fibrosis)\n3. Inability to expand lungs due to\n(a) muscular weakness (eg, poliomyelitis)\n(b) increase in abdominal volume (eg, pregnancy)\n(c) pleural effusion\nB. INCREASED FRC and RV:\n$=$ characteristic of air trapping and overinflation (eg, asthma, emphysema)\nAssociated with: increased TLC\n$\\sqrt{ }$ normal level of inflation to $8^{\\text {th }}$ posterior rib\nC. DECREASED FRC and RV:\n4. Process reducing overall volume of lungs",
            "images": [
                {
                    "id": "img-55.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 924,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 480,
            "markdown": "(eg, diffuse pulmonary fibrosis)\n2. Process that occupies volume within alveoli (eg, alveolar microlithiasis)\n3. Process that elevates diaphragm (eg, ascites, pregnancy), usually associated with decreased TLC\n\n# Flow Rates \n\nA. Spirometric measurements:\n\n1. Forced expiratory volume (FEV)\n$=$ amount of air expired during a certain period (usually $1+3$ seconds)\nNormal values: $\\mathbf{F E V}_{\\mathbf{1}}=83 \\% ; \\mathbf{F E V}_{\\mathbf{3}}=97 \\%$\n2. Maximal midexpiratory flow rate (MMFR)\n$=$ amount of gas expired during middle half of forced expiratory volume curve (largely effort independent)\nIndicator of small airway resistance\n3. Flow-volume loop\n$=$ gas flow is plotted against the actual volume of lung at which this flow is occurring Useful in identifying obstruction in large airways\nB. Resistance in small airways\n\nClosing volume $=$ lung volume at which dependent lung zones cease to ventilate because of airway closure in small airway disease or loss of lung elastic recoil\n\n- decrease in FEV, MMFR, MBC:\n(a) expiratory airway obstruction (reversible as in spasmodic asthma / irreversible as in emphysema)\n(b) respiratory muscle weakness\n\n\n## Diffusing Capacity\n\n$=$ rate of gas transfer across alveolocapillary membrane in relation to constant pressure differences across it; measured by carbon monoxide diffusion method DLCO.\nTechnique:\n» patient inspires maximally a gas with a known small concentration of CO\n» breath-holding for 10 seconds followed by slow expiration to residual volume (RV)\n» an aliquot of the end-expired (alveolar) gas is analyzed for amount of CO absorbed during breath\nMeasurement: in mL of CO absorbed $/ \\mathrm{min} / \\mathrm{mmHg}$\nCauses of reduction:\n\n1. Ventilation / perfusion inequality: less CO is taken up by poorly ventilated or poorly perfused areas (eg, emphysema)\n2. Reduction of total surface area (eg, emphysema, surgical resection)\n3. Reduction in permeability from thickening of alveolar membrane (eg, cellular infiltration, edema, interstitial fibrosis)\n4. Anemia with lack of hemoglobin\n\n## Arterial Blood Gas Abnormalities\n\n- decreased pulmonary arterial O2:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 481,
            "markdown": "1. Alveolar hypoventilation\n2. Impaired diffusion\n3. Abnormal ventilation / perfusion ratios\n4. Anatomic shunting\n\n- elevated pulmonary arterial $\\mathrm{CO}_{2}$ :\n\n1. Alveolar hypoventilation\n2. Impaired ventilation / perfusion ratios\n\n# V/Q Inequality \n\nA. NORMAL\n(a) blood flow decreases rapidly from base to apex\n(b) ventilation decreases less rapidly from base to apex\n$\\diamond \\mathrm{V} / \\mathrm{Q}$ is low at base and high at apex\n$\\diamond$ Pulmonary arterial O 2 is substantially higher at apex\n$\\diamond$ Pulmonary arterial $\\mathrm{CO}_{2}$ is substantially higher at base\nB. ABNORMAL\nchiefly resulting from non- / underventilated lung regions\n$\\diamond$ Non- / underperfused regions do NOT result in blood gas disturbances!\n\n## Compliance\n\n$=$ relationship of the change in intrapleural pressure to the volume of gas that moves into the lungs\nA. DECREASED COMPLIANCE\nedema, fibrosis, granulomatous infiltration\nB. INCREASED COMPLIANCE\nemphysema (faulty elastic architecture)\n$\\sqrt{ }$ height of diaphragm at TLC can provide some indication of lung compliance, particularly valuable in sequential roentgenograms for comparison in:\n\n1. Diffuse interstitial pulmonary edema\n2. Diffuse interstitial pulmonary fibrosis\n\n## LUNG ZONES\n\n## Pressure Gradients in Upright Position (Erect Lung)\n\nGravity 20 mmHg blood pressure gradient between top and bottom for erect lung\n$\\mathrm{P}_{\\text {alveolar }} \\quad 0 \\pm 2 \\mathrm{~cm} \\mathrm{H}_{2} 0(1.5 \\mathrm{mmHg})$ at zero flow at end expiration equal to atmospheric pressure\n$\\mathrm{P}_{\\text {venous }} \\sim 5(-5$ at apex $\\rightarrow+15 \\mathrm{mmHg}$ at base $) \\mathrm{mmHg}$\n$\\mathrm{P}_{\\text {arterial }} \\quad 15$ (range, 5 at apex $\\rightarrow 25 \\mathrm{mmHg}$ at base) mmHg\n\n## Vertical Zonal Distribution\n\nZone 1: $\\mathrm{P}_{\\text {alveolar }}>\\mathrm{P}_{\\text {arterial }}>\\mathrm{P}_{\\text {venous }}$\npositive pressure ventilation / lung hemorrhage $\\rightarrow$ complete vascular collapse $\\rightarrow$ cessation of blood flow (= alveolar dead space)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 482,
            "markdown": "Zone 2: $\\mathrm{P}_{\\text {arterial }}>\\mathrm{P}_{\\text {alveolar }}>\\mathrm{P}_{\\text {venous }}$\nabout 3 cm above the heart $\\rightarrow$ cyclical capillary blood flow ( $=$ no flow in diastole to maximum flow during systole $=$ starlings resistor or waterfall effect)\nZone 3: $\\mathrm{P}_{\\text {arterial }}>\\mathrm{P}_{\\text {venous }}>\\mathrm{P}_{\\text {alveolar }}$\nlung in health $\\rightarrow$ continuous blood flow throughout cardiac cycle determined by arteriovenous pressure difference; transmural pressure increases due to gravity $\\rightarrow$ increase in vessel caliber\nZone 4: $\\mathrm{P}_{\\text {arterial }}>$ Pinterstitial $>\\mathrm{P}_{\\text {venous }}>\\mathrm{P}_{\\text {alveolar }}$\nlung base at low lung volumes or pulmonary edema $\\rightarrow$ interstitial pressure rises with $\\Downarrow$ in lung volume ( $\\leftarrow$ reduced radial tethering of lung) OR fluid leakage from lung vessels; pressure is highest at lung base due to weight of lung above $\\rightarrow$ increase in resistance to flow $\\rightarrow \\Downarrow$ caliber of extra-alveolar blood vessels\nEffect on V/Q ratio\n> highest in zone 1 of lung apex in erect person because perfusion is nearly absent\n> lower in zone 3 with both high ventilation, perfusion and lymphatic drainage in erect chest\n\n# MEDIASTINUM \n\nTerminology: coined by Spigelius \"Quod per medium stat\" = \"what sits in the middle\"\nA. SUPERIOR MEDIASTINAL COMPARTMENT\n$=$ thoracic inlet\nB. INFERIOR MEDIASTINAL COMPARTMENT\n(1) Anterior mediastinum = retrosternal region\n\nAnterior boundary: sternum\nPosterior boundary: pericardium, aorta, brachiocephalic vessels\nSuperior boundary: thoracic inlet\nInferior boundary: diaphragm\nContents: thymus, lymph nodes, adipose tissue, internal mammary vessels\n(2) Middle mediastinum = visceral region\n\nAnterior boundary: pericardium\nPosterior boundary: pericardium, posterior tracheal wall\nSuperior boundary: thoracic inlet\nInferior boundary: diaphragm\nContents: heart, pericardium, ascending + transverse aorta, SVC, IVC, brachiocephalic vessels, pulmonary vessels, trachea + main bronchi, lymph nodes, phrenic n., vagus n., left recurrent laryngeal n .\n(3) Posterior mediastinum = contains esophagus, descending aorta, paraspinal region\n\nAnterior boundary: posterior trachea, pericardium\nPosterior boundary: line 1 cm posterior to the anterior edge of vertebral column\nSuperior boundary: thoracic inlet\nInferior boundary: diaphragm\nContents: esophagus, descending aorta, azygos + hemiazygos veins, thoracic duct, vagus n., splanchnic n., lymph nodes, fat",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 483,
            "markdown": "# Lung-Mediastinal Interfaces on Frontal CXR \n\n1. Anterior junction line\n$=$ apposing pleural reflections\nLocation: anterior to aorta behind upper $2 / 3$ of sternum; does not extend above manubriosternal junction\nThickness: 4 layers of pleura separated by variable amount of fat\nCourse: obliquely from upper right to lower left\nVisualization in: $25-57 \\%$\nAbnormal in: thyroid mass, lymphadenopathy, neoplasm, thymic mass, lipomatosis\n2. Posterior junction line\n$=$ apposing 4 layers of pleural reflections\nLocation: posterior to esophagus and anterior to spine (between $3^{\\text {rd }}-5^{\\text {th }}$ thoracic vertebrae); typically projecting through trachea\nCourse: vertically from lung apices to top of aortic arch (above suprasternal notch)\nVisualization in: $32 \\%$\nAbnormal in: esophageal mass, lymphadenopathy, aortic disease, neurogenic tumor\n3. Right paratracheal stripe\n$=1-4 \\mathrm{~mm}$ uniformly thick line between tracheal air column and right lung\nLocation: undersurface of right clavicle to azygos arch\nCourse: vertical\nVisualization in: 94-97\\%\nAbnormal in: paratracheal lymphadenopathy, tracheal ca. + stenosis, thyroid + parathyroid neoplasm\n4. Left paratracheal stripe\n$=$ uniformly thick line between tracheal air column and left upper lobe\nLocation: superiorly from aortic arch to left subclavian a.\nCourse: vertical\nVisualization in: $21-31 \\%$\nAbnormal in: left pleural effusion, left paratracheal lymphadenopathy, neoplasm, mediastinal hematoma\n5. Azygoesophageal recess\n$=$ right lung abutting the azygos vein posteriorly and esophagus anteriorly\nLocation: undersurface of azygos arch to aortic hiatus\nCourse: vertical straight / mild leftward convexity\nAbnormal in: lymphadenopathy, hiatal hernia, bronchopulmonary foregut malformation, esophageal neoplasm, pleural abnormalities, cardiomegaly with left atrial enlargement\n6. Right paraspinal line\n$=$ lung abutting the lateral margins of thoracic vertebral bodies (left paraspinal line more often seen than right)\nLocation: from $8^{\\text {th }}$ to $12^{\\text {th }}$ thoracic vertebra\nCourse: straight vertical\nVisualization in: $23 \\%$\nAbnormal in: osteophytes, prominent mediastinal fat, neoplasm, mediastinal hematoma, extramedullary hematopoiesis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 484,
            "markdown": "# 7. Left paraspinal line \n\n![img-56.jpeg](img-56.jpeg)\n$=$ lung abutting the lateral margins of thoracic vertebral bodies, mediastinal fat, paraspinal muscles\nLocation: aortic arch to diaphragm, typically medial to lateral wall of descending thoracic aorta\nCourse: straight vertical\nVisualization in: $41 \\%$\nAbnormal in: osteophytes, prominent mediastinal fat, neoplasm, mediastinal hematoma, extramedullary hematopoiesis, tortuosity of descending thoracic aorta, esophageal varices\n8. Aorticopulmonary stripe\n$=$ interface of anterior left lung + mediastinal fat anterolateral to left pulmonary artery + aortic arch\nCourse: straight / mildly convex\nAbnormal in: pneumomediastinum, thyroid + thymic mass, prevascular lymphadenopathy\n9. Aortic-pulmonary (AP) window / stripe\n$=$ space between inferior wall of aortic arch + superior wall of left pulmonary artery Border:\n> superior: inferior wall of aortic arch\n> inferior: superior wall of left pulmonary artery\n$>$ posterior: anterior wall of ascending aorta",
            "images": [
                {
                    "id": "img-56.jpeg",
                    "top_left_x": 391,
                    "top_left_y": 259,
                    "bottom_right_x": 1302,
                    "bottom_right_y": 1117,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 485,
            "markdown": "> anterior: posterior wall of ascending aorta\n> lateral: left lung + pleura\n> medial: trachea, lateral wall of LMB, esophagus\nLocation: posterior to aorticopulmonary stripe\nCourse: straight / concave reflection along mediastinum\nAbnormal in: mediastinal fat, lymphadenopathy, aneurysm of aorta / bronchial artery, nerve sheath tumor (recurrent laryngeal nerve, left vagus nerve)\n\n# Lung-Mediastinal Interfaces on Lateral CXR \n\n1. Tracheoesophageal / posterior tracheal stripe\n$=$ formed by air within trachea and right lung\nLocation: anterior border of retrotracheal space (= Raider triangle)\nThickness: up to 2.5 mm ; up to 5.5 mm (if wall of air-containing esophagus included)\nCourse: vertical\nAbnormal in: congenital developmental anomalies of aortic arch, acquired vascular lesion, esophageal lesion, lymphatic malformation, mediastinitis, posttraumatic hematoma\n![img-57.jpeg](img-57.jpeg)\n2. Posterior wall of bronchus intermedius\n$=$ formed by air in bronchus intermedius, which descends for $3-4 \\mathrm{~cm}$, and lung within azygoesophageal recess\nCourse: thin vertical / slightly oblique stripe that projects through the radiolucent area created by left upper lobe bronchus",
            "images": [
                {
                    "id": "img-57.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 906,
                    "bottom_right_x": 1319,
                    "bottom_right_y": 1757,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 486,
            "markdown": "Thickness: $0.5-3.0 \\mathrm{~mm}$\nVisualization in: 90-95\\%\nAbnormal in: pulmonary edema, lung neoplasm, lymphadenopathy\n\n# THYMUS \n\n[thymos, Greek = warty excrescence, soul, spirit]\nEmbryogenesis:\ndorsal + ventral wings of $3^{\\text {rd }}$ (and possibly $4^{\\text {th }}$ ) pharyngeal (branchial) pouch begin to form elongated cylindrical primordia during $7^{\\text {th }}$ week (= thymopharyngeal ducts); both ducts migrate caudally and medially into anterior mediastinum pulling inferior parathyroid glands along; thymic primordia fuse at their lower poles inferior to thyroid gland during $8^{\\text {th }}$ week; thymic tail thins + disappears by $8^{\\text {th }}$ week of GA\n$\\diamond$ Residual thymic tissue in neck in $1.8-21 \\%$\nHisto: contains elements of all 3 germinal layers; until $9^{\\text {th }}$ week EGA purely epithelial; during $10^{\\text {th }}$ week EGA lymphoid cells migrate from fetal liver + bone marrow into primordia causing thymic lobulation; differentiation into cortex and medulla completed by $16^{\\text {th }}$ week EGA\nCortex: primarily lymphocytes = thymocytes\nMedulla: more epithelial cells = nurse cells (essential for maturation of T lymphocytes); Hassall corpuscles (round keratinized formations with mature epithelial cells)\nFunction: development + maturation of immune system during childhood, ie, T-cells (regulating cellular immunity) and B cells (regulating humoral immunity)\nThymic weight:\nincreases from birth to age $11-12$ years ( $22 \\pm 13 \\mathrm{~g}$ in neonate, $34 \\pm 15 \\mathrm{~g}$ at puberty); ratio of thymic weight to body weight decreases with age (largest during infancy, fatty involution after puberty, total fatty replacement after age 60 )\nExtent: from manubrium to $4^{\\text {th }}$ costal cartilage; may bulge into neck / extend down to diaphragm\n$\\checkmark$ normal thymus visible in $50 \\%$ of neonates $0-2$ years of age\n$\\checkmark$ \"notch\" sign = indentation at junction of thymus + heart\n$\\checkmark$ \"sail\" sign = triangular density extending from superior mediastinum\n$\\checkmark$ \"wave\" sign = rippled border due to indentation by ribs\n$\\checkmark$ shape changes with respiration + position\nCXR:\n$\\checkmark$ prominent normal thymus visible in $50 \\%$ of neonates + infants $0-3$ years of age\n$\\checkmark$ \"notch\" sign = indentation at junction of thymus + heart\n$\\checkmark$ \"sail\" sign $(5 \\%)=$ triangular slightly right-convex density extending from superior mediastinum, usually on right side with sharply demarcated base caused by minor fissure\n$\\checkmark$ \"wave\" sign = rippled / undulated / scalloped / wavy lateral border due to indentation by ribs\n$\\checkmark$ shape changes with respiration + position\n$D D x$ : mediastinal mass, upper lobe pneumonia, atelectasis\nCT:\n$\\checkmark$ measurement (perpendicular to axis of aortic arch):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 487,
            "markdown": "> mean thickness of 11 (5) mm at $<20$ ( $>50$ ) years\n> maximal thickness of $<18(<13) \\mathrm{mm}$ at $<20$ ( $>20$ ) years\n$\\checkmark$ visualization of thymus:\n$\\checkmark$ detected in $83 \\%(17 \\%)$ of subjects $<50$ ( $>50)$ years of age\n$\\checkmark$ shape of thymus:\n$\\checkmark$ quadrilateral with convex borders in child $<5$ years\n$\\checkmark$ triangular like an arrowhead ( $62 \\%$ ), bilobed ( $32 \\%$ ), single lobe ( $6 \\%$ ) in older child\n$\\checkmark$ density of thymus:\n$\\checkmark$ muscular density of 30 HU (before puberty)\n$\\checkmark$ flat / concave borders with abundant fat (after puberty)\nUS (supra-, trans-, parasternal approach in infants):\n$\\checkmark$ homogeneous finely granular echotexture with multiple linear / branching echogenic foci\n$\\checkmark$ mildly hypoechoic ( $25 \\%$ ) / isoechoic ( $75 \\%$ ) to liver, spleen, thyroid\n$\\checkmark$ smooth well-defined margin $\\leftarrow$ fibrous capsule\n$\\checkmark$ hypo- / avascular\nN.B.: pliable organ WITHOUT causing compression / displacement of adjacent structures MR:\n$\\checkmark$ homogeneous texture hyperintense to muscle on T1WI\n$\\checkmark$ signal intensity close to fat on T2WI\nPET:\n$\\checkmark$ usually barely visible\n$\\checkmark$ striking FDG avidity in rebound hyperplasia\n\n# Ectopic Thymus \n\n$\\checkmark$ solid mass of identical attenuation / signal as normal thymus\n$\\checkmark$ often connected to normal thymus\n$\\checkmark$ cystic mass (= endodermal-lined cavity of thymopharyngeal duct / cystic degeneration of Hassall corpuscles or glandular epithelium)\n(1) Unilateral failure of thymic primordium to descend\n$\\checkmark$ neck mass of thymic tissue on one side of neck\n$\\checkmark$ ipsilateral absence of normal thymic lobe\n$\\checkmark$ parathyroid tissue within ectopic thymus\n(2) Small rest of thymus left behind within thymopharyngeal tract during migration $\\leftarrow$ failure to involute\n$\\checkmark$ neck mass $(32 \\%)$\n$\\checkmark$ normally positioned bilobed thymus\n(3) Atypical location $\\leftarrow$ sequestration: trachea, skull base, intrathyroidal, behind thyroid (26\\%), adjacent to SVC / brachiocephalic vessels / aorta, posterior mediastinum, dermis $\\checkmark$ widened superior mediastinum\n$R x$ : no treatment unless symptomatic\n\n## DIAPHRAGM\n\n$=$ musculofibrous septum separating abdominal + thoracic cavities\nTime of formation: $4^{\\text {th }}-12^{\\text {th }}$ weeks of embryonic life\nEmbryologic precursors \\& final structures:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 488,
            "markdown": "ventral septum transversum $\\rightarrow$ gradually extends posteriorly around esophagus + great vessels $\\rightarrow$ fuses with foregut mesentery $\\rightarrow$ forms posteromedial portions by $8^{\\text {th }}$ week $\\rightarrow$ lateral margins of diaphragm from muscles of thoracic wall $\\rightarrow$ posterolaterally located pleuroperitoneal foramina close last\n(1) Septum transversum ventrally during $3^{\\text {rd }}-5^{\\text {th }}$ week $\\rightarrow$ central tendon\n(2) Pleuroperitoneal membrane $\\rightarrow$ muscular diaphragm\n(3) Dorsal mesentery of esophagus $\\rightarrow$ median portion of diaphragm and crura\n(4) Body wall $\\rightarrow$ peripheral muscle fibers of diaphragm attached to\n(a) sternum\n(b) costal margin of inferior ribs\n(c) lumbar portion\n> arcuate ligaments $=2$ pairs of medial + lateral lumbocostal arches\n» medial arcuate ligament: arches over psoas major m. + attaches to anterior aspect of transverse process of L1\n» lateral arcuate ligament: arches over quadratus lumborum m. + attaches laterally to $12^{\\text {th }}$ rib + medially to anterior aspect of transverse process of L1\n> diaphragmatic crura = bilateral musculotendinous pillars attaching to anterolateral surface of lumbar vertebrae + intervertebral fibrocartilage:\n»L1-L3 for longer + broader right crus\n» L1-L2 for shorter left crus\n[crus, Latin = shin, leg, pillar support of a bridge]\n» medial fibers of ascending crura join to form an arch ventral to aorta just above celiac trunk = median arcuate ligament\n![img-58.jpeg](img-58.jpeg)\n\nFunction: major respiratory muscle for quiet breathing (in concert with accessory muscles of respiration); contraction $\\rightarrow$ expansion of thoracic cavity $\\rightarrow \\Downarrow$ intrathoracic pressure $\\rightarrow$ drawing of air into lungs\nOpenings: (1) aortic hiatus at T12 behind median arcuate lig.\n(2) esophageal hiatus at T10\n(3) vena cava hiatus at T8 through central tendon",
            "images": [
                {
                    "id": "img-58.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 1144,
                    "bottom_right_x": 1319,
                    "bottom_right_y": 1711,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 489,
            "markdown": "(4) Medial arcuate ligament covering psoas muscle\n(5) Lateral arcuate ligament covering quadratus lumborum muscle\n\nInnervation: both phrenic nerves (C3-C5) + lower intercostal nn.\nBlood supply: aorta $\\rightarrow$ internal thoracic a. + inferior phrenic aa. $\\rightarrow$ pericardiophrenic a. + musculophrenic artery\nPleuroperitoneal pressure gradient: negative $7-22 \\mathrm{~cm} \\mathrm{H}_{2} \\mathrm{O}$\nUS:\n$\\sqrt{ }$ thick echogenic line $=$ specular reflection from air-diaphragm interface\n$\\sqrt{ }$ thin hypoechoic line = diaphragmatic muscle\n$\\sqrt{ }$ both domes are visualized together (on oblique transverse subxiphoid view obtained from midline position)\nCXR:\n@ Infant / young child:\n$\\sqrt{ }$ right dome of diaphragm at level of anterior $6^{\\text {th }}$ rib\n$\\sqrt{ }$ left dome of diaphragm at level of anterior $7^{\\text {th }}$ rib (= one intercostal space lower)\n@ Adult\n$\\sqrt{ }$ right dome at $9.7 \\pm 0.8$ (range, $7.4-11.3$ ) thoracic vertebral levels below the top of $1^{\\text {st }}$ thoracic vertebra\n$\\sqrt{ }$ left dome at $10.2+/-0.8$ (range, $8.1-11.8$ ) thoracic vertebral levels below the top of $1^{\\text {st }}$ thoracic vertebra\n$\\diamond$ Position of diaphragm tends to be lower with higher age, lower weight, smaller thoracic dimensions; flatter with higher age, weight, transverse thoracic dimension, pack-years smoked, and male gender\n\n# Diaphragmatic Variants \n\n1. Diaphragmatic slip\n$=$ fold / strip of muscle bundle protruding from inferior surface of diaphragm $\\pm$ indentation of liver or spleen\n$D D x$ : peritoneal implant, lymph node, mass\n2. Hypertrophic median arcuate ligament\n$=$ fibrous arch uniting diaphragmatic crura passing over aorta\n(a) superior to origin of celiac trunk $(85 \\%)$\n(b) crossing over proximal portion of celiac trunk $\\rightarrow$ vessel indentation $(15 \\%) \\rightarrow$ celiac artery compression / median arcuate ligament syndrome\n3. Partial duplication of diaphragm $(\\mathrm{R}>\\mathrm{L})$\n\nAssociated with: cardiovascular malformations, ipsilateral pulmonary maldevelopment\n$\\sqrt{ }$ duplicated accessory diaphragm extends obliquely upward + backward to attach to $3^{\\text {rd }}-$ $7^{\\text {th }}$ ribs posteriorly\n$\\sqrt{ }$ lower lung lobe may be partially / completely contained within accessory diaphragm + true hemidiaphragm\n4. Diaphragmatic discontinuity $(11 \\%)$\n\nLocation: between crura + lateral arcuate ligaments\n$D D x$ : diaphragmatic rupture\n\n## Retrocrural Space",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 490,
            "markdown": "$=$ triangular region forming the most inferior portion of the posterior mediastinum Boundaries:\n> anteriorly and laterally: diaphragmatic crura decussating in front of aorta\n> posteriorly: ventral aspect of vertebral bodies\nCommunication: posterior mediastinum + retroperitoneum\nContents:\n> vessels:\n» aorta and its arterial branches (= lower posterior intercostal + subcostal arteries)\n» azygos vein (R), hemiazygos vein (L)\n» ascending lumbar venous plexus = valveless venous system freely communicating along entire extent of spine\n> nerves: sympathetic trunks + splanchnic nerves\n> lymphatics: lymph nodes (draining stations for posterior diaphragm, posterior mediastinum, lumbar spine), thoracic duct, cisterna chyli\n> fat\n![img-59.jpeg](img-59.jpeg)\n\n# Cisterna Chyli \n\n= bulbous dilatation formed by convergence of lymphatic channels at level of upper lumbar vertebral bodies\nLocation: usually to right of aorta (occasionally left-sided / retroaortic)\n> receives 2 afferent lumbar and intestinal lymphatic trunks\n> ascends as thoracic duct\n$\\sqrt{ }$ tubular shape (most common, in $30-43 \\%$ ) / rounded / oval / plexiform / fusiform:\nLymphangiography: visualized in $52 \\%$\nCT: visualized in $1.7 \\%$\n$\\sqrt{ }$ low near-water attenuation\n$\\sqrt{ }$ delayed enhancement after oral ingestion of ethiodized oil / IV injection of contrast material\nMR: visualized in $15 \\%-96 \\%$\n\n## Thoracic Duct",
            "images": [
                {
                    "id": "img-59.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 825,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1375,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 491,
            "markdown": "Origin: arises from cisterna chyli anterior to L1-L2 (10-15 mm in diameter and 5-7 cm long)\nCourse: enters thorax through aortic hiatus; ascends in right prevertebral location (between azygos vein and descending aorta); swings to left at T4-6 posterior to esophagus; ascends for a short distance along right of aorta; crosses behind aortic arch; runs ventrally at T3 between left common carotid artery + left subclavian artery\nTermination: $3-5 \\mathrm{~cm}$ above clavicle at venous angle (= junction of left subclavian + internal jugular veins)\nVariation: two ( $33 \\%$ ) or more (in up to $50 \\%$ ) main ducts each consisting of up to 8 separate channels\n\n# Azygos Vein \n\n$=$ major tributary of SVC\nOrigin: arises from junction of lumbar azygos with right ascending lumbar + subcostal vein\nCourse: travels along right anterior borders of thoracic vertebrae up to level of carina $\\rightarrow$ traverses middle mediastinum $\\rightarrow$ arches over right tracheobronchial angle $\\rightarrow$ drains posteriorly into distal SVC\nAzygos arch: on PA CXR at tracheobronchial angle = inferior margin of right paratracheal stripe\nTransverse diameter: $6-7 \\mathrm{~mm}$ (normal); 10 mm (upper limits); up to 15 mm (in pregnancy)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 492,
            "markdown": "# CHEST DISORDERS \n\n## AIDS\n\n$=$ ACQUIRED IMMUNE DEFICIENCY SYNDROME\n$=$ ultimately fatal disease characterized by HIV seropositivity, specific opportunistic infections, specific malignant neoplasms (Kaposi sarcoma, Burkitt lymphoma, primary lymphoma of brain)\n$=$ patient with CD4 cell count $<200$ cells $/ \\mu \\mathrm{L}$ (normal range, $800-1,200$ cells $/ \\mu \\mathrm{L}$ )\nPrevalence: 36.9 million HIV infections worldwide with 2 million new infections (2014); 47,352 North Americans newly infected with HIV with 13,712 deaths from AIDS (2013); $13 \\%$ unaware of infection; $>50 \\%$ develop pulmonary disease\n\nOrganism: human immunodeficiency virus (HIV) = human T-cell lymphotropic virus type III (HTLV III) = lymphadenopathy-associated virus (LAV)\nPathomechanism:\nHIV retrovirus attaches to CD4 molecule on surface of T-helper lymphocytes + macrophages + microglial cells; after cellular invasion HIV genetic information is incorporated into cell's chromosomal DNA; virus remains dormant for weeks to years; after an unknown stimulus for viral replication CD4 lymphocytes are destroyed (normal range of $800-1,000$ cells $/ \\mathrm{mm}^{3}$ ) and others become infected leading to impairment of the immune system; CD4 lymphocyte number and function decreases (at a rate of $\\sim 50-80$ cells/year)\nAIDS-defining illness related to CD4 T-lymphocyte count [cells/ $\\mu$ L]:\n$<400$ extrapulmonary Mycobacterium tuberculosis, Kaposi sarcoma\n$<200$ Candida albicans (thrush, hairy leukoplakia), Histoplasma capsulatum, Cryptosporidium species, Pneumocystis carinii pneumonia, non-Hodgkin lymphoma\n$<150$ cerebral toxoplasmosis\n$<100$ Cytomegalovirus, Herpes simplex virus, Mycobacterium avium complex (intestinal CMV + MAI infection)\n$<50$ AIDS-related lymphoma\nPrognosis: median survival with a CD4 lymphocyte count of $<50$ cells $/ \\mathrm{mm}^{3}$ is 12 months\nTransmission by: intimate sexual contact, exposure to contaminated blood / bloody body secretions\nGroups at risk:\n\n1. Homosexual males $(74 \\%)$\n2. IV drug abusers $(16 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 493,
            "markdown": "![img-60.jpeg](img-60.jpeg)\n3. Recipients of contaminated blood products (3\\%)\n4. Sexual partner of drug abuser + bisexual man\n5. Infants born to a woman infected with HIV virus\n$\\diamond$ HIV antibodies present in $>50 \\%$ of homosexuals $+90 \\%$ of IV drug abusers!\n$\\diamond$ Rate of heterosexual transmission is increasing!\nClinical classification:\ngroup I acute HIV infection with seroconversion\ngroup II asymptomatic HIV infection\ngroup III persistent generalized lymphadenopathy\ngroup IV other HIV disease\n> subgroup A constitutional disease\n> subgroup B neurologic disease\n> subgroup C secondary infectious disease\n> subgroup D secondary cancers\n> subgroup E other conditions\nAIDS-defining pulmonary conditions (CDC, 1993):\n(1) Tracheal / bronchial / pulmonary candidiasis\n(2) Pulmonary CMV infection\n(3) Herpes simplex bronchitis / pneumonitis\n(4) Kaposi sarcoma\n(5) Immunoblastic / Burkitt lymphoma\n(6) Pneumocystis carinii pneumonia",
            "images": [
                {
                    "id": "img-60.jpeg",
                    "top_left_x": 198,
                    "top_left_y": 191,
                    "bottom_right_x": 1166,
                    "bottom_right_y": 974,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 494,
            "markdown": "(7) Mycobacterium tuberculosis / avium complex / kansasii\n(8) Recurrent pneumonia\nA. LYMPHADENOPATHY\n\nCause: reactive follicular hyperplasia $=$ HIV adenopathy ( $50 \\%$ ), AIDS-related lymphoma (20\\%), mycobacterial infection (17\\%), Kaposi sarcoma (10\\%), metastatic tumor, opportunistic infection with multiple organisms, drug reaction\nLocation: mediastinum, axilla, retrocrural\nB. OPPORTUNISTIC INFECTION\naccounts for majority of pulmonary disease\n$\\diamond$ Pulmonary infection is often the first AIDS-defining illness!\n\n1. Pneumocystis jirovecii pneumonia ( $60-80 \\%$ ) (formerly Pneumocystis carinii pneumonia)\n$20-40 \\%$ develop $>1$ episode during disease\n\n- CD4+ T helper lymphocyte cell count $\\leq 200 / \\mathrm{mm}^{3}$\n- subacute insidious onset with malaise, minimal cough\n$\\checkmark$ bilateral ground-glass infiltrates without effusion / adenopathy\n$\\checkmark$ bilateral perihilar interstitial infiltrates\n$\\checkmark$ diffuse bilateral alveolar infiltrates\n$\\checkmark$ frequently associated with pneumatoceles\n$\\checkmark$ apical predominance (in patients on prophylactic aerosolized pentamidine)\nMortality: in $25 \\%$ fatal\n\n2. Fungal disease $(<5 \\%)$\n(a) Cryptococcus neoformans pneumonia ( $2-15 \\%$ ) usually associated with brain / meningeal disease\n$\\checkmark$ segmental infiltrate + superimposed pulmonary nodules $\\pm$ lymphadenopathy $\\pm$ pleural effusion\n(b) Histoplasma capsulatum\n$\\checkmark$ typically diffuse nodular / miliary pattern at time of diagnosis\n$\\checkmark$ normal CXR in up to $35 \\%$\n(c) Coccidioides immitis\n$\\checkmark$ diffuse infiltrates + thin-walled cavities\n(d) Candida albicans\n(e) Aspergillus: less common + less invasive $\\leftarrow$ relative preservation of neutrophilic function\n> invasive pulmonary aspergillosis\n> chronic necrotizing aspergillosis\n> necrotizing tracheobronchitis\n> obstructing bronchopulmonary aspergillosis\n3. Mycobacterial infection ( $10 \\%$ per year)\n(a) M. tuberculosis (increasing frequency)\n$\\diamond$ AIDS patients are 500 times more likely to become infected than general population!\n$\\checkmark$ postprimary TB pattern with upper-lobe cavitating infiltrate\n\n- CD4 lymphocyte count of 200-500 cells $/ \\mathrm{mm}^{3}$\n$\\checkmark$ primary TB pattern with lung infiltrate / lung masses + hilar / mediastinal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 495,
            "markdown": "lymphadenopathy + pleural effusion\n\n- CD4 lymphocyte count of 50-200 cells $/ \\mathrm{mm}^{3}$ )\n$\\sqrt{ }$ atypical TB pattern with diffuse reticular / nodular infiltrates (CD4 lymphocyte count of $<50$ cells $/ \\mathrm{mm}^{3}$ )\n$\\sqrt{ }$ adenopathy of low attenuation + rim enhancement\n(b) M. avium-intracellulare (5\\%)\n- in patients with low CD4 lymphocyte count only\n$\\sqrt{ }$ diffuse bilateral reticulonodular infiltrates\n$\\checkmark$ adenopathy, miliary disease\n(c) M. kansasii and others\n\n4. Bacterial pneumonia (5-30\\%):\n(a) Haemophilus influenzae, Streptococcus pneumoniae, Staphylococcus aureus\n$\\checkmark$ frequently multilobar distribution\n\n- bacteremia (common)\n(b) Nocardia pneumonia ( $<5 \\%$ )\nusually occurs in cavitating pneumonia\n$\\checkmark$ segmental / lobar alveolar infiltrate $\\pm$ cavitation $\\pm$ ipsilateral pleural effusion\n(c) Rhodococcus equi (aerobic, Gram-negative)\n$\\checkmark$ cavitary pneumonia\n(d) Bartonella henselae (Gram-negative)\n$=$ bacillary angiomatosis\n- cutaneous lesions\n$\\checkmark$ highly vascular small pulmonary nodules\n$\\checkmark$ dramatic enhancement of enlarged lymph nodes\n\n5. CMV pneumonia\nmost frequent infection found at autopsy (49-81\\%), diagnosed before death in only 13$24 \\%$;\nhigh prevalence combined with Kaposi sarcoma\n\n- fever, nonproductive cough, dyspnea, hypoxia\n$\\checkmark$ bilateral hazy infiltrates, focal nodules, masses\n$\\checkmark$ scattered widespread ground-glass opacities\n$\\checkmark$ thickening of bronchovascular bundles\n$\\checkmark$ tree-in-bud pattern\n$\\checkmark$ bronchiectasis / bronchial wall thickening\n\n6. Toxoplasmosis\n$\\checkmark$ coarse interstitial / nodular pattern\n$\\checkmark$ focal areas of consolidation $\\pm$ cavities\n$D D x$ : indistinguishable from PCP\nC. TUMOR\n7. Kaposi sarcoma (15\\%)\n8. AIDS-related lymphoma of B-cell origin (2-5\\%) primarily immunoblastic NHL/\n\nBurkitt lymphoma / non-Burkitt lymphoma; occasionally Hodgkin disease\nLocation: pulmonary involvement ( $8-15 \\%$ ), CNS, GI tract, liver, spleen, bone marrow Site: primarily extranodal\n$\\checkmark$ pleural effusion ( $50 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 496,
            "markdown": "$\\sqrt{ }$ hilar / mediastinal adenopathy ( $25 \\%$ ) $\\pm$ axillary / supraclavicular / cervical adenopathy\n$\\sqrt{ }$ solitary / multiple well-defined pulmonary nodules (occasionally with doubling times of 4-6 weeks)\n$\\sqrt{ }$ diffuse bilateral reticulonodular heterogeneous opacities\n$\\sqrt{ }$ alveolar infiltrates\n$\\sqrt{ }$ paraspinal masses\nD. LYMPHOID INTERSTITIAL PNEUMONITIS\n\nAge: in children $<13$ years of age\nE. SEPTIC EMBOLI\nF. PREMATURE DEVELOPMENT OF BULLAE (40\\%) with disposition to spontaneous pneumothorax\n\n# AIDS-related Complex (ARC) \n\n$=$ GENERALIZED LYMPHADENOPATHY SYNDROME\n$=$ prodromal phase of HIV seropositivity, generalized lymphadenopathy, CNS diseases other than those associated with AIDS\nTime interval: $\\sim 10$ years between seroconversion + clinical AIDS\n\n- weight loss, malaise, diarrhea\n- fever, night sweats, lymphadenopathy\n- lymphopenia with selective decrease in helper T-cells\n\n\n## ADULT RESPIRATORY DISTRESS SYNDROME\n\n$=$ SHOCK LUNG = POSTTRAUMATIC PULMONARY INSUFFICIENCY = HEMORRHAGIC LUNG SYNDROME\n$=$ RESPIRATOR LUNG $=$ STIFF LUNG SYNDROME $=$ PUMP LUNG $=$ CONGESTIVE ATELECTASIS $=$ OXYGEN TOXICITY = ACUTE RESPIRATORY DISTRESS SYNDROME\n$=$ severe unexpected life-threatening acute respiratory distress characterized by abrupt onset of marked dyspnea, increased respiratory effort, severe hypoxemia associated with widespread airspace consolidation\nEtiology:\n$\\diamond$ ARDS is the most severe form of permeability edema associated with diffuse alveolar damage\nA. PRIMARY = DIRECT INJURY $(\\leftarrow$ pulmonary disease)\n$=$ exposure to chemical agents, infectious pathogens, gastric fluid, toxic gas\nAssociated with: pulmonary consolidation\nB. SYSTEMIC CONDITION ( $\\leftarrow$ extrapulmonary disease)\n$=$ sepsis, pancreatitis, severe trauma, blood transfusion $\\rightarrow$ systemic biochemical cascade creating oxidating agents, inflammatory mediators, enzymes\nAssociated with: interstitial edema, alveolar collapse\nHisto:\n> up to 12 hr : fibrin + platelet microemboli\n$>12-24 \\mathrm{hr}: \\quad$ interstitial edema\n$>24-48 \\mathrm{hr}: \\quad$ capillary congestion, extensive interstitial + alveolar proteinaceous edema + hemorrhage, widespread microatelectasis, destruction of type I alveolar",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 497,
            "markdown": "epithelial cells\n> 5-7 d: extensive hyaline membrane formation, hypertrophy + hyperplasia of type II alveolar lining cells\n> 7-14 d: extensive fibroblastic proliferation in interstitium + within alveoli, rapidly progressing collagen deposition + fibrosis; almost invariably associated with infection\n\n# Predisposed: \n\nhemorrhagic / septic shock, massive trauma (pulmonary / general body), acute pancreatitis, aspiration of liquid gastric contents, heroine / methadone intoxication, massive viral pneumonia, traumatic fat embolism, near-drowning, conditions leading to pulmonary edema mnemonic: DICTIONARIES\n\nDisseminated intravascular coagulation\nInfection\nCaught drowning\nTrauma\nInhalants: smoke, phosgene, $\\mathrm{NO}_{2}$\n$\\mathrm{O}_{2}$ toxicity\nNarcotics + other drugs\nAspiration\nRadiation\nIncludes pancreatitis\nEmboli: amniotic fluid, fat\nShock: septic, hemorrhagic, cardiogenic, anaphylactic\n\n- initially few / no symptoms\n- rapidly progressive dyspnea, tachypnea, cyanosis\n- hypoxia unresponsive to oxygen therapy $\\leftarrow \\mathrm{AV}$ shunting\n- NO increase in pulmonary capillary pressure\n\nStages (often overlapping):\n$1^{\\text {st }}$ (early / exudative) stage\n$=$ interstitial edema with high protein content rapidly filling the alveolar spaces associated with hemorrhage $\\rightarrow$ ensuing hyaline membrane formation\n$\\sqrt{ }$ interstitial edema (with high protein content) initially\n$\\sqrt{ }$ perihilar areas of increased opacity following rapidly\n$\\sqrt{ }$ widespread alveolar consolidation with predominantly peripheral cortical distribution\n$\\sqrt{ }$ air bronchogram\n$\\sqrt{ }$ gravitational gradient (best seen on CT) $\\leftarrow$ dependent atelectasis\n$D D x$ : cardiogenic edema (cardiomegaly, apical vascular distribution, Kerley lines)\n$2^{\\text {nd }}$ (proliferative) stage\n= organization of fibrinous exudate + subsequent regeneration of alveolar lining + thickening of alveolar septa\n$\\sqrt{ }$ inhomogeneous areas of patchy / diffuse ground-glass opacities\n$3^{\\text {rd }}$ (fibrotic) stage (after days to weeks)\n$=$ varying degrees of scarring\n$\\sqrt{ }$ dependent gradient of consolidation (often)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 498,
            "markdown": "$\\sqrt{ }$ bronchial dilatation with improvement / even resolution\n$\\sqrt{ } \\pm$ progression to irreversible varicoid bronchial enlargement\n$\\sqrt{ }$ subpleural and intrapulmonary cysts\n$C x$ : pneumothorax\nCXR:\n$\\sqrt{ }$ NO cardiomegaly / pleural effusion\n> up to 12 hours:\n$\\sqrt{ }$ characteristic 12-hour delay between clinical onset of respiratory failure and CXR abnormalities\n> 12-24 hours:\n$\\sqrt{ }$ patchy ill-defined opacities throughout both lungs\n$>24-48$ hours:\n$\\sqrt{ }$ massive airspace consolidation of both lungs\n$>5-7$ days:\n$\\sqrt{ }$ consolidation becomes inhomogeneous $\\leftarrow$ resolution of alveolar edema\n$\\sqrt{ }$ local areas of consolidation $\\leftarrow$ pneumonia\n$>7$ days:\n$\\sqrt{ }$ reticular / bubbly lung pattern $\\leftarrow$ diffuse interstitial + airspace fibrosis\n\n# ALPHA-1 ANTITRYPSIN DEFICIENCY \n\n$=$ rare autosomal recessive disorder\nSource: alpha-1 antitrypsin (glycoprotein) is to $>90 \\%$ synthesized in hepatocytes + released into serum\nGene: codominant gene expression on chromosome 14 with $>100$ genetic variants of the protein; most severe hepatopulmonary manifestations result from homozygous PiZZ phenotype\nAction: proteolytic inhibitor of neutrophil elastase, trypsin, chymotrypsin, plasmin, thrombin, kallikrein, leukocytic + bacterial proteases; neutralizes circulating proteolytic enzymes\nMode of injury from deficiency:\nPMNs + alveolar macrophages sequester into lung during recurrent bacterial infections + release neutrophil elastase, which acts unopposed + digests basement membrane\nAge: early age of onset (20-30 years); $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n\n- rapid + progressive deterioration of lung function:\n- dyspnea in $4^{\\text {th }}$ and $5^{\\text {th }}$ decade\n$\\diamond 20 \\%$ of homozygotic individuals never develop clinically apparent emphysema\n- chronic sputum production ( $50 \\%$ )\n$\\sqrt{ }$ severe panacinar emphysema with basilar predominance $\\leftarrow$ gravitational distribution of pulmonary blood flow:\n$\\sqrt{ } \\downarrow$ in size $+\\downarrow$ in number of pulmonary vessels in lower lobes\n$\\sqrt{ }$ redistribution of blood flow to unaffected upper lung zones\n$\\sqrt{ }$ bullae at both lung bases\n$\\sqrt{ }$ marked flattening of diaphragm\n$\\sqrt{ }$ minimal diaphragmatic excursion\n$\\sqrt{ }$ multilobar cystic bronchiectasis $(40 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 499,
            "markdown": "$\\sqrt{ }$ hepatopulmonary syndrome\nCx: hepatic cirrhosis (in homozygotic individuals)\n$\\diamond$ Most common metabolic liver disease in children\nPrognosis: 15-20-year decrease in longevity in smokers relative to nonsmokers\n\n# ALVEOLAR MICROLITHIASIS \n\n$=$ very rare disease of unknown etiology characterized by myriad of calcospherites (= microliths composed of calcium + phosphorus) within alveoli\nCause: autosomal recessive inheritance of a gene mutation preventing production of a transporter protein for sodium-dependent transfer of phosphate into type II pneumocytes $\\rightarrow$ phosphorus ions stay in alveolar space\nAge peak: 30-50 years; begins in early life; has been identified in utero; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$; in $50 \\%$ familial (in at least one sibling)\n\n- usually asymptomatic $(70 \\%)$\n- progressive dyspnea on exertion, cyanosis, clubbing of fingers\n- striking discrepancy between marked radiographic findings and mild clinical symptoms\n- NORMAL serum calcium + phosphorus levels\n- restrictive lung disease ( $\\downarrow$ in residual volume and $\\downarrow$ diffusion capacity)\n\nDistribution: predisposition for posterior segments of lower lobes + anterior segments of upper lobes; medial lung $>>$ lateral lung\n$\\sqrt{ }$ very fine, sharply defined, sandstorm-like micronodular ( $<1 \\mathrm{~mm}$ ) pattern\n$\\checkmark$ diffuse involvement of both lungs\n$\\checkmark$ obscuration of mediastinal + diaphragmatic reflections\n$\\checkmark$ vertical linear radiolucency between ribs + lung parenchyma $\\leftarrow$ subpleural cystic changes\n$\\checkmark$ intense uptake on bone scan\nHRCT:\n$\\checkmark$ thickening + micronodulation of interlobular septa $\\leftarrow$ innumerable microliths within periphery of secondary pulmonary lobule\n$\\checkmark$ thickened micronodular appearance of bronchovascular + subpleural interstitium\n$\\checkmark$ pleural calcifications\n$\\checkmark$ ground-glass appearance (of microliths $<1 \\mathrm{~mm}$ ) $\\pm$ \"crazy paving\" pattern\nPrognosis:\n(a) late development of pulmonary insufficiency $\\leftarrow$ interstitial fibrosis + cor pulmonale\n(b) disease may become arrested\n(c) microliths may continue to form / enlarge\n$R x:$ NO effective treatment aside from lung transplant\n$D x:$ open lung biopsy\nDDx: (1) Pulmonary alveolar proteinosis, sarcoidosis, pneumoconiosis, pulmonary hemosiderosis, amyloidosis, miliary tuberculosis, metastatic pulmonary calcifications of renal failure\n(2) \"Mainline\" pulmonary granulomatosis (IV abuse of talc-containing drugs such as methadone, rarely as numerous + scarring + loss of volume)\n\n## ALVEOLAR PROTEINOSIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 500,
            "markdown": "$=$ PULMONARY ALVEOLAR PROTEINOSIS (PAP)\n$=$ rare disorder characterized by accumulation of lipoproteinaceous material in alveoli $\\leftarrow$ altered surfactant homeostasis\nForms:\nA. CONGENITAL PAP\nB. PRIMARY ACQUIRED PAP ( $90 \\%$ )\n\nAge: median 39 years; $\\mathrm{M}>>\\mathrm{F}$\nPredisposed: smoking in $72 \\%$\nC. SECONDARY PAP\n\nCause: hematologic cancers, pharmacologic immunosuppression, inhalation of inorganic dust (eg, silica), toxic fumes, certain infections\nPathophysiology: functional impairment / reduced number of alveolar macrophages\nEtiology: ?; associated with dust exposure (eg, silicoproteinosis is histologically identical to PAP), immunodeficiency, hematologic + lymphatic malignancies, AIDS, chemotherapy\n\n# Pathophysiology: \n\n(a) overproduction of surfactant by granular pneumocytes\n(b) defective clearance of surfactant by alveolar macrophages\n\nHisto: alveoli filled with proteinaceous material (the ONLY pure airspace disease), normal interstitium\nAge peak: 39 years (range, $2-70$ years); $\\mathrm{M}+\\mathrm{F}=3 \\div 1$\n\n- asymptomatic ( $10-20 \\%$ ), gradual onset of dyspnea + cough\n- weight loss, weakness, hemoptysis, defect in diffusing capacity\n$\\sqrt{ }$ bilateral air-space disease with ill-defined nodular / confluent ground-glass pattern:\n$\\sqrt{ }$ perihilar predominance of \"bat-wing\" configuration WITHOUT signs of left-sided heart failure\n$\\sqrt{ }$ small acinar nodules + coalescence + consolidation\n$\\sqrt{ }$ patchy peripheral / primarily unilateral infiltrates (rare)\n$\\sqrt{ }$ reticular / reticulonodular / linear interstitial pattern with Kerley B lines (late stage)\n$\\sqrt{ }$ slow clearing over weeks or months\n$\\sqrt{ }$ slow progression $\\left(1 / 3\\right)$, remaining stable $\\left(5 / 3\\right)$\n$\\sqrt{ }$ NO adenopathy, NO cardiomegaly, NO pleural effusion\nHRCT:\n$\\sqrt{ }$ crazy-paving pattern = combination of patchy ground-glass opacities + smooth interlobular septal thickening often in geographic distribution\n$\\sqrt{ }$ sharp demarcation between normal + abnormal lung\n$\\sqrt{ }$ consolidation\nCx: susceptible to pulmonary infections $\\leftarrow$ poorly functioning macrophages + excellent culture medium for opportunistic pathogens (esp. Nocardia asteroides), other common respiratory pathogens\nPrognosis:\nhighly variable course with clinical and radiologic episodes of exacerbation + remissions\n(a) $50 \\%$ improvement / recovery\n(b) $30 \\%$ death within several years under progression",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 501,
            "markdown": "$D x$ : bronchoalveolar lavage, transbronchial / open lung biopsy\n$R x$ : bronchopulmonary lavage\n$D D x$ :\n(a) during acute phase: pulmonary edema, diffuse pneumonia, ARDS\n(b) in chronic stage:\n\n1. Idiopathic pulmonary hemosiderosis (boys, symmetric involvement of mid + lower zones, progression to nodular + linear pattern)\n2. Hemosiderosis (bleeding diathesis)\n3. Pneumoconiosis\n4. Hypersensitivity pneumonitis\n5. Goodpasture syndrome (more rapid changes, renal disease)\n6. Desquamative interstitial pneumonia (\"ground-glass\" appearance, primarily basilar + peripheral)\n7. Pulmonary alveolar microlithiasis (widespread discrete intraalveolar calcifications primarily in lung bases, rare familial disease)\n8. Sarcoidosis (usually with lymphadenopathy)\n9. Lymphoma\n10. Bronchioloalveolar cell carcinoma (more focal, slowly enlarging with time)\n\n# AMNIOTIC FLUID EMBOLISM \n\n$=$ most common cause of maternal peripartum death\n\n- dyspnea, shock during / after labor + delivery\n\nPathogenesis: amniotic debris enters maternal circulation resulting in:\n(1) Pulmonary embolization\n(2) Anaphylactoid reaction\n(3) DIC\n$\\sqrt{ }$ usually fatal before radiographs obtained\n$\\sqrt{ }$ may demonstrate pulmonary edema\n\n## AMYLOIDOSIS OF THE CHEST\n\n$=$ disease characterized by an extracellular deposition of insoluble fibrillar proteins aggregating into twisted $\\beta$-pleated sheets of great chemical diversity\nHisto: protein (immunoglobulin) / polysaccharide complex; affinity for Congo red stain\n\n## Pulmonary Amyloidosis\n\nFrequency: $1^{\\circ}$ amyloidosis (in up to $70 \\%$ ), $2^{\\circ}$ amyloidosis (rare)\nA. NODULAR PARENCHYMAL TYPE (most common)\n\nAge: $50-60$ years of age; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\n\n- usually asymptomatic, incidental discovery on CXR\n\nSize: $5-15 \\mathrm{~cm}$\nSite: subpleural / peripheral\nDistribution: concentrated in lower lobes\n$\\sqrt{ }$ solitary mass $=$ amyloidoma $(60 \\%)$\n$\\sqrt{ }$ multiple pulmonary nodules:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 502,
            "markdown": "$\\sqrt{ }$ smooth lobulated / spiculated margins\n$\\sqrt{ }$ cavitation (rare)\n$\\sqrt{ } \\pm$ central calcification / ossification (in up to $50 \\%$ )\n$D D x$ : chronic renal failure\n$\\sqrt{ }$ mediastinal / hilar adenopathy\n$D x$ : AL amyloid (= amyloid light chain) on biopsy\nPrognosis: excellent with slow progression over years; incurable; treatment rarely required\n$R x$ : low-dose prednisone, colchicine\n$D D x$ : metastatic disease, granulomatous disease (fungal, TB), rheumatoid lung, sarcoidosis, mucoid impaction, bronchogenic carcinoma, chondroma\n\n| Classification of Amyloidosis |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| Subtype | Common Anatomic Distribution | Fibrillar protein | Common Disease Associations | Treatment |\n| Primary amyloidosis | multiple organs | amyloid light chain (AL) | plasma cell dyscrasias (eg, multiple myeloma) | chemotherapy (melphalan, steroids), stem cell transplantation |\n| Secondary amyloidosis | single organ | serum amyloid A (AA) | chronic infection (eg, osteomyelitis), chronic systemic inflammation (eg, rheumatoid arthritis) | symptomatic (eg, diuresis in cardiac amyloidosis, surgery in tracheal amyloidosis), treatment of underlying condition |\n\n# B. DIFFUSE ALVEOLAR SEPTAL TYPE (least common) \n\n$\\diamond$ Most commonly associated with systemic amyloidosis\nAge: $>60$ years of age\nMay be associated with: concurrent systemic involvement\n\n- usually asymptomatic with normal CXR\n- cough + dyspnea with abnormal CXR\n\nCT:\n$\\checkmark$ well-defined scattered $2-4 \\mathrm{~mm}$ micronodules\n$\\checkmark$ reticulations $=$ widespread small irregular densities (exclusively interstitial involvement) $\\pm$ calcification\n$\\checkmark$ interlobular septal thickening\n$\\checkmark$ may become confluent $\\pm$ honeycombing\nDistribution: basal + peripheral predominance\n$\\checkmark$ punctate lung calcifications\n$\\checkmark$ pleural thickening\n$\\checkmark \\pm$ pleural effusion\n$\\checkmark$ rarely associated with thin-walled cysts (most commonly in Sjögren syndrome)\n$D x$ : AL amyloid (= amyloid light chain) on biopsy\nPrognosis: median survival of 16 months $\\leftarrow$ pulmonary hypertension, respiratory failure\n$D D x$ : pneumoconiosis (especially asbestosis), idiopathic pulmonary fibrosis, rheumatoid lung, Langerhans cell histiocytosis, scleroderma, cancer with lymphangitic spread\n\n[^0]\n[^0]:    Airway Amyloidosis (2 ${ }^{\\text {nd }}$ most common manifestation)\n    = TRACHEOBRONCHIALTYPE\n    = diffuse / solitary (rarely) submucosal deposition of amyloid in trachea + segmental airways Age: $\\quad 50-70$ years; $\\mathrm{M}>\\mathrm{F}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 503,
            "markdown": "Rarely associated with: systemic amyloidosis\n\n- hemoptysis (most frequent complaint)\n- stridor, cough, dyspnea, hoarseness, wheezing\n\nCXR: notoriously insensitive\nCT:\n$\\sqrt{ }$ diffuse rigid narrowing of a long tracheal segment (best depicted on COR and SAG reconstructions)\n$\\sqrt{ }$ calcified / ossified tracheal wall also affecting posterior membrane of trachea (DDx to tracheobronchopathia osteochondroplastica / relapsing polychondritis)\n$\\sqrt{ }$ luminal narrowing by multiple nodules protruding from wall of trachea / large bronchi\n$\\sqrt{ }$ prominent bronchovascular markings\n$\\sqrt{ }$ obstruction with consolidation\n$\\sqrt{ }$ atelectasis\n$\\sqrt{ }$ hyperinflation\n$\\sqrt{ }$ bronchiectasis\n$\\sqrt{ }$ destructive pneumonitis\nPET/CT:\n$\\sqrt{ }$ increased FDG uptake may allow detection of early amyloidosis + response to treatment\n$C x$ : recurrent pneumonia\n$R x$ : local bronchoscopic resection, laser therapy, stent placement, radiation therapy\nPrognosis: 30-50\\% 5-year survival; worse for proximal disease\n$D D x$ : endobronchial neoplasm\nMediastinal Amyloidosis (3rd most common manifestation)\nCommonly associated with: systemic amyloidosis\nLocation: multistation lymphadenopathy / anatomically localized isolated tumefactive amyloidoma\n\n- asymptomatic lymphadenopathy (frequent)\n$\\sqrt{ }$ enhancing lymphadenopathy\n$\\sqrt{ }$ punctate / diffuse / eggshell lymph node calcifications\n\n\n# ASBESTOS-RELATED DISEASE \n\n[asbestos, Greek = inextinguishable $=$ several fibrous silicate minerals sharing the property of heat resistance]\nSubstances:\nAspect (length-to-diameter) ratio effects carcinogenicity:\neg, aspect ratio of $32=8 \\mu \\mathrm{~m}$ long x $0.25 \\mu \\mathrm{~m}$ wide\n> commercial amphiboles: straight, rigid, needlelike\n\n- crocidolite $=$ blue $/$ black asbestos\n- amosite $=$ brown asbestos\n> commercial serpentines (= nonamphiboles):\n- chrysotile $=$ white asbestos (the only mineral in the serpentine group accounting for $>$ $90 \\%$ of asbestos used in the USA)\n> noncommercial contaminated amphiboles",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 504,
            "markdown": "- actinolite; anthophyllite; tremolite\n(a) relatively benign:\n(1) Chrysotile in Canada\n(2) Anthophyllite in Finland, North America\n(3) Tremolite\n(b) relatively malignant:\n(1) Crocidolite in South Africa, Australia\n(2) Amosite\n$\\diamond$ Very fine fibers (crocidolite) are associated with the largest number of pleural disease!\n$\\diamond$ Asbestos fibers up to $100 \\mu \\mathrm{~m}$ in length\nOccupational exposure:\n(a) asbestos mining, milling, processing\n(b) insulation manufacturing, textile manufacturing, construction and demolition, pipe fitting, shipbuilding, gaskets, brake linings\nPathophysiology:\nasbestos-activated macrophages produce a variety of growth factors that interact to induce fibroblast proliferation; oxygen-free radicals released by macrophages damage proteins + lipid membranes sustaining the inflammatory process\n\n\n# Asbestos-related Pleural Disease \n\n1. Pleural Effusion (21\\%)\n$=$ earliest asbestos-related pleural abnormality, frequently followed by diffuse pleural thickening + rounded atelectasis\nPrevalence: 3\\% (higher with increasing levels of asbestos exposure)\nLatency period: $8-10$ years after exposure\n\n- benign asbestos pleurisy:\n- may be associated with chest pain $(1 / 3)$\n- usually small sterile serous / hemorrhagic exudate\n$\\sqrt{ }$ recurrent bilateral effusions\n$\\sqrt{ } \\pm$ plaque formation\n$D D x:$ TB, mesothelioma\n\n2. Focal Pleural Plaques (65\\%)\n$=$ hyalinized collagen in submesothelial layer of parietal pleura\n$\\diamond$ Most useful marker of asbestos exposure!\nFrequency: most common manifestation of exposure; $6 \\%$ of general population will show plaques; $3-14 \\%$ of dockyard workers; $58 \\%$ of insulation workers\nLatency period: in $10 \\%(50 \\%)$ after 20 (40) years\nHisto: dense hypocellular undulating collagen fibers often arranged in a \"basket weave\" pattern $\\pm$ focal / massive calcifications; may contain large numbers of asbestos fibers (almost exclusively chrysotile)\nLocation: bilateral + multifocal; posterolateral chest wall between $7^{\\text {th }}-10^{\\text {th }}$ rib following rib contours; lateral chest wall between $6^{\\text {th }}-9^{\\text {th }}$ rib; aponeurotic dome of diaphragm; mediastinum\n$\\diamond$ Apices + costophrenic angles are spared!\n$\\diamond$ RARE in fissures of lung (visceral pleura)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 505,
            "markdown": "Site: parietal pleura (visceral pleura typically spared)\n\n- asymptomatic, no functional impairment\n\nCXR:\n$\\sqrt{ }$ geographic / holly leaf-shaped veil-like opacity\n$\\sqrt{ }$ localized sharply marginated pleural thickening\nCT (more sensitive + specific):\n$\\sqrt{ }$ usually focal nodular area of pleural thickening ( $<1 \\mathrm{~cm}$ thick) with edges thicker than central portions of plaque; in $48 \\%$ only finding; in $41 \\%$ with parenchymal changes; stable over time\n$\\sqrt{ }$ thin layer of extrapleural fat separates plaque from underlying rib + intercostal muscle\n$\\sqrt{ }$ \"hairy plaque\" = visceral pleural plaque + underlying short interstitial lines radiating from plaque (rare)\n$\\sqrt{ }$ no hilar adenopathy\n$\\sqrt{ }$ calcified (in $10-15 \\%$ by X-ray, in $15-20 \\%$ by CT)\nPrognosis: NO risk of malignant degeneration; increased risk of developing mesothelioma + bronchogenic carcinoma\n$D D x$ : chest wall fat, rib fractures, rib companion shadow\n3. Pleural Calcification (21-25-60\\%)\n$\\diamond$ HALLMARK of asbestos exposure!\n$\\diamond$ detected by CXR (CT) in $25 \\%(60 \\%)$\nLatency: $20 \\%(40 \\%)$ become visible in $>20(40)$ years\nHisto: calcification starts in parietal pleura; calcium deposits may form within center of plaques\n$\\sqrt{ }$ dense lines paralleling the chest wall, mediastinum, pericardium, diaphragm\n$\\diamond$ Bilateral diaphragmatic calcifications with clear costophrenic angles are PATHOGNOMONIC!\n$\\sqrt{ }$ advanced calcifications are leaflike with thick-rolled edges\n$D D x$ : talc exposure, hemothorax, empyema, therapeutic pneumothorax for TB (often unilateral, extensive sheetlike, on visceral pleura)\n4. Diffuse Pleural Thickening (17\\%)\n$=$ smooth uninterrupted diffuse thickening of parietal pleura extending over at least $1 / 4$ of chest wall (visceral pleura involved in $90 \\%$, but difficult to demonstrate)\n\n- may cause restriction of pulmonary function\n\nMay be associated with: rounded atelectasis\n$\\sqrt{ }$ bilateral process with \"shaggy heart\" appearance (20\\%)\n$\\sqrt{ }$ smooth (difficult to assess when viewed en face)\n$\\sqrt{ }$ thickening of interlobar fissures\n$\\sqrt{ }$ focally thickened diaphragm\n$\\sqrt{ }$ obliterated costophrenic angles (minority of cases)\n$D D x$ : pleural thickening from parapneumonic effusion, hemothorax, connective tissue disease\n\n# Pulmonary Asbestosis \n\n= (term \"asbestosis\" reserved for) chronic progressive diffuse interstitial pulmonary fibrosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 506,
            "markdown": "$\\leftarrow$ inhalation of asbestos fibers\nFrequency: in 49-52\\% of industrial asbestos exposure; 1,229 new cases annually in USA (2013)\n\nLatency period: 40-45 years; dose-effect relationship\nHisto: interstitial fibrosis begins around respiratory bronchioles, then progresses to involve adjacent alveoli\nDiagnostic criteria:\n\n1. Reliable history of exposure\n2. Appropriate time interval between exposure + detection\n3. Radiographic opacities classified as ILO s,t,u\n4. Restrictive pattern of lung impairment\n5. Diffusing capacity below normal range\n6. Bilateral crackles at posterior lung bases, NOT cleared by cough\n\n- dyspnea\n- restrictive pulmonary function tests: progressive reduction of vital capacity + diffusing capacity\n- asbestos bodies in macrophages from bronchoalveolar lavage (BAL) fluid (= single asbestos fiber surrounded by segmented protein-iron coat)\nLocation: lower posterior bases $>$ apices\nSite: most severe in subpleural zones (asbestos fibers concentrate beneath visceral pleura) CXR:\n$\\sqrt{ }$ small irregular linear opacities (NOT rounded as in coal / silica) progressing from fine to coarse reticulations:\n$\\sqrt{ }$ confined to lung bases, progressing superiorly\n$\\checkmark$ septal lines (= fibrous thickening around 2 ndary lobules)\n$\\checkmark$ honeycombing (uncommon)\n$\\checkmark$ \"shaggy\" (obscured) heart border $\\leftarrow$ parenchymal + pleural changes\n$\\checkmark$ ill-defined outline of diaphragm\n$\\checkmark$ rarely massive fibrosis, predominantly at lung bases without migration toward hilum (DDx from silicosis / CWP)\n$\\checkmark$ ABSENCE of hilar / mediastinal adenopathy (if present consider other diagnosis)\n\n\n# HRCT: \n\n$\\diamond$ Obtain scan in prone position to differentiate from gravity-related physiologic phenomena\n$\\checkmark$ thickened intralobular lines as initial finding $\\leftarrow$ centrilobular peribronchiolar fibrosis:\n$\\checkmark$ multiple subpleural curvilinear branching lines (\"subpleural pulmonary arcades\") = dotlike reticulonodularities connected to the most peripheral branch of pulmonary artery\nSite: most prominent posteriorly parallel to and within 1 cm of pleura\n$\\checkmark$ thickened interlobular septal lines (= interlobular fibrotic / edematous thickening):\n$\\checkmark$ reticulations $=$ network of linear densities, usually posteriorly at lung bases\n$\\checkmark$ architectural distortion of lobule\n$\\checkmark$ parenchymal band formation $=$ linear $<5 \\mathrm{~cm}$ long + several mm wide opacity, often extending to pleura, which may be thickened + retracted at site of contact",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 507,
            "markdown": "$\\sqrt{ }$ subpleural curvilinear lines\n$\\sqrt{ }$ patchy areas of ground-glass attenuation (= alveolar wall thickening due to fibrosis / edema)\n$\\sqrt{ }$ honeycombing $=$ multiple cystic spaces $<1 \\mathrm{~cm}$ in diameter with thickened walls\nNUC:\n$\\sqrt{ }^{67} \\mathrm{Ga}$ uptake gives a quantitative index of inflammatory activity\n$C x$ : pulmonary fibrosis, pleuropulmonary malignancy (latency period of $>20$ years)\n$D D x$ : idiopathic pulmonary fibrosis (NO parietal pleural thickening)\n\n# Atelectatic Asbestos Pseudotumor \n\n$=$ ROUND ATELECTASIS = \"FOLDED LUNG\"\n$=$ infolding of redundant pleura accompanied by segmental / subsegmental atelectasis\n$\\diamond$ Most common of benign masses caused by asbestos exposure!\nLocation: posteromedial / posterolateral basal region of lower lobes (most common); frequently bilateral\n$\\sqrt{ } 2.5-8 \\mathrm{~cm}$ focal subpleural mass abutting a region of thickened pleura\n$\\sqrt{ }$ size + shape show little progression, occasionally $\\downarrow$ in size\nCT:\n$\\sqrt{ }$ rounded / lentiform / wedge-shaped peripheral mass\n$\\sqrt{ }$ pleural thickening $\\pm$ calcification always present and frequently greatest near mass\n$\\sqrt{ }$ \"crow's feet\" = linear bands radiating from mass into lung parenchyma (54\\%)\n$\\sqrt{ }$ \"vacuum cleaner\" / \"comet\" sign\n$=$ bronchovascular markings emanating from nodular subpleural mass + coursing toward ipsilateral hilum\n$\\sqrt{ }$ \"Swiss cheese\" air bronchogram (18\\%)\n$\\sqrt{ }$ partial interposition of lung between pleura + mass\n$\\sqrt{ }$ volume loss of affected lobe $\\pm$ hyperlucency of adjacent lung\n\n## Asbestos-related Malignancy\n\nEstimated yearly asbestos-related deaths in USA (2013):\n$12,000-15,000$ annually\n\n## Lung Cancer\n\nIncidence: 180,000 new cases annually in USA; 20-25\\% of workers heavily exposed to asbestos\nOccurrence related to:\n(a) cumulated dose of asbestos fibers\n(b) smoking (synergistic carcinogenic effect)\n$\\diamond 100$-fold increased risk in smokers versus a 7 -fold increased risk in nonsmokers!\n(c) preexisting interstitial disease\n(d) occupational exposure to known carcinogen\n\nLatency period: $25-35$ years\nAssociated with: increased incidence of gastric carcinoma\nHisto: bronchioloalveolar cell carcinoma (most common); bronchogenic carcinoma (adenocarcinoma + SCC)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 508,
            "markdown": "Location: at lung base / in any location if associated with smoking\n\n# Malignant Mesothelioma \n\nIncidence: 2,686 new cases annually in USA (2013); 7,000-fold increase in incidence\nRisk: $10 \\%$ over lifetime of an asbestos worker; household members of asbestos worker; residents near asbestos mines and plants\nLatency period: $20-40$ years\n\n## Gastrointestinal Neoplasm\n\n$=$ pancreatic, liver, gallbladder, colon, rectal, stomach cancer\nFrequency: 3 -fold increase (weak link)\n\n## ASKIN TUMOR\n\n$=$ EXTRASKELETAL EWING SARCOMA = PRIMITIVE NEUROECTODERMAL TUMOR (PNET)\n$=$ uncommon tumor probably arising from intercostal nerves\nMean age: 14.5 years; $\\mathrm{M}+\\mathrm{F}=1 \\div 3$; Caucasian\nPath: neuroectodermal small cell tumor containing neuron-specific enolase (may also be found in neuroblastoma)\n\n- chest wall mass with / without pain\n- constitutional symptoms: fever, anorexia, weight loss\n$\\checkmark$ large tumor involving chest wall + pleura\n$\\checkmark$ high tumor vascularity\n$\\checkmark$ rib destruction (occasionally arising from rib) in $25-63 \\%$\n$\\checkmark$ often large malignant pleural effusion\n$\\checkmark$ pulmonary parenchymal disease ( $25 \\%$ )\n$\\checkmark$ calcifications $(10 \\%)$\n$\\checkmark$ ipsilateral hilar + mediastinal lymphadenopathy\n$\\checkmark \\pm$ pneumothorax $\\leftarrow$ pulmonary involvement\nCT:\n$\\checkmark$ large unilateral heterogeneous chest wall mass with intra- and extrathoracic components\n$\\checkmark \\pm$ pleural, pericardial, diaphragmatic, vertebral, spinal extension and involvement\nMR:\n$\\checkmark$ predominantly intermediate SI on T1WI + high SI on T2WI\n$\\checkmark$ prominent areas of high SI on T2WI $\\leftarrow$ hemorrhage + necrosis\n$\\checkmark$ commonly invasion of chest wall musculature + mediastinum + lung\nNUC:\n$\\checkmark \\uparrow$ activity on bone scan +111 In -pentetreotide $+99 \\mathrm{mTc}$-MIBI\n$\\checkmark$ NO uptake on FDG PET\nMetastatic to: lung, mediastinal nodes, bone (25\\%), CNS, liver, adrenal\n$\\diamond$ At presentation pulmonary metastases (in $38 \\%$ ) + mediastinal lymphadenopathy (in $25 \\%$ )\nPrognosis: median survival of 8 months\n$D D x$ : Ewing sarcoma, lymphoma, chest wall hamartoma in infancy\n\n\n## ASPERGILLOSIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 509,
            "markdown": "Organism:\nAspergillus fumigatus $=$ intensely antigenic ubiquitous fungus in soil, water, decaying vegetable and animal matter existing as\n(a) conidiophores $=$ reproductive form releasing thousands of spores\n(b) hyphae ( $=$ matured spores) characterized by $45^{\\circ}$ dichotomous branching pattern\n\nOccurrence:\ncommonly in sputum of normal persons, ability to invade arteries + veins facilitating hematogenous dissemination\n$\\mathrm{M} \\div \\mathrm{F}=3 \\div 1$\nTransmission: spore inhalation\nPredisposed:\n(a) preexisting lung disease (tuberculosis, bronchiectasis)\n(b) impairment of immune system (alcoholism, advanced age, malnutrition, concurrent malignancy, poorly controlled diabetes, cirrhosis, sepsis)\n\n- tracheo-bronchitis, bronchiolitis, bronchopneumonia\n- fungal hyphae in lumen of airways\n- positive precipitin test to Aspergillus antigen\n- elevated Aspergillus-specific IgE, IgG-ELISA, polymerase chain reaction identification\n\nCx: dissemination to heart, brain, kidney, GI tract, liver, thyroid, spleen\n$\\diamond$ Sputum cultures are diagnostically unreliable because of normal (saprophytic) colonization of upper airways!\n![img-61.jpeg](img-61.jpeg)\n\n# Noninvasive Aspergillosis = Mycetoma Formation \n\n$=$ SAPROPHYTIC ASPERGILLOSIS\n$=$ noninvasive colonization of preexisting cavity / cyst in immunologically normal patients with cystic / cavitary lung disease like:\ngranulomatous disease [sarcoidosis (common), remote TB, atypical mycobacterial infection, Pneumocystis jirovecii], bronchiectasis, cystic fibrosis, abscess, bullous emphysema, carcinoma, traumatic pneumatocele, ankylosing spondylitis, Marfan syndrome, neurofibromatosis type 1\n\n- blood-streaked sputum / severe hemoptysis (45-95\\%)\n- elevated serum precipitins level for Aspergillus (50\\%)\n$\\sqrt{ }$ solid round gravity-dependent mass within preexisting spherical / ovoid thin-walled cavity ( $=$ Monad sign):\n[monas, Greek = single, alone; - ad, Greek suffix = group, unit]",
            "images": [
                {
                    "id": "img-61.jpeg",
                    "top_left_x": 190,
                    "top_left_y": 1067,
                    "bottom_right_x": 1132,
                    "bottom_right_y": 1401,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 510,
            "markdown": "Histo: mycetoma $=$ aspergilloma $=$ fungus ball $=$ masslike collection of intertwined hyphae matted together with fibrin, mucus, cellular debris colonizing a pulmonary cavity\n$\\checkmark$ \"air-crescent\" sign = crescent-shaped air space separating fungus ball from nondependent cavity wall\n$\\checkmark$ fungus ball may calcify in scattered / rimlike fashion\n$\\checkmark$ pleural thickening adjacent to preexisting cyst / cavity = commonly first sign before visualizing mycetoma\nCx: life-threatening hemoptysis with mycetoma\nN.B.: search for hypertrophied bronchial arteries as road map for bronchial artery embolization\n$D x$ : transthoracic needle biopsy / bronchial washings\nDDx of other organisms causing fungus ball:\nCandida albicans, Pseudallescheria boydii, Coccidioides immitis, Nocardia, Actinomyces\n\n# Semiinvasive Aspergillosis \n\n$=$ CHRONIC NECROTIZING ASPERGILLOSIS\n$=$ chronic cavitary slowly progressive disease in patients with preexisting lung injury (COPD, radiation therapy), mild immune suppression, or debilitation (alcohol, diabetes)\n\n- symptoms mimicking pulmonary tuberculosis\n$\\checkmark$ progressive consolidation (usually upper lobe)\n$\\checkmark$ development of air crescent and fungus ball over a period of months\n$D x$ : pathologic examination demonstrating local tissue invasion\n\n\n## Invasive Pulmonary Aspergillosis\n\n$=$ often fatal form in severely immunocompromised patients with absolute neutrophil count of $<500$\nPredisposed: most commonly in lymphoma / leukemia patients with prolonged granulocytopenia; after organ transplantation\nPath: endobronchial fungal proliferation followed by trans- bronchial vascular invasion eventually causes widespread hemorrhage + thrombosis of pulmonary arterioles and ischemic tissue necrosis with systemic dissemination; fungus ball = devitalized sequestrum of lung infiltrated by fungi\n\n- history of series of bacterial infections + unremitting fever\n- pleuritic chest pain (mimicking emboli)\n- dyspnea, nonproductive cough\n- progression of pulmonary infiltrates not responding to broad-spectrum antibiotics\n(a) early signs\n\nFrequency: $96 \\%(19 \\%)$ on day 0 (day 14)\n$\\checkmark$ single / multiple ill-defined peripheral opacities abutting the pleural surface\n$\\checkmark$ \"CT halo\" sign = single / multiple $1-3-\\mathrm{cm}$ peripheral nodules ( $=$ necrotic lung) with halo of ground-glass attenuation ( $=$ hemorrhagic edema)\n$\\checkmark$ patchy localized bronchopneumonia\n(b) later signs of progression\n$\\checkmark$ enlargement of nodules into diffuse bilateral consolidation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 511,
            "markdown": "$\\sqrt{ }$ development into large wedge-shaped pleural-based lesions\n$\\sqrt{ }$ \"air-crescent\" sign (in up to $50 \\%$ ) = cavitation of existing nodule (air crescent between retracting sequestered necrotic tissue and surrounding rim of hemorrhagic lung parenchyma) 1-3 weeks after recovery from neutropenia\n$\\diamond$ has better prognosis than consolidation without cavitation (= feature of resolution phase)\nPrognosis: mortality rate of $50-90 \\%$\n$D x$ : biopsy showing branching hyphae at tissue examination; sputum culture positive in only $10 \\%$\n$R x$ : amphotericin B\n\n# Allergic Bronchopulmonary Aspergillosis \n\n$=\\mathrm{ABPA}=$ hypersensitivity reaction to aspergillus antigens released by colonization of tracheobronchial tree by Aspergillus fumigatus in patients with long-standing asthma / cystic fibrosis\n$\\diamond$ Most common + clinically important form of aspergillosis!\nPrevalence: in $2-32 \\%$ of patients with asthma; in $2-15 \\%$ of patients with cystic fibrosis\nAge: mostly young patients (begins in childhood); may be undiagnosed for 10-20 years\nPath: bronchocentric granulomas within bronchi and bronchioles with associated mucoid impactions\nHisto: deposition of immune complexes + inflammatory cells in bronchial mucosa $\\rightarrow$ necrosis + eosinophilic infiltrates\nPathogenesis: IgE-mediated type I hypersensitivity reaction + specific IgG-mediated type III hypersensitivity\nPathophysiology:\ninhaled spores trapped in segmental bronchi of individuals with asthma $\\rightarrow$ germinate and form hyphae $\\rightarrow$ aspergillus antigen reacts with IgG antibodies $\\rightarrow$ immune complexes activate complement $\\rightarrow$ release of proteolytic enzymes $\\rightarrow$ inflammatory infiltrates $\\rightarrow$ bronchial wall damage $\\rightarrow$ central bronchiectasis\nStaging (Patterson):\nI acute phase with all primary diagnostic criteria\nII remission $=$ clearing of pulmonary infiltrates with declining IgE levels\nIII exacerbation $=$ all criteria of stage I reappear after remission\nIV corticosteroid dependency",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 512,
            "markdown": "| Criteria for Diagnosis of ABPA (adapted Rosenberg-Patterson Criteria) |\n| :--: |\n| Major diagnostic criteria |\n| acronym: ARTEPICS |\n| Asthma (present in 84-96\\%) |\n| Roentgenographic fleeting / fixed pulmonary infiltrates |\n| Test for A. fumigatus positive: immediate skin reaction (type I hypersensitivity) |\n| Eosinophilia in blood (8-40\\%) |\n| Precipitating antibodies (IgG) in serum to A. fumigatus (70\\%) |\n| IgE in serum elevated $>1000 \\mathrm{IU} / \\mathrm{mL}$ |\n| Central bronchiectasis (late manifestation proves diagnosis) |\n| Serum A. fumigatus-specific $\\operatorname{IgG}+\\operatorname{IgE}$ ( $>2 \\mathrm{x}$ the value of pooled serum samples from asthmatics with Aspergillus hypersensitivity) |\n| Minor diagnostic criteria |\n| Aspergillus fumigatus mycelia in sputum |\n| Expectoration of brown sputum plugs (54\\%) |\n| Arthus reaction (= late skin reactivity with erythema and induration) to Aspergillus antigen |\n\nV irreversible lung fibrosis\nA. ACUTE ABPA\n\nType I reaction = immediate hypersensitivity (IgE-mediated mast cell degranulation)\nHisto: alveoli filled with eosinophils\n\n- bronchoconstriction, mucus production\n- bronchial wall edema $\\leftarrow \\uparrow$ vascular permeability\nB. CHRONIC ABPA\n\nType III reaction = delayed immune complex response = Arthus reaction (IgGmediated)\nHisto: bronchocentric granulomas + mucoid impaction; fungal hyphae without tissue invasion\n\n- flulike symptoms: fever, headache, malaise, weight loss, fleeting pleuritic chest pain\n- wheezing, expectoration of brown mucous plugs\n- positive skin test to A. fumigatus; peripheral eosinophilia\n- elevated IgE level correlates well with disease activity!\n\nCXR:\n$\\checkmark$ initial CXR normal in up to $50 \\%$\n$\\checkmark$ NORMAL peripheral bronchi\n$\\checkmark$ hyperinflation $\\leftarrow$ bronchospasm / emphysema\n(a) early stage:\n$\\checkmark$ migratory pneumonitis = ill-defined homogeneous transient recurrent \"fleeting\" alveolar patchy subsegmental / lobar opacities (in up to $90 \\%$ )\nLocation: upper lobes ( $50 \\%$ ), lower lobes ( $20 \\%$ ), middle lobe ( $7 \\%$ ); both lungs $(65 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 513,
            "markdown": "Duration: may persist for $>6$ months\n(b) later stage of bronchial wall damage:\n$\\sqrt{ }$ central varicose / cystic bronchiectasis with thickened bronchial walls:\n$\\sqrt{ }$ \"tramline\" / parallel line bronchial walls $\\leftarrow$ edema\n$\\sqrt{ } 1-2-\\mathrm{cm}$ ring shadows ( $=$ bronchus on end)\n$\\sqrt{ }$ \"finger in glove / gloved finger / toothpaste shadow\" $=\\mathrm{V}$ - or Y -shaped branching and tapering tubular opacities arising centrally and extending peripherally remaining for months + growing in size\nLocation: perihilar + upper lobes\nPath: plugging of airways by hyphal masses with mucoid impaction distally in $2^{\\text {nd }}$ order bronchi of $2.5-6 \\mathrm{~cm}$ in length\n$\\sqrt{ }$ perihilar opacities simulating hilar and/or mediastinal lymphadenopathy $\\leftarrow$ mucusfilled dilated central bronchi\n$\\sqrt{ }$ isolated lobar / segmental atelectasis (in $14 \\%$ ) with collateral air drift\n$\\sqrt{ }$ lobar consolidation (in 32\\%)\n$\\sqrt{ }$ cavitation (in $14 \\%$ ) $\\pm$ air-fluid levels $\\leftarrow$ postobstructive / eosinophilic abscess\n$\\sqrt{ }$ UNUSUAL: aspergilloma in cavity (7\\%), empyema, pneumothorax\n(c) chronic stage:\n$\\sqrt{ }$ pulmonary fibrosis + retraction\n$\\sqrt{ }$ hilar elevation $\\leftarrow$ lobar shrinkage\nCT:\n$\\sqrt{ }$ bronchiectasis of segmental + subsegmental bronchi affecting $>3$ lobes\n$\\sqrt{ }$ CHARACTERISTIC highly opaque mucus within dilated bronchi $\\leftarrow$ calcium salts / metals (iron and manganese) / desiccated mucus / calcifications (in 30\\%)\n$\\sqrt{ }$ tree-in-bud appearance $=$ centrilobular nodules connected to branching linear structures (more common in asthmatics)\n$\\sqrt{ }$ patchy areas of mosaic attenuation $\\leftarrow$ concomitant small-airway disease + areas of air trapping\n$\\sqrt{ }$ atelectasis, consolidation, air trapping\nPrognosis: end-stage pulmonary fibrosis $\\rightarrow$ respiratory and right heart failure (if untreated)\n$D D x$ : hypersensitivity pneumonitis or allergic asthma (no hyphae in sputum, normal levels of $\\mathrm{IgE}+\\mathrm{IgG}$ to A. fumigatus), tuberculosis, lipoid pneumonia, Löffler syndrome, bronchogenic carcinoma\n\n# Cerebral Aspergillosis \n\nTransmission:\n(1) hematogenous dissemination from distant pulmonary infection\n(2) angiotropic / perineural spread from paranasal sinus / orbital infection (rhinocerebral disease)\n(3) direct traumatic implantation\n$\\sqrt{ }$ ring-enhancing cerebral abscesses $\\leftarrow$ hematogenous dissemination\n$\\sqrt{ }$ hypoattenuating intracavitary projections without associated enhancement on T2WI + ADC map $\\leftarrow$ proliferating hyphae\n$\\sqrt{ }$ propensity for vascular invasion by fungal hyphae $\\leftarrow$ production of elastase\n$\\sqrt{ }$ zones of low T2 signal intensity $\\leftarrow$ iron, manganese, magnesium in paranasal fungal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 514,
            "markdown": "concretions\n$C x$ : cerebral infarction, hemorrhage ( $25 \\%$ ), mycotic aneurysm $\\leftarrow$ invasion of vessel wall\nPrognosis: in immunocompromised $\\sim 100 \\%$ mortality\n\n# Pleural Aspergillosis \n\n$=$ Aspergillus empyema in patients with pulmonary tuberculosis, bacterial empyema, bronchopleural fistula\n$\\sqrt{ }$ pleural thickening\n\n## Renal Aspergillosis\n\n$=$ uncommon renal infection\nRenal aspergillosis occurs in immunocompromised patients with diabetes / HIV infection / on corticosteroid therapy.\nRoute: hematogenous dissemination (most common) / ascending infection / Aspergillus casts in renal pelvis\n$\\sqrt{ }$ mimicks complex renal mass / cyst / abscess\nCT:\n$\\sqrt{ }$ hypoattenuating mass with thick enhancing wall\n$\\sqrt{ }$ internal septations\n$\\sqrt{ } \\pm$ features of focal pyelonephritis in surrounding renal parenchyma with delayed enhancement\n$D x$ : urinalysis, aspiration of lesion\n\n## ASPIRATION OF SOLID FOREIGN BODY\n\nIn suspected foreign-body ingestion the initial standard imaging protocol includes frontal and lateral radiographs of the chest, neck (often included on CXR) and abdomen.\nCXR (frontal + lateral view):\n$\\sqrt{ }$ apparently normal radiograph ( $20-35 \\%$ ) $\\leftarrow$ radiolucent foreign body (in $80 \\%$ )\n$\\sqrt{ }$ overdistension of hypopharynx\n$\\sqrt{ }$ prevertebral soft-tissue swelling\n$\\sqrt{ }$ ipsilateral lobar / segmental overinflation despite expiration:\n$\\sqrt{ }$ ipsilateral hyperlucency $\\leftarrow$ obstructive overinflation ( $68 \\%$ ) + reflex vasoconstriction (= decrease in perfusion of compromised segment $\\leftarrow$ air trapping)\n$\\sqrt{ }$ air trapping $\\rightarrow$ needs expiratory / bilateral decubitus views\n$\\sqrt{ }$ chronic volume loss of affected lobe $\\leftarrow$ atelectasis\n$\\sqrt{ }$ recurrent pneumonia / infiltrate ( $11 \\%$ )\n$\\sqrt{ }$ bronchiectasis\n$\\sqrt{ }$ pleural effusion\nCT (indicated to assess for residual foreign body after bronchoscopy / with suspected serious complication):\n$\\sqrt{ }$ intrabronchial foreign body:\n$\\sqrt{ }$ intrabronchial low-attenuation material (SUGGESTIVE)\n$\\sqrt{ }$ radiopaque foreign body ( $9 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 515,
            "markdown": "$\\sqrt{ }$ thickened bronchial wall adjacent to foreign body $\\rightarrow$ chronic inflammatory reaction around aspirated material\n$\\checkmark$ ipsilateral hilar adenopathy\n$\\checkmark$ hyperlucency\n$\\checkmark$ bronchiectasis\n$\\checkmark$ atelectasis (14-53\\%), lobar collapse\n$\\checkmark$ mucoid impaction, tree-in-bud pattern\n$\\checkmark$ ipsilateral pleural effusion\nNUC (V/Q scan):\n$\\checkmark$ ventilation defect (initial breath) + retention (washout)\n$C x$ : bronchiectasis (from long retention), hemoptysis, bronchial stricture, development of inflammatory polyps, abscess\n@: Childhood\nAge: peak prevalence 6 month-3 years; in $50 \\%<3$ years; in $70 \\%<15$ years\nDelay of diagnosis: within 2-3 days (usual) / > 24 hours; weeks to months (rare)\nSource:\n(a) young child: in $85 \\%$ vegetable origin (peanut, seed, bean, lentil, pea, barley grass); disk battery\n(b) older child: nonfood items like broken fragments of tooth\n\nDisk batteries lodged in esophagus $\\rightarrow$ battery-generated current $\\rightarrow$ potential leakage of caustic material $\\rightarrow$ esophageal perforation within hours\nN.B.: upper GI examination must follow to evaluate for esophageal stricture, erosion, tracheoesophageal / aortoesophageal fistulas\nLocation: R main-stem bronchus (almost exclusively in lower lobes), larynx (3\\%), valleculae, epiglottis, vocal folds, subglottis, trachea; $\\mathrm{R} \\div \\mathrm{L}=2 \\div 1$\n\n- varying degrees of cough mimicking asthma / bronchitis / chronic pneumonia\n- respiratory difficulty, wheezing, hemoptysis, recurrent pneumonia\n\nTechnique: inspiratory + expiratory phase images (in older cooperative child) / lateral decubitus images (in young less cooperative child)\n$\\checkmark$ hyperinflation is the most common finding in children $\\leftarrow$ \"ball-valve\" mechanism $\\leftarrow$ increased compliance of pediatric airway\n$D D x$ : impacted esophageal foreign body may also contribute to respiratory compromise; ingestion of dishwasher / laundry detergent \"pods\" $\\rightarrow$ severe caustic injury to esophagus and surrounding tissues\n@: Adulthood (unusual)\nContributing factors: CNS disorder, alcoholism, dental procedure\nSource: animal bones, nutshells, medications, metallic denture parts, needles\nDelay of diagnosis: for long periods of time\n\n- often clinically silent / recurrent pneumonia\n- massive life-threatening hemoptysis\n\nLocation: RLL, intermediate bronchus, left main bronchus\n\n# Lower Airway Foreign Body in Childhood \n\n$=75 \\%$ of foreign bodies aspirated into airways below larynx",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 516,
            "markdown": "Location: trachea (13\\%), right lung (60\\%), left lung (23\\%); bilateral (2\\%)\nSource: mostly organic material (ie, food)\n\n- episode of choking followed by asymptomatic period\nN.B.: consider aspirated / ingested occult foreign body with chronic cough / recurrent pneumonia\n$\\checkmark$ aspirated foreign body radiolucent ( $90 \\%$ ) / radiopaque ( $10 \\%$ )\n$\\checkmark$ unilateral hyperinflation, atelectasis, mediastinal shift\n$\\checkmark$ affected lung will remain lucent in expiration\nWith partial airway occlusion, expiratory view shows an increase in diagnostic accuracy $\\leftarrow$ airway narrowing $\\leftarrow$ air trapping $\\leftarrow$ ball-valve mechanism\nN.B.: lateral decubitus view is WITHOUT an increase in diagnostic accuracy\n\nCx: pneumomediastinum, pneumothorax\n$R x:$ bronchoscopy $=$ reference standard for diagnosis and management of aspirated foreign bodies\n\n# Aspiration Bronchiolitis \n\n$=$ chronic inflammatory reaction to repeated aspiration of foreign particles into bronchioles\nPredisposed: achalasia, Zenker diverticulum, hiatal hernia, gastroesophageal reflux, esophageal carcinoma\nHisto: resembling diffuse panbronchiolitis\n\n- dysphagia, regurgitation, aspiration\n$\\checkmark$ moderate / marked dilatation of esophagus\n$\\checkmark$ lobar / segmental / disseminated small nodules\nCT:\n$\\checkmark$ uni- / bilateral foci of branching areas of increased attenuation:\n$\\checkmark$ tree-in-bud appearance $=$ centrilobular nodules + uni- / bilateral branching areas of increased attenuation\n$\\checkmark$ mottled poorly defined opacified acinar areas\n\n\n## ASPIRATION PNEUMONIA\n\nFrequency: $4-8+1000$ inpatients in USA $\\rightarrow 50,000$ deaths each year from Cx of aspiration Predisposing conditions:\n(1) CNS disorders / intoxication: alcoholism, mental retardation, seizure disorders, recent anesthesia\n(2) Swallowing disorders: esophageal motility disturbances, head + neck surgery\n\nCough may be a potential indicator of aspiration due to oropharyngeal dysphagia. However, in up to $55 \\%$ aspiration can be silent producing no reflexive cough.\n\n- low-grade fever, choking on swallowing, productive cough\n\nLocation: gravity-dependent portions of lung, posterior segments of upper lobes + lower lobes in bedridden patients; frequently bilateral; right middle + lower lobe with sparing of left lung is common\nPrognosis: $20-65 \\%$ mortality in patients $>65$ years of age",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 517,
            "markdown": "# Acute Aspiration Pneumonia \n\nCause: gastric acid, food particles, anaerobic bacteria from GI tract provoke edema, hemorrhage, inflammatory cellular response, foreign-body reaction\nOrganism: Gram-negative bacteria; Pseudomonas aeruginosa, Actinomyces israelii\n$\\checkmark$ patchy bronchopneumonic pattern\n$\\checkmark$ lobar / segmental consolidation in dependent portion\n$\\checkmark$ necrotizing pneumonia\n$\\checkmark$ abscess formation\nAspiration of high-osmolar water-soluble contrast agents can lead to severe pulmonary edema. Isoosmolar or low-osmolar agents should be used in patients at increased risk for aspiration.\n\n## Chronic Aspiration Pneumonia\n\nCause: repeated aspiration of foreign material from GI tract over long time / mineral oil (eg, in laxatives)\nAssociated with: Zenker diverticulum, esophageal stenosis, achalasia, tracheoesophageal fistula, neuromuscular disturbances in swallowing\n$\\checkmark$ recurring segmental consolidation\n$\\checkmark$ progression to interstitial scarring (= localized honeycomb appearance)\n$\\checkmark$ bronchopneumonic infiltrates of variable location over months / years\n$\\checkmark$ residual peribronchial scarring\nUpper GI:\n$\\checkmark$ abnormal swallowing / aspiration\n\n## Mendelson Syndrome\n\n$=$ aspiration of gastric acid with a $\\mathrm{pH}<2.5$\nAssociated with: vomiting, gastroesophageal reflux, achalasia, hiatal hernia\nPathophysiology:\nacid rapidly disseminates throughout bronchial tree + lung parenchyma $\\rightarrow$ incites chemical pneumonitis within minutes; extent of injury from mild bronchiolitis to hemorrhagic pulmonary edema depends on $\\mathrm{pH}+$ aspirated volume\nLocation: posterior upper lobe segments + superior lower lobe segments (with patient in recumbent position)\n$\\checkmark$ bilateral perihilar ill-defined alveolar consolidations\n$\\checkmark$ multifocal patchy infiltrates\n$\\checkmark$ segmental / lobar consolidation localized to one / both lung bases\nPrognosis: $30 \\%$ mortality with massive aspiration; $>50 \\%$ with initial shock, apnea, secondary pneumonia, or ARDS\n\n## ASTHMA\n\n$=$ chronic episodic reversible bronchoconstriction (= airflow obstruction) $\\leftarrow$ hypersensitivity / hyperresponsiveness of airways to a variety of stimuli\nTerminology:\nReactive airway disease = clinical diagnosis of asthma not yet established, usually in children between 2 and 6 years of age",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 518,
            "markdown": "# A. INTRINSIC ASTHMA \n\nAge: middle age\nPathogenesis:\nprobably autoimmune phenomenon caused by viral respiratory infection and often provoked by infection, exercise, pharmaceuticals; NO environmental antigen\nB. EXTRINSIC ASTHMA $=$ ATOPIC ASTHMA\n\nPathogenesis:\nantigens produce an immediate hypersensitivity response (type I); reagin sensitizes mast cells $\\rightarrow$ histamine release $\\rightarrow$ increased vascular permeability, edema, small muscle contraction; effects primarily bronchi causing airway obstruction\nNonoccupational allergens:\npollens, dog + cat fur, tamarind seed powder, castor bean, fungal spores, grain weevil\nOccupational allergens:\n(a) natural substances: wood dust, flour, grain, beans\n(b) pharmaceuticals: antibiotics, ASA\n(c) inorganic chemicals: nickel, platinum\n\nPath: bronchial plugging with large amounts of viscid tenacious mucus (eosinophils, Charcot-Leyden crystals), edematous bronchial walls, hypertrophy of mucous glands + smooth muscle\n\n## ACUTE SIGNS:\n\n- during asthmatic attack low values for FEV + MMFR and abnormal V/Q ratios; normal diffusing capacity\n- increased resistance to airflow due to\n(a) smooth muscle contraction in airway walls\n(b) edema of airway wall caused by inflammation\n(c) mucus hypersecretion with airway plugging\n$\\sqrt{ }$ hyperexpansion of lungs $=$ severe overinflation + air trapping:\n$\\sqrt{ }$ increased anteroposterior chest diameter\n$\\sqrt{ }$ flattening of diaphragmatic domes\n$\\sqrt{ }$ increased retrosternal air space\n$\\sqrt{ }$ peribronchial cuffing $\\leftarrow$ inflammation of airway wall\n$\\sqrt{ }$ bronchial dilatation\n$\\sqrt{ }$ localized areas of hypoattenuation / atelectasis\n$\\sqrt{ }$ peripheral oligemia\nCHRONIC CHANGES:\nNormal chest x-ray in $73 \\%$, findings of abnormalities depend on\n(a) age of onset ( $<15$ years of age in $31 \\% ;>30$ years of age in none)\n(b) severity of asthma\n$\\sqrt{ }$ central ring shadows $=$ bronchiectasis\n$\\sqrt{ }$ scars (from recurrent infections)\nCx:\n(1) Pneumonia ( 2 x as frequent as in nonasthmatics)\n$\\sqrt{ }$ peripheral pneumonic infiltrates $\\leftarrow$ blocked airways\n(2) Atelectasis $(5-15 \\%) \\leftarrow$ mucoid impaction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 519,
            "markdown": "(3) Barotrauma in children (often overlooked on radiographs)pneumomediastinum (5\\%), pneumothorax, subcutaneous emphysema\n(4) Emphysema\n(5) Allergic bronchopulmonary aspergillosis with central bronchiectasis\n\n# ATYPICAL MEASLES PNEUMONIA \n\n$=$ clinical syndrome in patients who have been previously inadequately immunized with killed rubeola vaccine and are subsequently exposed to the measles virus (= type III immune complex hypersensitivity); noted in children who have received live vaccine before 13 months of age\n\n- 2- to 3-day prodrome of headache, fever, cough, malaise\n- maculopapular rash beginning on wrists + ankles (sometimes absent); history of exposure to measles\n- postinfectious migratory arthralgias\n$\\sqrt{ }$ extensive nonsegmental consolidation, usually bilateral\n$\\sqrt{ }$ hilar adenopathy $(100 \\%)$\n$\\sqrt{ }$ pleural effusion $(0-70 \\%)$\n$\\sqrt{ }$ nodular densities of $0.5-10 \\mathrm{~cm}$ in diameter in peripheral location, may calcify and persist up to 30 months\n\n\n## BARITOSIS\n\n$=$ inhalation of nonfibrogenic barium sulfate\n\n- asymptomatic; normal pulmonary function (benign course)\n$\\sqrt{ }$ bilateral nodular / patchy opacities, denser than bone $\\leftarrow$ high atomic number\n$\\sqrt{ }$ similar to calcified nodules\n$\\sqrt{ }$ NO cor pulmonale, NO hilar adenopathy\n$\\sqrt{ }$ regression if patient removed from exposure\n\n\n## BERYLLIOSIS\n\n$=$ chronic granulomatous disorder caused by exposure to beryllium dust / fumes (= acid salts from extraction of beryllium oxide)\nSubstance: one of the lightest metals (atomic weight 9), marked heat resistance, great hardness, fatigue resistance, no corrosion\nOccupational exposure: fluorescent light bulb factories, ceramics manufacture, nuclear weapon production, aerospace industry\nImmunology: cell-mediated immune response (= delayed hyper-sensitivity reaction) $\\rightarrow$ accumulation of CD4+ T helper cells + macrophages in lower respiratory tract\nHisto: noncaseating granulomas within interstitium + along vessels + in bronchial submucosa $\\rightarrow$ fibrosis\n$D D x$ : indistinguishable from other granulomatous disorders like sarcoidosis\n\n- positive beryllium lymphocyte transformation test (= sample of blood / bronchoalveolar lavage tested for T-lymphocyte transformation + proliferation to beryllium)\n\nAcute Berylliosis (25\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 520,
            "markdown": "$\\sqrt{ }$ pulmonary edema following an overwhelming exposure (in 54\\%)\nCx: pulmonary carcinoma\n\n# Chronic Berylliosis \n\n$=$ widespread systemic disease of liver, spleen, lymph nodes, kidney, myocardium, skin, skeletal muscle\nMetabolism: removed from lungs $\\rightarrow$ excreted via kidneys\nLatent period: $5-15$ years\nAssociated with: granulomatous hepatitis, hypercalcemia, kidney stones\n\n- dyspnea, cough, fever, anorexia, weight loss, skin lesions\n\nLocation: middle + upper lung zones\nCXR:\n$\\checkmark$ fine irregular reticulonodular opacities (granulomas similar to sarcoidosis) sparing apices + bases\n$\\checkmark$ progression to interstitial fibrosis, honeycombing\n$\\checkmark \\pm$ mass lesions $\\leftarrow$ coalescence of granulomas\n$\\checkmark$ moderate hilar + mediastinal adenopathy (may calcify)\n$\\checkmark$ emphysema in upper lobes\n$\\checkmark$ pneumothorax in $10 \\%$\nHRCT:\n$\\checkmark$ diffuse small parenchymal nodules ( $57 \\%$ ) along bronchovascular bundles\n$\\checkmark$ interlobular septal lines ( $50 \\%$ )\n$\\checkmark$ patches of ground-glass attenuation ( $32 \\%$ )\n$\\checkmark$ hilar / mediastinal lymphadenopathy ( $21-39 \\%$ ), only in the presence of parenchymal abnormalities\n$\\checkmark$ bronchial wall thickening ( $46 \\%$ )\n$\\checkmark$ pleural irregularities ( $25 \\%$ )\n$\\checkmark$ honeycombing ( $7 \\%$ ), conglomerate mass ( $7 \\%$ )\nRx: prolonged treatment with corticosteroids $\\pm$ oxygen\n$D D x$ : (1) Nodular pulmonary sarcoidosis (indistinguishable)\n(2) Asbestosis (no hilar adenopathy)\n\n## BLASTOMYCOSIS\n\n$=$ NORTH AMERICAN BLASTOMYCOSIS $=$ GILCHRIST DISEASE $=$ CHICAGO DISEASE\n$=$ rare systemic mixed pyogenic + granulomatous fungal infection mimicking many other diseases (TB, bacterial pneumonia, malignancy)\nOrganism: soil-born saprophytic dimorphic fungus Blastomyces dermatitidis; mycelial phase in soil; round thick-walled yeast form with broad-based budding in mammals\nGeographic distribution:\nworldwide; endemic in midwest + southeastern USA (Ohio + Mississippi river valleys), vicinity of Great Lakes, St. Lawrence River valley, Canada (northern Ontario), Africa, India, Israel, Saudi Arabia, Central + South America\nPrevalence: $1-40 \\div 100,000$ persons in endemic regions\nPeak age: $25-50$ (range, several months to 80 ) years; $\\mathrm{M}+\\mathrm{F}=10 \\div 1$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 521,
            "markdown": "Mode of infection:\ninhalation (primary portal of entry) of fungal conidia growing in warm wet soil of decayed vegetation + decomposing wood acquired through activities in woods (hunting, camping, logging); spread to extrapulmonary sites (in $17-30 \\%$ ) $\\rightarrow$ eg, skin, bone (often direct extension from skin lesion resembling actinomycosis), joints\nPathophysiology:\nconidia are usually destroyed by a granulomatous reaction mediated by neutrophils, monocytes and macrophages;\nif host defenses are overwhelmed conidia transform into yeast form, which is more resistant to destruction\nPredisposed: elderly, immunocompromised\nHisto:\n(a) exudative phase: accumulation of numerous neutrophils with infecting organism\n(b) proliferative phase: proliferation of epithelioid granulomas + giant cells with central microabscesses containing neutrophils and yeast forms\n\n- acute: fever, chills, cough similar to community-acquired pneumonia\n- chronic: intermittent low-grade fevers, mild persistent productive cough, chest pain, hemoptysis, malaise, fatigue, weight loss\n- mouth ulcers\n@ Lung $(100 \\%)$\n- clinical patterns following pulmonary infection:\n(a) severe pulmonary symptoms\n(b) asymptomatic pulmonary infection with spontaneous resolution\n(c) disseminated disease to single / multiple organs indolent for several years\n(d) extrapulmonary manifestation involving male GU system, skeleton, skin\n$\\diamond$ Highly variable imaging features!\n$\\sqrt{ }$ segmental / lobar patchy ill-defined airspace disease in lower lobes in acute illness (26$76 \\%)$\n$\\sqrt{ }$ solitary / multiple irregular masses of $3-10 \\mathrm{~cm}$ in diameter ( $31 \\%$ ) / satellite lesions in paramediastinal / perihilar location\n$\\sqrt{ }$ air bronchogram in area of consolidation ( $87 \\%$ )\n$\\sqrt{ }$ solitary / multiple nodules of $0.5-3.0 \\mathrm{~cm}$ in diameter ( $6 \\%$ )\n$\\sqrt{ }$ bilateral diffuse reticulonodular interstitial disease ( $6-9 \\%$ ) with tree-in-bud pattern on HRCT\n$\\sqrt{ }$ miliary disease ( $11-28 \\%$ ) with nodules of $<3 \\mathrm{~mm}$ in diameter in fulminant course\n$\\sqrt{ }$ cavitary lesions ( $13 \\%$ ) mimicking TB / other granulomatous disease if located in upper lobes\n$\\sqrt{ }$ hilar / mediastinal lymph node enlargement ( $<25 \\%$ )\n@ Skin ( $20-40 \\%$ in disseminated disease)\n- crusted verrucous lesions on exposed body areas\n- skin ulcers\n$\\sqrt{ }$ subcutaneous areas of soft-tissue + fluid attenuation with associated skin thickening\n@ Bone ( $25 \\%$ )\nLocation: spine, pelvis, sacrum, skull, ribs, long bones\n$\\sqrt{ }$ marked destruction $\\pm$ surrounding sclerosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 522,
            "markdown": "$\\sqrt{ }$ periosteal reaction in long bones, but NOT in short bones\n$\\sqrt{ }$ multiple osseous lesions (frequent)\n$\\sqrt{ }$ destruction of vertebral bodies + intervertebral disks (similar to tuberculosis)\n$\\sqrt{ }$ psoas abscess\n$\\sqrt{ }$ lytic skull lesions + soft-tissue abscess\n$\\sqrt{ }$ usually monoarticular arthritis: knee $>$ ankle $>$ elbow $>$ wrist $>$ hand\n@ GU tract (20\\%): prostatitis, epididymoorchitis\n@ CNS (5-10\\%): epidural / parenchymal abscess, meningitis\n$D x$ : (1) Culture of organism\n(2) Silver stain microscopy of tissues\n\nPrognosis: spontaneous resolution of acute disease in up to 4 weeks; disease may reactivate for up to 3 years; acute respiratory distress within 1 week (in rare fulminant course)\nRx: (1) Amphotericin B IV: 8-10 weeks for noncavitary $+10-12$ weeks for cavitary lesions (2) Ketoconazole\n\nDDx: other pneumonias (ie, bacterial, tuberculous, fungal), pseudolymphoma, malignant neoplasm (ie, alveolar cell carcinoma, lymphoma, Kaposi sarcoma)\n\n# BLUNT CHEST TRAUMA \n\nIncidence: 100,000 hospital admissions / year (in USA)\nPrevalence: $3^{\\text {rd }}$ most common site (after injury to head and extremities)\nCause: high-speed motor vehicle accidents ( $70 \\%$ ), fall, blow to chest\nType of injury:\n\n1. Pneumothorax $69 \\%$\n2. Lung contusion $67 \\%$\n3. Rib fracture $66 \\%$\n4. Hemothorax $28 \\%$\n5. Flail chest $14 \\%$\n6. Thoracic spine fracture $13 \\%$\n7. Clavicle fracture $13 \\%$\n8. Scapula fracture $8 \\%$\n9. Sternal fracture $5 \\%$\n10. Sternoclavicular dislocation\n11. Diaphragmatic injury $5 \\%$\n12. Tracheobronchial tear $2 \\%$\n13. Vascular injury $2 \\%$\n14. Esophageal rupture $1 \\%$\n\nPrognosis: $10.1 \\%$ fatality rate (especially due to cardiac and tracheobronchial-esophageal injury)\n\n## Fracture of Trachea / Bronchus\n\n$=$ TRACHEOBRONCHIAL TEAR\nPrevalence: $0.2-1.5-8.0 \\%$ of all blunt chest injuries\n\n- delayed diagnosis is common\n\nLocation: (a) mainstem bronchus within 2.5 cm of carina ( $80 \\%$ ); $\\mathrm{R}>\\mathrm{L}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 523,
            "markdown": "(b) just above carina $(20 \\%)$\n\nOrientation of tear: longitudinal at junction of cartilaginous and membranous portion of trachea / parallel to cartilage rings of bronchus\nAssociated injuries:\n$\\sqrt{ }$ fracture of first 3 ribs ( $53-91 \\%$ ), rare in children\n$\\sqrt{ }$ fracture of clavicle, sternum, scapula ( $40 \\%$ )\n$\\sqrt{ }$ pneumothorax ( $70 \\%$ ) without improvement after chest tube placement + suction\n$\\sqrt{ }$ increasing pneumomediastinum $\\pm$ subcutaneous emphysema of neck\n$\\sqrt{ }$ absence of pleural effusion\n$\\sqrt{ }$ \"fallen lung\" sign = collapsed lung droops to dependent position posterolaterally away from hilum (loss of anchoring support in complete bronchial transection)\n$\\sqrt{ }$ inadequate reexpansion of lung despite adequate placement of one / more chest tubes $\\leftarrow$ large size of air leak\n$\\sqrt{ }$ elevation of hyoid bone above level of C3 vertebra / elevation of greater cornu to $<2 \\mathrm{~cm}$ from angle of mandible (on LAT radiograph of spine) $\\leftarrow$ infrahyoid muscle rupture + unopposed action of suprahyoid muscles\n$\\sqrt{ }$ atelectasis (may be late development)\nCT:\n$\\sqrt{ }$ focal peribronchial collection of air\n$\\sqrt{ }$ discontinuity / irregularity of bronchial wall\n$\\sqrt{ }$ abnormal position of endotracheal tube:\n$\\sqrt{ }$ overdistension of tube cuff\n$\\sqrt{ }$ protrusion of tube wall beyond expected margins of trachea\n$\\sqrt{ }$ extraluminal position of tip of tube\nDx: bronchoscopy\nPrognosis: 30\\% mortality (in 15\\% within 1 hour)\nLong-term Cx: airway stenosis / bronchomalacia; recurrent atelectasis / pneumonia; abscess; empyema\n\n# Pulmonary Contusion \n\n$=$ acute traumatic injury to alveoli\nPrevalence: 17-70\\% (most common manifestation of blunt chest trauma, esp. deceleration trauma)\nPath: exudation of edema + hemorrhage into airspace + interstitium\nAt risk for: pneumonia, RDS\nTime of onset: apparent within 6 hours after trauma\n\n- may be clinically inapparent; hemoptysis (50\\%)\n\nLocation: posterior (in 60\\%)\nDistribution: nonsegmental\nSite: in lung periphery at site of impact $\\pm$ contrecoup lesion\n$\\diamond$ Frequently not visible on CXR $<6$ hours after injury\n$\\sqrt{ }$ irregular patchy / diffuse extensive homogeneous consolidation\n$\\sqrt{ }$ opacity may enlarge for $48-72$ hours\n$\\sqrt{ }$ rapid resolution beginning after $24-48$ hours",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 524,
            "markdown": "$\\sqrt{ }$ complete clearing in 3-10 days\n$\\sqrt{ }$ overlying rib fractures (frequent)\nCT (more sensitive than CXR):\n$\\diamond$ Immediately visible!\n$\\sqrt{ }$ nonsegmental coarse ill-defined crescentic (50\\%) / amorphous (45\\%) opacification of lung parenchyma without cavitation\n$\\sqrt{ }$ \"subpleural sparing\" $=1-2-\\mathrm{mm}$ rim of nonopacified clear lung between contusional lesion and pleura\nCx: pneumothorax\n$D D x$ : aspiration, pneumonia, fat embolism (1-2 days after injury)\n\n# Pulmonary Laceration \n\n$=$ disruption / tear of lung parenchyma resulting in lung cavity $\\leftarrow$ elastic recoil of lung\nPredisposed: children + young adults (greater flexibility of chest wall with higher likelihood of lung injury in blunt trauma)\nType:\n1 Compression rupture injury (most common)\n$=$ direct compressive force\nLocation: deep portions of lung\n2 Compression shear injury\n$=$ severe sudden blow to lower thorax $\\rightarrow$ shift of lower lobes across spine\nLocation: paraspinous portion of lung\n3 Rib penetration tear\n$=$ rib fracture + pneumothorax\nLocation: periphery of lung\n4 Adhesion tear\n$=$ laceration at preexisting pleuroparenchymal adhesion\nPrognosis: tear fills gradually with blood $\\rightarrow$ slow regression lasting up to several months\n$\\sqrt{ }$ single / multiple uni- / multilocular pulmonary lesions consisting of round / oval lung cavity filled with:\n(a) air $=$ traumatic pneumatocele\n(b) blood $=$ traumatic hematocele / pulmonary hematoma\n(c) both = traumatic hematopneumatocele with air-fluid level\n$\\diamond$ On CXR laceration often obscured by surrounding contusion!\n\n## Traumatic Lung Cyst\n\nAge: children + young adults are particularly prone\n$\\sqrt{ }$ thin-walled air-filled cavity $(50 \\%) \\pm$ air-fluid level preceded by homogeneous wellcircumscribed mass ( $=$ hematoma)\n$\\sqrt{ }$ oval / spherical lesion of $2-14 \\mathrm{~cm}$ in diameter\n$\\sqrt{ }$ single / multiple lesions; uni- or multilocular\n$\\sqrt{ }$ usually subpleural under point of maximal injury\n$\\sqrt{ }$ persistent up to 4 months + progressive decrease in size (apparent within 6 weeks)\n\n## Traumatic Lung Herniation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 525,
            "markdown": "$=$ pleura-covered part of lung extruding through a traumatic defect in the chest wall Associated with: rib fracture\n\n# BONE MARROW TRANSPLANTATION \n\n$=$ intravenous infusion of hematopoietic progenitor cells from patient's own marrow (autologous transplant) / HLA-matched donor (allogenic transplant) to reestablish marrow function after high-dose chemotherapy and total body irradiation for lymphoma, leukemia, anemia, multiple myeloma, congenital immunologic defects, solid tumors\n$C x$ : pulmonary complications in $40-60 \\%$\n\n## Neutropenic-Phase Pulmonary Complications\n\nTime: $2-3$ weeks after transplantation\n\n1. Angioinvasive aspergillosis\n$\\sqrt{ }$ nodule surrounded by halo of ground-glass attenuation (= fungal infection spreading into lung parenchyma with surrounding area of hemorrhagic infarction)\n$\\sqrt{ }$ segmental / subsegmental consolidation\n(= pulmonary infarction)\n$\\sqrt{ }$ cavitation of nodule with \"air-crescent\" sign (during recovery phase with resolving neutropenia)\n$\\sqrt{ }<5-\\mathrm{mm}$ centrilobular nodules to $5-\\mathrm{cm}$ peribronchial consolidation ( $=$ airway invasion with surrounding zone of hemorrhage / organizing pneumonia)\n2. Diffuse alveolar hemorrhage ( $20 \\%$ )\n\n- hemosiderin-laden macrophages on lavage\n$\\sqrt{ }$ bilateral areas of ground-glass attenuation / consolidation\n\n3. Pulmonary edema\n\nCause: infusion of large volumes of fluid combined with cardiac + renal dysfunction\n$\\sqrt{ }$ prominent pulmonary vessels, interlobar septal thickening, ground-glass attenuation, pleural effusions\n4. Drug toxicity\n\nCause: bleomycin, busulfan, bischloronitrosurea (carmustine), methotrexate\n$\\sqrt{ }$ bilateral areas of ground-glass attenuation / consolidation / reticular attenuation (= fibrosis)\n\n## Early-Phase Pulmonary Complications\n\nTime: up to 100 days after transplantation\n\n1. CMV pneumonia ( $23 \\%$ )\n$\\sqrt{ }$ multiple small nodules + associated areas of consolidation + ground-glass attenuation (= hemorrhagic nodules)\n2. Pneumocystis carinii pneumonia\n$\\sqrt{ }$ diffuse / predominantly perihilar / mosaic pattern of ground-glass attenuation with sparing of some secondary pulmonary lobules\n3. Idiopathic interstitial pneumonia ( $12 \\%$ )\n$\\sqrt{ }$ nonspecific findings (diagnosis of exclusion)\n\n## Late-Phase Pulmonary Complications",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 526,
            "markdown": "Time: after 100 days post transplantation\n\n1. Bronchiolitis obliterans (in up to 10\\%)\n2. BOOP\n3. Chronic graft-versus-host disease:\ninfections, chronic aspiration, bronchiolitis obliterans, lymphoid interstitial pneumonia\n\n# BRONCHIAL ADENOMA \n\n$=$ misnomer due to locally invasive features + tendency for recurrence + occasional metastasis to extrathoracic sites (in $10 \\%$ ) = low-grade malignancy\nPath: arises from duct epithelium of bronchial mucous glands (predominant distribution of Kulchitsky cells at bifurcations of lobar bronchi)\nFrequency: $6-10 \\%$ of all primary lung tumors\nMean age: 35-45 (range, 12-60) years; $90 \\%$ occur $<50$ years of age; most common primary lung tumor $<16$ years of age; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$; Whites $\\div$ Blacks $=25 \\div 1$\nTypes:\nmnemonic: CAMP\nCarcinoid $90 \\%$\nAdenoid cystic carcinoma $=$ cylindroma $6 \\%$\nMucoepidermoid carcinoma $3 \\%$\nPleomorphic carcinoma $1 \\%$\nLocation: most commonly near / at bifurcation of lobar / segmental bronchi; central $\\div$ peripheral\n\n$$\n=4 \\div 1\n$$\n\n> $48 \\%$ on right: RLL (20\\%), RML (10\\%), main right bronchus (8\\%), RUL (7\\%), intermediate bronchus ( $3 \\%$ )\n> $32 \\%$ on left: LLL (13\\%), LUL (12\\%), main left bronchus (6\\%), lingular bronchus (1\\%)\n\n- hemoptysis ( $40-50 \\%$ ), atypical asthma, persistent cough\n- recurrent obstructive pneumonia; asymptomatic ( $10 \\%$ )\n$\\sqrt{ }$ complete obstruction / air trapping in partial obstruction (rare) / nonobstructive (10-15\\%)\n$\\sqrt{ }$ obstructive emphysema\n$\\sqrt{ }$ recurrent postobstructive infection: pneumonitis, bronchiectasis, abscess\n$\\checkmark$ atelectasis / consolidation of a lung / lobe / segment (78\\%)\n$\\checkmark$ collateral air drift may prevent atelectasis\n$\\checkmark$ solitary round / oval slightly lobulated pulmonary nodule ( $19 \\%$ ) of $1-10 \\mathrm{~cm}$ in size\n$\\checkmark$ hilar enlargement / mediastinal widening $=$ central endo- / exobronchial mass\nCT:\n$\\checkmark$ well-marginated sharply defined mass\n$\\checkmark$ in close proximity to an adjacent bifurcation with splaying of bronchus\n$\\checkmark$ coarse peripheral calcifications in $1 / 3$ (cartilaginous / bony transformation)\n$\\checkmark$ may exhibit marked homogeneous enhancement\nBiopsy: risky $\\leftarrow$ high tumor vascularity\nPrognosis: 95\\% 5-year survival rate; 75\\% 15-year survival rate after resection\n\n\n## Cylindroma\n\n= ADENOID CYSTIC CARCINOMA (7\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 527,
            "markdown": "$\\diamond 2^{\\text {nd }}$ most common primary tumor of trachea\n$\\diamond$ Most common carcinoma of minor salivary tissue\nPath: mixed serous + mucous glands; resembles salivary gland tumor\nHisto:\nGrade 1: tubular + cribriform; no solid subtype\n$\\sqrt{ }$ entirely intraluminal\nGrade 2: tubular + cribriform; $<20 \\%$ solid subtype\n$\\sqrt{ }$ predominantly intraluminal\nGrade 3: solid subtype $>20 \\%$\n$\\sqrt{ }$ predominantly extraluminal\nAge peak: $4^{\\text {th }}-5^{\\text {th }}$ (range, $3^{\\text {rd }}-9^{\\text {th }}$ ) decade; $\\mathrm{M}=\\mathrm{F}$\n\n- typical history of refractory \"asthma\", hoarseness\n- hemoptysis, cough, stridor, wheezing, chest pain, dysphagia\n$\\sqrt{ }$ endotracheal mass with extratracheal extension\nMalignant potential: more aggressive than carcinoid with propensity for local invasion + distant metastases (lung, bone, brain, liver) in $25 \\%$\nRx: tracheal resection + adjunctive radiotherapy\nPrognosis: 8.3 years mean survival\n\n\n# Mucoepidermoid Carcinoma \n\nPath: squamous cells + mucus-secreting columnar cells; resembles salivary gland tumor\n$\\sqrt{ }$ may involve trachea $=$ locally invasive tumor\n$\\sqrt{ }$ sessile / polypoid endobronchial lesion\n\n## Pleomorphic Adenoma\n\n$=$ MIXED TYPE (extremely rare)\n\n## BRONCHIAL ATRESIA\n\n$=$ rare anomaly resulting from focal obliteration of proximal lumen of a lobar / segmental / subsegmental bronchus\nProposed causes:\n(a) local interruption of bronchial arterial perfusion $>16$ weeks GA (when bronchial branching is complete)\n(b) tip of primitive bronchial bud separates from bud and continues to develop\n\nPath: normal bronchial tree distal to occlusion is patent and filled with mucus; alveoli distal to occlusion are air-filled and mildly overinflated through collateral air drift\nAssociated with: lobar emphysema, cystic adenomatoid malformation\nMean age: 17 years; $\\mathrm{M}+\\mathrm{F}=2 \\div 1$\n\n- minimal symptoms, apparent later in childhood (most by age 15) / adult life\n- recurrent pulmonary infections (in 20\\%)\n\nLocation: apicoposterior segment of LUL ( $>>$ RUL / ML)\nCXR:\n$\\sqrt{ }$ lobular / ovoid / round / branching perihilar mass:\n$\\sqrt{ }$ CHARACTERISTIC \"gloved finger\" sign $\\leftarrow$ accumulation of mucus in dilated central bronchus distal to atretic lumen ( $=$ mucus impaction $=$ bronchocele $/$ mucocele)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 528,
            "markdown": "$\\sqrt{ }$ overexpanded hyperlucent lung segment (collateral air drift with expiratory air-trapping) CT:\n$\\sqrt{ }$ mucus-filled bronchus near hilum WITHOUT connection between mucocele + hilum\n$\\sqrt{ }$ air trapping in surrounding area\n$\\sqrt{ }$ decreased perfusion with focal parenchymal oligemia\nOB-US (detected $>24$ weeks MA):\n$\\sqrt{ }$ large echogenic fetal lung mass $\\leftarrow$ lung fluid-filled distal to occlusion (indistinguishable from other lung masses)\n$\\sqrt{ }$ dilated fluid-filled bronchus\nFetal MR:\n$\\sqrt{ }$ focal lung mass of homogeneously high SI on T2WI\n$R x$ : no treatment in asymptomatic patients; segmentectomy in symptomatic infected patients\n$D D x$ : allergic bronchopulmonary aspergillosis; cystic fibrosis; congenital lobar emphysema (no mucus plug)\n$D D x$ in fetus: congenital cystic adenomatoid malformation, bronchopulmonary sequestration\n\n# BRONCHIECTASIS \n\n$=$ localized mostly irreversible dilatation of bronchi often with thickening of the bronchial wall Pathophysiology:\n\"vicious cycle\" hypothesis = airway damage + infection play reinforcing roles in the development of bronchiectasis. Host factors that predispose to infection are impaired glandular secretion (cystic fibrosis), impaired ciliary function (ciliary dyskinesia), or systemic immune dysfunction.\nEtiology:\nA. Chronic or recurrent infection\n(a) congenital\n\n1. Structural defect of bronchi: bronchial atresia, Williams-Campbell syndrome Distribution: midorder bronchi\n$\\checkmark$ cartilage deficiency\n2. Abnormal mucociliary transport: Kartagener syndrome $=$ primary ciliary dyskinesia\nDistribution: middle lobe, lingula\n$\\sqrt{ }$ situs inversus, chronic sinusitis, bronchiectasis\n3. Abnormal secretions: cystic fibrosis\n\nDistribution: central upper lung zone\n$\\sqrt{ }$ extensive cystic + cylindrical bronchiectasis\n4. Mounier-Kuhn syndrome\n\nDistribution: central\n$\\sqrt{ }$ absence / atrophy of elastic fibers + muscle in trachea and main bronchial walls\n(b) congenital / acquired immune deficiency (usually IgG deficiency):\n\n1. Chronic granulomatous disease of childhood\n2. Alpha-1 antitrypsin deficiency\n(c) postinfectious childhood pneumonias (after necrotizing viral / bacterial bronchitis):\n3. Measles\n4. Whooping cough",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 529,
            "markdown": "3. Swyer-James syndrome\n\nDistribution: focal unilateral\n$\\sqrt{ }$ increased lucency of smaller lung $\\leftarrow$ air trapping\n4. Allergic bronchopulmonary aspergillosis\n\nDistribution: central upper lung zone\n$\\sqrt{ }$ high-attenuation mucus plugging\n5. Chronic granulomatous infection (TB)\n\nDistribution: asymmetric upper lobe involvement\n$\\sqrt{ }$ tree-in-bud nodules\n(d) fibrosing lung disease\n\n1. Sarcoidosis\n\nDistribution: central upper lung zone\n$\\sqrt{ }$ bihilar lymphadenopathy, perilymphatic nodules\n2. Pulmonary fibrosis\n\nDistribution: peripheral lower lung zone\n$\\sqrt{ }$ varicoid bronchiectasis, architectural distortion\n$\\sqrt{ }$ honeycombing in UIP\n3. Acute respiratory distress syndrome\n\nDistribution: middle lobe and lingula\n$\\sqrt{ }$ varicoid bronchiectasis, diffuse ground-glass opacities\nB. Distal to bronchial obstruction $\\leftarrow$ accumulation of secretions: neoplasm, inflammatory nodes, foreign body\nC. Aspiration / inhalation: gastric contents / inhaled fumes (late complication) / foreign object\n\nDistribution: periphery of lower lung zone\n$\\sqrt{ }$ hiatal hernia\nD Bronchiolitis obliterans\nDistribution: diffuse\n$\\sqrt{ }$ diffuse air trapping, post transplantation\nE. \"Traction bronchiectasis\" $\\leftarrow$ increased elastic recoil with bronchial dilatation + mechanical distortion of bronchi: advanced pulmonary fibrosis / radiation-induced lung injury\nF. Increased inflationary pressure\n\nThe distribution and morphologic features of bronchiectasis, architectural distortion and findings of fibrosis, mosaic attenuation, presence and pattern of diffuse nodular lung disease can provide clues to the diagnosis.\nClassification of anatomical abnormality: often in combination\n$\\diamond$ Of little value for illuminating etiology / pathogenesis!\n$\\diamond$ Little interobserver agreement as to bronchiectatic classes\nNormal lung: 17-20 bronchial subdivisions between lung periphery + hilum\n\n1. Cylindrical / tubular / fusiform bronchiectasis\n$=$ mildly uniformly dilated bronchi (least severe type)\n$\\diamond$ reversible if associated with pulmonary collapse\nPath: bronchial subdivisions between lung periphery + hilum reduced to 16\n$\\sqrt{ }$ square abrupt ending with lumen of uniform diameter and same width as parent",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 530,
            "markdown": "bronchus\nHRCT:\n$\\sqrt{ }$ \"tram lines\" of nontapering air ways (horizontal course)\n$\\sqrt{ }$ \"signet-ring\" sign (vertical course) = cross section of dilated bronchus + branch of pulmonary artery\n$\\sqrt{ }$ Y- or V-shaped areas of attenuation $=$ mucous plugs filling bronchiectatic segments\n2. Varicose / varicoid bronchiectasis\n$=$ moderately dilated and beaded bronchi (rare)\nAssociated with: Swyer-James syndrome, interstitial fibrosis $\\rightarrow$ bronchial traction\nPath: bronchial subdivisions between lung periphery + hilum reduced to $4-8$\n$\\sqrt{ }$ alternating segments of bronchial dilatation + narrowing with normal pattern distally\n3. Saccular / cystic bronchiectasis\n$=$ marked cystic dilatation $=$ focal pouch-like areas of enlargement (most severe type)\nAssociated with: cystic fibrosis, severe bronchial infection\nPath: bronchial subdivisions between lung periphery + hilum reduced to $<5$\n$\\sqrt{ }$ progressive ballooning dilatation toward periphery with diameter of saccules $>1 \\mathrm{~cm}$\n$\\sqrt{ }$ irregular constrictions may be present\n$\\sqrt{ }$ dilatation of bronchi on inspiration, collapse on expiration\n$\\sqrt{ }$ contains variable amounts of pooled secretions\nHRCT:\n$\\sqrt{ }$ string of cysts = \"string of pearls\" (horizontal course) / cluster of cysts = \"cluster of grapes\"\n$\\sqrt{ }$ air-fluid level (frequent)\nAge: predominantly pediatric disease\n\n- chronic productive cough, excess sputum production\n- recurrent infection with expectoration of purulent sputum\n- shortness of breath\n- hemoptysis $(50 \\%) \\leftarrow$ bronchial artery dilatation and neovascularity $\\leftarrow$ recurrent airway inflammation\n$\\diamond$ Most common cause of massive hemoptysis!\n- frequent exacerbations + resolutions $\\leftarrow$ superimposed infections\n- Spirometry often reveals an obstructive physiologic condition that worsens over time\n\nAssociated with: obliterative + inflammatory bronchiolitis (in 85\\%)\nLocation: posterior basal segments of lower lobes, bilateral (50\\%); middle lobe / lingula $(10 \\%)$; central bronchiectasis in bronchopulmonary aspergillosis\nCXR ( $37 \\%$ sensitive):\n$\\sqrt{ }$ tramlines $=$ dilated air-filled wall-thickened bronchi:\n$\\sqrt{ }$ parallel + ringlike opacities\n$\\sqrt{ }$ increased background density $\\leftarrow$ parenchymal volume loss:\n$\\sqrt{ }$ crowding of lung markings (if associated with atelectasis)\n$\\sqrt{ }$ increase in size of lung markings (mucous plugs)\n$\\sqrt{ }$ loss of definition of lung markings (peribronchial fibrosis)\n$\\sqrt{ }$ cystic spaces $\\pm$ air-fluid levels $<2 \\mathrm{~cm}$ in diameter (dilated bronchi)\n$\\sqrt{ }$ honeycomb pattern (in severe cases)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 531,
            "markdown": "$\\sqrt{ }$ compensatory hyperinflation of uninvolved ipsilateral lung\nHRCT ( $87-97 \\%$ sensitive, $93-100 \\%$ specific):\n$\\sqrt{ }$ lack of bronchial tapering (in $80 \\%=$ most sensitive finding)\n$\\sqrt{ }$ bronchial wall thickening\n$\\sqrt{ }$ \"signet ring\" sign = internal diameter of bronchus larger than adjacent pulmonary artery (in $60 \\%)$\n$\\sqrt{ }$ bronchi visible within 1 cm of pleura (in $45 \\%$ ) implies bronchiolectasis (DDx: honeycombing)\n$\\sqrt{ }$ mucus-filled dilated bronchi (in 6\\%)\n$\\sqrt{ }$ small bronchial arterial diameter with an increase in bronchoarterial ratio $\\leftarrow$ vasoconstriction $\\leftarrow$ small-vessel / small-airways disease\n$\\sqrt{ }$ dilatation of bronchial arteries $\\leftarrow$ pulmonary hypertension $\\rightarrow$ pseudo-normalization of bronchoarterial ratio\n$C x$ : frequent respiratory infections\nPrognosis: 20\\% 5-year mortality rate\n$R x$ : antibiotics for superimposed infection, bronchodilator, nasal oxygen therapy, chest physiotherapy, inhaled steroids\nDDx of CT appearance:\n(1) Emphysematous blebs (no definable wall thickness, subpleural location)\n(2) \"Reversible bronchiectasis\" = temporary dilatation during pneumonia with return to normal within 4-6 months\n\n# BRONCHIOLITIS \n\n$=$ LOWER RESPIRATORY TRACT INFLAMMATION\nCause: inflammation of small airways $\\leftarrow$ viral antigen (usually respiratory syncytial virus / rhinovirus)\nTerminology:\n> bronchiolitis: child $<2$ years of age\n> lower respiratory tract inflammation: child $>2$ years of age\n$\\sqrt{ }$ small airways $\\leftarrow$ perihilar bronchial wall thickening $\\leftarrow$ edema\n$\\sqrt{ }$ hyperinflation:\n$\\sqrt{ }>6$ anterior rib ends depicted on frontal projection\n$\\sqrt{ }$ downward sloping + flattening of hemidiaphragms\n$\\sqrt{ }$ increased retrosternal airspace\n$\\sqrt{ } \\pm$ lung tissue herniating through intercostal spaces\n$C x$ : atelectasis, consolidation\nPrognosis: development of asthma later in life\n\n## BRONCHIOLITIS OBLITERANS\n\n$=$ CONSTRICTIVE BRONCHIOLITIS = OBLITERATIVE BRONCHIOLITIS\n$=$ concentric narrowing of bronchial lumen\n\n- decrease in forced expiratory volume in 1 second $>20 \\%$\n\nPath: irreversible submucosal and peribronchiolar fibrosis of small airway walls (respiratory bronchiole, alveolar duct, alveoli) $\\rightarrow$ narrowing / obliteration of airway lumina by",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 532,
            "markdown": "granulation tissue of immature fibroblastic plugs (Masson bodies)\n\n# Etiology: \n\n(1) Idiopathic (most frequent) / cryptogenic: in immunocompetent patient\n(2) Inhalation: 1-3 weeks after exposure to toxic fumes (nitrogen dioxide, isocyanates, phosgene, ammonia, sulfur dioxide, chlorine, diacetyl (buttery flavor of popcorn)\n(3) Postinfectious: Mycoplasma (children), virus (older individual); cystic fibrosis (as a complication of repeated episodes of pulmonary infections)\n(4) Drugs: bleomycin, gold salts, cyclophosphamide, carmustine, methotrexate, Dpenicillamine, cocaine\n(5) Collagen vascular disorder: rheumatoid arthritis (especially after treatment with penicillamine / gold salts), systemic sclerosis (= scleroderma), systemic lupus erythematosus, mixed connective tissue disease\n(6) Transplantation: chronic graft-versus-host disease in bone marrow transplant, lung transplant, heart-lung transplant ( $30-56 \\%$ after 3 years)\n(7) Miscellaneous: ulcerative colitis, diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)Stevens-Johnson syndrome, paraneoplastic pemphigus\nPeak age: $40-60$ years; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n\n- insidious onset of dyspnea over many months\n- obstructive pulmonary function tests\n- no response to antibiotics, persistent nonproductive cough, fever\n$\\checkmark$ normal CXR (in up to $40 \\%$ )\n$\\checkmark$ hyperinflated lungs = limited disease with connective tissue plugs in airways\n$\\checkmark$ oligemia $=$ decreased vascularity $\\leftarrow$ reflex vasoconstriction\n$\\checkmark$ bilateral scattered heterogeneous + homogeneous opacities: typically peripheral in distribution; equally distributed between upper + lower lobes\n$\\checkmark$ bronchiectasis\nHRCT (paired expiration-inspiration images):\n$\\checkmark$ patchy air trapping on expiratory scan $\\leftarrow$ collateral air drift into postobstructive alveoli $=$ failure of change in attenuation (ie, volume) between expiration + inspiration\n$\\checkmark$ \"mosaic perfusion\" of lobular air trapping ( $85-100 \\%$ )\n$=$ patchy areas of decreased lung attenuation alternating with areas of normal attenuation:\n$\\checkmark$ areas of $\\downarrow$ attenuation $=$ vessels of decreased caliber $\\leftarrow$ secondary vasoconstriction of alveoli distal to bronchiolar obstruction $\\leftarrow$ alveolar hypoventilation\n$\\checkmark$ areas of $\\uparrow$ attenuation $=$ vessels of increased caliber $\\leftarrow$ compensatory increased perfusion in uninvolved areas\n$\\checkmark$ bronchial wall thickening ( $87 \\%$ )\n$\\checkmark$ central + peripheral bronchiectasis ( $66-80 \\%$ )\n$\\checkmark$ poorly defined nodular areas of consolidation\n$\\checkmark$ \"tree-in-bud\" appearance of bronchioles\n$=$ centrilobular branching structures and nodules caused by peribronchiolar thickening + bronchiolectasis with secretions (the only direct, but UNCOMMON sign)\n$\\checkmark$ centrilobular ground-glass opacities\n$R x:$ steroids may stop progression\n$D D x$ : (1) Bacterial / fungal pneumonia (response to antibiotics, positive cultures)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 533,
            "markdown": "(2) Chronic eosinophilic pneumonia (young female, eosinophilia in $\\%$ )\n(3) Usual interstitial pneumonia (irregular opacities, decreased lung volume)\n\n# BRONCHIOLOALVEOLAR CARCINOMA \n\n$=\\mathrm{BAC}=$ ALVEOLAR CELL CARCINOMA $=$ BRONCHIOLAR CARCINOMA\n$=$ type of adenocarcinoma showing lepedic growth pattern without surrounding stromal / vascular invasion\nFrequency: 1.5-6\\% of all primary lung cancers (increasing incidence to ? 20-25\\%)\nEtiology: development from type II alveolar epithelial cells\nAge: $40-70$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$ (strikingly high in women)\nPath: peripheral neoplasm arising beyond a recognizable bronchus with tendency to spread locally using lung structure as a stroma ( $=$ lepedic growth)\nHisto: subtype of well-differentiated adenocarcinoma; cuboidal / columnar cells grow along alveolar walls + septa without disrupting the lung architecture or pulmonary interstitium (serving as \"scaffolding\" for tumor growth)\nSubtypes:\n(a) mucinous ( $80 \\%$ ): mucin-secreting tall columnar peglike bronchiolar cells; more likely multicentric; $26 \\% 5$-year survival rate\n(b) nonmucinous ( $20 \\%$ ): cuboidal type II alveolar pneumocytes with production of surfactant / nonciliated bronchiolar (Clara) cells; more localized + solitary; $72 \\%$ 5 -year survival rate\nRisk factors: localized pulmonary fibrosis (tuberculous scarring, pulmonary infarct) in 27\\%, diffuse fibrotic disease (scleroderma), previous exogenous lipid pneumonia\n\n- history of heavy smoking $(25-50 \\%)$\n- often asymptomatic (even in disseminated disease) with insidious onset\n- pleuritic chest pain ( $\\leftarrow$ peripheral location)\n- cough (35-60\\%), hemoptysis ( $11 \\%$ )\n- bronchorrhea $=$ abundant white mucoid / watery expectoration (5-27\\%); can produce hypovolemia + electrolyte depletion; unusual + late manifestation only with diffuse bronchioloalveolar carcinoma\n- shortness of breath ( $15 \\%$ ), weight loss ( $13 \\%$ ), fever ( $8 \\%$ )\n\nLocation: peripherally, beyond a recognizable bronchus\nSpread: tracheobronchial dissemination = cells detach from primary tumor + attach to alveolar septa elsewhere in ipsi- / contralateral lung; lymphogenous and hematogenous dissemination\nMetastases: involving almost any organ (in 50-60\\%); 33\\% of skeletal metastases are osteoblastic\nA. LOCAL FORM (60-90\\%)\n\n1. Ground-glass attenuation\n$=$ early stage $(\\leftarrow$ lepedic growth pattern along alveolar septa with relative lack of acinar filling)\n$\\sqrt{ }$ ground-glass haziness\n$\\sqrt{ }$ bubblelike hyperlucencies / pseudocavitation\n$\\sqrt{ }$ airway dilatation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 534,
            "markdown": "$\\sqrt{ }$ lesion persists / progresses within 6-8 weeks\n\n| Spectrum of Adenocarcinoma of Lung (formerly Bronchioloalveolar Carcinoma 2011) |  |  |\n| :--: | :--: | :--: |\n| Term | Pathology | $C T$ |\n| Adenocarcinoma in situ (AIS) | noninvasive $\\leq 3 \\mathrm{~cm}$ mass, purely lepedic growth | nonsolid mass $\\pm$ small scattered sites of low attenuation |\n| Minimally invasive adenoca. (MIA) | invasive $\\leq 3 \\mathrm{~cm}$ mass with lepedic growth (depth of invasion $\\leq 5-\\mathrm{mm}$ ) | nonsolid mass $+5-\\mathrm{mm}$ central solid component |\n| Lepedic adenocarcinoma | invasive nonmucinous adenocarcinoma with predominantly lepedic growth | partly solid mass + bubblelike component |\n| Acinar / papillary / micropapillary / solid adenoca. | invasive nonmucinous adenocarcinoma + small proportion of lepedic growth | usually solid mass $\\pm$ small nonsolid component |\n| Invasive mucinous adenocarcinoma | invasive mucinous adenocarcinoma + lepedic growth as predominant component | solid / mostly solid / part solid / nonsolid mass |\n\n2. Single mass $(43 \\%)$\n$\\sqrt{ }$ well-circumscribed focal mass in peripheral / subpleural location arising beyond a recognizable bronchus\n$\\sqrt{ }$ \"open bronchus\" sign = air bronchogram = tumor / mucus surrounding aerated bronchus $\\pm$ narrowing / stretching / spreading of bronchi\n$\\sqrt{ }$ \"rabbit ears\" / pleural tags / triangular strand / \"tail\" sign (55\\%) = linear strands extending from nodule to pleura (desmoplastic reaction / scarring granulomatous disease / pleural indrawing)\n$\\sqrt{ }$ spiculated margin $=$ sunburst appearance $(73 \\%)$\n$\\sqrt{ }$ solitary cavity $\\leftarrow$ central necrosis $(7 \\%)$\n$\\diamond 2^{\\text {nd }}$ most common cell type associated with cavitation after squamous cell carcinoma\n$\\sqrt{ }$ pseudocavitation (= dilatation of intact air spaces from desmoplastic reaction / bronchiectasis / focal emphysema) in $50-60 \\%$\n$\\sqrt{ }$ heterogeneous attenuation $(57 \\%)$\n$\\sqrt{ }$ confined to single lobe\n$\\sqrt{ }$ rarely evolving into diffuse form\n$\\sqrt{ }$ slowly progressive growth on serial radiographs\n$\\sqrt{ }$ NO atelectasis\n$\\sqrt{ }$ negative FDG PET results in $55 \\%$\nPrognosis: $70 \\%$ surgical cure rate for tumor $<3 \\mathrm{~cm} ; 4-15$-years survival time with single nodule\nB. DIFFUSE FORM $=$ Pneumonic form $(10-40 \\%)$\n3. Diffuse consolidation $(30 \\%)$\n$\\sqrt{ }$ acinar airspace consolidation + air bronchogram + poorly marginated borders\n$\\sqrt{ }$ airspace consolidation may affect both lungs (mucus secretion)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 535,
            "markdown": "$\\sqrt{ } \\pm$ cavitation within consolidation\n$\\sqrt{ }$ \"CT angiogram\" sign = low-attenuation consolidation does NOT obscure vessels (mucin-producing subtype)\n2. Lobar form\n$\\sqrt{ } \\pm$ expansion of a lobe with bulging of interlobar fissures\n3. Multinodular form $(27 \\%)$\n$\\sqrt{ }$ multiple bilateral poorly / well-defined nodules similar to metastatic disease\n$\\sqrt{ }$ multiple poorly defined areas of ground-glass attenuation / consolidation\n\n- consolidation despite treatment with antibiotics\n$\\sqrt{ }$ pleural effusion $(8-10 \\%)$\nPrognosis: worse with extensive consolidation / multifocal / bilateral disease; death within 3 years with diffuse disease\n\n\n# BRONCHOCENTRIC GRANULOMATOSIS \n\n$=$ rare disorder characterized by destructive necrotizing granulomatous inflammation of bronchial + bronchiolar walls and surrounding parenchyma\nPeak age: $4^{\\text {th }}-7^{\\text {th }}$ decade\n\n- asthma with underlying allergic bronchopulmonary aspergillosis (33-50\\%)\n- fever, night sweats, cough, dyspnea, pleuritic chest pain\n- seropositive arthritis (rare), ocular scleritis (rare)\n\nPath: thick-walled ectatic bronchi + bronchioles containing viscous material of mucopurulent / caseous character\nHisto: necrotizing granulomas surrounding small airways; pulmonary arteritis as a secondary phenomenon\n(1) large masses of eosinophils in necrotic zones, associated with endobronchial mucus plugs, eosinophilic pneumonia, Charcot-Leyden crystals, fungal hyphae in granulomas (with asthma) in $1 / 3$\n(2) polymorphonuclear cell infiltrate in necrotic zones (without asthma) in $2 / 3$\n\nLocation: unilateral ( $75 \\%$ ); upper lung zones ( $60 \\%$ )\n$\\sqrt{ }$ branching opacities / atelectasis $\\leftarrow$ mucoid impaction\n$\\sqrt{ }$ solitary $>$ multiple nodules / masses (in $60 \\%$ )\nLocation: unilateral with upper lobe predominance\n$\\sqrt{ }$ ill-defined parenchymal consolidation (in $27 \\%$ )\n$\\sqrt{ } \\pm$ cavitation\n$R x:$ corticosteroid therapy\n\n## BRONCHOGENIC CARCINOMA\n\n$=$ LUNG CANCER $=$ LUNG CARCINOMA\n$\\diamond$ Most frequent cause of cancer deaths in males ( $35 \\%$ of all cancer deaths) and females ( $21 \\%$ of all cancer deaths); most common malignancy of men in the world; $6^{\\text {th }}$ leading cancer in women worldwide\nPrevalence: 225,000 new cases $+160,000$ deaths (2012)\nAge at diagnosis: $55-60$ years (range $40-80$ years); $\\mathrm{M}+\\mathrm{F}=1.4 \\div 1$\n\n- asymptomatic $(10-50 \\%)$ usually with peripheral tumors",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 536,
            "markdown": "- symptoms of central tumors:\n- cough ( $75 \\%$ ), wheezing, pneumonia\n- hemoptysis ( $50 \\%$ ), dysphagia ( $2 \\%$ )\n\n丶 Most common cause of massive hemoptysis at age $>40$.\n\n- symptoms of peripheral tumors:\n- pleuritic / local chest pain, dyspnea, cough, hoarseness\n- Pancoast syndrome, superior vena cava syndrome\n- symptoms of metastatic disease (CNS, bone, liver, adrenal gland)\n- paraneoplastic syndromes:\n- cachexia of malignancy, migratory thrombophlebitis\n- clubbing + hypertrophic osteoarthropathy\n- nonbacterial thrombotic endocarditis\n- ectopic hormone production: hypercalcemia, syndrome of inappropriate secretion of antidiuretic hormone (SIADH), Cushing syndrome, gynecomastia, acromegaly\nRisk factors:\n(1) Cigarette smoking (squamous cell carcinoma + SSC)\n> related to number of cigarettes smoked, depth of inhalation, age at which smoking began\n$\\diamond 85 \\%$ of lung cancer deaths are attributable to cigarette smoking!\n$\\diamond$ Passive smoking may account for $25 \\%$ of lung cancers in nonsmokers!\n(2) Radon gas: may be the $2^{\\text {nd }}$ leading cause for lung cancer with up to 20,000 deaths annually\n(3) Industrial exposure: asbestos, uranium, arsenic, chlormethyl ether\n(4) Concomitant disease: chronic pulmonary scar + pulmonary fibrosis\n\n\n# Scar carcinoma \n\n$\\diamond 45 \\%$ of all peripheral cancers originate in scars!\nFrequency: $7 \\%$ of lung tumors; $1 \\%$ of autopsies\nOrigin: related to infarcts ( $>50 \\%$ ), tuberculosis scar ( $<25 \\%$ )\nHisto: adenocarcinoma ( $72 \\%$ ), squamous cell ca. ( $18 \\%$ )\nLocation: upper lobes $(75 \\%)$\n\n## Location:\n\n$\\diamond 60-80 \\%$ arise in segmental bronchi\n> central: small cell carcinoma, squamous cell carcinoma (sputum cytology positive in 70\\%); arises in central airway often at points of bronchial bifurcation, infiltrates circumferentially, extends along bronchial tree\nmnemonic: Small cell and Squamous are Sentral\n> peripheral: adenocarcinoma, large cell carcinoma\n> upper lobe+lower lobe $=$ right lung + left lung $=3 \\div 2$\n> most common site: anterior segment of RUL\n> Pancoast tumor ( $3 \\%$ ) = superior sulcus tumor, frequently squamous cell carcinoma\n\n- atrophy of muscles of ipsilateral upper extremity $\\leftarrow$ lower brachial plexus involved\n- Horner syndrome (enophthalmos, miosis, ptosis, anhidrosis) $\\leftarrow$ sympathetic chain + stellate ganglion involved\n$\\checkmark$ apical pleural thickening / mass\n$\\checkmark \\pm$ soft-tissue invasion / bone destruction\n$\\checkmark$ coronal + sagittal MR images improve evaluation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 537,
            "markdown": ", SVC obstruction (5\\%): often in small cell carcinoma\nPresentation:\n$\\sqrt{ }$ solitary peripheral mass with corona radiata / \"pleural tail\" sign / satellite lesion\n$\\checkmark$ cavitation ( $16 \\%$ ): usually thick-walled with irregular inner surface; in $80 \\%$ squamous cell carcinoma, followed by bronchioloalveolar carcinoma\n$\\checkmark$ central mass ( $38 \\%$ ): common in small cell carcinoma\n$\\checkmark$ unilateral hilar enlargement $\\leftarrow$ primary tumor / enlarged lymph nodes\n\n| Histologic Classification of Lung Cancer <br> (WHO 2004) |  |\n| :-- | :--: |\n| Categories | $[\\%]$ |\n| Non-small cell lung cancer (NSCLC) | 85 |\n| Adenocarcinoma | $32-50$ |\n| Adenocarcinoma (not otherwise specified) |  |\n| Bronchioloalveolar carcinoma | $4-10$ |\n| Squamous cell lung carcinoma | $25-35$ |\n| Large cell lung carcinoma | $5-9$ |\n| Others (carcinoid (1-2\\%), sarcomatoid, |  |\n| adenosquamous, salivary gland tumor, etc.) |  |\n| Small cell lung cancer (SCLC) | 15 |\n| Limited disease / stage LS-SCLC (1/3) |  |\n| $=$ confined to hemithorax, mediastinum, | 5 |\n| supraclavicular nodes |  |\n| Rx: | curative intent chemo- + radiation therapy |\n| Extensive disease / stage ES-SCLC (2/3) |  |\n| $=$ hematogenous metastatic disease at presentation | 10 |\n| $R x:$ | chemotherapy |\n\n$\\checkmark$ calcified enlarged nodes frequently benign\n$\\checkmark$ nodes in short axis diameter:\n$>0-10 \\mathrm{~mm}$ normal (CAVE: micrometastases)\n$>>10 \\mathrm{~mm}(65 \\%$ sensitive + specific for tumor)\n$>20-40 \\mathrm{~mm}(37 \\%$ NOT involved by tumor)\n$\\checkmark$ PET ( $89 \\%$ sensitive, $99 \\%$ specific)\n$\\checkmark$ anterior + middle mediastinal widening (suggests small cell carcinoma)\n$\\checkmark$ segmental / lobar / lung atelectasis ( $37 \\%$ ) $\\leftarrow$ airway obstruction (particularly in squamous cell carcinoma):\n$\\checkmark$ postobstructive lung enhances to a greater extent than tumor\n$\\checkmark$ distal lung atelectasis has a higher SI on T2WI than the central mass (in $77 \\%$ ) $\\leftarrow$ accumulation of secretions in obstructed lung\n$\\checkmark$ \"(reverse) S\" sign of Golden on PA CXR = combination of:\n$\\checkmark$ RUL collapse (inferiorly concave margin of lateral portion of minor fissure, which moved superiorly and medially with compensatory expansion of RML)\n$\\checkmark$ bulge of central tumor (inferiorly convex margin of medial portion of minor fissure)\n$\\checkmark$ rat tail termination of bronchus\n$\\checkmark$ \"bronchial cuff\" sign = focal / circumferential thickening of bronchial wall imaged end-on",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 538,
            "markdown": "(early sign)\n$\\sqrt{ }$ local hyperaeration $\\leftarrow$ check-valve type endobronchial obstruction (best on expiratory view)\n$\\checkmark$ mucoid impaction of segmental / lobar bronchus $\\leftarrow$ endobronchial obstruction\n$\\checkmark$ persistent peripheral infiltrate $(30 \\%)=$ postobstructive pneumonitis\n$\\sqrt{ }$ NO air bronchogram\n$\\checkmark$ pleural effusion ( $8-15 \\%$ ): most commonly due to adenoca.\n$\\checkmark$ chest wall invasion:\n\n- localized chest wall pain $=$ most sensitive predictor\n$\\checkmark$ tumor interdigitation with chest wall musculature on T2WI\n$\\checkmark$ obliteration of high-intensity extrathoracic fat on T1WI\n$\\checkmark$ bone erosion of ribs / spine ( $9 \\%$ )\n$\\checkmark$ involvement of main pulmonary artery ( $18 \\%$ ); lobar + segmental arteries ( $53 \\%$ ) may result in additional peripheral radiopacity $\\leftarrow$ lung infarct\n$\\checkmark$ calcification in $7 \\%$ on CT (histologically in $14 \\%$ ) usually eccentric / finely stippled\n(a) preexisting focus of calcium engulfed by tumor\n(b) dystrophic calcium within tumor necrosis\n(c) calcium deposit from secretory function of carcinoma (eg, mucinous adenocarcinoma)\n\nPET-CT:\n$\\checkmark$ lung nodule $>1 \\mathrm{~cm}(97 \\%$ sensitive, $78 \\%$ specific $)$\nSpatial resolution: 4 mm diameter\nMetabolic resolution: 1 mm diameter $=1,000,000$ cells\nFalse positive: infection, granulomatous disease, other inflammatory disease\nFalse negative: partial volume effect, small tumor size $<1 \\mathrm{~cm}$, respiratory motion blurring, low glycolytic activity (bronchioloalveolar carcinoma, carcinoid tumor)\n(1) Staging (PET-CT better than any other modality)\n$\\diamond$ Occult metastases detected in up to $40 \\%$ of cases!\n(a) intrathoracic lymph nodes\n$\\checkmark$ lymph node with short-axis diameter $>1 \\mathrm{~cm}$ by CT + NOT FDG avid $=100 \\%$ NPV\n$\\checkmark$ small lymph node by CT + intense FDG uptake $=100 \\%$ PPV\n$\\checkmark$ cancerous mediastinal nodes ( $91 \\%$ sensitive, $86 \\%$ specific) better than CT alone ( $75 \\%$ sensitive, $66 \\%$ specific)\n$\\diamond 21 \\%$ of normal-sized nodes harbor metastatic dz",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 539,
            "markdown": "| T-Staging of Lung Cancer <br> $7^{\\text {th }}$ edition of TNM in Lung Cancer by International Association for the Study of Lung Cancer (2009) |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: |\n| Stage | Diameter | Endoscopy | Atelectasis / <br> obstructive pneumonia | Invasion of | Separate nodule(s) |\n| T1 | $\\begin{aligned} & \\mathrm{T} 1 \\mathrm{a} \\\\ & \\mathrm{~T} 1 \\mathrm{~b} \\\\ & >2 \\mathrm{t} \\end{aligned}$ | $\\begin{aligned} & \\text { 2 cm } \\\\ & \\text { 2 to } \\leq 3 \\mathrm{~cm} \\\\ & \\text { 3 to } \\leq 5 \\mathrm{~cm} \\\\ & \\text { 5 to } \\leq 7 \\mathrm{~cm} \\end{aligned}$ | no invasion proximal to lobar bronchus |  |  |\n| T2 | $\\begin{aligned} & \\mathrm{T} 2 \\mathrm{a} \\\\ & \\mathrm{~T} 2 \\mathrm{a} \\\\ & >3 \\mathrm{t} \\end{aligned}$ | $\\begin{aligned} & 3 \\mathrm{~cm} \\\\ & 3 \\mathrm{~cm} \\\\ & 5 \\mathrm{~cm} \\end{aligned}$ | main bronchus ( $\\geq 2 \\mathrm{~cm}$ distal to carina) | visceral pleura |  |\n| T3 | tumor $>7 \\mathrm{~cm}$ | main bronchus ( $\\geq 2 \\mathrm{~cm}$ distal to carina) | entire lung | parietal pleura, chest wall, diaphragm, mediastinal pleura, pericardium | within same lobe |\n| T4 | any tumor size |  |  | mediastinum / trachea / heart / great vessels / esophagus / vertebral body / carina | within different lobe |\n| Anatomic Definition of Lymph Node Stations <br> International Association for the Study of Lung Cancer (IASLC) |  |  |  |  |  |\n| Name | Location |  | Upper Border | Lower Border |  |\n| supraclavicular | low cervical, supraclavicular, sternal notch |  | cricoid | clavicles; manubrium |  |\n| superior mediastinal | upper paratracheal |  | apex of right lung; manubrium | intersection of innominate v. + trachea (RT); aortic arch (LT) |  |\n|  | prevascular, retrotracheal |  | apex of chest | carina |  |\n|  | lower paratracheal = para- and pretracheal |  | intersection of innominate v. + trachea (RT); aortic arch (LT) | $\\begin{aligned} & \\text { azygos v. (RT); Lt pulmonary artery } \\\\ & \\text { (LT) } \\end{aligned}$ |  |\n| aortic | subaortic = aortopulmonary window |  | lower aortic arch | Lt pulmonary artery |  |\n|  | paraaortic $=$ ascending aorta $/$ diaphragm |  | upper aortic arch | lower aortic arch |  |\n| inferior mediastinal | subcarinal |  | carina | bronchus intermedius (RT); lower lobe bronchus (LT) |  |\n|  | paraesophageal = below carina |  | bronchus intermedius (RT); lower lobe bronchus (LT) | diaphragm |  |\n|  | pulmonary ligament |  | inferior pulmonary v. | diaphragm |  |\n| N1 nodes | hilar, interlobar, lobar, segmental, subsegmental |  |  |  |  |\n\n$\\diamond 40 \\%$ of enlarged nodes are free of metastatic dz\n(b) adrenal metastasis\n$\\sqrt{ }$ PET scan: $100 \\%$ sensitive, $80-95 \\%$ specific\n$\\sqrt{ }$ FDG can differentiate adrenal \"incidentaloma\" from metastasis\n(c) bone metastasis\n$\\sqrt{ }$ bone scan: $80-94 \\%$ sensitive, $67-75 \\%$ specific\n$\\sqrt{ }$ PET scan: $92-96 \\%$ sensitive, $98 \\%$ specific\n(2) Recurrent disease (restaging) = residual tumor versus posttreatment changes\n$\\diamond$ radiotherapy + chemotherapy alter morphology causing confusion for CXR, CT, MR\n$\\sqrt{ }$ increased FDG uptake at sites of residual radiographic abnormality $>8$ weeks after completion of therapy\nFalse positive: radiation pneumonitis (evaluation must be postponed for 2-4 months)\nAngio:\n$\\sqrt{ }$ bronchogenic carcinoma supplied by bronchial arteries\n$\\sqrt{ }$ distortion / stenosis / occlusion of pulmonary arterial circulation\n$C x$ :\n(1) Diaphragmatic elevation (phrenic nerve paralysis)\n(2) Hoarseness (laryngeal nerve involvement, left > right)\n(3) SVC obstruction (5\\%): lung cancer is cause of all SVC obstructions in $90 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 540,
            "markdown": "(4) Pleural effusion (10\\%): malignant, parapneumonic, lymphoobstructive\n(5) Dysphagia: enlarged nodes, esophageal invasion\n(6) Pericardial invasion: pericardial effusion, localized pericardial thickening / nodular masses\n(7) massive hemoptysis $\\leftarrow$ neovascularity, parenchymal destruction, angioinvasion by tumor\n\nPrognosis: mean survival time $<6$ months; $15 \\%$ overall 5 -year survival; survival at 40 months: squamous cell $30 \\%>$ large cell $16 \\%>$ adenocarcinoma $15 \\%>$ oat cell $1 \\%$\n$R x$ :\n(1) Surgical resection for non-small cell histologic types\n\nUnresectable: involvement of heart, great vessels, trachea, esophagus, vertebral body, malignant pleural effusion\n(2) Adjuvant chemotherapy + radiation therapy in extensive resectable disease\n(3) Chemotherapy for small cell carcinoma + radiation therapy for bulky disease, CNS metastases, spinal cord compression, SVC obstruction\n(4) Embolization of bronchial artery\n\n# Multiple Primary Lung Cancers \n\nFrequency: $0.72-3.5 \\%$; in $1 / 3$ synchronous, in $2 / 3$ metachronous\n$\\diamond 10-32 \\%$ of patients surviving resection of a lung cancer will develop a second primary!\n$D x$ : biopsy mandatory for proper therapy because tumors may have / develop a different cell type\n\n## Paraneoplastic manifestations of Lung Cancer\n\n1. Carcinomatous neuromyopathy (4-15\\%)\n2. Migratory thrombophlebitis\n3. Hypertrophic pulmonary osteoarthropathy (3-5\\%)\n\n| NM-Staging of Lung Cancer <br> $7^{\\text {th }}$ edition of TNM in Lung Cancer IASLC (2009) |  |\n| :--: | :--: |\n| Stage | Description (node $\\geq 1 \\mathrm{~cm}$ in short axis) |\n| N1 | peribronchial / ipsilateral hilar nodes |\n| N2 | ipsilateral superior + inferior mediastinal nodes |\n| N3 | contralateral hilar / mediastinal nodes; <br> scalene / supraclavicular nodes on either side |\n| M1a | intrathoracic spread: <br> malignant pleural / pericardial effusion, separate <br> tumor nodule(s) in contralateral lung |\n| M1b | disseminated (extrathoracic) disease: <br> liver, bone, brain, adrenal gland, etc. |\n\n4. Endocrine manifestations (15\\%) usually with small cell carcinoma: Cushing syndrome, inappropriate secretion of ADH, HPT, excessive gonadotropin secretion\n\n## Spread of Lung Cancer\n\n1. Direct local extension\n2. Hematogenous (small cell carcinoma)\n3. Lymphatic spread (squamous cell carcinoma)\n$\\diamond$ Normal-sized lymph nodes harbor tumor in $10 \\%$\n4. Transbronchial spread - least common",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 541,
            "markdown": "# Distant Metastases of Lung Cancer \n\nLikelihood: small cell $>$ adeno $>$ large cell $>$ squamous\n@ Bone\n(a) marrow: in $40 \\%$ at time of presentation\n(b) gross lesions in $10-35 \\%$ :\n\nLocation: vertebrae ( $70 \\%$ ), pelvis ( $40 \\%$ ), femora ( $25 \\%$ )\n$\\checkmark$ osteolytic metastases ( $3 / 4$ )\n$\\checkmark$ osteoblastic metastases ( $1 / 4$ ) in small cell carcinoma / adenocarcinoma\n$\\checkmark$ occult metastases in $36 \\%$ of bone scans\n@ Adrenals: in $37 \\%$ at time of presentation\n$\\diamond 50 \\%$ of adrenal masses in lung cancer patients are benign!\n@ Brain: asymptomatic metastases on brain scan in $7 \\%$ ( $30 \\%$ at autopsy), in $2 / 3$ multiple\n@ Kidney, GI tract, liver, abdominal lymph nodes\n@ Lung-to-lung metastases (in up to $10 \\%$, usually in late stage)\n\n## Adenocarcinoma of Lung (32-50\\%)\n\n$\\diamond$ Most common histologic subtype of lung cancer (2011)!\n$=$ intermediate malignant potential $\\rightarrow$ slow growth, high incidence of early metastases\nDoubling time: $\\sim 150-180$ days\nHisto: formation of glands / intracellular mucin\nSubtype: bronchioloalveolar carcinoma\nLocation: almost invariably develops in periphery; frequently found in scars (tuberculosis, infarction, scleroderma, bronchiectasis) + in close relation to preexisting bullae\n$\\checkmark$ solitary peripheral subpleural mass ( $52 \\%$ ) / alveolar infiltrate / multiple nodules\n$\\checkmark$ may invade pleura + grow circumferentially around lung mimicking malignant mesothelioma\n$\\checkmark$ upper lobe distribution ( $69 \\%$ )\n$\\checkmark$ air bronchogram / bronchiologram on HRCT (65\\%)\n$\\checkmark$ calcification in periphery of mass ( $1 \\%$ )\n$\\checkmark$ smooth margin / spiculated margin $\\leftarrow$ desmoplastic reaction with retraction of pleura\n\n## Large Cell Carcinoma of Lung (5-9\\%)\n\n$=$ most heterogeneous of primary lung cancers\nPath: difficult DDx from poorly differentiated adenoca. / SCC\nSubtype: large cell $=\\mathrm{LC}$\n$>$ LC rhabdoid carcinoma\n$>$ LC basaloid carcinoma\n$>$ LC lymphoepithelioma\n$>$ LC neuroendocrine carcinoma (LCNEC, 2-3\\%)\n$>$ LC undifferentiated carcinoma\n\n## Large Cell Undifferentiated Carcinoma of Lung\n\n$\\diamond$ Strongly associated with smoking\nMalignant potential: intermediate $\\rightarrow$ rapid growth + early distant metastases\nDoubling time: $\\sim 120$ days",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 542,
            "markdown": "Histo: tumor cells with abundant cytoplasm + large nuclei + prominent nucleoli; diagnosed per exclusion due to lack of squamous / glandular / small cell differentiation\nSubtype: giant cell carcinoma with very aggressive behavior + poor prognosis\n$\\checkmark$ large bulky usually peripheral mass $>6 \\mathrm{~cm}(50 \\%)$\n$\\checkmark$ large area of necrosis\n$\\checkmark$ pleural involvement\n$\\checkmark$ large bronchus involved in central lesion ( $50 \\%$ )\n\n# Squamous Cell Carcinoma of Lung (25-35\\%) \n\n$=$ EPIDERMOID CARCINOMA\n$\\diamond$ Strongly associated with cigarette smoking\nHisto: mimics differentiation of epidermis by producing keratin (\"epidermoid carcinoma\"); central necrosis is common\nHistogenesis: chronic inflammation with squamous metaplasia $\\rightarrow$ progression to dysplasia + carcinoma in situ\n\n- positive sputum cytology\n$\\diamond$ Most common cell type that is radiologically occult!\n- hypercalcemia from tumor-elaborated parathyroid hormone-like substance\n$\\diamond$ Slowest growth rate, lowest incidence of distant metastases\nDoubling time: $\\sim 90$ days\n(a) Central location in main / lobar / segmental bronchus ( $5 / 3$ )\n$\\checkmark$ large central mass $\\pm$ cavitation\n$\\checkmark$ distal atelectasis $\\pm$ bulging fissure $\\leftarrow$ mass effect\n$\\checkmark$ postobstructive pneumonia\n$\\diamond$ All cases of pneumonia in adults should be followed to complete radiologic resolution!\n$\\checkmark$ airway obstruction with atelectasis (37\\%)\n(b) Solitary peripheral nodule ( $1 / 3$ )\n$\\checkmark$ characteristic cavitation (in $7-10 \\%$ )\n$\\checkmark$ invasion of chest wall\n$\\diamond$ Squamous cell carcinoma is the most common cell type to cavitate and to cause Pancoast tumor!\n\n\n## Small Cell Undifferentiated Lung Carcinoma (13-20\\%)\n\n$=$ OAT-CELL CARCINOMA = SMALL CELL LUNG CANCER\n$\\diamond$ Most common primary pulmonary neuroendocrine neoplasm!\nThe prevalence of SCLC in the USA has been declining over the past 30 years to $13 \\%-15 \\%$ !\nCause: associated with cigarette smoking (in 95\\%)\nBiologic behavior:\nmore aggressive than non-SCLC; rapid growth (= short doubling time); high growth fraction ( $=$ ratio of proliferating cells to total cells); high metastatic potential (early metastases in $60-70 \\%$ at time of diagnosis); should be regarded as systemic disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 543,
            "markdown": "regardless of stage; virtually never resectable\nDoubling time: $\\sim 30$ days\nPath: arises from bronchial mucosa with growth in submucosa + subsequent invasion of peribronchial connective tissue\nHisto: small blue cells of round / oval / fusiform shape with scant cytoplasm, ill-defined borders, finely granular nuclear chromatin, absent / inconspicuous nucleoli; high cellularity with very high mitotic rate $\\rightarrow$ large areas of necrosis; positive for neurosecretory granules (chromogranin, synaptophysin); in 20\\% coexistent with nonsmall cell histologic types (most frequently squamous cell)\nImmunohistochemistry:\npancytokeratin antibodies (AE1/AE3, CD56), chromogranin- synaptophysin, thyroid transcription factor 1 (TTF-1 in 80\\%), Ki-67 proliferation index (in 80-100\\%) most helpful in separating SCLC from carcinoids\nAge: $\\quad 60-70$ years; $\\mathrm{M} \\div \\mathrm{F}=2.6 \\div 1$ to $1 \\div 1$\n\n- weight loss, fatigue, anorexia, dyspnea, persistent cough\n- chest pain, hemoptysis, postobstructive pneumonia\n- symptoms of SVC syndrome (10\\%)\n\nO Most common primary lung cancer causing superior vena cava obstruction $\\leftarrow$ extrinsic compression / endoluminal thrombosis / invasion!\n\n- dysphagia $\\leftarrow$ esophageal invasion\n- hoarseness $\\leftarrow$ invasion of recurrent laryngeal nerve\n- smooth-appearing bronchial mucosal surface endoscopically\n- paraneoplastic syndrome ( $=$ ectopic hormone production):\n- inappropriate secretion of $\\mathrm{ADH} \\rightarrow \\downarrow$ concentration of urine, $\\downarrow$ plasma osmolarity, euvolemic hyponatremia\n- Cushing syndrome $\\leftarrow$ ectopic ACTH production\n- acromegaly $\\leftarrow$ ectopic GHRP\n- hypercalcemic hyperparathyroidism\n- Eaton-Lambert myasthenia syndrome (= autoimmune neuropathy) $\\rightarrow$ muscle weakness of limbs\n- encephalomyelitis, limbic encephalitis\n\nSigns of extrapulmonary metastases:\nbone marrow suppression, bone pain, pruritus, jaundice, seizures, mental status changes, ataxia\nLocation: 90-95\\% central within lobar / mainstem bronchus (primary tumor rarely visualized)\n\nThe most common manifestation of SCLC is a large centrally located lung mass or a mediastinal mass involving a hilum!\nCT:\n$\\sqrt{ }$ typically large hilar / perihilar parenchymal mass involving at least one hilum (85\\%):\n$\\checkmark$ extensive necrosis + hemorrhage\n$\\checkmark$ central mass often produced by a combination of primary neoplasm + mediastinal lymphadenopathy\n$\\checkmark$ centrally obstructing lesion $\\rightarrow$ atelectasis of entire lung / major lobar atelectasis (30\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 544,
            "markdown": "$\\sqrt{ }$ \"bronchus cut-off\" sign\n$\\sqrt{ }$ lobulated peripheral nodule without adenopathy (5\\%):\n$\\sqrt{ }$ fine spiculations $\\leftarrow$ vascular or lymphatic invasion / irregular intraalveolar spread\n$\\sqrt{ }$ marginal ground-glass opacity $\\leftarrow$ focal edema / hemorrhage / intraalveolar invasion\n$\\sqrt{ }$ enhancement reflecting tumor angiogenesis\n$\\sqrt{ }$ intratumoral calcification (in up to $23 \\%$ )\n$\\sqrt{ }$ large confluent mediastinal ( $92 \\%$ ) / hilar $84 \\%$ ) adenopathy\n$\\sqrt{ }$ displacement / narrowing of tracheobronchial tree ( $68 \\%$ ) or major vessels ( $68 \\%$ )\n$\\sqrt{ }$ atelectasis of entire lung / major lobar atelectasis ( $30 \\%$ )\n$\\sqrt{ }$ pleural effusion ( $38 \\%$ ) / thickening $\\pm$ nodules\nPET:\nUseful for: initial tumor staging, treatment planning, prognosis (high SUV suggests poor survival)\n$\\sqrt{ }$ avid FDG uptake ( $100 \\%$ )\nPET modifies management in up to $27 \\%$ of patients!\nStaging evaluation:\nCT of abdomen + head, bone scintigraphy, bilateral bone marrow biopsies\nVeterans Administration Lung Study Group (VALSG) Staging:\n$\\diamond$ Evaluate with CECT of chest (through adrenals) + brain MRI + PET/CT $\\pm$ bone marrow biopsy\nLimited disease / stage (LS-SCLC):\n$=$ without extrathoracic extension\n\n1. Encompassed within single radiation port\n2. Ipsilateral mediastinal / supraclavicular lymph nodes\n3. Contralateral mediastinal / supraclavicular nodes\n4. Ipsilateral (benign / malignant) pleural effusion\n\nExtensive disease / stage (ES-SCLC in 60-70\\%):\n$=$ hematogenous metastatic disease at presentation\n\n1. Not confined to single radiation port\n2. Metastatic disease: contralateral lung, bone (19-38\\%), liver (17-34\\%), adrenal gland ( $10-17 \\%$ ), bone marrow ( $17-23 \\%$ ), CNS ( $8-15 \\%$ ), retroperitoneum ( $11 \\%$ ), other lymph nodes\nPrognosis: 2-4 months median survival without treatment; $60-70 \\%$ initial response to chemotherapy with relapse and death within 2 years; 5-year survival rate of 10 $15 \\%$ for LS-SCLC $+1-5 \\%$ for ES-SCLC (unchanged for 30 years!)\n$R x$ : (a) chemoradiation + prophylactic cranial irradiation + surgical resection (for LSSCLC)\n(b) etoposide + cisplatin (for ES-SCLC)\n\n# BRONCHOGENIC CYST \n\n$=$ CONGENITAL BRONCHOGENIC CYST\n$=$ fluid-filled blind pouch of ventral primitive foregut\n$\\diamond$ Belongs to spectrum of foregut duplication cysts!\nCause: abnormal budding / branching of primitive foregut between $26^{\\text {th }}$ and $40^{\\text {th }}$ day of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 545,
            "markdown": "embryogenesis forming ventral diverticulum for tracheobronchial tree (dorsal segment $=$ esophagus)\nFrequency: most common intrathoracic foregut cyst (54-63\\% in surgical series)\nHisto: thin-walled cyst filled with mucinous material, lined by columnar respiratory epithelium, mucous glands, cartilage, elastic tissue, smooth muscle\nLocation: mediastinum (near carina) $>>$ lung parenchyma $>$ pleura $>$ diaphragm\n\n- mostly incidental\n- wheezing, stridor, dyspnea, dysphagia (in infants)\n$\\sqrt{ }$ sharply outlined round / oval mass\n$\\sqrt{ }$ may contain air-fluid level $\\leftarrow$ infection / communication with airway or GI tract\nCT:\n$\\checkmark$ hypoattenuating lesion with smooth imperceptible wall\n$\\checkmark$ cyst contents of water density $(50 \\%)$ / higher density $(50 \\%) \\leftarrow$ proteinaceous-mucoid material / milk of calcium\nOB-US:\n$\\checkmark$ single unilocular fluid-filled pulmonary cyst in middle / posterior mediastinum\n$\\diamond$ Most common cystic lesion in fetal chest!\n$\\checkmark$ echogenic distended lung obstructed by bronchogenic cyst\nFetal MR:\n$\\checkmark$ hyperintense signal relative to lung + CSF on T2WI\n$\\checkmark$ occasionally hyperintense signal relative to lung on T1WI (mucoid / hemorrhagic content)\n$\\checkmark$ hyperintense obstructed lobe on T2WI\n$D D x$ : esophageal duplication cyst (middle / posterior mediastinum), neurenteric cyst (posterior mediastinum, vertebral defect)\n\n\n# Mediastinal Bronchogenic Cyst (86\\%) \n\nAssociated with: spinal abnormalities\n$\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\n\n- asymptomatic (usually) vs. stridor, dysphagia\n\nLocation: pericarinal (52\\%), paratracheal (19\\%), esophageal wall (14\\%), retrocardiac $(9 \\%)$; usually on right\n$\\checkmark$ rarely communicates with tracheal lumen\n$\\checkmark$ may show esophageal compression\n\n## Intrapulmonary Bronchogenic Cyst (14\\%)\n\n$\\mathrm{M}>\\mathrm{F}$\n\n- infection (75\\%), dyspnea, hemoptysis (most common)\n\nLocation: lower + upper lobe $=2 \\div 1$; usually medial third\n$\\sqrt{ } 36 \\%$ will eventually contain air\n$D D x$ : solitary pulmonary nodule, cavitated neoplasm, cavitated pneumonia, lung abscess\n\n## BRONCHOPULMONARY DYSPLASIA\n\n$=$ RESPIRATOR LUNG $=$ BPD\n$=$ complication of respirator therapy (PPV or nasal CPAP) treated with $>21 \\%$ oxygen for $>28$ days",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 546,
            "markdown": "Cause: oxygen toxicity (lung damage by oxygen radicals) + barotrauma (bronchopulmonary injury from assisted ventilation)\n\n- chronic oxygen dependency in premature neonates:\n- mild BPD = breathing room air\n- moderate $\\mathrm{BPD}=$ need for $<30 \\%$ oxygen\n- severe $\\mathrm{BPD}=$ need for $\\geq 30 \\%$ oxygen $\\pm \\mathrm{PPV}$ or nasal CPAP\n\nPathogenesis: hypoxia + oxygen toxicity\n> capillary wall damage, leakage of fluid into interstitium and pulmonary edema\nStage I ( $0-3$ days):\nPath: loss of ciliated cells + necrosis of bronchiolar mucosa\n$\\sqrt{ }$ RDS pattern of hyaline membrane disease\nStage II (4-10 days):\nPath: hyaline membranes, eosinophilic exudate, squamous metaplasia, interstitial edema\nAssociated with: congestive failure from PDA\n$\\checkmark$ complete opacification with air bronchogram\n> fibrosis of interstitium + groups of emphysematous alveoli\nStage III (10-20 days):\nPath: fewer hyaline membranes, persistent injury of alveolar epithelium, exudation of macrophages\n$\\checkmark$ small round cystic lucencies alternating with regions of irregular opacity\nStage IV (after 1 month):\nPath: septal wall thickening, dilated + tortuous lymphatics\n$\\checkmark$ \"spongy\" / \"bubbly\" coarse linear densities, esp. in upper lobes\n$\\checkmark$ hyperaeration of lung\n$\\checkmark$ lower lobe emphysema\nCT:\n$\\checkmark$ regional air trapping\n$\\checkmark$ thickened interlobular septa\n$\\checkmark$ subsegmental atelectasis\n$\\checkmark$ reduced bronchoarterial diameter ratios\n$\\checkmark$ bronchial wall thickening\n$\\checkmark$ bullae + pneumatoceles\nPrognosis: $40 \\%$ mortality if not resolved by 1 month\nCx: (1) Increased airway reactivity = increased frequency of lower respiratory tract infections\n(2) Obstructive airway disease = asthmalike clinical picture\n(3) Focal atelectasis\n(4) Cor pulmonale\n(5) Rib fractures, rickets, renal calcifications ( $\\leftarrow$ chronic furosemide therapy)\n(6) Cholelithiasis ( $\\leftarrow$ hyperalimentation $\\pm$ ? furosemide)\n(7) Focal areas of tracheomalacia, tracheal stenosis, acquired lobar emphysema\n\nRx: supportive\nPrognosis:\n(1) Complete clearing over months / years ( $1 / 2$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 547,
            "markdown": "(2) Retained linear densities in upper lobe emphysema (29\\%)\n\nDDx:\n(a) conditions present at birth:\n(1) Diffuse neonatal pneumonia\n(2) Meconium aspiration\n(3) Total anomalous pulmonary venous return\n(4) Congenital pulmonary lymphangiectasia\n(b) conditions developing over time:\n(1) Recurrent pneumonias with scarring (gastroesophageal reflux, tracheoesophageal fistula, immune deficiency, etc)\n(2) Cystic fibrosis\n(3) Idiopathic pulmonary fibrosis\n(c) conditions not apparent at birth:\n(1) Wilson-Mikity syndrome\n(2) Pulmonary interstitial emphysema\n(3) Patent ductus arteriosus (uncommon appearance)\n(4) Overhydration\n(5) Perinatally acquired viral infection (especially CMV)\n\n# BRONCHOPLEURAL FISTULA \n\n$=$ BRONCHOPULMONARY FISTULA\n$=$ communication between the bronchial system / lung parenchyma + pleural space\nCause:\nA. TRAUMA\n\n1. Complication of resectional surgery (pneumonectomy, lobectomy, bullectomy)\n2. Blunt / penetrating trauma\n3. Barotrauma\nB. LUNG NECROSIS\n4. Putrid lung abscess\n5. Necrotizing pneumonia: Klebsiella, H. influenzae, Staphylococcus, Streptococcus; tuberculosis; fungus; Pneumocystis\n6. Infarction\nC. AIRWAY DISEASE\n7. Bronchiectasis (very rare)\n8. Emphysema complicated by pneumonia / pneumothorax\nD. MALIGNANCY: lung carcinoma with postobstructive pneumonia / tumor necrosis following therapy\n\n- large / persistent air leak; acute / chronic empyema\n\nHRCT:\n$\\sqrt{ }$ direct visualization of bronchopleural fistula (in 50\\%)\n$\\sqrt{ }$ peripheral air + fluid collection (indirect sign)\n$D x$ : (1) Introduction of methylene blue into pleural space, in $65 \\%$ dye appears in sputum\n(2) Sinography\n(3) Bronchography",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 548,
            "markdown": "$R x$ : tube thoracostomy, open drainage, decortication, thoraco-plasty, muscle-pedicle closure, transbronchial occlusions\n\n# BRONCHOPULMONARY SEQUESTRATION \n\n$=$ congenital malformation consisting of\n(1) Nonfunctioning bronchopulmonary tissue\n(2) No communication with tracheobronchial tree\n(3) Systemic arterial supply\n\nFrequency: $\\quad 0.15-6.4 \\%$ of all congenital lung malformations; $1.1-1.8 \\%$ of all pulmonary resections\n$\\diamond 2^{\\text {nd }}$ most common lung lesion found in utero after congenital pulmonary airway malformation!\nEtiology: formation of supernumerary tracheobronchial foregut bud caudad to normal lung bud\n(a) before development of pleura $=$ intralobar\n(b) after development of pleura $=$ extralobar\n$\\diamond$ Pulmonary sequestration with communication to GI tract is termed bronchopulmonary foregut malformation!\nSize: usually $>6 \\mathrm{~cm}$\n$\\sqrt{ }$ round / oval, smooth, well-defined solid homogeneous mass near diaphragm with mass effect\n$\\sqrt{ }$ occasionally fingerlike appendage posteriorly + medially (= anomalous vessel)\n$\\checkmark$ contrast enhancement of sequestration at the same time as thoracic aorta (on rapid sequential CT scans)\n$\\checkmark$ multiple / single air-fluid levels if infected\n$\\checkmark$ surrounded by recurrent pulmonary consolidation in a lower lobe that never clears completely\n$\\checkmark$ may communicate with esophagus / stomach\nOB-US:\n$\\diamond$ The vast majority of sequestrations in fetuses are extralobar!\nAge: usually in $2^{\\text {nd }}$ trimester\n$\\checkmark$ conical / triangular homogeneously hyperechoic mass (many interfaces from multiple microscopically dilated structures) in a paraspinal location\n$\\checkmark$ color duplex may demonstrate feeding artery from descending aorta\n$\\checkmark$ polyhydramnios (? esophageal compression, excessive fluid secretion by sequestration)\n$\\checkmark$ fetal hydrops (? venous compression):\n$\\checkmark$ edema, ascites\n$\\checkmark$ hydrothorax (obstructed lymphatics + veins in torsed sequestration)\n$R x$ : prenatal thoracoamniotic shunt\nFetal MR:\n$\\checkmark$ solid well-defined uniform hyperintense mass on T2WI\n$D D x$ : bronchiectasis, lung abscess, empyema, bronchial atresia, congenital lobar emphysema, cystic adenomatoid malformation, intrapulmonary bronchogenic cyst, Swyer-James syndrome, pneumonia, arteriovenous fistula, primary / metastatic neoplasm, hernia of Bochdalek\n\n## Intralobar Sequestration (75-86\\%)\n\n$=$ shares pleural investment with affected normal pulmonary lobe but separated from",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 549,
            "markdown": "bronchial tree\nEtiology: controversial\n(1) Possibly acquired through repeated lung inflammation $\\rightarrow$ hypertrophy of vessels in pulmonary ligament\n(2) Early appearance of congenital accessory tracheobronchial bud $\\rightarrow$ incorporation within one pleural investment\nPath: chronic inflammation fibrosis: multiple irregular cordlike adhesions to mediastinum, diaphragm, parietal pleura; vascular sclerosis; multiple cysts filled with fluid / thick gelatinous / purulent material\nhybrid lesion = intralobar sequestration + type II cystic adenomatoid malformation usually associated!\nAge at presentation: adulthood ( $50 \\%>20$ years); $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\nAssociated with congenital anomalies in 6-12\\%:\nskeletal deformities ( $4 \\%$ ): scoliosis, rib + vertebral anomalies; esophagobronchial diverticula ( $4 \\%$ ); diaphragmatic hernia ( $3 \\%$ ); cardiac anomalies (including tetralogy of Fallot); failure of renal ascent + rotation; cerebral anomalies; congenital pulmonary venolobar syndrome\n\n- about $50 \\%$ have symptoms by age 20 ; asymptomatic in $15 \\%$\n- pain, repeated infection in same location (eg, recurrent acute lower lobe pneumonias)\n- high-output congestive heart failure (in neonatal period) from L-to-L shunt\n- cough + sputum production, hemoptysis\n\nLocation: posterobasal segments, rarely upper lung / within fissure; $\\mathrm{L} \\div \\mathrm{R}=3 \\div 2$\nCXR:\n$\\sqrt{ }$ recurrent / persistent pneumonia localized to lower lobe\n$\\sqrt{ }$ cavitation and cysts $\\pm$ fluid levels\n$\\diamond$ Sequestered lung is aerated via pores of Kohn / communication with tracheobronchial tree!\nBronchogram:\n$\\sqrt{ }$ NO communication of rudimentary bronchial system of sequestration with tracheobronchial tree (rare exceptions)\nAngio:\n$\\sqrt{ }$ usually single large artery (mean diameter of 6 mm ) coursing through inferior pulmonary ligament from\n> distal thoracic aorta ( $73 \\%$ )\n> proximal abdominal aorta ( $22 \\%$ )\n> celiac / splenic artery\n> intercostal artery ( $4 \\%$ )\n> anomalous branch of coronary artery\n> subclavian artery\n$\\sqrt{ }$ multiple arteries in $16 \\%$ (with vessel diameter of $<3 \\mathrm{~mm}$ )\n$\\sqrt{ }$ combined systemic + pulmonary arterial supply\n$\\sqrt{ }$ venous drainage via\n> normal pulmonary veins to Latrium (in 95\\%)\n> azygos / hemiazygos vv. / intercostal vv. / SVC into R atrium (in 5\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 550,
            "markdown": "CT:\n$\\sqrt{ }$ single / multiple thin-walled cysts containing fluid / mucus / pus / air-fluid level / air alone\n$\\sqrt{ }$ mucus-impacted ectatic bronchi (= fat density) in sequestered lung\n$\\sqrt{ }$ emphysema bordering normal lung $(37 \\%)=$ postobstructive hyperinflation of sequestered lung\n$\\sqrt{ }$ homogeneous / inhomogeneous soft-tissue mass with irregular borders\n$\\sqrt{ }$ irregular enhancement (rare)\n$\\sqrt{ }$ one / two anomalous systemic arteries arising from aorta (DDx: AVM, interrupted pulmonary artery, isolated anomaly, chronic infection / inflammation of lung or pleura, surgically created shunt)\n$\\sqrt{ }$ premature atherosclerosis of anomalous arteries\n$\\diamond$ Mucoid impaction of bronchus surrounded by hyperinflated lung is CHARACTERISTIC!\nCx: massive spontaneous nontraumatic pleural hemorrhage, chronic inflammation, fibrosis\n$D D x$ of mass: neurogenic tumor, lateral thoracic meningocele, extramedullary hematopoiesis, pleural tumor, CPAM type III\n\n| Bronchopulmonary Sequestrations |  |  |\n| :-- | :--: | :--: |\n|  | Intralobar | Extralobar |\n| Prevalence | $75 \\%$ | $25 \\%$ |\n| Pleural investment | visceral pleura | own pleura |\n| Venous drainage | pulmonary veins | systemic veins |\n| Symptomatic | adulthood | first 6 months |\n| Etiology | acquired | developmental |\n| Congenital anomalies | $15 \\%$ | $50 \\%$ |\n\n$D D x$ of cavity: lung abscess, necrotizing pneumonia, fungal / mycobacterial pneumonia, cavitating neoplasm, empyema\n$D D x$ of cysts: pulmonary abscess, empyema, bronchiectasis, emphysema, bronchogenic foregut cyst, pericardial cyst, eventration of diaphragm, congenital cystic malformation\n\n# Extralobar Sequestration (14-25\\%) \n\n$=$ accessory lobe with its own pleural sheath (= \"Rokitansky lobe\") preventing collateral air drift $\\rightarrow$ airless round mass\n[Karl Freiherr von Rokitansky (1804-1878), professor of pathological anatomy at Allgemeines Krankenhaus, Wien, Austria]\nEtiology: anomalous accessory / supernumerary tracheo-bronchial foregut bud develops after formation of pleura\nPath: single ovoid / rounded / pyramidal airless lesion\nHisto: resembles normal lung with diffuse dilatation of bronchioles + alveolar ducts + alveoli; dilatation of subpleural + peribronchiolar lymph vessels; covered by mesothelial layer overlying fibrous connective tissue\nFrequency: $0.5-6.0 \\%$ of all congenital lung lesions\nAge: neonatal presentation; $61 \\%$ within first 6 months of life; occasionally in utero; $\\mathrm{M}+\\mathrm{F}=$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 551,
            "markdown": "$4 \\div 1$\nAssociated with congenital anomalies in 15-65\\%:\n@ Lung: congenital diaphragmatic hernia ( $20-30 \\%$ ), eventration / diaphragmatic paralysis (up to $60 \\%$ ), congenital cystic adenomatoid malformation type II ( $15-25 \\%$ ), lobar emphysema, bronchogenic cyst, pectus excavatum, congenital pulmonary venolobar syndrome\n$\\diamond$ May coexist / form part of spectrum with CAM\n@ Heart: anomalous pulmonary venous return, cardiac / pericardial anomalies (8\\%)\n@ GI tract: epiphrenic diverticula ( $2 \\%$ ), tracheoesophageal fistula ( $1.5 \\%$ ), intestinal duplication cyst, ectopic pancreas\n@ Others: renal anomaly, vertebral anomaly\n\n- respiratory distress + cyanosis + CHF in newborn $\\leftarrow$ shunting of blood\n$\\diamond$ Lower lobe pneumonia that does NOT clear with antibiotics!\n- feeding difficulties\n- asymptomatic (rarely becomes infected) in $10 \\%$\n\nLocation: $\\mathrm{L} \\div \\mathrm{R}=4 \\div 1$; typically within pleural space in posterior costodiaphragmatic sulcus between diaphragm + lower lobe ( $63-77 \\%$ ); mediastinum; within pericardium; within / below diaphragm (5-15\\%)\nSize: $\\quad 3-6$ (range, $1 / 2-15$ ) cm in diameter\n$\\sqrt{ }$ airless (NO communication with bronchial tree); presence of air $\\rightarrow$ connection with GI tract is inferred\n$\\sqrt{ }$ may contain cystic areas\n$\\sqrt{ }$ mediastinal shift (if large)\nAngio (diagnostic):\n$\\sqrt{ }$ arterial supply from\n> aorta as single / several small branches ( $80 \\%$ )\n> splenic, gastric, subclavian, intercostal branches ( $15 \\%$ )\n> pulmonary artery (5\\%)\n$\\sqrt{ }$ venous drainage via\n> systemic veins in $80 \\%$ (IVC, azygos, hemiazygos, SVC, portal vein) to right heart\n> pulmonary vein ( $25 \\%$ )\nCXR:\n$\\sqrt{ }$ single well-defined homogeneous triangular mass (most commonly located adjacent to posterior medial hemidiaphragm)\n$\\sqrt{ }$ NO air bronchograms\n$\\sqrt{ }$ small \"bump\" on hemidiaphragm / inferior paravertebral region\n$\\sqrt{ }$ opaque hemithorax $\\pm$ ipsilateral pleural effusion (if sequestration large)\n$\\sqrt{ } \\pm$ air-fluid level\nCT:\n$\\sqrt{ }$ homogeneous well-circumscribed soft-tissue density mass (no bronchial communication)\nNUC (radionuclide angiography):\n$\\sqrt{ }$ lack of perfusion during pulmonary phase followed by rapid perfusion in systemic phase\n$D D x$ : intrathoracic kidney, scimitar syndrome (with systemic supply to affected lung), hepatic herniation through diaphragm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 552,
            "markdown": "# DDx for chest lesion: \n\ncongenital cystic adenomatoid malformation, neuroblastoma, teratoma, diaphragmatic hernia\nDDx for infradiaphragmatic lesion:\nneuroblastoma, teratoma, adrenal hemorrhage, mesoblastic nephroma, foregut duplication\n$C x$ : infection (in case of communication with bronchus / GI tract)\n$R x$ : resection (delineation of vascular supply helpful)\nPrognosis: favorable (worse if pulmonary hypoplasia present); decreases in size / disappears in up to $65 \\%$ before birth\n\n## Esophageal / Gastric Lung\n\n$=$ rare variant of pulmonary sequestration\nAge: infancy (as it is symptomatic)\n\n- cough related to feeding; recurrent pulmonary infections\n$\\sqrt{ }$ communication of bronchial tree of sequestered lung with esophagus / stomach\n\n\n## CANDIDIASIS\n\n$=$ CANDIDOSIS\n$\\diamond$ Most common nosocomial fungal infection\nOrganism: ubiquitous human saprophyte (Candida albicans most commonly) characterized by blastospheres (yeasts) admixed with hyphae / pseudohyphae (conventional stains)\n$\\diamond$ Normal constituent of gut flora\nManifestation: (1) Superficial overgrowth (thrush)\n(2) Invasive systemic disease\n\nAt risk: particularly common in patients receiving immuno-suppressive therapy / with indwelling catheters\nEntry:\n(a) aspiration\n(b) hematogenous dissemination from GI tract / infected central venous catheter\n\n- prolonged fever despite broad-spectrum antibacterial coverage\n- cough, hemoptysis\n$\\checkmark$ patchy airspace consolidation in lower lobe distribution\n$\\checkmark$ interstitial pattern\n$\\checkmark$ diffuse micro- / macronodular disease\n$\\checkmark$ pleural effusion $(25 \\%)$\n\n\n## Cerebral Candidiasis\n\n$=$ disseminated disease\n$\\checkmark$ scattered cerebral microabscesses of $<3 \\mathrm{~mm}$\n$\\checkmark$ macroabscess + meningitis (uncommon)\nCx: angioinvasion $\\rightarrow$ thrombosis and hemorrhage\n\n## CARDIOPULMONARY SCHISTOSOMIASIS\n\n$=$ form of parasitic embolism\nOrganism: Schistosoma mansoni (endemic in Middle East, Africa, Atlantic coast of South",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 553,
            "markdown": "America, Caribbean; S. japonicum and S. haematobium (less commonly)\nAt risk: $>5$ years of continuous ova secretion\nPrerequisite: portal hypertension with periportal hepatic fibrosis\nCycle: eggs travel as emboli via portosystemic collateral pathways to lodge in pulmonary muscular arteries and arterioles ( $50-150 \\mu \\mathrm{~m}$ in diameter)\nPathogenesis:\neggs trapped in pulmonary arteries are antigenic $\\rightarrow$ incite an obliterative endarteritis (due to delayed host hypersensitivity) $\\rightarrow$ pulmonary hypertension\nPath: intra- and perivascular granulomas, intimal hyperplasia, medial hypertrophy, concentric collagen deposition and fibrosis of vessel walls; localized alveolitis with eosinophilic infiltration; pulmonary infarction\nAge: 25-35 (range, 1-93) years\n\n- gradually worsening hepatosplenomegaly\n- dyspnea, cough, chest pain\n- severe hypoxemia, cyanosis, digital clubbing\n\nCXR:\n$\\checkmark$ cardiomegaly\n$\\checkmark$ central pulmonary arterial enlargement\n$\\checkmark$ tiny scattered lung nodules occasionally\nHRCT:\n$\\checkmark$ nodules of $2-15 \\mathrm{~mm}$, interstitial thickening\n$\\checkmark$ larger nodules surrounded by ground-glass-opacity halo\n$\\checkmark$ dilatation of right atrium + right ventricle + central pulmonary arteries\n$C x:$ cor pulmonale $(2-33 \\%)$\nRx: praziquantel, oxamniquine\n\n# CASTLEMAN DISEASE \n\n$=$ ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA = BENIGN GIANT LYMPH NODE HYPERPLASIA = ANGIOMATOUS LYMPHOID HAMARTOMA = LYMPHOID HAMARTOMA\n[Benjamin Castleman (1906-1982), chief of anatomic pathology at Massachusetts General Hospital, Boston]\n$=$ diverse group of rare nonclonal lymphoproliferative disorders of differing histopathologic properties + biologic behavior\nEtiology: lymphoid-hamartomatous hyperplasia, autoimmune disease, immunodeficiency, chronic low-grade inflammation\nAssociated with: unregulated overproduction of interleukin-6\nHistopathogenetic classification:\n(a) hyaline-vascular Castleman disease (76-91\\%) nonclonal hyaline vascular lymph follicles; expanded mantle zones of small lymphocytes forming concentric rings (\"onionskin\"); prominent capillary proliferation with endothelial hyperplasia in interfollicular areas; involuted germinal centers often penetrated by single capillary vessel (\"lollipop\" appearance)\nAge: $3^{\\text {rd }}-4^{\\text {th }}$ decade\n\n- asymptomatic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 554,
            "markdown": "$\\sqrt{ }$ unicentric intensely enhancing mass (in $90 \\%$ )\n$\\sqrt{ }$ calcification + central fibrosis\nPrognosis: benign course\n$R x$ : curative surgical resection, steroids $\\pm$ chemotherapy\n(b) plasma cell Castleman disease (4-9-24\\%) sheets of plasma cells between normal / enlarged follicles; paucity of capillaries\nPrevalence: $<10 \\%$ of Castleman disease\nAge: $6^{\\text {th }}$ decade\n\n- systemic manifestations: fever, night sweats, malaise\n- anemia, thrombocytopenia, hyperglobulinemia\n$\\sqrt{ }$ multicentric / unicentric ( $9-24 \\%$ ) mass\n$\\sqrt{ }$ splenomegaly\nPrognosis: worse than hyaline vascular Castleman\n$R x$ : systemic chemotherapy, antiproliferative agents\n(c) HHV-8-associated Castleman Disease\n$[\\mathrm{HHV}=$ Human Herpes Virus]\n$=$ plasmablastic variant ( $=$ microlymphoma) in immunosuppressed patients with positive HIV status\n- generalized lymphadenopathy; constitutional symptoms\n- hematologic $\\pm$ immunologic abnormalities\n\nPrognosis: poor with several months of survival\n$R x$ : systemic chemotherapy, antiviral + antiproliferative regimens (rituximab)\n(d) multicentric not otherwise specified\n\nMorphologic classification: unicentric versus multicentric\nLocation: chest / mediastinum (46-70\\%), neck (15\\%), abdomen \\& pelvis (15\\%) extralymphatic: lung, larynx, parotid, pancreas, meninges, muscle\nMean size: 5 cm\n$\\sqrt{ }$ enlarged lymph node with preserved architecture\n\n# Localized / Unicentric Angiofollicular Lymph Node Hyperplasia \n\nCause: chronic viral antigenic stimulation with reactive lymphoid hyperplasia / developmental growth disturbance of lymphoid tissue\nAge: all age groups (peaks in $4^{\\text {th }}$ decade); $\\mathrm{M}+\\mathrm{F}=1 \\div 4$\nHisto: mostly hyaline-vascular cell type ( $95 \\%$ )\nLocation:\n(a) middle mediastinum + hila\n(b) cervical lymph nodes\n(c) mesenteric + retroperitoneal lymph nodes\n(d) extralymphatic sites: lung, larynx, parotid gland, pancreas, meninges, muscle\n\nMorphologic types:\n(a) solitary well-circumscribed mass without associated lymphadenopathy (50\\%)\n(b) dominant mass displacing / surrounding / invading contiguous structures + lymphadenopathy $(40 \\%)$\n(c) multiple enlarged matted lymph nodes confined to one mediastinal compartment (10\\%)\n\n- asymptomatic in $58-97 \\%$; growth retardation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 555,
            "markdown": "- cough, dyspnea, hemoptysis, lassitude, weight loss, fever\n- $\\uparrow$ sedimentation rate, refractory microcytic anemia\n- IgG, IgM, IgA hypergammaglobulinemia (50\\%)\n\nSize: up to 16 cm in diameter\nUS:\n$\\sqrt{ }$ well-defined homogeneous hypoechoic mass\n$\\sqrt{ }$ increased vascularity on color Doppler with large vessels at periphery extending centrally\nCT:\n$\\sqrt{ }$ sharply marginated smooth / lobulated homogeneous solitary mass of muscle density\n$\\sqrt{ }$ spotty coarse peripheral / central branching calcifications (10-31\\%)\n$\\sqrt{ }$ enhancing rim (vascular capsule)\n$\\sqrt{ }$ intense enhancement almost equal to aorta (in hyaline vascular type)\n$\\sqrt{ }$ slight enhancement (in plasma cell type)\n$\\sqrt{ }$ nonenhancing central areas $\\leftarrow$ fibrosis / cystic necrosis\n$\\sqrt{ }$ pleural effusion (uncommon)\nMR:\n$\\sqrt{ }$ heterogeneous mass iso- / hyperintense to muscle on T1WI\n$\\sqrt{ }$ markedly hyperintense on T2WI\n$\\sqrt{ }$ T2-hypointense stellate scar $=$ central area / linear web of hypointensity $\\leftarrow$ fibrosis / fibrous septa reminiscent of stellate scar of hepatic fibrolamellar carcinoma\n$\\sqrt{ }$ scar hypointense on early phase dynamic T1WI\n$\\sqrt{ }$ peripheral flow voids of feeding vessels surrounding mass (in hyaline vascular type)\nAngio:\n$\\sqrt{ }$ hypervascular mass with intense homogeneous blush (hyalin-vascular type)\n$\\sqrt{ }$ enlarged feeding vessels arising from bronchial / internal mammary / intercostal arteries\n$\\sqrt{ }$ some hypervascularity (plasma cell type)\n$D D x$ : indistinguishable from lymphoma\nPrognosis: good with treatment; $\\sim 100 \\%$ curative\nRx: (1) Complete surgical resection\n(2) Radiation + steroid therapy\n$D D x$ : thymoma, lymphoma, sarcoma, hemangiopericytoma, paraganglioma, neurofibroma, schwannoma, chest wall tumor, bronchial adenoma, mesenteric fibromatosis, inflammatory myofibroblastic tumor, microcystic lymphatic malformation\n\n# Disseminated / Generalized / Multicentric Angiofollicular Lymph Node Hyperplasia \n\n$=$ potentially malignant lymphoproliferative disorder\nCause: disordered immunoregulation with polyclonal plasma cells from viral infection with uncontrolled B-cell proliferation + interleukin-6 dysregulation\nMean age: $40-60$ years; $\\mathrm{M}+\\mathrm{F}=2 \\div 1$\nHisto: mostly plasma cell type ( $66 \\%$ ) with infiltration of nodes by sheets of mature plasma cells\nAssociated with:\n(a) hyperplasia without neuropathy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 556,
            "markdown": "- fatigue, anorexia, skin lesions, CNS disorders\n(b) hyperplasia with POEMS syndrome\n(c) osteosclerotic myeloma, HHV-8 (Kaposi sarcoma, AIDS)\n$\\checkmark 1-6 \\mathrm{~cm}$ large homogeneous lymph nodes in multiple mediastinal compartments\n$\\checkmark$ variable mild contrast enhancement\n$\\checkmark$ peripheral multicentric adenopathy\n$\\checkmark$ hepatosplenomegaly\n$\\checkmark$ salivary gland enlargement\n$\\checkmark$ ascites\n$\\checkmark$ lymphocytic interstitial pneumonitis (LIP):\n$\\checkmark \\pm$ ill-defined centrilobular nodules\n$\\checkmark$ ground-glass attenuation\n$\\checkmark$ air-space consolidation\n$\\checkmark$ cysts $\\leftarrow$ partial airway obstruction by peribronchial + peribronchiolar LIP\n$\\checkmark$ thickening of bronchovascular bundles\n$R x$ : surgical resection, irradiation, systemic chemotherapy + corticosteroids\nPrognosis: mean survival of 24-33 months",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 557,
            "markdown": "# CATAMENIAL PNEUMOTHORAX \n\n[kata, Greek = according to; men, Greek = month]\n$=$ recurrent spontaneous pneumothorax during menstruation associated with endometriosis of the diaphragm; $\\mathrm{R}>>\\mathrm{L}$\n\n- right scapular / thoracic pain within 24-72 hours after onset of menstruation\n\nFrequency: $24-33 \\%$ of recurrent spontaneous pneumothoraces in women of reproductive age referred for surgery\n$\\diamond$ Coexistent abdominal endometriosis in $60-80 \\%$\n$D x$ : brown nodules on video-assisted thoracoscopic surgery (VATS)\nRx: (1) Suppression of endometrial implants by hormonal manipulation\n(2) Resection of endometrial implants with closure of diaphragmatic holes\n\n## CHEMICAL PNEUMONITIS\n\n$=$ inhalation of noxious chemical substances\nA. ORGANIC: organophosphates, paraquat, polyvinyl chloride, polymer fumes, smoke\nB. NONORGANIC: ammonia, hydrogen sulfide, nitrogen oxide, sulfur dioxide\nC. METAL: cadmium, mercury, nickel, vanadium\n\n## Carbamates\n\n$=$ agricultural insecticides functioning as cholinesterase inhibitor (similar to organophosphates) but with poor penetration into CNS\n$\\checkmark$ pulmonary edema with respiratory failure\n\n## Paraquat\n\n$=$ agricultural herbicide\nExposure: often intentional ingestion\nPathophysiology: rapid accumulation in lungs with production of superoxide radicals damaging pulmonary cells\nCXR (wide radiographic variability:\n$\\sqrt{ }$ no abnormality\n$\\sqrt{ }$ increased interstitial / granular opacities\n$\\sqrt{ }$ pulmonary edema\n$\\checkmark$ pneumomediastinum\nHRCT:\n$\\checkmark$ bilateral diffuse areas of ground-glass attenuation evolving into consolidation with bronchiectasis, irregular lines, traction bronchiectasis of interstitial fibrosis\n\n## Hydrogen Sulfide\n\n$=$ irritant + chemical asphyxiant gas\nIndustries: coal mines, tanneries, petroleum manufacturing plants, geothermal power plants, aircraft factories, sewer works, rubber works\nEffect: toxic for respiratory (large quantities $\\rightarrow$ inhibition of medullary respiratory center) + neurologic systems\n\n- \"knockdown\" = brief loss of consciousness $\\leftarrow$ bronchial hyperresponsiveness",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 558,
            "markdown": "- determination of urine thiosulfate levels (to monitor occupational exposure); smell of rotten eggs\n$\\checkmark$ pulmonary edema\n\n\n# Ammonia \n\n$=$ highly soluble corrosive gas acts as a mucosal irritant\nIndustries: production of explosives, petroleum, agricultural fertilizer, plastics\n$\\checkmark$ pulmonary edema\nPrognosis: complete recovery; bronchiectasis + bronchiolitis obliterans may develop\n\n## Hydrocarbon\n\nExposure: ingestion / aspiration (eg, accidental poisoning in children; fire-eating performers)\nPath: (a) acute phase: intraalveolar, intrabronchial, peribronchial, interstitial accumulation of inflammatory cells + edema\n(b) chronic phase ( $1-2$ weeks after initial onset): proliferative bronchiolitis, parenchymal fibrosis, pneumatocele formation\n$\\sqrt{ }$ uni- / bilateral consolidation, well-defined nodules\n$\\checkmark$ pneumatoceles (from coalescing areas of bronchiolar necrosis / partial obstruction of bronchial lumen)\n\n## Mercury\n\nExposure: inhalation of mercury vapor\nIndustries: electrolysis, manufacture of thermometers, cleaning of boilers, smelting silver from dental amalgam containing mercury\nPathophysiology: acute chemical bronchiolitis + pneumonitis followed by diffuse alveolar damage with hyaline membrane formation\n\n- pulmonary function impairment\n$\\checkmark$ perivascular haziness + fine reticular opacities\n$\\checkmark$ pulmonary interstitial fibrosis\nPrognosis: acute inhalation poisoning usually fatal\n\n\n## CHYLOTHORAX\n\n$=$ leakage of chyle (= lymph containing chylomicrons of suspended fat) from thoracic duct or its branches into pleural space $\\leftarrow$ obstruction / disruption of thoracic duct (in $2 \\%$ )\nEtiology:\nA. Developmental defects\n\n1. Thoracic duct atresia\n2. Lymphangiectasia\n3. Lymphangioma\n4. Lymphangiomatosis (rare): mediastinal / thoracic cystic hygroma of neck growing into mediastinum\n5. Lymphangioleiomyomatosis $\\pm$ tuberous sclerosis\nB. Trauma\n6. Closed / penetrating chest trauma / birth trauma ( $25 \\%$ ): latent period of 10 days",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 559,
            "markdown": "2. Surgery ( $2^{\\text {nd }}$ most common cause): esophagectomy / cardiovascular surgery, esp. coarctation repair ( $0.5 \\%$ ), retroperitoneal surgery, neck surgery\n3. Subclavian venous catheter\nC. Neoplasm ( $54 \\%$ )\n4. Lymphoma (most common cause)\n5. Metastatic cancer\nD. Fibrosing conditions\n6. Mediastinitis\n7. Tuberculosis\n8. Filariasis (rare)\nE. Obstruction of central venous system / thoracic duct\nF. Idiopathic / cryptogenic ( $15 \\%$ ): most common cause in neonatal period\nG. Transdiaphragmatic passage of chylous ascites\n\nAge: in full-term infants; may be present in utero; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\nFrequency: $1 \\div 10,000$ deliveries\nMay be associated with:\ntrisomy 21, tracheoesophageal fistula, extralobar lung sequestration, congenital pulmonary lymphangiectasia\n\n- high in neutral fat + fatty acid (low in cholesterol):\n- triglyceride level $>110 \\mathrm{mg} / \\mathrm{dL}$\n- milky viscoid fluid (chylomicrons) after ingestion of milk / formula and clear during fasting\n$\\sqrt{ }$ usually unilateral loculated pleural effusion\n(a) right chylothorax $\\leftarrow$ duct disruption inferior to T5-6 (more common)\n(b) left-sided chylothorax if duct disrupted above T5-6\n$\\sqrt{ }$ low attenuation (fat) / high attenuation (protein content)\n$\\sqrt{ } \\pm$ leakage of lymphangiographic contrast\n$\\sqrt{ }$ polyhydramnios (? result of esophageal compression)\nCx: (1) Pulmonary hypoplasia\n(2) Hydrops (congestive heart failure $\\leftarrow$ impaired venous return)\n\nRx: (1) Thoracentesis $\\rightarrow$ loss of calories, lymphocytopenia, hypogammaglobulinemia\n(2) Total parenteral nutrition\n(3) Thoracic duct ligation (if drainage exceeds $1,500 \\mathrm{~mL} / \\mathrm{d}$ for adults or $100 \\mathrm{~mL} /$ yearage/day for children $>5$ years of age; drainage $>14$ days)\n(4) Pleuroperitoneal shunt; tetracycline pleurodesis; mediastinal radiation; intrapleural fibrin glue; pleurectomy\n\n# COAL WORKER PNEUMOCONIOSIS \n\n$=$ CWP $=$ ANTHRACOSIS $=$ ANTHRACOSILICOSIS\nPrevalence: $3 \\%$\nCoal dust: inert, HOWEVER admixed silica is fibrogenic\nCoal rank (= carbon content of coal):\nanthracite (highest risk) $>$ bituminous coal $>$ lignite coal; washed coal $=$ nearly free of silica\nPathophysiology of clearance:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 560,
            "markdown": "inhaled coal dust deposited predominantly in respiratory bronchioles (slower air flow) + alveoli\n(a) cleared by lymphatic flow (majority)\n(b) cleared by mucociliary action (particle size $>5 \\mu \\mathrm{~m}$ )\n(c) taken up by alveolar / interstitial macrophages $=$ anthracosis (seen also in smokers + urbanites)\nMay be associated with: Caplan syndrome (in 1\\%)\n$D D x$ : silicosis, mycobacterial infection, sarcoidosis, subacute hypersensitivity pneumonitis\n\n# Simple CWP \n\ncoal macule $=$ aggregate of centrilobular carbon-containing macrophages around bronchioles surrounded by network of collagen fibers + fibroblasts (about $1-5 \\mathrm{~mm}$ in diameter)\n$\\diamond$ NO progression in absence of further exposure\nPath: development of reticulin fibers associated with bronchiolar dilatation (focal emphysema) + bronchiolar artery stenosis ( $\\downarrow$ capillary perfusion); with disease progression nodules may coalesce + become centrally necrotic $\\leftarrow$ ischemia\n\n- poor correlation between symptoms + physiologic findings + roentgenogram\n\nLocation of coal macules:\naround respiratory bronchioles in upper lobes $>>$ lower lobes (higher pulmonary arterial gradient in lower portions of lung $\\rightarrow$ higher lymphatic flow $\\rightarrow$ coal dust particles clear more rapidly $\\rightarrow$ particle deposition less prominent in lower lobes)\nSize of nodules: $<10 \\mathrm{~mm}$\nCXR:\n$\\checkmark$ small round $1-5-\\mathrm{mm}$ nodular interstitial opacities (only seen by superposition after an exposure of $>10$ years):\n$\\checkmark$ granular appearance with poor definition of margins\n$\\checkmark$ nodularity correlates with amount of collagen (NOT amount of coal dust)\n$\\checkmark$ nodules calcify (in $10-20 \\%$ ) as central nodular dot\n$\\checkmark$ occasionally reticular / reticulonodular opacities\nCT:\n$\\checkmark$ small round nodules diffusely involving both lungs in a perilymphatic distribution:\n$\\checkmark$ calcifications within nodules in $30 \\%$\n$\\checkmark$ pleural pseudoplaques (= coalescent macules in subpleural region)\n$\\checkmark$ hilar / mediastinal lymph node enlargement in $30 \\%$\nCx: (1) Chronic obstructive bronchitis\n(2) Focal emphysema\n(3) Cor pulmonale\n$R x$ : reducing exposure, cessation of smoking, supplemental oxygen, bronchodilators, corticosteroids\n$D D x$ : silicosis (nodules diffusely calcified with well-defined margins, eggshell calcifications in only $1.3 \\%$ )\n\n## Progressive Massive Fibrosis\n\n$=$ COMPLICATED PNEUMOCONIOSIS\n$=$ CONGLOMERATE ANTHRACOSILICOSIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 561,
            "markdown": "May develop / progress after cessation of dust exposure\nPath: avascular amorphous central fibrotic mass of haphazardly arranged insoluble proteins stabilized by cross-links + ill-defined bundles of coarse hyalinized collagen at periphery; numerous pigment-laden macrophages and abundant free pigment; foci of frank necrosis, cholesterol clefts, chronic inflammatory cellular infiltrates\nLocation: almost exclusively restricted to posterior segment of upper lobe / superior segment of lower lobe\nSize of nodules: $>10 \\mathrm{~mm}$\n\n- cough (blackened sputum), dyspnea\n- low $\\mathrm{FEV}_{1}$ (may not correlate with radiograph!)\n$\\sqrt{ }$ large opacities initially at periphery of lung in middle + upper lung zones:\n$\\sqrt{ }$ irregular border + surrounding pericicatricial emphysema\n$\\sqrt{ }$ radiation toward hila starting at lung periphery; bilateral symmetry\n$\\sqrt{ }$ discoid contour $(44 \\%)=$ mass flat from front to back (thin opacity on lateral view, large opacity on PA view), medial border often ill-defined, lateral borders sharp + parallel to rib cage\n$\\sqrt{ }$ cavitation (occasionally) $\\leftarrow$ ischemic necrosis / superimposed TB infection\n$\\sqrt{ }$ apparent decrease in nodularity $\\leftarrow$ incorporation of nodules from surroundings\n$\\sqrt{ }$ bullous scar emphysema\n$\\sqrt{ }$ pulmonary hypertension\n$\\sqrt{ } \\pm$ enlargement + calcifications of mediastinal + hilar lymph nodes\nMR:\n$\\sqrt{ }$ low SI on T1WI + T2WI compared to muscle $\\leftarrow$ fibrosis\n$\\sqrt{ }$ peripheral contrast enhancement\nPET:\n$\\sqrt{ }$ hypermetabolic nodules (majority)\nN.B.: Exposure reduction to coal dust does not stop progression of disease!\n\nDDx: lung cancer (increased SI on T2WI), sarcoidosis, berylliosis, tuberculosis, talcosis\n\n# Carbon Black Pneumoconiosis \n\n$=$ burning of natural gas + petroleum products (filler in rubber, plastics, phonograph records, inks, carbon paper, carbon electrodes)\n$\\sqrt{ }$ fine reticulonodular pattern with lower zone predominance\n\n## COCCIDIOIDOMYCOSIS\n\nOrganism: dimorphic soil fungus Coccidioides immitis and its close relative Coccidioides posadasii; arthrospores in desert soil spread by wind aerosolized in dry dust; highly infectious\nGeographic distribution:\nendemic in southwest desert of USA (San Joaquin Valley, central southern Arizona, western Texas, southern New Mexico) + northern Mexico + in parts of Central + South America; similar to histoplasmosis\nMode of infection:\narthrospores deposited in alveoli after inhalation; maturation into large thick-walled",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 562,
            "markdown": "spherules $\\rightarrow$ rupture with release of hundreds of endospores (instead of budding)\nDx: (1) Culture of organism\n(2) Spherules in pathologic material (demonstrated with Gomori-methenamine silver stain)\n(3) Positive skin test\n(4) Complement fixation titer\n\n# Primary Pulmonary Coccidioidomycosis (40\\%) \n\n$=$ ACUTE RESPIRATORY COCCIDIOIDOMYCOSIS\n\n- $60-80 \\%$ asymptomatic\n- \"valley fever\" = influenza-like symptoms\n- desert rheumatism (33\\%) most commonly in ankle\n- rash, erythema nodosum / multiforme (5-20\\%)\n$\\checkmark$ segmental / lobar consolidation\n$\\checkmark$ patchy infiltrates mainly in lower lobes ( $46-80 \\%$ ) frequently subpleural + abutting fissures\n$\\checkmark$ peribronchial thickening\n$\\checkmark$ hilar adenopathy ( $20 \\%$ )\n$\\checkmark$ pleural effusion ( $10 \\%$ )\n\n\n## Chronic Respiratory Coccidioidomycosis (5-10\\%)\n\nPrevalence: 5\\% of infected patients\n\n- symptoms of postprimary tuberculosis, hemoptysis in $50 \\%$\n$\\checkmark$ one / several well-defined nodules ( $=$ coccidioidomycoma) of $5-30 \\mathrm{~mm}$ in size (in 50$70 \\%)$\n$\\checkmark$ persistent / progressive consolidation\n$\\checkmark$ \"grape skin\" thin-walled cavities (in $10-15 \\%$ ), in $90 \\%$ solitary, $70 \\%$ in anterior segment of upper lobes (DDx: TB), 3\\% rupture into pleural space due to subpleural location (pneumothorax / empyema / persistent bronchopleural fistula\n$\\checkmark$ bronchiectasis\n$\\checkmark$ mediastinal adenopathy $(10-20 \\%)$\n\n\n## Disseminated Coccidioidomycosis (1\\%)\n\n$=$ secondary phase of hematogenous spread to meninges, bones, skin, lymph nodes, subcutaneous tissue, joints (except GI tract)\n\n- skin granulomas / abscesses\n$\\checkmark$ micronodular \"miliary\" lung pattern\n$\\checkmark$ pericardial effusion\n\n\n## Cerebral Coccidioidomycosis\n\n$=$ fungal meningitis (in $50 \\%$ )\n$\\checkmark$ thick exudate + abnormal enhancement in basal cisterns + subarachnoid space\nCx: (1) Hydrocephalus\n(2) Vasculitis (in up to $40 \\%$ ) involving small perforators $\\rightarrow$ deep brain infarct\n(3) Subarachnoid hemorrhage $\\leftarrow$ granulomatous inflammation of large vessels\n(4) Cerebritis (especially in immunocompromised patients) $\\rightarrow$ fungal extension",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 563,
            "markdown": "along vessel walls / in perivascular spaces\n\n# CONGENITAL HIGH AIRWAY OBSTRUCTION SYNDROME (CHAOS) \n\nCause: complete / near-complete obstruction of fetal airway $\\rightarrow$ trapping of lung fluid + hyperplasia of pulmonary alveoli\n$\\sqrt{ }$ tracheal dilatation\n$\\sqrt{ }$ flattened / everted hemidiaphragm\n$\\sqrt{ }$ massive ascites\nFetal MR:\n$\\sqrt{ }$ enlarged hyperintense lungs on T2WI\n$C x$ : hydrops fetalis $\\leftarrow$ cardiac compression + obstructed venous return\nPrognosis: poor\n\n## CONGENITAL HYDROTHORAX\n\nPrevalence: $1 \\div 15,000$ pregnancies\nCause: disequilibrium across pleural membranes due to\n(a) primary cause: lymphatic duct abnormality $\\rightarrow$ chylothorax $\\rightarrow$ defective chest drainage\n(b) secondary cause: generalized fluid retention related to immune / nonimmune fetal hydrops\nAssociated abnormalities (in 40\\%):\ncongenital cystic adenomatoid malformation, congenital diaphragmatic hernia,\nbronchopulmonary sequestration cardiac anomalies, Turner syndrome, Down syndrome, cystic hygroma, infection\nFetal MR:\n$\\sqrt{ }$ lungs surrounded by fluid collection $=$ hypointense on T1WI + hyperintense on T2WI\n$R x$ : fetal intervention (thoracentesis / thoracoamniotic shunting) reserved for hydrothorax with marked mass effect\n\n## CONGENITAL LOBAR OVERINFLATION\n\n$=$ CONGENITAL LOBAR EMPHYSEMA (technically inaccurate term)\n$=$ progressive overdistension of one / multiple lobes\n$\\mathrm{M} \\div \\mathrm{F}=3 \\div 1$\nEtiology:\n(a) bronchomalacia: deficient / dysplastic / immature bronchial cartilage\n(b) endobronchial obstruction: mucosal fold / web\n(c) extrinsic bronchial compression: PDA, aberrant left pulmonary artery, pulmonary artery dilatation, bronchogenic cyst\n(d) polyalveolar / macroalveolar hyperplasia\n\nHisto: airspace enlargement without maldevelopment\nPathophysiology:\n(a) collapsed airway acts as 1 -way valve $\\rightarrow$ air trapping with expansion of alveoli but intact alveolar wall\n(b) bronchial obstruction $\\rightarrow$ hyperinflated lung $\\leftarrow$ collateral air drift",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 564,
            "markdown": "Associated with: CHD in 12-15\\% (PDA, VSD)\n\n- respiratory distress $(90 \\%)+$ progressive cyanosis within first 6 months of life; during first 2 days of life $(50 \\%)$\nLocation: LUL (42-43\\%) > RML (32-35\\%) > RUL (20\\%) > either lower lobe ( $<1 \\%$ )\n$\\sqrt{ }$ hazy masslike dense opacity immediately following birth $\\leftarrow$ delayed clearance of lung fluid in emphysematous lobe over 1-14 days\n$\\sqrt{ }$ hyperlucent overinflated lobe (after clearing of fluid via lymphatic + capillary system)\n$\\checkmark$ air trapping:\n$\\checkmark$ compression atelectasis of adjacent ipsilateral lobes\n$\\checkmark$ contralateral mediastinal shift\n$\\checkmark$ widening of rib spaces\n$\\checkmark$ depression of ipsilateral hemidiaphragm\n$\\checkmark$ widely separated but organized vascular markings\nOB-US / MR:\n$\\checkmark$ homogeneously hyperechoic mass\n$\\checkmark$ mass of homogeneously high SI on T2WI\nMortality: $10 \\%$\n$R x$ : ventilatory support (low-volume, low-pressure); surgical resection\n$D D x$ : pneumothorax, pulmonary cyst\n\n\n# CONGENITAL LYMPHANGIECTASIA \n\n## Primary Pulmonary Lymphangiectasia (\\%)\n\n$=$ CONGENITAL PULMONARY LYMPHANGIECTASIA\n$=$ abnormal development of lungs between $14^{\\text {th }}-20^{\\text {th }}$ week of GA characterized by anomalous dilatation of (pulmonary, subpleural, interlobar, perivascular, peribronchial) lymphatic vessels of chest\nPath: subpleural cysts, ectatic tortuous lymph channels in pleura, interlobular septa + along bronchoarterial bundles; NO obstruction\nAge: usually manifest at birth; $50 \\%$ stillborn; $\\mathrm{M}=\\mathrm{F}$\nMay be associated with:\ntotal anomalous pulmonary venous return, hypoplastic left heart, Noonan syndrome, Turner syndrome, Ehlers-Danlos syndrome, Down syndrome\n\n- respiratory distress within few hours of birth\n\nSite: diffuse involvement of both lungs, occasionally only in one / two lobes (with good prognosis)\n$\\checkmark$ marked prominence of coarse interstitial markings (simulating interstitial edema)\n$\\checkmark$ hyperinflation\n$\\checkmark$ scattered radiolucent areas (dilated airways)\n$\\checkmark$ patchy areas of pneumonia + atelectasis\n$\\checkmark$ pneumothorax\n$\\checkmark \\pm$ pleural effusion\nFetal MR:\n$\\checkmark$ bilateral inhomogeneity of the lung parenchyma on T2WI",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 565,
            "markdown": "$\\sqrt{ }$ high SI in pulmonary interstitium on T2WI\nPrognosis: with diffuse involvement invariably fatal at $<2$ months of age\n\n# Generalized Lymphangiectasia \n\n$=$ DIFFUSE LYMPHANGIOMA\n$=$ proliferation of mainly lymphatic vascular spaces with relentless systemic progression\nAge: children, young adults\nLocation: widespread visceral + skeletal involvement\n$\\sqrt{ }$ diffuse pulmonary interstitial disease\n$\\sqrt{ }$ chylous effusions in pleural + pericardial spaces\n$\\sqrt{ } \\pm$ lytic bone lesions\n$\\sqrt{ }$ lymphangiographic pooling of contrast material in dilated lymphatic channels / lymph nodes\n\n## Localized Lymphangioma\n\n$=$ rare benign usually cystic lesion\nHisto: collection of dilated + proliferated lymph vessels (? hamartoma / benign neoplasm / focal sequestration of ectatic lymph tissue)\nAge: first 3 years of life; $\\mathrm{M}=\\mathrm{F}$\n\n- asymptomatic ( $33 \\%$ ); dyspnea $\\leftarrow$ tracheal compression\n\nLocation: neck ( $80 \\%$ ), mediastinum, axilla, extremity\n$\\sqrt{ }$ discrete featureless mass\n$\\sqrt{ }$ may have chylous / pleural effusion\n$\\sqrt{ }$ may have lytic lesion in contiguous skeleton\nPrognosis: propensity for local recurrence\n$D D x$ : hemangioma\n\n## Secondary Pulmonary Lymphangiectasia\n\nCause: surgery, infection, tumor genesis, pulmonary venous obstruction ( $\\leftarrow$ total anomalous pulmonary venous return, hypoplastic left heart syndrome)\n\n## CONGENITAL PULMONARY AIRWAY MALFORMATION (CPAM)\n\n$=$ CONGENITAL CYSTIC ADENOMATOID MALFORMATION (CCAM)\n$=$ congenital abnormality of the lung characterized by an intralobar mass of disorganized pulmonary tissue communicating with bronchial tree; normal vascular supply + drainage (pulmonary artery + vein) with delayed clearance of fetal lung fluid\nPrevalence: $1 \\div 25,000-35,000$ pregnancies; $25 \\%$ of congenital lung disorders; $30-40 \\%$ of all congenital diseases $95 \\%$ of congenital cystic lung lesions\n$\\diamond$ Most common fetal lung mass diagnosed in neonatal period / in utero!\nCause: arrest of normal bronchoalveolar differentiation (= branching) between $5^{\\text {th }}-7^{\\text {th }}$ week of gestation with overgrowth of terminal bronchioles\nPath: proliferation of bronchial structures at the expense of alveolar saccular development; modified by inter-communicating cysts of various size (adenomatoid overgrowth of terminal bronchioles, proliferation of smooth muscle in cyst wall, absence of cartilage) hybrid lesion $=$ features of CPAM + bronchopulmonary sequestration with systemic arterial supply",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 566,
            "markdown": "Connections:\n(a) proximal airways: abnormal communication\n(b) blood supply: pulmonary artery\n\nException: hybrid lesion $\\rightarrow$ systemic blood supply\n(c) blood drainage: pulmonary veins\n\nModified Stocker classification (2002):\nType $0(<3 \\%$, added later):\n$=$ ACINAR DYSPLASIA OF THE LUNG (previous designation)\n$=$ severe global arrest of lung development\nOrigin: trachea / bronchus\nHisto: acinar dysgenesis / dysplasia = no cysts / very small ones $(<0.5 \\mathrm{~cm})$\nLocation: in any lobe\n\n- incompatible with life\n\nType $1=$ large cyst CPAM $(60-70 \\%)$ :\nOrigin: bronchus / bronchiolus\nHisto: (a) single large cyst $>20 \\mathrm{~mm}$\n(b) $1-10 \\mathrm{~cm}$ intercommunicating cysts surrounded by multiple smaller cysts lined by ciliated pseudo- stratified columnar epithelium, mucigenic (mucusproducing) cells in $1 / 3$; small amount of supporting fibrous tissue + smooth muscle; NO cartilage\n$\\sqrt{ }$ numerous variable-sized anechoic spaces of $1-10 \\mathrm{~cm}$ in diameter intermixed with echogenic soft tissue on US\n$\\checkmark$ hyperintense uni- / multilocular lesion with discrete walls on T2WI\n$\\checkmark$ mass of variable density $\\pm$ mediastinal shift on postnatal radiograph\n$\\checkmark$ round soft-tissue mass gradually filling with air on neonatal radiographs $\\leftarrow$ delayed clearance of fetal lung fluid through abnormal airway:\n$\\checkmark$ solitary well-defined air-filled cyst with thin wall\n$\\checkmark$ multiple air-filled cysts of varying sizes\n$\\checkmark \\pm$ air fluid levels\n$\\checkmark$ well-defined air-filled spaces on CT\n$\\checkmark \\pm$ abnormal systemic arterial supply\nPrognosis: excellent following resection\nType $2=$ small cyst CPAM $(15-20 \\%)$ :\nOrigin: bronchiolus\nHisto: multiple cysts / bronchiole-like structures $<20 \\mathrm{~mm}$ in diameter lined by ciliated cuboidal / columnar epithelium without normal lung airspaces (similar to pulmonary hyperplasia associated with laryngeal atresia)\nStrong association with: tracheoesophageal fistula, renal agenesis, intestinal atresia, diaphragmatic hernia\n$\\checkmark$ echogenic mass with multiple small $5-20 \\mathrm{~mm}$ cysts\n$\\checkmark$ variable appearance with cystic + solid T2 components\n$\\checkmark$ heterogeneous intrapulmonary mass with small air-filled cystic areas on postnatal radiograph / CT\n$\\checkmark \\pm$ abnormal systemic arterial supply = hybrid lesion demonstrating features of CPAM + bronchopulmonary sequestration",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 567,
            "markdown": "Prognosis: poor secondary to associated abnormalities\nType $3=$ microcystic solid CPAM (5-10\\%):\nOrigin: bronchiolar-alveolar duct (adenomatoid type)\nHisto: solitary large bulky firm mass of bronchuslike structures lined by ciliated cuboidal epithelium with $3-5-\\mathrm{mm}$ small microcysts / solid type\n$\\sqrt{ }$ large homogeneously echogenic mass compared with liver WITHOUT discernible cystic spaces\n$\\checkmark$ homogeneously hyperintense solid mass on T2WI\n$\\checkmark$ ill-defined area of increased attenuation on CT\nPrognosis: poor $\\leftarrow$ pulmonary hypoplasia / hydrops\nType $4(10-15 \\%$, added later):\nHisto: type of \"unlined\" peripheral lung cyst\nUnique association with: tension pneumothorax\n$\\sqrt{ }$ large cyst up to 10 cm in diameter indistinguishable from a low-grade cystic pleuropulmonary blastoma / type 1 CPAM (clinically / radiologically)\nIn $25 \\%$ associated with:\ncardiac malformation, pectus excavatum, renal agenesis, prune-belly syndrome, jejunal atresia, chromosomal anomaly, bronchopulmonary sequestration\nAge of detection: childhood, neonate, fetus; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n\n- respiratory distress + severe cyanosis in $1^{\\text {st }}$ week of life ( $66 \\%$ ) / within $1^{\\text {st }}$ year of life ( $90 \\%$ )\n$\\leftarrow$ compression of normal lung + airways\n- superimposed chronic recurrent infection ( $10 \\%$ ) after $1^{\\text {st }}$ year\n\nLocation: equal frequency in all lobes (rare in middle lobe); more than one lobe involved in $20 \\% ; \\mathrm{L} \\div \\mathrm{R}=1 \\div 1$\n$\\diamond$ Mostly unilateral affecting an entire lobe!\nCXR:\n$\\checkmark$ may appear normal due to prenatal regression\n$\\checkmark$ almost always unilateral expansile mass with well-defined margins $(80 \\%) \\leftarrow$ retained fetal lung fluid / type III lesion\n$\\checkmark$ multiple air-filled cysts $\\leftarrow$ progressive expansion of cysts $\\leftarrow$ communication with tracheobronchial tree\n$\\checkmark$ effects of compression of adjacent lung:\n$\\checkmark$ contralateral shift of mediastinum ( $87 \\%$ )\n$\\checkmark$ ipsilateral hypoplasia of uninvolved lung\n$\\checkmark$ proper position of abdominal viscera\n$\\checkmark$ spontaneous pneumothorax (late sign)\nCT:\n$\\diamond$ Postnatally becoming obstructed and filled with air\n$\\checkmark$ solitary / multiple thin-walled cysts filled with fluid / air $\\pm$ air-fluid / gas-liquid levels\n$\\checkmark$ surrounding focal emphysematous changes\nOB-US (detectable at about 20 weeks GA):\n$\\checkmark$ lesion with single large / multiple large / multiple small cysts\n$\\checkmark$ echogenic (= nondiscernible microcystic) solid mass\n$\\checkmark$ rapid growth at 20-26 weeks GA followed by stabilization",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 568,
            "markdown": "$\\sqrt{ }$ contralateral mediastinal shift $(89 \\%)$\n$\\sqrt{ }$ polyhydramnios $(25-75 \\%)$ ? $\\leftarrow$ compression of esophagus / increased fluid production by abnormal lung\n$\\sqrt{ }$ normal amniotic fluid ( $28 \\%$ ) / oligohydramnios ( $6 \\%$ )\n$\\sqrt{ }$ fetal ascites $(62-71 \\%)$\n$\\sqrt{ }$ fetal hydrops in $33-81 \\% \\leftarrow \\Downarrow$ venous return $\\leftarrow$ compression of heart / vena cava (= most important prognostic factor):\nPredictable by: mass-thorax ratio $>0.56$; CPAMvol $\\div \\mathrm{HC}$ ratio $>1.6$\nRisk of recurrence: none\nCx: ipsi- / bilateral pulmonary hypoplasia\nPrognosis: $50 \\%$ premature, $97 \\%$ survival rate (in absence of associated anomalies)\n$\\diamond$ Polyhydramnios, ascites, hydrops indicate a poor outcome!\n$\\diamond$ Postnatally lesions may regress / persist / remain stable: CPAM becomes smaller in fetuses in many cases + resolves spontaneously with $<60 \\%$ of total lung volume!\nRx: (1) Thoracoamniotic shunting for single large cyst with fetal hydrops\n(2) EXIT (ex utero intra partum) procedure after 32 weeks\n(3) Surgical resection $>1$ month of life (reason: risk of infection / small risk of malignancy)\n$D D x:$ (1) Congenital lobar emphysema\n(2) Diaphragmatic hernia\n(3) Bronchogenic cyst (small solitary cyst near midline)\n(4) Neurenteric cyst\n(5) Bronchial atresia\n(6) Bronchopulmonary sequestration (less frequently associated with polyhydramnios / hydrops)\n(7) Mediastinal / pericardial teratoma\n\n# CONGENITAL PULMONARY VENOLOBAR SYNDROME \n\n$=$ SCIMITAR SYNDROME\n$=$ unique form of congenital lung underdevelopment affecting one / more lobes in a constellation of distinctly different congenital anomalies of the thorax that often occur together; $\\mathrm{M} \\div \\mathrm{F}=$ $1 \\div 1.4$\n$\\diamond$ The most constant components of the syndrome are hypogenetic lung + partial anomalous pulmonary venous return\nA. MAJOR COMPONENTS\n\n1. Hypogenetic lung ( $69 \\%$ ): pulmonary lobar agenesis / aplasia / hypoplasia\n$\\sqrt{ }$ hypoplasia / aplasia of one / more lobes of the lung with errors in lobation (= bilateral left bronchial branching pattern / horseshoe lung)\n$\\sqrt{ }$ solid mass along posterior right hemidiaphragm (if trapped lung is unaerated)\n$\\sqrt{ }$ large ipsilateral apical cap + blunted costophrenic angle\n$\\sqrt{ }$ diminished radiolucency on involved side\n$\\sqrt{ }$ small ipsilateral hemithorax + mediastinal shift\n$\\sqrt{ }$ elevated hemidiaphragm\n$\\sqrt{ }$ heart shifted toward involved side $\\rightarrow$ cardiac dextroposition in right lung hypoplasia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 569,
            "markdown": "2. Ipsilateral partial anomalous pulmonary venous return (PAPVR) $\\rightarrow$ L-to-R shunt\n$\\checkmark$ \"scimitar vein\" ( $90 \\%$ ) commonly connecting to infradiaphragmatic or suprahepatic portion of IVC / portal vein / hepatic vein / coronary sinus / R atrium\n$\\checkmark$ on CXR seen only in $31 \\%$\n3. Absence of pulmonary artery ( $14 \\%$ )\n$\\checkmark$ reticular densities (enlarged bronchial / transpleural arterial collaterals)\n$\\checkmark$ indistinct hazy cardiomediastinal border on involved side\n$\\checkmark$ small hilum $\\leftarrow$ absent / small pulmonary artery\n$\\checkmark$ diminished pulmonary vascularity on involved side\n4. Pulmonary sequestration ( $24 \\%$ )\n5. Systemic arterialization of lung without sequestration ( $10 \\%$ )\n$\\checkmark$ systemic arterial supply to abnormal segment from\n> thoracic aorta: bronchial, intercostal, transpleural\n> abdominal aorta: celiac artery, transdiaphragmatic\n$\\checkmark$ rib notching\n6. Absence / interruption of inferior vena cava ( $7 \\%$ )\n7. Duplication of diaphragm $=$ accessory diaphragm $(7 \\%)$\n$=$ thin membrane in right hemithorax fused anteriorly with the diaphragm coursing posterosuperiorly to join with the posterior chest wall + trapping all / part of RML/ RLL\n$\\checkmark$ accessory fissurelike oblique line above right posterior costophrenic sinus (if trapped lung is aerated)\n$\\checkmark$ broad retrosternal band of opacity (LAT view)\nCT:\n$\\checkmark$ ovoid area of increased density in posterior right hemithorax (= dome of accessory diaphragm)\nB. MINOR COMPONENTS\n8. Tracheal trifurcation (extremely rare): 2 mainstem bronchi supplying the right lung\n9. Eventration of diaphragm\n10. Partial absence of diaphragm\n11. Phrenic cyst\n12. Horseshoe lung\n13. Esophageal / gastric lung\n14. Anomalous superior vena cava\n15. Absence of left pericardium\n\nAssociated with:\n(1) Vascular anomalies: hypoplastic artery, anomalous venous return, systemic arterial supply\n(2) Anomalies of hemidiaphragm on affected side:\n$\\checkmark$ retrosternal band on lateral CXR $\\leftarrow$ mediastinal rotation\n$\\checkmark$ phrenic cyst\n$\\checkmark$ diaphragmatic hernia\n$\\checkmark$ accessory hemidiaphragm\n(3) Hemivertebrae + scoliosis\n$\\checkmark$ rib hypoplasia / malsegmentation\n$\\checkmark$ anomalies of bony thorax / thoracic soft tissues",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 570,
            "markdown": "(4) CHD (25-50\\%): sinus venosus ASD, VSD, tetralogy of Fallot, PDA, coarctation of aorta, hypoplastic left heart, double-outlet right ventricle, double-chambered right atrium, endocardial cushion defect, persistent left SVC, pulmonary stenosis\nMay be associated with:\ncongenital tracheal stenosis, bronchogenic cyst, accessory diaphragm, diaphragmatic hernia, bronchitis, bronchiectasis\n\n- usually asymptomatic in isolated hypogenetic lung (40\\%)\n- may have exertional dyspnea / recurrent infections\n\nLocation: $\\mathrm{R}+\\mathrm{L}=3+1 ; \\operatorname{RML}(65 \\%)>\\operatorname{RUL}(40 \\%)>\\operatorname{RLL}(20 \\%)>\\operatorname{LUL}(20 \\%)>\\operatorname{LLL}(15 \\%)$; multiple lobes $(45 \\%)$\nOB-US:\n$\\checkmark$ isolated cardiac dextroposition + normal abdominal situs\n$\\checkmark$ polyhydramnios\n$\\checkmark$ mild narrowing of right pulmonary artery\nCXR:\n$\\checkmark$ curvilinear RLL density directed toward right hemidiaphragm\nCT:\n$\\checkmark$ small bronchus + lobe\n$\\checkmark$ small hemithorax + mediastinal shift\n$\\checkmark$ abnormalities of bronchial branching\n$\\checkmark$ anomalously located pulmonary fissure\n$\\checkmark$ discontinuity of hemidiaphragm\n$\\checkmark$ pulmonary arterial hypoplasia\n$\\checkmark$ arterial supply from thoracic / abdominal aorta $\\leftarrow$ absent / hypoplastic pulmonary artery\n$\\checkmark$ hyparterial (instead of eparterial) right bronchus\n$\\checkmark$ one / more vessels increasing in diameter toward diaphragm\n$\\checkmark$ rind of subpleural fatty tissue in affected hemithorax\n$\\checkmark$ lack of normal venous confluence of right lung\n$\\checkmark$ venous drainage into IVC, hepatic vein, portal vein, right atrium, coronary sinus\n$D D x$ : meandering pulmonary vein, dextrocardia, hypoplastic lung, Swyer-James syndrome\n\n# Horseshoe Lung \n\n= uncommon variant of hypogenetic lung syndrome in which RLL crosses midline between esophagus and heart + fuses with opposite LLL\n$\\checkmark$ oblique fissure in left lower hemithorax (if both lungs separated by pleural layers)\n$\\checkmark$ pulmonary vessels + bronchi crossing midline\n\n## COSTOCHONDRITIS\n\n$=$ musculoskeletal infection\nFrequency: increased with IV drug abuse\nAgents: Staphylococcus epidermidis, Streptococcus pneumoniae, Candida albicans, Aspergillus CT:\n$\\checkmark$ soft-tissue swelling\n$\\checkmark$ cartilage fragmentation, bone destruction\n$\\checkmark$ low-attenuation cartilage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 571,
            "markdown": "$\\sqrt{ }$ focal peripheral cartilaginous calcification\nRx: surgical excision\n\n# CRYPTOCOCCOSIS \n\n$=$ TORULOSIS $=$ EUROPEAN BLASTOMYCOSIS\nOrganism: encapsulated unimorphic yeastlike fungus Cryptococcus neoformans; spherical single-budding yeast cell with thick capsule; stains with India ink; often in soil contaminated with pigeon excreta\nHisto: granulomatous lesion with caseous necrotic center\nPredisposed: opportunistic invader in diabetics + immunocompromised patients\n\n- low-grade meningitis (affinity to CNS); $\\mathrm{M}+\\mathrm{F}=4 \\div 1$\n@ Lung\n$\\sqrt{ }$ well-circumscribed mass ( $40 \\%$ ) of $2-10 \\mathrm{~cm}$ in diameter, usually in peripheral location\n$\\sqrt{ }$ lobar / segmental consolidation (35\\%)\n$\\sqrt{ }$ cavitation ( $15 \\%$ )\n$\\sqrt{ }$ hilar / mediastinal adenopathy ( $12 \\%$ )\n$\\sqrt{ }$ calcifications (extremely rare)\n$\\sqrt{ }$ interstitial pneumonia (rare, in AIDS patients)\n@ Musculoskeletal\n$\\sqrt{ }$ osteomyelitis ( $5-10 \\%$ )\n$\\sqrt{ }$ arthritis (rare, usually from extension of osteomyelitis)\n\n\n## CYSTIC FIBROSIS\n\n$=\\mathrm{CF}=$ MUCOVISCIDOSIS $=$ FIBROCYSTIC DISEASE\n$=$ common autosomal recessive multisystem disease of exocrine gland dysfunction characterized by\n(a) mucous plugging (= thick tenacious material obstructing conducting system)\n(b) reduced mucociliary clearance\n\nFrequency: $\\quad 1 \\div 2,500$ livebirths; almost exclusively in Caucasians affecting 70,000 persons worldwide ( $5 \\%$ carry a CF mutant gene allele); unusual in Blacks ( $1 \\div 17,000$ ), Orientals, Polynesians\nGenetics: mutation of cystic fibrosis transmembrane regulator gene (CFTR) on long arm of chromosome 7 (usually necessary for absorption + secretion of salt and water); > 1000 different gene mutations (in $90 \\%$ DF508)\n$\\diamond$ Most common lethal autosomal recessive disease in white population (highest rate is in Ireland!)\nPathophysiology:\nfaulty CFTR protein at cell surface $\\rightarrow$ defective epithelial ion channel $\\rightarrow$ abnormal transmembrane conductance / block for Cl - into bronchial lumen and excessive resorption of $\\mathrm{Na}+\\rightarrow$ decrease in osmotic forces and luminal water $\\rightarrow$ mucous plugging in small + large airways $\\rightarrow$ increased incidence of bacterial airway infections\nScreening (for 6 most common mutations of CF gene):\n85\\% carrier detection rate for Northern Europeans, 90\\% for Ashkenazi Jews, 50\\% for American Blacks",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 572,
            "markdown": "Mean age at diagnosis: 2.9 years ( $70 \\%$ in $1^{\\text {st }}$ year of life, $80 \\%$ by age 4 years, $90 \\%$ by age 12 years); $50 \\%$ are now adults (2012); $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\nAffected organs: lung, pancreas, hepatobiliary system, kidney, GI tract\n\n- chronic sinusitis with nasal polyposis; infertility in males\n- elevated concentrations of sodium + chloride ( $>40 \\mathrm{mmol} / \\mathrm{L}$ for infants) in sweat, decreased urinary PABA excretion\n- increased susceptibility to infection by Staphylococcus aureus + Pseudomonas aeruginosa\n\nRx: aggressive nutrition and physiotherapy programs + antimicrobial and corticosteroid therapy, pancreatic enzyme supplementation, lung transplantation\nMedian survival: 41.1 years (in 2012)\n@ Lung\n\n- recurrent lung infections (reduced mucociliary clearance encourages Pseudomonas colonization), chronic cough\n- progressive respiratory insufficiency $\\leftarrow$ obstructive lung disease\n\nLocation: predilection for apical + posterior segments of upper lobes\n$\\sqrt{ }$ \"gloved finger\" sign $=$ mucous plugging $=$ mucoid impaction in dilated bronchi within $1^{\\text {st }}$ month of life\n$\\checkmark$ subsegmental / segmental / lobar atelectasis with right upper lobe predominance (10\\%)\n$\\checkmark$ progressive cylindrical / cystic bronchiectasis (in $100 \\%$ at $>6$ months of age) $\\pm$ air-fluid levels $\\leftarrow$ prolonged mucous plugging preponderant in upper lobes\n$\\checkmark$ parahilar linear densities + peribronchial cuffing\n$\\checkmark$ focal peripheral / generalized hyperinflation $\\leftarrow$ collateral air drift into blocked airways with air trapping\n$\\checkmark$ hilar adenopathy\n$\\checkmark$ large pulmonary arteries $\\leftarrow$ pulmonary arterial hypertension\n$\\checkmark$ recurrent local pneumonitis (initiated by Staphylococcus aureus / Haemophilus influenza, succeeded by Pseudomonas aeruginosa)\n$\\checkmark$ allergic bronchopulmonary aspergillosis (with bronchial dilatation + mucoid impaction) HRCT:\n$\\checkmark$ mosaic attenuation $\\leftarrow$ air trapping in early stage (on lateral decubitus HRCT in dependent lung)\n$\\checkmark$ bronchial + peribronchial thickening\n$\\checkmark$ cylindrical (varicose / cystic) bronchiectasis + bronchiolectasis\n$\\diamond$ in $30 \\%$ of children with normal lung function!\n$\\checkmark$ bronchiectatic cyst (= bronchus directly leading into sacculation) in $56 \\%$\n$\\checkmark$ interstitial cysts in $32 \\%$\n$\\checkmark$ emphysematous bulla (= peripheral air space with long pleural attachment + no communication to bronchus) in $12 \\%$\n$\\checkmark$ periseptal emphysema\n$\\checkmark$ mucous plugs $=$ tubular structures $\\pm$ branching pattern $\\rightarrow$ centrilobular nodules + tree-in-bud pattern\n$\\checkmark$ subsegmental / segmental atelectasis / consolidations\nNUC:\n$\\checkmark$ matched patchy areas of decreased ventilation + perfusion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 573,
            "markdown": "Cx: (1) Pneumothorax ( $\\leftarrow$ rupture of bulla / bleb) common + recurrent\n(2) Hemoptysis (parasitized bronchial arteries connect to pulmonary vessels resulting in AV fistulae)\n(3) Cor pulmonale\n(4) Hypertrophic pulmonary osteoarthropathy (rare)\n\nCause of death: massive mucous plugging (95\\%)\n$D D x$ : Immotile cilia syndrome (predominantly affecting middle lobe)\n$R x$ : (1) Intratracheal instillation of aerosolized adenoviral + liposomal vector-CFTR gene preparations\n(2) Lung transplant (using forced expiratory volume + body mass index as predictors of necessity)\n@ GI tract $(85-90 \\%)$\n\n- chronic obstipation, failure to thrive\n@ Esophagus\n$\\sqrt{ }$ gastroesophageal reflux $(21-39 \\%) \\leftarrow$ elevated abdominal pressures from chronic cough, hyperinflation, diaphragm depression, lower esophageal sphincter relaxation from long-term use of medication (eg, aminophylline):\n$\\checkmark$ esophagitis, reflux stricture, Barrett metaplasia\n@ Small bowel\n$\\checkmark$ thickened nodular gastric + duodenal mucosal folds $\\pm$ peptic ulcers $\\leftarrow$ unbuffered gastric acid, production of abnormal mucus, Brunner gland hypertrophy\n$\\checkmark$ mild generalized small bowel dilatation with diffuse distortion + thickening of mucosal folds (at times involving colon + rectum)\n$\\checkmark$ Crohn disease (increased frequency)\n$\\checkmark$ ileocecal intussusception (in 1\\%): often intermittent with spontaneous resolution / asymptomatic transient\nLead point: inspissated secretions, lymphoid tissue, chronically distended appendix\n@ Colon\n$\\checkmark$ meconium ileus ( $10-13-16 \\%$ at birth)\n$\\diamond$ Earliest clinical manifestation of cystic fibrosis!\n$\\checkmark$ meconium plug syndrome ( $25 \\%$, most common cause of colonic obstruction in the infant)\n$\\checkmark$ distal intestinal obstruction syndrome\n$\\checkmark$ proximal colonic wall thickening, pericolonic fat proliferation, mesenteric fat infiltration\n$\\checkmark$ large distended colon with mottled appearance (retained bulky dry stool) = acquired megacolon\n$\\checkmark$ \"microcolon\" = colon of normal length but diminished caliber\n$\\checkmark$ fibrosing colonopathy (in children) = stricture of right colon with longitudinal shortening $\\leftarrow$ submucosal fibrosis $\\leftarrow$ high-dose lipase supplementation\n$\\checkmark$ pneumatosis intestinalis of colon (5\\%) $\\leftarrow$ air block phenomenon of obstructive pulmonary disease:\n$\\checkmark$ cystic submucosal + subserosal foci of air lining up along dependent portion of bowel wall",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 574,
            "markdown": "$\\sqrt{ }$ \"jejunization of colon\" = coarse redundant hyperplastic colonic mucosa $\\leftarrow$ distended crypt goblet cells\n$\\sqrt{ }$ rectal prolapse between 6 months and 3 years (in 18-23\\%) $\\leftarrow$ frequent bulky stools and diminished muscle tone in undiagnosed patient\n@ Appendix\n$\\sqrt{ }$ chronically $>6 \\mathrm{~mm}$ distended appendix $\\leftarrow$ swollen appendix filled with inspissated secretions\n$\\checkmark$ acute appendicitis $(1-4 \\%)$\n$C x$ : gastrointestinal perforation with meconium peritonitis (in $50 \\%$ ), volvulus of dilated segments, bowel atresia, colon cancer (odds ratio $20 \\div 1$ )\n@ Liver (in up to $72 \\%$ of adult patients)\nPathophysiology:\nabsent / dysfunctional activity of CFTR protein $\\rightarrow$ impaired secretory function of biliary epithelium $\\rightarrow$ accumulation + precipitation of hyperviscous biliary secretions $\\rightarrow$ cholangiocyte injury $\\rightarrow$ hepatic parenchymal injury\n\n- asymptomatic / abnormal liver function tests\n$\\checkmark$ hepatic steatosis $(23-67 \\%) \\leftarrow$ untreated malabsorption, dietary deficiencies, hepatic dysfunction, medications (= initial manifestation in infants):\n$\\sqrt{ }$ diffuse / focal fatty infiltration\n$\\sqrt{ }$ multilobulated pseudomasses $=1-2 \\mathrm{~cm}$ lobulated fatty lesions with hyperechoic center surrounded by a hypoechoic ring $\\rightarrow$ heterogeneity of liver echotexture + irregularity of hepatic contour\n$\\checkmark$ diffuse increase in liver echogenicity + posterior acoustic attenuation + decreased depiction of vessel walls\n$\\checkmark$ diffuse low hepatic attenuation and prominent vessels\n$\\checkmark$ hepatic T1-hyperintensity + suppression on fat saturation\n$\\checkmark$ focal biliary cirrhosis $(40-78 \\%)$ :\n$\\checkmark$ focal portal fibrosis and cholestasis\n$\\checkmark>2 \\mathrm{~mm}$ thick hyperechoic periportal tissue\n$\\checkmark$ high signal intensity on T1WI\n$\\checkmark$ multilobular cirrhosis $(5-15 \\%) \\leftarrow$ inspissated bile:\n$=$ multiple regenerative nodules with diffuse involvement\n- signs of portal hypertension in multilobular form (clinically in $4-8 \\%$, autoptic in up to $50 \\%)$\nCx: dysplastic nodules, HCC\n$\\checkmark$ portal hypertension (in $1 \\%$ of biliary cirrhosis) + hepatosplenomegaly + hypersplenism\nMultilobular cirrhosis is the $3^{\\text {rd }}$ leading cause of death associated with CF (after cardiorespiratory + transplant complications) accounting for $2.5 \\%$ of overall mortality.\n@ Gallbladder\nHisto: mucus-containing cysts in gallbladder wall\n- symptoms of gallbladder disease (3.6\\%)\n$\\checkmark$ sludge (33\\%)\n$\\checkmark$ cholelithiasis (12-24\\%): mostly cholesterol stones $\\leftarrow$\n(a) interrupted enterohepatic circulation after ileal resection",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 575,
            "markdown": "(b) ileal dysfunction in distal intestinal obstruction syndrome\n$\\sqrt{ }$ gallbladder atony\n$\\sqrt{ }$ microgallbladder ( $4-45 \\%$ at autopsy) $\\leftarrow$ cystic duct atresia / stenosis $\\leftarrow$ inspissated material:\n$\\sqrt{ }$ false positive results in hepatobiliary scintigraphy\n$\\sqrt{ }$ gallbladder atrophy\n$\\sqrt{ }$ thickened trabeculated gallbladder wall $\\leftarrow$ cirrhosis, ascites, hypoalbuminemia, nutritional deficiencies\n$\\sqrt{ }$ subepithelial cysts of gallbladder wall\n@ Bile ducts\n\n- cholestasis $\\leftarrow$ CBD obstruction\n$\\sqrt{ }$ strictures + beading + dilatation of intra- and extrahepatic bile ducts similar to sclerosing cholangitis (in $50 \\%$ )\n$\\sqrt{ }$ choledocholithiasis + intrahepatic calculi\n$\\sqrt{ }$ sclerosing cholangitis\n$\\sqrt{ }$ hyperechoic periportal thickening $\\leftarrow$ fibrosis / focal fat\n$\\sqrt{ }$ ductal abnormalities at MRCP in $(65 \\%)$\n@ Pancreas\nThe pancreas is the most commonly involved abdominal organ in cystic fibrosis.\nPathophysiology:\ninspissated secretions in proximal pancreatic ducts $\\rightarrow$ luminal obstruction with increase in fluid pressure $\\rightarrow$ mild inflammatory reaction + acinar disruption $\\rightarrow$ widespread loss of acinar cells $\\rightarrow$ replacement with fibrous tissue + fat ( $=$ complete pancreatic atrophy / lipomatous pseudohypertrophy); increased pancreatic lobulation; recurrent acute and chronic pancreatitis $\\rightarrow$ diffuse fibrosis + with microcystic transformation\nHisto: progressive ductectasia $=$ dilatation of acini + ducts\nClassification of dysfunction:\n(1) Exocrine insufficiency ( $85-90 \\%$ ) $\\leftarrow$ fat malabsorption $\\leftarrow$ deficient pancreatic enzyme production $\\leftarrow$ duct obstruction $\\leftarrow$ inspissated secretions $\\leftarrow$ precipitation of relatively insoluble proteins ( $=$ protein plugs)\n- malnutrition, steatorrhea, fat intolerance, deficiency of fat-soluble vitamins\n\nThe degree of pancreatic fatty infiltration correlates with the severity of exocrine dysfunction. CF is the most common cause of exocrine pancreatic insufficiency in patients $<30$ years of age!\n(2) Endocrine gland dysfunction ( $30-50 \\%$ ) $\\leftarrow$ CF-related diabetes mellitus (unique combination of type 1 and 2$) \\leftarrow$ fibrosis and gland atrophy\n\n- abdominal pain, bloating, flatulence, failure to thrive\n- diabetes mellitus $\\leftarrow$ pancreatic fibrosis increasing with age (in $1 \\%$ of children $+13 \\%$ of adults):\n- glucose intolerance in $30-50 \\%$\n- $1-2 \\%$ require insulin therapy\n- acute ( $1.2 \\%$ ) by age 20 / recurrent acute ( $10 \\%$ ) pancreatitis\n$\\sqrt{ }$ partial (in $16 \\%$ ) / complete (in $42 \\%$ ) fatty replacement of pancreas by fibrofatty tissue by age 17 years:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 576,
            "markdown": "$\\sqrt{ }$ density of -90 to -120 HU on CT (in up to $93 \\%$ ) similar to retroperitoneal fat\n$\\checkmark$ generalized increased echogenicity $(70-100 \\%)$\n$\\checkmark$ loss of fine lobular pattern of pancreas on US\n$\\checkmark$ focal hypoechoic areas + cyst formation\n$\\checkmark$ variable T1 hyper- and hypointensity depending on proportion of fatty infiltration + fibrosis\n$\\checkmark$ lipomatous pseudohypertrophy of pancreas $=$ markedly enlarged pancreas $\\leftarrow$ complete fibrofatty replacement\n$\\checkmark$ diffuse pancreatic atrophy without fatty replacement (in $24 \\%$ )\n$\\checkmark$ periductal chronic calcific pancreatitis $(7 \\%)$\n$\\checkmark$ pancreatic duct strictures, beading, dilatation, obstruction\n$\\checkmark$ pancreatic cystosis (extremely rare) $=$ mostly $1-3-\\mathrm{mm}$ small cysts completely replacing pancreas, occasionally macroscopic cysts up to 12 cm in diameter\n\n- low levels of amylase + CEA in cyst fluid\n@ Kidney\n- immunoglobulin A nephropathy, amyloidosis\n- symptomatic renal stones ( $3-6 \\%$ vs. $2 \\%$ in general population)\n$\\checkmark$ nephrocalcinosis, nephrolithiasis (in $90 \\%$ at autopsy)\n@ Skull\n$\\checkmark$ sinusitis with opacification of well-developed maxillary, ethmoid, sphenoid sinuses\n$\\checkmark$ hypoplastic frontal sinuses\nOB-US:\n$\\checkmark$ hyperechogenic bowel (in up to $60-70 \\%$ of fetuses affected with cystic fibrosis)\nPrognosis: median survival of 41 years (2012); pulmonary Cx are the most predominant cause of morbidity and death $(90 \\%) ; 2.3$ deaths per 100 patients from cardiorespiratory causes $(78 \\%) /$ hepatic disease $(4 \\%)$\n\n\n# DIAPHRAGMATIC HERNIA \n\n## Congenital Diaphragmatic Hernia\n\n$=\\mathrm{CDH}=$ absence of closure of the pleuroperitoneal fold by $9^{\\text {th }}$ week of gestational age\nFrequency: $1 \\div 2,200-4,000$ livebirths $(0.04 \\%) ; \\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\n$\\diamond$ Most common intrathoracic fetal anomaly\n$\\diamond$ Delayed closure following group B streptococcal infection!\nEtiology:\n(1) Delayed fusion of diaphragm (spontaneous self-correction may occur) / premature return of bowel from its herniated position within the umbilical coelom\n(2) Insult that inhibits / delays normal migration of the gut + closure of the diaphragm between $8^{\\text {th }}$ and $12^{\\text {th }}$ week of embryogenesis\nClassification (Wiseman):\nI. herniation early during bronchial branching $\\rightarrow$ severe bilateral pulmonary hypoplasia; uniformly fatal\nII. herniation during distal bronchial branching $\\rightarrow$ unilateral pulmonary hypoplasia; survival possible\nIII. herniation late in pregnancy with compression of otherwise normal lung; excellent",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 577,
            "markdown": "prognosis\nIV. postnatal herniation with compression of otherwise normal lung; excellent prognosis\n\nAssociated anomalies in 20\\% of liveborn and in $90 \\%$ of stillborn fetuses:\n\n1. CNS ( $28 \\%$ ): neural tube defects, hydrocephalus\n2. Cardiovascular ( $9-23 \\%$ ): VSD, ASD, tetralogy of Fallot\n3. Gastrointestinal ( $20 \\%$ ): particularly malrotation, oral cleft, omphalocele, esophageal atresia\n4. Genitourinary ( $15 \\%$ ): cryptorchidism\n5. Chromosomal abnormalities ( $4 \\%$ ): trisomy $21,18,13$; tetrasomy 12 p\n6. Limb anomalies: polydactyly, syndactyly, reduction defects\n7. Spinal defects\n8. Genetic syndromes: Fryns, Lange, Marfan\n9. IUGR (with concurrent major abnormality in $90 \\%$ )\n\nLocation: $\\mathrm{L}+\\mathrm{R}=85 \\%+13 \\% ; 2 \\%$ bilateral\n$\\diamond$ Right-sided hernias are frequently fatal!\n\n- respiratory distress in neonatal period = life-threatening deficiency of small airways + alveoli; scaphoid abdomen\nHerniated organs:\nsmall bowel ( $90 \\%$ ), stomach ( $60 \\%$ ), large bowel ( $56 \\%$ ), spleen ( $54 \\%$ ), pancreas ( $24 \\%$ ), kidney ( $12 \\%$ ), adrenal gland, liver (major prognostic factor), gallbladder\n$\\checkmark$ bowel loops in chest\n$\\checkmark$ contralateral shift of mediastinum + heart\n$\\checkmark$ complete ( $1-2 \\%$ ) / partial absence of diaphragm\n$\\checkmark$ absence of stomach + small bowel in abdomen\n$\\checkmark$ passage of nasogastric tube under fluoroscopic control entering intrathoracic stomach\n$\\checkmark$ incomplete rotation + anomalous mesenteric attachment of bowel\nOB-US (diagnosis possible by 18 weeks GA):\n$\\checkmark$ solid / multicystic / complex chest mass\n$\\checkmark$ mediastinal shift\n$\\checkmark$ nonvisualization of fetal stomach below diaphragm\n$\\checkmark$ fetal stomach at level of fetal heart\n$\\checkmark$ peristalsis of bowel within fetal chest (inconsistent)\n$\\checkmark$ paradoxical motion of diaphragm with fetal breathing (defect in diaphragm sonographically not visible)\n$\\checkmark$ scaphoid fetal abdomen with reduced abdominal circumference\n$\\checkmark$ herniated liver frequently surrounded by ascites\n$\\checkmark$ polyhydramnios (common, due to partial esophageal obstruction or heart failure) / normal fluid volume / oligohydramnios\n$\\checkmark$ swallowed fetal intestinal contrast appears in chest (CT amniography confirms diagnosis)\n$\\checkmark$ fetal lung volume $<15-25 \\%$, decreased lung-head ratio\nOB-MR:\n$\\checkmark$ calculation of relative fetal lung volume:\n$<14.3 \\%=$ postnatal death, $>32.8 \\%=$ survival",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 578,
            "markdown": "$>44.0 \\%=\\mathrm{ECMO}$ not required\nCx: (1) Bilateral pulmonary hypoplasia\n(2) Persistent fetal circulation $\\rightarrow$ postsurgical pulmonary hypertension\n(3) PROM (47\\%), chorioamnionitis, premature labor\n\nPrognosis: (1) Stillbirth (35-50\\%)\n(2) Neonatal death (35\\%)\n$\\diamond$ Survival is determined by size of defect + time of entry + associated anomalies ( $34 \\%$ survival rate if isolated, $7 \\%$ with associated anomalies)\nIndicators of poor prognosis:\nlarge intrathoracic mass with marked mediastinal shift, IUGR, polyhydramnios, hydrops fetalis, detection $<25$ weeks MA, intrathoracic liver, dilated intrathoracic stomach, other malformations\nMortality: in $10 \\%$ death before surgery; $40-50 \\%$ operative mortality;\n(a) stomach intrathoracic vs. intraabdominal $=60 \\%$ vs. $6 \\%$\n(b) polyhydramnios vs. normal amniotic fluid $=89 \\%$ vs. $45 \\%$\n\nRx: Fetal endotracheal balloon occlusion (29-34 weeks)\n$D D x$ : bronchopulmonary foregut malformation, mediastinal cyst (bronchogenic, neurenteric, thymic), sequestration, congenital adenomatoid malformation, pulmonary agenesis / hypoplasia\n\n# Bochdalek Hernia (85-92\\%) \n\n[Vincent Alexander Bochdalek (1801-1883), professor of anatomy in Prague]\n= posterolateral hernia caused by maldevelopment of pleuroperitoneal folds / failure of fusion of folds and transverse septum with intercostal muscles\n$\\diamond 90 \\%$ of congenital diaphragmatic hernias; $\\mathrm{L}>\\mathrm{R}$\nAge: antenatal ultrasound @ 24 weeks GA; late presentation in $11 \\%$\nFrequency: $1 \\div 2,000-1 \\div 5,000$ live births\n\n- respiratory distress\n- asymptomatic with late presentation (in 11\\%)\n\nLocation: left (80\\%), right (15\\%), bilateral (3-5\\%)\nHerniated organs:\n(a) on left: omental fat (6\\%), bowel, spleen, left lobe of liver, stomach (rare), kidney, pancreas\n(b) on right: part of liver, gallbladder, small bowel, kidney\nmnemonic: 4 B's\nBochdalek\nBack (posterior location)\nBabies (age at presentation)\nBig (usually large)\n\n## Morgagni Hernia (9-12\\% of CDH)\n\n[Giovanni Battista Morgagni (1682-1771), professor of anatomy and theoretical medicine in Padua, Italy]\n$=$ anteromedial parasternal defect $=$ space of Larrey / foramen of Morgagni",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 579,
            "markdown": "$\\diamond<10 \\%$ of congenital diaphragmatic hernias\nCause: failure of fusion between septum transversum and lateral body wall where internal mammary artery crosses the diaphragm\nLocation: between sternum medially $+8^{\\text {th }}$ rib laterally; $\\mathrm{R}+\\mathrm{L}=9+1$ (mostly unilateral)\nTime of defect: between $3^{\\text {rd }}$ and $7^{\\text {th }}$ week of GA\nAge: children; incidental finding in adults\nFrequency: $1 \\div 4,800$ live births; $\\mathrm{M}>\\mathrm{F}$\nHerniated organs:\n(a) abdominal viscera: omentum, liver, transverse colon\n(b) heart may herniate into upper abdomen\n(c) fat may herniate into pericardial sac\n\nOften associated with:\ncongenital heart disease (component of pentalogy of Cantrell), pericardial deficiency, bowel malrotation, chromosomal abnormality (Down syndrome, Turner syndrome), mental retardation\nmnemonic: 4 M's\nMorgagni\nMiddle (anterior + central location)\nMature (tend to present in older children)\nMinuscule (usually small)\n\n- asymptomatic (majority), epigastric discomfort\n- chronic cough, choking, shortness of breath\n- respiratory distress, cyanosis (in neonates)\n- abdominal pain, nausea, vomiting\n$\\checkmark$ cardiophrenic angle mass\n$\\checkmark$ anteriorly located gas-filled loops of bowel on lateral chest x-ray (PATHOGNOMONIC)\n$C x$ : bowel incarceration + strangulation\n$D D x$ on $C X R$ : thymoma, teratoma, germ cell tumor, lymphoma, thyroid lesion, pericardial cyst, lymphangioma\n$D D x$ on CT: lipoma, liposarcoma (no omental vessels)\n\n\n# Septum Transversum Defect \n\n$=$ defect in central tendon\n\n## Hiatal Hernia (9\\% of CDH)\n\n$=$ congenitally large esophageal orifice with herniation of a portion of the stomach into mediastinum\n\n## Eventration (5\\%)\n\n$=$ congenital thinning of diaphragmatic muscle that causes an abnormal elevation of part (= focal bulge) / entire otherwise intact hemidiaphragm into chest cavity $\\rightarrow$ upward displacement of abdominal contents\nCause: ? congenitally thinned hypoplastic / absent muscle fibers consisting only of pleura + peritoneum; focal dyskinesia; neuromuscular dysfunction; weakness from ischemia / infarct",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 580,
            "markdown": "Unilateral eventration may be associated with:\nBeckwith-Wiedemann syndrome, trisomy 13, 15, 18\nBilateral eventration may be associated with:\ntoxoplasmosis, CMV, arthrogryposis\nLocation: $\\mathrm{R} \\div \\mathrm{L}=5 \\div 1$; anteromedial on right; complete involvement on left $(\\mathrm{M}>\\mathrm{F})$\n$\\sqrt{ }$ small diaphragmatic excursions\n$\\sqrt{ }$ often lobulated diaphragmatic contour\nDDx for right anteromedial eventration:\nMorgagni hernia, paraesophageal hernia, pericardial cyst, bronchogenic cyst, tumor\n$D D x$ for complete eventration: diaphragmatic paralysis\n\n# Traumatic Diaphragmatic Hernia \n\n$=$ DIAPHRAGMATIC RUPTURE = DIAPHRAGMATIC INJURY\nPrevalence: $0.8-8 \\%$ in blunt trauma patients; $5 \\%$ of all diaphragmatic hernias, but $90 \\%$ of all strangulated diaphragmatic hernias\nEtiology of traumatic rupture of diaphragm:\n(a) blunt trauma $(5-50 \\%) \\leftarrow$ sudden increase in intraabdominal / intrathoracic pressure against a fixed diaphragm: motor vehicle accident ( $>90 \\%$ ), fall from height, bout of hyperemesis; $\\mathrm{L} \\div \\mathrm{R}=3 \\div 1$, bilateral rupture in $<3.6 \\%$\n$\\diamond 7-66 \\%$ undiagnosed at initial presentation!\n(b) penetrating trauma ( $50 \\%$ ): bullet $>$ knife, repair of hiatus hernia\n$\\diamond 1-4 \\mathrm{~cm}$ in length; often only detected at surgery\n\n- may be asymptomatic for months / years following trauma, onset of symptoms may be so long delayed that traumatic event is forgotten\n- virtually all become ultimately symptomatic, $80 \\%$ in $<3$ years\n- Bergqvist triad:\n(1) Rib fractures\n(2) Fracture of spine / pelvis\n(3) Traumatic rupture of diaphragm\n\nLocation: 77-90-98\\% on left side; right hemidiaphragm has greater strength and is relatively protected by liver; $\\mathrm{L} \\div \\mathrm{R}=1.5 \\div 1$ to $7 \\div 1$\nSite: posterolateral central portion medial to spleen / medial central tendon with intrapericardial hernia (3.4\\%) / sites of attachments of diaphragm / esophageal hiatus (rare)\nSize: most tears are $>10 \\mathrm{~cm}$ in length\nHerniation of organs (32-58\\%) in order of frequency:\n(a) right: liver, small bowel, large bowel\n(b) left: stomach, colon, spleen, omentum, small bowel, kidney, pancreas\n\nCXR:\n$\\diamond$ The first posttraumatic CXR is abnormal in $46-77 \\%$ but nonspecific!\n$\\diamond$ Positive intrathoracic pressure from ventilation may delay herniation!\n$\\diamond$ Serial CXRs may show progressive changes!\n$\\sqrt{ }$ nonvisualization (loss) of diaphragmatic contour\n$\\sqrt{ }$ elevated asymmetric / irregular contour of hemidiaphragm $>4-6 \\mathrm{~cm}$ above level of contralateral hemidiaphragm + contralateral shift of mediastinum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 581,
            "markdown": "Cave: cephalad margin of bowel may simulate an elevated diaphragm (look for haustra)\n$\\sqrt{ }$ herniation of air-filled viscus: stomach, colon\n$\\sqrt{ }$ shift of mediastinum + lung to opposite side\n$\\sqrt{ }$ lower lobe mass / consolidation (herniated solid organ / omentum / airless bowel loop)\n$\\sqrt{ }$ inhomogeneous mass with air-fluid level in left hemithorax\n$\\sqrt{ }$ mushroomlike mass of herniated liver in right hemithorax\n$\\sqrt{ }$ hydrothorax / hemothorax suggests strangulation\n$\\sqrt{ }$ \"collar\" sign = hourglass constriction of afferent + efferent bowel loops at orifice\n$\\sqrt{ }$ multiple fractures of lower ribs + spine\n$\\sqrt{ }$ abnormal U-shaped course of nasogastric tube above suspected level of hemidiaphragm\nN.B.: tube first dips below diaphragm (rent spares esophageal hiatus with gastroesophageal junction remaining in its normal position)\n$\\sqrt{ }$ location of diaphragm may be documented by\n\n1. Gas-filled bowel constricted at site of diaphragmatic laceration\n2. Barium study\n\nCT ( $71 \\%$ sensitive, $100 \\%$ specific, $70 \\%$ accurate for right side; $80-87 \\%$ sensitive, $100 \\%$ specific, $88 \\%$ accurate for left side):\n$\\diamond$ Best detected on reformatted SAG + COR images!\nAssociated with: abdominal + pelvic injury in $90-94 \\%$\n(a) direct signs:\n$\\sqrt{ }$ segmental diaphragmatic defect $=$ abrupt discontinuity of hemidiaphragm (73-82\\%)\n$\\sqrt{ }$ \"absent diaphragm\" sign = failure to see diaphragm\n$\\sqrt{ }$ \"dangling diaphragm\" sign = free edge of injured diaphragm curls inwards + away from chest wall\n$\\sqrt{ }$ \"curled diaphragm\" sign = irregularity + thickening of diaphragmatic leaflet $\\leftarrow$ contracted torn muscle\n$\\sqrt{ }$ contiguous (= transdiaphragmatic) injury on either side of diaphragm in case of penetrating trauma\n$\\sqrt{ }$ wound trajectory crossing diaphragm\n(b) indirect signs:\n$\\sqrt{ }$ intrathoracic herniation of omentum / bowel / abdominal organs (55\\%)\n$\\sqrt{ }$ visualization of peritoneal fat / abdominal viscera lateral to lung or diaphragm / posterior to crus of hemidiaphragm\n$\\sqrt{ }$ \"collar\" sign = waistlike constriction of viscera at level of diaphragmatic rent $(27 \\%)$ :\n$\\sqrt{ }$ \"hump\" sign = rounded portion of superior liver protrudes through diaphragmatic rent\n$\\sqrt{ }$ \"band\" sign = linear area of hypoattenuation at level of torn free edge of diaphragm causing linear indentation of herniated liver edge\n$\\sqrt{ }$ \"dependent viscera\" sign = abdominal viscera (bowel loops / stomach) no longer supported posteriorly by torn diaphragm fall dependently against posterior chest wall\n$\\sqrt{ }$ \"sinus cutoff\" sign = herniated abdominal content prevents expected layering of pleural fluid",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 582,
            "markdown": "$\\sqrt{ }$ abdominal organ / fatty tissue peripheral to diaphragm / posterior to crura\n$\\sqrt{ }$ elevated / cephalad displacement of abdominal organs: hemidiaphragmatic elevation by $>5 \\mathrm{~cm}(\\mathrm{RT})$ and $>4 \\mathrm{~cm}(\\mathrm{LT})$\n$\\sqrt{ }$ concurrent pneumothorax, pneumoperitoneum, hemothorax, hemoperitoneum MR:\n$\\sqrt{ }$ interruption of hypointense band of diaphragmatic muscle outlined by hyperintense abdominal + mediastinal fat\nAssociated injuries (in 44-81-100\\%):\n$\\sqrt{ }$ head injury\n$\\sqrt{ }$ fractures of lower ribs / pelvis ( $42 \\%$ )\n$\\sqrt{ }$ intraabdominal injuries ( $72 \\%$ ):\n$\\checkmark$ perforation of hollow viscus\n$\\checkmark$ rupture of spleen / kidney\nReasons for diagnostic misses:\n(1) Left-sided defect covered by omentum\n(2) Right-sided defect sealed by liver\n(3) Positive pressure ventilation\n(4) Associated injuries mask tear: atelectasis, pleural effusion, lung contusion, phrenic nerve paralysis\n$C x$ : (1) Incarceration of herniated organs\n(2) Life-threatening strangulation of bowel / stomach occurs in majority\n$\\diamond 90 \\%$ of strangulated hernias are posttraumatic!\n(3) Bowel perforation\n\nPrognosis: 30\\% mortality in unrecognized cases\n$D D x$ : congenital hernia, acquired defect $=$ fenestration, diaphragmatic eventration, diaphragmatic paralysis, hiatal hernia, congenital Bochdalek hernia (6-11\\%)\n\n# DIAPHRAGMATIC PARALYSIS \n\n$=$ absent orthograde diaphragmatic excursion on quiet deep breathing with paradoxical motion on sniffing\nDiaphragmatic weakness $=$ reduced $/$ delayed orthograde excursion on deep breathing $\\pm$ paradoxical motion on sniffing\n\n## Cause:\n\n(1) Phrenic nerve injury during birth trauma / cardiac surgery / resection of thoracic tumors\n(2) Infection: West Nile virus, Lyme disease\n(3) Tumor of mediastinum / neck\n\n- difficulty in weaning from mechanical ventilation, ventilatory failure (common)\n- respiratory distress, tachypnea, increased oxygen requirements\n> Static imaging:\n$\\checkmark$ elevation of one hemidiaphragm on CXR (not sensitive or specific)\n> Functional imaging (= evaluation of diaphragmatic motion):\nFluoroscopy:\n$\\checkmark$ evaluate comparative movement of domes, excursion of individual dome, and shift of mediastinum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 583,
            "markdown": "$\\sqrt{ }$ sniff test:\n$\\checkmark$ both normal hemidiaphragms move downward\n$\\checkmark$ reduced excursion of weakened hemidiaphragm\n$\\checkmark$ absent / paradoxical motion (= elevation during inspiration and vice versa) of paralyzed hemidiaphragm\nM-mode US (SAG view, transducer position anteriorly, ventilator temporarily disconnected):\n$\\diamond$ US has replaced fluoroscopy in children!\n$\\checkmark$ diaphragm moves toward transducer during inspiration by $<4 \\mathrm{~mm}$\n$\\checkmark>50 \\%$ difference in excursion between domes\nCx: pneumonia, atelectasis, pulmonary collapse\n\n# DIFFUSE PULMONARY LYMPHANGIOMATOSIS \n\n$=$ rare condition consisting of proliferation + dilatation of communicating lymphatic channels in pleura + interlobular septa + mediastinum\nCause: congenital developmental abnormality of lymphatic channels\nAge: teenager, young adult\nPath: resembles lymphangioma\n\n- progressive dyspnea $\\rightarrow$ pulmonary failure\n\nLocation: predominantly upper lobes of lung\nCT:\n$\\checkmark$ smooth symmetric thickening of interlobular septa + peribronchovascular bundles\n$\\checkmark$ diffuse increased attenuation of mediastinal fat\n$\\checkmark$ mild perihilar infiltration\n$\\checkmark$ diffuse pleural thickening\n$\\checkmark$ pleural effusion\n$\\checkmark$ pericardial effusion\n$D x$ : biopsy; findings persist under diuretic therapy\n\n## DROWNED LUNG\n\n$=$ abnormal increase in lobar / rarely whole lung volume\nPathophysiology: bronchial obstruction $\\rightarrow$ acute collapse of airspaces $\\rightarrow$ rapid filling of alveoli + bronchi with secretions / fluid\nCause: bronchogenic carcinoma, carcinoid, foreign body, mucus plug\n\n- bronchial obstruction that persists beyond 3-4 weeks\n$\\checkmark$ bulging interlobar fissure\n$\\checkmark$ little / no mediastinal shift to contralateral side\n$\\checkmark$ obliteration of bronchial lumen leading to obstructed lobe",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 584,
            "markdown": "![img-62.jpeg](img-62.jpeg)\n$\\sqrt{ }$ absence of air bronchogram\n$\\sqrt{ }$ hilar mass + regional lymphadenopathy\nCT:\n$\\sqrt{ }$ postobstructive consolidation\n$\\sqrt{ }$ mucus bronchogram $=$ bronchi filled with low-attenuation material\nCECT:\n$\\sqrt{ }$ delineates enhancing tumor + lymph nodes from consolidated lung of low attenuation (= drowned lung)\nMR:\n$\\sqrt{ }$ T2WI differentiates drowned lung from obstructing tumor\nPET:\n$\\sqrt{ }$ high tumor activity centrally\n$C x$ : necrosis, cavitation, secondary infection\n$D D x$ : resorptive atelectasis, obstructive pneumonitis, endogenous \"golden\" lipoid pneumonia, Gram-negative pneumonia, large pleural effusion (marked mediastinal shift to contralateral side), unilateral veno-occlusive disease, unilateral aspiration\n\n# EMPHYSEMA \n\n= group of pulmonary diseases characterized by permanently enlarged air spaces distal to terminal bronchioles accompanied by destruction of alveolar walls + local elastic fiber network\n$\\diamond$ The clinical term \"chronic obstructive pulmonary disease (COPD)\" should not be used in image interpretation! It encompasses: asthma, chronic bronchitis, emphysema!\nPrevalence: 12.7 million people in USA (2002)\nCause: imbalance in elastase-antielastase system $\\leftarrow$ increase in elastase activity in smokers / $\\alpha 1$-antiprotease deficiency (causing proteolytic destruction of elastin resulting in alveolar wall destruction)\n\n- irreversible expiratory airflow obstruction $\\leftarrow$ decreased elastic recoil from parenchymal destruction; dyspnea on exertion\n- decreased carbon monoxide diffusing capacity\n\nCXR (moderately sensitive, highly specific):\n$\\sqrt{ }$ hyperinflated lung (most reliable sign):",
            "images": [
                {
                    "id": "img-62.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 187,
                    "bottom_right_x": 1319,
                    "bottom_right_y": 635,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 585,
            "markdown": "$\\sqrt{ }$ low hemidiaphragm (= at / below $7^{\\text {th }}$ anterior rib)\n$\\sqrt{ }$ flat hemidiaphragm ( $=<1.5 \\mathrm{~cm}$ distance between line connecting the costo- and cardiophrenic angles + top of midhemidiaphragm)\n$\\sqrt{ }$ retrosternal air space $>2.5 \\mathrm{~cm}$\n$\\sqrt{ }$ \"barrel chest\" = enlarged anteroposterior chest diameter\n$\\sqrt{ }$ saber-sheath trachea\n$\\sqrt{ }$ pulmonary vascular pruning + distortion ( $\\pm$ pulmonary arterial hypertension)\n$\\sqrt{ }$ right-heart enlargement\n$\\sqrt{ }$ bullae\nHRCT:\n$\\sqrt{ }$ well-defined areas of abnormally decreased attenuation without definable wall ( $<-910$ $\\mathrm{HU})$\n$\\diamond$ Centrilobular + panacinar forms of emphysematous lung destruction tend to coexist!\n$R x:$ lung volume reduction surgery\n\n# Centrilobular Emphysema \n\n$=$ CENTRIACINAR EMPHYSEMA = PROXIMAL ACINAR EMPHYSEMA\n$=$ emphysematous change selectively affecting the acinus at the level of $1^{\\text {st }}+2^{\\text {nd }}$ generations of respiratory bronchioles (most common form)\nPath: normal + emphysematous alveolar spaces adjacent to each other\nHisto: enlargement of respiratory bronchioles + destruction of centrilobular alveolar septa in the center of the secondary pulmonary lobule; CHARACTERISTICALLY surrounded by normal lung; distal alveoli spared; severity of destruction varies from lobule to lobule\nPredisposed: smokers (in up to 50\\%), coal workers\nCause: excess protease with smoking (elastase is contained in neutrophils + macrophages found in abundance in lung of smokers)\n\n- blue bloater\n\nSite: apical and posterior segments of upper lobe + superior segment of lower lobe (relatively greater ventilation-perfusion ratio in upper lobes favors deposition of particulate matter and release of elastase in upper lungs)\nCXR ( $80 \\%$ sensitivity for moderate / severe stages):\n$\\sqrt{ }$ irregular scattered area of radiolucency (best appreciated if lung opacified by edema / pneumonia / hemorrhage) = area of bullae, arterial depletion + increased markings\n$\\sqrt{ }$ hyperinflated lung\nHRCT:\n$\\sqrt{ }$ \"emphysematous spaces\" (= focal round area of air attenuation) $>1 \\mathrm{~cm}$ in diameter with central dot / line $=$ centrilobular location (representing the centrilobular artery of secondary pulmonary lobule) without definable wall and surrounded by normal lung\n$\\sqrt{ }$ pulmonary vascular distortion + pruning with lack of juxtaposition of normal lung (advanced stage)\n\n## Panacinar Emphysema\n\n$=$ PANLOBULAR EMPHYSEMA = DIFFUSE EMPHYSEMA = GENERALIZED EMPHYSEMA\n$=$ emphysematous change involving the entire acinus\n$=$ uniform nonselective destruction of all air spaces throughout both lungs (rare)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 586,
            "markdown": "Path: uniform enlargement of acini from respiratory bronchioles to terminal alveoli (from center to periphery of secondary pulmonary lobule) $\\leftarrow$ destruction of lung distal to terminal bronchiole\nCause: autosomal recessive a-1 antitrypsin deficiency in 10-15\\% (proteolytic enzymes carried by leukocytes in blood gradually destroy lung unless inactivated by a-1 protease inhibitor)\nAge: $\\quad 6^{\\text {th }}-7^{\\text {th }}$ decade ( $3^{\\text {rd }}-4^{\\text {th }}$ decade in smokers)\n\n- pink puffer\n\nSite: affects whole lung, but more severe at lung bases $\\leftarrow$ greater blood flow\nCXR:\n$\\checkmark$ hyperinflated lung\n$\\checkmark$ decreased pulmonary vascular markings\n$\\checkmark$ lung destruction extremely uniform\nHRCT:\n$\\sqrt{ }$ diffuse simplification of lung architecture with pulmonary septal and vascular distortion + pruning (difficult to detect early, ie, prior to considerable lung destruction for lack of adjacent normal lung)\n$\\checkmark$ paucity of vessels\n$\\checkmark$ bullae\n![img-63.jpeg](img-63.jpeg)\n\n# Paracicatricial Emphysema \n\n$=$ PERIFOCAL/IRREGULAR EMPHYSEMA\n$=$ airspace enlargement + lung destruction developing adjacent to areas of pulmonary scarring Usual cause: granulomatous inflammation, organized pneumonia, pulmonary infarction\nPath: no consistent relationship to any portion of secondary lobule / acinus; frequently associated with bronchiolectasis producing honeycomb lung\n\n- little functional significance\n\nCXR (rarely detectable):\n$\\checkmark$ fine curvilinear reticular opacities + interposed radiolucent areas\nHRCT:\n$\\checkmark$ low-attenuation areas adjacent to areas of fibrosis (diagnosable only in the absence of other forms of emphysema)",
            "images": [
                {
                    "id": "img-63.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 979,
                    "bottom_right_x": 1319,
                    "bottom_right_y": 1463,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 587,
            "markdown": "# Paraseptal Emphysema \n\n$=$ DISTAL ACINAR / LOCALIZED / LINEAR EMPHYSEMA\n$=$ focal subpleural enlargement + destruction of air spaces in one site of otherwise normal lung\nPath: predominant involvement of alveolar ducts + sacs\nSite: characteristically within subpleural lung and adjacent to interlobular septa + vessels\nCXR:\n$\\checkmark$ area of lucency, frequently sharply demarcated from normal lung\n$\\checkmark$ bands of radiopacity (residual vessels / interstitium) may be present\nHRCT:\n$\\checkmark$ peripheral low-attenuation area with remainder of lung normal\n$C x$ : spontaneous pneumothorax; bullae formation\n\n## EMPYEMA\n\n$=$ parapneumonic effusion characterized by presence of pus $\\pm$ positive culture\nOrganism: S. aureus, Gram-negative + anaerobic bacteria\n\n- positive Gram stain\n- positive culture (anaerobic bacteria most frequent)\n\n\n## Stage:\n\nI Exudative phase $=$ inflammation of visceral pleura results in increased capillary permeability with weeping of proteinaceous fluid into pleural space $=$ sterile exudate\n\n- $\\mathrm{pH}>7.20$\n- glucose $>40 \\mathrm{mg} / \\mathrm{dL}(2.2 \\mathrm{mmol} / \\mathrm{L})$\n- $\\mathrm{LDH}<1,000 \\mathrm{IU} / \\mathrm{L}$\n\nII Fibrinopurulent phase $=$ accumulation of inflammatory cells and neutrophils within pleural space + fibrin deposition on pleural surfaces\n> early stage II empyema\n\n- WBCs $>5 \\times 109 / \\mathrm{mm}^{3}$, but no gross pus\n- pH between 7.0 and 7.2\n- glucose level $>40 \\mathrm{mg} / \\mathrm{dL}$\n- $\\mathrm{LDH}<1,000 \\mathrm{IU} / \\mathrm{L}$\n> late stage II empyema\n- gross pus (WBC $>15,000 / \\mathrm{cm}^{3}$ ) = frank pus\n- $\\mathrm{pH}<7.0$\n- glucose level $<\\mathbf{4 0} \\mathbf{~ m g} / \\mathbf{d L}$\n- $\\mathrm{LDH}>\\mathbf{1 , 0 0 0} \\mathbf{I U} / \\mathbf{L}$\n$C x$ : multiloculation\n$R x$ : chest tube drainage\nIII Organizing phase $=$ recruitment of fibroblasts + capillaries results in deposition of collagen and granulation tissue on pleural surfaces $=$ pleural fibrosis $=$ \"pleural peel / pleural rind\"\n$C x$ : limited expansion of lung\n$R x$ : decortication (with persistent sepsis despite appropriate antibiotic Rx + drainage / persistent thick pleural rind trapping underlying lung)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 588,
            "markdown": "CT:\n$\\sqrt{ }$ thickening of parietal pleura in $60 \\%$ on NECT, in $86 \\%$ on CECT\n$\\sqrt{ }$ increased thickness + density of paraspinal subcostal tissue (= inflammation of extrapleural fat)\n$\\sqrt{ }$ curvilinear enhancement of chest wall boundary in $96 \\%$ (= inflammatory hyperemia of pleura)\n$\\sqrt{ }$ \"split pleura\" sign = pleural fluid between enhancing thickened parietal + visceral pleura\n$\\sqrt{ }$ gas bubbles in pleural space (gas-forming organism / bronchopleural fistula)\n$D D x:$ simple / complicated parapneumonic effusion (negative Gram + culture stain), malignant effusion after sclerotherapy, malignant invasion of chest wall, mesothelioma, pleural tuberculosis, reactive mesothelial hyperplasia, pleural effusion of rheumatoid disease\n\n# ENDOBRONCHIAL LIPOMA \n\nPrevalence: $0.1-0.5 \\%$ of lung tumors\nAge: middle-aged men\n\n- cough, hemoptysis, fever, dyspnea\n\nLocation: usually segmental bronchus\n$\\sqrt{ }$ atelectasis, consolidation, or both\n$\\sqrt{ }$ mass or nodule:\n$\\sqrt{ }$ homogeneous fatty mass without enhancement is DIAGNOSTIC (may not be large enough to characterize)\n$\\sqrt{ }$ high SI on T1WI + intermediate SI on T2WI\n\n## EOSINOPHILIC PNEUMONIA\n\n$=$ PULMONARY INFILTRATION WITH BLOOD / TISSUE EOSINOPHILIA (PIE)\nClassification:\nA. IDIOPATHIC EOSINOPHILIC LUNG DISEASE\n$=$ eosinophilic lung disease of unknown cause\n\n1. Simple Pulmonary Eosinophilia\n2. Acute eosinophilic pneumonia\n3. Chronic eosinophilic pneumonia\n4. Idiopathic hypereosinophilic syndrome\nB. EOSINOPHILIC LUNG DISEASE OF SPECIFIC ETIOLOGY\n$=$ eosinophilic lung disease of known cause\n(a) drug induced:\nnitrofurantoin, penicillin, sulfonamides, ASA, tricyclic antidepressants, hydrochlorothiazide, cromolyn sodium, mephenesin\n5. Toxic-oil syndrome\n$=$ oral ingestion of food-grade rapseed oil contaminated with aniline derivatives\n6. Eosinophilia-myalgia syndrome\n$=$ ingestion of L-tryptophan\n7. Toxic epidermal necrolysis\n8. Drug rash with eosinophilia and systemic symptoms (DRESS)\n$\\sqrt{ }$ nonspecific peripheral airspace consolidation with ground-glass-opacity",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 589,
            "markdown": "$\\sqrt{ }$ reticulonodular densities\n$\\sqrt{ }$ hilar adenopathy\n$\\sqrt{ }$ pleural effusion\n(b) parasite induced:\ntropical eosinophilia (ascariasis, schistosomiasis), strongyloidiasis, ancylostomiasis (hookworm), filariasis, Toxocara canis (visceral larva migrans), Dirofilaria immitis, amebiasis (occasionally - in RLL + RML), clonorchis infestation\n\n- peripheral blood eosinophil counts $>3000 / \\mathrm{mL}$\n- average BAL fluid eosinophilia of $50 \\%$\n(c) fungus induced:\n\n1. Allergic bronchopulmonary aspergillosis\n$\\sqrt{ }$ bronchiectasis $\\pm$ mucoid impaction in central upper lungs\n2. Bronchocentric granulomatosis\n$\\checkmark$ nonspecific focal mass / lobular consolidation with atelectasis\n(d) Pulmonary eosinophilia with asthma\nC. EOSINOPHILIC LUNG DISEASE ASSOCIATED WITH ANGIITIS $\\pm$ GRANULOMATOSIS\n$=$ eosinophilic vasculitis\n3. Allergic angiitis\n4. Churg-Strauss syndrome\n$\\checkmark$ subpleural consolidation in a lobular distribution\n$\\checkmark$ centrilobular nodules\n5. Wegener granulomatosis\n6. Lymphomatoid granulomatosis\n7. Necrotizing sarcoid granulomatosis\n8. Polyarteritis nodosa\n9. Rheumatoid disease\n10. Scleroderma\n11. Dermatomyositis\n12. Sjögren syndrome\n13. CREST\n\nMaybe associated with: rheumatoid arthritis\n$\\mathrm{M} \\pm \\mathrm{F}=1 \\div 2$\n$\\checkmark$ pulmonary opacities\n\n- pulmonary eosinophilia (regardless of eosinophilia in peripheral blood / in bronchoalveolar lavage)\n\n\n# Simple Pulmonary Eosinophilia \n\n$=$ TRANSIENT PULMONARY EOSINOPHILIA = LÖFFLER SYNDROME\n[Wilhelm Löffler (1887-1972), extraordinary professor of medicine at the University of Zurich, Switzerland]\n$=$ benign disorder of unknown etiology characterized by local areas of transient parenchymal consolidation associated with blood eosinophilia\nCause: unknown (in $1 / 3$ ); parasites, drug reaction, allergic bronchopulmonary aspergillosis (in some)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 590,
            "markdown": "Path: interstitial + alveolar edema containing a large number of eosinophils\n\n- no / mild symptoms, history of asthma + atopy (common)\n- high WBC + peripheral eosinophilia\n\nCXR:\n$\\checkmark$ peripheral patchy migratory / fleeting (= transient and shifting) noncavitary pleural-based pulmonary infiltrates changing within one to several days\n$\\sqrt{ }$ NO associated lymphadenopathy, NO pleural effusion\nLocation: mainly middle and upper lobes\nDistribution: uni- or bilateral, nonsegmental distribution, predominantly in lung periphery\nHRCT:\n$\\checkmark$ peripheral ground-glass and/or airspace consolidation with upper and middle lobe predominance\n$\\checkmark$ solitary / multiple pulmonary nodular opacities with surrounding ground-glass halo (rare)\nPrognosis: typically spontaneous resolution within 1 month\n$D D x$ : cryptogenic organizing pneumonia, pulmonary hemorrhage, multifocal pneumonia, atypical infection\n\n# Acute Eosinophilic Pneumonia \n\nEtiology: idiopathic (no evidence of infection / exposure to potential antigens) with abrupt increase in lung cytokines; strong association with cigarette smoking\nAge: $\\quad 32 \\pm 17$ years; $\\mathrm{M}>\\mathrm{F}$\nHisto: eosinophilic infiltrates + pulmonary edema $\\leftarrow$ release of eosinophilic granules altering vascular permeability\n\n- acute febrile illness peaking in 1-5 days, myalgia, chest pain\n- acute life-threatening respiratory failure within a few hours in previously healthy individuals\n- restrictive pulmonary function\n- DIAGNOSTIC markedly elevated levels of eosinophils of $>25 \\%$ in bronchoalveolar lavage (BAL) fluid\n- no peripheral eosinophilia\n$\\checkmark$ diffuse bilateral reticular opacities mimicking pulmonary interstitial edema\n$\\checkmark$ peripheral air space opacities (rare)\nHRCT:\n$\\checkmark$ bilateral patchy areas of ground-glass opacities\n$\\checkmark$ smooth interlobular septal thickening (frequent)\n$\\checkmark$ crazy-paving pattern (= ground-glass attenuation with intralobular reticular opacities)\n$\\checkmark$ small pleural effusion\nuncommon:\n$\\checkmark$ poorly defined centrilobular nodules\n$\\checkmark$ airspace consolidation\n$\\checkmark$ thickening of bronchovascular bundle\n$\\checkmark$ enlarged lymph nodes\n$R x:$ IV corticosteroids\nPrognosis: prompt + complete response to steroids; no relapse after discontinuation of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 591,
            "markdown": "# steroids \n\n$D D x$ : hydrostatic pulmonary edema (cardiomegaly), ARDS, acute interstitial pneumonia, atypical bacterial / viral pneumonia\n\n## Chronic Eosinophilic Pneumonia\n\nEtiology: unknown (NO underlying cause like parasites)\nHisto: accumulation of numerous eosinophils, macrophages, histiocytes, lymphocytes, PMNs within lung interstitium + alveolar sacs with interstitial fibrosis\nAge: middle age; $\\mathrm{M}<\\mathrm{F}$\n\n- insidious onset of fever, malaise, cough, chest pain, dyspnea develops over 4-8 months (DDx to Löffler syndrome)\n- common history of atopy in $\\sim 50 \\%$ (may occur during therapeutic desensitization procedure)\n- history of allergic rhinitis\n- adult-onset asthma (wheezing) in $50 \\%$\n- usually mild / moderate peripheral blood eosinophilia (with rare exceptions) of $>1000 / \\mu \\mathrm{L}$\n- increased serum IgE levels (in up to $75 \\%$ )\n- $>25 \\%$ (usually $>40 \\%$ ) of eosinophils in BAL fluid\n- restrictive / obstructive (asthma) pulmonary function\n$\\sqrt{ }$ (CLASSIC) homogeneous peripheral airspace consolidation:\n$\\sqrt{ }$ frequently multifocal bilateral $>$ unilateral nonsegmental with predilection for upper lung zones\n$\\sqrt{ }$ CHARACTERISTIC photographic negative of pulmonary edema (in $25-34 \\%$ )\n$\\sqrt{ }$ unchanged for many days to weeks (DDx to Löffler syndrome)\n$\\sqrt{ }$ fast regression of infiltrates under steroids\nCT:\n$\\sqrt{ }$ patchy consolidation / nodules with peripheral and upper lobe predominance\n$\\sqrt{ }$ ground-glass opacities with crazy paving\n$\\sqrt{ }$ subpleural reticulations (less common early, but frequent in later stages of disease)\n$\\sqrt{ }$ linear bandlike opacities parallel to pleural surface ( $>2$ months after onset of symptoms)\n$\\sqrt{ }$ pleural effusion (in $<10 \\%$ )\nPrognosis: chronic and progressive clinical features\n$R x$ : dramatic response to steroid therapy (within 3-10 days)\n$D D x$ : 1. Churg-Strauss syndrome (lobular distribution of peripheral consolidation, centrilobular nodules within ground-glass opacities)\n\n2. Löffler syndrome (shifting and transient pulmonary opacities in identical distribution)\n3. Cryptogenic organizing pneumonia\n\n## Idiopathic Hypereosinophilic Syndrome\n\n$=$ rare disorder characterized by overproduction of eosinophils ( $=$ primary hypereosinophilia) that eventually leads to organ injury\nAge: $\\quad 3^{\\text {rd }}-4^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=7 \\div 1$\nHisto: striking eosinophilic infiltration of involved organs associated with necrosis Diagnostic criteria:\n(1) Persistent eosinophilia of $>500$ eosinophils $/ \\mathrm{mm}^{3}$ for more than 6 months",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 592,
            "markdown": "(2) Absence of known causes of eosinophilia\n(3) Evidence of eosinophil-mediated end organ damage (heart, CNS) with multiorgan system dysfunction\n@ Heart\n\n- restrictive cardiomyopathy\n$\\checkmark$ endocardial fibrosis\n$\\checkmark$ valvular damage ( $=$ mitral + tricuspid insufficiency)\n$\\checkmark$ formation of mural cardiac thrombus\n@ Lungs (involved in 40\\%)\n- BAL fluid eosinophilia (as high as $73 \\%$ )\n$\\checkmark$ congestive heart failure with pulmonary edema\n$\\checkmark$ nonspecific focal / diffuse interstitial or alveolar nonlobar opacities\n$\\checkmark$ occasionally peripheral pulmonary opacities\n$\\checkmark$ pleural effusion (in 50\\%)\nCT:\n$\\checkmark$ nodules $\\pm$ surrounding ground-glass opacities\n$\\checkmark$ focal / diffuse areas of ground-glass opacities in a patchy + peripheral distribution\n$\\checkmark$ interlobular septal thickening\n@ CNS\n$\\checkmark$ peripheral neuropathy + encephalopathy\n@ Skin\n- urticaria, angioedema\n$D D x$ : (1) Churg-Strauss syndrome (vasculitis)\n(2) Eosinophilic leukemia (immature eosinophils)\n\n\n# ERDHEIM-CHESTER DISEASE \n\n$=$ LIPOID GRANULOMATOSIS = POLYOSTOTIC SCLEROSING HISTIOCYTOSIS\n[Jakob Erdheim (1874-1937), chief of the pathological-anatomical institute of the Vienna City Hospital, Austria]\n[William Chester (1903-1974), in 1930 pathology fellow under Erdheim, later American cardiologist]\n$=$ rare multisystem non-Langerhans cell histiocytosis (non-LCH) of unknown cause characterized by xanthomatous infiltration of organs by foamy lipid-laden histiocytes, commonly involving skin + long bones\nMean age: 53 (range, $7-84$ ) years; $\\mathrm{M} \\div \\mathrm{F}=3 \\div 1$\nHisto: mononuclear histiocytes with clear, foamy cytoplasm (xanthoma cells) and immunohistochemical reaction positive for CD68 + negative for CD1a and S-100 immunostaining protein or Birbeck granules (DDx to LCH)\n\n- fever, weight loss, malaise, heart failure\n@ Appendicular skeleton ( $95 \\%$ long bone involvement)\n- periarticular bone pain (mostly) in lower extremity (47\\%)\n\nLocation: commonly distal femoral metadiaphyses\nDistribution: diaphyses + metaphyses similar to progressive diaphyseal dysplasia\n$\\checkmark$ symmetric patchy long bone medullary osteosclerosis in metadiaphyseal region with",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 593,
            "markdown": "sparing of epiphyses\n$\\sqrt{ }$ lesser involvement of flat bones + axial skeleton\n$\\sqrt{ }$ loss of the corticomedullary junction\n$\\sqrt{ }$ coarsened trabecular pattern\n$\\sqrt{ }$ patchy areas of T2-signal hyperintensity\n$\\sqrt{ }$ sparing of epiphyses + hands and feet + axial skeleton\nAssociated with: bone infarcts, periostitis\n@ Retroperitoneum (29\\%)\n\n- progressive renal failure $\\leftarrow$ fibrous perinephritis\n$\\sqrt{ }$ perirenal rind of soft tissue with a hairy appearance encasing kidneys, ureters $\\pm$ aorta\n$D D x$ : lymphoma, retroperitoneal fibrosis\n$\\sqrt{ }$ low SI on T1WI + T2WI with minimal contrast enhancement\n$\\sqrt{ }$ hydronephrosis\n$C x$ : renal failure\n$R x$ : ureteral stent placement, steroids, chemo- and immunotherapy, radiation, surgery\n@ Lung (14-23\\%)\nAge: elderly men\n- dyspnea (5\\%) $\\leftarrow$ pulmonary fibrosis\n$\\sqrt{ }$ circumferential pleural thickening / effusion\n$\\sqrt{ }$ smooth interlobular septal thickening\n$\\sqrt{ }$ centrilobular nodules $\\pm$ lung cysts\n$\\sqrt{ }$ pericardial thickening\n$\\sqrt{ }$ mediastinal infiltration\nPrognosis: significant contributor to morbidity \\& mortality\n@ CNS $(<30 \\%)$\nTypes:\n(a) infiltrative: widespread nodules / masses predominantly involving cerebellum + brainstem\n(b) meningeal: meningioma-like nodular thickening along dura / dural xanthoma\n(c) composite\n\nAssociated with: osteosclerosis of sinus walls, orbital masses\nIntracranial lesions that also involve facial bones / orbits are suggestive of Erdheim-Chester disease.\n\n- painless bilateral exophthalmos (27\\%); diabetes insipidus\n$\\sqrt{ }$ retro-orbital infiltration / mass $\\rightarrow$ exophthalmos\n$\\sqrt{ }$ single / multiple dura-based extra-axial masses (particularly in sellar region) $\\pm$ diffuse pachymeningeal thickening\n$\\sqrt{ }$ iso- to slightly hypointense on T1WI\n$\\sqrt{ }$ avid homogeneous enhancement for up to 8 days after injection\n$\\sqrt{ }$ iso- to hypointense on T2WI\n@ Heart\n$\\sqrt{ }$ cardiac fibrosis $\\rightarrow$ cardiomyopathy\n$\\sqrt{ }$ pericardial thickening / effusion\n@ Skin: xanthelasma of eyelids, xanthoma (in 15\\%)\n$R x$ : corticosteroid therapy, chemotherapy, radiation, surgery",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 594,
            "markdown": "# EXTRINSIC ALLERGIC ALVEOLITIS \n\n$=$ HYPERSENSITIVITY PNEUMONITIS\n$=$ characterized by an inappropriate host response to repeatedly inhaled organic allergens often related to patient's occupation\nCause: inhalation of organic dust (= particulate organism / protein complex) typically of 1-2 $\\mu \\mathrm{m}$ (always $<5 \\mu \\mathrm{~m}$ ) particle size deposited in distal airspaces of lung acting as antigen for a type III + type IV immune reaction\nManifestation: after months / years of continuous / intermittent inhalation of inciting agent\nHisto: 1. Cellular bronchiolitis = chronic inflammatory cells lining small airways\n2. Diffuse chronic interstitial inflammatory infiltrate of lymphocytes, plasma cells, neutrophils, mast cells\n3. Poorly circumscribed interstitial nonnecrotizing (noncaseating) granulomas $<1 \\mathrm{~mm}$ in diameter\n4. Individual giant cells in alveoli / interstitium\n\n- asymptomatic ( $10-40 \\%$ ); recurrent episodes of fever, chills, dry cough, dyspnea following exposure after 6 -hour interval\n- resolution of episodic symptoms after cessation of exposure, abate spontaneously over 1-2 days\n- insidious onset of gradually progressive dyspnea\n- reduction in vital capacity, diffusing capacity, arterial pO2\n- intracutaneous injection of antigen results in delayed hypersensitivity reaction\n- presence of serum precipitins against antigen\n- positive aerosol provocation inhalation test\n- markedly increased cell count with often $>50 \\%$ T-lymphocytes on bronchoalveolar lavage\n\nLocation: predominantly midlung zones, occasionally lower lung zones, rarely upper lung zones Specific antigens for immune complex disease (type III = Arthus reaction):\n\n1. Farmer's lung from damp moldy hay (Thermoactinomyces vulgaris or Micropolyspora faeni)\n2. Pandora's pneumonitis from heating / humidifying / forced air conditioning systems (thermophilic actinomycetes)\n3. Bird-fancier's lung, pigeon breeder's lung from protein in bird serum / excrements / feathers\nAverage duration of exposure: 9 years\n4. Mushroom worker's lung from mushroom compost (Thermoactinomyces vulgaris or Micropolyspora faeni)\nAverage duration of exposure: 5 years\n5. Bagassosis from moldy sugar cane in sugar mill (contamination with Thermoactinomyces sacchari/vulgaris and Micropolyspora faeni)\n6. Malt worker's lung from malt dust (Aspergillus clavatus)\n7. Maple bark disease from moldy maple bark in saw mill (Cryptostroma corticale)\n8. Suberosis from moldy cork dust (Penicillium frequentans)\n9. Sequoiosis from redwood dust (Graphium species)\n10. Mollusk shell pneumonitis\n\nAverage duration of exposure: 11 years",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 595,
            "markdown": "11. Hot tub lung from colonization of heated water by M. avium Average duration of exposure: 2 years\nThermophilic actinomycetes:\n$=$ bacteria $<1 \\mu \\mathrm{~m}$ in diameter with morphologic characteristics of fungi; found in soil, grains, compost, fresh water, forced-air heating, cooling system, humidifier, airconditioning system\nIsocyanates: used for large-scale production of polyurethane polymers in the manufacture of flexible / rigid foams, elastomers, glue, adhesives, surface coating, spray paint $\\diamond$ Principal cause of occupational asthma!\nMycobacterium avium:\ncolonization of heated water in hot tub / lubrication of metalworking machinery\nAspergillus: in corn and malt workers\nPenicillium: in production of cheese, cork, peat moss\n$R x:$ mask, filter, industrial hygiene, alterations in forced-air ventilatory system, change in patient's habits / occupation / environment\n\n# Acute / Episodic Extrinsic Allergic Alveolitis \n\n$=$ renewed exposure to antigen with improvement between attacks usually within enclosed spaces with poor ventilation\nHisto: filling of air spaces by polymorph neutrophils + lymphocytes\nOnset of symptoms: 4-12 hours after exposure\n\n- fever, chills, myalgia, malaise, frontal headache\n- chest tightness, cough, dyspnea, scanty mucoid expectoration\n- arthralgia (common)\n$\\sqrt{ }$ No CXR abnormalities in $30-95 \\%$\n$\\sqrt{ }$ diffuse acinar consolidative pattern (edema + exudate filling alveoli) resolving within a few days\n$\\sqrt{ }$ lymph node enlargement ( $30 \\%$, more common with recurrence)\nHRCT (abnormal in $>90 \\%$ ):\n$\\sqrt{ }$ \"headcheese\" sign (= type of terrine with bits of meat scavenged from a calf or pig) = combination of patchy ground-glass opacities + normal regions + air trapping\n$\\sqrt{ }$ usually bilateral symmetric homogeneous patchy ground-glass opacities concentrated in middle part and base of lungs\n$\\sqrt{ }$ numerous round centrilobular ground-glass opacities usually $<5 \\mathrm{~mm}$ in diameter with indistinct border and small central lucency (= patent bronchiole)\n$\\sqrt{ }$ hypoattenuation + hypovascularity of scattered secondary lobules $\\leftarrow$ air trapping\n$\\sqrt{ }$ diffuse dense airspace consolidation (= confluent collections of intraalveolar histiocytes, interstitial + intraalveolar edema)\n$D x$ : classical presentation of a known exposure history + typical symptoms + detection of serum precipitins to suspected antigen + positive bronchoalveolar lavage (lymphocytes $>20-50 \\%)$\n$D D x$ : UIP, NSIP\n\n\n## Subacute Extrinsic Allergic Alveolitis\n\n$=$ less intense but continuous exposure to inhaled antigens, usually in domestic environment",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 596,
            "markdown": "Histo: predominantly interstitial lymphocytic infiltrate, poorly defined granulomas, cellular bronchiolitis\nOnset of symptoms after exposure: weeks - months\n\n- recurrent respiratory / systemic symptoms:\n- breathlessness upon exertion, fever + cough\n- weight loss, muscle + joint pain\n$\\sqrt{ }$ changes may be completely reversible if present for $<1$ year\n$\\sqrt{ }$ interstitial nodular / reticulonodular pattern\nHRCT:\n$\\sqrt{ }$ widespread patchy / diffuse ground-glass attenuation in $52 \\%$ (obstructive pneumonitis, filling of alveoli by large mononuclear cell infiltrates)\n$\\sqrt{ }$ poorly defined centrilobular micronodules $<5 \\mathrm{~mm}$ (cellular bronchiolitis + small granulomas)\n$\\sqrt{ }$ areas of decreased attenuation + mosaic perfusion ( $86 \\%$ )\n$\\sqrt{ }$ irregular reticular changes, septal lines, parenchymal bands\n\n\n# Chronic Extrinsic Allergic Alveolitis \n\n$=$ prolonged insidious dust exposure\nOnset of symptoms after exposure: months to years\n\n- insidious progressive exertional dyspnea indistinguishable from idiopathic pulmonary fibrosis\nHisto: proliferation of epithelial cells + predominantly peribronchiolar interstitial fibrosis\nLocation: usually in mid zones, relative sparing of lung apices + costophrenic sulci\n$\\sqrt{ }$ irregular linear opacities (= fibrosis)\n$\\sqrt{ }$ loss of lung volume $\\leftarrow$ cicatrization atelectasis\n$\\sqrt{ }$ pleural effusion (rare)\n$\\sqrt{ }$ lymph node enlargement may occur\nCT:\n$\\sqrt{ }$ fibrosis of middle + lower lung zones with relative sparing of lung bases:\n$\\sqrt{ }$ intralobular interstitial thickening\n$\\sqrt{ }$ irregular interlobular septal thickening\n$\\sqrt{ }$ honeycombing\n$\\sqrt{ }$ traction bronchiectasis\n$\\sqrt{ }$ focal air trapping / diffuse emphysema\n$\\sqrt{ }$ coexistent subacute changes $\\leftarrow$ continuing exposure\n\n\n## FAT EMBOLISM\n\n$=$ obstruction of pulmonary vessels by fat globules followed by chemical pneumonitis from unsaturated plasma fatty acids producing hemorrhage / edema\nFrequency: in 67-97\\% of necropsy series in patients with major skeletal trauma; however, symptomatic fat embolism syndrome in $<10 \\%(\\mathrm{M}>\\mathrm{F})$\nOnset: 24-72 hours after trauma\n\n- dyspnea (progressive pulmonary insufficiency), fever\n- systemic hypoxemia; mentation changes: headaches, confusion\n- petechiae ( $50 \\%$ ) from coagulopathy $\\leftarrow$ release of tissue thromboplastin",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 597,
            "markdown": "$\\sqrt{ }$ initial chest film usually negative (normal up to 72 hours)\n$\\sqrt{ }$ platelike atelectasis\n$\\sqrt{ }$ bilateral diffuse alveolar infiltrates\n$\\sqrt{ }$ consolidation (may progress to ARDS)\nNUC:\n$\\sqrt{ }$ mottled peripheral perfusion defects (1-4 days after injury), later enlarging $\\leftarrow$ pneumonic infiltrates\n\n# FOCAL ORGANIZING PNEUMONIA \n\n= unresolving pneumonia / pneumonia with incomplete resolution beyond 8 weeks\nPattern of organizing\n(a) unilateral / focal $(10-38 \\%)$\npneumonia:\n(b) diffuse (majority)\n\nCause: infection (most common), collagen-vascular disease, immunologic disorders, drug reaction, aspiration, toxic inhalation, radiation, organ transplantation, idiopathic (= cryptogenic organizing pneumonia)\nPrevalence: $5-10 \\%$ of all pneumonias ( $87 \\%$ of pneumonias resolve within 4 weeks, $12 \\%$ within $4-8$ weeks)\nPredisposing factors: ? age, diabetes mellitus, chronic bronchitis, overuse of antibiotics\nPath: intraalveolar exudate $\\rightarrow$ transformed into connective tissue as nonspecific response to lung injury\nHisto: organizing fibroblastic plugs of tissue composed of spindle-shaped cells in a pale staining matrix\nLocation: within airspace, alveolar septa, bronchial mucosa, bronchioles\n\n- cough, sputum, fever, hemoptysis (in $\\mathrm{l} / \\mathrm{s}$ )\n$\\sqrt{ }$ ill-defined localized parenchymal abnormality with irregular margin:\n$\\sqrt{ }$ solitary pulmonary nodule\n$\\sqrt{ }$ focal area of consolidation / ground-glass opacity in peribronchial distribution\n$\\sqrt{ }$ associated bronchiectasis / architectural distortion\n$\\sqrt{ }$ \"reverse halo\" sign = focal area of ground-glass opacity surrounded by a complete ring of denser consolidation\n$\\sqrt{ }$ \"atoll\" sign = incomplete ring of denser consolidation\n$\\sqrt{ }$ decrease in size of mass within 3-4 weeks\nHRCT:\n$\\sqrt{ }$ flat / ovoid lesion with irregular margin in subpleural location / along bronchovascular bundle\n$\\sqrt{ } \\pm$ satellite lesions ( $44 \\%$ ) + air bronchograms ( $22 \\%$ )\n$D D x$ : acute pneumonia, pulmonary hemorrhage, lung cancer (organizing pneumonia may be adjacent to malignancy)\n\n\n## GIANT CELL INTERSTITIAL PNEUMONIA\n\n$\\diamond$ ALMOST PATHOGNOMONIC for hard metal pneumoconiosis\n$\\sqrt{ }$ diffuse micronodular pattern\n$\\sqrt{ }$ reticular pattern; in advanced disease coarse and accompanied by small cystic spaces",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 598,
            "markdown": "$\\sqrt{ } \\pm$ lymph node enlargement\nHRCT:\n$\\sqrt{ }$ bilateral areas of ground-glass attenuation\n$\\sqrt{ }$ areas of consolidation\n$\\sqrt{ }$ extensive reticulations\n$\\sqrt{ }$ traction bronchiectasis\n\n# GOODPASTURE SYNDROME \n\n[Ernest William Goodpasture (1886-1960), chair of pathology at the medical school of Vanderbilt University, developed a method for cultivating viruses and rickettsiae]\n$=$ ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY DISEASE\n$=$ autoimmune disease characterized by\n(1) Glomerulonephritis\n(2) Circulating antibodies against glomerular + alveolar basement membrane\n(3) Pulmonary hemorrhage\n\n## Pathogenesis:\n\ncytotoxic antibody-mediated disease $=$ type II hypersensitivity; alveolar basement membrane becomes antigenic (perhaps viral etiology); $\\operatorname{IgG} / \\operatorname{IgM}$ antibody with complement activation $\\rightarrow$ cell destruction + pulmonary hemorrhage $\\rightarrow$ hemosiderin deposition and pulmonary fibrosis\nAge peak: 26 (range, 17-78) years; $\\mathrm{M} \\div \\mathrm{F}=7 \\div 1$\n\n- iron-deficiency anemia, systemic hypertension\n$\\sqrt{ }$ hepatosplenomegaly\n@ Lung\n- preceding upper respiratory infection (in $2 / 3$ ) + renal disease\n- mild hemoptysis ( $72 \\%$ ) with hemosiderin-laden macrophages in sputum, commonly precedes the clinical manifestations of renal disease by several months\n- cough, mild dyspnea, basilar rales\n$\\sqrt{ }$ extensive bilateral air-space consolidation:\n$\\sqrt{ }$ symmetric consolidation of perihilar area + lung bases with sparing of lung apices\n$\\sqrt{ }$ air bronchogram\n$\\sqrt{ }$ consolidation replaced by interstitial pattern within 2-3 days $\\rightarrow$ organization of hemorrhage resulting in interlobular septal thickening\n$\\sqrt{ }$ hilar lymph nodes may be enlarged during acute episode\n@ Kidney\n- glomerulonephritis with IgG deposits in characteristic linear pattern in glomeruli; hematuria\nPrognosis: death within 3 years (average 6 months) because of renal failure\n$R x$ : cytotoxic chemotherapy, plasmapheresis, bilateral nephrectomy\n$D D x$ : idiopathic pulmonary hemosiderosis\n\n\n## GRANULOMA OF LUNG\n\nCause:\nA. SARCOIDOSIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 599,
            "markdown": "# B. NON-SARCOID GRANULOMATOUS DISEASE \n\n(a) infectious\nbacterial: TB, gumma\n> opportunistic: cryptococcosis\n> parasitic: Dirofilaria immitis (dog heartworm)\n> fungal: histoplasmosis, coccidioidomycosis, nocardiosis\n(b) noninfectious\n> foreign body: talc, beryllium, algae, pollen, cellulose, lipids, abuse of nasally inhaled drugs, aspiration of medication\n> angiocentric lymphoproliferative disease\n> vasculitides\n> extrinsic allergic alveolitis\n> Langerhans cell histiocytosis\n> pulmonary hyalinizing granuloma\n> peribronchial granuloma\n> chronic granulomatous disease of childhood\nHisto: epithelial cells, lymphocytes, macrophages, giant cells of Langhans type\n[Theodor Langhans (1839-1915), professor of pathology at the University of Bern, Switzerland, and Giessen, Germany, discoverer of multi-nucleated giant cell = Langhans giant cell]\nFrequency: constitutes majority of solitary pulmonary nodules\n\n- nonproductive cough, shortness of breath\n$\\checkmark$ spontaneous pneumothorax\nCXR:\n$\\diamond$ CXR detection requires multiple granulomas / clusters of granulomas (individual granuloma too small)!\n$\\checkmark$ central nidus of calcification in a laminated / diffuse pattern\n$\\checkmark$ absence of growth for at least 2 years\nCT (most effective in nodules $\\leq 3 \\mathrm{~cm}$ of diameter with smooth discrete margins):\n$\\checkmark 50-60 \\%$ of pulmonary nodules demonstrate unsuspected calcification by CT\n$D D x$ : carcinoma (in $10 \\%$ eccentric calcification in preexisting scar / nearby granuloma / true intrinsic stippled calcification in larger lesion)\n\n\n## HAMARTOMA OF CHEST WALL\n\n$=$ MESENCHYMOMA (incorrect as it implies neoplasm)\n$=$ focal overgrowth of normal skeletal elements with a benign self-limited course; extremely rare\nAge: 1st year of life\n$\\checkmark$ moderate / large extrapleural well-circumscribed mass affecting one / more ribs\n$\\checkmark$ ribs near center of mass partially / completely destroyed\n$\\checkmark$ ribs at periphery deformed / eroded\n$\\checkmark$ significant amount of calcification / ossification (DDx: aneurysmal bone cyst)\n$\\checkmark$ mass compresses underlying lung\n$R x$ : resection curative",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 600,
            "markdown": "# HAMARTOMA OF LUNG \n\n$=$ most common benign tumor of the lung\nFrequency: $\\quad 0.25 \\%$ in population (autopsy); $6-8 \\%$ of all solitary pulmonary neoplasms; $77 \\%$ of all benign lung tumors\n\n## Etiology:\n\n1. Congenital malformation of a displaced bronchial anlage\n2. Hyperplasia of normal structures\n3. Cartilaginous neoplasm\n4. Response to inflammation\n\nPath: solitary mass composed of tissues normally found in this location in abnormal quantity, mixture, and arrangement\nHisto: columnar, cuboidal, ciliated epithelium, fat (in 50\\%), bone, cartilage (predominates), muscle, vessels, fibrous tissue, calcifications, plasma cells originating in fibrous connective tissue beneath mucous membrane of bronchial wall\nAge peak: $5^{\\text {th }}$ and $6^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1-3 \\div 1$\nMay be associated with:\nCarney triad (pulmonary chondromatous lesion, gastric leiomyosarcoma, functioning extraadrenal paraganglioma); pulmonary hamartoma syndrome\n\n- mostly asymptomatic; fever $\\leftarrow$ postobstructive pneumonitis\n- cough, hemoptysis (rare), vague chest pain\n\nLocation: $2 / 3$ peripheral; endobronchial in $1 \\%$; multiplicity (rare)\n$\\sqrt{ }$ round smooth lobulated mass $<4 \\mathrm{~cm}$ (average of 2.5 cm )\n$\\sqrt{ }$ calcification in $15-20 \\%$ (ALMOST PATHOGNOMONIC if of chondroid \"popcorn\" type)\n$\\sqrt{ }$ fat density in $50 \\%$ (DIAGNOSTIC)\n$\\sqrt{ }$ cavitation (extremely rare)\n$\\sqrt{ }$ growth patterns: slow / rapid / stable with later growth\n$\\sqrt{ }$ usually diameter increase by $1.5 \\mathrm{~mm} /$ year doubling in size every 14 years\nHRCT:\n$\\sqrt{ }$ fat density detectable in $34 \\%$ ( -80 to -120 HU )\n$\\sqrt{ }$ calcium + fat detectable in $19 \\%$\nTransthoracic needle biopsy: $85 \\%$ diagnostic accuracy\n$D D x$ : lipoid pneumonia (ill-defined mass / lung infiltrate); granulomatous disease, carcinoid tumor; metastatic mucinous adenocarcinoma, amyloidoma\n\n## HARD-METAL PNEUMOCONIOSIS\n\n$=$ alloy of tungsten, carbon and cobalt\nOccupational exposure: processing of tungsten carbide + cobalt (occasionally adding titanium, tantalum, nickel, chromium)\nMain cause: cobalt ( $=$ cytotoxic + allergic agent)\nHisto: obliterative bronchiolitis (earliest manifestation), subacute fibrosing alveolitis (= desquamation of epithelial cells + accumulation of macrophages in alveolar space), PATHOGNOMONIC giant cell interstitial pneumonia (multinuclear giant cells), chronic interstitial lung disease $=$ diffuse mural fibrosis with honeycombing (several years after initial exposure)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 601,
            "markdown": "- asthma, shortness of breath, chronic cough\n- dyspnea on exertion over prolonged period\n- restricted / obstructive pulmonary function tests\n$\\sqrt{ }$ diffuse small reticulonodular pattern + small cystic spaces\n$\\sqrt{ }$ panlobular bilateral ground-glass opacities / consolidation\n$\\sqrt{ }$ parenchymal distortion, honeycombing, traction bronchiectasis\n$D D x$ : idiopathic pulmonary fibrosis, non-specific interstitial pneumonia\n\n\n# HEREDITARY HEMORRHAGIC TELANGIECTASIA \n\n$=$ RENDU-OSLER-WEBER SYNDROME\n[Henri Jules Louis Marie Rendu (1844-1902), Head of the Department of Medicine at the Hôpital Necker, Paris]\n[Sir William Osler (1849-1919), first professor of medicine at Johns Hopkins University Medical School in Baltimore, USA]\n[Frederick Parkes Weber (1863-1962), dermatologist, London]\n$=$ group of autosomal dominant inherited disorders that result in a variety of systemic\nfibrovascular dysplasias affecting mucous skin, membranes, lung, brain, GI tract:\n\n| Phenotypes of Rendu-Osler-Weber Syndrome |  |  |\n| :-- | :-- | :-- |\n| Type | Gene mutation | Description (lesions $=A V M s+A V F s)$ |\n| HHT1 | ENG | most common phenotype; prevalence <br> of pulmonary lesions |\n| HHT2 | ALK1 | prevalence of hepatic lesions; <br> frequently pulmonary hypertension |\n| HHT3 | unknown | hepatic $>$ pulmonary lesions |\n| HHT4 | unknown | lesions in lung, brain, nose |\n| JPHT | SMAD4 | lesions in various sites + juvenile <br> polyposis |\n\n(1) Telangiectasias\n(2) Arteriovenous malformations (AV hemangiomas)\n(3) Aneurysms\n\nEtiology: gene mutation that encodes a protein binding transforming growth factor (TGF)- $\\beta$ controlling cell proliferation + differentiation + death $\\rightarrow$ abnormal vascular remodeling into fibrovascular dysplasia\nPrevalence: $1-20 \\div 100,000 ; \\mathrm{M}=\\mathrm{F}$\nAge: manifestation usually during adulthood\nPath: direct connections between arteries + veins with absence of capillaries (telangiectases are small AVMs)\n(a) small telangiectasis $=$ focal dilatation of postcapillary venules with prominent stress fibers in pericytes along luminal borders\n(b) fully developed telangiectasis $=$ markedly dilated + convoluted venules with excessive layers of smooth muscle without elastic fibers directly connecting to dilated arterioles\nHisto: absence of cellular intervals in vascular endothelial cells",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 602,
            "markdown": "Diagnostic criteria: $\\geq 3$ of the following conditions\n(1) Recurrent epistaxis\n(2) Multiple vascular dilatations in face + oral cavity\n(3) AVMs / AVFs in internal organs\n(4) $1^{\\text {st }}$-degree relative with this condition\n\n- frequent bleeding into mucous membranes, skin, lungs, GU system, GI system $\\leftarrow$ vascular weakness\n@ Nose ( $=$ telangiectasis of nasal mucosa)\n- recurrent epistaxis ( $32-85 \\%$ ): more severe over time in $66 \\%$; begins by age 10 , present by age 21 in most cases; up to 45 episodes per month\n@ Skin\n- telangiectases $=$ small red vascular blemishes\n\nAge: present in most cases by age 40; increase in number + size with age\nLocation: lips, tongue, floor of oral cavity, palate, fingers, face, conjunctiva, trunk, arms, nail beds\n@ Lung $(5-15 \\%)$\n$\\diamond 5-15 \\%$ of patients with hereditary hemorrhagic telangiectasia have pulmonary AVMs\n$\\diamond$ Up to $60 \\%$ of patients with pulmonary AVMs have hereditary hemorrhagic telangiectasia\n@ CNS (= cerebral or spinal AVMs)\n\n- headache; seizure; paraparesis (less common)\n$\\checkmark$ subarachnoid hemorrhage\n@ GI tract (stomach, duodenum, small bowel, colon)\n$=$ dilatation of small mucosal blood vessels\nMay be associated with: AVMs / angiodysplasia\n- recurrent GI bleeding (in $5^{\\text {th }}-6^{\\text {th }}$ decade)\n@ Liver $(8-74 \\%)$\n$\\checkmark$ hepatomegaly\n$\\checkmark$ presence of multiple AVMs (between hepatic artery branches + branches of hepatic / portal veins):\n$\\checkmark$ heterogeneous liver enhancement with mosaic perfusion\n$\\checkmark$ simultaneous enhancement of hepatic arteries + veins\n$\\checkmark$ multiple areas of transient hepatic attenuation differences on hepatic arterial phase:\n(a) arterioportal shunt $(65 \\%)$\n(b) telangiectasia $(63 \\%)$\n(c) confluent vascular mass $(25 \\%)$\n$\\checkmark$ dilated tortuous hepatic arteries\n$\\checkmark$ early enhancement of dilated hepatic veins\n$\\checkmark$ diffuse mottled capillary blush on angio\nCx: atypical cirrhosis, hyperdynamic portal hypertension, variceal GI hemorrhage, ascites, hepatic portosystemic encephalopathy\nCx: (1) Congestive heart failure $\\leftarrow \\mathrm{AV}$ shunting\n(2) Cerebral abscess $\\leftarrow$ paradoxical emboli\n\n\n# HISTOPLASMOSIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 603,
            "markdown": "Prevalence: nearly $100 \\%$ in endemic area; up to $30 \\%$ in Central + South America, Puerto Rico, West Africa, Southeast Asia; annually 500,000 infected in USA; up to $30 \\%$ of US population has positive skin reaction\nOrganism: Histoplasma capsulatum = ubiquitous dimorphic fungus; worldwide most often in temperate climates; widespread in soil enriched by bird droppings of central North America (endemic in Ohio, Mississippi, St. Lawrence River valley; exists as a spore in soil + transforms into yeast form at normal body temperature\nVector: fowl + other birds (passes through feces without infection due to high body temperature); bats\nInfection: inhalation of wind-borne spores (microconidia of $2-6 \\mu \\mathrm{~m}$, macroconidia of 6-14 $\\mu \\mathrm{m}$ ), which germinate within alveoli releasing yeast forms, which are phagocytized but not killed by macrophages; invasion of pulmonary lymphatics with spread to hilar + mediastinal lymph nodes; hematogenous dissemination of parasitized macrophages throughout reticuloendothelial system (spleen!)\nPath: spores incite formation of epithelioid granulomas, necrosis, calcification\n$D x$ : (1) Culture (sputum, lung tissue, urine, bone marrow, lymph node)\n(2) Identification of yeast forms stained with PAS / Gömöri methenamine silver\n(3) Complement fixation test (absolute titer of $1 \\div 64$ or 4 -fold rise in convalescent titer suggest active / recent infection)\n(4) Serum immunodiffusion: agar gel diffusion test (H precipitin band)\n\nRx: ketoconazole\n\n# Pulmonary Histoplasmosis \n\n## A. ACUTE HISTOPLASMOSIS\n\n- mostly asymptomatic and self-limiting illness (in 99.5\\%)\n- fever, cough, malaise simulating viral upper respiratory infection 3 weeks after massive inoculum / in debilitated patients (infants, elderly)\n- positive skin test for histoplasmosis; hypersensitivity develops in 1-2 weeks\n$\\sqrt{ }$ generalized lymphadenopathy\n$\\sqrt{ }$ bilateral nonsegmental bronchopneumonic pattern with tendency to clear in one area + appear in another\n$\\sqrt{ }$ multiple nodules changing into hundreds of punctate calcifications (usually $>4 \\mathrm{~mm}$ ) after $9-24$ months\n$\\sqrt{ }$ \"target lesion\" = PATHOGNOMONIC central calcification\n$\\sqrt{ }$ hilar / mediastinal lymph node enlargement (DDx: acute viral / bacterial pneumonia)\n$\\sqrt{ }$ \"popcorn\" calcification of mediastinal lymph nodes $>10 \\mathrm{~mm}(80 \\%$ probability of being caused by histoplasma)\n$\\sqrt{ }>5$ splenic calcifications $(40 \\%)$\nCT:\n$\\sqrt{ }$ paratracheal / subcarinal mass with regions of low attenuation (necrosis) + enhancing septa\nB. CHRONIC HISTOPLASMOSIS $(0.03 \\%)$\n\nPredisposed: individuals with chronic obstructive pulmonary disease + cigarette smoking\nAge: middle-aged white men",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 604,
            "markdown": "Pathophysiology: hyperimmune reaction\n\n- cough, low-grade fever, night sweats simulating postprimary tuberculosis\n$\\checkmark$ segmental wedge-shaped peripheral consolidation of moth-eaten appearance from scattered foci of emphysematous lung\n$\\checkmark$ fibrosis in apical posterior segments of upper lobes (indistinguishable from postprimary TB) adjacent to emphysematous blebs\nC. DISSEMINATED HISTOPLASMOSIS\n\nPredisposed: impaired T-cell immunity; AIDS; immunosuppression after organ transplant\nPrevalence: $1 \\div 50,000$ exposed individuals\nPathophysiology: progression of exogenous infection / reactivation of latent focus\n\n- acute rapidly fatal infection:\n- fever, weight loss, anorexia, malaise, cough $(<50 \\%)$\n- abdominal pain, nausea, vomiting, diarrhea\n- chronic intermittent illness:\n- low-grade fever, weight loss, fatigue\n- adrenal insufficiency\n$\\checkmark$ normal CXR ( $>50 \\%$ )\n$\\checkmark$ miliary nodules of $<3 \\mathrm{~mm}$\n$\\checkmark$ linear irregular reticulonodular opacities\n$\\checkmark$ segmental / lobar / diffuse airspace opacities\n$\\checkmark$ hilar + mediastinal adenopathy (uncommon in immunocompromised patients)\n$\\checkmark$ hepatosplenomegaly\n@ GI tract (cecum, small bowel)\n$\\checkmark$ mucosal nodularity + strictures $\\leftarrow$ ulceration\nCx: arthritis (most often knee), tenosynovitis, osteomyelitis\nD. DELAYED MANIFESTATIONS\n$\\diamond$ Organism recovered in only $50 \\%$ !\n$\\checkmark$ histoplasmoma ( $=$ continued growth of primary focus at $0.5-2.8 \\mathrm{~mm} /$ year) adjacent to pleura + typically with laminated calcific rings (\"lung stone\")\nIn $20 \\%$ associated with: mediastinal granulomas\n$\\checkmark$ broncholithiasis $=$ erosion of peribronchial calcified lymph node into bronchus:\n- hemoptysis, fever, chills, productive cough\n$\\checkmark$ change in position of stone on serial radiographs\n$\\checkmark$ mediastinal granuloma (more common)\n$=$ direct infection of mediastinal lymph nodes\nHisto: involved nodes with varying degrees of central caseation $\\pm$ calcification\n- usually asymptomatic\n\nLocation: subcarinal / right paratracheal / hilar lymph nodes\n$\\checkmark$ widened mediastinum (enlarged nodes + veins)\n$\\checkmark$ lobulated mass of low-density lymph nodes $3-10 \\mathrm{~cm}$ in thickness surrounded by a $2-$ 5-mm thick fibrous capsule crisscrossed by irregularly shaped enhancing septa (CHARACTERISTIC)\n$\\checkmark$ displacement of SVC / esophagus\n$\\checkmark$ fibrosing mediastinitis (less common)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 605,
            "markdown": "# HODGKIN DISEASE \n\n$=$ HODGKIN LYMPHOMA\n[Thomas Hodgkin (1798-1866), English physician and pathologist, first appointed physician at London Dispensary and curator of Pathology Museum at Guy's Hospital Medical School]\n$=$ disease of T cells\nFrequency: $0.75 \\%$ of all cancers diagnosed each year; $40 \\%$ of all lymphomas\nAge: bimodal peaks at age $25-30$ years and $75-80$ years; very rare in children $<5$ years; $\\mathrm{M}+\\mathrm{F}$ $=1 \\div 1$\nHisto: Hodgkin and Reed-Sternberg cells = binucleate cells with prominent centrally located nucleoli (= activated pre-B cells) scattered in infiltrate of inflammatory cells\n\n- positive for CD30, CD15, EBV\n(1) Nodular sclerosis ( $78 \\%$ )\n$=$ lymph nodes traversed by broad bands of birefringent collagen separating nodules, which consist of normal lymphocytes, eosinophils, plasma cells, and histiocytes\n- $1 / 3$ with systemic symptoms\n$\\sqrt{ }$ typically localized anterior mediastinal involvement\nPrognosis: good\n(2) Mixed cellularity (17\\%)\n$=$ diffuse effacement of lymph nodes with lymphocytes, eosinophils, plasma cells + relative abundance of atypical mononuclear and Reed-Sternberg cells; more commonly advanced stage at presentation and older age\n$\\sqrt{ }$ more commonly abdominal than mediastinal\nPrognosis: less favorable\n(3) Lymphocyte predominance (5\\%)\n$=$ abundance of normal-appearing lymphocytes + relative paucity of abnormal cells\n- often diagnosed in younger people $<35$ years\n- systemic symptoms are uncommon\n- frequently in early stage + localized disease\n\nPrognosis: most favorable natural history\n(4) Lymphocyte depletion (1\\%)\n$=$ paucity of normal-appearing lymphocytes + abundance of abnormal mononuclear and Reed-Sternberg cells; least common subtype with worst prognosis\nAge: older patients\n\n- systemic symptoms\n$\\sqrt{ }$ disseminated advanced stage\nPrognosis: rapidly fatal\n- painless lymphadenopathy: cervical $>$ supraclavicular $>$ inguinal $>$ axillary\n- alcohol-induced pain, generalized pruritus\n- unexplained fevers, drenching night sweats, weight loss\n@ CHEST\nAt presentation: $67 \\%$ with intrathoracic disease\nSites of lymphoid aggregates:\n\n1. Lymph nodes in mediastinum\n2. Lymph nodes at bifurcation of $1^{\\mathrm{st}}+2^{\\mathrm{nd}}$ order bronchi",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 606,
            "markdown": "3. Encapsulated lymphoid collections on thoracic surface deep to parietal pleura\n4. Unencapsulated nodules at points of divisions of more distally situated bronchi, bronchioles, pulmonary vessels\n5. Unencapsulated lymphoid aggregates within peribronchial connective tissue\n6. Small accumulations of lymphocytes in interlobular septa + lymphatic channels\n\n| Ann Arbor Staging Classification for HD (1971) |  |\n| :--: | :--: |\n| Stage | Description |\n| I | one anatomic region / lymphoid structure (eg, spleen, thymus, Waldeyer ring) or single extralymphatic site |\n| II | $\\geq 2$ lymph node regions / localized contiguous involvement of extranodal site + lymph node region on same side of diaphragm (number of sites indicated by subscript, eg, $\\mathrm{II}_{2}$ ) |\n| III | lymph node regions on both sides of diaphragm $\\pm$ spleen (Stage $\\mathrm{III}_{6}$ ) / Waldeyer ring / localized contiguous involvement of one extranodal site |\n| $\\mathrm{III}_{1}$ | $\\pm$ splenic / hilar / celiac / portal nodes |\n| $\\mathrm{III}_{2}$ | + paraortic / iliac / mesenteric nodes |\n| IV | diffuse / disseminated involvement of $\\geq 1$ extranodal organs lymph nodes |\n| A* | no symptoms |\n| $B^{*}$ | temperature $>38^{\\circ} \\mathrm{C}$, drenching night sweats, unexplained loss of $>10 \\%$ of body weight within preceding 6 months |\n| E* | single extranodal site contiguous to nodal site |\n| X* | bulky disease (mediastinum widened $>1 / 3$ ) OR nodal mass $>10 \\mathrm{~cm}$ |\n| CS* | clinical stage |\n| PS* | pathologic stage (as determined by laparoscopy) |\n| * these designations are applicable to any stage |  |\n\n# A. INTRAPULMONARY MANIFESTATIONS \n\nFrequency: $6-11 \\%$; in $4.3 \\%$ bilateral (more frequent in recurrent disease)\n$\\diamond$ Most commonly in nodular sclerosing type\n$\\diamond$ Subsequent to hilar adenopathy in ipsilateral lung\n\n1. Bronchovascular form (most common type)\n$\\sqrt{ }$ coarse reticulonodular pattern contiguous with mediastinum $=$ direct extension from mediastinal nodes along lymphatics\n$\\checkmark$ nodular parenchymal lesions\n$\\checkmark$ miliary nodules\n$\\checkmark$ endobronchial involvement\n$\\checkmark$ lobar atelectasis $\\leftarrow$ endobronchial obstruction (rare)\n$\\checkmark$ cavitation $\\leftarrow$ necrosis (rare)\n2. Subpleural form\n$\\checkmark$ circumscribed subpleural masses\n$\\checkmark$ pleural effusion $(20-50 \\%) \\leftarrow$ lymphatic obstruction\n3. Massive pneumonic form $(68 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 607,
            "markdown": "$\\sqrt{ }$ diffuse nonsegmental infiltrate (pneumonic type)\n$\\sqrt{ }$ massive lobar infiltrates ( $30 \\%$ )\n$\\sqrt{ }$ homogeneous confluent infiltrates with shaggy borders\n$\\sqrt{ }$ air bronchogram\n4. Nodular form\n$\\sqrt{ }$ multiple nodules $<1 \\mathrm{~cm}$ in diameter (DDx: metastatic disease)\n$D D x$ in treated patients:\nrelapse, infection, radiation pneumonitis, drug-induced lung disease\nB. EXTRAPULMONARY MANIFESTATIONS\n\n1. Mediastinal + hilar lymphadenopathy\nmost common manifestation, present in $90-99 \\%$, in thorax commonly multiple\nlymph node groups involved\nLocation:\nanterior mediastinal + retrosternal nodes commonly involved (DDx:\nsarcoidosis); confined to anterior mediastinum in $40 \\% ; 20 \\%$ with mediastinal\nnodes have hilar lymphadenopathy also; hilar lymph nodes involved bilaterally in $50 \\%$\nSpread from anterior mediastinum to:\nother mediastinal locations, pleura, pericardium, chest wall\n$\\diamond$ Involvement of multiple lymph node groups in $95 \\%$ !\n$\\sqrt{ }$ CXR: on initial film adenopathy identified in $50 \\%$\n$\\sqrt{ }$ necrotic lymph nodes (commonly nodular sclerosing type)\n$\\sqrt{ }$ lymph nodes may calcify following radiation / chemotherapy\n2. Pleural effusion $(13 \\%)$\n$\\diamond$ NOT of prognostic significance\nPrognosis: usually resolves following treatment\n3. Pleural masses + plaques\n$\\sqrt{ }$ sternal erosion\n$\\sqrt{ }$ invasion of anterior chest wall\n4. Thymic involvement\n$\\sqrt{ }$ thymic enlargement (in $56 \\%$ )\n$C x$ :\n5. Superimposed infection\n$\\sqrt{ }$ consolidation with bulging borders: necrotizing bacterial pneumonia\n$\\sqrt{ }$ multiple nodular foci: aspergillosis + nocardiosis\n$\\sqrt{ }$ bilateral diffuse consolidation: Pneumocystis carinii\n$\\sqrt{ }$ rapidly developing cavitation within consolidation: anaerobes / fungus\n$D x$ : by culture, sputum cytology, lung biopsy\n6. Drug toxicity\n\n# Extranodal Hodgkin Disease (15-30\\%) \n\n@ BONE (5-20\\%)\n$\\diamond$ During course of disease $5-32 \\%$ develop bone marrow involvement\nAt presentation: $1-4 \\%$; indicative of widespread aggressive disease with poor prognosis\nLocation: dorsolumbar spine $>$ pelvis $>$ ribs $>$ femora $>$ sternum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 608,
            "markdown": "$N U C$ : recommended only with bone pain + elevated serum alkaline phosphatase\n$\\checkmark$ solitary ( $33 \\%$ ) / polyostotic ( $66 \\%$ ) lesions:\n$\\checkmark$ usually wide ill-defined lesion edge / sclerotic margin\n$\\checkmark$ lamellated / \"sunburst\" periosteal reaction\n$\\checkmark$ predominantly osteolytic with blurred borders; rarely sclerotic / mixed lyticsclerotic\n$\\checkmark$ fractures occur rarely at presentation\n$\\checkmark$ vertebral osteolysis with collapse / patchy sclerosis / \"ivory vertebra\" / mixed lytic + blastic lesion\n$\\checkmark$ gouge defect of anterior vertebral body margin $\\leftarrow$ erosion by lymph nodes\n$\\checkmark$ osteolysis of sternum $\\leftarrow$ proximity to thoracic lymph ducts\n@ HEAD \\& NECK $(<1 \\%)$\n\n- nasopharyngeal biopsy positive in $20 \\%$\n$\\checkmark$ thyroid mass as secondary involvement ( $2 \\%$ )\n@ CNS (uncommon)\nFrequency: secondary hematogenous involvement in $0.2-0.5 \\%$; usually not part of standard staging without CNS symptoms / signs\nLocation: supratentorial cerebral cortex + meninges in inferior aspect of brain (most frequent)\n$\\checkmark$ leptomeningeal + choroid plexus masses\n$\\checkmark$ white matter mass, typically periventricular / basal ganglionic / cerebellar\n$\\checkmark$ paraneoplastic cerebellar atrophy\n$\\checkmark$ epidural mass with spinal cord compression (in 3.0-7.6\\%) from extension of paraspinal nodes through intervertebral neural foramen: $\\checkmark$ concomitant vertebral bone involvement (in 32-42\\%)\n@ THYMUS ( $30-56 \\%)$\n$\\diamond$ Considered a \"lymph node\" in staging\n$\\checkmark$ remains enlarged after treatment in $33 \\% \\leftarrow$ recurrent disease / rebound hyperplasia / persistence of thymic cysts\n@ CHEST WALL (6.4\\%)\n$\\checkmark$ infiltration of parasternal soft tissues by direct extension from internal mammary nodes\n$\\checkmark$ mass beneath / between pectoralis muscles (rare)\n@ HEART ( $7.5 \\%$ at autopsy)\n$\\checkmark$ pericardial effusion (with large mediastinal mass)\n$\\checkmark$ invasion of pericardium + SVC\n$\\checkmark$ pericardial nodular mass\n@ LIVER (6-20\\%)\n$\\diamond$ Primary involvement is very rare\nAssociated with: splenic disease (almost invariably)\n$\\checkmark$ discrete nodules $(10 \\%)=$ miliary lesions of $<10 \\mathrm{~mm}$\n$\\checkmark$ diffuse disease $(87 \\%)=$ patchy irregular infiltrates in portal areas\n@ SPLEEN\n$\\diamond$ Considered a \"nodal organ\"\nFrequency: $30-40 \\%$ at staging laparotomy\n$\\checkmark$ diffuse involvement (not detectable by imaging) $\\pm$ splenomegaly",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 609,
            "markdown": "$\\sqrt{ }$ hypoechoic hypoattenuating nodules with reduced contrast enhancement MR:\n$\\sqrt{ }$ hypo- / isointense nodules on T1WI + hyperintense on T2WI\n$\\sqrt{ }$ reduced enhancement compared with normal spleen\n$D D x:$ reactive splenomegaly (in 30\\%)\n@ PANCREAS (extremely rare)\n$\\diamond$ secondary to contiguous lymph node disease\n@ GI TRACT ( $10-15 \\%)$\n$=$ rarely affecting GI tract $\\rightarrow$ mostly $2^{\\text {nd }}$ ary involvement by tumor extension from adjacent lymph nodes\n$\\diamond$ primary HD in $<1 \\%$ of all primary gastric + small bowel lymphomas\nBarium:\n$\\sqrt{ }$ diffuse fold thickening / ulcerated mass in stomach\n$\\sqrt{ }$ irregular luminal narrowing + nodularity in esophagus, small bowel, colon\nCT:\n$\\sqrt{ }$ concentric thickening of affected bowel wall\n> Stomach ( $9 \\%$ of all intestinal lymphomas):\n$\\sqrt{ }$ narrow rigid obstructive lesion (DDx: scirrhous ca.)\n$\\sqrt{ }$ wall thickening + smoothly lobulated outer border\n> Small intestine:\n\n- spruelike symptoms, steatorrhea\n$\\sqrt{ }$ abundance of desmoplastic reaction (DDx from NHL)\n$\\sqrt{ }$ infiltrating ( $60 \\%$ ); polypoid ( $26 \\%$ ); ulcerated ( $14 \\%$ )\nPrognosis: poorer 5-year survival rate than with other forms of this disease\n> Esophagus (extremely rare):\n$\\sqrt{ }$ esophageal nodules / irregular narrowing\n$C x$ : focal stenosis, obstruction $\\leftarrow$ greater degree of fibrosis than lymphoma\n@ GU TRACT (extremely rare)\n$\\sqrt{ }$ perirenal / renal masses $\\leftarrow$ invasion from surrounding nodes\n$C x$ : increased risk for other malignancies from aggressive therapy (acute leukemia, NHL, radiation-induced sarcoma)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 610,
            "markdown": "| Clinical \\& HRCT Features of Idiopathic Interstitial Pneumonias American Thoracic Society and European Respiratory Society (2001) |  |  |  |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: |\n| Type | Onset $[y]$ | Gender | Onset | Smoking | Prognosis | Steroids | Distribution | HRCT |\n| $\\begin{aligned} & \\text { UIP } \\\\ & \\text { (IPF) } \\end{aligned}$ | $>50$ | $\\mathrm{M}>\\mathrm{F}$ | gradual | ? | poor | poor | apicobasal, subpleural | macrocystic honeycombing, reticular opacities, traction bronchiectasis, architectural distortion, focal ground-glass opacity, spatial + temporal heterogeneity |\n| NSIP | $40-50$ | $\\mathrm{M}=\\mathrm{F}$ | gradual / subacute | no | variable | good | no gradient, symmetric, subpleural | ground-glass opacities, irregular linear / reticular opacities, micronodules, consolidation, microcystic honeycombing |\n| COP | 55 | $\\mathrm{M}=\\mathrm{F}$ | subacute | $+$ | complete recovery | excellent | basal patchy, peripheral / peribronchial | airspace consolidation, mild bronchial dilatation, ground-glass opacities, large nodules (rare) |\n| RB-ILD | $30-40$ | $\\mathrm{M}>\\mathrm{F}$ | gradual | $+++$ | good after smoking cessation | good | diffuse / upper lobes | centrilobular nodules, patchy ground-glass opacities, bronchial wall thickening |\n| DIP | $30-40$ | $\\mathrm{M}>\\mathrm{F}$ | insidious | $++$ | good after smoking cessation | good | apicobasal, peripheral | ground-glass opacities, irregular linear / reticular opacities, sometimes cysts |\n| LIP | $40-50$ | $\\mathrm{F}>\\mathrm{M}$ | slow | no | variable | variable | basal / diffuse | ground-glass opacities, perivascular cysts, septal thickening, centrilobular nodules |\n| AIP | 50 | $\\mathrm{M}=\\mathrm{F}$ | acute | no | $>50 \\%$ mortality | unclear | lower lung, symmetric, bilateral | exudative: ground-glass opacities, airspace consolidation organizing: bronchial dilatation, architectural distortion |\n| CT Features and Differential Diagnosis of Idiopathic Interstitial Pneumonias American Thoracic Society and European Respiratory Society (2013 revision) |  |  |  |  |  |  |  |  |\n| Group \\& Diagnosis |  |  | CT Pattern |  | CT Distribution |  | Typical CT Findings | DDx of CT Morphology |\n| Chronic fibrosing IIPs |  |  |  |  |  |  |  |  |\n| Idiopathic pulmonary fibrosis |  |  | Usual interstitial pneumonia (UIP) |  | $\\checkmark$ peripheral $\\checkmark$ subpleural $\\checkmark$ basal | $\\checkmark$ reticular opacities $\\checkmark$ honeycombing $\\checkmark$ traction bronchiectasis / bronchiolectasis $\\checkmark$ architectural distortion $\\checkmark$ focal ground-glass attenuation |  | (1) Collagen vascular disease <br> (2) Hypersensitivity pneumonitis <br> (3) Asbestosis <br> (4) Sarcoidosis |\n| Idiopathic NSIP |  |  | Nonspecific interstitial pneumonia (NSIP) |  | $\\checkmark$ peripheral $\\checkmark$ basal $\\checkmark$ symmetric | $\\checkmark$ ground-glass attenuation $\\checkmark$ irregular lines $\\checkmark$ traction bronchiectasis $\\checkmark$ consolidation |  | (1) UIP <br> (2) DIP <br> (3) Cryptogenic organizing pneumonia <br> (4) Hypersensitivity pneumonitis |\n| Smoking-related IIPs |  |  |  |  |  |  |  |  |\n| Desquamative interstitial pneumonia |  |  | Desquamative interstitial pneumonia (DIP) |  | $\\checkmark$ lower zone $\\checkmark$ (mostly) peripheral predominance | $\\checkmark$ ground-glass attenuation $\\checkmark$ reticular lines $\\checkmark$ cysts |  | (1) RB-ILD <br> (2) NSIP <br> (3) Hypersensitivity pneumonitis |\n| RB-ILD |  |  | Respiratory bronchiolitis |  | $\\checkmark$ (often) upper lung predominant centrilobular | $\\checkmark$ bronchial wall thickening $\\checkmark$ centrilobular nodules $\\checkmark$ patchy ground-glass opacity |  | (1) DIP <br> (2) NSIP <br> (3) Hypersensitivity pneumonitis |\n| Acute / subacute IIPs |  |  |  |  |  |  |  |  |\n| Cryptogenic organizing pneumonia |  |  | Organizing pneumonia |  | $\\checkmark$ subpleural $\\checkmark$ peribronchial | $\\checkmark$ patchy consolidation / nodules $\\checkmark$ perilobular pattern $\\checkmark$ reverse halo sign |  | (1) Infection <br> (2) Aspiration <br> (3) Eosinophilic pneumonia <br> (4) NSIP <br> (5) Vasculitis <br> (6) Sarcoidosis <br> (7) Mucinous adenocarcinoma <br> (8) Lymphoma |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 611,
            "markdown": "| Group \\& Diagnosis | CT Pattern | CT Distribution | Typical CT Findings | DDx of CT Morphology |\n| :--: | :--: | :--: | :--: | :--: |\n| Acute interstitial pneumonia | Diffuse alveolar damage | $\\checkmark$ diffuse / patchy | $\\checkmark$ consolidation and groundglass opacity (often with lobular sparing) <br> $\\checkmark$ traction bronchiectasis (late) | (1) Hydrostatic edema <br> (2) Pneumonia <br> (3) Pulmonary hemorrhage <br> (4) Acute eosinophilic pneumonia |\n| Rare IIPs |  |  |  |  |\n| Lymphoid interstitial pneumonia | Lymphoid interstitial pneumonia | $\\checkmark$ lower lung predominant | $\\checkmark$ centrilobular nodules <br> $\\checkmark$ ground-glass attenuation <br> $\\checkmark$ septal + bronchovascular thickening <br> $\\checkmark$ thin-walled cysts | (1) NSIP <br> (2) Sarcoidosis <br> (3) Langerhans cell histiocytosis <br> (4) Other cystic lung disease |\n| Idiopathic pleuroparenchymal fibroelastosis | Idiopathic pleuroparenchymal fibroelastosis | $\\checkmark$ peripheral upper lung predominant | $\\checkmark$ pleural thickening <br> $\\checkmark$ subpleural fibrotic changes | (1) Sarcoidosis <br> (2) Pneumoconiosis <br> (3) Pulmonary fibrosis <br> (4) Connective tissue disease <br> (5) Hypersensitivity pneumonitis |\n\n\n| Classification of Idiopathic Interstitial Pneumonias American Thoracic Society and European Respiratory Society (2001) |  |  |\n| :--: | :--: | :--: |\n| \\# | Entities (in order of frequency) | Abbrev. |\n| 1 | Idiopathic Pulmonary Fibrosis | IPF |\n| 2 | Nonspecific Interstitial Pneumonia | NSIP |\n| 3 | Cryptogenic Organizing Pneumonia | COP |\n| 4 | Desquamative Interstitial Pneumonia* | DIP |\n| 5 | Respiratory Bronchiolitis-associated Interstitial Lung Disease* | RB-ILD |\n| 6 | Acute Interstitial Pneumonia | AIP |\n| 7 | Lymphoid Interstitial Pneumonia | LIP |\n| * smoking -related |  |  |\n| $D D x:$ | sarcoidosis, vasculitis, collagen vascular (connective tissue) disease, drug reaction, asbestosis, chronic hypersensitivity pneumonitis |  |\n\n# IDIOPATHIC INTERSTITIAL PNEUMONIA (IIP) \n\n## Acute Interstitial Pneumonia\n\n$=$ AIP $=[$ ACCELERATED INTERSTITIAL PNEUMONIA $]=$ DIFFUSE ALVEOLAR DAMAGE $=$ IDIOPATHIC ARDS $=$ ACUTE DIFFUSE INTERSTITIAL FIBROSIS $=$ HAMMAN-RICH SYNDROME\n$=$ rapidly progressive fulminant disease of unknown etiology that usually occurs in previously healthy subjects + produces diffuse alveolar damage\nCause: diffuse alveolar damage of unknown origin from a variety of toxic insults such as infection, drugs, sepsis, shock, aspiration, toxic inhalation / ingestation, exacerbation of idiopathic pulmonary fibrosis, etc.",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 612,
            "markdown": "![img-64.jpeg](img-64.jpeg)\n\nPath: temporally homogeneous organizing diffuse alveolar damage; little mature collagen deposition / architectural distortion / honeycombing (as opposed to UIP); indistinguishable from ARDS caused by sepsis + shock\nHisto: extensive diffuse alveolar damage\n(a) acute exudative phase: alveolar + interstitial edema; hyaline membrane formation (most prominent in $1^{\\text {st }}$ week after lung injury); diffuse alveolar infiltrates by lymphocytes\n(b) chronic organizing phase: uniform alveolar wall thickening $\\leftarrow$ marked interstitial (alveolar septal) fibroblast proliferation with stabilizing nonprogressive scarring + pneumocyte hyperplasia\nMean age: 50 years (wide range); $\\mathrm{M}=\\mathrm{F}$\n\n- prodromal viral upper respiratory infection: cough, fever\n- rapidly increasing dyspnea + acute respiratory failure\n- requires ventilation within days to $1-4$ weeks (= \"outpatient ARDS\")\n- decreased diffusing capacity for carbon monoxide\n- pulmonary capillary wedge pressure of $<18 \\mathrm{mmHg}$\n\nAIP is the only entity of idiopathic interstitial pneumonias with acute onset of symptoms!\nLocation: bilateral symmetric mainly in lower lung zones\nSite: predominantly central / subpleural (in 22\\%); anteroposterior lung attenuation gradient; costophrenic angles often spared",
            "images": [
                {
                    "id": "img-64.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 820,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 613,
            "markdown": "![img-65.jpeg](img-65.jpeg)\n\nCXR:\n$\\sqrt{ }$ progressive extensive bilateral hetero- / homogeneous airspace opacification: symmetric, bilateral, basilar\nHRCT:\n$\\sqrt{ }$ bilateral ground-glass opacities (in exudative phase) $\\leftarrow$ alveolar septal edema and hyaline membranes:\n$\\checkmark$ patchy geographic ( $67 \\%$ ) / diffuse ( $38 \\%$ )\n$\\checkmark$ diffuse bilateral airspace consolidation (in $67 \\%$ ) limited to dependent area of lung (similar to ARDS) $\\leftarrow$ intraalveolar edema and hemorrhage $\\leftarrow$ alveolar closure from weight + hydrostatic pressure of more-superior lung tissue\n$\\checkmark$ geographic focal sparing of lobules\n$\\checkmark$ bronchial dilatation\n$\\checkmark$ architectural distortion (in organizing phase) more severe in nondependent areas of lung (atelectasis + consolidation protect from damaging effect of mechanical ventilation):\n$\\checkmark$ airspace consolidation $\\leftarrow$ intraalveolar fibrosis\n$\\checkmark$ distortion of bronchovascular bundles\n$\\checkmark$ traction bronchiectasis\n$\\checkmark$ honeycomb lung\nRadiographic features of AIP are similar to ARDS with a symmetric bilateral distribution of lower lobe predominance!\n$D x:$ NEGATIVE bacterial / viral / fungal cultures;\nNO inhalational exposure to noxious agents;\nNO pulmonary drug toxicity\nPrognosis: death within 1-6 months ( $60-90 \\%$ ); recovery in $12 \\%$; frequently progression to fibrosis after survival in acute phase\n$R x$ : supportive with oxygen supplementation; corticosteroids in early phase",
            "images": [
                {
                    "id": "img-65.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 189,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 873,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 614,
            "markdown": "$D D x$ : (1) ARDS (less symmetric, no lower lobe predominance)\n(2) Widespread pneumonia\" esp. Pneumocystis jirovecii pneumonia\n(3) Hydrostatic edema (substantial interlobular septal thickening, pleural effusions)\n(4) Acute eosinophilic pneumonia (substantial interlobular septal thickening, pleural effusions)\n(5) Diffuse pulmonary hemorrhage\n(6) Acute hypersensitivity pneumonitis (profuse centrilobular nodules / mosaic attenuation)\n(7) Alveolar proteinosis\n\n# Subacute Interstitial Pneumonia \n\n## Nonspecific Interstitial Pneumonia\n\n$=$ NSIP $=$ IDIOPATHIC NONSPECIFIC INTERSTITIAL PNEUMONIA $=$ NONCLASSIFIABLE INTERSTITIAL PNEUMONIA\n$=$ provisional diagnosis for a probably heterogeneous group of interstitial pneumonia that cannot be easily classified as UIP / DIP / AIP / COP\n![img-66.jpeg](img-66.jpeg)\n\nFrequency: $14-36 \\%$ (second most common IIP)\nPath: spatially + temporally homogeneous alveolar wall thickening caused by inflammation and/or fibrosis\nHisto: (I) cellular NSIP $(48 \\%)=$ mild to moderate cellular interstitial infiltrate with little / no fibrosis\n(II) fibrotic NSIP $(52 \\%)=$ dense / loose fibrosis of uniform appearance\n\nClinical conditions associated with NSIP pattern:\n(1) Idiopathic\n(2) Collagen vascular disease ( $16 \\%$ ): scleroderma, polymyositis, dermatomyositis,",
            "images": [
                {
                    "id": "img-66.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 888,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1562,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 615,
            "markdown": "Sjögren syndrome, rheumatoid arthritis, mixed connective tissue disease, systemic lupus erythematosus\n(4) Drug-induced pneumonitis\n(3) Hypersensitivity pneumonitis: inhalational exposure to noxious agents (17\\%)\n(5) Infection (8\\%)\n(6) Immunodeficiency including HIV\n\nAge: 40-50 years (1 decade younger than IPF); $\\mathrm{M}=\\mathrm{F}$\n\n- gradually worsening dyspnea (1-week to 5-year history)\n- dry cough, low-grade fever, fatigue, weight loss\n- decreased diffusing capacity for carbon monoxide (less severe than idiopathic pulmonary fibrosis)\nLocation: lower lobe predominance ( $92 \\%$ ); symmetric involvement of both lungs\nSite: peribronchovascular / subpleural distribution (21-64\\%)\n$\\checkmark$ normal CXR in $14 \\%$\n$\\checkmark$ bibasilar irregular linear opacities + diffuse heterogeneous airspace consolidation\n$\\checkmark$ volume loss in lower lobe ( $91 \\%$ )\nHRCT ( $70 \\%$ sensitive, $63 \\%$ specific):\n$\\checkmark$ fibrosis:\n$\\checkmark$ irregular fine linear / reticular opacities (87\\%)\n$\\checkmark$ traction bronchiectasis ( $82 \\%$ )\n$\\checkmark$ lobar volume loss ( $77 \\%$ )\n$\\checkmark$ relative subpleural sparing\n$\\checkmark$ bilateral symmetric areas of scattered patchy ground-glass opacities (44\\%) without zonal preference $\\leftarrow$ homogeneous interstitial inflammation\n$\\checkmark$ areas of low attenuation ( $34 \\%$ )\n$\\checkmark$ microcystic honeycombing (inconspicuous, 30\\%)\n$\\checkmark$ airspace consolidation (uncommon)\n$\\checkmark$ diffuse micronodules (very infrequent)\n$\\checkmark$ mildly enlarged mediastinal lymphadenopathy ( $80 \\%$ )\n$\\checkmark$ follow-up (stable in $35 \\%$ ):\n$\\checkmark$ decrease in ground-glass attenuation\n$\\checkmark$ persistence of reticular abnormalities\n$\\checkmark$ marked increase in fibrosis\nConsider NSIP in homogeneous lung involvement without apicobasal gradient, a fine reticular pattern, and micronodules without progression to honeycombing!\nPrognosis: substantially better than idiopathic pulmonary fibrosis; $11 \\%$ overall mortality\n$D x$ : surgical lung biopsy necessary\nRx: systemic corticosteroids combined with cytotoxic drugs (cyclophosphamide, cyclosporine) $\\rightarrow$ clinical + functional + radiographic improvement in $50-86 \\%$\n$D D x$ : usual interstitial pneumonia (irregular reticular pattern + macrocystic honeycombing involving subpleural + lower lung zones); desquamative interstitial pneumonia; cryptogenic organizing pneumonia; chronic hypersensitivity pneumonitis\n\n\n# Respiratory Bronchiolitis-Interstitial Lung Disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 616,
            "markdown": "$=$ RB-ILD $=$ interstitial pneumonia of smokers in which respiratory bronchiolitis is associated with limited peribronchiolar interstitial inflammation; considered early and mild manifestation of DIP\nMean age: 36 (range, 30-40) years; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\nCause: heavy cigarette smoking $>30$ pack years\n$\\diamond$ Most common form of smoking-related lung injury\nHisto: bronchiolocentric intraluminal accumulation of brown-pigmented alveolar macrophages and mild interstitial inflammation in $1^{\\text {st }}$ and $2^{\\text {nd }}$ order respiratory bronchioles + neighboring alveoli; mild peribronchial thickening with contiguous extension into alveolar septa but without significant fibrosis\n\n- history of excessive smoking ( $>30$ pack year)\n- usually asymptomatic / mild dyspnea + cough\n- inspiratory crackles (50\\%)\n- pulmonary function test: normal / mixed restrictive + obstructive + reduced diffusing capacity\nLocation: diffuse / upper lobe predominance\nCXR (insensitive for detection):\n$\\sqrt{ }$ normal CXR $(21 \\%)$\n$\\sqrt{ }$ fine bilateral reticulonodular opacities $\\leftarrow$ thickening of central + peripheral bronchial walls $(71 \\%)$\n$\\sqrt{ }$ bibasilar atelectasis ( $12 \\%$ )\nHRCT:\n$\\sqrt{ }$ scattered patchy ground-glass opacities $(66 \\%) \\leftarrow$ macrophage accumulation in alveolar ducts + spaces\n$\\sqrt{ }$ inconspicuous poorly defined centrilobular micronodules (upper lobe predominance) $\\leftarrow$ peribronchial distribution of intraluminal infiltrates\n$\\sqrt{ }$ scattered lobules of reduced attenuation $\\leftarrow$ lobular air trapping at expiration (upper lobe predominance)\n$\\sqrt{ }$ mild interlobular septal thickening\n$\\sqrt{ }$ bronchial wall thickening\n$\\sqrt{ }$ upper lobe centrilobular + paraseptal emphysema (rarely severe)\n$\\sqrt{ }$ NO fibrosis\nPrognosis: excellent (after cessation of smoking / corticoid therapy) without progression to end-stage lung fibrosis\n$R x$ : smoking cessation (most important therapy!), corticosteroids\n$D D x$ : (1) Subacute hypersensitivity pneumonitis (more profuse + more diffuse poorly defined centrilobular nodules, exposure history, nonsmoker, lymphocytosis in BAL)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 617,
            "markdown": "![img-67.jpeg](img-67.jpeg)\n(2) Desquamative interstitial pneumonia (more extensive ground-glass attenuation, uncommon / sparse centrilobular nodules, lower lobe predominance)\n(3) Nonspecific interstitial pneumonia (NSIP)\n(4) Infectious bronchiolitis\n\n# Cryptogenic Organizing Pneumonia \n\n$=\\mathrm{COP}=$ BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA (BOOP) $=$ IDIOPATHIC BOOP $=$ PROLIFERATIVE BRONCHIOLITIS\nPrevalence: $20-30 \\%$ of all chronic infiltrative lung disease\nCause: pulmonary manifestation of collagen vascular disease, postobstructive pneumonia, organizing adult respiratory distress syndrome, pulmonary drug toxicity, extrinsic allergic alveolitis, silo filler disease, lung cancer, idiopathic $(50 \\%)$\nPath: temporally uniform homogeneous mild / moderate inflammation with preservation of lung architecture characterized by granulation tissue polyps filling the lumina of alveolar ducts and respiratory bronchioles (bronchiolitis obliterans) + variable degree of infiltration of interstitium and alveoli with macrophages (organizing pneumonia) [formerly known as bronchiolitis obliterans organizing pneumonia (BOOP)]\nHisto: patchy distribution of intraluminal organizing fibrosis in distal airspaces = plugs of immature intraalveolar fibroblast proliferations (Masson bodies) covered with low cuboidal epithelium, which may spread through collateral air drift pathways\nMay be associated with: rheumatoid arthritis, polymyositis\nMean age: 55 (range, $40-70$ ) years; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n\n- nonproductive cough + mild dyspnea of 1-4-month duration preceded by a brief flulike illness with sore throat ( $40 \\%$ ), low-grade fever, malaise (in $33 \\%$ )\n- NO association with cigarette smoking",
            "images": [
                {
                    "id": "img-67.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 189,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 873,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 618,
            "markdown": "- restrictive pulmonary function tests + diminished diffusing capacity on pulmonary function tests\n- consolidation often diagnosed as pneumonia with failure to respond to broad-spectrum antibiotic treatment\nLocation: lower lobe predominance\nSite: CHARACTERISTIC peripheral (= subpleural in 50\\%) + peribronchial distribution (in $30-50 \\%$ ); tendency to expand and migrate over time\nCXR: frequently a mixture of\n![img-68.jpeg](img-68.jpeg)\n$\\sqrt{ }$ preserved lung volumes\n$\\sqrt{ }$ uni- / bilateral patchy alveolar airspace consolidation (25-73\\%), often subpleural, resembling pneumonic infiltrates\n$\\sqrt{ } 3-5 \\mathrm{~mm}$ nodules (up to $50 \\%$ )\n$\\sqrt{ }$ irregular linear opacities ( $15-42 \\%$ )\n$\\sqrt{ }$ unilateral focal / lobar consolidation (5-31\\%)\n$\\sqrt{ }$ pleural thickening ( $13 \\%$ )\n$\\sqrt{ }$ cavitation / pleural effusion $(<5 \\%)$\nHRCT: far more extensive than suggested on CXR\n$\\sqrt{ }$ uni- / bilateral patchy airspace consolidation of triangular / polygonal shape (80$90 \\%$ ) a few cm in size\n$\\sqrt{ }$ patchy ground-glass opacities $\\leftarrow$ alveolitis ( $60 \\%$ ):\n$\\sqrt{ }$ \"atoll\" sign = \"reverse halo\" sign if surrounded by $10-\\mathrm{mm}$ thick crescentic / ringshaped opacities\n$\\sqrt{ }$ air bronchograms with mild cylindrical bronchial dilatation (in 36-70\\%)\n$\\sqrt{ }$ large nodules (rare)\n$\\sqrt{ }$ reticular opacities $\\leftarrow$ fibrosis (less common)\n$\\sqrt{ }$ pleural effusion $(28-35 \\%)$",
            "images": [
                {
                    "id": "img-68.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 547,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1221,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 619,
            "markdown": "$\\sqrt{ }$ adenopathy $(27 \\%)$\nFour distinctive HRCT patterns:\n(1) Multiple bilateral symmetric patchy airspace opacities\n(2) Diffuse bilateral reticular / nodular opacities\n(3) Focal airspace consolidation\n(4) Multiple large masses / nodules $\\pm$ cavitation\n\nDx: tissue examination from open lung biopsy\nPrognosis: radiologic improvement / resolution under steroids (in $84 \\%$ of patients with idiopathic form); persistent abnormalities ( $30 \\%$ ); $10 \\%$ mortality $\\leftarrow$ progressive / recurrent disease\n$D D x$ : bronchioloalveolar cell carcinoma; lymphoma; vasculitis; sarcoidosis; chronic eosinophilic pneumonia; infection; nonspecific interstitial pneumonia\n\n# Chronic Interstitial Pneumonia \n\n$=$ ORGANIZING INTERSTITIAL PNEUMONIA $=$ CHRONIC DIFFUSE SCLEROSING ALVEOLITIS\n\n## Lymphoid Interstitial Pneumonia\n\n$=$ LIP $=$ LYMPHOCYTIC INTERSTITIAL PNEUMONITIS\n$=$ benign lymphoproliferative disorder of lung parenchyma characterized by diffuse dense interstitial lymphoid infiltrate (probably immunologic disorder) with highly variable course\nFrequency: extremely rare\nAge: $50-80$ years; $\\mathrm{M}<\\mathrm{F}$\nHisto: extensive diffuse infiltration of alveolar interstitium (bronchovascular bundles, interlobular septa) and pleura by polyclonal mature small lymphocytes (predominantly T cells intermixed with some polytypic B cells) + plasma cells + histiocytes $\\rightarrow$ expansion of the alveolar septa; reactive lymphoid follicles along peribronchiolar region; lymphoid hyperplasia frequent; many cases reclassified as lymphoma\nClinical conditions associated with LIP pattern:\n(a) immune related\n\n1. Immunodeficiency\n2. Collagen vascular disease: Sjögren syndrome, rheumatoid arthritis, systemic lupus erythematosus\n3. Immunologic disorders: autoimmune hemolytic anemia, Hashimoto thyroid disease, Castleman disease, myasthenia gravis, pernicious anemia, chronic active hepatitis, primary biliary cirrhosis, celiac sprue, Crohn disease, dysproteinemia\n(b) infectious\n4. HIV / AIDS\n$\\diamond$ Indicative of AIDS when present in child $<13$ years of age!\n5. Epstein-Barr virus (EBV) infection\n6. Human herpesvirus 8\n7. Chronic active hepatitis\n8. Legionella pneumonia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 620,
            "markdown": "6. Pneumocystis jirovecii\n7. Tuberculosis\n(c) miscellaneous\n8. Drugs / toxic exposure: eg, Dilantin (phenytoin)-induced\n9. Allogenic bone marrow transplant\n10. Graft-versus-host disease\n\n- slowly progressive dyspnea + cough over $>3$ years\n- occasionally fever, night sweats, weight loss\n- cyanosis + clubbing ( $50 \\%$ )\n- enlargement of salivary glands ( $20 \\%$ )\n- NO lymphocytosis or history of atopy\n- dysproteinemia ( $60 \\%$ ): hypergammaglobulinemia $>$ hypogammaglobulinemia\n- monoclonal gammopathy (usually IgM)\n\nDistribution: bilateral; diffusely involving all lung zones / basilar predominance\nLIP is suggested by thin-walled perivascular cysts in mid lung zones in combination with ground-glass opacities!\nCXR (nonspecific):\n$\\sqrt{ }$ absence of findings\n$\\sqrt{ }$ fine reticulonodular pattern in both lower lungs\n$\\checkmark$ resembling airspace disease (in severe form)\nHRCT:\n$\\checkmark$ ill-defined centrilobular nodules of varying size ( $100 \\%$ )\n$\\checkmark$ ground-glass opacities $(100 \\%) \\leftarrow$ diffuse interstitial inflammation\n$\\checkmark$ subpleural small nodules (in majority)\n$\\checkmark$ peribronchovascular thin-walled $1-30 \\mathrm{~mm}$ cysts ( $68 \\%$ ) predominantly in lower lung $\\leftarrow$ air trapping $\\leftarrow$ ball-valve mechanism $\\leftarrow$ obstruction of small bronchioles $\\leftarrow$ peribronchiolar lymphocytic infiltration\n$\\checkmark$ mild patchy thickening of bronchovascular bundles + interlobular septal thickening (in majority) $\\leftarrow$ infiltration of interlobular septa with lymphocytes + plasma cells\n$\\checkmark$ mediastinal lymph node enlargement ( $50 \\%$ )\n$\\checkmark$ pleural effusion / airspace consolidation (extremely uncommon)\nN.B.: pleural effusion and $>11 \\mathrm{~mm}$ large / growing nodules concerning for coexisting lymphoma\nPrognosis:\n(a) recovery / slowly improving / stable disease\n(b) progression to fibrosis (in $33 \\%$ )\n$C x$ : malignant lymphoma (in 5\\%)\n$R x$ : responsive to steroids\n$D D x$ : infection; primary pulmonary lymphoma; pulmonary amyloidosis; hypersensitivity pneumonitis (ground-glass attenuation, small centrilobular nodules, NOT cystic airspaces / thickening of interlobular septa or bronchovascular bundles); sarcoidosis; lymphangitic carcinomatosis; Langerhans cell histiocytosis; lymphangioleio-myomatosis; emphysema; desquamative interstitial pneumonia with cysts",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 621,
            "markdown": "# Usual Interstitial Pneumonia \n\n$=$ UIP $=$ MURAL TYPE OF FIBROSING ALVEOLITIS\n$=$ CRYPTOGENIC FIBROSING ALVEOLITIS\n$=$ commonest $(90 \\%)$ form of idiopathic interstitial pneumonia (may represent late stage of DIP)\nClinical conditions associated with UIP pattern:\n(1) Idiopathic pulmonary fibrosis (IPF) / cryptogenic fibrosing alveolitis (50\\%)\n(2) Collagen vascular disease / immunologic disorder (mostly rheumatoid arthritis) $(20-30 \\%)$\n(3) Drug toxicity: bleomycin, cyclophosphamide (Cytoxan®), busulfan, nitrofurantoin\n(4) Chronic hypersensitivity pneumonitis\n(5) Asbestosis\n(6) Familial idiopathic pulmonary fibrosis ( $25 \\%$ )\n\nMean age: 64 years (usually $>50$ years); $\\mathrm{M}>\\mathrm{F}$\nPath: patchy scattered fibrotic lesions of different stages (fibroblastic foci + mature fibrosis + honeycombing) mixed with areas of normal lung tissue ( $=$ temporal + spatial variegation (heterogeneity)\n$D x$ : biopsy samples from $>1$ lobe (because UIP pattern rules independent of other coexisting patterns) $\\leftarrow$ HRCT serves as a guide for appropriate biopsy sites\nHisto: proteinaceous exudate in interstitium + hyaline membrane formation in alveoli; necrosis of alveolar lining cells followed by cellular infiltration of mono- and lymphocytes + regeneration of alveolar lining; intraalveolar histiocytes; proliferation of fibroblasts + deposition of collagen fibers + smooth muscle proliferation; progressive disorganization of pulmonary architecture\n\n- progressive dyspnea, dry cough, fatigue (over 1-3 years)\n- bibasilar fine inspiratory crackles = \"Velcro\" rales\n- clubbing of fingers $(83 \\%)$\n- lymphocytosis on bronchoalveolar lavage ( $=$ marker of alveolitis)\n- pulmonary function tests: restrictive defects + decreased diffusing capacity for carbon monoxide\nConsider UIP with low lung volumes, subpleural reticular opacities, macrocystic honeycombing and traction bronchiectasis with apicobasal gradient!\nCXR:\n$\\sqrt{ }$ occasionally ground-glass pattern in early stage of alveolitis (= alveolar wall injury, interstitial edema, proteinaceous exudate, hyaline membranes, infiltrate of monocytes + lymphocytes) in $15-62 \\%$\n$\\sqrt{ }$ bilateral diffuse linear / small irregular reticulations (100\\%); basilar (85\\%) + peripheral $(59 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 622,
            "markdown": "![img-69.jpeg](img-69.jpeg)\n$\\checkmark$ reticulonodular pattern $=$ superimposition of linear opacities\n$\\checkmark$ heart border \"shaggy\"\n$\\checkmark$ macrocystic honeycombing = numerous cystic spaces (up to $74 \\%$ )\n$\\checkmark$ elevated diaphragm = progressive loss of lower-lobe lung volume (45-75\\%)\n$\\checkmark$ 1.5-3-mm diffusely distributed nodules (15-29\\%)\n$\\checkmark$ pleural effusion (4-6\\%), pleural thickening (6\\%)\n$\\checkmark$ pneumothorax in $7 \\%$ (in late stages)\n$\\checkmark$ normal CXR (2-8\\%)\nHRCT ( $88 \\%$ sensitive, $70-100 \\%$ PPV):\nThe primary role of CT is to separate chronic fibrosing lung diseases with a UIP pattern from those with non-UIP lesions, including those with findings associated with other idiopathic interstitial pneumonias like RB-ILD, lymphoid interstitial pneumonia, and idiopathic pleuroparenchymal fibroelastosis.\nLocation: apicobasal gradient affecting lung bases in 68-80\\%\nSite: predominantly subpleural regions (79\\%)",
            "images": [
                {
                    "id": "img-69.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 189,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1346,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 623,
            "markdown": "$\\sqrt{ }$ patchy distribution with areas of normal parenchyma, active alveolitis, early + late fibrosis present at the same time (HALLMARK)\n$\\sqrt{ }$ reticular opacities $(82 \\%)$\n$\\sqrt{ }$ small peripheral convoluted cysts ( $=$ traction bronchiectasis) in $50 \\%$\n$\\sqrt{ }$ prominent architectural distortion of secondary pulmonary lobule (= lung fibrosis)\n$\\sqrt{ }$ minimal focal ground-glass opacities (= diffuse inflammatory mononuclear cell infiltrates of active disease + fibroblast proliferation) in $65-76 \\%$ progressing to fibrosis\n$\\sqrt{ }$ subpleural areas of macrocystic honeycombing with cystic spaces outlined by thick fibrous walls (up to $96 \\%$ ) enlarging slowly over time\n$\\sqrt{ }$ subpleural lines (= fibrosis / functional atelectasis)\n$\\sqrt{ }$ interlobular septal thickening ( $10 \\%$ )\nNOT: micronodules, air trapping, nonhoneycomb cysts, extensive ground-glass opacification, consolidation, predominantly peribronchovascular distribution\n$C x$ : bronchogenic carcinoma ( $10-15 \\%$ ), opportunistic infections with therapy, accelerated deterioration\n$R x$ : usually no response to steroids (only in $10-15 \\%$ )\nPrognosis: median survival of 2.5-3.5 years; $43 \\% 5$-year survival rate, $15 \\% 10$-year survival rate; $87 \\%$ overall mortality; no recovery\n$D D x$ : collagen vascular disease, chronic hypersensitivity pneumonitis, asbestosis\n\n# Desquamative Interstitial Pneumonia \n\n$=$ DIP = DESQUAMATIVE TYPE OF FIBROSING ALVEOLITIS = ALVEOLAR MACROPHAGE PNEUMONIA\n$=$ end spectrum of RB-ILD; $2^{\\text {nd }}$ most common (although rare) form of idiopathic interstitial pneumonia of a more benign course than UIP; may be self-limited disease or lead to UIP\nCause: cigarette smoking (history in up to $90 \\%$ ), lung infection, exposure to organic dust\nMean age: 42 (range, $30-40$ ) years ( $\\sim 8$ years younger than in UIP); $\\mathrm{M}+\\mathrm{F}=2 \\div 1$\nPath: spatially homogeneous thickening of alveolar septa + intraalveolar accumulation of macrophages; relative preservation of lung architecture + mild interstitial fibrosis (temporally uniform)\nHisto: alveoli lined by large cuboidal cells + filled with heavy accumulation of mononuclear cells (pigmented macrophages, NOT desquamated alveolar cells); histologic uniformity from field to field\n\n- average smoking history of 18 pack-years\n- asymptomatic, weight loss\n- insidious onset of dyspnea + nonproductive dry cough (for 6-12 months)\n- inspiratory crackles ( $60 \\%$ ), clubbing of fingers ( $40 \\%$ )\n- markedly $\\Downarrow$ diffusing capacity + restrictive defects\n\nDistribution: lower lung lobe predominance, peripheral; more diffuse + uniform compared to RB-ILD\nCXR (nonspecific):\n$\\sqrt{ }$ normal chest x-ray (3-22\\%)\n$\\sqrt{ }$ ground-glass alveolar pattern sparing costophrenic angles (25-33\\%), diffuse groundglass opacities ( $15 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 624,
            "markdown": "$\\sqrt{ }$ linear irregular opacities $(60 \\%)$, bilateral + basilar $(46-73 \\%)$\n$\\sqrt{ }$ lung nodules $(15 \\%)$\n$\\sqrt{ }$ honeycombing $(13 \\%)$\n$\\sqrt{ }$ preserved lung volume\nHRCT:\nLocation: apicobasal gradient affecting mainly middle + lower lung zones (73\\%); bilateral + symmetric ( $86 \\%$ )\nSite: predominantly subpleural distribution (59\\%); random distribution (23\\%)\n$\\sqrt{ }$ bilateral peripheral patchy / diffuse ground-glass opacities ( $23 \\%$ ) $\\leftarrow$ spatially homogeneous intraalveolar accumulation of macrophages and thickening of alveolar septa:\n$\\sqrt{ }$ progression to reticular pattern (in 20\\%)\n$\\sqrt{ }$ round thin-walled cysts $<2 \\mathrm{~cm}$ within ground-glass opacities\n$\\sqrt{ }$ some irregular linear / limited reticular opacities (= fibrosis) + architectural distortion ( $59 \\%$ ) confined to subpleural lung bases\n$\\sqrt{ }$ little peripheral honeycombing + traction bronchiolectasis (32\\%)\n$\\sqrt{ } \\pm$ coexistent centrilobular emphysema\n$\\sqrt{ }$ fibrosis of lower lung zones in late stage\nPrognosis: better response to corticosteroid Rx than UIP (in 60-80\\%); improvement with smoking cessation; median survival of 12 years; $5 \\% 5$-year mortality rate (overall $16-27 \\%$ ); $70 \\% 10$-year survival\n$D D x$ : (1) RB-ILD (centered on respiratory bronchiole, ground-glass opacities less extensive, more patchy, more poorly defined)\n(2) Acute interstitial pneumonia\n(3) NSIP (fibrotic features like traction bronchiectasis + lower lobe volume loss)\n(4) Acute / subacute hypersensitivity pneumonitis\n(5) P. carinii pneumonia\n(6) Sarcoidosis\n\n# Idiopathic Pleuroparenchymal Fibroelastosis \n\n$=$ rare condition consisting of a form of fibrosis rich in elastic fibers involving pleura and subpleural lung parenchyma, predominantly of upper lobes\nDistribution: striking apical subpleural predominance\nCT:\n$\\sqrt{ }$ irregular pleural thickening + tags in upper zones merging with fibrotic changes in subjacent lung\n$\\sqrt{ }$ substantial upper lobe volume loss: architectural distortion, traction bronchiectasis, hilar elevation\nPrognosis: disease progression (60\\%), death (40\\%)\n$D D x$ : (1) Familial pulmonary fibrosis\n(2) Connective tissue disease (esp. ankylosing spondylitis)\n(3) Fibrotic sarcoidosis\n(4) Chronic hypersensitivity pneumonitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 625,
            "markdown": "![img-70.jpeg](img-70.jpeg)",
            "images": [
                {
                    "id": "img-70.jpeg",
                    "top_left_x": 0,
                    "top_left_y": 0,
                    "bottom_right_x": 1698,
                    "bottom_right_y": 2200,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 626,
            "markdown": "# IDIOPATHIC PULMONARY FIBROSIS \n\n$=$ USUAL INTERSTITIAL PNEUMONIA\n$=$ specific form of chronic progressive fibrosing interstitial pneumonia of unknown cause\n$=$ clinical syndrome associated with morphologic pattern of UIP and related to cigarette smoking (in $41-83 \\%$ )\n$\\diamond$ Most common form of idiopathic interstitial lung disease!\nHisto: UIP pattern = cluster of fibroblasts + immature connective tissue within pulmonary interstitium $\\rightarrow$ remodeling of lung architecture with honeycombing; temporal + spatial heterogeneity of fibrotic lesions of different stages ( $=$ fibroblastic foci, mature fibrosis, honeycombing)\nDistribution: bibasilar peripheral + subpleural\nAge: $50-70$ years; $\\mathrm{M}=\\mathrm{F}$\n\n- chronic dry cough, gradually progressing exertional dyspnea\n- basilar \"Velcro-type\" inspiratory crackles\n- digital clubbing (in $\\%$ )\n- PFTs: restrictive defect $+4$ diffusing capacity for CO\n- decreased total lung capacity + functional residual capacity + residual volume\n\nDistribution: lung periphery with apicobasal gradient, often patchy, asymmetric (in 25\\%)\nCXR:\n$\\checkmark$ decreased lung volume, progressive over time\n$\\checkmark$ bibasilar subpleural reticular opacities\n$\\checkmark$ honeycombing ( $30 \\%$ )\n$\\checkmark$ bibasilar ground-glass appearance (uncommon)\n$\\checkmark$ small nodules $(<10 \\%)$, occasionally ossified\nHRCT ( $95-100 \\%$ PPV):\n(a) classic:\n$\\checkmark$ lower zone macrocystic honeycombing ( $90 \\%$ ) often combined with traction bronchiectasis\n(b) possible:\n$\\checkmark$ irregular reticular opacities ( $=$ intralobular interstitial thickening) in peripheral basal distribution\n$\\checkmark$ ground-glass opacities in area of fibrosis (occasionally)\n$\\checkmark$ discrete nodules (occasionally)\n$\\checkmark$ mild mediastinal lymph node enlargement ( $70 \\%$ )\n$\\checkmark$ coexisting emphysema (common) makes Dx less reliable",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 627,
            "markdown": "```\nCriteria for Diagnosis of IPF (without Surgical Biopsy)\nAmerican Thoracic Society and European Respiratory Society (2001)\nMajor criteria\n    - exclusion of other causes of interstitial lung disease: toxic\n        effects of certain drugs, environmental exposures, connective\n        tissue disease\n    - abnormal PFT: reduced vital capacity, \\(\\uparrow \\mathrm{FEV}_{1} / \\mathrm{FVC}\\) ratio\n    - impaired gas exchange: \\(\\mathrm{PAO}_{2}-\\mathrm{PaO}_{2}, \\mathrm{PaO}_{2}\\) with rest /\n        exercise, \\(\\downarrow\\) DLCO\n    \\(\\checkmark\\) lower zone macrocystic honeycombing ( \\(90 \\%\\) ) often combined\n        with traction bronchiectasis\n    \\(\\checkmark\\) bibasilar irregular reticular opacities\n    \\(\\checkmark\\) minimal ground-glass opacities\nMinor criteria\n    Age: \\(>50 \\mathrm{y}\\)\n    - insidious onset of otherwise unexplained dyspnea on exertion\n    - duration of illness \\(<3\\) months\n    - bibasilar inspiratory crackles (dry / \"Velcro\" type)\n```\n\nCT's primary role is to separate chronic fibrosing lung disease with a UIP pattern from non-UIP lesions associated with other IIPs (eg, RB-ILD, lymphoid interstitial pneumonia, and idiopathic pleuroparenchymal fibroelastosis).\n$D x$ : (a) exclusion of other known causes of interstitial lung dz\n(b) UIP pattern on CT in appropriate clinical setting $=$ sufficient for diagnosis in $>50 \\%$\n(c) on follow-up subpleural reticular opacities in upper lung zones = fibrosis creeping up along lung periphery\n$R x$ : cyclosporine $\\mathrm{A}+$ corticosteroids (for acute exacerbations only); lung transplantation\nPrognosis: poor with invariable deterioration and a mean survival of 2.5-3.5 years (30-50\\% 5 -year survival)\n$\\diamond$ Substantially poorer prognosis than NSIP, COP, RB-ILD, DIP, LIP\n$D D x$ : (1) Connective tissue disease\n(2) Asbestosis (exposure history, pleural plaques, diffuse pleural thickening, subpleural dotlike / branching opacities, less-coarse reticular shadows)\n(3) Chronic hypersensitivity pneumonitis (poorly defined fine micronodules, multilobular decreased attenuation / air trapping, sparing of lung bases)\n(4) Sarcoidosis (large cysts, peribronchovascular nodules)\n(5) Coal workers pneumoconiosis (less traction bronchiectasis, more subpleural homogeneous attenuation, more random distribution of fibrosis)\n\n# IDIOPATHIC PULMONARY HEMOSIDEROSIS \n\n$=\\mathrm{IPH}=$ probable autoimmune process with clinical + radiologic remissions + exacerbations characterized by eosinophilia + mastocytosis, immunoallergic reaction, pulmonary hemorrhage, iron deficiency anemia\nAge: (a) chronic form: most commonly $<10$ years of age\n(b) acute form (rare): in adults; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 628,
            "markdown": "Histo: hemosiderin-laden macrophages in bronchoalveolar lavage\n\n- recurrent episodes of severe hemoptysis, clubbing of fingers\n- hepatosplenomegaly ( $25 \\%$ ), bilirubinemia\n- iron deficiency anemia\n\nDistribution: perihilar + lower lung zone predominance\n$\\sqrt{ }$ bilateral patchy alveolar-filling pattern (= blood in alveoli); initially for 2-3 days with return to normal in 10-12 days unless episode repeated\n$\\checkmark$ reticular pattern (= deposition of hemosiderin in interstitial space) later\n$\\checkmark$ moderate fibrosis after repeated episodes\n$\\checkmark$ hilar lymph nodes may be enlarged during acute episodes\nCT:\n$\\checkmark$ diffuse homogeneous areas of ground-glass attenuation (during exacerbation)\n$\\checkmark$ nodules + patchy areas of ground-glass attenuation (subacute phase)\nPrognosis: death within 2-20 years (average survival 3 years)\n$D D x$ :\n\n1. Secondary pulmonary hemosiderosis\n\nCause: mitral valve disease\n$\\checkmark$ septal lines (NOT in idiopathic form)\n$\\checkmark$ lung ossifications (NOT in idiopathic form)\n2. Goodpasture syndrome\n\n- antiglomerular basement membrane antibodies\n\n\n# INFLAMMATORY PSEUDOTUMOR \n\n$=$ INFLAMMATORY MYOBLASTIC PSEUDOTUMOR $=$ PLASMA CELL GRANULOMA $=$ PLASMACYTOMA $=$ (FIBROUS) HISTIOCYTOMA $=$ XANTHOGRANULOMA $=$ XANTHOMA $=$ XANTHOFIBROMA $=$ SCLEROSING HEMANGIOMA $=$ PSEUDOLYMPHOMA\n$=$ rare mass characterized by fibroblastic / myofibroblastic spindle cell proliferation with varying degrees of inflammatory cell infiltration (lymphocytes, plasma cells, histiocytes)\nCause: ? low-grade malignancy versus primary inflammation\nAssociated with: minor trauma, surgery, malignancy, occult infection (Epstein-Barr virus, Mycobacterium, Actinomyces), IgG4-related sclerosing disease\nPrevalence: $<1 \\%$ of all tumors of lung + airways\nPath: nonencapsulated circumscribed nodular mass, occasionally with infiltrative margins\nHisto: mixture of inflammatory cells (plasma cells, lymphocytes, eosinophils, neutrophils) + myofibroblastic proliferation (fibroblasts, blood vessels); foamy histiocytes + multinucleated giant cells + spindle cells ( $70 \\%$ of tumor) grouped in CHARACTERISTIC pinwheel / whorled pattern\n$D D x$ : malignancy $\\leftarrow$ highly cellular areas with mitoses\nAge: young patient\n\n- asymptomatic\n- airway obstruction (symptoms often attributed to asthma / pneumonia), fever, malaise, weight loss, abdominal pain\nLocation: described in all major organs\n@ Chest: lung $>$ bronchus $/$ trachea $>$ pleura",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 629,
            "markdown": "@ Orbit\n@ Abdomen: liver ( $2^{\\text {nd }}$ most common), spleen, pancreas, adrenal gland, kidney, retroperitoneum, diaphragm, mesentery GI tract, GU tract\n$\\sqrt{ }$ well-defined smoothly marginated / infiltrating mass\nUS:\n$\\sqrt{ }$ solid process with variable echogenicity $\\pm$ Doppler flow\nCT:\n$\\sqrt{ }$ variable heterogeneous attenuation $\\pm$ central calcification\n$\\sqrt{ }$ no / heterogeneous / peripheral enhancement\nMR:\n$\\sqrt{ }$ hypointense lesion $\\leftarrow$ fibrotic component\n$\\sqrt{ }$ NO restricted diffusion\n$R x$ : surgical excision\n$D D x$ : any soft-tissue tumor\n\n# KARTAGENER SYNDROME \n\n$=$ IMMOTILE / DYSMOTILE CILIASYNDROME\n[Manes Kartagener (1897-1975), internist at the University department of medicine in Zurich, Switzerland]\n$=$ uncommon autosomal recessive disease characterized by congenital impairment of mucociliary transport\nFrequency: $1 \\div 40,00$; high familial incidence\nEtiology: abnormal mucociliary function $\\leftarrow$ generalized deficiency of dynein arms of cilia affecting respiratory epithelium, auditory epithelium, sperm\nTriad: (1) Situs inversus (in 50\\%)\n\n- Kartagener syndrome is present in $20 \\%$ of patients with situs inversus!\n(2) Nasal polyposis with chronic sinusitis\n(3) Bronchiectasis\n- chronic respiratory tract infections beginning in early childhood $\\rightarrow$ chronic bronchitis + rhinosinusitis\n- otitis $\\rightarrow$ deafness; male infertility (abnormal sperm tails)\n\nLocation: middle lobe, lingula, lower lobes\n$\\sqrt{ }$ ground-glass opacity / pulmonary consolidation ( $60 \\%$ )\n$\\sqrt{ }$ peribronchial / bronchial wall thickening ( $96 \\%$ )\n$\\sqrt{ }$ mucous plug $(85 \\%)+$ atelectatic areas\n$\\sqrt{ }$ bronchiectasis ( $73 \\%$ ) / bronchiolectasis\n$\\sqrt{ }$ air trapping $(38 \\%)=$ hyperinflation\n$\\sqrt{ } \\pm$ small centrilobular opacities $=$ tree-in-bud pattern\nAssociated anomalies:\ntransposition of great vessels, trilocular / bilocular heart, pyloric stenosis, postcricoid web, epispadia, pectus excavatum, polysplenia ( $8 \\%$ )\n$D D x$ : cystic fibrosis (predominantly upper lobe lesions)\n\n## KLEBSIELLA PNEUMONIA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 630,
            "markdown": "$\\diamond$ Most common cause of Gram-negative pneumonias; community acquired\nFrequency: responsible for $5 \\%$ of adult pneumonias\nOrganism: Friedländer bacillus $=$ Klebsiella pneumoniae $=$ encapsulated, nonmotile, Gramnegative rod\n[Carl Friedländer (1847- 1887), German pathologist and microbiologist at Städtische Krankenhaus Am Friedrichshain, Berlin, introduced the ampoule, also first described thromboangiitis obliterans]\nPredisposed: elderly, debilitated, alcoholic, chronic lung disease, malignancy\n\n- bacteremia in $25 \\%$\n$\\checkmark$ propensity for posterior portion of upper lobe / superior portion of lower lobe\n$\\checkmark$ dense lobar consolidation\n$\\checkmark$ bulging of fissure (large amounts of inflammatory exudate) CHARACTERISTIC but unusual\n$\\checkmark$ empyema (one of the most common causes)\n$\\checkmark$ patchy bronchopneumonia may be present\n$\\checkmark$ uni- / multilocular cavities ( $50 \\%$ ) appearing within 4 days\n$\\checkmark$ pulmonary gangrene $=$ infarcted tissue (rare)\nCx: meningitis, pericarditis\nPrognosis: $25-50 \\%$ mortality rate\n$D D x$ : Acute pneumococcal pneumonia (bulging of fissures, abscess + cavity formation, pleural effusion / empyema frequent)\n\n\n# LEGIONELLA PNEUMONIA \n\n$=$ LEGIONNAIRES' DISEASE\nOrganism: Legionella pneumophila, $1-2 \\mu \\mathrm{~m}$, aerobic, Gram-negative bacillus, weakly acidfast, silver-impregnation stain\nPredisposed: middle-aged / elderly, immunosuppressed, alcoholism, chronic obstructive lung disease, diabetes, cancer, cardiovascular disease, chronic renal failure, transplant recipients\nTransmission: direct inhalation (air conditioning systems)\nPrevalence: 6\\% of community-acquired pneumonias\nHisto: leukocytoclastic fibrinopurulent pneumonia with histiocytes in intraalveolar exudate\n\n- fever; absence of sputum / lack of purulence (22-75\\%)\n\nClue: involvement of other organs with\n\n- diarrhea ( $0-25 \\%$ ), myalgia, toxic encephalopathy\n- liver + renal disease; hyponatremia (20\\%)\n- elevated serum transaminase / transpeptidase levels\n- lack of quick response to penicillin / cephalosporin / aminoglycoside\n\nConcomitant infection (in 5-10\\%):\nStreptococcus pneumoniae, Chlamydia pneumoniae, Mycobacterium tuberculosis, Pneumocystis carinii\nLocation: unilateral / bilateral (less frequent); lobar / segmental\n$\\checkmark$ patchy bronchopneumonia (= multifocal consolidation)\n$\\checkmark$ moderate volume of pleural effusion (6-30-63\\%)\n$\\checkmark$ cavitation (rare)\nCx: progressive respiratory failure (most common cause of death; $6 \\%$ mortality in otherwise healthy patients)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 631,
            "markdown": "# LIPOID PNEUMONIA \n\n## Acute Exogenous Lipoid Pneumonia\n\n$=$ FIRE-EATER PNEUMONIA\nMaterial: liquid paraffin, petroleum (hydrocarbons)\nCause: accidental poisoning in children, fire-eaters\n$\\sqrt{ }$ ill-defined nodular areas of increased radiopacity\n$\\sqrt{ }$ pneumatoceles / thin-walled collections of air\n\n## Chronic Exogenous Lipoid Pneumonia\n\nEtiology: aspiration / inhalation of fatlike material\nTypes of oils:\n(a) vegetable oil: sesame oil used in medical suspensions for the treatment of constipation\n(b) animal oil: cod liver oil (commonly given to children); squalene $=$ derivative of shark liver oil (folk remedy in some Asian countries); milk\n(c) mineral oil (most common): as liquid paraffin in nose drops (taken at bedtime) / oral laxatives $=$ inert pure hydrocarbon that does not initiate cough reflex\nPredisposed: elderly, debilitated, neuromuscular disease, swallowing abnormalities (eg, scleroderma)\nPath: pool of oil emulsified by lung lipase + surrounded by giant cell foreign body reaction (mineral oil aspiration) / necrotizing hemorrhagic bronchopneumonia (higher content of free fatty acid in animal fat aspiration)\n$\\diamond$ The degree + type of tissue reaction depend on the frequency of aspiration + chemical character of oil\nHisto: numerous lipid-laden macrophages distending alveolar walls + interstitium, accumulation of lipid material, inflammatory cellular infiltration, variable amount of fibrosis\n\n- mostly asymptomatic; fever, constitutional symptoms\n- lipid-laden macrophages in sputum / lavage fluid\n- oil droplets in bronchial washing / needle aspirate\n\nLocation: predilection for RML + lower lobes\n$\\sqrt{ }$ homogeneous segmental airspace consolidation (most common)\n$\\sqrt{ }$ interstitial reticulonodular pattern (rare)\n$\\sqrt{ }$ paraffinoma $=$ circumscribed peripheral mass (granulomatous reaction + fibrosis often causing stellate appearance)\n$\\sqrt{ }$ slow progression / no change\nCT:\n$\\sqrt{ }$ diffuse ground-glass opacity of centri- / panlobular distribution (= acinar pattern) + thickening of interlobular septa as earliest finding\n$\\sqrt{ }$ airspace consolidation (filling of alveoli with exudate + inflammatory cells) at 1 week\n$\\sqrt{ }$ return to ground-glass opacity $\\leftarrow$ expectoration + lymphatic drainage of lipid droplets + inflammatory cells at $2-4$ weeks\n$\\sqrt{ }$ volume loss + fibrosis of interlobular septa and pleura at 14-16 weeks",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 632,
            "markdown": "$\\sqrt{ }$ mass of low-attenuation approaching that of subcutaneous fat ( -150 to 50 HU )\n$D x$ : bronchoalveolar lavage, transbronchial biopsy\n\n# LUNG TRANSPLANT \n\nIndications for transplantation:\nemphysema / COPD (39\\%), idiopathic pulmonary fibrosis (17\\%), cystic fibrosis (16\\%), alpha-1 antitrypsin deficiency ( $9 \\%$ ), CHD, primary pulmonary hypertension, sarcoidosis, pneumoconiosis, malignancy (lung cancer contraindicated)\nUnilateral lung transplants:\nin selected cases of emphysema, pulmonary fibrosis\nContraindicated in: cystic fibrosis; bronchiectasis $\\leftarrow$ cross-contamination\nOperative mortality: up to $8 \\%$\nCommon causes of mortality: bacterial infection, chronic graft dysfunction\nRecurrence of primary disease:\nsarcoidosis (in 35\\%); others (in 1\\%): lymphangioleiomyomatosis, Langerhans cell\nhistiocytosis, talc granulomatosis, diffuse panbronchiolitis, alveolar cell proteinosis\nSurvival rate: $75 \\%$ for 1 year, $50 \\%$ for 5 years, $35 \\%$ for 10 years, $25 \\%$ for 15 years\nImmediate Complications of Lung Transplant (< 24 hours)\nA. Malpositioned monitoring tubes and lines\nB. Donor-recipient mismatch\nC. Hyperacute Rejection of Lung Transplant\n$=$ rejection in cases of an immunoglobulin G donor-specific HLA antibody positive crossmatch\nPath: acute diffuse alveolar damage\n$\\sqrt{ }$ diffuse homogeneous infiltrate of entire allograft\nEarly Complications of Lung Transplant (24 hours to 1 week)\nAcute Pleural Complications of Lung Transplant\nFrequency: $22 \\%$\nTypes:\n\n1. Pneumothorax (most common)\n2. Postoperative effusion (resolves by 2 weeks)\n3. Air leaks $\\leftarrow$ airway ischemia, bronchial dehiscence\n\n## Reperfusion Edema\n\n$=$ ISCHEMIA-REPERFUSION INJURY = PULMONARY REIMPLANTATION RESPONSE\n$=$ noncardiogenic pulmonary edema $=$ infiltrate appearing within 48 hours after transplantation unrelated to fluid overload, LV failure, infection, atelectasis, or rejection; diagnosed by exclusion\n$\\diamond$ Most frequent immediate postoperative complication!\nRisk factors: poor organ preservation, prolonged ischemic time, unsuspected donor pathology (contusion, aspiration), interrupted lymphatic flow, cytokinemediated injury",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 633,
            "markdown": "Pathogenesis: permeability edema $\\leftarrow$ lymphatic disruption, pulmonary denervation, organ ischemia, surgical trauma\nHisto: fluid accumulation in interstitium consistent with noncardiogenic pulmonary edema Time course: manifests after 24 hours, peaks on $4^{\\text {th }}$ postoperative day, generally resolves by end of $1^{\\text {st }}$ week (up to 6 months)\n\n- increasing hypoxia before extubation; poor correlation between radiographic severity + physiologic parameters\nLocation: perihilar areas + basal regions in transplanted lung\n$\\sqrt{ }$ perihilar haze / rapid uni- or bilateral heterogeneously dense interstitial and/or airspace disease\n$\\sqrt{ }$ small pleural effusions\n$D x$ : per exclusion (radiographic changes not due to LV failure, hyperacute rejection, fluid overload, infection, atelectasis)\nPrognosis: usually resolves over 7-10 days\n$R x$ : diuresis, mechanical support\nIntermediate Complications (8 days - 2 months)\n\n\n# Acute Rejection of Lung Transplant \n\nCause: cell-mediated immune response\nHisto: mononuclear cell infiltrate around arteries, veins, bronchioles, alveolar septa with alveolar edema (initially) + fibrinous exudate (later)\nFrequency: $60-80 \\%$ with $2-3$ significant episodes in first 3 months\n$\\diamond$ Most patients will have at least 1 episode in the year following transplantation!\nTime of onset: first episode 5-10 days after transplantation; occasionally by 48 hours\n\n- drop in arterial oxygen pressure WITHOUT infection /airway obstruction / fluid overload\n- pyrexia, fatigue, decreased exercise tolerance\n$\\checkmark$ heterogeneous opacities in perihilar areas\n$\\checkmark$ peribronchial cuffing\n$\\checkmark$ ground-glass attenuation on HRCT\n$\\checkmark$ new increasing pleural effusion + septal thickening (most common, $90 \\%$ specific, $68 \\%$ sensitive) WITHOUT concomitant signs of LV dysfunction (= increase in cardiac size / vascular pedicle width / vascular redistribution)\n$\\checkmark$ subpleural edema, peribronchial cuffing, airspace disease\n$D x$ : (1) Transbronchial biopsy\n(2) Rapid improvement of radiologic abnormalities after treatment with IV bolus of corticosteroids for 3 days\n$R x$ : methylprednisolone, polyclonal T-cell antibody (antithymocyte globulin), monoclonal antibodies (CD3, OKT3), lymphoid irradiation\n\nDelayed Lung Transplant Complications (> 4 months)\n\n## Chronic Rejection of Lung Transplant\n\n$=$ BRONCHIOLITIS OBLITERANS SYNDROME (BOS)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 634,
            "markdown": "Prevalence: $50 \\%$ at 5 years\n$\\diamond$ Probably develops in all transplant patients given sufficient time!\nRisk factor: frequent / severe bouts of acute rejection, gastroesophageal reflux\nPath: obliterative bronchiolitis (36\\%), interstitial pneumonitis, rejection-mediated vasculopathy\nTime of onset: 3-6-75 months after transplantation\n\n- persistent coughing and wheezing\n- slowly worsening exertional dyspnea\n- physiologic airflow obstruction + decline in forced expiratory volume at 1 second CXR:\n$\\checkmark$ frequently normal\n$\\checkmark$ increased lung volumes (= hyperinflation)\n$\\checkmark$ regional volume contraction\n$\\checkmark$ diminished peripheral lung markings ( $=$ decreased peripheral vascularity)\n$\\checkmark$ thin irregular areas of increased opacity (= subsegmental atelectasis)\n$\\checkmark$ bronchiectasis\n$\\checkmark$ pleural thickening\n$\\checkmark$ nodular / reticular opacities associated with peribronchial thickening\nHRCT:\n$\\checkmark$ air trapping on expiratory HRCT (HALLMARK)\n$\\checkmark$ mosaic lung attenuation (= regions of mixed hypo- and hyperattenuation)\n$\\checkmark$ central + peripheral cylindrical bronchiectasis\n$\\checkmark$ bronchial wall thickening\n\n\n# Complications of Lung Transplant (any time) \n\n## Anastomotic Complications of Lung Transplant\n\nPrevalence: $15 \\%$\n\n1. Bronchial dehiscence $(2-8 \\%)$\n\nTime of onset: within 1 month\n$\\sqrt{ }$ presence of extraluminal air collections at anastomotic site ( $80 \\%$ )\n$\\checkmark$ bronchial wall defect / narrowing / irregularity\n$D D x$ : telescoped anastomosis\n2. Airway stricture / stenosis\n\nDefinition: stenosis $=\\geq 50 \\%$ diameter reduction\n$D D x$ : telescoped anastomosis\n$R x$ : laser resection, balloon bronchoplasty\n3. Bronchomalacia\n$\\checkmark$ transient airway narrowing on expiratory CT\n4. Vascular stenosis\n5. Diaphragmatic hernia from omentopexy\n\nProcedure: omental pedicle is harvested at time of transplantation through a small diaphragmatic incision + wrapped around anastomosis to prevent dehiscence",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 635,
            "markdown": "# Posttransplantation Infection \n\nCause: immunosuppression, reduced mucociliary clearance, interruption of lymphatic drainage, direct contact of transplant with environment via airways\n$\\diamond$ May occur at any time during postoperative period!\nFrequency: $35-86 \\%$ of transplant recipients\nA. INFECTION OF LUNG TRANSPLANT\n\nPrevalence: $35-50 \\%$; major cause of morbidity + mortality in early postoperative period\nCause: absent cough reflex, impaired mucociliary transport in denervated lung, interruption of lymphatics, immunosuppressive drugs\nOrganism: bacteria (23\\%): Staphylococcus, Pseudomonas, Klebsiella $>$ CMV $>$ Aspergillus (6\\%) > Pneumocystis\n(1) within 1st month: Gram-negative bacteria, fungi (candidiasis, aspergillosis)\n(2) after 1st month: viruses (CMV [50\\%], community-acquired viruses [RSV, parainfluenza, influenza, adenovirus]); Pneumocystis carinii; bacteria; fungi\n\n- fever, leukocytosis\n$\\sqrt{ }$ lobar / multilobar consolidation $\\leftarrow$ bacterial $>$ fungal pathogens\n$\\sqrt{ }$ diffuse heterogeneous air-space / ground-glass opacities $\\leftarrow$ parainfluenza + RSV + adenovirus / disseminated fungal pathogens\n$\\sqrt{ }$ bronchial wall thickening $\\leftarrow$ adenovirus, influenza virus, RSV\n$\\sqrt{ }$ bronchial dilatation $\\leftarrow$ RSV\n$\\sqrt{ }$ nodules $\\leftarrow$ fungal / unusual bacterial pathogens / CMV / septic emboli\n$\\sqrt{ }$ septal lines\n$\\sqrt{ }$ pleural effusion\n$C x$ : may progress rapidly to respiratory failure + death\n$D x$ : transbronchial / open biopsy ( $80 \\%$ accurate)\nB. EXTRAPULMONARY INFECTION\nthoracotomy wound infection, bacteremia, sepsis, empyema, central venous line infection\nPrognosis: primary cause of postoperative mortality in up to $50 \\% ; 2-12 \\%$ mortality for CMV; $50 \\%$ mortality for Aspergillus\n\n\n## LYMPHANGIOMYOMATOSIS\n\n$=$ LAM + LYMPHANGIOLEIOMYOMATOSIS\n$=$ rare disorder characterized by\n(1) Gradually progressive diffuse interstitial lung disease\n(2) Recurrent chylous pleural effusions\n(3) Recurrent pneumothoraces\n\nPrevalence: $1 \\div 400,000 ; 1,300$ women in USA (in 2001)\nEtiology: unknown; hamartomatous proliferation of a particular form of HMB-45 positive smooth muscle (? forme fruste of tuberous sclerosis)\nMean age: 34 (range, 17-62) years, exclusively in women of childbearing age\nPath: enlarged lungs with extensive diffuse air- / fluid-filled 5-20 mm cysts affecting both lungs + distorting pleural surfaces; $\\pm$ involvement of lymph nodes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 636,
            "markdown": "Histo: abnormal proliferation of atypically short + plump smooth muscle cells with a high nuclear-to-cytoplasmic ratio (LAM cells) in pulmonary lymphatic vessels, blood vessels, walls of airways; NO atypia / mitoses; positive staining for human melanin black-45 (HMB-45)\nPathogenesis:\nproliferation of immature smooth muscle cells in a haphazard fashion causes obstruction of\n(a) bronchioles $\\rightarrow$ trapping of air, overinflation, formation of cysts, pneumothorax\n(b) venules $\\rightarrow$ venous occlusion $\\rightarrow$ hemorrhage (hemoptysis), hemosiderosis\n(c) lymphatics $\\rightarrow$ thickening of lymphatics, chylous effusions of thorax + abdomen\n\nHormonal influence: menstruation, pregnancy, exogenous estrogen treatment may result in exacerbation of symptoms\nCause of thin-walled lung cysts:\n(a) air trapping distal to small airways narrowed by smooth muscle proliferation\n(b) destruction of collagen + elastin in the interstitium from metalloproteinases elaborated by LAM cells\nIn $1 \\%$ associated with: tuberous sclerosis\n\n- progressive exertional dyspnea (59\\%) + cough (39\\%)\n- hemoptysis ( $30-40 \\%$ ), chyloptysis (rare)\n- combination of restrictive + obstructive ventilatory defects:\n- radiologic-physiologic discrepancy = severe airflow obstruction in $100 \\%$ (reduced $\\mathrm{FEV}_{1}$, reduced ratio of $\\mathrm{FEV}_{1} / \\mathrm{FVC}$ ) despite relatively normal findings on CXR\n- decreased DLCO (= diffusing capacity for lung carbon monoxide) in $54 \\%$\n- hypoxemia without hypercapnia on arterial blood gas\n- positive immunohistochemical staining of LAM cells with HMB-45 (monoclonal antibody for melanocytic lesion)\nCXR:\n$\\sqrt{ }$ classic signs:\n$\\sqrt{ }$ coarse reticular / reticulonodular interstitial pattern diffusely + equal in all lung zones caused by summation of multiple cyst walls ( $80-90 \\%$ )\n$\\sqrt{ }$ recurrent unilateral pneumothorax ( $39-53 \\%$ at presentation; in up to $81 \\%$ during course of disease)\n$\\sqrt{ }$ recurrent uni- / bilateral chylothorax ( $14 \\%$ at presentation; in up to $39 \\%$ during course of disease)\n$\\sqrt{ }$ normal ( $55-78 \\%$ ) / increased ( $22-45 \\%$ ) lung volume\n$\\diamond$ The only interstitial lung disease to develop an increase in lung volume!\n$\\sqrt{ }$ Kerley B lines $=$ interlobular septal thickening $\\leftarrow$ dilated lymphatics ( $7-9 \\%$ )\n$\\sqrt{ }$ pulmonary cysts (visible if $>1 \\mathrm{~cm}$ ) + honeycombing\n$\\sqrt{ }$ pericardial effusion / chylous pericardial effusion (rare)\n$\\sqrt{ }$ mediastinal + retroperitoneal adenopathy $\\leftarrow$ smooth muscle proliferation\n\nCT:\n$\\sqrt{ }$ numerous randomly scattered thin-walled ( $<2 \\mathrm{~mm}$ ) cysts of various sizes (typically $2-5$ mm , up to 30 mm ) surrounded by normal lung parenchyma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 637,
            "markdown": "| Parenchymal Involvement |  | Cyst Size |\n| :-- | :--: | :--: |\n| mild | $<25 \\%$ | $<5 \\mathrm{~mm}$ |\n| moderate | $25-80 \\%$ | $5-10 \\mathrm{~mm}$ |\n| severe | $>80 \\%$ | $>10 \\mathrm{~mm}$ |\n\n$\\sqrt{ }$ patchy areas of ground-glass attenuation $\\leftarrow$ hemorrhage following destruction of pulmonary microvasculature\n$\\sqrt{ }$ dilated thoracic duct\n$\\checkmark$ pleural effusion: proteinaceous / chylous ( -17 HU )\n$\\checkmark$ chylous pericardial effusion (rare)\n$\\checkmark$ hilar + mediastinal lymphadenopathy (in up to $50 \\%$ )\nNUC (V/Q scan):\n$\\sqrt{ }$ \"speckling\" = well-defined hot spots on ventilation scan (presumably due to accumulation of coalescing droplets of DTPA aerosol trapped in peripheral cysts) in $66 \\%$\n@ Abdomen (in $76 \\%$ positive findings)\n\n- bloating, increased abdominal girth, abdominal pain\n- flank / pelvic pain\n- perineal swelling, chylous vaginal discharge\n- lower-extremity lymphedema, paresthesias\n$\\sqrt{ }$ lymphadenopathy of up to $4 \\mathrm{~cm}(33 \\%)$ :\nHisto: replacement of lymph node with smooth muscle\nLocation: retroperitoneum ( $77 \\%$ ) $>$ pelvis ( $11 \\%$ ) $>$ mesentery $>$ posterior mediastinum $>$ axilla $>$ neck\n$\\checkmark$ central hypoattenuating areas of -72 to +50 HU (due to chylous lymph collections / fat) $\\pm$ fat-fluid level\n$\\checkmark$ lymphangioleiomyoma ( $5-21 \\%$ ) = well-defined lobulated complex lymphatic mass:\nPath: smooth muscle proliferation in walls of lymphatics resulting in lymphatic dilatation + mural thickening\nSite: retroperitoneum near aorta + renal arteries, posterior mediastinum, mesentery\n$\\checkmark$ thin- / thick-walled mass with hypoattenuating center of $3-25 \\mathrm{HU} \\pm$ fat-fluid level\n$\\checkmark$ volumes of $10-1,500 \\mathrm{~mL}$\n$\\checkmark$ anechoic irregularly shaped thin-walled cysts with intraluminal septa (= ectatic lymphatic vessels)\n$\\checkmark$ diurnal variations in size ( $\\uparrow$ over course of day)\n$\\checkmark$ chylous ascites ( $10-33 \\%$ ): low-density ascites of -10 to $+21 \\mathrm{HU} \\leftarrow$ rupture of overdistended lymph cysts\n$\\checkmark$ dilatation of thoracic duct ( $10 \\%$ )\n$\\checkmark$ fatty liver masses (5\\%): AML/ lipoma\n$\\checkmark$ uterine leiomyomas\n$\\checkmark$ lymphaticoureteric, lymphaticovenous communication\n@ Kidneys\n\n- flank pain, hematuria, severe hypotension, chyluria (with $>4 \\mathrm{~cm}$ large angiomyolipoma)\n$\\checkmark$ angiomyolipoma (in $20-70 \\%$ ):\n$\\checkmark$ occasionally lacking fat\n$\\checkmark$ multiplicity in $<20 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 638,
            "markdown": "$\\sqrt{ }$ simple cysts (occasionally large enough to lead to renal insufficiency)\n$D x$ : open / transbronchial lung biopsy; image-guided biopsy of an extrapulmonary mass\n$R x$ : hormone therapy, oophorectomy, lung transplantation\nPrognosis: survival rate of $91 \\%$ at 5-year, $79 \\%$ at 10 years, $71 \\%$ at 15 years; death from progressive respiratory failure + cor pulmonale\n$D D x$ :\n(1) Tuberous sclerosis (cortical tubers, subependymal nodules, retinal hamartomas, facial angiofibromas, periungual fibromas, mental retardation, epilepsy, multiple renal AML in $40-80 \\%)$\n(2) Langerhans cell histiocytosis (irregular cysts in upper $2 / 3$ of lung with sparing of costophrenic angles, cyst walls more variable in thickness, pulmonary nodules and cavitation, septal thickening)\n(3) Centrilobular emphysema (imperceptible cyst walls, cysts chiefly distributed in upper lobes, lobular architecture preserved with bronchovascular bundle in central position, areas of lung destruction without arcuate contour)\n(4) Paraseptal emphysema (evident walls, arrayed in a single subpleural tier)\n(5) Idiopathic pulmonary fibrosis = fibrosing alveolitis (small irregular thick-walled cysts in a predominantly peripheral subpleural + basilar distribution, surrounded by abnormal distorted lung parenchyma)\n(6) Neurofibromatosis (cystic air spaces predominantly in apical location)\n\n# LYMPHANGITIC CARCINOMATOSIS \n\n$=$ INTERSTITIAL CARCINOMA $=$ LYMPHANGITIS CARCINOMATOSA\n$=$ tumor cell accumulation within connective tissue (bronchovascular bundles, interlobular septa, subpleural space, pulmonary lymphatics) from tumor embolization of blood vessels followed by lymphatic obstruction, interstitial edema, and collagen deposition (fibrosis from desmoplastic reaction when tumor cells extend into adjacent pulmonary parenchyma)\nFrequency: $7 \\%$ of all pulmonary metastases\nTumor origin: bronchogenic carcinoma, carcinoma of breast (56\\%), stomach (46\\%), thyroid, pancreas, larynx, cervix\nmnemonic: Certain Cancers Spread By Plugging The Lymphatics\nCervix\nColon\nStomach\nBreast\nPancreas\nThyroid\nLarynx\nPath: (a) interstitial edema\n(b) interstitial fibrotic changes\n(c) lymphatic dilatation\n(d) tumor cells within connective tissue planes\n\n- dyspnea (often preceding radiographic abnormalities)\n- rarely dry cough + hemoptysis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 639,
            "markdown": "Location: bilateral; unilateral if secondary to lung primary\nCXR (accuracy 23\\%):\n$\\checkmark$ normal chest radiograph\n$\\checkmark$ reticular / reticulonodular opacities\n$\\checkmark$ coarsened bronchovascular markings\n$\\checkmark$ Kerley A + B lines\n$\\checkmark$ small lung volume\n$\\checkmark$ hilar ( $20-50 \\%$ ) / mediastinal lymphadenopathy\n$\\checkmark$ pleural effusion\nHRCT:\n$\\checkmark$ normal lung architecture without distortion\n$\\checkmark$ focal / diffuse, uni- / bilateral distribution\n$\\checkmark$ well-defined smoothly thickened polygonal reticular network of $10-25 \\mathrm{~mm}$ in diameter ( $=$ thickened interlobular septa)\n$\\checkmark$ irregular / nodular = \"beaded\" thickening of interlobular septa\n$\\checkmark$ central dot within secondary pulmonary lobule $=$ thickened centrilobular bronchovascular bundle\n$\\checkmark$ smooth / nodular thickening of fissures\n$\\checkmark$ subpleural thickening\n$\\checkmark$ pleural effusion ( $30-50 \\%$ )\n$\\checkmark$ hilar / mediastinal lymphadenopathy ( $30-50 \\%$ )\nPrognosis: death within 1 year\n$D D x$ : (1) Fibrosing alveolitis (peripheral predominance)\n(2) Extrinsic allergic alveolitis (no polygonal structures, pleural changes rare)\n(3) Sarcoidosis (nodules of irregular outline more frequent in upper lobes, polygonal structures uncommon)\n(4) pulmonary edema (smooth septal thickening)\n\n# LYMPHOMA \n\n$=$ NON-HODGKIN LYMPHOMA (NHL) = MALIGNANT LYMPHOMA\n$=$ most common primary hematopoietic malignancy\n$\\diamond 7^{\\text {th }}$ leading cause of death from cancer in USA\nPathogenesis: ? viral cause\nFrequency: $4.3 \\%$ of all newly diagnosed cancers (2015); 3rd most common cancer in childhood (behind leukemia + CNS neoplasms); 4 times more common than Hodgkin disease\nPredisposed: (40-100 times greater risk) congenital immuno-deficiency syndromes, immunosuppressed organ transplant recipients, patients with HIV infection, collagen vascular disease\nAge: all ages; median age of 55 years; $\\mathrm{M} \\div \\mathrm{F}=1.4 \\div 1$\n\n- chest / shoulder pain, dyspnea, dysphagia\n- CHF, hypotension, SVC syndrome\n\nModified Rappaport Classification:\n$=$ categorization according to histologic distribution of lymphomatous cells\nA. Nodular form $=$ organized in clusters",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 640,
            "markdown": "1. Poorly differentiated lymphocytic (PDL)\n2. Mixed lymphocytic / histiocytic (mixed cell)\n3. Large cell (histiocytic)\nB. Diffuse form $=$ distortion of tissue architecture\n4. Well-differentiated lymphocytic (WDL)\n5. Intermediate-differentiated lymphocytic (IDL)\n6. Poorly differentiated lymphocytic (PDL)\n7. Mixed lymphocytic / histiocytic large cell (histiocytic) (DLCL); undifferentiated Burkitt lymphoma; undifferentiated non-Burkitt lymphoma (pleiomorphic); lymphoblastic (LBL); unclassified\nWorking Formulation Classification (Kiel / Lennert):\n$=$ categorization by grade\nA. Low grade\n8. Small lymphocytic $(3.6 \\%)$\n9. Follicular, small cleaved cell $(22.5 \\%)$\n10. Follicular, mixed $(7.7 \\%)$\nB. Intermediate grade\n11. Follicular, large cell $(3.8 \\%)$\n12. Diffuse, small cleaved cell $(6.9 \\%)$\n13. Diffuse, mixed $(6.7 \\%)$\n14. Diffuse, large cell $(19.7 \\%)$\nC. High grade\n15. Large cell, immunoblastic $(7.9 \\%)$\n16. Lymphoblastic $(4.2 \\%)$\n17. Small noncleaved cell $(5 \\%)$\nD. Miscellaneous $(12 \\%)$\ncomposite, mycosis fungoides, histiocytic, extramedullary plasmacytoma\nLuke and Collins Classification:\n$=$ categorization by morphologic characteristics of cell + cell of origin (T cell, B cell, non-B, non-T cell)\nHistologic types:\nA. B-cell\n18. Diffuse large B-cell lymphoma\n$\\diamond$ The largest subtype of NHL\nPrognosis: extranodal involvement frequent at presentation, rapid spread to nodes, curable in $<50 \\%$\n19. Mantle cell lymphoma\n$\\diamond 4-8 \\%$ of all NHL\n$\\checkmark$ extranodal involvement of GI tract + bone marrow\nPrognosis: poor\n20. Follicular lymphoma\n\nFDG PET reliable for staging + follow-up ( $98 \\%$ sensitive, $94 \\%$ specific, $95 \\%$ PPV, $98 \\%$ NPV)\n$\\checkmark$ potential for upstaging in a high number of patients with apparent early-stage disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 641,
            "markdown": "Prognosis: good response to initial therapy, pattern of repeated relapses, tendency to progress to diffuse large B-cell lymphoma\n\n# 4. Burkitt Lymphoma \n\n[Denis Parsons Burkitt (1911-1993), Irish surgeon who served with the Royal Army Medical Corps in England and later in Kenya and Somaliland settling in Uganda]\n(a) endemic type (Africa)\n(b) Non-African Burkitt lymphoma sporadic type (Europe, US, Japan) and immunodeficiency type (HIV-infected patients)\n$\\checkmark$ often in abdominal location\n$\\checkmark$ extremely hypermetabolic\n5. Mucosa-associated lymphoid tissue (MALT)\n$\\diamond$ Subtype related to chronic inflammation and autoimmune disease\n$\\checkmark$ orbital MALT (low metabolism) + pulmonary MALT (metabolism similar to pneumonia) + gastric MALT (physiologic FDG accumulation) $\\rightarrow$ difficult to diagnose\nB. T-cell\n\n1. Lymphoblastic lymphoma\n\nPrevalence: higher in Far East than Western nations\nAge: young adults\n$\\checkmark$ usually manifests with a mediastinal mass\n$\\checkmark<25 \\%$ leukemia cells in bone marrow (DDx to acute lymphoblastic leukemia with $>25 \\%)$\n2. Peripheral T-cell lymphoma\n\nFDG PET only $40 \\%$ sensitive\n3. Adult T-cell lymphoma-leukemia\n\nGeography: Japan (Kyushu region), Caribbean, Central African Republic, Central \\& South America\n\n- positive human adult T-lymphotropic virus type 1 (HTLV-1)\n\n4. Malignancy associated with Epstein-Barr virus\n\nEpstein-Barr virus (= human herpesvirus 4) may induce natural killer cell (NK) and Tcell lymphoproliferative disorders; associated with infectious mononucleosis, chronic active Epstein-Barr virus infection\n\n| Malignancy Grade vs. Type of Lymphoma at FDG PET |  |  |\n| :--: | :--: | :--: |\n| Malignancy Grade | B-Cell Lymphoma | T-Cell Lymphoma |\n| Indolent | Follicular lymphoma (grade 1-3a); MALT lymphoma; chronic lymphocytic leukemia; nodal marginal zone B-cell lymphoma | Adult T-cell leukemia-lymphoma (chronic); mycosis fungoides; large granular T-cell lymphocytic leukemia |\n| Aggressive | Follicular lymphoma (grade 3b); diffuse large B-cell lymphoma; plasma cell myeloma; intravascular large B-cell lymphoma; primary effusion lymphoma; Burkitt lymphoma; mantle cell lymphoma | Peripheral T-cell lymphoma; extranodal T-cell lymphoma; T-cell prolymphocytic leukemia; angioimmunoblastic T-cell lymphoma, aggressive natural killer-cell leukemia; enteropathy-type T-cell lymphoma;hepatosplenic T-cell lymphoma |\n| Very aggressive | Burkitt lymphoma; lymphoblastic lymphoma | Adult T-cell leukemia-lymphoma (acute); lymphoblastic lymphoma |\n\n## 5. Nasal type extranodal NK/T-cell lymphoma (angiocentric lymphoma)\n\nAge: 40 years",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 642,
            "markdown": "Geography: frequent in Asia\nHisto: angiocentric invasion\nPrognosis: poor\nPET/CT ( $88-100 \\%$ sensitive):\n$\\diamond$ Most useful tool for primary diagnosis + assessment of response to treatment + prognosis CT / MR:\n$\\checkmark$ homogeneous attenuation / signal intensity\n$\\checkmark$ vascular penetration = \"sandwich\" sign (CHARACTERISTIC for mesenteric lymphoma)\n$\\checkmark$ spread across existing structure $\\leftarrow$ permeative nature\nStaging: same Ann Arbor system as for Hodgkin disease\n$R x$ : involved-field radiation (stage I or II); chemotherapy (stage III and IV)\nPrognosis: $64 \\% 5$-year survival; death rate of $8.9 / 100,000$ males $+5.7 / 100,000$ females\n\n# Extranodal Involvement in Lymphoma (NHL) \n\nSites other than: nodal (see below)\nFrequency: NHL (in 20-40\\%); Hodgkin disease (4-5\\%)\nA. FOCAL / MULTIFOCAL SOLID ORGAN DISEASE\n\nCT:\n$\\checkmark$ discrete round well-defined homogeneous solid nodules in focal / multifocal disease\n$\\checkmark \\pm$ heterogeneous appearance $\\leftarrow$ central necrosis\n$\\checkmark$ mild uniform contrast enhancement\nUS:\n$\\checkmark$ homogeneously hypoechoic nodules resembling cysts\n$\\checkmark \\pm$ bull's-eye appearance\n$\\checkmark$ absence of posterior acoustic enhancement\nMR:\n$\\checkmark$ nodules of low to intermediate SI on T1WI + moderately high SI on T2WI\n$\\checkmark$ moderate uniform contrast enhancement\n$D D x$ : metastases, primary cancer, infection, granulomatous disease\nB. DIFFUSE SOLID ORGAN DISEASE\n\nCT / MR:\n$\\checkmark$ NO structural abnormality $\\rightarrow$ detection difficult\n$\\checkmark$ organomegaly $\\rightarrow$ very low sensitivity \\& specificity for diagnosis of lymphoma\n$\\checkmark$ uniform infiltration of involved site\n$\\checkmark$ subtle heterogeneous areas after contrast administration, NOT visible on unenhanced images\n$\\checkmark$ uptake on PET\n$\\checkmark$ CHARACTERISTIC amorphous infiltration of tissues outside involved organ with minimal mass effect\n@ Chest $(40-50 \\%)$ :\nlung ( $6 \\%$ ), pleural fluid ( $3.3 \\%$ ), pericardial fluid ( $0.7 \\%$ ), heart ( $0.2 \\%$ )\n$\\checkmark$ hilar + mediastinal adenopathy (DDx: sarcoidosis; anterior nodes favor lymphoma)\n$\\diamond$ Nodes frequently not involved!\n$\\checkmark$ isolated lymph nodes may enhance (DDx: Castleman dz)\n$\\checkmark$ lung nodules + air bronchograms",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 643,
            "markdown": "$\\checkmark$ pleural effusion\nPrognosis: unfavorable\n@ Spleen (41\\%)\n@ Pancreas (30\\%)\n@ Liver (14\\%)\n@ GI tract: stomach (3\\%), small bowel (5\\%), large bowel (2\\%), peritoneal nodules + ascites $(1.4 \\%)$\n@ GU tract (10\\%): kidneys (6\\%), testes (1.2\\%), ovaries (1.8\\%), uterus (1.2\\%)\n@ Skin (6.4\\%)\n@ Bone (3.8\\%)\n@ CNS (2.4\\%)\n\n- cranial nerve palsy / spinal cord compression\n@ Head and neck (1.7\\%)\n@ Breast (1.2\\%)\n\n\n# Nodal Involvement in Lymphoma (NHL) \n\nSites: lymph nodes, spleen, thymus, tonsils, pharyngeal lymphatic (Waldeyer throat) ring\n@ Mesenteric lymph nodes (51\\%): predominantly in middle mediastinum, cardiophrenic angle\n$\\diamond$ Single lymph node involvement is often the only manifestation of intrathoracic disease!\n@ Splenic hilar lymph nodes (53\\%)\n$\\diamond$ Lymphography $89 \\%$ sensitive $+86 \\%$ specific\n@ Paraaortic lymph nodes (49\\%)\n\n## Differences between NHL and Hodgkin Disease\n\nHD: contiguous spread $\\rightarrow$ scan only abnormal area\nNHL: noncontiguous spread $\\rightarrow$ requires scanning of chest, abdomen, pelvis\n@ Thoracic lymphadenopathy anterior mediastinal, pretracheal, hilar, subcarinal, axillary, periesophageal, paracardiac, superior diaphragmatic, internal mammary lymph nodes\n$>$ anterior mediastinum: nodular sclerosing type of HD (75\\%); M < F\n> posterior mediastinum: NHL\n@ Spleen\n\n| Differences between NHL and Hodgkin Disease |  |  |\n| :--: | :--: | :--: |\n| Organ Involvement | NHL | HD |\n| Thoracic involvement | $45 \\%$ | $85 \\%$ |\n| Mediastinal nodes | posterior | anterior |\n| Lung involvement | $4 \\%$ | $12 \\%$ |\n| Lymphadenopathy |  |  |\n| Periaortic adenopathy | $49 \\%$ | $25 \\%$ |\n| Mesenteric adenopathy | $51 \\%$ | $4 \\%$ |\n| Liver involvement | $14 \\%$ | $8 \\%$ |\n| Hepatomegaly | $57 \\%$ | $<30 \\%$ |\n| Splenic involvement | $41 \\%$ | $37 \\%$ |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 644,
            "markdown": "| Differences between Adult and Childhood NHL |  |  |\n| :-- | :--: | :--: |\n| Characteristics | Adult NHL | Childhood NHL |\n| Primary site | nodal | extranodal |\n| Histology | $50 \\%$ follicular, |  |\n|  | $50 \\%$ diffuse | diffuse |\n| Grade | low, intermediate, high | high |\n| Histologic subtype | many | three |\n| Sex predilection | none | $70 \\%$ male |\n\n$H D$ : most common site of abdominal involvement\nNHL: $3^{\\text {rd }}$ most common site of abdominal involvement; may be initial manifestation in large cell NHL\n@ Gastrointestinal involvement in $10 \\%$ of patients with abdominal lymphoma (uncommon in HD, common in histiocytic NHL); NHL accounts for $80 \\%$ of all gastric lymphomas\n@ Renal involvement late manifestation, most commonly in NHL\n@ Adrenal involvement more common in NHL\n@ Extranodal involvement more frequent with histologically diffuse forms of NHL\n\n# Lymphoma (NHL) in Childhood \n\nFrequency: $3^{\\text {rd }}$ most common childhood malignancy (after leukemia + CNS tumors); $7 \\%$ of all malignancies in children $<15$ years of age\nOrigin: B or T cell (in $90 \\%$ ) located outside marrow; (rarely) non-B and non-T cells located within bone marrow\nMedian age: 10 years; $<15$ years of age (most common); unusual $<5$ years of age; $\\mathrm{M}+\\mathrm{F}=$ $2 \\div 1$\n\n- chest pain, back pain, cough, dyspnea, fever\n- anorexia, weight loss, $\\pm$ peripheral blood involvement\n- bone marrow involvement:\n$<25 \\%=$ lymphoma; $>25 \\%=$ leukemia\nHisto: Burkitt lymphoma (most common), Burkitt-like lymphoma, large B-cell lymphoma, lymphoblastic lymphoma, anaplastic large cell lymphoma, peripheral T-cell lymphoma\nPrognosis: $80 \\%$ cure rate with multiple-agent chemotherapy\n$D D x$ : (1) Acute lymphocytic leukemia ( $>25 \\%$ lymphoblasts within bone marrow)\n(2) Hodgkin disease (contiguous spread, nodes are site of origin)\n\nUndifferentiated / Small Noncleaved NHL (39\\%)\nPath: non-Burkitt lymphoma; Burkitt lymphoma\n\n- abdominal mass $\\pm$ ascites\n- pain similar to appendicitis / intussusception\n\nPrimary site: abdomen (distal ileum, cecum, appendix); ovaries",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 645,
            "markdown": "| St. Jude Children Hospital Staging Classification for NHL |  |\n| :--: | :--: |\n| Stage | Description |\n| I | single extranodal tumor / single nodal area outside abdomen and mediastinum |\n| II | single tumor with regional node involvement; $\\geq 2$ tumors / nodal areas on same side of diaphragm; primary resected GI tumor $\\pm$ regional node involvement |\n| III | tumors / nodal involvement on both sides of diaphragm; any intrathoracic / extensive intraabdominal disease; any paraspinal / epidural tumor |\n| IV | bone marrow* / CNS ${ }^{\\text {A }}$ disease regardless of other sites |\n| * 5\\% malignant cells with normal peripheral blood cell count; in lymphoblastic lymphoma with $>25 \\%$ malignant cells = leukemia |  |\n| ${ }^{\\text {A }}$ in lymphoblastic lymphoma a WBC $\\geq 5 / \\mu \\mathrm{L}$ with malignant cells |  |\n\nCommon site: mesenteric, inguinal, iliac nodes; CNS; bone marrow; kidney\nRare site: orbit, supradiaphragmatic paraspinal region, mediastinum, paranasal sinuses, bone, testes, pulmonary parenchyma\n$C x$ : \"leukemic transformation\" (= extensive bone marrow involvement)\n\n# Lymphoblastic (T-cell) NHL (28\\%) \n\nPrimary site: mediastinum ( $66 \\%$ )\nCommon site: neck, thymus, liver, spleen, CNS, bone marrow, gonads\nRare site: subdiaphragmatic (ileum, cecum, kidney, mesentery, retroperitoneum), orbit, paranasal sinus, thyroid, parotid\n\n- respiratory distress, dysphagia\n- SVC syndrome, pericardial tamponade\n\n\n## Large Cell (histiocytic) NHL (26\\%)\n\nOrigin: B cell, T cells (small percentage)\nLocation: nodal + extranodal\nPrimary site: variable (Waldeyer ring, Peyer patches)\nCommon site: peripheral lymph nodes, lung, bone, brain, skin\nRare site: hard palate, esophagus, trachea\nPET - SUV measurement: $92 \\%$ sensitive, $90 \\%$ specific\n\n## LYMPHOMATOID GRANULOMATOSIS\n\n$=$ angioinvasive + angiodestructive oligo- / monoclonal lymphoproliferative + granulomatous disease\nCause: combination of Epstein Barr virus infection and immunosuppression\nMean age: 48 (range, $7-85$ ) years; $\\mathrm{M}+\\mathrm{F}=2 \\div 1$\nPath: multiple sharply marginated masses adjacent to a bronchus causing obstructive pneumonitis\nHisto: angiocentric infiltrate of atypical lymphoid cells (CD20-positive B-cells, some infected with Epstein-Barr virus); necrotic lung parenchyma in higher grade lesions; giant cells absent (DDx to Wegener granulomatosis)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 646,
            "markdown": "- malaise, weight loss (35\\%); NO specific serum markers\n$\\diamond$ Less commonly found in lymph nodes, bone marrow, spleen\n$\\diamond$ Involvement of upper respiratory tract + sinuses is very unusual\n@ Lung ( $100 \\%)$\n- fever (60\\%), cough (56\\%), dyspnea (29\\%)\n$\\checkmark$ normal CXR\n$\\checkmark$ diffuse reticulonodular opacities (= granulomas)\n$\\checkmark$ large masslike opacities (= granulomas + pulmonary infarcts)\n$\\checkmark$ multiple bilateral nodules in middle + lower lobes ( $80 \\%$ )\n$\\checkmark$ unilateral involvement ( $21 \\%$ )\n$\\checkmark$ small pleural effusions ( $40 \\%$ )\n$\\checkmark$ hilar lymphadenopathy ( $25 \\%$ )\nCT:\nDistribution: peribronchovascular\n$\\checkmark$ peripheral subpleural $0.6-8.0 \\mathrm{~cm}$ large nodules / masses\n$\\checkmark$ reticular / nodular airspace opacities ( $10-43 \\%$ ):\n$\\checkmark$ central cavitation ( $30 \\%$ )\n$\\checkmark$ peripheral ground-glass halo $\\pm$ air bronchogram\n@ Skin (39-53\\%)\n- nodules, ulcers, maculopapular rash (20-39\\%)\n@ CNS (37-53\\%) $\\rightarrow$ very poor prognosis\n- neurologic complaints ( $21 \\%$ )\n@ Kidneys (32-40\\%)\nCx: lymphoma (12-47\\%)\nMortality: in 53-90\\% from sepsis, respiratory failure, pulmonary embolism, massive hemoptysis, CNS lesions\n\n\n# LYMPHOPROLIFERATIVE DISEASE AFTER TRANSPLANTATION \n\n$=$ POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD)\nPTLD encompasses a group of lymphoproliferative disorders post stem cell and organ transplantation that ranges from benign polyclonal proliferation to malignant monoclonal disease. PTLD is intimately associated with EBV infection.\nCause: sequelae of chronic immunosuppression with limited ability to suppress neoplastic activity $\\leftarrow$ oral secretion transmission of virus, residual EBV DNA within bronchusassociated lymphoid tissue, lymphocytes of donated allograft, blood transfusion containing EBV-infected B cells\n\n## Pathogenesis:\n\n90-95\\% of adults are Epstein-Barr virus (EBV) seropositive $\\rightarrow \\mathrm{T}$ cells fight initial EBV infection by eradicating B cells that display EBV antigens $\\rightarrow$ EBV-specific cytotoxic T cells may be completely lost within 6 months of transplantation\n\nIn a state of T-cell-depletion latently infected B cells can proliferate and result in PTLD.\nImmunosuppressive therapy in transplant recipients is responsible for a 3 - to 8 -fold increase in malignancies.",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 647,
            "markdown": "# Pathophysiology of B-cell origin: \n\n1. Infection of B lymphocytes (in 85\\%) with EBV (Epstein-Barr virus) $\\rightarrow$ increased proliferation of B cells (= polyclonal B-cell expansion)\n\n| PTLD [in \\%] with Various Organ Transplantations |  |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: | :--: |\n| PTLD | All <br> Tx | Pancreas <br> Tx | Liver <br> Tx | Heart <br> Tx | Kidney <br> Tx | Lung <br> Tx |\n| GI tract | $5-15$ | 33 | $12-30$ | $14-24$ | $11-22$ | 20 |\n| Liver |  | $22-40$ | $30-45$ | $9-23$ | 5 | $5-10$ |\n| Spleen | $10-40$ |  | $+++$ |  |  |  |\n| Kidney | $10-30$ |  | 0 | 0.6 | $10-75$ | 1.4 |\n| Adrenal | 5 |  |  |  |  |  |\n| Pancreas |  | $10-75$ |  |  |  |  |\n| Abd. <br> nodes | $15-20$ |  |  |  |  |  |\n| Chest |  |  | $4-24$ | $16-32$ | $4-15$ | $69-100$ |\n| CNS | $3-16$ | 16 | 4 | $4-13$ | $12-13$ |  |\n| Any <br> PTLD |  |  | $2-8$ | $2-3$ | $1-5$ | $2-8$ |\n\n2. Loss of protective immune control by T cells allows for uncontrolled proliferation of EBV-infected B lymphocytes (= oligoclonal B-cell expansion)\n3. Genetic mutation transforms some B cells into malignant cells\n\nFrequency: PTLD in $2 \\%$ of all allograft recipients (different rates likely related to differences in degree and regimen of immunosuppression)\nbone marrow transplantation $0.6 \\%$\nkidney transplantation 1-5\\%\ncardiac transplantation $1.8-3.4 \\%$\nlung transplantation $1.8-7.9 \\%$\nliver transplantation $2.2-8.4 \\%$\nheart-lung transplantation $9.4 \\%$\nmultivisceral transplantation $13-33 \\%$\nbowel transplantation $13-33 \\%$\n$\\diamond$ Prevalence of NHL is 35 x greater than in general population!\nThe incidence + prognosis of PTLD vary according to the organ transplanted, recipient age, and intensity of immuno-suppression therapy. The risk is greatest within $1^{\\text {st }}$ year of transplantation, declining thereafter.\nRisk factor: pretransplantation seronegative for EBV, autoimmune hepatitis, Langerhans cell histiocytosis, chronic interstitial nephritis\nTime of onset: as early as 1 month after transplantation with very aggressive immunosuppressive regimen; mean of $2-5$ months after bone marrow, lung, heartlung transplantation; mean of 23-32 months after kidney, heart, liver transplantation\n$\\diamond$ Under cyclosporine / OKT3 within 1 month",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 648,
            "markdown": "Categories by location:\n> nodal\n» mediastinal\n» retroperitoneal\n> extranodal\n» GI tract\n» solid organ\n\n- obstructive: kidney, liver\n- hilar / solitary mass: kidney, liver, spleen, lung\n- scattered parenchymal: kidney, liver, spleen, lung\n- infiltrative: solid organ / abdominal wall\n» CNS: basal ganglia, subcortical white matter\nUnique features:\n(a) high propensity for extranodal involvement ( $80 \\%$ ): liver ( $50 \\%$ ), small bowel ( $25 \\%$ ), kidney $(17 \\%)$\n\n| Features of Posttransplant Lymphoproliferative Disorder (PTLD) |  |\n| :--: | :--: |\n| Clinical data: | Post stem cell and organ transplant patients Associated with EBV infection |\n| Histopathology: | Proliferation of EBV-infected B cells Spectrum of poly- to monoclonal proliferation |\n| Imaging findings: | Distribution: peribronchovascular, subpleural <br> $\\checkmark$ multiple pulmonary nodules / masses / airspace consolidation $\\checkmark \\pm$ ground-glass halo $\\checkmark$ air bronchograms $\\checkmark$ septal thickening $\\checkmark$ mediastinal + hilar lymphadenopathy $\\checkmark \\pm$ pleural effusion $\\checkmark$ invasion of adjacent structures $\\checkmark$ avidly hypermetabolic on PET/CT |\n| $D D x$ : | Angioinvasive aspergillosis |\n\n(b) varied morphologic appearance\n(c) strong causal association with EBV infection\n(d) frequent absence of immunophenotypic / genotypic evidence of monoclonality\n(e) poor response to cytolytic chemotherapy / irradiation\n\n- unexplained fever / lymphadenopathy\n- illness resembling infectious mononucleosis = pharyngitis, fever, lymphadenopathy, hepatosplenomegaly\nAnatomic distribution:\n$\\diamond$ Frequency of location varies with type of allograft!\n@ Thorax (most commonly involved in $1^{\\text {st }}$ year)\n$\\checkmark$ pulmonary mass $(50 \\%)$\n$\\checkmark$ multiple / solitary discrete well-circumscribed pulmonary nodules (40-50\\%) (DDx: cryptococcosis, fungus, Kaposi sarcoma):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 649,
            "markdown": "$\\sqrt{ } \\pm$ low-attenuation center $\\pm$ ground-glass halo\n$\\sqrt{ }$ patchy airspace consolidation ( $7-10 \\%$ ) (DDx: edema, infection, rejection)\n$\\sqrt{ }$ mediastinal / hilar lymphadenopathy (in up to $50 \\%$ )\n$\\sqrt{ }$ pleural masses\n@ Lymph nodes (in $2-10 \\%$ of various allografts)\n@ Gastrointestinal tract\nLocation: distal jejunum + ileum $>$ duodenum $>$ colon (prox $>$ distal $)>$ stomach $>$ esophagus\n$\\sqrt{ }$ bowel wall thickening + dilatation\n$\\sqrt{ }$ eccentric mass, luminal ulceration\n$\\sqrt{ }$ short-segment intussusception\n$C x$ : visceral perforation (frequent)\n@ Gallbladder\n$\\sqrt{ }$ gallbladder thickening, biliary obstruction\n@ Liver\nSite: intrahepatic / extrahepatic (frequently extranodal)\n$\\sqrt{ }$ discrete hypoattenuating hypovascular nodular lesion:\n$\\sqrt{ }$ single / multiple parenchymal lesions\n$\\sqrt{ }$ diffuse ill-defined infiltrative pattern of hepatic involvement $\\rightarrow$ hepatomegaly\n$\\sqrt{ }$ hypoechoic heterogeneous soft tissue mass encasing hilar structures\n$C x$ : narrowing of bile duct, hepatic artery, portal vein\n$\\sqrt{ }$ periportal adenopathy\n$\\sqrt{ }$ portal vein constriction / focal thrombus ( $15 \\%$ )\nIn posttransplant lymphoproliferative disease extrahepatic involvement is frequently extranodal and appears at US / CT as ill-defined hypoechoic / hypoattenuating periportal heterogeneous soft tissue that encases the hilar structures.\n@ Spleen\n$\\sqrt{ }$ splenomegaly\n\n| WHO Histopathologic Classification of Posttransplant Lymphoproliferative Disorder (PTLD) |  |\n| :--: | :--: |\n| Category | Subtypes |\n| Hyperplastic PTLD (early) | Infectious mononucleosis-like plasmacytic hyperplasia |\n| Polymorphic PTLD | Polymorphic diffuse B-cell hyperplasia <br> Polymorphic diffuse B-cell lymphoma |\n| Monomorphic (lymphomatous) PTLD | Diffuse large B-cell lymphoma <br> Burkitt lymphoma <br> Plasma cell myeloma <br> Plasmacytoma-like PTLD <br> T-cell neoplasm (up to 14\\%) <br> Natural killer cell neoplasm |\n| Hodgkin-like PTLD | Hodgkin disease, Hodgkin-like variants |\n\n$\\sqrt{ }$ multiple focal hypoattenuating lesions (less frequent)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 650,
            "markdown": "@ Kidney\n$\\checkmark$ heterogeneous mass surrounding hilar vessels\n$\\checkmark$ multifocal discrete round hypovascular parenchymal masses (almost always unilateral)\n$\\checkmark$ diffuse infiltrative disease $\\rightarrow$ renal enlargement\n@ CNS\n$\\checkmark$ solitary hyperdense typically periventricular mass usually surrounded by vasogenic edema\n@ Disseminated disease ( $10-14 \\%$ of various allografts)\nPET (modality of choice for disease staging + assessment of therapy response)\n$\\checkmark$ extremely hypermetabolic active lesions\n@ Others: skin, eye, area of prior trauma / surgery, bone marrow (uncommon)\n$D x:$ tissue sampling for DDx from invasive aspergillosis\n$D D x:$ posttransplant opportunistic infection, lymphoid hyperplasia (spontaneous resolution)\nRx: (1) Antiviral agents (controversial)\n(2) Reduction / cessation of immunosuppressive agent (first-line treatment for patients with early polymorphic lesions)\n(3) Rituximab $=$ monoclonal antibody against B-cell receptor CD20 ( $60 \\%$ response rate)\n(4) Surgical resection of tumor mass (complete resolution in $63 \\%$ )\n\n# MALARIA \n\n[mala aria, Italian $=$ bad air] [anopheles, Greek $=$ useless]\n$=$ mosquito-borne infectious disease by Plasmodium species\n\n| Type of Malaria | Organism | Fever spikes |\n| :-- | :-- | :-- |\n| malignant tertian fever | P falciparum | irregular |\n| benign tertian fever | P vivax, P ovale | every 48 h |\n| quartan fever | P malariae | every 72 h |\n\nPrevalence: 400-500 million new cases annually worldwide\nPrognosis: 2.2-2.7 million deaths annually in mostly young children\n$\\diamond$ Most deadly parasitic infection in the world!\nEndemic to: sub-Saharan Africa, South America, southern Asia\nTransmission: bite by female Anopheles mosquito (definite host)\nTransmission vector: sporozoite $=$ motile infective form\nSecondary host: vertebrate (human)\nLife cycle:\n(a) with a mosquito's bite the motile infective form (sporozoite) travels through blood vessels to hepatocytes $\\rightarrow$ asexual reproduction ( $=$ tissue schizogony) $\\rightarrow$ thousands of merozoites\n(b) merozoites infect new RBCs initiating a series of asexual multiplication cycles (= blood schizogony) producing 8-24 new infective merozoites $\\rightarrow$ bursting of RBC (= hemolysis) at different time intervals depending on species\n(c) other merozoites develop into immature gametocytes ( $=$ precursors of male + female gametes); during bite of an infected person by fertilized mosquito, gametocytes are taken up with blood and mature in mosquito gut\n(d) male + female gametocytes fuse and form an ookinete (= fertilized motile zygote) $\\rightarrow$ develop into new sporozoites that migrate to salivary glands of insect $\\rightarrow$ transmission",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 651,
            "markdown": "during mosquito bite\n\n- fever with chills, sweating, anemia, leukopenia, splenomegaly\n@ Lung\n\nAdult respiratory distress syndrome (ARDS)\nCause: (a) RBC sequestration + destruction $\\rightarrow$ vascular injury\n(b) release of parasite + erythrocyte material into circulation\n(c) host response to these events\n$\\checkmark$ noncardiogenic diffuse interstitial pulmonary edema\n$\\checkmark$ pleural effusion\n$\\checkmark$ lobar consolidation\n$D x$ : identification of trophozoites / other parasitic forms within RBCs (thin blood smear) / parasites (thick smear)\n\n# Cerebral Malaria (2\\%) \n\nCause: sequestration of infected erythrocytes in microcirculation\n\n- encephalopathy, coma, retinal whitening at fundoscopy\n$\\checkmark$ diffuse cerebral edema $\\leftarrow$ microvascular occlusion\n$\\checkmark$ cortical infarcts\n$\\checkmark$ nonspecific white matter hyperintensity $\\leftarrow$ small-vessel ischemia\nLocation: cerebral cortex, thalamus, basal ganglia, splenium of corpus callosum\n$\\checkmark$ petechial hemorrhages, hemorrhagic infarctions\nPrognosis: $15-25 \\%$ mortality rate\n$R x$ : quinine (from cinchona bark), artemisinin (from sweet wormwood)\n\n\n## MECONIUM ASPIRATION SYNDROME\n\n$=$ most common cause of neonatal respiratory distress in full term / postmature infants (hyaline membrane disease most common cause in premature infants)\nEtiology: fetal circulatory accidents / placental insufficiency / postmaturity $\\rightarrow$ perinatal\nhypoxia + fetal distress $\\rightarrow$ defecation of meconium in utero\nPathogenesis: severe hypoxemia induces gasping reflex with inhalation of tenacious meconium that produces medium and small airway obstruction + chemical pneumonitis\nFrequency: $10 \\%$ of all deliveries have meconium-stained amniotic fluid; $1 \\%$ of all deliveries have respiratory distress\n\n- cyanosis (rare)\n- persistent fetal circulation syndrome $=$ neonatal pulmonary hypertension $(\\leftarrow$ thick-walled pulmonary arterioles) + R-to-L shunt through PDA and foramen ovale + severe cyanosis\n$R x$ : extracorporeal membrane oxygenation (major indication besides diaphragmatic hernia + neonatal pneumonia)\n$\\checkmark$ large infant\n$\\checkmark$ bilateral diffuse grossly patchy opacities (atelectasis + consolidation)\n$\\checkmark$ hyperinflation with areas of emphysema $\\leftarrow$ air trapping\n$\\checkmark$ spontaneous pneumothorax + pneumomediastinum ( $25-40 \\%$ ) requiring no therapy\n$\\checkmark$ small pleural effusions $(10-20 \\%)$\n$\\checkmark$ NO air bronchograms",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 652,
            "markdown": "$\\sqrt{ }$ rapid clearing usually within 48 hours\nCx: morbidity from anoxic brain damage is high\n\n# MEDIASTINAL LIPOMATOSIS \n\n$=$ excess unencapsulated fat deposition\nEtiology:\nA. exogenous steroids (average daily dose of $>30 \\mathrm{mg}$ prednisone):\n(1) Chronic renal disease, renal transplant (5\\%)\n(2) Collagen vascular disease, vasculitis\n(3) Hemolytic anemia\n(4) Asthma\n(5) Dermatitis\n(6) Crohn disease\n(7) Myasthenia gravis\nB. endogenous steroid elevation\n(1) Adrenal tumor\n(2) Pituitary tumor / hyperplasia $=$ Cushing disease\n(3) Ectopic ACTH-production (carcinoma of the lung)\nC. obesity\n\n- moon facies, buffalo hump, supraclavicular + episternal fat\n\nLocation: upper mediastinum (common), cardiophrenic angles + paraspinal areas (less common)\n$\\checkmark$ upper mediastinal widening\n$\\checkmark$ paraspinal widening\n$\\checkmark$ increase in epicardial fat-pads\n$\\checkmark$ symmetric slightly lobulated extrapleural deposits extending from apex to $9^{\\text {th }}$ rib laterally\nOTHER FEATURES:\n$\\checkmark$ osteoporosis\n$\\checkmark$ fractures\n$\\checkmark$ aseptic necrosis\n$\\checkmark$ increased rectosacral distance\n\n## MEDIASTINITIS\n\n## Acute Mediastinitis\n\n$=$ life-threatening condition with high mortality + morbidity\nCause: acute inflammation of connective tissues + fat surrounding mediastinal structures secondary to\n(a) surgery (= postoperative)\n(b) transmural esophageal perforation\n(c) osteomyelitis of adjacent bone\n(d) direct extension of head \\& neck infection\n(e) hematogenous spread of any infection\n\n- acute chest pain, high fever, chills, shortness of breath",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 653,
            "markdown": "- leukocytosis\n\nCXR:\n$\\checkmark$ widening + loss of normal contours of mediastinum\n$\\checkmark$ diffuse / focal gas bubbles within mediastinum\nCT (modality of choice):\n$\\checkmark$ increased attenuation of mediastinal fat\n$\\checkmark$ free gas bubbles in mediastinum\n$\\checkmark$ localized fluid collections\n$\\checkmark$ enlarged lymph nodes, pleural effusions, empyema\n\n# Postoperative Mediastinitis \n\nFrequency: $0.5-5.0 \\%$ after median sternotomy\nOrganism: Staphylococcus aureus\nRisk factors: obesity, insulin-dependent diabetes, internal mammary artery graft\nFrequently associated with: sternal dehiscence\nCXR:\n$\\checkmark$ displacement, rotation, fracture of sternal wires\n$\\checkmark$ midsternal lucent stripe (rare)\nCT:\n$\\checkmark$ midsternal lucent stripe $>3 \\mathrm{~mm}=$ sternal dehiscence\n$\\checkmark$ pleural / pericardial effusion\nN.B.: mediastinal gas bubbles + fluid collections after $14^{\\text {th }}$ postoperative day (almost $100 \\%$ sensitive and specific)\nMortality rate: $7-80 \\%$\n\n## Descending Necrotizing Mediastinitis\n\n$=\\mathrm{DNM}=$ rare acute emergent polymicrobial infection of mediastinum\nSource: oropharyngeal / cervical / odontogenic infection\nPathways: (a) pretracheal route $\\rightarrow$ anterior mediastinum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 654,
            "markdown": "![img-71.jpeg](img-71.jpeg)\n(b) lateral pharyngeal route (via carotid space) $\\rightarrow$ middle mediastinum\n(c) retropharyngeal-retrovisceral route $\\rightarrow$ posterior mediastinum (most common)\n(d) \"danger space\" = between cervical alar fascia and prevertebral fascia from skull base $\\rightarrow$ posterior mediastinum and diaphragm (posterior to retropharyngeal space)\nClassification of disease extent:\ntype $1=$ localized above carina\ntype $2 \\mathrm{~A}=$ extends to lower anterior mediastinum\ntype $2 B=$ extension to anterior + posterior mediastinum\nX-Ray:\n$\\checkmark$ subcutaneous emphysema\n$\\checkmark$ prevertebral soft-tissue swelling\n$\\checkmark$ mediastinal air\n$\\checkmark$ widening of superior mediastinum\nCT:\n$\\checkmark$ thickening of subcutaneous tissues of neck\n$\\checkmark$ thickening + enhancement of cervical fascia + muscles\n$\\checkmark$ increased attenuation of mediastinal fat\n$\\checkmark$ mediastinal fluid collections\n$\\checkmark$ locules of gas within mediastinum\n$\\checkmark$ pericardial / pleural effusion\n$\\checkmark$ enlarged lymph nodes\nMortality: $25-50 \\% \\leftarrow$ delayed diagnosis $\\leftarrow$ nonspecific subtle symptoms and findings\n$R x$ : aggressive airway management, early mediastinal exploration, débridement, drainage",
            "images": [
                {
                    "id": "img-71.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 191,
                    "bottom_right_x": 1164,
                    "bottom_right_y": 891,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 655,
            "markdown": "# Chronic Mediastinitis \n\nEtiology:\n(1) Granulomatous infection: histoplasmosis (most frequent), tuberculosis, actinomycosis, Nocardia\n(2) Mediastinal granuloma\n(3) Fibrosing mediastinitis\n(4) Radiation therapy\n\n## Mediastinal Granuloma\n\n$=$ relatively benign massive coalescent adenitis with caseating / noncaseating lesions\nCause: primary lymph node infection (commonly tuberculosis / histoplasmosis)\nHisto: thin fibrous capsule surrounding granuloma\n$\\checkmark$ lymphadenopathy\n$D D x$ : fibrosing mediastinitis (infiltrative, rare)\n\n## Fibrosing Mediastinitis\n\n$=$ SCLEROSING MEDIASTINITIS = MEDIASTINAL COLLAGENOSIS = MEDIASTINAL FIBROSIS\n$=$ uncommon benign disorder characterized by progressive proliferation of dense fibrous tissue within mediastinum\nTypes:\n\n1. Granulomatous fibrosing mediastinitis\n$=$ focal granulomatous form\nCause: idiosyncratic reaction to Histoplasma capsulatum antigens (organisms recovered in $50 \\%$, risk of $<1 \\div 20,000$ patients), TB, cryptococcosis, aspergillosis, sarcoidosis\n\nThe most common focal granulomatous form of fibrosing mediastinitis is caused by idiopathic proliferation of fibrous tissue in response to Histoplasma capsulatum antigen stimulation.\n$\\checkmark$ often calcified focal mediastinal mass\n$\\checkmark$ calcified hepatic + splenic granulomas\n2. Nongranulomatous fibrosing mediastinitis\n$=$ diffuse form\nCause: autoimmune disorders / radiation therapy / reaction to drugs (eg, methysergide)\nAssociated with:\nretroperitoneal fibrosis, orbital pseudotumor, systemic lupus erythematosus, sclerosing thyroiditis, Riedel thyroiditis, IgG4-related disease\n$\\checkmark$ noncalcified diffuse mediastinal infiltration\n$\\checkmark$ smooth lobulated contours\nPath: ill-defined soft-tissue mass with minimal / NO apparent granulomatous foci\nHisto: abundant paucicellular fibrous tissue infiltrating + obliterating adipose tissue\nAge: $2^{\\text {nd }}-5^{\\text {th }}$ decade of life; $\\mathrm{M}=\\mathrm{F}$\nMost common narrowed mediastinal structures:\nairways, pulmonary arteries + veins, esophagus, SVC\n\n- symptoms of central airway obstruction:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 656,
            "markdown": "- cough ( $41 \\%$ ), dyspnea ( $32 \\%$ )\n- symptoms of pulmonary venous occlusion:\n- \"pseudo-mitral stenosis syndrome\" = progressive exertional dyspnea, hemoptysis $(31 \\%)$\n- cor pulmonale $\\leftarrow$ pulmonary arterial hypertension $\\leftarrow$ compression of pulmonary arteries / veins\n- dysphagia ( $2 \\%)$\n- superior vena cava syndrome (6-39\\%)\n- low left atrial pressure + widely differential elevation of pulmonary capillary wedge pressures\nLocation: middle mediastinum (subcarinal and paratracheal regions) + hila; right > left side of mediastinum\nCXR:\n$\\checkmark$ nonspecific widening of mediastinum:\n$\\checkmark$ distortion of normally recognizable interfaces\n$\\checkmark$ lobulated (in $86 \\%$ calcified) paratracheal / hilar mass\n$\\checkmark$ typically unilateral pulmonary artery obstruction:\n$\\checkmark$ enlargement of main pulmonary artery + right heart\n$\\checkmark$ diminution in size + quantity of vessels of affected lung\n$\\checkmark$ localized regional oligemia of affected lung\n$\\checkmark$ pulmonary venous obstruction:\n$\\checkmark$ peribronchial cuffing, septal thickening\n$\\checkmark$ ipsilateral Kerley B lines\n$\\checkmark$ pulmonary infarct\n$\\checkmark$ central airway narrowing:\n$\\checkmark$ segmental / lobar atelectasis\n$\\checkmark$ recurrent pneumonia\nUGI:\n$\\checkmark$ circumferential narrowing / long-segment stricture of esophagus at junction of upper + middle $1 / 3$\n$\\checkmark$ \"downhill\" esophageal varices\nCT:\n$\\checkmark$ focal mediastinal mass ( $82 \\%$ ):\n$\\checkmark$ dense / stippled calcifications (in $63 \\%$ ) in right paratracheal / subcarinal / hilar locations\n$\\checkmark$ distortion and narrowing of adjacent structures\n$\\checkmark$ calcified granulomas in lymph nodes, lung, liver, spleen\n$\\checkmark$ diffusely infiltrative mediastinal mass ( $18 \\%$ ) involving several mediastinal compartments:\n$\\checkmark$ soft-tissue attenuation, NO calcification\n$\\checkmark$ obliteration of normal mediastinal fat planes\n$\\checkmark$ encasement / invasion of adjacent structures (vascular stenosis / obstruction)\n$\\checkmark$ generally NO signs of remote granulomatous infection\n$\\checkmark$ wedge-shaped peripheral consolidation of venous / arterial infarction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 657,
            "markdown": "$\\sqrt{ }$ ipsilateral bronchial artery dilatation $\\leftarrow$ critical narrowing / encasement of pulmonary artery\nMR:\n$\\sqrt{ }$ heterogeneous infiltrative mass of intermediate SI on T1WI\n$\\sqrt{ }$ mixture of regions of increased + markedly decreased SI on T2WI\nNUC:\n$\\sqrt{ }$ unilateral decreased / absent perfusion with normal ventilation (in focal hilar fibrosis)\n$\\sqrt{ }$ large segmental / smaller subsegmental unmatched perfusion defects\n$\\sqrt{ }$ ventilation defects in lobar / segmental occlusion\nPET:\n$\\sqrt{ }$ variable activity $\\rightarrow$ not routinely performed\nAngio (with therapeutic intent):\n$\\sqrt{ }$ unilateral / asymmetric narrowing of central pulmonary arteries / distal arterial cutoffs\n$\\sqrt{ }$ funnel-like pulmonary vein stenosis / obstruction / focal dilatation near left atrium\n$C x$ : (1) Compression of SVC $(64 \\%)+$ pulmonary veins $(4 \\%)$\n(2) Chronic obstructive pneumonia (narrowing of trachea / central bronchi) in 5\\%\n(3) Esophageal stenosis $(3 \\%)$\n(4) Pulmonary infarcts + fibrosis $\\leftarrow$ narrowing of pulmonary artery\n(5) Prominent intercostal arteries $\\leftarrow$ narrowing of pulmonary artery\n$D x$ : tissue diagnosis is essential to diagnose malignancy\n$R x$ : resection (laser therapy, venous graft), ketoconazole, steroid therapy (limited success); stent insertion\n$D D x$ : (1) Bronchogenic carcinoma\n(2) Lymphoma\n(3) Metastatic carcinoma\n(4) Mediastinal sarcoma\n\n# MESOTHELIOMA OF CHEST \n\n## Benign Pleural Mesothelioma\n\n$=$ LOCALIZED FIBROUS MESOTHELIOMA $=$ LOCALIZED FIBROUS TUMOR OF THE PLEURA $=$ SOLITARY FIBROUS TUMOR OF PLEURA = BENIGN LOCALIZED MESOTHELIOMA = BENIGN PLEURAL FIBROMA = FIBROSING MESOTHELIOMA = PLEURAL FIBROMYXOMA\n$=$ slowly growing, primary pleural neoplasm unrelated to asbestos exposure\nFrequency: $<5 \\%$ of all pleural tumors\n$\\diamond$ No recognized association with asbestos exposure!\nMean age: $50-60$ years (range, $3^{\\text {rd }}-8^{\\text {th }}$ decade); $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\nPath: usually solitary mass arising from visceral pleura in $80 \\%+$ parietal pleura in $20 \\%$\nHisto: tumor originates from submesothelial fibroblasts, lined by layer of mesothelial cells\n(a) relatively acellular fibrous tissue\n(b) rounded spindle-shaped densely packed cells\n(c) resembling hemangiopericytoma of lung",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 658,
            "markdown": "- asymptomatic in $50 \\%$; episodic hypoglycemia (4\\%)\n- cough, fever, dyspnea, chest pain (larger mass)\n- digital clubbing (rare) + hypertrophic pulmonary osteoarthropathy in 20-35\\%\n\nLocation: near lung periphery / adjacent to pleural surface / within fissure\nSize: $\\quad 2-30 \\mathrm{~cm}$ in diameter\n$\\sqrt{ }$ sharply circumscribed spherical / ovoid lobular mass:\n$\\sqrt{ }$ sessile with smooth tapered margin (common) / pedunculated (almost 50\\%)\n$\\sqrt{ }$ obtuse angle toward chest wall (rare, benign feature)\n$\\sqrt{ }$ tumor may change in shape + location upon alteration of patient's position / during respiration (if pedunculated)\n$\\sqrt{ }$ areas of hemorrhage / necrosis may be present (favors malignancy)\n$\\sqrt{ }$ ipsilateral pleural effusion (rare) containing hyaluronic acid\n$\\sqrt{ }$ mass effect on adjacent lung + mediastinum\nCT:\n$\\sqrt{ }$ homogeneous mass of intermediate to high attenuation\n$\\sqrt{ }$ calcification (7\\%) associated with necrosis in large tumor\nCECT:\n$\\sqrt{ }$ substantial contrast enhancement\n$\\sqrt{ }$ heterogeneous enhancement with central areas of low attenuation in large tumor $\\leftarrow$ myxoid changes / hemorrhage / necrosis / cystic degeneration\nMR:\n$\\sqrt{ }$ hypointense on T1WI + hyperintense on T2WI\n$C x$ : malignant degeneration in $37 \\%$\n$D D x$ : metastatic deposit\n$R x$ : excision is curative (recurrence rate lower for pedunculated versus nodular tumor)\n\n# Malignant Pleural Mesothelioma \n\n$=$ DIFFUSE MALIGNANT MESOTHELIOMA\n$=$ uncommon fatal neoplasm of serosal lining of pleura\n$\\diamond$ Most common primary neoplasm of pleura!\nPrevalence: $7-13 \\div 1,000,000$ persons per year; 2,000-3,000 cases per year in USA\nEtiology: asbestos exposure (13-100\\%); zeolite (nonasbestos mineral fiber); chronic inflammation (TB, empyema); irradiation\nCarcinogenic potential:\nproportional to aspect ratio of asbestos fibers (= length-to-diameter) of fiber and durability in human tissue:\ncrocidolite $>$ amosite $>$ chrysotile $>$ actinolite, anthophyllite, tremolite\n$\\diamond$ Occupational exposure of asbestos found in only $40-80 \\%$ of all cases!\n$\\diamond 5-10 \\%$ of asbestos workers will develop mesothelioma in their lifetime (risk factor of 30 compared with general population)\n$\\diamond$ No relation to duration / degree of exposure or smoking Hx !\nLatency period: 20-35-45 years (earlier than asbestosis; later than asbestos-related lung cancer)\nPeak age: $50-70$ years ( $66 \\%$ ); $\\mathrm{M} \\div \\mathrm{F}=2-4-6 \\div 1$\nPath: multiple tumor masses involving predominantly the parietal pleura + to a lesser degree",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 659,
            "markdown": "the visceral pleura; progression to thick sheetlike / confluent masses resulting in rindlike tumoral encasement of lung\nHisto: (a) epithelioid (60\\%), (b) sarcomatoid (15\\%), (c) biphasic (25\\%); intracellular asbestos fibers in $25 \\%$; positive stain for epithelial membrane antigen, calretinin, Wilms tumor I antigen, cytokeratin 5/6, HBME-1, mesothelin\nAssociated with: peritoneal mesothelioma; hypertrophic osteoarthropathy (10\\%)\nStaging (Boutin modification of Butchart staging):\nIA confined to ipsilateral parietal / diaphragmatic pleura\nIB + visceral pleura, lung, pericardium\nII invasion of chest wall / mediastinum (esophagus, heart, contralateral pleura) or metastases to thoracic lymph nodes\nIII penetration of diaphragm with peritoneal involvement or metastases to extrathoracic lymph nodes\nIV distant hematogenous metastases\nStage at presentation: II in $50 \\%$, III in $28 \\%$, I in $18 \\%$, IV in $4 \\%$\n\n- nonpleuritic (56\\%) / pleuritic chest pain (6\\%), dyspnea (53\\%)\n- fever + chills + sweats ( $30 \\%$ ), cough ( $24 \\%$ ), weight loss ( $22 \\%$ )\n- weakness, fatigue, malaise ( $30 \\%$ ), anorexia ( $10 \\%$ )\n- expectoration of asbestos bodies ( $=$ fusiform segmented rodlike structures $=$ iron-protein deposition on asbestos fibers [a subset of ferruginous bodies])\n- elevated serum mesothelin-related protein (84\\%)\n\nSpread:\n(a) contiguous: chest wall, mediastinum, contralateral chest, pericardium, diaphragm, peritoneal cavity; lymphatics, blood, lung\n(b) lymphatic: hilar + mediastinal (40\\%), celiac (8\\%), axillary + supraclavicular (1\\%), cervical nodes\n(c) hematogenous: lung, liver, kidney, adrenal gland\n$\\checkmark$ extensive irregular lobulated bulky pleural-based masses typically $>5 \\mathrm{~cm} /$ pleural thickening $(60 \\%)$\n$\\checkmark$ recurrent exudative / hemorrhagic unilateral pleural effusion (30-60-80\\%) without mediastinal shift (\"frozen hemithorax\" = fixation by pleural rind of neoplastic tissue); bilateral effusions (in $10 \\%$ ) contain hyaluronic acid in $80-100 \\%$\n$\\checkmark$ distinct pleural mass without effusion $(<25 \\%)$\n$\\checkmark$ associated pleural plaques in $50 \\%=$ HALLMARK of asbestos exposure\n$\\checkmark$ pleural calcifications $(20 \\%)$\n$\\checkmark$ circumferential rindlike encasement of entire lung = involvement of all pleural surfaces (mediastinum, pericardium, fissures) as late manifestation\n$\\checkmark$ extension into interlobar fissures ( $40-86 \\%$ )\n$\\checkmark$ superficial invasion of underlying lung (primarily as extension into interlobular septa)\n$\\checkmark$ rib destruction in $20 \\%$ (in advanced disease)\n$\\checkmark$ ascites (peritoneum involved in $35 \\%$ )\nCT:\n$\\checkmark$ circumferential + nodular pleural thickening $>1 \\mathrm{~cm}(92 \\%)$\n$\\checkmark$ thickening of mediastinal pleura",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 660,
            "markdown": "$\\sqrt{ }$ thickening of interlobar fissure ( $86 \\%$ )\n$\\sqrt{ }$ unilateral pleural effusion $(74 \\%) \\rightarrow$ level of fluid accumulation diminishes with advanced disease\n$\\sqrt{ }$ contraction of affected hemithorax ( $42 \\%$ ):\n$\\checkmark$ ipsilateral mediastinal shift\n$\\checkmark$ narrowed intercostal spaces\n$\\checkmark$ elevation of ipsilateral hemidiaphragm\n$\\checkmark$ calcified pleural plaques ( $20 \\%$ )\nMR (best modality to determine resectability):\n$\\checkmark$ minimally hyperintense relative to muscle on T1WI\n$\\checkmark$ moderately hyperintense relative to muscle on T2WI\nPET-CT (useful in identifying occult distant metastases)\nMetastases to:\nipsilateral lung ( $60 \\%$ ), hilar + mediastinal nodes, contralateral lung + pleura (rare), extension through chest wall + diaphragm, pericardium\n$\\checkmark$ invasion of chest wall:\n$\\checkmark$ obscured fat planes in chest wall\n$\\checkmark$ invasion of intercostal muscles\n$\\checkmark$ separation / destruction of ribs by tumor\n$\\checkmark$ invasion of mediastinum:\n$\\checkmark$ obliteration of fat planes around heart, great vessels, esophagus, trachea\nPrognosis: $10 \\%$ of occupationally exposed individuals die of mesothelioma (in $50 \\%$ pleural + in $50 \\%$ peritoneal mesothelioma); 5-12 months mean survival time\n$D D x$ : pleural fibrosis from infection (TB, fungal, actinomycosis), fibrothorax, empyema, asbestos-related benign pleural disease, pleural lymphoma, metastatic adenocarcinoma (differentiation impossible)\n$D x$ : video-assisted thoracoscopic surgery (postprocedural radiation therapy of all entry ports for tumor seeding of needle track [21\\%])\n\n# METASTASIS TO LUNG \n\nPulmonary metastases occur in $30 \\%$ of all malignancies; mostly hematogenous\nAge: $>50$ years (in $87 \\%$ )\nIncidence of pulmonary metastases:\nmnemonic: CHEST\nChoriocarcinoma $60 \\%$\nHypernephroma / Wilms tumor 30 / 20\\%\nEwing sarcoma $18 \\%$\nSarcoma (rhabdomyo- / osteosarcoma) $21 / 15 \\%$\nTesticular tumor $12 \\%$\nCommon primaries of intravascular metastases:\nbreast, stomach, liver, kidney, lung, prostate, choriocarcinoma\n$\\diamond$ Right atrial myxoma + RCC tend to embolize to large central + segmental pulmonary arteries\n\n- progressive dyspnea, subacute pulmonary hypertension",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 661,
            "markdown": "- symptoms of acute pulmonary thromboembolism\n$\\sqrt{ }$ multiple nodules (in $75 \\%$ ), $82 \\%$ subpleural:\n$\\sqrt{ }$ often smooth + well-defined\n$\\sqrt{ }$ varying sizes (most typical)\n$\\sqrt{ }$ usually in random distribution\n$\\sqrt{ }$ fine micronodular pattern: highly vascular tumor (renal cell, breast, thyroid, prostate carcinoma, bone sarcoma, choriocarcinoma)\n$\\sqrt{ }$ pneumothorax ( $2 \\%$ ): especially in children with sarcoma + frequently with osteosarcoma $\\leftarrow$ bronchopleural fistula $\\leftarrow$ subpleural metastasis\n\n| Frequency of Pulmonary Metastases |  |  |  |\n| :-- | :-- | :-- | :-- |\n| Origin of pulmonary mets | Probability of pulmonary mets |  |  |\n| Breast | $22 \\%$ | for Kidney cancer | $75 \\%$ |\n| Kidney | $11 \\%$ | for Osteosarcoma | $75 \\%$ |\n| Head and neck | $10 \\%$ | for Choriocarcinoma | $75 \\%$ |\n| Colorectal | $9 \\%$ | for Thyroid cancer | $65 \\%$ |\n| Uterus | $6 \\%$ | for Melanoma | $60 \\%$ |\n| Pancreas | $5 \\%$ | for Breast cancer | $55 \\%$ |\n| Ovary | $5 \\%$ | for Prostate cancer | $40 \\%$ |\n| Prostate | $4 \\%$ | for Head and neck CA | $30 \\%$ |\n| Stomach | $4 \\%$ | for Esophagus CA | $20 \\%$ |\n\nCT:\n$\\sqrt{ }$ noncalcified multiple ( $>10$ ) round lesions $>2.5 \\mathrm{~cm}$ likely to be metastatic\n$\\sqrt{ }$ lesions connected to pulmonary arterial branches ( $75 \\%$ ):\n$\\sqrt{ }$ filling defects in large pulmonary arteries (tumor thromboemboli)\n$\\sqrt{ }$ multifocal dilatation / beading of subsegmental arteries\n$\\sqrt{ }$ tree-in-bud appearance of arterioles in secondary pulmonary lobules\n\n# Solitary Metastatic Lung Nodule \n\n$\\diamond$ A solitary lung nodule represents a primary lung tumor in $62 \\%$ in patients with known history of neoplasm\n$\\diamond 0.4-5.0-9.0 \\%$ of all solitary nodules are metastatic; most likely origin: colon carcinoma ( $30-40 \\%$ ), melanoma, osteosarcoma, renal cell carcinoma, bladder cancer, testicular cancer, breast carcinoma\n\n## Calcifying Lung Metastases (< 1\\%)\n\nmnemonic: BOTTOM\nBreast\nOsteo- / chondrosarcoma\nThyroid (papillary)\nTesticular\nOvarian\nMucinous adenocarcinoma (colon)\n\n+ others: synovial sarcoma, giant cell tumor of bone, lung metastases following radiation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 662,
            "markdown": "# Cavitating Lung Metastases \n\nFrequency: $4 \\%$ (compared with $9 \\%$ in primary bronchogenic carcinoma)\nHisto: squamous cell carcinoma (10\\%), adenocarcinoma (9.5\\%)\nmnemonic: Squamous Cell Metastases Tend to Cavitate\nSquamous cell carcinoma, Sarcoma\nColon\nMelanoma\nTransitional cell carcinoma\nCervix, during Chemotherapy\n\n## Hemorrhagic Lung Metastases\n\nCT: vill-defined nodules with fuzzy margin + \"halo\" sign (= surrounding ground-glass opacity)\n\n1. Angiocarcinoma\n2. Choriocarcinoma\n3. Renal cell carcinoma\n4. Melanoma\n5. Thyroid carcinoma\n\n## Endobronchial Metastasis\n\nFrequency: $1 \\%$\n$\\checkmark$ subsegmental / segmental atelectasis or atelectasis of entire unilateral lung\n$\\checkmark$ round endobronchial lesion on CT\n\n1. Bronchogenic carcinoma\n2. Lymphoma\n3. Colorectal carcinoma\n4. Breast cancer\n5. Renal cell carcinoma\n\n## Lung Metastases in Childhood\n\nmnemonic: ROWE\nRhabdomyosarcoma\nOsteosarcoma\nWilms tumor\nEwing sarcoma\n\n## Metastases with Airspace Pattern\n\n$=$ lepedic growth along intact alveolar walls similar to bronchioloalveolar carcinoma mimicking pneumonia\n$\\checkmark$ airspace nodules\n$\\checkmark$ consolidation with air bronchogram\n$\\checkmark$ focal /extensive ground-glass opacities\n\n1. Adenocarcinoma of GI tract $(10 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 663,
            "markdown": "2. Adenocarcinoma of breast / ovary\n\n# Sterilized Metastasis \n\n$=$ persistence of metastatic nodule without significant change in size after adequate chemotherapy\nHisto: necrotic nodule $\\pm$ fibrosis without viable tumor cells\n\n1. Choriocarcinoma\n2. Testicular cancer\n$\\sqrt{ }$ growing teratoma syndrome $=$ conversion to a benign mature teratoma\n$\\sqrt{ }$ pulmonary lacunae (= transformation into thin-walled cavity) may persist for years\n\n## Metastasis of Benign Tumor to Lung\n\n1. Leiomyoma of uterus\n2. Hydatidiform mole of uterus\n3. Giant cell tumor of bone\n4. Chondroblastoma\n5. Pleomorphic adenoma of salivary gland\n6. Meningioma\n\n## METASTASIS TO PLEURA\n\n1. Lung $(36 \\%)$\n2. Breast $(25 \\%)$\n3. Lymphoma $(10 \\%)$\n4. Ovary $(5 \\%)$\n5. Stomach $(2 \\%)$\n\n## MIXED CONNECTIVE TISSUE DISEASE\n\n$=$ OVERLAP SYNDROME\n$=$ disorder that shares distinctive features of $\\geq 2$ different connective tissue diseases in same patient (overlapping features of SLE, RA, scleroderma (PSS), poly- / dermatomyositis)\nAge peak: $2^{\\mathrm{nd}}+3^{\\mathrm{rd}}$ decade; $\\mathrm{M}+\\mathrm{F}=1 \\div 10$\n\n- Raynaud phenomenon, swollen hands, acrosclerosis\n- arthritis / arthralgia, esophageal dysmotility + GERD, myositis\n- high titer of speckled fluorescent antinuclear antibodies\n- moderate to high serum level of antibodies against ribonucleoprotein (anti-U1-RNP)\n@ Chest involvement (in $20-85 \\%$ )\n$\\sqrt{ }$ interstitial lung disease ( $21-66 \\%$ ):\n\nPattern: NSIP, UIP, LIP\n$\\sqrt{ }$ groundglass opacities predominantly in lower lung fields\n$\\sqrt{ }$ pulmonary arterial hypertension (in $10-45 \\%$ ):\nCause: interstitial pulmonary fibrosis / intimal proliferation of pulmonary arterioles\n\n- decrease in CO diffusing capacity\n$\\sqrt{ }$ pleural thickening / effusion $(<10 \\%)$\n$\\sqrt{ }$ pulmonary vasculitis, thromboembolism",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 664,
            "markdown": "$\\checkmark$ alveolar hemorrhage\n$\\checkmark$ respiratory muscle dysfunction\n$C x$ : aspiration pneumonia $\\leftarrow$ esophageal dysmotility\n\n# MYCOPLASMA PNEUMONIA \n\n$=$ PRIMARY ATYPICAL PNEUMONIA(PAP)\n$\\diamond$ Varied radiographic + clinical picture!\n$\\diamond$ Commonest cause of community-acquired nonbacterial pneumonia with a mild course (only $2 \\%$ require hospitalization), usually lasts $2-3$ weeks; only $10 \\%$ of infected subjects develop pneumonia\nFrequency: $10-33 \\%$ of all pneumonias; autumn peak\nOrganism: Eaton agent $=$ pleuropneumonia-like organism $=350 \\mu \\mathrm{~m}$ long pleomorphic Mycoplasma pneumoniae with lack of cell wall\nSpread: direct contact / aerosol\nAge: 5-20 years (most common, esp. in closed populations)\nHisto: peribronchial mononuclear cell infiltrates (similar to viral lower respiratory infection)\n\n- incubation period: $1-2$ weeks\n- gradual onset beginning with pharyngitis, headache, myalgia (rhinorrhea + nasal congestion uncommon)\n- mild symptoms of dry cough + low fever, malaise, otitis\n- sputum with PMNs but few bacteria, mild leukocytosis (20\\%)\n- most common respiratory cause of cold agglutinin production ( $60 \\%$ )\n$\\diamond$ Severity of radiologic findings discrepant to mild clinical condition with pulmonary infiltrates having a significant lag time\n$\\checkmark$ focal reticular interstitial infiltrate:\n$\\checkmark$ unilobar from hilum into lower lobe as earliest change ( $52 \\%$ ), bilobar ( $10 \\%$ )\n$\\checkmark$ parahilar peribronchial opacification ( $12 \\%$ )\n$\\checkmark$ atelectasis ( $29 \\%$ )\n$\\checkmark$ alveolar infiltrates:\n$\\checkmark$ patchy inhomogeneous unilateral ( $\\mathrm{L}>\\mathrm{R}$ ) airspace consolidation in segmental lower lobe in $50 \\%$, bilateral in $10-40 \\%$\n$\\checkmark$ small pleural effusions in $20 \\%$\n$\\checkmark$ hilar adenopathy $(7-22 \\%)$\n$R x$ : erythromycin, azithromycin, tetracycline\n$C x$ : ? as an autoimmune response\n(1) Acute disseminated encephalomyelitis\n(2) Cerebral arteriovenous occlusion\n(3) Erythema nodosum, erythema multiforme, Stevens-Johnson syndrome\n(4) pulmonary: Swyer-James syndrome, pulmonary fibrosis, bronchiolitis obliterans, ARDS\nPrognosis: $20 \\%$ with recurrent symptoms of pharyngitis + bronchitis $\\pm$ infiltrations\n$D D x$ : viral infection of lower respiratory tract, pertussis, chlamydia (indistinguishable)\n\n\n## NEAR DROWNING",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 665,
            "markdown": "$=$ asphyxiation $\\leftarrow$ water inhalation followed by survival for a minimum of 24 hour Stage 1:\n(a) acute laryngospasm after inhalation of a small amount of water\n$\\sqrt{ }$ NO roentgenographic abnormality\n(b) prolonged laryngospasm $=$ \"dry drowning\" $\\leftarrow$ negative pressure edema arising from a prolonged episode of the Müller maneuver as in postobstructive pulmonary edema\n$\\sqrt{ }$ Kerley lines, peribronchial cuffing\n$\\sqrt{ }$ patchy perihilar alveolar airspace consolidation\nPrognosis: resolution within 24-48 hours (under therapy)\nStage 2:\n$=$ laryngospasm + swallowing of water into the stomach\nStage 3:\n(a) persistent laryngospasm with dry drowning (10-15\\%)\n$\\sqrt{ }$ pressure edema\n(b) aspiration of water after hypoxia-induced relaxation of laryngospasm (85-90\\%)\n$\\sqrt{ }$ permeability edema $\\leftarrow$ hypoxia + diffuse alveolar damage\n$C x$ : ARDS, aspiration of gastric fluid, infection by fresh-water saprophytic bacteria\n\n1. Sea-water drowning\n\n- hemoconcentration, hypovolemia\n\n2. Fresh-water drowning\n\n- hemodilution, hypervolemia, hemolysis\n\n3. Secondary drowning\n(a) pneumonia $\\leftarrow$ toxic debris\n(b) progressive pulmonary edema\n4. Dry drowning $(20-40 \\%)$\n$=$ laryngeal spasm prevents water from entering\n$\\sqrt{ }$ no roentgenographic abnormality\nSimilarities of all 4 types:\n\n- hypoxemia, metabolic acidosis\n$\\sqrt{ }$ central extensive fluffy areas of increased opacity (alveolar edema indistinguishable from other types):\n$\\sqrt{ }$ tendency for opacities to coalesce\n$\\sqrt{ }$ hyaline membrane formation $=$ considerable loss of protein from blood\n$C x$ : pneumonia $\\leftarrow$ aspirated bacteria / fungi / mycobacteria\n\n\n# NECROTIZING SARCOID GRANULOMATOSIS \n\nEtiology: ? variant of sarcoidosis\nMean age: 49 years (range, $3^{\\text {rd }-7^{\\text {th }}}$ decade); $\\mathrm{M}+\\mathrm{F}=1 \\div 2.2$\nPath: pleural + subpleural + peribronchovascular scattered nodules / conglomerate masses $\\pm$ central cavitation\nHisto: confluent noncaseating granulomas, extensive necrosis, vasculitis of muscular pulmonary arteries + veins with frequently total vascular occlusion, bronchiolar obstruction, bronchiolitis obliterans, obstructive pneumonitis\n\n- asymptomatic $(15-40 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 666,
            "markdown": "- cough, chest pain, dyspnea, fever, weight loss, fatigue\n- uveitis, hypothalamic insufficiency (13\\%)\n\nO Almost exclusively affects lungs\n$\\sqrt{ }$ multiple bilateral subpleural + peribronchovascular pulmonary nodules\n$\\sqrt{ }$ numerous ill-defined parenchymal opacities\n$\\sqrt{ } \\pm$ cavitation\n$\\sqrt{ }$ hilar lymphadenopathy $(8-79 \\%)$\n$\\sqrt{ }$ pleural thickening\n$\\diamond$ NO upper airway disease / glomerulonephritis / systemic vasculitis\nRx: corticosteroid therapy alone\n$D D x$ : sarcoidosis (high prevalence of mediastinal + hilar lymphadenopathy, little propensity for cavitation)\n\n# NEONATAL PNEUMONIA \n\n## Pathogenesis:\n\n(a) in utero infection: ascending from premature rupture of membranes or prolonged labor / transplacental route) $=$ major risk factor\n(b) aspiration of infected vaginal secretions during delivery\n(c) infection after birth\n\n## Organism:\n\n(1) Group B streptococcus (GBS) = most common cause: in low-birth-weight premature infants; $50 \\%$ mortality\n$\\sqrt{ }$ pulmonary opacities $(87 \\%)$ :\n$\\sqrt{ }$ appearance identical to RDS (in $52 \\%$ )\n$\\sqrt{ }$ appearance suggests retained lung fluid / focal infiltrates (35\\%)\n$\\sqrt{ }$ normal CXR (13\\%)\n$\\sqrt{ }$ cardiomegaly (common)\n$\\sqrt{ }$ pleural effusions (in $2 / 3$, but RARE in RDS)\nAssociated with: delayed onset of diaphragmatic hernia (evidenced by clinical deterioration)\nPrognosis: often lethal\n(2) Pneumococci: RDS-like\n(3) Listeria: RDS-like\n(4) Candida: progressive consolidation + cavitation\n(5) Chlamydia trachomatis: bronchopneumonic pattern\n(6) others: H. influenzae, Staphylococcus aureus, E. coli, CMV, Pneumocystis\n\n- afebrile, lower ventilatory pressure requirements\n$\\sqrt{ }$ bilateral focal / diffuse areas of opacities (may initially appear similar to fetal aspiration syndrome)\n$\\sqrt{ }$ hyperaeration\n$\\sqrt{ }$ may cause lobar atelectasis\n$\\sqrt{ }$ may cause pneumothorax / pneumomediastinum\n$\\sqrt{ }$ pleural effusion (exceedingly rare)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 667,
            "markdown": "# NEUROENDOCRINE TUMOR OF LUNG \n\n$=$ tumors arising from Kulchitsky cells (normally present in bronchial mucosa)\nIncidence: $25 \\%$ of all pulmonary neoplasms\nHisto: neuroendocrine morphology = organoid nesting, palisading, rosettes, trabecular growth pattern\n\n| Classification of Pulmonary Neuroendocrine Neoplasms <br> (WHO 2004) |  |\n| :-- | :-- |\n| Histologic Categories |  |\n| Low-grade malignant neoplasm |  |\n| Typical carcinoid |  |\n| Intermediate-grade neoplasm |  |\n| Atypical carcinoid |  |\n| High-grade neoplasm |  |\n| Large cell neuroendocrine tumor |  |\n| Small cell lung cancer (SCLC) |  |\n\nClassification (Travis):\n\n1. Carcinoid $(25 \\%)$\n2. Large cell neuroendocrine carcinoma\n3. Small cell lung cancer\n\n## Carcinoid Tumor of Lung\n\n$=$ NEUROENDOCRINE CARCINOMA/NEOPLASM\n$\\diamond 2^{\\text {nd }}$ most common location after GI tract\nFrequency: $1-2 \\%$ of all pulmonary neoplasms; $20-30 \\%$ of all carcinoid tumors; $20-25 \\%$ of all invasive primary lung cancers\n$\\diamond$ Most common primary pulmonary neoplasm in children!\n\n| DDx of Typical Carcinoid versus Atypical Carcinoid |  |  |\n| :--: | :--: | :--: |\n| Criterion | Typical Carcinoid (80-90\\%) | Atypical Carcinoid $(10-20 \\%)$ |\n| Path | well-differentiated | intermediate grade npl. |\n| Histo | NO necrosis; $<2$ mitoses +10 HPFs $/ 2 \\mathrm{~mm}^{2}$ | areas of punctate necrosis; $2-10$ mitoses +10 HPFs |\n| Association |  | cigarette smoking (83-94\\%) |\n| Age | younger patient; $\\mathrm{M}+\\mathrm{F}=1 \\div 10$ (?) | $\\sim 1$ decade older patient; $\\mathrm{M}+\\mathrm{F}=2 \\div 1$ to $3 \\div 1$ |\n| Location | central: <br> endobronchial growth | peripheral $>$ central |\n| Mean size | 2.3 cm | 3.6 cm |\n| Spread | rare: to lymph node in $3 \\%$ | adrenal gland, brain, liver, skin, bone (osteoblastic) in $30 \\%$; lymph node ( $25-50 \\%$ ) |\n| Prognosis | 5 (10)-year survival of $87-100 \\%(82-94 \\%)$ | 5 (10)-year survival of $44-88 \\%(18-64 \\%)$ |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 668,
            "markdown": "Mean age: 46 (range, 4-95) years; $4 \\%$ occur in children + adolescents; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$; very uncommon in Blacks\nAssociated with: MEN 1 in $<4 \\%$ (almost all hormonally inactive)\nPath:\nwell-defined pulmonary nodule / mass that originates from neurosecretory cells of bronchial mucosa (= Kulchitsky cells = argentaffin cells); part of APUD (amine precursor uptake and decarboxylation) system = chromaffin paraganglioma, which produces serotonin, ACTH, norepinephrine, bombesin, calcitonin, ADH, bradykinin\nHisto: neuroendocrine morphology = organoid nesting, palisading, rosettes, trabecular growth pattern; uniform cells separated by prominent vascular stroma + numerous thinwalled blood vessels\nImmunohisto: positive for neuron-specific enolase, CD56, Ki-67, chromogranin A, synaptophysin\n\n- asymptomatic $(20-50 \\%) \\leftarrow$ peripheral tumor\n- recurrent unifocal pneumonitis, hemoptysis\n- wheezing, persistent cough, dyspnea, chest pain\n- paraneoplastic syndromes (rare):\n(a) Cushing syndrome: in $2 \\%$ of bronchial carcinoids\n(b) carcinoid syndrome: in $0.7 \\%$ of pulmonary carcinoids\n- endobronchial exophytic mass at endoscopy\n\nLocation:\n$>70-90 \\%$ in main / lobar / segmental bronchi, often near bifurcation; $\\mathrm{R} \\div \\mathrm{L}$ lung $=3 \\div 2$\nSite: relationship to central bronchus\n(a) completely endobronchial / endoluminal\n(b) partially endoluminal (\"tip of iceberg\" sign)\n(c) abutting airway\n$>10-42 \\%$ peripheral in lung parenchyma\nSite: no relationship to bronchus\nAverage size: 3 (range, 2-5) cm; atypical carcinoid is larger + more peripheral\nCXR:\n$\\sqrt{ }$ well-defined central hilar / perihilar mass:\n$\\sqrt{ } \\pm$ consolidation $\\leftarrow$ atelectasis / postobstructive pneumonitis / recurrent pneumonia\n$\\sqrt{ } \\pm$ mucus plugging = \"gloved finger\" appearance\n$\\sqrt{ }$ solitary well-defined round / ovoid peripheral nodule / mass distal to segmental bronchus\n$\\sqrt{ } \\pm$ lobulated borders $<3 \\mathrm{~cm}$ in size\nCT:\n$\\sqrt{ }$ spherical / ovoid polypoid nodule / mass (with long axis parallel to adjacent bronchovascular bundle):\n$\\sqrt{ }$ well-defined slightly lobulated border\n$\\sqrt{ }$ \"bronchus sign\" (= bronchus leading directly to the tumor) may allow diagnosis prospectively\n$\\sqrt{ }$ \"collar button\" lesion = extension through bronchial wall involving bronchial lumen + parenchyma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 669,
            "markdown": "$\\sqrt{ }$ diffuse scattered eccentric punctate calcifications / dense ossification (26-33\\%): central carcinoid $\\div$ peripheral carcinoid $=10 \\% \\div 43 \\%$\n$\\checkmark$ cavitation (rare)\n$\\checkmark$ intense $>30 \\mathrm{HU}$ net enhancement $\\leftarrow$ vascular tumor supplied by bronchial circulation\n$\\checkmark$ bronchiectasis, mucoid impaction, atelectasis, air trapping\n$\\checkmark$ postobstructive pneumonia\n$\\checkmark$ hilar / mediastinal lymphadenopathy $(6-25 \\%) \\leftarrow$ metastasis / reactive hyperplasia $\\leftarrow$ recurrent pneumonia\n$\\checkmark$ metastases in liver, bone, adrenal glands\nMR:\n$\\checkmark$ mass of high T2 + STIR signal intensity\n$\\checkmark$ intense enhancement during systemic circulatory phase\nNUC:\nAgents: 111In-octreotide / lanreotide (short-acting / long-acting somatostatin analogs), $\\mathrm{MIBG}=$ meta-iodobenzylguanidine (norepinephrine analog)\n$\\checkmark$ typically for staging / assessing response to therapy\n$\\checkmark$ helpful in detecting occult tumor (depending on degree of somatostatin-receptor expression rather than hormonal hypersecretion)\n$\\checkmark$ MIBG less sensitive than octreotide\nPET (high false-negative rate):\n$\\sqrt{ }$ NO (most often) / increased activity (occasionally)\nPrognosis: death from valvular disease\nRx: lobectomy, pneumonectomy, endobronchial resection, bronchial sleeve resection, segmentectomy\n$D D x$ : lung cancer, pulmonary hamartoma, bronchial gland tumor, metastasis\n\n# Large Cell Neuroendocrine Carcinoma \n\n= poorly differentiated high-grade neuroendocrine tumor as a variant of large-cell carcinoma\nPrevalence: $3 \\%$ of all resected lung cancers; $19 \\%$ of pulmonary endocrine tumors; $12 \\%$ of all large cell undifferentiated carcinomas\nHisto: high mitotic rate of $>10$ per 10 HPFs ; large cell size, polygonal shape, low nuclear-cytoplasmic ratio, finely granular eosinophilic cytoplasm, coarse nuclear chromatin, frequent nucleoli; positive neuroendocrine marker (chromogranin A, synaptophysin, neural cell adhesion molecule [NCAM/CD56], thyroid transcription factor (TTF)-1 [41-75\\%], Ki-67 proliferation index [50-100\\%])\nMean age: 65 (range, 44-82) years; $\\mathrm{M} \\div \\mathrm{F}=2.5 \\div 1$\nAssociated with: heavy smoking (30-62 pack-years) in $60 \\%$\n\n- asymptomatic $(25 \\%)$\n- chest pain, hemoptysis, cough, dyspnea, weight loss, fever\n\nLocation: peripheral ( $70-80 \\%$ ) / central ( $20-30 \\%$ )\nMean size: 3.7 (range, $1.3-9.2$ ) cm\nCXR:\n$\\sqrt{ } 3.7-\\mathrm{cm}$ peripheral pulmonary mass\nCT:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 670,
            "markdown": "$\\sqrt{ }$ nonspecific well-defined lobulated nodule / mass:\n$\\sqrt{ }\\pm$ air bronchogram, cavity, bubbly lucency, necrosis\n$\\sqrt{ }$ intratumoral calcifications ( $9 \\%$ )\n$\\sqrt{ }$ homo- / heterogeneous enhancement\n$\\sqrt{ }$ attendant atelectasis / distal mucus plugging\n$\\sqrt{ }$ pleural effusion $(24 \\%)$\nPET:\n$\\sqrt{ }$ avid FDG uptake; SUV > 13.7 suggests shortened survival\nSpread: mediastinal lymphadenopathy (27\\%); extrathoracic metastasis (36\\%)\nPrognosis: 5-year survival rate of $15-57 \\%$; recurrence in supraclavicular / mediastinal lymph nodes within 2 years\n$D D x$ : small cell lung cancer, atypical carcinoid\n\n# NOCARDIOSIS \n\nOrganism: Gram-positive acid-fast bacterium resembling fungus\nPredisposed: immunocompromised\n$\\sqrt{ }$ multiple poorly / well-defined nodules $\\pm$ cavitation\n$\\sqrt{ }$ lobar consolidation\n$\\sqrt{ }$ empyema without sinus tracts\n$\\sqrt{ }$ SVC obstruction (rare)\n\n## NODULAR LYMPHOID HYPERPLASIA\n\n$=$ PSEUDOLYMPHOMA $=$ LOCALIZED MASSLIKE FORM OF LIP\n$=$ reactive benign lesion $=$ uncommon localized lymphoid hyperplasia; no progression to lymphoma\nPath: usually single involvement of small area of lung\nHisto: aggregates of polymorphous large + small lymphoid cells (B and T cells); multiple germinal centers; infiltration and expansion of alveolar interstitium by lymphocytes (T cells) and plasma cells, occasional giant cell; variable fibrosis; common lymphoepithelial lesions (= invasion of bronchial epithelium by lymphoid cells)\nMay be associated with: collagen vascular disease, Sjögren syndrome, dysgammaglobulinemia\n\n- mostly asymptomatic / cough, dyspnea\n\nLocation: subpleural / $\\pm$ peribronchial\nCXR:\n$\\sqrt{ }$ well-demarcated dense infiltrate(s) as nodule / mass / masslike consolidation\nCT:\n$\\sqrt{ }$ infiltrate typically in central location extending to visceral pleura\n$\\sqrt{ }$ prominent central air bronchogram\n$\\sqrt{ }$ NO invasion of adjacent bronchus / pleural space\n$\\sqrt{ }$ NO hilar / mediastinal lymphadenopathy\n$\\sqrt{ }$ NO pleural effusion\nPrognosis: occasionally progression to non-Hodgkin lymphoma\n$R x$ : most patients respond well to steroids initially\n$D x$ : surgical biopsy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 671,
            "markdown": "# NONTUBERCULOUS MYCOBACTERIAL LUNG INFECTION \n\n$=$ ATYPICAL TUBERCULOSIS = ATYPICAL MYCOBACTERIAL INFECTION\nOrganism:\nM. kansasii: lung infection in subjects with good immune status\nM. marinum: \"swimming pool granuloma\"\nM. ulcerans: \"Buruli ulcer\" in tropical areas\nM. scrofulaceum: cervical lymphadenitis in infants\nM. avium intracellulare: esp. in AIDS (most common)\n\nOrganism causing pulmonary disease (Runyon classification):\nubiquitous organisms as part of normal environmental flora\n\n1. Photochromogens M. kansasii, M. simiae, M. asiaticum\n\n- colonies turn yellow with exposure to light\n$\\diamond 70-80 \\%$ of individuals from rural areas test positive on PPD-B ( $=$ antigen from M . kansasii)!\n2. Scotochromogens M. scrofulaceum, M. xenopi, M. szulgai, M. gordonae\n- yellow colonies turn orange with exposure to light\n\n3. Nonchromogens M. avium-intracellulare, M. malmoense, M. terrae\n\n- white / beige colonies without color change\n\n4. Rapid growers M. fortuitum-chelonei\n\n- appear in culture in 3-5 days (all other groups appear in culture in 2-4 weeks)\n\nHisto: lesions indistinguishable from M. tuberculosis\nSource: soil, water, dairy products, bird droppings\nInfection: inhalation of aerosolized water droplets (M. avium-intracellulare complex), food aspiration in patients with achalasia (M. fortuitum-chelonei), GI tract (in AIDS)\n\n- cough ( $60-100 \\%$ ), hemoptysis ( $15-20 \\%$ ), asthma, dyspnea\n- fever distinctly uncommon ( $10-13 \\%)$\n- weakness + weight loss (up to $50 \\%$ )\n- weekly positive tuberculin skin test\n\nA. CLASSIC FORM\n\nAge: $6^{\\text {th }}-7^{\\text {th }}$ decade; in Whites ( $80-90 \\%$ ); M > F\nPredisposing factors:\nCOPD (25-72\\%), previous TB (20-24\\%), interstitial lung disease (6\\%), smoking $>30$ pack-years ( $46 \\%$ ), alcohol abuse ( $40 \\%$ ), cardiovascular disease ( $36 \\%$ ), chronic liver disease ( $32 \\%$ ), previous gastrectomy ( $18 \\%$ )\nLocation: apical + anterior segments of upper lobes\n$\\sqrt{ }$ chronic fibronodular / fibroproductive apical opacities (indistinguishable from reactivation TB)\n$\\sqrt{ }$ cavitation in $80-95 \\%$\n$\\sqrt{ }$ apical pleural thickening in $37-56 \\%$\n$\\sqrt{ }$ additional patchy nodular alveolar opacities in ipsi- / contralateral lung in $40-70 \\% \\leftarrow$ bronchogenic spread\n$\\sqrt{ }$ adenopathy $(0-4 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 672,
            "markdown": "$\\sqrt{ }$ pleural effusion $(5-20 \\%)$\n$\\sqrt{ }$ typically NO hilar elevation\nB. NONCLASSIC FORM $(20-30 \\%)$\n\nAge: $7^{\\text {th }}-8^{\\text {th }}$ decade; $86 \\%$ in Whites; $\\mathrm{M}+\\mathrm{F}=1 \\div 4$\n\n- chronic cough, hemoptysis, malaise, weight loss, fatigue\n- older woman with thin body habitus = \"Lady Windermere syndrome\":\n[Oscar Wilde's Victorian-era play Lady Windermere's Fan exemplifies the fastidious behavior believed to cause the syndrome by suppressing cough and never displaying any signs of illness]\n- pectus excavatum chest wall deformity, thoracic scoliosis\n- mitral valve prolapse\n- older men with chronic obstructive pulmonary disease\n\nPredisposing factors: NONE\nLocation: predominantly in middle lobe + lingula\n$\\sqrt{ }$ multiple bilateral centrilobular nodules throughout both lungs in random distribution\n$\\sqrt{ }$ irregular curvilinear interstitial opacities\n$\\sqrt{ }$ mild to moderate cylindrical bronchiectasis\n$\\sqrt{ }$ atelectasis / scarring\nHRCT:\n$\\sqrt{ }$ bronchiectasis, bronchial wall thickening\n$\\sqrt{ }$ mucoid bronchial impaction\n$\\sqrt{ }$ scattered tree-in-bud nodules\n$\\sqrt{ }$ areas of segmental + subsegmental atelectasis + scarring\nC. ASYMPTOMATIC GRANULOMAS\n$\\sqrt{ }$ cluster of similar-sized nodules\nD. ACHALASIA-RELATED INFECTION\nwith M. fortuitum-chelonei\nE. DISSEMINATED DISEASE\nin immunocompromised patients: AIDS, transplant patients, lymphoproliferative disorders (esp. hairy cell leukemia), steroid + immunosuppressive therapy\nCT:\n$\\sqrt{ }$ multifocal bronchiectasis (79-94\\%), esp. middle lobe + lingula\n$\\sqrt{ }$ centrilobular nodules of varying sizes, usually $<1 \\mathrm{~cm}$ (= micronodules) in $76-97 \\%$\n$\\sqrt{ }$ bronchial wall thickening ( $97 \\%$ )\n$\\sqrt{ }$ airspace disease ( $76 \\%$ )\n$\\sqrt{ }$ cavitation ( $21 \\%$ ), esp. in upper lobes\n$\\sqrt{ }$ interlobular septal thickening ( $12 \\%$ )\n$\\diamond$ Unfavorable response to antituberculous therapy is suspicious for atypical TB!\n$R x$ : multidrug regimen typically prescribed for at least 1 year\n$D D x$ : M. tuberculosis (bronchiectasis less common + less extensive), bronchiolitis obliterans, sarcoidosis, fungal disease\n\n# PANBRONCHIOLITIS \n\n$=$ DIFFUSE PANBRONCHIOLITIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 673,
            "markdown": "$=$ progressive inflammatory lung disease characterized by chronic inflammation of paranasal sinuses + respiratory bronchioles, prevalent in Asians but rare in Europeans + North Americans\nPathogenesis: unknown\nHisto: thickening of respiratory bronchiole wall + transmural infiltration of lymphocytes + plasma cells + histiocytes\nLocation: predominantly in lung bases\nHRCT:\n$\\sqrt{ }$ tree-in-bud pattern $=$ small centrilobular nodules of $<5 \\mathrm{~mm}$ connected to centrilobular branching structures ( $=$ segments of bronchiolectasis filled with secretions)\n$\\sqrt{ }$ bronchial wall thickening\n$\\sqrt{ }$ mosaic perfusion\n$\\sqrt{ }$ bronchiectasis\n$\\sqrt{ }$ cystic lesions + air trapping (in later stage)\n$D D x$ : bronchiolitis obliterans\n\n# PARAGONIMIASIS OF LUNG \n\n$=$ PLEUROPULMONARY PARAGONIMIASIS\n$=$ parasitic disease caused by trematode Paragonimus (usually P. westermani = lung fluke / P. kellicotti)\nPrevalence: 20.7 million infected\nEndemic to: certain areas of East + Southeast Asia (China, Korea, Japan, Thailand, Laos, Philippines, India); Latin America (primarily Peru); Africa (primarily Nigeria); in US among Indo-Chinese and Latin American immigrants\nInfection: ingestion of raw / incompletely cooked freshwater crustaceans (crab / crayfish) infected with metacercariae; larva exists in small intestine $\\rightarrow$ penetrates intestinal wall $\\rightarrow$ enters peritoneal cavity; $\\rightarrow$ penetrates diaphragm + pleura $\\rightarrow$ enters lung (target organ)\nCycle:\nfrom final host (tiger, cat, dog, fox, weasel, opossum, wild boar, human) eggs of worm pass to the outside with blood-streaked sputum; in fresh water ciliated embryos (miracidia) develop $\\rightarrow$ become tailed larvae (cercariae) after invading a fresh-water snail; when infected snail is eaten by a crustacean, their tails detach and they become $300 \\mu \\mathrm{~m}$ encysted larvae (metacercariae)\n\n- parasitic eggs in sputum / BAL fluid / pleural fluid / feces\n- intradermal and serologic tests\n@ Chest\n- fever, chest pain, chronic cough, hemoptysis\n\nLocation: pulmonary lesions in $83 \\%$, pulmonary + pleural lesions in $44 \\%$, pleural lesions in $17 \\%$ )\nEarly findings (lesions occur 3-8 weeks after ingestion when organisms migrate to pleural space)\n$\\sqrt{ }$ uni- / bilateral pneumo- / hydropneumothorax (17\\%)\n$\\sqrt{ }$ uni- / bilateral pleural effusion (3-54\\%) / empyema $\\pm$ pleural thickening",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 674,
            "markdown": "$\\sqrt{ }$ focal patchy migrating airspace consolidation (= worm migration causes focal exudative / hemorrhagic pneumonia) in $45 \\%$ :\n$\\sqrt{ } \\pm$ cavitation\n$\\sqrt{ }$ lobar / segmental collapse $\\leftarrow$ airway obstruction from egg granuloma / intrusion of worm\n$\\sqrt{ } 2-4-\\mathrm{mm}$ thick and $2-7-\\mathrm{cm}$ long linear opacities / hyperattenuation abutting the pleura $(41 \\%) \\leftarrow$ peripheral atelectasis / worm migration track (visible in up to $50 \\%$ )\nCT:\n$\\sqrt{ }$ hypoattenuating fluid-filled cysts surrounded by hyperattenuating consolidation in adjacent lung\n$\\sqrt{ }$ mediastinal lymphadenopathy\nLate findings when organisms reside and reproduce in lung parenchyma:\n$\\sqrt{ }$ lung cyst $\\leftarrow$ cyst formation $\\leftarrow$ infarction $\\leftarrow$ arteriolar / venous obstruction by worm or egg / expansion of small airway by intraluminal parasite:\n$\\sqrt{ }$ thick-walled cyst $\\leftarrow$ fibrosis\n$\\sqrt{ }$ \"eclipse effect\" = eccentric thickening of cyst wall $\\leftarrow$ one / two intracystic worms\n$\\sqrt{ }<3 \\mathrm{~mm}$ thin-walled cyst $\\leftarrow$ cyst connected to airway\n$\\sqrt{ } 10-15-\\mathrm{mm}$ poorly marginated subpleural / subfissural worm cyst (= nodules + masslike consolidation in $24 \\%$ ):\n$\\sqrt{ }$ cyst initially masked by pericystic airspace consolidation\n$\\sqrt{ } \\pm$ cyst filled with chocolate-colored necrotic fluid of low opacity\n$\\sqrt{ }$ adjacent bronchiectasis ( $35 \\%$ )\n$\\sqrt{ }$ cavity formation\n$\\sqrt{ }$ high radiotracer uptake on PET\n@ CNS\n\n- meningoencephalitis (in 25\\%)\n$\\sqrt{ }$ shell-like / soap-bubble-like calcifications of varying size ( $50 \\%$ )\n$D x:$ eggs of parasite in sputum or in pleural / BAL fluid\n$D D x$ : tuberculosis (nodular slowly changing lesion, residual fibrosis after treatment, no subpleural linear opacities), cryptococcosis, bacterial infection with abscess formation, vasculitis\n\n\n# PNEUMATOCELE \n\n$=$ discrete thin-walled cystic air collection within lung parenchyma $\\leftarrow$ obstructive overinflation\n$=$ regional obstructive emphysema\n$\\diamond$ Does not indicate destruction of lung parenchyma\n$\\diamond$ Occurs during healing phase\n$\\diamond$ Appears to enlarge while patient improves\n$\\diamond$ Frequently multiple\nDevelopmental theories:\n(1) small bronchioles undergo severe distension $\\leftarrow$ check-valve endobronchial / peribronchial obstruction\n(2) focus of necrotic lung $\\rightarrow$ evacuates through a bronchus narrowed by edema / inflammation $\\rightarrow$ subsequent airspace enlargement due to check-valve mechanism from enlarging",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 675,
            "markdown": "pneumatocele / inflammatory exudate\n(3) air from ruptured alveoli / bronchioles dissects along interstitial interlobular tissue and accumulates between visceral pleura and lung parenchyma $=$ subpleural emphysematous bulla $=$ subpleural air cyst\n$\\sqrt{ }$ well-defined thin-walled pulmonary parenchymal cyst\n$\\sqrt{ }$ may be entirely filled with gas / air-fluid level\n$\\sqrt{ } \\pm$ contralateral mediastinal shift + compressive atelectasis\nCx: rupture $\\rightarrow$ tension pneumothorax\n\n# Pneumatocele Associated with Infection \n\nOrganism: Staphylococcus (in childhood), Pneumococcus, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae\nAge: infant + young child; $<3$ years of age in up to $70 \\%$\n$\\sqrt{ }$ appears within 1 st week, disappears within 6 weeks\n$\\sqrt{ }$ thin-walled + completely air-filled cavity\n$\\sqrt{ } \\pm$ air-fluid level + wall thickening (during infection)\n$\\sqrt{ }$ pneumothorax\n$\\sqrt{ }$ spontaneous resolution over several weeks to months\n\n## Traumatic Pneumatocele = Pneumatocyst\n\nCause: blunt chest trauma\n(a) air trapped within area of pulmonary laceration is initially obscured by surrounding contusion (hematoma):\n$\\sqrt{ }$ pneumatocyst appears within hours after trauma\n$\\sqrt{ }$ cyst spontaneously resolves within 3 weeks\n(b) intensive inflammatory response from hydrocarbon (furniture polish, kerosene) inhalation / ingestion\n$\\sqrt{ }$ single / multiple pneumatoceles with sparing of apices\n\n## \"Pulverized Lung\"\n\nCause: severe chest trauma\n$\\sqrt{ }$ multiple $5-10-\\mathrm{mm}$ air cysts in an area of airspace opacification\n\n## PNEUMOCOCCAL PNEUMONIA\n\nMost common Gram-positive pneumonia ( $90 \\%$ community-acquired, $10 \\%$ nosocomial)\nFrequency: $15 \\%$ of all adulthood pneumonias, uncommon in childhood; peaks in winter + early spring; increased during influenza epidemics\nOrganism: Streptococcus pneumoniae (formerly Diplococcus pneumoniae, Gram-positive, in pairs / chains, encapsulated, capsular polysaccharide responsible for virulence + serotyping)\nSusceptible: elderly, debilitated, alcoholics, CHF, COPD, multiple myeloma, hypogammaglobulinemia, functional / surgical asplenia\n\n- rusty blood-streaked sputum, left-shift leukocytosis\n- impaired pulmonary function\n\nLocation: usually involves one lobe only; bias for lower lobes + posterior segments of upper",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 676,
            "markdown": "lobes $\\leftarrow$ bacteria flow under gravitational influence to most dependent portions as in aspiration\n$\\sqrt{ }$ extensive airspace consolidation abutting against visceral pleura (lobar / beyond confines of one lobe through pores of Kohn) CHARACTERISTIC\n$\\checkmark$ slight expansion of involved lobes\n$\\checkmark$ prominent air bronchograms ( $20 \\%$ )\n$\\checkmark$ patchy bronchopneumonic pattern (in some)\n$\\checkmark$ pleural effusion (parapneumonic transudate) uncommon with antibiotic therapy\n$\\checkmark$ cavitation (rare, with type III)\nVariations (pneumonia modified by bronchopulmonary disease, eg, chronic bronchitis, emphysema):\n$\\checkmark$ bronchopneumonia-like pattern\n$\\checkmark$ effusion may be only presentation (esp. in COPD)\n$\\checkmark$ empyema (with persistent fever)\n$>$ in children:\n$\\checkmark$ round pneumonia $=$ sharply defined round lesion\nPrognosis: prompt response to antibiotics (if without complications); 5\\% mortality rate\n$D x$ : blood culture (positive in $30 \\%$ )\n$C x$ : meningitis, endocarditis, septic arthritis, empyema (now rarely seen)\n\n# PNEUMOCYSTOSIS \n\n$=$ PNEUMOCYSTIS CARINII PNEUMONIA\n$\\diamond$ Most common cause of interstitial pneumonia in immuno-compromised patients, which quickly leads to airspace disease\nOrganism:\nubiquitous obligate extracellular protozoan / fungus Pneumocystis carinii\n(a) trophozoite develops into a cyst\n(b) cyst produces up to eight daughter sporozoites, which are released at maturity + develop into trophozoites\nPathomechanism:\ntrophozoite attaches to cell membrane of type I alveolar pneumocytes $\\rightarrow$ cell death + leakage of proteinaceous fluid into alveolar space\nPredisposed:\n(a) debilitated premature infants, children with hypogammaglobulinemia (12\\%)\n(b) AIDS $(60-80 \\%)$\n(c) other immunocompromised patients: congenital immuno-deficiency syndrome, lymphoproliferative disorders, organ transplant recipients (renal transplant patients in $10 \\%$ ), patients on long-term corticosteroid therapy (nephrotic syndrome, collagen vascular disease), patients on cytotoxic drugs [under therapy for leukemia ( $40 \\%$ ), lymphoma (16\\%)]\n$\\diamond$ Often associated with simultaneous infection by CMV, Mycobacterium aviumintracellulare, herpes simplex\n\n- severe dyspnea + cyanosis over 3-5 days\n- subacute insidious onset of malaise + minimal cough (frequent in AIDS patients), respiratory failure $(5-30 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 677,
            "markdown": "- WBC slightly elevated (PMNs)\n- lymphopenia (50\\%) heralds poor prognosis\n$\\checkmark$ normal CXR in $10-39 \\%$\n$\\checkmark$ bilateral diffuse symmetric finely granular / reticular interstitial / airspace infiltrates (in 80\\%) with perihilar + basilar distribution (CHARACTERISTIC central location)\n$\\checkmark$ response to therapy within 5-7 days\n$\\checkmark$ rapid progression to diffuse alveolar homogeneous consolidation (DDx: pulmonary edema)\n$\\checkmark$ air bronchogram\n$\\checkmark$ fine / coarse linear / reticular pattern = thickened coarse interstitial lung markings (in healing phase)\n$\\checkmark$ pleural effusion + hilar lymphadenopathy (uncommon)\n$\\checkmark$ atypical pattern (in 5\\%):\n$\\checkmark$ isolated lobar disease / focal parenchymal opacities\n$\\checkmark$ lung nodules $\\pm$ cavitation\n$\\checkmark$ hilar / mediastinal lymphadenopathy\n$\\checkmark$ thin- / thick-walled regular / irregular cysts / cavities with predilection for upper lobes + subpleural regions\n$\\checkmark$ effect of prophylactic use of aerosolized pentamidine:\n$\\checkmark$ redistribution of infection to upper lobes\n$\\checkmark$ cystic lung disease\n$\\checkmark$ spontaneous pneumothorax, frequently bilateral (6-7\\%)\n$\\checkmark$ disseminated extrapulmonary disease (1\\%)\n$\\checkmark$ punctate / rimlike calcifications in enlarged lymph nodes + abdominal viscera\nCT:\n$\\checkmark$ patchwork pattern (56\\%)\n= bilateral asymmetric patchy mosaic appearance with sparing of segments / subsegments of pulmonary lobe\n$\\checkmark$ ground-glass pattern (26\\%)\n= bilateral diffuse / perihilar airspace disease (fluid + inflammatory cells in alveolar space) in symmetric distribution\n$\\checkmark$ interstitial pattern (18\\%)\n= bilateral symmetric / asymmetric, linear / reticular markings (thickening of interlobular septa)\n$\\checkmark$ air-filled spaces (38\\%):\n(a) pneumatoceles = thin-walled spaces without lobar predilection resolving within 6 months\n(b) subpleural bullae (due to premature emphysema)\n(c) thin-walled cysts (? check-valve obstruction of small airways from aerosolized pentamidine)\n(d) necrosis of PCP granuloma\n$\\checkmark$ pneumothorax (13\\%)\n$\\checkmark$ lymphadenopathy (18\\%)\n$\\checkmark$ pleural effusion (18\\%)\n$\\checkmark$ pulmonary nodules usually due to malignancy (leukemia, lymphoma, Kaposi sarcoma,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 678,
            "markdown": "metastasis) / septic emboli\n$\\checkmark$ pulmonary cavities / cyst formation (chronic) usually due to superimposed fungal / mycobacterial infection\nNUC:\n$\\checkmark$ bilateral and diffuse 67Ga uptake without mediastinal involvement prior to roentgenographic changes\n$D D x:$ TB / MAI infection (with mediastinal involvement)\n$D x$ : (1) Sputum collection\n(2) Bronchoscopy with lavage\n(3) Transbronchial / transthoracic / open lung Bx\n\nPrognosis: rapid fulminant disease; death within 2 weeks\nRx: co-trimoxazole IV, nebulized pentamidine\n\n# PNEUMONECTOMY CHEST \n\nEarly signs (within 24 hours):\n$\\checkmark$ partial filling of thorax\n$\\checkmark$ ipsilateral mediastinal shift + diaphragmatic elevation\nLate signs (after 2 months):\n$\\checkmark$ complete obliteration of space\nN.B.: Depression of diaphragm / shift of mediastinum to contralateral side indicates a bronchopleural fistula / empyema / hemorrhage!\n\n## POLAND SYNDROME\n\n$=$ congenital chest wall anomalies\nMay be associated with: hypo- / aplasia of mamilla / breast\nAutosomal recessive\n$\\checkmark$ unilateral partial / complete absence of muscles:\n> pectoralis major (absence of sternocostal head) + minor\n> latissimus dorsi\n> serratus anterior\n> intercostal muscles\n$\\checkmark$ ipsilateral syndactyly + brachydactyly\n$\\checkmark$ hypoplasia / absence of ribs\n$\\checkmark \\pm$ scoliosis\n\n## POSTOBSTRUCTIVE PNEUMONIA\n\n$=$ chronic inflammatory disease distal to bronchial obstruction; despite the name coexistent infection is uncommon\nCause:\n\n1. Bronchogenic carcinoma (most commonly)\n2. Bronchial adenoma\n3. Granular cell myoblastoma (almost always tracheal lesion)\n4. Bronchostenosis\n\nHisto: \"golden pneumonia\" = cholesterol pneumonia = endogenous lipid pneumonia $\\leftarrow$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 679,
            "markdown": "mixture of edema, atelectasis, round cell infiltration, bronchiectasis, liberation of lipid material from alveolar pneumocytes $\\leftarrow$ inflammatory reaction\n$\\checkmark$ frequently associated with some degree of atelectasis\n$\\checkmark$ persists unchanged for weeks\n$\\checkmark$ recurrent pneumonia in same region after antibiotic Rx\n\n# PRIMARY PULMONARY LYMPHOMA \n\n$=$ monoclonal lymphoid proliferation within lung parenchyma\nFrequency of primary lung lymphomas:\n> MALT lymphoma (most common)\n> diffuse large B-cell NHL ( $2^{\\text {nd }}$ most common)\n> Hodgkin disease (least common)\n\n## Pulmonary MALT Lymphoma\n\n$=$ low-grade marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue\n$\\diamond$ Most common type of lymphoma involving the pulmonary parenchyma (in up to $90 \\%$ )\nPrevalence: $3-4 \\%$ of extranodal lymphomas; $1 \\%$ of lung malignancies\nCause: chronic inflammation of bronchus-associated lymphoid tissue (BALT)\nAge: $6^{\\text {th }}$ decade\nAssociated with:\nautoimmune disease (eg, Sjögren syndrome, rheumatoid arthritis, immunodeficiency); chronic inflammation from smoking; infections (eg, HIV, hepatitis C)\nHisto: sheets of monoclonal lymphocytes + occasional interspersed plasma cells (containing intranuclear inclusions of immunoglobulins $=$ Dutcher bodies); often additional cells causing confusion, like giant cells, granulomas, reactive germinal centers\n\n- cough, dyspnea, hemoptysis, weight loss\n- asymptomatic $(50 \\%)$\n\nLocation: bi- / unilateral\n$\\checkmark$ multiple nodules / masses / consolidations\n$\\checkmark$ areas of ground-glass attenuation / consolidation in bronchovascular distribution\n$\\checkmark$ air bronchograms (frequent) $\\pm$ dilatation\n$\\checkmark$ patchy large areas of ground-glass attenuation throughout lungs (rare)\n$\\checkmark$ mosaic attenuation $\\leftarrow$ infiltration along airways\n$\\checkmark$ hilar / mediastinal lymphadenopathy (in up to $30 \\%$ )\n$\\checkmark$ pleural effusions (uncommon)\n$\\checkmark$ hypermetabolic at PET/CT $(50 \\%)$\nPrognosis: 84-88\\% 5-10-year survival rate\n$D D x$ : granulomatosis with polyangiitis (= Wegener granulomatosis), sarcoidosis, perilymphatic spread of metastatic disease, infection\n\n## PSEUDOMONAS PNEUMONIA\n\n$=$ most dreaded nosocomial infection because of resistance to antibiotics in patients with debilitating diseases on multiple antibiotics + corticosteroids; rare in community",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 680,
            "markdown": "Organism: Pseudomonas aeruginosa, Gram-negative\n\n- bradycardia, temperature with morning peaks\n$\\sqrt{ }$ widespread patchy bronchopneumonia $\\leftarrow$ bacteremia (unlike other Gram-negative pneumonias)\n$\\sqrt{ }$ predilection for lower lobes\n$\\sqrt{ }$ extensive bilateral consolidation\n$\\sqrt{ }$ \"spongelike pattern\" with multiple nodules $>2 \\mathrm{~cm}$ (= extensive necrosis with formation of multiple abscesses)\n$\\sqrt{ }$ small pleural effusions\n\n\n# PULMONARY ARTERIAL MALFORMATION \n\n$=$ PULMONARY ARTERIOVENOUS ANEURYSM = PAVM\n= PULMONARY ARTERIOVENOUS FISTULA = PULMONARY ARTERIOVENOUS MALFORMATION = PULMONARY ANGIOMA = PULMONARY TELANGIECTASIA\n$=$ abnormal vascular communication between pulmonary artery and vein ( $95 \\%$ ) or systemic artery and pulmonary vein $(5 \\%)$\nEtiology:\n(a) congenital defect of capillary structure (common)\n(b) acquired in cirrhosis (hepatogenic pulmonary angiodysplasia), cancer, trauma, surgery (Glenn and Fontan procedure), schistosomiasis, actinomycosis, TB (Rasmussen aneurysm)\nPath: hemangioma of cavernous type\nPathophysiology:\nlow-resistance extracardiac R-to-L shunt (which may result in paradoxical embolism); quantification with ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-labeled albumin microspheres by measuring fraction of dose reaching kidneys\nAge: $3^{\\text {rd }}-4^{\\text {th }}$ decade; manifest in adult life, $10 \\%$ in childhood\nOccurrence:\n(a) isolated single abnormality (in $\\%$ )\n(b) multiple (in $\\%$ )\n\nAssociated with: Rendu-Osler-Weber syndrome (in 30-60-88\\%) = hereditary hemorrhagic telangiectasia\n$\\diamond 15-50 \\%$ of Rendu-Osler-Weber patients have pulmonary AVMs!\nTypes:\n\n1. Simple type $(79 \\%)$\n$=$ single feeding artery empties into a bulbous nonseptated aneurysmal segment with a single draining vein\n2. Complex type $(21 \\%)$\n$=$ more than one feeding artery empties into a septated aneurysmal segment with more than one draining vein\n\n- asymptomatic in $56 \\%$ (until $3^{\\text {rd }}-4^{\\text {th }}$ decade) if AVM single and $<2 \\mathrm{~cm}$\n- orthodeoxia = with lesion in lower lobes increase in arterial hypoxemia $\\left(=\\mathrm{PaO}_{2}<85 \\mathrm{mmHg}\\right)$ in erect position $\\leftarrow$ L-to-R shunting larger in sitting or standing position $\\leftarrow$ gravitational shift of pulmonary blood flow to base of lung\n- cyanosis with normal-sized heart (R-to-L shunt) in $25-50 \\%$, clubbing",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 681,
            "markdown": "- audible bruit over lesion (increased during inspiration)\n- dyspnea on exertion (60-71\\%), tachypnea, palpitation, chest pain, hemoptysis (10-15\\%); No CHF\nLocation: lower lobes $(60-70 \\%)>$ middle lobe $>$ upper lobes; bilateral ( $8-20 \\%$ ); medial third of lung\n$\\sqrt{ }$ \"coin lesion\" = sharply defined, lobulated oval / round mass ( $90 \\%$ ) of 1 to several cm in size\n$\\sqrt{ }$ cordlike bands from mass to hilum (= feeding artery + draining veins)\n$\\sqrt{ }$ enlargement with advancing age\n$\\sqrt{ }$ change in lesion size:\n$\\sqrt{ }$ decrease: expiration, Valsalva maneuver, recumbent position\n$\\sqrt{ }$ increase: inspiration, Müller maneuver (= forced inspiration against a closed glottis after full expiration), erect position\n$\\sqrt{ }$ phleboliths (occasionally)\n$\\sqrt{ }$ increased pulsations of hilar vessels\nCT ( $98 \\%$ detection rate):\n$\\sqrt{ }$ homogeneous circumscribed noncalcified nodule / serpiginous mass up to several cm in diameter\n$\\sqrt{ }$ vascular connection of mass with enlarged feeding artery + draining vein\n$\\sqrt{ }$ sequential enhancement of feeding artery + aneurysmal part + efferent vein on dynamic CT\nMR (if contraindication to contrast material / if flow slow due to partial thrombosis / for followup):\n$\\sqrt{ }$ irregular T2-hypointense lesion, usually adjacent to hilum\n$\\sqrt{ }$ signal void on standard spin echo / high SI on GRASS images\nAngio (mostly obviated by MR / CT unless surgery or embolization contemplated):\n$\\diamond 100 \\%$ sensitive for detection of vessels $>2 \\mathrm{~mm}$\nCx: CNS symptoms are commonly the initial manifestation\n(1) Cerebrovascular accident: stroke (18\\%), transient ischemic attack (37\\%) $\\leftarrow$ paradoxical bland emboli\n(2) Brain abscess (5-9\\%) $\\leftarrow$ loss of pulmonary filter function for septic emboli\n(3) Hemoptysis ( $13 \\%$ ) $\\leftarrow$ rupture of PAVM into bronchus, most common presenting symptom\n(4) Hemothorax ( $9 \\%$ ) $\\leftarrow$ rupture of subpleural PAVM\n(5) Polycythemia\n\nPrognosis: $26 \\%$ morbidity, $11 \\%$ mortality\nRecommendation: screening of first-degree relatives\n$D D x$ : solitary / multiple pulmonary nodules\n$R x$ : embolization with coils / detachable balloons\n\n# PULMONARY CAPILLARY HEMANGIOMATOSIS \n\n= bilateral pulmonary disease behaving like a low-grade nonmetastatic vascular neoplasm with slowly progressive pulmonary hypertension\nHisto: sheets of thin-walled capillary blood vessels infiltrating pulmonary interstitium + invading pulmonary vessels, bronchioles, and pleura\nPathomechanism of pulmonary hypertension ( $p H T N$ ):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 682,
            "markdown": "(a) venoocclusive phenomenon $\\leftarrow$ invasion of small pulmonary veins\n(b) progressive vascular obliteration $\\leftarrow$ in situ thrombosis + infarction\n(c) pulmonary scar formation $\\leftarrow$ recurrent pulmonary hemorrhage\n\nAge: $20-40$ years\n\n- cor pulmonale: jugular venous distension, pedal edema, ECG signs of RV failure (DDx: pulmonary venoocclusive disease)\n- elevated PA pressures + normal pulmonary wedge pressure\n- dyspnea on exertion; hemoptysis + pleuritic chest pain in $1 / 3$ (DDx: pulmonary thromboembolic disease)\nCXR:\n$\\checkmark$ diffuse reticulonodular pattern\n$\\checkmark$ focal areas of interstitial fibrosis (recurrent episodes of pulmonary hemorrhage + thrombotic infarction)\nCT:\n$\\checkmark$ thickening + nodularity of interlobular septa + walls of pulmonary veins\n$\\checkmark$ poorly defined centrilobular ground-glass nodules\n$\\checkmark$ pleural effusions\n$\\checkmark$ lymphadenopathy\nAngio:\n$\\checkmark$ combination of increased flow (to hemangiomatous areas) + decreased flow (to regions of thrombosis, infarction, and scarring)\nPrognosis: death after 2-12-year interval from onset of symptoms\n$R x$ : bilateral lung transplantation\nPulmonary capillary hemangiomatosis may develop fatal pulmonary edema if treated with vasodilators!\n$D x$ : open lung biopsy $\\rightarrow$ extremely hazardous with pHTN\n$D D x$ : (1) Pulmonary venoocclusive disease\n(2) Idiopathic interstitial fibrosis\n(3) Primary pulmonary hypertension (no increase in lung markings)\n(4) Pulmonary hemangiomatosis (only in children, cavernous hemangiomas involving several organs)\n\n\n# PULMONARY INFARCTION \n\n$=$ ischemic coagulative necrosis of lung parenchyma\nFrequency: rare due to protective effect of collateral blood flow from bronchial circulation\nPath: dark necrotic material (with faint ghostlike structures of lung tissue remaining evident on histology) surrounded by a narrow rim of hyperemia + inflammation\nCause: pulmonary artery occlusion (medium- to small-sized vessel)\nPathogenesis:\nischemic capillary endothelial injury $\\rightarrow$ increased vascular permeability + reperfusion via bronchial circulation causes intraalveolar extravasation of blood cells in a confined area with possible progression to infarction\nCo-condition to progress to infarction:\nCHF, high embolic burden, underlying malignancy, diminished bronchial flow (due to shock, hypotension, chronically impaired circulation), vasodilator use, elevated pulmonary venous",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 683,
            "markdown": "pressure, interstitial edema\nPrognosis: replacement by vascular fibrous tissue folding into a collagenous platelike mass $\\rightarrow$ pleural retraction\n\n# PULMONARY INTERSTITIAL EMPHYSEMA \n\n$=$ PIE $=$ complication of respirator therapy with PEEP\nPathogenesis:\ngas escapes from overdistended alveolus $\\rightarrow$ dissects into perivascular sheath surrounding arteries, veins, and lymphatics $\\rightarrow$ tracks into mediastinum forming clusters of blebs\n\n- sudden deterioration in patient's condition during respiratory Rx\n$\\checkmark$ meandering tubular + cystic lucencies following distribution of bronchovascular tree\n$\\checkmark$ bilateral symmetrical distribution\n$\\checkmark$ pseudocysts (localized form of PIE) = multiple circular well-defined air collections with uniformly thin walls\nLocation: right parahilar region\n$\\checkmark$ lobar overdistension (occasionally)\n$C x$ : (1) pneumothorax $(77 \\%) \\leftarrow$ rupture of cyst\n(2) pneumomediastinum (37\\%)\n(3) subcutaneous emphysema, pneumopericardium, intracardiac air, pneumoperitoneum, pneumatosis intestinalis\n(4) air-block phenomenon $=$ buildup of pressure in mediastinum / pericardial tamponade impeding blood flow in low-pressure pulmonary veins $\\rightarrow$ diminished blood return to heart (obstruction esp. during expiration); esp. common in neonatal period\n$\\checkmark$ microcardia\nRx: (1) High-frequency jet / oscillatory ventilation\n(2) Placing affected side of infant down for $24-48$ hours\n(3) Selective bronchial intubation\n$D D x$ : air bronchograms (branching / tapering)\n\n\n## PULMONARY LANGERHANS CELL HISTIOCYTOSIS\n\n$=$ PLCH $=$ LCH\n$=$ rare pulmonary disorder that typically affects the young adult in isolation and is associated with cigarette smoking\nAssociated with: extrapulmonary manifestation (in 5-15\\%):\nbone lesions, diabetes insipidus ( $10-25 \\%$ ), skin lesions\nPrevalence: in $3.4 \\%$ of chronic diffuse infiltrative lung disease\nIncidence: $0.05-0.50 \\div 100,000$ per year\nAge: most frequently in $3^{\\text {rd }}-5^{\\text {th }}$ decade (range, 3 months to 69 years); $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$; Caucasians $>>$ Blacks\n$\\diamond$ All children with PLCH show multisystem involvement\n$\\diamond$ In $30 \\%$ of adolescents with PLCH lung affected alone\nPathogenesis:\nheavy cigarette smoking in young men $\\rightarrow$ accumulation + activation of Langerhans cells (in",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 684,
            "markdown": "$90-100 \\%$ current / former smokers) as a result of excess neuroendocrine cell hyperplasia + secretion of bombazine-like peptides\n$\\diamond 90-100 \\%$ of patient with PLCH smoke\n$\\diamond 3-5 \\%$ of smokers get PLCH\nPath:\nmultifocal granulomatous infiltration centered on walls of bronchioles (= bronchiolitis) often extending into surrounding alveolar interstitium $(<1 \\mathrm{~cm}) \\rightarrow$ bronchiolar destruction $\\rightarrow$ thickwalled cysts presumably caused by check-valve bronchial obstruction + pneumothorax (NO necrosis); in end-stage disease foci of PLCH are replaced by fibroblasts forming CHARACTERISTIC stellate \"starfish\" scars with central remnants of persisting inflammatory cells\n\n- asymptomatic (in up to $25 \\%$ ); occasionally crackles + wheezes\n- nonproductive cough ( $75 \\%$ ), dyspnea ( $40 \\%$ )\n- normal or mild obstructive / restrictive / mixed abnormalities on pulmonary function tests\n- $\\downarrow$ CO diffusing capacity (in up to $90 \\%$ )\n- constitutional symptoms (in up to $1 / 3$ ): fatigue, fever, night sweats, weight loss, anorexia\n- chest pain ( $15-25 \\%$ ) $\\leftarrow$ spontaneous pneumothorax / eosinophilic granuloma in rib\n- lymphocytosis with predominance of T-suppressor cells on bronchoalveolar lavage (DDx: excess of T-helper cells in sarcoidosis)\nLocation: usually bilaterally symmetric, upper + mid lung predominance, sparing of bases + costophrenic angles\nEvolutionary sequence on radiography:\nnodule $\\rightarrow$ cavitated nodule $\\rightarrow$ thick-walled cyst $\\rightarrow$ thin-walled cyst (secondary to progressive enlargement + air trapping of original cavitary nodule)\n$\\diamond$ CXR abnormalities more severe than clinical symptoms + pulmonary function tests!\n$\\sqrt{ }$ diffuse fine reticular / reticulonodular pattern $\\leftarrow$ cellular infiltrate with predilection for apices:\n$\\checkmark$ nodules $1-10 \\mathrm{~mm}$ (granuloma stage):\n$\\checkmark$ ill-defined / stellate with irregular borders\n$\\checkmark$ cavitation of large nodules (in up to $10 \\%$ )\n$\\checkmark$ may develop into \"honeycomb lung\" = multiple $1-5-\\mathrm{cm}$ cysts + subpleural blebs (fibrotic stage)\n$\\checkmark$ lung volume increased in $1 / 3$ or normal (DDx: most other interstitial lung diseases have decreased lung volumes!)\n$\\checkmark$ pleural effusion ( $8 \\%$ ), hilar adenopathy (unusual)\n$\\checkmark$ thymic enlargement $\\leftarrow$ infiltration\nCT (CLASSIC manifestation):\n$\\checkmark<10-\\mathrm{mm}$ small cysts with varying wall thickness $\\rightarrow$ often coalescing to form irregular larger cysts / bullae\n$\\checkmark$ multiple small scattered bilateral peribronchiolar nodules with early signs of cavitation HRCT:\n\nThe combination of nodules + cysts in correlation with demographic + clinical factors are considered DIAGNOSTIC for PLCH and obviate a lung biopsy.\n$\\checkmark$ complex / branching perivascular thin-walled ( $<1 \\mathrm{~mm}$ ) cysts individually $<5 \\mathrm{~mm}$ in size:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 685,
            "markdown": "$\\sqrt{ }$ confluent contiguous cysts $2-3 \\mathrm{~cm}$ in size\n$\\sqrt{ }$ equally distributed in central + peripheral zones of upper + mid lung while sparing the bases\n$\\diamond$ As cysts become more numerous in later stages nodules occur less frequently!\n$\\checkmark$ thick-walled cysts\n$\\sqrt{ } 1-5-\\mathrm{mm}$ centrilobular $\\pm$ cavitary nodules with irregular borders in peribronchiolar distribution associated with cysts\n$\\checkmark$ fine reticular opacities $(50 \\%)$\n$\\checkmark$ ground-glass opacities\n$\\checkmark$ perivascular honeycombing\n$\\checkmark$ thickening of bronchovascular bundles + interlobular septa\n$\\checkmark$ intervening lung appears normal\nDDx for nodules:\nsarcoidosis, hypersensitivity pneumonitis, berylliosis, TB, atypical TB, metastases, silicosis, coal worker's pneumoconiosis\n$D D x$ for cysts:\nemphysema (no definable wall), bronchiectasis (communicating branching pattern), idiopathic pulmonary fibrosis, lymphangio-myomatosis (almost exclusively in women, diffuse involvement of entire lung)\n$D D x$ : sarcoidosis (equal sex distribution, always multisystem disease, not related to smoking, erythema nodosum, bilateral hilar lymphadenopathy, lung cavitation + pneumothorax rare, epithelioid cells)\n$C x$ : 1. Recurrent pneumothoraces in $25 \\%$ (from rupture of subpleural cysts) CHARACTERISTIC\n2. Pulmonary hypertension $\\leftarrow$ severe diffuse pulmonary vasculopathy involving pulmonary muscular arteries and interlobar veins\n3. Superimposed Aspergillus fumigatus infection\n\nPrognosis: poor with multisystem disease + organ dysfunction (especially with skin lesions)\n(a) complete / partial regression $(50 \\%)$\n(b) stable symptoms of variable severity $(30-40 \\%)$\n(c) rapid progression ( $10-20 \\%$ ) to air-flow obstruction + impaired diffusing capacity + respiratory failure + cor pulmonale\n$\\diamond$ May recur in transplanted lung if smoking is continued or resumed!\nMortality: $2-25 \\%$\nRx: smoking cessation; chemotherapy (vincristine sulfate, prednisone, methotrexate, 6mercaptopurine); lung transplant",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 686,
            "markdown": "# PULMONARY MAINLINE GRANULOMATOSIS \n\n$=$ PULMONARY TALCOSIS\n$=$ pulmonary microembolism in drug addicts $\\leftarrow$ chronic IV injection of suspensions prepared from crushed tablet compounds (talc is a common insoluble additive)\nDrugs: amphetamines, methylphenidate hydrochloride (\"West coast\"), tripelen amine (\"blue velvet\"), methadone hydrochloride, Dilaudid ${ }^{\\circledR}$, meperidine, pentazocine, propylhexedrine, hydromorphone hydrochloride\nPathogenesis: talc (= magnesium silicate) particles incite a pronounced granulomatous foreign-body reaction + subsequent fibrosis in perivascular distribution\nPath: multiple scattered whitish nodules of $0.3-3 \\mathrm{~mm}$ converging into gritty fibrotic masses in central + upper lungs measuring several cm in diameter\nHisto: widespread granulomas packed with doubly refractile talc particles expanding the walls of muscular pulmonary arteries and arterioles + perivascular connective tissue + alveolar septa\n\n- talc retinopathy $(80 \\%)=$ small glistening crystals\n- angiothrombotic pulmonary hypertension + cor pulmonale\n\nEarly changes:\n$\\sqrt{ }$ widespread micronodularity of \"pinpoint\" size (1-2-3 mm) with perihilar / basilar predominance\n$\\sqrt{ }$ well-defined nodules predominantly in middle zones\nLate changes:\n$\\sqrt{ }$ loss of lung volume of upper lobes + hilar elevation + hyperlucency at lung bases\n$\\sqrt{ }$ indistinctly marginated coalescent opacities similar to progressive massive fibrosis (DDx: in silicosis slightly further away from pulmonary hila + distinct margin)\n$C x$ : mycotic pulmonary artery aneurysm; right-sided endocarditis with septic emboli; chronic respiratory failure; emphysema; systemic talc breakthrough to liver + spleen + kidneys + retina\nDDx of late changes:\n(1) Progressive massive fibrosis of silicosis / coal worker's pneumoconiosis\n(2) Chronic sarcoidosis\n$D x$ : lung biopsy\n\n## PULMONARY THROMBOEMBOLIC DISEASE\n\n$=$ PULMONARY EMBOLISM ( PE)\nIncidence: 600,000 Americans / year ( $0.23 \\%$ ) with missed / delayed diagnosis in 400,000, causing death in 100,000; diagnosed in $1 \\%$ of all hospitalized patients; in 12-64\\% at autopsy; in $9-56 \\%$ of patients with deep venous thrombosis\nAge: $60 \\%>60$ years of age\nCause: deep vein thrombosis (DVT) of extremities / pelvis ( $>90 \\%$ ), right atrial neoplasia / thrombus, thrombogenic intravenous catheters, endocarditis of tricuspid / pulmonic valves\nTime of onset: PE usually occurs within first 5-7 days of thrombus formation\nPredisposing factors:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 687,
            "markdown": "primary thrombophlebitis (39\\%), immobilization (32\\%), recent surgery (31\\%), venous insufficiency ( $25 \\%$ ), recent fracture ( $15 \\%$ ), myocardial infarction ( $12 \\%$ ), malignancy ( $3-8 \\%$ ) with higher frequency in gynecologic malignancies + melanoma (hypercoagulability $\\leftarrow$ direct thrombogenic effects of malignancy / chemotherapy), CHF (5\\%), no predisposition (6\\%)\nPathophysiology: A clot from the deep veins of the leg breaks off $\\rightarrow$ fragments in right side of heart $\\rightarrow$ showers lung with emboli of varying size\n$\\diamond$ On average $>6-8$ vessels are embolized!\n$\\diamond$ Clinical presentation is protean + nonspecific!\n$\\diamond$ False-positive clinical diagnosis in $62 \\%$\n\n- Classic triad $(<33 \\%)$ :\n(1) Hemoptysis ( $25-34 \\%$ )\n(2) Pleural friction rub\n(3) Thrombophlebitis\n- symptoms (nonfatal PE versus fatal PE):\n- pleuritic chest pain ( $88 \\%$ versus $10 \\%$ )\n- acute dyspnea ( $84 \\%$ versus $59 \\%$ )\n- apprehension ( $59 \\%$ versus $17 \\%$ )\n- cough ( $53 \\%$ versus. $3 \\%$ ); hemoptysis ( $30 \\%$ versus. $3 \\%$ )\n- sweats ( $27 \\%$ versus. $9 \\%$ ); syncope ( $13 \\%$ versus $27 \\%$ )\n- signs (nonfatal PE versus fatal PE):\n- respiratory rate $>16(92 \\%$ versus. $66 \\%)$\n- rales due to loss of surfactant ( $58 \\%$ versus $42 \\%$ )\n- tachycardia $>100 \\mathrm{bpm}(44 \\%$ versus $54 \\%)$\n- temperature $>37.8^{\\circ} \\mathrm{C}(43 \\%$ versus $30 \\%)$\n- diaphoresis ( $36 \\%$ versus $10 \\%$ )\n- heart gallop ( $34 \\%$ versus $10 \\%$ ); phlebitis ( $32 \\%$ versus $7 \\%$ )\n- heart murmur ( $23 \\%$ ); cyanosis ( $19 \\%$ versus $12 \\%$ )\n- ECG changes ( $83 \\%$ ), mostly nonspecific: P-pulmonale, right-axis deviation, right bundle branch block, classic S1Q3T3 pattern\n- elevated levels of fibrinopeptide-A = small peptide split off of fibrinogen during fibrin generation\n- positive D-dimer assay (generated during clot lysis)\n\nLocation of PE: bilateral emboli (in 45\\%), R lung only (36\\%), L lung only (18\\%); multiple emboli ( $3-6$ on average) in $65 \\%$\nDistribution: RUL (16\\%), RML (9\\%), RLL (25\\%), LUL (14\\%), LLL (26\\%)\nSite: central = segmental / larger (in 58\\%);\nperipheral = subsegmental / smaller (in 42\\%);\nin subsegmental branches exclusively (in 30\\%)\n$\\diamond$ Emboli are occlusive in $40 \\%$ !\nA. EMBOLISM WITHOUT INFARCTION (90\\%)\n\nHisto: hemorrhage + edema\nB. EMBOLISM WITH INFARCTION (10-60\\%)\n$=$ any opacity developing as a result of thromboembolic disease; more likely to develop in presence of cardiopulmonary disease with obstruction of pulmonary venous outflow (diagnosed in retrospect)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 688,
            "markdown": "| Clinical Probability of PE: Wells Score |  |  |\n| :--: | :--: | :--: |\n| Variable |  | Points |\n| clinically suspected DVT |  | 3.0 |\n| alternative diagnosis is less likely than PE |  | 3.0 |\n| tachycardia |  | 1.5 |\n| immobilization / surgery in previous four weeks |  | 1.5 |\n| history of DVT or PE |  | 1.5 |\n| hemoptysis |  | 1.0 |\n| malignancy (treatment for within 6 months, palliative) |  | 1.0 |\n| Interpretation |  |  |\n| Score $>6.0$ | High (59\\% probability) |  |\n| Score 2.0 to 6.0 | Moderate (29\\% probability) |  |\n| Score $<2.0$ | Low ( $15 \\%$ probability) |  |\n\nHisto: (1) incomplete infarction = reversible transient hemorrhagic congestion / edema usually resolving over several days to weeks\n(2) complete infarction $=$ hemorrhagic infarction with necrosis of lung parenchyma remaining permanently\nPrognosis: majority of pulmonary thromboemboli resolve with appropriate therapy\n\n# Acute Pulmonary Thromboembolism \n\n$\\diamond$ Hypertension disappears as emboli lyse\nMortality:\n$3 \\div 1,000$ surgical procedures; 200,000 deaths in 1975; 7-10\\% of all autopsies (death\nwithin first hour of PE in most patients); $26-30 \\%$ if untreated; $3-10 \\%$ if treated; $50-58 \\%$ /\n$8-15 \\%$ with hemodynamic instability / stability\n$\\diamond$ Healthy patients may survive obstruction of $50-60 \\%$ of vascular bed, fatal if $>60 \\%$ of pulmonary bed obstructed\n\n- sudden onset of chest pain, acute dyspnea\n- hemoptysis occasionally\n- enzyme-linked immunosorbent D-dimer assay test (detects one of the products of fibrin breakdown) $>500 \\mu \\mathrm{~g} / \\mathrm{L}$\nAssessment of severity of PE:\nECG:\n$\\checkmark$ straightening / leftward bowing of IVS\n$\\checkmark$ paradoxical motion of interventricular septum\n$\\checkmark$ \"empty LV\" appearance $=\\downarrow$ LV volume\n$\\checkmark$ loss of inspiratory collapse of IVC\n$\\checkmark$ tricuspid regurgitation + dilatation of PA\n$\\checkmark$ McConnell sign = regional RV wall motion abnormality with sparing of apex\nCT:\n$\\checkmark \\mathrm{RV} \\div \\mathrm{LV}$ diameter ratio $>1$ on 4 -chamber view\n$\\checkmark$ leftward septal bowing (with RV wall $<6 \\mathrm{~mm}$ thick)\n$\\checkmark \\uparrow$ size of azygos v. + SVC $\\leftarrow \\uparrow$ R heart pressure",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 689,
            "markdown": "$\\sqrt{ }$ contrast reflux into IVC $\\leftarrow$ tricuspid valve insufficiency\nCXR ( $33 \\%$ sensitive, $59 \\%$ specific):\n$\\diamond$ Abnormal nonspecific CXR in $84 \\%$; a normal CXR has a negative predictive value of only $74 \\%$ !\n$\\checkmark$ general findings (patients with PE versus no PE):\n$\\checkmark$ atelectasis / infiltrate ( $68 \\%$ versus $48 \\%$ )\n$\\checkmark$ pleural effusion ( $48 \\%$ versus $31 \\%$ )\n$\\checkmark$ pleural opacity ( $35 \\%$ versus $21 \\%$ )\n$\\checkmark$ elevated diaphragm ( $24 \\%$ versus $19 \\%$ )\n$\\checkmark$ decreased vascularity ( $21 \\%$ versus $12 \\%$ )\n$\\checkmark$ prominent pulmonary artery ( $17 \\%$ versus $28 \\%$ )\n$\\checkmark$ cardiomegaly ( $12 \\%$ versus $11 \\%$ )\n$\\checkmark$ pulmonary edema ( $4 \\%$ versus. $13 \\%$ )\n$\\checkmark$ local findings:\n$\\checkmark$ Westermark sign = area of oligemia in $2-7 \\% \\leftarrow$ vasoconstriction distal to embolus\n$\\checkmark$ Fleischner sign = local widening of artery by impaction of embolus $\\leftarrow$ distension by clot / developing pulmonary hypertension $\\leftarrow$ peripheral embolization\n$\\checkmark$ \"knuckle\" sign = abrupt tapering of an occluded vessel distally\n$\\checkmark$ Fleischner lines = long-line shadows (fibrotic scar) from invagination of pleura at the base of the collapse resulting in pseudofissure\n$\\checkmark$ Hampton hump $=$ segmentally distributed pleura-based shallow wedge-shaped consolidation with base against pleural surface + convex medial border:\n$\\checkmark$ NO air-bronchogram $\\leftarrow$ hemorrhage into alveoli\n$\\checkmark \\pm$ cavitation\n$\\checkmark$ \"melting\" sign = within few days to weeks regression from periphery toward center\n$\\checkmark$ subsequent nodular / linear scar\n$\\checkmark$ thoracentesis: bloody ( $65 \\%$ ), predominantly PMNs ( $61 \\%$ ), exudate ( $65 \\%$ )\nNECT (purpose):\n$\\checkmark$ depiction of acute changes of PE:\n$\\checkmark$ atelectasis / linear bands ( $100 \\%$ )\n$\\checkmark$ pleural effusion ( $87 \\%$ )\n$\\checkmark$ consolidation ( $57 \\%$ )\n$\\checkmark$ ground-glass opacification (57\\%)\n$\\checkmark$ Hampton's hump ( $50 \\%$ )\n$\\checkmark$ intraluminal area of high attenuation (= hyperdense artery) measuring $33 \\pm 15 \\mathrm{HU}$\n$\\checkmark$ dilated central / segmental pulmonary artery\n$\\checkmark$ depiction of chronic changes of PE\n$\\checkmark$ chest findings leading to alternative diagnosis\n$\\checkmark$ localization of volume-of-interest for CECT\nCT angio (method of choice):\nN.B.: CT (2.2-6.0 mSv) has a 1.6-4.3 times higher radiation dose than a V/Q scan ( 1.4 mSv$)$ !\n$\\diamond$ Helical CT equal to angio in detection of emboli within proximal arteries of $\\leq 5^{\\text {th }} / 6^{\\text {th }}$ generation\n$\\diamond$ Subsegmental intraluminal filling defects (in 2-30\\%) usually not detectable!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 690,
            "markdown": "$\\diamond$ Detection poor in middle lobe + lingular branches (in 18\\%)!\nN.B.: evaluate the vessel adjacent to a bronchus\n$\\checkmark$ complete filling defect of low attenuation occupying entire arterial section creating convex interface with the contrasted lumen\n$\\checkmark \\pm$ enlargement of thrombosed artery\n$\\checkmark$ \"railway track\" sign = partial filling defect = embolus floating freely within lumen surrounded by areas of intravascular contrast enhancement\n$\\checkmark$ eccentric mural filling defect forming acute angles with arterial wall\n$\\checkmark$ RV dysfunction (ratio $\\mathrm{RV} \\div \\mathrm{LV} \\geq 1 \\div 1$ )\nPseudo-filling defects:\n(1) Breathing artifact in tachypneic patient\n(2) Too short / long scanning delay\n(3) Unilateral increase in vascular resistance\n(4) R-to-L shunt\n(5) Window setting\n(6) Partial voluming\n\nAnatomic pathologic mimics:\n(1) Peribronchial lymph node\n(2) Unopacified veins\n(3) Mucus-filled bronchi\n(4) Perivascular edema\n\nTechnical failure rate: $3-4 \\%$ due to severe dyspnea\nCT of lung parenchyma:\n$\\checkmark$ peripheral wedge-shaped area of infarct / hemorrhage in arteries of $<3 \\mathrm{~mm}$ in diameter\n$\\checkmark$ linear parenchymal band\nMR:\n$\\checkmark$ filling defect in pulmonary artery on coronal contrast-enhanced 3-D maximum intensity projection\nAngio ( $>95 \\%$ sensitive \\& specific):\nIndication for pulmonary angiography:\n(1) Indeterminate V/Q scan with high clinical suspicion + risky anticoagulation therapy (angio within 24 hours)\n(2) Mismatch between interpretation + clinical findings\n(3) Significant risk for anticoagulation + high probability for PE\n(4) Specific diagnosis necessary for proper management (vasculitis, drug induced, lung cancer with predominant vascular involvement)\n(5) Prior to intervention: pulmonary embolectomy, caval ligation, caval filter placement\n(6) Patients too ill to undergo V/Q scan\n\nTechnique: AP \\& ipsilateral posterior oblique projection\n$\\checkmark$ intraluminal defect ( $94 \\%$ )\n$\\checkmark$ abrupt termination of pulmonary arterial branch\n$\\checkmark$ pruning + attenuation of branches\n$\\checkmark$ wedge-shaped parenchymal hypovascularity\n$\\checkmark$ absence of draining vein in affected segment\n$\\checkmark$ tortuous arterial collaterals",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 691,
            "markdown": "Risks of pulmonary angiography:\n(1) left bundle branch block: requires temporary pacing wire prior to right heart catheterization\n(2) marginal cardiac function: therapy must be available to treat frank pulmonary edema\n(3) Right ventricular end diastolic pressure $>20 \\mathrm{mmHg}$ : selective catheterization with occlusion balloon\nCx of pulmonary angiography (1-2\\%):\narrhythmia, endocardial injury, cardiac perforation, cardiac arrest, contrast reaction\nMortality rate of pulmonary angiography: $0.2-0.5 \\%$\n\n| Clinical Classification of Pulmonary Thromboembolic Disease according to Severity |  |  |  |  |\n| :-- | :--: | :--: | :--: | :--: |\n| Signs \\& Symptoms | Class 1 | Class 2 | Class 3 | Class 4 |\n| Occlusion of pulmonary arteries | $<20 \\%$ | $20-30 \\% \\%$ | $30-50 \\%$ | $>50 \\%$ |\n| Symptoms | asymptomatic | anxiety, hyperventilation | dyspnea, collapse | shock, dyspnea |\n| Arterial $\\mathrm{pO}_{2}$ | normal | $<80$ torr | $<65$ torr | $<50$ torr |\n| Arterial $\\mathrm{pCO}_{2}$ | normal | $<35$ torr | $<30$ torr | $<30$ torr |\n| Central venous pressure | normal | normal | elevated | elevated |\n| Mean PA pressure | normal | - | - | $>20 \\mathrm{mmHg}$ |\n| Systolic blood pressure | normal | - | - | $<100 \\mathrm{mmHg}$ |\n\nFalse-negative rate:\n$1-4-9 \\%$ due to difficulty in visualizing subsegmental emboli (with only $30 \\%$\ninterobserver agreement about presence of subsegmental emboli)\nNUC (V/Q scan = guide for angiographic evaluation) interpreted in reference to Biello or\nPIOPED criteria:\nIndication:\n(1) Allergy to iodinated contrast media\n(2) Renal insufficiency\n(3) Weight limit of CT table exceeded\n$\\sqrt{ }$ low- / intermediate-probability scans in $50-70 \\%$ :\n$\\diamond$ results in recommending additional studies; although only $12-14 \\%$ will undergo angiography\n$\\diamond 25-30 \\%$ disagreement between expert readers in interpreting intermediate- and lowprobability V/Q scans\n$\\checkmark$ high-probability scan: in $12 \\%$ normal angiogram\nN.B.: V/Q abnormalities vary over time $\\leftarrow$ autoregulation (hypoxic vasoconstriction, hypercapneic bronchoconstriction) and resolution\nPrognosis:\n$\\diamond$ Resolution less favorable with increasing age + cardiac disease\n$\\diamond$ Resolution improved with urokinase $>$ heparin\n(a) total resolution ( $90 \\%$ ) within 30 days after treatment $\\leftarrow$ mechanical fragmentation + endogenous fibrinolysis\n(b) no resolution in $10 \\%$ : organization of thromboembolus leading to retraction with total / partial obstruction, recanalization, stenosis, fibrous webs / cords and vessel atrophy\n$C x$ : pulmonary arterial hypertension (in 4\\%)\n$R x$ :",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 692,
            "markdown": "1. Heparin IV: $10,000-15,000$ units as initial dose; $8,000-10,000$ units/hour during diagnostic evaluation; continued for $10-14$ days\n2. Streptokinase: better results with massive PE\n3. Urokinase: slightly better than streptokinase\n4. Coumadin: maintained for at least 3 months ( $15 \\%$ complication rate)\n\n# Acute Pulmonary Embolism in Pregnancy \n\nRisk: increased x 4 during pregnancy\n\n- D-dimer frequently elevated\n$\\diamond$ Lung scintigraphy + CTA have comparable diagnostic performances\nIndeterminate results in $19 \\%$ :\nsimilar for V/Q scan and CTA (mostly poor arterial opacification $\\leftarrow$ increase in\nmaternal blood volume)\nAdvantage of CT over Lung Scintigraphy:\n(1) Better interobserver agreement\n(2) Unsuspected alternative diagnosis in $12 \\%$ (eg, bronchopneumonia, pericardial effusion)\nDose comparison CT versus V/Q:\n(a) radiation exposure of mother\n> mean dose from CTA $(7.3 \\mathrm{mSv})$ is higher than for lung scintigraphy $(0.9 \\mathrm{mSv})$\n> CTA ( $10-70 \\mathrm{mGy}$ ) has a higher dose to breast than low-dose perfusion scan ( $0.11-$ 0.30 mGy )\n(b) radiation exposure of fetus\n\nV/Q scan (640-800 mSv) has a 5-267 times higher radiation dose than a CT scan $(3-131 \\mathrm{mSv})$ during all trimesters!\nIodine exposure: contrast during pregnancy\n\n## Chronic Pulmonary Thromboembolism\n\n$=$ CHRONIC THROMBOEMBOLIC DISEASE\nFrequency: $1-5 \\%$ of patients with acute pulmonary thromboembolism, especially in patients with large emboli / recurrent episodes\nAt risk: underlying malignancy, cardiovascular disease, pulmonary disease, splenectomy, ventriculoatrial shunt for hydrocephalus, permanent central venous line, chronic inflammatory bowel disease, myeloproliferative syndromes; $\\mathrm{M}<\\mathrm{F}$\nPath: fibrous webs and bands (= organized thromboemboli), often with overlying recent thrombosis; embolic material is incorporated into vessel wall + covered over by a thin layer of endothelial cells\nPathogenesis:\npatent pulmonary arteries develop medial hypertrophy + intimal thickening +\natherosclerotic plaques in response to pressure elevation; bronchial arteries may dilate + form extensive collateral pathways to minimize areas of lung infarction\n\n- may be clinically silent / asymptomatic for years (\"honeymoon period\")\n$\\diamond$ To become symptomatic at least $60 \\%$ of the arterial bed must be obstructed!\n- history of previous embolic episodes; $63 \\%$ lack a history of acute thromboembolism\n- recurrent acute / gradual progressive exertional dyspnea (DDx: interstitial lung disease)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 693,
            "markdown": "- chronic nonproductive cough, atypical chest pain\n- tachycardia, syncope\n- loss of RV functional capacity: elevated pulmonary arterial pressure ( $36-78 \\mathrm{mmHg}$ ), normal pulmonary capillary wedge pressure; high right atrial pressures, reduced cardiac output\n- lupus anticoagulant $=$ anticardiolipin $(11-24 \\%)$\n- elevated plasma levels of thrombophilic factors (factor VIII + antiphospholipid antibodies) CXR:\n$\\checkmark$ prominence of right side of heart\n$\\checkmark$ asymmetric enlargement of central pulmonary arteries\n$\\checkmark$ oligemic vascularity in patchy distribution\n$\\checkmark$ triangular / rounded opacity + adjacent pleural thickening $\\leftarrow$ pulmonary infarction\n$\\checkmark$ patchy bilateral perihilar alveolar opacities of \"reperfusion edema\" after thrombendarterectomy\n![img-72.jpeg](img-72.jpeg)\n\nCT angio ( $77 \\%$ sensitive):\n$\\diamond$ CT angio rivals conventional angiography!\n@ Heart\n$\\checkmark$ enlargement + hypertrophy of RA + RV:\n$\\checkmark$ RV myocardial thickness $>4 \\mathrm{~mm}$\n$\\checkmark$ cardiomegaly $\\leftarrow$ chamber dilatation",
            "images": [
                {
                    "id": "img-72.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 743,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1698,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 694,
            "markdown": "$\\sqrt{ }$ transverse diameter of $\\mathrm{RA}>35 \\mathrm{~mm}$\n$\\sqrt{ }$ transverse diameter of $\\mathrm{RV}>45 \\mathrm{~mm}$\n$\\sqrt{ } \\mathrm{RV} \\div \\mathrm{LV}>1 \\div 1$ with leftward bowing of interventricular septum into LV\n$\\sqrt{ } \\pm$ opacification of IVC + suprahepatic veins $\\leftarrow$ tricuspid valve regurgitation $\\leftarrow$ dilatation of tricuspid valve annulus\n$\\sqrt{ }$ mild pericardial thickening\n$\\sqrt{ }$ small pericardial effusion\n@ Pulmonary vessels\n$\\sqrt{ }$ pulmonary hypertension (secondary signs):\n$\\sqrt{ }$ pulmonary trunk diameter $>29 \\mathrm{~mm}$ measured in scan plane of its bifurcation at right angle to long axis lateral to ascending aorta\n$\\sqrt{ }$ diameter ratio of main pulmonary artery to aorta $>1 \\div 1$\n$\\sqrt{ }$ right + left pulmonary arteries $>18 \\mathrm{~mm}$ in diameter measured in their intrapericardial portion 1 cm beyond origin: often asymmetric in size\n$\\sqrt{ }$ visualization of chronic thrombus (most specific):\n$\\sqrt{ }$ flattened eccentric incomplete filling defect of organized thrombus forming obtuse angles with arterial wall\n$\\sqrt{ }$ irregular contour of intimal surface\n$\\sqrt{ }$ completely obstructing thrombus:\n$\\sqrt{ }$ abrupt termination / narrowing / obliteration of a pulmonary artery\n$\\sqrt{ }$ convex margin of contrast column ( $=$ \"pouch defect\") best appreciated on reformatted images\n$\\sqrt{ }$ occlusion of main pulmonary artery $(3 \\%)$\n$\\sqrt{ }$ thrombus of increased density $(87 \\pm 30 \\mathrm{HU}) \\leftarrow$\n(a) enhancement of organizing thrombus\n(b) thrombus retraction with concentration of hemoglobin + iron\n$\\sqrt{ }$ clot may become calcified $=$ atherosclerotic pulmonary artery plaque (rare)\n$\\sqrt{ }$ postobstructive signs:\n$\\sqrt{ }$ absence of contrast in distal vessel segment\n$\\sqrt{ }$ abrupt persistent decrease in caliber of artery distal to occlusion compared to accompanying bronchus $\\leftarrow$ retraction of thrombus\n$\\sqrt{ }$ poststenotic dilatation / aneurysm / tortuosity\n$\\sqrt{ }$ recanalized thrombus:\n$\\sqrt{ }$ thickened walls of arteries with irregular contour of intimal surface in vessel parallel to scan plane / peripheral crescent-shaped intraluminal filling defect in vessel transverse to scan plane\n$\\sqrt{ }$ arterial band ( $=1-3-\\mathrm{mm}$ linear structure attached at both ends to vessel wall) / flap ( $=$ attached at one end to vessel wall) / web ( $=$ network of multiple branching bands)\n$\\sqrt{ }$ collateral systemic supply of occluded pulmonary arterial bed $\\leftarrow$ participation in gas exchange:\n$\\sqrt{ }$ bronchial artery dilatation $\\geq 1.5 \\mathrm{~mm}+$ tortuosity (47-77\\%) within mediastinum supplied by inferior phrenic, intercostal + internal mammary arteries\n@ Parenchymal abnormalities:\n$\\sqrt{ }$ mosaic perfusion on HRCT (77-100\\%) in segmental / subsegmental distribution:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 695,
            "markdown": "$\\sqrt{ }$ scattered geometric areas of low attenuation with vessels of small cross-sectional diameter $\\leftarrow$ oligemic hypoperfusion / small-vessel arteriopathy\n$\\sqrt{ }$ regional sharply demarcated enhancing areas of high attenuation with enlarged vessels $\\leftarrow$ compensatory hyperperfusion of lung + collateral blood flow\n$\\sqrt{ }$ NO air trapping on expiratory scan\n$D D x$ : primary pulmonary hypertension (more diffuse pattern of mosaic perfusion)\n$\\sqrt{ }$ isolated focal areas of ground-glass attenuation in perihilar region $\\leftarrow$ systemic perfusion\n$\\sqrt{ }$ infarcted tissue replaced by scar ( $72-87 \\%$ ):\nLocation: lower lung ( $70 \\%$ ), often multiple\n$\\sqrt{ }$ wedge-shaped pleura-based opacities with tip pointing to hilum\n$\\sqrt{ }$ linear opacities (= parenchymal bands)\n$\\sqrt{ }$ peripheral nodule / cavity\n$\\sqrt{ }$ often accompanied by pleural thickening\n$\\sqrt{ }$ cylindrical bronchial dilatation of segmental and subsegmental bronchi (64\\%) adjacent to severely stenosed / completely occluded + retracted pulmonary arteries $\\leftarrow$ hypoxic bronchodilatation\nMR:\n$\\sqrt{ }$ discrete fixed areas of low-to-medium SI on T1WI\nDisadvantage: slow flow in central vessels may obscure fixed signal of emboli\nNUC:\n\n- A history of prior PE decreases the probability of acute embolism because small V/Q mismatches never resolve!\n$\\sqrt{ } \\mathrm{V} / \\mathrm{Q}$ scan characteristically of high probability with multiple unmatched segmental perfusion defects\nAngio (reference standard with highest specificity):\n$\\sqrt{ }$ webs, bands\n$\\sqrt{ }$ stenotic / absent arterial segments\n$\\sqrt{ }$ pouchlike filling defects $=$ convex margin of contrast material bolus\n$\\sqrt{ }$ abrupt cutoffs often confined to one / two lung segments\n$\\sqrt{ }$ unilateral occlusion / hypoperfusion\n$\\sqrt{ }$ selective bronchial arteriography shows dilated bronchial artery collaterals (up to $30 \\%$ of systemic blood flow) filling pulmonary arteries downstream from sites of occlusion\n$\\diamond$ Bronchial artery dilatation suggests chronic rather than acute thromboembolic disease!\n- measurement of pulmonary artery pressure $\\rightarrow$ quantification of disease severity + postoperative prognosis\nDisadvantage: sensitivity for central emboli lower than for CT angio\nPrognosis: partial or complete obstruction of the pulmonary vascular bed $\\rightarrow$ pulmonary hypertension $\\rightarrow$ cor pulmonale; $30 \\% 5$-year survival with a mean PA pressure of $>$ 30 mmHg\n$R x$ :\n(1) Thrombendarterectomy for main / lobar / proximal segmental arteries ( $4-14 \\%$ operative mortality) in patients with hemodynamic / ventilatory impairment\n(2) Lifelong supplemental warfarin anticoagulation therapy (to avoid recurrent / growth of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 696,
            "markdown": "thromboembolism) $\\pm$ vasodilators\n$D D x$ :\n(1) Idiopathic pulmonary hypertension (arteries rarely enlarged)\n(2) Acute thromboembolism (diameter of pulmonary artery may be increased, nonobstructive filling defect in central location, eccentric filling defect forms acute angles with vessel wall, no dilatation of bronchial arteries, lower attenuation of thrombus, no hypertrophy of RV)\n(3) Interruption of pulmonary artery (associated with congenital cardiovascular anomaly, smooth abrupt tapering of pulmonary artery blindly ending at hilum, NO endoluminal changes)\n(4) Takayasu arteritis (concentric inflammatory mural thickening, mainly segmental + subsegmental arteries affected in $50-80 \\%$ of late stage disease, involvement of aorta + its branches, delayed mural contrast enhancement, increased FDG uptake)\n(5) Primary sarcoma of pulmonary artery (unilateral filling defect spans entire luminal diameter $\\pm$ expansion of main / proximal pulmonary artery / RV, extension into lung parenchyma / mediastinum)\n\n# Ventilation-Perfusion (V/Q) Scan \n\nIndication:\n(1) Allergy to iodinated contrast media\n(2) Renal insufficiency\n(3) Weight limit of CT table exceeded\n\nRationale for Perfusion Scan:\nperfusion images will detect\n$>90 \\%$ of surface perfusion defects $>2 \\times 2 \\mathrm{~cm}$\n$>90 \\%$ of emboli completely occluding a vessel $>1 \\mathrm{~mm}$ in diameter\n$>26 \\%$ of emboli partially occluding a vessel\n$\\diamond$ A pulmonary embolus (PE) presents as segmentally hypo-perfused but normally ventilated lung ( $=\\mathrm{V} / \\mathrm{Q}$ mismatch)\n$\\diamond$ A normal perfusion scan excludes PE for practical purposes\nRationale for Adding Ventilation Scan \\& Chest X-ray\n$\\diamond$ A perfusion defect requires further evaluation with a ventilation scan + CXR to determine the most likely etiology\n$\\diamond$ If ventilation scan + CXR are normal an embolus must be suspected\n$\\diamond$ A ventilation scan detects obstructive lung disease because a CXR is insensitive for this entity.\nTerminology:\nNonsegmental $=$ does not conform to a lung segment (eg, enlarged hilar structures / aorta, small pleural effusion, elevated hemidiaphragm, cardiomegaly)\nSubsegmental $=$ involves $26-75 \\%$ of a known bronchopulmonary segment\nSegmental $=$ involves $>75 \\%$ of a known bronchopulmonary segment\nV/Q match $=$ area of abnormal ventilation identical to perfusion defect in size, shape, a location\nTriple match $=$ matched ventilation-perfusion defect with an associated matching area of increased opacity on CXR",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 697,
            "markdown": "V/Q mismatch $=$ normal ventilation / normal CXR in region of perfusion defect or perfusio defect larger than ventilation defect / CXR abnormality\nReverse $\\quad=$ area with better perfusion than ventilation suggestive of non-thromboembr mismatch cause\nInterpretation: refer to Biello or PIOPED (Prospective Investigation of Pulmonary Embolism Diagnosis) criteria\nInterpretive algorithm:\n$\\sqrt{ }$ no perfusion defect\nDiagnosis: normal\nInterpretation: no PE\n$\\sqrt{ }$ perfusion defect WITHOUT lung disease ( $=$ normal ventilation + normal $\\mathrm{CXR}=\\mathrm{V} / \\mathrm{Q}$ mismatch)\nDiagnosis: PE\nInterpretation: high probability for PE; $>1$ perfusion defect is necessary to increase certainty\n$\\sqrt{ }$ perfusion defect WITH lung disease:\n(a) ventilation abnormality + clear CXR:\n\nDiagnosis: COPD\nInterpretation: low probability for PE\n$\\diamond$ COPD does not diminish usefulness of V/Q scan, but increases likelihood of an indeterminate result!\n(b) absent ventilation + consolidation on CXR:\n\nDiagnosis: pneumonia, pulmonary embolism with infarction, segmental atelectasis\n$\\sqrt{ }$ perfusion defect larger than CXR opacity\nInterpretation: high probability for PE\n$\\sqrt{ }$ perfusion defect substantially smaller than opacity\nInterpretation: low probability for PE\n$\\sqrt{ }$ perfusion defect of comparable size\nInterpretation: intermediate probability\n$\\sqrt{ }$ \"stripe\" sign = rim of preserved peripheral activity around a perfusion defect usually indicates",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 698,
            "markdown": "![img-73.jpeg](img-73.jpeg)\n\nNo V/Q defects \\& normal ventilation \\& normal CXR = normal\n![img-74.jpeg](img-74.jpeg)\n\nMatching nonsegmental V/Q defects \\& normal CXR = low probability\n![img-75.jpeg](img-75.jpeg)\n\nNo definite V/Q mismatch \\& normal CXR = moderate probability\n![img-76.jpeg](img-76.jpeg)\n\nSegmental perfusion defect \\& normal ventilation = high probability\n![img-77.jpeg](img-77.jpeg)\ntriple-match defect in pulmonary infarction\nMatching segmental V/Q defect \\& CXR opacity = indeterminate\nCombined Interpretation of V/Q Scans and Chest X-Ray",
            "images": [
                {
                    "id": "img-73.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 189,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 468,
                    "image_base64": null
                },
                {
                    "id": "img-74.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 528,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 756,
                    "image_base64": null
                },
                {
                    "id": "img-75.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 809,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1040,
                    "image_base64": null
                },
                {
                    "id": "img-76.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 1100,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1339,
                    "image_base64": null
                },
                {
                    "id": "img-77.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 1397,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1628,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 699,
            "markdown": "![img-78.jpeg](img-78.jpeg)",
            "images": [
                {
                    "id": "img-78.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 184,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1856,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 700,
            "markdown": "| Correlation between V/Q Scan and Chest X-Ray (CXR should be taken within 6-12 hours of scan) |  |\n| :--: | :--: |\n| CXR Category | Nondiagnostic V/Q Scan |\n| No acute abnormality | $12 \\%$ |\n| Linear atelectasis | $12 \\%$ |\n| Pulmonary edema | $12 \\%$ |\n| Pleural effusion | $36 \\%$ |\n| Parenchymal consolidation | $82 \\%$ |\n\n\n| Criteria for Very Low Probability Interpretation of V/Q Lung Scans ( $<10 \\%$ PPV for thromboembolism) |  |\n| :--: | :--: |\n| Criterion | PPV |\n| $\\sqrt{ }$ nonsegmental perfusion abnormality | $8 \\%$ |\n| $\\sqrt{ }$ perfusion defect smaller than corresponding radiographic defect | $8 \\%$ |\n| $\\sqrt{ }$ stripe sign | $7 \\%$ |\n| $\\sqrt{ }$ triple matched defect in upper / middle lung zone | $4 \\%$ |\n| $\\sqrt{ }$ matched ventilation-perfusion defects in 2 / 3 zones of a single lung + normal CXR | $3 \\%$ |\n| $\\sqrt{ } 1$ to 3 small segmental perfusion defects | $1 \\%$ |\n\n\n| Study Results of Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) |  |  |\n| :--: | :--: | :--: |\n| Probability of PE | in | Angiogram Positive in |\n| High | $13 \\%$ | $88 \\%$ |\n| Intermediate | $39 \\%$ | $33 \\%$ |\n| Low | $34 \\%$ | $16 \\%$ |\n| Normal | $14 \\%$ | $9 \\%$ |\n\n\n| Probability Estimate for Pulmonary Thromboembolism |  |\n| :--: | :--: |\n| indeterminate | lungs cannot be adequately evaluated due to underlying consolidation / obstructive disease; impossible to give a probability estimate |\n| high | $>85 \\%$ (more than one segmental mismatch) $\\rightarrow$ $12 \\%$ normal angiogram! |\n| intermediate | $\\sim 30 \\%=$ perfusion abnormality falling short of diagnostic confidence for PE (eg, single segmental mismatch) |\n| low | $<15 \\%$ |\n| normal | $<1 \\%$ |\n| N.B.: | low- / intermediate-probability scans are diagnosed in $50-70 \\%$ of all V/Q scans with disagreement between expert readers in $25-30 \\% \\rightarrow$ recommendation of additional studies (but only $12-14 \\%$ will undergo angiography) |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 701,
            "markdown": "| Effect of Clinical Probability for PE on Presence of PE |  |  |  |\n| :--: | :--: | :--: | :--: |\n| V/Q scan | Clinical Probability | PE Present |  |\n| High-probability | $>80 \\%$ | $96 \\%$ |  |\n| Low-probability | $<20 \\%$ | $4 \\%$ |  |\n| Indeterminate | DVT present | $93 \\%$ |  |\n| Indeterminate V/Q Lung Scans |  |  |  |\n| Criterion |  |  | PPV |\n| $\\sqrt{ }$ Q defect $<<$ CXR consolidation |  |  | $14 \\%$ |\n| $\\sqrt{ }$ Q defect equal to CXR |  |  | $26 \\%$ |\n| $\\sqrt{ }$ Q defect $>>$ CXR consolidation |  |  | $89 \\%$ |\n\n\n| Interpretation Criteria for V/Q Lung Scans |  |  |\n| :--: | :--: | :--: |\n| Probability of PE | Modified Biello Criteria | Modified PIOPED Criteria |\n| Normal | $\\sqrt{ }$ normal perfusion | $\\sqrt{ }$ normal perfusion |\n| Low <br> $(0-19 \\%)$ | $\\sqrt{ }$ small (< $25 \\%$ segment) V/Q mismatches | $\\sqrt{ }$ small perfusion defects regardless of number / ventilation scan finding / CXR finding |\n|  | $\\sqrt{ }$ focal V/Q matches without corresponding CXR consolidation | $\\sqrt{ }$ perfusion defect substantially smaller than CXR abnormality; ventilation findings irrelevant |\n|  | $\\sqrt{ }$ perfusion defects substantially smaller than CXR abnormality | $\\sqrt{ }$ V/Q match in $\\leq 50 \\%$ of one lung $/ \\leq 75 \\%$ of upper $/$ mid $/$ lower lung zone; CXR normal / nearly normal |\n|  |  | $\\sqrt{ }$ single moderate perfusion defect with normal CXR; ventilation findings irrelevant |\n|  |  | $\\sqrt{ }$ nonsegmental perfusion defects |\n| Indeterminate <br> Intermediate $(25-50 \\%)$ | $\\sqrt{ }$ severe COPD with perfusion defects | $\\sqrt{ } 1$ large (segmental) $\\pm 1$ moderate (subsegmental) V/Q mismatch |\n|  | $\\sqrt{ }$ perfusion defect with corresponding CXR consolidation | $\\sqrt{1-3}$ moderate (subsegmental) V/Q mismatches |\n|  | $\\sqrt{ }$ single moderate / large V/Q mismatch without corresponding CXR abnormality | $\\sqrt{ } 1$ matched V/Q with normal CXR |\n| High (> 85\\%) | $\\sqrt{ }$ perfusion defects substantially larger than CXR abnormalities | $\\sqrt{ } \\geq 2$ large (segmental) perfusion defects without match |\n|  | $\\sqrt{ }$ $\\geq 2$ moderate ( $25-90 \\%$ segment) / <br> $\\geq 2$ large ( $>90 \\%$ segment) V/Q mismatches; no corresponding CXR abnormality | $\\sqrt{ }>2$ large (segmental) perfusion defects substantially larger than matching ventilation / CXR abnormality |\n|  |  | $\\sqrt{ } \\geq 2$ moderate (subsegmental) +1 large (segmental) perfusion defect without match |\n|  |  | $\\sqrt{ } \\geq 4$ moderate (subsegmental) perfusion defects; ventilation + CXR findings normal |\n\n(a) nonembolic cause\n(b) old / resolving pulmonary embolism\n$\\sqrt{ }$ focal lung opacity:\n$\\sqrt{ }$ not ventilated + not perfused $=$ \"indeterminate scan\"\n$\\sqrt{ }$ not changed $>1$ week + not ventilated + not perfused $=$ low probability for PE\nN.B.: With a lung opacity, evaluate well-aerated areas for perfusion defects!\n$\\diamond 75 \\%$ of patients with pulmonary edema + without pulmonary embolism have a normal perfusion scan!\nEffect of a priori suspicion for pulmonary embolus:\n> increased in patients with risk factors (immobilization, recent surgery, known hypercoagulable state, malignancy, previous pulmonary embolus, DVT, estrogen therapy)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 702,
            "markdown": ", incidence of PE for a low probability scan increases from $15 \\%$ to $40 \\%$ in patients with a high clinical risk!\nTherapeutic implications:\n(a) high probability scan : treat for PE\n(b) indeterminate scan : pulmonary angiogram\n(c) low probability scan : consider other diagnosis, unless clinical suspicion very high\n\nOverall accuracy:\n$68 \\%$ for perfusion scan only\n$84 \\%$ for ventilation-perfusion scan\n$\\diamond 100 \\%$ sensitivity in detection of $\\mathrm{PE} \\leftarrow$ occurrence of multiple emboli (usually $>6-8$ ), at least one of which causes a perfusion defect!\n$\\diamond$ A normal perfusion scan virtually excludes PE!\n$\\diamond$ In an individual $<45$ years of age a subsegmental perfusion defect + pleuritic chest pain in the same region is indicative of pulmonary embolism in $77 \\%$ ! (DDx: idiopathic / viral pleurisy)\n$\\diamond 73-82 \\%$ of patients have equivocal perfusion scans (ie, low and intermediate probability)!\n$\\diamond$ Interobserver variability for intermediate- and low-probability scans is $30 \\%$ !\nFalse-positive scans: nonthrombotic emboli, IV drug abuse, vasculitis, redistribution of flow, acute asthma (due to mucus plugging)\nFalse-negative scans: saddle embolus\n\n# Temporal Resolution of V/Q Scan \n\nN.B.: V/Q abnormalities vary over time $\\leftarrow$ autoregulation (hypoxic vasoconstriction, hypercapneic bronchoconstriction) and resolution\n(1) Abnormality resolves within weeks / months (in most)\n(2) Abnormality may last permanently\n$\\diamond$ Baseline study necessary to detect new emboli!\n\n## Characteristic V/Q Pattern of Nonthromboembolic Disease\n\n1. Reverse mismatch\n\nCause: mucus plugging, atelectasis\nAssociated with: functional venous-to-systemic shunt contributing to hypoxemia\n2. Matched perfusion-ventilation defect\n\nCause: chronic obstructive pulmonary disease, asthma exacerbation\n3. Peripheral perfusion defects of microembolic disease\n\nCause: fat / amniotic fluid / tumor cell emboli\n\n## Cause of Unilateral Lung Perfusion\n\nFrequency: $2 \\%$\nA. PULMONARY EMBOLISM (23\\%)\nB. AIRWAY DISEASE\n(a) Unilateral pleural / parenchymal disease (23\\%)\n(b) Bronchial obstruction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 703,
            "markdown": "1. Bronchogenic carcinoma (23\\%)\n2. Bronchial adenoma\n3. Aspirated endobronchial foreign body\nC. CONGENITAL HEART DISEASE (15\\%)\nD. ARTERIAL DISEASE\n4. Swyer-James syndrome (8\\%)\n5. Congenital pulmonary artery hypoplasia / stenosis\n6. Shunt procedure to pulmonary artery (eg, Blalock-Taussig)\nE. ABSENCE OF LUNG\n7. Pneumonectomy (8\\%)\n8. Unilateral pulmonary agenesis\nmnemonic: SAFE POEM\nSwyer-James syndrome\nAgenesis (pulmonary)\nFibrosis (mediastinal)\nEffusion (pleural)\nPneumonectomy, Pneumothorax\nObstruction by tumor\nEmbolus (pulmonary)\nMucous plug\n\n# Cause of Perfusion Defect \n\nA. VASCULAR DISEASE\n(a) Acute / previous pulmonary embolus\n\n1. Pulmonary thromboembolic disease\n2. Fat embolism\n$\\sqrt{ }$ nonsegmental perfusion defect\n3. Air embolism\n$\\sqrt{ }$ characteristic decortication appearance in uppermost portion on perfusion scintigraphy\n4. Embolus of tumor / cotton wool / balloon for occlusion of AVM / obstruction by Swan-Ganz catheter, other foreign body\n5. Dirofilaria immitis (dog heartworm): clumps of heartworms break off cardiac wall + embolize pulmonary arterial tree\n6. Sickle cell disease\n(b) Vasculitis\n7. Collagen vascular disease: sarcoidosis\n8. IV drug abuse\n9. Previous radiation therapy:\n$\\sqrt{ }$ defect localized to radiation port\n10. Tuberculosis\n(c) Vascular compression\n11. Bronchogenic carcinoma:\n$\\sqrt{ }$ perfusion defect depending on tumor size + location\n12. Lymphoma / lymph node enlargement",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 704,
            "markdown": "3. Pulmonary artery sarcoma\n4. Fibrosing mediastinitis $\\leftarrow$ histoplasmosis\n5. Idiopathic pulmonary fibrosis:\n$\\checkmark$ small subsegmental defects in both lungs\n6. Aortic aneurysm (large saccular / dissecting)\n7. Intrathoracic stomach\n(d) Altered pulmonary circulation\n8. Absence / hypoplasia of pulmonary artery\n9. Peripheral pulmonary artery stenosis\n10. Bronchopulmonary sequestration\n11. Primary pulmonary hypertension\n$\\checkmark$ upward redistribution + large hilar defects\n$\\checkmark$ multiple small peripheral perfusion defects\n12. Pulmonary venoocclusive disease\n13. Mitral valve disease\n$\\checkmark$ predilection for right middle lobe + superior segments of lower lobes\n14. Congestive heart failure\n$\\checkmark$ diffuse nonsegmental V/Q mismatch\n$\\checkmark$ enlargement of cardiac silhouette + perihilar regions\n$\\checkmark$ reversed distribution: more activity anteriorly than posteriorly\n$\\checkmark$ accentuation of fissures\n$\\checkmark$ flattening of posterior margins of lung (lateral view)\n$\\checkmark$ pleural effusion\nB. AIRWAY DISEASE\n$\\diamond$ Nearly all pulmonary disease produces decreased pulmonary blood flow to affected lung zones = autoregulatory reflexive vasoconstriction!\n15. Asthma, chronic bronchitis, bronchospasm, mucus plugging\n16. Bronchiectasis (bronchiolar destruction)\n17. Emphysema (bulla / cyst)\n18. Pneumonia / lung abscess\n19. Lymphangitic carcinomatosis\n$\\checkmark$ perfusion defects in area of hypoxia\n$\\checkmark$ abnormal ventilation to a similar / more severe degree\n$\\checkmark$ mostly multiple nonanatomic defects (in 20\\%)\n\n# Tumor Embolism \n\n$\\diamond$ Diagnosis frequently missed until postmortem exam!\nFrequency: $2-26 \\%$ of patients with known malignancy\nPrimary: gastric carcinoma (most common), breast, liver, kidney, prostate, lung, ovarian, osteosarcoma, lymphoma, choriocarcinoma\n$\\diamond$ Right atrial myxoma + RCC tend to embolize to large central + segmental pulmonary arteries!\nPathogenesis: tumor cells form emboli in vena cava subsequently occlude small muscular pulmonary arteries + arterioles\nHisto: intravascular malignant cells, acute and organizing platelet-fibrin thrombi, small",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 705,
            "markdown": "artery intimal fibrosis, adjacent intralymphatic tumor\n\n- progressive dyspnea, cough, pleuritic chest pain\n- hemoptysis, syncope; hypoxemia $<50 \\mathrm{mmHg}$\n\nCXR:\n$\\sqrt{ }$ enlarged central pulmonary arteries\n$\\sqrt{ }$ cardiomegaly\n$\\sqrt{ }$ ill-defined nodular / confluent peripheral parenchymal opacities (with multiple pulmonary infarcts)\n$\\sqrt{ }$ focal / diffuse heterogeneous opacities = lymphangitic carcinomatosis\nCT:\n$\\sqrt{ }$ subpleural linear + wedge-shaped opacities (at sites of pulmonary infarctions)\n$\\sqrt{ }$ companion manifestations: lymphadenopathy, pulmonary venous hypertension, lymphangitic carcinomatosis:\n$\\sqrt{ }$ multifocal dilatation / beading of vessels\n$\\sqrt{ }$ thickening of interlobular septa\n$\\sqrt{ }$ tree-in-bud pattern $\\leftarrow$ filling of centrilobular arteries with tumor cells / carcinomatous endarteritis $\\leftarrow$ fibrocellular intimal hyperplasia initiated by tumor microemboli\nCECT:\n$\\sqrt{ }$ filling defects in main pulmonary artery branches\n$\\sqrt{ }$ multifocal beading + dilatation of subsegmental pulmonary arteries\nNUC (V/Q scan):\n$\\sqrt{ }$ multiple small subsegmental unmatched perfusion defects\nAngio:\n$\\sqrt{ }$ delayed arterial phase\n$\\sqrt{ }$ filling defects / occlusions of subsegmental arterial branches\n$\\sqrt{ }$ arterial wall irregularities\n$\\sqrt{ }$ peripheral pruning of smaller arteries\n$C x$ : subacute cor pulmonale (heralds death within 4-12 weeks)\n\n\n# Mercury Embolism \n\nCause: accidental / suicidal IV injection\nPathomechanism: intravascular mercury becomes encased in thrombus or migrates into pulmonary interstitium / alveolar spaces resulting in significant granulomatous response\n$\\sqrt{ }$ high-density fine-caliber branching structures in symmetric distribution\n$\\sqrt{ }$ mercury collection within apex of right ventricle\n\n## PULMONARY VENO-OCCLUSIVE DISEASE\n\n$=$ fibrous narrowing / occlusion of pulmonary venules + small veins; the postcapillary counterpart of primary pulmonary arterial hypertension\n\nPulmonary veno-occlusive disease may develop fatal pulmonary edema if treated with vasodilators!\nPrevalence: $01 .-0.2$ per 1,000,000 persons\nAge: $<20$ years in $30-50 \\%$ (range, 9 days to 70 years); $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nCause: idiopathic (rare condition); venous thrombosis initiated by infection / toxic exposure /",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 706,
            "markdown": "immune complex deposition\nMay be associated with:\npregnancy, transplantation, drug toxicity (carmustine, bleomycin, mitomycin)\nHemodynamics:\n\n- $\\uparrow$ pressure in right atrium + pulmonary artery (PAH)\n- normal / low / variably elevated pulmonary capillary wedge pressure (PCWP); decreased cardiac output\n- normal pressure in left atrium + left ventricle (excludes cardiac disease as the cause for venous hypertension)\nHisto:\n(a) specific changes: webs, recanalized thrombus (in up to 95\\%), intimal fibrosis with narrowing / occlusion of pulmonary veins of all sizes; \"capillary hemangiomatosis\" = sheets and nodular collections of thin-walled capillaries invading pulmonary arteries + veins + bronchioles + pleura\n(b) nonspecific changes of venous hypertension: venous medial hypertrophy, edematous interlobular septa with dilated lymphatic spaces, paraseptal venous infarction, interstitial + pleural lymphatic dilatation, intraalveolar hemosiderin-laden macrophages; muscularized arterioles + medial hypertrophy of muscular pulmonary arteries\n- progressive dyspnea and fatigue, hemoptysis, digital clubbing\n- antecedent flulike symptoms; dry / productive chronic cough\n- chest pain, syncope; episodes of acute pulmonary edema\n\nCXR:\n$\\checkmark$ enlargement of main pulmonary artery (PAH)\n$\\checkmark$ prominent Kerley B lines\n$\\checkmark$ pulmonary veins of normal caliber\n$\\checkmark$ normal contours of LA + LV\n$\\checkmark \\pm$ pleural effusions\n$\\checkmark$ diffuse interstitial $\\pm$ alveolar pulmonary edema:\n$\\checkmark$ central and gravity-dependent parenchymal ground-glass attenuation\n$\\checkmark$ multifocal airspace consolidation $\\leftarrow$ parenchymal hemorrhage, pulmonary edema, pulmonary infarction\n$\\checkmark$ mediastinal lymphadenopathy $\\leftarrow$ vascular transformation of lymph node sinus with various degrees of sclerosis\nCT:\n$\\checkmark$ markedly small central pulmonary veins\n$\\checkmark$ dilated central pulmonary arteries\n$\\checkmark$ smoothly thickened interlobular septa\n$\\checkmark$ peribronchovascular thickening\n$\\checkmark$ diffuse / geographic / mosaic / perihilar / patchy / centrilobular ground-glass opacity\n$\\checkmark$ right heart enlargement + normal-sized left atrium\n$\\checkmark$ pleural effusions\n$\\diamond$ The combination of signs of pulmonary arterial hypertension + interstitial / alveolar pulmonary edema is virtually DIAGNOSTIC of pulmonary venoocclusive disease!\nNUC:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 707,
            "markdown": "$\\sqrt{ }$ patchy distribution of 99 mTc -MAA (of \"upstream\" pulmonary arterial hypertension)\nAngio:\n$\\sqrt{ }$ enlarged right ventricle + central pulmonary arteries\n$\\sqrt{ }$ prolonged parenchymal phase enhancement\n$\\sqrt{ }$ delayed filling of normal pulmonary veins\n$\\sqrt{ }$ normal to small left atrium\n$C x$ : potentially fatal pulmonary edema following administration of vasodilators for misdiagnosed presumed precapillary pulmonary hypertension\n$D x$ : often missed initially (clinical presentation + radiographic findings mimic interstitial lung disease)\nPrognosis: death within 3 years $\\leftarrow$ NO effective therapy\nRx: lung / heart-lung transplant (only curative option); supportive diuretics, anticholinesterase (ACE) inhibitors, cardiac glycosides (digoxin), oxygen supplementation, pulmonary vasodilators (calcium channel blockers, prostacyclin), immunosuppressive agents\n\n# PULMONARY VEIN VARIX \n\n$=$ abnormal tortuosity + focal dilatation of pulmonary vein just before entrance into left atrium Etiology: congenital / associated with chronic pulmonary venous hypertension or mitral valve disease\n\n- usually asymptomatic\n- hemoptysis $\\leftarrow$ rupture / thromboembolic disease\n\nLocation: medial $1 / 3$ of either lung below hila close to left atrium\n$\\sqrt{ }$ well-defined lobulated round / oval mass without Ca2+\n$\\sqrt{ }$ change in size during Valsalva / Müller maneuver\n$\\sqrt{ }$ opacification at same time as LA (on CECT)\nRisk: (1) Death upon rupture during worsening heart failure\n(2) Source of cerebral emboli\n$D D x$ : pulmonary arteriovenous malformation, pulmonary nodule, hilar lymphadenopathy\n\n## RADIATION PNEUMONITIS\n\n$=$ damage to lungs after radiation therapy depends on:\n(a) irradiated lung volume (most important):\n\n- asymptomatic in $<25 \\%$ of lung volume\n(b) radiation dose (almost always exceeds critical value for tumoricidal doses):\n> pneumonitis unusual if $<20$ Gy given in $2-3$ weeks\n> pneumonitis common if $>60$ Gy given in 5-6 weeks\n> significantly increased risk for pneumonitis if daily dose fraction $>2.67$ Gy\n(c) fractionation of dose\n(d) concurrent / later chemotherapy\n\nPathologic phases:\n(1) Exudative phase $=$ edema fluid + hyaline membranes\n(2) Organizing / proliferative phase\n(3) Fibrotic phase $=$ interstitial fibrosis\n\nTime of onset: usually 4-6 months after treatment",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 708,
            "markdown": "Location: confined to radiation portals\n\n# Acute Radiation Pneumonitis \n\nOnset: within 4-8 (range, 1-12) weeks after radiation Rx\nPath: depletion of surfactant ( 1 week to 1 month later), plasma exudation, desquamation of alveolar + bronchial cells\n\n- asymptomatic (majority), acute respiratory failure (rare)\n- nonproductive cough, shortness of breath, weakness, fever (insidious onset)\n$\\sqrt{ }$ changes usually within portal entry fields\n$\\checkmark$ patchy / confluent consolidation, may persist up to 1 month (exudative reaction)\n$\\checkmark$ atelectasis + air bronchogram\n$\\checkmark$ spontaneous pneumothorax (rare)\nCT:\n$\\sqrt{ }$ mild hazy homogeneous increase in attenuation obscuring vessel outlines (2-4 months after Rx)\n$\\checkmark$ coalescing patchy consolidations ( $1-12$ months after therapy) not conforming to shape of portals\n$\\checkmark$ nonuniform discrete consolidation (most common; 3 months to 10 years after therapy) forming sharp edges and conforming to treatment portals\nPrognosis: recovery / progression to death / fibrosis\nRx: steroids\n\n\n## Chronic Radiation Pneumonitis\n\nOnset: 9-12 (range, 6-24) months after radiation therapy; stabilized by 1-2 years after therapy\nHisto: permanent damage of endothelial + type I alveolar cells\nMay be associated with:\n(1) Thymic cyst\n(2) Calcified lymph nodes (in Hodgkin disease)\n(3) Pericarditis + effusion (within 3 years)\n$\\checkmark$ severe loss of volume\n$\\checkmark$ dense fibrous strands from hilum to periphery\n$\\checkmark$ thickening of pleura\n$\\checkmark$ pericardial effusion\nCT:\n$\\checkmark$ solid consolidation with parenchymal distortion $\\leftarrow$ radiation fibrosis + atelectasis\n$\\checkmark$ traction bronchiectasis\n$\\checkmark$ mediastinal shift\n$\\checkmark$ pleural thickening\n\n## RESPIRATORY DISTRESS SYNDROME OF NEWBORN\n\n$=$ RDS $=$ SURFACTANT DEFICIENCY DISORDER $=$ HYALINE MEMBRANE DISEASE\n$=$ acute pulmonary disorder characterized by generalized atelectasis, intrapulmonary shunting, ventilation-perfusion abnormalities, reduced lung compliance\nFrequency: $6 \\div 1,000$ neonates (in 2002); $\\mathrm{M} \\div \\mathrm{F}=1.8 \\div 1$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 709,
            "markdown": "Cause: relative lack of mature type II pneumocytes $\\rightarrow$ deficiency of endogenous surfactant (production usually begins at 18-20 weeks of gestational age) $\\rightarrow$ increased alveolar surface tension + decreased alveolar distensibility $\\rightarrow$ acinar atelectasis (persistent collapse of alveoli) + dilatation of terminal airways\nHisto: uniformly collapsed alveoli + variable distension of alveolar ducts + terminal bronchioles; lined by fibrin (\"hyaline membranes\") $\\leftarrow$ protein seepage from damaged hypoxic capillaries\nPredisposed: perinatal asphyxia; maternal / fetal hemorrhage, term infants of diabetic mothers, multiple gestations, premature infants ( $<1,000 \\mathrm{~g}$ in $66 \\% ; 1,000 \\mathrm{~g}$ in $50 \\% ; 1,500$ g in $16 \\% ; 2,000$ g in $5 \\% ; 2,500$ g in $1 \\%$ )\nOnset: $<2-5$ hours after birth, increasing in severity from 24-48 hours, gradual improvement after $48-72$ hours\n\n- nonspecific tachypnea, nasal flaring\n- expiratory grunting (expiratory breathing against a partially closed glottis to augment alveolar distension)\n- circumoral cyanosis (carbon dioxide retention)\n- substernal + intercostal retraction of chest wall\n$\\sqrt{ }$ decreased lung expansion (counteracted by respirator therapy)\n$\\checkmark$ symmetric generalized consolidation of variable severity:\n$\\checkmark$ complete \"white out\" of lung\n$\\checkmark$ diffuse reticulogranular texture (coincides with onset of clinical signs, maximum severity at 12-24 hours of life) = summation of collapsed alveoli, transudation of fluid into interstitium, air distension of terminal bronchioles + alveolar ducts\n$\\checkmark$ evolving hazy opacities to clearing over several days\n$\\checkmark$ effacement of normal pulmonary vessels\n$\\checkmark$ prominent air bronchograms (distension of compliant airways)\nPrognosis: spontaneous clearing within 7-10 days (mild course in untreated survivors); death in $18 \\%$\nRx: (1) Antenatal maternal corticosteroid therapy\n(2) Surfactant replacement therapy (liquid bolus of exogenous surfactant delivered into tracheobronchial tree\n(3) Nasal continuous positive airway pressure (CPAP)\n(4) High-frequency oscillatory ventilation (HFOV)\n(5) Extracorporeal membrane oxygenation (ECMO)\n\nDDx: (1) Diffuse pneumonia accompanying sepsis\n(2) Retained fetal lung fluid (first few hours)\n(3) Pulmonary hemorrhage\n(4) Pulmonary venous congestion (eg, TAPVR, pulmonary vein atresia, hypoplastic left heart)\n(5) Premature with accelerated lung maturity (PALM baby)\n\n# Causes of Asymmetric Clearing after Surfactant \n\n(a) maldistribution of surfactant into right mainstem bronchus\n(b) insufficient surfactant requiring additional application\n(c) regional differences in aeration before surfactant treatment",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 710,
            "markdown": "$D D x$ : neonatal pneumonia, meconium aspiration, unilateral tension pneumothorax, hemorrhagic pulmonary edema\n\n# Acute \\& Subacute Complications of RDS \n\n(a) persistent patency of ductus arteriosus (PDA) with oxygen stimulus missing to close duct; gradual $\\downarrow$ in pulmonary resistance (by end of $1^{\\text {st }}$ week) $\\rightarrow$ significant L-to-R shunt\n(b) barotrauma with air-block phenomena\n(c) hemorrhage\n\n1. Pulmonary hemorrhage\n2. Cerebral hemorrhage\n(d) focal atelectasis (usually from mucus plug)\n(e) persisting fetal circulation\n(f) myocardial ischemia\n(g) diffuse opacity\n3. Worsening RDS (first 1-2 days only)\n4. Congestive heart failure (PDA, fluid overload)\n5. Pulmonary hemorrhage\n6. Superimposed pneumonitis\n7. Massive aspiration\n8. Stage II bronchopulmonary dysplasia\n9. \"Weaning effect\" from removal of endotracheal tube / diminished ventilator pressure\n10. Extracorporeal membrane oxygenation\n(h) disseminated intravascular coagulopathy\n(i) necrotizing enterocolitis\n(j) acute renal failure\n(k) metabolic disturbance (eg, hyperbilirubinemia, hypocalcemia)\n\n## Chronic Complications of RDS\n\n1. Bronchopulmonary dysplasia ( $10-20 \\%$ )\n2. Subglottic stenosis (intubation)\n3. Localized interstitial emphysema\n4. Hyperinflation\n5. Retrolental fibroplasia\n6. Malnutrition, rickets\n7. Lobar emphysema\n8. Delayed onset of diaphragmatic hernia\n9. Recurrent inspiratory tract infections\n\n## Complication of Continuous Positive Pressure Ventilation\n\nCause: airway overdistension (volutrauma) rather than high airway pressure (barotrauma) Path:\n(a) rupture of alveoli along margins of interlobular septa + vascular structures (= parenchymal pseudocyst)\n(b) air dissecting along interlobular septa + perivascular spaces = pulmonary interstitial emphysema (PIE)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 711,
            "markdown": "$\\sqrt{ }$ \"pseudoclearing\" of RDS\n(c) interstitial air migrating centripetally into pleural space (= pneumothorax) / mediastinum ( $=$ pneumomediastinum) / pericardial cavity ( $=$ pneumopericardium)\n(d) interstitial air rupturing into peritoneal space ( $=$ pneumoperitoneum) / retroperitoneal space ( $=$ pneumoretroperitoneum)\n(e) air dissecting into skin ( $=$ subcutaneous emphysema)\n(f) air rupturing into vessel ( $=$ gas embolism)\n$\\sqrt{ }$ streaky / mottled lucencies radiating from hila without branching / tapering often outlining bronchovascular bundles (DDx: air bronchogram)\n$\\sqrt{ }$ large subpleural cysts without definable wall usually at diaphragmatic + mediastinal surface compressing adjacent lung\n$\\sqrt{ }$ pneumothorax (in up to $25 \\%$ )\n$R x$ : mechanical ventilatory assistance with positive end-expiratory pressure (to increase oxygen diffusion)\n\n# RETAINED FETAL LUNG FLUID \n\n$=$ NEONATAL WET LUNG DISEASE $=$ TRANSIENT RESPIRATORY DISTRESS OF THE NEWBORN $=$ TRANSIENT TACHYPNEA OF THE NEWBORN\nFrequency: 6\\%; most common cause of respiratory distress in newborn\nCause: cesarean section, precipitous delivery, breech delivery, prematurity, maternal diabetes\nPathophysiology:\ndelayed resorption of fetal lung fluid (normal clearance occurs through capillaries ( $40 \\%$ ), lymphatics ( $30 \\%$ ), thoracic compression during vaginal delivery ( $30 \\%$ ); stiff lungs cause labored ventilation until fluid is cleared\nOnset: within 6 hours of life; peaks at 1st day of life\n\n- increasing respiratory rates during first $2-6$ hours of life\n- intercostal + sternal retraction\n- normal blood gases during hyperoxygenation\n$\\sqrt{ }$ linear opacities + perivascular haze + thickened fissures + interlobular septal thickening (interstitial edema):\n$\\checkmark$ symmetric perihilar radiating congestion\n$\\checkmark$ mild hyperaeration\n$\\checkmark$ mild cardiomegaly\n$\\checkmark$ small amount of pleural fluid\nPrognosis: resolving within 1-2-4 days (retrospective Dx)\n$D D x$ : (1) Normal (during first several hours of life)\n(2) Diffuse pneumonitis / sepsis\n(3) Mild meconium aspiration syndrome\n(4) Alveolar phase of RDS\n(5) \"Drowned newborn syndrome\" = clear amniotic fluid aspiration\n(6) Pulmonary venous congestion (eg, left heart failure, overhydration, placental transfusion)\n(7) Pulmonary hemorrhage\n(8) Hyperviscosity syndrome $=$ thick blood",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 712,
            "markdown": "(9) Immature lung syndrome $=$ premature with accelerated lung maturity (PALM baby)\n\n# RHEUMATOID LUNG \n\n$=$ autoimmune disease of unknown pathogenesis\nFrequency: $2-54 \\%$ of patients with rheumatoid arthritis; $\\mathrm{M}+\\mathrm{F}=5 \\div 1$ (although incidence of rheumatoid arthritis: $\\mathrm{M}+\\mathrm{F}=1 \\div 3$ )\n$\\diamond$ Lung disease is $2^{\\text {nd }}$ most common cause of death after infection!\n\n- rheumatoid arthritis\n\nStage 1: multifocal ill-defined alveolar infiltrates\nStage 2: fine interstitial reticulations (histio- and lymphocytes)\nStage 3: honeycombing\nA. PLEURAL DISEASE (38-73\\%)\n$\\diamond$ Most frequent thoracic manifestation!\n$\\diamond$ NOT related to pulmonary disease!\n\n- history of pleurisy ( $21 \\%$ )\n\nAssociated with: pericarditis, subcutaneous nodules\n$\\diamond$ Usually late in the disease, but may antedate rheumatoid arthritis\n\n- exudate (with protein content $>4 \\mathrm{~g} / \\mathrm{dL}$ )\n- low in sugar content ( $<30 \\mathrm{mg} / \\mathrm{dL}$ ) without rise during glucose infusion ( $75 \\%$ ); low WBC high in lymphocytes\n- positive for rheumatoid factor, LDH, RA cells\n$\\checkmark$ pleural thickening, usually bilateral\n$\\checkmark$ pleural effusion ( $3-5 \\%$ ) with little change for months:\n$\\checkmark$ unilateral ( $92 \\%$ ), usually small, may be loculated\n$\\checkmark$ tendency to resolve spontaneously\n$\\checkmark$ usually not associated with parenchymal disease\nB. BRONCHIAL ABNORMALITIES\n$\\checkmark$ cystic bronchiectasis on HRCT (30\\%)\n$\\checkmark$ bronchiolitis obliterans (may be transient regardless of penicillamine / gold therapy):\n$\\checkmark$ mosaic pattern ( $=$ areas of decreased attenuation + vascularity $\\leftarrow$ air trapping in small airways) on end-expiratory HRCT\n$\\checkmark$ bronchiolitis obliterans organizing pneumonia (BOOP):\n$\\checkmark$ bilateral air-space consolidation in peripheral / peribronchial distribution\n$\\checkmark$ follicular bronchiolitis (in 66\\%):\nHisto: hyperplasia of peribronchial + peribronchiolar lymphatic follicles\n$\\checkmark$ multiple small centrilobular nodules with patchy areas of ground-glass attenuation\nC. DIFFUSE INTERSTITIAL FIBROSIS\n\nPrevalence: $2-5-9 \\%$ of patients with rheumatoid arthritis\n\n- restrictive ventilatory defect\n\nLocation: lower lobe predominance\nHisto: deposition of IgM in alveolar septa (DDx to IPF)\nPatterns: UIP $>$ NSIP, cryptogenic organizing pneumonia, follicular bronchiolitis, bronchiolitis obliterans\n$\\checkmark$ punctate / nodular densities (mononuclear cell infiltrates in early stage)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 713,
            "markdown": "$\\sqrt{ }$ reticulonodular densities\n$\\sqrt{ }$ medium to coarse reticular opacities (mature fibrous tissue in later stage):\n$\\sqrt{ }$ irregular interlobular septal thickening on HRCT, predominantly in periphery of lower lung zones\n$\\sqrt{ }$ traction bronchiectasis\n$\\sqrt{ }$ honeycomb lung (uncommon in late stage)\n$\\sqrt{ }$ architectural distortion + progressive lower-lobe volume loss (advanced disease)\n$\\sqrt{ } \\pm$ groundglass opacities (less extensive / impressive)\nD. NECROBIOTIC (RHEUMATOID) NODULES (rare)\n$=$ well-circumscribed nodular mass in lung, pleura, pericardium identical to subcutaneous nodules associated with advanced rheumatoid arthritis\nPath: central zone of eosinophilic fibrinoid necrosis surrounded by palisading fibroblasts; nodule often centered on necrotic inflamed blood vessel (? vasculitis as initial lesion)\n$\\mathrm{M}>\\mathrm{F}$\n\n- subcutaneous nodules (same histology)\n- frequently seen in smokers with subcutaneous nodules + high rheumatoid factor titers\n- may arise before manifestation of rheumatoid arthritis\n\nAssociated with: interstitial lung disease\nDistribution: commonly in lung periphery of upper and middle lung regions\nSize: $3-70 \\mathrm{~mm}$\n$\\sqrt{ }$ usually multiple well-circumscribed nodules\n$\\sqrt{ }$ may increase in size / resolve spontaneously\n$\\sqrt{ }$ new ones may arise while older ones resolve\n$\\sqrt{ } \\pm$ cavitation with thick symmetric walls + smooth inner lining (in $50 \\%$ )\n$\\sqrt{ } \\pm$ central calcification (very rare)\n$C x$ : rupture into pleural space: pneumothorax, pleural effusion, empyema\nE. CAPLAN SYNDROME\n$=$ RHEUMATOID PNEUMOCONIOSIS SYNDROME\n$=$ hyperimmune reactivity to irritating silica inhalation (of coal workers with rheumatoid arthritis)\nFrequency: $2-6 \\%$ of all men affected by pneumoconioses (exclusively in Wales)\nPath: disintegrating macrophages deposit a pigmented ring of dust surrounding the central necrotic core + zone of fibroblasts palisading the zone of necrosis\n$\\diamond$ NOT necessarily evidence of long-standing pneumoconiosis\n\n- concomitant with joint manifestation (most frequent) / may precede arthritis by several years\n- concomitant with systemic rheumatoid nodules\n$\\sqrt{ }$ rapidly developing well-defined nodules of $5-50 \\mathrm{~mm}$ in size with a tendency to appear in crops predominantly in upper lobes + in periphery of lung\n$\\sqrt{ }$ nodules may remain unchanged / increase in number / calcify / result in thick-walled cavities\n$\\sqrt{ }$ background of pneumoconiosis\n$\\sqrt{ }$ pleural effusion (may occur)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 714,
            "markdown": "# F. PULMONARY ARTERITIS \n\n$=$ fibroelastoid intimal proliferation of pulmonary arteries\n\n- pulmonary arterial hypertension + cor pulmonale\nG. CARDIAC ENLARGEMENT\n(pericarditis + carditis / congestive heart failure)\nH. BONE ABNORMALITIES ON CXR\n$\\sqrt{ }$ erosive arthritis of acromioclavicular joint, sternoclavicular joint, shoulder joint:\n$\\sqrt{ }$ resorption of distal end of clavicles\n$\\sqrt{ }$ ankylosis of vertebral facet joints\n$\\sqrt{ }$ vertebral body collapse $\\leftarrow$ steroid use\n$\\sqrt{ }$ cricoarytenoid arthritis (frequently overlooked!)\n- foreign body sensation, soreness / fullness in throat, hoarseness, dyspnea, pain radiating into ears, stridor, dysphagia, odynophagia, pain with speech\nI. DRUG-INDUCED LUNG DISEASE\n\nGold, penicillamine: diffuse alveolar damage, obliterative bronchiolitis\nMethotrexate: pneumonitis\n\n## SARCOIDOSIS\n\n$=$ BOECK SARCOID [sarkos, Greek = flesh; sarcoid = sarcoma-like]\n[Caesar Peter Möller Boeck (1845-1917), Norwegian dermatologist describes skin lesions in 1899]\n= immunologically mediated multisystem granulomatous disease of unknown etiology with variable presentation, progression and prognosis characterized by noncaseating nonnecrotic epitheloid cell granulomas\nBilateral hilar lymphadenopathy is the most common radiologic finding. Adenopathy in the right paratracheal nodes, left aortic-pulmonary window, and subcarinal nodes can also be seen, often with associated pulmonary infiltrates.\nPrevalence: 10-48 $\\div 100,000$ in USA in 2010 (highest in African-Americans, Swedes, Danes); Blacks $\\div$ Whites in USA $=3 \\div 1$ to $10 \\div 1$ (rare in African / South American Blacks); more common in blood group A\nAge peak: $20-40$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 3$\nEpidemiology: found with varying frequency in every country in the world; prevalence higher in temperate climates than tropical regions $(<10 \\div 100,000)$\nImmunology:\nunknown environmental antigen(s) activate alveolar macrophages in a genetically susceptibel host releasing\n> interleukin-1 (T-cell activator)\n> fibronectin (fibroblast chemotactic factor)\n> alveolar macrophage-derived growth factor (stimulates fibrosis)\nand activate T-lymphocytes releasing\n> interleukin-2 (stimulates growth of T-helper / cytolytic cells)\n> immune interferon (polyclonal B-cell activator)\n> monocyte chemotactic factor (attracts circulating monocytes and stimulates granuloma formation)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 715,
            "markdown": "Path: (a) acute phase: lymphocytes + scattered macrophage giant cells + small granulomas (b) intermediate phase: well=formed granulomas + minimal scarring\n(c) late phase: predominant fibrosis + few granulomas + chronic inflammation\n\nHisto: noncaseous granulomas composed of central core (histiocytes, epitheloid cells, multinucleated giant cells) surrounded by lymphocytes, scattered plasma cells, fibroblasts and collagen; occasional minimal central coagulative necrosis $D D x$ : indistinguishable from granulomas of berylliosis, treated TB, leprosy, fungal disease, hypersensitivity pneumonitis, Crohn disease, primary biliary cirrhosis\nLaboratory:\n\n- angiotensin-converting enzyme (ACE) elevated in 70\\% (ACE is a product of macrophages and an indicator for the granuloma burden of the body)\n$D D x$ : tuberculosis, leprosy, histoplasmosis, berylliosis, cirrhosis, hyperthyroidism, diabetes\n- CD4+CD8 ratio in blood serum commonly decreased\n- hypercalcemia + hypercalciuria in $2-15 \\% \\leftarrow$ increased intestinal resorption of calcium $\\leftarrow$ hydroxylation of 1,25-dihydroxy vitamin D in macrophages\n- Kveim-Siltzbach test (positive in 70\\%) = intracutaneous injection of $0.1-0.2 \\mathrm{~mL}$ of a previously validated saline suspension of human sarcoid spleen / lymph nodes; no longer considered specific $\\rightarrow$ rarely used\n- functional pulmonary impairment (even with NO radiographic abnormality):\n(a) restrictive ventilatory defect\n> reduced VC + FRC + TLC $\\leftarrow$ generalized reduction in lung volume\n> low lung compliance $\\leftarrow$ diffuse interstitial disease\n(b) obstructive ventilatory defect $(6 \\%) \\leftarrow$ endobronchial lesions / peribronchial fibrosis\n- NO identification of infectious / inflammatory agent\n$D x$ : based on a combination of clinical + radiological + histologic features after exclusion of other infectious / inflammatory entities\nDiagnostic criteria:\n(1) Compatible clinical + radiologic picture\n(2) Noncaseous epithelioid granulomas on bronchial / transbronchial US-guided biopsy (diagnostic results in $60-95 \\%$ and $80-95 \\%$ respectively) or from extrapulmonary sites like cervical lymph nodes and liver\n(3) Negative results of special stains / cultures for other entities\n\nAssessment of activity:\n(1) ACE titer (= angiotensin I converting enzyme)\n(2) Bronchoalveolar lavage (BAL): 20-50\\% lymphocytes with T-suppressor lymphocytes 420 times above normal\n(3) Gallium scan\n$\\sqrt{ }$ uptake in lymph nodes + lung parenchyma + salivary glands (correlates with alveolitis + disease activity); monitor of therapeutic response (indicator of macrophage activity)\n(4) PET\n$\\sqrt{ }$ degree of FDG uptake correlates well with disease activity for monitoring response to therapy\nClinical Forms:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 716,
            "markdown": "# A. ACUTE FORM \n\n- fever + malaise + arthralgia of large joints\n- erythema nodosum; (occasionally) uveitis + parotitis\n\nLöfgren Syndrome (17\\%)\n$=$ (1) erythema nodosum (2) periarticular ankle inflammation (3) mediastinal lymphadenopathy\nPrognosis: self-limiting course with spontaneous resolution\nB. CHRONIC FORM\n$=$ insidious onset (especially with involvement of lung or multiple extrapulmonary lesions) that may be followed by progressive fibrosis of lung and other organs\n\n- asymptomatic ( $30-50 \\%$ ); fever, malaise, weight loss\n- dry cough + shortness of breath ( $25 \\%$ )\n- hemoptysis in $4 \\%$ (from endobronchial lesion / vascular erosion / cavitation)\n\nExtrathoracic involvement (most commonly of skin and eyes) can be an initial manifestation in $1 / 2$ of symptomatic patients.\n$R x$ : inhaled / oral corticosteroids; immunosuppressive drugs (methotrexate, cyclophosphamide) with aggressive disease / frequent recurrence\n\n## Abdominal Sarcoidosis (30\\%)\n\n- strikingly elevated ACE levels in $91 \\%$\n\nScattered hypoattenuating nodules involving liver and spleen suggest a diagnosis of sarcoidosis or lymphoma.\n@: Liver (24-59\\%):\nPrevalence: autoptic (50-80\\%), bioptic (24-59\\%)\n$\\sqrt{ }$ mild homogeneous hepatomegaly (18-29\\%)\n$\\sqrt{ }$ cirrhotic appearance (rare) $\\leftarrow$ diffuse granulomatous involvement along periportal tracts followed by fibrosis\nCT:\n$\\sqrt{ }$ scattered $2-5-\\mathrm{mm}$ hypoattenuating nodular lesions in liver (in 5-15\\%) $\\leftarrow$ coalescent granulomata occurring within 5 years of diagnosis\n$\\sqrt{ }$ hypoenhancing lesions relative to background on early phase + minimal enhancement on delayed phase\nMR:\n$\\sqrt{ }$ heterogeneous nodular hepatic texture hypointense on all pulse sequences\n$\\sqrt{ }$ lesions most conspicuous on fat-saturated T2WI\n@: Spleen (pathologic involvement in 24-59\\%)\n$\\sqrt{ }$ splenomegaly ( $20-33 \\%$ )\n$\\sqrt{ }$ scattered hypoattenuating nodular lesions (18\\%): more common + larger than in liver\n@: Abdominal lymphadenopathy ( $10-31 \\%$ )\n\n- frequently associated with thoracic adenopathy\n\nLocation: mesenteric (periportal, perisplenic), retroperitoneal\nMean size: 2.6 cm\n$D D x$ : tumor-related sarcoid-like reaction = development of noncaseating granulomas in",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 717,
            "markdown": "# treated malignancy \n\n@ Pancreas\n$\\sqrt{ }$ mass + pain mimicking pancreatic carcinoma\n\n## Cardiac Sarcoidosis (5\\%)\n\nFrequency: 5\\% clinically, $20-50 \\%$ at autopsyy\n\n1. Global / regional hypokinesis with systolic dysfunction $\\rightarrow \\downarrow$ LV ejection fraction $+\\uparrow$ enddiastolic LV diameter\n2. Ventricular arrhythmia\n3. Cardiomyopathy, congestive failure, angina\n\n- may be asymptomatic throughout life\n- CHF $(25 \\%) \\leftarrow$ diffuse myocardial involvement\n- cor pulmonale $\\leftarrow$ pulmonary hypertension\n- conduction disturbances (in $23-30 \\%$ ): isolated bundle branch block to complete heart block\n- heart block (= CLASSIC clinical presentation)\n- supraventricular + ventricular arrhythmias\n- sudden cardiac death (in 12-65\\%) $\\leftarrow$ dysrhythmia\n\nDistribution: basal portion of septum, LV wall\nN.B.: rare in papillary muscle / RV\n\nEcho (nonspecific):\n$\\sqrt{ }$ wall motion abnormalities\n$\\sqrt{ }$ thinning of basal septum\n$\\sqrt{ }$ LV dilatation ( $30 \\%$ )\nCT:\n$\\sqrt{ }$ cardiomegaly ( $25 \\%$ )\n$\\sqrt{ }$ pericardial effusion\n$\\sqrt{ }$ ventricular aneurysm ( $10 \\%$ )\nMR ( $75-100 \\%$ sensitive, $77-79 \\%$ specific):\nCAVE: often contraindicated $\\leftarrow$ cardiac pacemakers (unless device is MR compatible)\n$\\sqrt{ }$ myocardial thickening\n$\\sqrt{ }$ nodular / patchy areas of high SI on T2WI / SSFP (bright-blood steady-state free\nprecession) $\\leftarrow$ edema\n$\\sqrt{ }$ late gadolinium-induced enhancement (LGE) of myocardium $\\leftarrow$ expansion of\nextracellular space\nLocation:\n(a) transmural\n(b) nontransmural: subepi- / midmyocardial along basal or midventricular septum (in $67 \\%)$\n$D D x$ : ischemic heart disease (subendocardial distribution in vascular territory)\n$\\sqrt{ }$ focal wall thinning + regional wall motion abnormalities $\\leftarrow$ myocardial fibrosis + scarring:\n$\\sqrt{ }$ subepicardial $>$ midmyocardial $>$ subendocardial scars in random distribution\n$\\sqrt{ }$ LV thinning with transmural involvement\nNUC ( ${ }^{99 \\mathrm{~m}} \\mathrm{Tc},{ }^{201} \\mathrm{Th}$ SPECT, ${ }^{82} \\mathrm{Rb}$ PET):\n$\\sqrt{ }$ resting perfusion defects $\\leftarrow$ inflammation-induced tissue damage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 718,
            "markdown": "PET ( $89 \\%$ sensitive, $78 \\%$ specific):\nN.B.: useful in patients with cardiac pacemakers!\n$\\sqrt{ }$ increased FDG-uptake (SUV range, 2.5-15.8) in nonperivascular distribution $\\leftarrow$ active necrotizing granulomatous disease\nalso involvement of:\n$\\sqrt{ }$ mediastinal + hilar lymph nodes (39\\%)\n$\\sqrt{ }$ lung parenchymal nodules ( $15 \\%$ ) in peribronchovascular distribution\n$\\sqrt{ }$ spleen, liver, muscle, salivary glands, subcutaneous tissue, bone (less frequent)\n$C x:$ ventricular aneurysm, pericardial effusion\n$D x$ : treatment-responsive cardiomyopathy, conduction defects at ECG, abnormal imaging findings, endomyocardial biopsy (on right side of heart)\n\nEndomyocardial biopsy is rarely performed because of its diagnostic yield of only $20-50 \\%$ and lack of information about cardiac distribution.\nRx: based on symptoms, ECG, imaging findings and disease course, rather than histologic confirmation\n$D D x$ : (1) Dilated cardiomyopathy (dilated LV with global dysfunction, linear stripe of LGE in ventricular septum)\n(2) Hypertrophic cardiomyopathy (LV hypertrophy $>15 \\mathrm{~mm}$, scattered patchy midmyocardial involvement)\n(3) Arrhythmogenic right ventricular cardiomyopathy (RV dilatation + dysfunction, fibrofatty infiltration of RV, dyskinetic free wall of RV + RV aneurysm)\n(4) Myocarditis (patchy epicardial LGE in often inferolateral distribution, hyperemia)\n(5) Amyloidosis (biventricular hypertrophy, global + diffuse LGE, LA enhancement, diffuse myocardial nulling abnormality)\n\nGastrointestinal Sarcoidosis (< 1\\%)\nLocation: anywhere from esophagus to rectum\n@ Stomach (most common)\n$\\sqrt{ }$ polypoid / nodular mass frequently in antrum\n$\\sqrt{ } \\pm$ ulcer (simulating peptic ulcer disease)\n$\\sqrt{ }$ diffuse fold thickening (mimicking Ménétrier disease)\n$\\sqrt{ }$ circumferential narrowing + loss of antral compliance (resembling scirrhous carcinoma)\n@ Colon ( $2^{\\text {nd }}$ most common)\n$\\sqrt{ }$ plaque-like lesions / ulcers\n$\\sqrt{ }$ fold thickening, focal nodularity\n$\\sqrt{ }$ annular segmental narrowing with obstruction\n@ Esophagus\n$\\sqrt{ }$ plaquelike lesions, narrowing, aperistalsis\n@ Small bowel\n$\\sqrt{ }$ circumferential thickening of terminal ileum (rare)\nGenitourinary Sarcoidosis (0.2-5\\%)\n@ Kidney",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 719,
            "markdown": "- interstitial nephritis, glomerulonephritis (rare)\n$\\sqrt{ }$ renal calculi\nCT:\n$\\sqrt{ }$ striated nephrograms in case of interstitial nephritis\n$\\sqrt{ }$ multiple low-attenuation tumorlike nodules (rare)\n@) Scrotum $(0.5 \\%)=$ Testicular sarcoid\n$\\sqrt{ }$ diffuse enlargement of epididymis\n$\\sqrt{ }$ hypoechoic lesions in epididymis (bilateral in $1 / 3$ )\n$\\sqrt{ }$ multiple hypoechoic lesions in testis (typically bilateral)\nMR:\n$\\sqrt{ }$ T2-hypointense nodules with enhancement on T1WI\nEthnicity: African-American+white males $=20 \\div 1$\n$\\diamond$ Strongly consider sarcoidosis in cases of multiple masses simultaneously affecting epididymis and testis.\n\n\n# Musculoskeletal Sarcoidosis (6-20\\%) \n\n$\\diamond$ Portends a more chronic + adverse prognosis!\n$\\diamond$ Usually accompanied by cutaneous manifestations!\n@ Joint (up to 40\\%)\n\n- unimpaired joint function\n\nLocation: knee, ankle, elbow, wrist\n$\\sqrt{ }$ inflammatory arthralgia\n@ Muscle\n$\\sqrt{ }$ increased T2 signal intensity of involved muscle\n$\\sqrt{ }$ sarcoid nodules with centrally low signal intensity on all sequences (= area of fibrosis)\n$\\sqrt{ }$ granulomas peripherally hyperintense on T2WI with contrast-enhancement on T1WI\n@ Bone (5-10\\%)\nHisto: medullary granulomas infiltrate cortical bone $\\rightarrow$ bone destruction / reactive sclerosis\nLocation: hands + feet (metaphyseal ends of distal + middle phalanges, metacarpals, metatarsals); vertebrae; skull\n\n- pain and swelling\n$\\sqrt{ }$ sharply marginated cystlike lesions of varying size:\n$\\sqrt{ }$ reticulated \"lacelike\" trabecular pattern\n$\\sqrt{ }$ neuropathy-like destruction of terminal phalanges (DDx: scleroderma)\n$\\sqrt{ }$ extensive bone erosion with pathologic fractures\n$\\sqrt{ }$ phalangeal endosteal sclerosis + periosteal new bone (infrequent)\n$\\sqrt{ }$ densely sclerotic lesions in spine, pelvis, ribs:\n$\\sqrt{ }$ vertebral involvement unusual: destructive lesions with sclerotic margin\n$\\sqrt{ }$ diffuse sclerosis of multiple vertebral bodies\n$\\sqrt{ }$ paravertebral soft-tissue mass (DDx: indistinguishable from tuberculosis)\n$\\sqrt{ }$ preservation of disk spaces\n$\\sqrt{ }$ osteolytic changes in skull\nNUC (bone scan):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 720,
            "markdown": "$\\sqrt{ }$ positive before radiographic manifestation\n\n# Neurosarcoidosis (9\\%) \n\n$=$ SARCOIDOSIS OF CNS\n$=$ dural / leptomeningeal noncaseating granulomas\nIncidence: CNS involvement clinically in 1-5-10\\% (in up to $25 \\%$ of autopsies)\nAge: bimodal distribution: initial peak around 20-29 years $+2^{\\text {nd }}$ peak $>50$ years more common in women + people of West African descent; black+white $=3 \\div 1$ to $10 \\div 1$\nSuspected neurosarcoidosis is difficult to confirm without evidence of systemic disease; chest imaging may be helpful to evaluate for pulmonary involvement.\n\n- cranial neuropathy (facial $>$ acoustic $>$ optic $>$ trigeminal nerves) $\\leftarrow$ granulomatous infiltration + leptomeningeal fibrosis ( $50-75 \\%$ ) of rapid onset with spontaneous resolution\n- peripheral neuropathy + myopathy\n- aseptic meningitis ( $20 \\%$ )\n- diffuse encephalopathy, dementia\n- pituitary + hypothalamic dysfunction (eg, diabetes insipidus in 5-10\\%)\n- generalized / focal seizures (herald poorer prognosis)\n- multiple sclerosislike symptoms (from multifocal parenchymal involvement)\n- prompt improvement following therapy with steroids\n- spinal fluid: normal (in up to $30 \\%$ ) or nonspecific ( $\\uparrow$ protein, $\\uparrow$ leukocyte count, $\\leftrightarrow / \\downarrow$ glucose)\nLocation: leptomeninges, dura mater, subarachnoid space, peripheral nerves, brain parenchyma, ventricular system\n$\\diamond$ Affects meninges + cranial nerves more often than brain!\nNeurosarcoidosis has a strong predilection for the base of the brain.\n@ Meningeal / ependymal invasion\n$\\sqrt{ }$ diffuse meningeal thickening + enhancement (most common) / meningeal nodules (less common)\nSite: particularly in basal cisterns (suprasellar, sellar, subfrontal regions) with extension to optic chiasm, hypothalamus, pituitary gland, cranial nerves at points of exit from brainstem\n$C x$ : communicating / obstructive hydrocephalus (most common finding) $\\leftarrow$ arachnoiditis / adhesions\n$D D x$ : carcinomatous / fungal / tuberculous meningitis\n$\\sqrt{ }$ dense enhancement of falx + tentorium (granulomatous invasion of dura)\n$\\sqrt{ }$ solitary / multiple dura-based small enhancing nodules / masses on brain surface + in perivascular spaces\n$D D x$ : granulomatous meningitis, TB, carcinomatous meningitis\n$\\sqrt{ }$ ependymal enhancement\n$\\sqrt{ }$ meningeal lesions usually imperceptible on unenhanced MR: T1-isointense + T2hypointense relative to gray matter\n$\\sqrt{ }$ intense diffuse meningeal enhancement\n@ Parenchymal disease $\\leftarrow$ extension from meningeal / ventricular surfaces",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 721,
            "markdown": "$\\sqrt{ }$ single / multiple ringlike nodules / masses (= invasion of brain parenchyma via perivascular spaces of Virchow-Robin):\n$\\sqrt{ }$ T2-hyperintense\n$\\sqrt{ }$ iso- to hyperdense\n$\\sqrt{ }$ homogeneously enhancing (if biologically active)\nSite: periphery of parenchyma, periventricular, deep white matter, intraspinal\n$C x$ : stenosis / occlusion of blood vessels\n$D D x$ : glioblastoma, metastases\n$\\sqrt{ }$ small vessel ischemic change\n$\\sqrt{ }$ lacunar infarction (especially brain stem + basal ganglia)\n$\\sqrt{ }$ focal / widespread infarcts of peripheral gray matter / at gray-white matter junction $\\leftarrow$ periarteritis\n$\\sqrt{ }$ reactive subcortical vasogenic edema\n$\\sqrt{ }$ usual hyperintensity of posterior pituitary lobe no longer identifiable on unenhanced T1WI $\\leftarrow$ depletion of intracellular neurosecretory granules\n@ Spinal cord\n$\\sqrt{ }$ hyperintense enlargement of spinal cord (common) on T2WI $\\leftarrow$ edema\n$\\sqrt{ }$ intramedullary lesion of decreased T2-signal\n$\\sqrt{ }$ enhancing focus of sarcoid granuloma on T1WI\n\n# Skin / Cutaneous Sarcoidosis (25\\%) \n\n(1) Erythema nodosum = nongranulomatous panniculitis:\n$=$ multiple bilateral tender erythematous nodules mostly on anterior surface of lower extremities\n\n- often associated with fever + arthralgia (= painful swollen adjacent joints)\n\nOnset: typically associated with benign self-limiting acute sarcoidosis (eg, Löfgren syndrome)\nPrognosis: remission in 6-8 weeks\n(2) Lupus pernio = indurated red-brown to violaceous (= bluish purple) papules + plaques\n\nLocation: nasal alae, cheeks, ear lobes, fingers, toes\nAssociated with: pulmonary fibrosis, lytic lesions of phalanges\n(3) Asymptomatic pink-yellow / red-brown papules + plaques\n\nOnset: typically associated with chronic sarcoidosis\nLocation: face, posterior neck, previous trauma site\n\n- characteristic \"apple jelly\" color on diascopy (= pressure applied with glass slide)\n- skin plaques / scars\n\n\n## Thoracic Sarcoidosis (90\\%)\n\n$\\diamond$ Extrathoracic manifestations without intrathoracic involvement in $<10 \\%$ !\nSilzbach CXR stage versus percentage at presentation:\n0 normal chest radiograph $5-10 \\%$\n1 hilar + mediastinal lymphadenopathy only $50 \\%$\n2 lymphadenopathy + parenchymal disease $25-30 \\%$\n3 diffuse parenchymal disease only $10-12 \\%$\n4 pulmonary fibrosis $5 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 722,
            "markdown": "$\\diamond$ Progression to pulmonary fibrosis in $25 \\%$ !\nSpontaneous remissions versus Siltzbach stage:\n$60-90 \\%$ for stage 1 disease\n$40-70 \\%$ for stage 2 disease\n$10-20 \\%$ for stage 3 disease\n$0 \\%$ for stage 4 disease\n\n- mild symptoms in spite of extensive radiographic changes (DIAGNOSTICALLY SIGNIFICANT):\n- dry cough, dyspnea, hyperreactivity\n- fatigue, night sweats, weight loss, erythema nodosum\n- pulmonary arterial hypertension ( $50 \\%$ )\n\nAssociated with: tuberculosis in up to $13 \\%$\n@ intrathoracic lymphadenopathy ( $85 \\%$ by CT):\nTypical patterns of lymphadenopathy:\n$\\sqrt{ }$ symmetric enlargement of bilateral hilar nodes + right paratracheal and aortopulmonary window nodes $(75-95 \\%)=$ \"1-2-3\" sign = Garland triad\n\n| Clinical Diagnostic Criteria of Cardiac Sarcoidosis established by Japanese Ministry of Health and Welfare (2007) |\n| :--: |\n| Major criteria |\n| - advanced atrioventricular block |\n| $\\sqrt{ }$ basal thinning of interventricular septum |\n| $\\sqrt{ }$ positive cardiac gallium uptake |\n| $\\sqrt{ }$ LV ejection fraction depressed by $<50 \\%$ |\n| Minor criteria |\n| - abnormal ECG: ventricular arrhythmias, complete right bundle branch block axis deviation, abnormal Q wave |\n| $\\sqrt{ }$ abnormal echo: abnormality of regional wall motion / morphology (ventricular aneurysm, wall thickening) |\n| $\\sqrt{ }$ perfusion defect on ${ }^{209} \\mathrm{Th} /{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ myocardial scintigraphy |\n| $\\sqrt{ }$ late / delayed Gd-enhancement of myocardium |\n| - endomyocardial Bx: interstitial fibrosis / monocyte infiltration |\n\n$\\sqrt{ }$ enlargement of middle mediastinal nodes $=$ left paratracheal, subcarinal, aortopulmonary $(50 \\%)$\nAtypical patterns of lymphadenopathy:\n$\\sqrt{ }$ asymmetric lymph node enlargement\n$\\sqrt{ }$ isolated unilateral hilar nodal enlargement $(<5 \\%)$\n$\\sqrt{ }$ lymphadenopathy in unusual locations: internal mammary, paravertebral, retrocrural\n$\\sqrt{ }$ mediastinal lymphadenopathy without hilar nodes\n$\\sqrt{ }$ calcification of lymph nodes (in $3 \\%$ after 5 years, in $20 \\%$ after 10 years): amorphous, punctate, popcornlike, eggshell-like\nPrognosis: adenopathy commonly $\\downarrow$ as parenchymal disease $\\uparrow$; subsequent parenchymal disease in $32 \\%$; adenopathy does NOT develop subsequent to parenchymal disease\n@ parenchymal disease (in $60 \\%$ by CT):\nLocation: usually bilateral + symmetric; predominantly in upper lung + mid-zone",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 723,
            "markdown": "$\\diamond$ NOT associated with lymphadenopathy in $16-20 \\%$\n$\\diamond$ Parenchymal granulomas are invariably present on open lung biopsy!\nTypical parenchymal manifestations:\n$\\sqrt{ }$ multiple bilateral symmetric micronodules (75-90\\%)\nCause: noncaseous epitheloid cell granulomas deposited along course of lymphatics\nDistribution: subpleural peribronchovascular $>$ interlobular septal sites\nSize: $2-4 \\mathrm{~mm}$\n$\\checkmark$ macronodules $\\geq 5 \\mathrm{~mm}$\nCause: coalescence of micronodules\n$\\checkmark$ bilateral perihilar consolidations radiating from hilum toward periphery $\\pm$ air bronchogram\n$\\checkmark$ progressive patchy fibrosis in $20 \\%$ :\n$\\checkmark$ linear reticular opacities\n$\\checkmark$ traction bronchiectasis\n$\\checkmark$ architectural distortion\n$\\checkmark$ volume loss\nPattern of distribution + upper lung predominance with coexistent mediastinal lymphadenopathy strongly favor sarcoidosis differentiating it from other nodular lesions (EG, miliary TB, metastasis).\n\nAtypical parenchymal manifestations:\n$\\checkmark$ airspace consolidation ( $15-25 \\%$ ):\n$\\checkmark$ multiple bilateral $1-4 \\mathrm{~cm}$ pulmonary nodules and masses:\n$\\checkmark \\pm$ air bronchograms\n$\\checkmark$ cavitation $(0.6 \\%)$\nCause: coalescent interstitial granulomas\nDistribution: in perihilar and peripheral regions\n$\\checkmark$ conglomerate masses\n$\\checkmark$ nonspecific \"galaxy\" sign = small satellite nodules at periphery of masses\nCause: coalescent parenchymal lesions\n$D D x$ : progressive massive fibrosis\n$\\checkmark$ \"sarcoid cluster\" = cluster of multiple micronodules distributed along lymph vessels\n$\\checkmark$ solitary lung nodule / mass (rare)\n$\\checkmark$ \"alveolar sarcoidosis\" = bilateral symmetric patchy airspace consolidation $\\pm$ air bronchograms fading into a nodular pattern peripherally ( $10-20 \\%$ )\nCause: confluence of acinar + interstitial micro-nodules compressing surrounding alveoli\n$D D x$ : pneumonia, tuberculosis, BOOP\n$\\checkmark$ patchy ground-glass opacities ( $40 \\%$ )\nCause: confluence of micronodular granulomatous + fibrotic interstitial lesions $\\rightarrow$ airway compression without airspace filling\n$D D x$ : bronchoalveolar cell carcinoma, lymphoma, pneumoconiosis, pneumonia, BOOP\n$\\checkmark$ reticulolinear opacities ( $50 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 724,
            "markdown": "Cause: interlobular + intralobular septal thickening\n$D D x$ : lymphangitic carcinomatosis\n$\\sqrt{ }$ fibrocystic changes $=$ cyst, bulla, bleb, paracicatricial emphysema\nCause: advanced stage of chronic fibrosis\n$\\checkmark$ honeycomb-like cysts\n$\\checkmark$ cavitation / pseudocavitation of parenchymal lesion ( $10 \\%$ of end-stage sarcoidosis / primary cavitary sarcoidosis in $<1 \\%$ )\n$\\checkmark$ mycetoma formation of stage 4 cystic sarcoidosis (1-3\\%)\n$\\checkmark$ miliary opacities $(<1 \\%)$\n$D D x$ : tuberculosis, pneumoconiosis, metastases, histoplasmosis, chickenpox, Langerhans cell histiocytosis\n@ airway disease by CT:\n$\\checkmark$ mosaic attenuation $=$ inhomogeneous attenuation at inspiratory CT\nCause: patchy interstitial disease, obstructed small airways, vascular disease\n$\\checkmark$ air trapping $=$ focal areas of $\\downarrow$ attenuation on expiratory CT $(95 \\%)$\n$\\checkmark$ tracheobronchial stenosis ( $2 \\%$ ):\n$\\checkmark$ atelectasis $\\leftarrow$ compression by large lymph nodes / endobronchial granulomas\n$\\checkmark$ bronchiectasis $\\leftarrow$ scarring / fibrosis\n@ pleural disease ( $1-4 \\%$ ) by CT:\n$\\checkmark$ usually small pleural effusion (transudative / exudative, hemorrhagic, chylous) clearing within $2-3$ months\n$\\checkmark$ pneumothorax\nCause: rupture of emphysematous bleb, necrosis of subpleural sarcoid granuloma\n$\\checkmark$ pleural plaquelike opacities\nCause: multiple subpleural coalescent micronodules\nHRCT:\n(a) reversible $\\leftarrow$ granulomatous inflammation resolving with time (in $80 \\%$ ):\n$\\checkmark$ micronodules, macronodules\n$\\checkmark$ airspace consolidation / confluent alveolar opacities\n$\\checkmark$ ground-glass opacities\n$\\checkmark$ interlobular septal thickening\n$\\checkmark$ intralobular linear opacities\n(b) irreversible $\\leftarrow$ chronic interstitial fibrosis (in 20\\%):\n$\\checkmark$ honeycomb-like opacities, cysts, bullae, emphysema\n$\\checkmark$ architectural distortion\n$\\checkmark$ traction bronchiectasis / bronchiolectasis\n$\\checkmark$ volume loss in upper lobes with retraction of hila\n$\\checkmark$ mycetoma (in $10 \\%$ of preexisting cavity)\nNUC:\n$\\checkmark$ FDG uptake in lung parenchyma + mediastinal nodes $\\leftarrow$ regional inflammation + sarcoid lesions\nAtypical manifestations (25\\%):\n$\\checkmark$ bronchostenosis ( $2 \\%$ ) with lobar / segmental atelectasis\nCx: (1) pneumothorax $\\leftarrow$ chronic lung fibrosis (rare)\n(2) cardiomegaly $\\leftarrow$ cor pulmonale (rare)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 725,
            "markdown": "(3) aspergilloma formation in apical bulla\n\nPrognosis:\n$80 \\%$ spontaneous remission of stage $1+2$ disease\n$75 \\%$ complete resolution of hilar adenopathy\n$33 \\%$ complete resolution of parenchymal disease\n$30 \\%$ significant improvement\n$20 \\%$ irreversible pulmonary fibrosis (may persist unchanged for $>15$ years)\n$5 \\%$ mortality: cor pulmonale ( $\\leftarrow$ lung fibrosis), CNS, liver cirrhosis, pulmonary hemorrhage ( $\\leftarrow$ mycetoma); in Japan death from cardiac involvement in $80 \\%$\n$25 \\%$ relapse (in $50 \\%$ detected by CXR)\n$5 \\%$ recurrence after remission lasting $>1$ year\nFactors effecting poor prognosis: stage $2 / 3$ at time of initial diagnosis, disease onset $>40$ years of age, black race, hypercalcemia, splenomegaly, osseous involvement, chronic uveitis, lupus pernio\nFactors effecting good prognosis: fever, polyarthritis, erythema nodosum, bilateral hilar lymphadenopathy (Löfgren syndrome)\n$D D x$ : mycobacterial / fungal infection, malignancy, pneumoconiosis (silicosis, berylliosis)\n$\\diamond$ \"The great mimic\" = initially broad imaging DDx\n\n# Sarcoidosis of Head \\& Neck \n\n$\\checkmark$ granulomas may enhance\n@ Cervical lymph nodes (rare)\n\n- palpable peripheral lymphadenopathy ( $1 / 3$ ): discrete, nontender and movable\n@ Ophthalmic sarcoidosis $(25-80 \\%)$\n- typically bilateral uveitis, photophobia, blurred vision, glaucoma (rare)\n$\\checkmark$ commonly bilateral enlarged enhancing lacrimal glands $\\leftarrow$ chronic dacryoadenitis\n$\\checkmark$ masslike appearance of optic nerve / nerve sheath\n$\\checkmark$ enlargement of optic canal $\\leftarrow$ optic neuritis\n$\\checkmark$ avidly enhancing orbital soft-tissue masses with involvement of extraocular muscles + lacrimal glands\n@ Larynx (5\\%)\n$\\checkmark$ thickening of larynx with enhancement of granulomas\n@ Nose\n$\\checkmark$ multiple small granulomas of septum + turbinates\n@ Parotid gland (6\\%), other salivary glands (30\\%)\nCT:\n$\\checkmark$ multiple diffusely dense noncavitating nodules within parotid gland\n$\\checkmark$ enlargement of intraparotid lymph nodes\nNUC:\n$\\checkmark$ \"panda\" sign $=67 \\mathrm{Ga}$ uptake in both parotid glands + both lacrimal glands + nose\n\n\n## Heerfordt Syndrome\n\n(1) Parotid enlargement (6\\%)\n$\\diamond$ May be the initial and only manifestation of sarcoid",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 726,
            "markdown": "- diffuse bilateral painless enlargement (10-30\\%)\n- xerostomia\n(2) Uveitis\n(3) Facial nerve paralysis\n\n\n# Uveoparotid Fever \n\n(1) Parotitis\n(2) Uveitis\n(3) Fever\n\n## Sarcoidosis of Other Organs\n\n@ Peripheral lymph node enlargement (30\\%)\n@ Muscle ( $25 \\%$ ): myopathy\n\n## SEPTIC PULMONARY EMBOLI\n\n$=$ lodgement of an infected thrombus in a pulmonary artery\nOrganism: S. aureus, Streptococcus\nPredisposed: IV drug abusers, alcoholism, immunodeficiency, CHD, dermal infection (cellulitis, carbuncles)\n\n## Source:\n\n(a) infected venous catheter / pacemaker wires, arteriovenous shunts for hemodialysis, drug abuse producing septic thrombophlebitis (eg, heroin addicts), pelvic thrombophlebitis, peritonsillar abscess, osteomyelitis\n(b) tricuspid valve endocarditis (most common cause in IV drug abusers)\n\nAge: majority $<40$ years\n\n- sepsis, cough, dyspnea, chest pain\n- shaking chills, high fever, severe sinus tachycardia\n\nLocation: predilection for lung bases\n$\\sqrt{ }$ multiple nondescript pulmonary infiltrates (initially)\n$\\checkmark$ migratory infiltrates (old ones heal, new ones appear)\n$\\checkmark$ cavitation (frequent), usually thin-walled\n$\\checkmark$ pleural effusion (rare)\nCT (more sensitive than CXR):\n$\\checkmark$ multiple peripheral parenchymal nodules $\\pm$ cavitation / air bronchogram (83\\%)\n$\\checkmark$ wedge-shaped subpleural lesion with apex of lesion directed toward pulmonary hilum $(50 \\%)$\n$\\checkmark$ \"feeding vessel\" sign = pulmonary artery leading to nodule (67\\%)\n$\\checkmark$ cavitation ( $50 \\%$ ), esp. in staphylococcal emboli\n$\\checkmark$ air bronchogram within pulmonary nodule (28\\%)\nCx: empyema (39\\%)\n\n## SIDEROSIS\n\n$=$ ARC WELDER PNEUMOCONIOSIS\n$=$ inhalation of inert iron oxide / metallic iron deposits\nOccupational exposure:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 727,
            "markdown": "electric arc welding, oxyacetylene torch workers (iron oxide in fumes), mining + processing of iron ores, cutting / burning of iron + steel, foundry workers, grinders, fettlers, silver polishers (jewelry industry)\nPath: iron phagocytized by macrophages in alveoli / respiratory bronchioles, elimination from lung by lymphatic circulation; NOT associated with fibrosis unless admixed with silica\nLocation: middle $1 / 3$ of lung, perihilar region\n\n- asymptomatic (for pure siderosis)\n$\\sqrt{ }$ small nodules / diffuse fine reticulonodular opacities $\\leftarrow$ radiopaque accumulation of iron particles in macrophages aggregated in lymphatics along bronchovascular bundles:\n$\\checkmark$ may disappear after exposure is discontinued\n$\\checkmark$ small round opacities (indistinguishable from silica / coal)\n$\\sqrt{ }$ NO secondary fibrosis + NO hilar adenopathy (unless mixed dust inhalation as in\nsiderosilicosis / silicosiderosis $=$ mixed-dust pneumoconiosis)\nHRCT:\n$\\checkmark$ widespread poorly defined centrilobular micronodules ( $71 \\%$ )\n$\\checkmark \\pm$ branching linear structures $\\leftarrow$ deposition of minute iron oxide particles along perivascular + peribronchial lymphatic vessels\n$\\checkmark$ extensive ground-glass attenuation + reticulation without zonal predominance\n$\\checkmark$ emphysematous changes ( $33 \\%$ ) likely due to smoking\n$\\checkmark$ honeycombing resembling usual interstitial pneumonia\n$\\checkmark$ pleural irregularity (suggestive of exposure to asbestos)\n$\\checkmark$ conglomerate masses with areas of high attenuation (= organizing pneumonia with siderosis)\n$D D x:$ silicosis (nodular opacities more dense + profuse)\n\n\n# SILICOSIS \n\n= inhalation of crystalline silicon dioxide (= silica, one of the most widespread elements on earth); most prevalent silicosis of progressive nature after termination of exposure; similar to CWP (because of silica component in CWP)\nSubstance: crystalline silica (quartz); tridymite / cristbalite (less fibrogenic)\nOccupational exposure:\ntunneling, mining, quarrying, stone cutting, polishing, glass manufacturing, foundry work, sandblasting, pottery, brick lining, boiler scaling, vitreous enameling, ceramic industry\nDust deposition: dependent on\n(a) airflow: deposition of $1-5-\\mu \\mathrm{m}$ particles predominantly around respiratory bronchioles in a centrilobular location within secondary pulmonary lobule\n(b) lymphatic clearance: related to pulmonary arterial pressure (gravity-related vertical gradient) + blood flow (higher blood flow through LUL) + passive milking of lymphatics by respiratory motion (lateral $>$ anterior $>$ posterior chest wall)\nPath: small particles engulfed by macrophages; liberation of silica results in cell death; 2-3mm nodules with layers of laminated connective tissue around smaller vessels\nClinical classification:\n\n1. Acute silicosis $=$ alveolar silicoproteinosis\n2. Classic silicosis $=$ chronic interstitial reticulonodular",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 728,
            "markdown": "Radiographic classification:\n(a) simple $=$ small + round / irregular opacities\n(b) complicated = progressive massive fibrosis\n\nCx: predisposes to tuberculosis + carcinoma\n$D D x$ : coal worker pneumoconiosis (identical radiographs)\n\n# Acute Silicosis \n\n$=$ ALVEOLAR SILICOPROTEINOSIS\n$=$ heavy exposure to respirable free silica in enclosed space with minimal / no protection of airways (sandblasters!)\nHisto: alveolar filling with PAS-positive staining substance; proliferation of type II pneumatocytes + profuse surfactant production\nExposure time: as short as 6-8 months\nAssociated with: increased risk to develop autoimmune disease\nDistribution: lung periphery; predominantly lower lung zones; bilateral\n$\\sqrt{ }$ diffuse bilateral perihilar airspace / ground-glass disease\n$\\sqrt{ }$ air bronchograms\nHRCT:\n$\\sqrt{ }$ numerous bilateral patchy centrilobular nodular ground-glass opacities\n$\\sqrt{ }$ multifocal patchy ground-glass opacities + consolidation\n$\\sqrt{ }$ \"crazy paving\" = airspace filling + fine interlobular septal thickening $\\leftarrow$ edematous + fibrous tissue\nCx: infection with TB + atypical mycobacteria\nPrognosis: often rapidly progressive with death from respiratory failure + cor pulmonale\n$D D x$ : alveolar proteinosis\n\n## Classic Silicosis\n\n$=$ chronic interstitial reticulonodular disease\nPath: silicotic nodules $=$ mature collagen centrally + peripheral zone of particle laden macrophages\nHisto: birefringent silicate crystals of $1-3 \\mu \\mathrm{~m}$ in length\n\n## Chronic Simple Silicosis\n\nLag time: at least 10-20 years of dust exposure before appearance of roentgenographic abnormality\nLocation: posterior portion of upper lobes bilaterally\nCXR:\n$\\sqrt{ }$ multiple small 2-5 (range, 1-10)-mm round well-defined opacities:\n$\\sqrt{ }$ typically central calcifications in $10-20 \\%$\n$\\sqrt{ }$ hilar + mediastinal lymphadenopathy, may calcify in 5\\% (\"eggshell pattern\")\n$\\sqrt{ } \\pm$ reticulonodular pattern\nHRCT:\n$\\sqrt{ }$ multiple small calcified nodules of $2-5 \\mathrm{~mm}$ in size:\nDistribution: perilymphatic (= centrilobular, paraseptal, subpleural)\n$\\sqrt{ }$ \"pleural pseudoplaques\" = aggregate of subpleural nodules in round / triangular",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 729,
            "markdown": "configuration\n$\\sqrt{ }$ thickened intra- and interlobular lines\n$\\sqrt{ }$ subpleural curvilinear lines $\\leftarrow$ peribronchiolar fibrosis\n$\\sqrt{ }$ ground-glass pattern $=$ mild thickening of alveolar wall + interlobular septa $\\leftarrow$ fibrosis / edema\n$\\sqrt{ }$ parenchymal fibrous bands\n$\\sqrt{ }$ traction bronchiectasis\n$\\sqrt{ }$ honeycombing\n\n# Complicated Silicosis \n\n$=$ PROGRESSIVE MASSIVE FIBROSIS\n$=$ appearance of large opacities $>1 \\mathrm{~cm}$ in diameter $\\leftarrow$ expansion + confluence of individual silicotic nodules\nLocation: mid lung zone / peripheral $1 / 3$ of upper lung migrating toward hilum\nDistribution: often bilateral symmetric + nonsegmental\n$\\sqrt{ }$ focal conglomerate sausage-shaped masses with ill-defined / irregular margins (in advanced stages):\n$\\sqrt{ }$ lateral interface typically parallels lateral chest wall\n$\\sqrt{ }$ surrounding compensatory emphysema in unaffected portion between mass + pleura\n$\\sqrt{ }$ slow change over years\n$\\sqrt{ }$ may calcify + cavitate $\\leftarrow$ ischemic necrosis\n\n## Silicotuberculosis\n\n$=$ synergistic relationship between silicosis + primary tuberculosis (in 25\\%)\n\n- intermittently positive sputa\n$\\sqrt{ }$ asymmetric nodules / consolidation\n$\\sqrt{ }$ cavitation (strongest indicator of associated TB)\n$\\sqrt{ }$ rapid disease progression\n\n\n## Caplan Syndrome\n\nMore common in coal worker's pneumoconiosis\n\n## SOLITARY FIBROUS TUMOR\n\n$=$ rare benign ubiquitous spindle cell neoplasm; frequently misdiagnosed as hemangiopericytoma\nOrigin: neoplasm of submesothelial origin (primitive mesenchymal cell)\nPath: well-defined pseudoencapsulated lobulated neoplasm of whorled fibrous tissue WITHOUT necrosis / cyst formation / hemorrhage\n$\\diamond$ Most solitary fibrous tumors are benign!\nHisto: (a) fibrous type: hypercellular areas composed of spindle cells resembling fibroblasts + variable amount of hypocellular fibrous areas (= hyalinized collagen)\n(b) cellular type: monotonous moderate to high cellularity + little intervening fibrous tissue\nCHARACTERISTIC strong CD34 immunoreactivity + EMA negativity\nMean age: 54 years; $\\mathrm{M}>\\mathrm{F}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 730,
            "markdown": "# Location: \n\n(a) visceral pleura (most common)\n(b) extrapleural location: lung, mediastinum, pericardium, extraperitoneal spaces, nose, paranasal sinuses, orbit, kidney, liver, skin\nExtrapleural solitary fibrous tumor: mesentery, peritoneum\n\n- hypertrophic osteoarthropathy (35\\%), hypoglycemia (4\\%)\n$\\sqrt{ }$ solitary well-circumscribed unencapsulated lobulated mass\n$\\checkmark$ mobile mass if pedunculated\n$\\checkmark$ heterogeneous texture if large\n$\\checkmark \\pm$ dystrophic calcifications and enhancing internal vessels\n$\\checkmark$ intense arterial enhancement $\\leftarrow$ hypervascularity\nMR:\n$\\checkmark$ intermediate SI on T1WI\n$\\checkmark$ heterogeneous SI + multiple flow voids representing prominent vascular channels on T2WI (common)\nCEMR:\n$\\sqrt{ }$ SUGGESTIVE avidly enhancing areas of low T2 signal $\\leftarrow$ fibrosis with abundant collagen\n$\\checkmark$ persistent delayed enhancement $\\leftarrow$ fibrous tumor component\nPrognosis: $10-15 \\%$ of extrapleural solitary fibrous tumors show malignant behavior ( $\\leftarrow$ recurrence after resection / metastatic disease)\n$D D x$ : (1) Hypervascular neoplasm: angiosarcoma, hemangioendothelioma, angiomyxoma\n(2) Fibrous neoplasm: malignant fibrous histiocytoma, fibrosarcoma, leiomyoma, desmoid tumor\n\n\n## Solitary Fibrous Tumor of CNS\n\nMean age: 57 years; (?) $\\mathrm{F}>>\\mathrm{M}$\n\n- headache\n\nLocation: dura (falx, occipital + spinal dura, tentorium, cerebellopontine angle), ventricle\n$\\sqrt{ }$ hyperattenuating mass $\\pm$ dural tail\n$\\checkmark$ diffuse / heterogeneous enhancement\n$\\checkmark$ smooth erosion of adjacent skull\n$\\checkmark$ lipid + lactate peaks + elevated myo-inositol ( 3.5 ppm )\n$D D x$ : meningioma (hyperostosis)\n\n## Solitary Fibrous Tumor of Pelvis\n\nAge: $\\quad 5^{\\text {th }}$ decade (range, 20-70 years); $\\mathrm{M}=\\mathrm{F}$\nLocation: pelvic peritoneum / retroperitoneum\n\n- mostly asymptomatic, pressure, hypoglycemia ( $<5 \\%$ )\n$R x$ : complete surgical resection $\\pm$ preoperative embolization; surgical cytoreduction + intraoperative chemotherapy + radiation therapy\n$\\checkmark$ well-defined mass with intense heterogeneous enhancement that persists into delayed phase\n$\\checkmark$ areas of central low attenuation $\\leftarrow$ necrosis / hemorrhage / cystic change\n\n\n## Staphylococcal pneumonia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 731,
            "markdown": "$\\diamond$ Most common cause of bronchopneumonia!\n(a) common nosocomial infection (patients on antibiotic drugs most susceptible)\n(b) accounts for $5 \\%$ of community-acquired pneumonias (esp. in infants + elderly)\n$\\diamond$ Secondary invader to influenza (commonest cause of death during influenza epidemics)\nOrganism: Staphylococcus aureus $=$ Gram-positive, appears in coagulase-producing clusters\n$\\sqrt{ }$ rapid spread through lungs\n$\\sqrt{ }$ empyema (esp. in children)\n$\\sqrt{ }$ pneumothorax, pyopneumothorax\n$\\sqrt{ }$ abscess formation\n$\\sqrt{ }$ bronchopleural fistula\nA. in CHILDREN:\n$\\sqrt{ }$ rapidly developing lobar / multilobar consolidation\n$\\sqrt{ }$ pleural effusion $(90 \\%)$\n$\\sqrt{ }$ pneumatocele ( $40-60 \\%)$\nB. in ADULTS:\n$\\sqrt{ }$ patchy often confluent bronchopneumonia of segmental distribution, bilateral in $>60 \\%$\n$\\sqrt{ }$ segmental collapse (air bronchograms absent)\n$\\sqrt{ }$ late development of thick-walled lung abscess ( $25-75 \\%$ )\n$\\sqrt{ }$ pleural effusion / empyema ( $50 \\%$ ) (DDx from other pneumonias)\nCx: meningitis, metastatic abscess to brain / kidneys, acute endocarditis\n\n# STREPTOCOCCAL PNEUMONIA \n\nFrequency: 1-5\\% of bacterial pneumonias (rarely seen); most common in winter months\nOrganism: Group A 8-hemolytic streptococcus\n$=$ Streptococcus pyogenes, Gram-positive cocci appearing in chains\nPredisposed: newborns, following infection with measles\nAssociated with: delayed onset of diaphragmatic hernia (in newborns)\n\n- rarely follows tonsillitis + pharyngitis\n$\\sqrt{ }$ patchy bronchopneumonia\n$\\sqrt{ }$ lower lobe predominance (similar to staphylococcus)\n$\\sqrt{ }$ empyema\nCx: (1) Residual pleural thickening (15\\%)\n(2) Bronchiectasis\n(3) Lung abscess\n(4) Glomerulonephritis\n\n\n## SWYER-JAMES SYNDROME\n\n$=$ MACLEOD SYNDROME $=$ UNILATERAL LOBAR EMPHYSEMA $=$ IDIOPATHIC UNILATERAL HYPERLUCENT LUNG\n$=$ chronic complication of infectious obliterative bronchiolitis in infancy or childhood as early as 9 months after initial infectious insult\nEtiology: acute viral bronchiolitis in infancy / early childhood (adenovirus, RSV, mycoplasma) preventing normal development of lung\nPath: variant of postinfectious constrictive bronchiolitis with acute obliterative bronchiolitis,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 732,
            "markdown": "bronchiectasis, distal airspace destruction (developing in 7-30 months)\n\n- asymptomatic; history of recurrent lower respiratory tract infections during childhood\n- chronic cough, wheezing, dyspnea on exertion, hemoptysis\n- obstructive lung disease pattern at pulmonary function test\n\nLocation: one / both lungs (usually entire lung, occasionally lobar / subsegmental)\n$\\sqrt{ }$ hyperlucency of one lung $\\leftarrow$ air trapping $\\leftarrow$ bronchiolar obstruction\n$\\sqrt{ }$ diminished number + size of pulmonary vessels:\n$\\checkmark$ small ipsilateral hilum $\\leftarrow$ diminuted hilar vessels + attenuated arteries)\n$\\checkmark$ small hemithorax with decreased volume\n$\\checkmark$ normal hyperexpanded hemithorax $\\leftarrow$ collateral air drift\n$\\checkmark$ air trapping during expiration\n$D D x$ : no air trapping with proximal interruption of pulmonary artery (no hilum), hypogenetic lung syndrome, pulmonary embolus\n$\\checkmark$ mild cylindrical bronchiectasis with paucity of bronchial subdivisions (cutoff at $4^{\\text {th }}-5^{\\text {th }}$ generation = \"pruned tree\" bronchogram)\nHRCT (most useful modality):\n$\\checkmark$ bilateral areas of decreased attenuation:\n$\\checkmark$ areas of normal lung attenuation within hypoattenuating lung\n$\\checkmark$ air trapping within hypoattenuating lung\n$\\checkmark$ ipsilateral bronchiectasis\n$\\checkmark$ diminished size of pulmonary vessels in hyperlucent areas\nAngio:\n$\\checkmark$ \"pruned tree\" appearance\nNUC (V/Q scan):\n$\\checkmark$ matched defects of perfusion + ventilation (with delayed washout) in hyperlucent regions\nBronchography:\n$\\checkmark$ incomplete filling of ipsilateral peripheral bronchioles\n$\\checkmark$ dilated bronchi with sharply terminating segments\n$D D x$ : pulmonary artery atresia (uncommon in adults), localized bullous emphysema (deviation of vessels), bronchial obstruction\n\n# SYSTEMIC LUPUS ERYTHEMATOSUS \n\n$=\\mathrm{SLE}=$ most prevalent of the potentially grave connective tissue diseases characterized by involvement of vascular system, skin, serous + synovial membranes\nIncidence: $1-10 \\div 100,000$ persons per year; Blacks $\\div$ Caucasians $=3 \\div 1$; increased risk in relatives\nCause: complex systemic autoimmune disease including complement system, T suppressor cells, and cytokine production with deposition of antigen-antibody complexes / autoantibodies inducing necrotizing vasculitis (type III immune complex phenomenon) of arterioles + capillaries $\\leftarrow$ dysfunctional suppressive controls on immune system\nAge: 16-41 years; in adults $\\mathrm{M} \\div \\mathrm{F}=1 \\div 11$ (in $\\geq 90 \\%$ in women of childbearing age); in children $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\nDiagnostic criteria ( $\\geq 4$ criteria $=98 \\%$ specific, $97 \\%$ sensitive):\n(1) Malar rash",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 733,
            "markdown": "(2) Discoid lesions\n(3) Photosensitivity\n(4) Oral ulcers\n(5) Nonerosive arthritis\n(6) Serositis (pleuritis or pericarditis)\n(7) Positive antinuclear antibody test\n(8) Renal disease\n(9) Neurologic disease: seizures / psychosis\n(10) Hematologic abnormalities\n(11) Immunologic disorder\n\nDisease severity: defined by number of organ systems involved\n\n- fatigue, malaise, anorexia, fever, weight loss\n- clinically heterogeneous $\\leftarrow$ different types of serum antibodies\n- antinuclear DNA antibodies ( $87 \\%$ )\n- hypergammaglobulinemia (77\\%); Sjögren syndrome (frequent)\n- LE cells (= antigen-antibody complexes engulfed by PMNs) in $78 \\%$\n- chronic false-positive Wassermann test for syphilis (24\\%)\n- anemia (78\\%), leukopenia (66\\%), thrombocytopenia (19\\%)\n\nCx: deep venous thrombosis ( $9-35 \\%$ ) + thromboembolism with antiphospholipid antibodies in serum; $\\uparrow$ prevalence of lymphoreticular malignancies; frequent infections\nPrognosis: 60-90\\% 10-year survival; death from renal failure / sepsis / CNS involvement / myocardial infarction\n$R x$ : nonsteroidal antiinflammatory drugs / oral steroids\n\n# Antiphospholipid Antibody Syndrome \n\n$=($ aPL-ab syndrome $)$ characterized by arterial + veno-occlusive disease, thrombocytopenia, recurrent vascular thromboses + miscarriages\nPath: antibodies target cell surface molecules on vascular endothelium and platelets; acquired free protein $S$ deficiency\n\n- recurrent strokes + pulmonary embolism, Budd-Chiari syndrome, dural venous sinus thrombosis, ischemic bowel\n- lupus anticoagulant serves as marker of functional activity\n\nDx: $\\quad>1$ clinical criterion: deep venous thrombosis, arterial thrombosis, pregnancy loss, thrombocytopenia AND\n$>1$ laboratory criterion: lupus anticoagulant, immunoglobulins [IgG, IgM, IgA] against cardiolipin\nMinor criteria: heart valve abnormality, livedo reticularis, migraine, pulmonary hypertension, AVN, myelopathy, chorea\nCx: pulmonary arterial hypertension ( $25 \\%$ ) $\\leftarrow$ recurrent pulmonary thromboembolism\n$R x$ : anticoagulants (for vascular occlusion)\n\n## Cardiovascular SLE\n\n@ Cardiac valves (18-74\\%)\nmore often seen in patients with antiphospholipid antibody (aPL-ab) syndrome\n$\\sqrt{ }$ valve leaflet thickening",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 734,
            "markdown": "# $\\sqrt{ }$ Libman-Sacks endocarditis: \n\n$=$ small granular vegetations on mitral / aortic valve\n$\\sqrt{ } 1-4 \\mathrm{~mm}$ single / multiple verrucous vegetations\n$C x:$ valve destruction\n@ Pericardium (17-50\\%)\n$\\sqrt{ }$ exudative pericardial effusion $=$ serositis of pericardium\n$\\sqrt{ }$ abnormal thickening + enhancement of pericardium\n@ Myocardium\n\n- clinically silent (in up to $50 \\%$ )\n$\\sqrt{ }$ global left ventricular dysfunction (uncommon)\n$\\sqrt{ }$ cardiomegaly $=$ primary lupus cardiomyopathy\nHisto: myositis (myocarditis) with perivascular infiltration by lymphocytes and neutrophils\n@ Vasculature\n$\\sqrt{ }$ coronary atherosclerosis\nMortality rate: 9 x that of general population\n$\\sqrt{ }$ marked arterial wall thickening $<100 \\mu \\mathrm{~m}$ in diameter\nHisto: vasculitis with fibrinoid necrosis and minimal infiltration by inflammatory cells\n$C x$ : ischemia / hemorrhage into bowel wall $\\rightarrow$ perforation $\\rightarrow$ peritonitis\n$\\sqrt{ }$ aortitis (uncommon) $\\rightarrow$ dissection, aneurysm\n\n\n## Drug-induced Lupus Erythematosus (DIL)\n\n- temporary phenomenon\n\nAgents: procainamide, hydralazine, isoniazid, phenytoin account for $90 \\%$\n$\\sqrt{ }$ pulmonary + pleural disease more common than in SLE\nGastrointestinal SLE (in up to 50\\%)\n\n- nonspecific vague abdominal pain (10-37\\%)\n- buccal erosions / ulcerations; GI tract bleeding\n@ Esophagus\n- dysphagia, gastroesophageal reflux, atypical chest pain\n$\\sqrt{ }$ hypomotility of distal $1 / 3(13-32 \\%)$ similar to scleroderma\n$\\sqrt{ }$ mucosal granularity $\\pm$ ulceration $\\leftarrow$ reflux esophagitis\n$C x$ : reflux esophagitis\n@ Pancreas\n$\\sqrt{ }$ peripancreatic mesenteric fatty infiltration, phlegmon formation $\\pm$ glandular enlargement $=$ acute focal / diffuse pancreatitis (in 8-28\\%)\n$\\sqrt{ }$ calcium deposition within ductal system + organ atrophy $=$ chronic pancreatitis\n@ Liver, spleen\n$\\sqrt{ }$ hepatomegaly, hepatitis, cirrhosis, splenomegaly\n$\\sqrt{ }$ \"painful\" ascites\n@ Bowel\n$\\sqrt{ }$ features of gastritis\n$\\sqrt{ }$ features of bowel ischemia with $\\leftarrow$ small vessel vasculitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 735,
            "markdown": "Cx: pneumatosis intestinalis, perforation\n$\\sqrt{ }$ mesenteric ischemia: colitis, pseudoobstruction, ileus, thumbprinting, luminal narrowing\n\n# Musculoskeletal SLE \n\n@ Joints\n\n- arthralgia ( $95 \\%)$\n\nLocation: small joints of hand, wrist, knee, shoulder\n$\\sqrt{ }$ CHARACTERISTIC symmetric nonerosive nondeforming polyarthritis of hands\n$\\checkmark$ Jaccoud arthropathy ( $10 \\%$ )\n$\\checkmark$ tumoral calcinosis\n@ Ligaments\n$\\checkmark$ deformities in initially reversible SLE $\\leftarrow$ ligamentous instability and laxity\n@ Bone\n$\\checkmark$ osteonecrosis / AVN (5-50\\%) of weight-bearing joints:\nLocation: femoral head $>$ humeral head $>$ femoral condyle $>$ tibial plateau\n$\\checkmark$ insufficiency fracture\nCause: deconditioning, accelerated bone loss $\\leftarrow$ steroid therapy\n$\\checkmark$ septic arthritis and osteomyelitis\nOrganism: S aureus, Gram-negative bacilli, M. tuberculosis\n\n## Renal SLE\n\nPrevalence: kidneys involved in $100 \\%$ with renal disease developing in $30-50 \\%$\nHisto: focal membranoproliferative glomerulonephritis = immune complex deposition in subepithelial and subendothelial layers of glomeruli (SLE nephritis)\n\n- renal failure $\\leftarrow$ fibrinoid thickening of basement membrane\n$\\checkmark$ aneurysms in interlobular + arcuate arteries (similar to but less frequent than polyarteritis nodosa)\n$\\checkmark$ normal / decreased renal size\n$\\checkmark$ hydronephrosis $\\leftarrow$ detrusor muscle spasm with vesicoureteral reflux / fibrosis of ureterovesical junction\nUS:\n$\\checkmark$ kidney enlarged (early) / diminutive (late stage)\n$\\checkmark$ increased parenchymal echogenicity\nCT:\n$\\checkmark$ multiple linear hypoattenuating bands $\\leftarrow$ vasculitis\nCx: (1) Nephrotic syndrome (common)\n(2) Renal vein thrombosis (in $33 \\%$ ) $\\leftarrow$ nephrotic syndrome induces hypercoagulability\n\nPrognosis: end-stage renal disease is common cause of death\n\n## Skin SLE $(81 \\%)$\n\n- \"butterfly rash\" (= facial erythema), discoid lupus erythematosus, alopecia, photosensitivity\n- Raynaud phenomenon (15\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 736,
            "markdown": "# Thoracic SLE $(30-70 \\%)$ \n\n$\\diamond$ Affects respiratory system more commonly than any other connective tissue disease\n\n- pleuritic chest pain (35\\%); fever, cough, dyspnea (40-57\\%)\n- respiratory dysfunction ( $>50 \\%$ ): single-breath diffusing capacity for carbon monoxide most sensitive indicator\n@ Pleura (50\\%)\n$\\sqrt{ }$ recurrent small uni- / bilateral ( $1 / 2$ ) pleural effusions (in $30-50 \\%$ during course of disease) $\\leftarrow$ pleuritis\n$\\sqrt{ }$ pleural thickening / fibrosis (50-83\\%)\n$D x$ : pleural fluid analysis (exudate positive for lupus erythematosus cells, immune complexes, anti-DNA antibodies)\n@ Lung ( $>50 \\%$ )\nCause: chronic antibody damage to alveolar-capillary membrane\n$\\sqrt{ }$ parenchymal opacification:\n$\\sqrt{ }$ pneumonia (most common) $\\leftarrow$ bacteria / opportunistic organism\nRisk: 3 x higher than in general population $\\leftarrow \\Downarrow$ phagocytic activity $+\\Downarrow$ natural killer cell activity against pathogens + poor clearance of secretions + immunosuppressive therapy\n$\\sqrt{ }$ diffuse alveolar hemorrhage ( $2-5 \\%$ ):\n$\\sqrt{ }$ bilateral areas of consolidation + ground-glass opacities + septal thickening in lower lungs\nPrognosis: $80 \\%$ mortality $\\leftarrow$ extensive blood loss\n$\\sqrt{ }$ pulmonary edema\n$\\sqrt{ }$ acute lupus pneumonitis ( $10-14 \\%$ ):\nHisto: diffuse alveolar damage + necrosis with cellular infiltrates + hyaline membranes\n$R x$ : responsive to corticosteroids\n$\\sqrt{ }$ uni- / bilateral poorly defined patchy areas of increased density peripherally at lung bases (alveolar pattern)\n$\\sqrt{ }$ ground-glass opacity on CT\n$\\sqrt{ }$ cavitating nodules (vasculitis)\n$\\sqrt{ }$ pulmonary fibrosis ( $<3 \\%$ ):\nPattern: nonspecific interstitial pneumonia (NSIP)\n$\\sqrt{ }$ architectural distortion, honeycombing\n$\\sqrt{ }$ subpleural interstitial reticulations in lower lung fields (chronic form) in 3\\%\n$\\sqrt{ }$ fleeting platelike atelectasis in both bases (? infarction due to vasculitis)\n$\\sqrt{ }$ hilar + mediastinal lymphadenopathy (extremely rare)\n@ Diaphragm\nPath: respiratory muscle dysfunction ( $25 \\%$ ) $\\leftarrow$ primary myopathy + phrenic neuropathy + pleural inflammation\n- dyspnea out of proportion to severity of chest radiographic abnormalities\n- $\\downarrow$ static lung volumes + vital capacity $\\leftarrow$ restrictive process with normal diffusing capacity\n$\\sqrt{ }$ linear atelectasis + ill-defined juxtadiaphragmatic areas of increased opacity",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 737,
            "markdown": "$\\sqrt{ }$ shrinking lung syndrome $(0.6 \\%)$ :\n$\\sqrt{ }$ progressive loss of lung volume\n$\\sqrt{ }$ elevated diaphragms\n$\\sqrt{ }$ sluggish diaphragmatic excursions\nCx: (1) Community-acquired pneumonia (14\\%)\n(2) Pulmonary arterial hypertension ( $14 \\%$ ) $\\leftarrow$ chronic interstitial disease, vasculopathy, recurrent pulmonary embolism\n\n# Neuropsychiatric SLE / CNS Lupus \n\nPrevalence: $30-40 \\% ; 19 \\%$ of lupus-related deaths\n\n- psychosis, stroke, epilepsy, headache, cognitive defects\n$\\sqrt{ }$ cerebral ischemia + infarction:\nCause: (a) coagulopathy $\\leftarrow$ aPL-ab syndrome\n(b) accelerated atherosclerosis $\\leftarrow$ steroids\n(c) vasculitis,\n(d) thromboemboli $\\leftarrow$ Libman-Sacks disease\n\nAverage age: 35 years\nDistribution:\n(a) clearly defined arterial territory of large-vessel disease\n(b) small cortical / deep gray matter infarcts $\\leftarrow$ lupus angiitis / vasculitis\n$\\sqrt{ }$ reduced diameter / occlusion of ICA\n$\\sqrt{ }$ intracranial venous occlusion (in 29\\%)\n$\\sqrt{ }$ intracranial hemorrhage (in up to $42 \\%$ ) = parenchymal / subarachnoid hemorrhage, subdural hematoma, petechial hemorrhage, hemorrhagic infarcts\n$\\sqrt{ }$ cerebral white matter lesions in subcortical and periventricular regions at FLAIR + T2WI (in $60-86 \\%)$\n$\\sqrt{ }$ cerebral atrophy (in about $43 \\%$ )\n$\\sqrt{ }$ myelopathy (in $1-3 \\%$ )\n$\\sqrt{ }$ optic neuritis (in $21-48 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 738,
            "markdown": "# TALCOSIS \n\n$=$ prolonged inhalation of talc ( $=$ hydrated magnesium silicate)\nOccupational exposure: manufacture of leather, rubber, paper, textiles, ceramic tiles\nOften associated with: quartz, mica, kaolin, asbestos (amphibole fibers of tremolite and anthophyllite)\nDifferent forms of disease depending on composition:\n(1) Pure talcosis\n\nCXR:\n$\\checkmark$ generalized haziness, nodulation, reticulation\n$\\checkmark$ large opacities resembling progressive massive fibrosis\nHRCT:\n$\\checkmark$ small centrilobular + subpleural nodules\n$\\checkmark$ conglomerate masses + internal foci of high attenuation\n(2) Talcosilicosis\n$\\checkmark$ small rounded + large opacities\n$\\checkmark$ fibrogenic process (NO regression after removal of patient from exposure)\n(3) Talcoasbestosis\n$\\checkmark$ massive and bizarre pleural plaques\n$\\checkmark$ may encase lung with calcification\n(4) Recreational IV drug use\n$\\checkmark$ diffuse small nodules, perihilar conglomerate masses, ground-glass opacities, emphysema\nLocation: typically sparing of apices + costophrenic sulci\n\n## TERATOID TUMOR OF MEDIASTINUM\n\n$=$ MEDIASTINAL GERM CELL TUMOR $=[=$ TERATOMA $]$\nPathogenesis: \"misplaced\" multipotential primitive germ cells during migration from yolk endoderm to gonad\nFrequency:\n) adult: $15 \\%$ of anterior mediastinal tumors\n> child: $24 \\%$ of anterior mediastinal tumors\n> fetus: $\\quad 10 \\%$ of all fetal teratomas\n$\\diamond 16-28 \\%$ of all mediastinal cysts!\n$\\diamond$ Occurs in same frequency as the usually larger thymoma!\n$\\diamond 1 / 3$ of primary neoplasms in this area are in children\nClasses: (1) Mature teratoma (solid)\n(2) Cystic teratoma (dermoid cyst)\n(3) Immature teratoma\n(4) Malignant teratoma (teratocarcinoma)\n(5) Mixed teratoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 739,
            "markdown": "| Gonzalez-Crussi Grading System of Teratomas |  |\n| :--: | :-- |\n| Grade | Classification |\n| 0 | mature |\n| 1 | immature / probably benign |\n| 2 | immature / possibly malignant |\n| 3 | frankly malignant |\n\nLocation: mediastinum is $3^{\\text {rd }}$ most common site for teratoid lesions (after gonadal + sacrococcygeal location); $5 \\%$ of all teratomas occur in mediastinum, mostly anterosuperiorly (in only $1 \\%$ posteriorly)\n$\\diamond$ The anterior mediastinum is the most common extragonadal site of primary germ cell tumors $(1-3 \\%$ of all germ cell tumors)!\nCXR:\n$\\checkmark$ usually incidental large round lobulated mediastinal mass\n$\\checkmark$ DIAGNOSTIC teeth / bone / fat / amorphous peripheral wall calcifications (in 20\\%)\n$\\checkmark$ frontal CXR:\n$\\checkmark$ silhouetting of heart\n$\\checkmark$ obtuse angle to mediastinum + lung\n$\\checkmark$ disruption of azygoesophageal recess / anterior junction line\n$\\checkmark$ \"hilum overlay\" sign (= not of hilar origin!)\nlateral CXR:\n$\\checkmark$ obliteration of retrosternal clear space\nMR:\n$\\checkmark$ variable appearance depending on components of teratoma:\n$\\checkmark$ areas of high signal intensity on T1WI $\\leftarrow$ fat\n$\\checkmark$ areas of low SI on T1WI + high SI on T2WI $\\leftarrow$ fluid\nCx: (1) Hemorrhage\n(2) Pneumothorax $\\leftarrow$ bronchial obstruction with air trapping + alveolar rupture\n(3) Respiratory distress $\\leftarrow$ rapid increase in size from fluid production with compression of trachea / SVC (SVC syndrome)\n(4) Fistula formation to aorta, SVC, esophagus\n(5) Rupture into bronchus $\\rightarrow$ expectoration of oily substance / trichoptysis in 5-14\\%, lipoid pneumonia)\n(6) Rupture into pericardium (pericardial effusion), pleural cavity (pleural effusion)\n\nDDx: thymoma\n\n# Benign Teratoid Tumor (75-86\\%) \n\n$=$ MATURE (CYSTIC) TERATOMA = BENIGN TERATOMA\n$\\diamond$ Most common histologic type\n\n1. Epidermoid $(52 \\%)=$ ectodermal derivatives\n2. Dermoid $(27 \\%)=$ ecto- + mesodermal derivatives\n3. Teratoma $(21 \\%)=$ ecto- + meso- + endodermal derivatives\n\nPath: spherical lobulated well-encapsulated tumor; typically multi- / unilocular cystic cavities with clear / yellow / brown liquid",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 740,
            "markdown": "# Histo: \n\n(a) ectoderm: skin, sebaceous material, hair, cysts lined by squamous epithelium\n(b) mesoderm: bone, cartilage, muscle\n(c) endoderm: GI + respiratory tissue, mucus glands\n$\\diamond$ Tumor capsule commonly has remnants of thymic tissue!\n$\\diamond$ Cyst formation is typical (usually lined by mucus-secreting tall epithelial cells)!\nAge: young adults / children; $\\mathrm{M}=\\mathrm{F}$\n\n- asymptomatic (in up to $53 \\%$ )\n- cough, dyspnea, chest pain, pulmonary infection, respiratory distress $\\leftarrow$ compression by large tumor\nLocation:\n(a) anterior superior mediastinum near thymus / within thymic parenchyma\n(b) posterior mediastinum (rare, $3-8 \\%$ )\n\nCT:\n$\\checkmark$ smooth round mass bulging into right / left hemithorax\n$\\checkmark$ mass sharply demarcated by well-encapsulated wall\n$\\checkmark$ multicystic mass of internal heterogeneity with densities varying from -100 to +300 HU (that may all be present):\n$\\checkmark$ water density ( $85-90 \\%$ ), fat density ( $65-75 \\%$ )\n$\\checkmark$ DIAGNOSTIC fat-fluid level (in $10 \\%$ )\n$\\checkmark$ proteinaceous / hemorrhagic fluid component\n$\\checkmark$ homogeneous soft-tissue density (indistinguishable from lymphoma / thymoma)\n$\\checkmark$ curvilinear peripheral / central calcification ( $20-53 \\%, 4 \\mathrm{x}$ more common in benign lesions) in tumor wall / substance, ossification in mature bone\n$\\checkmark$ PATHOGNOMONIC visualization of tooth\n$\\checkmark$ often inseparable from thymic gland\n$\\checkmark$ enhancement of rim / tissue septa\nMR:\n$\\checkmark$ fat, fluid, soft-tissue signal intensities on T1WI + T2WI\n$\\checkmark$ macroscopic fat on fat-suppressed imaging\n$\\checkmark$ intracellular lipid on in- and out-of-phase imaging\nPrognosis: $\\sim 100 \\%$-year survival rate\n$R s:$ complete surgical excision\n\n\n## Malignant Teratoid Tumor (14-20\\%)\n\n$=$ TERATOCARCINOMA $=$ MALIGNANT TERATOMA\nPeak prevalence: $3^{\\text {rd }}$ decade; $\\mathrm{M}>\\mathrm{F}$\nHisto: similar to mature teratoma but with primitive / immature tissue elements; commonly neural tissue arranged in rosettes / primitive tubules\n$\\checkmark$ features of malignancy:\n$\\checkmark$ nodular poorly defined mass with more solid components\n$\\checkmark$ areas of necrosis or hemorrhage; fat density in $40 \\%$\n$\\checkmark$ thick enhancing capsule\n$\\checkmark$ compression of adjacent structures\n\n1. Seminoma $=$ germinoma $=$ dysgerminoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 741,
            "markdown": "$\\diamond 2^{\\text {nd }}$ most common mediastinal germ cell tumor!\n$\\diamond$ Most common primary malignant germ cell tumor of mediastinum!\nFrequency: $2-6 \\%$ of all mediastinal tumors; $5-13 \\%$ of all malignant mediastinal tumors\nAge: $3^{\\text {rd }}-4^{\\text {th }}$ decade; $\\mathrm{M}>>\\mathrm{F}$; white\nHisto: uniform polyhedral / round cells arranged in sheets or forming small lobules separated by fibrous septa; varying amounts of mature lymphocytes\nPath: large unencapsulated well-circumscribed mass\n\n- asymptomatic (20-30\\%); SVC obstruction (10\\%)\n- chest pain / pressure, shortness of breath, weight loss, hoarseness, dysphagia, fever\n- $\\uparrow$ serum levels of hCG ( $7-18 \\%$ )\n- $\\uparrow$ serum levels of LDH ( $80 \\%$ ) correlate with tumor burden + rate of tumor growth\n\nMetastases: to regional lymph nodes, lung, bone, liver\n$\\checkmark$ large bulky well-marginated lobulated mass\n$\\checkmark$ usually NO calcification\n$\\checkmark$ homogeneous soft-tissue density with slight enhancement\nPrognosis: 75-100\\% 5-year survival rate; death from distant metastases\n$R x$ : surgery + radiation therapy (very radiosensitive) $\\pm$ cisplatin\n2. Nonseminomatous malignant germ cell tumor\n(a) embryonic tissue\n(1) Embryonal carcinoma\n(b) extraembryonic tissue\n(2) Volk sac $=$ endodermal sinus tumor\n(3) Choriocarcinoma (least frequent)\n(c) combination $=$ mixed germ cell tumor\n\nPath: large unencapsulated heterogeneous soft-tissue mass with tendency for invasion of adjacent structures\nAge: during $2^{\\text {nd }}-4^{\\text {th }}$ decade: $\\mathrm{M} \\div \\mathrm{F}=9 \\div 1$; in children $\\mathrm{M}=\\mathrm{F}$\nAssociated with: Klinefelter syndrome (in 20\\%), hematologic malignancy\n\n- chest pain, dyspnea, cough, weight loss, fever, SVC syndrome ( $90-100 \\%$ )\n- $\\uparrow$ serum level of $\\alpha$-fetoprotein ( $80 \\%$ ) for endodermal sinus tumor / embryonal carcinoma\n- $\\uparrow$ serum level of LDH ( $60 \\%$ )\n- $\\uparrow$ serum level of hCG (30\\%) (DDx: lung cancer; hepatocellular carcinoma; adenocarcinoma of pancreas, colon, stomach)\nMetastases to: lung, liver\n$\\checkmark$ large tumor of heterogeneous texture with central hemorrhage / necrosis\n$\\checkmark$ well circumscribed / with irregular margins\n$\\checkmark$ enhancement of tumor periphery\n$\\checkmark$ lobulation suggests malignancy\n$\\checkmark$ invasion of mediastinal structures (SVC obstruction is ominous)\n$\\checkmark \\pm$ pleural / pericardial effusion (from local invasion)\n$\\diamond$ The absence of a primary testicular tumor / retroperitoneal mass proves a primary malignant germ cell tumor!\n$R x$ : cisplatin-based chemotherapy + tumor resection",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 742,
            "markdown": "# THORACIC DUCT CYST \n\n$=$ exceedingly rare benign mass of posterior mediastinum\nOrigin: congenital / degenerative weakening of thoracic duct wall\nHisto: cystic space lined by hyalinized fibrous connective tissue surrounded by patchy collections of lymphocytes\nLocation: anywhere along thoracic duct\nSize: $3-22 \\mathrm{~cm}$\n\n- asymptomatic (up to $50 \\%$ )\n- dysphagia, chest pain / pressure, dyspnea, dysphonia\n$\\sqrt{ }$ well-circumscribed posterior mediastinal mass\n$\\checkmark$ contiguity with cisterna chyli\n$\\checkmark$ enhancement of a smooth thin wall\nCT:\n$\\checkmark$ homogeneous well-defined mass of water attenuation\nMRI:\n$\\sqrt{ }$ variable SI on T1WI; mildly hyperintense $\\leftarrow$ increased lipids + proteins\n$\\checkmark$ variously heterogeneous hyperintense mass on T2WI\n$C x$ : rapid enlargement / spontaneous rupture after high-fat meal\n$R x$ : resection under preservation of thoracic duct pedicles to avoid postoperative chylothorax\n$D D x$ : bronchogenic cyst (located adjacent to carina / in pulmonary parenchyma), esophageal duplication cyst (thick wall, young patient), pericardial cyst (located anteriorly at pericardiophrenic angle), hiatal hernia\n\n\n## THORACIC PARAGANGLIOMA\n\n$=$ CHEMODECTOMA\n$=$ rare neural tumor arising from paraganglionic tissue\nAge: $3^{\\text {rd }}-5^{\\text {th }}$ decade; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\nPath: extremely vascular well-marginated / irregular mass that may adhere to / envelop / invade adjacent mediastinal structures (bronchus, spinal canal)\nHisto: anastomosing cords of granule-storing chief cells arranged in a trabecular pattern; identical appearance for benign and malignant tumors\nMay be associated with:\nsyn- / metachronous adrenal / extrathoracic paragangliomas; multiple endocrine neoplasia type 2; bronchial carcinoid tumor\n\n- asymptomatic; dyspnea, cough, chest pain, hemoptysis, neurologic deficits, SVC syndrome (if tumor large)\n- signs of excessive catecholamine production: hypertension, headache, tachycardia, palpitations, tremor\nLocation: base of heart + great vessels (adjacent to pericardium / heart, within interatrial septum / left atrial wall); paravertebral sulci\nCT:\n$\\checkmark$ sharply marginated $5-7-\\mathrm{cm}$ middle / posterior mediastinal mass",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 743,
            "markdown": "$\\sqrt{ }$ hypodense areas $\\leftarrow$ extensive cystic degeneration / hemorrhage\n$\\checkmark$ exuberant enhancement\nMR:\n$\\checkmark$ heterogeneous intermediate SI with areas of signal void from flowing blood on T1WI\n$\\checkmark$ high signal intensity on T2WI\nNUC (123I / 131I metaiodobenzylguanidine):\n$\\checkmark$ useful and relatively specific for localization purposes\nAngio:\n$\\checkmark$ marked hypervascularity, multiple feeding vessels\n$\\checkmark$ homogeneous capillary blush\nCave: Angio may precipitate cardiovascular crisis!\n$R x$ : surgical excision with preoperative administration of $\\alpha$ - or $\\beta$-blockers (hypertensive crisis, tachycardia, dysrhythmia during manipulation)\n\n# THORACIC SPLENOSIS \n\n$=$ autotransplantation of splenic tissue to pleural space following thoracoabdominal trauma; discovered $10-30$ years later\nPathophysiology: splenic tissue parasitizes blood supply from pleura / chest wall / diaphragm\nFrequency: $18 \\%$ with injury of spleen and diaphragm by blunt trauma; more common in penetrating injury\n$\\mathrm{M} \\div \\mathrm{F}=3 \\div 1$ (higher rate of trauma in young men)\n\n- usually asymptomatic / RARELY recurrent hemoptysis\n$\\checkmark$ one or several nodules in left pleura / fissures measuring several mm to 6 cm\n$\\checkmark$ splenectomy / splenules in left upper quadrant\n$\\checkmark$ positive ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-labeled heat-damaged RBCs (most sensitive), ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid scan / 111 Indium-labeled platelets\n\n\n## THYMIC CYST\n\n## Pathogenesis:\n\n(1) Congenital cyst = persistent embryonic remnant of $3^{\\text {rd }}$ pharyngeal pouch (= tubular thymopharyngeal duct), develops during $5^{\\text {th }}-8^{\\text {th }}$ week of gestation)\n(2) Acquired reactive multilocular cyst = progressive cystic degeneration of thymic (Hassall) corpuscles + thymic epithelial reticulum induced by an inflammatory process: eg, HIV, before + after chemotherapy for NHL / Hodgkin disease\n(3) Neoplastic cyst (cystic teratoma, cystic degeneration within thymoma), thymic carcinoma, Hodgkin disease + NHL, germ cell tumor\n$\\diamond$ No association with myasthenia gravis / neoplasia!\nFrequency: very uncommon lesion; $1-2 \\%$ of mediastinal masses\nAge: $2 / 3$ in $1^{\\text {st }}$ decade; $1 / 3$ in $2^{\\mathrm{nd}}+3^{\\mathrm{rd}}$ decades; $\\mathrm{M}>\\mathrm{F}$\nPath: unilocular thin-walled cyst with thymic tissue\nHisto: squamous / cuboidal / respiratory epithelium in cyst wall; lobulated lymphoid tissue in cyst wall containing Hassall corpuscles; cholesterol crystals; small foci of thyroid / parathyroid tissue\n\n- commonly asymptomatic slowly enlarging painless mass",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 744,
            "markdown": "- hoarseness, dysphagia, stridor, respiratory distress in newborns\n- sudden symptomatic enlargement with Valsalva maneuver / hemorrhage / recent viral infection\n\nLocation:\n(a) adjacent to carotid sheath from angle of mandible to thoracic inlet (along path of thymopharyngeal duct) parallel to sternocleidomastoid muscle; $\\mathrm{L}>\\mathrm{R}$\n(b) anterior mediastinum\n$\\sqrt{ }$ unilocular cyst with thin walls containing clear fluid / multilocular cyst with thick walls containing turbid fluid or gelatinous material\n$\\sqrt{ }$ direct extension / fibrous cord along migratory tract of thymic tissue into mediastinum in $50 \\%$ : through thyrohyoid membrane into pyriform sinus\n$\\sqrt{ }$ may show partial wall calcification (rare)\n$\\sqrt{ }$ low-density fluid $(0-10 \\mathrm{HU})$, may be higher depending on cyst contents\nUS:\n$\\sqrt{ }$ typically anechoic\n$D D x$ : branchial cleft cyst (no thymic tissue), benign thymoma, teratoma, dermoid cyst, Hodgkin disease, non-Hodgkin lymphoma, pleural fibroma\n\n# THYMIC HYPERPLASIA \n\n$\\diamond$ Most common anterior mediastinal mass in pediatric age group through puberty\n$D D x$ : thymoma (focal mass, loss of normal fatty infiltration)\n\n## True Thymic Hyperplasia\n\n$=$ increase in size + weight of thymus with preservation of its organized microscopic features\n$\\leftarrow$ rebound hyperplasia after recovery from recent stress\nAge: commonly in child, also in adult\nStress events: systemic infection (eg, pneumonia); surgery, burns; neoplasm; corticosteroid / radiation / chemotherapy ( $10-25 \\%$ )\n$\\diamond$ Thymus atrophies under bodily stress to as little as $40 \\%$ of its original volume $\\leftarrow$ endogenous steroids\nTiming: rebound within 2 years of initiation of chemotherapy\n$\\sqrt{ }$ size:\n$\\sqrt{ }$ diffuse enlargement\n$\\sqrt{ }>50 \\%$ transient overgrowth (reducible with steroids)\n$\\sqrt{ }$ after recovery regrowth to original size within 9 months\n$\\sqrt{ }$ shape:\n$\\sqrt{ }$ smooth contour, normal vessels\n$\\sqrt{ }$ normal / oval shape with loss of its distinct bilobed appearance\n$\\sqrt{ }$ fine mixture of fat and lymphoid tissue\nMR:\n$\\sqrt{ }$ homogeneously decreased signal on out-of-phase images $\\leftarrow$ fatty infiltration of normal / hyperplastic thymus (unlike thymoma)\nPET/CT:\n$\\sqrt{ }$ may take up FDG mimicking thymoma\n\n## Thymic Lymphoid Hyperplasia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 745,
            "markdown": "$=$ increase in number of active lymphoid germinal centers in thymic medulla associated with lymphocytic and plasma cell infiltration\nAssociated with autoimmune disease:\n\n| WHO Classification of Thymic Epithelial Tumors <br> (poorly reproducible and without clinical implications) |  |\n| :--: | :-- |\n| Tumor Type | Description |\n| A | medullary (epithelial cells: oval / fusiform shape) |\n| AB | mixed |\n| B | (epithelial cells: epitheloid shape) |\n| B1 | lymphocyte rich, predominantly cortical |\n| B2 | cortical |\n| B3 | epithelial = well-differentiated thymic carcinoma |\n| C | thymic carcinoma |\n\nhyperthyroidism (most common), Graves disease, idiopathic thyromegaly, thyrotoxicosis, myasthenia gravis ( $65 \\%$ ), connective tissue disease (SLE, rheumatoid arthritis, scleroderma, vasculitis), sarcoidosis, red blood cell aplasia, acromegaly, Addison disease\n$\\sqrt{ }$ diffuse symmetric enlargement / normal size\n\n# THYMOLIPOMA \n\nFrequency: $2-9 \\%$ of thymic tumors\nAge: 3-60 years (mean age of 22 years); $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\nPath: lobulated pliable encapsulated tumor capable of growing to large size (in $68 \\%>500 \\mathrm{~g}$, in $20 \\%>2,000 \\mathrm{~g}$, the largest $>16 \\mathrm{~kg}$ )\nHisto: benign adult adipose tissue interspersed with areas of normal / hyperplastic / atrophic thymus tissue (thymic tissue $<33 \\%$ of tumor mass)\n\n- usually asymptomatic; chest pain, dyspnea, cough (in 50\\%)\n$\\checkmark$ fatty mass with fibrous septa\n$\\checkmark$ large lesions slump inferiorly from anterior mediastinum toward diaphragm enlarging the cardiophrenic space\n$\\checkmark$ may drape around heart enlarging cardiac silhouette on frontal view\n$\\checkmark$ apparent elevation of diaphragm on lateral view\n$\\checkmark$ NO compression / invasion of adjacent structures\n$D D x$ : mediastinal lipoma (most common of intrathoracic fatty tumors), liposarcoma, teratoma (cystic changes, no connection to thymic bed)\n\n\n## THYMOMA\n\n$=$ THYMIC EPITHELIAL TUMOR\n$=$ slow growing neoplasm potentially exhibiting aggressive behavior (invasion of adjacent structures + involvement of pleura and pericardium), but rarely distant metastases\n$\\diamond$ Most common primary neoplasm of anterior mediastinum\nIncidence: $1-5 \\div 1,000,000$ per year; $1 \\%$ of all adult malignancies; $20 \\%$ of all mediastinal neoplasms in adults; $<5 \\%$ of mediastinal tumors in children\nAge peak: $5^{\\text {th }}-6^{\\text {th }}$ decade ( $70 \\%$ ); almost all $>25$ years of age; less frequent in young adults,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 746,
            "markdown": "rare in children; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\nAssociated with: parathymic (paraneoplastic) systemic syndromes (40\\%) such as\n\n1. Myasthenia gravis ( $30-50 \\%$ )\n$=$ autoimmune disorder characterized by antibodies against nicotinic acetylcholine receptors of the postjunctional muscle membrane $(\\mathrm{M}<\\mathrm{F})$\n\n- fatigability of skeletal muscles innervated by cranial nerves, eg, ptosis, diplopia, dysphagia, dysarthria, drooling, difficulty with chewing, progressive weakness, fatigue\n- $\\uparrow$ serum level of anti-acetylcholine receptor antibodies\n$\\diamond 30-50 \\%$ of thymoma patients have myasthenia gravis; removal of thymic tumor often results in symptomatic improvement; myasthenia gravis may develop after surgical thymoma excision\n$\\diamond 10-15 \\%$ of myasthenia gravis patients have a thymoma (in $65 \\%$ thymic hyperplasia) Rx: edrophonium chloride (cholinesterase inhibitor)\n\n2. Pure red cell aplasia (5\\%)\n$=$ aregenerative anemia\n$=$ almost total absence of marrow erythroblasts + blood reticulocytes $\\rightarrow$ severe normochromic normocytic anemia\n$\\diamond 5 \\%$ of thymoma patients develop red cell aplasia\n$\\diamond 50 \\%$ of patients with red cell aplasia have thymoma\n3. Acquired hypogammaglobulinemia (6\\%)\n$\\diamond 6 \\%$ of thymoma patients have hypogammaglobulinemia\n$\\diamond 10 \\%$ of hypogammaglobulinemia patients have thymoma\n4. Autoimmune disorders:\n\nDermatomyositis; SLE; Rheumatoid arthritis; Cushing syndrome (ACTH production); Myocarditis; Syndrome of inappropriate antidiuretic hormone secretion (SIADH)\n5. Nonthymic cancers: NHL, GI cancer, sarcoma, multiple myeloma\n$\\diamond$ Thymic carcinomas rarely cause paraneoplastic syndromes\nPath: round / ovoid slow-growing primary epithelial neoplasm with smooth / lobulated surface divided into lobules by fibrous septa; areas of hemorrhage / necrosis / cystic component $(1 / 3)$\n(a) encapsulated $\\left(2 / 3\\right)=$ thick fibrous capsule $\\pm$ calcifications\n(b) locally invasive $=$ microscopic foci outside capsule $(1 / 3)$\n(c) metastasizing = benign cytologic appearance with pleural + pulmonary parenchymal seeding\n(d) thymic carcinoma\n\n# Histo: \n\n(a) biphasic thymoma (most common)\n$=$ epithelial + lymphoid elements in equal amounts\n(b) predominantly lymphocytic thymoma\n$=>2 / 3$ of cells are lymphocytic\n(c) predominantly epithelial thymoma\n$=>3 / 3$ of cells are epithelial\n$\\diamond$ Prognosis unrelated to cell type!\nClassification: (1) Thymoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 747,
            "markdown": "(2) Thymic carcinoma\n\n- asymptomatic ( $50 \\%$ discovered incidentally)\n- signs of mediastinal compression ( $25-30 \\%$ ):\n- cough, dyspnea, chest pain (in up to $1 / 3$ )\n- respiratory infection, hoarseness (recurrent laryngeal nerve), diaphragmatic paralysis, dysphagia\n- signs of tumor invasion (rare): SVC syndrome\n- systemic complaints $\\leftarrow$ paraneoplastic syndromes $\\leftarrow$ secretion of hormones, antibodies, cytokines by tumor\nLocation: any anterior mediastinal location between thoracic inlet and cardiophrenic angle; rare in neck, other mediastinal compartments, lung parenchyma, or tracheobronchial tree\nMean size: 5 (range, $1-10$ ) cm; maximum 34 cm\nCXR:\n$\\sqrt{ }$ abnormally wide mediastinum + nodule / mass in retrosternal region\n$\\sqrt{ }$ mass usually on one side of midline obscuring heart border\n$\\sqrt{ }$ displacement of heart + great vessels posteriorly\n$\\checkmark$ thickening of anterior junction line\n$\\checkmark$ irregular borders with adjacent lung $\\leftarrow$ advanced disease\n$\\checkmark$ elevation of hemidiaphragm $\\leftarrow$ phrenic nerve involvement\n$\\checkmark$ pleural nodularity $\\leftarrow$ pleural metastases (stage IVa)\nCT:\n$\\sqrt{ }$ oval / round well-marginated unilateral asymmetric homogeneous mass of soft-tissue density (equal to muscle)\n$\\sqrt{ }$ smooth / lobulated border partially / completely outlined by fat\n$\\sqrt{ }$ soft-tissue nodules in a cystic anterior mediastinal lesion = cystic thymoma\n$\\sqrt{ } \\pm$ intratumoral punctate / amorphous coarse flocculent / curvilinear capsular calcifications $(5-25 \\%)$\n$\\sqrt{ }$ homogeneous enhancement (CHARACTERISTIC)\n$\\sqrt{ }$ areas of decreased attenuation + heterogeneous enhancement $(1 / 3) \\leftarrow$ necrosis / cystic change / hemorrhage\nSigns of invasion:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 748,
            "markdown": "| Masaoka-Koga Staging System for Thymoma (as a good predictor of survival) |  |\n| :--: | :--: |\n| Stage | Description |\n| I | intact capsule |\n| II | pericapsular growth into mediastinal fat |\n| IIA | microscopic pericapsular growth |\n| IIB | macroscopic growth into surrounding fat |\n| III | invasion of neighboring organs such as lung, pericardium, SVC, aorta |\n| IV | metastatic |\n| IVA | within thoracic cavity (metastases to pleura + lung in $6 \\%$, pericardium) |\n| IVB | extrathoracic metastases (liver, bone, lymph nodes, kidneys, brain) |\n\n> signs of Masaoka stage II-IV thymoma:\n$\\sqrt{ }$ lobulated / irregular contours\n$\\sqrt{ }$ cystic / necrotic regions within the tumor\n$\\sqrt{ }$ multifocal calcifications\n> signs of Masaoka stage III-IV thymoma:\n$\\sqrt{ }$ primary tumor $\\geq 7 \\mathrm{~cm}$\n$\\sqrt{ }$ fat infiltration surrounding tumor\n$\\sqrt{ }$ lobulated tumor contours\n> signs of vascular invasion:\n$\\sqrt{ }$ irregular contour of vessel lumen\n$\\sqrt{ }$ vascular encasement / obliteration\n$\\sqrt{ }$ endoluminal soft tissue $\\pm$ extension into heart chambers\n> pleural drop metastases:\n$\\sqrt{ }$ smooth nodular / diffuse pleural nodules / masses, almost always ipsilateral to anterior mediastinal tumor\n$\\sqrt{ }$ pleural effusion uncommon with pleural metastases\nMR:\n$\\sqrt{ }$ low to intermediate signal intensity = isointense to skeletal muscle on T1WI\n$\\sqrt{ }$ high signal intensity approaching fat on T2WI\n$\\sqrt{ }$ heterogeneous signal intensity:\n$\\sqrt{ }$ low T1 + high T2 SI $\\leftarrow$ tumor necrosis / cystic change\n$\\sqrt{ }$ low-signal-intensity regions $\\leftarrow$ fibrous tumor septa and nodularity / hemosiderin deposition\n$R x$ : surgical resection for stage I; radiation therapy\n$\\diamond$ Completeness of resection is a major prognostic factor\n$D D x$ : $\\diamond$ Thymoma rarely manifests with lymphadenopathy /pleural effusions / extrathoracic metastases\n(1) Thymic hyperplasia (young child, smooth borders, preserved normal thymic shape)\n(2) Primary thymic malignancy: thymic carcinoma, thymic carcinoid\n(3) Nonthymic tumor: lymphoma, germ cell tumor, small-cell lung cancer (mediastinal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 749,
            "markdown": "lymphadenopathy, pleural effusions, pulmonary metastases)\n\n# Noninvasive [Benign] Thymoma \n\nTerminology: \"benign\" not acceptable $\\leftarrow$ all thymomas are malignant tumors with potential to metastasize\n\n## Thymic Carcinoma\n\n$=$ INVASIVE [MALIGNANT] THYMOMA\n$\\diamond$ Malignancy defined according to extent of invasion into adjacent mediastinal fat + fascia!\nFrequency: $20-35 \\%$ of thymic epithelial tumors\nMean age: 50 years; uncommon in adults, rare in children\nPath: thymic carcinomas usually lack well-defined capsule\nDistant metastases at diagnosis:\n$>50-65 \\%$ of patients with thymic carcinomas\n$>5 \\%$ of patients with invasive thymomas\nCT:\n$\\checkmark$ large multilobulated mass with irregular contour:\n$\\checkmark$ heterogeneous attenuation\n$\\checkmark$ invasion of mediastinal fat\n$\\checkmark$ spread by contiguity along pleural reflections, extension along aorta reaching posterior mediastinum / crus of diaphragm / retroperitoneum (transdiaphragmatic tumor extension):\n$\\checkmark$ unilateral diffuse nodular pleural thickening / pleural masses encasing lung circumferentially\n$\\checkmark$ vascular encroachment\n$\\checkmark$ pleural effusion UNCOMMON\n$\\checkmark$ distant metastases + regional lymphadenopathy\nMR:\n$\\checkmark$ high signal intensity on both T1WI and T2WI\n$\\checkmark$ heterogeneous signal intensity $\\leftarrow$ hemorrhage / necrosis\n$D D x$ : malignant mesothelioma, lymphoma, thymic carcinoma / malignant germ cell tumor (older male, no diffuse pleural seeding), peripheral lung carcinoma (no dominant mediastinal mass), metastatic disease (not unilateral)\n$R x$ : radical excision $\\pm$ adjuvant radiation therapy\nPrognosis: 5-year survival of $93 \\%$ for stage I, $86 \\%$ for stage II, $70 \\%$ for stage III, $50 \\%$ for stage IV; $2-12 \\%$ recurrence rate for resected encapsulated thymoma\n\n## TORSION OF LUNG\n\n$=$ rare complication of severe chest trauma\nFrequency: rare ( $<30$ cases)\nAge: almost invariably in children\nCause: compression of lower thorax, tear on inferior pulmonary ligament, completeness of fissures\nMechanism: compression of lower thorax with lung twisted through $180^{\\circ}$; usually in presence of a large amount of pleural air / fluid\nAssociated with:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 750,
            "markdown": "surgery (lobectomy), trauma, diaphragmatic hernia, pneumonia, pneumothorax, bronchusobstructing tumor\nHisto: $\\pm$ hemorrhagic infarction + excessive air trapping\n$\\sqrt{ }$ collapsed / consolidated lobe in unusual position + configuration:\n$\\sqrt{ }$ hilar displacement of atelectatic-appearing lobe in an inappropriate direction\n$\\sqrt{ }$ change in position of opacified lobe on sequential radiographs\n$\\sqrt{ }$ alteration in normal course of pulmonary vasculature:\n$\\sqrt{ }$ main lower lobe artery sweeping upward toward apex\n$\\sqrt{ }$ rapid opacification of an ipsilateral lobe from edema + hemorrhage into airspaces $\\leftarrow$ infarction (DDx: pleural effusion)\n$\\sqrt{ }$ bronchial cutoff / distortion\n$\\sqrt{ }$ lobar air trapping\n$\\sqrt{ }$ lower lung vessels diminutive\n\n# TRACHEOBRONCHOMEGALY \n\n$=$ MOUNIER-KUHN SYNDROME\n$=$ primary atrophy / dysplasia of supporting structures of trachea + major bronchi with abrupt transition to normal bronchi at $4^{\\text {th }}-5^{\\text {th }}$ division\nFrequency: $0.5-1.5 \\%$\nAge: discovered in $3^{\\text {rd }}-5^{\\text {th }}$ decade\n\n- cough with copious sputum, shortness of breath on exertion\n- long history of recurrent pneumonias\n\nMay be associated with: Ehlers-Danlos syndrome\n$\\sqrt{ }$ marked dilatation of trachea ( $>29 \\mathrm{~mm}$ ), right ( $>20 \\mathrm{~mm}$ ) + left ( $>15 \\mathrm{~mm}$ ) mainstem bronchi\n$\\sqrt{ }$ sacculated outline / diverticulosis of trachea on lateral CXR ( $=$ protrusion of mucous membrane between rings of trachea)\n$\\sqrt{ }$ may have emphysema / bullae in perihilar region\n\n## TRACHEOBRONCHOPATHIA OSTEOCHONDROPLASTICA\n\n$=$ rare benign disease characterized by multiple submucosal cartilaginous / osseous nodules projecting into tracheobronchial lumen\nCause: unknown; may be due to chronic inflammation, degenerative process, irritation by oxygen / chemical, metabolic disturbance, amyloidosis, tuberculosis, syphilis, heredity (high prevalence in Finland)\nPathogenetic theories:\n(1) Ecchondrosis / exostosis of cartilage rings\n(2) Cartilaginous / osseous metaplasia of internal elastic fibrous membrane of trachea\n\nPath: foci of submucosal hyaline cartilage with areas of lamellar bone\nHisto: adipose tissue + calcified areas with foci of bone marrow; thinned normal overlying mucosa with inflammation + hemorrhage\nAverage age: 50 (range, 11-78) years; $\\mathrm{M}+\\mathrm{F}=3 \\div 1$\n\n- usually asymptomatic (incidentally diagnosed)\n- dyspnea, productive cough, hoarseness, hemoptysis, fever, recurrent pneumonia\n\nLocation: distal $2 / 3$ of trachea, larynx, lobar / segmental bronchi, entire length of trachea; spares",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 751,
            "markdown": "posterior membrane of trachea\nCXR:\n$\\sqrt{ }$ scalloped / linear opacities surrounding + narrowing trachea (best on lateral view)\nCT:\n$\\sqrt{ }$ deformed thickened narrowed tracheal wall\n$\\sqrt{ }$ irregularly spaced $1-3-\\mathrm{mm}$ calcific submucosal nodules of trachea + bronchi (similar to plaques)\n$D x:$ bronchoscopy\n$D D x$ : relapsing polychondritis, tracheobronchial amyloidosis (does not spare posterior membranous wall of trachea), sarcoidosis, papillomatosis, tracheobronchomalacia\n\n# TUBERCULOSIS \n\nPrevalence: 10 million people worldwide; active TB develops in 5-10\\% of those exposed; $3 \\div 100,00$ in USA (2014)\nOrganism: Mycobacterium = acid-fast aerobic rods staining red with carbol-fuchsin: M. tuberculosis ( $95 \\%$ ), atypical types increasing: M. avium-intracellulare, M. kansasii, M. fortuitum\n\nSusceptible: infants, pubertal adolescents, elderly, alcoholics, Blacks, diabetics, silicosis, measles, AIDS ( $30-40 \\%$ infected with HIV), sarcoidosis (in up to $13 \\%$ )\nAt risk: immunocompromised, minorities, poor, alcoholics, immigrants from $3^{\\text {rd }}$ world countries, prisoners, the aged, nursing home residents, homeless\n\n## Pathologic phases:\n\n(a) exudative reaction (initial reaction, present for 1 month)\n(b) caseous necrosis (after $2-10$ weeks with onset of hypersensitivity)\n(c) hyalinization $=$ invasion of fibroblasts $\\rightarrow$ granuloma formation in $1-3$ weeks\n(d) calcification / ossification\n(e) chronic destructive form in $10 \\%$ ( $<1$ year of age, adolescents, young adults)\n\nSpread: regional lymph nodes, hematogenous dissemination, pleura, pericardium, CNS, head \\& neck, spondylitis, osteomyelitis, arthritis, peritonitis, GI \\& GU tract\n\n- Positive PPD tuberculin test: 3 weeks after infection\n- Negative PPD test: overwhelming tuberculous infection (miliary TB); sarcoidosis; corticosteroid therapy; pregnancy; infection with atypical Mycobacterium\nFormer Rx: plombage with insertion of plastic packs, Lucite ${ }^{\\mathrm{TM}}$ balls, polythene spheres; oleothorax (= injection of oil / paraffin)\nMortality: $1 \\div 100,000$\n\n\n## Tuberculoma\n\n$=$ manifestation of primary / postprimary TB\n$\\sqrt{ }$ round / oval smooth sharply defined mass\n$\\sqrt{ } 0.5-4 \\mathrm{~cm}$ in diameter remaining stable for a long time\n$\\sqrt{ }$ lobulated mass $(25 \\%)$\n$\\sqrt{ }$ satellite lesions $(80 \\%)$\n$\\sqrt{ }$ may calcify\n\n## Cavitary Tuberculosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 752,
            "markdown": "$=$ hallmark of reactivation tuberculosis\n$=$ semisolid caseous material is expelled into bronchial tree after lysis\n$\\sqrt{ }$ moderately thick-walled cavity with smooth inner surface\nCx:\n(1) Dissemination to other bronchial segments\n$\\sqrt{ }$ multiple small acinar shadows remote from massive consolidation\n(2) Colonization with Aspergillus\n$\\sqrt{ }$ aspergilloma\nRasmussen, Fritz Valdemar (1837-1877), chair of pathology at University of Copenhagen, Denmark\n(3) Rasmussen aneurysm = fragile aneurysm of terminal branches of pulmonary artery within wall of TB cavity $\\leftarrow$ inflammatory necrosis of the vessel wall ( $4 \\%$ at autopsies of cavitary TB):\n[Fritz Valdemar Rasmussen (1837-1877), chair of pathology at University of Copenhagen, Denmark]\n\n- sentinel hemoptysis prior to catastrophic hemorrhage\n$\\sqrt{ }$ central cavity near hilum:\n$\\sqrt{ }$ enlargement of intracavitary solid protrusion\n$\\sqrt{ }$ replacement of cavity by a nodule\n$\\sqrt{ }$ rapidly growing mass\n$\\sqrt{ }$ opacification of pseudoaneurysm on CT / angio\n\n\n# Endobronchial (Acinar) Tuberculosis \n\n$\\diamond$ Most common complication of tuberculous cavitation with active organisms spreading via airways following caseous necrosis of bronchial wall\nPath: ulceration of bronchial mucosa $\\rightarrow$ fibrosis $\\rightarrow$\n(a) bronchial stenosis $\\rightarrow$ lobar consolidation\n(b) bronchiectasis\n(c) acinar nodules reflecting airway spread\n\nHRCT:\n$\\sqrt{ }$ clustered centrilobular nodules\n$\\sqrt{ }$ \"tree-in-bud\" appearance $=$ small poorly defined centrilobular nodules + branching centrilobular areas of increased opacity (= severe bronchiolar impaction with clubbing of distal bronchioles) occurring at multiple contiguous branching sites\n$\\sqrt{ }$ masslike areas of consolidation\n$\\sqrt{ }$ cavitation in larger nodules / masses\n$\\sqrt{ }$ bronchiectasis\n\n## Primary Pulmonary Tuberculosis\n\n$=$ self-limiting disease in patients not previously exposed\nMode of infection: inhalation of infected airborne droplets $\\leftarrow$ coughing expels and aerosolizes organism in $1-5-\\mu \\mathrm{m}$ particles remaining suspended in air for several hours\nAge: most common form in infants + childhood (highest prevalence in children $<5$ years of age); increasingly encountered in adults (23-34\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 753,
            "markdown": "- asymptomatic ( $91 \\%$ ); symptomatic (5-10\\%)\n\n@ Parenchymal disease\nLocation: middle lobe, lower lobes, anterior segment of upper lobes\n$\\sqrt{ }$ normal radiograph (in up to $15 \\%$ )\n$\\sqrt{ }$ one / more areas of homogeneously dense well-defined airspace consolidation of 1-7 cm in diameter in $25-78 \\%$ :\n$\\sqrt{ }$ absent response to antibiotic Rx for \"pneumonia\"\n$D D x$ : bacterial pneumonia\n$\\sqrt{ }$ fine discrete nodular areas of increased opacity\n$D D x$ : varicella pneumonia, histoplasmosis, metastases, sarcoidosis, pneumoconiosis, hemosiderosis\n$\\sqrt{ }$ lobar / segmental atelectasis (in 8-18\\%)\nLocation: anterior segment of upper lobe / medial segment of middle lobe\nAge: in children $<2$ years of age\nCause: (a) endobronchial tuberculosis\n(b) bronchial / tracheal compression by enlarged lymph nodes (68\\%)\n@ Lymphadenopathy (up to $96 \\%$ of children, $43 \\%$ of adults)\n$\\diamond$ may be the sole radiographic manifestation\nLocation: typically right unilateral (hilum + paratracheal region); bilateral in $1 / 3$\n$\\sqrt{ }$ in children: massive hilar ( $60 \\%$ ) / paratracheal ( $40 \\%$ ) / subcarinal lymphadenopathy in adults: mediastinal lymphadenopathy in 5-35-48\\%\n$D D x$ of Lnn: metastases, histoplasmosis\n$\\sqrt{ }$ nodes $>2 \\mathrm{~cm}$ with low-attenuation center $\\leftarrow$ necrosis $=$ highly suggestive of active disease\n$\\sqrt{ }$ lymph node calcification ( $36 \\%$ ) in hilum / mediastinum usually $>6$ months after initial infection\n@ Pleural effusion\n$\\diamond$ Often sole manifestation of TB\nOnset: 3-7 months after initial exposure $\\leftarrow$ subpleural foci rupturing into pleural space\nFrequency: $10 \\%$ in childhood, $23-38 \\%$ in adulthood\nUS:\n$\\sqrt{ }$ usually unilateral often complex septated effusion\n$\\sqrt{ }$ may result in pleural thickening + calcification\nCx (rare): empyema, fistulization, bone erosion\n\n# Outcome of Primary Infection: \n\n1. Restitutio ad integrum (in $2 / 3$ )\n$=$ resolution of primary focus without sequelae\n$\\sqrt{ }$ Simon focus $=$ healed site of primary infection in lung apex; may take up to 2 years\n2. Immunity prevents multiplication of organism\n$=$ containment of initial infection by delayed hyper-sensitivity response + granuloma formation in $1-3$ weeks\n$\\sqrt{ }$ calcified lung lesion (in up to $17 \\%$ ) / parenchymal scar $<5 \\mathrm{~mm}=$ Ghon focus (lesion)\n$\\sqrt{ }$ Ranke complex $=$ Ghon lesion + calcified lymph node $(22 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 754,
            "markdown": "$D D x:$ histoplasmosis\n3. Progressive primary TB\n$=$ inadequate immune mechanism $\\rightarrow$ local progression in $10 \\%$, most common in older children / teenagers\n$\\sqrt{ }$ persistent masslike opacity $=$ tuberculoma $(9 \\%) \\pm$ cavitation\n4. Miliary tuberculosis (uncontrolled massive hematogenous dissemination overwhelming host defense system)\n5. Postprimary TB = reactivation TB (= reactivation of dormant organisms after asymptomatic years)\nPrognosis: 3.6\\% mortality rate; usually self-limiting\nCx: (1) Bronchopleural fistula + empyema\n(2) Fibrosing mediastinitis\n\nDDx: postprimary tuberculosis (predilection for upper lobes, cavitation, absence of lymphadenopathy\n\n# MILIARY PULMONARY TUBERCULOSIS \n\n$=$ massive hematogenous dissemination of organisms within 6 months of initial exposure Cause:\n(1) severe immunodepression during postprimary state of infection\n(2) impaired defenses during primary infection in elderly / infants $=$ PROGRESSIVE PRIMARY TB\nFrequency: $1-3.5-7 \\%$ of all forms of TB\nOnset: radiographically recognizable after 6 weeks post hematogenous dissemination\n$\\checkmark$ CXR initially normal / with signs of hyperinflation\n$\\checkmark$ chronic focus often not identifiable\n$\\checkmark$ generalized evenly distributed small interstitial granulomatous foci of pinpoint to $2-3$ mm size with slight lower lobe predominance (in $85 \\%$ )\n$\\checkmark \\pm$ coalescence into focal / diffuse consolidation\n$\\checkmark$ resolution with appropriate therapy within 2-6 months\nHRCT (earlier detection than CXR):\n$\\checkmark$ diffusely scattered discrete $1-2-\\mathrm{mm}$ nodules in random distribution\nCx: dissemination via bloodstream affecting lymph nodes, liver, spleen, skeleton, kidneys, adrenals, prostate, seminal vesicles, epididymis, fallopian tubes, endometrium, meninges\nResolution: within 2-6 months under treatment\n$\\checkmark$ NO scarring / calcification\n$\\checkmark$ may coalesce into focal / diffuse consolidation\n\n## Postprimary Pulmonary Tuberculosis\n\n$=$ REACTIVATION TB $=$ RECRUDESCENT TB\n$=$ progressive infection under the influence of acquired hypersensitivity and immunity $\\leftarrow$ longevity of bacillus + impairment of cellular immunity\nFrequency: $1 \\%$ per year with normal immunity, in up to $10 \\%$ with deficient T-cell immunity Age: primarily in adolescents + adults\nEtiology:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 755,
            "markdown": "(a) reinfection\n(b) reactivation of focus acquired in childhood ( $90 \\%$ )\n(c) continuation of initial infection = progressive primary tuberculosis (rare)\n(d) initial infection in individual vaccinated with BCG\n\nPath: foci of caseous necrosis with surrounding edema, hemorrhage, mononuclear cell infiltration; formation of tubercles = accumulation of epithelioid cells + Langhans giant cells; bronchial perforation leads to intrabronchial dissemination (19-21\\%)\nSite: $\\quad 85 \\%$ in apical + posterior segments of upper lobe, $10 \\%$ in superior segment of lower lobe, $5 \\%$ in mixed locations (anterior + contiguous segments of upper lobe); $\\mathrm{R}>\\mathrm{L}$ (DDx: histoplasmosis tends to affect anterior segment)\n\n- hemoptysis (most common cause worldwide)\n\nRx: bronchial artery embolization\nPrognosis: progressive\nThe features of primary and postprimary tuberculosis may overlap. The distinguishing features of postprimary tuberculosis include cavitation, a predilection for the upper lobes, and the absence of lymphadenopathy.\n\n# Local Exudative Tuberculosis \n\n$\\sqrt{ }$ patchy / confluent ill-defined areas of acinar consolidation (87-91\\%), commonly involving two / more segments (earliest finding)\n$\\checkmark$ thin-walled cavitation with smooth inner surface (present in more advanced disease):\n$\\checkmark$ cavity under tension (air influx + obstructed efflux)\n$\\checkmark$ air-fluid level $=$ strong evidence for superimposed bacterial / fungal infection\n$\\checkmark$ \"air-crescent\" sign = mobile intracavitary mycetoma\n$\\checkmark$ accentuated drainage markings toward ipsilateral hilum\n$\\checkmark$ acinar nodular pattern $(20 \\%) \\leftarrow$ bronchogenic spread\n$\\checkmark$ pleural effusion $(18 \\%)$\nCT:\n$\\checkmark$ micronodules in centrilobular location $(62 \\%)=$ solid caseation material in / surrounding the terminal / respiratory bronchioles\n$\\checkmark$ interlobular septal thickening $(34-54 \\%)=$ increase in lymphatic flow as inflammatory response / impaired lymphatic drainage $\\leftarrow$ hilar lymphadenopathy\n\n## Local Fibroproductive Tuberculosis\n\n@ Parenchymal disease:\n$\\checkmark$ sharply circumscribed irregular + angular masslike fibrotic lesion (in up to $7 \\%$ )\n$\\checkmark$ cavitation (HALLMARK) $\\leftarrow$ expulsion of caseous necrosis into airways; rare in children, in up to $45-51 \\%$ in adults; often multiple suggesting high likelihood of active TB:\nSite: apical / posterior segments of upper lobes\n$\\checkmark$ cavity forms within areas of consolidation\n$\\checkmark$ thick irregular cavity wall $\\rightarrow$ smooth thin cavity wall with successful treatment\n$\\checkmark \\pm$ air-fluid level (rare) may indicate superinfection\n$\\checkmark$ reticular pulmonary scars\n$\\checkmark$ cicatrization atelectasis $=$ volume loss in affected lobe",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 756,
            "markdown": "$\\checkmark$ peripheral tree-in-bud opacities (indicative of active disease)\n$\\checkmark$ pneumothorax (5\\%)\n@ Airway involvement\n$\\checkmark$ long-segment bronchial stenosis (in 10-40\\%) with irregular wall thickening, luminal obstruction, and extrinsic compression:\n$\\checkmark$ persistent segmental / lobar collapse\n$\\checkmark$ lobar hyperinflation\n$\\checkmark$ obstructive pneumonia\n$\\checkmark$ mucoid impaction\n$\\checkmark$ traction bronchiectasis in apical / posterior segments of upper lobes\n$\\checkmark$ tree-in-bud opacities in lung periphery $\\leftarrow$ endobronchial spread of active infection\n@ Pleural extension:\n$\\checkmark$ small septated pleural effusions remaining stable for years (in 18\\%):\n$\\checkmark$ air-fluid level in pleural space $=$ bronchopleural fistula\n$\\checkmark$ pleural thickening:\n$\\checkmark$ apical cap = pleural rind $=$ thickening of layer of extrapleural fat $(3-25 \\mathrm{~mm})+$ pleural thickening $(1-3 \\mathrm{~mm})$\n$\\checkmark$ rim-enhancing / calcified soft-tissue mass of chest wall\n$\\checkmark$ destruction of bone / costal cartilage\n$\\checkmark$ fistulization to skin\n@ Lymphadenopathy (in 5\\%):\n$\\checkmark$ tuberculous lymphadenitis = enlarged nodes with central areas of low attenuation\n$\\checkmark$ calcified hilar / mediastinal nodes:\n\n- broncholithiasis = erosion into adjacent airway\n\n\n# Extrapulmonary Tuberculosis \n\nIn order of frequency: kidney, liver, spleen, bone, adrenal\n@ Genitourinary\n@ Hepatosplenic\n@ Musculoskeletal system (1-3\\%): spine (5\\%)\n@ Lymph nodes, peritoneum, GI tract\n@ Head \\& neck (15\\%)\n@ CNS (5\\%)\n@ Heart $(0.5 \\%)$\n$\\checkmark>3 \\mathrm{~mm}$ irregular pericardial thickening (in adults)\n$\\checkmark$ IVC distention to $>3 \\mathrm{~cm}$ in diameter\n$\\checkmark$ pericardial effusion / localized pericardial calcification ( $<20 \\%$ )\n$\\checkmark$ miliary lesions / tuberculomas of myocardium\n$\\checkmark$ typically bilateral pleural effusions\n$\\checkmark$ deformities of intraventricular septum\n\n## Extrarenal Signs of TB on Abdominal Plain Film\n\n$\\checkmark$ osseous / paraspinous changes of TB (= diskitis + psoas abscess)\n$\\checkmark$ calcified granulomas in liver, spleen, lymph nodes, adrenals",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 757,
            "markdown": "# UNILATERAL PULMONARY AGENESIS \n\n$=$ one-sided lack of primitive mesenchyme\nCause: ? abnormal blood flow in dorsal aortic arch during $4^{\\text {th }}$ week of gestation\nAssociated with:\nanomalies in $60 \\%$ (higher if right lung involved): PDA, anomalies of great vessels, pulmonary sling, tetralogy of Fallot (left-sided pulmonary agenesis), bronchogenic cyst, congenital diaphragmatic hernia, complete tracheal rings, bone anomalies\n\n- may be asymptomatic versus respiratory infections\n\nLocation: R (worse prognosis) $>\\mathrm{L}$ (better prognosis)\n$\\sqrt{ }$ completely opaque hemithorax\n$\\sqrt{ }$ ipsilateral absence of pulmonary vessels (arteries + veins)\n$\\sqrt{ }$ absent ipsilateral mainstem bronchus + airways\n$\\sqrt{ }$ symmetrical chest cage with approximation of ribs\n$\\sqrt{ }$ marked contralateral lung hyperexpansion + hyperlucency\n$\\sqrt{ }$ ipsilateral shift of mediastinum + diaphragm\n\n## VARICELLA-ZOSTER PNEUMONIA\n\nFrequency: $14 \\%$ overall; $50 \\%$ in hospitalized adults\nAge: $>19$ years ( $90 \\%$ ); $3^{\\text {rd }}-5^{\\text {th }}$ decade ( $75 \\%$ ); contrasts with low incidence of varicella in this age group\n\n- vesicular rash\n$\\sqrt{ }$ patchy diffuse airspace consolidation\n$\\sqrt{ }$ tendency for coalescence near hila + lung bases\n$\\sqrt{ }$ widespread nodules ( $30 \\%$ ) representing scarring\n$\\sqrt{ }$ tiny $2-3-\\mathrm{mm}$ calcifications widespread throughout both lungs ( $2 \\%$ )\nCx: unilateral diaphragmatic paralysis\nPrognosis: $11 \\%$ mortality rate\n\n\n## WILLIAMS-CAMPBELL SYNDROME\n\n$=$ congenital bronchial cartilage deficiency in the $4^{\\text {th }}-6^{\\text {th }}$ bronchial generation either diffuse or restricted to focal area\nHRCT:\n$\\sqrt{ }$ cystic bronchiectasis distal to $3^{\\text {rd }}$ bronchial generation\n$\\sqrt{ }$ emphysematous lung distal to bronchiectasis\n$\\sqrt{ }$ inspiratory ballooning + expiratory collapse of dilated segments\n\n## WILSON-MIKITY SYNDROME\n\n$=$ PULMONARY DYSMATURITY\n$=$ similarity to bronchopulmonary dysplasia in normal preterm infants breathing room air; rarely encountered anymore due to mechanical assisted ventilation\nPredisposed: premature infants $<1,500 \\mathrm{~g}$ who are initially well\n\n- gradual onset of respiratory distress between 10 and 14 days\n$\\sqrt{ }$ hyperinflation\n$\\sqrt{ }$ reticular pattern radiating from both hila",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 758,
            "markdown": "$\\sqrt{ }$ small bubbly lucencies throughout both lungs (identical to bronchopulmonary dysplasia)\nPrognosis: resolution over 12 months\n$D D x$ : perinatally-acquired infection (especially CMV)\n\n# ZYGOMYCOSIS \n\n$=$ PHYCOMYCOSIS\n$=$ group of severe opportunistic sinonasal + pulmonary disease caused by a variety of\nPhycomycetes (soil fungi)\nOrganism: ubiquitous Mucor (most common), Rhizopus, Absidia with broad nonseptated hyphae of irregular branching pattern\nAt risk: immunoincompetent host with\n(1) Lymphoproliferative malignancies and leukemia\n(2) Acidotic diabetes mellitus\n(3) Immunosuppression through steroids, antibiotics, immunosuppressive drugs (rare)\nEntry: inhalation / aspiration from sinonasal colonization\nPath: angioinvasive behavior similar to aspergillosis\nA. RHINOCEREBRAL FORM\n$=$ involvement of paranasal sinuses (frontal sinus usually spared) with extension into:\n(a) orbit $=$ orbital cellulitis\n(b) base of skull $=$ meningoencephalitis + cerebritis\nB. PULMONARY FORM\n$\\sqrt{ }$ segmental homogeneous consolidation\n$\\sqrt{ }$ cavitary consolidation + \"air-crescent\" sign\n$\\sqrt{ }$ nodules (from arterial thrombi + infarction)\n$\\sqrt{ }$ rapidly progressive (often fatal) pneumonia\n$D x$ : culture of fungus from biopsy specimen / demonstration within pathologic material\n$D D x$ : aspergillosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 759,
            "markdown": "# DIFFERENTIAL DIAGNOSIS OF BREAST DISORDERS \n\n## VARIATIONS IN BREAST DEVELOPMENT\n\n## Unilateral Breast Development\n\nmay exist 2 years before other breast becomes palpable\n\n## Premature Thelarche\n\n$=$ breast development $<7$ years of age (in African American girls) and $<8$ years of age (in white girls)\nCause:\n(1) isolated idiopathic $=$ mostly subtle hyperfunction of pituitary-ovarian axis\n\nAge: $1-3$ years\n\n- NO growth spurt / advanced bone age / menses\n(2) central precocious puberty\n$\\checkmark$ enlargement of uterus + ovaries\n$\\checkmark$ advanced bone age\n$\\sqrt{ }$ uni- / bilateral normal breast tissue\n\n\n## Congenital Anomalies\n\n1. Polythelia $=$ more than normal number of nipples\n2. Polymastia $=$ more than normal number of breasts\n3. Amastia $=$ absence of mammary glands\n\n## BREAST DENSITY\n\n$=$ relative amount of radiopaque epithelial + stromal elements compared with amount of radiolucent fat on mammography\nThe masking effect of dense breasts on cancer detection is greatly reduced by digital over film-screen mammography.\nInter- and intraobserver variability on breast density:\n\n- low reliability of interreader density agreement $(\\kappa=0.59)$\n- imperfect intrareader agreement $(\\kappa=0.72)$\n\nFactors affecting breast density between mammograms:\nbody mass index, weight changes, age, HRT, dietary intake\nBreast density may vary over time through variability of interpretation, physiologic changes and breast positioning.\nMammographic sensitivity vs. breast density:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 760,
            "markdown": "Mammographic sensitivity plummets from $80-98 \\%$ in women with entirely fatty breasts to $30-64 \\%$ in women with extremely dense breasts.\n\n# Asymmetric Breast Density \n\nA. BENIGN\n\n1. Postsurgical scarring\n2. Noniatrogenic trauma\n3. Postinflammatory fibrosis\n4. Radial scar\n5. Ectopic / accessory breast tissue (in axillary tail / close to abdomen)\n6. Asymmetric breast development / asymmetric involution\n7. Simple cyst\n8. Fibrocystic conditions: fibrosis / sclerosing adenosis\n9. Hormonal therapy: replacement, contraceptives\nB. MALIGNANT\n10. Invasive ductal carcinoma: desmoplastic reaction\n11. Invasive lobular carcinoma\n12. Tubular carcinoma\n13. Primary lymphoma of breast\nC. IMAGING PROBLEMS\n14. Superimposed normal fibroglandular tissue\n15. Lesion obscured by overlapping dense parenchyma\n16. Lesion outside field of view\n\n## Diffuse Increase in Breast Density\n\n$\\diamond$ Increased breast density masks breast cancer detection and is also a primary risk factor for breast cancer!\nThe relative risk for cancer in women with heterogeneously dense breasts compared with the average woman is $\\sim 1.2$.\nThe relative risk for cancer in women with extremely dense breasts compared with the average woman is $\\sim 2.1$.\n$\\checkmark$ generalized increased density\n$\\checkmark$ skin thickening\n$\\checkmark$ reticular pattern in subcutis\nA. CANCER\n\n1. \"Inflammatory\" breast cancer\n2. Diffuse primary noninflammatory breast cancer\n3. Diffuse metastatic breast cancer\n4. Lymphoma / leukemia $\\leftarrow$ obstructive lymphedema of breast\nB. INFECTIOUS mastitis\nusually in lactating breast\nC. RADIATION\n(a) diffuse exudative edema within weeks after beginning of radiation therapy\n(b) indurational fibrosis months after radiation therapy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 761,
            "markdown": "# D. EDEMA \n\nE. HEMORRHAGE\n\n1. Posttraumatic\n2. Anticoagulation therapy\n3. Bleeding diathesis\nF. ACCIDENTAL INFUSION OF FLUID\ninto subcutaneous tissue\n\n## Breast Edema\n\n1. Lymphatic obstruction: extensive axillary / intrathoracic lymphadenopathy, mediastinal / anterior chest wall tumor, axillary surgery, SVC syndrome, filariasis, intestinal lymphangiectasia\n2. Skin disorder: psoriasis, burns\n3. Generalized body edema: congestive heart failure (breast edema may be unilateral if patient in lateral decubitus position), hypoalbuminemia (renal disease, liver cirrhosis), fluid overload\n\n## Abnormal Uptake of Bone Agents within Breast\n\n1. Breast carcinoma\n2. Prosthesis\n3. Drug-induced\n\n## MAMMOGRAPHIC RISK ASSESSMENT\n\nfor invasive breast carcinoma\nA. NO INCREASED RISK\n\n1. Nonproliferative lesions: adenosis, florid adenosis, apocrine metaplasia without atypia, macro- / microcysts, duct ectasia, fibrosis, mild hyperplasia (more than 2 but not more than 4 epithelial cells deep), mastitis, periductal mastitis, squamous metaplasia\n2. Fibroadenoma\nB. PROLIFERATIVE LESIONS WITHOUT ATYPIA\n\nRelative risk increase: 1.5-2.0\n\n1. Columnar cell change / hyperplasia $=$ blunt duct adenosis\n2. Moderate + florid solid / papillary hyperplasia without atypia\n3. Sclerosing adenosis\n4. Intraductal papilloma with fibrovascular core\n5. Pseudoangiomatous stromal hyperplasia (PASH)\n6. Radial sclerosing lesion\nC. PROLIFERATIVE LESIONS WITH ATYPIA\n\nRelative risk increase: 4-5\n\n1. Atypical ductal hyperplasia (ADH)\n2. Lobular neoplasia: separation based on degree of distension of affected terminal ductules:\n(a) Atypical lobular hyperplasia (ALH)\n(b) Lobular carcinoma in situ (LCIS)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 762,
            "markdown": "# BREAST LESION \n\n## Mammographic Evaluation of Breast Masses\n\nTrue mass or pseudomass?\nA. SIZE\n> well-defined nodules $<1.0 \\mathrm{~cm}$ are of low risk for cancer\n> \"most likely benign\" nodules approaching 1 cm should be considered for ultrasound / aspiration / biopsy\nB. SHAPE\n> increase in probability of malignancy: architectural distortion $>$ irregular $>$ lobulated $>$ oval $>$ round\nC. MARGIN / CONTOUR (most important factor)\n> well-circumscribed mass with sharp abrupt transition from surrounding tissue is almost always benign\n> \"halo\" sign of apparent lucency = optical illusion of Mach effect + true radiolucent halo is almost always $(92 \\%)$ benign but NOT pathognomonic for benignity\n> microlobulated margin worrisome for cancer\n> obscured margin may represent infiltrative cancer\n> irregular ill-defined margin has a high probability of malignancy\n> spiculated margin due to\n(a) fibrous projections extending from main cancer mass\n(b) previous surgery\n(c) sclerosing duct hyperplasia (radial scar)\nD. LOCATION\n> intramammary lymph node typically in upper outer quadrant (in 5\\% of all mammograms)\n> large hamartoma + abscess common in retro- / periareolar location\n> sebaceous cyst in subcutaneous tissue\nE. X-RAY ATTENUATION = DENSITY\n> fat-containing lesions are never malignant\n> high-density mass suspicious for carcinoma (density higher than for equal volume of fibroglandular tissue $\\leftarrow$ fibrosis)\nF. NUMBER\n> multiplicity of identical lesions decreases risk\nG. INTERVAL CHANGE\n> enlarging mass needs biopsy\nH. PATIENT RISK FACTORS\n> increasing age increases risk for malignancy\n> positive family history\n> history of previous abnormal breast biopsy\n> history of extramammary malignancy\n\n## Focal Asymmetry\n\nDefinition:\n$=$ asymmetry confined to less than a quadrant\n(a) lesion with definable borders only seen on 1 view",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 763,
            "markdown": "(b) lesion of similar shape on 2 orthogonal views lacking convex margins + conspicuity of a true mass\n\nA real lesion may not be included in the field of view of the orthogonal view!\nCause:\n\n1. Pseudolesion (in $2 \\%$ of screening mammograms)\n$=$ summation artifact of overlapping breast tissue\n2. Breast cancer\n$\\diamond$ A focal asymmetry is a malignancy in only $1-3 \\%$\n$\\diamond$ A developing / new focal asymmetry represents a malignancy in 6-27\\%\n$\\diamond$ In $9-38 \\%$ missed cancers were retrospectively visible as a focal asymmetry\nA 1-view lesion is of concern if associated with: outward convex margins / straight lines of architectural distortion or spiculation / microcalcifications / palpability\nDense fibroglandular tissue may obscure a real lesion on the orthogonal view!\nHisto: invasive lobular carcinoma (in 33\\%), invasive ductal carcinoma\n\n# Well-circumscribed Breast Mass \n\n$\\diamond$ Well-defined nonpalpable lesions have a $4 \\%$ risk of malignancy!\nA. BENIGN\n\n1. Cyst $(45 \\%)$\n2. Fibroadenoma\n3. Sclerosing adenoma\n4. Intraductal papilloma (intracystic / solid)\n5. Galactocele\n6. Sebaceous cyst\n7. Pseudoangiomatous stromal hyperplasia\nB. MALIGNANT\n8. Medullary carcinoma\n9. Mucinous carcinoma\n10. Intracystic papillary carcinoma\n11. Invasive ductal cancer not otherwise specified (rare)\n12. Pathologic intramammary lymph node\n13. Metastases to breast: melanoma, lymphoma / leukemia, lung cancer, hypernephroma\n\n## De Novo Mass in Woman > 40 Years of Age\n\n1. Cyst\n2. Papilloma\n3. Carcinoma ( $10-20 \\%$ )\n(a) Invasive ductal carcinoma (not otherwise specified)\n(b) Mucinous carcinoma\n(c) Medullary carcinoma\n(d) Intracystic papillary carcinoma\n(e) Invasive papillary carcinoma\n(f) Metaplastic carcinoma\n(g) Malignant phyllodes tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 764,
            "markdown": "(h) Adenoid cystic carcinoma\n4. Sarcoma (rare)\n5. Fibroadenoma (exceedingly rare)\n6. Metastasis (extremely rare)\n\n# Fibrous Breast Lesion \n\n1. Fibroadenoma\n2. Phyllodes tumor\n3. Sclerosing lobular hyperplasia\n4. Pseudoangiomatous stromal hyperplasia\n5. Diabetic mastopathy\n6. Focal fibrosis\n7. Fibromatosis\n\n## Fat-containing Breast Lesion\n\n$\\diamond$ Fat contained within a lesion usually proves benignity!\n\n1. Lipoma\n2. Galactocele\n$=$ fluid with high lipid content (last phase)\n\n- during / shortly after lactation\n\n3. Oil cyst $=$ traumatic lipid cyst $=$ fat necrosis\n\n- site of prior surgery / trauma\n\n4. Focal collection of normal breast fat\n\n## Mixed Fat- and Water-density Lesion\n\n1. Fibroadenolipoma / hamartoma\n2. Intramammary lymph node\n3. Galactocele\n4. Hamartoma $=$ lipofibroadenoma $=$ fibroadenolipoma\n5. Small superficial hematoma\n6. Cancer engulfing fat\n$\\sqrt{ }$ irregular / spiculated margins]\n\n## Secretory Disease\n\n1. Retained lactiferous secretions\n$=$ incomplete / prolonged involution of lactiferous ducts\n$\\sqrt{ }$ branching pattern of fat density in dense breast (high lipid content)\n2. Prolonged inspissation of secretion + intraductal debris\n$=$ Mammary duct ectasia\n3. Galactocele\n4. Plasma cell mastitis\n\n## Breast Lesion with Halo Sign\n\nA. HIGH-DENSITY LESION\n$=$ vessels + parenchymal elements not visible in superimposed lesion\n\n1. Cyst",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 765,
            "markdown": "2. Sebaceous cyst\n3. Wart\nB. LOW-DENSITY LESION\n$=$ vessels + parenchyma seen superimposed on lesion\n4. Fibroadenoma\n5. Galactocele\n6. Cystosarcoma phylloides\n\n# Stellate / Spiculated Breast Lesion \n\n$=$ mass / architectural distortion characterized by thin lines radiating from its margins\nThe majority of invasive breast cancers are stellate (stellate $\\div$ circular $=65 \\div 35$ )\n, $93 \\%$ of all stellate lesions are malignant\nRisk of malignancy:\n$75 \\%$ for nonpalpable spiculated masses\n$32 \\%$ for nonpalpable irregular masses\nA. PSEUDOSTELLATE STRUCTURE\n$=$ SUMMATION SHADOW / ARTIFACT\ncaused by fortuitous superimposition of normal fibrous + glandular structures; unveiled by rolled views, spot compression views $\\pm$ microfocus magnification technique\nB. \"BLACK STAR\"\n$\\checkmark$ groups of fine straight / curvilinear fibrous strands bunched together like a broom\n$\\checkmark$ circular / oval lucencies within center\n$\\checkmark$ change in appearance from view to view\n\n1. Radial scar $=$ sclerosing duct hyperplasia $(86 \\%)$\n2. Sclerosing adenosis\n3. Posttraumatic fat necrosis $(11 \\%)$\nC. \"WHITE STAR\"\n$\\checkmark$ individual straight dense spicules\n$\\checkmark$ central solid tumor mass\n$\\checkmark$ little change in different views\n(a) malignant lesions\n4. Invasive ductal carcinoma $(65 \\%)=$ scirrhous carcinoma\n$=$ desmoplastic reaction + secondary retraction of surrounding structures\n\n- clinical dimensions $>$ mammographic size\n$\\checkmark$ distinct central tumor mass with irregular margins\n$\\checkmark$ length of spicules increase with tumor size\n$\\checkmark$ localized skin thickening / retraction when spiculae extend to skin\n$\\checkmark$ commonly associated with malignant-type calcifications\n\n2. Invasive lobular carcinoma ( $21 \\%$ )\n\n- palpable mass\n$\\checkmark$ lack of central tumor mass\n\n3. Tubular carcinoma ( $9 \\%$ )\n4. Other $(5 \\%)$\n(b) benign lesions\n5. Postoperative scar",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 766,
            "markdown": "- correlation with history + site of biopsy\n$\\sqrt{ }$ scar diminishes in size + density over time\n\n2. Postoperative hematoma\n\n- clinical information\n$\\sqrt{ }$ short-term mammographic follow-up confirms complete resolution\n\n3. Breast abscess\n\n- clinical information\n$\\sqrt{ }$ high-density lesion with flamelike contour\n\n4. Hyalinized fibroadenoma with fibrosis\n$\\checkmark$ changing pattern with different projections\n$\\checkmark$ may be accompanied by typical coarse calcifications of fibroadenomas\n5. Granular cell myoblastoma\n6. Fibromatosis\n7. Extra-abdominal desmoid\nmnemonic: STARFASH\n\nSummation shadow\nTumor (malignant)\nAbscess\nRadial scar\nFibroadenoma (hyalinized), Fat necrosis\nAdenosis (sclerosing)\nScar (postoperative)\nHematoma (postoperative)\n\n# Tumor-mimicking Lesions \n\n1. \"Phantom breast tumor\" = simulated mass\n(a) asymmetric density\n$\\checkmark$ scalloped concave breast contour\n$\\checkmark$ interspersed fatty elements\n(b) summation artifact = chance overlap of normal glandular breast structures\n$\\checkmark$ failure to visualize \"tumor\" on more than one view\n2. Silicone injections\n3. Skin lesions\n(a) Dermal nevus\n$\\checkmark$ sharp halo / fissured appearance\n(b) Skin calcifications\n$\\checkmark$ lucent center (= clue)\n$\\checkmark$ superficial location (tangential views)\n(c) Sebaceous / epithelial inclusion cyst\n(d) Neurofibromatosis\n(e) Biopsy scar\n4. Lymphedema\n5. Lymph nodes\n\nFrequency: $5.4 \\%$ for intramammary nodes\nLocation: axilla, subcutaneous tissue of axillary tail, lateral portion of pectoralis muscle,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 767,
            "markdown": "intramammary (typically in upper outer quadrant)\n$\\sqrt{ }$ ovoid / bean-shaped mass(es) with fatty notch representing hilum\n$\\sqrt{ }$ central zone of radiolucency (fatty replacement of center) surrounded by \"crescent\" rim of cortex\n$\\sqrt{ }$ usually $<1.5 \\mathrm{~cm}$ (up to 4 cm ) in size\n$\\sqrt{ }$ well-circumscribed with slightly lobulated margin\nUS:\n$\\sqrt{ }$ reniform hypoechoic rim with echogenic center\n$\\sqrt{ }$ echogenic hilum for entry and exit of vessels\n6. Hemangioma\n\n# Solid Breast Lesion by Ultrasound \n\n## Morphologic Descriptors of Solid Benign Breast Mass\n\n| 1. Shape | oval ( $84 \\%$ NPV), round, irregular ( $62 \\%$ PPV) |\n| :--: | :--: |\n| 2. Orientation | parallel ( $78 \\%$ NPV), nonparallel ( $69 \\%$ PPV) to chest wall (\"taller-than-wide\" / \"vertical\") |\n| 3. Margin | circumscribed ( $90 \\%$ NPV), microlobulated, indistinct, angular, spiculated ( $86 \\%$ PPV) |\n| 4. Lesion boundary | abrupt, echogenic halo |\n| 5. Internal echo pattern | anechoic, hyperechoic, complex, hypoechoic, isoechoic (in reference to SQ fat) |\n| 6. Posterior acoustic feature | shadowing, enhancement |\n\n## Posterior Acoustic Shadowing\n\n1. Invasive carcinoma\n2. Postoperative scar\n3. Complex sclerosing lesion\n4. Microcalcifications\n5. Dense breast tissue\n\n## Posterior Acoustic Enhancement\n\n1. Normal anatomic structure\n2. Cyst: simple / complicated\n3. Fibroadenoma\n4. Nodular sclerosing adenosis\n5. Papilloma\n6. Complex cystic mass\n7. Invasive ductal carcinoma\n8. Lymphoma\n\n## Echogenic Breast Lesion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 768,
            "markdown": "Incidence: $0.6-5.6 \\%$ of breast masses\n$\\diamond$ Hyperechogenicity alone does not allow exclusion of malignancy!\nA. Benign\n\n1. Lipoma\n2. Angiolipoma\n3. Hematoma\n4. Seroma\n5. Fat necrosis\n6. Silicone granuloma\n7. Sebaceous / epidermal inclusion cyst\n8. Abscess\n9. PASH\n10. Galactocele / lactating adenoma\n11. Ductal ectasia\n12. Apocrine metaplasia\n\nAn echogenic mass that correlates with a well-delineated radiolucent mass at mammo is benign!\nB. Malignant\n\n1. Invasive ductal carcinoma\n2. Invasive lobular carcinoma\n3. Metastasis\n4. Lymphoma\n5. Angiosarcoma\n\nBreast carcinoma is RARELY purely echogenic!\n\n# Malignant Sonographic Characteristics \n\n$\\diamond$ Approximately 5 malignant features are found per cancer. The combination of 5 findings increases the sensitivity to $98.4 \\%$ !\n$\\checkmark$ spiculation $=$ straight lines radiating perpendicularly from surface of tumor:\n$\\checkmark$ coarse spiculation (less common) = hypoechoic lines (= fingers of invasive tumor /\nDCIS) alternating with hyperechoic lines (= interface between tumor and surrounding tissue)\n$\\checkmark$ fine spiculation (more common):\n$\\checkmark$ hyperechoic spicules in fatty tissue\n$\\checkmark$ hypoechoic spicules in fibrous tissue\n$\\checkmark$ thick echogenic halo $=$ spicules too small to resolve\n$\\checkmark$ angular margins $=$ contour of junction between hypo- or isoechoic solid nodule and surrounding tissue at acute / obtuse $/ 90^{\\circ}$ angles\n$\\checkmark$ acoustic shadowing behind all / part of nodule (= desmoplastic reaction as host response to tumor)\n$\\checkmark$ taller-than-wide lesion (feature of small lesions)\n$=$ AP dimension greater than craniocaudal / transverse dimension\n$\\checkmark$ microlobulations $=$ many small lobulations at surface of solid nodule ( $=$ duct distended with DCIS / cancerized lobule)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 769,
            "markdown": "$\\sqrt{ }$ duct extension (= intraductal growth of breast cancer in single large duct extending toward nipple)\n$\\sqrt{ }$ branch pattern (= intraductal growth of breast cancer in multiple small ducts extending away from nipple)\n$\\sqrt{ }$ hypoechoic texture $=$ central part of solid lesion markedly hypoechoic with respect to fat $\\leftarrow$ invasive tumor mass / fluid within tumor / acoustic shadow\n$\\sqrt{ }$ punctate echogenic calcifications within hypoechoic duct extension / branch pattern / microlobulations (acoustic shadowing commonly not present)\n\n| Sonographic Findings of Malignancy (according to data from A.T. Stavros) |  |\n| :--: | :--: |\n| Certainty | US Finding |\n| Hard = invasive carcinoma | Spiculation, thick echogenic halo <br> Angular margins <br> Acoustic shadowing |\n| Indeterminate | Hypoechoic texture <br> Taller-than-wide orientation |\n| Soft = DCIS component | Microlobulation <br> Duct extension <br> Branch pattern <br> Calcifications |\n\n# Benign Sonographic Characteristics \n\n$\\sqrt{ }$ absence of any malignant characteristics\n$\\diamond$ A single malignant feature prohibits classification of a nodule as benign!\n$\\sqrt{ }$ marked hyperechogenic well-circumscribed nodule compared with fat $=$ normal stromal\nfibrous tissue (may represent a palpable pseudomass / fibrous ridge)\n$\\sqrt{ }$ smooth well-circumscribed ellipsoid shape\n$\\sqrt{ } 2-3$ smooth well-circumscribed gentle lobulations\n$\\sqrt{ }$ thin echogenic capsule\n$\\sqrt{ }$ kidney-shaped lesion $=$ intramammary lymph node\n$\\diamond$ If specific benign features are not found the lesion is classified as indeterminate!\n\n## Complex Cystic Breast Mass\n\n$=$ cyst with thick wall, thick septa, intracystic discrete solid components\nClassification:\nType 1 thick outer wall $\\pm$ thick internal septa\nType 2 one / more intracystic masses\nType 3 mixed cystic ( $>50 \\%$ ) and solid components\nType 4 predominantly solid + eccentric cystic foci\n(a) benign breast lesion\n\n1. Fibrocystic changes: adenosis, sclerosing adenosis, apocrine metaplasia, cyst formation $\\pm$ rupture, ductal ectasia\n2. Intraductal / intracystic papilloma\n3. Fibroadenoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 770,
            "markdown": "4. Breast varix\n(b) atypical (high-risk) breast lesion\n5. Atypical ductal hyperplasia\n6. Atypical papilloma\n7. Lobular neoplasia\n(c) malignant breast lesion\n8. DCIS\n9. Infiltrating ductal carcinoma\n10. Infiltrating lobular carcinoma\n\n| Benign Sonographic Characteristics <br> (according to data from A.T. Stavros) |  |  |  |  |\n| :-- | :--: | :--: | :--: | :--: |\n| US Characteristic | Sens. | Specif. | NPV | Rel. risk |\n| Hyperechoic | 100.0 | 7.4 | 100.0 | 0.00 |\n| $\\leq 3$ lobulations | 99.2 | 19.4 | 99.2 | 0.05 |\n| Ellipsoid shape | 97.6 | 51.2 | 99.1 | 0.05 |\n| Thin echogenic capsule | 95.2 | 76.0 | 98.8 | 0.07 |\n\n# MALE BREAST DISEASE \n\n## Benign Male Breast Disease\n\n1. Gynecomastia\n2. Lipoma\n3. Pseudoangiomatous stromal hyperplasia\n4. Granular cell tumor\n5. Fibromatosis / desmoid tumor\n6. Myofibroblastoma\n7. Schwannoma\n8. Hemangioma\n\n## Malignant Male Breast Disease\n\nA. CARCINOMA\n\n1. Invasive ductal carcinoma\n\nIncidence: $0.17 \\%$ of all male breast cancers\nMean age: 59 years\n$\\checkmark$ microcalcifications in only $13-30 \\%$\n2. Papillary carcinoma\n3. Invasive lobular carcinoma\n4. Adenoid cystic carcinoma\nB. SARCOMA\n\n1. Liposarcoma\n2. Dermatofibrosarcoma\n3. Pleomorphic hyalinizing angiectatic tumor\nC. OTHERS\n4. Basal cell carcinoma of nipple",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 771,
            "markdown": "2. Lymphoma / leukemia\n$=$ most common hematopoietic disease of the breast\n$\\checkmark$ axillary lymphadenopathy: unilateral in primary / bilateral in secondary breast lymphoma\n3. Metastasis\n\n# BREAST CALCIFICATIONS \n\n$=$ deposits of calcium salts\n(a) precipitated salts in accumulated fluid secreted by epithelial cells\nb) in / on necrotic cells\n(c) fibrous capsule of foreign object\n\nIndicative of focally active process; often requiring biopsy\n$\\diamond 75-80 \\%$ of biopsied clusters of calcifications represent a benign process\n$\\diamond 10-30 \\%$ of microcalcifications in asymptomatic patients are associated with cancers\nComposition: hydroxyapatite / tricalcium phosphate / calcium oxalate\nResults of breast biopsies for microcalcifications:\n(without any other mammographic findings)\n(a) benign lesions $(80 \\%)$\n\n1. Mastopathy without proliferation $44 \\%$\n2. Mastopathy with proliferation $28 \\%$\n3. Fibroadenoma $4 \\%$\n4. Solitary papilloma $2 \\%$\n5. Miscellaneous $2 \\%$\n(b) malignant lesions $(20 \\%)$\n6. Lobular carcinoma in situ $10 \\%$ in $8 \\%$ no spatial relationship to LCIS\n7. Infiltrating carcinoma $6 \\%$\n8. Ductal carcinoma in situ $4 \\%$\n$\\diamond$ A positive biopsy rate of $>35 \\%$ is desirable goal!\nA. LOCATION\n(a) intramammary\n9. Ductal microcalcifications\n$\\checkmark 0.1-0.3 \\mathrm{~mm}$ in size, irregular, sometimes mixed linear + punctate\nOccurrence: secretory disease, epithelial hyperplasia, atypical ductal hyperplasia, intraductal carcinoma\n10. Lobular microcalcifications\n$\\checkmark$ smooth round, similar in size + density\nOccurrence:\ncystic hyperplasia, adenosis, sclerosing adenosis, atypical lobular hyperplasia, lobular carcinoma in situ, cancerization of lobules ( $=$ retrograde migration of ductal carcinoma to involve lobules), ductal carcinoma obstructing egress of lobular contents\nN.B.: lobular and ductal microcalcifications occur frequently in fibrocystic disease + breast cancer!\n(b) extramammary: arterial wall, duct wall, fibroadenoma, oil cyst, skin, etc.",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 772,
            "markdown": "B. SIZE\n$\\diamond$ Mammography detects calcifications $>100 \\mu \\mathrm{~g}$; down to $\\sim 75 \\mu \\mathrm{~g}$ for spot magnification views\n$\\sqrt{ }$ malignant calcifications usually $<0.5 \\mathrm{~mm}$; rarely $>1.0 \\mathrm{~mm}$\nC. NUMBER\n$\\sqrt{ }<4-5$ calcifications per $1 \\mathrm{~cm}^{2}$ have a low probability for malignancy\nD. MORPHOLOGY\n(a) benign\n\n1. Smooth round calcifications: formed in dilated acini of lobules\n2. Solid / lucent-centered spheres: usually $\\leftarrow$ fat necrosis\n3. Crescent-shaped calcifications that are concave on horizontal beam lateral projection $=$ sedimented milk of calcium at bottom of cyst\n4. Lucent-centered calcifications: around accumulated debris within ducts / in skin\n5. Solid rod-shaped calcifications / lucent-centered tubular calcifications: formed within / around normal / ectatic ducts\n6. Rimlike / eggshell calcifications in rim of breast cyst, fibrous wall of fat necrosis (\"oil cyst\"), pseudocapsule of fibroadenoma\n7. Calcifications with parallel track appearance $=$ vascular calcifications\n(b) malignant\n$=$ calcified cellular secretions / necrotic cancer cells within ducts\n$\\sqrt{ }$ calcifications of vermicular form, varying in size, of linear / branching shape\nE. DISTRIBUTION\n8. Clustered heterogeneous calcifications: adenosis, peripheral duct papilloma, hyperplasia, cancer\n9. Segmental calcifications within single duct network: suspect for multifocal cancer within lobe\n10. Regional / diffusely scattered calcifications with random distribution throughout large volumes of breast: almost always benign\nF. TIME COURSE\nmalignant calcifications can remain stable for $>5$ years!\nG. DENSITY\n\n# Malignant Calcifications \n\n1. Granular calcifications $=$ resembling fine grains of salt\n$\\sqrt{ }$ amorphous, dotlike / elongated, fragmented\n$\\sqrt{ }$ grouped very closely together\n$\\sqrt{ }$ irregular in form, size, and density\n2. Casting calcifications $=$ fragmented cast of calcifications within ducts\n$\\sqrt{ }$ variable in size + length\n$\\sqrt{ }$ great variation in density within individual particles + among adjacent particles\n$\\sqrt{ }$ jagged irregular contour\n$\\sqrt{ } \\pm$ Y-shaped branching pattern\n$\\sqrt{ }$ clustered ( $>5$ per focus within an area of $1 \\mathrm{~cm}^{2}$ )\n\n## Benign Calcifications",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 773,
            "markdown": "1. Lobular calcifications $=$ arise within a spherical cavity of cystic hyperplasia, sclerosing adenosis, atypical lobular hyperplasia\n$\\sqrt{ }$ sharply outlined homogeneous solid spherical \"pearl-like\"\n$\\sqrt{ }$ little variation in size\n$\\sqrt{ }$ numerous + scattered\n$\\checkmark$ associated with considerable fibrosis\n(a) adenosis\n$\\checkmark$ diffuse calcifications involving both breasts symmetrically\n(b) periductal fibrosis\n$\\checkmark$ diffuse / grouped calcifications + irregular borders, simulating malignant process\n2. Sedimented milk of calcium\n\nFrequency: $4 \\%$\n$\\checkmark$ multiple bilateral scattered / occasionally clustered calcifications within microcysts\n$\\checkmark$ smudge-like particles (\"cotton balls\") at bottom of cyst on vertical beam (CC image)\n$\\checkmark$ crescent-shaped on horizontal projection = \"teacup-like\" (ML / MLO image)\n3. Plasma cell mastitis $=$ periductal mastitis\n$\\checkmark$ sharply marginated calcifications of uniform density $=$ intraductal form\n$\\checkmark$ sharply marginated hollow calcifications $=$ periductal form\n4. Peripheral eggshell calcifications\n(a) with radiolucent lesion\n> liponecrosis micro- / macrocystica calcificans (= fatty acids precipitate as calcium soaps at capsular surface) as calcified fat necrosis / calcified hematoma\n$\\diamond$ May mimic malignant calcifications!\n(b) with radiopaque lesion\n> degenerated fibroadenoma\n> macrocyst\n$\\checkmark$ high uniform density in periphery\n$\\checkmark$ usually subcutaneous\n$\\checkmark$ no associated fibrosis\n5. Papilloma\n$\\checkmark$ solitary raspberry configuration in size of duct\n$\\checkmark$ central / retroareolar\n6. Degenerated fibroadenoma\n$\\checkmark$ bizarre, coarse, sharply outlined, \"popcornlike\" very dense calcification within dense mass ( $=$ central myxoid degeneration)\n$\\checkmark$ eggshell type calcification (= subcapsular myxoid degeneration)\n$\\checkmark$ heterogeneously grouped macrocalcifications with circumferential nature in postmenopausal woman\n7. Arterial calcifications\n$\\checkmark$ parallel lines of calcifications\n8. Metastatic calcifications\n\nCause: $2^{\\circ}$ hyperparathyroidism (in up to $68 \\%$ )\n\n# Dermal Calcifications \n\nSite: hair follicle, nevus, sebaceous cyst, lupus erythematosus, dermatomyositis, scar",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 774,
            "markdown": "Cause: inspissated material in sebaceous glands, secondary to chronic folliculitis\nLocation: most commonly visible in lower inner breast\nSite: near periphery of skin surface (may project deep within breast even on 2 views at $90^{\\circ}$ angles)\nSize: same size as skin pores\n$\\sqrt{ }$ round lucent centered calcifications:\n$\\sqrt{ }$ hollow radiolucent center (hair follicle)\n$\\sqrt{ }$ linear orientation when caught in tangent\n$\\sqrt{ }$ polygonal shape\nProof: superficial marking technique (= skin localization work-up)\n\n# Dystrophic Calcifications \n\n$=$ calcium deposits on / in necrotic material, cellular debris, devitalized tissue\n(a) skin: lupus erythematosus, dermatomyositis, scar, parasite, breast implant\n(b) foreign body: suture, parasite, breast implant\n$\\sqrt{ }$ larger coarser calcifications than with DCIS\n\n## Calcifications in Branching Tubular Opacity\n\n1. Ductal carcinoma in situ\n2. Atypical ductal hyperplasia\n3. Secretory disease\n4. Peripheral papillomatosis\n5. Vascular: calcified artery; Mondor disease (= thrombophlebitis of superficial vein)\n6. Fat necrosis\n7. S/P Galactography\n\n## NIPPLE \\& AREOLA\n\n## Nipple-Areolar Complex\n\n(a) benign process\n\n1. Nipple inversion\n\nCause: mammary duct ectasia, postsurgical changes, fat necrosis, fibrocystic changes, Mondor disease\n$\\sqrt{ }$ uni- / bilateral\n$D D x$ : malignancy (developing over a few months)\n2. Inflammation / abscess\n3. Mammary duct ectasia\n4. Calcifications\n$\\sqrt{ }$ spherical with central area of lucency (associated with glands + hair follicles)\n$\\sqrt{ }$ nonspecific in association with sutures, fat necrosis, intraductal papilloma, Paget disease, intraductal ca.\n5. Cutaneous horn\n$=$ conical projection of keratin above skin surface that may grow rapidly\n\n- vulnerable to trauma\n$D D x$ : squamous cell carcinoma, Paget disease, sebaceous adenoma, granular cell",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 775,
            "markdown": "6. Nipple adenoma\n(B) MALIGNANT PROCESS\n7. Paget disease\n8. Subareolar carcinoma\n9. Lymphoma\n\n# Benign Mass of the Nipple \n\n1. Papilloma\n2. Fibroadenoma\n3. Nipple adenoma\n\n## Nipple Retraction\n\n1. Positional\n2. Relative to inflammation / edema of periareolar tissue\n3. Congenital\n4. Acquired (carcinoma, ductal ectasia)\n\n## Nipple Discharge\n\nPrevalence: $7.4 \\%$ of breast surgeries\n$\\diamond 3^{\\text {rd }}$ most common breast complaint\nClassification:\nA. Provoked\npostovulatory state, duct ectasia, medication, stimulation by exercise, breast selfexamination, sexual manipulation\nB. Spontaneous\n(a) physiologic: pregnancy; lactation; galactorrhea, duct ectasia; duct stricture; communicating cysts\n(b) pathologic: benign / malignant neoplasm; galactorrhea $\\leftarrow$ hyperprolactinemia from a pituitary adenoma\nC. Unilateral\n$\\diamond$ Unilateral spontaneous discharge is significant + requires investigation!\n(a) benign ( $50 \\%$ ): duct ectasia; intraductal papilloma\n(b) malignant ( $15 \\%$ ): papillary carcinoma; ductal carcinoma in situ (DCIS); invasive ductal carcinoma\nD. Bilateral\n$\\diamond$ Expressed bilateral multipore blood-negative discharge is physiologic and benign!\n\n## Type of discharge:\n\nA. Lactating breast: galactorrhea\nB. Nonlactating breast:\n(a) normal:\n> milky\n> multicolored sticky (blue, green, gray, brown, black)\n(b) abnormal:\n> purulent: antibiotics, incision, drainage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 776,
            "markdown": "(c) surgically significant (in $14.3 \\%$ cancerous)\n> clear / watery: cancer in $33 \\%$\n> bloody / sanguineous: cancer in $28 \\%$,\n> pink / serosanguinous: cancer in $13 \\%$\n> yellow / serous: cancer in $6 \\%$\n> cheesy: chronic duct ectasia with chronic periductal mastitis / comedo-DCIS\n$\\diamond$ Intraductal papilloma is the most common cause of bloody and serosanguinous discharge (in $40 \\%$ )!\n\nExfoliative cytology not helpful (TP in only $11 \\%$, FN in $18 \\%$ )\nSite of origin:\nA. Lobules + terminal duct lobular unit:\n\n1. Galactorrhea\n2. Fibrocystic changes\nB. Larger lactiferous ducts (collecting duct, segmental duct, subsegmental duct)\n3. Solitary papilloma\n4. Papillary carcinoma\n5. Duct ectasia\n\nHigh-risk nipple discharge:\n$=$ discharge likely caused by carcinoma / papilloma\n(1) Spontaneous\n(2) Unilateral\n(3) Single duct orifice\n(4) Clear / serous / serosanguinous / frankly bloody\n\nLow-risk nipple discharge:\n$=$ discharge likely caused by hyperprolactinemia, duct ectasia, fibrocystic change\n(1) Expressible only\n(2) Bilateral\n(3) Multiple duct orifices\n(4) Greenish / milky\n\n# Galactography / Ductography \n\n$=$ diagnostic procedure of choice for spontaneous $\\pm$ guaiac-positive unilateral nipple discharge\n» injection of $0.2-0.3 \\mathrm{~mL}$ of water-soluble contrast material (Conray $60^{\\circledR}$, Isovue ${ }^{\\circledR}$ ) through straight blunt 27 -gauge pediatric sialography cannula ( $0.4-0.6 \\mathrm{~mm}$ outer diameter) / 30-gauge cannula (Ranfac Corp, Avon, MA) / Jabczenski cannula (tip bent $90^{\\circ}$ )\nTiming: within 24 hours of noticing discharge (without squeezing nipple / breast)\nResults of positive galactography:\npapilloma ( $48 \\%$ ), benign conditions ( $42 \\%$ ), intraductal carcinoma ( $10 \\%$ )\nContraindications to ductography:\nhistory of severe allergy to iodinated contrast material; inability of patient to cooperate (debilitating anxiety, mental disorder); history of prior nipple surgery; abscess; diffuse mastitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 777,
            "markdown": "DDx of dilated ducts:\n(1) Duct ectasia\n(2) Blocked duct (during lactation)\n(3) Inflammatory infiltrates\n(4) Periductal mastitis\n(5) Apocrine metaplasia\n\nDDx of intraductal defects:\n(1) Papilloma\n(2) Gas bubble, clot, inspissated secretions, infection\n(3) Epithelial hyperplastic lesion\n(4) Duct carcinoma\n\n| Galactographic Filling Defect |  |  |\n| :--: | :--: | :--: |\n| Type of Tumor | Single | Multiple |\n| Multiple papilloma | $5.60 \\%$ | $14.0 \\%$ |\n| Cancer | $0.05 \\%$ | $9.7 \\%$ |\n\n# BREAST SKIN \n\n## Skin (Dermal) Lesions of Breast\n\nA. DERMAL\n\n1. Sebaceous cyst\n2. Epidermal inclusion cyst\n3. Dermal calcifications\nB. HYPODERMAL = subcutaneous fat\n(a) fat-containing lesions\n4. Lipoma\n5. Fat necrosis\n(b) vascular lesions\n6. Hemangioma\n7. Angiolipoma\n8. Thrombosed vessel\n(c) neurogenic\n9. Granular cell tumor\n(d) lymphatic\nC. SUPERFICIAL MAMMARY TISSUE = anterior TDLU\nN.B.: TDLUs may be located within anterior Cooper ligament extensions into subcutaneous fat\n10. Superficial breast cancer\n11. Peripheral papilloma\n12. Fibroadenoma\n13. Adenosis\n\nLesions of Nipple-Areolar Complex\n\n1. Epidermal inclusion cyst",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 778,
            "markdown": "2. Sebaceous cysts / obstructed Montgomery gland\n3. Breast cancer arising from anterior TDLUs / large lactiferous ducts / central papillomas\n4. Nipple adenoma\n5. Paget disease of nipple\n\n# NIPPLE CHANGES \n\n(a) benign: eczema, psoriasis, allergic contact dermatitis, irritant dermatitis, lichen simplex chronicus\n(b) malignant: Paget disease, Bowen disease (squamous cell carcinoma in situ)\n\n## Skin Thickening of Breast\n\nNormal skin thickness: $\\quad 0.8-3 \\mathrm{~mm} ; 0.5-2 \\mathrm{~mm}$ at MRI; may exceed 3 mm in inframammary region\n$\\diamond$ Epidermis is indistinguishable as a separate layer from the dermis at imaging!\nA. LOCALIZED SKIN THICKENING\n\n1. Trauma prior biopsy, burns\n2. Carcinoma\n3. Abscess\n4. Nonsuppurative mastitis\n5. Dermatologic conditions: psoriasis\nB. GENERALIZED SKIN THICKENING\n\n| Skin Thickening on MR |  |  |\n| :--: | :--: | :--: |\n| Mild | Moderate | Severe |\n| $<3 \\mathrm{~mm}$ | $3-5 \\mathrm{~mm}$ | $>5 \\mathrm{~mm}$ |\n\n$\\diamond$ Skin is thickened initially and to the greatest extent in the lower dependent portion of the breast!\n$\\sqrt{ }$ overall increased density with coarse reticular pattern $\\leftarrow$ dilated lymph vessels + interstitial fluid triggering fibrosis\n(a) axillary lymphatic obstruction\n\n1. Primary breast cancer\n> advanced breast cancer\n> invasive comedocarcinoma in large area\n$\\diamond$ Primary breast cancer not necessarily seen due to small size / hidden location (axillary tail, behind nipple)!\n2. Primary malignant lymphatic disease (eg, lymphoma)\n(b) intradermal + intramammary obstruction of lymph channels\n3. Lymphatic spread of breast cancer from contralateral side\n4. Inflammatory breast carcinoma $=$ diffusely invasive ductal carcinoma\n(c) mediastinal lymphatic blockage\n5. Sarcoidosis\n6. Hodgkin disease\n7. Advanced bronchial / esophageal carcinoma\n8. Actinomycosis\n(d) advanced gynecologic malignancies",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 779,
            "markdown": "via thoracoepigastric collaterals\n\n1. Ovarian cancer\n2. Uterine cancer\n(e) inflammation\n3. Acute mastitis\n4. Retromamillary abscess\n5. Fat necrosis\n6. Radiation therapy\n7. Reduction mammoplasty\n(f) right heart failure\nmay be unilateral $(\\mathrm{R}>\\mathrm{L}) /$ migrating with change in patient position (to avoid decubitus ulcer)\n(g) nephrotic syndrome, anasarca\n8. Dialysis\n9. Renal transplant\n(h) subcutaneous extravasation of pleural fluid following thoracentesis\n\n# LYMPHADENOPATHY \n\nTerminology for microscopic metastatic deposits:\n> \"isolated tumor cells\": $<0.2 \\mathrm{~mm}$\n> \"micrometastasis\": $0.2-2.0 \\mathrm{~mm}$\nN.B.: Metastases $<2 \\mathrm{~mm}$ are NOT identifiable at imaging!\n\n## Imaging of Normal Lymph Nodes\n\n- nonpalpable\n\nMammo:\n$\\sqrt{ }$ well-circumscribed mass of low to moderate density:\n$\\sqrt{ }$ round to oval / bean-shaped\n$\\sqrt{ }$ slightly lobulated margin\n$\\sqrt{ }$ radiolucent fatty notch / hilum (visible in $78 \\%$ )\n$\\sqrt{ }$ central zone of radiolucency (= fatty replacement of center) surrounded by \"crescent\" rim of cortex\n$\\sqrt{ }$ usually $<1.5 \\mathrm{~cm}$ (up to 4 cm ) in size:\n$\\sqrt{ }<1 \\mathrm{~cm}$ within breast tissue, $<1.5 \\mathrm{~cm}$ within axilla\n$\\diamond$ Normal axillary nodes may be larger than 5 cm !\nUS:\n$\\sqrt{ }$ reniform hypoechoic rim + hyperechoic center\n$\\sqrt{ }$ echogenic hilum for entry and exit of vessels\n$\\sqrt{ }$ bidirectional hilar blood flow\nMR:\n$\\sqrt{ }$ smooth cortex + axillary symmetry $\\rightarrow$ high NPV for exclusion of metastasis\n$\\sqrt{ }$ cortical thickness of $<3 \\mathrm{~mm}(91 \\% \\mathrm{NPV})$\n> T1WI\n$\\sqrt{ }$ lymph nodes not recognizable within parenchyma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 780,
            "markdown": "$\\sqrt{ }$ recognizable in extraparenchymal location as oval well-circumscribed hypointense lesion with central hyperintense area\n> enhanced T1WI:\n$\\sqrt{ }$ no / slight enhancement of bland lymph nodes\n$\\sqrt{ }$ strong enhancement of cortex + type III wash-out kinetic pattern\n> T2WI / STIR:\n$\\sqrt{ }$ intermediate to increased signal intensity\n\n# Intramammary Lymphadenopathy \n\n$=$ adenopathy $>1 \\mathrm{~cm}$ surrounded by breast tissue\nFrequency: $5.4 \\%$\nLocation: axilla, subcutaneous tissue of axillary tail, lateral portion of pectoralis muscle, intramammary (typically in upper outer quadrant)\nN.B.: nodes located high within axillary tail (= tail of Spence) are mammographically difficult to differentiate from inferior axillary lymph nodes\n[James Spence (1812-1882), chair of systematic surgery at Edinburgh University in Scotland]\n\n## Axillary Lymphadenopathy\n\n$=$ solid node $>1.5 \\mathrm{~cm}$ in size without fatty hilum\nN.B.: lymph nodes of up to 3 cm may be normal if largely replaced by fat\nA. MALIGNANT\n\n1. Metastasis from breast cancer in $26 \\%$\n$\\diamond$ Primary breast lesion may not be found in $33 \\%$ !\nCurrently, axillary surgery is considered the only definitive test to determine the absence of axillary metastases.\nThe main goal of preoperative imaging of the axilla is to identify metastases with a high-enough PPV to proceed directly to axillary lymph node dissection.\n2. Metastases from non-breast primary (lung, melanoma, thyroid, GI tract, ovary)\n3. Lymphoproliferative disease: lymphoma / chronic lymphocytic leukemia (17\\%)\nB. BENIGN\n4. Nonspecific benign lymphadenopathy ( $29 \\%$ )\n5. Reactive nodal hyperplasia (breast infection / abscess / biopsy)\n6. Collagen vascular disease: rheumatoid arthritis, SLE\n7. Granulomatous disease: sarcoidosis\n8. Psoriasis\n9. HIV-related adenopathy\n10. Silicone-related adenopathy\n\n## Bilateral Axillary Lymphadenopathy\n\nA. NEOPLASM\n\n1. Secondary breast lymphoma\n$\\diamond$ Bilateral axillary lymphadenopathy is suggestive of lymphoproliferative disease!\n2. Other neoplasms\n3. Metastases\nB. BENIGN",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 781,
            "markdown": "1. Collagen vascular disease\n2. Granulomatous disease\n3. HIV\n4. Silicone-related adenopathy\n\n# Lymph Node Features Suspicious For Malignancy \n\n$\\sqrt{ }$ size increase of $>100 \\%$ over baseline:\n$\\sqrt{ }$ size $>3.3 \\mathrm{~cm}$\n$\\diamond$ Size of node usually NOT useful criterion (although small nodes have high NPV)\n$\\checkmark$ change in shape:\n$\\checkmark$ round shape / long-to-short axis ratio of $<2$\n$\\checkmark$ focal bulge / eccentric cortical thickening\n$\\checkmark$ spiculation of margins\n$\\checkmark$ intranodal microcalcifications (without history of gold Rx)\n$\\checkmark$ loss of radiolucent fatty center / hilar notch\n$\\checkmark$ increase in density\n\n## Ultrasound of Malignant Lymph Nodes\n\nUltrasound is the primary nonsurgical method for evaluating axillary nodes!\nValue: $62-92 \\%$ sensitive, $75-91 \\%$ specific\nPath: metastases embed subcortically in end vasculature\n$\\checkmark$ loss of reniform shape\n$\\checkmark$ bulbous contour with cortical thickening:\n$\\checkmark$ focal eccentric cortical thickening\n$\\checkmark$ symmetric diffuse cortical thickening $>3-5 \\mathrm{~mm}$\n(a) adjacent to several normal nodes\n(b) while contralateral nodes are normal\n$\\diamond$ Cortical thickening is the target for biopsy!\n$\\checkmark$ loss of normal central fatty hilum / hilar indentation\n$\\checkmark$ severely flattened / compressed node with loss of echogenic center\n$\\checkmark$ more than 1 feeding vessel:\n$\\checkmark$ hyperemic hilar blood flow\n$\\checkmark$ nonhilar cortical blood vessel ( $=$ entering capsule rather than lymph node mediastinum)\n$\\checkmark$ high-impedance waveform with sharp systolic high-velocity peak\n$D D x$ : reactive node (symmetric cortical thickening, adjacent nodes with similar morphology, often bilateral, no capsular vessels, low-impedance pattern with round low-velocity systolic peak)\n\n## MR of Malignant Axillary Lymph Nodes\n\n$\\diamond$ Axilla may be obscured by pulsation artifact from heart\nAdvantage: more global view of axillae compared to US allowing side-to-side comparison\n\nMRI findings highly suggestive of metastatic lymph nodes (similar to other modalities):\n$\\checkmark$ markedly enlarged lymph node",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 782,
            "markdown": "$\\sqrt{ }$ morphologically grossly abnormal (= distinctly different from other visible axillary nodes)\n$\\sqrt{ }$ perifocal edema ( $100 \\%$ PPV)\nDynamic CEMR:\n$\\sqrt{ }$ strong heterogeneous enhancement (DDx: reactive inflammatory node)\n$\\sqrt{ }$ rim enhancement $=$ higher SI in node periphery than center at 11 min after contrast infusion ( $100 \\%$ PPV)\n\n# VASCULAR BREAST DISEASE \n\n## Venous Disorders of Breast\n\n1. Collateral flow $\\leftarrow$ venous blockage / occlusion\n$\\checkmark$ unilateral dilatation of breast veins $\\leftarrow$ axillary or subclavian vein blockage\n$\\checkmark$ bilaterally enlarged breast veins $\\leftarrow$ occlusion of SVC\n2. Congestive heart failure\n$\\checkmark$ bilateral breast venous congestion\n$\\checkmark$ bilateral skin thickening\n$\\checkmark$ interstitial breast edema\n\n## Benign Vascular Breast Mass\n\n1. Hemangioma\n2. Lymphangioma\n$=$ extremely rare mass in child / young adult\nHisto: dilated lymphatic channels filled with lymphatic fluid + lined with endothelial cells\nLocation: axilla / axillary tail of breast\n$\\sqrt{ }$ solitary lobulated mass with single cystic space (lymphangioma circumscriptum) / multicystic mass\n3. Angiolipoma\n\n## Malignant Vascular Breast Mass\n\n1. Angiosarcoma\n2. Hemangiopericytoma\n\n## Devascularized Breast Mass\n\n$=$ loss of normal blood supply $\\rightarrow$ infarction of breast tissue most commonly associated with fat necrosis\nCause: trauma, radiation therapy, spontaneous infarction of breast mass (hamartoma)\n\n1. Infarcted lactating adenoma\n2. Infarcted giant juvenile fibroadenoma\n\n## T2-HYPERINTENSE BREAST TUMOR\n\n(in order of descending frequency)\nA. EPITHELIAL TUMOR\n\n1. Mucinous carcinoma\n2. Invasive ductal carcinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 783,
            "markdown": "3. Metaplastic carcinoma\n4. Papillary carcinoma\n5. Invasive lobular carcinoma\n6. Adenoid cystic carcinoma\n7. Sebaceous carcinoma\n8. Intraductal papilloma\nB. MESENCHYMALTUMOR\n9. Fibrosarcoma\n10. Myofibroblastoma\n11. Cavernous hemangioma\nC. FIBROEPITHELIAL TUMOR\n12. Myxoid fibroadenoma\n13. Phyllodes tumor: benign / borderline / malignant\n\nT2-hyperintensity is seen with extensive tumor necrosis, cystic + microcystic components, fatty (sebaceous) components, mucinous stroma, loose myxoid stroma, stromal edema, hemorrhagic changes!\n\n# MR ENHANCEMENT PATTERNS \n\n## Enhancement Kinetics\n\n$\\diamond$ Best performed on days $7-12\\left(=2^{\\text {nd }}\\right.$ week of menstrual cycle) to minimize hormonal effect!\n$\\diamond$ Considerable overlap in enhancement characteristics between benign and malignant lesions!\n![img-79.jpeg](img-79.jpeg)\n$\\diamond$ Nonmass-like lesion (invasive lobular carcinoma) may exhibit low-magnitude and persistent-enhancement kinetics (? due to weak angiogenic activity)\nMalignant: plateau or washout pattern ( $63 \\%$ sensitive, $65 \\%$ specific)\n\n## INITIAL PHASE\n\n$=$ initial peak SI within first $2-3 \\mathrm{~min}$ after contrast administration relative to SI of unenhanced image\nor when shape of kinetic curve begins to change",
            "images": [
                {
                    "id": "img-79.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 1192,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1647,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 784,
            "markdown": "Categories: $<50 \\%$ (slow); $\\geq 50 \\%$ and $<100 \\%$ (medium); $\\geq 100 \\%$ (fast)\nIntensity threshold (color): 2 minutes $>50-100 \\%$\nDCIS: $70 \\%$ exhibit fast, initial enhancement, with variable delayed-phase enhancement patterns\n\n# Delayed PHASE \n\n$=$ enhancement curve that develops after $2-3$ minutes or after kinetic curve changes $\\left(\\mathrm{SI}_{\\text {postinitial }}=\\right.$ postinitial intensity during $4^{\\text {th }}, 5^{\\text {th }}, 6^{\\text {th }}$ minute +SI at 6 minutes by comparison with the initial peak obtained during $1^{\\text {st }}, 2^{\\text {nd }}$ and $3^{\\text {rd }}$ minute)\n\n## Type 1 = Persistent / Progressive / Continuous Pattern\n\n$=$ continuous increase in $\\mathrm{SI}_{\\text {postinitial }}>\\mathbf{1 0 \\%}$\n\n- usually benign\n\nDistribution: $83 \\%$ benign, $9 \\%$ malignant\nBenign lesion: $52 \\%$ sensitive, $71 \\%$ specific\n$\\diamond 45 \\%$ PPV for malignancy\n\n## Type $2=$ Plateau Pattern\n\n$=\\mathrm{SI}_{\\text {postinitial }}$ change of $\\pm \\mathbf{1 0 \\%}$\n\n- occasionally malignant\n\nMalignant lesion: $43 \\%$ sensitive, $75 \\%$ specific\n\n## Type $3=$ Washout Pattern\n\n$=$ progressive decrease of $\\mathrm{SI}_{\\text {postinitial }}<\\mathbf{1 0 \\%}$\n\n- highly suspicious\n\nMalignant lesion: $21 \\%$ sensitive, $90 \\%$ specific\n$\\diamond 76 \\%$ PPV for malignancy\n\n## Quantitative Kinetic Parameters\n\n1. Initial enhancement percentage $\\left(\\mathrm{E}_{1}\\right)$\n2. Peak enhancement percentage $\\left(\\mathrm{E}_{\\text {peak }}\\right)$\n3. Time to peak enhancement $\\left(\\mathrm{T}_{\\text {peak }}\\right)$\n\n## Lack of Enhancement\n\n- palpable lesion\n- mammographically visible abnormality\n\nNPV: $\\quad 88-96 \\%$\nFN: DCIS (48\\%), small invasive carcinoma / small invasive component (52\\%)\n$\\sqrt{ }$ nonenhancing architectural distortion suggests a radial scar\n\n## Unilateral Diffuse Enhancement on MR\n\n$>$ Common\n\n1. Parenchymal asymmetry\n2. Fibrocystic changes\n3. Adenosis\n4. Unilateral implant",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 785,
            "markdown": ") Rare\n5. Normal: unfavorable cycle phase, HRT\n6. Mastitis\n7. Inflammatory breast cancer\n8. Extensive carcinoma: diffuse lobular carcinoma, lymphangiosis, extensive DCIS\n9. Prior ipsilateral radiotherapy within last few months\n\n# Background Parenchymal Enhancement (BPE) \n\n$=$ additional tool for risk stratification in high-risk women\n$\\diamond \\uparrow$ odds of breast cancer with moderate / marked BPE\n\n1. False-positive interpretation $\\leftarrow$ focal / regional /asymmetric BPE\n2. False-negative interpretation $\\leftarrow$ moderate / marked BPE\n\n## ENHANCING LESIONS ON BREAST MR\n\n## Homogeneously Enhancing Well-Demarcated Round Lesion\n\n$\\diamond$ Homogeneous enhancement suggests benign disease!\n) Common\n\n1. Fibroadenoma: endotumoral septa\n2. Adenoma\n3. Papilloma\n4. Carcinoma\n) Rare\n5. Intramammary node:\n$\\checkmark$ lipomatous hilum\n6. Fat necrosis:\n$\\checkmark$ macrocalcifications on mammogram\n7. Granuloma\n8. Carcinoma: esp. medullary form\n9. Phylloides tumor\n10. Metastasis\n\n## Rim-Enhancing Lesion\n\n) Common\n\n1. Complicated cyst / postoperative seroma:\n$\\checkmark$ narrow hyperintense ring on T2\n2. Invasive carcinoma:\n$\\checkmark$ broad hypo- / isointense ring on T2WI $\\leftarrow$ vital tumor\n$\\checkmark$ thick irregular shaggy rim\n3. Fat necrosis:\n$\\checkmark$ centrally low signal of fat content\n$\\checkmark$ confirmatory low-density lesion on mammogram\n4. Superimposition of blood vessels: tubular structures on MIP\n) Rare\n5. Adenosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 786,
            "markdown": "6. Abscess\n7. Lymphadenitis\n\n# Multiple Homogeneously Enhancing Lesions with Well-defined Borders \n\n$>$ Common\n\n1. Fibrocystic changes\n2. Fibroadenomas\n3. Adenoma\n4. Papilloma\n> Rare\n5. Multicentric carcinoma\n6. Metastases\n\n## Dendritic Enhancement\n\n$>$ Common\n\n1. Adenosis\n2. Fibrocystic change\n3. DCIS\n4. Motion artifacts on subtraction image\n5. Superposition of intramammary veins\n> Rare\n6. Previous galactography: history\n7. Chronic mastitis\n\n## Lesion-in-Lesion Morphology\n\n1. Giant juvenile fibroadenoma\n2. Phyllodes tumor\n3. Papilloma\n4. Papillary carcinoma\n5. Hemorrhage\n\n## Enhancing Lesion\n\n## Benign Enhancing Lesion\n\n1. Nonproliferative lesion: mild hyperplasia, fibroadenoma\n2. Proliferative lesion without atypia: sclerosing adenosis, radial and complexing sclerosing lesion, moderate hyperplasia, intraductal papilloma\n3. Atypical lobular and ductal hyperplasia\n4. Normal breast parenchyma in premenopausal woman\n\n## Morphologic Criteria for Benignity\n\n$\\sqrt{ }$ smooth margin ( $95 \\%$ NPV)\n$\\sqrt{ }$ low-signal-intensity internal septa ( $98 \\%$ NPV)\n$\\sqrt{ }$ lobulated margin + minimal / no enhancement ( $100 \\%$ NPV)\n$\\sqrt{ }$ enhanced portion on T1WI shows hyperintensity on T2WI",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 787,
            "markdown": "# Morphologic Criteria for Malignancy \n\n$\\checkmark$ regional enhancement with a mass ( $81 \\%$ PPV)\n$\\checkmark$ segmental distribution ( $78 \\%$ PPV)\n$\\checkmark$ irregular / spiculated margin ( $84-91 \\%$ PPV)\n$\\checkmark$ rimlike enhancement ( $84 \\%$ PPV)\n$\\checkmark$ heterogeneous internal enhancement\n$\\checkmark$ enhancing internal septa\n$\\checkmark$ linear / branching ductal distribution ( $24-85 \\%$ PPV)\n$\\checkmark$ regional enhancement WITHOUT a mass:\n$\\checkmark$ homogeneous enhancement ( $67 \\%$ PPV)\n$\\checkmark$ clumped enhancement ( $60 \\%$ PPV)\n$\\checkmark$ heterogeneous enhancement ( $53 \\%$ PPV)\n$\\checkmark$ stippled enhancement ( $25 \\%$ PPV)\n\n## Ancillary Features of Enhancing Lesions\n\n$\\checkmark$ hyperintense T2 signals in enhancing portion suggests benignity (eg, myxoid fibroadenoma of younger woman):\n$\\checkmark$ not reliable for any irregular / spiculated mass\nException: medullary cancer\n$\\checkmark$ iso- / hypointense T2 signal suggests malignancy\n$\\checkmark$ focal perilesional edema highly suggestive of malignancy\n\n| MRI Differentiation of Benign from Malignant Lesion |  |  |\n| :-- | :-- | :--: |\n|  | Benign | Malignant |\n| Morphology | smooth | irregular |\n| Kinetics | continuous rise | rapid rise |\n| Enhancement | homogeneous | heterogeneous |\n| T2 signal | high | variable (usually low) |\n| Tl signal | high (protein, blood, <br> melanin) | variable (usually low) |\n| internal septa | nonenhancing | enhancing |\n\n$\\checkmark$ enhancing architectural distortion highly suggestive of malignancy\n\n## POSTLUMPECTOMY BREAST MRI\n\n## Benign Postlumpectomy Changes\n\n1. Skin thickening\n2. Architectural distortion\n3. Edema\n\n- may never resolve entirely\n$\\checkmark$ persists in $25 \\%$ at 6 years after breast conservation Rx\n\n4. Signal voids / flare from surgical / biopsy clips\n5. Fluid cavity filled with blood / seroma\n6. Bleeding / hemosiderin",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 788,
            "markdown": "# Probably Benign Postlumpectomy Changes \n\n1. Small focal / thin linear non-masslike enhancement\n$\\sqrt{ }$ seen for up to 18 months\n$\\sqrt{ }$ slow initial + persistent delayed enhancement\n2. Fat necrosis\n$\\sqrt{ }$ persists up to 5 years\n\n## Suspicious Postlumpectomy Changes\n\n$\\sqrt{ }$ nodular non-masslike enhancement (NMLE) $>5 \\mathrm{~mm}$ around a seroma cavity\n$\\sqrt{ }$ segmental / ductal / clumped NMLE\n$\\sqrt{ }$ masslike enhancement\n$\\sqrt{ }$ rapid initial + washout kinetics NOT consistent with fat necrosis\n$\\sqrt{ }$ increasing size of formerly \"probably benign\" lesion\n\n## Highly Suspicious Postlumpectomy Changes\n\n$\\sqrt{ }$ focal / multifocal masses with rapid initial + delayed washout kinetics\n$\\sqrt{ }$ irregular / spiculated margins ( $84-91 \\%$ PPV)\n$\\sqrt{ }$ rim enhancement\n\n## MAMMOGRAPHIC FILM READING TECHNIQUE\n\n1. Confirm patient identifiers are correct\n2. Ensure images are of adequate quality:\n> good contrast\n> good compression\n> adequate positioning (nipple in profile)\n> lack of blur\n> lack of artifacts\n3. Compare with earlier films (preferably $\\geq 2$ years) whether finding is new / growing / stable\n$\\diamond$ Beware of stability = breast cancer may grow slowly\nLesion morphology takes precedence over stability!\n4. Compare left with right side\n5. Scan \"forbidden / living in the wrong neighborhood\" areas\n> MLO-view\n(a) \"Milky Way\" $=2-3 \\mathrm{~cm}$ wide area parallel to the edge of the pectoral muscle\n(b) inferior triangle\n> CC-view\n(c) \"No man's land\" = retromammary fat between posterior border of parenchyma + chest wall\n(d) Medial / inner triangle of breast\n\nAlmost $3 / 4$ of breast cancers in women $<50$ years occur in a $1-\\mathrm{cm}$ wide zone beneath the SQ fat!\n6. Look for:\n> global / focal asymmetry in breast parenchymal pattern disrespecting normal breast architecture + boundaries",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 789,
            "markdown": ") increased retroareolar density\n> contour deformity at interface with fat\n![img-80.jpeg](img-80.jpeg)",
            "images": [
                {
                    "id": "img-80.jpeg",
                    "top_left_x": 362,
                    "top_left_y": 305,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1920,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 790,
            "markdown": "![img-81.jpeg](img-81.jpeg)\n\nShift in Position from MLO to ML View (right breast) medial (stellate) lesion projects lower on MLO and wanders higher on ML view; lateral lesion (calcifications) projects higher on MLO view and wanders lower on ML view\nmnemonic: \"Lead (lateral) sinks, muffins (medial) rise\";\n$\\diamond$ Central lesion shifts little, far lateral or medial lesions substantially!\n(a) inwardly convex angulated margin mnemonic: \"Look for the hook\"\n(b) outwardly convex margin (= loss of scalloped margin) mnemonic: \"Slow down for the speed bump\"\n> straight lines superimposed on normal scalloped contour\n> architectural distortion (magnification views!)\ncalcifications (magnification views!)\n7. DON'T STOP looking after one lesion is found\n\n# Diagnostic Evaluation of a Mass / Focal Asymmetry \n\nNever recommend a biopsy based on screening alone!\nPurpose of diagnostic workup:\n\n1. Locate mass / focal asymmetry with additional views\n(a) mandatory additional views to characterize a lesion:\n> true LM / ML view depending on lesion location\n> spot compression in CC and MLO projections to reduce geometric unsharpness + blur\nNote: magnification (requires $\\uparrow$ in exposure time $\\rightarrow \\uparrow$ likelihood of motion-related blurring)\n$\\diamond$ Magnify microcalcifications NOT soft-tissue abnormalities",
            "images": [
                {
                    "id": "img-81.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 191,
                    "bottom_right_x": 1322,
                    "bottom_right_y": 774,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 791,
            "markdown": "(b) optional additional views to localize a lesion:\n> exaggerated CC lateral view\n> cleavage view\n> step-oblique views @ $15^{\\circ}$ intervals between true lateral and CC views\n> medially / laterally rolled CC views\n$\\diamond$ Roll breast on the view that reveals the abnormality!\n$\\diamond$ Roll focal asymmetry toward fat!\n2. Characterization of mass / focal asymmetry to develop a level of suspicion $\\rightarrow$ for equivocal findings supplement with targeted US\n3. Extent of disease\n4. Multifocality\n\nRule of multiples $=$ the likelihood of malignancy decreases if multiple similar findings are present, especially if bilateral\n$\\diamond$ All lesions must have exclusively benign features!\n5. Staging of axilla with ultrasound\n$\\diamond$ The most predictive sign of axillary metastasis is a lymph node with a cortex $>2 \\mathrm{~mm}$ thick\n6. Discuss findings with patient, answer questions\n7. Arrange for biopsy\n\n# Skin Localization Work-up \n\n» Use mammographic paddle with alphanumeric grid\n(1) Compress breast with grid opening along surface $\\mathrm{Ca}^{2+}$\n(2) Place metallic skin marker directly over calcification cluster at appropriate alphanumeric location\n(3) Repeat image to confirm accurate skin marker placement\n(4) Obtain magnification view in orthogonal plane with skin marker tangential to x-ray beam Interpretation:\n$\\rightarrow$ calcifications in skin project into dermis\n$\\rightarrow$ superficial parenchymal calcifications project into breast tissue\n\n## Surveillance\n\n(1) Only for lesion that satisfies benign criteria = BI-RADS ${ }^{\\circledR}$ category 3\n(2) Obtain reproducible mammographic image (CC views are more consistent compared with MLO)\n(3) Change\n$\\diamond$ Stability for several years does not guarantee benignity (eg, tubular carcinoma)\n$\\diamond$ Any new mass requires workup\n$\\diamond$ A 3-mm change represents a doubling of volume in a $1-\\mathrm{cm}$ lesion\nIf lesion acquires certain benign features change to BI-RADS ${ }^{\\circledR}$ category 2\n(4) Requires a compliant patient following recommended intervals\nN.B.: $\\sim 40 \\%$ of patients are not compliant (numbers are different for US, mammography and MRI)!\nFalse negative rate: $<2 \\%$ if done appropriately",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 792,
            "markdown": "| Receptor Status Correlated with Histopathology |  |\n| :-- | :-- |\n| Receptor Status | Histopathology |\n| ER- | Nonmass-like enhancement (in $<20 \\%$ of lesions) |\n| ER+ | Nonmass-like enhancement (in $0 \\%$ of lesions) |\n| ER+ or ER- | equal incidence of multiple masses |\n| HER2+ | multicentric masses (in 60\\%) |\n| triple negative | masses |\n| ER = estrogen receptor; HER2 = human epidermal growth factor |  |\n\n# MAMMOGRAPHY REPORT \n\nbased on BI-RADS ${ }^{\\circledR}$ (Breast Imaging Reporting and Data System) published by the ACR (American College of Radiology)\n\n## Report Contents\n\n1. Indication for exam\n2. Comparison to previous studies\n3. Breast Composition\n4. Findings\n5. Overall Assessment\n6. Communication of result (as IMPORTANT as the diagnosis)\nA. ASYMMETRY\n$=$ planar density seen only in a single projection WITHOUT convex margins / suspicious calcifications / architectural distortion $\\pm$ interspersed fat\n7. Global asymmetry ( $=$ asymmetric breast tissue)\n$=$ parenchymal volume greater in one breast compared to the other involving at least one quadrant\n$=$ common and usually normal variant\nOf concern if associated with:\narchitectural distortion / decrease in breast size (\"shrinking breast\") / skin thickening / axillary adenopathy / clinical findings\n8. Focal asymmetry\n$=$ asymmetry confined to less than a quadrant\nB. MASS (challenge of perception)\n$=3$-dimensional space occupying lesion with convex margins seen in two different projections\nsize measurements\nshape round, oval, lobulated, irregular\nmargins circumscribed, lobulated, obscured, indistinct, spiculated\ndensity relative to an equal volume of breast tissue: high, equal, low, fat\nlocation based on face of clock; depth (anterior, middle, posterior); subareolar; central; axillary\nposterior pectoralis muscle / chest wall\nextent",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 793,
            "markdown": "# C. ARCHITECTURAL DISTORTION \n\n$=$ straight lines in a radial arrangement\nD. CALCIFICATIONS (challenge of disposition)\nbenign skin, vascular, coarse popcorn-like, large rodlike (secretory), round, punctate, lucent center, eggshell / rim, milk of calcium, suture, dystrophic indeterminate amorphous / indistinct probably pleomorphic (coarse heterogeneous / fine pleomorphic), fine linear / fine malignant linear branching\nnumber\nsize\ndistribution grouped / clustered, linear, segmental, regional (within large volume of breast tissue), scattered / diffuse, multiple groups\nstability increasing, stable\nE. Associated Findings\nskin invasion thickening (diffuse, focal), retraction\nnipple involvement retraction, inversion\ntrabeculae thickening, architectural distortion\naxilla adenopathy\nF. MULTIPLE MASSES $=$ multicentricity $/$ multifocality\nnumber $>1$ distance between 2 masses (outer edge to outer edge)\n\n## Breast Imaging Reporting and Data System (BI-RADS®)\n\n$\\diamond$ Additional image evaluation may be necessary: off-angle / spot compression mammographic views; ultrasound\n$\\diamond$ Unexplained abnormalities warrant biopsy\n\n## Asymmetric Breast Tissue\n\n$=$ greater volume / density in one breast compared with corresponding area in contralateral breast\n\n## DENSITY IN ONE PROJECTION\n\n$=$ density seen on only one standard mammographic view\n\n## ARCHITECTURAL DISTORTION\n\n$=$ focal area of distorted breast tissue (spiculations with common focal point / focal retraction / tethering) without definable central mass\n\n## FOCAL Asymmetric Density\n\n$=$ focal asymmetric density seen on two mammographic views but not identified as a true mass\n\n## Lexicon Descriptors for Breast MR Reports\n\nsuspicious areas are described as (underlined signs suggest malignancy)\nA. Focus / foci area $<5 \\mathrm{~mm}$ in diameter\nshape\n( $=$ mini-mass: round / oval, spiculated $/$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 794,
            "markdown": "|  | irregular |\n| :-- | :-- |\n| margin | smooth, not smooth |\n| T2 | bright, not bright |\n| hilum | with fat, without fat |\n| curve | persistent, washout |\n| priors | stable, new / increasing) |\n\nB. Mass 3-D space-occupying lesion $\\geq 5 \\mathrm{~mm}$ with a convex margin shape\nmargin\ninternal enhancement\nround, oval, lobulated, irregular smooth, irregular, spiculated\nhomogeneous, dark internal septations, heterogeneous, rimlike, enhancing internal septations, central\nC. Nonmass-like Enhancement (NMLE)\ndistribution focal area ( $<25 \\%$ of quadrant), linear (not ductal, sheetlike), diffuse, ductal, segmental, regional, multiregional (not ductal)\nhomogeneous, heterogeneous, stippled / punctate, clumped, reticular / dendritic symmetry symmetrical, asymmetrical\n$\\diamond$ Biopsy if associated with microcalcifications / if segmentally distributed / if asymmetric / if patient $>45$ years\nD. Associated findings\nedema\nadenopathy\ncysts\nskin involvement\nchest wall involvement\nE. Kinetic curve assessment (if morphology is probably benign)\ninitial phase\nslow, medium, rapid\ndelayed phase\npersistent / plateau ( $\\rightarrow$ follow up), washout $(\\rightarrow$\nbiopsy)\n\n# Report Notice on Breast Density \n\n\"If your mammogram demonstrates that you have dense breast tissue, which could hide small abnormalities, you might benefit from supplementary screening tests, which can include a breast ultrasound screening or a breast MRI examination, or both, depending on your individual risk factors. A report of your mammography results, which contains information about your breast density, has been sent to your physician's office and you should contact your physician if you have any questions or concerns about this report.\"",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 795,
            "markdown": "| BI-RADS ${ }^{\\circledR}$ Categories (American College of Radiology) |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| Cat. | Mammography | Ultrasound | MR | Malignancy <br> Likelihood |\n| 0 | Need additional imaging evaluation or prior mammogram for comparison: <br> eg, spot compression, magnification, special views, ultrasound | Need additional imaging: <br> eg, an MR for <br> (1) palpable confirmed mass <br> (2) recurrence versus scar after lumpectomy | Need additional imaging evaluation: eg, (1) technically unsatisfactory scan (2) screening MR without kinetic imaging (3) incomplete information | $-$ |\n| 1 | Negative: symmetric breasts, no masses, architectural distortion, suspicious calcifications | Negative: no mass, architectural distortion, skin thickening, microcalcifications | Negative: symmetric breasts; no architectural distortion, abnormal enhancement, or mass | $0 \\%$ |\n| 2 | Benign findings: eg, involuting calcified fibroadenoma, multiple secretory calcifications, oil cyst, lipoma, galactocele, hamartoma, intramammary node, vascular calcifications, implants, architectural distortion related to prior surgery | Benign findings: eg, simple cyst, intramammary lymph node, breast implant, stable postsurgical changes, probable fibroadenoma | Benign findings: hyalinized nonenhancing fibroadenoma, cyst, scar, fat-containing lesion (oil cyst, lipoma, galactocele, mixed-density hamartoma), breast implant | $0 \\%$ |\n| 3 | Probably benign ( $<2 \\%$ risk of malignancy) - initial short-interval follow-up suggested (in 6 months), not expected to change (over $>2$ years) after complete diagnostic work-up: eg, noncalcified circumscribed solid mass, focal asymmetry, cluster of round punctate calcifications | Probably benign - short-interval follow-up suggested (< $2 \\%$ risk of malignancy): eg, classic findings of a fibroadenoma, nonpalpable complicated cyst, clustered microcysts | Probably benign - short-interval follow-up suggested: <br> a malignancy is highly unlikely | $\\begin{gathered} 2 \\% \\\\ \\text { (only } 71 \\% \\\\ \\text { comply! } \\end{gathered}$ |\n| 4 | Suspicious abnormality - biopsy should be considered: not classic appearance of malignancy | Suspicious abnormality - biopsy should be considered: intermediate (3-94\\%) probability of malignancy: eg, solid mass without all criteria of a fibroadenoma | Suspicious abnormalitybiopsy should be considered: lesion morphology not characteristic of breast cancer but of concern | $3-90 \\%$ |\n| $4 a$ | Low probability | Low suspicion |  | $3-50 \\%$ |\n| 4b | Intermediate probability / suspicion | Intermediate suspicion |  | $50-80 \\%$ |\n| 4 c | Moderate probability / suspicion | Moderate suspicion |  | $80-90 \\%$ |\n| 5 | Highly suggestive of malignancy ( $\\geq 95 \\%$ probability of cancer) - appropriate action should be taken: eg, lesion could be considered for one-stage surgical treatment, however, biopsy usually required | Highly suggestive of malignancy ( $>95 \\%$ probability) - appropriate action should be taken: image-guided core needle biopsy | Highly suggestive of malignancy - appropriate action should be taken: almost certainly malignant | $>90 \\%$ |\n| 6 | Known biopsy-proven malignancy eg, mammogram during neoadjuvant chemotherapy comparing it to pre-therapy mammogram | Known biopsy-proven malignancy eg, prior to chemotherapy, lumpectomy, mastectomy | Known biopsy-proven malignancy corresponding to the lesion imaged with MR | $100 \\%$ |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 796,
            "markdown": "# BREAST ANATOMY AND MAMMOGRAPHIC TECHNIQUE \n\n## BREAST DEVELOPMENT\n\n## Embryology\n\n$6^{\\text {th }}$ \"milk line\" develops from ectodermal elements on ventral surface of embryo week extending from axilla to medial thigh\nGA\n$12^{\\text {th }} \\quad$ nipple-areolar complex in $4^{\\text {th }}$ intercostal space develops with differentiation of week mesenchymal cells into smooth muscle\n$16^{\\text {th }} \\quad$ special apocrine glands form Montgomery glands consisting of 8-12 mammary week ducts associated with sebaceous glands near epidermis\n$32^{\\text {nd }} \\quad$ differentiation into breast parenchyma + pigmentation of nipple-areolar complex week\n\n## Nipple-Areolar Complex\n\n, composed of pigmented squamous epithelium\n, contains sebaceous Montgomery glands\n, contains many sensory nerve endings\n, contains layer of circumferential smooth muscle\n, contains abundant lymphatic system (= subareolar lymphatic plexus = Sappey plexus)\n, hair follicles around areola may contain calcifications\n, overlies area between $2^{\\text {nd }}$ and $6^{\\text {th }}$ rib at full development\n[Marie Philibert Constant Sappey (1810-1896), professor of anatomy and president of Académie Nationale de Médecine, Paris, France]\n\n## Montgomery Gland\n\n= large type of sebaceous gland of areola transitional between sweat glands + mammary gland\n[William Fetherstone Montgomery (1797-1859), professor of midwifery at College of Physicians in Dublin, Ireland]\n, capable of secreting milk\n, openings at $1-2-\\mathrm{mm}$ small raised papules in periphery of areola (= Morgagni tubercles)\n\n## Variant Anatomy\n\nPolythelia $=$ supernumerary accessory nipple(s); usually unilateral; most inferior location = proximal medial thigh; may be mistaken for moles\nPolymastia $=$ true accessory mammary gland; most often in axilla\nHypoplasia $=$ underdevelopment of breast\nAmazia $=$ lack of breast tissue + proper nipple; usually due to surgery / irradiation\nAmastia $=$ lack of breast tissue + lack of nipple; associated with aplasia of pectoral",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 797,
            "markdown": "muscle (Poland syndrome)\nTuberous $=$ reduced parenchymal volume + herniation of breast parenchyma through breast nipple-areolar complex\n\n# Tanner Stages \n\n$=$ scale of physical development\nStage I (prepubertal)\nHisto: epithelial-lined ducts surrounded by connective tissue stroma\n\n- nipple elevates\n- palpable subareolar nodules for first 6-12 months\n$\\sqrt{ }$ ill-defined mildly heterogeneous hyperechoic retroareolar tissue\n$\\sqrt{ }$ ducts often enlarged in full-term infants $\\leftarrow$ effect of maternal hormones\nStage II (formation of breast bud)\nCause F: estrogen for ductal proliferation and branching + progesterone for terminal ductal-lobular units\nM: transient proliferation with spontaneous resolution $\\leftarrow 30$-fold increase in testosterone\n- palpable subareolar bud $=$ thelarche begins with onset of puberty (at $<13$ years of age; mean age: 9.8 years)\n$\\diamond$ may be asymmetric / unilateral\n- breast tissue + nipple arise as a single mound of tissue\n$\\checkmark$ hyperechoic retroareolar nodule\n$\\checkmark$ central star-shaped / linear hypoechoic area (= simple branched ducts)\nStage III (breast extension beyond areolar margin)\n- enlargement + elevation of single mound\n$\\checkmark$ hyperechoic glandular tissue extending away from retroareolar area\n$\\checkmark$ central spider-shaped hypoechoic area\nStage IV (mounding of areola + papilla)\n- secondary mound develops (very transient) with nipple + areolar complex projecting above the breast tissue\n$\\checkmark$ hyperechoic periareolar fibroglandular tissue\n$\\checkmark$ prominent central hypoechoic nodule\nStage V (mature breast)\n- regression of areola forming a smooth contour with the rest of the breast tissue\n$\\checkmark$ hyperechoic glandular tissue\n$\\checkmark$ increased subcutaneous adipose tissue anteriorly\n$\\checkmark$ NO hypoechoic central nodule\n\n\n## BREAST ANATOMY\n\n## Lobes\n\n15-20 lobes disposed radially around nipple; each lobe has a main lactiferous duct of 2 mm in diameter",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 798,
            "markdown": "# Nipple \n\n(a) 5-20 duct openings on nipple surface: immediately deep to orifices are areas of dilatation ( $=$ milk sinuses) $\\leftarrow$ storage function during lactation\n![img-82.jpeg](img-82.jpeg)\n$\\diamond>90 \\%$ of nipples contain 5-9 ductal orifices\n(b) multiple other blind-ending orifices: connected to sebaceous glands of $1-4 \\mathrm{~cm}$ in length\n$\\checkmark$ bilateral symmetric enhancement pattern of normal nipple:\n$\\checkmark 1-2 \\mathrm{~mm}$ superficial layer of intense linear enhancement\n$\\checkmark$ underlying region of nonenhancement deep to dermis\n\n## Ducts\n\nlactiferous ducts coalesce in subareolar region into $5-8 \\mathrm{~mm}$ wide lactiferous sinuses exiting in the central portion of nipple; organized into\n(a) central ducts: extending to chest wall\n(b) peripheral ducts: arranged in a radial fashion\n\nMain lactiferous duct $\\rightarrow$ branches dichotomously into segmental duct $\\rightarrow$ subsegmental duct $\\rightarrow$ terminal duct $\\rightarrow$ blunt-ending acinus\n\n## Terminal Duct Lobular Unit (TDLU)",
            "images": [
                {
                    "id": "img-82.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 343,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1372,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 799,
            "markdown": "(1) Extralobular terminal duct\n\nHisto: lined by columnar cells + prominent coat of elastic fibers + outer layer of myoepithelium\n(2) Lobule\n(a) intralobular terminal duct\n\nHisto: lined by 2 layers of cuboidal cells + outer layer of myoepithelium (for milk propulsion)\nSignificance: invasive ductal, papillary, mucinous, medullary adenoid cystic cancers arise from ductal epithelium in TDLU and most commonly appear as spiculated irregular masses $\\pm$ calcifications / developing asymmetries\n(b) ductules / acini\n(c) intralobular connective tissue\n\nSize: $\\quad 1-2$ (range, $1-8$ ) mm in diameter\nChange:\n(a) reproductive age: cyclic proliferation (up to time of ovulation) + cyclic involution (during menstruation)\n(b) post menopause: regression with fatty replacement\n\nSignificance:\nTDLU is the site of fibroadenoma, epithelial cyst, apocrine metaplasia, adenosis (= proliferation of ductules + lobules), epitheliosis (= proliferation of mammary epithelial cells within preexisting ducts + lobules), ductal + lobular carcinoma in situ, infiltrating ductal + lobular carcinoma\n\n# Components of Normal Breast Parenchyma \n\n1. Nodular densities surrounded by fat\n(a) $1-2 \\mathrm{~mm}=$ normal lobules\n(b) $3-9 \\mathrm{~mm}=$ adenosis\n2. Linear densities\n$=$ ducts and their branches + surrounding elastic tissue\n3. Structureless ground-glass density\n$=$ stroma / fibrosis with concave contours\n\n## Parenchymal Breast Pattern (László Tabár)\n\nEffect of breast density on sensitivity:\nwomen in their 40 s have a $68 \\%$ higher risk of a FN screening mammogram compared to older women\nRecommendation: perform mammography during $1^{\\text {st }}$ week of menstrual cycle\nInter- and intraobserver variability on breast density:\n> low reliability of interreader density agreement $(\\kappa=0.59)$\n> imperfect intrareader agreement $(\\kappa=0.72)$\nFactors affecting breast density between mammograms:\nbody mass index, weight changes, age, HRT, dietary intake",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 800,
            "markdown": "| Breast Composition (BI-RADS ${ }^{\\circledR}$ ) |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Breast <br> Density | Population <br> $[\\%]$ | Descriptor | Glandular <br> tissue [\\%] |\n| 1 | 9 | Almost entirely fatty breast | $<25$ |\n| 2 | 44 | Scattered fibroglandular tissue <br> that could obscure a lesion | $25-50$ |\n| 3 | 38 | Heterogeneously dense <br> tissue that may lower <br> mammographic sensitivity | $51-75$ |\n| 4 | 9 | Extremely dense breast tissue <br> that lowers mammographic <br> sensitivity | $>75$ |\n\n![img-83.jpeg](img-83.jpeg)\n\nOverall odds ratio of breast cancer for $>75 \\%$ tissue density:\n> compared to $10 \\%$ density 4.74\n> with interval cancer developed in 1 year 17.81\nRelative risk of cancer associated with breast density:\n> breast tissue density of $50-74 \\% 2.92$\n> breast tissue density of $>75 \\% 4.64$\n\n# Pattern I \n\nnamed QDY = quasi dysplasia (for Wolfe classification)\n$\\sqrt{ }$ concave contour from Cooper's ligaments\n$\\sqrt{ }$ evenly scattered $1-2 \\mathrm{~mm}$ nodular densities ( $=$ normal terminal ductal lobular units)\n$\\sqrt{ }$ oval-shaped / circular lucent areas ( $=$ fatty replacement)\n\n## Pattern II\n\nsimilar to N1 (Wolfe)\n$\\sqrt{ }$ total fatty replacement\n$\\sqrt{ }$ NO nodular densities\n\n## Pattern III\n\nsimilar to P1 (Wolfe)\n$\\sqrt{ }$ normal parenchyma occupying $<25 \\%$ of breast volume in retroareolar location\nPattern IV = adenosis pattern",
            "images": [
                {
                    "id": "img-83.jpeg",
                    "top_left_x": 357,
                    "top_left_y": 697,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1188,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 801,
            "markdown": "similar to P2 (Wolfe)\nCause: hypertrophy + hyperplasia of acini within lobules\nHisto: small ovoid proliferating cells with rare mitoses\n$\\sqrt{ }$ scattered $3-7 \\mathrm{~mm}$ nodular densities ( $=$ enlarged terminal ductal lobular units) $=$ adenosis\n$\\sqrt{ }$ thick linear densities ( $=$ periductal elastic tissue proliferation with fibrosis) $=$\nfibroadenosis\n$\\sqrt{ }$ no change with increasing age (genetically determined)\nPattern V\nsimilar to DY (Wolfe)\n$\\sqrt{ }$ uniformly dense parenchyma with smooth contour (= extensive fibrosis)\n\n# Enhancement of Normal Parenchyma on MR \n\n$=$ Background Parenchymal Enhancement (BPE)\n$\\diamond$ Breast enhancement does NOT correlate with breast density\n\n- varies among women + within same woman over time\n\nProper enhancement present if:\n> veins contrasted on MIP\n> both internal mammary arteries depicted\n$>$ nipple enhances\nCommon pattern of enhancement:\n$\\sqrt{ }$ bilateral symmetric diffuse enhancement:\n$\\sqrt{ }$ slow minimal / early enhancement\n$\\sqrt{ }$ persistent delayed enhancement\n$\\sqrt{ }$ linear patchy enhancement\n$\\sqrt{ }$ confluent enhancement on late dynamic scan\nDistribution of enhancement:\n$\\sqrt{ }$ bilateral symmetric enhancement with\n(a) moderate / marked degree of BPE\n(b) diffuse / regional distribution\n(c) homogeneous / internally stippled\n$\\sqrt{ }$ \"picture framing\" of vascular inflow $=$ enhancement commonly begins in periphery + gradually becomes apparent in more central breast tissue\n$\\sqrt{ }$ scattered innumerable $9-10 \\mathrm{~mm}$ foci of enhancement\n$\\sqrt{ }$ geographic areas of symmetric regional enhancement\n$\\sqrt{ }$ multiple larger symmetric areas of enhancement (DDx: asymmetry suggest malignancy)\nBPE Effect on Interpretation of MR Images:\n\n1. Falsely positive $\\leftarrow$ focal / regional / asymmetric background parenchymal enhancement\n2. Falsely negative $\\leftarrow$ moderate / marked BPE\n\nClassification of Background Parenchymal Enhancement:\nMinimal $<25 \\%$ of glandular tissue\nMild $\\quad 25-50 \\%$\nModerate $50-75 \\%$\nMarked $>75 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 802,
            "markdown": "# Hormonal Influence on BPE \n\n1. Menstruation\n$\\sqrt{ }$ enhancement high during days $21-28$ and days $1-6$ after menstruation + low during days $7-20$\n2. Lactation\n$\\diamond$ Breast involution after lactation takes 3 months\nNote: NO impairment in cancer detection in lactating patients!\nBreast-feeding: safe after contrast-enhanced MRI $\\leftarrow$ minute amounts of Gd in breast milk\n3. Postmenopausal period without HRT\n$\\sqrt{ }$ decrease in fibroglandular tissue $\\rightarrow$ degree of BPE typically less than that in premenopausal women\n4. Hormone replacement therapy (HRT)\n$\\sqrt{ }$ increase in BPE in amount + degree + distribution with great interindividual variations:\n$\\diamond$ Hormonal effect reverses after 30-60 days\n5. Endocrine antihormonal therapy\n\nAntiestrogenic agents: selective estrogen receptor modulators, aromatase inhibitors\n$\\sqrt{ }$ significant decrease in amount of fibroglandular tissue + cysts + BPE\n$\\sqrt{ }$ effect on BPE evident early in treatment ( $<90$ days)\n$\\sqrt{ }$ tamoxifen rebound after medication discontinued:\n$\\checkmark$ global / focal increase in BPE\n6. Oophorectomy $\\rightarrow$ decrease in BPE\n\nMRI preferably performed during $2^{\\text {nd }}$ week of menstrual cycle!\n\n## Lymphatic Drainage\n\n1. Axillary nodes\n$=5$ groups of lymph nodes in axilla divided into 3 levels by pectoralis minor muscle",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 803,
            "markdown": "![img-84.jpeg](img-84.jpeg)\n\nCancerous involvement: $97 \\%$\n(a) Inferior group $=$ Berg I level\n\nLocation: inferior to inferolateral border of pectoralis minor muscle\nDivided into:\n> lateral group (deep)\nLandmark: $3^{\\text {rd }}$ segment of axillary a. +v .; subscapular artery (arising from inferior surface of axillary artery)\n> subscapular group (posterolateral)\nLandmark: along course of hook-shaped thoracodorsal artery\n> pectoral group (anteromedial)\nLandmark: lateral thoracic artery parallel and posterior to lateral margin of pectoralis minor muscle arising from terminal portion of $2^{\\text {nd }}$ segment of axillary artery\nMost sentinel nodes are inferior level I axillary nodes!\n(b) Central group $=$ Berg II level\n\nLocation: posterior to and between lateral and medial borders of pectoralis minor muscle + between pectoralis minor muscle and pectoralis major m. (= Rotter space nodes)\nLymphatic route: received from level I nodes\nStaging: N1 $=<4$ nonmatted movable nodes N2 $=>4$ / matted nonmovable nodes\n(c) Apical group $=$ Berg III level\n\nLocation: medial to superior border of pectoralis minor muscle (+ infraclavicular nodes)\nLymphatic route: received from level II nodes $\\rightarrow$ subclavian lymphatic trunk and supraclavicular nodes $\\rightarrow$ (left-sided) thoracic duct + right",
            "images": [
                {
                    "id": "img-84.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1322,
                    "bottom_right_y": 932,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 804,
            "markdown": "# lymphatic duct \n\nStaging: N3 = stage IIIC disease\n2. Internal mammary nodes $(3 \\%)$\n\nThe presence of internal mammary nodal metastasis changes stage, prognosis and radiation therapy field!\nLocation: follow internal mammary artery and vein between pleura / endothoracic fascia and chest wall near margin of sternum in $1^{\\text {st }}-6^{\\text {th }}$ intercostal spaces\nLymphatic route: from level of diaphragm (= anterior phrenic nodes) to termination in thoracic venous system on right and thoracic duct on left\n![img-85.jpeg](img-85.jpeg)\n\nNormal size: $<6 \\mathrm{~mm}$\nCancerous involvement: isolated in 3\\% originating from deep / medial lesion\nStaging: (a) without axillary met $=\\mathrm{N} 2$\n(b) with axillary met $=\\mathrm{N} 3 \\mathrm{~b} /$ stage IIIC disease\n\nMetastases to internal mammary nodes usually occur after a tumor has metastasized to the axilla!\n\n## Axillary Artery\n\nOrigin: lateral margin of $1^{\\text {st }}$ rib (out of subclavian artery)\nSegments \\& Branches:\nmnemonic: \"Screw The Lawyers Save A Patient\"\n\n1. Segment: medial to pectoralis minor m .\n\nSuperior thoracic a.\n2. Segment: posterior to pectoralis minor m .\n\nThoracoacromial a.\nLateral thoracic a.",
            "images": [
                {
                    "id": "img-85.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 598,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1309,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 805,
            "markdown": "3. Segment: lateral to pectoralis minor m .\n\nSubscapular a.\nAnterior humeral circumflex a.\nPosterior humeral circumflex a.\nTerminus: lower margin of teres major m. (into brachial a.)\n![img-86.jpeg](img-86.jpeg)\n\n# Arterial Supply of Breast \n\n1. Branches of internal thoracic artery (= dominant vessel)\n\nSupply: medial + central breast parenchyma\n2. Branches of lateral thoracic artery\n\nSupply: superolateral breast parenchyma\n3. Branches of subclavian + axillary arteries (including thoracoacromial + subscapular + thoracodorsal arteries)\nSupply: portion of superior breast parenchyma\n4. Branches of musculophrenic artery (= continuation of internal thoracic artery)\n\nSupply: variable portion of inferior breast\n5. Perforating branches of anterior + posterior intercostal arteries perforate chest wall musculature\nSupply: deep central breast parenchyma\n\n## BREAST DURING PREGNANCY \\& LACTATION\n\nCause: increase in estrogen, progesterone, prolactin\nOnset: early in $2^{\\text {nd }}$ month of $1^{\\text {st }}$ trimester\nHisto:\n1st trimester:\n(a) marked ductular sprouting with some branching + discrete lobular growth",
            "images": [
                {
                    "id": "img-86.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 426,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1146,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 806,
            "markdown": "(b) involution of fibrofatty stroma\n\n| Breast Changes during Pregnancy \\& Lactation |  |  |\n| :--: | :--: | :--: |\n| Period | Histo | Hormone |\n| $2^{\\text {nd }}$ month of $1^{\\text {st }}$ trimester | marked ductular sprouting $\\rightarrow$ some branching + discrete lobular growth; simultaneous involution of fibrofatty stroma; increase in glandular vascularity; | estrogen |\n| $2^{\\text {nd }}+3^{\\text {rd }}$ trimester | marked lobular growth with great epithelial proliferation; <br> relative decrease of stromal components; alveolar cells of TDLU differentiate into colostrum-cell epithelium; initiation of protein synthesis (lactogenesis I) | progesterone |\n|  |  | prolactin opposed by progesterone |\n| Lactation <br> (= secretory state) | cytoplasm of lobular cells becomes vacuolated; secretion progressively accumulates in distended lobular glands: hyperchromatic nuclei often with small nucleoli + flattening of myoepithelial cells | high prolactin level after rapid withdrawal of progesterone |\n|  | marked distention of lobular glands + accumulation of secretion of fat, lactose, and proteins (lactogenesis II) as basic nutrients of milk | in conjunction with insulin, corticosteroids, thyroid hormone, growth hormones |\n| Milk ejection | maintenance of milk production (lactogenesis III) regulated by autocrine system (= neuroendocrine mechanism in the posterior pituitary gland) | release of oxytocin stimulated by breast-feeding |\n| Breast involution | characterized by marked lobular atrophy that occurs over a period of about 3 months after lactation ceases |  |\n\n(c) increase in glandular vascularity\n\n2nd + 3ol trimester:\n(a) marked lobular growth\n(b) stromal decrease\n(c) epithelial proliferation with cellular enlargement\n(d) differentiation of alveolar cells into colostrum-cell epithelium\nlactation:\n$=$ formation + secretion of milk (= fat + lactose + proteins)\n\n- high levels of prolactin + rapid withdrawal of progesterone\n(a) cytoplasmic vacuolation of lobular cells with hyperchromatic nuclei + small nucleoli\n(b) distension of lobular glands $\\leftarrow$ accumulating secretions\n(c) flattening + attenuation of myoepithelial cells\n\nMammography (low sensitivity):\n\n- To be performed immediately after breast-feeding in case of a suspected malignancy\n- Effective in detecting microcalcifications / subtle areas of distortion\n$\\sqrt{ }$ diffuse, markedly dense, heterogeneously coarse, confluent nodular breast parenchyma (NOT in all patients)\n$\\sqrt{ }$ marked decrease in adipose tissue\nUS (method of choice):\n$\\diamond$ identifies a palpable area as a true mass / normal parenchyma\n(a) during pregnancy\n$\\sqrt{ }$ slight diffuse hypoechogenicity of enlarged nonfatty fibroglandular component\n(b) during lactation\n$\\sqrt{ }$ diffuse hyperechogenicity of breast parenchyma\n$\\sqrt{ }$ prominent ductal system + increased vascularity\nMR (routine use is inappropriate + interpretation difficult):\n$\\sqrt{ }$ diffuse high SI on T2WI $\\leftarrow \\uparrow$ fraction of mobile water",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 807,
            "markdown": "$\\sqrt{ }$ rapid enhancement + early plateau\n\n# Lactogenesis \n\nLactogenesis I\n= formation of colostrum around 16 weeks EGA\nLactogenesis II\n$=$ secretion of copious milk around day 4 postpartum\nLactogenesis III\n$=$ maintenance of milk supply around day 10 postpartum via autocrine control\n\n- release of oxytocin in posterior pituitary gland stimulated by breast feeding $\\rightarrow$ milk ejection\nLactogenesis IV\n$=$ decreased milk production $\\leftarrow$ epithelial apoptosis\n- gradual breast involution completed by 3 months\n\n\n## MAMMOGRAPHIC TECHNIQUE\n\n## BEAM QUALITY\n\nMolybdenum target material with characteristic emission peaks of $17.9+19.5 \\mathrm{keV}$ (lower average energy than tungsten)\nFOCAL SPOT\n$0.1-0.4 \\mathrm{~mm}(0.1 \\mathrm{~mm}$ for magnification views $)$\nTUBE OUTPUT\n$80-100 \\mathrm{~mA}$\nEXPOSURE\n(a) without grid: 25 kV (optimum between contrast + penetration), exposure time of 1.0 sec\n(b) with grid: $26-27 \\mathrm{kV}$; exposure time of 2.3 sec\n(c) microfocus magnification: $26-27 \\mathrm{kV} ; 1.5-2.0$ times magnification with $16-30 \\mathrm{~cm}$ air gap\n(d) specimen radiography: $22-24 \\mathrm{kV}$\n\nFILTER\n(a) beryllium window (absorbs less radiation than glass tube)\n(b) molybdenum filter ( 0.03 mm ): allows more of lower energy radiation to reach breast REDUCTION OF SCATTER RADIATION\n(1) adequate compression (also improves contrast + decreases radiation dose)\n(2) beam collimation to $<8-10 \\mathrm{~cm}$\n(3) air gap with microfocus magnification (greater spatial resolution, 2-3-fold increase in radiation exposure)\n(4) Moving grid\ngrid if compressed breast $>5 \\mathrm{~cm} /$ very dense breast (facilitates perception, 2-3-fold increase in radiation exposure)\nSCREEN-FILM COMBINATION\n(1) Intensifying screen phosphor single screen systems\n(2) Film-screen contact\n(3) Mammography film with minimal base fog, sufficient maximum density + contrast FILM PROCESSING",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 808,
            "markdown": "(1) Processing time of $3 \\mathrm{~min}(42-45 \\mathrm{sec}$ in developing fluid) superior to $90-\\mathrm{sec}$ processor for double-emulsion film (which creates underdevelopment + compensatory higher radiation exposure)\n(2) Developing temperature of $35^{\\circ} \\mathrm{C}\\left(95^{\\circ} \\mathrm{F}\\right)$\n(3) Developing fluid replenishment rate: $450-500 \\mathrm{~mL}$ replenisher per square meter of film\nQUALITY CONTROL\n(1) Processor (daily)\nwith sensito- / densitometric measurements\n(a) base fog $<0.16-0.17$\n(b) maximum density $>3.50$\n(c) contrast $>1.9-2.0$\n(2) X-ray unit (semiannually)\n(a) beam quality\n(b) phototimer\n\nAverage glandular dose:\n$<0.6 \\mathrm{mGy}$ per breast for nonmagnification film-screen mammogram (ACR accreditation requirement)\nScreen/film technique (molybdenum target; 0.03 mm molybdenum filter, 28 kVp ): mean absorbed dose: 0.05 rad for CC view 0.06 rad for LAT view\nEffective dose equivalent HE:\nscreen-film mammography 0.11 mSv\nxeroradiographic mammography 0.78 mSv\nchest 0.05 mSv\nskull 0.15 mSv\nabdomen 1.40 mSv\nlumbar spine 2.20 mSv\nAdvantages of magnification mammography:\n\n1. Sharpness effect $=$ increased resolution\n2. Noise effect $=$ noise reduced by a factor equal to the degree of magnification\n3. Air-gap effect $=$ increased contrast by reduction in scattered radiation\n4. Visual effect $=$ improved perception and analysis of small detail\n\n# Computer-Aided Detection (CAD) \n\nUtility of Computer-Aided Detection (CAD):\n(a) significant\n\n1. Clustered microcalcifications\n2. Spiculated lesion\n(b) moderate\n3. Poorly defined mass / asymmetry\n(c) low\n4. Focal asymmetry\n5. Architectural distortion ( $1-2 \\%$ detected)\n(d) none\n6. Developing asymmetry (no comparison with prior)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 809,
            "markdown": "# Cancers missed by Computer-Aided Detection (CAD): \n\n(1) Microcalcifications few\n(2) Nonspiculated mass $20 \\%$\n(3) Architectural distortion $50 \\%$\n(4) Focal asymmetry $99 \\%$\n(5) Developing asymmetry $100 \\%$\n\n## Factors Affecting Mammographic Image Quality\n\n## Radiographic Sharpness\n\n$=$ subjective impression of distinctness / perceptibility of structure boundary / edge\n\n1. Radiographic contrast\n$=$ magnitude of optical density difference between structure of interest + surroundings influenced by\n(a) subject contrast\n$=$ ratio of x-ray intensity transmitted through one part of the breast to that transmitted through a more absorbing adjacent part; affected by\n> absorption differences in the breast (thickness, density, atomic number)\n> radiation quality (target material, kilovoltage, filtration)\n> scattered radiation (beam limitation, grid, compression)\n(b) receptor contrast\n$=$ component of radiographic contrast that determines how the x-ray intensity pattern will be related to the optical density pattern in the mammogram\naffected by analog factors\n> film type\n> processing (chemicals, temperature, time, agitation)\n> photographic density\n> fog (storage, safelight, light leaks)\nCauses of poor contrast:\nunderexposure, inadequate compression, high kV , target material selection (tungsten vs. molybdenum), look-up table selection (altered by engineer)\n2. Radiographic blurring\n$=$ lateral spreading of a structural boundary ( $=$ distance over which the optical density between the structure and its surroundings changes)\n(a) motion\nreduced by compression + short exposure time\n(b) geometric blurring\naffected by\n> focal spot: size, shape, intensity distribution\nfor analog only:\n> focus-object distance (= cone length)\n> object-image distance\n(c) receptor blurring\n$=$ light diffusion (= spreading of the light emitted by the screen) affected by\n> phosphor thickness + particle size",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 810,
            "markdown": "> light-absorbing dyes + pigments\n> screen-film contact\nCauses of image blur:\nlarge focal spot size, damaged anode, patient motion (inadequate compression, poor patient cooperation, long exposure time)\nCauses of long exposure:\ninadequate compression, kV too low, low mAs output, dense breast, large breast, magnification\n\n# Radiographic Noise \n\n$=$ unwanted fluctuation in optical density\n\n1. Radiographic mottle\n= optical density variations consist of\n(a) receptor graininess\n= optical density variation from random distribution of finite number of silver halide grains\n(b) quantum mottle (principal contributor to mottle)\n= variation in optical density from random spatial distribution of x-ray quanta absorbed in image receptor\naffected by\n> film speed + contrast\n> screen absorption + conversion efficiency\n> light diffusion\n> radiation quality\n(c) structure mottle\n= optical density fluctuation from nonuniformity in the structure of the image receptor (eg, phosphor layer of intensifying screen)\n2. Artifacts\n$=$ unwanted optical density variations in the form of blemishes on the mammogram\n(a) improper film handling (static, crimp marks, fingerprints, scratches)\n(b) improper exposure (fog)\n(c) improper processing (streaks, spots, scratches)\n(d) dirt + stains\n\nArtifacts in digital mammography:\n(a) transmission\n(b) data loss\n> processing artifact (edge artifact): raw data not affected\n> horizontal line artifact due to failure of detector element\n(c) decompression artifact\n(d) gain calibration",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 811,
            "markdown": "# BREAST DISORDERS \n\n## ABSCESS OF BREAST\n\n$=$ complication of mastitis\nOrganism:\n(a) aerobes: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes\n(b) anaerobes: Peptostreptococcus, Bacteroides\n(c) others: TB, other mycobacteria, fungi, parasites\n(d) sterile culture $(21-45 \\%)$\n\n- palpable mass, pain ( $80 \\%$ ), redness ( $71 \\%$ ), heat, fever ( $5-47 \\%$ ):\n- Clinical signs same as for mastitis!\n\nUS:\n$\\sqrt{ }$ ill-defined area of altered echotexture:\n$\\sqrt{ }$ hypoechoic often multiloculated fluid collection with acoustic enhancement + surrounding increased flow\n$\\sqrt{ }$ adjacent hypoechoic glandular parenchyma\n$\\sqrt{ }$ increased echogenicity of surrounding inflamed fat lobules\n$\\sqrt{ }$ mild skin thickening $\\leftarrow$ distended lymphatics\n$\\sqrt{ }$ mild to moderate cortical thickening of axillary lymph nodes + increased flow on Doppler\nMammo (to exclude malignancy):\nIndication: in women $>30$ years of age; prolonged course during breast-feeding period N.B.: delay until after acute episode if possible\n$\\sqrt{ }$ asymmetric density / mass / distortion\n$\\sqrt{ }$ skin thickening\n$D D x$ : inflammatory breast carcinoma $(<1 \\%)$\n$R x$ : percutaneous drainage + antibiotics\nRarely a malignant breast abscess can occur in inflammatory breast cancer!\n\n## Puerperal / Chronic Abscess of Breast (14-59\\%)\n\n$=$ Lactational ABSCESS $=$ COLD ABSCESS\nFrequency: $5-11 \\%$ of cases of mastitis during lactation; most common in primiparous mothers $(65 \\%)$\nCause: complication of mastitis (in 5-11\\%) developing in 1-24\\% of primiparous breastfeeding women\nTime of onset: within 12 weeks after birth / weaning\nOrganism: penicillinase-producing Staphylococcus aureus\nRoute of infection: small skin laceration\n\n- fever, leukocytosis, breast erythema, induration, pain\n- rapid response to antibiotics\n\nLocation: most commonly in central / subareolar area\n$\\sqrt{ }$ ill-defined / circumscribed mass of increased density with flamelike contour",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 812,
            "markdown": "$\\sqrt{ }$ secondary changes common: architectural distortion, nipple + areolar retraction, lymphedema, skin thickening, pathologic axillary nodes\n$\\sqrt{ }$ liquefied center can be aspirated\nUS:\n$\\sqrt{ }$ nearly anechoic / mixed / echogenic area with posterior enhancement\nMR (reserved for typical situation):\n, T1WI:\n$\\checkmark$ hyperintense round / ovoid lesion (high protein content)\n, enhanced T1WI:\n$\\checkmark$ no contrast uptake centrally\n$\\checkmark$ strong enhancement of abscess wall\n, T2WI:\n$\\checkmark$ hyperintense round / oval lesion\n$D D x$ : seroma, inflammatory breast cancer\n$R x$ : antibiotics, repeated aspirations, percutaneous drainage $>$ surgery; continue breast feeding to disengorge ducts; cessation of breast feeding with antibiotics (contraindicated for newborn / with surgical drainage)\n\n# Nonpuerperal Abscess (41-86\\%) \n\n$=$ abscess occurring outside breast-feeding period\nRisk factors: black race, obesity, tobacco smoking, diabetes\nOrganism: mixed flora (Staphylococcus, Streptococcus); greater risk of anaerobes\n\n## Central / Periareolar Nonpuerperal Abscess\n\n$=$ complication of periductal mastitis\nMost common form of abscess that develops outside of the breast-feeding period in young smoking woman!\n\nFrequency: $34-94 \\%$ of all breast abscesses\nPathophysiology:\nsquamous metaplasia of cuboidal epithelium $\\rightarrow$ keratin plug + acute infiltrate + cellular debris $\\rightarrow$ distension of obstructed lactiferous duct $\\rightarrow$ secondary infection with abscess formation + cutaneous fistula\nZuska disease $=$ recurring central nonpuerperal abscesses associated with lactiferous fistulas\nPrognosis: difficult to treat; $25-40 \\%$ recurrence rate\n$R x$ : percutaneous drainage + antibiotics; cessation of smoking; diagnostic mammogram if $>35$ years of age to rule out malignancy\n\n## Peripheral Nonpuerperal Abscess\n\nCause: underlying chronic medical condition (diabetes, rheumatoid arthritis), on steroids, recent breast intervention (postoperative / postradiation Rx)\nAge: older age group\nPrognosis: good response to therapy; rare recurrences\n\n## BREAST CANCER",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 813,
            "markdown": "# Epidemiology of Breast Cancer \n\nIncidence: 1.5-4.5 cases per 1,000 women per year in USA; 246,660 new cases of invasive breast cancer $+61,000$ new cases of carcinoma in situ (2016) $\\mathrm{M} \\div \\mathrm{F}=100 \\div 1$, whites + blacks $=70 \\div 1$\n$\\diamond 2^{\\text {nd }}$ most common cancer among women (after lung cancer)!\n$\\diamond 2^{\\text {nd }}$ leading cause of death by cancer in women (after lung cancer)!\n$\\diamond 12.5 \\%$ lifetime risk of breast cancer $=1$ in 8 women will develop breast cancer!\nAge: $\\quad 0.3-2 \\%$ in women $<30$ years of age;\n$15 \\%$ in women $<40$ years of age;\n$85 \\%$ in women $>30$ years of age\nMortality: about 40,450 deaths in USA per year (2016)\n\n## Risk Factors (increasing risk):\n\n## DEMOGRAPHIC FACTORS in BREAST CANCER\n\n- increasing age ( $66 \\%$ of cancers in women $>50$ years):\n\n| Age | Prevalence of Breast Cancer |  |\n| :--: | :--: | :--: |\n| 25 | $5 \\div 100,000$ | $1 \\div 19,608$ |\n| 40 | $80 \\div 100,000$ | $1 \\div 1,250$ |\n| 45 | $1075 \\div 100,000$ | $1 \\div 93$ |\n| 50 | $180 \\div 100,000$ | $1 \\div 555$ |\n| 55 | $3030 \\div 100,000$ | $1 \\div 33$ |\n| 60 | $240 \\div 100,000$ | $1 \\div 416$ |\n| Relative Risk | Compared with Woman of Age 60 |  |\n| 30 years of age | 0.07 | 60 years of age |\n| 35 years of age | 0.19 | 70 years of age |\n| 40 years of age | 0.35 | 80 years of age |\n| 50 years of age | 0.71 |  |\n\n- Ashkenazi Jewish women + nuns\n- upper $>$ lower social class\n- unmarried $>$ married women\n- Whites $>$ Blacks after age 40\n\n\n## REPRODUCTIVE VARIABLES in BREAST CANCER\n\n- nulliparous $>$ parous:\n\n| Relative Risk Compared with Nulliparous: |  |  |\n| :-- | :-- | :--: |\n| age at 1st pregnancy | $<19$ years | 0.5 |\n| age at 1st pregnancy | $20-30$ years | - |\n| age at 1st pregnancy | $30-34$ years | 1.0 |\n| age at 1st pregnancy | $>35$ years | $>1.0$ |\n\n- first full-term pregnancy after age 35: 2 x risk\n- low parity $>$ high parity",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 814,
            "markdown": "- early age at menarche ( $<12$ years):\nrelative risk compared with onset of regular ovulatory cycle:\n\n|  | Menarche $<12$ | Menarche $>12$ |\n| :-- | :--: | :--: |\n| immediately | 3.7 | 1.6 |\n| $1-4$ years | 2.3 | 1.6 |\n\n- late age at menopause:\nrelative risk compared with menopause before age 44 :\nnatural menopause $>55$ years of age 2.00\n- early bilateral oophorectomy:\nrelative risk compared with menopause between ages 45-49 years:\nartificial menopause at $50-54$ years 1.34\nartificial menopause before age 450.77\n\n\n# Multiple Primary Cancers in Breast Cancer \n\n- $4-5 \\mathrm{x}$ increase in risk for cancer in contralateral breast\n- increased risk after ovarian + endometrial cancer\n\n\n## BRCA (breast cancer)\n\n$=$ mutation of tumor suppressor gene accounts for $50 \\%$ of hereditary breast cancers\n$5-10 \\%$ of all breast cancers are hereditary!\n\n- BRCA1 on long arm of chromosome 17\n- BRCA2 on chromosome 13\n\nCarrier: group of women at high risk for breast cancer\n$\\diamond$ Strict surveillance mandatory!\n$1 \\%$ of women are at very high risk for developing breast cancer due to a genetic disposition!\n\n## Family History of Breast Cancer\n\n- breast cancer in first-degree relative:\n\nRelative risk compared with negative family Hx:\n$(+)$ for mother 1.8\n$(+)$ for sister 2.5\n$(+)$ for mother + sister 5.6\n\n- $25 \\%$ of patients with carcinoma have a positive family history\n- carcinoma tends to affect successive generations $\\sim 10$ years earlier\n\n\n## Benign Breast Disease and Breast Cancer\n\n- 2-4 x increased risk with atypical hyperplasia relative risk compared with no biopsy: benign breast disease in all patients 1.5\nnonproliferative disease 0.9\nproliferative disease without atypia 1.6\nfibroadenoma + hyperplasia 3.5\natypical duct hyperplasia (ADH):\nno family history of breast cancer 4.4\nfamily history of breast cancer 8.9",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 815,
            "markdown": "# Parenchymal Breast Pattern and Breast Cancer \n\n- prominent duct pattern + extremely dense breasts according to Wolfe classification N1 ( $0.14 \\%$ ), P1 ( $0.52 \\%$ ), P2 (1.95\\%), DY (5.22\\%)\n\n\n## Radiation Exposure and Breast Cancer\n\nexcess risk of 3.5-6 cases per 1,000,000 women per year per rad after a minimum latent period of 10 years (atomic bomb, fluoroscopy during treatment of tuberculosis, irradiation for postpartum mastitis, Hodgkin disease)\n\n## GeOGRAPHY\n\n- Western + industrialized nations (highest incidence)\n- Asia, Latin America, Africa (decreased risk)\n\n\n## Breast Cancer Evaluation\n\n|  | MRI | Mamma | US | Physical | all 4 |\n| :-- | --: | --: | --: | --: | --: |\n| Sensitivity [\\%] | $77-100$ | $25-40$ | $33-40$ | 9 | 95 |\n| Specificity [\\%] | $81-97$ | $93-99$ | $91-96$ |  |  |\n| Recall [\\%] | 10.8 | $3.9-5.4$ |  |  |  |\n| FN [\\%] | $0.2-0.4$ | $0.4-1.5$ |  |  |  |\n\n## Localizing Signs of Breast Cancer\n\n$=$ PRIMARY SIGNS OF BREAST CANCER\n\n1. Dominant mass seen on two views with\n(a) Spiculation $=$ stellate / star-burst appearance ( $=$ fine linear strands of tumor extension + desmoplastic response); \"scirrhus\" caused by:\n(1) infiltrating ductal carcinoma ( $75 \\%$ of all invasive cancers)\n(2) invasive lobular carcinoma (occasionally)\n$\\sqrt{ }$ mass feels larger than its mammographic / sonographic size\n$D D x$ : prior biopsy / trauma / infection\n(b) Smooth border\n(1) intracystic carcinoma (rare): subareolar area; bloody aspiration\n(2) medullary carcinoma: soft tumor\n(3) mucinous / colloid carcinoma: soft tumor\n(4) papillary carcinoma\n$\\sqrt{ }$ \"telltale\" signs: lobulation, small comet tail, flattening of one side of the lesion, slight irregularity\n$\\sqrt{ }$ \"halo\" sign (= Mach band) may be present\n$D D x$ : cyst (sonographic evaluation)\n(c) Lobulation\nappearance similar to fibroadenoma (only characteristic calcifications may exclude malignancy)\n$\\diamond$ The likelihood of malignancy increases with number of lobulations\n\n- clinical size of mass > radiographic size (1951) (Leborgne's law)\n[Raul Alfredo Leborgne Fossemale (1907-1986), Uruguayan radiologist created the mammograph, discovered radiological signs and developed the first method of radiologically guided mammary biopsy]",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 816,
            "markdown": "2. Asymmetric density $=$ star-shaped lesion\n$\\sqrt{ }$ distinct central tumor mass with volumetric rather than planar appearance $\\rightarrow$ additional coned compression view\n$\\sqrt{ }$ denser relative to other areas ( $=$ vessels + trabeculae cannot be seen within highdensity lesion)\n$\\sqrt{ }$ fat does not traverse density\n$\\sqrt{ }$ corona of spicules\n$\\sqrt{ }$ in any quadrant $\\rightarrow$ but fatty replacement occurs last in upper outer quadrant\n$D D x$ : postsurgical fibrosis, traumatic fat necrosis, sclerosing duct hyperplasia\n3. Microcalcifications\nassociated with malignant mass by mammogram in $40 \\%$, pathologically with special stains in $60 \\%$, on specimen radiography in $86 \\%$\n$\\diamond 20 \\%$ of clustered microcalcifications represent a malignant process!\n(a) shape: fragmented, irregular contour, polymorphic, casting rod-shaped without polarity, Y-shaped branching pattern, granular \"salt and pepper\" pattern, reticular pattern\n(b) density: various densities\n(c) size: $100-300 \\mu \\mathrm{~m}$ (usually); rarely up to 2 mm\n(d) distribution: tight cluster over an area of $1 \\mathrm{~cm}^{2}$ or less is most suggestive; coursing along ductal system seen in ductal carcinoma with comedo elements\n\n# 4. Architectural distortion \n\nCause: desmoplastic reaction\n$\\sqrt{ }$ ragged irregular borders\n$D D x$ : postsurgical fibrosis\n5. Interval change\n(a) neodensity = de novo developing density $\\rightarrow$ in $6 \\%$ malignant\n(b) enlarging mass $\\rightarrow$ in $10-15 \\%$ malignant\n6. Enlarged single duct\n$=$ low probability for cancer in asymptomatic woman with normal breast palpation\n$\\sqrt{ }$ solitary dilated duct $>3 \\mathrm{~cm}$ long\n$D D x$ : inspissated debris / blood / papilloma\n7. Diffuse increase in density (late finding)\n\nCause: (1) plugging of dermal lymphatics with tumor cells\n(2) less flattening of sclerotic + fibrous elements of neoplasm in comparison with more compressible fibroglandular breast tissue\n\n## Nonlocalizing Signs of Breast Cancer\n\n$=$ SECONDARY SIGNS OF BREAST CANCER\n\n1. Asymmetric thickening\n2. Asymmetric ducts especially if discontinuous with subareolar area\n3. Skin changes\n(a) skin retraction $=$ dimpling of skin\n\nCause: desmoplastic reaction $\\rightarrow$ shortening of Cooper ligaments / direct extension of tumor to skin",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 817,
            "markdown": "$D D x$ : trauma, biopsy, abscess, burns\n(b) skin thickening $\\leftarrow$ blocked lymphatic drainage / tumor in lymphatics\n\n- peau d'orange\n$D D x$ : normal in inframammary region\n\n4. Nipple / areolar abnormalities\n(a) retraction / flattening of nipple\n$D D x$ : normal variant\n(b) Paget disease $=$ eczematoid appearance of nipple + areola in ductal carcinoma $\\sqrt{ }$ associated with ductal calcifications toward nipple\n$D D x$ : nipple eczema\n(c) nipple discharge\n\n- spontaneous persistent discharge\n- need not be bloody\n$D D x$ : lactational discharge\n\n5. Axillary nodes (sign of advanced / occult cancer)\n$\\sqrt{ }>1.5 \\mathrm{~cm}$ without fatty center\n$D D x$ : reactive hyperplasia\n6. Abnormal veins\n$\\sqrt{ }$ venous diameter ratio of $>1.4 \\pm 1$ in $75 \\%$ of cancers ( $=$ late sign + thus not very important)\n\n# Location of Breast Masses \n\nbenign + malignant masses are of similar distribution\n@ upper outer quadrant $54 \\%$\n@ upper inner quadrant $14 \\%$\n@ lower outer quadrant $10 \\%$\n@ lower inner quadrant $7 \\%$\n@ retroareolar $15 \\%$\n$\\diamond$ Mediolateral oblique view is important part of screening because it includes largest portion of breast tissue + considers most common location of cancers!\n\n## Metastatic Breast Cancer\n\n@ Axillary lymph adenopathy\nPrevalence: $40-74 \\%$\nRisk for positive nodes: $30 \\%$ if primary $>1 \\mathrm{~cm}, 15 \\%$ if primary $<1 \\mathrm{~cm}$\n@ Bone\n@ Liver\nPrevalence: $48-60 \\%$\nUS:\n$\\sqrt{ }$ hypoechoic ( $83 \\%$ ) / hyperechoic ( $17 \\%$ ) mass\n\n## Screening of Asymptomatic Patients\n\nDefinition of screening (World Health Organization):\nA screening test must\n(a) be adequately sensitive and specific",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 818,
            "markdown": "(b) be reproducible in its results\n(c) identify previously undiagnosed disease\n(d) be affordable\n(e) be acceptable to the public\n(f) include follow-up services\n\nGuidelines of American Cancer Society, American College of Radiology, American Medical Association, National Cancer Institute:\n\n1. Breast self-examination to begin at age 20\n2. Breast examination by physician every 3 years between $20-40$ years, in yearly intervals after age 40\n3. Baseline mammogram between age 35-40; follow-up screening based upon parenchymal pattern + family Hx\n4. Initial screening at 30 years if patient has first-degree relative with breast cancer in premenopausal years; follow-up screening based upon parenchymal pattern\n5. Mammography at yearly intervals after age 40\n6. All women who have had prior breast cancer require annual follow-up\n\nAdditional recommendations:\n7. Screening at 2-year intervals for women $>70$ years\n8. Baseline mammogram 10 years earlier than age of mother / sister when their cancer was diagnosed\nRate of detected abnormalities:\n30 abnormalities in 1,000 screening mammograms:\n$20-23$ benign lesions\n$7-10$ cancers\nAcceptable recall rate for screening examination:\n$10 \\%$ for initial prevalence screening;\n$5 \\%$ for subsequent incidence screening\nInterval cancers: $10-20 \\%$ of cancers surface between annual screenings",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 819,
            "markdown": "| Predictive Value of Radiographic Signs <br> of Malignancy Related to Clinical Findings |  |  |\n| :-- | :--: | :--: |\n| Mammographic Sign | Palpable | PPV (\\%) |\n| Classic for malignancy | + | 100 |\n| Classic for malignancy | - | 74 |\n| Microcalcifications* | + | 25 |\n| Microcalcifications* | - | 21 |\n| Indeterminate mammogram | + | 11 |\n| Indeterminate mass | - | 5 |\n| Benign mass | + | 2 |\n| Asymmetric density (? mass) | + | 4 |\n| Asymmetric density (? mass) | - | 0 |\n| Dilated vein |  | 0 |\n| Skin thickening |  | 0 |\n| Dilated duct |  | 0 |\n| ( $>3$ punctate irregular microcalcifications in area $<1 \\mathrm{~cm}^{2}$ ) |  |  |\n\n# Role of Mammography \n\nOverall detection rate:\n$58-69 \\% ; 8 \\%$ if $<1 \\mathrm{~cm}$ in size\nMammographic accuracy:\n$88 \\%$ correctly diagnosed by radiologist\n$27 \\%$ detected only by mammography\n$8 \\%$ misinterpretations\n$4 \\%$ not detected\n15- positive predictive value (national average):\n$30 \\% \\quad 25 \\%$ PPV for women in $5^{\\text {th }}$ decade\n$50 \\%$ PPV for women in $8^{\\text {th }}$ decade\n\n## Value of Screening Mammography\n\nIndication:\ndecrease in cancer mortality through earlier detection + intervention when tumor size is small + lymph nodes negative; tumor grade of no prognostic significance in tumors $<10$ mm in size\n\n1. Health Insurance Plan (HIP) 1963-1969\nrandomized controlled study of 62,000 women aged 40-64\n$>25-30 \\%$ reduction in mortality in women $>50$ years (followed for 18 years)\n$>25 \\%$ reduction in mortality in women 40-49 years (followed for 18 years); no significant effect at 5- and 10-year follow-up\n$>19 \\%$ of cancers found by mammography alone\n$>61 \\%$ of cancers found at physical examination\n> effectiveness of screening $<50$ years of age is uncertain\n2. Breast Cancer Detection Demonstration Project (BCDDP) 1973-1980",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 820,
            "markdown": "4,443 cancers found in 283,000 asymptomatic volunteers\n$>41.6 \\%$ of cancers found by mammography alone ( $77 \\%$ with negative nodes)\n$>8.7 \\%$ of cancers found by physical examination alone\n$>59 \\%$ of noninfiltrating cancers found by mammography alone\n$>25 \\%$ of cancers were intraductal (versus $5 \\%$ in previous series)\n$>21 \\%$ of cancers found in women aged 40-49 years (mammography alone detected $35.4 \\%)$\n$>51 \\%$ of cancers found with both mammography + physical examination\n3. Swedish Two-county Trial 1977-1990\nrandomized controlled study of 78,000 women in study group $+56,700$ in control group aged $40-74$ years with screening phase lasting 7 years\n(a) single MLO mammogram at 2-year intervals for women $<50$ years of age\n(b) single MLO mammogram at 3-year intervals for women $\\geq 50$ years of age\n$>40 \\%$ reduction in mortality at 7 years in women $50-74$ years\n$>0 \\%$ reduction in mortality at 7 years in women $40-49$ years\nAt 29-year follow-up 34 years of life per 1000 women were saved screened over a 7 -year period\nAt 29-year follow-up 1 breast cancer was prevented for each 519 women screened for 7 years\n4. Meta-analysis of combined results of 5 Swedish trials for women aged 39-49\n\n- $29 \\%$ reduction in breast cancer mortality with screening mammograms offered at intervals from 18 to 28 months\n\n\n# Occult versus Palpable Breast Cancer \n\n$\\diamond 27 \\%$ are occult cancers (NO age difference)\nPositive axillary nodes:\noccult cancers (19\\%); palpable cancers (44\\%)\n10-year survival:\noccult cancers (65\\%); palpable cancers (25\\%)\n\n## Mammographically Missed Cancers\n\nFalse-negative screening mammogram:\n$=$ pathologic diagnosis of breast cancer within 1 year after negative mammogram with the following types of misses:\n(a) lesion could not be seen in retrospect ( $25-33 \\%$ ) = \"acute cancer\" = cancer surfacing in screening interval\n(b) cancer undetected by first reader but correctly identified by second reader (14\\%)\n(c) cancer visible in retrospect on prior mammogram ( $61 \\%$ )\n\nPrevalence: $\\sim 4-15-34 \\%$ of all cancers; $\\sim 3$ cancers $\\div 2,000$ mammograms; $5-15-22 \\%$ of palpable breast cancers\n$\\diamond$ A second reader will detect an additional $5-15 \\%$ of cancers!\n\n## Cause:\n\n1. Logistical error\n(a) prior films not made available\n(a) prior films not back far enough",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 821,
            "markdown": "$\\diamond$ For comparison use a mammographic interval of 3 years to detect slowly developing asymmetries (tumor doubling time $\\sim 150$ days)\n2. Interpretation error $(52 \\%)$ :\n(a) benign appearance ( $18 \\%$ ): medullary carcinoma, colloid carcinoma, intracystic papillary carcinoma, some infiltrating ductal carcinomas\n(b) present on previous mammogram ( $17 \\%$ )\n(c) seen on one view only $(9 \\%)$\n(d) site of previous biopsy $(8 \\%)$\n(e) calcifications assumed to be benign\n3. Observer error $(30-43 \\%)$ :\n(a) overlooked: one lesion / group of calcifications doesn't fit the rule of multiplicity\n(b) intrinsic distraction = presence of an obvious finding leads to overlooking of a more subtle lesion = \"satisfied search\" phenomenon\n(c) no knowledge of clinical finding\n(d) rushed interpretation\n(e) heavy caseload\n(f) extraneous distraction\n(g) eye fatigue\n(h) inexperience\n4. Wrong assumption\n(a) misleading long history of a lump results in screening rather than diagnostic mammogram\n(b) acceptance of irreconcilable size discrepancy / lesion location between sonogram and mammogram\n(c) suspicious findings remain suspicious!\n4. Technical error $(5 \\%)$ :\n(a) inadequate radiographic technique: improper positioning, inadequate compression, under- / overexposed image, poor screen-film contact, geometric motion blurring\n(b) misapplied workup = failure to image region of interest: spot compression magnification view may displace lesion out of field of view\n(c) suboptimal viewing conditions: inadequate luminance of view boxes, extraneous view box light, high ambient room light\n5. Tumor biology:\n(a) small tumor size\n(b) failure to incite desmoplastic reaction (eg, invasive lobular carcinoma)\n(c) limitations of screen-film mammography in physically dense breasts\n(d) no associated microcalcifications ( $\\sim 50 \\%$ of cancers)\n(e) developing soft-tissue density\n$\\diamond$ A developing density that cannot be reconciled with a history of trauma, inflammation or hormones and does not represent a cyst or lymph node requires a biopsy!\n(f) stability of mammographic findings\n$\\diamond$ Malignant calcifications may be stable for up to 63 months",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 822,
            "markdown": "$\\diamond$ A mass may not change for up to 4.5 years\n6. Difficult location:\n(a) axillary tail\n(b) inframammary fold\n(c) busy subareolar region\n\nLocation of missed cancers:\nretroglandular area ( $33 \\%$ ), lateral parenchyma ( $31 \\%$ ), central ( $18 \\%$ ), medial ( $13 \\%$ ), subareolar $(4 \\%)$\n\n# Disclosing Unanticipated Outcomes \n\n(a) Content to be disclosed to patient:\n\n1. Provide facts about events = presence of error / system failure if known\n2. Express regret $=$ apology\n(b) Institutional requirements:\n3. Integrate disclosure, patient safety and risk management\n4. Establish disclosure support system\n5. Use performance improvement tools to track and enhance disclosure\n\n## Radiation-induced Breast Carcinoma\n\n$\\diamond$ Lifetime risk with cumulative carcinogenic effect related to age!\n(a) women age $<35$ : 7.5 additional cancers per 1 million irradiated women per year per rad\n(b) women age $>35: 3.5$ additional cancers per 1 million irradiated women per year per rad\n\n## Role of Breast Ultrasound in Breast Cancer\n\nIndications:\n$\\diamond$ Ultrasound is no screening tool!\nA. TARGETED EXAM\n(1) Initial study of palpable lump in patient $<30$ years of age / pregnant / lactating $\\diamond$ Ultrasound will not add useful information in an area that contains only fatty tissue on a mammogram!\n(2) Characterization of mammographic / palpable mass as fluid-filled / solid\n$\\diamond$ Ultrasound will add useful information if there is water-density tissue in the area of palpable abnormality!\n$\\diamond$ Differentiation of cystic from solid lesion is the principal role of ultrasound!\n(3) Additional evaluation of nonpalpable abnormality with uncertain mammographic diagnosis\n(4) Search for focal lesion as cause for mammographic asymmetric density\n(5) Confirmation of lesion seen in one mammographic projection only\nB. WHOLE-BREAST EXAM\n(1) Breast secretions\n(2) Suspected leaks from silicone implant\n(3) Follow-up of multiple known mammographic / sonographic lesions\n(4) Radiographically dense breast with strong family history of breast cancer",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 823,
            "markdown": "(5) Metastases thought to be of breast origin, but with negative clinical + mammographic exam\n(6) Mammography not possible: \"radiophobic\" patient, bedridden patient, after mastectomy\nC. INTERVENTIONAL PROCEDURE\n(1) Ultrasound-guided cyst aspiration\n(2) Ultrasound-guided core biopsy\n(3) Ultrasound-guided ductography, if\n(a) secretions cannot be expressed\n(b) duct cannot be cannulated\n\nAccuracy: 98\\% accuracy for cysts; $99 \\%$ accuracy for solid masses; small carcinomas have the least characteristic features\n\n# Role of Breast MR in Breast Cancer \n\n$\\diamond$ Impact of routine breast MRI on survival still unknown $\\rightarrow$ use of MRI for preoperative staging controversial!\nPathophysiology of tumor detection:\ngrowth of tumor vessels (= neoangiogenesis) with abnormal leaky capillaries (= increased permeability) $\\rightarrow$ rapid uptake (= early enhancement) and rapid washout of intravenous contrast material in cancerous lesions\nIndications:\n(1) Improve detection + characterization of primary\n\n- palpable mass + negative mammogram + sonogram\n- status post lumpectomy with positive resection margins\n$\\diamond$ Helps to reduce the rate of re-excision (4-43\\%)\n- repeated indeterminate mammogram\n- staging:\n> tumor size: MR more accurate in estimate of tumor size than mammography / ultrasound\n> detection of extensive intraductal component: MR superior to mammography\n> multifocality ( $16-50 \\%$ ): in $70 \\%$ detected by MR only\n> multicentricity( $15-30 \\%$ ): in $50 \\%$ detected by MR only\n$\\diamond$ Reduces rate of \"recurrence\" / preoperatively undetected foci of cancer from $6.8 \\%$ to $1.2 \\%$\n$\\diamond$ May change accelerated partial breast irradiation to whole-breast irradiation\n> before + after $2^{\\text {nd }}$ cycle of neoadjuvant chemotherapy to separate responders from nonresponders\n> chest wall invasion\n(2) \"Clearing\" (= screening) of contralateral breast:\nbilaterality ( $3-5 \\%$ ) in $75 \\%$ detected by MR only\n$\\diamond$ Increases detection of contralateral breast cancer from $4 \\%$ to $17 \\%$ (of which $35 \\%$ are DCIS)\n(3) Screening of high-risk groups\n- young patient with positive BRCA1 gene\n- dense breast + high-risk lesion of LCIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 824,
            "markdown": "- status post mastectomy + breast reconstruction with implant (yearly screening)\n(4) Improve detection of recurrent breast cancer\n- planning for biopsy to determine scar versus recurrent tumor after breast-conserving therapy\n(5) Evaluate response to neoadjuvant chemotherapy\n(6) Examine breasts in patient with metastatic breast cancer but unknown origin of primary $(2-7 \\%)$\n- axillary node malignancy + negative mammogram\n(7) Implant imaging\n\nSensitivity: 72-90-100\\% (for DCIS 40-73-100\\%, for invasive cancer 91\\%)\nSpecificity: $37-70-100 \\%$\n$\\diamond$ A normal MR mammogram\n> correctly rules out malignancy in $>96 \\%$\n$>$ means no invasive cancer $>3 \\mathrm{~mm}$\n$>$ means no further exam for 2 years (for 1 year if BRCA positive)\n$>$ FN: DCIS, LCIS, lobular cancer, tubular cancer\nOptimal timing of MR: 7-20 days after beginning of cycle; 6 months after open biopsy; 12 months after radiation therapy\nMR:\nMalignant morphology always trumps kinetics!\n$\\sqrt{ }$ reduced signal on T2WI\n$\\sqrt{ }$ irregular morphology\n$\\sqrt{ }$ lymphangitic bridges / streaks\n$\\sqrt{ }$ contrast enhancement:\n$\\sqrt{ }$ rapid $\\uparrow$ in SI after contrast injection $=$ rapid wash-in\n$\\diamond \\mathbf{9 0 / 9 0}$ rule $=$ cancers show an SI increase of $>90 \\%$ in the first 90 sec !\n$\\sqrt{ }$ markedly $\\uparrow$ amplitude than normal parenchymal tissue\n\n| Indication for Screening Breast MR <br> (if score $>2.0$ ) |  |\n| :-- | :--: |\n| History | Score |\n| BRCA 1 or 2 | 2.0 |\n| Personal history of breast / ovarian cancer | 2.0 |\n| Breast cancer in mother $<60$ years | 1.0 |\n| Breast cancer in sibling $<60$ years | 0.5 |\n| Menstruation $>35$ years | 0.5 |\n| Nulliparous | 0.5 |\n| First pregnancy $>30$ years | 0.5 |\n| Breast cancer in first-degree relative (nonsibling) | 0.5 |\n| Ashkenazi Jew | 0.5 |\n| Dense breast | 0.5 |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 825,
            "markdown": "| BI-RADS ${ }^{\\circledR}$ Score \\& Interpretation of Breast MR |  |\n| :--: | :--: |\n| Descriptor | Score |\n| Major feature |  |\n| Peak enhancement in 90 sec | 2.0 |\n| Centripetal wash-in | 2.0 |\n| Spiculated lesion | 2.0 |\n| Rapid wash-out | 2.0 |\n| T2 isointense mass | 1.0 |\n| Initial contrast uptake $>100 \\%$ | 1.0 |\n| Minor feature |  |\n| Perilesional edema (T2 / STIR) | 1.0 |\n| Branching lesion | 1.0 |\n| Dendritic configuration adjacent to primary | 1.0 |\n| Heterogeneous lesion on T2 | 1.0 |\n| Size of lesion $>10 \\mathrm{~mm}$ | 0.5 |\n| Lobulated margins of lesion | 0.5 |\n| Interpretation |  |\n| Compatible with malignancy | $>7$ |\n| Probably malignant | $>5$ |\n| Indeterminate | $3-5$ |\n| Probably benign | $<3$ |\n| Compatible with benignity | $<1$ |\n\n$\\sqrt{ }$ plateau / fast wash-out in postinitial phase\n$\\sqrt{ }$ \"arterial feeder\" sign\n$\\sqrt{ }$ intense early rim / peripheral enhancement ( $\\pm$ central necrosis)\n$\\sqrt{ }$ centripetal progression of enhancement\n$\\sqrt{ }$ malignant mass margination\n\n# Slowly/ Nonenhancing Breast Cancer on MR \n\n1. Lobular carcinoma\n2. Tubular carcinoma\n3. Mucinous carcinoma\n4. Grade I invasive ductal carcinoma\n\n## Role of PET/CT in Breast Cancer\n\nPET-CT useful ONLY in\n(a) inflammatory breast cancer\n(b) $>3 \\mathrm{~cm}$ large breast cancer\n(c) stage II/III breast cancer\n\n## Staging of Breast Cancer\n\n(1) Initial staging\n$\\diamond$ PET/CT is efficient for locally advanced + inflammatory breast cancer",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 826,
            "markdown": "$\\sqrt{ } 40 \\%$ of breast primaries NOT visualized\n$\\sqrt{ } 61 \\%$ sensitive $+80 \\%$ specific for axillary nodes\n$\\sqrt{ }$ unsuspected disease detected in mediastinal / internal mammary lymph nodes in $30 \\%$\n(2) Restaging\n$\\diamond$ PET/CT performs better than all other imaging\n$\\sqrt{ } 92-100 \\%$ sensitive for recurrence, $72-82 \\%$ specific (changes with time interval since therapy)\n$\\sqrt{ }$ PET/CT may change clinical management in $36 \\%$\n\n# High SUV Values in Breast Cancer \n\n(1) Ranking: infiltrating ductal carcinoma $>$ infiltrating lobular carcinoma $>$ ductal carcinoma in situ\n(2) Estrogen receptor-negative tumor\n(3) Cancer with poor prognosis: triple negative breast tumor (negative for estrogen + progesterone receptors + HER2/neu overexpression)\n\n## Distant Metastases in Breast Cancer\n\nSoft-tissue lesion: mediastinal nodes (24\\%), liver (15\\%), supracentimetric lung nodules Bone lesion:\n(a) osteosclerotic: PET lacks sensitivity; downstaging with no FDG uptake (in 12\\%)\n(b) osteolytic / mixed lesions: PET more efficient than CT / bone scintigraphy\n$\\diamond$ Bone scintigraphy may no longer be necessary!\n\n## Role of Stereotactic Biopsy\n\nIndications: obviously malignant nonpalpable lesion, indeterminate likely benign lesion, anxiety over lesion\nTargets: well-defined solid mass, indistinct / spiculated mass, clustered microcalcifications\nAdvantage: single-stage surgical procedure\nProblematic: $3-5-\\mathrm{mm}$ small lesion, fine scattered microcalcifications, indistinct density, area of architectural distortion\nSensitivity: $85-99 \\%$ with core needle biopsy ( $100 \\%$ specific), $68-93 \\%$ with fine-needle aspiration ( $88-100 \\%$ specific)\nIndication for excision:\n(a) anatomic reason: lesion close to chest wall, lesion in axillary tail, very superficial lesion\n(b) pathologic reason:\n\n1. Radial scar suspected (in up to $28 \\%$ associated with tubular carcinoma)\n2. Atypia / atypical hyperplasia (in $49-61 \\%$ associated with malignancy)\n3. Carcinoma in situ (in $9-20 \\%$ associated with invasion)\n4. Branching microcalcifications suggestive of DCIS with comedo necrosis\n\nMiss rate: $3-8 \\%$ for stereotactic biopsy, $3 \\%$ for surgery\n\n## Incidental Breast Cancer Detection by CT\n\nb highly predictive features:\n$\\sqrt{ }$ irregular margins, irregular shape, rim enhancement",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 827,
            "markdown": "$\\checkmark$ washout pattern on postcontrast images\n$\\checkmark$ diffuse regional enhancement\n$>$ most accurate sign:\n$\\checkmark$ spiculated + irregular margin\n\n# Categories of Breast Cancer \n\nA. Invasive ductal carcinoma (NOS) + DCIS $85 \\%$\nB. Other types of malignancy $15 \\%$\n(a) Invasive lobular carcinoma (ILC)\n![img-87.jpeg](img-87.jpeg)\n(b) Well-differentiated subtypes of IDC\n\n1. Tubular carcinoma\n2. Mucinous carcinoma\n3. Medullary carcinoma\n4. Papillary carcinoma\n(c) Cancers of stromal origin\n5. Phyllodes tumor\n6. Angiosarcoma\n7. Osteosarcoma\n8. Adenoid cystic carcinoma\n(d) Metastatic disease ( $0.5-2.0 \\%$ )\n9. NHL\n10. Malignant melanoma\n11. Metastatic carcinoma\n12. Rhabdomyosarcoma\n13. Leukemia\n\nOrigin: terminal ductal lobular unit (TDLU);\nterminal duct $\\rightarrow$ ductal carcinoma ( $85 \\%$ )\nacinus $\\rightarrow$ lobular carcinoma ( $10-12 \\%$ )\nstroma $\\quad \\rightarrow$ fibrosarcoma, liposarcoma, angiosarcoma, phylloides sarcoma",
            "images": [
                {
                    "id": "img-87.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 580,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1133,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 828,
            "markdown": "# Staging of Breast Cancer \n\n(a) primary tumor\n(b) lymph nodes:\n> anatomy\n> signs of malignancy\nInternal mammary node metastases usually occur after axillary involvement indicating stage N3b / IIIC.\nIsolated internal mammary node metastases occur in $1-5 \\%$ of breast cancers usually from a deep / medial lesion indicating N2b disease.\n(c) distant metastasis $=$ stage IV disease\n$\\diamond 4 \\%$ of patients present with distant metastases and of those $10 \\%$ have lesions at multiple sites\nLocation: bone, lung, brain, liver\nPrognosis: $22 \\% 5$-year survival rate\n(c) AJCC stage (American Joint Committee on Cancer)\n\n| Stage 0 | TisN0M0 |\n| :-- | :-- |\n| Stage IA | T1N0M0 |\n| Stage IB | T0-T1 with N ${ }^{1 \\mathrm{~m} i}$ and M0 |\n| Stage IIA | T0-T1 with N1M0 / T2N0M0 |\n| Stage IIB | T2N1M0 / T3N0M0. |\n| Stage IIIA | T0-T2 with N2M0 / T3 with N1-N2 + M0 |\n| Stage IIIB | T4 with N0-N2 and M0 |\n| Stage IIIC | any T with N3M0. |\n| Stage IV | M1 with any T + any N |\n\n## NONINVASIVE BREAST CANCER (15 \\%)\n\n$=$ malignant transformation of epithelial cells lining mammary ducts + lobules confined within boundaries of basement membrane\n$R x$ : few data are available to provide insight into proper treatment\n\n## Ductal Carcinoma In Situ (DCIS)\n\n$=$ highly heterogeneous group of intraductal carcinomas (\"cancer waiting to become malignant\")\n$=$ nonobligate precursor to invasive cancer\n$\\diamond 30 \\%$ become invasive over 10 years\nIncidence: $20-25 \\%$ of all cancers in screening population; $70 \\%$ of noninvasive carcinomas",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 829,
            "markdown": "| T Descriptors in TNM Staging of Breast Cancer |  |\n| :--: | :--: |\n| Descriptor | Definition (= tumor size + locoregional invasion) |\n| Tis | Carcinoma in situ: DCIS, LCIS, Paget disease of nipple (not associated with invasive carcinoma / carcinoma in situ in underlying breast parenchyma) |\n| T1 | all invasive tumors $\\leq 20 \\mathrm{~mm}$ |\n| T1mi | Tumor $\\leq 1 \\mathrm{~mm}$ |\n| T1a | Tumor $>1 \\mathrm{~mm}$ but $\\leq 5 \\mathrm{~mm}$ |\n| T1b | Tumor $>5 \\mathrm{~mm}$ but $\\leq 10 \\mathrm{~mm}$ |\n| T1c | Tumor $>10 \\mathrm{~mm}$ but $\\leq 20 \\mathrm{~mm}$ |\n| T2 | Tumor $>20 \\mathrm{~mm}$ but $\\leq 50 \\mathrm{~mm}$ <br> mnemonic: \"T2 over 2 cm \" |\n| T3 | Tumor $>50 \\mathrm{~mm}$ |\n| T4 | Any tumor size with extension to chest wall / skin (invasion of dermis alone does not qualify) |\n| T4a | extension to chest wall = involvement of ribs /serratus anterior muscle / intercostal muscles (pectoralis muscle invasion alone does not qualify) |\n| T4b | ulceration, ipsilateral satellite skin nodules $\\pm$ skin edema (= peau d'orange without meeting classic criteria for inflammatory breast cancer) |\n| T4c | T4a + T4b |\n| T4d | inflammatory carcinoma (IBC) |\n| Size of largest tumor determines stage, if $>1$ malignancy in same breast. Tumor size is most accurately measured by MRI (size is underestimated by $14 \\%$ on mammo and by $18 \\%$ on US) |  |\n| N Descriptors in TNM Staging of Breast Cancer |  |\n| Descriptor | Definition (metastases to ...) |\n| N1 | ipsilateral level I-II axillary lymph nodes |\n| N2 |  |\n| N2a | clinically \"fixed\" / matted N1 |\n| N2b | ipsilateral internal mammary lymph nodes in the absence of axillary nodes |\n| N3 |  |\n| N3a | ipsilateral infraclavicular (level III) lymph nodes |\n| N3b | ipsilateral level I-II axillary + internal mammary nodes |\n| N3c | ipsilateral supraclavicular nodes |\n| Biopsy the most suspicious lymph node! <br> $\\sqrt{ }$ lymph node anatomy <br> $\\sqrt{ }$ imaging criteria of malignancy |  |\n\nAge-adjusted prevalence: $32.5 \\div 100,000$ women (2005); $88 \\div 100,000$ women 50-64 years Age: most $>55(40-60)$ years\nPath: heterogeneous group of malignancies with proliferation of malignant cells lining",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 830,
            "markdown": "TDLU + duct\nHisto: proliferation of malignant epithelial cells that line a TDLU without invasion through basement membrane $\\rightarrow$ duct diameter increases from $90 \\mu \\mathrm{~m}$ to $360 \\mu \\mathrm{~m}$\nSubgroups: comedonecrosis (often); non-comedocarcinomas (solid, papillary, micropapillary, cribriform)\nNuclear grade: low, intermediate, high\nVan Nuys Classification (most reproducible):\nGroup 1: low / intermediate grade without necrosis\nGroup 2: low / intermediate nuclear grade with necrosis\nGroup 3: high nuclear grade\nVan Nuys group 1 lesions more likely manifest as noncalcified abnormalities than higher-grade lesions!\nAssociated with: ADH + invasive ductal carcinoma\nN.B.: by definition not capable of metastasizing to regional lymph nodes, HOWEVER axillary metastases in $1.3-13 \\%$\nRisk factors: increasing age, family history, high breast density, postmenopausal hormone use\n\n- may persist for years without palpable abnormality (in screening population)\n- palpable mass ( $12 \\%$ ) / Paget disease of nipple / nipple discharge (in $12 \\%$ of symptomatic patients)\n$\\diamond 50 \\%$ of DCIS are $>5 \\mathrm{~cm}$ in size\n$\\diamond$ Histologic size of DCIS is independent of histologic subgroup\n$\\diamond$ Almost all \"comedo\" type DCIS contain significant microcalcifications\n$\\diamond$ DCIS often involves the nipple + subareolar ducts\n$\\diamond$ Calcifications in ductal orientation like \"string of beads\"\nMulticentricity: in $8-47 \\%$ (increasing with tumor size)\nMultifocality: in $27 \\%$\n\n| Multicentricity | Multifocality |\n| :-- | :-- |\n| $>1$ focus in different breast <br> quadrants with a minimum <br> distance of $2 \\mathrm{~cm} \\rightarrow$ mastectomy <br> mnemonic: \"C before D\" = Centricity for Different quadrants | $>2$ foci in same breast quadrant <br> $\\rightarrow$ breast conservation therapy |\n\nAverage size: $10-15 \\mathrm{~mm}$\nMammo (27-95\\% sensitive):\n$\\sqrt{ }$ microcalcifications (in $90 \\%$ ):\n) in $75 \\%$ sole finding\n> in $15 \\%$ associated with soft-tissue component\nShape: amorphous; coarse; heterogeneous; fine pleomorphic (most common)\nDistribution: clustered / linear / segmental\n$\\sqrt{ }$ fine linear / fine linear branching (high-grade DCIS)\n$\\checkmark$ amorphous microcalcifications (low-grade DCIS)\n$\\checkmark$ soft-tissue mass / asymmetry ( $10 \\%$ ):\n$\\diamond$ more frequently associated with low-grade DCIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 831,
            "markdown": "$\\sqrt{ }$ dominant mass with well-defined margin (14\\%)\n$\\sqrt{ }$ ill-defined indistinct obscured mass (2\\%)\n$\\sqrt{ }$ architectural distortion ( $7-13 \\%$ )\n$\\sqrt{ }$ soft-tissue abnormality + calcifications (14\\%)\n$\\sqrt{ }$ invisible (6\\%)\nUS:\n$\\sqrt{ }$ microcalcifications:\n$\\sqrt{ }$ associated with ductal changes (most common)\n$\\sqrt{ }$ echogenic regions without duct changes / mass\n$\\sqrt{ }$ intraductal mass $\\pm$ multiple punctate echogenic foci within dilated duct\n$\\sqrt{ }$ solid mildly hypoechoic irregularly shaped intraparenchymal mass with indistinct / microlobulated margins + normal acoustic transmission\n$\\sqrt{ }$ pseudomicrocystic appearance\nMR (60-100\\% sensitive, 18-100\\% FN [!]):\n\n| DCIS Grade | MR Sensitivity |\n| :-- | :--: |\n| high | $98 \\%$ |\n| intermediate | $91 \\%$ |\n| low | $80 \\%$ |\n\nSensitivity for DCIS is much higher for MRI (92\\%) than for mammography (56\\%)!\n$\\diamond$ Preoperative MR evaluation is utilized in women with newly developed breast cancer to discover:\n(a) extent of disease and tumor margins\n(b) ipsilateral multicentric involvement\n(c) contralateral disease (in $3.3 \\%$ )\n$\\sqrt{ }$ hypo- to isointense to surrounding parenchyma on T1WI + fatsat T2WI\n$\\diamond$ Not helpful in decision whether to biopsy clustered microcalcifications or not! CEMR:\n\n| Morphology of DCIS on Enhanced MRI |  |  |\n| :--: | :--: | :--: |\n| Type | Definition | Frequency |\n| NME | nonmass-like enhancement of an area that is not a mass | $60-81 \\%$ |\n|  | 3-dimensional space-occupying lesion of enhancement | $14-41 \\%$ |\n| focus | $<5 \\mathrm{~mm}$ region of enhancement | $1-12 \\%$ |\n\nHigh likelihood of cancer:\n$\\sqrt{ }$ clumped linear (beady, string of pearls) ductal / segmental enhancement (HALLMARK)\n$\\sqrt{ }$ linear enhancement adjacent to synchronous malignant mass\nEnhancement pattern of DCIS:\nThe internal enhancement pattern of nonmass-like DCIS is commonly clumped or heterogeneous ( $50 \\%$ vs. $20 \\%$ )\n$\\sqrt{ }$ nonmass-like ( $60-81 \\%$ ) enhancement (NME) pattern:\n$\\sqrt{ }$ clumped $(41-64 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 832,
            "markdown": "$\\sqrt{ }$ internally heterogeneous (16-29\\%) / homogeneous (16\\%)\n$\\sqrt{ }$ reticular / dendritic ( $9 \\%$ ), stippled ( $8 \\%$ ), punctate ( $3 \\%$ )\n$\\sqrt{ }$ oval / round masslike ( $14-41 \\%$ ) enhancement pattern:\n$\\sqrt{ }$ irregular ( $14-83 \\%$ ) / spiculated ( $0-92 \\%$ ) / smooth ( $4-8 \\%$ ) mass margins\nDCIS most frequently manifests as an irregular mass!\n$\\sqrt{ }$ homogeneous ( $9-25 \\%$ ) / heterogeneous ( $9-67 \\%$ ) internal enhancement / rim enhancement $(0-8 \\%)$\n$\\sqrt{ }$ focal $(1-12 \\%)$ enhancement pattern\n$\\sqrt{ }$ no enhancement (in $5-10 \\%$ )\nEnhancement distribution of DCIS:\n$\\sqrt{ }$ segmental ( $42 \\%$ ), focal ( $33 \\%$ ), diffuse ( $9 \\%$ ), linear-ductal ( $9 \\%$ ), regional ( $6 \\%$ )\nA segmental distribution is the most common pattern accounting for $33-77 \\%$ of all DCIS!\nEnhancement kinetics of DCIS:\n$\\sqrt{ }$ initial period: fast (49-68\\%), medium (20\\%), slow (20\\%)\n$\\sqrt{ }$ delayed period: plateau ( $20-52 \\%$ ), washout ( $28-44 \\%$ ), persistent ( $20-30 \\%$ )\n$\\diamond$ There is no pathognomonic kinetic pattern:\n> lower-grade lesions tend to show steep initial period + washout\n> higher-grade lesions tend to show persistent increase\nThe most common enhancement kinetics for DCIS are a fast initial phase with a delayed-phase plateau!\nPrognosis: 96-98\\% 10-year survival rate\nRx: (1) Simple / modified mastectomy: cure rate of $98 \\%$; reserved for tumor $>5 \\mathrm{~cm}$ or multicentric / diffuse disease\n(2) Local excision alone (breast-conserving Rx): local recurrence in 4 years:\n$>19 \\%$ for poorly differentiated\n$>10 \\%$ for moderately differentiated\n$>0 \\%$ for well differentiated\n(3) Lumpectomy + radiotherapy: $7 \\%$ rate of recurrence\n\n# Treatment problems: \n\n$\\diamond$ Underestimation of extent of disease in $30 \\%$ for mammography and in $19 \\%$ for MRI!\nMRI provides an accurate assessment of the extent of DCIS ( $89 \\%$ ) compared to mammo ( $55 \\%$ ) and US ( $47 \\%$ ) or an overestimation!\n\n1. Occult invasion in $5-20 \\%$ of patients\n2. Multifocality in $30 \\%$\n3. Multicentricity in $14 \\%$ of lesions $<25 \\mathrm{~mm}$, in $100 \\%$ of lesions $>50 \\mathrm{~mm}$\n4. Axillary metastases in $1-2 \\%$\n\nIncreased risk of recurrent DCIS:\n(1) Positive margins after surgery\n(2) Residual synchronous foci of DCIS\n\nPresentation: $50 \\%$ as invasive cancer; $20 \\%$ as distant metastases in 10 years\nHigh Nuclear Grade DCIS (\"comedo type\")",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 833,
            "markdown": "Prevalence: $60 \\%$ of all DCIS\nPrecursor: none; one stage de novo development\nPath: \"comedo\" = pluglike appearance of necrotic material that can be expressed from the cut surface\n[ comedo, Latin = worm of waxy material that can be squeezed from a blackhead believed to feed ( edere $=$ to eat) on the body]\nCharacteristics:\n> nuclear grade: large / intermediate nuclei, numerous mitoses, aneuploidy\n> growth pattern: predominantly solid cell proliferation; atypically papillary / micropapillary / cribriform\n[cribriform, Latin = small holes or open spaces like a sieve)\n> necrosis: extensive (HALLMARK) $\\leftarrow$ rapid growth\n> calcifications ( $90 \\%$ ): dystrophic / amorphous within necrosis in center of dilated ductal system outlining most of the lobe in classic solid growth pattern\n\n- estrogen-receptor + progesterone-receptor negative\n- overexpression of ErbB-2 oncogene product and P53 suppressor gene mutation\n- often symptomatic lesion with nipple discharge\n$\\checkmark$ ductal system enlarged to $300-350 \\mu \\mathrm{~m}$\n$\\checkmark$ linear / branching pattern of calcifications scattered in a large part of lobe / whole lobe\n$\\checkmark$ large solid high-density casting calcifications (fragmented, coalesced, irregular) in solid growth pattern\n$\\checkmark$ \"snake skin-like\" / \"birch tree flowerlike\" dotted casting calcifications within necrosis of micropapillary / cribriform growth pattern\n$\\checkmark$ palpable dominant mass without calcifications (very unusual)\n$\\checkmark$ nipple discharge (rare)\nPrognosis: higher recurrence rate than noncomedo-group\n\n\n# Low Nuclear Grade DCIS (\"noncomedo type\") \n\nPrevalence: $40 \\%$ of all DCIS\nPrecursor lesion: atypical ductal hyperplasia (ADH) with slight / moderate / severe atypia\n$\\diamond 52-56 \\%$ of ADH at core biopsy are associated with malignancy at excision!\n\n## Characteristics:\n\n> nuclear grade: monomorphic small round nuclei, few / no mitoses\n> growth pattern: predominantly micropapillary / cribriform; atypically solid cell proliferation (often coexist)\n> necrosis: not present in classic micropapillary / cribriform growth pattern\n> calcifications (50\\%): laminated / psammoma-like $\\leftarrow$ active secretion by malignant cells into duct lumen\n$\\checkmark$ fine granular \"cotton ball\" calcifications in cribriform growth pattern\n$\\checkmark$ coarse granular \"crushed stone\" / \"broken needle tip\" / \"arrowhead\" calcifications in less common solid growth pattern\n$\\diamond$ Size of \"noncomedo\" DCIS often underestimated mammographically (? $\\leftarrow$ lower density of calcifications at periphery of lesion)!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 834,
            "markdown": "$\\checkmark$ powdery calcifications (45\\%)\n$\\checkmark$ palpable dominant mass without calcifications (intracystic papillary carcinoma, multifocal papillary carcinoma in situ)\n$\\checkmark$ nonpalpable asymmetric density with architectural distortion\n$\\checkmark$ occasionally serous / bloody nipple discharge + ductal filling defects on galactography\nRisk of recurrence: $2 \\%$\nPrognosis: $30 \\%$ eventually develop into invasive cancer\n$D x:$ surgical biopsy\n$\\diamond$ Core needle biopsy could result in diagnosis of only proliferative breast disease that is usually intermixed!\n\n# Lobular Carcinoma In Situ (LCIS) \n\n$=$ arises in epithelium of blunt ducts of mammary lobules\n$\\diamond$ NOT a precancerous lesion - BUT a marker for an increased risk of subsequent invasive cancer in either breast! (\"Risk factor waiting to become malignant\")\nPrevalence: $\\quad 0.8-3.6 \\%$ in screening population; $3-6 \\%$ of all breast malignancies; $25 \\%$ of all noninvasive carcinomas; high incidence during reproductive age $\\rightarrow$ decreasing with age\nAge: most 40-54 years (earlier than DCIS / invasive tumors)\nHisto: monomorphous small cell population filling + expanding ductules of the lobule $\\diamond$ Synchronous invasive cancer in 5\\%!\n\n- not palpable\n$\\checkmark$ mammographically occult\n$\\checkmark$ may atypically present as a noncalcified mass (in 7\\%), calcifications + mass (in 10\\%), asymmetric opacity $(2 \\%)$\nMR:\n> T1WI:\n$\\checkmark$ isointense to breast parenchyma\n> enhanced T1WI:\n$\\checkmark$ ill-defined enhancement with nonspecific intensity curves\n$\\diamond$ High frequency of multicentricity ( $50-70 \\%)+$ bilaterality ( $30 \\%$ )!\n$D x$ : incidental microscopic finding depending on accident of biopsy (performed for unrelated reasons + findings)\nPrognosis:\n$\\diamond$ LCIS serves as a marker of increased risk for developing invasive carcinoma in either breast!\n$\\diamond 20-30 \\%$ develop invasive ductal $>$ lobular carcinoma within 20 years after initial diagnosis\n$\\diamond 1 \\%$ per year lifetime risk for invasive malignancy\n$R x$ : recommendations range from observation (with follow-up examinations every 3-6 months + annual mammograms) to uni- / bilateral simple mastectomy\n\n\n## Intracystic Papillary Carcinoma In Situ (0.5-2\\%)\n\n$=$ rare variant of noncomedo DCIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 835,
            "markdown": "Age: usually older postmenopausal woman; peak 34-52 years\nHisto: papillary fronds within the wall of a cystically dilated duct; (partial) absence immunohistochemical marker p63 for myoepithelial cell layer\n\n- well-circumscribed + freely movable\n- aspiration yields straw-colored / dark red / brown fluid $\\leftarrow$ ruptured capillaries in cyst wall / necrosis of tumor cells; reaccumulation of fluid within 3-4 weeks\n- fluid cytology negative for cancer in $80 \\%$\n\nSize: $\\quad 1.9$ (range, $0.4-7.5) \\mathrm{cm}$\n$\\sqrt{ }$ solid intracystic mass on US\n$\\sqrt{ }$ round benign appearing mass with sharply circumscribed lobulated borders on mammography\n$\\sqrt{ }$ intracystic mass on pneumocystography\n$\\sqrt{ }$ fast growth $\\leftarrow$ accumulation of fluid + proliferation of neoplastic cells\n$R x:$ lumpectomy\nPrognosis: 10-year disease-free survival rate of $91 \\%$\nDDx on mammogram: mucinous / medullary carcinoma, hematoma, metastasis\n\n# INVASIVE BREAST CANCER (85\\%) \n\n$=$ cancer cells outside mammary ducts / TDLUs after penetrating basement membrane\nPathophysiology:\nmalignant cells of $\\sim 1$ billion cells $=1 \\mathrm{~cm}^{3}$ (= critical mass) outgrow their nutrient supply inside confines of basement membrane $\\rightarrow$ tumor elaborates\n(1) angiogenic factor stimulating growth of new arterial channels (neovascularity) and\n(2) proteolytic enzyme weakening / dissolving basement membrane\n\nSubtypes: estrogen receptor, progesterone receptor, Her2 (= Human egfr 2), CK5/6 (= CytoKeratin 5/6), EGFR (= Epidermal Growth Factor Receptor)\nGrowth rate: average doubling time of 110-150 (range, 25-1000) days\n$\\sqrt{ }$ mass $=3$-dimensional lesion apparent on 2 views:\n$\\sqrt{ } \\pm$ spicules $=$ extension of malignant cells\n$\\sqrt{ }$ focal asymmetry $=$ confined parenchymal area of similar shape\n$>$ without identifiable borders in 2 views\n$>$ with definable border on 1 view\n$\\sqrt{ }$ architectural distortion $=$ alteration of anticipated normal orderly undulating curvilinear\nbreast parenchyma into straight or converging lines / a convexity / acute angle:\n$\\sqrt{ }$ surrounding corona of radiolucency\n$\\sqrt{ }$ nipple retraction / skin retraction\n$\\sqrt{ }$ tenting / flattening / shrinking\n$\\sqrt{ }$ bulging contour\n$\\sqrt{ }$ edema (lymphatic obstruction) + skin thickening\n$\\sqrt{ }$ adenopathy\nMR:\n$\\sqrt{ }$ peripheral / rim enhancement\nPrognosis:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 836,
            "markdown": "| Tumor size | Survival at 10 years after diagnosis |\n| :-- | :-- |\n| $<1 \\mathrm{~cm}$ | $95 \\%$ (independent on tumor grade) |\n| $1-2 \\mathrm{~cm}$ | $85 \\%$ |\n| $2-5 \\mathrm{~cm}$ | $60 \\%$ (dependent on tumor grade) |\n\nA reduction of breast cancer mortality is possible through detection of small invasive cancers!\n\n# Infiltrating / Invasive Ductal Carcinoma (65\\%) \n\n$=$ NO SPECIAL TYPE / NOT OTHERWISE SPECIFIED (NOS)\n$\\diamond$ Most frequently encountered breast malignancy\n$\\diamond 10 \\%$ false-negative ratio\nAge: any age; peaks between 50 and 60 years\nHisto:\ngrade I = well-differentiated\ngrade II = moderately differentiated\ngrade III = poorly differentiated\n$\\diamond$ Strong fibrotic component!\n\n- palpable: $70 \\%$ are first palpated by the patient\n- larger by palpation than on mammogram (Leborgne's law)\n- often poorly movable + indolent\n\nLocation: multifocal in 15\\%; bilateral in 5\\%\nMammo:\n$\\sqrt{ }$ spiculated (36\\%) / irregular mass = PRINCIPAL FINDING\n$\\sqrt{ }$ developing asymmetry\n$\\sqrt{ }$ lobulated / round / oval mass\n$\\sqrt{ }$ increased central density\n$\\sqrt{ }$ + malignant calcifications (45-60\\%)\nUS:\n$\\sqrt{ }$ ill-defined hypoechoic mass with intermediate hyperechoic margins\n$\\sqrt{ }$ central / peripheral acoustic shadowing\n$\\sqrt{ }$ ductal extension (HIGHLY SPECIFIC)\n$\\sqrt{ }$ perilesional hypervascularity\nless common:\n$\\sqrt{ }$ irregular cystic lesion with surrounding round / tubular hypoechoic areas (= ductal extension)\n$\\sqrt{ }$ intraductal mass\n$\\sqrt{ }$ ill-defined spiculated hyperechoic mass with acoustic shadowing\nCT:\n$\\sqrt{ }$ dense spiculated mass\n$\\sqrt{ }$ marked early and / or peripheral enhancement\nMR (88-98\\% sensitive)\n> T1WI:\n$\\sqrt{ }$ isointense to parenchyma; hypointense to fat\n> enhanced T1WI:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 837,
            "markdown": "$\\sqrt{ }$ round / ovoid / spiculated lesion with ill-defined margins\n$\\sqrt{ }$ ring enhancement in up to $50 \\%$ with centripetal progression\n$\\sqrt{ }$ strong ( $60 \\%$ ) / moderate ( $35 \\%$ ) / mild ( $5 \\%$ ) contrast uptake\n$\\sqrt{ }$ plateau (most frequent) / wash-out (often) / continuous increase (rare) on postinitial phase\n$\\sqrt{ }$ dilated veins draining the tumor\n) T2WI:\n$\\sqrt{ }$ moderately hyperintense $\\leftarrow$ viable tumor cells in tumor periphery\n$\\sqrt{ }$ hyperintense $\\leftarrow$ central area of necrosis / infarction\nOn T2WI areas of tumor infarction + necrosis exhibit high SI, viable tumor cells show moderately high SI!\n\n# Infiltrating / Invasive Lobular Carcinoma (10-15\\%) \n\n$=$ neoplasm arising from terminal ductules of breast lobules\n$=$ ILC\n$\\diamond 2^{\\text {nd }}$ most common form of invasive breast cancer\n$\\diamond 30-50 \\%$ of patients will develop a second primary in same / opposite breast within 20 years\nMedian age: 45-56 years; $2 \\%$ of breast cancers in women $<35$ years; $11 \\%$ of breast cancers in women $>75$ years\nMultiplicity: multicentric (30\\%) + bilateral (6-28\\%)\n$\\diamond$ Relatively high frequency of bilaterality!\nHisto: straight single file of uniform small cells with round oval nuclei + scanty cytoplasm growing around ducts, vessels, and lobules with lack of cohesiveness + without destruction of anatomic structures (\"Indian files, targetoid growth pattern) like a spiderweb resulting in subtle changes in architecture; little desmoplastic stromal reaction\nGrade: $20 \\%$ grade I, $64 \\%$ grade II, $16 \\%$ grade III\nSpread: by diffuse infiltration with little disruption of underlying anatomy\nMetastases: peritoneum, retroperitoneum, gynecologic organs, GI tract, carcinomatous meningitis\n$\\diamond$ Consider ILC in women presenting with ascites, hydronephrosis, pelvic masses!\n\n- palpable in $69 \\%$ :\n- area of subtle thickening / induration\n- skin / nipple retraction\n- large rubbery / indiscrete firm mass / fine nodularity\n- decreasing breast size; aching / pulling sensation\n\nMammo (57-81\\% sensitive):\n$\\diamond$ Mammogram often underestimates tumor size relative to physical finding + histology; highest FN rate of all invasive breast cancers (up to 19\\%)\n$\\sqrt{ }$ solitary inhomogeneous mass (44-65\\%):\n$\\sqrt{ }$ with spiculated / ill defined margins ( $40 \\%$ )\n$\\sqrt{ }$ round well-circumscribed (1-3-11\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 838,
            "markdown": "$\\sqrt{ }$ opacity equal to / lower than normal fibroglandular tissue\n$\\sqrt{ }$ architectural distortion (= retraction of normal glandular tissue with thickening + disturbance of fibrous septa) in $10-15-34 \\%$\n$\\sqrt{ }$ focal asymmetry ( $=$ ill-defined area of increased density without central tumor nidus) in $8-16-19 \\%$\n$\\diamond$ May be evident on ONLY one standard view: CC (typically better compressed) $>$ ML $>$ MLO!\n$\\sqrt{ }$ global asymmetry with unilateral increase in parenchymal volume (1-11-14\\%)\n$\\sqrt{ }$ \"shrinking breast\" = in large tumor breast size appears mammographically smaller compared to contralateral side due to decreased compliance + compressibility\n\n- physical size at inspection symmetric + unchanged\n$\\sqrt{ }$ microcalcifications $(0-24 \\%)$\n$\\sqrt{ }$ retraction of skin $(25 \\%)+$ nipple $(26 \\%)$\n$\\sqrt{ }$ skin thickening\n$\\sqrt{ }$ normal / benign finding ( $8-16 \\%$ )\nUS (68-98\\% sensitive):\n$\\sqrt{ }$ irregular / angular hypoechoic mass with heterogeneous internal echoes + ill-defined / spiculated margins + posterior acoustic shadowing (54-61\\%):\n$\\sqrt{ }$ circumscribed shadowing mass (pleomorphic ILC)\n$\\sqrt{ }$ focal shadowing without a discrete mass (classic ILC)\n$\\sqrt{ }$ rarely hyperechoic mass\nMR (83-100\\% sensitive):\n$\\diamond$ Additional unexpected ipsilateral lesions (in 32\\%) + contralateral lesion (in 7\\%):\n$\\sqrt{ }$ dominant lesion surrounded by multiple small enhancing foci\n) T1WI:\n$\\sqrt{ }$ isointense to parenchyma\n, enhanced T1WI:\n$\\sqrt{ }$ moderate / strong initial enhancement\n$\\sqrt{ }$ postinitial plateau (frequently) / wash-out (rare) / delayed maximum enhancement (typical)\n$\\sqrt{ }$ lack of mass effect + amorphous asymmetry\n$\\sqrt{ }$ ring enhancement of nodular tumor form (in up to $50 \\%$ )\n$\\sqrt{ }$ enhancing solitary irregular / angular mass with spiculated / ill-defined margins (31$43 \\%)$\n$\\sqrt{ }$ multiple small enhancing foci with interconnected enhancing strands\n$\\sqrt{ }$ enhancing septa\n) T2WI:\n$\\sqrt{ }$ iso- to hypointense to breast parenchyma\n$D x:$ core biopsy (controversial) may help in surgical planning prior to surgical excision\n$R x$ : frequently associated with positive margins at excision\nPrognosis: survival rate slightly higher than for usual type of invasive ductal carcinomas\n$D D x$ : radial sclerosing lesion\n\n\n# Adenoid Cystic Carcinoma (0.1-0.4\\%) \n\nHisto: mixed glandular + stromal material with predominantly basaloid cells in a variable",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 839,
            "markdown": "architectural pattern (solid, cribriform, tubular, trabecular); microcystic areas formed by coalescent spaces in dilated glands (in 25\\%)\n$\\sqrt{ }$ well-defined irregular mass with parallel growth\n$\\sqrt{ }$ smooth macrolobulated / indistinct margins\n$\\sqrt{ }$ architectural distortion\n$\\sqrt{ }$ asymmetric density\nUS:\n$\\sqrt{ }$ heterogeneous hypoechoic irregular mass\nMR:\n$\\sqrt{ }$ variable signal intensity on T2WI\n$\\sqrt{ }$ predominantly persistent enhancement kinetics\nPrognosis: excellent\n\n# Tubular Carcinoma (< 2\\%) \n\n$=$ well-differentiated low nuclear-grade ductal carcinoma\nMultiplicity: multicentric (28\\%), bilateral (12-38\\%)\n(a) low grade: bilateral in $1 \\div 3$\n(b) high grade: bilateral in $1 \\div 300$\n\nAssociated with: lobular carcinoma in situ in $40 \\%$\nMedian age: 44-49 years\n\n- positive family history in up to $40 \\%$; nonpalpable\n\nMean size: 8 mm (up to 17 mm in diameter)\n$\\sqrt{ }$ high-opacity nodule with spiculated margins:\n$\\sqrt{ }$ spicules often longer than central mass\n$\\sqrt{ }$ may be stable for years\n$\\sqrt{ }$ associated microcalcifications (50\\%)\n$\\sqrt{ }$ multicentric (28\\%), bilateral (12-38\\%)\nUS:\n$\\sqrt{ }$ hypoechoic solid mass + ill-defined margins + posterior acoustic shadowing MR:\n) T1WI:\n$\\sqrt{ }$ stellate hypointense lesion well seen in fat\n) enhanced T1WI:\n$\\sqrt{ }$ stellate tumor with moderate / strong initial uptake\n$\\sqrt{ }$ ring enhancement rare\n$\\sqrt{ }$ postinitial plateau (frequent) / wash-out (rare) / continuous increase (very rare)\n) T2WI:\n$\\sqrt{ }$ iso- / slightly hypointense to parenchyma\n$\\sqrt{ }$ occasional peritumoral edematous zone\nPrognosis: 97\\% 10-year survival\n$D D x$ : radial scar (histologically $\\alpha$-smooth muscle / maspin staining of myoepithelial cells)\n\n## Medullary Carcinoma (2\\%)\n\n$=$ SOLID CIRCUMSCRIBED CARCINOMA\n$\\diamond$ Fastest growing breast cancer!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 840,
            "markdown": "O Often associated with BRCA gene!\nPrevalence: $<5 \\%$ of all breast carcinomas; $11 \\%$ of breast cancers in women $<35$ years\nPath: well-circumscribed mass with nodular architecture + lobulated contour; central necrosis is common in larger tumors; reminiscent of medullary cavity of bone\nHisto: poorly differentiated cells with scant stroma + intense lymphoplasmacytic infiltration (reflecting host resistance); propensity for syncytial growth; no glands\nMean age: 46-54 years\n\n- softer than average breast cancer\n- often palpable tumor $\\leftarrow$ rapid growth\n\nMean size: $2-3 \\mathrm{~cm}$\n$\\sqrt{ }$ well-defined round / oval noncalcified uniformly dense mass ( $\\leftarrow$ hemorrhage) with lobulated margin\n$\\sqrt{ }$ may have partial / complete \"halo\" sign\nUS:\n$\\sqrt{ }$ hypoechoic homogeneous / mildly heterogeneous mass with some degree of through transmission\n$\\sqrt{ }$ distinct / indistinct margins\n$\\sqrt{ }$ large central cystic component\nMR:\n$\\sqrt{ }$ irregular internal architecture (no septa!)\n$>$ T1WI:\n$\\sqrt{ }$ well-circumscribed hypointense lesion difficult to detect in parenchyma\n$>$ enhanced T1WI:\n$\\sqrt{ }$ moderately / strongly enhancing round / ovoid lesion with smooth edge\n$\\sqrt{ }$ homogeneous internal enhancement ( $\\leftarrow$ high cellularity) / (occasionally) ring enhancement\n$\\sqrt{ }$ postinitial type II plateau pattern (frequent) / wash-out (occasionally) / continuous increase (rare)\n$>$ T2WI:\n$\\sqrt{ }$ iso- or mildly hypointense to parenchyma\n$D D x:$ myxoid fibroadenoma\nPrognosis: 92\\% 10-year survival rate\n\n# Metaplastic Carcinoma $(<1 \\%)$ \n\n$=$ metaplastic conversion of ductal carcinoma into nonglandular growth pattern of squamous / spindle / heterogeneous mesenchymal cells\nPrevalence: $<1 \\%$ of all newly diagnosed breast cancers; $<5 \\%$ of invasive breast cancers\nHisto: spectrum from poorly differentiated ductal to keratinizing squamous cell carcinoma Age: $\\quad>50$ years\n\n- rapidly growing palpable mass\n$\\sqrt{ }$ predominantly circumscribed noncalcified mass of high density\nUS:\n$\\sqrt{ }$ round lobular mass with well-circumscribed microlobulated margin\n$\\sqrt{ } \\pm$ complex internal echogenicity with solid + cystic components $\\leftarrow$ necrosis / cystic degeneration",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 841,
            "markdown": "MR:\n> enhanced T1WI:\n$\\sqrt{ }$ rimlike enhancement\n$\\sqrt{ }$ postinitial type III wash-out pattern in enhancing peripheral portion\n> T2WI:\n$\\sqrt{ }$ high signal intensity $\\leftarrow$ necrosis, cystic degeneration, myxoid matrix, intratumoral hemorrhage, loose edematous stroma\n\n# Mucinous / Colloid Carcinoma (1-7\\%) \n\n$=$ well-differentiated low nuclear-grade ductal carcinoma with large amount of extracellular epithelial mucus\nPrevalence: $1-7 \\%$ of all invasive breast cancers\nHisto:\n(a) pure form: aggregates of tumor cells floating in abundant pools of extracellular mucin (gelatinous / colloid fluid) $\\rightarrow$ less aggressive slow growth\n(b) mixed form: contains areas of infiltrating ductal carcinoma not surrounded by mucin Age: $7 \\%$ of all carcinomas in women $>75$ years; $1 \\%$ of breast cancers in women $<35$ years\n\n- \"swish\" / \"crush\" sensation during palpation\n- $60 \\%$ estrogen-receptor positive\n$\\sqrt{ }$ well-circumscribed usually lobulated round / ovoid mass of low density:\n$\\sqrt{ }$ poorly defined margins on spot compression\n$\\sqrt{ }$ pleomorphic clustered / clumped amorphous / punctate calcifications (rare)\n$\\sqrt{ }$ may enlarge fast (through mucin production)\nUS:\n$\\sqrt{ }$ heterogeneous mass with mixture of solid + cystic components\n$\\sqrt{ }$ posterior acoustic enhancement (common)\n$\\sqrt{ }$ posterior acoustic shadowing (uncommon)\nMR:\n> T1WI:\n$\\sqrt{ }$ well-circumscribed lobulated lesion of variable intensity $\\leftarrow$ differences in protein concentration\n> enhanced T1WI:\n$\\sqrt{ }$ typically type I persistent enhancement pattern\n$\\sqrt{ }$ very strong (usually) / moderate (occasionally) / slight (rare) initial uptake\n$\\sqrt{ }$ postinitial plateau (frequent) / wash-out (occasionally) / continuous increase (very rare)\n$\\sqrt{ }$ rarely ring enhancement\n> T2WI:\n$\\sqrt{ }$ homo- / heterogeneously hyperintense mass $\\leftarrow$ predominant mucin component\nPrognosis: excellent (unless of mixed form)\n\n\n## Papillary Carcinoma (1-2\\%)\n\n$=$ rare ductal carcinoma arising from benign papilloma\nN.B.: Do not confuse with micropapillary / cribriform growth pattern of ductal carcinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 842,
            "markdown": "Histo: multilayered papillary projections extending from vascularized stalks; no myoepithelial layer (as in benign lesions); neurosecretory granules + positive CEAreactivity in $85 \\%$ (absent in benign lesions)\nTypes:\n(a) intraductal papillary carcinoma (often multiple)\n(b) intracystic papillary carcinoma $=$ in situ malignancy\n(c) invasive carcinoma with papillary growth pattern (microscopic frond formation)\n\nMean age: 63-67 (range, 25-89) years; peak of 40-75 years\n\n- slow growing palpable central mass $(67 \\%)$\n- nipple discharge ( $22-34 \\%$ ) often tinged with blood\n- rich in estrogen and progesterone receptors\n\nLocation: single nodule in central portion of breast; multiple nodules extending from subareolar area to periphery of breast\nSize: average diameter of $2-3 \\mathrm{~cm}$\n$\\sqrt{ }$ multinodular pattern $(55 \\%)=$ lobulated mass / cluster of well-defined contiguous nodules\n$\\sqrt{ }$ solitary well-circumscribed round / ovoid mass of equal or high density $\\leftarrow$ hemorrhage into cystic space\n$\\checkmark$ usually confined to single quadrant\n$\\checkmark$ associated microcalcifications in $60 \\%$\n$\\checkmark$ multiple filling defects / disruption of an irregular duct segment / complete obstruction of duct system at galactography\nUS:\n$\\sqrt{ }$ cyst with an intracystic mass of lobulated smooth margins + acoustic enhancement\n$\\sqrt{ }$ complex mass\n$\\sqrt{ } \\pm$ blood flow on color Doppler\nMR:\n) T1WI:\n$\\checkmark$ well-circumscribed hypointense retroareolar lesion\n> enhanced T1WI:\n$\\checkmark$ strong initial enhancement + postinitial wash-out (type II washout pattern) / (less often) plateau\n$\\checkmark$ ring enhancement possible\n> T2WI:\n$\\checkmark$ well-circumscribed lesion of intermediate intensity in signal-intense cyst\nPrognosis: 90\\% 5-year survival after simple mastectomy + axillary node dissection\n$D D x$ : solitary central duct papilloma; multiple peripheral benign papillomas\n\n# Intraductal Papillary Carcinoma \n\nPath: growth within dilated ducts surrounded by zone of fibrosis without cystic component\n$\\sqrt{ }$ single / multiple clusters of microcalcifications (most common feature)\nMR:\n$\\sqrt{ }$ clumped areas of enhancement\nDistribution: focal / ductal / segmental / regional\n$\\checkmark$ intratumoral high T2 signal $\\leftarrow$ microcystic components",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 843,
            "markdown": "# Intracystic Papillary Carcinoma \n\nPrevalence: $2-5 \\%$ of all breast cancers\nOrigin: dilated duct\nPath: friable bosselated well-circumscribed mass within a cystic space (0.3-2.0\\%) / without a cyst as solid variant\nHisto: epithelial frond-forming growth pattern supported by a fibrovascular core lined by $\\geq 1$ layer of epithelial malignant cells; incomplete / absent myoepithelial cell layer identified by immunohistochemical marker p63\nAverage age: 70 (range, 27-99) years\n\n- asymptomatic; slowly enlarging palpable mass\n- bloody nipple discharge (22-34\\%)\n\nLocation: retroareolar; multifocal\n$\\sqrt{ }$ round / oval well-circumscribed mass\n$\\sqrt{ }$ spiculation\n$\\sqrt{ }$ nipple retraction\nUS / MR:\n$\\sqrt{ }$ cystic mass $\\pm$ septa\n$\\sqrt{ }$ intracystic solid papillary mass with peripheral fronds projecting from cyst wall into lumen\n$\\sqrt{ }$ thick fibrotic cyst wall\n$\\sqrt{ }$ fluid-debris level $\\leftarrow$ spontaneous hemorrhage\n$\\sqrt{ }$ positive color Doppler flow\n$\\sqrt{ }$ posterior acoustic enhancement $\\leftarrow$ fluid component\n$\\sqrt{ }$ fluid component serous (low signal on T1WI + high signal on T2WI) / frequently hemorrhagic (high signal on T1WI + T2WI)\n$\\sqrt{ }$ marked enhancement of mural nodule + cyst wall + septa\n$D x$ : surgical excision to document invasion at tumor periphery\nPrognosis: 10-year survival rate approaches $100 \\%$\n$D D x$ : cyst, mucinous / medullary carcinoma, hematoma, metastasis\n\n## Paget Disease of the Nipple (5\\%)\n\n[Paget, Sir James Paget, ${ }^{\\text {st }}$ Baronet (1814-1899), English surgeon at St. Bartholomew's Hospital, London, England and one of the founders of scientific medical pathology; first described in 1874]\n= uncommon manifestation of breast cancer characterized by infiltration of the nipple epidermis by adenocarcinoma\n$\\diamond$ NEARLY ALWAYS a sign of underlying breast malignancy!\nOrigin: likely from preexisting DCIS / invasive ductal cancer\nPrevalence: $1-3 \\%$ of all breast cancers\nAge: all ages; peak between 40 and 60 years\n\n- nipple changes (32\\%): eczema, erythema of nipple + areola, scaly / flaky skin, nipple erosion, nipple ulceration, nipple inversion, retraction of nipple and areola, bloody discharge:\n$\\diamond$ Median delay of correct diagnosis by 6-11 months as features suggest a benign diagnosis of eczema!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 844,
            "markdown": "- nipple changes + palpable mass / thickening of breast (45\\%)\n- palpable mass / thickening of breast only (14\\%)\n- nipple itching, $\\pm$ serous / sanguineous nipple discharge\n\nHisto: Paget cell = large round cell with pale clear abundant cytoplasm + enlarged pleomorphic nucleus invading epidermis; histologically and biologically similar to comedocarcinoma\nHistogenesis:\n(1) Epidermotropic theory = subareolar cancer cells break away from malignancy $\\rightarrow$ migrate through milk ducts along basal membrane $\\rightarrow$ enter nipple and areola\n(2) Intraepidermal transformation theory = in situ malignant transformation / degeneration of existing cells\nAssociated with:\nextensive invasive ( $30 \\%$ ) / in situ ductal carcinoma ( $60 \\%$ ) limited to one duct in subareolar area / remote + multicentric\nStaging: Paget disease associated with breast carcinoma should be categorized on the basis of parenchymal disease!\nThe mammographic appearance is normal in $22-50 \\%$ !\n@ nipple-areolar complex\n$\\sqrt{ }$ nipple / areolar / skin thickening\n$\\sqrt{ }$ nipple retraction\n$\\sqrt{ }$ dilated duct\n$\\sqrt{ }$ linearly distributed subareolar malignant microcalcifications\n$\\sqrt{ }$ discrete retroareolar soft-tissue mass / masses\n@ breast parenchyma\n$\\sqrt{ }$ discrete mass(es) $>2 \\mathrm{~cm}$ from nipple-areolar complex elsewhere in breast with asymmetry, architectural distortion, diffuse malignant calcifications\nMR:\n) T1WI:\n$\\sqrt{ }$ flattening / thickening of mamillary region\n> enhanced T1WI:\n$\\sqrt{ }$ variable initial uptake: absent / mild / intense\n$\\sqrt{ }$ postinitial plateau / wash-out\n$\\sqrt{ }$ asymmetric enhancement of nipple\n$\\sqrt{ }$ retroareolar lymphatic enhancement\n> T2WI:\n$\\sqrt{ }$ rarely asymmetric areolar hyperintensity\nDx: full-thickness biopsy of nipple + areola $\\rightarrow$ followed by radiologic evaluation to detect an underlying malignancy;\ncytologic smear of a weeping nipple secretion\nPrognosis: survival rate with palpable mass similar to infiltrating duct carcinoma; 85-90\\% 10-year survival rate without palpable mass; positive axillary nodes in $0-13 \\%$\n\n# Inflammatory Breast Carcinoma (IBC) \n\n$=$ clinical entity with diffuse erythema + edema involving $>1 / 3$ of breast skin $\\pm$ angiolymphatic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 845,
            "markdown": "tumor emboli\nPrevalence: $2-5 \\%$ of breast cancers\nAverage age: 52 years\nHisto: no specific type\n$\\diamond$ Tumor invasion of dermal lymphatics demonstrated in only $60 \\%$ of specimens!\nStaging: T4d (T4b if $<1 / 3$ of breast skin involved)\n$\\diamond 20-40 \\%$ risk of distant metastases at time of Dx\nN.B.: dermal lymphatic invasion alone is NOT necessary / sufficient for a diagnosis of IBC\nLocation: $\\mathrm{L}>\\mathrm{R}$ breast; bilaterality in $30-55 \\%$\n$\\diamond$ Metastatic at time of presentation in $20 \\%$ !\nSite: often dorsal + central within breast\n\n- rapid symptomatic development $>1 / 3$ of breast surface:\n- palpable tumor ( $63 \\%$ ); nipple retraction ( $13 \\%$ )\n- diffuse erythema + edema of skin (13-64\\%)\n- erysipeloid edge = peau d'orange edema of skin (13\\%)\n- palpable axillary adenopathy (in up to $91 \\%$ )\n$\\sqrt{ }$ NO fluid collection (DDx to abscess)\n$\\checkmark$ tumor mass $\\pm$ malignant-type calcifications\n$\\checkmark$ dense edematous breast\n$\\checkmark$ stromal coarsening ( $50 \\%$ )\n$\\checkmark$ thickening of Cooper ligaments\n$\\checkmark$ extensive skin thickening ( $71 \\%$ )\nCT:\n$\\sqrt{ }$ marked skin thickening + peripheral enhancement\nPET/CT (superior in staging + restaging of IBC):\n$\\checkmark$ detection of primary breast lesion, skin involvement\n$\\checkmark$ extent of lymph node metastases for radiation therapy planning: ipsilateral axillary, subpectoral, infra- and supraclavicular, internal mammary (25\\%)\n$\\checkmark$ detection of unexpected distant metastases\nMR (most accurate modality):\n> T1WI:\n$\\checkmark$ unilateral breast enlargement\n$\\checkmark$ skin thickening\n> enhanced T1WI:\n$\\checkmark$ patchy asymmetric enhancement of parenchyma + Cooper ligaments\n$\\checkmark$ strong increased uptake in thickened skin:\n$\\checkmark$ \"punched-out\" sign = patchy nodular enhancement of skin at different points in time + different locations\n$\\checkmark$ strong increased uptake in tumor infiltrated parenchyma:\n$\\checkmark$ occasionally delineation of primary tumor\n> T2WI:\n$\\checkmark$ diffuse increase in intensity compared to contralateral breast (= prepectoral edema)\n$\\checkmark$ sometimes hypovascular tumor surrounded by nontumoral edema",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 846,
            "markdown": "$D x: \\quad$ skin punch biopsy\n$\\diamond$ MRI can help identify a biopsy target to confirm Dx.\nBoth tissue diagnosis \\& clinical evidence of inflammatory disease are required for a diagnosis of IBC.\n$R x$ : multimodal: neoadjuvant chemotherapy + surgery (ie, modified radical mastectomy) + radiation therapy $\\pm$ further adjuvant medical therapy with anti-HER antibody / hormonal therapy\nPrognosis: 25-50\\% 5-year survival; median survival time of 7 months (untreated) + 18 months (after radical mastectomy)\n$D D x$ :\n\n1. Mastitis\n$\\sqrt{ }$ often arises in subareolar area\n(a) infectious mastitis (test treatment for 2-3 weeks with macrolide antibiotic azithromycin, eg, Zithromax Z-pak*)\n(b) inflammatory mastitis (connective tissue disease, SLE, psoriasis)\n(c) granulomatous mastitis\n2. Breast abscess\n3. Edema (lymphedema, venous obstruction from cardiac pacemakers / dialysis catheters, vascular stenosis / malformation, nephrogenic systemic fibrosis)\n4. Ruptured epidermal inclusion / sebaceous cyst associated with skin trauma / follicular inflammation\n5. latrogenic (prior radiation Rx)\n\n- localized scleroderma-type skin reaction (rare) = radiation-induced morphea [ morpheus, Greek = God of dreams or maker of shapes]\n$\\sqrt{ }$ skin thickening + fat necrosis\n\n6. Recurrent breast cancer\n7. Noninflammatory locally advanced breast cancer (LABC)\n\n- onset of symptoms usually longer than 3 months with slow progression\n$\\diamond 10 \\%$ risk of distant metastases at time of Dx\nAverage age: 66 years\n\n8. Metastasis: melanoma, GI cancer, ovarian cancer, lymphoma / leukemia\n\n# Pregnancy-Associated Breast Cancer \n\n$=\\mathrm{PABC}=$ breast cancer that occurs during pregnancy / within 1 year of delivery\nFrequency: $1 \\div 3,000-10,000$ pregnancies; $3 \\%$ of all breast malignancies\nPath: high rates of inflammatory tumor; lymph node involvement (in $>50 \\%$ )\nHisto: high-grade tumor (in $>50 \\%$ ); high prevalence of hormone-receptor-negative and HER2/neu-positive tumors $\\leftarrow$ aggressive biologic growth pattern\n\n- palpable mass, swelling, erythema, diffuse breast enlargement\n$\\sqrt{ }$ same radiologic features as for non-PABC\nMammo:\n$\\sqrt{ }$ required to detect malignant microcalcifications, multifocality, multicentricity, bilaterality\nSensitivity: lower in pregnant / lactating patients $\\leftarrow$ increased glandular density",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 847,
            "markdown": "Recommendation: Try to avoid mammography during $1^{\\text {st }}$ trimester - evaluate breast disease with US instead!\nRisk to fetus: malformations may occur with exposure to $>0.05$ Gy of radiation\nDose: standard 2-view mammography of each breast performed with abdominal shielding subjects fetus to only 0.004 Gy of radiation\n$\\diamond$ Abdominal shielding can be performed during pregnancy with minimal / no risk to fetus!\nMR: MRI should be avoided during pregnancy!\nBreast biopsy: cytologic diagnosis of breast lesions during pregnancy and lactation should be avoided - use core biopsy instead!\nPrognosis: tendency for larger more advanced neoplasms at diagnosis $\\rightarrow$ poorer outcome $\\leftarrow$ delayed diagnosis + aggressive growth pattern; recurrence common within 2-3 years\n\n# BREAST CYST \n\nFrequency: most common single cause of breast lumps between 35 and 55 years of age\nAge: any; most common in later reproductive years + around menopause\nHisto: cyst wall lined by single layer of\n(a) flattened epithelial cells\n\n- cyst fluid with $\\mathrm{Na}+/ \\mathrm{K}+$ ratio $\\geq 3$\n(b) epithelial cells with apocrine metaplasia $\\rightarrow$ secretory function\n- cyst fluid with $\\mathrm{Na}+/ \\mathrm{K}+$ ratio $<3$\n\nCause: fluid cannot be absorbed $\\leftarrow$ obstruction of extralobular terminal duct by fibrosis / intraductal epithelial proliferation\n\n- size changes over time\n$\\diamond$ A simple cyst in a male is suspicious because benign cystic disease typically does not occur in men!\n\n\n## Simple Breast Cyst\n\n$\\sqrt{ }$ well-defined flattened oval / round (if under pressure) mammographic mass + surrounding halo (DDx: well-defined solid mass)\n$\\sqrt{ }$ solitary / multiple\n$\\sqrt{ }$ needle aspiration of fluid (proof) + postaspiration mammogram as new baseline US ( $98-100 \\%$ accuracy):\n$\\diamond$ Correlate with palpation / mammogram as to size, shape, location, surrounding tissue density!\n$\\sqrt{ }$ spherical / ovoid lesion with anechoic center\n$\\sqrt{ }$ well-circumscribed thin echogenic capsule\n$\\sqrt{ }$ posterior acoustic enhancement (may be difficult to demonstrate in small / deeply situated cysts)\n$\\sqrt{ }$ thin edge shadows\n$\\sqrt{ }$ occasionally multilocular $\\pm$ thin septations / cluster of cysts\nMR:\n) T1WI:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 848,
            "markdown": "$\\sqrt{ }$ well-circumscribed hypointense lesion without discernible cyst wall; well seen within adipose parenchyma; poorly seen in normal parenchyma\n, enhanced T1WI:\n$\\sqrt{ }$ no change in SI; improved demarcation $\\leftarrow$ enhancement of surrounding parenchyma\n) T2WI:\n$\\sqrt{ }$ well-circumscribed hyperintense lesion with homogeneous internal texture (detectable at a diameter of $\\sim 2 \\mathrm{~mm}$ )\n\n# Pneumocystogram (for symptomatic cysts) \n\n$\\sqrt{ }$ air remains mammographically detectable for up to 3 weeks\n$\\sqrt{ }$ therapeutic effect of air insufflation (equal to $60-70 \\%$ of aspirated fluid volume): no cyst recurrence in $85-94 \\%$ ( $40-45 \\%$ cyst recurrence without air insufflation)\n\n## Complex / Complicated Breast Cyst\n\n$=$ any cyst that does not meet criteria of simple cyst\nCause: fibrocystic changes (vast majority), infection, malignancy (extremely rare)\n$\\diamond 0.3 \\%$ of all breast cancers are intracystic\n$\\diamond$ A complex cystic mass in a male should prompt Bx!\n$\\diamond$ Patients with apocrine cysts are at greater risk to develop breast cancer!\n$\\sqrt{ }$ uniformly thick wall + tenderness $=$ inflammation / infection\n$\\sqrt{ }$ diffuse low-level internal echoes (= \"foam\" cyst):\n(a) with mobility upon increase in power output\n$=$ subcellular material like protein globs, floating cholesterol crystals, cellular debris\n(b) without mobility upon increase in power output\n$=$ cells like foamy macrophages, apocrine metaplasia, epithelial cells, pus, blood\n$\\sqrt{ }$ fluid-debris level\n$R x$ : aspiration to rule out blood / pus\n$\\sqrt{ }$ thick septation / eccentric wall thickening further characterized by:\n, protruding ill-defined outer margin\n, convex microlobulated inner margin (\"mural nodule\")\nnonmobile mass with coarse heterogeneous echotexture\n, color Doppler flow within thickening\n$R x$ : treated like solid nodule\n$\\sqrt{ }$ spongelike cluster of microcysts\n$R x$ : treated like solid nodule\nMR:\n) T1WI:\n$\\sqrt{ }$ hyper- / isointense cyst content (hemorrhage) $\\pm$ sign of sedimentation\n, enhanced T1WI:\n$\\sqrt{ }$ thick ring-enhancing cyst wall (inflammation)\n$\\sqrt{ }$ slight contrast uptake in surrounding tissue (= reactive hyperemia)\n$R x$ : complete aspiration (assures benign cause), core needle biopsy (if partially / nonaspiratable)\n$D D x$ : artifactual scatter in superficial / deep small cysts, fibroadenoma, papilloma, carcinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 849,
            "markdown": "# Cyst Aspiration \n\n- inspection of cyst fluid:\n(a) normal: turbid greenish / grayish / black fluid\n(b) abnormal: straw-colored clear fluid / dark blood\n$\\sqrt{ }$ needle moves within nonaspiratable complex cyst\nProcessing of fluid:\n(1) Fluid without blood should be discarded\n(2) Bloody fluid should be examined cytologically\n\n\n## CARCINOMA OF MALE BREAST\n\nIncidence: $1.3 \\div 100,000$ per year (in 2000); 2,600 new cases / year with 440 deaths (in 2016); $1 \\%$ of all breast cancers; $0.17 \\%$ of all male cancers\n$\\diamond 3.7 \\%$ of male breast carcinomas occur in men with Klinefelter syndrome!\nPeak age: 60-69 (mean, 59) years\nAt risk: males with chronically increased estrogen levels\n\n1. Advanced age\n2. Klinefelter syndrome (20- to 50 -fold risk over normals): XXY chromosomes\n3. Liver dysfunction: cirrhosis, schistosomiasis, malnutrition\n4. Genetic predisposition: BRCA2 > BRCA1 mutation, family history in 1 st-degree male / female relative (in up to $30 \\%$ )\n5. Testicular atrophy: injury, mumps orchitis, undescended testes\n6. Radiation therapy to chest (latent period of $12-35$ years)\n7. Occupational heat exposure (diminished testicular function)\n8. Jewish background\n$\\diamond$ Gynecomastia is NOT a risk factor!\nHisto: same as in females; invasive ductal carcinoma NOS (80-85\\%), associated DCIS (35$50 \\%$ ), infiltrating mammary carcinoma with mixed features, invasive papillary carcinoma ( 2 x more than in women); invasive lobular carcinoma distinctly uncommon (tubular structures usually not found in male breast)\n\n- breast swelling, bloody nipple discharge ( $25 \\%$ )\n- firm painless irregular mass $\\pm$ associated gynecomastia\n- nipple retraction, skin ulceration / thickening\n\nLocation: $\\mathrm{L}>\\mathrm{R}$ breast; bilateral in $<1 \\%$\nSite: retroareolar / upper-outer-quadrant\nMammo (screening not feasible $\\leftarrow$ low incidence):\n$\\sqrt{ }$ high-density irregular mass:\n$\\sqrt{ }$ spiculated / lobulated / microlobulated margin resembling scirrhous carcinoma of female breast\n$\\sqrt{ }$ usually located eccentrically\n$\\sqrt{ }$ microcalcifications (in only $13-30 \\%$ ): fewer + less linear ( $=$ more scattered) + more round + coarser than in female\n$\\sqrt{ }$ solid nodules / papillary projections arising along a cyst wall (= papillary carcinoma)\n$\\sqrt{ }$ enlarged axillary nodes (in $50 \\%$ at time of presentation)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 850,
            "markdown": "US:\n$\\sqrt{ }$ invasive ductal carcinoma appears as a solid hypoechoic subareolar mass of irregular shape with spiculated / microlobulated margins, eccentric to the nipple!\n$\\sqrt{ }$ metastases to pleura, lung, bone, liver\nDelay in diagnosis from onset of symptoms: 6-18 months\nRx: simple / modified radical mastectomy + sentinel node biopsy, hormonal manipulation ( $85 \\%$ estrogen receptor and $75 \\%$ progesterone receptor positive)\nPrognosis: 5-year survival rate for stage $1=82-100 \\%$, for stage $2=44-77 \\%$, for stage $3=$ $16-45 \\%$, for stage $4=4-8 \\%$ (same as for women!)\n$D D x$ : breast abscess, gynecomastia, epidermal inclusion cyst\n\n# DERMATOPATHIC LYMPHADENOPATHY \n\n$=$ benign reactive lymphadenopathy within breast associated with cutaneous rashes\nCause: exfoliative dermatitis, erythroderma, psoriasis, atopic dermatitis, skin infection)\nHisto: follicular pattern retained, germinal centers enlarged, enlarged paracortical area with pale-staining cells (lymphocytes, Langerhans cells, interdigitating reticulum cells)\n\n- mobile nontender firm subcutaneous nodules\n\nLocation: often bilateral\nSite: predominantly upper outer quadrant\n$\\sqrt{ }$ regional subcentimeter masses with central / peripheral radiolucent notches\n\n## DESMOID TUMOR (MAMMARY FIBROMATOSIS)\n\n$=$ LOW-GRADE FIBROSARCOMA $=$ AGGRESSIVE FIBROMATOSIS\n$=$ rare tumor without metastatic potential\nIncidence: over 100 isolated cases reported\nHisto: spindled fibroblasts + myofibroblasts forming interlacing fascicles entrapping ducts + lobules; actin positive, variably positive for desmin + S-100; nuclear expression of $\\beta$ catenin\nMay be associated with: trauma, surgery, Gardner syndrome, familial adenomatous polyposis, familial multicentric fibromatosis\n$\\mathrm{M} \\div \\mathrm{F}=3 \\div 1$\n\n- painless firm mobile mass\n- $\\pm$ skin retraction, dimpling, nipple retraction\n\nSize: $0.5-10 \\mathrm{~cm}$\n$\\sqrt{ }$ spiculated mass without calcifications\n$\\sqrt{ }$ hypoechoic mass with spiculated / irregular / microlobulated margins\n$\\sqrt{ }$ low to intermediate SI on T1WI + variable SI on T2WI\n$\\sqrt{ }$ benign progressive kinetic enhancement pattern (common)\nMRI is the optimal modality for assessment of chest wall involvement, given its superior soft-tissue resolution and the locally aggressive nature of fibromatosis!\nPrognosis: $27-29 \\%$ recurrence rate\n\n## DIABETIC (FIBROUS) MASTOPATHY",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 851,
            "markdown": "$=$ rare fibroinflammatory breast disease\nCause: long-standing type 1 diabetes $\\rightarrow$ increased resistance of collagen to normal degradation\nHisto: stromal sclerosis with an increased number of spindle cells, scattered epithelial cells and perivascular dense lymphocytic infiltrate\nAge: young woman, 20 years after onset of diabetes\n\n- firm to hard nontender breast mass\n$\\checkmark$ nonspecific discrete mass / regional asymmetry of dense tissue\nUS:\n$\\checkmark$ single / multiple bilateral masses hypoechoic to SQ fat\n$\\checkmark$ hypovascular / avascular on color flow imaging\n$\\checkmark$ posterior acoustic shadowing\n$D x:$ (frequently required) core biopsy\n$D D x:$ breast cancer\n\n\n# DUCT ECTASIA \n\n$=$ nonspecific dilatation of one / more ducts $>2 \\mathrm{~mm} /$ of ampullary duct segment $>3 \\mathrm{~mm}$\nCause: ?; periductal inflammation; malignancy\n\n- occasionally nipple discharge / retraction\n- palpable mass, pain / tenderness\n(a) benign\n\nLocation: central\n$\\sqrt{ }$ retroareolar serpentine radiodense structures converging on the nipple-areolar complex\n$\\sqrt{ }$ anechoic smooth-walled branching structures tapering toward the periphery\n$\\sqrt{ }$ filled with fluid / thick inspissated secretions or cellular debris $\\pm$ movement of particulate matter\n$\\sqrt{ }$ $\\pm$ coarse smooth-bordered rod-/ cigar-shaped calcifications pointing toward the nipple\n(b) malignant features\n\nLocation: peripheral\n$\\sqrt{ }$ irregularity of duct margin\n$\\sqrt{ }$ focal thickening of duct wall\n$\\sqrt{ }$ adjacent hypoechoic tissue\nAn echogenic intraductal mass within an ectatic duct warrants biopsy to exclude malignancy!\n$D D x$ : blocked duct (during lactation); inflammatory infiltrate (masslike intraductal lesions); periductal mastitis (premenopausal, periductal enhancement)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 852,
            "markdown": "# EPIDERMAL INCLUSION CYST \n\n$=$ most common benign cutaneous / subcutaneous lesion\nOrigin: infundibulum (uppermost portion) of hair follicle\nCause: ?\n(a) spontaneous: congenital, ? squamous metaplasia of ductal epithelium\n(b) trauma (breast core biopsy, reduction mammoplasty $\\rightarrow$ displacement of epidermis during surgery\nPath: cyst filled with keratin\nHisto: wall lined by stratified squamous epithelium\n\n- palpable skin cyst with tiny visible skin opening:\n- smooth round nodule attached to skin with \"blackhead\" (= blackened pore = clogged hair follicle), movable against underlying tissue\n- occasional whitish discharge from opening + subsequent decompression of palpable mass\n$\\sqrt{ }$ circumscribed isodense or high-density mass\n$\\sqrt{ }$ contiguous with dermis (tangential view)\n$\\sqrt{ } \\pm$ calcifications\nUS:\n$\\sqrt{ }$ hypoechoic well-circumscribed solid / cystic lesion\n$\\sqrt{ }$ heterogeneous content $\\leftarrow$ variable amounts of internal keratinous debris and granulation tissue:\n$\\sqrt{ } \\pm$ internal whorled / onion-ring appearance (= lamellated keratinous material)\n$\\sqrt{ }$ ill-defined margins + peripheral vascularity if inflamed\n$D x:$ CHARACTERISTIC imaging findings\n$\\diamond$ NO biopsy $\\leftarrow$ increased risk of inflammatory response\n$D D x$ : sebaceous cyst (indistinguishable)\n\n\n## FAT NECROSIS OF BREAST\n\n$=$ TRAUMATIC LIPID CYST = OIL CYST\n$=$ nonsuppurative saponification of fat by tissue lipase $\\leftarrow$ local destruction of fat cells with release of lipids + hemorrhage + fibrotic proliferation\nEtiology: direct external trauma (seat belt injury), lumpectomy, reduction mammoplasty, implant removal, breast reconstruction, irradiation, nodular panniculitis (Weber-Christian disease), ductal ectasia of chronic mastitis, foreign body reaction (to silicone / paraffin injection)\nPrevalence: $0.5 \\%$ of breast biopsies\nAt risk: middle-aged obese women with fatty pendulous breasts\nHisto: cavity with oily material surrounded by \"foam cells\" (= lipid-laden macrophages)\n\n- history of trauma in $40 \\%$ (eg, prior surgery, radiation $>6$ months ago, reduction mammoplasty, lumpectomy)\n- usually clinically occult\n- firm, slightly fixed tender / painless mass\n- skin retraction ( $50 \\%$ ); yellowish fatty fluid on aspiration\n\nLocation: anywhere; more common in superficial periareolar region; near biopsy site / surgical",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 853,
            "markdown": "scar\n$\\sqrt{ }$ early: ill-defined irregular spiculated dense mass\n$\\sqrt{ }$ later: well-circumscribed mass with translucent areas at center (= homogeneous fat density of oil cyst) surrounded by thin pseudocapsule (in old lesion)\n$\\sqrt{ }$ calcifies in $4-7 \\%$ (= liponecrosis macrocystica calcificans):\n$\\checkmark$ occasionally curvilinear / eggshell calcification in wall\n$\\checkmark$ fine spicules of low density vary with projection\n$\\checkmark$ localized skin thickening / retraction possible\nUS:\n$\\checkmark$ hypo- / anechoic mass with ill- / well-defined margins $\\pm$ acoustic shadowing\n$\\checkmark$ occasionally echogenic $\\pm$ acoustic shadowing\n$\\checkmark$ complex cyst with mural nodules / echogenic bands\nMR:\n) T1WI:\n$\\checkmark$ signal intensity nearly isointense to fat\n$\\checkmark$ round lesion with hyperintense fat signal (oil cyst)\n$\\checkmark$ signal loss with macrocalcifications\n> enhanced T1WI:\n$\\checkmark$ localized ill-defined area of moderate enhancement + continuous postinitial increase (= granulation tissue) within 6 months after trauma\n$\\checkmark$ rim-enhancement / no enhancement in late lesion / oil cyst\n> T2WI:\n$\\checkmark$ ill-defined hyperintense area (= reactive edema of fresh lesion)\n$\\checkmark$ round lesion with central SI of fat (in oil cyst)\n$D D x$ : breast cancer (indistinguishable from carcinoma if associated with distortion, skin thickening, retraction), breast abscess\n\n# Weber-Christian Disease \n\n$=$ nonsuppurative panniculitis with recurrent bouts of inflammation = areas of fat necrosis, involving subcutaneous fat + fat within internal organs\n\n- accompanied by fever + nodules over trunk and limbs\n\n\n## FIBROADENOMA\n\n$=$ ADULT-TYPE FIBROADENOMA\n$=$ estrogen-induced benign fibroepithelial tumor originating from TDLU; forms during adolescence; pregnancy and lactation are growth stimulants; regression after menopause (mucoid degeneration, hyalinization, involution of epithelial components, calcification)\nFrequency: $3^{\\text {rd }}$ most common type of breast lesion after fibrocystic disease + carcinoma; most common benign solid tumor in women of childbearing age ( $\\sim 10 \\%$ )\nMean age: 30 (range, 13-80) years; most common breast tumor under age 25 years\nHormonal influence:\nslight enlargement at end of menstrual cycle + during pregnancy; regresses after menopause; may occur in postmenopausal women receiving estrogen replacement therapy\nPath: well-circumscribed smooth / mildly lobulated mass with well-demarcated interface",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 854,
            "markdown": "between stroma + uninvolved parenchyma (NO capsule)\nHisto: concurrent proliferation of fibrous stroma + glandular epithelium\n(a) intracanalicular fibroadenoma: dense stroma compressing ducts into slitlike space\n(b) pericanalicular fibroadenoma: NO duct compression\n(c) combination\n$\\diamond$ Cellular FA = highly cellular predominantly epithelial elements in younger woman\n$\\diamond$ Fibrous FA = acellular predominantly fibrotic elements in older postmenopausal woman\n\n- slowly enlarging firm rubbery, smooth, sometimes lobulated, freely movable mass\n- in $35 \\%$ not palpable; NO skin fixation\n- rarely tender / painful; clinical size = radiographic size\n\nSize: $1-5 \\mathrm{~cm}$ (in $60 \\%$ )\nLocation: multifocal in $15-25 \\%$; bilateral in $4 \\%$; often located in upper outer quadrant\n$\\checkmark$ circular / oval-shaped lesion of low density\n$\\checkmark$ nodular / lobulated contour when larger (= areas with different growth rates)\n$\\checkmark$ well-defined smooth discrete margins (indistinguishable from cysts when small)\n$\\checkmark$ often with \"halo\" sign\n$\\checkmark$ smoothly contoured calcifications of high + fairly equal density in $3 \\% \\leftarrow$ necrosis from regressive changes in older women:\n(a) peripheral subcapsular myxoid degeneration\n$\\checkmark$ peripheral marginal ring- / dotlike calcifications that coalesce over time\n(b) central myxoid degeneration\n$\\checkmark$ \"popcorn\" type of calcification (PATHOGNOMONIC)\n(c) small calcifications within ductal elements\n$\\checkmark$ pleomorphic / dystrophic linear $\\pm$ branching pattern\n$D x$ : biopsy may be necessary\n$\\diamond$ Calcifications enlarge as soft-tissue component regresses!\nUS:\n$\\checkmark$ round (3\\%) / oval (96\\%) mass with long axis parallel to chest wall with length-to-depth ratio of $>1.4$ (in carcinomas usually $<1.4$ )\n$\\checkmark$ hypoechoic similar to fat lobules ( $80-96 \\%$ ) / hyperechoic / mixed pattern / anechoic / isoechoic compared with adjacent fibroglandular tissue\n$\\checkmark$ homogeneous ( $48-89 \\%$ ) / inhomogeneous ( $12-52 \\%$ ) texture\n$\\checkmark$ regular (57\\%) / lobulated (15-31\\%) / irregular (6-58\\%) contour\n$\\checkmark$ \"hump and dip\" sign = small focal contour bulge immediately contiguous with a small sulcus $(57 \\%)$\n$\\checkmark$ intratumoral bright echoes $(10 \\%)=$ macrocalcifications\n$\\checkmark$ posterior acoustic enhancement ( $17-25 \\%$ ) / acoustic shadow without calcifications (9$11 \\%)$\n$\\checkmark$ echogenic halo (capsule) with lateral shadowing\n$\\checkmark$ slight compressibility of tumor\n$\\checkmark$ avascular / some central vascularity on color flow imaging\nMR:\n) T1WI:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 855,
            "markdown": "$\\sqrt{ }$ iso- / mildly hypointense compared to parenchyma\n$\\sqrt{ }$ more obvious in fatty tissue\n$\\sqrt{ }$ endotumoral signal loss $\\leftarrow$ macrocalcifications\n> enhanced T1WI:\n$\\sqrt{ }$ very strong enhancement (with proportionately larger epithelial component)\n$\\sqrt{ }$ postinitial continuous increase / plateau\n$\\sqrt{ }$ endotumoral septa with mild contrast uptake\n> T2WI:\n$\\sqrt{ }$ high SI (for tumor with proportionately larger epithelial component) in $50 \\%$\n$\\sqrt{ }$ occasionally endotumoral septations $\\leftarrow$ fibrotic component\n$\\sqrt{ }$ iso- / slightly hypointense compared to breast parenchyma (for predominantly fibrotic tumor) in $50 \\%$\nManagement: follow-up in 6 month to assess interval growth\nCx: spontaneous infarction (esp. during $3^{\\text {rd }}$ trimester of pregnancy / after delivery) $\\leftarrow$ intravascular thrombosis\n$D D x$ : phyllodes tumor (rapid growth, recurrence of fibroadenoma, cellular fibroadenoma in postmenopausal patient); adenosis tumor / florid adenosis\n\n# Juvenile / Giant / Cellular Fibroadenoma \n\n$=$ fibroadenoma $>5 \\mathrm{~cm}$ in diameter / weighing $>500 \\mathrm{~g}$\nFrequency: $7-8 \\%$ of all fibroadenomas; multiple / bilateral in 10-25\\%\nCause: hyperplasia + distortion of normal breast lobules $\\leftarrow$ hormonal imbalances between estradiol + progesterone levels\nAge: any (mostly in adolescent girls); most often in African-American girls\nHisto: more glandular + more stromal cellularity than adult type of fibroadenoma; ductal epithelial hyperplasia\n\n- rapidly enlarging well-circumscribed nontender mass\n- dilated superficial veins, stretched skin $\\pm$ ulceration\n$\\sqrt{ }$ discrete mass with rounded borders\n$\\sqrt{ } \\pm$ cleftlike depressions and tiny cysts (similar to phyllodes tumor)\nMR:\n> T1WI:\n$\\sqrt{ }$ iso- to slightly hypointense round / oval mass difficult to separate from normal breast parenchyma\n> enhanced T1WI:\n$\\sqrt{ }$ strong enhancement with sharp demarcation from surrounding tissue + endotumoral septations\n> T2WI:\n$\\sqrt{ }$ typically hyperintense\nCx: infarction $\\rightarrow$ edema, hemorrhage\n$D D x$ : medullary / mucinous / papillary carcinoma / carcinoma within fibroadenoma\n\n\n## Tubular Adenoma\n\n$=$ variant of pericanalicular fibroadenoma with florid epithelium like in adenosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 856,
            "markdown": "# FIBROCYSTIC CHANGES \n\n$=$ MAZOPLASIA $=$ MASTITIS FIBROSA CYSTICA $=$ CHRONIC CYSTIC MASTITIS $=$ CYSTIC DISEASE $=$ GENERALIZED BREAST HYPERPLASIA $=$ DESQUAMATED EPITHELIAL HYPERPLASIA $=$ FIBROADENOMATOSIS $=$ MAMMARY DYSPLASIA $=$ SCHIMMELBUSCH DISEASE $=$ FIBROUS MASTITIS $=$ MAMMARY PROLIFERATIVE DISEASE\n$\\diamond$ Not a disease since it is found in $72 \\%$ of screening population $>55$ years of age\n$\\diamond$ The College of American Pathologists suggests use of the term \"fibrocystic changes / condition\" in mammography reports!\nPrevalence: most common diffuse breast disorder; in $51 \\%$ of 3,000 autopsies\nAge: $\\quad 35-55$ years\nEtiology: exaggeration of normal cyclical proliferation + involution of the breast with production + incomplete absorption of fluid by apocrine cells $\\leftarrow$ hormonal imbalance\nHisto:\n(1) overgrowth of fibrous connective tissue $=$ stromal fibrosis, fibroadenoma\n(2) cystic dilatation of ducts + cyst formation (in $100 \\%$ microscopic, in $20 \\%$ macroscopic)\n(3) hyperplasia of ducts + lobules + acini $=$ adenosis; ductal papillomatosis\n\n- asymptomatic with macrocystic disease\n- fullness, tenderness, pain in microcystic disease\n- palpable nodules + thickening\n- symptoms occur with ovulation\n- regression with pregnancy + menopause\n$\\checkmark$ individual round / ovoid cysts with discrete smooth margins\n$\\checkmark$ lobulated multilocular cyst\n$\\checkmark$ enlarged nodular pattern (= fluid-distended lobules + extensive extralobular fibrous connective tissue overgrowth)\n$\\checkmark$ \"teacup-like\" curvilinear thin calcifications with horizontal beam + low-density round calcifications in craniocaudal projection $=$ milk of calcium $(4 \\%)$\n$\\checkmark$ \"oyster pearl-like\" / psammoma-like calcifications\n$\\checkmark$ \"involutional type\" calcifications = very fine punctate calcifications evenly distributed within one / more lobes against a fatty background $\\leftarrow$ mild degree of hyperplasia in subsequently atrophied glandular tissue\nUS:\n$\\checkmark$ ductal pattern, ductectasia, multiple cysts of varying size, ill-defined focal echogenic lesions with / without posterior sound attenuation\nMR:\n) T1WI:\n$\\checkmark$ hypointense compared to intramammary adipose tissue\n$\\checkmark$ interspersed hypointense cysts of varying sizes\n> enhanced T1WI:\n$\\checkmark$ patchy to diffuse increased enhancement (correlating with degree of adenosis)\n$\\diamond$ Avoid scheduling patient during $1^{\\text {st }}$ and $4^{\\text {th }}$ week of menstrual cycle / under HRT\n$\\checkmark$ continuous rise after postinitial phase\n) T2WI:\n$\\checkmark$ occasionally diffusely increased SI (in $2^{\\text {nd }}$ half of menstrual cycle / under HRT)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 857,
            "markdown": "$\\sqrt{ }$ interspersed hyperintense cysts of varying sizes\nRisk for invasive breast carcinoma:\nA. NO INCREASED RISK (70\\%)\n\n1. Nonproliferative lesions: adenosis, florid adenosis, apocrine metaplasia without atypia, macro- / microcysts, duct ectasia, fibrosis, mild hyperplasia (more than 2 but not more than 4 epithelial cells deep), mastitis, periductal mastitis, squamous metaplasia\n2. Fibroadenoma\nB. SLIGHTLY INCREASED RISK (1.5-2 times):\n3. Moderate + florid solid / papillary hyperplasia\n4. Papilloma with fibrovascular core\n5. Sclerosing adenosis\nC. MODERATELY INCREASED RISK (5 times):\n\nDuctal / lobular atypical hyperplasia (= borderline lesion with some features of carcinoma in situ)\nD. HIGH RISK (8-11 times):\n\n1. Atypical hyperplasia + family history of breast cancer\n2. Ductal / lobular carcinoma in situ\n\n| Classification of Fibrocystic Changes |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Grade | Frequency | Histological Category | Breast <br> Cancer Risk |\n| I | $70 \\%$ | Nonproliferative lesion | 0 |\n| II | $25 \\%$ | Proliferative lesion without atypia | $2 x$ |\n| III | $5 \\%$ | Proliferative lesion with atypia | $4-5 x$ |\n\n# Adenosis \n\nAge: all\nPath: lobulocentric lesion derived from TDLU with distortion and effacement of underlying lobules\nHisto: epithelial and myoepithelial proliferation of ductules + lobules with nuclear pleomorphism + increase in cell size\n$\\sqrt{ }$ increase in size of TDLUs to $3-7 \\mathrm{~mm}$\n$\\sqrt{ }$ \"snowflake pattern\" of widespread ill-defined nodular densities\n$\\sqrt{ }$ often round intralobular microcalcifications / milk of calcium (less common + less extensive than in sclerosing adenosis)\nUS:\n$\\sqrt{ }$ adenosis lobules are sonographically iso- to mildly hypoechoic compared with fat MR:\n$\\sqrt{ }$ no abnormalities on T1WI / T2WI\n$\\sqrt{ }$ usually strong, occasionally branching contrast uptake in focal areas of adenosis\n$D D x$ : malignancy\n\n## Sclerosing Adenosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 858,
            "markdown": "Path: myoepithelial proliferation + reactive stromal fibrosis\nHisto: stromal sclerosis involving $>50 \\%$ of all TDLUs, which become elongated + distorted + compressed by sclerosis\n$D D x$ : tubular carcinoma (absence of basement membrane + myoepithelial cells); radial scar (more extensive fibrosis + central fibrocollagenous scar)\n\n- palpable mass (rare) = \"adenosis tumor\"\n\nRarely associated with: lobular carcinoma in situ > ductal carcinoma in situ\n$\\diamond$ Sclerosing adenosis is not a risk factor / precursor of breast cancer!\n![img-88.jpeg](img-88.jpeg)\n$\\sqrt{ }$ punctate calcifications of calcium oxalate casts forming in obstructed acini in $50 \\%$\n(a) focal form\n$\\sqrt{ }$ \"rosettes\" = focal cluster of microcalcifications occupying all acini of one / several TDLUs\n$\\checkmark$ architectural distortion\n$\\checkmark$ focally dense breast $\\rightarrow$ as a nodule / spiculated lesion\n(b) diffuse form\n$\\checkmark$ adenosis + diffusely scattered \"starry night\" calcifications",
            "images": [
                {
                    "id": "img-88.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 545,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1610,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 859,
            "markdown": "$\\sqrt{ }$ diffusely dense breast\n$D D x$ : other spiculated lesions\n\n# Adenosis Tumor $=$ Florid Adenosis \n\nAverage age: 30 years\nHisto: focal proliferation of ductules and lobular glands with hyperplasia of epithelial + myoepithelial cells\n\n- firm clinically discrete / ill-defined mass\n$\\sqrt{ }$ nodular mass usually $<2 \\mathrm{~cm}$ in diameter\n$\\sqrt{ } \\pm$ microcalcifications\n$D D x$ : fibroadenoma\n\n\n## Gestational \\& Secretory Hyperplasia\n\n(a) gestational (= related to pregnancy):\n\nHisto: calcifications in lobular acini\n$\\sqrt{ }$ round microcalcifications in a diffuse / focal distribution (most commonly)\n(b) secretory (= related to lactation)\n\nHisto: ductal hyperplasia\n$\\sqrt{ }$ irregular microcalcifications in a linear distribution + branching pattern closely resembling malignancy (less commonly)\n(c) coexistence of both types of microcalcifications\n\nDDx: pseudolactational hyperplasia (same radiologic-pathologic findings in nonpregnant nonlactating women)\n\n## Fibrosis\n\n$\\sqrt{ }$ round / oval clustered microcalcifications with smooth contours + associated fine granular calcifications filling lobules\n\n## Atypical Lobular Hyperplasia\n\n$=$ proliferation of round cells of LCIS type growing along terminal ducts in permeative fashion (pagetoid growth) between benign epithelium + basal myoepithelium BUT NOT completely obliterating terminal ductal lumina / distending lobules (as in lobular carcinoma in situ)\n$\\sqrt{ }$ no mammographic correlate\n\n## Atypical Ductal Hyperplasia\n\n$=$ low-grade intraductal proliferation with partial / incompletely developed features of noncomedo DCIS\n$\\sqrt{ }$ frequent calcifications\n\n## Sclerosing Lobular Hyperplasia\n\n$=$ FIBROADENOMATOID MASTOPATHY\n$=$ benign proliferative lesion\nPath: enlarged lobules, increased number of intralobular ductules, sclerosis of intralobular septa",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 860,
            "markdown": "Mean age: 32 years; black woman\n\n- palpable circumscribed mass\n$\\checkmark$ resembles noncalcified fibroadenoma\n\n\n# FIBROUS NODULE OF BREAST \n\n$=$ FIBROUS DISEASE OF THE BREAST = FIBROUS DISEASE = FOCAL FIBROSIS OF THE BREAST = FIBROUS MASTOPATHY = FIBROUS TUMOR OF THE BREAST\nFrequency: 3-4\\% of benign masses; 8\\% of surgical breast specimens\nHisto: focally dense collagenous stroma surrounding atrophic epithelium; NONSPECIFIC Age: $20-50$ years; only $8 \\%$ postmenopausal\n\n- palpable / nonpalpable mass: edge merges into surrounding dense tissue\n\nLocation: unilateral ( $80-85 \\%) /$ bilateral ( $15-20 \\%$ )\n$\\checkmark$ circumscribed (55\\%) / indistinct (32\\%) margin\n$\\checkmark$ suggestive of malignancy ( $11 \\%$ ): irregular shape, spiculated margin, posterior acoustic shadowing\n$D D x:$ fibroadenoma, malignancy\n\n## GALACTOCELE\n\n$=$ retention cyst of fatty material in areas of cystic duct dilatation appearing during / (more commonly) shortly after lactation\n$\\diamond$ Most common benign breast lesion in lactating women!\nCause: ? abrupt suppression of lactation / obstructed milk duct\nPath: smooth-walled cyst lined by simple cuboidal to columnar apocrine-type epithelium filled with milky fluid; often accompanied by inflammatory / necrotic debris $\\leftarrow$ leakage of cyst fluid\nAge: occurs during / shortly after lactation; may occur in children of either gender\n\n- enlarging painless mass; thick inspissated milky fluid (colostrum)\n\nLocation: retroareolar area; uni- / bilateral\n$\\checkmark$ large radiopaque lesion of water density (1st phase)\n$\\checkmark$ smaller lesion of mixed density + SPECIFIC fat-water level with horizontal beam (2nd phase)\n$\\checkmark$ pseudohamartoma $=$ NO physical separation of fat + water $\\leftarrow$ high viscosity of milk\n$\\checkmark$ pseudolipoma $=$ small radiolucent lesion resembling lipoma\n$\\checkmark \\pm$ fluid-calcium level\nUS:\n$\\checkmark$ heterogeneous complex mass / cyst with a mixture of low + high internal echogenicity $\\leftarrow$ hypoechoic water component + hyperechoic fat component\n$\\checkmark$ hyperechoic-hypoechoic fat-fluid level $\\leftarrow$ fresh milk\n$\\checkmark$ well-defined solid-appearing mass with posterior acoustic enhancement + highly echogenic material\nMR:\n$\\checkmark$ enhancement of wall + septations\n$C x:$ infection (relatively common)\n$D x:$ diagnostic + therapeutic aspiration of milky fluid",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 861,
            "markdown": "# GIGANTOMASTIA \n\n$=$ very rare condition characterized by massive enlargement of both breasts\nIncidence: $1 \\div 100,000$ pregnancies\nEtiology: ? abnormal response to hormonal stimulation during pregnancy\n\n- dramatic growth of breasts up to $4-6 \\mathrm{~kg}$ per breast $\\rightarrow$ dyspnea\n$\\sqrt{ }$ radiologic studies NOT required\n$C x$ : tissue necrosis, ulceration, infection, hemorrhage\n$R x$ : bromocriptine administration; surgical intervention (reduction mammoplasty / simple mastectomy with posterior reconstruction) if disorder progresses\n\n\n## GYNECOMASTIA\n\n$=$ benign usually reversible excessive development of male breast\n$\\diamond$ NOT a risk factor for development of breast cancer!\n$\\diamond$ Most common disease in males\nCause:\n(1) Hormonal stimulation by excess estrogens or decreased androgens\n(a) neonate: influence from maternal estrogens crossing placenta\n(b) puberty: high estradiol levels\n\nPrevalence: in up to $60-75 \\%$ of healthy adolescents\nAge: 1 year after onset of puberty (13-14 years)\nPrognosis: subsides within 1-2 years\n(c) senescence: decline in serum testosterone levels of elderly\n(d) hypogonadism (Klinefelter syndrome, anorchism, acquired testicular failure (eg, testicular neoplasm), pituitary hormone deficiency\n(2) Other hormonal disorders obesity (increased conversion of testosterone to estrogen), hyperthyroidism\n(3) Neoplasm: hepatoma (with estrogen production), feminizing adrenocortical tumor, gonadotropin-secreting tumor (hepatoblastoma, fibrolamellar carcinoma, choriocarcinoma), pituitary tumor (prolactinoma), estrogen-producing testicular tumor (Sertoli / Leydig cell tumor), hyperthyroidism, testicular feminization syndrome, neurofibromatosis I\n(4) Systemic disorders\nadvanced alcoholic cirrhosis, hemodialysis in chronic renal failure, chronic pulmonary disease (emphysema, TB), malnutrition",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 862,
            "markdown": "| Gynecomastia versus Male Breast Cancer |  |  |\n| :-- | :-- | :-- |\n| Feature | Gynecomastia | Breast Cancer |\n| Age | peripubertal $+>50$ years | $>60$ years |\n| Clinical | soft tender; mobile mass | soft / firm nontender / <br> nonmobile mass |\n| Site | central | eccentric |\n| Location | (commonly) bilateral | (usually) unilateral |\n| Mammo | fan- / flame-shaped <br> density | discrete mass, <br> calcifications, skin <br> thickening, nipple <br> retraction, axillary <br> adenopathy |\n\n(5) Drug-induced\nmarijuana, anabolic steroids, corticosteroids, leuprolide acetate (Lupron Depot ${ }^{\\circledR}$ ), estrogen treatment for prostate cancer, thiazide diuretics, cimetidine, omeprazole, digitalis, spironolactone, reserpine, isoniazid, ergotamine, diazepam, tricyclic antidepressants\n(6) Idiopathic\nmnemonic: CODES\nCirrhosis\nObesity\nDigitalis\nEstrogen\nSpironolactone\nFrequency: $85 \\%$ of all male breast masses\nAge: neonatal period; adolescent boys ( $40 \\%$ ); men $>50$ years ( $32 \\%$ )\nHisto: hyperplasia ( $=$ increased number) of ducts, proliferation of duct epithelium, periductal edema, fibroplastic stroma, adipose tissue\n\n- breast enlargement\n- (usually) uni- (less common) bilateral breast tenderness, subjective burning sensation\n- palpable firm nodules $>2 \\mathrm{~cm}$ in subareolar region\n\nLocation: bilateral (63\\%), left-sided (27\\%), right-sided (10\\%)\nSite: concentric to the nipple-areola complex\nPattern:\nGynecomastia has 3 radiographic patterns: nodular, dendritic, diffuse, which reflect the underlying pathologic changes.\n(a) nodular gynecomastia: in early florid phase\n\n- symptoms for less than 1 year\n\nHisto: hyperplasia of intraductal epithelium + periductal inflammation + stromal edema\n$\\checkmark$ hypoechoic subareolar nodule of disk / fan shape $\\pm$ hypervascularity\n$\\checkmark$ indistinct borders\nPrognosis: reversible if stimulus eliminated\n(b) dendritic gynecomastia: during quiescent fibrotic phase\n\n- symptoms for more than 1 year\n\nHisto: fibrous gynecomastia with more hyalinized fibrous stroma + dilated ducts",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 863,
            "markdown": "$\\sqrt{ }$ flame-shaped subareolar density with linear projections interdigitating into deeper adipose tissue\n$\\sqrt{ }$ fingerlike projections extending into retroareolar breast\nPrognosis: irreversible $\\leftarrow$ fibrosis\n(c) diffuse glandular gynecomastia\n\n- often $2^{\\circ}$ to exposure to high-dose exogenous estrogen\n$\\checkmark$ heterogeneously dense breasts\n$\\checkmark$ combination of nodular + dendritic gynecomastia\nUS:\n$\\checkmark$ hypoechoic echotexture\n$\\checkmark$ absence of posterior acoustic enhancement\n$\\checkmark$ mild prominence of subareolar ducts in nodular / poorly defined / flame-shaped distribution (focal type)\n$\\checkmark$ homogeneously dense breast (diffuse type)\nMR:\n$\\checkmark$ hypointense retromamillary area\n$\\checkmark$ no / slight contrast enhancement\n$R x$ : surgical removal; discontinuation of offending drug\n$D D x$ : pseudogynecomastia (= fatty proliferation without glandular elements in obese males); breast cancer (hard / firm to palpation, usually unilateral, frequently not central to nipple-areola complex)\n\n\n# HAMARTOMA OF BREAST \n\n$=$ FIBROADENOLIPOMA $=$ LIPOFIBROADENOMA $=$ ADENOLIPOMA\nPrevalence: $2-16 \\div 10,000$ mammograms\nMean age: 45 (range, 27-88) years\nHisto: normal / dysplastic mammary tissue composed of dense fibrous tissue + variable amount of fat, delineated from surrounding tissue without a true capsule\n\n- soft, often nonpalpable ( $60 \\%$ )\n\nLocation: retroareolar ( $30 \\%$ ), upper outer quadrant ( $35 \\%$ )\n$\\checkmark$ round / ovoid well-circumscribed mass usually $>3 \\mathrm{~cm}$\n$\\checkmark$ mixed density with mottled center ( $2^{\\circ}$ to fat) = \"slice of sausage\" pattern\n$\\checkmark$ thin smooth pseudocapsule ( $=$ thin layer of surrounding fibrous tissue)\n$\\checkmark$ \"halo\" sign = peripheral radiolucent zone $\\leftarrow$ compression of surrounding tissue\n$\\checkmark$ may contain calcifications\nMR:\n) T1WI:\n$\\checkmark$ well-circumscribed round / oval / lobulated lesion with pseudocapsular demarcation:\n$\\checkmark$ intermediate intensity for parenchymal component\n$\\checkmark$ high intensity for lipomatous component\n$\\checkmark$ low intensity for cystic component\n) enhanced T1WI:\n$\\checkmark$ no / strong enhancement in parenchymal component with continuous postinitial increase (dependent on vascularization)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 864,
            "markdown": "> T2WI:\n$\\sqrt{ }$ intermediate intensity for parenchymal + lipomatous components\n$\\sqrt{ }$ high intensity for cystic component\n$D D x$ : liposarcoma, Cowden disease\n\n# HEMANGIOMA OF BREAST \n\n$=$ rare tumor in breast\nIncidence: up to $11 \\%$ at autopsies\nHisto: dilated endothelium-lined vascular channels filled with erythrocytes; negative for Sphase kinase-associated protein 2; low value for Ki-67\nClassification: capillary / cavernous\n\n- may be palpable\n\nLocation: within superficial tissue; parallel to chest wall\n$\\sqrt{ }$ circumscribed oval / macrolobulated mass $\\pm$ calcifications\nUS:\n$\\sqrt{ }$ well-defined hypoechoic / ill-defined hyperechoic mass (DDx: fibroadenoma; complex cyst)\nMR:\n$\\sqrt{ }$ ovoid mass with intermediate SI on T1WI (similar to fibroglandular tissue) $\\pm$ peripheral areas of $\\uparrow$ signal $\\leftarrow$ fat\n$\\sqrt{ }$ hyperintense on T2WI $\\leftarrow$ cavernous / cystic spaces with slow-flowing blood\n$\\sqrt{ }$ low-signal-intensity foci $\\leftarrow$ calcification / flow void / fibrosis / thrombosis\n$\\sqrt{ }$ early diffuse enhancement (DDx: angiosarcoma)\n$\\sqrt{ }$ delayed central fill-in enhancement\nClue: excessive bleeding during core biopsy\n$D D x$ : low-grade angiosarcoma (skin discoloration, large palpable lesion, positive for S-phase kinase-associated protein 2, value for Ki-67 > 175 on pathology)\n\n## HEMATOMA OF BREAST\n\n$=$ area of localized hemorrhage\nCause: (1) Surgery / biopsy (most common)\n(2) Blunt trauma\n(3) Coagulopathy: leukemia, thrombocytopenia\n(4) Anticoagulant therapy\n$\\sqrt{ }$ well-defined ovoid mass (= hemorrhagic cyst)\n$\\sqrt{ }$ ill-defined mass with diffuse increased density $\\leftarrow$ edema + hemorrhage)\n$\\sqrt{ }$ adjacent skin thickening / prominence of reticular structures\n$\\sqrt{ }$ regression within several weeks leaving\n(a) no trace\n(b) architectural distortion\n(c) incomplete resolution\n$\\sqrt{ }$ calcifications (occasionally)\nUS:\n$\\sqrt{ }$ complex hypoechoic mass with internal echoes dependent on age of hematoma:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 865,
            "markdown": "$\\sqrt{ }$ hyperechoic (in acute stage + occasionally before resolution)\n$\\sqrt{ }$ hypoechoic to anechoic (= hematoma progression)\nMR:\n) T1WI:\n$\\sqrt{ }$ homogeneous high signal $\\pm$ sedimentation (fresh)\n$\\sqrt{ }$ low SI + peripheral ring of high signal (deoxyhemoglobin of subacute hematoma)\n> enhanced T1WI:\n$\\sqrt{ }$ no uptake within hematoma\n$\\sqrt{ }$ moderate diffuse reactive enhancement surrounding hematoma + continuous postinitial increase\n) T2WI:\n$\\sqrt{ }$ homogeneous low signal intensity (fresh)\n$\\sqrt{ }$ low SI + peripheral ring of low SI\n$D x:$ resolution on short-term follow-up; biopsy\n\n# JUVENILE PAPILLOMATOSIS \n\n$=$ distinctive rare benign clinical-pathologic entity that characteristically involves young patients\nFrequency: low but increasing\nPath: $1-8 \\mathrm{~cm}$ tumor composed of many aggregated cysts of $<2 \\mathrm{~cm}$ with interspersed dense stroma (\"swiss cheese disease\"); calcifications common\nHisto: multiple macrocysts lined by flat duct epithelium / epithelium with apocrine metaplasia, sclerosing adenosis, ductectasia; marked papillary hyperplasia of duct epithelium with often extreme atypia\nMean age: 23 (range, 12-48) years\n\n- localized palpable firm tumor; no nipple discharge\n- family history of breast cancer in $28-58 \\%$ (affected first-degree relative in $8 \\%$; in one / more relatives in $28-53 \\%$ )\n$\\sqrt{ }$ usually negative mammogram / asymmetric density\n$\\sqrt{ } \\pm$ microcalcifications\n$\\sqrt{ }$ marked enhancement with benign enhancement profile on MR\nUS:\n$\\sqrt{ }$ ill-defined hypoechoic masses filled with multiple cysts of variable size clearly demarcated from surrounding normal parenchyma\nPrognosis: development of synchronous (4\\%) / metachronous (5-15\\%) breast cancer after 8-9 years\nRecommendation: follow-up of female relatives $\\leftarrow$ development of carcinomas in nearly $50 \\%$\n$D x:$ may be suspected with core biopsy\n$R x$ : complete surgical excision requiring negative margins\n$D D x$ : fibroadenoma\n\n\n## LACTATING ADENOMA\n\n$=$ newly discovered painless benign breast mass during pregnancy / lactation\nEtiology: ?",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 866,
            "markdown": "(a) adenomatous / lactational transformation of preexisting fibroadenoma / tubular adenoma / lobular hyperplasia\n(b) de novo neoplasm unique to pregnancy\n\nPath: well-circumscribed yellow spherical mass with lobulated surface + rubbery firm texture and without capsule\nHisto: pure adenoma composed of secretory lobules lined by granular and foamy to vacuolated cytoplasm separated by scant stromal components of connective tissue\n\n- firm rubbery smooth slightly lobulated freely movable mass\n- may enlarge rapidly during first 2 trimesters\n- usually painless unless infarction has occurred\n\nSize: typically $<3 \\mathrm{~cm}$\nMammo (insensitive $\\leftarrow$ increased breast density during pregnancy):\n$\\sqrt{ }$ mass of equal / slightly decreased density = fat content of milk $\\leftarrow$ lactational hyperplasia\n$\\sqrt{ }$ punctate calcifications may be present\nUS:\n$\\sqrt{ }$ usually benign features:\n$\\sqrt{ }$ homogeneously hypoechoic / isoechoic mass\n$\\sqrt{ }$ smooth lobulations + well-defined margins\n$\\sqrt{ }$ long axis parallel to chest wall\n$\\sqrt{ }$ posterior acoustic enhancement\n$\\sqrt{ }$ occasionally malignant features:\n$\\sqrt{ }$ irregular angulated margins\n$\\sqrt{ }$ posterior acoustic shadowing\n$\\sqrt{ }$ fibrous septa may be present\n$\\sqrt{ } \\pm$ small central hyperechoic foci (= fat within milk)\n$\\sqrt{ }$ increased vascularity by Doppler\n$D x$ : biopsy\n$C x$ : infarction $\\rightarrow$ painful breast mass\nPrognosis: regression after completion of breast feeding\n$R x$ : excision if without spontaneous resolution / with pain\n$D D x$ : fibroadenoma; complex cyst; tubular adenoma (rare, typically in young woman); galactocele (after cessation of breast feeding); phyllodes tumor; lymphoma; breast carcinoma $(1 \\div 1,300-1 \\div 6,200$ pregnancies)\n\n# LIPOMA OF BREAST \n\n= usually solitary unilateral asymptomatic slow-growing lesion\n$\\diamond$ Most common benign tumor of male breast\nPrevalence: extremely rare\nHisto: encapsulated tumor containing mature fat cells\nMean age: 45 years + post menopause\n\n- clinically often occult; soft, freely movable, well delineated\n$\\sqrt{ }$ usually $>2 \\mathrm{~cm}$\n$\\sqrt{ }$ radiolucent tumor easily seen in dense breast; almost invisible in fatty breast\n$\\sqrt{ }$ discrete thin radiopaque line (= capsule), seen in most of its circumference",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 867,
            "markdown": "$\\sqrt{ }$ displacement of adjacent breast parenchyma\n$\\sqrt{ }$ calcification with fat necrosis (extremely rare)\n$\\sqrt{ }$ may enlarge in response to hormonal stimulation\nUS:\n$\\sqrt{ }$ homogeneously hypo-, iso- or mildly hyperechoic lesion\n$\\sqrt{ }$ posterior acoustic enhancement possible\n$\\sqrt{ } \\pm$ encapsulated margin\n$\\sqrt{ }$ no internal / peripheral vascularity\nMR:\n) T1WI:\n$\\sqrt{ }$ well-circumscribed hyperintense lesion\n$\\sqrt{ } \\pm$ thin hypointense capsule\n$\\sqrt{ }$ no contrast enhancement\n) T2WI:\n$\\sqrt{ }$ signal intensity equivalent to subcutaneous fat\n$D D x$ : fat lobule surrounded by trabeculae / suspensory ligaments; fat necrosis\n\n# Angiolipoma of Breast \n\n$=$ rare fat-containing tumor\nFrequency: $5-17 \\%$ of all benign fatty tumors\nPath: mature adipocytes intermixed with vascular proliferation; NO malignant potential\n(a) infiltrative type\n(b) noninfiltrative type: in breast\n\nHisto: vascular lesion with cellular atypia + mitotic activity; HALLMARK of scattered microthrombi in small blood vessels\nLocation: back, neck, shoulder, rare in breast\n\n- faint skin discoloration\n$\\sqrt{ }$ solid circumscribed mass without characteristic imaging finding\n$\\sqrt{ }$ asymmetry with mixed density (= soft-tissue density interspersed with fat density)\nUS:\n$\\sqrt{ }$ iso- to hyperechoic / hypoechoic mass with internal vascularity\n$D x$ : biopsy required to make diagnosis\n$D D x$ : lipoma; fibroadenolipoma (hamartoma)\n\n\n## LYMPHOMA OF BREAST\n\n## A. PRIMARY LYMPHOMA\n\n$=$ extranodal lymphoma of the breast without prior history of lymphoma / leukemia\nPrevalence: $0.12-0.53 \\%$ of all breast malignancies; $2.2 \\%$ of all extranodal lymphomas\n\n- asymptomatic\nB. SECONDARY LYMPHOMA\n$\\diamond$ One of the most common metastatic lesion in the breast!\n- fever, pain\n\nHisto: B-cell NHL (majority), Hodgkin disease, leukemia (CLL), plasmacytoma\nAge: $50-60$ years; $\\mathrm{M}<\\mathrm{F}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 868,
            "markdown": "Location: right-sided predominance; $13 \\%$ bilateral\n$\\sqrt{ }$ well / incompletely circumscribed round / oval lobulated mass / masses\n$\\checkmark$ infiltrative with poorly defined borders\n$\\checkmark$ NO calcifications / spiculations\n$\\checkmark$ skin thickening + trabecular edema\n$\\checkmark$ bilateral axillary adenopathy in $30-50 \\%$\nUS:\n$\\checkmark$ oval / round homo- / heterogeneously hypoechoic mass(es)\n$\\checkmark$ sharply defined / poorly defined borders\n$\\checkmark$ posterior acoustic shadowing / enhancement\nPrognosis: 3.4\\% 5-year disease-free survival for all stages; $50 \\%$ remission rate with aggressive chemotherapy\nRecurrence: mostly in contralateral breast / other distant sites\n$D D x$ : circumscribed breast carcinoma, fibroadenoma, phylloides tumor, metastatic disease\n\n# Pseudolymphoma \n\n$=$ lymphoreticular lesion as an overwhelming response to trauma\n\n## MAMMARY DUCT ECTASIA\n\n$=$ PLASMA CELL MASTITIS $=$ VARICOCELE TUMOR OF BREAST $=$ MASTITIS OBLITERANS $=$ COMEDOMASTITIS $=$ PERIDUCTAL MASTITIS $=$ SECRETORY DISEASE OF BREAST\n$=$ rare aseptic inflammation of subareolar area\nPathogenesis (speculative):\n(1) Stasis of intraductal secretion $\\rightarrow$ duct dilatation + leakage of inspissated material into parenchyma $\\rightarrow$ aseptic chemical mastitis (periductal mastitis); the extravasated material is rich in fatty acids $\\rightarrow$ nontraumatic fat necrosis\n(2) Periductal inflammation $\\rightarrow$ damage to elastic lamina of duct wall $\\rightarrow$ duct dilatation\n\nHisto: ductal ectasia, heavily calcified ductal secretions; infiltration of plasma cells + giant cells + eosinophils\nMean age: 54 years; may develop in young children\n\n- often asymptomatic; bloody nipple discharge in children\n- breast pain, nipple retraction, mamillary fistula, subareolar breast mass\n\nLocation: subareolar, often bilateral + symmetric; may be unilateral + focal\n$\\checkmark$ dense triangular mass with apex toward nipple\n$\\checkmark$ duct dilatation $=$ distended ducts connecting to nipple\n$\\checkmark$ periphery blending with normal tissue\n$\\checkmark$ multiple often bilateral dense round / oval a few mm long calcifications with lucent center + polarity (= linear orientation toward subareolar area / nipple)\n(a) periductal\n$\\checkmark$ oval / elongated calcified ring around dilated ducts with very dense periphery (= surrounding deposits of fibrosis + fat necrosis)\n(b) intraductal\n$\\checkmark$ fairly uniform linear, often rod-shaped / sausage-shaped / needle-shaped calcifications of wide caliber, occasionally branching (within ducts / confined to duct walls)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 869,
            "markdown": "$\\sqrt{ }$ nipple retraction / skin thickening may occur\nSequelae: cholesterol granuloma\n$D D x:$ breast cancer\n\n# MAMMOPLASTY \n\n$=$ COSMETIC BREAST SURGERY\n\n## Augmentation Mammoplasty\n\n$\\diamond$ Most frequently performed plastic surgery in USA\nFrequency: 307,180 procedures in 2011 ( $70 \\%$ for cosmetic reasons, $30 \\%$ for reconstruction); 5,083,717 American women have breast implants (estimate for $2010)=4.9 \\%$ (census data)\n\n## Methods:\n\n1. Injection augmentation (no longer practiced): paraffin, silicone, fat from liposuction\n$C x$ : tissue necrosis resulting in dense, hard, tender breast masses; lymphadenopathy; infection; granuloma formation ( $=$ siliconoma)\n2. Implants (prepectoral / subpectoral)\n(a) spongelike masses of Ivalon ${ }^{\\circledR}$, Etheron ${ }^{\\circledR}$, Teflon ${ }^{\\circledR}$\n(b) Silicone elastomer (silastic) smooth / textured shell containing silicone oil / saline: $>100$ varieties of dimethylpolysiloxane\n> single lumen of polymerized methyl polysiloxane with smooth / textured outer silicone shell / polyurethane coating\n> double lumen with inner core of silicone + outer chamber of saline\n> \"reverse double-lumen\" = inner saline-filled lumen surrounded by silicone-filled envelope\n> triple lumen\nSilicone breast implants were FDA-approved for primary breast augmentation in 2006.\n(c) expandable implant $\\pm$ intraluminal valves $=$ saline injection into port with gradual tissue expansion for breast reconstruction\nLocation: retroglandular / subpectoral\n3. Autogenous tissue transplantation\n(for breast reconstruction) with musculocutaneous flap: transverse rectus abdominis muscle (TRAM), latissimus dorsi, tensor fasciae latae, gluteus maximus\nMammographic technique for implants:\n4. Two standard views (CC and MLO views) for most posterior breast tissue\n$\\diamond 22-83 \\%$ of fibroglandular breast tissue obscured on standard views by implant depending on size of breast + location of implant + degree of capsular contraction!\n$\\diamond$ The false-negative rate of mammography increases from $10-20 \\%$ to $41 \\%$ in patients with implants!\n5. Two Eklund ( $=$ implant displacement) views (CC and $90^{\\circ}$ LAT views) for compression views of anterior breast tissue $=$ \"push-back\" view $=$ breast tissue pulled anteriorly in front of implant while implant is pushed posteriorly + superiorly thus excluding most of the implant\n\nMammographic sensitivity for breast cancer detection: $45 \\%$ with augmentation versus $67 \\%$ without",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 870,
            "markdown": "augmentation\nMR technique for implants:\nPhysical principle: resonant frequencies of water, fat ( $\\sim 220 \\mathrm{~Hz}$ lower than water) and silicone ( $\\sim 100 \\mathrm{~Hz}$ lower than fat) differ\nMost effective sequence: inversion recovery (IR), which suppresses fat\n(a) with additional suppression of water $=$ pure depiction of silicone\n(b) with additional suppression of silicone $=$ pure depiction of saline component\n\nOrientation: axial + sagittal (2 angulations mandatory)\nCx of silicone-gel-filled implant:\nScreening MRI for asymptomatic implant rupture at 3 years after implantation followed by 2-year intervals!\n$\\diamond$ Increase of complication rate with augmentation (desire for a larger breast) $>$ reconstruction (after mastectomy) $>$ revision (subsequent surgery in 15-25\\%)\n\n1. Capsular fibrosis $(100 \\%)$\n$=$ normal host response to wall off foreign body\n$\\sqrt{ }$ low-intensity implant shell + fibrous capsule cannot be differentiated on MR\n$\\sqrt{ }$ physiologic fluid may occupy space between implant shell + fibrous capsule\n$\\sqrt{ }$ radial folds (normal) = hypointense lines emanating from the fibrous capsule-shell junction as a wrinkle\n$\\sqrt{ }$ gently undulating circumferential contour (normal)\n2. Contracture ( $12-20 \\%$ ): more frequent with retroglandular implants $\\rightarrow$ increasing with time\n\n- distortion of breast contour, hardening of breast\n- tightness, pain\n$\\sqrt{ }$ crenulated contour (US helpful)\n$\\sqrt{ }$ capsular calcifications at periphery of prosthesis\n$\\sqrt{ }$ focal bulge $=$ herniation of a locally weakened fibrous capsule\n$\\sqrt{ }$ fibrous capsule delineated by US (unleaked silicone is echolucent)\n$\\sqrt{ }$ extensive periprosthetic calcifications\nMR (low specificity):\n$\\sqrt{ }$ rounded implants with transverse diameter $<2 x$ the anteroposterior diameter\n$\\sqrt{ }$ marked thickening of fibrous capsule\n$\\sqrt{ }$ signal-free periprosthetic zone of macrocalcifications\n$\\sqrt{ }$ complete absence of radial folds\n$\\sqrt{ }$ contrast enhancement $\\leftarrow$ granulomatous inflammation\n$R x$ : not health hazard; capsulotomy (release); capsulectomy (removal of scar tissue)\n\n2. Implant migration\n\nCause: overdistension of implant pocket at surgery\n3. Rupture of prosthesis\n$=$ hole / tear in implant shell observed at surgery\nImplant failure: $11 \\%$ after 5 years, $49 \\%$ after 12 years, $95 \\%$ after 20 years\nCause: violation of elastomer shell during surgery (years 1-5); mechanical / fatigue (years 5-10)\nResult: total / partial / no collapse of shell",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 871,
            "markdown": "- change in contour / location of implant\n- flattening of implant, breast pain\n\n4. \"Gel bleed\" = silicone leaching ( $100 \\%=$ normal condition as all implants bleed)\n$=$ leakage of microscopic quantities of silicone oil through semiporous but intact barrier shell made of silicone elastomer\n$\\sqrt{ }$ silicone-equivalent signal within keyhole-shaped terminal bend of radial folds + between capsule and implant shell\n$D x:$ microscope\n5. Infection / hematoma formation\n6. Localized pain / paresthesia\nN.B.: NO association between silicone breast implants and connective tissue disease / malignancy\n\n# Intracapsular Rupture \n\n$=$ broken implant casing, which swims within silicone gel contained by intact fibrous capsule\nFrequency: $80-90 \\%$ of all ruptures\nMammo (11-23\\% sensitive, 89-98\\% specific):\n$\\checkmark$ bulging / peaking of implant contour (DDx: herniation through locally weakened capsule)\nUS (59-70\\% sensitive, 57-92\\% specific, $49 \\%$ accurate):\n$\\checkmark$ \"stepladder\" sign = series of parallel horizontal echogenic straight / curvilinear lines inside implant ( $=$ collapsed implant shell floating within silicone gel)\n$\\checkmark$ heterogeneous aggregates of low- to medium-level echogenicity ( $65 \\%$ sensitive, $57 \\%$ specific)\nN.B.: visualization of internal lumen within anechoic space in double-lumen implants can be confused on US with intracapsular rupture\nMR (81-94\\% sensitive, 93-97\\% specific, $84 \\%$ accurate):\n$\\checkmark$ multiple curvilinear low-signal-intensity lines often parallel to fibrous capsule (corresponding to collapsed prosthesis shell inside the silicone-filled fibrous capsule):\n$\\checkmark$ \"linguine\" sign = multiple hypointense wavy lines within implant (= pieces of freefloating collapsed envelope), $100 \\%$ PPV\n$\\checkmark$ in incomplete rupture \"inverted teardrop\" / \"noose\" / \"keyhole\" / \"lariat (= lasso)\" sign = loop-shaped hypointense structure contiguous with implant envelope ( $=$ small focal invagination / fold of shell with silicone on either side)\n[la reata, Spanish = lasso]\n$D D x:$ radial fold (extending from periphery perpendicular to surface directed toward center of implant)\n$\\checkmark$ \"water droplet\" / \"salad-oil\" sign = appearance of multiple droplets of fluid of extracapsular origin / saline-containing envelope within lumen of silicone implant (DDx: 1-2 droplets may be normal; after injection of saline / Betadine ${ }^{\\circledR}$ / antibiotics / steroids)\n\n## Extracapsular Rupture",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 872,
            "markdown": "$=$ extrusion + migration of silicone droplets through tear in both implant shell + fibrous capsule\nFrequency: up to $20 \\%$ of all ruptures\n\n- palpable breast masses\n\nUS:\n$\\sqrt{ }$ \"snowstorm\" / \"echogenic noise\" pattern = markedly hyperechoic nodule with welldefined anterior + indistinct echogenic noise posteriorly (= free silicone droplets mixed with breast tissue)\n$\\sqrt{ }$ highly echogenic area with acoustic shadowing\n$\\sqrt{ }$ hypoechoic masses almost indistinguishable from cysts + usually surrounded by echogenic noise (= large to medium-sized collections of free silicone) with low-level internal echoes\nMR:\n$\\sqrt{ }$ discrete hypointense foci on fat-suppressed T1WI + hyperintense signal on watersuppressed T2WI in continuity with / separate from implant\n$\\sqrt{ }$ \"linguine\" sign = sign of associated intracapsular rupture\nMammography:\n$\\sqrt{ }$ lobular / spherical dense area of opacities adjacent to / separate from silicone implant\n$\\sqrt{ }$ rim calcifications\n\n# EXTRACAPSULAR SPREAD OF SILICONE \n\nSource: gel bleed, implant rupture (11-23\\%) more common with thinner shell + older implants\n\n- silicone lymphadenopathy\n- paresthesia of arm $\\leftarrow$ nerve impingement $\\leftarrow$ fibrosis surrounding silicone migrated to axilla / brachial plexus\n- silicone nipple discharge (rare)\n- migration to arm ( $\\rightarrow$ constrictive neuropathy of radial nerve), subcutaneous tissue of lower abdominal wall, inguinal canal\n$\\sqrt{ }$ migration to ipsilateral chest wall + axillary nodes\n$\\sqrt{ }$ silicone droplets in breast in $11-23 \\%$ ( $97 \\%$ specific, $5 \\%$ sensitive)\n\n\n## Siliconoma $=$ Silicone Granuloma\n\n$=$ collection of silicone within breast parenchyma surrounded by a foreign-body granulomatous reaction\nHisto: granuloma formation + fibrosis\nLocation: typically at edge of breast implant\n$\\sqrt{ }$ hyperechoic mass with fine internal echoes\n$\\sqrt{ }$ \"dirty\" posterior acoustic shadowing / \"snowstorm\" pattern of acoustic scattering\n\n## Reduction Mammoplasty\n\n$=$ removal of excess fat + glandular tissue + skin\nPurpose:\n(1) Aesthetics to achieve desired breast size",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 873,
            "markdown": "(2) Relief of back pain\n(3) Restore chest symmetry after contralateral lumpectomy\n$\\checkmark$ swirled architectural distortion (in inferior breast best seen on mediolateral view)\n$\\checkmark$ postsurgical distortion\n$\\checkmark$ residual isolated islands of breast tissue\n$\\checkmark$ fat necrosis\n$\\checkmark$ dystrophic calcifications\n$\\checkmark$ asymmetric tissue oriented in nonanatomic distribution\n\n# MASTITIS \n\n## Acute Mastitis\n\n$=$ infection of the breast with primary ascending canalicular + secondary interstitial spread\nCause: mammary duct obstruction / ectasia; cellulitis; immunocompromised state; nipple injury\nPathogen: S. aureus (most commonly)\nHisto: acute + chronic inflammatory infiltration, fibrosis, occasional multinucleated giant cells\nAge: any; most commonly in lactating woman\n\n- tender swollen erythematous breast (DDx: inflammatory ca.)\n- enlarged painful axillary lymph nodes\n- fever (5-12-47\\%), elevated ESR, leukocytosis\n$\\checkmark$ diffuse increased density\n$\\checkmark$ diffuse skin thickening\n$\\checkmark$ swelling of breast\n$\\checkmark$ enlarged axillary lymph nodes\n$\\checkmark$ rapid resolution under antibiotic therapy\nUS:\n$\\checkmark$ increased echogenicity in fat lobules\n$\\checkmark$ hypoechoic thick-walled complex multiloculated collection + acoustic enhancement $=$ abscess\n$\\checkmark$ increased peripheral color Doppler flow\nMR:\n$\\checkmark$ circumscribed area of low signal intensity on T1WI\n$\\checkmark$ strong initial enhancement + postinitial plateau\nCx: abscess, fistula\n\n\n## Puerperal Mastitis (14-59\\%)\n\n$=$ LACTATIONAL MASTITIS\n$=$ usually interstitial infection during lactational period\n(a) through infected nipple crack / skin abrasion\n(b) hematogenous\n(c) ascending via ducts $=$ galactophoritis\n\nPrevalence: $1-24 \\%$ of breast-feeding women\nAt risk: primipara ( $65 \\%$ of cases)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 874,
            "markdown": "Risk factor: milk stasis $=$ excellent culture medium\nOrganism: S. aureus $>$ Streptococcus (from nose + throat of nursing infant)\n$\\sqrt{ }$ imaging NOT required\n$\\sqrt{ }$ skin and trabecular thickening from breast edema\n$C x$ : abscess (in 5-11\\%) in first 12 weeks after birth / at time of weaning\n$R x$ : continue breast feeding under conservative therapy to disengorge ducts (unless contraindicated by type of antibiotic!); amoxicillin-clavulanate / cloxacillin; incision + drainage\n\n# Nonpuerperal Mastitis (41-86\\%) \n\n$=$ outside breast-feeding period\nOrganism: Streptococcus, E. coli\n\n1. Infected cyst\n2. Purulent mastitis with abscess formation\n3. Plasma cell mastitis\n4. Nonspecific mastitis\n\n## Central Nonpuerperal Mastitis\n\n$=$ PERIAREOLAR MASTITIS (most common)\nCause: complication of periductal mastitis\nPathophysiology:\nsquamous metaplasia of cuboidal epithelium $\\rightarrow$ keratin plugs $\\rightarrow$ central acute\ninflammatory infiltrate $\\rightarrow$ obstruction of lactiferous ducts $\\rightarrow$ secondary infection $\\rightarrow$\ncutaneous fistula\nAt risk: smoker\nPrognosis: recurrence in $25-40 \\%$\n\n## Peripheral Nonpuerperal Mastitis\n\nAt risk: diabetes, rheumatoid arthritis, steroid medication, recent breast intervention\n\n## Granulomatous Mastitis\n\n$=$ very rare chronic inflammatory process\nMedian age: 41 years (most commonly during post partum / post lactation period)\nHisto: noncaseating nonvasculitic granulomatous inflammatory reaction centered on lobules under exclusion of:\n\nTB, fungal infection, sarcoidosis, Wegener granulomatosis, granulomatous reaction associated with carcinomas\nOrganism: Corynebacterium (in up to 75\\%)\n\n- acute onset of a distinct firm / hard tender painful mass sparing subareolar region; nipple retraction\n$\\sqrt{ }$ focal asymmetric density (most frequently)\n$\\sqrt{ }$ dense breast tissue / mass with benign / malignant features\n$\\sqrt{ }$ reactive enlargement of axillary nodes (in up to $15 \\%$ )\nUS:\n$\\sqrt{ }$ multiple clustered contiguous tubular hypoechoic lesions\n$\\sqrt{ } \\pm$ large hypoechoic mass",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 875,
            "markdown": "Prognosis: spontaneous healing over time; corticotherapy\n\n# METASTASIS TO BREAST \n\nPrevalence: $0.5-3 \\%$ of all malignant breast tumors; $5 \\%$ of all male breast cancers\nMean age: 43 years\nIntramammary primary:\ncommonly located in contralateral breast\nExtramammary primary:\nmalignant melanoma $>\\mathrm{NHL}>$ lung cancer (small- and large-cell types) $>$ sarcoma $>$\ncarcinoma of ovary, stomach, kidney, prostate\n$\\diamond$ In up to $40 \\%$ no known history of primary cancer!\nin children: rhabdomyosarcoma, acute leukemia, NHL\nLocation: subcutaneous fat rather than glandular tissue; bilaterality in up to $30 \\%$\n$\\checkmark$ round homogeneous mass with smooth margin\n$\\checkmark$ solitary mass, esp. in upper outer quadrant\n$\\checkmark$ usually multiple masses\n$\\checkmark$ skin adherence $(25 \\%) \\pm$ skin thickening\n$\\checkmark$ axillary node involvement $(40 \\%)$\n$\\checkmark$ No calcifications\nUS:\n$\\checkmark$ hypervascularity in a predominantly echogenic mass (in $64 \\%$ of breast lymphoma, in $99 \\%$ of melanoma)\n\n## Hemorrhagic Metastasis to Breast\n\n1. Malignant melanoma\n2. RCC\n3. Choriocarcinoma\n4. Kaposi sarcoma\n\n## MONDOR DISEASE\n\n$=$ rare usually self-limited thrombophlebitis of subcutaneous veins (mostly thoracoepigastric v.) of the breast / anterior chest wall\nCause: unknown; trauma, physical exertion, surgery, breast cancer, inflammation, dehydration\nMay be associated with: carcinoma (in up to 12\\%), DVT\n\n- painful tender palpable cordlike structure\n- skin dimpling, erythema\n\nLocation: usually lateral aspect of breast\n$\\checkmark$ linear ropelike tubular superficial structure $\\pm$ beading\n$\\checkmark$ rarely calcification of vein\nUS:\n$\\checkmark$ superficial hypoechoic tubular structure containing low-level internal echoes (= thrombus)\nPrognosis: resolves spontaneously in 2-4 weeks\n\n## MYOFIBROBLASTOMA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 876,
            "markdown": "$=$ SPINDLE CELL TUMOR OF BREAST $=$ SPINDLE CELL LIPOMA $=$ FIBROMA $=$ MYOGENIC STROMAL TUMOR $=$ SOLITARY FIBROUS TUMOR $=$ ATYPICAL VARIANT OF LEIOMYOMA\n$=$ rare benign stromal tumor\nAge: $6^{\\text {th }}-7^{\\text {th }}$ decade\nMay be associated with: gynecomastia\n\n- slow growing unilateral painless mobile mass\n\nPath: bands of hyalinized collagen separating short fascicles of bland spindle cell with pseudoencapsulation of peripherally compressed fibrous tissue; positive for musclespecific actin $+\\alpha$-smooth muscle actin + desmin\nSize: $1-4 \\mathrm{~cm}$\n$\\sqrt{ }$ well-defined round / ovoid dense mass\nUS:\n$\\sqrt{ }$ solid well-circumscribed homogeneously hypoechoic mass\n$\\checkmark$ occasionally ill-defined with posterior acoustic shadowing\nMR:\n$\\checkmark$ homogeneous enhancement (similar to fibroadenoma) with nonenhancing internal septations on T2WI\n\n# NIPPLE ADENOMA \n\n$=$ FLORID PAPILLOMATOSIS $=$ EROSIVE ADENOMATOSIS $=$ SUPERFICIAL PAPILLARY ADENOMATOSIS\n$=$ uncommon variant of intraductal papilloma involving nipple\n\n- bloody discharge, crusting, nodularity\n- tenderness, swelling, erythema (resembling Paget disease)\n$R x:$ complete local excision\n\n\n## PAPILLOMA OF BREAST\n\n$=$ proliferation of ductal epithelial tissue on a fibrovascular stalk within a duct\nPrevalence: rare; $1-2 \\%$ of all benign tumors\nAge: 30-77 years (juvenile papillomatosis $=20-26$ years); may occur in men\nHisto: hyperplastic proliferation of ductal epithelium; lesion may be pedunculated / broadbased; connective tissue stalk covered by epithelial cells proliferating in the form of apocrine metaplasia / solid hyperplasia $\\rightarrow$ may cause duct obstruction + distension to form an intracystic papilloma; immunohistochemical marker p63 for myoepithelial cell layer present in a complete layer\nMammo:\n$\\checkmark$ negative mammogram / intraductal nodules in subareolar area\n$\\checkmark$ may be associated with coarse microcalcifications\nGalactography:\n$\\checkmark$ dilated duct with distorting intraluminal filling defect / complete duct obstruction\nUS:\n$\\checkmark$ solid round / oval / slightly lobulated well-circumscribed hypoechoic mass in dilated duct\n$\\checkmark \\pm$ hypervascularity on color Doppler\nMR:\n> T1WI:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 877,
            "markdown": "$\\sqrt{ }$ round / oval tumor with signal isointense to parenchyma (usually not detectable on precontrast T1WI)\n$\\sqrt{ }$ homo- / heterogeneous contrast enhancement stronger than surrounding parenchyma\n$\\sqrt{ }$ continuous postinitial increase / occasionally plateau\n$C x:$ invasive papillary carcinoma / DCIS (lesion $>1 \\mathrm{~cm}$, location $>3 \\mathrm{~cm}$ from nipple, patient age $>50$ years)\n$R x:$ surgical excision (because of low risk of upgrade to DCIS)\nPrognosis: in $24 \\%$ recurrence after surgical treatment\n\n# Central Solitary Papilloma \n\n$=$ NOT premalignant\nLocation: major subareolar duct; bilateral in $25 \\%$\n\n- asymptomatic\n- spontaneous usually bloody / serous ( $9-48 \\%$ ) / clear nipple discharge (52-88-100\\%):\n\n\n## - Most common cause of serous / serosanguinous nipple discharge!\n\n- \"trigger point\" = nipple discharge produced upon compression of area with papilloma\n- intermittent mass disappearing with discharge\n$\\checkmark$ asymmetrically dilated single duct\n\n\n## Peripheral Multiple Papillomas\n\n$=$ INTRADUCTAL PAPILLOMATOSIS\nAge: perimenopausal\nLocation: within terminal ductal lobular unit; bilateral in up to $14 \\%$\nIn 10-38\\% associated with:\natypical ductal hyperplasia, lobular carcinoma in situ, DCIS (papillary + cribriform intraductal cancers), invasive cancer, sclerosing adenosis, radial scar\n$\\checkmark$ segmental distribution with dilated duct extending from beneath the nipple (20\\%)\n\n## PHYLLODES TUMOR\n\n[ phyllon, Greek = leaf $\\rightarrow$ phyllodes $=$ leaflike $]$\nPrevalence: $1 \\div 6,300$ examinations; $0.3-1.5 \\%$ of all breast neoplasms; $3 \\%$ of all fibroadenomas\nMean age: 45 years ( $5^{\\text {th }}-6^{\\text {th }}$ decade); occasionally in women $<20$ years of age\nHisto: similar to fibroadenoma but with increased cellularity + pleomorphism of its stromal elements (wide variations in size, shape, differentiation); fibroepithelial tumor with leaflike growth pattern $=$ branching projections of tissue within cleftlike spaces lined with layers of myoepithelial and ductal epithelium; cavernous structures contain mucus, cystic degeneration + hemorrhage\nSubtypes: (a) benign (b) borderline (c) malignant\n\n- sense of fullness\n- rapidly enlarging breast mass; periods of remission\n- huge, firm rubbery, mobile, discrete, lobulated, smooth mass\n- thinning + livid discoloration of skin, wide veins, shining skin $\\rightarrow$ skin ulceration / invasion of chest wall\nSize: $1-20 \\mathrm{~cm}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 878,
            "markdown": "Mammo:\n$\\checkmark$ large homogeneous noncalcified isodense mass with smooth polylobulated margins mimicking fibroadenoma\n$\\checkmark$ rapid growth to large size ( $>6-10 \\mathrm{~cm}$ ), may fill entire breast\n$\\checkmark$ occasional \"halo\" sign $\\leftarrow$ compression of surrounding tissue\nUS:\n$\\checkmark$ round / lobulated hypoechoic mass with smooth margins\n$\\checkmark$ heterogeneous internal echoes without acoustic shadowing\n$\\checkmark$ anechoic fluid-filled clefts in large tumors (DDx from fibroadenoma)\nMR:\n) T1WI:\n$\\checkmark$ hypo- / isointense to parenchyma\n$\\checkmark$ hypointense regions of cystic / necrotic changes (occasionally)\n$>$ enhanced T1WI:\n$\\checkmark$ strong initial uptake in solid tumor component\n$\\checkmark$ continuous increase / plateau in postinitial phase\n$\\checkmark$ increasing demarcation of nonenhancing cystic components (mass-in-mass morphology)\n$>$ T2WI:\n$\\checkmark$ iso - to hyperintense to breast parenchyma\n$\\checkmark$ hyperintense regions of cystic / necrotic changes (occasionally) = \"slit-like\" cystic channels\n$D x$ : excisional biopsy $\\leftarrow$ histopathology of core biopsy may mimic hypercellular fibroadenoma\n$C x$ : malignant degeneration $(25 \\%)$\n$D D x$ : fibroadenoma (uncommon in postmenopausal woman)\n\n# Benign Phyllodes Tumor \n\n$=$ FIBROADENOMA PHYLLODES $=$ GIANT FIBROADENOMA\n$=$ benign giant form of intracanalicular fibroadenoma\nHisto: low mitotic activity ( $0-4$ mitoses / 10 HPF)\n$C x$ : in $5-10 \\%$ degeneration into malignant fibrous histiocytoma / fibro- / lipo- / leiomyo- /\nchondro- / osteosarcoma with local invasion + hematogenous metastases to lung, pleura, bone (axillary metastases quite rare)\nPrognosis: $15-20 \\%$ recurrence rate after excision\n\n## Malignant Phyllodes Tumor (16-30\\%)\n\n$=$ PHYLLODES SARCOMA $=$ CYSTOSARCOMA PHYLLODES $=$ ADENOSARCOMA\n$=$ rare fibroepithelial neoplasia\nHisto: high mitotic activity ( $>5$ mitoses / 10 HPF ) in a predominantly sarcomatous differentiation (angio-, chondro-, myo-, osteo-, liposarcoma); rare transformation into metaplastic breast cancer (squamous cell carcinoma in $1 \\%$ )\n$\\checkmark \\pm$ coarse / eggshell calcifications\n$\\checkmark$ type III washout pattern in solid tumor portion\nPrognosis: hematogenous spread in $20 \\%$ (lung $>$ bone $>$ heart $>$ liver) as late as 12 years after initial Rx; $20 \\%$ local relapse rate; $65 \\% 5$-year survival; death in $30 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 879,
            "markdown": "Rx: wide excision (without axillary node dissection); radiation + chemotherapy not useful\n\n# PSEUDOANGIOMATOUS STROMAL HYPERPLASIA \n\n$=$ PASH $=$ benign hormonally stimulated mesenchymal myofibroblastic proliferation of mammary stroma\nSpectrum: from focal incidental findings to clinically and mammographically evident breast masses\nHisto: (a) incidental focal microscopic finding in $23 \\%$ of all breast specimens\n(b) tumoral form (rare)\n\n## Tumoral Form of PASH\n\nAge: $\\quad 4^{\\text {th }}-5^{\\text {th }}$ decade (range, 14-67 years); frequently in pre- and perimenopausal women Associated with: gynecomastia in men (in 20-47\\%); immunosuppressive condition (eg, HIV); neurofibromatosis type 1\nPath: well-defined mass with pseudocapsule\nHisto: proliferating myofibroblasts creating slit-like anastomosing spaces positive for vimentin + CD34 (+ muscle actin + desmin); ER + PR positive in $95 \\%$; similar in appearance to low-grade angiosarcoma\nPathogenesis: high density of progesterone receptors\n\n- single palpable movable painless firm rubbery mass\n- may grow rapidly\n\nMean size: 4.2 (range, $1-12$ ) cm\nMammo:\n$\\checkmark$ dense well / partially circumscribed noncalcified mass\n$\\checkmark$ rarely indistinct / spiculated border\nUS:\n$\\checkmark$ hypoechoic solid ovoid mass with long axis parallel to chest wall:\n$\\checkmark$ slightly heterogeneous texture $\\pm$ echogenic component\n$\\checkmark$ rarely predominantly hyperechoic\n$\\checkmark \\pm$ circumscribed margins\n$\\checkmark \\pm$ small cystic component\n$\\checkmark$ usually no posterior phenomena\nMR:\n$\\checkmark$ commonly persistent (type 1) or less frequently plateau (type 2) / washout (type 3) enhancement\nRx: excision for symptomatic / growing mass\nPrognosis: recurrence after excisional biopsy (in 5-18\\%) requires $1-2 \\mathrm{~cm}$ excisional margins; concurrent DCIS / invasive carcinoma in surrounding tissue (in 4-10\\%)\n$D D x$ : fibroadenoma; phyllodes tumor; angiosarcoma (slitlike spaces with atypical cell nuclei containing erythrocytes, positive for CD31 + factor VIII)\n\n## RADIAL SCAR\n\n$=$ SCLEROSING DUCT HYPERPLASIA = INDURATIVE MASTOPATHY = FOCAL FIBROUS DISEASE = BENIGN SCLEROSING DUCTAL PROLIFERATION = INFILTRATING EPITHELIOSIS = NONENCAPSULATED",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 880,
            "markdown": "SCLEROSING LESION\n$=$ benign proliferative breast lesion (malignant potential is controversial) unrelated to prior surgery / trauma\nPrevalence: $0.1-2.0 \\div 1,000$ screening mammograms; in $2-16 \\%$ of mastectomy specimens\nCause: ? localized inflammatory reaction, ? chronic ischemia with slow infarction\nPath: \"scar\" = sclerotic center composed of acellular connective tissue (= fibrosis) and elastin deposits (= elastosis); entrapped ductules with intact myoepithelial layer in sclerotic core; corona of distorted ducts + lobules composed of benign proliferations (sclerosing adenosis, ductal hyperplasia, cyst formation, papillomatosis)\nIn up to $50 \\%$ associated with:\ntubular carcinoma, comedo carcinoma, invasive lobular carcinoma + contralateral breast cancer\n$\\diamond$ Avoid frozen section, fine-needle aspiration, core needle biopsy (controversial)!\n\n- rarely palpable\n$\\sqrt{ }$ mean diameter of 0.33 cm (range, $0.1-0.6 \\mathrm{~cm}$ )\n$\\checkmark$ typically no central mass (BUT: irregular noncalcified mass often with architectural distortion)\n$\\checkmark$ variable appearance in different projections (= radial scars are typically planar in configuration)\n$\\checkmark$ oval / circular translucent areas at center\n$\\checkmark$ very thin long spicules, clumped together centrally\n$\\checkmark$ radiolucent linear structures (= fat) paralleling spicules (\"black star\" appearance)\n$\\checkmark$ no skin thickening / retraction\nMR:\n) T1WI:\n$\\sqrt{ }$ stellate lesion with SI equal to parenchyma (difficult / impossible to visualize within parenchyma; good in adipose tissue)\n> enhanced T1WI:\n$\\checkmark$ slight to moderate uptake with nonspecific curve\n> T2WI:\n$\\checkmark$ no characteristic finding\n$R x$ : surgical excision required for definitive diagnosis\n$D D x$ : carcinoma, postsurgical scar, fat necrosis, fibromatosis, granular cell myoblastoma\n\n\n# SARCOMA OF BREAST \n\nFrequency: $<1 \\%$ of malignant mammary lesions\nAge: $45-55$ years\nHisto: fibrosarcoma, rhabdomyosarcoma, osteogenic sarcoma, mixed malignant tumor of the breast, malignant fibrosarcoma and carcinoma, liposarcoma\n\n- rapid growth ( $4-6 \\mathrm{~cm}$ at time of detection)\n$\\checkmark$ smooth / lobulated large dense mass\n$\\checkmark$ well-defined outline\n$\\checkmark$ palpated size similar to mammographic size\n\n\n## Angiosarcoma of Breast",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 881,
            "markdown": "$=$ rare highly malignant endovascular breast tumor\nPrevalence: 200 cases in world literature; $0.05 \\%$ of all malignant breast tumors; $8 \\%$ of all breast sarcomas\nAge: $\\quad 3^{\\text {rd }}-4^{\\text {th }}$ decade of life\nHisto: hyperchromatic neoplastic endothelial cells; network of communicating vascular spaces\nstage I: cells with large nucleoli\nstage II: endothelial lining displaying tufting + intraluminal papillary projections\nstage III: mitoses, necrosis, marked hemorrhage (= \"blood lakes\")\nImmunohisto: factor VIII-related antigen, CD34, ulex-lectin antigen, desmin, vimentin, S-phase kinase-associated protein 2\nMetastasis: hematogenous spread to lung, skin, SQ tissue, bone, liver, spleen, omentum, adrenal, gland, psoas muscle, brain, ovary; NO lymphatic spread\n\n- rapidly enlarging painless immobile breast mass\n\nLaterality: bilateral angiosarcoma (often in pregnancy)\nMammo:\n$\\checkmark$ normal (in 33\\%)\n$\\checkmark$ ill-defined / circumscribed lobulated round / oval mass\n$\\checkmark \\pm$ coarse calcifications\nUS:\n$\\checkmark$ skin thickening + nipple retraction\n$\\checkmark$ large solitary hypo- / hyperechoic heterogeneous mass\n$\\checkmark$ diffuse mixed echotexture without definable mass (38\\%)\n$\\checkmark$ well- / ill-defined multilobulated nonspiculated border\n$\\checkmark$ hyperechoic areas ( $\\leftarrow$ hemorrhage) $\\pm$ acoustic shadowing\n$\\checkmark$ hypervascularity on color Doppler\nMR:\n$\\checkmark$ heterogeneous mass with low SI on T1WI + intermediate to high SI on T2WI\n$\\checkmark$ pronounced early arterial enhancement with higher pathologic tumor grade\n$\\checkmark$ prolonged enhancement $\\leftarrow$ blood-filled vascular spaces\n$\\checkmark$ small focus of enhancement in irradiated thickened skin\nPET/CT (useful for initial staging + surveillance):\n$\\checkmark$ FDG-avid\nBiopsy: fine-needle aspiration / punch biopsies not diagnostic or misleading $\\rightarrow$ excisional biopsy\nPrognosis: dismal with 1.2-3.1 years median survival; 15\\% overall 5-year survival rate $R x$ : simple mastectomy without axillary lymph node dissection\n$D D x$ : phylloides tumor, lactating breast, juvenile hypertrophy\n$\\diamond$ Frequently misdiagnosed as lymph- / hemangioma (negative for S-phase kinaseassociated protein 2)\n\n# Secondary Angiosarcoma of Breast \n\nPrevalence: $0.9-1.6 \\div 1000$ after radiation therapy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 882,
            "markdown": "Risk factor: breast-conserving therapy accompanied by radiation therapy\nCause: radiogenic DNA mutations, genetic predisposition, congenital, idiopathic, traumatic factors; Stewart-Treves syndrome $=$ angiosarcoma arising in region of chronic lymphedema\nAge: $>65$ years\nTypes:\n(a) postradiation angiosarcoma (more common)\n(b) lymphedema-associated cutaneous angiosarcoma (less common)\n\nCriteria for radiation-associated neoplasm:\n(a) site of origin within / adjacent to field of prior irradiation\n(b) significant amount of radiation ( $25-80 \\mathrm{~Gy}$ )\n(c) interval of $>3-4$ years since time of irradiation\n(d) secondary sarcoma histologically different from primary neoplasm\n\nMean age: 65 years\n\n- palpable mass\n- skin macules / papules / vesicles $\\rightarrow$ ulceration + edema\n- change in skin color $\\rightarrow$ blue, red, purple discoloration often accompanied by ecchymotic / telangiectatic /erythematous / eczematous component\n\n\n# Dermatofibrosarcoma Protuberans \n\n$=$ uncommon locally aggressive mesenchymal tumor; rarely in breast\nIncidence: $5 \\div 1,000,000$ persons annually\nOrigin: dermis\nAge: early / middle adulthood\nHisto: CD34-positive spindle cell malignancy of typically storiform arrangement containing short fascicles within myxoid + hyalinized stromal background\n\n- slow growing erythematous indurated subcutaneous nodule\n$\\sqrt{ }$ hyperdense mass; NO calcifications; NO fat\nUS:\n$\\sqrt{ }$ heterogeneously hypoechoic ovoid mass\n$\\sqrt{ }$ parallel orientation\n$\\sqrt{ }$ predominantly circumscribed microlobulated margins\n$\\sqrt{ }$ scattered areas of internal vascularity\nMR:\n$\\sqrt{ }$ homogeneous mass T1-isointense to breast parenchyma\n$\\sqrt{ }$ hyperintense mass on T2WI\n$\\sqrt{ }$ intense enhancement\nPrognosis: $20-50 \\%$ recurrence rate\n$R x$ : surgical excision with $2-3 \\mathrm{~cm}$ wide margin\n\n\n## Liposarcoma of Breast\n\nPrevalence: $0.7 \\%$ of all breast cancers; $15 \\%$ of all sarcomas\n\n- slowly enlarging painful unilateral mass\n- NO axillary lymphadenopathy; NO skin change\n\nMedian size: 8 cm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 883,
            "markdown": "Histo: lipoblasts with scalloped irregular hyperchromatic nuclei + intracytoplasmic vacuoles indenting the nucleus confirm diagnosis\n$\\sqrt{ }$ large encapsulated circumscribed hyperdense mass $\\pm$ irregular margins\nUS:\n$\\sqrt{ }$ heterogeneous hyperechoic echotexture\n$R x:$ wide surgical excision\n\n# Pleomorphic Hyalinizing Angiectatic Tumor of Breast \n\n$=$ PHAT\n$=$ rare low-grade mesenchymal tumor of uncertain lineage\nHisto: nonencapsulated mass with sheets of spindle + pleomorphic cells alternating with clusters of thin-walled ectatic vasculature surrounded by fibrin + collagen; positive for vimentin; variably positive for CD34, CD99, factor XIIIa and vascular endothelial growth factor\nLocation: lower extremity; breast\n\n- slow-growing painless subcutaneous mass\n$\\sqrt{ }$ large well-circumscribed retroareolar mass\n$\\sqrt{ }$ NO calcifications\nUS:\n$\\sqrt{ }$ ill-defined heterogeneous mass + flow on color Doppler\nMR:\n$\\sqrt{ }$ large solid + complex cystic mass:\n$\\sqrt{ }$ hypointense SI on T1WI\n$\\sqrt{ }$ hyperintense SI on T2WI\n$\\sqrt{ }$ homogeneous enhancement\n$D D x$ : hematoma, Kaposi sarcoma\n\n\n## SEBACEOUS CYST\n\n$=$ epithelial cyst $\\leftarrow$ obstructed sebaceous gland arising from outer root sheath of hair follicle\nPrevalence: less common dermal lesion than epidermal inclusion cyst\nLocation: dermis $\\pm$ expansion into subcutaneous fat;\naxilla / sternum (= steatocystoma) with flattened sebaceous gland lobules in relation to cyst wall\n$\\diamond$ NOT readily distinguishable from epidermal inclusion cyst by imaging / clinical features\nSize: $0.8-10.0 \\mathrm{~cm}$ in diameter\n$\\sqrt{ }$ circumscribed round / oval mass of low (fatty) to variable density\nUS:\n$\\sqrt{ }$ circumscribed mixed (commonly) / hyperechoic (occasionally) solid mass\n$\\sqrt{ }$ cystic / solid depending on the internal contents\n$\\sqrt{ }$ contiguous with dermis on tangential view\n$\\sqrt{ }$ exiting hypoechoic track toward skin surface\n$D D x$ : epidermal inclusion cyst (indistinguishable)\n\n## SEROMA OF BREAST",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 884,
            "markdown": "$=$ localized postoperative fluid collection of wound serum\nAverage size: 3.9 (range, $0.7-8.3$ ) cm\n$\\sqrt{ }$ oval / round mass with convex (outward-bulging) margins\n$\\sqrt{ }$ slowly diminishes in size ( $=$ contraction)\n$\\sqrt{ }$ evolution into scar by 1 year after surgery\n$\\sqrt{ }$ occasionally reaccumulates / persists\nUS:\n$\\sqrt{ }$ fluid collection $\\pm$ solid echogenic component\nCT:\n$\\sqrt{ }$ hypo- / isodense lesion\nMR:\n) T1WI:\n$\\sqrt{ }$ circumscribed area of mildly hypointense signal\n> enhanced T1WI:\n$\\sqrt{ }$ smooth $\\leq 5 \\mathrm{~mm}$ thin rim enhancement of surrounding parenchyma\n) T2WI:\n$\\sqrt{ }$ hyperintense area of fluid retention\n$D x:$ gradual resolution / persistence on follow-up\n$D D x$ : indistinguishable from hematoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 885,
            "markdown": "# HEART AND GREAT VESSELS \n\n## DIFFERENTIAL DIAGNOSIS OF CARDIOVASCULAR DISORDERS\n\n| Approach to Congenital Heart Disease |  |  |\n| :--: | :--: | :--: |\n| Acyanotic |  | Cyanotic |\n|  | $\\sqrt{ }$ enlarged main pulmonary artery | $\\sqrt{ }$ concave main pulmonary artery |\n| Increased Pulmonary BF <br> + increased C/T ratio | L-R shunts | Admixture lesions = bidirectional shunts $=$ T-lesions |\n|  | VSD | Transposition |\n|  | ASD | Truncus arteriosus |\n|  | PDA | TAPVR |\n|  | ECD | Tricuspid atresia (without RVOT obstruction) |\n|  | PAPVR | \"Tingles\" (single ventricle / atrium) |\n| Normal Pulmonary Blood Flow <br> + normal C/T ratio <br> + pulmonary venous HTN | LV outflow obstruction <br> AS |  |\n|  | Coarctation |  |\n|  | Interrupted aortic arch |  |\n|  | Hypoplastic left heart |  |\n|  | LV inflow obstruction |  |\n|  | Obstructed TAPVR |  |\n|  | Cor triatriatum |  |\n|  | Pulmonary vein atresia |  |\n|  | Congenital MV stenosis |  |\n|  | Muscle disease |  |\n|  | Cardiomyopathy |  |\n|  | Myocarditis |  |\n|  | Anomalous LCA |  |\n| Decreased Pulmonary BF <br> + normal C/T ratio |  | R-to-L shunts <br> + nonrestrictive intracardiac shunt <br> Tetralogy of Fallot <br> Tricuspid atresia (with PS + nonrestrictive ASD) <br> Pulmonary atresia + nonrestrictive VSD <br> + restrictive intracardiac shunt <br> Pulmonary atresia + ASD without VSD <br> PS with ASD / patent foramen ovale <br> Tricuspid atresia + PS + restrictive ASD <br> Trilogy of Fallot <br> Ebstein anomaly <br> Congenital tricuspid insufficiency |\n\n## CONGENITAL HEART DISEASE\n\n## Incidence of CHD in Liveborn Infants\n\nOverall incidence: $8-9 \\div 1000$ livebirths\n$\\diamond$ Most common CHD: bicuspid aortic valve (2\\%) [usually not recognized before late infancy / childhood]",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 886,
            "markdown": "$\\diamond$ ASD + VSD + PDA account for $45 \\%$ of all CHD\n$\\diamond 12$ lesions account for $89 \\%$ of all CHD:\nVentricular septal defect $30.3 \\%$\nPatent ductus arteriosus $8.6 \\%$\nPulmonic stenosis $7.4 \\%$\nOstium secundum defect $6.7 \\%$\nCoarctation of aorta $5.7 \\%$\nAortic stenosis $5.2 \\%$\nTetralogy of Fallot $5.1 \\%$\nTransposition $4.7 \\%$\nEndocardial cushion defect $3.2 \\%$\nHypoplastic right ventricle $2.2 \\%$\nHypoplastic left heart syndrome $1.3 \\%$\nTAPVR $1.1 \\%$\nTruncus arteriosus $1.0 \\%$\nSingle ventricle $0.3 \\%$\nDouble outlet right ventricle $0.2 \\%$\nHigh-risk pregnancy:\n(1) Previous sibling with CHD: $2-5 \\%$\n(2) Previous 2 siblings with CHD: $10-15 \\%$\n(3) One parent with CHD: $2-10 \\%$\n\n# Congenital Abnormality of Aortic Valve \n\n1. Bicuspid aortic valve\n$\\diamond$ Most common congenital cardiac anomaly!\n2. Unicuspid / unicomissural aortic valve\n$=$ single commissure in (commonly) L posterior position\nIncidence: $0.02 \\%$\n$C x$ : early aortic stenosis, aneurysmal dilatation of ascending aorta\n3. Quadricuspid aortic valve\n\nIncidence: 200 cases reported\n$C x$ : regurgitation\n4. Aneurysmal dilatation of sinus of Valsalva\n\nCause: (a) congenital: connective tissue disorder (Marfan), aortic insufficiency, bicuspid aortic valve, VSD\n(b) acquired: infection (endocarditis, syphilis, TB), medial degeneration, trauma, hypertension\n\n## Congenital Abnormality of Mitral Valve\n\n1. Endocardial cushion defect\n2. Parachute mitral valve (Shone syndrome)\n\n## CHD Presenting in 1st Year of Life\n\n1. VSD",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 887,
            "markdown": "2. d-Transposition of great vessels\n3. Tetralogy of Fallot\n4. Isolated coarctation\n5. Patent ductus arteriosus\n6. Hypoplastic left heart syndrome\n\nMost common causes for CHF + PVH in neonate:\n\n1. Left ventricular failure $\\leftarrow$ outflow obstruction\n2. Obstruction of pulmonary venous return\n\n| Presenting Age in CHD |  |  |\n| :--: | :--: | :--: |\n| Age | Severe PVH | PVH + Shunt Vascularity |\n| $0-2 \\mathrm{~d}$ | Hypoplastic left heart | Hypoplastic left heart |\n|  | Aortic atresia | TAPVR above diaphragm |\n|  | TAPVR below diaphragm | Complete transposition |\n|  | Myocardiopathy in IDM |  |\n| $3-7 \\mathrm{~d}$ | PDA in preterm infant |  |\n| $7-14 \\mathrm{~d}$ | CoA + VSD / PDA | Coarctation of aorta |\n|  | Aortic valve stenosis | Peripheral AVM |\n|  | Peripheral AVM |  |\n|  | Endocardial fibroelastosis |  |\n|  | Anomalous LCA |  |\n\n# CHD Compatible with Relatively Long Life \n\n1. Mild tetralogy: mild pulmonic stenosis + small VSD\n2. Valvular pulmonic stenosis: with relatively normal pulmonary circulation\n3. Transposition of great vessels: some degree of pulmonic stenosis + large VSD\n4. Truncus arteriosus: delicate balance between systemic + pulmonary circulation\n5. Truncus arteriosus type IV: large systemic collaterals\n6. Tricuspid atresia + transposition + pulmonic stenosis\n7. Eisenmenger complex\n8. Ebstein anomaly\n9. Corrected transposition without intracardiac shunt\n\n## Classic Signs of Congenital Cardiovascular Anomalies\n\n1. \"Boot-shaped\" heart\n2. \"Box-shaped\" cardiomegaly\n3. \"Egg-on-a-string\" sign\n4. \"Figure-of-3\" and reverse \"figure-of-3\" sign\n5. \"Gooseneck\" sign\n6. \"Scimitar\" sign\n7. \"Snowman\" sign\n\n## Juxtaposition of Atrial Appendages\n\n1. Tricuspid atresia with transposition",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 888,
            "markdown": "2. Complete transposition\n3. Corrected transposition of great arteries\n4. DORV\n\n# Continuous Heart Murmur \n\n1. PDA\n2. AP window\n3. Ruptured sinus of Valsalva aneurysm\n4. Hemitruncus\n5. Coronary arteriovenous fistula\n\n## Syndromes with CHD\n\n## 5 p - (Cri-du-chat) Syndrome\n\nIncidence of CHD: $20 \\%$\n\n## DiGeorge Syndrome\n\n$=$ congenital absence of thymus + parathyroid glands\n\n1. Conotruncal malformation\n2. Interrupted aortic arch\n\n## Down Syndrome\n\n$=$ MONGOLISM $=$ TRISOMY 21\n\n1. Endocardial cushion defect $(25 \\%)$\n2. Membranous VSD\n3. Ostium primum ASD\n4. AV communis\n5. Cleft mitral valve\n6. PDA\n7. 11 rib pairs $(25 \\%)$\n8. Hypersegmented manubrium ( $90 \\%$ )\n\nEllis-van Creveld Syndrome\nIncidence of CHD: $50 \\%$\n\n- polydactyly\n$\\sqrt{ }$ single atrium\n\n\n## Holt-Oram Syndrome\n\n$=$ UPPER LIMB-CARDIAC SYNDROME\nIncidence of CHD: $50 \\%$\n\n1. ASD\n2. VSD\n3. Valvular pulmonary stenosis\n4. Radial dysplasia\n\n## Hurler Syndrome\n\nCardiomyopathy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 889,
            "markdown": "# Ivemark Syndrome \n\nIncidence of CHD: $100 \\%$\n\n- asplenia\n$\\checkmark$ complex cardiac anomalies\n\n\n## Klippel-Feil Syndrome\n\nIncidence of CHD: 5\\%\n\n1. Atrial septal defect\n2. Coarctation\n\n## Marfan Syndrome\n\n$=$ ARACHNODACTYLY\n\n1. Annuloaortic ectasia\n2. Aortic aneurysm\n3. Aortic regurgitation\n4. Pulmonary aneurysm\n\n## Noonan Syndrome\n\n1. Pulmonary stenosis\n2. ASD\n3. Hypertrophic cardiomyopathy\n\n## Osteogenesis Imperfecta\n\n1. Aortic valve insufficiency\n2. Mitral valve insufficiency\n3. Pulmonic valve insufficiency\n\n## Postrubella Syndrome\n\n- low birth weight, deafness, cataracts, mental retardation\n\n1. Peripheral pulmonic stenosis\n2. Valvular pulmonic stenosis\n3. Supravalvular aortic stenosis\n4. PDA\n\nTrisomy 13-15\nVSD, tetralogy of Fallot, DORV\n\n## Trisomy 16-18\n\nVSD, PDA, DORV\n\n## Turner Syndrome (XO)\n\n$=$ OVARIAN DYSGENESIS\nIncidence of CHD: $35 \\%$\n\n1. Coarctation of the aorta (in $15 \\%$ )\n2. Bicuspid aortic valve\n3. Dissecting aneurysm of aorta",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 890,
            "markdown": "# Williams Syndrome \n\n$=$ IDIOPATHIC HYPERCALCEMIA\n\n- peculiar elfinlike facies, mental + physical retardation\n- hypercalcemia (not in all patients)\n\n1. Supravalvular aortic stenosis (33\\%)\n2. ASD, VSD\n3. Valvular + peripheral pulmonary artery stenosis\n4. Aortic hypoplasia, stenoses of more peripheral arteries\n\n## SHUNT EVALUATION\n\n## Evaluation of L-to-R Shunts\n\nA. AGE\n, Infants:\n(1) Isolated VSD\n(2) VSD with CoA / PDA / AV canal\n(3) PDA\n(4) Ostium primum\n> Children / adults:\n(1) ASD\n(2) Partial AV canal with competent mitral valve\n(3) VSD / PDA with high pulmonary resistance\n(4) PDA without murmur\nB. SEX\n\n99\\% chance for ASD / PDA in female patient\nC. CHEST WALL ANALYSIS\n$\\sqrt{ } 11$ pair of ribs + hypersegmented manubrium $\\rightarrow$ Down syndrome\n$\\sqrt{ }$ pectus excavatum + straight back syndrome + funnel chest $\\rightarrow$ prolapsing mitral valve\n$\\sqrt{ }$ rib notching\nD. CARDIAC SILHOUETTE\n$\\sqrt{ }$ absent pulmonary trunk:\ncorrected transposition with VSD; pink tetralogy\n$\\sqrt{ }$ left-sided ascending aorta:\ncorrected transposition with VSD\n$\\sqrt{ }$ tortuous descending aorta:\naortic valve incompetence + ASD\n$\\sqrt{ }$ huge heart:\npersistent complete AV canal (PCAVC); VSD + PDA; VSD + mitral valve incompetence\n$\\sqrt{ }$ enlarged left atrium:\nintact atrial septum; mitral regurgitation (endocardial cushion defect, prolapsing mitral valve + ASD)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 891,
            "markdown": "| Differential Diagnosis of L-R Shunts |  |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: | :--: |\n|  | $R A$ | $R V$ | $P A$ | $L A$ | $L V$ | Prox. Ao |\n| ASD | $\\uparrow$ | $\\uparrow$ | $\\uparrow$ | $\\leftrightarrow$ | $\\leftrightarrow$ | $\\leftrightarrow$ |\n| VSD | $\\leftrightarrow$ | $\\uparrow$ | $\\uparrow$ | $\\uparrow$ | $\\uparrow$ | $\\leftrightarrow$ |\n| PDA | $\\leftrightarrow$ | $\\leftrightarrow$ | $\\uparrow$ | $\\uparrow$ | $\\uparrow$ | often $\\uparrow$ |\n\nShunt with Normal Left Atrium\nA. Precardiac shunt\n\n1. Anomalous pulmonary venous connection\nB. Intracardiac shunt\n2. $\\operatorname{ASD}(8 \\%)$\n3. VSD $(25 \\%)$\nC. Postcardiac shunt\n4. PDA $(12 \\%)$\n\n# Aortic Size in Shunts \n\nA. Extracardiac shunts\n$\\sqrt{ }$ aorta enlarged + hyperpulsatile\n\n1. PDA\nB. Pre- and intracardiac shunts\n$\\sqrt{ }$ aorta small but not hypoplastic\n2. Anomalous pulmonary venous return\n3. ASD\n4. VSD\n5. Common AV canal\n\n## Left-to-Right Shunts Missed on Echocardiography\n\n1. Sinus venosus defect\n2. Patent ductus arteriosus\n3. Anomalous pulmonary venous return\n\n## SITUS\n\n= \"position / site / location\" referring to the position of the atria and viscera relative to the midline\n\n## Segmental Analysis of CHD\n\n= 3-part Van Praagh notation of congenital heart disease corresponding to atria \\& ventricles \\& great vessels\n$\\diamond$ Only one type of situs anomaly is possible in any patient!\nStep 1. Visceroatrial situs $\\left\\{\\mathrm{X}, \\ldots \\_\\}\\right.$ :\nsolitus $=\\{\\mathrm{S}\\}$, inversus $=\\{\\mathrm{I}\\}$, ambiguus $=\\{\\mathrm{A}\\}$\n(a) establish atrial situs by morphology of atrial appendages\n$\\sqrt{ }$ broad blunt (triangular) appendage $=\\mathrm{RA}$\n$\\sqrt{ }$ narrow pointed tubular (fingerlike) appendage $=\\mathrm{LA}$\n$\\diamond$ Morphologic RA is on patient's right side",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 892,
            "markdown": "(b) establish atrial situs by lung morphology:\n> morphologic RT lung\n$\\sqrt{ }$ main RT lung bronchus is eparterial\n> morphologic LT lung\n$\\sqrt{ }$ main LT bronchus is hyparterial\nThe relationship between main RT + LT bronchi and pulmonary arteries is a reliable indicator of atrial arrangement.\n(c) establish visceral situs:\n$\\sqrt{ }$ largest lobe of liver on RT; stomach + spleen on LT\n(b) establish thoracoabdominal situs:\n$\\sqrt{ }$ supradiaphragmatic IVC connects to anatomic RA\n![img-89.jpeg](img-89.jpeg)\n$\\sqrt{ }$ RT lung + largest lobe of liver on right side\nSupradiaphragmatic IVC / coronary sinus usually drain into anatomic RA (= rule of venoatrial concordance)\n$\\diamond$ Atrial + thoracoabdominal situs are usually concordant!",
            "images": [
                {
                    "id": "img-89.jpeg",
                    "top_left_x": 190,
                    "top_left_y": 679,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1786,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 893,
            "markdown": "Step 2. Ventricular loop orientation $\\left.\\left.\\{_{-}, \\mathrm{X}_{-}\\right\\}\\right)$ :\nEmbryology:\ncomponents of craniocaudal tube are truncus arteriosus (future great vessels), bulbus cordis (future right ventricle), embryonic LV, primitive atria, sinus venosus; tube curves toward right (D-loop) placing RV to right of LV\n(a) identify morphologic RV and LV\n(b) determine location of RV relative to LV\n\nHand rule: approaching heart from anteriorly place right / left hand in RV with palm against IVS. If right thumb is in inflow tract + right fingers in outflow tract $=$ D-loop\nStep 3. Position of great vessels $\\left.\\{\\_, \\mathrm{X}\\}\\right)$ :\n(a) identify morphologic aorta (Ao supplies at least 1 coronary artery + most systemic arteries) and main pulmonary artery (MPA supplies right + left pulmonary artery)\n(a) designate position of Ao relative to MPA at level of aortic + pulmonic valves:\n> normal or inverse position: solitus $=\\{S\\}$, inversus $=\\{I\\}$\n> transposition of great arteries: dextrotransposition $=\\{\\mathrm{D}-\\mathrm{TGV}\\}$, levotransposition $=$ $\\{\\mathrm{L}-\\mathrm{TGV}\\}$\n> malposition if both arteries override / originate from same ventricle: Ao rightward from MPA $=\\{\\mathrm{D}-\\mathrm{MGV}\\}$, Ao leftward from MPA $=\\{\\mathrm{L}-\\mathrm{MGV}\\}$\n![img-90.jpeg](img-90.jpeg)",
            "images": [
                {
                    "id": "img-90.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 994,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1940,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 894,
            "markdown": "# Situs Solitus = Normal / Usual Situs \n\n|  | Right side | Left side |\n| :-- | :-- | :-- |\n| $\\checkmark$ systemic atrium | $\\checkmark$ pulmonary atrium |  |\n| $\\checkmark$ trilobed lung | $\\checkmark$ bilobed lung |  |\n| $\\checkmark$ liver | $\\checkmark$ stomach |  |\n| $\\checkmark$ gallbladder | $\\checkmark$ single spleen |  |\n| $\\checkmark$ IVC | $\\checkmark$ aorta |  |\n\nAssociated with:\n(a) levocardia : $0.6-0.8 \\%$ chance for CHD\n(b) dextrocardia : $95 \\%$ chance for CHD\n\n## SITUS ANOMALY\n\nAssociated with: CHD, primary ciliary dyskinesia, abdominal anomalies (eg, intestinal malrotation)\n\n## Situs Inversus\n\n$=$ mirror-image arrangement of situs solitus\nFrequency: $0.01 \\%$ Associated with:\n(a) dextrocardia $=$ situs inversus totalis (usual variant): $3-5 \\%$ chance for CHD (eg, Kartagener syndrome in 20\\%)\n(b) levocardia (extremely rare): $95 \\%$ chance for CHD\n\n|  | Left side | Right side |\n| :-- | :-- | :-- |\n| $\\checkmark$ systemic atrium | $\\checkmark$ pulmonary atrium |  |\n| $\\checkmark$ trilobed lung | $\\checkmark$ bilobed lung |  |\n| $\\checkmark$ liver | $\\checkmark$ stomach |  |\n| $\\checkmark$ gallbladder | $\\checkmark$ single spleen |  |\n| $\\checkmark$ IVC | $\\checkmark$ aorta |  |\n\n## Situs Ambiguus = Heterotaxy\n\n[heteros, Greek = other / different; taxis, Greek = arrangement]\n$=$ visceral malposition + dysmorphism associated with indeterminate atrial arrangement\nAssociated with: CHD in 50-100\\%\nSubclassification:\n\n1. Asplenia syndrome = double / bilateral right-sidedness\n2. Polysplenia syndrome = double / bilateral left-sidedness\n\n## Bronchial Situs\n\nClassification:\n\n1. Right bronchial isomerism\n$\\checkmark$ bilateral eparterial upper lobe bronchi = morphologically right lung\n2. Left bronchial isomerism\n$\\checkmark$ bilateral hyparterial upper lobe bronchi = morphologically left lung\nThe relationship of the upper lobe bronchus to the ipsilateral pulmonary artery is the most",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 895,
            "markdown": "reliable marker of bronchial situs at CT for details see Anatomy and Function of Lung\nLess reliable: number of lobes, ratio of left to right main bronchial lengths, bronchial branching pattern\n\n# Cardiac Malposition \n\n$=$ location of heart other than within left hemothorax in situs solitus or within left hemithorax when other organs are ambiguous\n$\\diamond$ Determined by base-apex axis; no assumption is made regarding cardiac chamber / vessel arrangement\n\nIn general, cardiac and situs anomalies are less frequently found with a concordant position of the cardiac apex, stomach, and aortic arch.\nA. POSITION OF CARDIAC APEX\n\n1. Levocardia $=$ apex directed leftward\n2. Dextrocardia $=$ apex directed rightward\n3. Mesocardia $=$ vertical / midline heart (usually with situs solitus)\n$\\sqrt{ }$ atrial septum characteristically bowed into LA in cardiac situs solitus with dextrocardia + cardiac situs inversus with levocardia (DDx: juxtapositioned atrial appendages)\n\n| Cardiac Position as Predictor of CHD |  |\n| :--: | :--: |\n| Visceroatrial Situs | Frequency of CHD |\n| Situs solitus |  |\n| with levocardia | $<1 \\%$ |\n| with dextrocardia | $95 \\%$ |\n| Situs inversus |  |\n| with dextrocardia | $3-5 \\%$ |\n| with levocardia | $100 \\%$ |\n| Situs ambiguus |  |\n| with left isomerism (polysplenia) | $90 \\%$ |\n| with right isomerism (asplenia) | $99-100 \\%$ |\n\n$\\diamond$ Does not imply a particular internal structure / specific location of other thoracoabdominal organs!\nB. CARDIAC DISPLACEMENT\nby extracardiac factors (eg, lung hypoplasia, pulmonary mass)\n\n1. Dextroposition\nsuggests hypoplasia of ipsilateral pulmonary artery (PAPVR implies scimitar syndrome)\n2. Levoposition\n3. Mesoposition\nC. CARDIAC INVERSION\n$=$ alteration of normal relationship of chambers\n4. D-bulboventricular loop\n5. L-bulboventricular loop",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 896,
            "markdown": "# D. TRANSPOSITION \n\n$=$ alteration of anterior-posterior relationship of great vessels\n\n## CYANOTIC HEART DISEASE\n\nChemical cyanosis $=\\mathrm{PaO}_{2} \\leq 94 \\%$\nClinical cyanosis $=\\mathrm{PaO}_{2} \\leq 85 \\%$\n$\\diamond$ Decrease in hemoglobin delays detectability!\nMost common cause of cyanosis:\n$>$ in newborn: transposition of great vessels\n$>$ in child: tetralogy of Fallot!\nN.B.: tricuspid atresia $=$ the great mimicker\n\n## Increased Pulmonary Blood Flow with Cyanosis\n\n$=$ ADMIXTURE LESIONS\n$=$ bidirectional shunt with 2 components:\n(a) mixing of saturated blood (L-R shunt) and unsaturated blood (R-L shunt)\n(b) NO obstruction to pulmonary blood flow\n\n## Evaluation process:\n\n$\\checkmark$ cardiomegaly\n$\\checkmark$ increased pulmonary blood flow\n$\\checkmark$ concave main pulmonary artery:\n$\\checkmark$ PA segment absent $=$ transposition\n$\\checkmark$ PA segment present:\n(a) Latrium normal ( $=$ extracardiac shunt $)=$ TAPVR\n(b) Latrium enlarged ( $=$ intracardiac shunt $)=$ truncus arteriosus\nN.B.: Overcirculation + cyanosis $=$ complete transposition until proven otherwise!\n\n## Admixture Lesions $=$ T-lesions\n\nmnemonic: 5 T's + CAD\nTransposition of great vessels $=$ complete TGV $\\pm$ VSD\n$\\diamond$ Most common cause for cyanosis in neonate\nTricuspid atresia with or without transposition + VSD\n$\\diamond 2^{\\text {nd }}$ most common cause for cyanosis in neonate\nTruncus arteriosus\nTotal anomalous pulmonary venous return (TAPVR) above diaphragm:\n(a) supracardiac\n(b) cardiac (coronary sinus / right atrium)\n\"Tingle\" = single ventricle\nCommon atrium\nAortic atresia\nDouble-outlet right ventricle (DORV type I) / Taussig-Bing anomaly (DORV type II)\nClues:\n$\\checkmark$ skeletal anomalies: Ellis-van Creveld syndrome (truncus / common atrium)\n$\\checkmark$ polysplenia: common atrium",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 897,
            "markdown": "$\\sqrt{ }$ R aortic arch: persistent truncus arteriosus\n$\\sqrt{ }$ ductus infundibulum: aortic atresia\n$\\sqrt{ }$ pulmonary trunk seen: supracardiac TAPVR; DORV; tricuspid atresia; common atrium\n$\\sqrt{ }$ ascending aorta with leftward convexity: single ventricle\n$\\sqrt{ }$ dilated azygos vein: common atrium + polysplenia + interrupted IVC; TAPVR to azygos vein\n$\\sqrt{ }$ left-sided SVC: vertical vein of TAPVR\n$\\sqrt{ }$ \"waterfall\" right hilum: single ventricle + transposition\n$\\sqrt{ }$ large left atrium (rules out TAPVR)\n$\\sqrt{ }$ prominent L heart border: single ventricle with inverted rudimentary RV; levoposition of appendage of RA (tricuspid atresia + transposition)\n$\\sqrt{ }$ age of onset $\\leq 2$ days: aortic atresia\n\n# Decreased Pulmonary Blood Flow with Cyanosis \n\n$=$ two components of\n(a) impedance of blood flow through right heart $\\leftarrow$ obstruction / atresia at pulmonary valve / infundibulum\n(b) R-to-L shunt\n\n- pulmonary circulation maintained through systemic arteries / PDA\n$\\sqrt{ }$ normal / decreased pulmonary blood flow\n$\\sqrt{ }$ concave main pulmonary artery\n$\\sqrt{ }$ cardiomegaly\n$\\sqrt{ }$ restrictive intracardiac R-to-L shunt\nmnemonic: P2 TETT\nPulmonic stenosis with ASD\nPulmonic atresia\nTetralogy of Fallot\nEbstein anomaly\nTricuspid atresia with pulmonic stenosis\nTransposition of great vessels with pulmonic stenosis\nA. SHUNT AT VENTRICULAR LEVEL\n\n1. Tetralogy of Fallot\n2. Tetralogy physiology (associated with pulmonary obstruction):\n> complete / corrected transposition\n> single ventricle\n> DORV\n> tricuspid atresia (PS in 75\\%)\n> asplenia syndrome\n$\\sqrt{ }$ prominent aorta with $\\mathrm{L} / \\mathrm{R}$ aortic arch; inapparent pulmonary trunk\n$\\sqrt{ }$ normal RA (without tricuspid regurgitation)\n$\\sqrt{ }$ normal-sized heart $\\leftarrow$ escape mechanism into aorta\nClues:\n3. Skeletal anomaly (eg, scoliosis): tetralogy ( $90 \\%$ )\n4. Hepatic symmetry: asplenia\n5. Right aortic arch: tetralogy, complete transposition, tricuspid atresia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 898,
            "markdown": "4. Aberrant right subclavian artery: tetralogy\n5. Leftward convexity of ascending aorta: single ventricle with inverted right rudimentary ventricle, corrected transposition, asplenia, JAA (tricuspid valve atresia)\nB. SHUNT AT ATRIAL LEVEL\nmnemonic: PET\n6. Pulmonary stenosis / atresia with intact ventricular septum\n7. Ebstein malformation + Uhl anomaly\n8. Tricuspid atresia (ASD in 100\\%)\n$\\sqrt{ }$ moderate to severe cardiomegaly\n$\\sqrt{ }$ RA dilatation\n$\\sqrt{ }$ RV enlargement $\\leftarrow$ massive tricuspid incompetence\n$\\sqrt{ }$ inapparent aorta\n$\\sqrt{ }$ left aortic arch\n\n# Pulmonary Venous Hypertension with Cyanosis \n\n(a) during $1^{\\text {st }}$ week of life\n\n1. Hypoplastic left heart syndrome\n$\\sqrt{ }$ marked cardiomegaly\n2. TAPVR below diaphragm\n$\\sqrt{ }$ normal cardiac size\n(b) during $2^{\\text {nd }}$ week of life\n3. Aortic coarctation\n4. Aortic atresia\n(c) during $4^{\\text {th }}-6^{\\text {th }}$ week of life\n5. Critical aortic stenosis\n6. Endocardial fibroelastosis\n7. Anomalous origin of LCA\n8. Atresia of common pulmonary vein\n\n## ACYANOTIC HEART DISEASE\n\n## Increased Pulmonary Blood Flow without Cyanosis\n\n$=$ indicates L-R shunt with increased pulmonary blood flow (shunt volume $>40 \\%$ )\nA. WITH LEFT ATRIAL ENLARGEMENT\nindicates shunt distal to mitral valve $=$ increased volume without escape defect\n\n1. VSD ( $25 \\%$ ): small aorta in intracardiac shunt\n2. PDA ( $12 \\%$ ): aorta + pulmonary artery of equal size in extracardiac shunt\n3. Ruptured sinus of Valsalva aneurysm (rare)\n4. Coronary arteriovenous fistula (very rare)\n5. Aortopulmonary window (extremely rare)\nB. WITH NORMAL LEFT ATRIUM indicates shunt proximal to mitral valve $=$ volume increased with escape mechanism through defect\n6. ASD $(8 \\%)$\n7. Partial anomalous pulmonary venous return (PAPVR) + sinus venosus ASD",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 899,
            "markdown": "3. Endocardial cushion defect (ECD) (4\\%)\n\n# Normal Pulmonary Blood Flow without Cyanosis \n\nA. OBSTRUCTIVE LESION\n\n1. Right ventricular outflow obstruction\n(a) at level of pulmonary valve: subvalvular / valvular / supravalvular pulmonic stenosis\n(b) at level of peripheral pulmonary arteries: peripheral pulmonary stenosis\n2. Left ventricular inflow obstruction\n(a) at level of peripheral pulmonary veins: pulmonary vein stenosis / atresia\n(b) at level of left atrium: cor triatriatum\n(c) at level of mitral valve: supravalvular mitral stenosis, congenital mitral stenosis / atresia, \"parachute\" mitral valve\n3. Left ventricular outflow obstruction\n(a) at level of aortic valve:\nanatomic subaortic stenosis, functional subaortic stenosis (IHSS), valvular aortic stenosis, hypoplastic left heart, supravalvular aortic stenosis\n(b) at level of aorta:\ninterruption of aortic arch, coarctation of aorta\nB. CARDIOMYOPATHY\n4. Endocardial fibroelastosis\n5. Hypertrophic cardiomyopathy\n6. Glycogen storage disease\nC. HYPERDYNAMIC STATE\n7. Noncardiac AVM: cerebral AVM, vein of Galen aneurysm, large pulmonary AVM, hemangioendothelioma of liver\n8. Thyrotoxicosis\n9. Anemia\n10. Pregnancy\nD. MYOCARDIAL ISCHEMIA\n11. Anomalous left coronary artery\n12. Coronary artery disease (CAD)\n\n## ACQUIRED HEART DISEASE\n\n$\\sqrt{ }$ LA enlargement $=$ MV disease\n$\\sqrt{ }$ dilated ascending aorta $=$ aortic valve disease\n$\\sqrt{ }$ RA enlargement $=$ tricuspid valve disease\n\n## Pressure Overload\n\n1. Systemic hypertension\n2. Aortic stenosis\n3. Mitral stenosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 900,
            "markdown": "# Decreased Compliance \n\n1. Myocardial infarction\n2. Hypertrophic cardiomyopathy\n3. Restrictive cardiomyopathy\n\n## Volume Overload\n\n1. Aortic insufficiency\n2. Mitral insufficiency\n3. Tricuspid insufficiency\n\n## Systolic Anterior Motion of Mitral Valve\n\n1. Hypertrophic Cardiomyopathy\n2. Hypertensive heart\n3. Diabetes mellitus\n4. Acute myocardial infarction\n5. Mitral valve dysfunction/repair\n\n## Concentric Left Ventricular Hypertrophy\n\n1. Symmetric hypertrophic cardiomyopathy\n\n| Approach to Acquired Heart Disease |  |  |\n| :--: | :--: | :--: |\n| Criteria | Mild-Moderate Cardiomegaly | Moderate-Severe Cardiomegaly |\n| C/T ratio | $0.45-0.55$ | $>0.55$ |\n| LA enlargement | pressure overload | volume overload |\n|  | mitral stenosis | mitral insufficiency |\n|  | decreased LV compliance |  |\n|  | hypertrophic cardiomyopathy |  |\n|  | restrictive cardiomyopathy |  |\n| Enlarged ascending aorta | pressure overload | volume overload |\n|  | aortic stenosis | aortic insufficiency |\n| Normal LA + aorta | myocardial | myocardial |\n|  | acute infarction | dilated cardiomyopathy |\n|  | hypertrophic cardiomyopathy | ischemic cardiomyopathy |\n|  | restrictive cardiomyopathy |  |\n|  | pericardial | pericardial |\n|  | constrictive pericarditis | pericardial effusion |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 901,
            "markdown": "2. Amyloidosis\n3. Cardiac sarcoidosis\n4. Athlete's heart\n$\\sqrt{ } \\uparrow$ LV mass, $\\uparrow$ LV diastolic cavity dimension, $\\uparrow$ LV wall thickness\n$\\sqrt{ }$ lack of areas of delayed myocardial hyperenhancement\nDx ( $80 \\%$ sensitive, $99 \\%$ specific):\nLV Thicknessdiastole + Volumeend-diastole (corrected to body surface area) $<0.15$ $\\mathrm{mm} / \\mathrm{m} 2 / \\mathrm{mL}$\n5. Fabry disease\n= rare X-linked autosomal recessive metabolic storage disorder caused by lysosomal agalactosidase\n$\\checkmark$ concentric thickening of LV wall\n$\\checkmark$ delayed hyperenhancement of LV midwall on CEMR\n6. Adaptive LV hypertrophy: hypertension, aortic stenosis\n\n# CARDIOMEGALY \n\n1. CHF\n2. Multivalvular disease\n3. Pericardial effusion\n$\\sqrt{ }$ absence of pulmonary venous hypertension + hydrostatic edema\n\n## Cardiothoracic Ratio\n\n$=$ widest transverse cardiac diameter + widest inside thoracic diameter\n$=$ primarily a measure of LV dilatation\n$<0.45$ normal\n$0.45-0.55$ mild cardiomegaly\n$>0.55$ moderate / severe cardiomegaly\nFalsely normal: with LV enlargement in up to $66 \\%$, moderate enlargement of LA + RV\nFalsely elevated: in expiration, in recumbent position\n\n## Vascular Pedicle Width\n\n$=$ distance on a horizontal line between (1) point where right mainstem bronchus + SVC cross and (2) point where left subclavian artery crosses horizontal line\n$48 \\pm 5 \\mathrm{~mm}$ normal\n$>53 \\mathrm{~mm} \\quad$ in $60 \\%$ of cardiogenic edema, in $85 \\%$ of volume overload\n\n## Cardiomegaly in Newborn\n\nA. NONCARDIOGENIC\n(a) metabolic:\n\n1. Ion imbalance in serum levels of sodium, potassium, and calcium\n2. Hypoglycemia\n(b) decreased ventilation\n3. Asphyxia\n4. Transient tachypnea\n5. Perinatal brain damage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 902,
            "markdown": "(c) erythrocyte function\n\n1. Anemia\n2. Erythrocythemia\n(d) endocrine\n3. Glycogen storage disease\n4. Thyroid disease: hypo- / hyperthyroidism\n(e) infant of diabetic mother\n(f) arteriovenous fistula\n5. Vein of Galen aneurysm\n6. Hepatic angioma\n7. Chorioangioma\nB. CARDIOGENIC\n8. Arrhythmia\n9. Myo- / pericarditis\n10. Cardiac tumor\n11. Myocardial infarction\n12. Congenital heart disease\n\n# Abnormal Heart Chamber Dimensions \n\nA. LEFT VENTRICULAR VOLUME OVERLOAD\n\n1. VSD\n2. PDA\n3. Mitral incompetence\n4. Aortic incompetence\nB. LEFT VENTRICULAR HYPERTROPHY\n5. Coarctation\n6. Aortic stenosis\nC. RIGHT VENTRICULAR VOLUME OVERLOAD\n7. ASD\n8. Partial APVR / total APVR\n9. Tricuspid insufficiency\n10. Pulmonary insufficiency\n11. Congenital / acquired absence of pericardium\n[6. Ebstein anomaly] - not truly RV\nD. RIGHT VENTRICULAR HYPERTROPHY\n12. Pulmonary valve stenosis\n13. Pulmonary hypertension\n14. Tetralogy of Fallot\n15. VSD\nE. Fixed subvalvular aortic stenosis\nF. Hypoplastic left / right ventricle, common ventricle\nG. Congestive cardiomyopathy\n\n## Right Atrial Enlargement\n\nCause: tricuspid stenosis / regurgitation, ASD, atrial fibrillation, dilated",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 903,
            "markdown": "cardiomyopathy, Ebstein anomaly, pulmonary atresia\n$\\diamond$ RA enlarges in rightward + posterior direction\nPA CXR:\n$\\checkmark$ prominent round superior border at junction with SVC\n$\\checkmark>5.5 \\mathrm{~cm}$ from midline to most lateral RA margin\n$\\checkmark>2.5 \\mathrm{~cm}$ from right vertebral margin\n$\\checkmark>50 \\%$ vertical height of RA compared with cardiovascular mediastinal height (from top of aortic arch to base of heart)\nLAT CXR:\n$\\checkmark$ sharp horizontal interface with lung above RV\n$\\checkmark$ displacement of heart posterior to IVC mimicking LV enlargement\n\n# Right Ventricular Enlargement \n\nCause: pulmonary valve stenosis, cor pulmonale, ASD, tricuspid regurgitation, dilated cardiomyopathy, secondary to LV failure\n$\\diamond$ RV enlarges in anterior, superior + leftward direction causing levorotation of heart\nPA CXR:\n$\\diamond$ Only extreme dilatation causes recognizable signs on frontal view!\n$\\checkmark$ straightening / convexity of left upper cardiac contour\n$\\checkmark$ upturned cardiac apex\n$\\checkmark$ left upper cardiac margin parallels left mainstem bronchus as a long convex curvature\n$\\checkmark$ increased distance between left upper cardiac margin + left mainstem bronchus\n$\\checkmark$ small appearance of rotated aortic arch + SVC\n$\\checkmark$ large appearance of main pulmonary artery\nLAT CXR (most sensitive view):\n$\\checkmark$ filling of retrosternal air space by prominent convexity of anterior heart border $>1 / 3$ of distance from sternodiaphragmatic angle to the point where trachea meets sternum\n\n## Left Atrial Enlargement\n\n## Cause:\n\n(a) acquired: mitral stenosis / regurgitation, LV failure, LA myxoma\n(b) congenital: VSD, PDA, hypoplastic left heart\n$\\diamond$ LA enlarges in multiple directions\nPA CXR:\n$\\checkmark$ right retrocardiac double density with inferomedial curvature (earliest sign)\n$\\checkmark>7.0$ (female) / 7.5 (male) cm distance between midpoint of undersurface of left mainstem bronchus + right lateral LA shadow\n$\\checkmark$ left retrocardiac double density\n$\\checkmark>75^{\\circ}$ splaying of carina with horizontal orientation of distal left mainstem bronchus\n$\\checkmark$ enlarged left-convex left atrial appendage $\\pm$ calcifications $(\\leftarrow$ rheumatic heart disease in $90 \\%$ )\nLAT CXR:\n$\\checkmark$ increased convexity of posterosuperior cardiac margin\n$\\checkmark$ posterosuperior atrial convexity crosses vertical plane formed by tracheal midline + upper lobe bronchus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 904,
            "markdown": "$\\checkmark$ posterior displacement of barium-filled esophagus\n$\\checkmark$ posterior displacement of LUL bronchus\n\n# Left Ventricular Enlargement \n\n## Cause:\n\n(a) pressure overload: hypertension, aortic stenosis\n(b) volume overload: aortic or mitral regurgitation, VSD\n(c) wall abnormalities: LV aneurysm, hypertrophic cardiomyopathy\n$\\diamond$ LV enlarges in posterior, inferior + leftward direction\nPA CXR:\n$\\checkmark$ leftward displacement of downturned cardiac apex $=$ left ventricular configuration\n$\\checkmark$ depression of left hemidiaphragm + gastric bubble (with diaphragmatic inversion)\nLAT CXR:\n$\\checkmark$ increased convexity of posteroinferior cardiac margin\n$\\checkmark$ posterior cardiac margin projects $>1.8 \\mathrm{~cm}$ posterior to IVC measured at a point 2 cm above intersection of IVC with right hemidiaphragm (Hofman-Rigler rule)\n\n## Flattening / Inversion of Interventricular Septum\n\n$=$ position determined by pressure difference between RV + LV\n$\\checkmark$ normally convex shape with slight right-sided bulge during ventricular filling (LV diastolic pressure $>$ RV pressure)\n(a) RV volume / pressure overload:\n\n1. ASD\n2. Acute / chronic cor pulmonale\n(b) pericardial abnormality:\n3. Cardiac tamponade ( $\\uparrow$ pericardial pressure)\n4. Constrictive pericarditis ( $\\downarrow$ pericardial compliance)\n\n## Enlargement of Coronary Sinus\n\n## Conditions Causing RA Dilatation\n\n1. Tricuspid stenosis / regurgitation\n2. Right ventricular dysfunction (failure): CHF, cardiomyopathy, atrial fibrillation, atrioventricular node reentrant tachycardia\n3. Severe pulmonary hypertension\n4. Right atrial hypertension\n5. Cardiac tamponade\n\n## Congenital Structural Anomaly\n\n(a) increased volume of systemic venous blood\n(1) persistent left SVC draining into coronary sinus\n(2) interrupted IVC with hemiazygos continuation to a left SVC / hepatic veins connecting directly into coronary sinus\nThe coronary sinus dilates most commonly due to a left SVC draining into the coronary sinus!\n(b) L-to-R shunt: oxygenated blood",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 905,
            "markdown": "> low-pressure shunt:\n\n1. Interatrial shunt (= coronary sinus-ASD) LA $\\rightarrow$ unroofed coronary sinus\n\nAn unroofed coronary sinus is a complete / partial wall defect partitioning the coronary sinus from the left atrium!\n2. TAPVR\n> high-pressure shunt:\n3. Coronary arteriovenous fistula\n\n# Small Coronary Sinus \n\nA. ACQUIRED\n\n1. Atrial systole\n2. Lipomatosis\n3. Small heart\n4. Stenosis\nB. CONGENITAL\n5. Atresia\n6. Hypoplasia: corrected TGA\n7. Unroofed coronary sinus\n8. CHD: corrected TGA, tetralogy of Fallot, Ebstein\n\n## Neonatal Cardiac Failure\n\nA. LEFT-SIDED OBSTRUCTIVE LESIONS\n\n1. Segmental hypoplasia of aorta\n2. Critical coarctation of the aorta\n3. Aortic valve stenosis\n4. Asymmetrical septal hypertrophy / hypertrophic obstructive cardiomyopathy\n5. Mitral valve stenosis\n6. Cor triatriatum\nB. VOLUME OVERLOAD\n7. Congenital mitral valve incompetence\n8. Corrected transposition with left (= tricuspid) AV valve incompetence\n9. Congenital tricuspid insufficiency\n10. Ostium primum ASD\nC. MYOCARDIAL DYSFUNCTION / ISCHEMIA\n11. Nonobstructive cardiomyopathy\n12. Anomalous origin of LCA from pulmonary trunk\n13. Primary endocardial fibroelastosis\n14. Glycogen storage disease (Pompe disease)\n15. Myocarditis\nD. NONCARDIAC LESIONS\n16. AV fistulas: hemangioendothelioma of liver, AV fistula of brain, vein of Galen aneurysm, large pulmonary AV fistula\n17. Transient tachypnea of the newborn\n18. Intraventricular / subarachnoid hemorrhage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 906,
            "markdown": "4. Neonatal hypoglycemia (low birth weight, infants of diabetic mothers)\n5. Thyrotoxicosis (transplacental passage of LATS hormone)\n\nCongestive Heart Failure \\& Cardiomegaly\nmnemonic: Ma McCae \\& Co.\nMyocardial infarction\nanemia\nMalformation\ncardiomyopathy\nCoronary artery disease\naortic insufficiency\neffusion\nCoarctation\n\n# Congenital Cardiomyopathy \n\nmnemonic: CAVE GI\nCystic medial necrosis of coronary arteries\nAberrant left coronary artery / Absent coronary artery\nViral myocarditis\nEndocardial fibroelastosis\nGlycogen storage disease (Pompe)\nInfant of diabetic mother / Ischemia\n\n## Delayed Myocardial Hyperenhancement on MRI\n\nA. Ischemic heart disease (MI)\nB. Nonischemic\n\n1. Dilated / hypertrophic cardiomyopathy\n2. Myocarditis\n3. Sarcoidosis\n4. Systemic sclerosis\n5. Endocardial fibroelastosis\n6. Fabry disease\n7. Chagas disease\n8. RV pressure overload\n9. Amyloidosis\n10. Cardiac transplantation\n11. Uremia\n\n## Subendocardial Enhancement\n\n1. Ischemic heart disease\n2. Amyloidosis\n3. Löffler endocarditis (hypereosinophilic syndrome)\n\n## Transmural Enhancement\n\n1. Ischemic heart disease\n2. Myocarditis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 907,
            "markdown": "# Subepicardial Enhancement \n\n1. Myocarditis\n\n## Mesocardial Enhancement\n\n$=$ delayed enhancement in midinterventricular septum\n\n1. Hypertrophic cardiomyopathy\n2. Dilated cardiomyopathy\n\n## Nodular Patchy Enhancement\n\n1. Amyloidosis\n2. Myocarditis\n3. Cardiac sarcoidosis\n\n## Cardiac Accumulation of FDG\n\n## Myocardial Uptake\n\n1. Physiologic FDG uptake $\\leftarrow$ depending on levels of blood glucose and free fatty acids\n$\\sqrt{ }$ none / diffuse / focal uptake in walls of ventricles\nRemedy: uptake suppressed by low-carbohydrate dinner followed by 12-hour fast\n2. Drug interaction\n(a) lowering uptake:\n> Bezafibrate for treating hyperlipidemia\n> Levothyroxine (thyroid hormone)\n(b) increasing uptake:\n> benzodiazepines: Diazepam\n3. Sarcoidosis\n$\\checkmark$ hypermetabolic myocardial foci in nonperivascular distribution\n4. Biventricular chemotherapy-induced cardiomyopathy\n$\\checkmark$ increased metabolic activity in ventricular myocardium\n5. Ventricular enlargement associated with systemic + pulmonary hypertension and valvular heart disease\n$\\checkmark$ diffuse uniform increase in myocardial activity\n6. Inflammatory myocarditis\n7. Endocarditis $\\leftarrow$ infected valve\n8. Neoplasia: sarcoma, metastasis (breast, lung, melanoma, lymphoma), myxoma\n9. Coronary artery disease $\\leftarrow$ shift from fatty acid metabolism to glucose utilization $\\leftarrow$ ischemia\n\n## Atrial Uptake\n\n1. Atrial fibrillation\n2. Radiofrequency ablation for atrial fibrillation\n3. Crista terminalis: ? physiologic\n\n## Pericardial Uptake\n\n1. Post-radiation pericarditis\n2. Malignant pericardial effusion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 908,
            "markdown": "3. Epipericarditis\n4. Lipomatous hypertrophy interatrial septum\n\n# CARDIAC TUMOR \n\n$\\diamond$ Extremely rare; often asymptomatic until very large!\n\n- symptoms of cardiopulmonary diseases:\n- congestive heart failure: dyspnea, orthopnea, peripheral edema, paroxysmal nocturnal dyspnea\n- palpitations, heart murmur, cough, chest pain\n- symptoms caused by peripheral emboli to cerebral / systemic / coronary circulation: syncope\n- weight loss, fever, malaise\n\nLocation: intracavitary (obstruction, emboli), intramural (arrhythmia), pericardial (tamponade) CXR:\n$\\checkmark$ cardiomegaly, pericardial effusion\n$\\checkmark$ signs of CHF\n$\\checkmark$ abnormal cardiac contour\n$\\checkmark$ pleural effusion\n$D D x$ : thrombus, pericardial and bronchogenic cyst, intrathoracic neoplasm, gastrointestinal hernia\n\n## Primary Heart Tumor\n\nPrevalence: $0.002-0.250 \\% ; 0.001-0.030 \\%$ (autopsy series)\nBenign Heart Tumor in Adults (75\\%)\n\n- More common than malignant neoplasms\n\n1. Myxoma (with almost $50 \\%$ the most common primary cardiac tumor; $25 \\%$ of all cardiac tumors)\n2. Papillary fibroelastoma ( $10 \\%$ of all primary cardiac tumors; with $75 \\%$ most common valvular tumor)\n3. Lipoma ( $10 \\%$ of all cardiac tumors)\n4. Hydatid cyst (uncommon):\n$\\checkmark$ localized bulge of left cardiac contour\n$\\checkmark$ curvilinear / spotty calcifications (resembling myocardial aneurysm)\n$C x$ : may rupture into cardiac chamber / pericardium\nMalignant Heart Tumors (25\\%)\nPrevalence: $25 \\%$ of all cardiac tumors in adults;\n$10 \\%$ of all cardiac tumors in children\n\n1. Sarcomas\n2. Rhabdomyosarcoma\n3. Lymphoma (rare)\n4. Pericardial mesothelioma\n5. Malignant teratoma\n6. Multiple cardiac myxomas",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 909,
            "markdown": "# Secondary (Metastatic) Heart Tumor \n\n$\\diamond$ Most common cause of a neoplastic cardiac mass!\nAge: typically $>60$ years with disseminated tumor\nPrevalence: metastatic+primary disease $=30 \\div 1 ; 10-12 \\%$ of cancer patients develop metastases to the heart (autopsy)\nOrigin: lung, breast, esophagus, melanoma, lymphoma, leukemia\n$\\diamond$ Melanoma has the highest prevalence of cardiac seeding of any neoplasm!\n\n- asymptomatic (frequently)\n- arrhythmia (most common clinical sign)\n- chest wall pain $\\leftarrow$ transient ischemic attack\n- CHF (shortness of breath, fatigue, peripheral edema)\n\nSite:\n(a) peri- / epicardium (most common): lung $>$ breast $>$ lymphoma $>$ leukemia $>$ breast $>$ esophagus\n(b) myocardium: malignant melanoma; secondary extension to myocardium from epicardium\n$\\diamond$ Most common sites for myocardial lesions are LV free wall + interventricular septum ( $=$ greatest myocardial mass)\n(c) endocardial / intracavitary (in only 5\\%)\n(d) transvenous extension: RCC, hepatoma, adrenal adenocarcinoma\n$\\checkmark$ nonspecific imaging features\nECHO: iso- / hyperechoic\nUS/CT/MR: enhancement\nMR: T1-hypointense + T2-hyperintense\nException: T1-hyperintensity of melanoma, hemorrhagic lesion\nPrognosis: death $(1 / 2) \\leftarrow$ cardiac tamponade / CHF / coronary artery invasion, sinoatrial node invasion\n\n## Cavoatrial Tumor Extension\n\n$=$ neoplasm arising in infradiaphragmatic sites\n\n1. Hepatocellular carcinoma\nextension into hepatic veins / IVC (7.5\\%), into RA (4\\%)\n2. RCC\ninvasion of renal vein / IVC (5-15\\%), into RA (1\\%)\n3. Wilms tumor\ninto renal veins / IVC (4-10\\%), into RA (1\\%)\n4. Adrenocortical carcinoma\n5. Uterine leiomyoma\n6. Leiomyosarcoma of IVC\n7. Osteogenic sarcoma of pelvis\nN.B.: sudden death may occur when tumor in RA intermittently obstructs tricuspid valve leading to low cardiac output\n\n## Congenital Cardiac Tumor\n\nThe majority of primary cardiac tumors in children are benign, rhabdomyoma and fibroma accounting",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 910,
            "markdown": "for $70 \\%$ !\nPrevalence: $1 \\div 10,000$\n\n1. Rhabdomyoma (58\\%): usually multiple masses\n2. Teratoma (20\\%): intrapericardiac, extracardiac $\\sqrt{ }$ multicystic mass\n3. Cardiac fibroma ( $12 \\%$ )\n4. Cardiac hemangioma\n\n# Cardiac Tumor by Location \n\nA thrombus is the most common cause of a cardiac mass!\nA. ENDOCARDIAL / INTRACAVITARY\n\n1. Myxoma\n2. Thrombus\n3. Myofibroblastic sarcomas (MFH, leiomyo- sarcoma, fibrosarcoma, myxosarcoma)\nB. VALVULAR\n4. Papillary fibroelastoma\n5. Valve vegetations\n6. Thrombus\n7. Myxoma\nC. MYOCARDIAL / INTRAMURAL\n8. Rhabdomyoma of heart\n9. Cardiac fibroma\nD. ENDO- / MYO- / EPICARDIAL\n10. Cardiac lipoma\n11. Cardiac sarcoma\n12. Lymphoma of heart\n\n## Left Atrial Mass\n\n1. Myxoma\n2. Thrombus\n3. Septal lipoma\n\n## Right Atrial Mass\n\n1. Thrombus\n2. Myxoma\n3. Hypernephroma\n4. Eustachian valve\n5. Chiari network\n6. Angiosarcoma\n\n## Left Ventricular Mass\n\n1. Thrombus\n2. Papillary muscle\n3. Rhabdomyoma\n4. Metastasis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 911,
            "markdown": "5. Fibroma\n\n# Right Ventricular Mass \n\n1. Thrombus\n2. Rhabdomyoma\n3. Secondary deposit\n4. Angiosarcoma\n\n## Mitral Valve Mass\n\n(a) frequent\n\n1. Idiopathic mitral annular calcification (most common)\n$C x$ : caseous degeneration of annulus\nCT:\n$\\sqrt{ }$ well-defined peripherally calcified mass\n$\\sqrt{ }$ central region of variable attenuation\nMR:\n$\\sqrt{ }$ hypointense mass on all sequences\n2. Vegetation, usually infective ( $2^{\\text {nd }}$ most common) $\\leftarrow$ rheumatic disease / mitral valve prolapse / mitral valve prosthesis\n3. Thrombus\n4. Papillary fibroelastoma\n(b) rare:\n5. Myxoma\n6. Lymphoma\n7. Sarcoma\n8. Metastasis\n\n## Myocardial Fat\n\n$=$ focal area of attenuation $<20 \\mathrm{HU} /$ fat-suppression on MR\n\n1. Physiologic fat: $\\uparrow$ in degree with age\n\nPrevalence: $16-43 \\%$ on CT; $85 \\%$ on autopsy; $\\uparrow$ with age\nLocation: anterolateral free wall + RVOT\nSite: outer half of RV wall $\\rightarrow$ extension toward endocardium sparing subendocardium\n$\\sqrt{ }$ increase of total myocardial thickness: $\\mathrm{RV}>\\mathrm{LV}$\nPhysiologic RV myocardial fat is most frequent on anterolateral free wall, i.e. basal superior wall > middle superior wall $>$ RVOT!\n2. Healed myocardial infarct\n$=$ replacement of scar by fat; usually $>6$ months after MI\nPrevalence: $22-62 \\%$ with history of MI\nLocation: subendocardial region of culprit coronary a.\n$\\sqrt{ }$ thin linear / curvilinear configuration\n3. Arrhythmogenic RV cardiomyopathy\n4. Cardiac lipoma\n5. Lipomatous hypertrophy of interatrial septum\n6. Tuberous sclerosis complex",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 912,
            "markdown": "7. Dilated cardiomyopathy\n\n# CARDIAC CALCIFICATIONS \n\nDetected by:\nfluoroscopy (at low-beam energies $\\leq 75 \\mathrm{kVp}$ is $57 \\%$ sensitive) $<$ digital subtraction\nfluoroscopy $<$ conventional CT $<$ ultrafast CT ( $96 \\%$ sensitive)\n@ Coronary arteries\n@ Cardiac valves\n$\\diamond$ Valvar calcification means stenosis - its amount is proportionate to degree and duration of stenosis!\n\n1. Aortic valve\n$\\diamond$ Valve calcium best seen on lateral view!\n$\\diamond$ Good correlation between amount of calcium and degree of stenosis:\n> heavy calcification = significant stenosis\n> no calcification = aortic stenosis unlikely\nCause: congenital bicuspid valve ( $70-85 \\%$ ) > atherosclerotic degeneration $>$ rheumatic aortic stenosis (rare), syphilis, ankylosing spondylitis\nLocation: above + anterior to a line connecting carina + anterior costophrenic angle (lateral view)\n(a) Congenital bicuspid aortic valvular stenosis\n\n- calcium first detected at an average age of 28 years\n$\\diamond$ In patients $<30$ years aortic valve calcifications are mostly due to a bicuspid aortic valve!\n$\\checkmark$ usually extensive cluster of heavy densely calcific deposits:\n$\\checkmark$ nearly circular calcification with interior linear bar (DIAGNOSTIC)\n$\\checkmark$ poststenotic dilatation of ascending aorta\n(b) Isolated rheumatic aortic stenosis\n- calcium first detected at an average age of 47 years\n$\\diamond$ In patients $30-60$ years of age aortic valve calcification suggests rheumatic valve disease!\n$\\checkmark$ cluster of heavy dense calcific deposits without bicuspid contour\n(c) Degenerative aortic stenosis\n- calcium first detected at an average age of 54 years\n$\\diamond$ In patients $>65$ years aortic valve calcification in $90 \\%$ due to atherosclerosis!\n$\\checkmark$ curvilinear shape of calcium outlining tricuspid leaflets\n$\\checkmark$ diffuse dilatation + tortuosity of aorta (NO poststenotic dilatation)\n\n2. Mitral valve (MV)\n\nCause: rheumatic heart disease (virtually always), infected endocarditis, tumor attached to mitral valve, mitral valve prolapse\nLocation: inferior to a line connecting carina + anterior costophrenic angle (on lateral view)\n\n- calcium first detected in early 30 s when patients become overtly symptomatic\n$\\diamond$ a severely calcified MV is usually stenotic, but MV stenosis frequently exists without",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 913,
            "markdown": "calcium\n$\\sqrt{ }$ delicate calcification similar to coronary arteries (DDx: calcium in RCA / LCX)\n$\\sqrt{ }$ superior-to-inferior motion\n3. Pulmonic valve\n\nCause: tetralogy of Fallot, pulmonary stenosis, atrial septal defect\n$\\sqrt{ }$ calcific pattern similar to calcified mitral valve\n4. Tricuspid valve (extremely rare)\n\nCause: rheumatic heart disease, septal defect, tricuspid valve defect, infective endocarditis\n@ Annulus\n$=$ valve rings serve as fibrous skeleton of the heart for attachment of myocardial fibers + cardiac valves\n\n1. Mitral annulus\n\nCause: degenerative (physiologic in elderly)\nAge: $>65$ years; $\\mathrm{M}+\\mathrm{F}=1 \\div 4$\nMay be associated with: mitral valve prolapse\nCommonly associated with:\naortic valve calcium (= aortic stenosis), hypertension, hypertrophic cardiomyopathy; NOT MV dysfunction\n$\\sqrt{ }$ dense bandlike calcification starting at posterior aspect + progressing laterally frequently forming a \"reversed C\" / \"O\" / \"U\" / \"J\"\nCx: mitral insufficiency ( $\\leftarrow$ impaired anterior mitral leaflet); atrial fibrillation; heart block ( $\\leftarrow$ infiltration into posterior wall conduction pathway)\nPrognosis: doubles risk of stroke\n2. Aortic annulus\n$\\sqrt{ }$ usually in combination with degenerative aortic valve calcification $\\rightarrow$ NO effect on valve function\n3. Tricuspid annulus\n\nAssociated with: long-standing RV hypertension\nLocation: right AV groove\n$\\sqrt{ }$ bandlike C-shaped configuration\n@ Pericardium\nCause: idiopathic pericarditis, rheumatic fever (5\\%), TB, viruses, uremia, trauma, radiotherapy to mediastinum\nLocation: calcification over less pulsatile right-sided chambers along diaphragmatic surface, atrioventricular grooves, pulmonary trunk\n$\\sqrt{ }$ clumpy amorphous calcium deposits, frequently in atrioventricular groove\n$\\sqrt{ }$ diffuse eggshell calcification sparing LA (not covered by pericardium)\nCx: constrictive pericarditis\n$\\diamond 50 \\%$ of patients with constrictive pericarditis show pericardial calcifications!\n@ Myocardium\nCause: infarction, aneurysm, rheumatic fever, myocarditis\nFrequency: in $8 \\%$ post myocardial infarction; $\\mathrm{M}>\\mathrm{F}$\nLocation: apex / anterolateral wall of LV (coincides with LAD vascular distribution +",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 914,
            "markdown": "typical location of LV aneurysms)\n$\\sqrt{ }$ thin curvilinear contour outlining the aneurysm\n$\\sqrt{ }$ shaggy laminated calcification suggests calcification of associated mural thrombus\n$\\sqrt{ }$ coarse amorphous calcifications caused by trauma, cardioversion, infection, endocardial fibrosis\n@ Interventricular septum\nLocation: triangular fibrous area between mitral + tricuspid annuli (= trigona fibrosa) representing the basal segment of interventricular septum, closely related to bundle of His\nAlways associated with:\nheavy calcification of mitral annulus / aortic valve\n$C x$ : heart block\n@ Left atrial wall\nCause: rheumatic endocarditis\n(a) diffuse sheetlike form\n\n- patient usually in CHF + atrial fibrillation\n$\\sqrt{ }$ curvilinear calcification sparing interatrial septum + posterolateral wall on right side\n$\\checkmark$ shaggy nodular deposits in atrial appendage\n$C x$ : mural thrombus formation + emboli\n$\\diamond$ LA wall calcification indicates atrial fibrillation!\n(b) localized form\n$\\sqrt{ }$ nodular calcific scar in posterior wall (= MacCallum patch) $\\leftarrow$ injury from a forceful jet in mitral valve insufficiency\n[William George MacCallum (1874-1944), one of the first graduates of the Johns Hopkins Medical School in 1897, professor of pathology at Columbia University and Johns Hopkins University]\n@ Cardiac tumor\natrial myxoma (in 5-10\\% calcified), rhabdomyoma, fibroma, angioma, osteosarcoma, osteoclastoma\n@ Endocardium\nCause: cardiac aneurysm, thrombus, endocardial fibroelastosis\n@ Pulmonary artery\nCause: severe precapillary arterial pulmonary hypertension (pHTN), syphilis\n@ Ductus arteriosus\n(a) in adults: indicates patency of ductus with associated long-standing precapillary arterial pHTN\n(b) in ductus likely closed\nchildren:\n$\\sqrt{ }$ calcium deposition in ligament of Botallo\n[Leonardo Botallo (1530-1600), Italian surgeon and anatomist in the French royal medical service in Paris]\n\n\n# Coronary Artery Calcification \n\n$\\diamond$ The amount of coronary calcification correlates with the extent of atherosclerosis!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 915,
            "markdown": "$\\diamond$ The absence of coronary calcifications implies the absence of angiographically significant coronary vessel stenosis!\nCause: (1) Arteriosclerosis of intima\n(2) Mönckeberg medial sclerosis (exceedingly rare)\n\nHisto: calcified subintimal plaques\nPathophysiology:\ninjury to endothelium $\\rightarrow$ allows circulating histiocytes to lodge in vessel wall $\\rightarrow$ transformation into macrophages; these accumulate lipids (\"fatty streaks\" beneath surface endothelium); lipids calcify; the thin fibrous cap overlying lipid deposits may rupture allowing circulating blood to mount a thrombogenic reaction resulting in narrowing of lumen\n$\\diamond$ Calcium is deposited as calcium hydroxyapatite in hemorrhagic areas within atheromatous plaques!\nLocation: \"coronary artery calcification triangle\"\n$=$ triangular area along mid left heart border, spine, and shoulder of LV containing calcifications of left main coronary artery + proximal portions of LAD + LCX\nFrequency (autoptic): LAD (93\\%), LCX (77\\%), main LCA (70\\%), RCA (69\\%)\nCXR (detection rate up to $42 \\%$ ):\n$\\checkmark$ parallel calcified lines (lateral view)\n$\\diamond$ Indicates more severe coronary artery disease\nFluoroscopy: (promoted as inexpensive screening test)\n(a) asymptomatic population\n> calcifications in $34 \\%$ in asymptomatic male individuals\n> in $35 \\%$ of patients with calcifications exercise test will be positive (without calcifications only in $4 \\%$ positive)\n> calcifications indicate $>50 \\%$ stenosis ( $72-76 \\%$ sensitive, $78 \\%$ specific); frequency of coronary artery calcifications with normal angiogram increases with age; predictive value in population $<50$ years as good as exercise stress test\n(b) symptomatic population\n> in $54 \\%$ of symptomatic patients with ischemic heart disease\n$\\diamond$ In symptomatic patients $94 \\%$ specificity for obstructive disease ( $>75 \\%$ stenosis) of at least one of the three major vessels!\nCT:\n(a) electron beam: threshold of +130 HU\n(b) spiral CT: threshold of +90 HU\n\nClinical outcome:\n(a) for coronary calcifications detected at fluoroscopy: $5.4 \\%$ event risk at 1 year (vs. $2.1 \\%$ without calcification)\n(b) for electron beam CT a calcification score of $\\geq 100$ is highly predictive in identifying patients with events\nPrognosis: $58 \\%$ (87\\%) 5-year survival rate with (without) calcifications\n\n# PERICARDIUM",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 916,
            "markdown": "# Pericardial Compressive Syndromes \n\n1. Cardiac tamponade\n2. Constrictive pericarditis $\\leftarrow$ loss of elasticity $\\leftarrow$ scarring\n3. Concomitant effusive-constrictive pericarditis\n$=$ constrictive physiology + coexisting pericardial effusion\n\n- central venous pressure remains elevated after drainage of pericardial effusion\n\n\n## Pericardial Thickening\n\n$=$ pericardial thickness $\\geq 4 \\mathrm{~mm}$\n$\\diamond$ Pericardial thickening / calcifications are NOT DIAGNOSTIC of constrictive pericarditis! It requires symptoms of physiologic constriction / restriction.\nA. PERICARDITIS WITH RESTRICTION\n\n- clinical findings of heart failure\n\n1. Constrictive pericarditis\nB. PERICARDITIS WITHOUT RESTRICTION\n\n- no clinical findings of heart failure\n$\\sqrt{ }$ enhancement of thickened pericardium indicates inflammation\n\n1. Acute pericarditis\n2. Uremia\n3. Rheumatic heart disease\n4. Rheumatoid arthritis\n5. Sarcoidosis\n6. Mediastinal irradiation\n\n## Pericardial Effusion\n\n$=$ pericardial fluid $>50 \\mathrm{~mL}$\n\n- dyspnea, fatigue, symptoms of cardiac tamponade (50\\%)\n\nEtiology:\nA. SEROUS FLUID = transudate congestive heart failure, hypoalbuminemia (liver insufficiency), renal failure, irradiation, Dressler syndrome, postpericardiotomy syndrome, myxedema, druginduced pericarditis\nB. BLOOD = hemopericardium\n(a) iatrogenic: cardiac surgery / catheterization, anticoagulants, chemotherapy, radiation\n(b) trauma: penetrating / nonpenetrating\n(c) acute myocardial infarction / rupture of free wall\n(d) aneurysm rupture of left ventricle / coronary artery\n(e) rupture of ascending aorta / pulmonary trunk / ruptured aortic dissection\n(f) coagulopathy\n(g) neoplasm (30\\%): mesothelioma, sarcoma, teratoma, fibroma, angioma, metastasis (lung, breast, lymphoma, leukemia, melanoma)\nC. LYMPH\nneoplasm, congenital, cardiothoracic surgery, obstruction of hilum / SVC",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 917,
            "markdown": "D. FIBRIN = exudate\n(a) infection: viral, pyogenic, tuberculous\n(b) renal insufficiency: $18 \\%$ in acute uremia; $51 \\%$ in chronic uremia; dialysis patient\n(c) collagen vascular disease: SLE, rheumatoid arthritis, acute rheumatic fever\n(d) hypersensitivity: Dressler syndrome\nmnemonic: CUM TAPPIT RV\nCollagen vascular disease\nUremia\nMetastasis\nTrauma\nAcute myocardial infarction\nPurulent infection\nPost MI syndrome\nIdiopathic\nTuberculosis\nRheumatoid arthritis\nVirus\nCXR:\n$\\sqrt{ }$ normal with fluid $<250 \\mathrm{~mL} /$ in acute pericarditis\n$\\sqrt{ }$ \"water bottle configuration\" = symmetrically enlarged cardiac silhouette\n$\\sqrt{ }$ loss of retrosternal clear space\n$\\sqrt{ }$ \"fat-pad\" sign = separation of retrosternal from epicardial fat line $>2 \\mathrm{~mm}$ (in 15\\%) by water density\n$\\sqrt{ }$ rapidly appearing cardiomegaly + normal pulmonary vascularity\n$\\sqrt{ }$ \"differential density\" sign = increase in lucency at heart margin $\\leftarrow$ slight difference in contrast between pericardial fluid + heart muscle\n$\\sqrt{ }$ diminished cardiac pulsations\nCT:\n$\\sqrt{ }$ effusion of greater than water density = hemopericardium, malignancy, purulent effusion, hypothyroid state\n$\\sqrt{ }$ effusion of low attenuation = chylopericardium\n$\\sqrt{ }$ pericardial thickening $>4 \\mathrm{~mm}$ suggests pericarditis\nMR:\n$\\sqrt{ }$ effusion hypointense on T1WI + hyperintense on T2WI = simple transudate\n$\\sqrt{ }$ effusion hyperintense on T1WI + hypointense on T2WI = proteinaceous / hemorrhagic fluid\n$\\sqrt{ }$ septations + debris + pericardial thickening = complex effusion as in inflammatory pericarditis of uremia / TB\nECHO:\n$\\sqrt{ }$ separation of epi- and pericardial echoes extending into diastole (rarely behind LA)\n$\\sqrt{ }$ volume estimates by M-mode:\n(a) separation only posteriorly $=<300 \\mathrm{~mL}$\n(b) separation throughout cardiac cycle $=300-500 \\mathrm{~mL}$\n(c) plus anterior separation $=>1000 \\mathrm{~mL}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 918,
            "markdown": "# Pneumopericardium \n\nEtiology: shearing mechanism of injury of the heart during blunt trauma\nPath: tear in fibrous pericardium, usually along course of phrenic nerve, allows pneumomediastinal air to enter\n$\\sqrt{ }$ thick shaggy soft-tissue density of fibrous pericardium separated by air from cardiac density\n$\\sqrt{ }$ air limited to distribution of pericardial reflection\n\n## Tension Pneumopericardium\n\n$=$ intrapericardial pressure $>265 \\mathrm{~mm} \\mathrm{H}_{2} \\mathrm{O}$ (normal intrapericardial pressure $=50-100$ $\\mathrm{mm} \\mathrm{H}_{2} \\mathrm{O}$ )\n$\\diamond$ MEDICAL EMERGENCY!\nCause: blunt / penetrating trauma, iatrogenic, positive pressure ventilation (barotrauma), pericarditis with gas-forming organisms, direct extension of inflammatory process from adjacent structures, fistulous communication with air-containing structures, extension of pneumomediastinum\n\n- chest pain, dyspnea, cyanosis, hypotension, tachycardia\n- cardiac tamponade + hemodynamic compromise\n\nCXR:\n$\\checkmark$ \"halo\" sign = continuous rim of air outlining the heart borders\n$\\checkmark$ \"small heart\" sign = sudden substantial decrease in size of cardiac silhouette\nCT:\n$\\checkmark$ substantial amount of air in pericardial cavity\n$\\checkmark$ compression + displacement of heart:\n$\\checkmark$ collapse of heart chambers\n$\\checkmark$ flattening of anterior heart border\n$\\checkmark$ distension of IVC\n$R x$ : needle pericardiocentesis / placement of drain\n\n## Pericardial disease\n\nA. CONGENITAL\n\n1. Pericardial cyst / diverticulum\n2. Pericardial defect\nB. ACQUIRED\n3. Pericardial effusion\n4. Cardiac tamponade\n5. Inflammatory pericarditis\n6. Constrictive pericarditis\nC. PERICARDIAL PSEUDOMASS\ncystic lesion, hematoma, gossypiboma (= foreign body granuloma around surgical sponge), complex organized effusion, abundant epicardial fat, epicardial fat necrosis\nD. TRUE PERICARDIAL MASS\n\nPericardial neoplasms are rarely asymptomatic usually presenting with nonspecific diverse symptoms:\n\n- exertional dyspnea, chest pain, cough, palpitations",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 919,
            "markdown": "- fatigue, night sweats, fever\n- facial / lower-extremity edema\ndue to: pericarditis, pericardial effusion, invasion of adjacent structures\n(a) Primary pericardial tumor (extremely rare)\n\n1. Pericardial mesothelioma\n2. Pericardial sarcoma: angio-, lipo-, rhabdomyo-, synovial sarcoma, undifferentiated sarcoma\n3. Pericardial lymphoma\n4. Pericardial teratoma\n5. Pericardial fibroma, hemangioma, lipoma\n(b) Secondary pericardial tumor (in $10-12 \\%$ ):\n> direct invasion by neoplasm of lung, mediastinum (lymphoma), heart (angiosarcoma)\n> hematologic spread from malignant melanoma, lymphoma, breast cancer\n> venous extension from renal cell carcinoma, HCC\n$C x$ : (1) invasion of mediastinal structures\n(2) regional / distant metastases\n(3) pericardial effusion\n(4) cardiac tamponade\n(5) compression of vascular structures / cardiac chambers\n(6) encasement of vital structures\n(7) involvement of coronary arteries\n(8) myocardial infarction\n(9) diastolic dysfunction\n(10) constrictive physiology\n\n# PULMONARY VASCULARITY \n\n## Normal Pulmonary Vasculature\n\nA. VASCULAR DISTRIBUTION\n$\\sqrt{ }$ pulmonary vessels within upper perihilum approximate $1 / 3$ of total vascularity\n$\\sqrt{ }$ pulmonary vessels within lower perihilum approximate $2 / 3$ of total vascularity\nB. VASCULAR TAPERING\n$\\sqrt{ }$ pulmonary vessels taper near transition of middle $1 / 3$ to outer $1 / 3$ of lung\nC. VASCULAR CALIBER\n$\\sqrt{ }$ straight / slightly concave main pulmonary artery contour (mild convexity is normal in young females)\n$\\sqrt{ }$ pulmonary trunk measures $<4.5 \\mathrm{~cm}$ (leftward distance from vertical line at carina to most lateral aspect of main pulmonary artery contour)\n$\\sqrt{ }$ right interlobar / intermediate pulmonary artery measures 10-15 (9-14) mm in males (females) on PA radiographs\n$\\sqrt{ }$ pulmonary vessel size $<1-2 \\mathrm{~mm}$ in extreme lung periphery\n$\\sqrt{ }$ artery within $1^{\\text {st }}$ anterior intercostal space measure $\\leq 3 \\mathrm{~mm}$\nCT:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 920,
            "markdown": "$\\sqrt{ }$ upper limits of normal for main pulmonary artery $=3 \\mathrm{~cm}$\nNormal Pulmonary Vascularity \\& Normal-sized Heart\nmnemonic: MAN\nMyocardial ischemia\nAfterload (= pressure overload problems)\nNormal\n\n# Increased Pulmonary Vasculature \n\nA. OVERCIRCULATION\n$=$ shunt vascularity $=$ arterial + venous overcirculation\n(a) congenital heart disease (most common)\n(1) L-R shunts\n(2) Admixture cyanotic lesions\n(b) high-flow syndromes\n(1) Thyrotoxicosis\n(2) Anemia\n(3) Pregnancy\n(4) Peripheral arteriovenous fistula\n$\\sqrt{ }$ diameter of right descending pulmonary artery larger than trachea just above aortic knob\n$\\checkmark$ increased size of vessels (veins + arteries) larger than accompanying bronchus (= \"kissing cousin\" sign), best seen just above hila on AP view\n\n| Evaluation of Pulmonary Vasculature on ERECT Chest Film |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n|  | Normal | $P A H$ | PVH | Overload |\n| Distribution $(U L+L L)$ | $1 \\div 2$ | $1 \\div 2$ | $1 \\div 1$ or $1 \\div 2$ | $1 \\div 1$ |\n| Vessel tapering | middleouter $1 / 3$ | variably pruned | outer third | outer third |\n| Vascular caliber |  | increased | increased | increased |\n| Artery-to-bronchus ratio: |  |  |  |  |\n| upper lung | $0.85 \\pm 0.15$ |  | $1.50 \\pm 0.25$ | $1.62 \\pm 0.31$ |\n| lower lung | $1.34 \\pm 0.25$ |  | $0.87 \\pm 0.20$ | $1.56 \\pm 0.28$ |\n| Vessel margins (edema) | sharp | sharp | obscured | obscured |\n\n$\\sqrt{ }$ enlarged hilar vessels (lateral view)\n$\\sqrt{ }$ visualization of vessels below $10^{\\text {th }}$ posterior rib\nB. PULMONARY VENOUS HYPERTENSION\n$\\sqrt{ }$ redistribution of flow (not seen in younger children)\n$\\sqrt{ }$ indistinctness of vessels with Kerley lines (= interstitial edema)\n$\\sqrt{ }$ fine reticulated pattern\n$\\sqrt{ }$ alveolar edema",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 921,
            "markdown": "# C. PRECAPILLARY HYPERTENSION \n\n$\\sqrt{ }$ enlarged main + right and left pulmonary arteries\n$\\sqrt{ }$ abrupt tapering of pulmonary arteries\nD. PROMINENT SYSTEMIC / AORTOPULMONARY COLLATERALS\n\n1. Tetralogy of Fallot with pulmonary atresia (= pseudotruncus)\n2. VSD + pulmonary atresia (single ventricle, complete transposition, corrected transposition)\n3. Pulmonary-systemic collaterals\n$\\sqrt{ }$ coarse vascular pattern with irregular branching arteries (from aorta / subclavian arteries)\n$\\sqrt{ }$ small central vessels despite apparent $\\uparrow$ in vascularity\n\n## Decreased Pulmonary Vascularity\n\n$=$ obstruction to pulmonary flow\n$\\sqrt{ }$ vessels reduced in size and number\n$\\sqrt{ }$ hyperlucent lungs\n$\\sqrt{ }$ small pulmonary artery segment + hilar vessels\n\n## PULMONARY ARTERY\n\n## Invisible Main Pulmonary Artery\n\nA. UNDERDEVELOPED $=$ RVOT obstruction\n\n1. Tetralogy of Fallot\n2. Hypoplastic right heart syndrome (tricuspid / pulmonary atresia)\nB. MISPLACED PULMONARY ARTERY\n3. Complete transposition of great vessels\n4. Persistent truncus arteriosus\n\n## Major Aortopulmonary Collateral Arteries\n\n$=$ systemic pulmonary supply via aortic branches\n\n1. Pulmonary atresia with VSD = severe form of tetralogy of Fallot\n2. Tetralogy of Fallot\n3. Transposition of great arteries\n4. Double-outlet right ventricle\n5. Truncus arteriosus\n\n## Decreased Diameter of Pulmonary Artery\n\n1. Lung cancer\n$\\diamond$ Tumor extending $>180^{\\circ}$ of arterial circumference of main pulmonary artery indicates unresectability!\n2. Mediastinal fibrosis\n3. Takayasu arteritis\n4. Chronic thromboembolic disease\n\n## Unequal Pulmonary Blood Flow",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 922,
            "markdown": "1. Tetralogy of Fallot\n$\\sqrt{ }$ diminished flow on left side (hypoplastic / stenotic pulmonary artery in 40\\%)\n2. Persistent truncus arteriosus (esp. type IV)\n$\\sqrt{ }$ diminished / increased blood flow to either lung\n3. Pulmonary valvular stenosis\n$\\sqrt{ }$ increased flow to left lung $\\leftarrow$ jet phenomenon\n\n# Dilatation of Pulmonary Artery \n\n1. Idiopathic dilatation of pulmonary trunk\n2. Pulmonic valve stenosis\n$\\checkmark$ poststenotic dilatation of trunk + left pulmonary artery\n3. Pulmonary regurgitation\n(a) severe pulmonic valve insufficiency\n(b) absence of pulmonic valve (may be associated with tetralogy)\n4. Congenital L-to-R shunts\n5. Pulmonary arterial hypertension\n6. Aneurysm: mycotic / traumatic\n7. Intravascular pulmonary metastases\n\n## Filling Defect in Pulmonary Artery\n\n1. Thromboembolism ( $99 \\%$ )\n2. Nonthrombotic embolus: fat droplets, bubbles of air / nitrogen, tumor, foreign bodies (talc, polymethylmethacrylate particles)\n$\\diamond$ Particles mostly too small to be visualized\n3. Primary sarcoma\n\n## PULMONARY VEIN\n\n## Congenital Anomalies of Pulmonary Veins\n\nA. ANOMALIES IN NUMBER\n\n1. Anomalous unilateral single pulmonary vein = meandering pulmonary vein\n$\\checkmark$ serpentine tubular opacity adjacent to lung hilum\n$D D x$ : scimitar syndrome, $A V M$, lung nodule\nB. ANOMALIES IN DIAMETER\n2. Congenital unilateral pulmonary vein stenosis / atresia\n$\\checkmark$ small lung with ipsilateral mediastinal deviation\n$\\checkmark$ reticular opacities with Kerley B lines\n$D D x$ : pulmonary neoplasm, fibrosing mediastinitis\n3. Pulmonary vein varix\nC. ANOMALIES IN DRAINAGE\n4. TAPVR\n5. PAPVR\n6. Scimitar syndrome\n7. Sinus venosus defect\n8. Malposition of septum primum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 923,
            "markdown": "# 9. Cor triatriatum \n\n## Pulmonary Vein Stenosis / Obstruction\n\nMechanism: extrinsic compression / invasion\n\n1. Radiofrequency ablation for atrial fibrillation ( $1-10 \\%$ )\n2. Surgery: heart surgery, correction of APVR, lung transplantation\n3. Neoplastic infiltration: lung primary, atrial tumor, primary sarcoma\n4. Fibrosing mediastinitis\n5. Benign inflammatory process: sarcoidosis, tuberculosis\n\n## Pulmonary Vein Calcification\n\n1. Rheumatic mitral valve disease (long-term): associated with atrial fibrillation, considerable LA dilatation, high prevalence of dyspnea, female predominance\n2. Chronic renal failure: (= deposits of extraskeletal metastatic calcium) associated with cardiac arrhythmia\n\n## PULMONARY HYPERTENSION (pHTN)\n\n$=$ sustained mean pulmonary arterial pressure of $\\geq 25 \\mathrm{mmHg}$ at rest $/>30 \\mathrm{mmHg}$ with exercise\n$=$ pulmonary capillary wedge pressure $\\leq 15 \\mathrm{mmHg}$ determined by right heart catheterization\nRight heart catheterization is the reference standard for pulmonary HTN because it enables direct measurement of pulmonary pressure, resistance, and cardiac output!\nNormal: resting mean pulmonary artery pressure $\\leq 20 \\mathrm{mmHg}$\nCause: elevated precapillary pulmonary resistance + normal pulmonary venous pressure (= pulmonary wedge pressure $\\leq 15 \\mathrm{mmHg}$ )\nPathophysiology:\nreduction in cross-sectional area of the pulmonary vascular bed $\\rightarrow$ chronic elevation in pulmonary arterial pressure $\\rightarrow$ RV hypertrophy $\\rightarrow$ RA dilatation $\\rightarrow$ abnormal septal motion impairing LV function $\\rightarrow$ RV dilatation $\\rightarrow$ tricuspid regurgitation $\\rightarrow$ decreased cardiac output $\\rightarrow$ right heart failure\nIn severe pulmonary hypertension the hypertrophied RV is of spherical shape with a greater crosssectional area than the LV resulting in abnormal septal motion that impairs left ventricular function.\n$\\diamond$ The most useful noninvasive parameters to assess RV function: RV volume + RV ejection fraction measured at cardiac MR imaging!\nHisto: intimal cellular proliferation + medial hypertrophy in walls of muscular arteries\nClassification by anatomic level:\nA. PRECAPILLARY CAUSE\n$=$ changes limited to pulmonary arterial circulation @ level of muscular arteries\n\n1. Chronic thromboembolic pulmonary disease as a complication of single or multiple undiagnosed (? \\%) / diagnosed (4\\%) acute symptomatic pulmonary thromboembolic events\n2. In-situ pulmonary arterial thrombotic disease (polycythemia, sickle-cell disease)\n3. Widespread pulmonary embolism by intravascular\n(a) malignant cells (= tumor emboli) in cancer of kidney, liver, stomach, breast,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 924,
            "markdown": "prostate, ovary, malignant melanoma, choriocarcinoma, right atrial myxoma\n(b) parasites (= parasitic emboli), commonly of Schistosoma mansoni\n(b) foreign material, eg. talcosis of IV drugs\n$\\diamond$ Fat, amniotic fluid, septic emboli rarely produce clinically significant PAH!\n4. Pulmonary vasculitis: eg, collagen vascular disease (especially scleroderma), CREST, HIV\n5. Longstanding cardiac L-to-R shunt = Eisenmenger syndrome with reversal into R-to-L shunt: VSD (in 10\\%), ASD (in 5\\%), PDA, TGV\n6. Alveolar hypoventilation syndromes\n7. Primary pHTN (idiopathic)\nB. PULMONARY PARENCHYMAL DISEASE\n$=$ mechanical interference with small pulmonary arteries (classified under precapillary cause)\n(a) hypoxic lung disease:\n\n1. Chronic obstructive pulmonary disease\n2. Interstitial pulmonary fibrosis (in $46 \\% \\mathrm{PAH}$ )\n3. Ventilatory failure $\\leftarrow$ thoracic cage deformity (kyphoscoliosis, thoracoplasty, restrictive pleural disease), diaphragmatic disorder, neuromuscular disease, spinal cord injury\n(b) connective tissue disorder:\n4. Scleroderma (PAH in 12\\%)\n5. CREST variant of scleroderma (calcinosis, Raynaud phenomenon, esophageal motility disorder, sclerodactyly, telangiectasia)\n6. Polymyositis, dermatomyositis, systemic lupus erythematosus, rheumatoid arthritis\n(c) infection:\n7. HIV ( $6-12 \\mathrm{x}$ compared to general population)\n8. Sarcoidosis\n9. Tuberculosis\nC. POSTCAPILLARY CAUSE\n$=$ PULMONARY VENOUS HYPERTENSION\n$=$ findings located in pulmonary venous circulation + between capillary bed and left atrium\n10. Elevated left atrial pressure: usually MV disease, chronic left heart failure, left atrial tumor / thrombus\n11. Fibrosing mediastinitis $\\rightarrow$ narrowing of pulmonary veins, which may also affect precapillary vessels\n12. Pulmonary venoocclusive disease: idiopathic\n13. Pulmonary capillary hemangiomatosis\n\n- often not clinically recognized until advanced stage\n- nonspecific symptoms: exertional dyspnea, fatigue, syncope\n\nECG with Doppler ( $79-100 \\%$ sensitive, $68-98 \\%$ specific):\n$\\sqrt{ }$ systolic pulmonary artery pressure\n$\\sqrt{ }$ tricuspid regurgitant jet velocity\nCXR:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 925,
            "markdown": "$\\sqrt{ }$ may be normal in early stage\n$\\sqrt{ }$ central pulmonary arterial dilatation\n$\\sqrt{ }$ pruning of peripheral arteries\n$\\sqrt{ } \\uparrow$ diameter of right interlobar artery: $>16$ ( $>15$ ) mm in men (women) measured from its lateral margin to interlobar bronchus\n$\\sqrt{ } \\downarrow$ retrosternal air space (LAT view) by RV enlargement\nNUC (V/Q scan):\n$\\diamond$ A normal V/Q scan rules out chronic thromboembolic disease (modality of choice)!\n![img-91.jpeg](img-91.jpeg)\n$\\sqrt{ }$ normal / diffuse patchy perfusion defects in severe pHTN\nCT pulmonary angiogram:\n$\\sqrt{ }$ vascular signs:\n$\\sqrt{ }$ widest short-axis diameter of pulmonary trunk $\\geq 29 \\mathrm{~mm}$ ( $87 \\%$ sensitive, $89 \\%$ specific, $97 \\%$ PPV) measured on transverse sections at level of PA bifurcation CAVE: in pulmonary fibrosis PA dilatation occurs without pHTN\n$\\sqrt{ }$ diameter ratio of distal pulmonary trunk to ascending aorta (measured at same level) $>1$ ( $96 \\%$ PPV, $92 \\%$ specific) independent of systolic-diastolic variations with strong correlation in patients $<50$ years\n$\\sqrt{ }$ diameter of main left + right pulmonary artery $>16 \\mathrm{~mm}$ (= poor indicator of pulmonary arterial hypertension)\n$\\sqrt{ }$ segmental artery-to-bronchus ratio $>1$ in 3 of 4 lobes ( $100 \\%$ specific)\n$\\sqrt{ }$ \"pruning\"/ tapering of peripheral pulmonary arteries\n$=\\downarrow$ in caliber of smaller muscular arteries ( $\\leftarrow$ vasocon-striction) + disproportionate increase in caliber of central fibrous arteries ( $\\leftarrow$ sustained increase in flow by a factor of $>2$ )\n$\\sqrt{ }$ pulmonary veins",
            "images": [
                {
                    "id": "img-91.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 547,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1265,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 926,
            "markdown": "(a) small: $\\leftarrow$ precapillary pulmonary HTN\n(b) enlarged: $\\leftarrow$ left-sided heart disease\n$\\sqrt{ }$ enlargement of bronchial systemic arteries to $>1.5 \\mathrm{~mm}$ : chronic thromboembolic pHTN $(73 \\%)>$ primary $\\mathrm{pHTN}(14 \\%)$\n$\\checkmark$ vascular complications:\n$\\checkmark$ subpleural pulmonary infarcts (with elevated pulmonary venous pressure / underlying malignancy)\n$\\checkmark$ calcified plaques of central pulmonary arteries (PATHOGNOMONIC)\n$\\checkmark$ dissection / massive apposition thrombus of central pulmonary arteries\n$\\checkmark$ lung parenchymal signs (HRCT):\n$\\checkmark$ centrilobular ground-glass nodules (common in idiopathic pHTN)\nHisto: cholesterol granulomas $\\leftarrow$ ingestion of RBCs by macrophages following repeated episodes of pulmonary hemorrhage\n$\\checkmark$ geographic mosaic pattern of lung attenuation $\\leftarrow$ regional variations in lung perfusion without dilatation of bronchi:\n$\\checkmark$ hyperdense areas containing large caliber vessels ( $=\\uparrow$ vessel diameter in areas of hyperattenuation)\nN.B.: increase in density $=$ increase in vessel caliber\n$\\checkmark$ hypodense areas containing small caliber vessels $\\leftarrow$ tapering of peripheral vessels in areas of hypoattenuation\n$\\diamond$ MOST COMMON + SPECIFIC SIGN of chronic pulmonary thromboembolism!\n$\\checkmark$ mediastinal \\& cardiac signs:\n$\\checkmark$ right heart hypertrophy + dilatation:\n$\\checkmark$ RV myocardial thickness $>4 \\mathrm{~mm}$\n$\\checkmark$ straightening / leftward bowing of interventricular septum\n$\\checkmark$ right heart dilatation $=$ ratio of $\\mathrm{RV} \\div \\mathrm{LV}>1 \\div 1$ at midventricular level on axial image\n$\\checkmark$ RA enlargement\n$\\checkmark$ dilatation of tricuspid valve annulus\n$\\checkmark$ dilatation of IVC + coronary sinus\n$\\checkmark$ reflux of contrast medium into IVC + hepatic veins (usefulness diminishes with injection rate $>3 \\mathrm{~mL} / \\mathrm{sec}$ )\n$\\checkmark$ mild pericardial thickening + pericardial effusion\n$\\checkmark$ adenopathy + septal lines + ground-glass opacities suggestive of pulmonary venoocclusive disease\n$\\checkmark$ NO increase of pulsations in middle third of lung",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 927,
            "markdown": "| Dana Point Classification of Pulmonary Hypertension (2008) (based on similar pathophysiologic traits) |  |\n| :--: | :--: |\n| Group | Description |\n| 1 | Pulmonary arterial hypertension (paHTN) |\n| 1.1 | Idiopathic pulmonary arterial hypertension |\n| 1.2 | Heritable |\n| 1.3 | Drug / toxin induced |\n| 1.4 | Associated with connective tissue disease, HIV infection, portopulmonary hypertension, CHD, schistosomiasis, chronic hemolytic anemia |\n| 1.5 | Persistent pulmonary hypertension in newborn |\n| $1^{\\prime}$ | Pulmonary veno-occlusive disease / pulmonary capillary hemangiomatosis |\n| 2 | pHTN due to left heart failure: <br> systolic / diastolic dysfunction, valvular disease |\n|  | pHTN due to lung disease / hypoxia: <br> chronic obstructive pulmonary disease, interstitial lung disease, mixed restrictive + obstructive disease, sleep-disordered breathing, alveolar hypoventilation disorder, chronic high altitude exposure |\n| 4 | pHTN due to chronic thromboembolic disease |\n| 5 | pHTN with unclear multifactorial mechanisms: hematologic disorders (myeloproliferative disorder, splenectomy); systemic disorder (sarcoidosis, Langerhans cell histiocytosis, lymphangioleiomyomatosis, neurofibromatosis, vasculitis); metabolic disorder (glycogen storage disease, Gaucher disease, thyroid disorder); others (tumoral obstruction, fibrosing mediastinitis, chronic renal failure on dialysis) |\n| $\\because$ | distinct category not completely separated from PAH but difficult to categorize |\n\n# $\\sqrt{ }$ functional parameter: \n\n$\\sqrt{ }$ reduced right pulmonary artery distensibility (= change in cross-sectional area between systole and diastole) of $<16.5 \\%$ ( $86 \\%$ sensitive, $96 \\%$ specific) measured as (Areamax -\nAreamin) $\\div$ Area max $\\cdot$ 100\n$\\diamond$ Strong correlation with mean pulmonary artery pressure!\n$\\sqrt{ }$ decrease in RV ejection fraction\nMR (steady-state free precession cine):\n$\\sqrt{ }$ RV hypertrophy (in almost $100 \\%$ if RV systolic pressure exceeds 70 mmHg ):\n$\\sqrt{ }$ mean thickness of RV wall $=6 \\mathrm{~mm}$\n$\\sqrt{ }$ ventricular mass index ( $=$ RV mass $\\div$ LV mass $)>0.6$\n$\\sqrt{ }$ RV dilatation:\n$\\sqrt{ }$ mean RV end-diastolic volume $=80 \\mathrm{~mL}$\n$\\sqrt{ }$ tricuspid regurgitation $\\leftarrow$ dilatation of tricuspid valve annulus\n$\\sqrt{ }$ enlargement of RA + IVC + SVC\n$\\sqrt{ }$ septum straight / bowed leftward\n$\\sqrt{ }$ diminished RV ejection fraction (mean of $45 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 928,
            "markdown": "$\\sqrt{ }$ reduced distensibility of main pulmonary artery (mean of $8 \\%$ )\n$\\sqrt{ }$ systolic intraluminal signals in pulmonary arteries $\\leftarrow$ slow flow correlating with severity of PAH:\n$\\sqrt{ }$ mean average velocity $<11.7 \\mathrm{~cm} / \\mathrm{sec}(93 \\%$ sensitive, $82 \\%$ specific $)$ on phase-contrast imaging\nAngio (reference standard):\n$\\diamond$ Right heart catheterization $=$ the only test that confirms $\\mathrm{pHTN!}$\n$\\sqrt{ }$ direct measurement pulmonary pressure + resistance + cardiac output\n$C x$ : central arterial thrombosis, premature atherosclerosis of central elastic + muscular pulmonary arteries, aneurysmal dissection of pulmonary arteries, hypertrophy + dilatation of right side of heart\n$D x$ : clinical assessment of hemodynamic parameters, medical history, histologic findings\n\n# Pulmonary Arterial Hypertension (PAH) \n\n$=$ precapillary $\\mathrm{pHTN}$\nPathogenesis:\nA. HYPERKINETIC CAUSES\n\n1. L-to-R shunt\n2. High cardiac output states: thyrotoxicosis, chronic anemia\n3. Diffuse pulmonary arteriovenous shunts: hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu), pregnancy, polysplenia syndrome, liver cirrhosis, complex cardiac malformations\nB. OBLITERATIVE CAUSES\n(a) vascular $=$ precapillary $\\mathrm{pHTN}:$\n4. Primary plexogenic pulmonary arteriopathy $=$ Primary $\\mathrm{pHTN}$\n5. Arteritis (eg, Takayasu)\n6. Embolization\n> chronic thromboembolic disease\n> tumor\n$\\checkmark$ lymphangitic carcinomatosis\n> parasites, eg, schistosomiasis\n$\\checkmark$ hepatosplenomegaly\n> talc crystals\n$\\checkmark$ micronodular opacities\n$\\checkmark$ perihilar fibrotic masses\n7. Persistent fetal circulation\n8. Pulmonary capillary hemangiomatosis\n(b) pleuropulmonic disease\n9. Chronic interstitial lung disease $=$ cor pulmonale:\n\nCOPD, emphysema, chronic bronchitis, asthma, bronchiectasis, malignant infiltrate, granulomatous disease, cystic fibrosis, end-stage fibrotic lung, S/P lung resection, idiopathic hemosiderosis, alveolar proteinosis, alveolar microlithiasis\n2. Pleural disease + chest deformity: fibrothorax, thoracoplasty, kyphoscoliosis\n(c) vasoconstriction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 929,
            "markdown": "1. Chronic alveolar hypoxia\n$=$ hypoxic pulmonary arterial hyperperfusion:\nchronic high altitude; sleep apnea; chronic hypercapnea $\\leftarrow$ hypoventilation $\\leftarrow$ neuromuscular disease / obesity\n2. Portopulmonary hypertension (in $5 \\%$ of patients with liver cirrhosis and portal hypertension)\n(c) vasodilatation\n3. Hepatopulmonary syndrome (in $20 \\%$ of patients with liver cirrhosis) excessive vascular production of vasodilator nitric oxide\n\n# C. CHRONIC PULMONARY VENOUS HYPERTENSION \n\n## Cor Pulmonale\n\nmnemonic: TICCS BEV\nThoracic deformity\nIdiopathic: primary pulmonary hypertension (1\\%)\nChronic pulmonary embolism\nCOPD\nShunt: ASD, VSD, etc\nBronchiectasis\nEmphysema\nVasculitis\n\n## Pulmonary Venous Hypertension (PVH)\n\n$=$ INCREASED VENOUS PULMONARY PRESSURE $=$ VENOUS CONGESTION\n$=$ postcapillary $\\mathrm{pHTN}=$ primary findings located within pulmonary venous circulation between capillary bed +LA\n$D x:$ uniform / widely variable elevation of pulmonary capillary wedge pressure (PCWP) > 15 mmHg\nCause:\nA. LV INFLOW TRACT OBSTRUCTION\n$\\checkmark$ normal-sized heart with right ventricular hypertrophy\n$\\checkmark$ prominent pulmonary trunk\n@ proximal to mitral valve:\n$\\checkmark$ normal-sized left atrium\n> pulmonary veins\n\n1. TAPVR below the diaphragm\n2. Pulmonary venoocclusive disease\n3. Stenosis of individual pulmonary veins\n4. Atresia of common pulmonary vein\n> mediastinum\n5. Fibrosing mediastinitis (may also affect precapillary vessels)\n6. Constrictive pericarditis\n> left atrium\n7. Cor triatriatum\n8. Left atrial mass: thrombus, myxoma, sarcoma, metastasis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 930,
            "markdown": "3. Supravalvular ring of left atrium\n@ at mitral valve level $=$ mitral valve stenosis\n$\\checkmark$ enlarged left atrium\n4. Rheumatic mitral valve stenosis $\\pm$ regurgitation ( $99 \\%$ )\n$\\checkmark$ enlarged left atrial appendage\n5. Congenital mitral valve stenosis\n6. Parachute mitral valve (= single bulky papillary muscle)\nB. LEFT VENTRICULAR FAILURE (more common)\n(a) ABNORMALPRELOAD with secondary mitral valve incompetence ( $=$ volume overload)\n7. Aortic valve regurgitation\n8. Eisenmenger syndrome ( $=$ R-to-L shunt in VSD)\n9. High-output failure:\nnoncardiac AVM (cerebral AVM, vein of Galen aneurysm, large pulmonary AVM, hemangioendothelioma of liver, iatrogenic), thyrotoxicosis, anemia, pregnancy\n(b) ABNORMAL afterload ( $=$ pressure overload)\n$=$ LV outflow tract obstruction\n10. Hypoplastic left heart syndrome\n11. Aortic stenosis (supravalvular, valvular, anatomic subaortic)\n12. Interrupted aortic arch\n13. Coarctation of the aorta\n(c) DISORDERS OF CONTRACTION AND RELAXATION\n14. Endocardial fibroelastosis\n15. Glycogen storage disease (Pompe disease)\n16. Cardiac aneurysm\n17. Cardiomyopathy\n> congestive (alcohol)\n> hypertrophic obstructive cardiomyopathy, particularly in IDM\n(1) Asymmetric septal hypertrophy\n(2) Idiopathic hypertrophic subaortic stenosis\n(d) MYOCARDIAL ISCHEMIA\n18. Anomalous left coronary artery\n19. Coronary artery disease\n\nHisto:\n(a) primary changes: venous medial hypertrophy + intimal proliferation, marked thickening of venous internal elastic lamina\n(b) secondary changes: capillary bed congestion with adjacent vascular proliferation, interlobular septal and pleural edema + fibrosis, lymphatic dilatation, alveolar hemosiderosis, paraseptal venous infarcts adjacent to complete venous occlusion\n$C x$ : secondary pulmonary arterial hypertension\nCT:\n$\\checkmark$ interlobular septal thickening\n$\\checkmark$ pleural effusion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 931,
            "markdown": "$\\checkmark$ pulmonary edema\n$\\checkmark$ vascular redistribution (on coronal reformatted images!)\n$\\checkmark$ dilated left atrium (with left-sided heart disease)\nCXR:\n$\\checkmark$ equalization of pulmonary vascularity: PCWP $13-15 \\mathrm{mmHg}$\n$\\checkmark$ cephalization of pulmonary vascularity: PCWP $16-18 \\mathrm{mmHg}$\n$\\checkmark$ interstitial pulmonary edema (PCWP 19-24 mmHg)\n$=$ fluid within peribronchovascular connective tissue:\n$\\checkmark$ peribronchial thickening / cuffing\n$\\checkmark$ indistinct vessel margins\n$\\checkmark$ Kerley B lines = short horizontal reticulations within lateral subpleural lung bases\n$\\checkmark$ Kerley A lines $=3-4-\\mathrm{cm}$-long lines of interlobular septal thickening radiating from hila to mid and upper lung zones\n$\\checkmark$ perihilar haze $=$ hilar interstitial edema\n$\\checkmark$ thickened pleural fissures / pseudoeffusion $=$ fluid within subpleural connective tissue\n$\\checkmark$ small pleural effusions\n$\\checkmark$ alveolar pulmonary edema ( $\\mathrm{PCWP} \\geq 25 \\mathrm{mmHg}$ )\n$=$ bilateral perihilar and basilar airspace opacification\n\n# HEART VALVES \n\n## Pathology of Cardiac Valves\n\n1. Degenerative disease\n2. Inherited cause\n3. Postrheumatic heart disease\n\n## AORTA\n\n## Enlarged Aorta\n\nDefinition: diameter $>50 \\%$ above high end of normal range (depending on age + sex + body size + segment)\nPA CXR:\n$\\checkmark$ aortic knob $>4.0 \\mathrm{~cm}$ measured from indented trachea to most lateral margin of aorta\n$\\checkmark$ right convex contour above RA margin + lateral displacement of SVC ( $=$ dilatation of ascending aorta)\nA. INCREASED VOLUME LOAD\n\n1. Aortic insufficiency\n2. PDA\nB. POSTSTENOTIC DILATATION\n3. Valvular aortic stenosis\nC. INCREASED INTRALUMINAL PRESSURE\n4. Coarctation\n5. Systemic hypertension\nD. MURAL WEAKNESS / INFECTION\n6. Cystic media necrosis: Marfan / Ehlers-Danlos syndrome",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 932,
            "markdown": "2. Congenital aneurysm\n3. Syphilitic aortitis\n4. Mycotic aneurysm\n5. Atherosclerotic aneurysm (compromised vasa vasorum)\nE. LACERATION OF AORTIC WALL\n6. Traumatic aneurysm\n7. Dissecting hematoma\n\n# Enlarged Aortic Root \n\nA. COMMON CAUSES\n\n1. Connective tissue disorder: eg, Marfan syndrome, Ehlers-Danlos syndrome\n2. Bicuspid aortic valve\n3. Loeys-Dietz syndrome:\ninherited autosomal dominant disorder with typically severe + widespread arterial disease\nCx: aortic dissection at small aortic diameter\n4. Hypertension\n5. Atherosclerosis: aneurysm typically diffuse + fusiform; descending $>$ ascending aorta; root typically spared\nB. LESS COMMON CAUSES\n6. Infection: eg, syphilis\n7. Vasculitis: eg, Takayasu arteritis, giant cell arteritis\n8. Trauma\n9. Familial thoracic aneurysm disease:\nmostly autosomal dominant of variable expression + penetrance $\\rightarrow$ aneurysm at significantly younger age\n10. Turner syndrome\n\n## Aortic Wall Thickening\n\n1. Intramural hematoma\n$=$ aortic dissection without intimal tear\n2. Aortitis segments of aortic arch + branch vessels\n3. Atherosclerotic plaque\n$\\sqrt{ }$ irregular narrowing of aortic lumen\n4. Adherent thrombus\n\n## Aortitis\n\nA. Infectious aortitis\nB. Idiopathic conditions\n\n1. Idiopathic aortitis (pathologic diagnosis only)\n2. Idiopathic inflammatory aortic aneurysm\n3. Idiopathic retroperitoneal fibrosis\nC. Noninfectious aortitis $=$ vasculitis\n\nSegment: mostly affecting ascending aorta\n(a) rheumatic diseases commonly causing aortitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 933,
            "markdown": "1. Takayasu arteritis\n2. Ankylosing spondylitis\n3. Giant cell arteritis (GCA)\n4. Cogan syndrome\n5. Relapsing polychondritis\n(b) rheumatic diseases uncommonly causing aortitis\n6. Rheumatoid arthritis\n7. Seronegative spondyloarthropathies\n8. Behçet disease\n9. SLE\n(c) rheumatic diseases rarely causing aortitis\n10. Sarcoidosis\n11. Antineutrophil cytoplasmic antibody-associated aortitis: Wegener granulomatosis, polyarteritis nodosa\n12. Juvenile rheumatoid arthritis\n\nRheumatic diseases with an $>10 \\%$ prevalence of aortitis include Takayasu arteritis, GCA, long-standing ankylosing spondylitis, Cogan syndrome, relapsing polychondritis.\n\n# Acute Aortic Syndrome \n\n1. Intramural hematoma\n2. Penetrating atherosclerotic ulcer\n3. Aortic dissection with overt false lumen\n\n## Narrowing of Abdominal Aorta in Childhood\n\n1. Takayasu arteritis\n2. Fibromuscular dysplasia\n3. Prior radiation therapy\n4. Neurofibromatosis-1\n5. Williams syndrome\n6. Midaortic syndrome\n\n## Aortic Calcifications\n\n## Intimal Calcification\n\nCause: part of atherosclerotic plaque\nAssociated with: inflammatory cells, lipid, vascular smooth muscle cells\nSite: within perimeter of internal elastic lamina\n$\\sqrt{ }$ discrete punctate lesion on radiograph\n\n## Medial Calcification\n\nCause: aging, diabetes, end-stage renal disease, neuropathy, genetic syndromes\nAssociated with: elastin + vascular smooth muscle cells\n$\\sqrt{ }$ linear deposit along elastic lamellae resembling railroad tracks (when severe)\n\n## Vascular Rings\n\n$=$ anomaly characterized by encirclement of trachea + esophagus by aortic arch + branches",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 934,
            "markdown": "Prevalence: $<1 \\%$ of all congenital cardiac defects\nCause: abnormal persistence / regression of 1 of 6 embryonic aortic arches\nA. Usually symptomatic vascular ring\n\n- chronic stridor, wheezing, recurrent pneumonia\n- dysphagia, failure to thrive\n\n1. Double aortic arch with R descending aorta +L ductus arteriosus\n2. R aortic arch with R descending aorta + aberrant L subclavian artery + persistent L ductus / ligamentum arteriosum\nN.B.: left obliterated ductus arteriosus\n(= ligament of Botallo) passes from\nL pulmonary artery to descending aorta /\nL subclavian artery\n\n- symptoms + radiographic findings identical to double aortic arch\n$\\checkmark$ indentation on right lateral esophageal wall (by aortic arch)\n$\\checkmark$ impression on the anterolateral esophageal wall (by ligament of Botallo)\n$\\checkmark$ origin of L subclavian artery frequently dilated\n\n3. L arch with L descending aorta + R ductus / ligamentum\n4. Aberrant L pulmonary artery = \"pulmonary sling\"\n\nFrequency of CXR findings:\n![img-92.jpeg](img-92.jpeg)",
            "images": [
                {
                    "id": "img-92.jpeg",
                    "top_left_x": 190,
                    "top_left_y": 981,
                    "bottom_right_x": 1530,
                    "bottom_right_y": 1982,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 935,
            "markdown": "> frontal CXR:\n$\\checkmark$ right aortic arch $(85 \\%)$\n$\\checkmark$ focal indentation of distal trachea ( $73 \\%$ )\n> lateral CXR:\n$\\checkmark$ anterior tracheal bowing $(92 \\%)$\n$\\checkmark$ increased retrotracheal opacity ( $79 \\%$ )\n$\\checkmark$ focal tracheal narrowing $(77 \\%)$\nB. Occasionally symptomatic lesions\n\n1. Anomalous R innominate artery\n2. Anomalous L common carotid artery / common trunk\n3. R aortic arch with L descending aorta +L ductus / ligamentum\nC. Usually asymptomatic lesions\n4. L aortic arch + aberrant R subclavian artery\n5. L aortic arch with R descending aorta\n6. R aortic arch with R descending aorta + mirror-image branching\n7. R aortic arch with R descending aorta + aberrant L subclavian artery\n8. R aortic arch with R descending aorta + isolation of L subclavian artery\n9. R aortic arch with L descending aorta + L ductus / ligamentum\n\n# Complete Vascular Rings",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 936,
            "markdown": "![img-93.jpeg](img-93.jpeg)\n\n1. Double aortic arch $(55 \\%)$\n2. R aortic arch + aberrant L subclavian a. + L ligamentum arteriosum (12-25\\%)\n3. R aortic arch with mirror-image branching + retroesophageal L ligamentum arteriosum",
            "images": [
                {
                    "id": "img-93.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 187,
                    "bottom_right_x": 1319,
                    "bottom_right_y": 1819,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 937,
            "markdown": "4. L aortic arch +R descending aorta, R subclavian artery +R ligamentum arteriosum\n\n# Abnormal Left Ventricular Outflow Tract \n\nLVOT = area between IVS + aML from aortic valve cusps to mitral valve leaflets\n\n1. Membranous subaortic stenosis\n$=$ crescent-shaped fibrous membrane extending across LVOT + inserting at aML\n$\\sqrt{ }$ diffuse narrowing of LVOT\n$\\sqrt{ }$ abnormal linear echoes in LVOT space (occasionally)\n2. Prolapsing aortic valve vegetation\n3. Narrowed LVOT ( $<20 \\mathrm{~mm}$ )\n(a) Long-segment subaortic stenosis\n$\\sqrt{ }$ aortic valve closure in early systole with coarse fluttering\n$\\sqrt{ }$ high-frequency flutter of mitral valve in diastole (aortic regurgitation)\n$\\sqrt{ }$ symmetric LV hypertrophy\n(b) $\\mathrm{ASH} / \\mathrm{IHSS}$\n$\\sqrt{ }$ asymmetrically thickened septum bulging into LV + LVOT\n$\\sqrt{ }$ systolic anterior motion of aML (SAM)\n(c) Mitral stenosis\n(d) Endocardial cushion defect\n\n## Obstruction of Left Ventricular Outflow Tract\n\n1. Bicuspid aortic valve\n2. Coarctation of aorta\n3. Subvalvular aortic stenosis\n4. Supravalvular aortic stenosis\n\n## VENA CAVA\n\n## Vena cava anomalies\n\n## Persistent Left SVC\n\n$=$ BILATERALSVCS\nPrevalence: $0.3-0.5 \\%$ of general population; $3-11 \\%$ of patients with CHD\n$\\diamond$ Most common congenital thoracic venous anomaly\nEtiology: failure of involution of left anterior + left common cardinal veins + left horn of sinus venosus\nOrigin: confluence of left IJV + subclavian vein\nCourse: lateral to aortic arch, anterior to left hilum\nTerminus: drains into enlarged coronary sinus (in 92\\%) / into LA (in 8\\%) creating a R-toL shunt (increased prevalence of CHD)\nAssociated with:\n(a) Right SVC (82-90\\%) normal / small = SVC duplication\n(b) Bridging vein connecting right + left SVC (35-55\\%)\n(c) Absence of right SVC (in 10-18\\%): $\\rightarrow$ increased incidence of CHD (ASD, VSD, tetralogy of Fallot, bicuspid aortic valve, aortic coarctation, mitral atresia, cor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 938,
            "markdown": "triatriatum, azygos continuation of IVC)\n$\\checkmark$ persistent left SVC should be suspected when a dilated coronary sinus is seen at crosssectional imaging\n$\\sqrt{ }$ left SVC arises from confluence of left subclavian and jugular veins + traverses caudally lateral to aortic arch\n$\\sqrt{ }$ left SVC lies anterior to left hilum $\\rightarrow$ traverses along ligament of Marshall $\\rightarrow$ drains into RA via dilated coronary sinus\n$\\sqrt{ }$ CVC placement into left SVC may be mistaken for arterial / mediastinal / pleural placement (frontal CXR)\n$\\checkmark$ hemiazygos arch formed by left superior intercostal vein + persistent left SVC (20\\%)\n$\\sqrt{ }$ left brachiocephalic vein: present in $25-35 \\%$; absent / small in $65 \\%$\n\n# Circumaortic Left Renal Vein \n\nPrevalence: $1.5-8.7 \\%$\nEtiology: persistence of anterior intersubcardinal + posterior intersupracardinal anastomosis\n$\\sqrt{ }$ venous collar encircling aorta\n$\\sqrt{ }$ superior left renal vein crosses aorta anteriorly\n$\\sqrt{ }$ inferior left renal vein receives left gonadal vein + crosses aorta posteriorly $1-2 \\mathrm{~cm}$ below the superior left renal vein\nSignificance: preoperative plan for nephrectomy\n\n## Duplicated IVC\n\n$=$ DOUBLE IVC\nPrevalence: $0.2-3 \\%$\nEtiology: persistence of both supracardinal veins\n$\\sqrt{ }$ small / equal-sized left IVC formed by left iliac vein\n$\\sqrt{ }$ crossover to right IVC via left renal vein / or more inferiorly\n$\\sqrt{ }$ crossover usually anterior / rarely posterior to aorta\nSignificance: recurrent pulmonary embolism after IVC filter placement\n$D D x$ : left gonadal v./ a., inferior mesenteric v.\n\n## DOUBLE IVC WITH RETROAORTIC RIGHT RENAL VeIN AND AZYGOS CONTINUATION OF IVC\n\nEtiology: persistence of left supracardinal v. and dorsal limb of renal collar + regression of ventral limb + failure of formation of right subcardinal-hepatic anastomosis\n\n## Double IVC with Retroaortic Right Renal vein and Hemiazygos Continuation of IVC\n\nEtiology: persistence of left lumbar + thoracic supracardinal v. + left suprasubcardinal anastomosis + failure of formation of right subcardinal-hepatic anastomosis\n$\\sqrt{ }$ right IVC and right renal vein join the left IVC and continue cephalad as the hemiazygos vein\n$\\sqrt{ }$ hemiazygos vein follows alternative pathways:\n(a) crosses posterior to aorta at T8-9 and joins the rudimentary azygos vein\n(b) continues cephalad + joins coronary vein via persistent left SVC\n(c) accessory hemiazygos continuation to left brachiocephalic vein",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 939,
            "markdown": "$\\sqrt{ }$ hepatic segment of IVC drains into right atrium\n\n# Left IVC \n\n$=$ TRANSPOSITION OF IVC $=$ SOLITARY LEFT IVC\nPrevalence: $0.2-0.5 \\%$\nEtiology: persistence of left + regression of right supracardinal vein\n$\\sqrt{ }$ left IVC usually joins left renal vein\n$\\sqrt{ }$ crossover as left renal vein usually anterior / rarely posterior to aorta\n$D D x$ : left-sided paraaortic adenopathy\nSignificance: difficult transjugular access to infrarenal IVC filter placement\n\n## Retroaortic Left Renal Vein\n\nPrevalence: $1.8-2.1 \\%$\nEtiology: persistence of posterior intersupracardinal anastomosis + regression of anterior intersubcardinal anastomosis\n$\\sqrt{ }$ crossover usually below / occasionally at level of right renal vein\n\n## SVC Obstruction / Stricture\n\n- SVC syndrome\nA. INTRINSIC CAUSE long-standing CVCs, transvenous pacemaker, postoperative / postradiation effects, fibrin sheath, bland / tumor thrombus\nB. EXTRINSIC CAUSE\ncompression from malignancy (small cell + non-small cell lung cancer, lymphoma, metastatic lymphadenopathy, tracheal malignancy), mediastinal mass, fibrosing mediastinitis, lymphadenopathy, ascending aortic aneurysm\n\n\n## IVC Obstruction\n\nA. INTRINSIC OBSTRUCTION\n(a) neoplastic (most frequent)\n\n1. Renal cell carcinoma (in 10\\%), Wilms tumor\n2. Adrenal carcinoma, pheochromocytoma\n3. Pancreatic carcinoma, hepatic adenocarcinoma\n4. Metastatic disease to retroperitoneal lymph nodes (carcinoma of ovary, cervix, prostate)\n(b) nonneoplastic\n5. Idiopathic\n6. Proximally extending thrombus from femoroiliac veins\n7. Systemic disorders: coagulopathy, Budd-Chiari syndrome, dehydration, infection (pelvic inflammatory disease), sepsis, CHF\n8. Postoperative / traumatic phlebitis, ligation, plication, clip, cava filter, severe exertion\nB. INTRINSIC CAVAL DISEASE\n(a) neoplastic\n9. Leiomyoma, leiomyosarcoma, endothelioma\n(b) nonneoplastic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 940,
            "markdown": "1. Congenital membrane\nC. EXTRINSIC COMPRESSION\n(a) neoplastic\n2. Retroperitoneal lymphadenopathy (adults) $\\leftarrow$ metastatic disease, lymphoma, granulomatous disease (TB)\n3. Renal + adrenal tumors (children)\n4. Hepatic masses\n5. Pancreatic tumor\n6. Tumor-induced desmoplastic reaction (eg, metastatic carcinoid)\n(b) nonneoplastic\n7. Hepatomegaly\n8. Tortuous aorta / aortic aneurysm\n9. Retroperitoneal hematoma\n10. Massive ascites\n11. Retroperitoneal fibrosis\nD. FUNCTIONAL OBSTRUCTION\n12. Pregnant uterus\n13. Valsalva maneuver\n14. Straining / crying (in children)\n15. Supine position with large abdominal mass\nE. COLLATERAL PATHWAYS\n16. Deep pathway: ascending lumbar veins to azygos vein (right) + hemiazygos vein (left) + intravertebral, paraspinal, extravertebral plexus (Batson plexus)\n17. Intermediate pathway: via periureteric plexus + left gonadal vein to renal vein\n18. Superficial pathway: external iliac vein to inferior epigastric vein + superior epigastric vein + internal mammary vein into subclavian vein\n19. Portal pathway: retrograde flow through internal iliac vein + hemorrhoidal plexus into inferior mesenteric vein + splenic vein into portal vein\n\n# Reflux of Contrast Media \n\n## IVC Reflux\n\n1. Cardiac tamponade\n2. Tricuspid regurgitation\n3. Hypovolemic / cardiogenic shock\n4. Pulmonary embolism\n\n## Azygos Vein Reflux\n\n$=$ sign of raised central venous pressure\n\n1. Pulmonary arterial hypertension\n2. Massive pulmonary embolism\n3. Cor pulmonale\n4. Ischemic right heart failure\n5. Cardiac tamponade\n6. Tumoral obstruction of main pulmonary artery",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 941,
            "markdown": "6. Bilateral pneumothoraces\n7. Positive pressure ventilation for ARDS\n\n# INFLAMMATORY CARDIOVASCULAR DISEASE \n\n@ Myocardium\n\n1. Cardiac sarcoidosis\n2. Myocarditis\n@ Peri- \\& Epicardium\n3. Pericarditis\n4. Epipericarditis\n@ Vessels\n5. Atherosclerosis\n6. Vasculitis\n\n## Eosinophilic Diseases with Cardiac Involvement\n\n1. Eosinophilic heart disease\n2. Churg-Strauss syndrome\n3. Early giant cell myocarditis\n4. Drug-induced hypersensitivity reaction\n5. Parasitic infection\n6. Tropical endomyocardial fibrosis\n7. Malignancy\n\n## Vasculitis\n\n= inflammation and necrosis of vessel wall\nA. LARGE-VESSEL VASCULITIS\n\n1. Giant cell arteritis (= temporal arteritis)\n2. Takayasu arteritis\n3. Ankylosing spondylitis\n4. Reiter syndrome\nB. MEDIUM-SIZED-VESSEL VASCULITIS\n5. Polyarteritis nodosa\n6. Kawasaki disease\n7. Relapsing polychondritis\n8. Drug-induced vasculitis:\n> methamphetamine\n> cocaine: neurovascular, cardiovascular complications, aortic dissection, venous thrombosis, mesenteric artery thrombosis, renal infarction\nC. SMALL-VESSEL VASCULITIS\n(a) ANCA-associated small-vessel vasculitis (= antineutrophil cytoplasmic autoantibodies)\n9. Granulomatosis with polyangiitis $=$ Wegener granulomatosis\n10. Eosinophilic granulomatosis with polyangiitis $=$ Churg-Strauss syndrome\n11. Microscopic polyangiitis\n(b) immune-complex small-vessel vasculitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 942,
            "markdown": "1. IgA vasculitis $=$ Henoch-Schönlein purpura\n2. Essential cryoglobulinemic vasculitis\n3. Cutaneous leukocytoclastic angiitis\nothers: lupus, rheumatoid, Sjögren, Behçet, Goodpasture, serum sickness, druginduced, hypocomplementemic urticaria\n(c) inflammatory bowel disease vasculitis\nD. VARIABLE-SIZED-VESSEL VASCULITIS\n4. Behçet disease\n5. Cogan syndrome\nE. SINGLE-ORGAN VASCULITIS\n6. Primary angiitis of CNS (PACNS)\nF. VASCULITIS OF A SYSTEMIC DISEASE\n7. Systemic lupus erythematosus (SLE)\n8. Sjögren syndrome\n9. Rheumatoid arthritis\n10. APLA (antiphospholipid antibody) syndrome\n11. Scleroderma\nG. VASCULITIS WITH PROBABLE ETIOLOGY\n12. Infection-induced vasculitis\n13. Acute septic meningitis\n14. Mycobacterium tuberculosis\n15. Neurosyphilis\n16. Viral: HIV-related vasculitis, varicella-zoster vasculopathy\n![img-94.jpeg](img-94.jpeg)",
            "images": [
                {
                    "id": "img-94.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 1144,
                    "bottom_right_x": 1506,
                    "bottom_right_y": 1667,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 943,
            "markdown": "| Major Pediatric Vasculitides with Major Sites of Involvement |  |  |\n| :--: | :--: | :--: |\n| Type | Predilection Site | EULAR-PRES Criteria <br> (European League Against Rheumatism - Paediatric Rheumatology European Society) |\n| Takayasu arteritis | aortic arch \\& branches, pulmonary arteries | Angio: characteristic abnormalities + absent peripheral pulses / claudication, blood pressure discrepancy in any limb, bruits, HTN, elevated acute phase reactants |\n| Kawasaki disease | coronary arteries | fever $>5$ days + bilateral conjunctival injection, changes of lips \\& oral cavity, cervical lymphadenopathy, polymorphous exanthem, changes in peripheral extremities / perineal area |\n| Polyarteritis nodosa | GI tract, kidneys | Angio: abnormalities of medium to small-sized arteries with systemic necrotizing vasculitis + skin involvement, myalgia, HTN, peripheral neuropathy, renal involvement (proteinuria, hematuria, impaired function) |\n| Granulomatosis with polyangiitis | upper + lower respiratory tract, kidneys | upper airway involvement + laryngotracheobronchial stenosis + pulmonary \\& renal involvement, histopathologic granulomatous inflammation, ANCA positivity |\n| Henoch-Schönlein purpura | gut, skin, kidneys | purpura / petechiae with lower limb predominance + arthritis / arthralgia, abdominal pain, renal involvement (hematuria, proteinuria), IgA deposition |\n\n6. Fungal: mucormycosis aspergillosis\n7. Parasitic: cysticercosis\n8. Malignancy-induced vasculitis\n9. Drug-induced vasculitis\n10. Radiation-induced vasculitis\n\n# Classification of Childhood Vasculitis \n\nEuropean League against Rheumatism (EULAR) \\& Paediatric Rheumatology European Society (PRES)\nIncidence: $23 \\div 100,000$ annually\nThe 2 most common types of primary pediatric vasculitis are Henoch-Schönlein purpura (49\\%) and Kawasaki disease ( $23 \\%$ ).\nA. LARGE VESSEL\n\n1. Takayasu Arteritis\nB. MEDIUM VESSEL\n2. Kawasaki disease\n3. Polyarteritis nodosa\n4. Cutaneous polyarteritis\nC. SMALL-VESSEL GRANULOMATOUS\n5. Wegener granulomatosis\n6. Eosinophilic granulomatosis with polyangiitis\nD. SMALL-VESSEL NONGRANULOMATOUS\n7. Henoch-Schönlein purpura\n8. Microscopic polyangiitis\n9. Isolated cutaneous leukocytoclastic vasculitis\n10. Hypocomplementemic urticarial vasculitis\nE. OTHERS\n11. Behçet disease\n12. Vasculitis associated with connective tissue disease\n13. Secondary to infection, malignancy, drugs\n14. Isolated vasculitis of CNS\n15. Cogan syndrome",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 944,
            "markdown": "# Multiple Aneurysms \n\n1. Polyarteritis nodosa\n\n- fever, malaise, weight loss, myalgia\n- proteinuria, hematuria\n\n2. Rheumatoid vasculitis\n\n- advanced rheumatoid arthropathy\n\n3. Systemic lupus erythematosus\n\n- arthritis, photosensitivity\n- malar rash, discoid rash, oral ulcers\n\n4. Churg-Strauss syndrome\n5. Heroin / methamphetamine abuse\n6. Wegener granulomatosis\n7. Scleroderma\n\n- skin thickening, induration and tightness\n\n8. Diabetes\n9. Giant cell temporal arthritis (rare)\n\n## VASCULAR TUMORS \\& MALFORMATIONS\n\nClassification of International Society for the Study of Vascular Anomalies (ISSVA)\n\n## Vascular Tumors\n\n$=$ true neoplastic lesion with cellular proliferation and hyperplasia characterized by rapid early proliferative stage and later involuting stage\n\n1. Infantile hemangioma\n2. Congenital hemangioma\n3. Kaposiform hemangioendothelioma\n4. Tufted angioma\n5. Hemangiopericytoma\n6. Pyogenic granuloma\n7. Spindle cell hemangioendothelioma\n\n## Developmental Vascular Malformations\n\n$=$ error of vascular morphogenesis $\\rightarrow$ collection of dysplastic abnormally dilated arteries, veins, capillaries, lymphatics characterized by\n\n- greater conspicuity with age $\\leftarrow$ steady growth commensurate with patient growth (puberty, pregnancy, trauma, surgery may cause growth spurts)\n- NO spontaneous involution / regression\n\n1. Slow-flow vascular malformation\n$\\sqrt{ }$ absence of flow voids on SE images\n$D D x$ : low-signal-intensity striations, septa, thrombosed vessels, phleboliths\n(a) Venous malformation\n(b) Lymphatic malformation\n(c) Capillary malformation\n2. High-flow vascular malformation\n\nFrequency: $10 \\%$ of malformations in extremities",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 945,
            "markdown": "$\\sqrt{ }$ presence of signal voids demonstrating enhancement and high-signal-intensity foci on GRE images\n(a) Arteriovenous malformation\n(b) Congenital arteriovenous fistula\n\nCharacterization:\n$\\sqrt{ }$ NO blood flow = lymphatic malformation\n$\\sqrt{ }$ venous flow ONLY:\n$\\sqrt{ }$ WITH phlebolith $=$ venous malformation\n$\\sqrt{ }$ NO phlebolith = low-flow vascular malformation\nRx: sclerotherapy\n\n1. Klippel-Trénaunay syndrome\n2. Sturge-Weber syndrome\n3. Blue rubber bleb nevus\n4. Proteus syndrome\n5. Gorham-Stout syndrome\n6. Maffucci syndrome\n$\\sqrt{ }$ arterial flow:\n(a) WITH mass $=$ vascular tumor\n7. PHACE syndrome\n8. Kasabach-Merritt syndrome\n(b) NO mass = high-flow vascular malformation\nRx: arterial embolization\n9. Parkes Weber syndrome\n10. Hereditary hemorrhagic telangiectasia\n11. Vascular metameric syndrome\n(a) Wyburn-Mason syndrome\n(b) Cobb syndrome\n\n# Serpentine High-Flow Vascular Channels on MRI \n\n1. Hemangioendothelioma\n2. Hemangiopericytoma\n\n3 Angiosarcoma\n4. Rhabdomyosarcoma\n5. Synovial sarcoma\n6. Alveolar soft-part sarcoma\n7. Extraskeletal Ewing sarcoma\n\n## LYMPH FLOW DISORDERS\n\n1. Lymphatic dysplasia\n2. Lymphedema\n\n## PRIMARY HYPERCOAGULABLE STATES\n\n$=$ THROMBOPHILIA\n\n- DVT of extremities / pulmonary embolism",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 946,
            "markdown": "(a) Qualitative defect / quantitative $\\downarrow$ in an antithrombotic protein:\n> antithrombin III\n> protein C\n> protein S\n> Trousseau phenomenon in cancer: HCC, pancreatic ca.\n(b) Increased level of a prothrombotic protein\n> activated protein C resistance (Factor V Leiden)\n> G20210A prothrombin gene mutation\n\n# SUDDEN CARDIAC DEATH IN YOUNG ADULTS \n\n$=$ death from unexpected circulatory arrest within 1 hour of onset of symptoms $\\leftarrow$ usually a result of cardiac arrhythmia\nIncidence: $1-2 \\div 1000$\nAge range: 18-35 years\n\n- precipitated by:\n- ventricular tachycardia / fibrillation (75-80\\%)\n- bradyarrhythmia (15-20\\%) = AV block, asystole\n\nCause:\nA. ANOMALOUS CORONARY ARTERY\n\n1. Interarterial / intramural course\n2. LCA arising from pulmonary artery\n3. Coronary artery fistula\nB. PRIMARY CARDIOMYOPATHY\n4. Hypertrophic / dilated / noncompaction cardiomyopathy\n5. Lysosomal / glycogen storage disease\n6. Arrhythmogenic right ventricular hypertrophy\nC. INHERITED ARRHYTHMIA SYNDROME\n7. Long / short QT syndrome\n8. Brugada syndrome\n9. Catecholaminergic polymorphic ventricular tachycardia\nD. VALVULAR DISEASE\n10. Mitral valve prolapse\n11. Aortic stenosis\nE. CONGENITAL HEART DISEASE\n12. L- and D-transposition of great vessels\n13. Tetralogy of Fallot\n14. Single left ventricle\n\nIn order of frequency:\nhypertrophic cardiomyopathy $>$ anomalous coronary artery with an interarterial / intramural course $>$ arrhythmogenic right ventricular cardiomyopathy (ARVC)\n\n## CARDIAC SURGERY\n\n## Surgical Procedures",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 947,
            "markdown": "# A. AORTICOPULMONARY WINDOW SHUNT \n\n$=$ side-to-side anastomosis between ascending aorta and left pulmonary artery (reversible procedure)\n$\\rightarrow$ tetralogy of Fallot\nB. BLALOCK-HANLON PROCEDURE\n$=$ surgical creation of ASD\n$\\rightarrow$ complete transposition\nC. BLALOCK-TAUSSIG SHUNT\n$=$ end-to-side anastomosis of subclavian artery to pulmonary artery, performed ipsilateral to innominate artery / opposite to aortic arch\nMODIFIED BLALOCK-TAUSSIG SHUNT uses synthetic graft material such as polytetrafluoroethylene (Gore-Tex ${ }^{\\circledR}$ ) in an end-to-side anastomosis between subclavian artery + ipsilateral branch of pulmonary artery\n$\\rightarrow$ tetralogy of Fallot, tricuspid atresia with pulmonic stenosis\nD. FONTAN PROCEDURE\n$=$ systemic flow of venous blood to lungs without passing through any ventricle\n(1) External conduit from right atrium to pulmonary trunk ( $=$ venous return enters pulmonary artery directly)\n(2) Closure of ASD: floor constructed from flap of atrial wall and roof from piece of prosthetic material\n$\\rightarrow$ tricuspid atresia\nE. GLENN SHUNT\n$=$ end-to-side shunt between distal end of right pulmonary artery and SVC; reserved for patients with cardiac defects in which total correction is not anticipated\n$\\rightarrow$ tricuspid atresia\nF. NORWOOD PROCEDURE\n(1) Construction of \"neoaorta\" from aortic arch + descending aorta + main pulmonary artery supplying coronary and systemic circulation\n(2) Communication between RV as systemic ventricle and systemic circulation\n(3) Shunt between innominate artery + main pulmonary artery to control pulmonary arterial blood flow\n(4) Excision of distal ductus arteriosus + atrial septum to prevent pulmonary venous hypertension\n$\\rightarrow$ hypoplastic left heart syndrome\nG. POTT SHUNT\n$=$ side-to-side anastomosis between descending aorta + left pulmonary artery\n$\\rightarrow$ tetralogy of Fallot\nH. MUSTARD PROCEDURE\n(a) removal of atrial septum\n(b) pericardial baffle placed into common atrium such that systemic venous blood is rerouted into LV and pulmonary venous return into right ventricle and aorta\n$\\rightarrow$ complete transposition\nI. RASHKIND PROCEDURE\n$=$ balloon atrial septostomy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 948,
            "markdown": "![img-95.jpeg](img-95.jpeg)\n$\\rightarrow$ complete transposition\nJ. RASTELLI PROCEDURE\nexternal conduit (Dacron) with porcine valve connecting RV to pulmonary trunk\n$\\rightarrow$ transposition\nK. WALDHAUSEN PROCEDURE\n$=$ subclavian artery used to augment aortic lumen\n$=$ SUBCLAVIAN FLAP ANGIOPLASTY\n(a) ligation of left subclavian artery at origin of left vertebral artery $\\pm$ ligation of vertebral artery\n(b) lateral incision of subclavian artery with extension into aortic isthmus\n(c) excision of diaphragm of coarctation",
            "images": [
                {
                    "id": "img-95.jpeg",
                    "top_left_x": 355,
                    "top_left_y": 189,
                    "bottom_right_x": 1343,
                    "bottom_right_y": 1522,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 949,
            "markdown": "(d) subclavian artery flap folded down into incision\n$\\rightarrow$ coarctation\nL. WATERSTON-COOLEY SHUNT\n$=$ side-to-side anastomosis between ascending aorta and right pulmonary artery;\n(a) extrapericardial (WATERSTON)\n(b) intrapericardial (COOLEY)\n$\\rightarrow$ tetralogy of Fallot\n\n# Heart Valve Prosthesis \n\n(a) mechanical valve requiring long-term anticoagulation\n\n1. Starr-Edwards\n$\\checkmark$ caged ball\n$\\diamond$ Predictable performance from large long-term experience\n2. Björk-Shiley / Lillehei-Kaster / St. Jude\n$\\checkmark$ tilting disk\n$\\diamond$ Excellent hemodynamics, very low profile, durable\n(b) tissue (biologic) valve of limited durability\n3. Hancock / Carpentier-Edwards (= porcine xenograft) Ionescu-Shiley (= bovine xenograft)\n$\\diamond$ Low incidence of thromboembolism, no hemolysis, central flow, inaudible\n\n## Postoperative Thoracic Deformity\n\nA. ON RIGHT SIDE\n\n1. Systemic-PA shunt: Blalock-Taussig shunt, Waterston-Cooley shunt, Glenn shunt, central conduit shunt\n2. Atrial septectomy: Blalock-Hanlon procedure\n3. VSD repair: through RA\n4. Mitral valve commissurotomy\nB. ON LEFT SIDE\n5. PDA\n6. Coarctation\n7. PA banding\n8. Mitral valve commissurotomy\n9. Systemic-PA shunt: Blalock-Taussig shunt, Pott shunt\n\n## Postoperative Complications of Mitral Valve Surgery\n\n1. Paravalvular abscess\n2. Valvular vegetation\n3. Pseudoaneurysm\n4. Restricted leaflet excursion\n5. Dehiscence of valve prosthesis / annuloplasty band\n6. LCx artery injury\n\n## PULSUS ALTERNANS\n\n$=$ alternating arterial pulse height with regular cardiac rhythm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 950,
            "markdown": "1. Intrinsic myocardial abnormality severe left ventricular dysfunction (CHF, aortic valvular disease, hypothermia, hypocalcemia, hyperbaric stress, ischemia)\n2. Alternating end-diastolic volumes abnormalities in venous filling + return (obstructed venous return, IVC balloon\n\n# CARDIAC CONDUCTION DEVICES (CCD) \n\n## Components of CCD\n\nA. Pulse generator hardware, programmable software, lithium iodide battery (5-10-year lifespan)\nB. Leads for pacemaker / ICD\n\n1. Conductor\n2. Insulation: silicone rubber / polyurethane\n3. Electrode(s): uni- / bipolar\n4. Lead tip fixation in cardiac trabeculae:\n(a) passive: prongs, tines, fins, helix, cone\n(b) active: helical screw\n5. Proximal terminal connector pin $\\rightarrow$ well seated in connector block\n\n## Cardiac Pacemaker\n\n$=$ electronic device providing small electrical stimuli for cardiac contraction as substitute for sinoatrial node activity in wall of RA near junction with SVC\nIndication: periods of bradycardia / arrhythmia caused by disruption of electric conduction pathway (degenerative aging of SA node / AV node / conduction tissue, myocardial infarction)\nA. Temporary epicardial electrode\nB. Single-chamber pacemaker $=1$ lead pacing RV / RA\n\nPlacement:\n\n1. Apex of RV\n$=$ single-lead intramyocardial electrode\nIndication: problematic conduction pathway\n2. Into RA (uncommon)\n\nIndication: SA node dysfunction, aberrant SA focus\nB. Dual-chamber pacemaker $=2$ leads pacing RV + RA\n\nPlacement:\n\n1. 1 lead in RA\n2. 1 lead into apex of RV\n\nIndication: coordination of signals to atria + ventricles\nC. Biventricular pacemaker $=3$ leads pacing RV + LV $\\pm \\mathrm{RA}$\n\nPurpose: more efficient pumping action with simultaneous contraction of LV + RV\nIndication: moderate to severe drug-refractory CHF associated with inter-/ intraventricular dyssynchrony; weakened enlarged heart\nPlacement:\n\n1. 1 lead into apex of RV",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 951,
            "markdown": "2. 1 lead through coronary sinus into a posterior / lateral cardiac vein for LV\n3. 1 lead into RA\n$=$ right atrial-biventricular synchronous pervenous device\n$R x: \\quad$ cardiac resynchronization therapy (CRT) in combination with implantable defibrillator into appendage of RA\n\n# Implantable Cardioverter-Defibrillator (ICD) \n\n$=$ AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (AICD)\n$=$ electronic device generating a large amount of electrical energy to defibrillate the heart back into a normal rhythm\nIndication: tachydysrhymthia (ventricular tachycardia / ventricular fibrillation) to prevent cardiac arrest\n$\\sqrt{ }$ single lead with 2 shock coils\nPlacement:\n\n1. 1 shock coil at junction of brachiocephalic vein + SVC\n2. 1 shock coil into RV\n\n## Preferred Lead Implant Sites\n\n1. Right atrial pacemaker lead\n\nLocation: electrode tip in right atrial appendage\n$\\sqrt{ }$ electrode tip pointing upward + anteriorly\n$\\sqrt{ }$ electrode tip may be shaped into a preformed \"J loop\"\n$\\sqrt{ }$ slight redundancy of lead desirable to avoid tension during deep inspiration / arm movement\n2. Right ventricular pacemaker / ICD lead\n\nLocation: electrode tip in apex of RV\n$\\sqrt{ }$ electrode tip to left of spine (frontal view)\n$\\sqrt{ }$ electrode tip pointing anteriorly (lateral view)\n$\\sqrt{ }$ (rarely) electrode tip intended for RVOT\n3. Left ventricular pacemaker lead\n\nLocation: electrode tip in cardiac vein along lateral / posterior free wall of LV\n$\\sqrt{ }$ electrode tip posteriorly (lateral view)\n$\\sqrt{ }$ inferiorly + laterally (frontal view)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 952,
            "markdown": "![img-96.jpeg](img-96.jpeg)\n\nDual-Chamber Cardiac Pacemaker\n![img-97.jpeg](img-97.jpeg)",
            "images": [
                {
                    "id": "img-96.jpeg",
                    "top_left_x": 583,
                    "top_left_y": 191,
                    "bottom_right_x": 1076,
                    "bottom_right_y": 734,
                    "image_base64": null
                },
                {
                    "id": "img-97.jpeg",
                    "top_left_x": 363,
                    "top_left_y": 820,
                    "bottom_right_x": 1319,
                    "bottom_right_y": 1364,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 953,
            "markdown": "![img-98.jpeg](img-98.jpeg)\n\nNormal Blood Pressures\nPCWP = pulmonary capillary wedge pressure",
            "images": [
                {
                    "id": "img-98.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 389,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1139,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 954,
            "markdown": "![img-99.jpeg](img-99.jpeg)\n\nRight Ventricle Viewed from Front\nDemarcation between posteroinferior inflow portion and anterosuperior outflow portion by prominent muscular bands forming an almost circular orifice (parietal band, crista supraventricularis, septomarginal trabeculae ( $=$ septal band and moderator band)\n$\\mathrm{apm}=$ anterior papillary muscle attaches near apex of RV with chordae tendineae for anterior \\& posterior cusps\nAnterior papillary muscle originates from moderator band! $\\mathrm{mcpm}=$ medial supracristal (conal) papillary muscle arises from septal band with chordae tendineae for anterior \\& medial cusps $\\mathrm{ppm}=$ posterior papillary muscle attaches near apex of RV with chordae tendineae for posterior \\& medial cusps\n$\\mathrm{Ao}=$ aorta IVC $=$ inferior vena cava $\\quad \\mathrm{PT}=$ pulmonic trunk $\\mathrm{RA}=$ right atrium $\\mathrm{SVC}=$ superior vena cava",
            "images": [
                {
                    "id": "img-99.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1102,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 955,
            "markdown": "![img-100.jpeg](img-100.jpeg)\n\nDevelopment of Major Blood Vessels numbers refer to embryologic aortic arches (most portions of aortic arches I, II and V regress) mnemonic: Aor from Four\n![img-101.jpeg](img-101.jpeg)",
            "images": [
                {
                    "id": "img-100.jpeg",
                    "top_left_x": 498,
                    "top_left_y": 189,
                    "bottom_right_x": 1220,
                    "bottom_right_y": 913,
                    "image_base64": null
                },
                {
                    "id": "img-101.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 1130,
                    "bottom_right_x": 1322,
                    "bottom_right_y": 1819,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 956,
            "markdown": "![img-102.jpeg](img-102.jpeg)\n\n# HEART SIZE \n\n## Cardiothoracic Ratio\n\n$=$ CT ratio $=$ widest transverse cardiac diameter + widest inside thoracic diameter\n$<0.5=$ normal in $>1$ month old ( $45 \\%$ sensitive, $85 \\%$ specific, $59 \\%$ accurate)\n$<0.6=$ normal in $<1$ month old\nPurpose: measurement of LV dilatation\nDependent on:\n\n- lung volume: CT ratio enlarges in expiration\n- patient position: CT ratio increases on supine film\n\nPitfalls:\n> no change unless LV volume increases by $>2 / 3$\n$>$ no change in moderate enlargement of LA / RV\n\n## CARDIAC IMAGING PLANES\n\n## Vertical Long Axis\n\n$=$ parasagittal plane along long axis of LV\nBest assessment of:\n\n1. LA and LV (relationship)\n2. Inferior + anterior walls of LV myocardium\n3. Bicuspid MV (structure \\& function) versus LV",
            "images": [
                {
                    "id": "img-102.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1322,
                    "bottom_right_y": 1062,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 957,
            "markdown": "4. LV (structure \\& function)\n5. LA appendage and coronary sinus\n\n# Horizontal Long Axis / 4-Chamber View \n\n$=$ horizontal plane bisecting all 4 chambers\nBest assessment of:\n\n1. Chamber size and valve position\n2. Septal + apical + lateral LV walls\n3. AV valve (subjective assessment in cine mode)\n4. Ventricular function (subjective assessment)\n5. LA size (quick measurement)\n\n## Three-Chamber View\n\n$=$ oblique long-axis view optimizing visualization of LV, LA, aortic root, MV, aortic valve\nBest assessment of:\n\n1. LV outflow tract, aortic valve, aortic root, proximal ascending thoracic aorta\n2. Posteromedial papillary muscles arising from LV free (lateral) wall\n3. Chordae tendineae of MV\n\n## Short Axis View\n\n$=$ oblique coronal plane across barrel of LV lumen\n\n1. Basal, middle, apical portions of LV myocardium\n2. LV size (easy assessment)\n3. LV myocardial contractility (easy assessment)\n\n## CARDIAC REPORTING\n\n1. Coronary arteries: origin, course, segmental anatomy\n2. Dominance and size of LAD artery, LCx artery, and RCA\n3. Number of diagonal + marginal branches\n4. Size of heart + cardiac chambers\n5. LV function with ejection fraction and wall motion\n6. End-diastolic + end-systolic LV volume\n7. LV myocardial mass + thickness\n\n## HEART VALVES\n\n## Embryology:\n\nsemilunar valves develop simultaneously with formation of RV + right ventricular outflow tract (RVOT) from conotruncal endocardial cushions around distal part of conus\n\n## Heart Valve Positions\n\nPA CXR:\nreference line $=$ oblique line drawn from distal left mainstem bronchus to right cardiophrenic angle\n$\\sqrt{ }$ aortic valve resides in profile superior to this line overlying the thoracic spine\n$\\sqrt{ }$ pulmonic valve just inferior to left mainstem bronchus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 958,
            "markdown": "$\\sqrt{ }$ mitral valve resides inferior to this line centrally located within cardiac silhouette\n$\\sqrt{ }$ tricuspid valve inferior to this line more basilar and midline\nLAT CXR:\nreference line $=$ oblique line drawn from carina / right pulmonary artery shadow to anterior cardiophrenic sulcus\n$\\sqrt{ }$ aortic valve resides superior to this line\n$\\sqrt{ }$ pulmonic valve anterior + superior to aortic valve\n$\\sqrt{ }$ mitral valve resides inferoposteriorly to this line\n$\\sqrt{ }$ tricuspid valve inferior to this line anteriorly\n\n# Aortic Valve \n\n= separates LV outflow tract from ascending aorta by a valve composed of annulus, commissures and usually 3 (range, $1-4$ ) thin semilunar valve leaflets / cusps\n(a) right cusp: inferior to right coronary sinus + origin of RCA\n(b) left cusp: inferior to left coronary sinus + origin of LCA\n![img-103.jpeg](img-103.jpeg)",
            "images": [
                {
                    "id": "img-103.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 818,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1370,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 959,
            "markdown": "![img-104.jpeg](img-104.jpeg)\n\nAttitudinal CT of Semilunar Valves \\& Cusps\nintrathoracic attitudinal view versus heart-centric short-axis view\nleft-facing sinus $=$ left anterolateral $=$ anterior\nright-facing sinus $=$ right anterolateral $=$ right posterior\nnonfacing sinus $=$ posterior $=$ left posterior",
            "images": [
                {
                    "id": "img-104.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 633,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 960,
            "markdown": "![img-105.jpeg](img-105.jpeg)\n\nDiagram of the Relationship of the Four Cardiac Valves in Cross Section\naTL, pTL, sTL = anterior, posterior, septal (medial) tricuspid valve leaflets\nAttachment of chordae tendineae:\n> anterior papillary muscle attach to aTL + pTL\n> posterior papillary muscle attach to $\\mathrm{pTL}+\\mathrm{sTL}$\n> medial (conal) papillary muscle attach to aTL + sTL\naML, pML = anterior, posterior mitral valve leaflet\nAttachment of chordae tendineae:\n> anterior + posterior papillary mm. both attach to aML + pML\nre, le, nc (Ao) = right, let, noncoronary cusps of aortic valve\nre, le, ac (PA) = right, left, anterior cusps of pulmonary artery",
            "images": [
                {
                    "id": "img-105.jpeg",
                    "top_left_x": 501,
                    "top_left_y": 191,
                    "bottom_right_x": 1319,
                    "bottom_right_y": 891,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 961,
            "markdown": "| Echocardiogram of Aortic Root |  |  |\n| :--: | :--: | :--: |\n| Aortic root dimension | measured at end-diastole at R-wave of ECG | $2.1-4.3 \\mathrm{~cm}$ |\n| increased in: | aneurysm of aorta, aortic insufficiency |  |\n| Aortic cusp separation |  | $1.7-2.5 \\mathrm{~cm}$ |\n| decreased in: | aortic stenosis, low stroke volume |  |\n| increased in: | aortic insufficiency |  |\n| Left atrial diameter | measured at moment of mitral valve opening | $2.3-4.4 \\mathrm{~cm}$ |\n| Eccentricity index of aortic valve cusps | ratio of anterior to posterior dimension (rarely used) | $<1.3$ |\n| Ratio of LA-to-aortic root dimension |  | $0.87-1.11$ |\n\n(c) posterior / noncoronary cusp\n\nNodules of Arantius $=$ thickened fibrous bulge at center of each free cusp margin forming central coaptation area\nCommissures $=$ junctions of cusps at attachment to aortic wall at level of sinotubular junction\nArea: $\\quad 2.5-4.0 \\mathrm{~cm}^{2}$\nAortic valve planimetry is optimal during midsystole $=20 \\%$ of R-R interval or $50-100 \\mathrm{msec}$ from Rwave peak!\n\n# Mitral Valve \n\n$=$ bicuspid valve ( $=2$ leaflets) anchored on mitral valve annulus + connected to LV papillary muscles by chordae tendineae; MV and aortic valve share fibrous continuity\nArea: $\\quad 4-6 \\mathrm{~cm}^{2}$\nCircumference: 10 cm\nEmbryology: develops during $5^{\\text {th }}-15^{\\text {th }}$ week of gestation\n\n## Papillary Muscles of Mitral Valve\n\nOrigin: lateral wall of LV\n(a) anterolateral papillary muscle\n(b) posteromedial papillary muscle (single blood supply)\n\nPrognosis: vulnerable to ischemia + rupture\n\n## Mitral Valve Annulus\n\n= D-shaped ring within L atrioventricular groove; imbedded within myocardium as part of cardiac skeleton\n(a) straight border $=$ anterior portion of annulus; in fibrous continuity with aortic valve + heart skeleton\n(b) curved border = posterior portion of annulus: attached to pliant endocardium\n\nFunction: site of valve leaflet attachment",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 962,
            "markdown": "Border: LCx artery + coronary sinus\n\n# Mitral Valve Leaflets \n\nNormal thickness: $<5 \\mathrm{~mm}$\n(a) semicircular anterior leaflet attaches to $1 / 3$ of annulus + forms part of LVOT Segments: lateral A1, middle A2, medial A3\n(b) crescentic posterior leaflet Segments: lateral P1, middle P2, medial P3\nMitral valve components are best evaluated on reformatted 2-chamber long-axis images perpendicular to the valve during middiastole $=65 \\%$ of R-R interval for open mitral valve and $5 \\%$ of R-R for closed mitral valve!\n\n## Pulmonic / Pulmonary Valve\n\n$=$ separates RV outflow tract from main pulmonary artery by a semilunar valve composed of 3 cusps (similar to aortic valve although separate from atrioventricular valve)\nmnemonic: A cusp on P and P cusp on A anterior cusp (short-axis view) $\\leftarrow$ pulmonic valve posterior (noncoronary) cusp $\\leftarrow$ aortic valve\n(a) anterior cusp\n(b) right cusp\n(b) left cusp\n\nArea: $\\quad 2.0 \\mathrm{~cm}^{2} / \\mathrm{m} 2$ of body surface area\n\n## Tricuspid Valve\n\n$=$ right atrioventricular valve separating RA from RV; anchored on tricuspid valve annulus + connected to RV papillary muscles by chordae tendineae; composed of 3 (range, 2 to 4) leaflets\nCrista supraventricularis: muscular ridge that separates TV from pulmonary valve\n(a) septal leaflet\n(b) anterior leaflet\n(b) posterior leaflet\n\n## VENTRICLES\n\n## Right Ventricle\n\nTrabeculae: coarse\nPapillary muscles: attached to interventricular septum + free wall; apical moderator band Differentiating features of RV (from LV):\n\n1. Heavily trabeculated apex\n2. Well-developed infundibulum\n3. Septal papillary muscles\n4. Lack of fibrous continuity of AV valve + outflow tract\n\n## Moderator Band\n\n$=$ muscular band extending from interventricular septum to base of anterior papillary muscle",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 963,
            "markdown": "Function: part of right bundle branch conduction system\n\n# Right Ventricular Outflow Tract (RVOT) \n\n$=$ smooth muscular infundibulum / conus inferior to PV\nIn the right ventricle, trabeculae are coarse, and presence of an apical moderator band is CHARACTERISTIC!\n\n## Left Ventricle\n\nTrabeculae: thin, delicate, smooth septal surface\nPapillary muscles: attached to free wall only\n\n## ATRIA\n\n## Embryology of Atrial Septa\n\n1. Septum primum = thin partition dividing primitive atrium into right and left atria at $4^{\\text {th }}$ week; membrane grows from dorsal atrial wall toward endocardial cushion $\\rightarrow$ ultimately forms thin flap valve of fossa ovalis\n2. Ostium primum $=$ temporary orifice between septum primum + endocardial cushions close to AV valves; it becomes obliterated by $5^{\\text {th }}$ week\n3. Ostium secundum = multiple small coalescing fenestrations in center of septum primum\n4. Septum secundum $=$ stiff membrane developing on right side of septum primum growing from right atrial roof $\\rightarrow$ ultimately forms thicker limbus of fossa ovalis\n5. Foramen ovale $=$ orifice limited by septum secundum + septum primum\n6. Foramen ovale flap = lower edge of septum primum (patent in $6 \\%$, probe-patent in $25 \\%$ ); not considered an ASD\n\n## Right Atrium (RA)\n\nComponents:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 964,
            "markdown": "![img-106.jpeg](img-106.jpeg)",
            "images": [
                {
                    "id": "img-106.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1592,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 965,
            "markdown": "| Echocardiogram of Right and Left Ventricle |  |  |\n| :--: | :--: | :--: |\n| RV end-diastolic dimension | at R-wave of ECG | $0.7-2.3 \\mathrm{~cm}$ |\n| increased in: | RV volume overload |  |\n| Septal thickness | end-diastolic thickness at R-wave of ECG | $0.9 \\pm 0.06 \\mathrm{~cm}$ |\n| decreased in: | CAD |  |\n| increased in: | asymmetric septal hypertrophy, IHSS |  |\n| LV end-diastolic dimension | at R-wave of ECG | $4.6 \\pm 0.54 \\mathrm{~cm}$ |\n| LVPW thickness | end-diastolic thickness at peak of R-wave | $0.94 \\pm 0.09 \\mathrm{~cm}$ |\n| increased in: | LV hypertrophy |  |\n| LV end-systolic dimension |  | $2.9 \\pm 0.5 \\mathrm{~cm}$ |\n| IVS $\\div$ LVPW thickness |  | $<1.3$ |\n| Fractional shortening | (EDD - ESD)/EDD x 100 |  |\n| for LV |  | $25-42 \\%$ |\n| for IVS |  | $28-62 \\%$ |\n| for LVPW |  | $36-70 \\%$ |\n| Morphologic Characteristics of Cardiac Ventricles |  |  |\n| Feature | Right ventricle | Left ventricle |\n| Septum | moderator, septal and parietal bands | smooth septal surface |\n| Trabeculae | coarse | thin and fine |\n| Papillary muscles | attach to free wall and IVS | attach to free wall only |\n| AV valve | tricuspid | bicuspid |\n| Morphologic Characteristics of Cardiac Atria |  |  |\n| Feature | Right Atrium | Left Atrium |\n| Appendage | blunt with broad connection to RA trapezoidal shape | small with narrow connection to RA fingerlike tubular shape |\n| Blood from | coronary sinus and IVC | pulmonary veins |\n| Pectinate muscle | extends outward toward AV canal | within tubular appendage |\n| Myocardial component | crista terminalis and tenía sagittalis | none |\n\n(1) appendage\n(2) venous part\n(3) vestibule",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 966,
            "markdown": "Embryology: originates from primitive trabeculated RA (persists as RA appendage) + from sinus venosus forming smooth-walled portion of RA\n\n# Right Atrial Appendage \n\n$=$ triangular superior extension of RA that wraps around aortic root\n$\\sqrt{ }$ pyramidal shape with narrow base\n$R x$ : right atrial lead tip is typically placed at right atrial appendage for pacemaker / internal cardiac defibrillator\n\n## Sinus Venosus\n\n, located in posterolateral wall of RA between orifices of SVC and IVC\n(a) right horn: gives rise to crista terminalis, eustachian ridge, thebesian valve\n(b) left horn: gives rise to coronary sinus\n\n## Vestibule of Right Atrium\n\n$=$ smooth muscular rim surrounding tricuspid orifice\n\n## Crista Terminalis\n\n$=$ prominent fibromuscular ridge separating smooth-walled venous part of posterior RA (= sinus venosus) from trabeculated muscle fibers of appendage anteriorly\nVariations: in size + extent among individuals\nLocation: junction of sinus venosus and primitive RA\nClinical significance:\nthickening of crista terminalis $\\rightarrow$ development of atrial flutter + focal right tachycardias\n( $2 / 3$ arise in crista terminalis) $\\rightarrow$ target for catheter RF ablation\n$\\sqrt{ }$ vertically oriented smooth muscular ridge varying in size + thickness amongst individuals:\n$\\sqrt{ }$ small thin valvelike / broad-based structure\n$\\sqrt{ }$ may be large $\\leftarrow$ fatty infiltration of crista terminalis in lipomatous hypertrophy of the atrial septum\n$\\checkmark$ superiorly arches anterior to the orifice of the SVC\n$\\checkmark$ extends to area of anterior interatrial groove\n$\\checkmark$ merges with interatrial bundle (= Bachmann bundle)\n$\\sqrt{ }$ indistinct inferior border located near IVC orifice merging with small trabeculations of inferior portion of cavotricuspid isthmus\n, gives rise to thick muscle bundles\n(a) anterior pectinate muscles fanning out anteriorly\n(b) septum spurium $=$ most prominent anterior pectinate muscle (in $80 \\%$ ) arising from crista terminalis\nMean thickness: 4.5 mm\n\n## Sinoatrial Node\n\n$=$ subepicardial spindle-shaped structure as source of cardiac impulse (= dominant pacemaker)\nLength: $20 \\pm 3 \\mathrm{~mm}$\nLocation: in myocardium at superior cavoatrial junction between crista terminalis and",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 967,
            "markdown": "# SVC \n\n$\\sqrt{ }$ surrounds sinoatrial nodal artery, which may course centrally ( $70 \\%$ ) / eccentrically within node\n\n## Koch Triangle\n\nLocation: at orifice of coronary sinus\nBorders:\n) posteriorly: fibrous extension from eustachian valve (tendon of Todaro) = Todaroeustachian ridge\n> anteriorly: attachment of septal leaflet of tricuspid valve\n> inferiorly: coronary sinus\n) at apex: central fibrous body of heart (= site of penetration of His bundle)\n> midportion: contains compact AV node (fast pathway)\n> base: bordered by coronary sinus ostium + septal isthmus (= area between edge of coronary sinus ostium + septal tricuspid valve); contains slow pathway\n$\\diamond$ Septal isthmus = frequently target for ablation of slow pathway in AV node reentrant tachycardia!\n\n## AV Node\n\nLocation: within Koch triangle\nBorders:\n> coronary sinus ostium\n> septal leaflet of tricuspid valve\n> tendon of Todaro = fibrous band connecting eustachian and thebesian valves\n[Francesco Todaro (1839-1918), Italian professor of anatomy at the Universities of Messina and Rome]\nImportance: electrophysiologists frequently modify this node in dual atrioventricular nodal pathways $\\rightarrow$ AV nodal reentrant tachycardia\n\n## Terminal Groove / Sulcus Terminalis\n\n$=$ fat-filled groove on epicardial side corresponding internally to crista terminalis close to cavoatrial junction\nlocation of sinus node + terminal segment of sinoatrial nodal artery\n\n## Eustachian Valve\n\n[Bartolomeo Eustachi (1500 or 1514-1574), one of the founders of the science of human anatomy in Rome, Italy]\n$=$ valve of inferior vena cava (guarding entrance into IVC)\nFunction: directs flow toward foramen ovale\nLocation: junction of RA and IVC; inserts medially onto eustachian ridge (= border between oval fossa + coronary sinus)\n> directs blood from IVC to foramen ovale in fetus\n> free border continues as tendon of Todaro\n$\\checkmark$ thin linear structure, not routinely imaged\n$\\diamond$ Rarely an unusually large muscular valve may pose an obstacle to passage of a catheter!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 968,
            "markdown": "# Cavotricuspid Isthmus \n\n$=$ area between IVC + tricuspid valve of highly variable isthmian anatomy\n$\\diamond$ Target of catheter ablation as treatment of choice for isthmus-dependent atrial flutter!\nN.B.: obstacles to successful ablation may be a large eustachian ridge, aneurysmal pouches, or a concave deformation of the entire isthmus\n\n## Thebesian Valve\n\n$=$ valve of coronary sinus\n[Adam Christian Thebesius (1686-1732), anatomist and municipal physician in Hirschberg, Silesia]\nPrevalence: in $80 \\%$ of cadaveric specimens\nFunction: prevents reflux from RA into coronary sinus\nLocation: entry of coronary sinus into RA\nMorphology: complete circular (30\\%), crescentic (35\\%), absent (20\\%), threadlike (2\\%), fenestrated $(10 \\%)$\n$\\sqrt{ }$ thin semilunar fold at anteroinferior rim of coronary sinus ostium\nMechanical barrier: large eustachian valve / ridge ( $25 \\%$ ), $>5 \\mathrm{~mm}$ deep subthebesian recess ( $45 \\%$ ), hypoplastic coronary sinus ostium, large thebesian valve\n\n## Subthebesian Pouch\n\n$=$ subeustachian sinus $=$ sinus of Keith\n$=$ pouchlike atrial wall inferior to orifice of coronary sinus\nDepth: $4.3 \\pm 2.1$ (range, $1.5-9.4) \\mathrm{mm}$\n$\\diamond$ Substrate for reentrant circuit during atrial flutter\nN.B.: main source of RF procedural difficulty\n\n## Interatrial Septum\n\nSeptum $=$ wall that can be removed without exposing heart cavity to extracardiac structures\nParts: flap valve of foramen ovale (septum primum) + part of its anteroinferior margin\n$\\diamond$ Superior rim of fossa (septum secundum = infolded wall between SVC and right pulmonary veins) is not a true septum!\n$\\checkmark$ thin septum that is difficult to image\n$\\checkmark$ may contain small amount of fat sparing fossa ovalis\n$D D x$ : Lipomatous hypertrophy of interatrial septum\n$\\checkmark$ characteristic dumbbell shape $\\leftarrow$ sparing of fossa ovalis\n$\\checkmark$ abnormal amount of fat in older / obese adults\n\n## Fossa Ovalis\n\n$=$ circular indentation in interatrial septum\nVariant: patent fossa ovalis / foramen ovale\n\n## Patent Foramen Ovale\n\n$=$ PATENT FOSSA OVALIS\nPrevalence: $15 \\%$\nFunction: can result in R-to-L shunt",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 969,
            "markdown": "Associated with:\nparadoxical emboli, cryptogenic stroke, hypoxemia in patients with obstructive sleep apnea, increased risk for decompression sickness, increased risk for atrial fibrillation after cardiac surgery\n$\\checkmark$ demonstrated by contrast-enhanced echocardiography\n\n# Left Atrium (LA) \n\nComponents: venous component, vestibule, appendage\nEmbryology: originates from primitive trabeculated LA (persists as LA appendage) + from pulmonary veins forming smooth-walled portion of LA\n$\\checkmark$ smooth walled venous + septal component + vestibule\n$\\sqrt{ }$ ridge of smooth muscle ( $\\pm$ bulbous tip) at junction of LA appendage and entrance of left superior pulmonary vein\n\n## Venous Component of Left Atrium\n\n$=$ located posteriorly $\\rightarrow$ pulmonary vein orifices at each corner\n\n## Left Atrial Vestibule\n\n$=$ surrounds the mitral orifice\n\n## Left Atrial Appendage\n\n$=$ arises from superolateral aspect of LA\n$\\sqrt{ }$ rough trabeculated surface of tubular shape\n$\\sqrt{ }$ projects anteriorly over proximal LCx artery\n$\\sqrt{ } 3.5-6.5 \\mathrm{~mm}$ thick superior wall / dome\nCx: narrow neck predisposes to thrombus deposition\n\n## Atrial Appendages\n\n$\\sqrt{ }$ linear filling defects $(\\mathrm{R}>\\mathrm{L})=$ pectinate muscles fibers running parallel to each other measuring $>1 \\mathrm{~mm}$ (in $97 \\%$ )\n$D D x$ : thrombus in LA\n\n## CORONARY ARTERIES\n\n## Anatomy of Left Coronary Artery (LCA)\n\narises from left (posterior) coronary sinus (= left sinus of Valsalva) near sinotubular ridge; passes to left and posterior to pulmonary trunk\n\n1. Left main coronary artery (LM)\n\nSegments: ostium to bifurcation $=5-20 \\mathrm{~mm}$ short stem\nbifurcates into LAD + LCx\n) trifurcates (in $15 \\%$ ) = ramus intermedius (RI) branch coursing laterally toward LV free wall similar to D1\n2. Left anterior descending (LAD)\n\nCourse: within anterior interventricular groove toward apex\nSupply: majority of LV + anterolateral papillary muscle $\\pm$ small branches to anterior RV wall",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 970,
            "markdown": "Segments:\n> proximal: from left main bifurcation to origin of $1^{\\text {st }}$ septal branch\n> midportion: from $1^{\\text {st }}$ septal branch to an acute angle (may coincide with origin of $2^{\\text {nd }}$ septal perforator)\n\n- otherwise split halfway between $1^{\\text {st }}$ septal perforator and apex into:\n> middle LAD\n> distal LAD\n> apical segment $=$ termination of LAD\n(a) Diagonal perforating branches (D1, D2, etc) arise from LAD, course over anterolateral wall of LV\nSupply: LV free wall\nmnemonic: Diagonals course downward from LAD\n(b) Septal perforating branches (S) course medially toward anterior interventricular septum\nSupply: majority of interventricular septum +AV bundle + proximal bundle branch\n\n3. Left circumflex artery ( LCx ) travels within left atrioventricular sulcus (groove); terminates at obtuse (blunt / round) margin of heart\n(a) Obtuse marginal (lateral) branches (OM1, OM2, etc) for lateral wall of LV\n(b) Left atrial circumflex artery (LACX) for atrium\n(c) variably: branches to posterolateral + posterior descending artery supplying diaphragmatic portion of LV (= left dominance)\nSupply: LV free wall + variable portion of anterolateral papillary muscle\nTerminology from surface perspective of apical view:\n> rounded obtuse margin of heart formed mainly by LV\n> sharp angle $=$ acute margin of heart formed mainly by RV\nSegments: proximal + distal (based on origin of large obtuse marginal branches)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 971,
            "markdown": "![img-107.jpeg](img-107.jpeg)",
            "images": [
                {
                    "id": "img-107.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1319,
                    "bottom_right_y": 1713,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 972,
            "markdown": "![img-108.jpeg](img-108.jpeg)",
            "images": [
                {
                    "id": "img-108.jpeg",
                    "top_left_x": 413,
                    "top_left_y": 189,
                    "bottom_right_x": 1276,
                    "bottom_right_y": 891,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 973,
            "markdown": "![img-109.jpeg](img-109.jpeg)",
            "images": [
                {
                    "id": "img-109.jpeg",
                    "top_left_x": 391,
                    "top_left_y": 191,
                    "bottom_right_x": 1302,
                    "bottom_right_y": 1458,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 974,
            "markdown": "![img-110.jpeg](img-110.jpeg)\n\n# ![img-111.jpeg](img-111.jpeg) \n\nCoronary Anatomy (circle \\& half-loop model)",
            "images": [
                {
                    "id": "img-110.jpeg",
                    "top_left_x": 413,
                    "top_left_y": 189,
                    "bottom_right_x": 1285,
                    "bottom_right_y": 1566,
                    "image_base64": null
                },
                {
                    "id": "img-111.jpeg",
                    "top_left_x": 413,
                    "top_left_y": 1599,
                    "bottom_right_x": 1315,
                    "bottom_right_y": 1870,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 975,
            "markdown": "![img-112.jpeg](img-112.jpeg)\n\nRight Coronary Artery Anatomy\n(RAO cranial projection)\n17-Segment Classification by American Heart Association\n$1=$ proximal segment of main artery\n$2=$ middle segment of main artery\n$3=$ distal segment of main artery\n$4=$ posterior descending branch\n$16=$ posterior left ventricular branch\nSN $=$ sinonodal branch\n$\\mathrm{CB}=$ conal branch",
            "images": [
                {
                    "id": "img-112.jpeg",
                    "top_left_x": 634,
                    "top_left_y": 191,
                    "bottom_right_x": 1093,
                    "bottom_right_y": 688,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 976,
            "markdown": "![img-113.jpeg](img-113.jpeg)\n\n# Coronary Artery Angiograms of Varying Dominance \n\nAVNA $=$ atrioventricular node artery\nCB $=$ conus branch artery\nD1 $=1^{\\text {st }}$ diagonal artery\nD2 $=2^{\\text {nd }}$ diagonal artery\nLACx $=$ left atrial circumflex artery\nLAD $=$ left anterior descending artery\nLCx $=$ left circumflex artery\nLM $=$ left main coronary artery\nM1 $=1$ st acute marginal branch artery\nM2 $=2^{\\text {nd }}$ acute marginal branch artery\nOM1 $=1^{\\text {st }}$ obtuse marginal artery\nOM2 $=2^{\\text {nd }}$ obtuse marginal artery\nPDA $=$ posterior descending artery\nPLB $=$ posterolateral branch\nPLSA $=$ posterolateral segment artery\n$\\mathrm{R} \\quad=$ ramus intermedius (in $15 \\%$ )\nS $=$ septal branch\nSANA $=$ sinoatrial node artery",
            "images": [
                {
                    "id": "img-113.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 187,
                    "bottom_right_x": 850,
                    "bottom_right_y": 1421,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 977,
            "markdown": "# Anatomy of Right Coronary Artery (RCA) \n\narises from right (anterior) coronary sinus $\\rightarrow$ passes to right + posteriorly to pulmonary artery $\\rightarrow$ travels downward within right atrioventricular sulcus (groove) $\\rightarrow$ rounds the acute margin of the heart toward crux\nTerminology based on posterior surface view of heart:\ncrux cordis $=$ cross formed by\n$>$ AV groove (transecting a line formed by)\n> posterior interventricular + interatrial sulci\n[crux, Latin = cross, junction]\nSegments:\n> proximal: ostium to halfway to acute margin of heart\n$>$ mid:\n$>$ distal: acute angle of heart to origin of PDA\n\n1. Conus artery $(\\mathrm{CB})$\n$=1^{\\text {st }}$ branch of RCA (in $50-60 \\%$ of patients); may originate directly from coronary sinus of aorta (in $30-35 \\%$ )\n$\\sqrt{ }$ forms circle of Vieussens = anastomosis with LAD\nSupply: RVOT = conus arteriosus\n2. Sinoatrial node artery (SANA)\n$=2^{\\text {nd }}$ branch of RCA (in 60\\%) / from LCx (in 40\\%)\n$\\sqrt{ }$ courses along anterior interatrial groove toward superior cavoatrial junction\n$\\sqrt{ }$ at cavoatrial junction circling either anteriorly (precaval) / posteriorly (retrocaval) to enter node\n3. Marginal branches (M1, M2, etc) have an anterior course\n> acute marginal branch = at junction of middle + distal RCA\nSupply: RV\n4. Posterior descending artery (PDA)\n$=$ origin of PDA determines coronary artery dominance\nOrigin: usually RCA near crux (in 70\\%) / distal acute marginal branch (= right dominance)\nSupply: posterior third of ventricular septum + diaphragmatic segment of $\\mathrm{LV}+$ posteromedial papillary muscle\n5. Atrioventricular node artery (AVNA)\n$=$ small branch to AV node\nOrigin: apex of U-turn of distal RCA (80-87\\%) / terminal portion of LCx (8-13\\%) / both RCA and LCx $(2-10 \\%)$\nSupply: posterior interventricular septum, interatrial septum, AV node, His bundle $\\sqrt{ }$ penetrates base of posterior interatrial septum at crux\n$\\sqrt{ }$ may course beneath endocardium near ostium of coronary sinus + septal isthmus $\\diamond$ High risk for AV nodal artery coagulation during RF ablation!\n6. Posterolateral segment arteries (PLSA)\nsupplies posterolateral wall of LV\n\n## Coronary Artery Territory",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 978,
            "markdown": "septum\n$=$ LAD\nanterior wall\n$=$ LAD\nlateral wall\n$=$ LCx\nposterior wall\n$=$ RCA\ninferior / diaphragmatic wall $=$ RCA\napex + inferolateral wall $=$ watershed areas\n\n# Coronary Artery Dominance \n\nWhichever artery crosses the crux of the heart and gives off the posterior descending artery (PDA) is considered the dominant coronary artery!\n$=$ artery that supplies the inferior portion of LV\n> RCA in $70-85 \\%$ (= right dominance)\n$>$ LCx in $7-10 \\%$ (= left dominance)\n$>\\mathrm{RCA}+\\mathrm{LCx}=$ codominance / balanced supply ( $7-8 \\%$ )\n\n## Coronary Arteriography\n\n$\\diamond$ Average coronary artery diameter: $4 \\mathrm{~mm}(\\mathrm{M}) ; 3 \\mathrm{~mm}(\\mathrm{~F})$\nContrast agents:\n\n1. Monomeric ionic contrast material:\n(a) negative inotropic $=$ depression of myocardial contractility $\\leftarrow$ hyperosmolality of sodium + decrease in total calcium\n(b) peripheral vasodilatation\n2. Meglumine diatrizoate (contains small quantities of sodium citrate + EDTA)\n3. Nonionic contrast material $=$ slight increase in LV contractility\n\nDose: $\\quad 3-10 \\mathrm{~mL}$\nMortality: $0.05 \\%$\nRisk factors associated with death:\n\n1. Multiple ventricular premature contractions\n2. Congestive heart failure\n3. Systemic hypertension\n4. Severe triple-vessel coronary artery disease (highest risk)\n5. LV ejection fraction $<30 \\%$\n6. Left main coronary artery stenosis\n\nClues for projection:\n$45-70^{\\circ} \\mathrm{LAO}:$\n$\\sqrt{ }$ ribs slanting to left side of image\n$\\sqrt{ }$ catheter in descending aorta on right side of image\n$15-30^{\\circ} \\mathrm{RAO}:$\n$\\sqrt{ }$ ribs slanting to right side of image\n$\\sqrt{ }$ catheter in descending aorta on left side of image\nTechnique:\n$\\diamond 20-30^{\\circ}$ of cranial / caudal angulation variably used\nCatheter in left coronary orifice:\n(a) $\\mathrm{LAO}+$ caudocranial angulation:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 979,
            "markdown": "proximal $1 / 3$ of LAD + origin of first diagonal branch\n(b) $\\mathrm{LAO}+$ craniocaudal angulation = \"spider view\":\n\nLCA, proximal LCx, first marginal / diagonal branches\n(c) $\\mathrm{RAO}+$ craniocaudal angulation:\nproximal third of LCx + origin of its branches\n(d) $\\mathrm{RAO}+$ caudocranial angulation:\nseparation of LAD from diagonal branches\nCatheter in right coronary artery orifice: $\\mathrm{LAO} \\pm \\mathrm{RAO}$\nFalse-negative interpretation:\n(1) Eccentric lesion in $75 \\%$\n(2) Foreshortening of vessel\n(3) Overlap of other vessels remedied by angulated projections: improved diagnosis $(50 \\%)$, upgrade to more significant stenosis ( $30 \\%$ ), lesion unmasked (20\\%)\n\n# Coronary Artery Collaterals \n\nA. INTRACORONARY COLLATERALS\n$=$ filling of a distal portion of an occluded vessel from the proximal portion\n$\\sqrt{ }$ tortuous course outside the normal path\nB. INTERCORONARY COLLATERALS\n$=$ between different coronary arteries / between branches of the same artery\nLocation: on epicardial surface, in atrial / ventricular septum, in myocardium\n\n1. Proximal RCA to distal RCA\n(a) by way of acute marginal branches\n(b) from sinoatrial node artery (SANA) to atrio-ventricular node artery (AVNA) = Kugel collateral\n2. RCA to LAD\n(a) between PDA and LAD through ventricular septum / around apex\n(b) conus artery (1st branch of RCA) to proximal part of LAD\n(c) acute marginals of RCA to right ventricular branches of LAD\n3. Distal RCA to distal LCx\n(a) posterolateral segment artery of RCA to distal LCx (in AV groove)\n(b) AVNA of RCA to LCx (through atrial wall)\n(c) posterolateral branch of RCA to obtuse marginal branches of LCx (over left posterolateral ventricular wall)\n4. Proximal LAD to distal LAD\n(a) proximal diagonal to distal diagonal artery of LAD\n(b) proximal diagonal to LAD directly\n5. LAD to obtuse marginal of LCx\n\n## Coronary Artery Anomalies\n\nPrevalence: $0.3-1.3 \\%$; in $4-25 \\%$ responsible for nontraumatic sudden death in young adults",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 980,
            "markdown": "![img-114.jpeg](img-114.jpeg)\n\n# Coronary Artery Anomaly of Hemodynamic Significance \n\n$=2^{\\text {nd }}$ most common cause of sudden cardiac death among young adults\n\n1. $\\mathrm{ALCAPA}=$ most serious anomaly\n2. Origin from opposite sinus of Valsalva / opposite coronary artery + interarterial / intramural course\n3. Congenital coronary artery fistula\n\n## Coronary Artery Atresia\n\n1. Congenital atresia of left main coronary artery\n$\\sqrt{ }$ fibrous connection between LAD-LCx junction + left coronary cusp\n2. Atresia of right coronary artery\n3. Atresia of left circumflex coronary artery\n\n## Anomaly of Coronary Artery Origin\n\n1. High takeoff point from aorta ( $6 \\%$ )\n$=$ origin of RCA / LCA above the junctional zone between sinus + tubular part\n$\\diamond$ May be difficult to cannulate!\n2. Multiple ostia\n(a) $\\mathrm{RCA}+$ conus branch arise separately\n(b) $\\mathrm{LAD}+\\mathrm{LCx}$ arise separately without LCA $(0.41 \\%)$\n3. Single coronary artery $(0.0024-0.0440 \\%)$\n4. Anomalous origin from pulmonary artery\n5. Origin of coronary artery from opposite sinus / noncoronary sinus\n(a) RCA arising from left coronary sinus ( $0.03-0.17 \\%)$\n(b) LCA arising from right coronary sinus ( $0.09-0.11 \\%)$\n(c) LCx / LAD arising from right coronary sinus ( $0.32-0.67 \\%)$\n(d) LCA / RCA arising from noncoronary sinus\nmay take the following course:\n> interarterial \"malignant\" course (between aorta + pulmonary trunk) just above pulmonary valve",
            "images": [
                {
                    "id": "img-114.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 191,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 792,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 981,
            "markdown": "$\\diamond$ Most common clinically significant coronary artery anomaly $\\rightarrow$ compression of coronary artery between aorta and $\\mathrm{PA} \\rightarrow$ acute ischemia / arrhythmia $\\rightarrow$ sudden cardiac death\n$\\checkmark$ anomalous artery surrounded by epicardial fat\n> trans-septal: subpulmonic / beneath RVOT\n> prepulmonic: anterior to RVOT\n> retroaortic: posterior to aorta\n> intramural: LCA within aortic wall $\\rightarrow$ compression throughout cardiac cycle\n$\\checkmark$ slitlike coronary artery lumen\n$\\checkmark$ impaired coronary artery blood flow\nAmong 6.3 million military recruits 64 patients died from a cardiac\ncause: $54 \\%$ had a left main coronary artery arising from the right sinus of Valsalva with an interarterial course!\n\n# Anomaly of Coronary Artery Course \n\n1. Myocardial bridging\n$=$ band of myocardial muscle overlying a segment of a coronary artery\n2. Duplication of arteries: eg, LAD\n\n## Anomaly of Termination of Coronary Artery\n\n1. Coronary artery fistula\n2. Coronary arcade\n$=$ angiographically demonstrable communication between RCA and LCA in the absence of a coronary artery stenosis\n$\\sqrt{ }$ prominent straight connection near crux\n$D D x$ : tortuous collateral vessel\n3. Extracardiac termination\n\nCause: atherosclerotic CAD\nReceiver: bronchial, internal mammary, pericardial, anterior mediastinal, superior / inferior phrenic, intercostal arteries\n\n## EMBRYOGENESIS OF VEINS\n\nTime of development: $6^{\\text {th }}-8^{\\text {th }}$ week of embryonic life\nOrigin: 3 main paired venous systems drain into sinus venosus\nA. Vitelline (omphalomesenteric) venous system:\nblood from yolk sac to sinus venosus invagination separates left horn of sinus venous from LA\nB. Umbilical venous system blood from chorionic villi to sinus venosus via ductus venosus\nC. Intraembryonic cardinal venous system\n$=$ continuous appearance + regression of 3 paired embryonic veins\n(1) Cardinal veins\n(a) anterior cardinal vein drains the cranial (cephalic) region\n> part of left anterior cardinal vein $\\rightarrow$ left superior intercostal vein + adjacent left brachiocephalic vein\n(b) posterior cardinal vein drains caudal portion of embryo (body of embryo +",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 982,
            "markdown": "mesonephros + anterior extremities)\nLocation: dorsolateral part of urogenital fold\n> right posterior cardinal vein $\\rightarrow$ part of azygos vein\n(c) right + left common cardinal veins (= ducts of Cuvier) formed by confluence of anterior + posterior cardinal veins\n> right common cardinal vein $\\rightarrow$ superior vena cava\n> right horn of sinus venosus $\\rightarrow$ posterior wall of RA\n> left horn of sinus venosus $\\rightarrow$ coronary sinus\n> regressing left common cardinal vein $\\rightarrow$ ligament / vein of left atrium (vein of Marshall)\n(d) vessel connecting right + left superior cardinal veins $\\rightarrow$ left brachiocephalic vein\n(2) Subcardinal veins drain urogenital system of metanephros + suprarenal glands\n\nLocation: ventromedial to posterior cardinal veins + ventrolateral to aorta\n> intersubcardinal anastomoses form anterior to aorta below superior mesenteric artery and connect left + right subcardinal veins\n(3) Supracardinal veins\ndrain body wall via intercostal veins\nLocation: dorsomedial to posterior cardinal vein + dorsolateral to aorta\n> CRANIAL\n(a) azygos vein on the right\ndrains $4-11$ right intercostal veins\n(b) portion of superior intercostal vein drains 2-3 left intercostal veins\n(c) accessory hemiazygos drains $4-7$ left intercostal veins\n(d) hemiazygos vein drains left $8-11$ intercostal veins\n> CAUDAL: lumbar veins\n\n# Superior Vena Cava \n\nEmbryology: right common cardinal vein + proximal aspect of right anterior cardinal vein + right horn of sinus venosus form right superior vena cava\n> Left common cardinal vein + proximal part of left anterior cardinal vein form left superior vena cava",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 983,
            "markdown": "![img-115.jpeg](img-115.jpeg)\n> Left superior vena cava involutes with development of innominate vein $\\rightarrow$ ligament of Marshall\nOrigin: formed by confluence of right + left brachiocephalic vv.\nMean length: $7.1 \\pm 1.4 \\mathrm{~cm}$\nDiameter: $2.1 \\pm 0.7 \\mathrm{~cm}$ (in adults)\nShape on cross-section: major axis (1.5-2.8 cm), minor axis (1-2.4 cm)\nArea threshold: $<1.07 \\mathrm{~cm}^{2} \\rightarrow$ obstruction / compression\nCECT:\n$\\sqrt{ }$ excellent uniform enhancement of SVC 60-75 seconds after injection of contrast agent into a peripheral vein\n$\\sqrt{ }$ nonenhanced blood from contralateral veins and azygos vein can mimic a thrombus\n\n# Congenital Anomalies of SVC \n\n1. Persistent left SVC\n\n## Inferior Vena Cava\n\n1. Hepatic $=$ posthepatic segment\n\nOrigin: terminal part of right vitelline vein\n2. Suprarenal segment",
            "images": [
                {
                    "id": "img-115.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 191,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1234,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 984,
            "markdown": "Origin: subcardinal-hepatic anastomosis\n3. Renal segment\n\nOrigin: part of right subcardinal vein + supracardinal-subcardinal anastomoses\n4. Infrarenal segment\n\nOrigin: right supracardinal / sacrocardinal vein\n\n# Congenital Anomalies of the IVC \n\n1. Absence of hepatic segment of IVC with azygos continuation\n2. Absence of infrarenal IVC with azygos / hemiazygos continuation\n3. Duplication of IVC with azygos / hemiazygos continuation\n\n## CARDIAC VEINS\n\n## Classification:\n\nA. Greater cardiac (epicardial) venous system $70 \\%$\n> coronary sinus tributaries: $50 \\%$ coronary sinus, anterior + posterior interventricular v., great cardiac v., small cardiac v., oblique vein of Marshall, atrial + septal vv.\n> noncoronary sinus tributaries: $20 \\%$ anterior RV v., LA + RA vv., superior septal vv.\nB. Smaller cardiac (intramural) venous system: $30 \\%$ venoluminal, arterioluminal, venosinusoidal, arteriosinusoidal ( $=$ thebesian vessels $2^{\\circ}$ to arterial component)\nC. Compound cardiac venous system: venous tunnels of RA, sinoatrial node v., atrioventricular node v., RA wall v., ventricular septal v.\n![img-116.jpeg](img-116.jpeg)",
            "images": [
                {
                    "id": "img-116.jpeg",
                    "top_left_x": 357,
                    "top_left_y": 1062,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1841,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 985,
            "markdown": "![img-117.jpeg](img-117.jpeg)",
            "images": [
                {
                    "id": "img-117.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 187,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1047,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 986,
            "markdown": "![img-118.jpeg](img-118.jpeg)\n\n# Coronary Sinus \n\n$=$ distal portion of great cardiac vein\nOrigin: left horn of sinus venosus + adjacent left common cardinal vein receiving cardiac veins\n> right horn of sinus venosus persists as venous portion of right atrium\nOstium: in RA medial to IVC + just superior to septal leaflet of tricuspid valve; guarded by thebesian valve\nLength: $\\quad 30-50 \\mathrm{~mm}$ (in $75 \\%$ )\nFunction: collects blood from left marginal vein; left posterior ventricular vein; small, middle, great, oblique cardiac veins\nClinical significance:\n(1) Catheterization easiest via SVC $\\leftarrow$ sharp angle between coronary sinus and LA\n(2) For cardiac resynchronization therapy ( $=$ implantation of automatic cardioverterdefibrillator for treatment of heart failure) a LV pacer lead is usually placed into posterior vein of LV / left marginal vein\n(3) Conduit for catheter treatment of arrhythmias\n\n## Congenital Anomalies of Coronary Sinus\n\n(a) variations",
            "images": [
                {
                    "id": "img-118.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1203,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 987,
            "markdown": "> in morphology: diverticulum (common at inferior aspect at junction with middle cardiac vein)\n> in shape: wind sock ( $40 \\%$ ), tubular ( $50 \\%$ ), filiform ( $10 \\%$ ), varicoid, bifid\n> in course: straight ( $16 \\%$ ), gently curved ( $62 \\%$ ), high-riding ( $22 \\%$ )\nSignificance: difficult cannulation for mapping, ablation, left ventricular pacing; rarely of hemodynamic consequence\n(b) enlargement\n(c) absence / atresia: associated with heterotaxy syndromes + complex CHD\n(d) atretic coronary sinus ostium\n> with persistent left SVC\n> with communication to LA\n\n# Coronary Sinus-Great Cardiac Vein Junction \n\nLocation: within 10 mm of each other\n(1) Valve of Vieussens (in $65-85 \\%$ ) located $32 \\pm 5 \\mathrm{~mm}$ from coronary sinus ostium\n(2) Annular narrowing of external surface $(20 \\%) \\leftarrow$ sphincterlike thickening of myocardial sleeve of coronary sinus\n(3) Proximal / adjacent to oblique vein of Marshall\n\nValve of Vieussens: bi-/ unicuspid ( $65 \\%$ ) or incomplete valve; present in $80 \\%$; cause of obstruction to cannulation\n[Raymond Vieussens (1635-1715), French anatomist and pioneer in cardiology, head physician at Hôtel Dieu Saint-Éloi in Montpellier]\nThe 3 most constant anatomic landmarks of GCV-CS junction:\n(1) orifice of the oblique vein of Marshall,\n(2) valve of Vieussens,\n(3) left margin of myocardial sleeve of coronary sinus\n\n## Great Cardiac Vein (GCV)\n\nLocation: inferior aspect of the heart in AV groove before emptying into RA\nCourse: crosses LAD + LCx\nDrains: anterior interventricular septum, anterior surfaces of both ventricles, part of LA, cardiac apical region\nSize: $\\quad 45 \\mathrm{~mm}$ long; $10-12 \\mathrm{~mm}$ in diameter\nOstium: valve of Vieussens\nBranches:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 988,
            "markdown": "![img-119.jpeg](img-119.jpeg)\n(1) Inferior interventricular (IIV) / posterior interventricular / middle cardiac vein Location: posterior interventricular sulcus from apex to base of heart\nTerminus: coronary sinus 1 cm from ostium\nDrains: inferior walls of ventricles + cardiac apex + posterior $2 / 3$ of septum\n(2) Left posterior / posterolateral vein of LV\n\nPrevalence: $95 \\%$; single v. ( $60 \\%$ ), up to 3 veins\nTerminus: coronary sinus ( $75 \\%$ ), GCV (25\\%)\n(3) Left (obtuse) marginal vein\n\nPrevalence: $70-95 \\%$\nTerminus: GCV (80\\%), coronary sinus (20\\%)\nDrains: much of LV myocardium\n(4) Great cardiac vein\n\nLocation: left AV groove with LCx artery\n(5) Anterior interventricular vein\n\nLocation: anterior interventricular groove from base of heart toward apex adjacent to LAD\n\n# Variability in Cardiac Veins \n\n1. Absence of left marginal vein (15\\%)\n2. Absence of posterior vein of LV (45\\%)\n\n## Variability in Great Cardiac Vein\n\n@ beginning of coronary sinus\n\n1. Oblique vein of Marshall = outer constriction\n2. Vieussens valve $=$ internal constriction\n@ crossing of muscular LCx",
            "images": [
                {
                    "id": "img-119.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 939,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 989,
            "markdown": "$\\sqrt{ }$ kink in vein $\\rightarrow$ luminal obstruction of great cardiac v .\n\n# PERICARDIUM \n\n$=$ double-walled sac (2-layered membrane) that envelops all cardiac chambers + origin of great vessels without direct attachment to heart\nPericardial thickness: $0.4-1.0 \\mathrm{~mm}(1.2-1.7 \\mathrm{~mm}$ by MRI; $0.7-2.0 \\mathrm{~mm}$ by CT$)$\nFunction: regulates normal ventricular compliance by minimizing dilatation of RV + RA; physically protects heart by production of fluid + surfactants; limits displacement of heart within mediastinum; acts as pressure transducer between pleural space + cardiac chambers (augments systemic venous return +RV filling during inspiration)\nA. FIBROUS / PARIETAL PERICARDIUM = FIBROSA\n$=$ tough outer parietal layer that is mildly stretched\n$\\sqrt{ }$ attaches to sternum + proximal great vessels\n$\\sqrt{ }$ intrapericardial location of ascending aorta, main pulmonary artery, portions of venae cavae, most of PVs\nB. SEROUS / VISCERAL PERICARDIUM = serosa\n$=$ epicardium\n$=$ delicate inner visceral layer forming a completely closed sac around the pericardial cavity; consists of a single layer of mesothelial cells\n\n- intimately connected to heart + epicardial fat\nC. PERICARDIAL CAVITY\n$=$ space between visceral and parietal pericardium\n$\\sqrt{ }$ sac contains $15-50 \\mathrm{~mL}$ of serous fluid produced by mesothelial cells that line serosa\n$\\sqrt{ }$ normal intrapericardial pressure $=50-100 \\mathrm{~mm} \\mathrm{H}_{2} \\mathrm{O}$\n\n\n## Pericardial Sinuses and Recesses\n\n$=$ extensions of pericardial cavity\n$*=$ percentages give depiction on HRCT\nA. Recesses of pericardial cavity proper\n\n1. Postcaval recess $23 \\%$ *",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 990,
            "markdown": "![img-120.jpeg](img-120.jpeg)\n$\\checkmark$ behind and right lateral to SVC\n2. Right pulmonic vein recess $29 \\%$ * $\\checkmark$ behind and right lateral to SVC\n3. Left pulmonic vein recess $60 \\%$ * $\\checkmark$ behind and right lateral to SVC\nB. Transverse sinus\n$\\checkmark$ posterior to ascending aorta and pulmonary trunk + above left atrium $95 \\%$ *\n\n1. Superior (aortic) recess\n$\\checkmark$ along ascending aorta; may be divided into anterior, posterior, right lateral portion $D D x$ : aortic dissection on NECT\n2. Left pulmonic recess\n$\\checkmark$ below left pulmonary artery + posterolateral to proximal right pulmonary artery\n3. Right pulmonic recess\n$\\checkmark$ below right pulmonary artery + above left atrium\n4. Inferior aortic recess\n$\\checkmark$ between ascending aorta + inferior SVC / right atrium\n$\\checkmark$ extending down to level of aortic valve\nC. Oblique sinus $89 \\%$ *\n$\\checkmark$ behind left atrium + anterior to esophagus\n$\\checkmark$ separated from transverse sinus by double reflection of pericardium (and fat) between right + left superior pulmonic veins\n5. Posterior pericardial recess $67 \\%$ *\n$\\checkmark$ behind distal right pulmonary artery + medial to bronchus intermedius\n$D D x$ : lymph nodes, esophageal / thymic process, vascular abnormality, pericardial cyst / tumor\n\n# Epicardial Fat \n\nThickness: increased in obesity\nAsymmetric distribution: 3-4 x more along RV compared to left heart",
            "images": [
                {
                    "id": "img-120.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 187,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 814,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 991,
            "markdown": "- can directly influence atherogenesis by free diffusion of fatty acids + adipokines into wall of coronary arteries\n\n\n# ANATOMY OF AORTA \n\nSegments: Aortic root $\\rightarrow$ Ascending aorta $\\rightarrow$ Transverse aortic arch $\\rightarrow$ Isthmus $\\rightarrow$ Descending aorta\n\n## Aortic Root\n\n(a) Aortic annulus = aortic valvular plane\n![img-121.jpeg](img-121.jpeg)\n[anulus (diminutive of anus), Latin = small ring]\n$=$ firm fibrous band at aortoventricular junction surrounding and supporting aorta + valve leaflets\n(b) Aortic valve sinus = Valsalva sinus\n$=3$ subtle dilatations of aortic root between aortic valve annulus + sinotubular ridge; associated with right + left + noncoronary cusp\n(c) Sinotubular junction = landmark between aortic root and tubular portion of ascending aorta\n\n## Sinus of Valsalva\n\n[Antonio Valsalva (1666 - 1723), professor of anatomy in Bologna, Italy and president of the Academy of the Sciences]\n$=3$ subtle outward bulges of aortic root wall between aortic valve annulus + sinotubular",
            "images": [
                {
                    "id": "img-121.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 583,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1452,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 992,
            "markdown": "ridge, each associated with corresponding right, left, noncoronary aortic valve cusp\nEmbryology: left + right truncoconal swellings develop along inferior end of truncus arteriosus during $5^{\\text {th }}$ week of embryogenesis $\\rightarrow$ septation of truncus into anterior pulmonary + posterior aortic channels $\\rightarrow$ each ventricular outflow tract contains 3 tubercles $\\rightarrow$ form cusps of aortic and main pulmonary artery $\\rightarrow$ formation of Valsalva sinuses + aortic valve leaflets ( $5^{\\text {th }}-9^{\\text {th }}$ weeks)\n\n# Aortic Diameter \n\nMeasurements are to be taken orthogonally to aortic lumen $\\leftarrow$ off-axis measurements overestimate the true diameter\n(average diameter increases with age) underlined are points of standard aortic measurements (represented by thick arrows in drawing)\n\n1. Sinotubular junction 36 mm\n2. Ascending aorta ( 1 cm proximal to arch)\n\nLocation: aortic root $\\rightarrow$ origin of right brachiocephalic a.\nDiameter: always $<4 \\mathrm{~cm}$ at any age\n> Midascending aorta = midpoint between 35 mm sinoaortic junction + proximal aortic arch\n3. Aortic arch\n\nLocation: right brachiocephalic artery $\\rightarrow$ attachment of ligamentum arteriosum\n> aorta@ origin of brachiocephalic trunk 29 mm\n(A) proximal aortic arch:\n$=$ immediately distal to innominate artery from right brachiocephalic artery $\\rightarrow$ left subclavian artery\n(B) distal (mid)aortic arch:\n$=$ immediately distal to left common carotid a.\n4. Aortic isthmus $=$ left subclavian artery $\\rightarrow$ attachment of ligamentum arteriosum\n5. Descending thoracic aorta\n\nLocation: attachment of ligamentum arteriosum $\\rightarrow$ aortic hiatus at diaphragm\nDiameter: always $<3 \\mathrm{~cm}$ at any age\n(a) proximal descending aorta: 26 mm\n2 cm distal to left subclavian artery\n(b) middescending aorta: 25 mm\n(c) distal descending aorta: 24 mm\n@ diaphragm $=2 \\mathrm{~cm}$ above celiac axis origin\n6. Abdominal aorta @ celiac axis origin\n7. Abdominal aorta @ most cephalic renal artery\n8. Abdominal aorta @ most caudal renal artery\n9. Infrarenal abdominal aorta\n(a) 15 mm below caudal renal artery\n(b) aorta just above bifurcation\n\n## Aortic Arch Branching Patterns\n\n1. \"Standard\" branching pattern (65-75\\%) brachiocephalic trunk, left CCA, left subclavian",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 993,
            "markdown": "artery\n2. Common origin of brachiocephalic trunk + left CCA (13\\%)\n3. Bovine aortic arch $(9 \\%)$\n$=$ origin of left CCA from brachiocephalic trunk\n4. Vertebral artery (usually left) arising from aortic arch (3\\%)\n5. Left and right brachiocephalic trunks ( $1 \\%$ )\n6. Aberrant right subclavian artery as the last branch of the aortic arch $(<1 \\%)$\n\n# Cervical Aortic Arch \n\nAssociated with: right aortic arch (in $\\left.{ }^{2} / \\mathrm{s}\\right)$\n\n- pulsatile neck mass, upper airway obstruction, dysphagia\n$\\sqrt{ }$ mediastinal widening\n$\\sqrt{ }$ absence of normal aortic knob\n$\\sqrt{ }$ aortic arch near lung apex\n$\\sqrt{ }$ tracheal displacement to opposite side + anteriorly\n$\\sqrt{ }$ apparent cutoff of tracheal air column $\\leftarrow$ crossing of descending aorta to side opposite of arch\n$D D x$ : carotid aneurysm\n\n\n## Aortic Isthmus Variants\n\n## Aortic Isthmus\n\n$=$ narrowing of the aorta in newborn between left subclavian artery and ductus arteriosus Age: up to 2 months of age\nPrognosis: aortic isthmus disappears $\\leftarrow$ cessation of flow through ductus arteriosus + increased flow through narrowed region\n\n## Aortic Spindle (16\\%)\n\n$=$ congenital narrowing of the aorta at the ligamentum arteriosum with distal fusiform dilatation\n$\\sqrt{ }$ smooth circumferential bulge below isthmus in first portion of descending aorta\n\n## Ductus Diverticulum\n\n$=$ convex focal bulge along anterior undersurface of aortic isthmus\nOrigin: remnant of enlarged mouth of ductus arteriosus / result of traction from ligamentum arteriosum\nFrequency: in $33 \\%$ of infants, in $9 \\%$ of adults\n$\\sqrt{ }$ focal bulge with smooth uninterrupted margin and obtuse angle with aortic wall:\n$\\sqrt{ }$ gently sloping symmetric shoulders (classic ductus diverticulum)\n$\\sqrt{ }$ shorter steeper slope superiorly + more gentle slope inferiorly (atypical ductus diverticulum)\n$D D x$ : posttraumatic pseudoaneurysm\n\n## Ductus Arteriosus\n\nOrigin: left $6^{\\text {th }}$ aortic arch",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 994,
            "markdown": "![img-122.jpeg](img-122.jpeg)\n\nLocation: connects proximal descending aorta (immediately distal to origin of left subclavian artery) with left pulmonary artery (at level of junction with main pulmonary artery)\nFunction: shunting of blood away from lungs (during fetal life)\nNormal ductus physiology in mature infant:\n$\\uparrow$ arterial oxygen pressure $\\rightarrow$ constriction + closure of duct\n$\\diamond$ Functional closure $\\leftarrow$ muscular contraction within 10-18-48 hours after birth\n$\\diamond$ Anatomic closure $\\leftarrow$ subintimal fibrosis + thrombosis: in $35 \\%$ by 2 wks; in $90 \\%$ by 2 mo ; in $99 \\%$ by 1 year\n$C x$ : premature closure $\\rightarrow$ heart failure, fetal hydrops\n\n# PULMONARY VESSELS \n\n## Pulmonary Artery\n\n1. Diameter of root: $<35 \\mathrm{~mm}$\n2. Diameter at level of bifurcation: $<28 \\mathrm{~mm}$\n\nLocation: near bronchus\n\n## Pulmonary Veins\n\n$=2$ (superior + inferior) veins from R and L lung drain into either side of LA with separate ostia\nEmbryology: during first 2 months of fetal life lungs drain into systemic veins; these obliterate when common primitive pulmonary vein (developed from primitive LA) fuses with primitive lung\nPulmonary venous trunk:\n$=-$ distance from ostium to $1^{\\text {st }}$-order branch:\nLength: (a) superior pulmonary vein: $21.6 \\pm 7.5 \\mathrm{~mm}$\n(b) inferior pulmonary vein: $14.0 \\pm 6.2 \\mathrm{~mm}$\n\nPulmonary vein ostium:\n(a) superior pulmonary vein: $19-20 \\mathrm{~mm}$\n(b) inferior pulmonary vein: $16-17 \\mathrm{~mm}$",
            "images": [
                {
                    "id": "img-122.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 704,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 995,
            "markdown": "# Drainage: \n\n$\\mathrm{RUL}+\\mathrm{RML} \\rightarrow$ right superior pulmonary v.\nLUL + lingula $\\rightarrow$ left superior pulmonary v.\nRLL / LLL $\\rightarrow$ right / left inferior pulmonary v.\n\n## Variations of Pulmonary Vein Anatomy (in 38\\%)\n\n1. Conjoined (common) left / right pulmonary vein (25\\%)\n2. Supernumerary vein\n> separate right middle pulmonary vein draining RML:\n$\\sqrt{ }$ aberrant insertion with perpendicular orientation to posterior left atrial wall\nMean size of ostium: $\\quad 9.9 \\pm 1.9 \\mathrm{~mm}$\nStrong association with: atrial fibrillation\n3. Early branching of pulmonary vein $(<1 \\mathrm{~cm})$\n\nClinical significance:\nLA muscle (as a focus of ectopic electrical activity) can extend into venous ostia $\\rightarrow$ atrial fibrillation $\\rightarrow$ treatment with radiofrequency catheter ablation\nPulmonary veins contribute to the origination and maintenance of atrial fibrillation, most commonly with a focus in the left superior pulmonary vein!\n$\\diamond$ Alert cardiologist about variant anatomy of additional pulmonary veins prior to RF ablation!\n\n## COLLATERAL CIRCULATION OF HAND\n\nVascular supply to hand is predominantly through ulnar a. with connections to radial artery via superficial + deep palmar arches\nBlood supply: (1) Radial a. (2) Ulnar a. $\\pm$ (3) Median a. (4) Interosseous a.\nCircuits:\n$>$ at level of carpus\n(1) Anterior carpal arch\n(2) Posterior carpal arch\n> at midcarpal level (with blood supply to fingers)\n(3) Superficial palmar arch (larger)\n$=$ anastomosis between termination of ulnar a. + palmar branch of radial a.\n$\\sqrt{ }$ origin to 3 common palmar digital arteries\n(4) Deep palmar arch (smaller)\n$=$ anastomosis between termination of radial a. + palmar branch of ulnar a.\n$\\sqrt{ }$ proximal to superficial arch\n$\\sqrt{ }$ crosses bases of metacarpal bones\n$\\sqrt{ }$ origin to 3 palmar metacarpal branches\nVariations of arterial termination:\n(1) Complete superficial palmar arch (66-96\\%)\n$=$ supplies all fingers + ulnar side of thumb\n(2) Incomplete superficial palmar arch (4-7\\%)\n$=$ supplies all fingers + NO supply of thumb\n(3) Distal end of superficial palmar arch of ulnar artery communicates with radial artery",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 996,
            "markdown": "(4) Complete palmar arch + anastomosis to superficial palmar branch of radial artery (10\\%)\n(5) Complete deep palmar arch (77-97\\%)\n(6) Radial artery dominance\n(7) Malformations of ulnar artery\n\n# Allen Test \n\n$=$ good clinical indicator of relative contribution of radial + ulnar arteries to circulation of hand\nPurpose:\n(1) Continuity assessment of palmar arch\n(2) Test for arterial disease: thrombangiitis obliterans, scleroderma, occupational vasospastic disease\n(3) Radial artery harvest of the nondominant arm for coronary artery bypass grafting (CABG)\n(4) Prior to puncture / insertion of monitoring catheters into radial artery (19-92\\% incidence of occlusion after cannulation)\nPathophysiology: obliteration of one circulation $\\rightarrow$ distal hypoperfusion $+\\downarrow$ pressure $+\\downarrow$ resistance $\\rightarrow$ augmented flow in the opposite artery\n\n## Clinical Allen Test\n\nRequirement: conscious cooperative patient\nTechnique: assessment of capillary refilling after active \"exsanguination\" of hand (= repetitive clenching into fist) under simultaneous compression of both radial and ulnar arteries followed by relaxed extension of fingers and release of one artery (more common)\nN.B.: AVOID hyperextension of wrist or hand!\n\n## Results:\n\n(1) Normal = complete capillary refilling and blush of entire hand within 6 sec . following release of arterial compression of one artery\n(2) Incomplete continuity of palmar arch = any portion of hand without capillary refilling\n(3) Occlusion of released artery = no capillary refilling of entire hand\n$\\diamond$ Considerable rate of false-positive and false-negative results!\n\n## Doppler Allen Test\n\n$\\diamond$ Independent of patient cooperation!\nTechnique: Doppler velocity detector placed on radial / ulnar artery at wrist before and during a period of compression of the opposite artery\nResults:\nNormal: arterial velocity increases in response to compression of opposite artery\nAbnormal: absence of velocity increase indicates a lack of continuity between radial + ulnar circulation (= interruption of palmar arch)\n\n## Modified Allen Test For Radial Artery Harvest\n\nTechnique:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 997,
            "markdown": "Doppler examination with recording of PSV (peak systolic velocity) + EDV (end diastolic velocity) of\n(a) subclavian a., axillary a., brachial a., radial a. (at wrist), ulnar a. (at wrist)\n(b) superficial palmar arch of radial a. (at imaginary line following proximal segment of $2^{\\text {nd }}$ metacarpal bone)\n(c) princeps pollicis a. (medial aspect of base of thumb)\n(d) $2^{\\text {nd }}$ common palmar digital a. (between heads of $2^{\\text {nd }}+3^{\\text {rd }}$ metacarpal bones)\n(i) $3^{\\text {rd }}$ common palmar digital a. (between heads of $3^{\\text {rd }}+4^{\\text {th }}$ metacarpal bones)\n\nPatient position: supine after a 10 -min rest at standard room temperature\nCriteria for safe radial artery harvest:\n(1) Over $20 \\%$ increase in systolic-diastolic flow rate in ulnar artery (suggests good arterial compliance to receive the entire flow from the brachial artery)\n(2) Flow reversal in superficial palmar arch (indicates anatomic continuity of superficial palmar arch)\n(3) Stable flow in $3^{\\text {rd }}$ common palmar digital a. (good palmar circulation)\n(4) Up to $70 \\%$ flow reduction in $2^{\\text {nd }}$ common palmar digital a.\n(5) Up to $30 \\%$ flow reduction in $1^{\\text {st }}$ common palmar digital a.\n\nContraindication to removal ( $6 \\%$ ):\n(1) Absence of expected increases in PSV and EDV in ulnar artery (MAIN CONTRAINDICATION)\n(2) Atherosclerosis of upper limb arteries ( $1.6 \\%$ )\n$\\diamond$ Patients are susceptible to catastrophic embolic episodes with a single artery supplying the forearm!\n(3) Raynaud disease\n(4) Disappearance of flow in superficial palmar arch\n\n# VENOUS SYSTEM OF LOWER EXTREMITY \n\n## Deep Veins of Lower Extremity\n\n3 paired stem veins of the calf accompany the arteries as venae commitantes + anastomose freely with each other:\n\n1. Anterior tibial veins\ndraining blood from dorsum of foot, running within extensor compartment of lower leg close to interosseous membrane\n2. Posterior tibial veins\nformed by confluence of superficial + deep plantar veins behind ankle joint\n3. Peroneal veins\ndirectly behind + medial to fibula\n4. Calf veins\n(a) Soleus muscle veins\nbaggy valveless veins in soleus muscle (= sinusoidal veins); draining into posterior tibial + peroneal veins or lower part of popliteal vein\n(b) Gastrocnemius veins\nthin straight veins with valves; draining into lower + upper parts of popliteal vein",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 998,
            "markdown": "![img-123.jpeg](img-123.jpeg)\n\n# 5. Popliteal vein \n\nformed by stem veins of lower leg\n6. Femoral / superficial femoral vein\ncontinuation of popliteal vein; receives deep femoral vein about 9 cm below inguinal ligament\n7. Deep femoral vein\ndraining together with superficial femoral vein into common femoral vein; may connect to popliteal vein $(38 \\%)$\n8. Common femoral vein\nformed by confluence of deep + superficial femoral vein; becomes external iliac vein as it passes beneath inguinal ligament\n\n## Superficial Veins of Lower Extremity\n\n1. Great (greater) saphenous vein (GSV)\nformed by union of veins from medial side of sole of foot with medial dorsal veins; ascends in front of medial malleolus; passes behind medial condyles of tibia + femur\n(a) Posterior arch vein\nconnected to deep venous system by communicating veins\n(b) Anterior superficial tibial vein = Anterior arch vein from lateral malleolus along lateral edge of tibia across tibia to join greater saphenous vein at upper $1 / 3$ of calf",
            "images": [
                {
                    "id": "img-123.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 189,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1166,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 999,
            "markdown": "(c) Posteromedial superficial thigh vein often connects with upper part of lesser saphenous vein\n(d) Anterolateral superficial thigh vein\n(e) Tributaries in fossa ovalis\n> superficial inferior epigastric vein\n> superficial external pudendal vein\n> superficial circumflex iliac vein\n2. Small (lesser) saphenous vein (SSV)\noriginates at outer border of foot behind lateral malleolus as continuation of dorsal venous arch; enters popliteal vein between heads of gastrocnemius in popliteal fossa within 8 cm of knee joint ( $60 \\%$ ) or joins with greater saphenous vein via posteromedial / anterolateral superficial thigh vein $(20 \\%)$\n\n# Communicating $=$ Perforating Veins \n\n$>100$ veins in each leg\nA. MEDIAL\n\n1. Submalleolar communicating vein\n2. Cockett group\ngroup of 3 veins located $7,12,18 \\mathrm{~cm}$ above the tip of medial malleolus connecting posterior arch vein with posterior tibial vein\n3. Boyd vein\nlocated 10 cm below knee joint connecting main trunk of greater saphenous vein to posterior tibial veins\n4. Dodd group\ngroup of 1 or 2 veins passing through Hunter canal (= subsartorial canal) to join greater saphenous vein with superficial femoral vein\nB. LATERAL\n5. Lateral communicating vein\nlocated from just above lateral malleolus to junction of lower-to-mid thirds of calf connecting lesser saphenous vein with peroneal veins",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        }
    ],
    "model": "mistral-ocr-2503-completion",
    "usage_info": {
        "pages_processed": 1000,
        "doc_size_bytes": 11829044
    }
}